PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA
J	Hemminki, A; Tomlinson, I; Markie, D; Jarvinen, H; Sistonen, P; Bjorkqvist, AM; Knuutila, S; Salovaara, R; Bodmer, W; Shibata, D; delaChapelle, A; Aaltonen, LA				Hemminki, A; Tomlinson, I; Markie, D; Jarvinen, H; Sistonen, P; Bjorkqvist, AM; Knuutila, S; Salovaara, R; Bodmer, W; Shibata, D; delaChapelle, A; Aaltonen, LA			Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis	NATURE GENETICS			English	Article							SOLID TUMORS; CANCER	Many human cancer susceptibility genes have been successfully mapped by genetic linkage studies(1). One that has so far eluded researchers is that for Peutz-Jeghers (P-J) syndrome, a condition characterized by intestinal hamartomatous polyposis and melanin spots of the lips, buccal mucosa and digits(2,3). A dramatically elevated risk of malignancy has also been documented(4). Gastrointestinal tumours as well as cancers of the breast, ovary, testis and uterine cervix appear to be overrepresented in families with this syndrome(4,5). The nature of hamartomatous polyps is equivicol. Hamartomas are usually considered histologically benign(6), but in the case of Peutz-Jeghers patients, there are reports of adenomatous and malignant changes in the polyps, and the possibility of a hamartoma-carcinoma sequence has been discussed(5,7,8). A search for a putative tumour suppressor locus was made using comparative genomic hybridization (CGH) of Peutz-Jeghers polyps, combined with loss of heterozygosity (LOH) study. Genetic linkage analysis in 12 families using markers from a deletion site demonstrated the presence of a high-penetrance locus in distal 19p with a multipoint lod score of 7.00 at marker D19S886 without evidence of genetic heterogeneity. The study demonstrates the power of CCH combined with LOH analysis in identifying putative tumour suppressor loci, and provides molecular evidence of malignant potential in hamartomas.	UNIV HELSINKI,DEPT MED GENET,HAARTMAN INST,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,DEPT PATHOL,HAARTMAN INST,FIN-00014 HELSINKI,FINLAND; IMPERIAL CANC RES FUND,CANC GENET LAB,LONDON WC2A 3PX,ENGLAND; DUNEDIN SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND; UNIV HELSINKI,CENT HOSP,DEPT SURG 2,FIN-00290 HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND; UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033				Markie, David/I-7893-2019; Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286; Bodmer, Walter/0000-0001-6244-9792; Markie, David/0000-0001-5452-9194			COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Defago MR, 1996, ENDOSCOPY, V28, P267, DOI 10.1055/s-2007-1005447; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; HIZAWA K, 1993, DIS COLON RECTUM, V36, P953, DOI 10.1007/BF02050632; JEGHERS H, 1949, NEW ENGL J MED, V241, P992; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J, 1991, ANAL HUMAN GENETIC L; Peutz J, 1921, NEDERL MAANDSCHR GEN, V10, P134; PHILLIPS RK, 1994, FAMILIAL ADENOMATOUS; ROSAI J, 1996, ACKERMANS SURGICAL P; SHIBATA D, 1992, AM J PATHOL, V141, P539; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676	15	337	352	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					87	90		10.1038/ng0197-87			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300027	8988175				2022-01-24	
J	MATSUDA, F; SHIN, EK; NAGAOKA, H; MATSUMURA, R; HAINO, M; FUKITA, Y; TAKAISHI, S; IMAI, T; RILEY, JH; ANAND, R; SOEDA, E; HONJO, T				MATSUDA, F; SHIN, EK; NAGAOKA, H; MATSUMURA, R; HAINO, M; FUKITA, Y; TAKAISHI, S; IMAI, T; RILEY, JH; ANAND, R; SOEDA, E; HONJO, T			STRUCTURE AND PHYSICAL MAP OF 64 VARIABLE SEGMENTS IN THE 3(I)0.8-MEGABASE REGION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS	NATURE GENETICS			English	Article							ARTIFICIAL-CHROMOSOME LIBRARIES; HUMAN MONOCLONAL-ANTIBODY; VH GENE SUBGROUPS; GERM-LINE GENES; B-CELL LINES; NUCLEOTIDE-SEQUENCES; PREFERENTIAL UTILIZATION; RHEUMATOID-ARTHRITIS; GEL-ELECTROPHORESIS; DNA AUTOANTIBODIES	We have constructed the physical map of the 0.8 megabase DNA fragment which contains the 3' 64 variable region (V) gene segments of the human immunoglobulin heavy chain (H) locus. The organization of the V(H) locus showed several features that indicate dynamic reshuffling of this locus. The sequenced 64 V(H) segments include 31 pseudogenes, of which 24 are highly conserved except for a few point mutations. Comparison of the 64 germline V(H) sequences shows that each V(H) family has conserved sequences, suggesting that there might be some genetic or selection mechanisms involved in maintenance of each family. The total number of the human V(H) segments was estimated to be about 120, including at least 7 orphons.	KYOTO UNIV,FAC MED,CTR MOLEC BIOL,SAKYO KU,KYOTO 606,JAPAN; KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN; ICI PHARMACEUT PLC,DEPT BIOTECHNOL,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND				Takaishi, Shigeo/AAS-3319-2021; Matsuda, Fumihiko/B-9893-2009; Honjo, Tasuku/N-4470-2016				ADDERSON EE, 1991, J IMMUNOL, V147, P1667; AKAHORI Y, 1990, J CLIN INVEST, V85, P1722, DOI 10.1172/JCI114627; ALEXANDER A, 1988, J CLIN INVEST, V82, P1244, DOI 10.1172/JCI113722; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BERMAN JE, 1988, EMBO J, V7, P723; BRODEUR PH, 1988, J EXP MED, V168, P2261, DOI 10.1084/jem.168.6.2261; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAIRNS E, 1989, J IMMUNOL, V143, P685; CHEN PP, 1990, SCAND J IMMUNOL, V31, P257, DOI 10.1111/j.1365-3083.1990.tb02767.x; CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; DERSIMONIAN H, 1989, J IMMUNOL, V142, P4027; DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496; EBELING SB, 1992, INT IMMUNOL, V4, P313, DOI 10.1093/intimm/4.3.313; FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927; FRIEDMAN DF, 1991, J EXP MED, V174, P525, DOI 10.1084/jem.174.3.525; GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARINDRANATH N, 1991, INT IMMUNOL, V3, P865, DOI 10.1093/intimm/3.9.865; HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.bi.54.070185.004103; HUGHESJONES NC, 1990, BIOCHEM J, V268, P135, DOI 10.1042/bj2680135; HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; Kabat E. A., 1991, SEQUENCES PROTEINS I; KISHIMOTO T, 1989, NUCLEIC ACIDS RES, V17, P4385, DOI 10.1093/nar/17.11.4385; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7; LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667; MATSUDA F, 1990, EMBO J, V9, P2501, DOI 10.1002/j.1460-2075.1990.tb07429.x; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATTHYSSENS G, 1980, P NATL ACAD SCI-BIOL, V77, P6561, DOI 10.1073/pnas.77.11.6561; MILLI M, 1991, MOL IMMUNOL, V28, P753; MORTARI F, 1992, EUR J IMMUNOL, V22, P241, DOI 10.1002/eji.1830220135; NICKERSON KG, 1989, J EXP MED, V169, P1391, DOI 10.1084/jem.169.4.1391; NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833; PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841; RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405; RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SANZ I, 1989, J IMMUNOL, V142, P4054; SANZ I, 1989, J IMMUNOL, V142, P883; SANZ I, 1989, EMBO J, V8, P3471; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; SILVERSTEIN LE, 1989, J EXP MED, V169, P1631; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YANG PH, 1990, P NATL ACAD SCI USA, V88, P7907	54	337	339	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					88	94		10.1038/ng0193-88			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	WOS:A1993KF37200019	8490662				2022-01-24	
J	KARTNER, N; AUGUSTINAS, O; JENSEN, TJ; NAISMITH, AL; RIORDAN, JR				KARTNER, N; AUGUSTINAS, O; JENSEN, TJ; NAISMITH, AL; RIORDAN, JR			MISLOCALIZATION OF DELTA-F508 CFTR IN CYSTIC-FIBROSIS SWEAT GLAND	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE; IDENTIFICATION; LOCALIZATION; EXPRESSION; ANTIBODIES; MUTATIONS; CHLORIDE; TRANSPORT; PANCREAS	Misprocessing and mislocalization of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) has been described for the major CF-causing mutation (DELTA-F508) in heterologous expression systems in vitro. We have generated monoclonal antibodies (mAbs) to CFTR with the aim of localizing the protein and its CF variants in vivo. Of the tissues where CFTR was observed, only the sweat gland is readily available and does not undergo secondary changes due to CF disease pathology. Sweat ducts from CF patients homozygous for DELTA-F508 did not show the typical apical membrane staining seen in control biopsies. This demonstrates that the biosynthetic arrest and intracellular retention of DELTA-F508 CFTR initially observed in vitro does occur in vivo and emphasizes the need to focus efforts on understanding the mislocalization.	HOSP SICK CHILDREN,CYST FIBROSIS RES DEV PROGRAM,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A8,ONTARIO,CANADA		KARTNER, N (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.						ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BARON DA, 1984, LAB INVEST, V51, P233; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1992, FASEB J, V6, pA127; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; BLOMFIEL.J, 1973, GUT, V14, P558, DOI 10.1136/gut.14.7.558; BLOMFIELD J, 1973, ARCH DIS CHILD, V48, P267, DOI 10.1136/adc.48.4.267; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DISANTAGNESE PA, 1958, PEDIATRICS, V22, P507; DONOWITZ M, 1986, ANNU REV PHYSIOL, V48, P135, DOI 10.1146/annurev.ph.48.030186.001031; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; FORSTNER GG, 1987, GENETICS EPITHELIAL; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; JOHNSTON WH, 1956, ARCH DIS CHILD, V31, P477, DOI 10.1136/adc.31.160.477; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOPELMAN H, 1989, CLIN INVEST MED, V12, P207; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; MCGRADY K, 1955, AMA AM J DIS CHILD, V90, P610; MUNGER BL, 1961, J PEDIATR-US, V59, P497, DOI 10.1016/S0022-3476(61)80233-3; REDDY MM, 1989, AM J PHYSIOL, V257, pC727, DOI 10.1152/ajpcell.1989.257.4.C727; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SARKADI B, 1992, J BIOL CHEM, V267, P2087; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0	38	337	340	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					321	327		10.1038/ng0892-321			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	WOS:A1992JJ12100007	1284548				2022-01-24	
J	SERIKAWA, T; KURAMOTO, T; HILBERT, P; MORI, M; YAMADA, J; DUBAY, CJ; LINDPAINTER, K; GANTEN, D; GUENET, JL; LATHROP, GM; BECKMANN, JS				SERIKAWA, T; KURAMOTO, T; HILBERT, P; MORI, M; YAMADA, J; DUBAY, CJ; LINDPAINTER, K; GANTEN, D; GUENET, JL; LATHROP, GM; BECKMANN, JS			RAT GENE-MAPPING USING PCR-ANALYZED MICROSATELLITES	GENETICS			English	Article							SOMATIC-CELL HYBRIDIZATION; INSITU HYBRIDIZATION; CHROMOSOMAL LOCALIZATION; INVITRO AMPLIFICATION; BINDING-PROTEIN; INBRED STRAINS; HUMAN GENOME; LINKAGE; NORVEGICUS; ASSIGNMENT	One hundred and seventy-four rat loci which contain short tandem repeat sequences were extracted from the GenBank or EMBL data bases and used to define primers for amplification by the polymerase chain reaction (PCR) of the microsatellite regions, creating PCR-formatted sequence-tagged microsatellite sites (STMSs). One hundred and thirty-four STMSs for 118 loci, including 6 randomly cloned STMSs, were characterized: (i) PCR-analyzed loci were assigned to specific chromosomes using a panel of rat x mouse somatic cell hybrid clones. (ii) Length variation of the STMSs among 8 inbred rat strains could be visualized at 85 of 107 loci examined (79.4%). (iii) A genetic map, integrating biochemical, coat color, mutant and restriction fragment length polymorphism loci, was constructed based on the segregation of 125 polymorphic markers in seven rat backcrosses and in two F2 crosses. Twenty four linkage groups were identified, all of which were assigned to a defined chromosome. As a reflection of the bias for coding sequences in the public data bases, the STMSs described herein are often associated with genes. Hence, the genetic map we report coincides with a gene map. The corresponding map locations of the homologous mouse and human genes are also listed for comparative mapping purposes.	CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; UNIV HEIDELBERG,DEPT PHARMACOL,W-6900 HEIDELBERG,GERMANY; UNIV HEIDELBERG,GERMAN INST HIGH BLOOD PRESSURE,W-6900 HEIDELBERG,GERMANY; INST PASTEUR,F-75724 PARIS 15,FRANCE; INST RECH INTERDISCIPLINAIRE BIOL HUM,B-1070 BRUSSELS,BELGIUM		SERIKAWA, T (corresponding author), KYOTO UNIV,FAC MED,INST LAB ANIM,KYOTO 606,JAPAN.		Beckmann, Jacques S/A-9772-2008	Beckmann, Jacques S/0000-0002-9741-1900			ADAMS M, 1984, BIOCHEM GENET, V22, P611, DOI 10.1007/BF00485848; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BENDER K, 1981, ANIM BLOOD GROUPS BI, V12, P31; BRDICKA R, 1968, ACTA U CAROL MED, V14, P93; CARTER ND, 1969, NATURE, V224, P1214, DOI 10.1038/2241214a0; COLLARD JG, 1982, CYTOGENET CELL GENET, V32, P257; COOKE NE, 1986, ENDOCRINOLOGY, V119, P2451, DOI 10.1210/endo-119-6-2451; CRAMER DV, 1986, BIOCHEM GENET, V24, P217, DOI 10.1007/BF00502790; CRAMER DV, 1985, BIOCHEM GENET, V23, P623, DOI 10.1007/BF02399399; CRAMER DV, 1981, IMMUNOGENETICS, V13, P555, DOI 10.1007/BF00343723; DENDUNNEN JT, 1987, EXP EYE RES, V45, P747, DOI 10.1016/S0014-4835(87)80122-7; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONNER ME, 1985, BIOCHEM GENET, V23, P787, DOI 10.1007/BF02399409; ERIKSSON K, 1976, HEREDITY, V37, P341, DOI 10.1038/hdy.1976.98; FRENCH EA, 1971, BIOCHEM GENET, V5, P397, DOI 10.1007/BF00485864; FULCHIGNONILATAUD MC, 1990, CYTOGENET CELL GENET, V53, P172, DOI 10.1159/000132922; GAL A, 1984, MOL GEN GENET, V195, P153, DOI 10.1007/BF00332738; GASSER DL, 1972, BIOCHEM GENET, V6, P61, DOI 10.1007/BF00485966; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; GOLDNERSAUVE A, 1991, BIOCHEM GENET, V29, P275, DOI 10.1007/BF00590108; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; HAMADA S, 1987, EXP ANIM TOKYO, V36, P267, DOI 10.1538/expanim1978.36.3_267; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HEDRICH HJ, 1990, GENETIC MONITORING I; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HILLIKER CE, 1991, GENOMICS, V10, P867, DOI 10.1016/0888-7543(91)90174-D; HILLYARD AL, 1991, MOUSE GENOME, V89, P16; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KANO Y, 1976, CHROMOSOMA, V55, P37, DOI 10.1007/BF00288325; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, GENOMICS, V2, P157; LEVAN G, 1991, GENOMICS, V10, P699, DOI 10.1016/0888-7543(91)90455-N; LITT M, 1989, AM J HUM GENET, V44, P397; LOBEL SA, 1981, IMMUNOGENETICS, V13, P465, DOI 10.1007/BF00343714; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; LYON MF, 1991, MOUSE GENOME, V89, P37; MARINO MW, 1986, CYTOGENET CELL GENET, V42, P36, DOI 10.1159/000132248; MCALPINE PJ, 1991, CYTOGENET CELL GENET, V58, P5, DOI 10.1159/000133160; MIZUNO M, 1978, JPN J GENET, V53, P137, DOI 10.1266/jjg.53.137; MONTAGUTELLI X, 1990, J HERED, V81, P490, DOI 10.1093/oxfordjournals.jhered.a111033; MONTAGUTELLI X, 1991, MAMM GENOME, V1, P255, DOI 10.1007/BF00352333; MORI M, 1989, CYTOGENET CELL GENET, V50, P42, DOI 10.1159/000132716; MORI M, 1992, CYTOGENET CELL GENET, V59, P31, DOI 10.1159/000133194; MORI M, 1992, IN PRESS CYTOGENET C; MORI M, 1992, IN PRESS GENOMICS; MOUTIER R, 1973, BIOCHEM GENET, V10, P395, DOI 10.1007/BF00485992; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; PALM J, 1971, TRANSPLANTATION, V11, P175, DOI 10.1097/00007890-197102000-00011; PEAR W, 1986, IMMUNOGENETICS, V23, P293; PRAVENEC M, 1987, J IMMUNOGENET, V14, P313; PRAVENEC M, 1991, GENOMICS, V9, P466, DOI 10.1016/0888-7543(91)90412-8; RAMPERSAUD A, 1987, J BIOL CHEM, V262, P5649; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SCHRODER J, 1980, IMMUNOGENETICS, V10, P125, DOI 10.1007/BF01561561; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; STOLC V, 1990, RAT NEWS, V23, P25; SUGIYAMA K, 1984, JPN J GENET, V59, P577, DOI 10.1266/jjg.59.577; SUMEGI J, 1983, NATURE, V306, P497, DOI 10.1038/306497a0; SZPIRER C, 1991, CYTOGENET CELL GENET, V56, P193, DOI 10.1159/000133086; SZPIRER C, 1989, CYTOGENET CELL GENET, V50, P23, DOI 10.1159/000132712; SZPIRER C, 1990, GENOMICS, V6, P679, DOI 10.1016/0888-7543(90)90504-N; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; SZPIRER J, 1991, GENOMICS, V10, P539, DOI 10.1016/0888-7543(91)90433-F; TAKAHASHI R, 1986, P NATL ACAD SCI USA, V83, P1079, DOI 10.1073/pnas.83.4.1079; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; VANZUTPHEN LFM, 1985, BIOCHEM GENET, V23, P599, DOI 10.1007/BF00504294; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WIENER F, 1982, INT J CANCER, V29, P413; WILLIAMSON RW, 1992, CYTOGENET CELL GENET, V58, P1190; WOMACK JE, 1973, BIOCHEM GENET, V9, P13, DOI 10.1007/BF00485587; WOMACK JE, 1980, BIOCHEM GENET, V18, P1019, DOI 10.1007/BF00500132; YAMADA J, 1980, BIOCHEM GENET, V18, P433, DOI 10.1007/BF00484392; YAMADA T, 1989, J HERED, V80, P383, DOI 10.1093/oxfordjournals.jhered.a110879; YASUE M, 1991, CYTOGENET CELL GENET, V57, P142, DOI 10.1159/000133133; YASUE M, 1992, GENOMICS, V12, P659, DOI 10.1016/0888-7543(92)90290-9; YOSHIDA MC, 1978, CYTOGENET CELL GENET, V22, P606, DOI 10.1159/000131034; YOSHIDA MC, 1982, CYTOGENET CELL GENET, V32, P330; ZHANG J, 1988, CYTOGENET CELL GENET, V48, P121, DOI 10.1159/000132604	81	337	344	0	5	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUL	1992	131	3					701	721					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HZ815	WOS:A1992HZ81500017	1628813				2022-01-24	
J	Speed, D; Hemani, G; Johnson, MR; Balding, DJ				Speed, Doug; Hemani, Gibran; Johnson, Michael R.; Balding, David J.			Improved Heritability Estimation from Genome-wide SNPs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-STRUCTURE; ASSOCIATION; ARCHITECTURE; SUSCEPTIBILITY; PROPORTION	Estimation of narrow-sense heritability, h(2), from genome-wide SNPs genotyped in unrelated individuals has recently attracted interest and offers several advantages over traditional pedigree-based methods. With the use of this approach, it has been estimated that over half the heritability of human height can be attributed to the similar to 300,000 SNPs on a genome-wide genotyping array. In comparison, only 5%-10% can be explained by SNPs reaching genome-wide significance. We investigated via simulation the validity of several key assumptions underpinning the mixed-model analysis used in SNP-based h(2) estimation. Although we found that the method is reasonably robust to violations of four key assumptions, it can be highly sensitive to uneven linkage disequilibrium (LD) between SNPs: contributions to h(2) are overestimated from causal variants in regions of high LD and are underestimated in regions of low LD. The overall direction of the bias can be up or down depending on the genetic architecture of the trait, but it can be substantial in realistic scenarios. We propose a modified kinship matrix in which SNPs are weighted according to local LD. We show that this correction greatly reduces the bias and increases the precision of h(2) estimates. We demonstrate the impact of our method on the first seven diseases studied by the Wellcome Trust Case Control Consortium. Our LD adjustment revises downward the h(2) estimate for immune-related diseases, as expected because of high LD in the major-histocompatibility region, but increases it for some nonimmune diseases. To calculate our revised kinship matrix, we developed LDAK, software for computing LD-adjusted kinships.	[Speed, Doug; Balding, David J.] UCL, Univ Coll London Genet Inst, London WC1E 6BT, England; [Hemani, Gibran] Univ Queensland, Diamantina Inst, Brisbane, Qld 4102, Australia; [Johnson, Michael R.] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London W6 8RF, England		Speed, D (corresponding author), UCL, Univ Coll London Genet Inst, Mortimer St, London WC1E 6BT, England.	doug.speed@ucl.ac.uk	Speed, Doug/AAM-1032-2021; Balding, David/G-9898-2011	Balding, David/0000-0002-1480-6115; Hemani, Gibran/0000-0003-0920-1055; Speed, Doug/0000-0002-0096-9765	UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0901388]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0901388] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0901388] Funding Source: UKRI	We thank Will Astle and Vincent Plagnol for fruitful discussions, as well as the two anonymous reviewers for helpful comments. Access to Wellcome Trust data was authorized as work related to the project "Genome-wide association study of susceptibility and clinical phenotypes in epilepsy." This work is funded by the UK Medical Research Council under grant G0901388.	Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Browning SR, 2011, AM J HUM GENET, V89, P191, DOI 10.1016/j.ajhg.2011.05.025; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; DEMPSTER ER, 1950, GENETICS, V35, P212; HARTLEY HO, 1967, BIOMETRIKA, V54, P93, DOI 10.1093/biomet/54.1-2.93; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson, 1991, STAT SCI, V6, P15, DOI 10.1214/ss/1177011933.; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706	25	336	337	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1011	1021		10.1016/j.ajhg.2012.10.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	WOS:000312417400004	23217325	Green Published, hybrid			2022-01-24	
J	Hon, GC; Hawkins, RD; Caballero, OL; Lo, C; Lister, R; Pelizzola, M; Valsesia, A; Ye, Z; Kuan, S; Edsall, LE; Camargo, AA; Stevenson, BJ; Ecker, JR; Bafna, V; Strausberg, RL; Simpson, AJ; Ren, B				Hon, Gary C.; Hawkins, R. David; Caballero, Otavia L.; Lo, Christine; Lister, Ryan; Pelizzola, Mattia; Valsesia, Armand; Ye, Zhen; Kuan, Samantha; Edsall, Lee E.; Camargo, Anamaria Aranha; Stevenson, Brian J.; Ecker, Joseph R.; Bafna, Vineet; Strausberg, Robert L.; Simpson, Andrew J.; Ren, Bing			Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer	GENOME RESEARCH			English	Article							NUCLEAR LAMINA INTERACTIONS; BODY-SPECIFIC METHYLATION; COLORECTAL CANCERS; PROMOTER HYPERMETHYLATION; SOMATIC MUTATIONS; SATELLITE REPEATS; EPITHELIAL-CELLS; RENAL-CARCINOMA; COMMON EVENT; HUMAN GENOME	While genetic mutation is a hallmark of cancer, many cancers also acquire epigenetic alterations during tumorigenesis including aberrant DNA hypermethylation of tumor suppressors, as well as changes in chromatin modifications as caused by genetic mutations of the chromatin-modifying machinery. However, the extent of epigenetic alterations in cancer cells has not been fully characterized. Here, we describe complete methylome maps at single nucleotide resolution of a low-passage breast cancer cell line and primary human mammary epithelial cells. We find widespread DNA hypomethylation in the cancer cell, primarily at partially methylated domains (PMDs) in normal breast cells. Unexpectedly, genes within these regions are largely silenced in cancer cells. The loss of DNA methylation in these regions is accompanied by formation of repressive chromatin, with a significant fraction displaying allelic DNA methylation where one allele is DNA methylated while the other allele is occupied by histone modifications H3K9me3 or H3K27me3. Our results show a mutually exclusive relationship between DNA methylation and H3K9me3 or H3K27me3. These results suggest that global DNA hypomethylation in breast cancer is tightly linked to the formation of repressive chromatin domains and gene silencing, thus identifying a potential epigenetic pathway for gene regulation in cancer cells.	[Hon, Gary C.; Hawkins, R. David; Ye, Zhen; Kuan, Samantha; Edsall, Lee E.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Caballero, Otavia L.; Strausberg, Robert L.; Simpson, Andrew J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ludwig Collaborat Lab Canc Biol & Therapy, Baltimore, MD 21231 USA; [Lo, Christine; Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci, La Jolla, CA 92093 USA; [Lister, Ryan; Pelizzola, Mattia; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, Genom Anal Lab, La Jolla, CA 92037 USA; [Valsesia, Armand; Stevenson, Brian J.] Univ Lausanne, Ludwig Inst Canc Res, Swiss Inst Bioinformat, CH-1011 Lausanne, Switzerland; [Camargo, Anamaria Aranha] Ludwig Inst Canc Res, BR-01323903 Sao Paulo, Brazil; [Strausberg, Robert L.; Simpson, Andrew J.] Ludwig Inst Canc Res Ltd, New York, NY 10017 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA		Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	biren@ucsd.edu	Valsesia, Armand/F-1724-2010; Camargo, Anamaria A/E-9388-2012; Lister, Ryan/B-5168-2012; Bafna, Vineet/AAY-8111-2020; Ecker, Joseph R/B-9144-2008	Camargo, Anamaria A/0000-0002-6076-9597; Lister, Ryan/0000-0001-6637-7239; Bafna, Vineet/0000-0002-5810-6241; Ecker, Joseph R/0000-0001-5799-5895; Valsesia, Armand/0000-0003-0746-9664; Pelizzola, Mattia/0000-0001-6672-9636; Edsall, Lee Elizabeth/0000-0002-0326-2829	Ludwig Institute for Cancer Research; Mary K. Chapman Foundation; Howard Hughes Medical InstituteHoward Hughes Medical Institute; Gordon and Betty Moore foundationGordon and Betty Moore Foundation; NSFNational Science Foundation (NSF) [NSF-CCF-1115206]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5RO1-HG004962]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004962] Funding Source: NIH RePORTER	This work was supported by the Ludwig Institute for Cancer Research and the Mary K. Chapman Foundation (J.R.E.). Work in the laboratory of J.R.E. is supported by the Howard Hughes Medical Institute and the Gordon and Betty Moore foundation. J.R.E. is a HHMI-GBMF Investigator. C.L. and V.B. were supported by an NSF fellowship, and grants 5RO1-HG004962 (NIH), and NSF-CCF-1115206 to V.B.	Alvarez-Diaz S, 2009, J CLIN INVEST, V119, P2343, DOI 10.1172/JCI37205; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding Y, 2006, MOL CELL BIOL, V26, P1979, DOI 10.1128/MCB.26.5.1979-1996.2006; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hibi K, 2009, ANTICANCER RES, V29, P5053; Hibi K, 2009, HEPATO-GASTROENTEROL, V56, P1642; Hinshelwood RA, 2008, J MOL MED, V86, P1315, DOI 10.1007/s00109-008-0386-3; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; HOLLIDAY R, 1979, BRIT J CANCER, V40, P513, DOI 10.1038/bjc.1979.216; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; JONES PA, 1983, RECENT RES CANCER, V84, P202; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lakshmikuttyamma A, 2010, ONCOGENE, V29, P576, DOI 10.1038/onc.2009.361; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullins M, 2007, CLIN CHEM, V53, P1273, DOI 10.1373/clinchem.2006.083725; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Prak ETL, 2000, NAT REV GENET, V1, P134; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schulz WA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83672; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Tapia T, 2008, EPIGENETICS-US, V3, P157, DOI 10.4161/epi.3.3.6387; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Wild L, 2010, BBA-REV CANCER, V1806, P50, DOI 10.1016/j.bbcan.2010.03.003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yuan BZ, 1998, CANCER RES, V58, P2196	103	336	341	0	43	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	FEB	2012	22	2					246	258		10.1101/gr.125872.111			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	883BA	WOS:000299606400008	22156296	Green Published, Bronze			2022-01-24	
J	Gronau, I; Hubisz, MJ; Gulko, B; Danko, CG; Siepel, A				Gronau, Ilan; Hubisz, Melissa J.; Gulko, Brad; Danko, Charles G.; Siepel, Adam			Bayesian inference of ancient human demography from individual genome sequences	NATURE GENETICS			English	Article							ANCESTRAL POPULATION SIZES; DIVERGENCE TIMES; HISTORY; DNA; MITOCHONDRIAL; MODELS; RATES	Whole-genome sequences provide a rich source of information about human evolution. Here we describe an effort to estimate key evolutionary parameters based on the whole-genome sequences of six individuals from diverse human populations. We used a Bayesian, coalescent-based approach to obtain information about ancestral population sizes, divergence times and migration rates from inferred genealogies at many neutrally evolving loci across the genome. We introduce new methods for accommodating gene flow between populations and integrating over possible phasings of diploid genotypes. We also describe a custom pipeline for genotype inference to mitigate biases from heterogeneous sequencing technologies and coverage levels. Our analysis indicates that the San population of southern Africa diverged from other human populations approximately 108-157 thousand years ago, that Eurasians diverged from an ancestral African population 38-64 thousand years ago, and that the effective population size of the ancestors of all modern humans was similar to 9,000.	[Gronau, Ilan; Hubisz, Melissa J.; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA		Siepel, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	acs4@cornell.edu		Hubisz, Melissa/0000-0002-9561-6830; Siepel, Adam/0000-0002-3557-7219; Danko, Charles/0000-0002-1999-7125	Packard FellowshipThe David & Lucile Packard Foundation; National Science FoundationNational Science Foundation (NSF) [DBI-0644111]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD052471] Funding Source: NIH RePORTER	This research was supported by a Packard Fellowship (to A. S.), National Science Foundation grant DBI-0644111 and National Institutes of Health training grant T32HD052471 (to C. G. D.). We thank S. Schuster, W. Miller, D. Reich, G. Coop, J. Hey, J. Wall, R. S. Wells, A. Keinan, A. G. Clark, S. C. Choi, C. D. Bustamante, B. Henn and others for helpful discussions and feedback.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beaumont MA, 2002, GENETICS, V162, P2025; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burgess R, 2008, MOL BIOL EVOL, V25, P1979, DOI 10.1093/molbev/msn148; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewontin R., 1972, EVOLUTIONARY BIOL, V6; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nielsen R, 2001, GENETICS, V158, P885; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Paul JS, 2011, GENETICS, V187, P1115, DOI 10.1534/genetics.110.125534; Rannala B, 2003, GENETICS, V164, P1645; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	35	336	341	2	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2011	43	10					1031	U151		10.1038/ng.937			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	WOS:000295316200022	21926973	Green Accepted			2022-01-24	
J	Tregouet, DA; Konig, IR; Erdmann, J; Munteanu, A; Braund, PS; Hall, AS; Grosshennig, A; Linsel-Nitschke, P; Perret, C; DeSuremain, M; Meitinger, T; Wright, BJ; Preuss, M; Balmforth, AJ; Ball, SG; Meisinger, C; Germain, C; Evans, A; Arveiler, D; Luc, G; Ruidavets, JB; Morrison, C; van der Harst, P; Schreiber, S; Neureuther, K; Schafer, A; Bugert, P; El Mokhtari, NE; Schrezenmeir, J; Stark, K; Rubin, D; Wichmann, HE; Hengstenberg, C; Ouwehand, W; Ziegler, A; Tiret, L; Thompson, JR; Cambien, F; Schunkert, H; Samani, NJ				Tregouet, David-Alexandre; Koenig, Inke R.; Erdmann, Jeanette; Munteanu, Alexandru; Braund, Peter S.; Hall, Alistair S.; Grosshennig, Anika; Linsel-Nitschke, Patrick; Perret, Claire; DeSuremain, Maylis; Meitinger, Thomas; Wright, Ben J.; Preuss, Michael; Balmforth, Anthony J.; Ball, Stephen G.; Meisinger, Christa; Germain, Cecile; Evans, Alun; Arveiler, Dominique; Luc, Gerald; Ruidavets, Jean-Bernard; Morrison, Caroline; van der Harst, Pim; Schreiber, Stefan; Neureuther, Katharina; Schaefer, Arne; Bugert, Peter; El Mokhtari, Nour E.; Schrezenmeir, Juergen; Stark, Klaus; Rubin, Diana; Wichmann, H-Erich; Hengstenberg, Christian; Ouwehand, Willem; Ziegler, Andreas; Tiret, Laurence; Thompson, John R.; Cambien, Francois; Schunkert, Heribert; Samani, Nilesh J.		Wellcome Trust Case Control Consor; Cardiogenics Consortium	Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease	NATURE GENETICS			English	Article							APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN(A) LEVELS; HEART-DISEASE; POLYMORPHISMS; ECTIM	We identify the SLC22A3-LPAL2-LPA gene cluster as a strong susceptibility locus for coronary artery disease (CAD) through a genome-wide haplotype association (GWHA) study. This locus was not identified from previous genome-wide association (GWA) studies focused on univariate analyses of SNPs. The proposed approach may have wide utility for analyzing GWA data for other complex traits.	[Tregouet, David-Alexandre; Munteanu, Alexandru; Perret, Claire; DeSuremain, Maylis; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMR S 525, F-75013 Paris, France; [Koenig, Inke R.; Grosshennig, Anika; Preuss, Michael; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Erdmann, Jeanette; Grosshennig, Anika; Linsel-Nitschke, Patrick; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Braund, Peter S.; van der Harst, Pim; Samani, Nilesh J.] Univ Leicester, Clin Sci Wing, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Alistair S.; Balmforth, Anthony J.; Ball, Stephen G.] Univ Leeds, LIGHT, Leeds LS1 3EX, W Yorkshire, England; [Meitinger, Thomas; Meisinger, Christa; Wichmann, H-Erich] Deutsch Forschungszentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Wright, Ben J.; Thompson, John R.] Univ Leicester, Dept Hlth Sci & Genet, Leicester LE1 7RH, Leics, England; [Germain, Cecile] Univ Paris 11, CNRS, UMR S 8623, Rech Informat Lab, F-91403 Orsay, France; [Evans, Alun] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Arveiler, Dominique] Multinat MONItoring Trends & Determinants CArdiov, Fac Med, Lab Epidemiol & Sante Publ EA1801, F-67085 Strasbourg, France; [Luc, Gerald] Univ Lille 2, Pasteur Inst Lille, INSERM, U545, F-59019 Lille, France; [Ruidavets, Jean-Bernard] MONICA Toulouse, Fac Med, INSERM, U518, F-31073 Toulouse, France; [Morrison, Caroline] Glasgow Royal Infirm, MONICA Project, Glasgow G4 0SF, Lanark, Scotland; [Schreiber, Stefan; Schaefer, Arne; El Mokhtari, Nour E.] Univ Kiel, Inst Klin Mol Biol, D-24105 Kiel, Germany; [Neureuther, Katharina; Stark, Klaus; Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany; [Bugert, Peter] Univ Heidelberg, Med Fac Mannheim, Inst Transfus Med & Immunol, Mol Biol Lab, D-69117 Heidelberg, Germany; [Schrezenmeir, Juergen; Rubin, Diana] Inst Physiol & Biochem Ernahrung, Bundesforsch Sanstalt Ernahrung & Lebensmittel, D-24121 Kiel, Germany; [Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England		Tregouet, DA (corresponding author), Univ Paris 06, INSERM, UMR S 525, F-75013 Paris, France.	david.tregouet@upmc.fr	Erdmann, Jeanette/A-4417-2009; Meitinger, Thomas/O-1318-2015; Hall, Alistair/K-1953-2019; Stark, Klaus/L-7367-2013; Tregouet, David-Alexandre/E-3961-2016; Konig, Inke R/A-4544-2009; Meisinger, Christine/B-5358-2014; Cambien, Francois/AAP-9751-2020; Hengstenberg, Christian/U-5485-2019; Tregouet, David-Alexandre/P-9210-2019; Stark, Klaus/D-3813-2009; Erdmann, Jeanette/P-7513-2014; Wichmann, Heinz Erich/AAA-5695-2022; Ziegler, Andreas/G-4246-2012	Stark, Klaus/0000-0002-7832-1942; Konig, Inke R/0000-0003-0504-6465; Tregouet, David-Alexandre/0000-0001-9084-7800; Stark, Klaus/0000-0002-7832-1942; Erdmann, Jeanette/0000-0002-4486-6231; Preuss, Michael/0000-0001-5266-8465; Hall, Alistair/0000-0003-0306-7887; Ziegler, Andreas/0000-0002-8386-5397; Meisinger, Christa/0000-0002-9026-6544; Meitinger, Thomas/0000-0002-8838-8403	Wellcome TrustWellcome TrustEuropean Commission; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); German National Genome Research Network; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF); State of Bavaria; European UnionEuropean Commission [INFSO-RI-031688]; BHFBritish Heart Foundation; CardiogenicsEuropean Commission [LSHM-CT-2006-037593]; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: UKRI; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007438/1] Funding Source: researchfish	The WTCCC Study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. We also acknowledge support of the Wellcome Trust Functional Genomics Initiative in Cardiovascular Genetics. The German Study was supported by the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and of the State of Bavaria. This work has also been partially supported by the EGEEII project funded by the European Union INFSO-RI-031688. N. J. S. is supported by a Chair funded by the BHF. The main sponsor of the current analysis is the EU funded integrated project 'Cardiogenics' (LSHM-CT-2006-037593).	BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Gagliardi F, 2005, PHILOS T R SOC A, V363, P1729, DOI 10.1098/rsta.2005.1603; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Li Y, 2006, AM J HUM GENET S, VS79, P2290; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	13	336	344	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2009	41	3					283	285		10.1038/ng.314			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	WOS:000263640200007	19198611	Green Published			2022-01-24	
J	Novembre, J; Stephens, M				Novembre, John; Stephens, Matthew			Interpreting principal component analyses of spatial population genetic variation	NATURE GENETICS			English	Article							SYNTHETIC MAPS; DEMIC EXPANSIONS; ASSOCIATION; STRATIFICATION; EUROPE; ORIGIN	Nearly 30 years ago, Cavalli-Sforza et al. pioneered the use of principal component analysis (PCA) in population genetics and used PCA to produce maps summarizing human genetic variation across continental regions(1). They interpreted gradient and wave patterns in these maps as signatures of specific migration events(1-3). These interpretations have been controversial(4-7), but influential(8), and the use of PCA has become widespread in analysis of population genetics data(9-13). However, the behavior of PCA for genetic data showing continuous spatial variation, such as might exist within human continental groups, has been less well characterized. Here, we find that gradients and waves observed in Cavalli-Sforza et al.'s maps resemble sinusoidal mathematical artifacts that arise generally when PCA is applied to spatial data, implying that the patterns do not necessarily reflect specific migration events. Our findings aid interpretation of PCA results and suggest how PCA can help correct for continuous population structure in association studies.	[Novembre, John; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA		Stephens, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 5th Floor, Chicago, IL 60637 USA.	stephens@galton.uchicago.edu	Novembre, John/G-1339-2011		NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG002585, R01 HG02585-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002585] Funding Source: NIH RePORTER		AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Brillinger D.R., 1975, TIME SERIES DATA ANA; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DIACONIS P, IN PRESS ANN APPL ST; FREIBERGER WF, 1960, INT DICT APPL MATH; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Heidemann G, 2006, IEEE T PATTERN ANAL, V28, P822, DOI 10.1109/TPAMI.2006.107; INWIN DE, 2005, SCIENCE, V307, P414; Jobling M.A, 2004, HUMAN EVOLUTIONARY G; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Podani J, 2002, ECOLOGY, V83, P3331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Rendine S, 1999, HUM BIOL, V71, P15; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sokal RR, 1999, HUM BIOL, V71, P1; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	30	336	338	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					646	649		10.1038/ng.139			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	WOS:000255366700034	18425127	Green Accepted			2022-01-24	
J	Nakatani, Y; Takeda, H; Kohara, Y; Morishita, S				Nakatani, Yoichiro; Takeda, Hiroyuki; Kohara, Yuji; Morishita, Shinichi			Reconstruction of the vertebrate ancestral genome reveals dynamic genome reorganization in early vertebrates	GENOME RESEARCH			English	Article							CIONA-INTESTINALIS; DRAFT GENOME; GENE MAP; DUPLICATION; EVOLUTION; INSIGHTS; CHORDATE; ORIGINS; AGE	Although several vertebrate genomes have been sequenced, little is known about the genome evolution of early vertebrates and how large-scale genomic changes such as the two rounds of whole-genome duplications (2R WGD) affected evolutionary complexity and novelty in vertebrates. Reconstructing the ancestral vertebrate genome is highly nontrivial because of the difficulty in identifying traces originating from the 2R WGD. To resolve this problem, we developed a novel method capable of pinning down remains of the 2R WGD in the human and medaka fish genomes using invertebrate tunicate and sea urchin genes to define ohnologs, i.e., paralogs produced by the 2R WGD. We validated the reconstruction using the chicken genome, which was not considered in the reconstruction step, and observed that many ancestral proto-chromosomes were retained in the chicken genome and had one-to-one correspondence to chicken microchromosomes, thereby confirming the reconstructed ancestral genomes. Our reconstruction revealed a contrast between the slow karyotype evolution after the second WGD and the rapid, lineage-specific genome reorganizations that occurred in the ancestral lineages of major taxonomic groups such as teleost fishes, amphibians, reptiles, and marsupials.	Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2770882, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Natl Inst Genet, Ctr Genet Resource Informat, Mishima, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, BIRD, Tokyo 1028666, Japan		Nakatani, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2770882, Japan.	nakatani@cb.k.u-tokyo.ac.jp; moris@cb.k.u-tokyo.ac.jp	TAKEDA, HIROYUKI/G-4950-2014				Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Burt DW, 2002, CYTOGENET GENOME RES, V96, P97, DOI 10.1159/000063018; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Durand D, 2003, TRENDS GENET, V19, P2, DOI 10.1016/S0168-9525(02)00008-2; El-Marbrouk N, 2003, SIAM J COMPUT, V32, P754, DOI 10.1137/S0097539700377177; Friedman R, 2001, GENOME RES, V11, P1842, DOI 10.1101/gr.200601; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; Gibson TJ, 2000, BIOCHEM SOC T, V28, P259, DOI 10.1042/bst0280259; Green D.M., 1991, AMPHIBIAN CYTOGENETI; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; HOLLAND PWH, 1994, DEVELOPMENT, P125; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kohn M, 2006, TRENDS GENET, V22, P203, DOI 10.1016/j.tig.2006.02.008; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Ohno S., 1970, P1; Olmo E, 2005, GENETICA, V125, P185, DOI 10.1007/s10709-005-8008-2; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Seoighe C, 2003, CURR OPIN GENET DEV, V13, P636, DOI 10.1016/j.gde.2003.10.005; Shoguchi E, 2006, GENOME RES, V16, P297, DOI 10.1101/gr.4156606; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305	35	336	347	4	30	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2007	17	9					1254	1265		10.1101/gr.6316407			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	207FL	WOS:000249236900002	17652425	Green Published, Bronze			2022-01-24	
J	Kwon, CH; Zhu, XY; Zhang, JY; Knoop, LL; Tharp, R; Smeyne, RJ; Eberhart, CG; Burger, PC; Baker, SJ				Kwon, CH; Zhu, XY; Zhang, JY; Knoop, LL; Tharp, R; Smeyne, RJ; Eberhart, CG; Burger, PC; Baker, SJ			Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; PROSTATE-CANCER; COWDEN-SYNDROME; PTEN(+/-) MICE; GLIOMA-CELLS; GENE; EXPRESSION; PTEN/MMAC1	Somatic inactivation of PTEN occurs in different human tumors including glioblastoma, endometrial carcinoma and prostate carcinoma. Germline mutations in PTEN result in a range of phenotypic abnormalities that occur with variable penetrance, including neurological features such as macrocephaly, seizures, ataxia and Lhermitte-Duclos disease (also described as dysplastic gangliocytoma of the cerebellum). Homozygous deletion of Pten causes embryonic lethality in mice. To investigate function in the brain, we used Cre-loxP technology to selectively inactivate Pten in specific mouse neuronal populations. Loss of Pten resulted in progressive macrocephaly and seizures. Neurons lacking Pten expressed high levels of phosphorylated Akt and showed a progressive increase in soma size without evidence of abnormal proliferation. Cerebellar abnormalities closely resembled the histopathology of human Lhermitte-Duclos disease. These results indicate that Pten regulates neuronal size in vivo in a cell-autonomous manner and provide new insights into the etiology of Lhermitte-Duclos disease.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Dept Pathol, Memphis, TN 38163 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA		Baker, SJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale, Memphis, TN 38105 USA.	suzanne.baker@stjude.org	Baker, Suzanne J/N-8167-2018; Kwon, Chang-hyuk/E-3450-2011		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA021765, P01CA071907] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA71907, CA21765] Funding Source: Medline		Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cheyney IW, 1999, CANCER RES, V59, P2318; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 1998, CANCER RES, V58, P5285; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Furnari FB, 1998, CANCER RES, V58, P5002; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goldowitz D, 2000, J NEUROSCI, V20, P4129; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Huang H, 1999, DEVELOPMENT, V126, P5365; Iida S, 1998, INT J MOL MED, V1, P925; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Marcus CD, 1996, NEURORADIOLOGY, V38, P529; Marino S, 2000, GENE DEV, V14, P994; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; MUCKE L, 1991, NEW BIOL, V3, P465; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; RAINOV NG, 1995, CLIN NEUROL NEUROSUR, V97, P175, DOI 10.1016/0303-8467(95)00017-E; Robinson S, 2000, NEUROSURGERY, V46, P371, DOI 10.1097/00006123-200002000-00021; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tuli S, 1997, CAN J NEUROL SCI, V24, P155, DOI 10.1017/S031716710002151X; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Zhu XY, 2001, CANCER RES, V61, P4569; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	50	336	349	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					404	411		10.1038/ng781			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	WOS:000172507500015	11726927				2022-01-24	
J	Chen, CC; Lu, RB; Chen, YC; Wang, MF; Chang, YC; Li, TK; Yin, SJ				Chen, CC; Lu, RB; Chen, YC; Wang, MF; Chang, YC; Li, TK; Yin, SJ			Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; DIAGNOSTIC INTERVIEW SCHEDULE; HUMAN-LIVER; KINETIC CHARACTERIZATION; JAPANESE ALCOHOLICS; ATAYAL NATIVES; GENOTYPES; ALLELE; ALDH2; CHINESE	The genes that encode the major enzymes of alcohol metabolism, alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), exhibit functional polymorphism. The variant alleles ADH2*2 and ADH3*1, which encode high-activity ADH isoforms, and the ALDH2*2 allele, which encodes the low-activity form of ALDH2, protect against alcoholism in East Asians. To investigate possible interactions among these protective genes, we genotyped 340 alcoholic and 545 control Han Chinese living in Taiwan at the ADH2, ADH3, and ALDH2 loci. After the influence of ALDH2*2 was controlled for, multiple logistic regression analysis indicated that allelic variation at ADH3 exerts no significant effect on the risk of alcoholism. This can be accounted for by linkage disequlibrium between ADH3*1 and ADH2*2 ALDH2*2 homozygosity, regardless of the ADH2 genotypes, was fully protective against alcoholism; no individual showing such homozygosity was found among the alcoholics. Logistic regression analyses of the remaining six combinatorial genotypes of the polymorphic ADH2 and ALDH2 loci indicated that individuals carrying one or two copies of ADH2*2 and a single copy of ALDH2*2 had the lowest risk (ORs 0.04-0.05) for alcoholism, as compared with the ADH2*1/*1 and ALDH2*1/*1 genotype. The disease risk associated with the ADH2*2/*2-ALDH2*1/*1 genotype appeared to be about half of that associated with the ADH2*2/*2-ALDH2*1/*1 genotype. The results suggest that protection afforded by the ADH2*2 allele may be independent of that afforded by ALDH2*2.	Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; Natl Def Med Ctr, Grad Inst Med Sci, Taipei 10764, Taiwan; Taipei City Psychiat Ctr, Dept Adult Psychiat, Taipei, Taiwan; Taipei Med Coll, Dept Psychiat, Taipei, Taiwan; Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan; Tamkang Univ, Dept Math, Tamsui, Taiwan; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA		Yin, SJ (corresponding author), Natl Def Med Ctr, Dept Biochem, POB 90048, Taipei 10764, Taiwan.	yinsj@tpts5.seed.net.tw			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA002342, P60AA007611, R37AA002342, P50AA007611] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA07611, AA02342] Funding Source: Medline		AGARWAL DP, 1992, PHARMACOGENETICS, V2, P48, DOI 10.1097/00008571-199204000-00002; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017; BURNELL JC, 1989, BIOCHEMISTRY-US, V28, P6810, DOI 10.1021/bi00443a005; Carr LG, 1996, ALCOHOL CLIN EXP RES, V20, P43, DOI 10.1111/j.1530-0277.1996.tb01041.x; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chen WJ, 1997, BIOL PSYCHIAT, V41, P703, DOI 10.1016/S0006-3223(96)00072-8; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CONSALVI V, 1986, BIOCHEM BIOPH RES CO, V139, P1009, DOI 10.1016/S0006-291X(86)80278-9; COUZIGOU P, 1990, ALCOHOL ALCOHOLISM, V25, P623, DOI 10.1093/oxfordjournals.alcalc.a045058; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; CRABB DW, 1995, GENETICS ALCOHOLISM, P202; DANDRE F, 1995, MOL CELL PROBE, V9, P189, DOI 10.1006/mcpr.1995.0030; EDENBERG HJ, 1997, COMPREHENSIVE TOXICO, V3, P119; EDMAN K, 1992, HUM GENET, V90, P395; EKLUND H, 1987, EUR J BIOCHEM, V167, P185, DOI 10.1111/j.1432-1033.1987.tb13322.x; FARRES J, 1994, J BIOL CHEM, V269, P13854; GILDER FJ, 1993, ADDICTION, V88, P383, DOI 10.1111/j.1360-0443.1993.tb00825.x; Goldman D, 1993, Recent Dev Alcohol, V11, P231; Han CL, 1998, EUR J BIOCHEM, V254, P25, DOI 10.1046/j.1432-1327.1998.2540025.x; HARADA S, 1981, LANCET, V2, P982; HELZER JE, 1990, ARCH GEN PSYCHIAT, V47, P313; Higuchi S, 1996, HUM GENET, V97, P431; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; HSU LC, 1986, AM J HUM GENET, V38, P641; HURLEY TD, 1994, J MOL BIOL, V239, P415, DOI 10.1006/jmbi.1994.1382; HWU HG, 1990, ACTA PSYCHIAT SCAND, V82, P374, DOI 10.1111/j.1600-0447.1990.tb01404.x; IWAHASHI K, 1995, ALCOHOL CLIN EXP RES, V19, P564, DOI 10.1111/j.1530-0277.1995.tb01549.x; JORNVALL H, 1995, ALCOHOL ALCOHOLISM, V30, P153; Kissin B., 1996, PHARM ALCOHOL ALCOHO, P15; LI TK, 1977, P NATL ACAD SCI USA, V74, P4378, DOI 10.1073/pnas.74.10.4378; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; MAEZAWA Y, 1995, ALCOHOL CLIN EXP RES, V19, P951, DOI 10.1111/j.1530-0277.1995.tb00972.x; MARDH G, 1985, P NATL ACAD SCI USA, V82, P4979, DOI 10.1073/pnas.82.15.4979; MARDH G, 1986, P NATL ACAD SCI USA, V83, P8908, DOI 10.1073/pnas.83.23.8908; MARDH G, 1986, BIOCHEMISTRY-US, V25, P7279, DOI 10.1021/bi00371a005; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; MIZOI Y, 1979, PHARMACOL BIOCHEM BE, V10, P303, DOI 10.1016/0091-3057(79)90105-9; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Nielsen DA, 1998, ARCH GEN PSYCHIAT, V55, P593, DOI 10.1001/archpsyc.55.7.593; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; PARES X, 1994, ALCOHOL ALCOHOLISM, V29, P701; PENG GS, IN PRESS PHARMACOGEN; PIETRUSZKO R, 1983, ISOZYMES-CURR T BIOL, V8, P195; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.0.CO;2-T; SELLERS EM, 1981, NEW ENGL J MED, V305, P1255; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; SINGH S, 1989, HUM GENET, V83, P119, DOI 10.1007/BF00286702; SMITH M, 1986, ADV HUM GENET, V15, P249; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; STONE CL, 1993, J BIOL CHEM, V268, P892; SVENSSON S, 1999, EUR J BIOCHEM, V261, P1; TAKASE S, 1989, HEPATOLOGY, V9, P704, DOI 10.1002/hep.1840090508; Tanaka F, 1997, ALCOHOL CLIN EXP RES, V21, P596, DOI 10.1111/j.1530-0277.1997.tb03808.x; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Valdes AM, 1997, AM J HUM GENET, V60, P703; Wang XP, 1996, J BIOL CHEM, V271, P31172, DOI 10.1074/jbc.271.49.31172; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; Xiao Q, 1996, J CLIN INVEST, V98, P2027, DOI 10.1172/JCI119007; XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272; YASUNAMI M, 1990, GENOMICS, V7, P152, DOI 10.1016/0888-7543(90)90535-3; YIN SJ, 1995, ADV EXP MED BIOL, V372, P9; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; YIN SJ, 1994, ALCOHOL ALCOHOL S2, V29, P113; YIN SJ, 1994, ADV EXP MED BIOL, V463, P265; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; YOSHIDA A, 1983, AM J HUM GENET, V35, P1107; Zimatkin SM, 1997, ADDICT BIOL, V2, P387, DOI 10.1080/13556219772444	76	336	348	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					795	807		10.1086/302540			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	WOS:000082426400026	10441588	Bronze, Green Published			2022-01-24	
J	SANGO, K; YAMANAKA, S; HOFFMANN, A; OKUDA, Y; GRINBERG, A; WESTPHAL, H; MCDONALD, MP; CRAWLEY, JN; SANDHOFF, K; SUZUKI, K; PROIA, RL				SANGO, K; YAMANAKA, S; HOFFMANN, A; OKUDA, Y; GRINBERG, A; WESTPHAL, H; MCDONALD, MP; CRAWLEY, JN; SANDHOFF, K; SUZUKI, K; PROIA, RL			MOUSE MODELS OF TAY-SACHS AND SANDHOFF DISEASES DIFFER IN NEUROLOGIC PHENOTYPE AND GANGLIOSIDE METABOLISM	NATURE GENETICS			English	Article							HEXOSAMINIDASE-A; DEGRADATION; STORAGE; PROTEIN; GM2	Tay-Sachs and Sandhoff diseases are clinically similar neurodegenerative disorders. These two sphingolipidoses are characterized by a heritable absence of beta-hexosaminidase A resulting in defective G(M2) ganglioside degradation. Through disruption of the Hexa and Herb genes in embryonic stem cells, we have established mouse models corresponding to each disease, Unlike the two human disorders, the two mouse models show very different neurologic phenotypes. Although exhibiting biochemical and pathologic features of the disease, the Tay-Sachs model showed no neurological abnormalities. In contrast, the Sandhoff model was severely affected. The phenotypic difference between the two mouse models is the result of differences in the ganglioside degradation pathway between mice and humans.	NIDDKD,GENET & BIOCHEM BRANCH,BIOCHEM GENET SECT,BETHESDA,MD 20892; UNIV BONN,INST ORGAN CHEM & BIOCHEM,D-53121 BONN,GERMANY; NICHHD,MAMMALIAN GENES & DEV LAB,BETHESDA,MD 20892; NIMH,EXPTL THERAPEUT BRANCH,BEHAV NEUROPHARMACOL SECT,BETHESDA,MD 20892; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,BRAIN & DEV RES CTR,CHAPEL HILL,NC 27599				Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270; McDonald, Michael P./0000-0002-9642-964X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD03110] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS24453] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS024453] Funding Source: NIH RePORTER		BURG J, 1983, H-S Z PHYSIOL CHEM, V364, P821, DOI 10.1515/bchm2.1983.364.2.821; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CONZELMANN E, 1991, DEV NEUROSCI-BASEL, V13, P197, DOI 10.1159/000112160; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; GRAVEL RA, 1995, METABOLIC MOL BASES, P2839; KLIMA H, 1993, BIOCHEM J, V292, P571, DOI 10.1042/bj2920571; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; RIBONI L, 1995, J NEUROCHEM, V64, P451; Robertson EJ, 1987, TERATOCARCINOMAS EMB; SANDHOFF K, 1977, ANGEW CHEM INT EDIT, V16, P273, DOI 10.1002/anie.197702733; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1967, BIOCHIM BIOPHYS ACTA, V141, P442, DOI 10.1016/0304-4165(67)90124-9; SCHWARZMANN G, 1978, BIOCHIM BIOPHYS ACTA, V529, P106, DOI 10.1016/0005-2760(78)90108-X; SONDERFELD S, 1985, EUR J BIOCHEM, V149, P247, DOI 10.1111/j.1432-1033.1985.tb08919.x; SUZUKI K, 1991, DEV NEUROSCI-BASEL, V13, P205, DOI 10.1159/000112161; SUZUKI Y, 1971, NEUROLOGY, V21, P313, DOI 10.1212/WNL.21.4.313; TANLIKE M, 1995, ACTA NEUROPATHOL, V89, P296; VANDENEIJNDEN DH, 1971, Z PHYSIOL CHEM, V352, P1601; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975	21	336	344	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					170	176		10.1038/ng1095-170			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	WOS:A1995RX80600019	7550345				2022-01-24	
J	Sturtevant, AH; Beadle, GW				Sturtevant, AH; Beadle, GW			The relations of inversions in the X chromosome of Drosophila melanogaster to crossing over and disjunction	GENETICS			English	Article									Calif Inst Technol, William G Kerckhoff Labs Biol Sci, Pasadena, CA USA								AGOL IJ, 1929, J EXPTL BIOL RUSSIAN, V5, P84; Beadle GW, 1935, P NATL ACAD SCI USA, V21, P384, DOI 10.1073/pnas.21.6.384; Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160; Bridges CB, 1916, GENETICS, V1, P1; Bridges CB, 1916, GENETICS, V1, P107; Bridges CB, 1926, GENETICS, V11, P41; Dobzhansky T, 1931, AM NAT, V65, P214, DOI 10.1086/280364; DOBZHANSKY TH., 1934, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V68, P134; DUBININ NICOLAI, 1932, BIOL ZENTRALBL, V52, P147; DUBININ NP, 1930, J EXP BIOL RUSSIAN, V6, P4; Gershenson S, 1935, J GENET, V30, P115, DOI 10.1007/BF02982209; GERSHENSON SM, 1930, REP 4 C ZOOL KEIV RU, P7; GERSHENSON SM, 1932, J GENET, V28, P297; Huettner AF, 1924, J MORPHOL PHYSIOL, V39, P249, DOI 10.1002/jmor.1050390108; KAUFMANN BP, 1935, REC GENET SOC AM, V4, P71; KIKKAWA H, 1932, GYTOLOGIA, V3, P340; Lancefield DE, 1922, GENETICS, V7, P335; Lancefield RC, 1921, P NATL ACAD SCI USA, V7, P225, DOI 10.1073/pnas.7.8.225; Lancefield RC, 1922, AM NAT, V56, P211, DOI 10.1086/279862; Mather K, 1934, HEREDITAS, V19, P303; MCCLINTOCK, 1931, MO AGR EXP STA RES B, V163; MCCLINTOCK, 1933, Z ZELLF MIKR ANAT, V19, P191; Morgan LV, 1933, GENETICS, V18, P0250; Muller HJ, 1935, P NATL ACAD SCI USA, V21, P16, DOI 10.1073/pnas.21.1.16; Muller HJ, 1928, GENETICS, V13, P279; MULLER HJ, 1931, ANAT REC, V47, P393; MULLER HJ, 1933, AM NAT, V67, P64; Noujdin N. I., 1935, Zool J Moscow, V14, P317; OFFERMANN C. A., 1932, Proceedings. 6th Int. Congr. Genet., V2, P143; Painter TS, 1934, GENETICS, V19, P0448; Patterson JT, 1935, GENETICS, V20, P0172; Schweitzer MD, 1935, GENETICS, V20, P0581; Sidorov BN, 1935, NATURE, V136, P108, DOI 10.1038/136108c0; SIDOROV BP, 1930, P 4 C ZOOL RUSS, P149; Sivertzev-Dobzhansky NP, 1933, GENETICS, V18, P0173; Smith SG, 1935, J GENET, V30, P227, DOI 10.1007/BF02982237; Stone LHA, 1933, ANN BOT-LONDON, V47, P815, DOI 10.1093/oxfordjournals.aob.a090418; STONE WILSON, 1935, GENETICA, V17, P170, DOI 10.1007/BF01984187; Sturtevant A. H., 1931, Publications of the Carnegie Institution, Vno. 421, P1; Sturtevant AH, 1934, P NATL ACAD SCI USA, V20, P515, DOI 10.1073/pnas.20.9.515; [No title captured]	41	336	336	0	14	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	1936	21	5					554	604					51	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V22VD	WOS:000201542100007	17246812				2022-01-24	
J	Bridges, CB				Bridges, CB			Non-disjunction as proof of the chromosome theory of heredity (concluded)	GENETICS			English	Article									Columbia Univ, New York City, NY USA								Bateson W, 1911, J GENET, V1, P185, DOI 10.1007/BF02981551; Boring Alice M., 1909, Archiv fuer Zellforschung Leipzig, V4; Bridges C. B., 1914, Science New York N S, V40, DOI 10.1126/science.40.1020.107; Bridges CB, 1913, J EXP ZOOL, V15, P587, DOI 10.1002/jez.1400150406; Bridges CB, 1913, SCIENCE, V37, P112, DOI 10.1126/science.37.942.112; Dexter JS, 1914, AM NAT, V48, P317, DOI 10.1086/279409; Doncaster L, 1913, J GENET, V3, P1, DOI 10.1007/BF02981560; Doncaster L, 1914, J GENET, V4, P1, DOI 10.1007/BF02981816; DONCASTER L, 1914, Q J M S, V39, P487; Durham F. M., 1908, Report to the Evolution Committee of the Royal Society London, V4; FROLOWA S, 1912, ARCH ZELLF, V9, P145; Gates RR, 1914, Q J MICROSC SCI, V59, P523; Gregory RP, 1914, P R SOC LOND B-CONTA, V87, P484, DOI 10.1098/rspb.1914.0035; JANSSENS FA, 1909, CELLULE, V25, P389; Lutz Anne May, 1912, BIOL CENTRALBL, V32, P385; Metz CW, 1914, J EXP ZOOL, V17, P45, DOI 10.1002/jez.1400170103; Metz CW, 1915, AM NAT, V49, P187, DOI 10.1086/279473; MORGAN, 1915, MECH MENDELIAN HERED; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Morgan TH, 1911, J EXP ZOOL, V11, P365, DOI 10.1002/jez.1400110404; Morgan TH, 1911, SCIENCE, V34, P384, DOI 10.1126/science.34.873.384; Morgan TH, 1913, J EXP ZOOL, V15, P429, DOI 10.1002/jez.1400150403; Muller HJ, 1914, AM NAT, V48, P508, DOI 10.1086/279426; Nabours RK, 1914, J GENET, V3, P141, DOI 10.1007/BF02981711; STANDFUSS M, 1910, IRIS, V24, P155; STANDFUSS M, 1906, HDB PALAARKTISCHEN G; Stevens NM, 1908, J EXP ZOOL, V5, P453, DOI 10.1002/jez.1400050402; Stevens NM, 1912, BIOL BULL-US, V22, P219, DOI 10.2307/1535887; Stevens NM, 1912, BIOL BULL-US, V22, P231, DOI 10.2307/1535888; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Sturtevant AH, 1912, J EXP ZOOL, V12, P499, DOI 10.1002/jez.1400120404; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Whiting PW, 1915, AM NAT, V49, P518, DOI 10.1086/279497; Wilson EB, 1914, P R SOC LOND B-CONTA, V88, P333, DOI 10.1098/rspb.1914.0079; Wilson EB, 1909, J EXP ZOOL, V6, P147, DOI 10.1002/jez.1400060202; Wilson EB, 1907, BIOL BULL-US, V12, P303, DOI 10.2307/1535680; Wilson EB, 1910, J EXP ZOOL, V9, P53, DOI 10.1002/jez.1400090104	37	336	340	0	10	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAR	1916	1	2					107	163					58	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V23KL	WOS:000201581900001	17245853				2022-01-24	
J	Ben-David, U; Ha, G; Tseng, YY; Greenwald, NF; Oh, C; Shih, J; McFarland, JM; Wong, B; Boehm, JS; Beroukhim, R; Golub, TR				Ben-David, Uri; Ha, Gavin; Tseng, Yuen-Yi; Greenwald, Noah F.; Oh, Coyin; Shih, Juliann; McFarland, James M.; Wong, Bang; Boehm, Jesse S.; Beroukhim, Rameen; Golub, Todd R.			Patient-derived xenografts undergo mouse-specific tumor evolution	NATURE GENETICS			English	Article							GENE-EXPRESSION; BREAST-CANCER; GENOMIC CHARACTERIZATION; COPY NUMBER; CHROMOSOMAL INSTABILITY; STEM-CELLS; MODELS; HETEROGENEITY; SIGNATURE; CHEMOTHERAPY	Patient-derived xenografts (PDXs) have become a prominent cancer model system, as they are presumed to faithfully represent the genomic features of primary tumors. Here we monitored the dynamics of copy number alterations (CNAs) in 1,110 PDX samples across 24 cancer types. We observed rapid accumulation of CNAs during PDX passaging, often due to selection of preexisting minor clones. CNA acquisition in PDXs was correlated with the tissue-specific levels of aneuploidy and genetic heterogeneity observed in primary tumors. However, the particular CNAs acquired during PDX passaging differed from those acquired during tumor evolution in patients. Several CNAs recurrently observed in primary tumors gradually disappeared in PDXs, indicating that events undergoing positive selection in humans can become dispensable during propagation in mice. Notably, the genomic stability of PDXs was associated with their response to chemotherapy and targeted drugs. These findings have major implications for PDX-based modeling of human cancer.	[Ben-David, Uri; Ha, Gavin; Tseng, Yuen-Yi; Greenwald, Noah F.; Oh, Coyin; Shih, Juliann; McFarland, James M.; Wong, Bang; Boehm, Jesse S.; Beroukhim, Rameen; Golub, Todd R.] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Ha, Gavin; Shih, Juliann; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Greenwald, Noah F.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Greenwald, Noah F.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Beroukhim, Rameen] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA		Beroukhim, R; Golub, TR (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Beroukhim, R (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Golub, TR (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Golub, TR (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Golub, TR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	rameen_beroukhim@dfci.harvard.edu; golub@broadinstitute.org	Ha, Gavin/N-1984-2019; Ben-David, Uri/H-4119-2019	Ha, Gavin/0000-0001-7578-7272; Ben-David, Uri/0000-0001-7098-2378; Greenwald, Noah/0000-0002-7836-4379; Golub, Todd/0000-0003-0113-2403	Human Frontiers Science Program postdoctoral fellowship; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 CA188228]; Gray Matters Brain Cancer Foundation; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA188228] Funding Source: NIH RePORTER	We thank L. Franke for assistance with functional genomic mRNA profiling; A. Bass, K. Ligon, A.J. Aguirre and J. Lorch for providing the clinical samples for cell line derivation; A. Tubelli for assistance with figure preparation; M. Meyerson, A. J. Cherniack, A. Taylor, A. Pearson and Z. Tothova for helpful discussions; and W.J. Gibson for copy number data. U.B.-D. is supported by a Human Frontiers Science Program postdoctoral fellowship, R.B. received support from the US National Institutes of Health (R01 CA188228) and the Gray Matters Brain Cancer Foundation, and T.R.G. received support from the Howard Hughes Medical Institute.	Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-David U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12160; Ben-David U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5825; Ben-David U, 2013, NAT PROTOC, V8, P989, DOI 10.1038/nprot.2013.051; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bi WL, 2017, NPJ GENOM MED, V2; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Burrell RA, 2010, J CELL BIOCHEM, V111, P782, DOI 10.1002/jcb.22781; Cai YY, 2016, CANCER CELL, V29, P751, DOI 10.1016/j.ccell.2016.04.003; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen GB, 2015, CELL, V160, P771, DOI 10.1016/j.cell.2015.01.026; Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079874; Cifola I, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-244; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Gu QY, 2015, ONCOTARGET, V6, P20160, DOI 10.18632/oncotarget.3969; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hedberg ML, 2016, J CLIN INVEST, V126, P1606, DOI 10.1172/JCI86862; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hollingshead MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-393; Huynh H, 2008, J HEPATOL, V49, P52, DOI 10.1016/j.jhep.2008.02.022; Jager W, 2015, ONCOTARGET, V6, P21522; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Khan F, 2010, TOXIN REV, V29, P130, DOI 10.3109/15569543.2010.516463; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Kresse SH, 2012, CANCER-AM CANCER SOC, V118, P558, DOI 10.1002/cncr.26276; Larson JL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0571-7; Lee SML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107567; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lim B, 2015, ONCOTARGET, V6, P22179, DOI 10.18632/oncotarget.4246; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Ma CX, 2012, J CLIN INVEST, V122, P1541, DOI 10.1172/JCI58765; Monsma DJ, 2014, PEDIATR BLOOD CANCER, V61, P1570, DOI 10.1002/pbc.25039; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Peng SH, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-198; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/nchembio.1986, 10.1038/NCHEMBIO.1986]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roschke AV, 2003, CANCER RES, V63, P8634; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Silk AD, 2013, P NATL ACAD SCI USA, V110, pE4134, DOI 10.1073/pnas.1317042110; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Smith KB, 2013, AM J PATHOL, V182, P1400, DOI 10.1016/j.ajpath.2013.01.002; Sveen A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006225; Tempest HG, 2008, HUM REPROD, V23, P251, DOI 10.1093/humrep/dem389; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Um SW, 2016, CANCER RES, V76, P6568, DOI 10.1158/0008-5472.CAN-16-0873; Wong NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-416; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhang XT, 2015, CLIN CANCER RES, V21, P4698, DOI 10.1158/1078-0432.CCR-15-0157	69	335	341	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2017	49	11					1567	+		10.1038/ng.3967			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL0OD	WOS:000413909800005	28991255	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Bentham, J; Morris, DL; Graham, DSC; Pinder, CL; Tombleson, P; Behrens, TW; Martin, J; Fairfax, BP; Knight, JC; Chen, LY; Replogle, J; Syvanen, AC; Ronnblom, L; Graham, RR; Wither, JE; Rioux, JD; Alarcon-Riquelme, ME; Vyse, TJ				Bentham, James; Morris, David L.; Graham, Deborah S. Cunninghame; Pinder, Christopher L.; Tombleson, Philip; Behrens, Timothy W.; Martin, Javier; Fairfax, Benjamin P.; Knight, Julian C.; Chen, Lingyan; Replogle, Joseph; Syvanen, Ann-Christine; Ronnblom, Lars; Graham, Robert R.; Wither, Joan E.; Rioux, John D.; Alarcon-Riquelme, Marta E.; Vyse, Timothy J.			Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION STRATIFICATION; SUSCEPTIBILITY VARIANTS; HLA ALLELES; T-CELLS; POLYMORPHISM; AUTOIMMUNE; EXPRESSION; RISK; IMPUTATION	Systemic lupus erythematosus (SLE) is a genetically complex autoimmune disease characterized by loss of immune tolerance to nuclear and cell surface antigens. Previous genome-wide association studies (GWAS) had modest sample sizes, reducing their scope and reliability. Our study comprised 7,219 cases and 15,991 controls of European ancestry, constituting a new GWAS, a meta-analysis with a published GWAS and a replication study. We have mapped 43 susceptibility loci, including ten new associations. Assisted by dense genome coverage, imputation provided evidence for missense variants underpinning associations in eight genes. Other likely causal genes were established by examining associated alleles for cis-acting eQTL effects in a range of ex vivo immune cells. We found an over-representation (n = 16) of transcription factors among SLE susceptibility genes. This finding supports the view that aberrantly regulated gene expression networks in multiple cell types in both the innate and adaptive immune response contribute to the risk of developing SLE.	[Bentham, James; Morris, David L.; Graham, Deborah S. Cunninghame; Pinder, Christopher L.; Tombleson, Philip; Chen, Lingyan; Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Behrens, Timothy W.; Graham, Robert R.] Genentech Inc, San Francisco, CA 94080 USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Fairfax, Benjamin P.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Replogle, Joseph] Harvard Univ, Sch Med, Boston, MA USA; [Syvanen, Ann-Christine; Ronnblom, Lars] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden; [Wither, Joan E.] Univ Hlth Network, TWRI, Toronto, ON, Canada; [Rioux, John D.] Univ Montreal, Genet & Genom Med Inflammat, Montreal, PQ, Canada; [Rioux, John D.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Alarcon-Riquelme, Marta E.] Pfizer Univ Granada Junta Andalucia, Ctr Genom & Invest Oncol GENYO, Granada, Spain; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England		Vyse, TJ (corresponding author), Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England.	timothy.vyse@kcl.ac.uk	Knight, Julian Charles/W-2399-2019; Rioux, John D/A-9599-2015; Martin, Javier/B-8141-2008; Alarcon-Riquelme, Marta E./ABF-8163-2020; Bentham, James/ABF-5746-2020; Martin, Javier/AAV-5209-2021	Knight, Julian Charles/0000-0002-0377-5536; Rioux, John D/0000-0001-7560-8326; Martin, Javier/0000-0002-2202-0622; Alarcon-Riquelme, Marta E./0000-0002-7632-4154; Replogle, Joseph/0000-0003-1832-919X; Morris, David/0000-0002-1754-8932; Fairfax, Benjamin/0000-0001-7413-5002; Bentham, James/0000-0001-5733-9417; Wither, Joan/0000-0001-5961-9228; Chen, Lingyan/0000-0003-3750-6761; Pinder, Christopher/0000-0003-4149-226X	George Koukis Foundation; Arthritis Research UK Special Strategic AwardVersus Arthritis [19289]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PS09/00129]; FEDER funds of the European UnionEuropean Commission; Consejeria de Salud de Andalucia [PI0012]; Swedish Research Council of Medicine; European Science FoundationEuropean Science Foundation (ESF)European Commission; Arthritis Research UK Special Strategic AwardVersus Arthritis; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [94825]; Wellcome Trust grantWellcome Trust [085492]; China Scholarship CouncilChina Scholarship Council [201406380127]; National Institute for Health Research (NIHR) Biomedical Research CentreNational Institute for Health Research (NIHR); King's College London; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG009740, RC2AG036495, RC4AG039029]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [3P50CA093459, 5P50CA097007, 5R01ES011740, 5R01CA133996]; Genes and Blood Clotting Study was provided through the US NIH/National Heart, Lung, and Blood Institute (NHLBI) [R37HL039693]; US NIH/NHLBI [R37HL039693]; Howard Hughes Medical InstituteHoward Hughes Medical Institute; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL13-Fairfax] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2012-13-004] Funding Source: researchfish; Versus ArthritisVersus Arthritis [19289] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50CA097007, P50CA093459, R01CA133996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R37HL039693] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES011740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RC2AG036495, U01AG009740, RC4AG039029] Funding Source: NIH RePORTER	T.J.V., J.D.R. and M.E.A.-R. were awarded funding to carry out genotyping and analysis from the George Koukis Foundation and an Arthritis Research UK Special Strategic Award (19289). M.E.A.-R. received grants from the Instituto de Salud Carlos III (PS09/00129), co-financed by the FEDER funds of the European Union, the Consejeria de Salud de Andalucia (PI0012) and the Swedish Research Council of Medicine, and from the European Science Foundation to the BIOLUPUS network. J.B. was funded by the George Koukis Foundation and the Arthritis Research UK Special Strategic Award. J.E.W. was funded by the Canadian Institutes of Health Research (94825). C.L.P. was funded by a Wellcome Trust grant (085492). P.T. is employed by the Biomedical Research Centre. L.C. was funded by the China Scholarship Council (201406380127). The research was funded and supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health.; HRS genetic data were obtained from the database of Genotypes and Phenotypes (dbGaP) under accession phs000187.v1.p1; the study is sponsored by the National Institute on Aging (grants U01AG009740, RC2AG036495 and RC4AG039029) and was conducted by the University of Michigan. The melanoma study data were obtained from dbGaP under accession phs000187.v1.p1. Research support to collect data and develop an application to support this project was provided by US National Institutes of Health (NIH) grants 3P50CA093459, 5P50CA097007, 5R01ES011740 and 5R01CA133996. Funding support for the Genes and Blood Clotting Study was provided through the US NIH/National Heart, Lung, and Blood Institute (NHLBI) (R37HL039693). The Genes and Blood Clotting Study is one of the Phase 3 studies that are part of the Gene-Environment Association Studies (GENEVA) under the Genes, Environment and Health Initiative (GEI). Assistance with genotype cleaning was provided by the GENEVA Coordinating Center (U01HG004446, US NIH). Funding support for DNA extraction and genotyping, which were performed at the Broad Institute, was provided by the US NIH/NHLBI (R37HL039693). Additional support was provided by the Howard Hughes Medical Institute. The data sets used for the analyses described in this manuscript were obtained from dbGaP under accession phs000304.v2.p1. CGEMS prostate cancer study data were obtained from dbGaP under accession phs000207.v1.p1. We thank Genentech, Inc., for providing the genotype data from their GWAS. We thank V. Anand and S. Ragan for their help in coordinating data collection. We thank T. Axelsson, B. Furnrohr, S. Ragan and J. Kelly for their help with the replication study.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Alexander T, 2013, ANN RHEUM DIS, V72, P1549, DOI 10.1136/annrheumdis-2012-202216; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Bronson PG, 2011, GENES IMMUN, V12, P667, DOI 10.1038/gene.2011.36; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caster DJ, 2013, J AM SOC NEPHROL, V24, P1743, DOI 10.1681/ASN.2013020148; Castillejo-Lopez C, 2012, ANN RHEUM DIS, V71, P136, DOI 10.1136/annrheumdis-2011-200085; Chrabot BS, 2013, GENES IMMUN, V14, P471, DOI 10.1038/gene.2013.42; Crispin JC, 2010, ARTHRITIS RHEUM-US, V62, P1431, DOI 10.1002/art.27385; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fujimoto M, 2004, INT IMMUNOL, V16, P303, DOI 10.1093/intimm/dxh030; Gagliano SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098122; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Jeffreys H., 1961, THEORY PROBABILITY; Karassa FB, 2002, ARTHRITIS RHEUM-US, V46, P1563, DOI 10.1002/art.10306; Kaufman KM, 2013, ANN RHEUM DIS, V72, P437, DOI 10.1136/annrheumdis-2012-201851; Kim SJ, 2013, J CLIN INVEST, V123, P823, DOI 10.1172/JCI64712; Knight J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014808; Kottyan LC, 2015, HUM MOL GENET, V24, P582, DOI 10.1093/hmg/ddu455; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; Lewis MJ, 2015, AM J HUM GENET, V96, P221, DOI 10.1016/j.ajhg.2014.12.024; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439; Manku H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003554; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Mori T, 2014, J IMMUNOL, V193, P1728, DOI 10.4049/jimmunol.1303243; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; Morris EE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3189; Namjou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069404; Namjou B, 2009, ARTHRITIS RHEUM-US, V60, P1085, DOI 10.1002/art.24387; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Noble JA, 2003, DIABETES, V52, P1579, DOI 10.2337/diabetes.52.6.1579; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Oparina NY, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204909; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rhodes B, 2012, ANN RHEUM DIS, V71, P2028, DOI 10.1136/annrheumdis-2012-201390; Sakurai D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003870; Scofield RH, 2008, ARTHRITIS RHEUM-US, V58, P2511, DOI 10.1002/art.23701; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Tchernev VT, 2002, MOL MED, V8, P56, DOI 10.1007/BF03402003; Vaughn SE, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00450; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhang J, 2013, ANN HUM GENET, V77, P344, DOI 10.1111/ahg.12018; Zhang Y, 2011, GENES IMMUN, V12, P231, DOI 10.1038/gene.2010.66; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148; Zhao H, 2012, GENES IMMUN, V13, P536, DOI 10.1038/gene.2012.33; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	79	335	342	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1457	+		10.1038/ng.3434			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	WOS:000365813200018	26502338	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Wang, H; Maurano, MT; Qu, HZ; Varley, KE; Gertz, J; Pauli, F; Lee, K; Canfield, T; Weaver, M; Sandstrom, R; Thurman, RE; Kaul, R; Myers, RM; Stamatoyannopoulos, JA				Wang, Hao; Maurano, Matthew T.; Qu, Hongzhu; Varley, Katherine E.; Gertz, Jason; Pauli, Florencia; Lee, Kristen; Canfield, Theresa; Weaver, Molly; Sandstrom, Richard; Thurman, Robert E.; Kaul, Rajinder; Myers, Richard M.; Stamatoyannopoulos, John A.			Widespread plasticity in CTCF occupancy linked to DNA methylation	GENOME RESEARCH			English	Article							INSULATOR PROTEIN CTCF; ENHANCER-BLOCKING ACTIVITY; CCCTC-BINDING FACTOR; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ZINC FINGERS; CANCER-CELLS; FREE DOMAINS; HUMAN GENOME	CTCF is a ubiquitously expressed regulator of fundamental genomic processes including transcription, intra- and interchromosomal interactions, and chromatin structure. Because of its critical role in genome function, CTCF binding patterns have long been assumed to be largely invariant across different cellular environments. Here we analyze genome-wide occupancy patterns of CTCF by ChIP-seq in 19 diverse human cell types, including normal primary cells and immortal lines. We observed highly reproducible yet surprisingly plastic genomic binding landscapes, indicative of strong cell-selective regulation of CTCF occupancy. Comparison with massively parallel bisulfite sequencing data indicates that 41% of variable CTCF binding is linked to differential DNA methylation, concentrated at two critical positions within the CTCF recognition sequence. Unexpectedly, CTCF binding patterns were markedly different in normal versus immortal cells, with the latter showing widespread disruption of CTCF binding associated with increased methylation. Strikingly, this disruption is accompanied by up-regulation of CTCF expression, with the result that both normal and immortal cells maintain the same average number of CTCF occupancy sites genome-wide. These results reveal a tight linkage between DNA methylation and the global occupancy patterns of a major sequence-specific regulatory factor.	[Wang, Hao; Maurano, Matthew T.; Qu, Hongzhu; Lee, Kristen; Canfield, Theresa; Weaver, Molly; Sandstrom, Richard; Thurman, Robert E.; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qu, Hongzhu] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing 100029, Peoples R China; [Varley, Katherine E.; Gertz, Jason; Pauli, Florencia; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA		Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu		Pauli Behn, Florencia/0000-0002-8984-4044; Sandstrom, Richard/0000-0002-3356-1547; Gertz, Jason/0000-0001-7568-6789; Varley, Katherine/0000-0003-1622-5290; Kaul, Rajinder/0000-0002-7895-9284	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54HG004592, U54HG0 04576]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG004576, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH094073] Funding Source: NIH RePORTER	We thank Jeff Vierstra, Andrew Stergachis, and Sam John for critical reading of the manuscript and many helpful suggestions. We also thank Daniel Bates, Morgan Diegel, and Doug Dunn at the University of Washington High-Throughput Genomics Center for technical assistance. This work was supported by National Institutes of Health grants U54HG004592 (J.A.S.) and U54HG0 04576 (R.M.M.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Davalos-Salas M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-232; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; ENVER T, 1988, GENE DEV, V2, P698, DOI 10.1101/gad.2.6.698; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Klenova EM, 2001, MOL CELL BIOL, V21, P2221, DOI 10.1128/MCB.21.6.2221-2234.2001; Lai AY, 2010, J EXP MED, V207, P1939, DOI 10.1084/jem.20100204; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; Matsuzaki H, 2010, HUM MOL GENET, V19, P1190, DOI 10.1093/hmg/ddp589; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Neph S, 2012, NATURE IN PRESS; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Rasko JEJ, 2001, CANCER RES, V61, P6002; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; SELKER EU, 1990, TRENDS BIOCHEM SCI, V15, P103, DOI 10.1016/0968-0004(90)90193-F; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Thurman RE, 2012, NATURE IN PRESS; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	68	335	345	0	35	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2012	22	9			SI		1680	1688		10.1101/gr.136101.111			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	998XD	WOS:000308272800010	22955980	Green Published, Green Submitted, hybrid			2022-01-24	
J	Comas, I; Borrell, S; Roetzer, A; Rose, G; Malla, B; Kato-Maeda, M; Galagan, J; Niemann, S; Gagneux, S				Comas, Inaki; Borrell, Sonia; Roetzer, Andreas; Rose, Graham; Malla, Bijaya; Kato-Maeda, Midori; Galagan, James; Niemann, Stefan; Gagneux, Sebastien			Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes	NATURE GENETICS			English	Article							ANTIBIOTIC-RESISTANCE; DRUG-RESISTANCE; BIOLOGICAL COST; BEIJING GENOTYPE; EVOLUTION; FITNESS; PHYLOGEOGRAPHY; PROTEINS; GENETICS; BACTERIA	Epidemics of drug-resistant bacteria emerge worldwide, even as resistant strains frequently have reduced fitness compared to their drug-susceptible counterparts(1). Data from model systems suggest that the fitness cost of antimicrobial resistance can be reduced by compensatory mutations(2); however, there is limited evidence that compensatory evolution has any significant role in the success of drug-resistant bacteria in human populations(3-6). Here we describe a set of compensatory mutations in the RNA polymerase genes of rifampicin-resistant M. tuberculosis, the etiologic agent of human tuberculosis (TB). M. tuberculosis strains harboring these compensatory mutations showed a high competitive fitness in vitro. Moreover, these mutations were associated with high fitness in vivo, as determined by examining their relative clinical frequency across patient populations. Of note, in countries with the world's highest incidence of multidrug-resistant (MDR) TB7, more than 30% of MDR clinical isolates had this form of mutation. Our findings support a role for compensatory evolution in the global epidemics of MDR TB8.	[Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Comas, Inaki; Rose, Graham] Natl Inst Med Res, Med Res Council, Div Mycobacterial Res, London NW7 1AA, England; [Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Roetzer, Andreas; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Kato-Maeda, Midori] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA; [Galagan, James] MIT, Broad Inst, Cambridge, MA 02139 USA; [Galagan, James] Harvard Univ, Cambridge, MA 02138 USA; [Galagan, James] Boston Univ, Dept Microbiol, Boston, MA 02215 USA		Gagneux, S (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	sebastien.gagneux@unibas.ch	Comas, Inaki/AAA-1155-2019; Gagneux, Sebastien/ABE-7909-2020; Niemann, Stefan/C-9327-2011; Comas, Inaki/F-1185-2011	Comas, Inaki/0000-0001-5504-9408; Comas, Inaki/0000-0001-5504-9408; Gagneux, Sebastien/0000-0001-7783-9048; Galagan, James/0000-0003-0542-3291; Niemann, Stefan/0000-0002-6604-0684; Rose, Graham/0000-0002-5097-5426	US National Institute of Allergy and Infectious Disease, US National Institutes of Health; US Department of Health and Human Services [HHSN266200400001C, AI090928, AI034238]; Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MRC_U117588500]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PP00A-119205]; European CommunityEuropean Commission [QLK-CT-2002-01612, FP7-223681]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U117581288] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI090928, R01AI034238] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U117581288] Funding Source: UKRI	We thank P. Small and C. Davis Long for stimulating discussions at the onset of this project, D. Young and M. Coscolla for reviewing the manuscript, A. Candel for advice in the interpretation of the RNA polymerase molecular structure and T. Van for technical support. We acknowledge the Wellcome Trust Sanger Institute for making available unpublished DNA sequence data (see URLs). We would like to thank T. Ubben, I. Razio and the other members of the German National Reference Center for Mycobateria for technical assistance and all partners that have contributed to previous studies in regions of high MDR TB incidence and collected some of the strains analyzed here. This project was funded wholly or in part by the US National Institute of Allergy and Infectious Disease, US National Institutes of Health and US Department of Health and Human Services (contract HHSN266200400001C, grants AI090928 and AI034238). This work was also supported by the Medical Research Council, UK (MRC_U117588500), the Swiss National Science Foundation (PP00A-119205) and the European Community LONG-DRUG (QLK-CT-2002-01612) and TB PAN-NET (FP7-223681) projects.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hazbon MH, 2008, ANTIMICROB AGENTS CH, V52, P3369, DOI 10.1128/AAC.00309-08; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Levin BR, 2000, GENETICS, V154, P985; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reynolds MG, 2000, GENETICS, V156, P1471; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Shcherbakov D, 2010, MOL MICROBIOL, V77, P830, DOI 10.1111/j.1365-2958.2010.07218.x; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msr121; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2010, GLOB TUB CONTR SURV	39	335	347	4	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					106	U147		10.1038/ng.1038			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	WOS:000298664000023	22179134	Green Accepted			2022-01-24	
J	Papaemmanuil, E; Hosking, FJ; Vijayakrishnan, J; Price, A; Olver, B; Sheridan, E; Kinsey, SE; Lightfoot, T; Roman, E; Irving, JAE; Allan, JM; Tomlinson, IP; Taylor, M; Greaves, M; Houlston, RS				Papaemmanuil, Elli; Hosking, Fay J.; Vijayakrishnan, Jayaram; Price, Amy; Olver, Bianca; Sheridan, Eammon; Kinsey, Sally E.; Lightfoot, Tracy; Roman, Eve; Irving, Julie A. E.; Allan, James M.; Tomlinson, Ian P.; Taylor, Malcolm; Greaves, Mel; Houlston, Richard S.			Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FAMILY; CANCER; IKAROS; GENE; DIFFERENTIATION; PROTEINS; DELETION; MEMBERS; GROWTH	To identify risk variants for childhood acute lymphoblastic leukemia (ALL), we conducted a genome-wide association study of two case-control series, analyzing the genotypes with respect to 291,423 tagging SNPs in a total of 907 ALL cases and 2,398 controls. We identified risk loci for ALL at 7p12.2 (IKZF1, rs4132601, odds ratio (OR) = 1.69, P = 1.20 x 10(-19)), 10q21.2 (ARID5B, rs7089424, OR = 1.65, P = 6.69 x 10(-19)) and 14q11.2 (CEBPE, rs2239633, OR = 1.34, P = 2.88 x 10(-7)). The 10q21.2 (ARID5B) risk association appears to be selective for the subset of B-cell precursor ALL with hyperdiploidy. These data show that common low-penetrance susceptibility alleles contribute to the risk of developing childhood ALL and provide new insight into disease causation of this specific hematological cancer. Notably, all three risk variants map to genes involved in transcriptional regulation and differentiation of B-cell progenitors.	[Papaemmanuil, Elli; Hosking, Fay J.; Vijayakrishnan, Jayaram; Price, Amy; Olver, Bianca; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Sheridan, Eammon] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Kinsey, Sally E.] St James Hosp, Dept Paediat & Adolescent Oncol & Haematol, Leeds LS9 7TF, W Yorkshire, England; [Lightfoot, Tracy; Roman, Eve] Univ York, Epidemiol & Genet Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Irving, Julie A. E.; Allan, James M.] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Tomlinson, Ian P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Taylor, Malcolm] Univ Manchester, St Marys Hosp, Canc Immunogenet Grp, Sch Canc Sci, Manchester M13 0JH, Lancs, England; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Surrey, England		Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Allan, James/B-4448-2009	Roman, Eve/0000-0001-7603-3704; Houlston, Richard/0000-0002-5268-0242; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Hosking, Fay/0000-0002-1101-039X; Allan, James/0000-0002-7580-5087	Cancer Research UKCancer Research UK [C1298/A8362] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934] Funding Source: Medline; Blood Cancer UK [13027] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934] Funding Source: UKRI		Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Boulton A, 2000, BRIT J CANCER, V82, P1073; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang LW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r38; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Couto E, 2005, BRIT J CANCER, V93, P1307, DOI 10.1038/sj.bjc.6602867; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hemminki K, 2002, LEUKEMIA, V16, P297, DOI 10.1038/sj.leu.2402351; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodgson S.V., 2007, PRACTICAL GUIDE HUMA, V3rd; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pettiti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Stiller CA, 1996, BRIT MED BULL, V52, P682; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95	25	335	348	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1006	U73		10.1038/ng.430			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	WOS:000269382100013	19684604	Green Accepted			2022-01-24	
J	Gudbjartsson, DF; Holm, H; Gretarsdottir, S; Thorleifsson, G; Walters, GB; Thorgeirsson, G; Gulcher, J; Mathiesen, EB; Njolstad, I; Nyrnes, A; Wilsgaard, T; Hald, EM; Hveem, K; Stoltenberg, C; Kucera, G; Stubblefield, T; Carter, S; Roden, D; Ng, MCY; Baum, L; So, WY; Wong, KS; Chan, JCN; Gieger, C; Wichmann, HE; Gschwendtner, A; Dichgans, M; Kuhlenbaumer, G; Berger, K; Ringelstein, EB; Bevan, S; Markus, HS; Kostulas, K; Hillert, J; Sveinbjornsdottir, S; Valdimarsson, EM; Lochen, ML; Ma, RCW; Darbar, D; Kong, A; Arnar, DO; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Holm, Hilma; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Walters, G. Bragi; Thorgeirsson, Gudmundur; Gulcher, Jeffrey; Mathiesen, Ellisiv B.; Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Hald, Erin M.; Hveem, Kristian; Stoltenberg, Camilla; Kucera, Gayle; Stubblefield, Tanya; Carter, Shannon; Roden, Dan; Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Gieger, Christian; Wichmann, H-Erich; Gschwendtner, Andreas; Dichgans, Martin; Kuhlenbaeumer, Gregor; Berger, Klaus; Ringelstein, E. Bernd; Bevan, Steve; Markus, Hugh S.; Kostulas, Konstantinos; Hillert, Jan; Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.; Lochen, Maja-Lisa; Ma, Ronald C. W.; Darbar, Dawood; Kong, Augustine; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari			A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke	NATURE GENETICS			English	Article							CHROMOSOME 4Q25; ATBF1; RISK; METAANALYSIS; PROTEIN	We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR = 1.21, P = 1.4 x 10(-10)). This variant also associated with ischemic stroke (OR = 1.11, P = 0.00054) and cardioembolic stroke (OR = 1.22, P = 0.00021) in a combined analysis of five stroke samples.	[Gudbjartsson, Daniel F.; Holm, Hilma; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Walters, G. Bragi; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCode Genet, Reykjavik, Iceland; [Holm, Hilma] Emory Univ, Sch Med, Div Cardiol, Dept Internal Med, Atlanta, GA 30322 USA; [Thorleifsson, Gudmar; Arnar, David O.] Landspitali Univ Hosp, Div Cardiol, Dept Internal Med, Reykjavik, Iceland; [Thorleifsson, Gudmar; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Mathiesen, Ellisiv B.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp N Norway, Dept Neurol, Tromso, Norway; [Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Lochen, Maja-Lisa] Univ Tromso, Inst Community Med, Tromso, Norway; [Nyrnes, Audhild] Univ Hosp N Norway, Dept Geriatr, Tromso, Norway; [Hald, Erin M.; Lochen, Maja-Lisa] Univ Hosp N Norway, Dept Cardiol, Tromso, Norway; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Stoltenberg, Camilla] Norwegian Inst Publ Hlth, Oslo, Norway; [Kucera, Gayle; Stubblefield, Tanya; Carter, Shannon; Roden, Dan; Darbar, Dawood] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany; [Gschwendtner, Andreas; Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Kuhlenbaeumer, Gregor] Univ Kiel, Inst Expt Med, Kiel, Germany; [Berger, Klaus] Inst Epidemiol & Social Med, Munster, Germany; [Ringelstein, E. Bernd] Univ Munster, Dept Neurol, Munster, Germany; [Ringelstein, E. Bernd] Univ Munster, Leibniz Inst Atherosclerosis Res, Munster, Germany; [Bevan, Steve; Markus, Hugh S.] St Georges Univ London, London, England; [Kostulas, Konstantinos; Hillert, Jan] Karolinska Univ Hosp Huddinge, Dept Neurol, Stockholm, Sweden; [Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland		Gudbjartsson, DF (corresponding author), DeCode Genet, Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Baum, Lawrence/B-1005-2013; Njolstad, Inger/X-3784-2019; Wong, Ka Sing Lawrence/N-3434-2015; Stefansson, Kari/AAE-7187-2019; Chan, Juliana/B-7918-2016; Roden, Dan/ABD-5412-2021; Ma, Ronald/C-2788-2009; Kuhlenbaumer, Gregor/A-5110-2009; Darbar, Dawood/C-9079-2015; Stoltenberg, Camilla/G-5090-2017; Walters, G. Bragi/L-4215-2013; Wichmann, Heinz Erich/AAA-5695-2022	Baum, Lawrence/0000-0002-5345-9355; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X; Darbar, Dawood/0000-0002-4103-5977; Walters, G. Bragi/0000-0002-5415-6487; Kong, Augustine/0000-0001-8193-5438; Lochen, Maja-Lisa/0000-0002-8532-6573; Gudbjartsson, Daniel/0000-0002-5222-9857; Gieger, Christian/0000-0001-6986-9554; Bevan, Steve/0000-0003-0490-6830	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL075266, U01 HL65962]; American Heart AssociationAmerican Heart Association [0940116N]; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01GI9909/3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL075266, U01HL065962] Funding Source: NIH RePORTER	This project was supported by US National Institutes of Health grants HL075266 and U01 HL65962 and American Heart Association grant 0940116N. Case ascertainment in the West Germany region (Westphalia) was part of the German Competence Net Stroke, which was supported by the German Federal Ministry of Education and Research (01GI9909/3). In the Dortmund Health Study (controls, West Germany) blood collection was done through funds of the Institute of Epidemiology and Social Medicine University of Muenster, the collection of sociodemographic and clinical variables was supported by the German Migraine & Headache Society (DMKG) and by unrestricted grants of equal share from Astra Zeneca, Berlin Chemie, Boots Healthcare, Glaxo-Smith-Kline, McNeil Pharma, MSD Sharp & Dohme and Pfizer to the University of Muenster.	Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Lip GYH, 2006, HEART, V92, P155, DOI 10.1136/hrt.2005.066944; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105	11	335	346	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					876	878		10.1038/ng.417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	WOS:000268432900007	19597491	Green Accepted			2022-01-24	
J	Bertram, L; Lange, C; Mullin, K; Parkinson, M; Hsiao, M; Hogan, MF; Schjeide, BMM; Hooli, B; DiVito, J; Ionita, L; Jiang, HY; Laird, N; Moscarillo, T; Ohlsen, KL; Elliott, K; Wang, X; Hu-Lince, D; Ryder, M; Murphy, A; Wagner, SL; Blacker, D; Becker, KD; Tanzi, RE				Bertram, Lars; Lange, Christoph; Mullin, Kristina; Parkinson, Michele; Hsiao, Monica; Hogan, Meghan F.; Schjeide, Brit M. M.; Hooli, Basavaraj; DiVito, Jason; Ionita, Luliana; Jiang, Hongyu; Laird, Nan; Moscarillo, Thomas; Ohlsen, Kari L.; Elliott, Kathryn; Wang, Xin; Hu-Lince, Diane; Ryder, Marie; Murphy, Amy; Wagner, Steven L.; Blacker, Deborah; Becker, K. David; Tanzi, Rudolph E.			Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-BASED ASSOCIATION; MISSENSE MUTATIONS; ONSET; GENE; EPSILON-4; VARIANTS; CLONING; AGE	Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. To date four genes have been established to either Cause early-onset autosomal-dominant AD (APP, PSEN1, and PSEN2(1-4)) or to increase susceptibility for late-onset AD (APOE However, the heritability of late-onset AD is as high as 80%,(6) and much of the phenotypic variance remains unexplained to date. We performed a genome-wide association (GWA) analysis using 484,522 single-nucleotide polymorphisms (SNPs) on a large (1,376 samples from 410 families) sample of AD families of self-reported European descent. We identified five SNPs showing either significant or marginally significant genome-wide association with a multivariate phenotype combining affection status and onset age. One of these signals (p = 5.7 x 10(-14)) was elicited by SNP rs4420638 and probably reflects APOE-epsilon 4, which maps 11 kb proximal (r(2) = 0.78). The other four signals were tested in three additional independent AD family samples composed of nearly 2700 individuals from almost 900 families. Two of these SNPs showed significant association in the replication samples (combined p values 0.007 and 0.00002). The SNP (rs11159647, on chromosome 14q31) with the strongest association signal also showed evidence of association with the same allele in GWA data generated in an independent sample of similar to 1,400 AD cases and controls (p = 0.04). Although the precise identity of the underlying locus(i) remains elusive, our study provides compelling evidence for the existence of at least one previously undescribed AD gene that, like APOE-epsilon 4, primarily acts as a modifier of onset age.	[Bertram, Lars; Mullin, Kristina; Parkinson, Michele; Hsiao, Monica; Hogan, Meghan F.; Schjeide, Brit M. M.; Hooli, Basavaraj; DiVito, Jason; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis MIND, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA; [Lange, Christoph; Ionita, Luliana; Jiang, Hongyu; Laird, Nan; Murphy, Amy] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Blacker, Deborah] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Moscarillo, Thomas; Blacker, Deborah] Massachusetts Gen Hosp, Dept Psychiat, Gerontol Res Unit, Charlestown, MA 02129 USA; [Ohlsen, Kari L.; Elliott, Kathryn; Wang, Xin; Hu-Lince, Diane; Ryder, Marie; Wagner, Steven L.] TorreyPines Therapeut, La Jolla, CA 92037 USA		Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis MIND, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019; Hogan, Meghan/AAD-4425-2020; Bertram, Lars/K-3889-2015	Tanzi, Rudolph/0000-0002-7032-1454; Bertram, Lars/0000-0002-0108-124X; Elliott, Kathryn/0000-0002-4926-1215; Hogan, Meghan/0000-0002-5767-1599	Cure Alzheimer Fund; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); Extendicare Foundation; EisaiEisai Co Ltd; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U24AG021886] Funding Source: NIH RePORTER	The authors wish to thank all families for participating in this study. This work was sponsored by grants from the Cure Alzheimer Fund (as part of the "Alzheimer Genorne Project"), the NIMH, and the Extendicare Foundation. Work completed at TorreyPines Therapeutics and was funded by Eisai. L.B. and R.E.T. are consultants to, and equity holders in, TorreyPines Therapeutics and Prana Biotechnology. R.E.T is also a consultant to Prana Biotechnology. R.E.T. is a cofounder of both TorreyPines Therapeutics and Prana Biotechnology. K.L.O., K.E., X.W., D.H.-L., M.R., K.D.B., and S.W. are employees of, and hold stock options in, TorreyPines Therapeutics. K.E. and S.W also hold stock in Merck.	Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Chen XN, 1999, GENOME RES, V9, P492; Fisher RA., 1925, STAT METHODS RES WOR; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Ionita-Laza I, 2007, AM J HUM GENET, V81, P607, DOI 10.1086/519748; Jiang HY, 2006, GENET EPIDEMIOL, V30, P124, DOI 10.1002/gepi.20132; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lee JH, 2008, NEUROGENETICS, V9, P51, DOI 10.1007/s10048-007-0103-3; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Orr HT, 2001, HUM MOL GENET, V10, P2307, DOI 10.1093/hmg/10.20.2307; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHJEIDE BMM, 2008, NEUROGENETI IN PRESS, DOI DOI 10.1007/S10048-008-0151-3; SCHJEIDE BMM, 2009, ARCH NEUROL IN PRESS; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; von Gunten S, 2006, FASEB J, V20, P601, DOI 10.1096/fj.05-5401hyp	29	335	343	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					623	632		10.1016/j.ajhg.2008.10.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	WOS:000261006900009	18976728	Green Published, Bronze			2022-01-24	
J	Wu, M; Eisen, JA				Wu, Martin; Eisen, Jonathan A.			A simple, fast, and accurate method of phylogenomic inference	GENOME BIOLOGY			English	Article							SEQUENCE ALIGNMENT; TREE; EVOLUTION; POSITION; GENES; TAXA; BIAS	The explosive growth of genomic data provides an opportunity for increased usage of protein markers for phylogenetic inference. In response, we have developed an automated pipeline for phylogenomic analysis ( AMPHORA) that overcomes the existing bottlenecks limiting large-scale protein phylogenetic inference. We demonstrated its high throughput capabilities and high quality results by constructing a genome tree of 578 bacterial species and by assigning phylotypes to 18,607 protein markers identified in metagenomic data collected from the Sargasso Sea.	[Wu, Martin; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Sect Evolut & Ecol, Coll Biol Sci, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Sch Med, Davis, CA 95616 USA		Wu, M (corresponding author), Univ Calif Davis, Genome Ctr, 5315 GBSF,451 Hlth Sci Dr,1 Shields Ave, Davis, CA 95616 USA.	martinwu@ucdavis.edu; jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Wu, Martin/0000-0003-3093-4077	NSFNational Science Foundation (NSF) [DEB-0228651]; Gordon and Betty Moore FoundationGordon and Betty Moore Foundation [1660]	The initial development of this work was supported in part by NSF grant DEB-0228651 to JAE. The final development and testing was funded by the Gordon and Betty Moore Foundation (grant # 1660 to JAE).	Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Brocchieri L, 2001, THEOR POPUL BIOL, V59, P27, DOI 10.1006/tpbi.2000.1485; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; COLE JR, 2006, GENOMICS GTL CONTRAC; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Garrity G.M., 2004, TAXONOMIC OUTLINE PR; GATESY J, 1993, MOL PHYLOGENET EVOL, V2, P152, DOI 10.1006/mpev.1993.1015; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1993, NATURE, V361, P23, DOI 10.1038/361023b0; HUSON DH, 2007, GENOME RES; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kasai, 1998, Genome Inform Ser Workshop Genome Inform, V9, P13; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; LOOMIS WF, 1990, P NATL ACAD SCI USA, V87, P9093, DOI 10.1073/pnas.87.23.9093; Ludwig W, 2000, BERGEYS MANUAL SYSTE, V1, P49; Maughan H, 2007, EVOLUTION, V61, P280, DOI 10.1111/j.1558-5646.2007.00026.x; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2005, SYST BIOL, V54, P527, DOI 10.1080/10635150590947023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOESE CR, 1991, SYST APPL MICROBIOL, V14, P364, DOI 10.1016/S0723-2020(11)80311-5; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065	41	335	342	1	49	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2008	9	10							R151	10.1186/gb-2008-9-10-r151			34	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	367YA	WOS:000260587300019	18851752	hybrid, Green Published			2022-01-24	
J	He, XC; Yin, T; Grindley, JC; Tian, Q; Sato, T; Tao, WA; Dirisina, R; Porter-Westpfahl, KS; Hembree, M; Johnson, T; Wiedemann, LM; Barrett, TA; Hood, L; Wu, H; Li, LH				He, Xi C.; Yin, Tong; Grindley, Justin C.; Tian, Qiang; Sato, Toshiro; Tao, W. Andy; Dirisina, Raminarao; Porter-Westpfahl, Kimberly S.; Hembree, Mark; Johnson, Teri; Wiedemann, Leanne M.; Barrett, Terrence A.; Hood, Leroy; Wu, Hong; Li, Linheng			PTEN-deficient intestinal stem cells initiate intestinal polyposis	NATURE GENETICS			English	Article							BETA-CATENIN; GERMLINE MUTATIONS; JUVENILE POLYPOSIS; CRYPT FISSION; SELF-RENEWAL; PROTEIN-KINASE; CANCER CELLS; CYCLIN D1; PHOSPHORYLATION; EXPRESSION	Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells ( ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog ( PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector beta-catenin. Akt phosphorylates beta-catenin at Ser552, resulting in a nuclear- localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN- deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of beta- catenin.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Inst Syst Biol, Seattle, WA 98103 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Northwestern Univ, Sch Med, Div Gastroenterol, Dept Med Microbiol & Immunol, Chicago, IL 60611 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Tao, Weiguo/AAL-2777-2020; Wiedemann, Leanne/E-3316-2010; Sato, Toshiro/J-3522-2014; Tao, Andy/N-1290-2019	Tao, Weiguo/0000-0002-5535-5517; Sato, Toshiro/0000-0001-8353-8137; Wiedemann, Leanne/0000-0002-0964-4676; Li, Linheng/0000-0001-9963-430X; Barrett, Terrence/0000-0001-6428-3271	NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI061701, R01 AI061701-02] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK070001] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI061701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK070001] Funding Source: NIH RePORTER		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Koike M, 2004, J BIOL CHEM, V279, P34038, DOI 10.1074/jbc.M405821200; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Megy S, 2005, PEPTIDES, V26, P227, DOI 10.1016/j.peptides.2004.09.021; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Preston SL, 2003, CANCER RES, V63, P3819; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wasan HS, 1998, J PATHOL, V185, P246; Wirtzfeld DA, 2001, ANN SURG ONCOL, V8, P319, DOI 10.1007/s10434-001-0319-7; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	50	335	346	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					189	198		10.1038/ng1928			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	WOS:000244063900016	17237784	Green Accepted			2022-01-24	
J	Lehner, B; Crombie, C; Tischler, J; Fortunato, A; Fraser, AG				Lehner, Ben; Crombie, Catriona; Tischler, Julia; Fortunato, Angelo; Fraser, Andrew G.			Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways	NATURE GENETICS			English	Article							ENHANCED RNA INTERFERENCE; C-ELEGANS; SPLIT-ENDS; MORPHOLOGICAL EVOLUTION; COMPLEX; COMPONENT; PROTEIN; SCREEN; RAS; CAPACITOR	Most heritable traits, including disease susceptibility, are affected by interactions between multiple genes. However, we understand little about how genes interact because very few possible genetic interactions have been explored experimentally. We have used RNA interference in Caenorhabditis elegans to systematically test similar to 65,000 pairs of genes for their ability to interact genetically. We identify similar to 350 genetic interactions between genes functioning in signaling pathways that are mutated in human diseases, including components of the EGF/Ras, Notch and Wnt pathways. Most notably, we identify a class of highly connected 'hub' genes: inactivation of these genes can enhance the phenotypic consequences of mutation of many different genes. These hub genes all encode chromatin regulators, and their activity as genetic hubs seems to be conserved across animals. We propose that these genes function as general buffers of genetic variation and that these hub genes may act as modifier genes in multiple, mechanistically unrelated genetic diseases in humans.	Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England		Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	agf@sanger.ac.uk	Fortunato, Angelo/AAI-1120-2019; Lehner, Ben/ABH-6562-2020; Lehner, Ben/L-3413-2014	Fortunato, Angelo/0000-0001-7363-0423; Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Fraser, Andrew/0000-0001-9939-6014	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Bach EA, 2003, GENETICS, V165, P1149; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; CARRERA I, 2003, DROS RES C, V44, pA346; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; CLARK DV, 1995, MOL GEN GENET, V247, P367, DOI 10.1007/BF00293205; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng Y, 2003, CANCER RES, V63, P8726; Gause M, 2006, MOL CELL BIOL, V26, P2347, DOI 10.1128/MCB.26.6.2347-2359.2006; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Herman MA, 1999, DEVELOPMENT, V126, P1055; Howard RM, 2002, GENE DEV, V16, P1815, DOI 10.1101/gad.998402; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; JANODY F, 2002, DROS RES C, V43, P90; Jiang LI, 1999, GENE DEV, V13, P877, DOI 10.1101/gad.13.7.877; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lin HV, 2003, DEVELOPMENT, V130, P3125, DOI 10.1242/dev.00527; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Moghal N, 2003, DEVELOPMENT, V130, P57, DOI 10.1242/dev.00189; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rebay I, 2000, GENETICS, V154, P695; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Staehling-Hampton K, 1999, GENETICS, V153, P275; SUNDARAM MV, WORMBOOK; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Haaften G, 2004, P NATL ACAD SCI USA, V101, P12992, DOI 10.1073/pnas.0403131101; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Zhang H, 2001, DEVELOPMENT, V128, P767	48	335	347	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					896	903		10.1038/ng1844			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	WOS:000239325700018	16845399				2022-01-24	
J	Bonneau, R; Reiss, DJ; Shannon, P; Facciotti, M; Hood, L; Baliga, NS; Thorsson, V				Bonneau, Richard; Reiss, David J.; Shannon, Paul; Facciotti, Marc; Hood, Leroy; Baliga, Nitin S.; Thorsson, Vesteinn			The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo	GENOME BIOLOGY			English	Article							DIFFERENTIALLY-EXPRESSED GENES; MODULES; REPRESSOR; DISCOVERY; MODELS; NRC-1	We present a method ( the Inferelator) for deriving genome-wide transcriptional regulatory interactions, and apply the method to predict a large portion of the regulatory network of the archaeon Halobacterium NRC-1. The Inferelator uses regression and variable selection to identify transcriptional influences on genes based on the integration of genome annotation and expression data. The learned network successfully predicted Halobacterium's global expression under novel perturbations with predictive power similar to that seen over training data. Several specific regulatory predictions were experimentally tested and verified.	NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; NYU, Dept Comp Sci, Courant Inst, New York, NY 10003 USA; Inst Syst Biol, Seattle, WA 98103 USA		Bonneau, R (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA.	bonneau@cs.nyu.edu	Facciotti, Marc/AAF-9227-2020; Bonneau, Richard/ABD-6737-2021	Facciotti, Marc/0000-0003-4453-3274; baliga, nitin/0000-0001-9157-5974	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM64361] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM064361] Funding Source: NIH RePORTER		Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Baliga NS, 2000, MOL MICROBIOL, V36, P1184, DOI 10.1046/j.1365-2958.2000.01916.x; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; CHENG Y, 2000, P 8 INT C INT SYST M, P93; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; Friedman J, 2008, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; FRIEDMAN N, 2003, BIOINFORMATICS, P57; Gustafsson M, 2005, IEEE ACM T COMPUT BI, V2, P254, DOI 10.1109/TCBB.2005.35; Hashimoto RF, 2004, BIOINFORMATICS, V20, P1241, DOI 10.1093/bioinformatics/bth074; Herrgard MJ, 2004, CURR OPIN BIOTECH, V15, P70, DOI 10.1016/j.copbio.2003.11.002; Hill PJ, 1998, INFECT IMMUN, V66, P4123; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mellor JC, 2002, NUCLEIC ACIDS RES, V30, P306, DOI 10.1093/nar/30.1.306; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Price MN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-19; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Segal E, 2001, Bioinformatics, V17 Suppl 1, pS243; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SHANNON P, IN PRESS BMC BIOINFO; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sheng QZ, 2003, BIOINFORMATICS, V19, pII196, DOI 10.1093/bioinformatics/btg1078; Shmulevich I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048701; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Thorsson V, 2005, STAT APPL GENET MOL, V4; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Someren E P, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P355; van Someren EP, 2002, PHARMACOGENOMICS, V3, P507, DOI 10.1517/14622416.3.4.507; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wahde M, 2001, J COMPUT BIOL, V8, P429, DOI 10.1089/106652701752236223; Weaver D C, 1999, Pac Symp Biocomput, P112; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yang J, 2002, PROC INT CONF DATA, P517, DOI 10.1109/ICDE.2002.994771; Yang J, 2003, THIRD IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING - BIBE 2003, PROCEEDINGS, P321	53	335	341	2	18	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2006	7	5							R36	10.1186/gb-2006-7-5-r36			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	059DG	WOS:000238712900011	16686963	hybrid, Green Published			2022-01-24	
J	Nguyen, DK; Disteche, CM				Nguyen, DK; Disteche, CM			Dosage compensation of the active X chromosome in mammals	NATURE GENETICS			English	Article							LINKED GENE-EXPRESSION; EARLY MOUSE EMBRYOS; DIFFERENTIAL EXPRESSION; TRANSCRIPTOME ANALYSIS; DOWN-SYNDROME; MUS MUSCULUS; MALE MEIOSIS; GENOME-WIDE; INACTIVATION; SPERMATOGENESIS	Monosomy of the X chromosome owing to divergence between the sex chromosomes leads to dosage compensation mechanisms to restore balanced expression between the X and the autosomes. In Drosophila melanogaster, upregulation of the male X leads to dosage compensation. It has been hypothesized that mammals likewise upregulate their active X chromosome. Together with X inactivation, this mechanism would maintain balanced expression between the X chromosome and autosomes and between the sexes. Here, we show that doubling of the global expression level of the X chromosome leads to dosage compensation in somatic tissues from several mammalian species. X-linked genes are highly expressed in brain tissues, consistent with a role in cognitive functions. Furthermore, the X chromosome is expressed but not upregulated in spermatids and secondary oocytes, preserving balanced expression of the genome in these haploid cells. Upon fertilization, upregulation of the active X must occur to achieve the observed dosage compensation in early embryos.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA		Disteche, CM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	cdistech@u.washington.edu					Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; Akhtar A, 2003, CURR OPIN GENET DEV, V13, P161, DOI 10.1016/S0959-437X(03)00016-9; Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birchler JA, 2003, GENETICA, V117, P179, DOI 10.1023/A:1022935927763; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Cheng MK, 2004, BIOESSAYS, V26, P821, DOI 10.1002/bies.20082; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Gartler S M, 1976, Adv Hum Genet, V7, P99; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GUPTA V, IN PRESS J BIOL; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; MCCARREY JR, 1992, GENET ANAL-BIOMOL E, V9, P117, DOI 10.1016/1050-3862(92)90051-6; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Ohno S., 1967, SEX CHROMOSOMES SEX; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Straub T, 2005, FEBS LETT, V579, P3258, DOI 10.1016/j.febslet.2005.03.050; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zheng P, 2004, BIOL REPROD, V70, P1419, DOI 10.1095/biolreprod.103.023796; Zhou X, 2005, J MED GENET, V42, P416, DOI 10.1136/jmg.2004.025353	49	335	340	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					47	53		10.1038/ng1705			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	WOS:000234227200016	16341221				2022-01-24	
J	Fukui, T; Atomi, H; Kanai, T; Matsumi, R; Fujiwara, S; Imanaka, T				Fukui, T; Atomi, H; Kanai, T; Matsumi, R; Fujiwara, S; Imanaka, T			Complete genome sequence of the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1 and comparison with Pyrococcus genomes	GENOME RESEARCH			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; BETA-D-GLUCOSAMINIDASE; LATERAL GENE-TRANSFER; CHITINOLYTIC PATHWAY; CRYSTAL-STRUCTURE; EXPRESSION; EVOLUTION; PROTEINS; CLONING; METHANOCOCCUS	The genus Thermococcus, comprised Of sulfur-reducing hyperthermophillic archaea, belongs to the order Thermococcales in Euryarchaeota along with the closely related genus Pyrococcus. The members of Thermococcus are ubiquitously present in natural high-temperature environments, and are therefore considered to play a major role in the ecology and metabolic activity of microbial consortia within hot-water ecosystems. To obtain insight into this important genus, we have determined and annotated the complete 2,088,737-base genome of Thermococcus kodakaraensis strain KOD1, followed by a comparison with the three complete genomes of Pyrococcus spp. A total of 2306 coding DNA sequences (CDSs) have been identified, among which half (1165 CDSs) are annotatable, whereas the functons of 41% (936 CDSs) cannot be predicted from the primary structures. The genome contains seven genes for probable transposases and four virus-related regions. Several proteins within these genetic elements show high similarities to those in Pyrococcus spp., implying the natural Occurrence of horizontal gene transfer Of such mobile elements among the order Thermococcales. Comparative genomics clarified that 1204 proteins, including those for information processing and basic metabolisms, are shared among T. kodakaraensis and the three Pyrococcus spp. On the other hand, among the set of 689 proteins unique to T. kodakaraensis, there are several intriguing proteins that might be responsible for the specific trait of the genus Thermococcus, Such as proteins involved in additional pyruvate oxidation, nucleotide metabolisms, unique or additional metal ion transporters, improved stress response system, and a distinct restriction system.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; Kyoto Univ, Katsura Inttech Ctr, Nishikyo Ku, Kyoto 6158510, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Nanobiotechnol Res Ctr, Sanda 6691337, Japan		Imanaka, T (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	imanaka@sbchem.kyoto-u.ac.jp	福居, 俊昭/K-5056-2012; Fukui, Toshiaki/S-6882-2019; Kanai, Tamotsu/I-5842-2012	福居, 俊昭/0000-0003-4557-6284; Fukui, Toshiaki/0000-0003-4557-6284; Kanai, Tamotsu/0000-0003-3537-2114; Atomi, Haruyuki/0000-0001-9687-6426			Adams HS, 2001, J EXPO ANAL ENV EPID, V11, P5, DOI 10.1038/sj.jea.7500152; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1111/j.1574-6976.2001.tb00576.x; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Chakravarty S, 2000, FEBS LETT, V470, P65, DOI 10.1016/S0014-5793(00)01267-9; Chinen A, 2000, GENE, V259, P109, DOI 10.1016/S0378-1119(00)00459-5; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; DiRuggiero J, 2000, MOL MICROBIOL, V38, P684, DOI 10.1046/j.1365-2958.2000.02161.x; Ettema TJG, 2004, J BACTERIOL, V186, P7754, DOI 10.1128/JB.186.22.7754-7762.2004; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Fukuda W, 2004, J BACTERIOL, V186, P4620, DOI 10.1128/JB.186.14.4620-4627.2004; Galichet A, 1999, FEBS LETT, V458, P188, DOI 10.1016/S0014-5793(99)01155-2; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Higashibata H, 2003, J BIOL CHEM, V278, P15983, DOI 10.1074/jbc.M207748200; Holden JF, 2001, FEMS MICROBIOL ECOL, V36, P51, DOI 10.1016/S0168-6496(01)00118-0; Huber R, 2001, METHOD ENZYMOL, V330, P11; Hutchins AM, 2001, J BACTERIOL, V183, P709, DOI 10.1128/JB.183.2.709-715.2001; Ideno A, 2002, GENE, V292, P57, DOI 10.1016/S0378-1119(02)00674-1; Ideno A, 2001, BIOCHEM J, V357, P465, DOI 10.1042/0264-6021:3570465; Imanaka T, 2002, CHEM REC, V2, P149, DOI 10.1002/tcr.10023; Itoh T, 2003, J BIOSCI BIOENG, V96, P203, DOI 10.1016/S1389-1723(03)80183-4; Izumi M, 1999, APPL ENVIRON MICROB, V65, P1801; Izumi M, 2001, BIOCHEM BIOPH RES CO, V280, P581, DOI 10.1006/bbrc.2000.4154; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kanai T, 2003, J BACTERIOL, V185, P1705, DOI 10.1128/JB.185.5.1705-1711.2003; KANAI T, 2005, IN PRESS J BIOTECHNO; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Koning Sonja M., 2002, Archaea, V1, P19, DOI 10.1155/2002/529610; Lecompte O, 2001, GENOME RES, V11, P981, DOI 10.1101/gr.GR1653R; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lucas S, 2002, APPL ENVIRON MICROB, V68, P5528, DOI 10.1128/AEM.68.11.5528-5536.2002; Ma K, 2001, METHOD ENZYMOL, V334, P40; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Makino S, 1999, P JPN ACAD B-PHYS, V75, P166, DOI 10.2183/pjab.75.166; Malandrin L, 1999, GENETICS, V152, P1315; Martusewitsch E, 2000, J BACTERIOL, V182, P2574, DOI 10.1128/JB.182.9.2574-2581.2000; McDonald JH, 1999, MOL BIOL EVOL, V16, P1785, DOI 10.1093/oxfordjournals.molbev.a026090; Mira A, 2002, CURR OPIN MICROBIOL, V5, P506, DOI 10.1016/S1369-5274(02)00358-2; Mitaku S, 1999, BIOPHYS CHEM, V82, P165, DOI 10.1016/S0301-4622(99)00116-7; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Niehaus F, 2000, FEMS MICROBIOL LETT, V190, P223, DOI 10.1016/S0378-1097(00)00339-6; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Nishioka M, 2001, J BIOTECHNOL, V88, P141, DOI 10.1016/S0168-1656(01)00275-9; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Peng X, 2000, J MOL BIOL, V303, P449, DOI 10.1006/jmbi.2000.4160; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Rashid N, 2002, J BACTERIOL, V184, P777, DOI 10.1128/JB.184.3.777-784.2002; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Sakiyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P670, DOI 10.1271/bbb.64.670; Sakuraba H, 2002, J BIOSCI BIOENG, V93, P441, DOI 10.1263/jbb.93.441; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; She QX, 2001, NATURE, V409, P478, DOI 10.1038/35054138; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Tachibana Y, 1996, J FERMENT BIOENG, V82, P224, DOI 10.1016/0922-338X(96)88812-X; Tachibana Y, 1997, J FERMENT BIOENG, V83, P540, DOI 10.1016/S0922-338X(97)81134-8; Tanaka T, 1999, APPL ENVIRON MICROB, V65, P5338; Tanaka T, 2004, J BIOL CHEM, V279, P30021, DOI 10.1074/jbc.M314187200; Tanaka T, 2003, J BACTERIOL, V185, P5175, DOI 10.1128/JB.185.17.5175-5181.2003; Tanaka T, 2001, J BIOL CHEM, V276, P35629, DOI 10.1074/jbc.M105919200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van der Oost J, 1998, J BIOL CHEM, V273, P28149, DOI 10.1074/jbc.273.43.28149; WATRIN L, 1995, APPL ENVIRON MICROB, V61, P1138, DOI 10.1128/AEM.61.3.1138-1140.1995; Woodson JD, 2004, P NATL ACAD SCI USA, V101, P3591, DOI 10.1073/pnas.0305939101; Woodward A, 2003, TOB CONTROL, V12, P1; Yada T, 2001, DNA RES, V8, P97, DOI 10.1093/dnares/8.3.97; Zivanovic Y, 2002, NUCLEIC ACIDS RES, V30, P1902, DOI 10.1093/nar/30.9.1902	82	335	773	0	34	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2005	15	3					352	363		10.1101/gr.3003105			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	902CB	WOS:000227327800002	15710748	Green Published, Bronze			2022-01-24	
J	Kurose, K; Gilley, K; Matsumoto, S; Watson, PH; Zhou, XP; Eng, C				Kurose, K; Gilley, K; Matsumoto, S; Watson, PH; Zhou, XP; Eng, C			Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas	NATURE GENETICS			English	Article							EXPRESSION; CANCERS	We have recently shown that loss of heterozygosity of specific markers, including those at 10q23, 17p13-p15 and 16q24, can occur in the stromal and epithelial compartments of primary invasive breast carcinomas. Here, we demonstrate high frequencies of somatic mutations in TP53 (encoding tumor protein p53) and PTEN (encoding phosphate and tensin homolog) in breast neoplastic epithelium and stroma. Mutations in TP53 and PTEN are mutually exclusive in either compartment. In contrast, mutations in WFDC1 (16q24, encoding WAP four-disulfide core domain 1) occur with low frequency in the stroma.	Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada; Univ Cambridge, Human Canc Genet Res Grp, Canc Res UK, Cambridge CB2 2XZ, England		Eng, C (corresponding author), Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA.			Eng, Charis/0000-0002-3693-5145; Watson, Peter/0000-0002-1642-0638			ENG C, 2001, METABOLIC MOL BASES, V1, P979; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Larsen M, 2000, MAMM GENOME, V11, P767, DOI 10.1007/s003350010135; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tomlinson IPM, 2002, GENE CHROMOSOME CANC, V34, P349, DOI 10.1002/gcc.10085; Wernert N, 2001, ANTICANCER RES, V21, P2259	8	335	349	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					355	357		10.1038/ng1013			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	WOS:000179034800009	12379854				2022-01-24	
J	Noble, JA; Valdes, AM; Cook, M; Klitz, W; Thomson, G; Erlich, HA				Noble, JA; Valdes, AM; Cook, M; Klitz, W; Thomson, G; Erlich, HA			The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONRADIOACTIVE OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN-REACTION; SEQUENCE POLYMORPHISM; AMPLIFIED DNA; A ANTIGENS; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY GENES; DISEASE ASSOCIATIONS; PARENTAL ORIGIN; ALLELES	We report here our analysis of HLA class II alleles in 180 Caucasian nuclear families with at least two children with insulin-dependent diabetes mellitus (IDDM). DRB1, DQA1, DQB1, and DPB1 genotypes were determined with PCR/sequence-specific oligonucleotide probe typing methods. The data allowed unambiguous determination of four-locus haplotypes in all but three of the families, Consistent with other studies, our data indicate an increase in DR3/DR4, DR3/DR3, and DR4/DR4 genotypes in patients compared to controls. In addition, we found an increase in DR1/DR4, DR1/DR3, and DR4/DR8 genotypes. While the frequency of DQB1*0302 on DR4 haplotypes is dramatically increased in DR3/DR4 patients, DR4 haplotypes in DR1/DR4 patients exhibit frequencies of DQB1*0302 and DQB1*0301 more closely resembling those in control populations. The protective effect of DR2 is evident in this data set and is limited to the common DRB1*1501-DQB1*0602 haplotype. Most DR2(+) patients carry the less common DR2 haplotype DRB1*1601-DQB1*0502, which is not decreased in patients relative to controls. DPB1 also appears to play a role in disease susceptibility. DPB1*0301 is increased in patients (P < .001) and may contribute to the disease risk of a number of different DR-DQ haplotypes. DPB1*0101, found almost exclusively on DR3 haplotypes in patients, is slightly increased, and maternal transmissions of DRB1*0301-DPB1*0101 haplotypes to affected children occur twice as frequently as do paternal transmissions. Transmissions of DR3 haplotypes carrying other DPB1 alleles occur at approximately equal maternal and paternal frequencies. The complex, multigenic nature of HLA class II-associated IDDM susceptibility is evident from these data.	CHILDRENS HOSP OAKLAND,RES INST,OAKLAND,CA 94609; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720		Noble, JA (corresponding author), ROCHE MOL SYST,DEPT HUMAN GENET,1145 ATLANTIC AVE,ALAMEDA,CA 94501, USA.			Valdes, Ana M./0000-0003-1141-4471	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK046626, R01DK046622] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK46626, DK46622] Funding Source: Medline		AWATA T, 1992, DIABETOLOGIA, V35, P906; AWATA T, 1992, DIABETOLOGIA, V35, P419, DOI 10.1007/BF02342437; BAIN SC, 1994, DIABETES, V43, P1462, DOI 10.2337/diabetes.43.12.1462; BALDUCCISILANO PL, 1995, AUTOIMMUNITY, V21, P13; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BLACKWELDER WC, 1986, GENET EPIDEMIOL, V3, P379; BODMER JG, 1995, TISSUE ANTIGENS, V46, P1; BUGAWAN TL, 1988, J IMMUNOL, V141, P4024; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; BUGAWAN TL, 1991, IMMUNOGENETICS, V34, P413, DOI 10.1007/BF01787493; CAILLATZUCMAN S, 1992, J CLIN INVEST, V90, P2242, DOI 10.1172/JCI116110; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; CUDWORTH AG, 1974, LANCET, V2, P1153; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEKOSTER HS, 1992, EUR J IMMUNOL, V22, P1531, DOI 10.1002/eji.1830220628; DESCHAMPS I, 1990, DIABETOLOGIA, V33, P425, DOI 10.1007/BF00404094; EASTEAL S, 1990, DIABETES, V39, P855, DOI 10.2337/diabetes.39.7.855; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; ERLICH H, 1993, ARCH PATHOL LAB MED, V117, P482; ERLICH HA, 1991, DIABETES, V40, P478, DOI 10.2337/diabetes.40.4.478; ERLICH HA, 1991, BAILLIERE CLIN ENDOC, V5, P395, DOI 10.1016/S0950-351X(05)80138-7; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; ERLICH HA, 1990, DIABETES, V39, P96, DOI 10.2337/diabetes.39.1.96; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; FOHLMAN J, 1993, ANN MED, V25, P569; HARFOUCH E, 1995, AUTOIMMUNITY, V21, P14; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; HORN GT, 1988, HUM IMMUNOL, V21, P249, DOI 10.1016/0198-8859(88)90034-1; HU CY, 1993, HUM IMMUNOL, V38, P105, DOI 10.1016/0198-8859(93)90526-7; Huang HS, 1995, HUM IMMUNOL, V44, P210, DOI 10.1016/0198-8859(95)00108-5; KLITZ W, 1994, AM J HUM GENET, V54, P497; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; LUO DF, 1995, AM J HUM GENET, V57, P911; MARGARITTEJEANNIN P, 1995, AM J HUM GENET, V56, P1080; NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; NERUP J, 1974, LANCET, V2, P864; OWERBACH D, 1989, DIABETES, V38, P942, DOI 10.2337/diabetes.38.7.942; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; PAYAMI H, 1989, AM J HUM GENET, V45, P541; REIJONEN H, 1995, 9 INT C IMM SAN FRAN; RISCH N, 1987, AM J HUM GENET, V40, P1; RONNINGEN KS, 1991, DIABETES, V40, P759, DOI 10.2337/diabetes.40.6.759; ROSENLICHT JW, 1993, IMMUNOGENETICS, V37, P479; ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SCHROEIJERS WEM, 1992, HUM IMMUNOL, V33, P229, DOI 10.1016/0198-8859(92)90329-L; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; TAIT BD, 1988, DIABETES, V37, P926, DOI 10.2337/diabetes.37.7.926; TAIT BD, 1991, BAILLIERE CLIN ENDOC, V5, P211, DOI 10.1016/S0950-351X(05)80124-7; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1995, AM J HUM GENET, V57, P474; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TRUCCO M, 1995, J PEDIATR ENDOCR MET, V8, P3; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; VADHEIM CM, 1986, NEW ENGL J MED, V315, P1314, DOI 10.1056/NEJM198611203152103; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	76	335	343	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1134	1148					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	WOS:A1996VN90000023	8900244				2022-01-24	
J	KUHNER, MK; YAMATO, J; FELSENSTEIN, J				KUHNER, MK; YAMATO, J; FELSENSTEIN, J			ESTIMATING EFFECTIVE POPULATION-SIZE AND MUTATION-RATE FROM SEQUENCE DATA USING METROPOLIS-HASTINGS SAMPLING	GENETICS			English	Article							MAXIMUM-LIKELIHOOD APPROACH; SEGREGATING SITES	We present a new way to make a maximum likelihood estimate of the parameter 4N(e) mu (effective population size times mutation rate per site, or theta) based on a population sample of molecular sequences. We use a Metropolis-Hastings Markov chain Monte Carlo method to sample genealogies in proportion to the product of their likelihood with respect to the data and their prior probability with respect to a coalescent distribution. A specific value of theta must be chosen to generate the coalescent distribution, but the resulting trees can be used to evaluate the likelihood at other values of theta, generating a likelihood curve. This procedure concentrates sampling on those genealogies that contribute most of the likelihood, allowing estimation of meaningful likelihood curves based on relatively small samples. The method can potentially be extended to cases involving varying population size, recombination, and migration.			KUHNER, MK (corresponding author), UNIV WASHINGTON,DEPT GENET,BOX 357360,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R55GM041716] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [2-R55GM41716-04] Funding Source: Medline		FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1992, EVOLUTION, V46, P159, DOI [10.2307/2409811, 10.1111/j.1558-5646.1992.tb01991.x]; FU YX, 1994, GENETICS, V136, P685; FU YX, 1994, GENETICS, V138, P1375; GRIFFITHS RC, 1993, P ROY SOC LOND B BIO, V344, P403; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman JFC, 1982, STOCH PROCESS APPL, V13, P235, DOI 10.1016/0304-4149(82)90011-4; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; SMOUSE PE, 1987, EVOLUTION, V41, P1162, DOI 10.1111/j.1558-5646.1987.tb02458.x; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; [No title captured]	19	335	337	0	15	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	AUG	1995	140	4					1421	1430					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL508	WOS:A1995RL50800023	7498781				2022-01-24	
J	WASCO, W; GURUBHAGAVATULA, S; DPARADIS, M; ROMANO, DM; SISODIA, SS; HYMAN, BT; NEVE, RL; TANZI, RE				WASCO, W; GURUBHAGAVATULA, S; DPARADIS, M; ROMANO, DM; SISODIA, SS; HYMAN, BT; NEVE, RL; TANZI, RE			ISOLATION AND CHARACTERIZATION OF APLP2 ENCODING A HOMOLOG OF THE ALZHEIMERS ASSOCIATED AMYLOID BETA-PROTEIN PRECURSOR	NATURE GENETICS			English	Article							MESSENGER-RNA; GENETIC-LINKAGE; DISEASE LOCUS; CDNA; LOCALIZATION; PEPTIDE; CHROMOSOME-14; RECEPTOR; MUTATION; MAPS	Familial Alzheimer's disease (FAD) is a genetically heterogeneous disorder that includes a rare early-onset form linked to mutations in the amyloid b protein precursor (APP) gene. Clues to the function of APP derive from the recent finding that it is a member of a highly conserved protein family that includes the mammalian amyloid precursor-like protein (APLP1) gene which maps to the same general region of human chromosome 19 linked to late-onset FAD. Here we report the isolation of the human APLP2 gene. We show that APLP2 is a close relative of APP and exhibits a very similar pattern of expression in the brain and throughout the body. Like APP, APLP2 contains a cytoplasmic domain predicted to couple with the GTP-binding protein G(o) indicating that it may be an additional cell surface activator of this G protein.	MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02115 USA; MCLEAN HOSP, MAILMAN RES CTR, BELMONT, MA 02178 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA		WASCO, W (corresponding author), MASSACHUSETTS GEN HOSP, CTR NEUROSCI, GENET & AGING LAB, BOSTON, MA 02129 USA.		Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Paradis, Marc d./0000-0003-2387-3157	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R29AG008487, R01AG008487] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG08487] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30428] Funding Source: Medline		BUSH AI, IN PRESS J BIOL CHEM; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GEISSLER EN, 1991, SOMAT CELL MOLEC GEN, V17, P207, DOI 10.1007/BF01232978; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GUILLEN A, 1990, EMBO J, V9, P1449, DOI 10.1002/j.1460-2075.1990.tb08261.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HYMAN BT, 1993, MOL BRAIN RES, V18, P253, DOI 10.1016/0169-328X(93)90197-W; JACOBSEN JS, 1991, NEUROBIOL AGING, V12, P575, DOI 10.1016/0197-4580(91)90089-3; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONIG G, 1992, J BIOL CHEM, V267, P19804; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; PALACIOS G, 1992, MOL BRAIN RES, V15, P195, DOI 10.1016/0169-328X(92)90109-O; PELLETIER J, 1991, GENOMICS, V10, P1079, DOI 10.1016/0888-7543(91)90203-Q; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRITMATTER SM, NATURE, V344, P836; TANZI RE, 1993, MOL BRAIN RES, V18, P246, DOI 10.1016/0169-328X(93)90196-V; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1991, ANN NY ACAD SCI, V640, P149; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WASCO W, 1992, GENOMICS, V15, P238; WASCO W, IN PRESS ALZHEIMERS; YAN YC, 1990, P NATL ACAD SCI USA, V87, P2405, DOI 10.1073/pnas.87.7.2405; ZIMMERMANN K, 1988, EMBO J, V7, P367, DOI 10.1002/j.1460-2075.1988.tb02822.x; 1991, PROGRAM MANUAL GCG P	51	335	342	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					95	100		10.1038/ng0993-95			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	WOS:A1993LV56500025	8220435				2022-01-24	
J	THOMSON, G; ROBINSON, WP; KUHNER, MK; JOE, S; MACDONALD, MJ; GOTTSCHALL, JL; BARBOSA, J; RICH, SS; BERTRAMS, J; BAUR, MP; PARTANEN, J; TAIT, BD; SCHOBER, E; MAYR, WR; LUDVIGSSON, J; LINDBLOM, B; FARID, NR; THOMPSON, C; DESCHAMPS, I				THOMSON, G; ROBINSON, WP; KUHNER, MK; JOE, S; MACDONALD, MJ; GOTTSCHALL, JL; BARBOSA, J; RICH, SS; BERTRAMS, J; BAUR, MP; PARTANEN, J; TAIT, BD; SCHOBER, E; MAYR, WR; LUDVIGSSON, J; LINDBLOM, B; FARID, NR; THOMPSON, C; DESCHAMPS, I			GENETIC-HETEROGENEITY, MODES OF INHERITANCE, AND RISK ESTIMATES FOR A JOINT STUDY OF CAUCASIANS WITH INSULIN-DEPENDENT DIABETES-MELLITUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN, SCH MED, DEPT PEDIAT, MADISON, WI 53706 USA; BLOOD CTR SE WISCONSIN, MILWAUKEE, WI USA; UNIV MINNESOTA, DEPT MED, DIV ENDOCRINOL & METAB, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA; ST ELISABETH HOSP, DEPT LAB MED, ESSEN, GERMANY; UNIV BONN, DEPT MED STAT, D-5300 BONN, GERMANY; BLOODTRANSFUS SERV, TISSUE TYPING LAB, HELSINKI, FINLAND; ROYAL MELBOURNE HOSP, PARKVILLE, VIC 3050, AUSTRALIA; VIENNA UNIV, KINDERKLIN, A-1090 VIENNA, AUSTRIA; RHEIN WESTFAL TH AACHEN, INST TRANSFUS MED, D-5100 AACHEN, GERMANY; LINKOPING UNIV, FAC HLTH SCI, DEPT PEDIAT, S-58183 LINKOPING, SWEDEN; STATE INST BLOOD GRP SEROL, LINKOPING, SWEDEN; MEM UNIV NEWFOUNDLAND, DIV ENDOCRINOL & METAB, St John A1C 5S7, NEWFOUNDLAND, CANADA; HOP ROBERT DEVRE, SERV ENDOCRINOL DIABET, PARIS, FRANCE		THOMSON, G (corresponding author), UNIV CALIF BERKELEY, DEPT GENET, BERKELEY, CA 94720 USA.		Robinson, Wendy P/I-9590-2014; Partanen, Jukka/B-7207-2014; Robinson, Wendy/AAB-6420-2020; Ludvigsson, Johnny/AAI-2051-2020	Robinson, Wendy P/0000-0002-2010-6174; Partanen, Jukka/0000-0001-6681-4734; Robinson, Wendy/0000-0002-2010-6174; Ludvigsson, Johnny/0000-0003-1695-5234	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-400] Funding Source: Medline; NIADDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [AM20729] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD12731] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD012731] Funding Source: NIH RePORTER		BACH FH, 1985, HUM IMMUNOL, V12, P59, DOI 10.1016/0198-8859(85)90343-X; BARBOSA J, 1982, DIABETES, V31, P585, DOI 10.2337/diab.31.7.585; BAUR MP, 1986, GENET EPIDEMIOL, P299; BAUR MP, 1984, HISTOCOMPATIBILITY T, P677; BELL G I, 1985, American Journal of Human Genetics, V37, pA188; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BERTRAMS J, 1984, HISTOCOMPATIBILITY T, P348; BOHME J, 1986, J IMMUNOL, V137, P941; CAMBONTHOMSEN A, IN PRESS FORENSIC HE; CHERN MM, 1982, DIABETES, V31, P1115, DOI 10.2337/diabetes.31.12.1115; CLERGETDARPOUX F, 1986, GENET EPIDEMIOL, P313; COHEN D, 1984, P NATL ACAD SCI-BIOL, V81, P1774, DOI 10.1073/pnas.81.6.1774; COHEN N, 1986, IMMUNOGENETICS, V23, P84, DOI 10.1007/BF00377966; COHENHAGUENAUER O, 1985, P NATL ACAD SCI USA, V82, P3335, DOI 10.1073/pnas.82.10.3335; CONTU L, 1982, TISSUE ANTIGENS, V20, P123; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DEGNBOL B, 1978, ANN HUM GENET, V42, P25, DOI 10.1111/j.1469-1809.1978.tb00929.x; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; DUNSWORTH TS, 1982, CLIN GENET, V21, P233; FARID NR, 1986, MOL BIOL MED, V3, P85; FARID NR, 1979, DIABETES, V28, P552, DOI 10.2337/diabetes.28.6.552; FESTENSTEIN H, 1986, NATURE, V322, P64, DOI 10.1038/322064a0; FIELD LL, 1986, GENET EPIDEMIOL, P323; FIELD LL, IN PRESS GENET EPIDE; GAMBLE DR, 1980, DIABETOLOGIA, V19, P341, DOI 10.1007/BF00280517; GORSUCH AN, 1982, DIABETES, V31, P862, DOI 10.2337/diabetes.31.10.862; HITMAN GA, 1986, IMMUNOGENETICS, V23, P47, DOI 10.1007/BF00376521; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; KLITZ W, 1988, NATURE, V333, P402, DOI 10.1038/333402c0; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; LOUIS EJ, 1984, HISTOCOMPATIBILITY T, P662; LOUIS EJ, 1986, THESIS U CALIFORNIA; LUDVIGSSON J, 1984, PEDIATR RES, V18, P1239, DOI 10.1203/00006450-198412000-00002; LUDVIGSSON J, 1986, DIABETOLOGIA, V29, P207, DOI 10.1007/BF00454876; MACDONALD MJ, 1980, DIABETES, V29, P110, DOI 10.2337/diab.29.2.110; MACDONALD MJ, 1986, P NATL ACAD SCI USA, V83, P7049, DOI 10.1073/pnas.83.18.7049; MACDONALD MJ, 1986, ANN NY ACAD SCI, V475, P356, DOI 10.1111/j.1749-6632.1986.tb20892.x; MOREL PA, IN PRESS P NATL ACAD; MORTON NE, 1983, AM J HUM GENET, V35, P201; MURPHY CC, 1983, CLIN GENET, V23, P405; NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114; NEPOM BS, 1986, J EXP MED, V164, P345, DOI 10.1084/jem.164.1.345; ODUM N, 1988, TISSUE ANTIGENS, V31, P235, DOI 10.1111/j.1399-0039.1988.tb02088.x; PARTANEN J, 1986, TISSUE ANTIGENS, V27, P291; PAYAMI H, 1985, ANN HUM GENET, V49, P303, DOI 10.1111/j.1469-1809.1985.tb01706.x; PLATZ P, 1981, DIABETOLOGIA, V21, P108; RICH SS, 1984, AM J HUM GENET, V36, P1015; RICH SS, 1986, GENET EPIDEMIOL, P341; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, IN PRESS GENET EPIDE; ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169; ROTTER JI, 1980, DIABETES, V29, P115, DOI 10.2337/diabetes.29.2.115; SCHOBER E, 1981, ARCH DIS CHILD, V56, P227, DOI 10.1136/adc.56.3.227; SEGALL M, 1986, HUM IMMUNOL, V17, P61, DOI 10.1016/0198-8859(86)90075-3; SHEEHY MJ, 1985, DIABETOLOGIA, V28, P891, DOI 10.1007/BF00703131; SHEEHY MJ, 1985, DIABETES, V34, P942, DOI 10.2337/diabetes.34.9.942; SHEEHY MJ, 1988, DIABETES, V37, pA91; SKANES VM, 1986, MOL BIOL MED, V3, P143; SOLOW H, 1979, DIABETES, V28, P1, DOI 10.2337/diabetes.28.1.1; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SPIELMAN RS, IN PRESS GENET EPIDE; SUCIUFOCA N, 1979, TRANSPLANT P, V11, P1309; SVEJGAARD A, 1981, ANN HUM GENET, V45, P293, DOI 10.1111/j.1469-1809.1981.tb00340.x; SVEJGAARD A, 1986, TISSUE ANTIGENS, V28, P237; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; SVEJGAARRD A, 1975, TRANSPLANT REV, V22, P1; TAIT BD, 1988, DIABETES, V37, P926, DOI 10.2337/diabetes.37.7.926; TAIT BD, 1986, TISSUE ANTIGENS, V28, P65; TARN AC, 1988, LANCET, V1, P845; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1986, GENET EPIDEMIOL, P363; THOMSON G, 1984, AM J HUM GENET, V36, P1309; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; THOMSON G, 1977, MEASURING SELECTION, P545; THOMSON G, IN PRESS GENET EPIDE; THOMSON G, 1977, HLA DISEASE, P280; TILLIL H, 1987, DIABETES, V36, P93, DOI 10.2337/diabetes.36.1.93; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; TODD JA, 1988, TRENDS GENET, V4, P129, DOI 10.1016/0168-9525(88)90135-7; TOSI R, 1986, DIABETOLOGIA, V29, P430, DOI 10.1007/BF00506534; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; WOLF E, 1983, DIABETOLOGIA, V24, P224	86	335	335	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					799	816					18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	WOS:A1988R344900002	3057885				2022-01-24	
J	Wang, JG; Cazzato, E; Ladewig, E; Frattini, V; Rosenbloom, DIS; Zairis, S; Abate, F; Liu, ZQ; Elliott, O; Shin, YJ; Lee, JK; Lee, IH; Park, WY; Eoli, M; Blumberg, AJ; Lasorella, A; Nam, DH; Finocchiaro, G; Iavarone, A; Rabadan, R				Wang, Jiguang; Cazzato, Emanuela; Ladewig, Erik; Frattini, Veronique; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Shin, Yong-Jae; Lee, Jin-Ku; Lee, In-Hee; Park, Woong-Yang; Eoli, Marica; Blumberg, Andrew J.; Lasorella, Anna; Nam, Do-Hyun; Finocchiaro, Gaetano; Iavarone, Antonio; Rabadan, Raul			Clonal evolution of glioblastoma under therapy	NATURE GENETICS			English	Article							TGF-BETA; GENOMIC ALTERATIONS; SEQUENCING DATA; BRAIN-TUMORS; CANCER GENOMICS; MSH6 MUTATIONS; GENE FUSIONS; GLIOMA; TEMOZOLOMIDE; LANDSCAPE	Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from 114 patients. The analysis shows a highly branched evolutionary pattern in which 63% of patients experience expression-based subtype changes. The branching pattern, together with estimates of evolutionary rate, suggests that relapse-associated clones typically existed years before diagnosis. Fifteen percent of tumors present hypermutation at relapse in highly expressed genes, with a clear mutational signature. We find that 11% of recurrence tumors harbor mutations in LTBP4, which encodes a protein binding to TGF-beta. Silencing LTBP4 in GBM cells leads to suppression of TGF-beta activity and decreased cell proliferation. In recurrent GBM with wild-type IDH1, high LTBP4 expression is associated with worse prognosis, highlighting the TGF-b pathway as a potential therapeutic target in GBM.	[Wang, Jiguang; Ladewig, Erik; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Syst Biol, New York, NY USA; [Wang, Jiguang; Ladewig, Erik; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Cazzato, Emanuela; Eoli, Marica; Finocchiaro, Gaetano] Fdn IRCCS Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy; [Frattini, Veronique; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Inst Canc Genet, New York, NY USA; [Shin, Yong-Jae; Lee, Jin-Ku; Lee, In-Hee; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Blumberg, Andrew J.] Univ Texas Austin, Dept Math, Austin, TX 78712 USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Dept Pathol, New York, NY USA; [Nam, Do-Hyun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Iavarone, Antonio] Columbia Univ, Dept Neurol, New York, NY USA		Rabadan, R (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY USA.; Rabadan, R (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY USA.; Finocchiaro, G (corresponding author), Fdn IRCCS Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy.; Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY USA.; Nam, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea.; Iavarone, A (corresponding author), Columbia Univ, Dept Pathol, New York, NY USA.; Nam, DH (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Iavarone, A (corresponding author), Columbia Univ, Dept Neurol, New York, NY USA.	nsnam@skku.edu; gaetano.finocchiaro@gmail.com; ai2102@columbia.edu; rr2579@cumc.columbia.edu	Eoli, Marica/K-7748-2016; Finocchiaro, Gaetano/AAG-6791-2020; Rabadan, Raul/AAZ-7367-2020; Wang, Jiguang/B-2717-2012	Eoli, Marica/0000-0003-4744-9377; Iavarone, Antonio/0000-0002-0683-4634; Lee, Jin-Ku/0000-0003-0263-3234; Finocchiaro, Gaetano/0000-0003-3583-4040; Rabadan, Raul/0000-0001-7946-9255; Park, Woong-Yang/0000-0003-4234-0380; Wang, Jiguang/0000-0002-6923-4097	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 CA193313, R01 CA185486, R01 CA179044, R01 CA101644, R01 CA131126, R01 CA178546, R01 NS061776]; Precision Medicine Fellowship [UL1 TR000040]; Cancer Biology Training Program [T32 CA09503]; US National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15 LM007079]; Personalized Medicine Fellowship [TL1 TR000082]; NIH (Chemotherapy Foundation)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; American Brain Tumor Association (ABTA); Italian Ministry of HealthMinistry of Health, Italy; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health and Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI14C3418]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA009503, R01CA178546, U54CA193313, R01CA185486, R01CA101644, R01CA179044, R01CA131126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000040, TL1TR000082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM117591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061776] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007079] Funding Source: NIH RePORTER	R.R. acknowledges funding from the NIH (U54 CA193313, R01 CA185486, and R01 CA179044). J.W. is supported by a Precision Medicine Fellowship (UL1 TR000040). E.L. is supported by the Cancer Biology Training Program (T32 CA09503). D.I.S.R. is supported by the US National Library of Medicine (T15 LM007079). S.Z. is supported by a Personalized Medicine Fellowship (TL1 TR000082). This work is also supported by NIH grants to A.L. (R01 CA101644 and R01 CA131126) and A.I. (R01 CA178546 and R01 NS061776 and a grant from the Chemotherapy Foundation). V.F. is supported by a fellowship from the American Brain Tumor Association (ABTA). G.F. is partly funded by the Italian Ministry of Health. D.-H.N. is supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI14C3418).	Abate F, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0097-z; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Han JF, 2015, AM J CANCER RES, V5, P945; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Kaminska B, 2013, ADV EXP MED BIOL, V986, P171, DOI 10.1007/978-94-007-4719-7_9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Melamed RD, 2015, J MOL CELL BIOL, V7, P203, DOI 10.1093/jmcb/mjv026; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S2; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-25; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zairis Sakellarios, 2014, Brain Informatics and Health. International Conference, BIH 2014. Proceedings: LNCS 8609, P528, DOI 10.1007/978-3-319-09891-3_48; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	61	334	339	4	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					768	+		10.1038/ng.3590			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	WOS:000378840100014	27270107	Bronze, Green Accepted	Y	N	2022-01-24	
J	Onengut-Gumuscu, S; Chen, WM; Burren, O; Cooper, NJ; Quinlan, AR; Mychaleckyj, JC; Farber, E; Bonnie, JK; Szpak, M; Schofield, E; Achuthan, P; Guo, H; Fortune, MD; Stevens, H; Walker, NM; Ward, LD; Kundaje, A; Kellis, M; Daly, MJ; Barrett, JC; Cooper, JD; Deloukas, P; Todd, JA; Wallace, C; Concannon, P; Rich, SS				Onengut-Gumuscu, Suna; Chen, Wei-Min; Burren, Oliver; Cooper, Nick J.; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Farber, Emily; Bonnie, Jessica K.; Szpak, Michal; Schofield, Ellen; Achuthan, Premanand; Guo, Hui; Fortune, Mary D.; Stevens, Helen; Walker, Neil M.; Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis; Daly, Mark J.; Barrett, Jeffrey C.; Cooper, Jason D.; Deloukas, Panos; Todd, John A.; Wallace, Chris; Concannon, Patrick; Rich, Stephen S.		Type 1 Diabet Genetics Consortium	Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; EXPRESSION; RISK; RESOURCE; LINKAGE	Genetic studies of type 1 diabetes (T1D) have identified 50 susceptibility regions(1,2), finding major pathways contributing to risk(3), with some loci shared across immune disorders(4-6). To make genetic comparisons across autoimmune disorders as informative as possible, a dense genotyping array, the Immunochip, was developed, from which we identified four new T1D-associated regions (P < 5 x 10(-8)). A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1D risk loci. Using a Bayesian approach, we defined credible sets for the T1D-associated SNPs. The associated SNPs localized to enhancer sequences active in thymus, T and B cells, and CD34(+) stem cells. Enhancer-promoter interactions can now be analyzed in these cell types to identify which particular genes and regulatory sequences are causal.	[Onengut-Gumuscu, Suna; Chen, Wei-Min; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Farber, Emily; Bonnie, Jessica K.; Szpak, Michal; Concannon, Patrick; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Onengut-Gumuscu, Suna] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA USA; [Chen, Wei-Min; Quinlan, Aaron R.; Mychaleckyj, Josyf C.; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Burren, Oliver; Cooper, Nick J.; Schofield, Ellen; Achuthan, Premanand; Guo, Hui; Fortune, Mary D.; Stevens, Helen; Walker, Neil M.; Cooper, Jason D.; Todd, John A.; Wallace, Chris] Univ Cambridge, Natl Inst Hlth Res,Dept Med Genet, Biomed Res Ctr,Wellcome Trust Diabet & Inflammat, Cambridge Inst Med Res,Juvenile Diabet Res Fdn, Cambridge, England; [Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kundaje, Anshul; Kellis, Manolis; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kundaje, Anshul; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Barrett, Jeffrey C.; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Wallace, Chris] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England		Rich, SS (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	ssr4n@virginia.edu	Vazquez, Federico/AAF-9825-2021; Kundaje, Anshul/Y-2598-2019; Paterson, Andrew D/A-4088-2011; Boehm, Bernhard Otto/F-8750-2015; Ludvigsson, Johnny/AAI-2051-2020; Kundaje, Anshul/Y-2739-2019; Briggs, Farren/Q-2164-2019; Tillmann, Vallo/G-8118-2012; Cameron, Fergus J/N-9535-2015; Paterson, Andrew/AAQ-7511-2020; de Bakker, Paul IW/B-8730-2009; Skrha, Jan/C-3095-2017; Roep, Bart/AAD-7609-2021; Todd, John A/A-3542-2010; Deloukas, Panos/B-2922-2013; Kellis, Manolis/ABE-7385-2020; Daly, Mark J/B-2453-2017; Urbanavicius, Vaidotas/D-4907-2016; Kretowski, Adam/U-6299-2018; Doria, Alessandro/H-9157-2018; Argente, Jesus/L-2928-2013	Vazquez, Federico/0000-0001-6493-2374; Kundaje, Anshul/0000-0003-3084-2287; Paterson, Andrew D/0000-0002-9169-118X; Ludvigsson, Johnny/0000-0003-1695-5234; Kundaje, Anshul/0000-0003-3084-2287; Briggs, Farren/0000-0003-0903-1359; Tillmann, Vallo/0000-0002-5279-4493; Paterson, Andrew/0000-0002-9169-118X; de Bakker, Paul IW/0000-0001-7735-7858; Skrha, Jan/0000-0001-8012-8802; Todd, John A/0000-0003-2740-8148; Deloukas, Panos/0000-0001-9251-070X; Kellis, Manolis/0000-0001-7113-9630; Daly, Mark J/0000-0002-0949-8752; vandiedonck, claire/0000-0002-6669-6923; Abdul Ghani, Rohana/0000-0002-3520-8472; Wallace, Chris/0000-0001-9755-1703; Barrett, Jeffrey/0000-0002-1152-370X; Schofield, Ellen/0000-0003-0648-1418; Szpak, Michal/0000-0002-9096-852X; Van der Auwera, Bart/0000-0003-4133-2565; Achuthan, Premanand/0000-0002-1119-6892; Metzger, Daniel/0000-0002-1715-4319; Burren, Oliver/0000-0002-3388-5760; Ampudia Blasco, Francisco Javier/0000-0003-0221-0901; Pociot, Flemming/0000-0003-3274-5448; Quinlan, Aaron/0000-0003-1756-0859; McLaren, William/0000-0001-6218-1116; Castano, Luis/0000-0003-0437-9401; Urbanavicius, Vaidotas/0000-0002-8601-4563; Johannesen, Jesper/0000-0003-2772-2567; Pirags, Valdis/0000-0002-3650-7394; Wagner, Ana M/0000-0002-7663-9308; Dunger, Professor David/0000-0002-2566-9304; Kretowski, Adam/0000-0002-4522-4978; McIndoe, Richard/0000-0002-3040-3631; Knip, Mikael/0000-0003-0474-0033; Walker, Neil/0000-0001-9796-7688; Doria, Alessandro/0000-0002-3830-4304; Argente, Jesus/0000-0001-5826-0276; CUCCA, Francesco/0000-0002-7414-1995; Colman, Peter/0000-0001-8718-6175; Plagnol, Vincent/0000-0002-5597-9215; Avbelj Stefanija, Magdalena/0000-0002-0836-5114; Sumnik, Zdenek/0000-0002-6462-6462; Concannon, Patrick/0000-0002-5801-1859; Willi, Steven/0000-0002-4910-2425; Ward, Lucas/0000-0002-8017-809X; Guo, Hui/0000-0003-0282-6933	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 DK062418]; NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK046635, DK085678]; joint JDRF; Wellcome TrustWellcome TrustEuropean Commission [WT061858/09115, 089989]; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Eli Lilly and CompanyEli Lilly; Wellcome Trust Strategic AwardWellcome Trust [100140]; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Wellcome Trust awardWellcome Trust [076113]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N01104X/1, G1001799, MC_U105261167] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/N01104X/1, G1001799, 1508956, MC_U105261167] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10274, NF-SI-0513-10143, NF-SI-0508-10275, NF-SI-0513-10012] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DP3DK085678, U01DK062418, R01DK096926, R01DK046635] Funding Source: NIH RePORTER; Div Of Biological InfrastructureNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0644282] Funding Source: National Science Foundation	This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD) and JDRF and supported by grant U01 DK062418 from the US National Institutes of Health. Further support was provided by grants from the NIDDK (DK046635 and DK085678) to P.C. and by a joint JDRF and Wellcome Trust grant (WT061858/09115) to the Diabetes and Inflammation Laboratory at Cambridge University, which also received support from the NIHR Cambridge Biomedical Research Centre. ImmunoBase receives support from Eli Lilly and Company. C.W. and H.G. are funded by the Wellcome Trust (089989). The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140).; We gratefully acknowledge the following groups and individuals who provided biological samples or data for this study. We obtained DNA samples from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council and the Wellcome Trust. We acknowledge use of DNA samples from the NIHR Cambridge BioResource. We thank volunteers for their support and participation in the Cambridge BioResource and members of the Cambridge BioResource Scientific Advisory Board (SAB) and Management Committee for their support of our study. We acknowledge the NIHR Cambridge Biomedical Research Centre for funding. Access to Cambridge BioResource volunteers and to their data and samples are governed by the Cambridge BioResource SAB. Documents describing access arrangements and contact details are available at http://www.cambridgebioresource.org.uk/. We thank the Avon Longitudinal Study of Parents and Children laboratory in Bristol, UK, and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. This study makes use of data generated by the Wellcome Trust Case Control Consortium, funded by Wellcome Trust award 076113; a full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Clayton D., 2012, SNPSTATS SNPMATRIX X; Concannon P, 2009, DIABETES, V58, P1018, DOI 10.2337/db08-1551; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Genuth S, 2003, DIABETES CARE, V26, P3160; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hilner JE, 2010, CLIN TRIALS, V7, pS5, DOI 10.1177/1740774510373497; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wallace C., 2013, WGSEA WILCOXON BASED; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zaykin DV, 2010, GENET EPIDEMIOL, V34, P725, DOI 10.1002/gepi.20536; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	48	334	336	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					381	U199		10.1038/ng.3245			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	WOS:000351922900014	25751624	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Huang, W; Massouras, A; Inoue, Y; Peiffer, J; Ramia, M; Tarone, AM; Turlapati, L; Zichner, T; Zhu, DH; Lyman, RF; Magwire, MM; Blankenburg, K; Carbone, MA; Chang, K; Ellis, LL; Fernandez, S; Han, Y; Highnam, G; Hjelmen, CE; Jack, JR; Javaid, M; Jayaseelan, J; Kalra, D; Lee, S; Lewis, L; Munidasa, M; Ongeri, F; Patel, S; Perales, L; Perez, A; Pu, LL; Rollmann, SM; Ruth, R; Saada, N; Warner, C; Williams, A; Wu, YQ; Yamamoto, A; Zhang, YQ; Zhu, YM; Anholt, RRH; Korbel, JO; Mittelman, D; Muzny, DM; Gibbs, RA; Barbadilla, A; Johnston, JS; Stone, EA; Richards, S; Deplancke, B; Mackay, TFC				Huang, Wen; Massouras, Andreas; Inoue, Yutaka; Peiffer, Jason; Ramia, Miquel; Tarone, Aaron M.; Turlapati, Lavanya; Zichner, Thomas; Zhu, Dianhui; Lyman, Richard F.; Magwire, Michael M.; Blankenburg, Kerstin; Carbone, Mary Anna; Chang, Kyle; Ellis, Lisa L.; Fernandez, Sonia; Han, Yi; Highnam, Gareth; Hjelmen, Carl E.; Jack, John R.; Javaid, Mehwish; Jayaseelan, Joy; Kalra, Divya; Lee, Sandy; Lewis, Lora; Munidasa, Mala; Ongeri, Fiona; Patel, Shohba; Perales, Lora; Perez, Agapito; Pu, LingLing; Rollmann, Stephanie M.; Ruth, Robert; Saada, Nehad; Warner, Crystal; Williams, Aneisa; Wu, Yuan-Qing; Yamamoto, Akihiko; Zhang, Yiqing; Zhu, Yiming; Anholt, Robert R. H.; Korbel, Jan O.; Mittelman, David; Muzny, Donna M.; Gibbs, Richard A.; Barbadilla, Antonio; Johnston, J. Spencer; Stone, Eric A.; Richards, Stephen; Deplancke, Bart; Mackay, Trudy F. C.			Natural variation in genome architecture among 205 Drosophila melanogaster Genetic Reference Panel lines	GENOME RESEARCH			English	Article							COPY NUMBER VARIATION; NUCLEOTIDE VARIABILITY; QUANTITATIVE TRAITS; DISRUPTION PROJECT; MUTATION-RATE; PAIRED-END; POLYMORPHISM; ASSOCIATION; DISCOVERY; POPULATIONS	The Drosophila melanogaster Genetic Reference Panel (DGRP) is a community resource of 205 sequenced inbred lines, derived to improve our understanding of the effects of naturally occurring genetic variation on molecular and organismal phenotypes. We used an integrated genotyping strategy to identify 4,853,802 single nucleotide polymorphisms (SNPs) and 1,296,080 non-SNP variants. Our molecular population genomic analyses show higher deletion than insertion mutation rates and stronger purifying selection on deletions. Weaker selection on insertions than deletions is consistent with our observed distribution of genome size determined by flow cytometry, which is skewed toward larger genomes. Insertion/deletion and single nucleotide polymorphisms are positively correlated with each other and with local recombination, suggesting that their nonrandom distributions are due to hitchhiking and background selection. Our cytogenetic analysis identified 16 polymorphic inversions in the DGRP. Common inverted and standard karyotypes are genetically divergent and account for most of the variation in relatedness among the DGRP lines. Intriguingly, variation in genome size and many quantitative traits are significantly associated with inversions. Approximately 50% of the DGRP lines are infected with Wolbachia, and four lines have germline insertions of Wolbachia sequences, but effects of Wolbachia infection on quantitative traits are rarely significant. The DGRP complements ongoing efforts to functionally annotate the Drosophila genome. Indeed, 15% of all D. melanogaster genes segregate for potentially damaged proteins in the DGRP, and genome-wide analyses of quantitative traits identify novel candidate genes. The DGRP lines, sequence data, genotypes, quality scores, phenotypes, and analysis and visualization tools are publicly available.	[Huang, Wen; Peiffer, Jason; Turlapati, Lavanya; Lyman, Richard F.; Magwire, Michael M.; Carbone, Mary Anna; Jack, John R.; Rollmann, Stephanie M.; Yamamoto, Akihiko; Anholt, Robert R. H.; Stone, Eric A.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27595 USA; [Massouras, Andreas; Deplancke, Bart] Ecole Polytech Fed Lausanne, Lab Syst Biol & Genet, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Massouras, Andreas; Deplancke, Bart] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Inoue, Yutaka] Osaka Univ, Ctr Educ Liberal Arts & Sci, Suita, Osaka 5600043, Japan; [Ramia, Miquel; Barbadilla, Antonio] IBB, Genom Bioinformat & Evolut Grp, Dept Genet & Microbiol, Bellaterra 08193, Spain; [Tarone, Aaron M.; Ellis, Lisa L.; Hjelmen, Carl E.; Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Zichner, Thomas; Korbel, Jan O.] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Zhu, Dianhui; Blankenburg, Kerstin; Chang, Kyle; Fernandez, Sonia; Han, Yi; Javaid, Mehwish; Jayaseelan, Joy; Kalra, Divya; Lee, Sandy; Lewis, Lora; Munidasa, Mala; Ongeri, Fiona; Patel, Shohba; Perales, Lora; Perez, Agapito; Pu, LingLing; Ruth, Robert; Saada, Nehad; Warner, Crystal; Williams, Aneisa; Wu, Yuan-Qing; Zhang, Yiqing; Zhu, Yiming; Muzny, Donna M.; Gibbs, Richard A.; Richards, Stephen] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Highnam, Gareth; Mittelman, David] Virginia Tech, Virginia Tech Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Highnam, Gareth; Mittelman, David] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA		Mackay, TFC (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27595 USA.	trudy_mackay@ncsu.edu	Barbadilla, Antonio/A-6915-2017; JAYASEELAN, JOY CHRISTINA/F-9824-2015; Anholt, Robert/S-5977-2019; Korbel, Jan O/G-6470-2012; Hjelmen, Carl/AAO-8084-2020; Kalra, D.K./H-6661-2019; Kalra, Divya/N-5453-2014; Stone, Eric/Q-7840-2016	Barbadilla, Antonio/0000-0002-0374-1475; JAYASEELAN, JOY CHRISTINA/0000-0002-7759-0139; Korbel, Jan O/0000-0002-2798-3794; Hjelmen, Carl/0000-0003-3061-6458; Kalra, D.K./0000-0001-5254-4067; Chang, Kyle/0000-0001-5295-9676; Deplancke, Bart/0000-0001-9935-843X; Tarone, Aaron/0000-0003-0965-7634; Zichner, Thomas/0000-0001-9848-7598; Huang, Wen/0000-0001-6788-8364; Richards, Stephen/0000-0001-8959-5466	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NHGRI U54 HG003273, GM R01 GM45146, R01 GM076083, R01 AA016560, R01 GM 59469]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [CRSI33_127485]; German Research FoundationGerman Research Foundation (DFG) [KO 4037/1-1]; NSFNational Science Foundation (NSF) [REU-BIO-1062178]; National Institute of Justice [2012-DN-BX-K024]; Spanish Ministerio Ciencia e InnovacionSpanish Government [BFU2009-09504]; Texas AgriLife Research; Texas A&M University College of Agriculture and Life Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM045146, R01GM076083, R01GM059469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA016560] Funding Source: NIH RePORTER	The work was supported by NIH grants NHGRI U54 HG003273 (R. A. G.), GM R01 GM45146 (T. F. C. M., R. R. H. A., E. A. S.), R01 GM076083 (T. F. C. M., R. R. H. A., E. A. S.), R01 AA016560 (T. F. C. M., R. R. H. A.), and R01 GM 59469 (R. R. H. A., T. F. C. M); the Swiss National Science Foundation grant CRSI33_127485 (B. D.); institutional support from the Ecole Polytechnique Federale de Lausanne (EPFL) and VITAL-IT for computational analyses (B. D.); the German Research Foundation Emmy Noether Fellowship grant KO 4037/1-1 (J.O.K., T.Z.); NSF grant REU-BIO-1062178 (C. E. H.); National Institute of Justice Grant 2012-DN-BX-K024 (A. M. T.); Spanish Ministerio Ciencia e Innovacion grant BFU2009-09504 (A. B.); and startup funds from Texas AgriLife Research and the Texas A&M University College of Agriculture and Life Sciences (A. M. T.). Points of view in this document are those of the authors and do not necessarily represent the official position or policies of the US Department of Justice.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Assis R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002508; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Corbett-Detig RB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003056; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobzhansky T., 1937, GENETICS ORIGIN SPEC; Ellis LL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004522; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281; Hare EE, 2011, METHODS MOL BIOL, V772, P3, DOI 10.1007/978-1-61779-228-1_1; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hu TT, 2013, GENOME RES, V23, P89, DOI 10.1101/gr.141689.112; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Jordan KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038722; Jovelin R, 2013, GENOME BIOL EVOL, V5, P978, DOI 10.1093/gbe/evt051; KIDWELL MG, 1993, ANNU REV GENET, V27, P235, DOI 10.1146/annurev.ge.27.120193.001315; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Leushkin EV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-476; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Massouras A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003055; Massouras A, 2010, NAT METHODS, V7, P485, DOI [10.1038/nmeth.f.308, 10.1038/NMETH.f.308]; McDonald MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000622; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; METTLER LE, 1977, GENETICS, V87, P169; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2000, GENETICS, V155, P685; Nei M., 1987, MOL EVOLUTIONARY GEN; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Onishi-Seebacher M, 2011, BIOESSAYS, V33, P840, DOI 10.1002/bies.201100075; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2013, R LANG ENV STAT COMP; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003129; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; STALKER HD, 1976, GENETICS, V82, P323; Stone EA, 2012, GENOME RES, V22, P966, DOI 10.1101/gr.129122.111; Swarup S, 2013, P NATL ACAD SCI USA, V110, P1017, DOI 10.1073/pnas.1220168110; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yamamoto A, 2009, GENET RES, V91, P373, DOI 10.1017/S0016672309990279; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	92	334	339	2	109	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2014	24	7					1193	1208		10.1101/gr.171546.113			16	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	AK1OS	WOS:000338185000013	24714809	Green Submitted, hybrid, Green Published			2022-01-24	
J	Brastianos, PK; Horowitz, PM; Santagata, S; Jones, RT; McKenna, A; Getz, G; Ligon, KL; Palescandolo, E; Van Hummelen, P; Ducar, MD; Raza, A; Sunkavalli, A; MacConaill, LE; Stemmer-Rachamimov, AO; Louis, DN; Hahn, WC; Dunn, IF; Beroukhim, R				Brastianos, Priscilla K.; Horowitz, Peleg M.; Santagata, Sandro; Jones, Robert T.; McKenna, Aaron; Getz, Gad; Ligon, Keith L.; Palescandolo, Emanuele; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Stemmer-Rachamimov, Anat O.; Louis, David N.; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen			Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMAS; NF2; PATHWAY; CANCER; MEDULLOBLASTOMA; COMPLEXITY; LANDSCAPE; PATTERNS; TUMORS	Meningiomas are the most common primary nervous system tumor. The tumor suppressor NF2 is disrupted in approximately half of all meningiomas(1), but the complete spectrum of genetic changes remains undefined. We performed whole-genome or whole-exome sequencing on 17 meningiomas and focused sequencing on an additional 48 tumors to identify and validate somatic genetic alterations. Most meningiomas had simple genomes, with fewer mutations, rearrangements and copy-number alterations than reported in other tumors in adults. However, several meningiomas harbored more complex patterns of copy-number changes and rearrangements, including one tumor with chromothripsis. We confirmed focal NF2 inactivation in 43% of tumors and found alterations in epigenetic modifiers in an additional 8% of tumors. A subset of meningiomas lacking NF2 alterations harbored recurrent oncogenic mutations in AKT1 (p.Glu17Lys) and SMO (p.Trp535Leu) and exhibited immunohistochemical evidence of activation of these pathways. These mutations were present in therapeutically challenging tumors of the skull base and higher grade. These results begin to define the spectrum of genetic alterations in meningiomas and identify potential therapeutic targets.	[Brastianos, Priscilla K.; Jones, Robert T.; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Hahn, William C.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Brastianos, Priscilla K.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Brastianos, Priscilla K.; Horowitz, Peleg M.; Santagata, Sandro; Ligon, Keith L.; Stemmer-Rachamimov, Anat O.; Louis, David N.; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen] Harvard Univ, Sch Med, Boston, MA USA; [Brastianos, Priscilla K.; Horowitz, Peleg M.; McKenna, Aaron; Getz, Gad; Hahn, William C.; Dunn, Ian F.; Beroukhim, Rameen] Broad Inst MIT & Harvard, Boston, MA USA; [Horowitz, Peleg M.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Horowitz, Peleg M.; Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Santagata, Sandro; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jones, Robert T.; Palescandolo, Emanuele; Van Hummelen, Paul; Ducar, Matthew D.; Raza, Alina; Sunkavalli, Ashwini; MacConaill, Laura E.; Hahn, William C.; Beroukhim, Rameen] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Stemmer-Rachamimov, Anat O.; Louis, David N.] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA		Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; idunn@partners.org; rameen@broadinstitute.org		Santagata, Sandro/0000-0002-7528-9668; Brastianos, Priscilla/0000-0003-4470-8425; Horowitz, Peleg/0000-0002-5177-1783; Jones, Robert/0000-0001-8007-4023	Brain Science Foundation; Pediatric Low-Grade Astrocytoma Foundation; American Brain Tumor Association; Conquer Cancer Foundation Young Investigator Award; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 CA122833, K08 NS064168, K12 CA090354-11]; US Department of Defense grant [W81XWE-12-1-0136]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K12CA090354, K08CA122833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS064168] Funding Source: NIH RePORTER	The authors would like to thank M. Lawrence, N. Stransky, M. Imielinski, K. Cibulskis, S. Carter, C. Stewart, C.-Z. Zhang, Y. Drier, S. Schumacher and B. Tabak for their assistance with genomic analyses; P. Wen, O. Al-Mefty, T. Batchelor, B. Reisler, M. Johnson, W. Richards and J. Kim for their assistance with tissue acquisition; and A. Pisarek-Horowitz, S.A. Horowitz, G. Bergthold and C.H. Brastianos for critical review of the manuscript. This work was supported by the Brain Science Foundation (I.F.D., P.K.B., R.B. and S.S.), the Pediatric Low-Grade Astrocytoma Foundation (R.B. and W.C.H.), the American Brain Tumor Association (P.K.B.), a Conquer Cancer Foundation Young Investigator Award (P.K.B.), US National Institutes of Health (NIH) grants K08 CA122833 (R.B.), K08 NS064168 (S.S.) and K12 CA090354-11 (P.K.B.), and US Department of Defense grant W81XWE-12-1-0136 (P.M.H.).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Choy W, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1116; Durand A, 2009, J NEURO-ONCOL, V95, P367, DOI 10.1007/s11060-009-9934-0; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Goutagny S, 2010, CLIN CANCER RES, V16, P4155, DOI 10.1158/1078-0432.CCR-10-0891; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Karst AM, 2011, GYNECOL ONCOL, V123, P5, DOI 10.1016/j.ygyno.2011.05.021; Ketter R, 2007, J NEURO-ONCOL, V83, P213, DOI 10.1007/s11060-006-9318-7; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Krayenbuhl N, 2007, NEUROSURGERY, V61, P495, DOI 10.1227/01.NEU.0000280009.79813.DE; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mathiesen T, 1996, NEUROSURGERY, V39, P2, DOI 10.1097/00006123-199607000-00002; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Nunes F, 2005, CANCER GENET CYTOGEN, V162, P135, DOI 10.1016/j.cancergencyto.2005.04.003; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reifenberger J, 1998, CANCER RES, V58, P1798; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Santos DCC, 2011, INT J DERMATOL, V50, P838, DOI 10.1111/j.1365-4632.2010.04866.x; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van Alkemade H, 2012, NEURO-ONCOLOGY, V14, P658, DOI 10.1093/neuonc/nos013; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; WELLENREUTHER R, 1995, AM J PATHOL, V146, P827; Wen PY, 2010, J NEURO-ONCOL, V99, P365, DOI 10.1007/s11060-010-0349-8; Yang HW, 2012, NEOPLASIA, V14, P20, DOI 10.1593/neo.111574	40	334	339	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2013	45	3					285	289		10.1038/ng.2526			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	WOS:000315664800012	23334667	Green Accepted, Green Submitted			2022-01-24	
J	Iqbal, Z; Caccamo, M; Turner, I; Flicek, P; McVean, G				Iqbal, Zamin; Caccamo, Mario; Turner, Isaac; Flicek, Paul; McVean, Gil			De novo assembly and genotyping of variants using colored de Bruijn graphs	NATURE GENETICS			English	Article							DIPLOID GENOME SEQUENCE; COPY-NUMBER VARIATION; HIGH-RESOLUTION HLA; STRUCTURAL VARIATION; POPULATION-SCALE; POLYMORPHIC GENOMES; CIONA-SAVIGNYI; HAPLOTYPE MAP; STRING GRAPH; GENE	Detecting genetic variants that are highly divergent from a reference sequence remains a major challenge in genome sequencing. We introduce de novo assembly algorithms using colored de Bruijn graphs for detecting and genotyping simple and complex genetic variants in an individual or population. We provide an efficient software implementation, Cortex, the first de novo assembler capable of assembling multiple eukaryotic genomes simultaneously. Four applications of Cortex are presented. First, we detect and validate both simple and complex structural variations in a high-coverage human genome. Second, we identify more than 3 Mb of sequence absent from the human reference genome, in pooled low-coverage population sequence data from the 1000 Genomes Project. Third, we show how population information from ten chimpanzees enables accurate variant calls without a reference sequence. Last, we estimate classical human leukocyte antigen (HLA) genotypes at HLA-B, the most variable gene in the human genome.	[Iqbal, Zamin; Turner, Isaac; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Iqbal, Zamin; Flicek, Paul] European Bioinformat Inst, Hinxton, England; [Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England		McVean, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mcvean@well.ox.ac.uk	Turner, Isaac/T-1092-2019	Iqbal, Zamin/0000-0001-8466-7547; McVean, Gil/0000-0002-5012-4162; Flicek, Paul/0000-0002-3897-7955; Turner, Isaac/0000-0002-2378-4886	Wellcome TrustWellcome TrustEuropean Commission [WT086084/Z/08/Z, 090532/Z/09/Z]; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/T/000PR6193] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/T/000PR6193] Funding Source: UKRI	We would like to thank the members of the 1000 Genomes Project Consortium for discussion, suggestions and sequencing data. We thank B. Ahiska, A. Auton, E. Birney, R. Durbin, G. Lunter, J. Woolf and D. Zerbino for discussion, two anonymous reviewers for their comments and members of the PanMap Project and the Genomics Core at the Wellcome Trust Centre for Human Genetics for access to sequence data. Z.I. is funded by a grant from the Wellcome Trust (WT086084/Z/08/Z to G.M.). The sequencing of NA12878 was performed by the Wellcome Trust Sequencing Core at Oxford, under a grant from the Wellcome Trust (090532/Z/09/Z).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; ALLSOPP CEM, 1991, HUM IMMUNOL, V30, P105, DOI 10.1016/0198-8859(91)90078-N; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ding L, 2010, HUM MOL GENET, V19, pR188, DOI 10.1093/hmg/ddq391; Donmez N, 2011, LECT N BIOINFORMAT, V6577, P38, DOI 10.1007/978-3-642-20036-6_5; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2009, NAT METHODS, V6, P473, DOI 10.1038/nmeth.f.256; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	52	334	337	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					226	232		10.1038/ng.1028			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	WOS:000299664400025	22231483	Green Accepted			2022-01-24	
J	Levitus, M; Waisfisz, Q; Godthelp, BC; de Vries, Y; Hussain, S; Wiegant, WW; Elghalbzouri-Maghrani, E; Steltenpool, J; Rooimans, MA; Pals, G; Arwert, F; Mathew, CG; Zdzienicka, MZ; Hiom, K; De Winter, JP; Joenje, H				Levitus, M; Waisfisz, Q; Godthelp, BC; de Vries, Y; Hussain, S; Wiegant, WW; Elghalbzouri-Maghrani, E; Steltenpool, J; Rooimans, MA; Pals, G; Arwert, F; Mathew, CG; Zdzienicka, MZ; Hiom, K; De Winter, JP; Joenje, H			The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J	NATURE GENETICS			English	Article							PROTEIN; BACH1	The protein predicted to be defective in individuals with Fanconi anemia complementation group J ( FA- J), FANCJ, is a missing component in the Fanconi anemia pathway of genome maintenance. Here we identify pathogenic mutations in eight individuals with FA- J in the gene encoding the DEAH- box DNA helicase BRIP1, also called FANCJ. This finding is compelling evidence that the Fanconi anemia pathway functions through a direct physical interaction with DNA.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 AL Leiden, Netherlands; Kings Coll London, Guys Hosp, Div Med & Mol Genet, London, England; Nicholas Copernicus Univ, Coll Med L Rydygier, Dept Mol Cell Genet, Bydgoszcz, Poland; MRC, Mol Biol Lab, Cambridge CB2 2QH, England		Joenje, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	joenje@vumc.nl	Mathew, Christopher G/G-3434-2015; Hiom, Kevin/B-4374-2009	Mathew, Christopher G/0000-0003-4178-1838; Pals, Gerard/0000-0003-4091-7115			Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Risinger MA, 2004, CANCER CELL, V6, P539, DOI 10.1016/j.ccr.2004.12.001; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	10	334	343	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					934	935		10.1038/ng1625			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	WOS:000231591900016	16116423				2022-01-24	
J	Bulavin, DV; Phillips, C; Nannenga, B; Timofeev, O; Donehower, LA; Anderson, CW; Appella, E; Fornace, AJ				Bulavin, DV; Phillips, C; Nannenga, B; Timofeev, O; Donehower, LA; Anderson, CW; Appella, E; Fornace, AJ			Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway	NATURE GENETICS			English	Article							CYCLIN D1; TRANSGENIC MICE; GENE PROMOTER; AMPLIFICATION; EXPRESSION; PPM1D; PHOSPHORYLATION; METHYLATION; APOPTOSIS; P53	Modulation of tumor suppressor activities may provide new opportunities for cancer therapy. Here we show that disruption of the gene Ppm1d encoding Wip1 phosphatase activated the p53 and p16 ( also called Ink4a) p19 ( also called ARF) pathways through p38 MAPK signaling and suppressed in vitro transformation of mouse embryo fibroblasts ( MEFs) by oncogenes. Disruption of the gene Cdkn2a ( encoding p16 and p19), but not of Trp53 ( encoding p53), reconstituted cell transformation in Ppm1d - null MEFs. In vivo, deletion of Ppm1d in mice bearing mouse mammary tumor virus ( MMTV) promoter driven oncogenes Erbb2 ( also called c - neu) or Hras1 impaired mammary carcinogenesis, whereas reduced expression of p16 and p19 by methylation-induced silencing or inactivation of p38 MAPK correlated with tumor appearance. We conclude that inactivation or depletion of the Wip1 phosphatase with resultant p38 MAPK activation suppresses tumor appearance by modulating the Cdkn2a tumor-suppressor locus.	NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA		Bulavin, DV (corresponding author), NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bulavin@nih.gov	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Timofeev, Oleg/0000-0002-3114-6403; Dudgeon, Crissy/0000-0001-9010-2569	DIVISION OF BASIC SCIENCES - NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01BC007184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIABC005599, Z01BC005599] Funding Source: NIH RePORTER		BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj.onc.1205025; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 1999, ONCOGENE, V18, P5611, DOI 10.1038/sj.onc.1202945; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; DICKINSON AJ, 1990, OPHTHALMIC PAED GEN, V11, P1, DOI 10.3109/13816819009012942; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; GILLETT C, 1994, CANCER RES, V54, P1812; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Koch-Paiz CA, 2000, BIOTECHNIQUES, V29, P706, DOI 10.2144/00294bm07; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nielsen NH, 2001, CANCER LETT, V163, P59, DOI 10.1016/S0304-3835(00)00674-1; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	38	334	349	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					343	350		10.1038/ng1317			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	WOS:000220647200017	14991053	Bronze			2022-01-24	
J	Wang, K; Zhou, B; Kuo, YM; Zemansky, J; Gitschier, J				Wang, K; Zhou, B; Kuo, YM; Zemansky, J; Gitschier, J			A novel member of a zinc transporter family is defective in acrodermatitis enteropathica	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ABSORPTION; PREDICTION; EXPRESSION; GENE	The rare inherited condition acrodermatitis enteropathica (AE) results from a defect in the absorption of dietary zinc. Recently, we used homozygosity mapping in consanguineous Middle Eastern kindreds to localize the AE gene to an similar to3.5-cM region on 8q24. In this article, we identify a gene, SLC39A4, located in the candidate region and, in patients with AE, document mutations that likely lead to the disease. The gene encodes a histidine-rich protein, which we refer to as "hZIP4," which is a member of a large family of transmembrane proteins, some of which are known to serve as zinc-uptake proteins. We show that Slc39A4 is abundantly expressed in mouse enterocytes and that the protein resides in the apical membrane of these cells. These findings suggest that the hZIP4 transporter is responsible for intestinal absorption of zinc.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA		Gitschier, J (corresponding author), Univ Calif San Francisco, Dept Med, U-286,Box 0794,3rd & Parnassus Ave, San Francisco, CA 94143 USA.	gitschi@itsa.ucsf.edu					BARNES PM, 1973, P ROY SOC MED, V66, P327, DOI 10.1177/003591577306600411; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hall TA, 1999, NUCL ACIDS S SER, P95; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kuo YM, 1997, HUM MOL GENET, V6, P1043, DOI 10.1093/hmg/6.7.1043; LOMBECK I, 1975, LANCET, V1, P855; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEEL L, 1985, AM J PHYSIOL, V248, pG46; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDENHAMER CJA, 1985, TRACE ELEMENTS MAN A, V5, P689; Wang K, 2001, AM J HUM GENET, V68, P1055, DOI 10.1086/319514; WEISMANN K, 1979, BRIT J DERMATOL, V101, P573, DOI 10.1111/j.1365-2133.1979.tb11889.x	21	334	349	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					66	73		10.1086/341125			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	WOS:000176307700007	12032886	Green Published, Bronze			2022-01-24	
J	Heppner, C; Kester, MB; Agarwal, SK; Debelenko, LV; EmmertBuck, MR; Guru, SC; Manickam, P; Olufemi, SE; Skarulis, MC; Doppman, JL; Alexander, RH; Kim, YS; Saggar, SK; Lubensky, IA; Zhuang, ZP; Liotta, LA; Chandrasekharappa, SC; Collins, FS; Spiegel, AM; Burns, AL; Marx, SJ				Heppner, C; Kester, MB; Agarwal, SK; Debelenko, LV; EmmertBuck, MR; Guru, SC; Manickam, P; Olufemi, SE; Skarulis, MC; Doppman, JL; Alexander, RH; Kim, YS; Saggar, SK; Lubensky, IA; Zhuang, ZP; Liotta, LA; Chandrasekharappa, SC; Collins, FS; Spiegel, AM; Burns, AL; Marx, SJ			Somatic mutation of the MEN1 gene in parathyroid tumours	NATURE GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-1; SUPPRESSOR GENE; TUMORS; CHROMOSOME-11; CARCINOMA; RETINOBLASTOMA; METHYLATION	Primary hyperparathyroidism is a common disorder with an annual incidence of approximately 0.5 in 1,000 (ref. 1), In more than 95% of cases, the disease is caused by sporadic parathyroid adenoma or sporadic hyperplasia. Some cases are caused by inherited syndromes, such as multiple endocrine neoplasia type 1 (MEN1; ref. 2), In most cases, the molecular basis of parathyroid neoplasia is unknown. Parathyroid adenomas are usually monoclonal(3,4), suggesting that one important step in tumour development is a mutation in a progenitor cell, Approximately 30% of sporadic parathyroid tumours show loss of heterozygosity (LOH) for polymorphic markers on 11q13, the site of the MEN1 tumour suppressor gene(4-8). This raises the question of whether such sporadic parathyroid tumours are caused by sequential inactivation of both alleles of the MEN1 gene(9). We recently cloned the MEN1 gene and identified MEN1 germline mutations in fourteen of fifteen kindreds with familial MEN1 (ref. 10). We have studied parathyroid tumours not associated with MEN1 to determine whether somatic mutations in the MEN1 gene are present, Among 33 tumours we found somatic MEN1 gene mutation in 7, while the corresponding MEN1 germline sequence was normal in each patient. All tumours with MEN1 gene mutation showed LOH on 11q13, making the tumour cells hemi- or homozygous for the mutant allele. Thus, somatic MEN1 gene mutation contributes to tumorigenesis in a substantial number of parathyroid tumours not associated with the MEN1 syndrome.	NIDDKD, METAB DIS BRANCH, NIH, BETHESDA, MD 20892 USA; NCI, PATHOL LAB, NIH, BETHESDA, MD 20892 USA; NHGRI, LAB GENE TRANSFER, NIH, BETHESDA, MD 20892 USA; NIH, CTR CLIN, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA; NCI, SURG BRANCH, NIH, BETHESDA, MD 20892 USA				Agarwal, Sunita K/D-1428-2016	Agarwal, Sunita K/0000-0002-7557-3191			Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; ARNOLD A, 1994, ENDOCRIN METAB CLIN, V23, P93, DOI 10.1016/S0889-8529(18)30118-X; Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Bright RK, 1997, CANCER RES, V57, P995; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; CRYNS VL, 1994, J CLIN ENDOCR METAB, V78, P1320, DOI 10.1210/jc.78.6.1320; Debelenko LV, 1997, CANCER RES, V57, P2238; Dotzenrath C, 1996, J CLIN ENDOCR METAB, V81, P3194, DOI 10.1210/jc.81.9.3194; EmmertBuck MR, 1997, CANCER RES, V57, P1855; Fain PR, 1996, HUM MOL GENET, V5, P1631, DOI 10.1093/hmg/5.10.1631; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; FRIEDMAN E, 1992, CANCER RES, V52, P6804; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hsi ED, 1996, J CLIN ENDOCR METAB, V81, P1736, DOI 10.1210/jc.81.5.1736; Jakobovitz G, 1996, J CLIN ENDOCR METAB, V81, P3164; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LIDA A, 1995, GENE CHROMOSOME CANC, V12, P73, DOI 10.1002/gcc.2870120114; Lubensky IA, 1996, CANCER RES, V56, P5272; MANICKAM P, IN PRESS HUM GENET; MATSUO K, 1991, MOL ENDOCRINOL, V5, P1873, DOI 10.1210/mend-5-12-1873; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Metz David C., 1994, P591; Pausova Z, 1996, J CLIN ENDOCR METAB, V81, P2711, DOI 10.1210/jc.81.7.2711; Pearce SHS, 1996, CLIN ENDOCRINOL, V45, P195, DOI 10.1046/j.1365-2265.1996.d01-1561.x; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; Tahara H, 1996, J CLIN ENDOCR METAB, V81, P3663, DOI 10.1210/jc.81.10.3663; Tahara H, 1996, CANCER RES, V56, P599; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403	35	334	337	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					375	378		10.1038/ng0897-375			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	WOS:A1997XM90900021	9241276				2022-01-24	
J	PICKLES, A; BOLTON, P; MACDONALD, H; BAILEY, A; LECOUTEUR, A; SIM, CH; RUTTER, M				PICKLES, A; BOLTON, P; MACDONALD, H; BAILEY, A; LECOUTEUR, A; SIM, CH; RUTTER, M			LATENT-CLASS ANALYSIS OF RECURRENCE RISKS FOR COMPLEX PHENOTYPES WITH SELECTION AND MEASUREMENT ERROR - A TWIN AND FAMILY HISTORY STUDY OF AUTISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PSYCHIATRIC-DISORDERS; INDIVIDUALS; DISEASE; MODELS; RELATIVES	The use of the family history method to examine the pattern of recurrence risks for complex disorders such as autism is not straightforward. Problems such as uncertain phenotypic definition, unreliable measurement with increased error rates for more distant relatives, and selection due to reduced fertility all complicate the estimation of risk ratios. Using data from a recent family history study of autism, and a similar study of twins, this paper shows how a latent-class approach can be used to tackle these problems. New findings are presented supporting a multiple-locus model of inheritance, with three loci giving the best fit.			PICKLES, A (corresponding author), INST PSYCHIAT,MRC,CHILD PSYCHIAT UNIT,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.		Pickles, Andrew R/A-9625-2011; Rutter, Michael/C-8570-2013; Bailey, Anthony/J-2860-2014	Pickles, Andrew R/0000-0003-1283-0346; Bailey, Anthony/0000-0003-4257-972X			AITKIN M, 1981, J ROY STAT SOC A STA, V144, P419, DOI 10.2307/2981826; ANDREASEN NC, 1986, ARCH GEN PSYCHIAT, V43, P421; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DELONG GR, 1988, J AUTISM DEV DISORD, V18, P593; ESSEN-MOLLER E, 1955, Acta Genet Stat Med, V5, P334; FARRALL M, 1992, AM J HUM GENET, V50, P270; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; GATH A, 1986, BRIT J PSYCHIAT, V149, P161, DOI 10.1192/bjp.149.2.161; HODGE SE, 1981, AM J HUM GENET, V33, P381; JORDE LB, 1991, AM J HUM GENET, V49, P932; Lazarsfeld PF., 1968, LATENT STRUCTURE ANA; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Majumder P P, 1983, Stat Med, V2, P13, DOI 10.1002/sim.4780020103; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; PIVEN J, 1990, J AM ACAD CHILD PSY, V29, P177, DOI 10.1097/00004583-199003000-00004; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; RISCH N, 1983, BEHAV GENET, V13, P441, DOI 10.1007/BF01065920; RISCH N, 1990, AM J HUM GENET, V46, P222; RUTTER M, 1994, J CHILD PSYCHOL PSYC, V35, P311, DOI 10.1111/j.1469-7610.1994.tb01164.x; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; THOMPSON WD, 1982, ARCH GEN PSYCHIAT, V39, P53; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X; ZOCCOLILLO M, 1992, PSYCHOL MED, V22, P971, DOI 10.1017/S003329170003854X; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	32	334	342	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					717	726					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RR605	WOS:A1995RR60500022	7668301				2022-01-24	
J	UEDA, H; ULLRICH, SJ; GANGEMI, JD; KAPPEL, CA; NGO, L; FEITELSON, MA; JAY, G				UEDA, H; ULLRICH, SJ; GANGEMI, JD; KAPPEL, CA; NGO, L; FEITELSON, MA; JAY, G			FUNCTIONAL INACTIVATION BUT NOT STRUCTURAL MUTATION OF P53 CAUSES LIVER-CANCER	NATURE GENETICS			English	Article							HEPATITIS-B VIRUS; PRIMARY HEPATOCELLULAR CARCINOMAS; TRANSFORMATION-RELATED PROTEIN; TUMOR-SUPPRESSOR GENE; ALPHA-B/D HYBRID; X-PROTEIN; SV40-TRANSFORMED CELLS; MONOCLONAL-ANTIBODY; TRANS-ACTIVATION; HOST PROTEIN	Structural mutations in the p53 gene are seen in virtually every form of human cancer. To determine whether such mutations are important for initiating tumorigenesis, we have been studying hepatocellular carcinoma, in which most cases are associated with chronic hepatitis B virus infections. Using a transgenic mouse model where expression of a single HBV gene product, the HBx protein, induces progressive changes in the liver, we show that tumour development correlates precisely with p53 binding to HBx in the cytoplasm and complete blockage of p53 entry into the nucleus. Analysis of tumour cell DNA shows no evidence for p53 mutation, except in advanced tumours where a small proportion of cells may have acquired specific base substitutions. Our results suggest that genetic changes in p53 are late events which may contribute to tumour progression.	AMER RED CROSS,JEROME H HOLLAND LAB,DEPT VIROL,ROCKVILLE,MD 20855; CLEMSON UNIV,GREENVILLE HOSP SYST,CLEMSON,SC 29634; THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,PHILADELPHIA,PA 19107				Jay, Gregory/C-6346-2013	Jay, Gregory/0000-0003-1517-8488			BARAK Y, 1992, EMBO J, V11, P2115, DOI 10.1002/j.1460-2075.1992.tb05270.x; BEASLEY RP, 1984, VIRAL HEPATITIS LIVE, P209; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; BUETOW KH, 1992, P NATL ACAD SCI USA, V89, P9622, DOI 10.1073/pnas.89.20.9622; COLGROVE R, 1989, J VIROL, V63, P4019, DOI 10.1128/JVI.63.9.4019-4026.1989; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; FEITELSON MA, 1993, ONCOGENE, V8, P1109; FELTELSON MA, 1990, VIROLOGY, V177, P367; FUJIYAMA A, 1983, NUCLEIC ACIDS RES, V11, P4601, DOI 10.1093/nar/11.13.4601; GANGEMI JD, 1989, J INTERFERON RES, V9, P227, DOI 10.1089/jir.1989.9.227; GREENBLATT MS, 1994, CANCER RES, V54, P4855; GUTIERREZ MI, 1992, CANCER RES, V52, P1032; HALEVY O, 1991, ONCOGENE, V6, P1593; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945; HOSONO S, 1991, ONCOGENE, V6, P237; HSU HC, 1993, CANCER RES, V53, P4691; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JAY G, 1979, COLD SPRING HARB SYM, V44, P659; JAY G, 1981, P NATL ACAD SCI USA, V78, P2931; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NISHIDA N, 1993, CANCER RES, V53, P358; ODA T, 1992, CANCER RES, V52, P6358; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PERRILLO RP, 1993, DIGEST DIS SCI, V38, P577, DOI 10.1007/BF01316785; PIETENPOL JA, 1993, NATURE, V365, P17, DOI 10.1038/365017a0; POPPER H, 1987, HEPATOLOGY, V7, P764, DOI 10.1002/hep.1840070425; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHEK N, 1991, ONCOGENE, V6, P1735; SETO E, 1988, P NATL ACAD SCI USA, V85, P8286, DOI 10.1073/pnas.85.21.8286; SHEU JC, 1992, CANCER RES, V52, P6098; SPANDAU DF, 1988, J VIROL, V62, P427, DOI 10.1128/JVI.62.2.427-434.1988; SZEKELY L, 1993, P NATL ACAD SCI USA, V90, P5455, DOI 10.1073/pnas.90.12.5455; TANAKA S, 1993, CANCER RES, V53, P2884; TERAMOTO T, 1994, CANCER RES, V54, P231; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TURKASPA R, 1990, J VIROL, V64, P1821, DOI 10.1128/JVI.64.4.1821-1824.1990; TWU JS, 1987, J VIROL, V61, P3448, DOI 10.1128/JVI.61.11.3448-3453.1987; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; ULLRICH SJ, 1993, P NATL ACAD SCI USA, V90, P5954, DOI 10.1073/pnas.90.13.5954; UNSAL H, 1994, P NATL ACAD SCI USA, V91, P822, DOI 10.1073/pnas.91.2.822; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	53	334	339	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					41	47		10.1038/ng0195-41			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	WOS:A1995PZ91300013	7704023				2022-01-24	
J	SMITH, TAG; MEHAFFEY, MG; KAYDA, DB; SAUNDERS, JM; YEI, S; TRAPNELL, BC; MCCLELLAND, A; KALEKO, M				SMITH, TAG; MEHAFFEY, MG; KAYDA, DB; SAUNDERS, JM; YEI, S; TRAPNELL, BC; MCCLELLAND, A; KALEKO, M			ADENOVIRUS-MEDIATED EXPRESSION OF THERAPEUTIC PLASMA-LEVELS OF HUMAN FACTOR-IX IN MICE	NATURE GENETICS			English	Article							GENE-TRANSFER; HEMOPHILIA-B; INVIVO; EPITHELIUM; KINETICS; ANIMALS; PROTEIN; CELLS; LIVER	Gene therapy strategies designed to combat haemophilia B, caused by defects in clotting factor IX, have so far concentrated on ex vivo approaches. We have now evaluated adenoviral vector-mediated expression of human factor IX in vivo. Injection of the vector Av1H9B, which encodes human factor IX cDNA, into the tail veins of mice resulted in efficient liver transduction and plasma levels of human factor IX that would be therapeutic for haemophilia B patients. However, levels slowly declined to baseline by nine weeks and were not re-established by a second vector injection. These results address both the advantages and obstacles to the use of adenoviral vectors for treatment of haemophilia B.	GENET THERAPY INC,GAITHERSBURG,MD 20878					McClelland, Alan/0000-0003-2949-3542			AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BRIET E, 1991, BLOOD COAGUL FIBRIN, V2, P47; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405; EVANS JP, 1989, BLOOD, V74, P207; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HEDNER U, 1989, METABOLIC BASIS INHE, V2, P2116; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HORWITZ MS, 1990, VIROLOGY, V2, P1723; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; JALLAT S, 1990, EMBO J, V9, P3295, DOI 10.1002/j.1460-2075.1990.tb07529.x; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MITTAL SK, 1993, VIRUS RES, V28, P67, DOI 10.1016/0168-1702(93)90090-A; PALMER TD, 1989, BLOOD, V73, P438; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SHENK T, 1984, CURR TOP MICROBIOL, V111, P1; SMITH KJ, 1981, BLOOD, V58, P625; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; THOMPSON AR, 1980, BRIT J HAEMATOL, V45, P329, DOI 10.1111/j.1365-2141.1980.tb07152.x; THOMPSON AR, 1986, BLOOD, V67, P565; THOMPSON AR, 1991, CURR STUD HEMATOL BL, V58, P59; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; 1991, B WORLD HEALTH ORGAN, V69, P17; 1993, HUM GENE THER, V4, P391	34	334	336	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					397	402		10.1038/ng1293-397			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	WOS:A1993ML14500018	8298650				2022-01-24	
J	PENTAO, L; WISE, CA; CHINAULT, AC; PATEL, PI; LUPSKI, JR				PENTAO, L; WISE, CA; CHINAULT, AC; PATEL, PI; LUPSKI, JR			CHARCOT-MARIE-TOOTH TYPE-1A DUPLICATION APPEARS TO ARISE FROM RECOMBINATION AT REPEAT SEQUENCES FLANKING THE 1.5 MB MONOMER UNIT	NATURE GENETICS			English	Article							HEREDITARY HYPERTROPHIC NEUROPATHY; ARTIFICIAL CHROMOSOME CLONES; TREMBLER MOUSE; MUSCULAR-DYSTROPHY; ALU-PCR; DISEASE; YEAST; DNA; DELETIONS; IDENTIFICATION	We have constructed a 3.1 megabase (Mb) physical map of chromosome 17p11.2-p12, which contains a submicroscopic duplication in patients with Charcot-Marie-Tooth disease type 1A (CMT1A). We find that the CMT1A duplication is a tandem repeat of 1.5 Mb of DNA. A YAC contig encompassing the CMT1A duplication and spanning the endpoints was also developed. Several low copy repeats in 17p11.2-p12 were identified including the large (> 17 kb) CMT1A-REP unit which may be part of a mosaic repeat. CMT1A-REP flanks the 1.5 Mb CMT1A monomer unit on normal chromosome 17 and is present in an additional copy on the CMT1A duplicated chromosome. We propose that the de novo CMT1A duplication arises from unequal crossing over due to misalignment these CMT1A-REP repeat sequences during meiosis.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030				; Patel, Pragna/H-9129-2017	Wise, Carol/0000-0002-6790-2194; Patel, Pragna/0000-0003-3584-1072			ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BIRD A, 1987, TRENDS GENET, V3, P341; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; Charcot JM, 1886, REV MED FR, V6, P97; DARRAS BT, 1988, AM J HUM GENET, V43, P620; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; HALLAM PJ, 1992, ANN NEUROL, V31, P570, DOI 10.1002/ana.410310518; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; HU XY, 1990, AM J HUM GENET, V46, P682; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LOW PA, 1977, NEUROPATH APPL NEURO, V3, P81, DOI 10.1111/j.1365-2990.1977.tb00572.x; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; LOW PA, 1976, J NEUROL SCI, V30, P327, DOI 10.1016/0022-510X(76)90138-6; LOW PA, 1975, J NEUROL SCI, V26, P565, DOI 10.1016/0022-510X(75)90057-X; LOW PA, 1978, J NEUROL SCI, V35, P93, DOI 10.1016/0022-510X(78)90104-1; LOW PA, 1977, J NEUROL NEUROSUR PS, V40, P434, DOI 10.1136/jnnp.40.5.434; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1900, IN PRESS AM J MED GE; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MACMILLAN JC, 1992, J MED GENET, V29, P12, DOI 10.1136/jmg.29.1.12; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMEMRMAN V, 1992, NATUER GENET, V1, P171; Tooth HH, 1886, PERONEAL TYPE PROGRE; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	51	334	337	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					292	300		10.1038/ng1292-292			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	WOS:A1992KB49500013	1303282				2022-01-24	
J	Core, LJ; Martins, AL; Danko, CG; Waters, CT; Siepel, A; Lis, JT				Core, Leighton J.; Martins, Andre L.; Danko, Charles G.; Waters, Colin T.; Siepel, Adam; Lis, John T.			Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers	NATURE GENETICS			English	Article							DIVERGENT TRANSCRIPTION; U1 SNRNP; ACTIVE ENHANCERS; MESSENGER-RNAS; GLOBIN GENE; POLYMERASE; CHROMATIN; RECRUITMENT; EXPRESSION; DISTINCT	Despite the conventional distinction between them, promoters and enhancers share many features in mammals, including divergent transcription and similar modes of transcription factor binding. Here we examine the architecture of transcription initiation through comprehensive mapping of transcription start sites (TSSs) in human lymphoblastoid B cell (GM12878) and chronic myelogenous leukemic (K562) ENCODE Tier 1 cell lines. Using a nuclear run-on protocol called GRO-cap, which captures TSSs for both stable and unstable transcripts, we conduct detailed comparisons of thousands of promoters and enhancers in human cells. These analyses identify a common architecture of initiation, including tightly spaced (110 bp apart) divergent initiation, similar frequencies of core promoter sequence elements, highly positioned flanking nucleosomes and two modes of transcription factor binding. Post-initiation transcript stability provides a more fundamental distinction between promoters and enhancers than patterns of histone modification and association of transcription factors or co-activators. These results support a unified model of transcription initiation at promoters and enhancers.	[Core, Leighton J.; Waters, Colin T.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Martins, Andre L.; Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA		Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	acs4@cornell.edu; jtl10@cornell.edu		Waters, Colin/0000-0002-3096-0833; Siepel, Adam/0000-0002-3557-7219	NIGMS (National Institute of General Medical Sciences)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM25232, HG0070707]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG007070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	Research reported in this publication was supported by NIGMS (National Institute of General Medical Sciences) and NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award numbers GM25232 to J.T.L. and HG0070707 to A.S. and J.T.L., respectively. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R., 2014, BIORXIV         0829, DOI [10.1101/005447, DOI 10.1101/005447]; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Foley JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-720; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; MARUYAMA K, 1994, GENE, V138, P171; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Venters BJ, 2014, NATURE, V513, P444, DOI 10.1038/nature13588; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	55	333	336	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1311	1320		10.1038/ng.3142			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AU3YU	WOS:000345547300012	25383968	Green Accepted			2022-01-24	
J	Wallace, C; Newhouse, SJ; Braund, P; Zhang, F; Tobin, M; Falchi, M; Ahmadi, K; Dobson, RJ; Maracano, ACB; Hajat, C; Burton, P; Deloukas, P; Brown, M; Connell, JM; Dominiczak, A; Lathrop, GM; Webster, J; Farrall, M; Spector, T; Samani, NJ; Caulfield, MJ; Munroe, PB				Wallace, Chris; Newhouse, Stephen J.; Braund, Peter; Zhang, Feng; Tobin, Martin; Falchi, Mario; Ahmadi, Kourosh; Dobson, Richard J.; Maracano, Ana Carolina B.; Hajat, Cother; Burton, Paul; Deloukas, Panagiotis; Brown, Morris; Connell, John M.; Dominiczak, Anna; Lathrop, G. Mark; Webster, John; Farrall, Martin; Spector, Tim; Samani, Nilesh J.; Caulfield, Mark J.; Munroe, Patricia B.		Wellcome Trust Case Control	Genome-wide association study identifies genes for biomarkers of cardiovascular disease: Serum urate and dyslipiclemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URIC-ACID; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK; HYPERTENSION; LOCI; CHOLESTEROL; MORTALITY; GLUCOSE	Many common diseases are accompanied by disturbances in biochemical traits. Identifying the genetic determinants could provide novel insights into disease mechanisms and reveal avenues for developing new therapies. Here, we report a genome-wide association analysis for commonly measured serum and urine biochemical traits. As part of the WTCCC, 500,000 SNPs genome wide were geno-typed in 1955 hypertensive individuals characterized for 25 serum and urine biochemical traits. For each trait, we assessed association with individual SNPs, adjusting for age, sex, and BMI. Lipid measurements were further examined in a meta-analysis of genome-wide data from a type 2 diabetes scan. The most promising associations were examined in two epidemiological cohorts. We discovered association between serum urate and SLC2A9, a glucose transporter (p 2 x 10-(15)) and confirmed this in two independent cohorts, GRAPHIC study (p = 9 x 10(-15)) and TwinsUK (p = 8 x 10(-19)). The odds ratio for hyperuricaemia (defined as urate >0.4 mMol/l) is 1.89 (95% CI 1.36-2.61) per copy of common allele. We also replicated many genes previously associated with serum lipids and found previously recognized association between LDL levels and SNPs close to genes encoding PSRCI and CELSR2 (p = 1 x 10(-7)). The common allele was associated with a 6% increase in nonfasting serum LDL. This region showed increased association in the meta-analysis (p = 4 x 10(-14)). This finding provides a potential biological mechanism for the recent association of this same allele of the same SNP with increased risk of coronary disease.	[Wallace, Chris; Newhouse, Stephen J.; Dobson, Richard J.; Maracano, Ana Carolina B.; Caulfield, Mark J.; Munroe, Patricia B.] Barts & London Queen Marys Sch Med & Dent, Barts & London, Clin Pharmacol & Genome Ctr, London EC1M 6BQ, England; [Braund, Peter; Hajat, Cother; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England; [Zhang, Feng; Falchi, Mario; Ahmadi, Kourosh; Spector, Tim] Kings Coll London, Sch Med, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; [Tobin, Martin; Burton, Paul] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Tobin, Martin; Burton, Paul] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Deloukas, Panagiotis] Sanger Ctr, Cambridge CB10 1SA, England; [Brown, Morris] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Connell, John M.; Dominiczak, Anna] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Lathrop, G. Mark] Ctr Natl Genotypage, F-91057 Evry, France; [Webster, John] Aberdeen Royal Infirm, Aberdeen AB9 2ZB, Scotland; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England		Munroe, PB (corresponding author), Barts & London Queen Marys Sch Med & Dent, Barts & London, Clin Pharmacol & Genome Ctr, London EC1M 6BQ, England.	p.b.munroe@qmul.ac.uk	Dobson, Richard j/C-9269-2011; Spector, Tim D/F-6533-2012; Dominiczak, Anna F/P-9390-2017; Dominiczak, Anna F/D-2262-2009; Falchi, Mario/F-5956-2013; Burton, Paul R/H-7527-2016; Newhouse, Stephen J/C-9330-2011; Deloukas, Panos/B-2922-2013	Dobson, Richard j/0000-0003-4224-9245; Dominiczak, Anna F/0000-0003-4913-3608; Newhouse, Stephen J/0000-0002-1843-9842; Deloukas, Panos/0000-0001-9251-070X; Caulfield, Mark/0000-0001-9295-3594; Wallace, Chris/0000-0001-9755-1703; s, hema/0000-0002-3440-9475; Falchi, Mario/0000-0002-5646-1004; Munroe, Patricia/0000-0002-4176-2947; Tobin, Martin/0000-0002-3596-7874	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9817803B] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0501942, G106/1216, G0400874] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0400874, G0501942, G106/1216] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [076113/B/04/Z] Funding Source: Medline		Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/twin.4.6.464; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Burton PR, 1999, GENET EPIDEMIOL, V17, P118, DOI 10.1002/(SICI)1098-2272(1999)17:2<118::AID-GEPI3>3.0.CO;2-V; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lo PK, 1999, ONCOGENE, V18, P7765, DOI 10.1038/sj.onc.1203167; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; ORRELL DH, 1971, CLIN CHIM ACTA, V35, P483, DOI 10.1016/0009-8981(71)90224-5; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; SPIELGELHALTER D, 2003, WINBUGS VERSION 4 US; STAURT A, 1999, KENDALLS ADV THEORY, P486; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; TEAM RDC, 2007, R LANGUAGE ENV STAT; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; Vincent JB, 2000, DNA RES, V7, P233, DOI 10.1093/dnares/7.3.233; *WHO, 2002, RED RISKS PROM HLTH, P58; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	41	333	346	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					139	149		10.1016/j.ajhg.2007.11.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	WOS:000253223800014	18179892	Bronze, Green Published			2022-01-24	
J	Wienholds, E; Koudijs, MJ; van Eeden, FJM; Cuppen, E; Plasterk, RHA				Wienholds, E; Koudijs, MJ; van Eeden, FJM; Cuppen, E; Plasterk, RHA			The microRNA-producing enzyme Dicer1 is essential for zebrafish development	NATURE GENETICS			English	Article							RNA-INTERFERENCE; GENES; ELEGANS	MicroRNAs (miRNAs) are produced by the Dicer1 enzyme; the role of Dicer1 in vertebrate development is unknown. Here we report target-selected inactivation of the dicer1 gene in zebrafish. We observed an initial build-up of miRNA levels, produced by maternal Dicer1, in homozygous dicer1 mutants, but miRNA accumulation stopped after a few days. This resulted in developmental arrest around day 10. These results indicate that miRNA-producing Dicer1 is essential for vertebrate development.	Netherlands Inst Dev Biol, Hubrecht Lab, Dept Funct Genom, NL-3584 CT Utrecht, Netherlands		Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Dept Funct Genom, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; Van Eeden, Freek/E-6198-2010	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; 			Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762	10	333	359	1	35	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					217	218		10.1038/ng1251			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	WOS:000186273300015	14528306				2022-01-24	
J	Suka, N; Luo, KH; Grunstein, M				Suka, N; Luo, KH; Grunstein, M			Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin	NATURE GENETICS			English	Article							SILENT MATING LOCI; TELOMERIC HETEROCHROMATIN; SACCHAROMYCES-CEREVISIAE; DOSAGE COMPENSATION; MOLECULAR-MODEL; MSL COMPLEX; H3; METHYLATION; DROSOPHILA; PROTEINS	The Sir3 protein helps form telomeric heterochromatin by interacting with hypoacetylated histone H4 lysine 16 (H4-Lys16). The molecular nature of the heterochromatin boundary is still unknown. Here we show that the MYST-like acetyltransferase Sas2p is required for the acetylation (Ac) of H4-Lys16 in euchromatin. In a sas2Delta strain or a phenocopy Lys16Arg mutant, Sir3p spreads from roughly 3 kb to roughly 15 kb, causing hypoacetylation and repression of adjacent chromatin. We also found that disruption of Sir3p binding in a deacetylase-deficient sir2Delta strain can be suppressed by sas2Delta. These data indicate that opposing effects of Sir2p and Sas2p on acetylation of H4-Lys16 maintain the boundary at telomeric heterochromatin.	Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA		Grunstein, M (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Boyer Hall, Los Angeles, CA 90095 USA.						Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown AJP, 1998, METHOD MICROBIOL, V26, P119; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KIMURA A, 2002, NAT GENET, V32; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wach A, 1998, METHOD MICROBIOL, V26, P67	33	333	343	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					378	383		10.1038/ng1017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	WOS:000179034800012	12379856				2022-01-24	
J	Cardle, L; Ramsay, L; Milbourne, D; Macaulay, M; Marshall, D; Waugh, R				Cardle, L; Ramsay, L; Milbourne, D; Macaulay, M; Marshall, D; Waugh, R			Computational and experimental characterization of physically clustered simple sequence repeats in plants	GENETICS			English	Article							COMPREHENSIVE GENETIC-MAP; ORYZA-SATIVA L; MICROSATELLITE LOCI; ARABIDOPSIS-THALIANA; LENGTH POLYMORPHISM; CULTIVATED POTATO; DNA-SEQUENCE; HUMAN GENOME; LINKAGE MAP; MARKERS	The type and frequency of simple sequence repeats (SSRs) in plant genomes was investigated using the expanding quantity of DNA sequence data deposited in public databases. In Arabidopsis, 306 genomic DNA sequences longer than 10 kb and 36,199 EST sequences were searched for all possible mono- to pentanucleotide repeats. The average frequency of SSRs was one every 6.04 kb in genomic DNA decreasing to one every 14 kb in ESTs. SSR frequency and type differed between coding, intronic, and intergenic DNA. Similar frequencies were found in other plant species. On the basis of these findings, an approach is proposed and demonstrated for the targeted isolation of single or multiple, physically clustered SSRs linked to ally gene that has been mapped using low-copy DNA-based markers. The approach involves sample sequencing a small number of subclones of selected randomly sheared large insert DNA clones (e.g., BACs). It is shown to be both feasible and practicable, given the probability of fortuitously sequencing through an SSR. The approach is demonstrated in barley where sample sequencing 34 subclones of a single BAC selected by hybridization to the Big1 gene revealed three SSRs. These allowed Big1 to be located at the top of barley linkage group 6HS.	Scottish Crop Res Inst, Dundee DD2 5DA, Scotland		Waugh, R (corresponding author), Scottish Crop Res Inst, Dundee DD2 5DA, Scotland.	r.waugh@scri.sari.ac.uk	Marshall, David F/F-2471-2011	Marshall, David F/0000-0001-9309-2570; Milbourne, Dan/0000-0002-8323-6195; Milne, Linda/0000-0002-1798-8022			Akagi H, 1996, THEOR APPL GENET, V93, P1071, DOI 10.1007/BF00230127; AKKAYA MS, 1992, GENETICS, V132, P1131; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antezana MA, 1999, J MOL EVOL, V49, P36, DOI 10.1007/PL00006532; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Bryan GJ, 1997, THEOR APPL GENET, V94, P557, DOI 10.1007/s001220050451; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Chakraborty R, 1999, ELECTROPHORESIS, V20, P1682; CONDIT R, 1991, GENOME, V34, P66, DOI 10.1139/g91-011; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Cregan PB, 1999, THEOR APPL GENET, V98, P919, DOI 10.1007/s001220051151; DEPEIGES A, 1995, THEOR APPL GENET, V91, P160, DOI 10.1007/BF00220873; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Echt CS, 1997, GENOME, V40, P9, DOI 10.1139/g97-002; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; Jones DA, 1997, ADV BOT RES, V24, P89; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Liu ZW, 1996, THEOR APPL GENET, V93, P869, DOI 10.1007/BF00224088; Loridon K, 1998, THEOR APPL GENET, V97, P591, DOI 10.1007/s001220050935; MANNINEN I, 1993, PLANT MOL BIOL, V22, P829, DOI 10.1007/BF00027369; Milbourne D, 1997, MOL BREEDING, V3, P127, DOI 10.1023/A:1009633005390; Milbourne D, 1998, MOL GEN GENET, V259, P233, DOI 10.1007/s004380050809; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; MORGANTE M, 1999, PLANT ANIMAL GENOME, P208; NIEWOHNER J, 1995, MOL BREEDING, V1, P65, DOI 10.1007/BF01682090; Paglia GP, 1998, MOL GEN GENET, V258, P466, DOI 10.1007/s004380050757; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Panstruga R, 1998, NUCLEIC ACIDS RES, V26, P1056, DOI 10.1093/nar/26.4.1056; Provan J, 1996, THEOR APPL GENET, V92, P1078, DOI 10.1007/BF00224052; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; RAMSAY L, 2000, IN PRESS GENETICS; RODER MS, 1995, MOL GEN GENET, V246, P327, DOI 10.1007/BF00288605; Roder MS, 1998, GENETICS, V149, P2007; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Senior ML, 1996, CROP SCI, V36, P1676, DOI 10.2135/cropsci1996.0011183X003600060043x; Smulders MJM, 1997, THEOR APPL GENET, V94, P264, DOI 10.1007/s001220050409; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; Sverdlov VE, 1998, MAMM GENOME, V9, P816, DOI 10.1007/s003359900873; WANG Z, 1994, THEOR APPL GENET, V88, P1, DOI 10.1007/BF00222386; WEISING K, 1989, NUCLEIC ACIDS RES, V17, P10128, DOI 10.1093/nar/17.23.10128; White G, 1997, MOL ECOL, V6, P851, DOI 10.1111/j.1365-294X.1997.tb00139.x; WU KS, 1993, MOL GEN GENET, V241, P225, DOI 10.1007/BF00280220; ZHAO XP, 1992, MOL GEN GENET, V231, P353, DOI 10.1007/BF00292702	46	333	483	0	26	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2000	156	2					847	854					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	362EZ	WOS:000089766800033	11014830				2022-01-24	
J	Stone, EM; Lotery, AJ; Munier, FL; Heon, E; Piguet, B; Guymer, RH; Vandenburgh, K; Cousin, P; Nishimura, D; Swiderski, RE; Silvestri, G; Mackey, DA; Hageman, GS; Bird, AC; Sheffield, VC; Schorderet, DF				Stone, EM; Lotery, AJ; Munier, FL; Heon, E; Piguet, B; Guymer, RH; Vandenburgh, K; Cousin, P; Nishimura, D; Swiderski, RE; Silvestri, G; Mackey, DA; Hageman, GS; Bird, AC; Sheffield, VC; Schorderet, DF			A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy	NATURE GENETICS			English	Article							AGE-RELATED MACULOPATHY; BEAVER DAM EYE; MACULAR DEGENERATION; GENE; FIBRILLIN; PROTEIN; DRUSEN; PREVALENCE; FAMILY; DNA	Malattia Leventinese (ML) and Doyne honeycomb retinal dystrophy (DHRD) refer to two autosomal dominant diseases characterized by yellow-white deposits known as drusen that accumulate beneath the retinal pigment epithelium(1-4) (RPE). Both loci were mapped to chromosome 2p16-21 (refs 5,6) and this genetic interval has been subsequently narrowed(6) (7). The importance of these diseases is due in large part to their close phenotypic similarity to age-related macular degeneration (AMD), a disorder with a strong genetic: components(8-10) that accounts for approximately 50% of registered blindness in the Western world(11-14). Just as in ML and DHRD, the early hallmark of AMD is the presence of drusen(15) (16). Here we use a combination of positional and candidate gene methods to identify a single non-conservative mutation (Arg345Trp) in the gene EFEMP1 (for EGF-containing fibrillin-like extracellular matrix protein 1) in all families studied. This change was not present in 477 control individuals or in 494 patients with age-related macular degeneration. Identification of this mutation may aid in the development of an animal model for drusen, as well as in the identification of other genes involved in human macular degeneration.	Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA; CHU Vaudois, Div Med Genet, CH-1011 Lausanne, Switzerland; Hop Jules Gonin, Lausanne, Switzerland; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Eye Res Inst Canada, Toronto, ON, Canada; Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Parkville, Vic 3052, Australia; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; Royal Victoria Hosp, Dept Ophthalmol, Belfast BT12 6BA, Antrim, North Ireland; Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas 7001, Australia; Moorfields Eye Hosp, Inst Ophthalmol, London, England; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA USA		Stone, EM (corresponding author), Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Lotery, Andrew/0000-0001-5541-4305; Sheffield, Val/0000-0002-6282-0835; Silvestri, Giuliana/0000-0001-5662-5374; Guymer, Robyn/0000-0002-9441-4356; Stone, Edwin M./0000-0003-3343-4414	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY011515, R01EY010539] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY11515, EY10539] Funding Source: Medline		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Collins T., 1913, OPHTHALMOSCOPE, V11, P537; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Doyne RW., 1899, T OPHTHAL SOC UK, V19, P71; Edwards AO, 1998, AM J OPHTHALMOL, V126, P417, DOI 10.1016/S0002-9394(98)00097-X; Evans J, 1996, BRIT J OPHTHALMOL, V80, P9, DOI 10.1136/bjo.80.1.9; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; FORNI S, 1962, Ophthalmologica, V143, P313; Gregory CY, 1996, HUM MOL GENET, V5, P1055, DOI 10.1093/hmg/5.7.1055; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heon E, 1996, ARCH OPHTHALMOL-CHIC, V114, P193, DOI 10.1001/archopht.1996.01100130187014; Ikegawa S, 1996, GENOMICS, V35, P590, DOI 10.1006/geno.1996.0402; Jay M, 1996, EYE, V10, P469, DOI 10.1038/eye.1996.103; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120, DOI 10.1128/MCB.15.1.120; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Meyers S M, 1994, Trans Am Ophthalmol Soc, V92, P775; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; SARKS JP, 1994, EYE, V8, P269, DOI 10.1038/eye.1994.57; SILVESTRI G, 1994, EYE, V8, P564, DOI 10.1038/eye.1994.138; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vogt A., 1925, HDB GESAMMTEN AUGENH, V3, P1; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WELLISZ T, 1993, J LONG-TERM EFF MED, V3, P223	30	333	342	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					199	202		10.1038/9722			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	WOS:000080680900030	10369267				2022-01-24	
J	Wigle, JT; Chowdhury, K; Gruss, P; Oliver, G				Wigle, JT; Chowdhury, K; Gruss, P; Oliver, G			Prox1 function is crucial for mouse lens-fibre elongation	NATURE GENETICS			English	Article							MORPHOGENESIS; GENE	Although insights have emerged regarding genes controlling the early stages of eye formation, little is known about lens-fibre differentiation and elongation, The expression pattern of the Prox1 homeobox gene suggests it has a role in a variety of embryonic tissues, including lens'. To analyse the requirement far Prox1 during mammalian development, we inactivated the locus in mice, Homozygous Prox1-null mice die at mid-gestation from multiple developmental defects; here we describe the specific effect an lens development Prox1 inactivation causes abnormal cellular proliferation, downregulated expression of the cell-cycle inhibitors Cdkn Ib (also known as p27(KIP1)) and Cdkn1b (also known as p57(KIP2)), misexpression of E-cadherin and inappropriate apoptosis. Consequently, mutant lens cells fail to polarize and elongate properly, resulting in a hollow lens, Our data provide evidence that the progression of terminal fibre differentiation and elongation is dependent on Prox1 activity during lens development.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany		Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.		Wigle, J.t./G-2005-2014	Wigle, J.t./0000-0002-4985-7684	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 21765] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM58462] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM058462] Funding Source: NIH RePORTER		BOBER E, 1994, DEVELOPMENT, V120, P603; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GORING DR, 1992, EXP EYE RES, V54, P785, DOI 10.1016/0014-4835(92)90034-P; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; SANDILANDS A, 1995, J CELL SCI, V108, P1397; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	12	333	338	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1999	21	3					318	322		10.1038/6844			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	WOS:000078977900029	10080188				2022-01-24	
J	Xia, JH; Liu, CY; Tang, BS; Pan, Q; Huang, L; Dai, HP; Zhang, BR; Xie, W; Hu, DX; Zheng, D; Shi, XL; Wang, DA; Xia, K; Yu, KP; Liao, XD; Feng, Y; Yang, YF; Xiao, JY; Xie, DH; Huang, JZ				Xia, JH; Liu, CY; Tang, BS; Pan, Q; Huang, L; Dai, HP; Zhang, BR; Xie, W; Hu, DX; Zheng, D; Shi, XL; Wang, DA; Xia, K; Yu, KP; Liao, XD; Feng, Y; Yang, YF; Xiao, JY; Xie, DH; Huang, JZ			Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant healing impairment	NATURE GENETICS			English	Article							MARIE-TOOTH DISEASE; HEARING IMPAIRMENT; DEAFNESS; HETEROGENEITY; FAMILIES; LINKAGE; REGION; MAPS	Hearing impairment is the most commonly occurring condition that affects the ability of humans to communicate(1). More than 50% of the cases of profound early-onset deafness are caused by genetic factors(2,3). Over 40 loci for non-syndromic deafness have been genetically mapped, and mutations in several genes have been shown to cause hearing loss(4). Mutations in the gene encoding connexin 26 (GJB2) cause both autosomal recessive and dominant forms of hearing impairment(5,6). To study the possible involvement of other members of the connexin family in hereditary hearing impairment, we cloned the gene (GJB3) encoding human gap junction protein beta-3 using homologous EST searching and nested PCR. GJB3 was mapped to human chromosome 1p33-p35. Mutation analysis revealed that a missense mutation and a nonsense mutation of GJB3 were associated with high-frequency hearing loss in two families. Moreover. expression of Gjb3 was identified in rat inner ear tissue by RT-PCR. These findings suggest that mutations in GJB3 may be responsible for bilateral high-frequency hearing impairment.	Affiliated Xiangya Hosp, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; Affiliated Xiangya Hosp, Dept Neurol, Changsha 410078, Hunan, Peoples R China; Affiliated Xiangya Hosp, Dept Otorhinol, Changsha 410078, Hunan, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Otorhinol, Changsha 410078, Hunan, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Changsha 410078, Hunan, Peoples R China; Zhejiang Med Univ, Affiliated Hosp 2, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China		Xia, JH (corresponding author), Affiliated Xiangya Hosp, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China.	nlmglcy@public.cs.hn.cn	Liu, Chunyu/G-7561-2012; Liu, chunyu/Q-3901-2017; XIA, KUN/AAO-3525-2020	Liu, Chunyu/0000-0002-5986-4415; Shi, Xiaoliu/0000-0002-9759-2254			AYIMU D, 1997, J AUDIOL SPEECH PATH, V5, P144; BENOTHMANE K, 1993, GENOMICS, V17, P370; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Engle EC, 1997, AM J HUM GENET, V60, P1150; FAIN PR, 1994, AM J HUM GENET, V54, P229; HULL R, 1978, HDB CLIN AUDIOLOGY, P426; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; VanCamp G, 1997, AM J HUM GENET, V60, P758; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202	19	333	412	1	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					370	373		10.1038/3845			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	WOS:000077199600025	9843210				2022-01-24	
J	COCKERHAM, CC				COCKERHAM, CC			ANALYSES OF GENE FREQUENCIES	GENETICS			English	Article									N CAROLINA STATE UNIV, DEPT STATISTICS, RALEIGH, NC 27607 USA								AIRY GB, 1861, ALGEBRAICAL NUMERICA; BARRAI I, 1971, AM J HUM GENET, V23, P95; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; CANNINGS C, 1969, AM J HUM GENET, V21, P245; COCKERHAM C. CLARK, 1963, NATL ACAD SCI NATL RES COUNC PUBL, V982, P53; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; COCKERHAM CC, 1970, MATHEMATICAL TOPICS; CROW J F, 1971, Theoretical Population Biology, V2, P437, DOI 10.1016/0040-5809(71)90033-5; Daniels H. E., 1939, JR STATIST SOC S, V6, P186; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher RA, 1925, STATISTICAL METHODS; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; HARVILLE DA, 1969, 690180 AER RES LAB R; HOGBEN LT, 1946, INTRO MATHEMATICAL G; KOCH GG, 1968, TECHNOMETRICS, V10, P551, DOI 10.2307/1267108; KOCH GG, 1967, TECHNOMETRICS, V9, P93, DOI 10.2307/1266321; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; LEWONTIN RC, 1959, EVOLUTION, V13, P561, DOI 10.2307/2406136; LI CC, 1969, ANN HUM GENET, V33, P23, DOI 10.1111/j.1469-1809.1969.tb01625.x; Lush Jay L., 1942, JOUR DAIRY SCI, V25, P975, DOI 10.3168/jds.S0022-0302(42)95362-1; LUSH JL, 1947, AM NAT, V81, P362, DOI 10.1086/281532; LUSH JL, 1947, AM NAT, V81, P241, DOI 10.1086/281520; LUSH JL, 1942, 836 US DEP AGR TECHN; Lush JL, 1948, GENETICS POPULATIONS; Malecot G, 1948, MATHEMATIQUES HEREDI; MALECOT G, 1967, 5 P BERK S MATH STAT, V4, P317; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; MORTON NE, 1968, AM J HUM GENET, V20, P411; PURSER AF, 1966, HEREDITY, V21, P322, DOI 10.1038/hdy.1966.28; RAO CR, 1972, J AM STAT ASSOC, V67, P112, DOI 10.2307/2284708; RAO CR, 1971, J MULTIVAR ANAL, V1, P445, DOI DOI 10.1016/0047-259X(71)90019-4; Rao CR, 1971, J MULTIVARIATE ANAL, V1, P257; ROBERTSON A, 1965, ANIM PROD, V7, P319, DOI 10.1017/S0003356100025770; ROBERTSON A, 1964, GENET RES, V5, P164, DOI 10.1017/S0016672300001129; Searle M, 1971, LINEAR MODELS; SEARLE SR, 1971, BIOMETRICS, V27, P1, DOI 10.2307/2528928; SMITH CAB, 1970, ANN HUM GENET, V33, P377, DOI 10.1111/j.1469-1809.1970.tb01664.x; SNEDECOR GW, 1946, STATISTICAL METHODS; TIPPETT LHC, 1931, METHODS STATISTICS; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WALLACE B, 1958, EVOLUTION, V12, P113, DOI 10.2307/2405911; Winsor CP, 1940, J MAR RES, V3, P1; WORKMAN PL, 1969, HUM BIOL, V41, P97; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1935, J GENET, V30, P243, DOI 10.1007/BF02982239; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1946, GENETICS, V31, P39; Wright S, 1943, GENETICS, V28, P114; Yates F, 1935, J AGR SCI-CAMBRIDGE, V25, P545, DOI 10.1017/S0021859600019663; [No title captured]	50	333	345	0	22	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1973	74	4					679	700					22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R1367	WOS:A1973R136700014	17248636				2022-01-24	
J	Braunschweig, U; Barbosa-Morais, NL; Pan, Q; Nachman, EN; Alipanahi, B; Gonatopoulos-Pournatzis, T; Frey, B; Irimia, M; Blencowe, BJ				Braunschweig, Ulrich; Barbosa-Morais, Nuno L.; Pan, Qun; Nachman, Emil N.; Alipanahi, Babak; Gonatopoulos-Pournatzis, Thomas; Frey, Brendan; Irimia, Manuel; Blencowe, Benjamin J.			Widespread intron retention in mammals functionally tunes transcriptomes	GENOME RESEARCH			English	Article							MESSENGER-RNA DECAY; HUMAN GENOME; GENE-EXPRESSION; POLYMERASE-II; DNA ELEMENTS; FEATURES; ARABIDOPSIS; ELONGATION; LANDSCAPE; COMPLEXITY	Alternative splicing (AS) of precursor RNAs is responsible for greatly expanding the regulatory and functional capacity of eukaryotic genomes. Of the different classes of AS, intron retention (IR) is the least well understood. In plants and unicellular eukaryotes, IR is the most common form of AS, whereas in animals, it is thought to represent the least prevalent form. Using high-coverage poly(A)(+) RNA-seq data, we observe that IR is surprisingly frequent in mammals, affecting transcripts from as many as three-quarters of multiexonic genes. A highly correlated set of cis features comprising an "IR code" reliably discriminates retained from constitutively spliced introns. We show that IR acts widely to reduce the levels of transcripts that are less or not required for the physiology of the cell or tissue type in which they are detected. This "transcriptome tuning" function of IR acts through both nonsense-mediated mRNA decay and nuclear sequestration and turnover of IR transcripts. We further show that IR is linked to a cross-talk mechanism involving localized stalling of RNA polymerase II (Pol II) and reduced availability of spliceosomal components. Collectively, the results implicate a global checkpoint-type mechanism whereby reduced recruitment of splicing components coupled to Pol II pausing underlies widespread IR-mediated suppression of inappropriately expressed transcripts.	[Braunschweig, Ulrich; Barbosa-Morais, Nuno L.; Pan, Qun; Nachman, Emil N.; Gonatopoulos-Pournatzis, Thomas; Irimia, Manuel; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Barbosa-Morais, Nuno L.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Nachman, Emil N.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Alipanahi, Babak; Frey, Brendan] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 2E4, Canada; [Barbosa-Morais, Nuno L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Irimia, Manuel] Ctr Genom Regulat CRG, EMBL CRG Res Unit Syst Biol, Barcelona 08003, Spain		Blencowe, BJ (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	mirimia@gmail.com; b.blencowe@utoronto.ca	Braunschweig, Ulrich/I-1070-2019; Irimia, Manuel/E-3040-2010; Barbosa-Morais, Nuno L/I-2743-2013	Braunschweig, Ulrich/0000-0001-6653-0926; Irimia, Manuel/0000-0002-2179-2567; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Alipanahi, Babak/0000-0001-8216-7178; Gonatopoulos-Pournatzis, Thomas/0000-0003-2669-2570	Canadian Institutes of Health Research and Canadian Cancer SocietyCanadian Institutes of Health Research (CIHR); EMBO long-term fellowships; Human Frontier Science Program Organization long-term fellowships; OSCI fellowship; CIHR postdoctoral fellowshipCanadian Institutes of Health Research (CIHR); NSERC studentshipNatural Sciences and Engineering Research Council of Canada (NSERC); Marie Curie IOF fellowshipEuropean Commission	We thank Andrew Delong and Eduardo Eyras for helpful discussions and insights, and members of the Blencowe laboratory for valuable comments on the manuscript. This work was supported by grants from the Canadian Institutes of Health Research and Canadian Cancer Society (BJ.B.); EMBO long-term fellowships (U.B. and T.G.-P.); Human Frontier Science Program Organization long-term fellowships (U.B. and M.I.); an OSCI fellowship (T.G.-P.); CIHR postdoctoral and Marie Curie IOF fellowships (N.L.B.-M.); and an NSERC studentship (E.N.).	Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Beckers JM, 2003, J ATMOS OCEAN TECH, V20, P1839, DOI 10.1175/1520-0426(2003)020<1839:ECADFF>2.0.CO;2; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; David CJ, 2011, TRANSCR-AUSTIN, V2, P221, DOI 10.4161/trns.2.5.17272; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garcia H, 2011, ONCOTARGET, V2, P783; Ge Y, 2014, BIOESSAYS, V36, P236, DOI 10.1002/bies.201300156; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard Kyle S, 2013, F1000Res, V2, P35, DOI 10.12688/f1000research.2-35.v1; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; McIlwain DR, 2010, P NATL ACAD SCI USA, V107, P12186, DOI 10.1073/pnas.1007336107; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2014, R LANGUAGE ENV STAT; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	59	332	341	2	47	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2014	24	11					1774	1786		10.1101/gr.177790.114			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	AS7NG	WOS:000344442000006	25258385	Green Published, hybrid			2022-01-24	
J	Van Deerlin, VM; Sleiman, PMA; Martinez-Lage, M; Chen-Plotkin, A; Wang, LS; Graff-Radford, NR; Dickson, DW; Rademakers, R; Boeve, BF; Grossman, M; Arnold, SE; Mann, DMA; Pickering-Brown, SM; Seelaar, H; Heutink, P; van Swieten, JC; Murrell, JR; Ghetti, B; Spina, S; Grafman, J; Hodges, J; Spillantini, MG; Gilman, S; Lieberman, AP; Kaye, JA; Woltjer, RL; Bigio, EH; Mesulam, M; al-Sarraj, S; Troakes, C; Rosenberg, RN; White, CL; Ferrer, I; Llado, A; Neumann, M; Kretzschmar, HA; Hulette, CM; Welsh-Bohmer, KA; Miller, BL; Alzualde, A; de Munain, AL; McKee, AC; Gearing, M; Levey, AI; Lah, JJ; Hardy, J; Rohrer, JD; Lashley, T; Mackenzie, IRA; Feldman, HH; Hamilton, RL; Dekosky, ST; van der Zee, J; Kumar-Singh, S; Van Broeckhoven, C; Mayeux, R; Vonsattel, JPG; Troncoso, JC; Kril, JJ; Kwok, JBJ; Halliday, GM; Bird, TD; Ince, PG; Shaw, PJ; Cairns, NJ; Morris, JC; McLean, CA; DeCarli, C; Ellis, WG; Freeman, SH; Frosch, MP; Growdon, JH; Perl, DP; Sano, M; Bennett, DA; Schneider, JA; Beach, TG; Reiman, EM; Woodruff, BK; Cummings, J; Vinters, HV; Miller, CA; Chui, HC; Alafuzoff, I; Hartikainen, P; Seilhean, D; Galasko, D; Masliah, E; Cotman, CW; Tunon, MT; Martinez, MCC; Munoz, DG; Carroll, SL; Marson, D; Riederer, PF; Bogdanovic, N; Schellenberg, GD; Hakonarson, H; Trojanowski, JQ; Lee, VMY				Van Deerlin, Vivianna M.; Sleiman, Patrick M. A.; Martinez-Lage, Maria; Chen-Plotkin, Alice; Wang, Li-San; Graff-Radford, Neill R.; Dickson, Dennis W.; Rademakers, Rosa; Boeve, Bradley F.; Grossman, Murray; Arnold, Steven E.; Mann, David M. A.; Pickering-Brown, Stuart M.; Seelaar, Harro; Heutink, Peter; van Swieten, John C.; Murrell, Jill R.; Ghetti, Bernardino; Spina, Salvatore; Grafman, Jordan; Hodges, John; Spillantini, Maria Grazia; Gilman, Sid; Lieberman, Andrew P.; Kaye, Jeffrey A.; Woltjer, Randall L.; Bigio, Eileen H.; Mesulam, Marsel; al-Sarraj, Safa; Troakes, Claire; Rosenberg, Roger N.; White, Charles L., III; Ferrer, Isidro; Llado, Albert; Neumann, Manuela; Kretzschmar, Hans A.; Hulette, Christine Marie; Welsh-Bohmer, Kathleen A.; Miller, Bruce L.; Alzualde, Ainhoa; Lopez de Munain, Adolfo; McKee, Ann C.; Gearing, Marla; Levey, Allan I.; Lah, James J.; Hardy, John; Rohrer, Jonathan D.; Lashley, Tammaryn; Mackenzie, Ian R. A.; Feldman, Howard H.; Hamilton, Ronald L.; Dekosky, Steven T.; van der Zee, Julie; Kumar-Singh, Samir; Van Broeckhoven, Christine; Mayeux, Richard; Vonsattel, Jean Paul G.; Troncoso, Juan C.; Kril, Jillian J.; Kwok, John B. J.; Halliday, Glenda M.; Bird, Thomas D.; Ince, Paul G.; Shaw, Pamela J.; Cairns, Nigel J.; Morris, John C.; McLean, Catriona Ann; DeCarli, Charles; Ellis, William G.; Freeman, Stefanie H.; Frosch, Matthew P.; Growdon, John H.; Perl, Daniel P.; Sano, Mary; Bennett, David A.; Schneider, Julie A.; Beach, Thomas G.; Reiman, Eric M.; Woodruff, Bryan K.; Cummings, Jeffrey; Vinters, Harry V.; Miller, Carol A.; Chui, Helena C.; Alafuzoff, Irina; Hartikainen, Paivi; Seilhean, Danielle; Galasko, Douglas; Masliah, Eliezer; Cotman, Carl W.; Tunon, M. Teresa; Martinez, M. Cristina Caballero; Munoz, David G.; Carroll, Steven L.; Marson, Daniel; Riederer, Peter F.; Bogdanovic, Nenad; Schellenberg, Gerard D.; Hakonarson, Hakon; Trojanowski, John Q.; Lee, Virginia M-Y			Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GLOBAL GENE-EXPRESSION; GENOTYPE DATA; DEMENTIA; PROGRANULIN; MUTATIONS; CONSENSUS; DISEASE; ONSET; FAMILIES	Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. The predominant neuropathology is FTLD with TAR DNA-binding protein (TDP-43) inclusions (FTLD-TDP) 1. FTLD-TDP is frequently familial, resulting from mutations in GRN (which encodes progranulin). We assembled an international collaboration to identify susceptibility loci for FTLD-TDP through a genome-wide association study of 515 individuals with FTLD-TDP. We found that FTLD-TDP associates with multiple SNPs mapping to a single linkage disequilibrium block on 7p21 that contains TMEM106B. Three SNPs retained genome-wide significance following Bonferroni correction (top SNP rs1990622, P = 1.08 x 10(-11); odds ratio, minor allele (C) 0.61, 95% CI 0.53-0.71). The association replicated in 89 FTLD-TDP cases (rs1990622; P = 2 x 10(-4)). TMEM106B variants may confer risk of FTLD-TDP by increasing TMEM106B expression. TMEM106B variants also contribute to genetic risk for FTLD-TDP in individuals with mutations in GRN. Our data implicate variants in TMEM106B as a strong risk factor for FTLD-TDP, suggesting an underlying pathogenic mechanism.	[Van Deerlin, Vivianna M.; Martinez-Lage, Maria; Chen-Plotkin, Alice; Wang, Li-San; Schellenberg, Gerard D.; Trojanowski, John Q.; Lee, Virginia M-Y] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Ctr Appl Genom, Div Human Genet,Sch Med, Philadelphia, PA 19104 USA; [Martinez-Lage, Maria] Univ Autonoma Barcelona, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Chen-Plotkin, Alice; Grossman, Murray; Arnold, Steven E.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Graff-Radford, Neill R.] Mayo Coll Med, Dept Neurol, Jacksonville, FL USA; [Dickson, Dennis W.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Boeve, Bradley F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Arnold, Steven E.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Arnold, Steven E.] Univ Penn, Sch Med, Penn Memory Ctr, Philadelphia, PA 19104 USA; [Mann, David M. A.; Pickering-Brown, Stuart M.] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Seelaar, Harro; van Swieten, John C.] Erasmus MC, Rotterdam, Netherlands; [Heutink, Peter] Vrije Univ Amsterdam, Med Ctr, Sect Med Genom, Dept Clin Genet, Amsterdam, Netherlands; [Murrell, Jill R.; Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Murrell, Jill R.; Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN USA; [Spina, Salvatore] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Grafman, Jordan] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, Bethesda, MD USA; [Spillantini, Maria Grazia] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Gilman, Sid] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Ann Arbor, MI USA; [Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Dept Neurol & Biomed Engn, Portland, OR 97201 USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Bigio, Eileen H.; Mesulam, Marsel] Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimer Dis Ctr, Chicago, IL 60611 USA; [al-Sarraj, Safa] Kings Coll Hosp London, Inst Psychiat, Dept Clin Neuropathol, London, England; [Troakes, Claire] Kings Coll Hosp London, MRC, London Neurodegenerat Dis Brain Bank, Inst Psychiat, London, England; [Rosenberg, Roger N.] Univ Texas SW Med Ctr Dallas, Rush Alzheimers Dis Ctr, Dallas, TX 75390 USA; [White, Charles L., III] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Ferrer, Isidro] Hosp Univ Bellvitge, Inst Neuropatol, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Llado, Albert] Hosp Clin Barcelona, Alzheimers Dis & Cognit Disorders Unit, Serv Neurol, Inst Clin Neurociencies, Barcelona, Spain; [Neumann, Manuela] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Hulette, Christine Marie] Duke Univ, Dept Pathol, Hlth Sci Ctr, Durham, NC 27706 USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Bryan Alzheimers Dis Res Ctr, Durham, NC 27710 USA; [Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Alzualde, Ainhoa] Hosp Donostia, Neurogenet Unit, Inst Biodonostia, San Sebastian, Spain; [Lopez de Munain, Adolfo] Hosp Donostia, Serv Neurol, San Sebastian, Spain; [McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.] Ctr Geriatr Res Educ & Clin, Bedford Vet Adm Med Ctr, Bedford, MA USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Alzheimers Dis Res Ctr, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Levey, Allan I.; Lah, James J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Hardy, John] UCL, Inst Neurol, Reta Lila Labs, London, England; [Hardy, John; Lashley, Tammaryn] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Rohrer, Jonathan D.] UCL, Inst Neurol, Dementia Res Ctr, London, England; [Lashley, Tammaryn] UCL, Inst Neurol, Queen Sq Brain Bank Neurol Disorders, London, England; [Mackenzie, Ian R. A.] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Mackenzie, Ian R. A.; Feldman, Howard H.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Feldman, Howard H.] Vancouver Gen Hosp, Div Neurol, Vancouver, BC, Canada; [Feldman, Howard H.] Bristol Myers Squibb Co, Neurosci, Wallingford, CT 06492 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Dekosky, Steven T.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [van der Zee, Julie; Kumar-Singh, Samir; Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [van der Zee, Julie; Kumar-Singh, Samir; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, B-2020 Antwerp, Belgium; [Mayeux, Richard; Vonsattel, Jean Paul G.] Columbia Univ, Taub Inst Res Alzheimers Dis, New York, NY USA; [Vonsattel, Jean Paul G.] Columbia Univ, New York Brain Bank, New York, NY USA; [Vonsattel, Jean Paul G.] Columbia Univ, Dept Pathol, New York, NY USA; [Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kril, Jillian J.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia; [Kril, Jillian J.] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Kwok, John B. J.; Halliday, Glenda M.] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW, Australia; [Bird, Thomas D.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA USA; [Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Ince, Paul G.; Shaw, Pamela J.] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO USA; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA; [McLean, Catriona Ann] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Alzheimers Dis Ctr, Imaging Dementia & Aging Lab,Ctr Neurosci, Sacramento, CA 95817 USA; [Ellis, William G.] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Freeman, Stefanie H.; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Freeman, Stefanie H.; Frosch, Matthew P.; Growdon, John H.] Harvard Univ, Sch Med, Boston, MA USA; [Growdon, John H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Perl, Daniel P.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Sano, Mary] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Sano, Mary] James J Peters Vet Affairs Med Ctr, New York, NY USA; [Bennett, David A.; Schneider, Julie A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Beach, Thomas G.] Sun Hlth Res Inst, Sun City, AZ USA; [Reiman, Eric M.] Univ Arizona, Banner Alzheimers Inst, Translat Genom Res Inst, Phoenix, AZ USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Woodruff, Bryan K.] Mayo Clin, Scottsdale, AZ USA; [Cummings, Jeffrey] Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Miller, Carol A.; Chui, Helena C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Alafuzoff, Irina] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Alafuzoff, Irina] Univ Kuopio, Dept Clin Med, FIN-70211 Kuopio, Finland; [Hartikainen, Paivi] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland; [Seilhean, Danielle] Univ Paris 06, Paris, France; [Seilhean, Danielle] AP HP, Paris, France; [Galasko, Douglas; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Cotman, Carl W.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Tunon, M. Teresa] Hosp Navarra Pathol Dept, Navarra, Spain; [Tunon, M. Teresa; Martinez, M. Cristina Caballero] Brain Bank Navarra, Navarra, Spain; [Martinez, M. Cristina Caballero] Navarra Hlth Serv Osasunbidea, Biomed Res Ctr, Navarra, Spain; [Munoz, David G.] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Carroll, Steven L.] Univ Alabama, Dept Pathol, Tuscaloosa, AL 35487 USA; [Marson, Daniel] Univ Alabama, Dept Neurol, Tuscaloosa, AL 35487 USA; [Marson, Daniel] Univ Alabama, Alzheimers Dis Res Ctr, Tuscaloosa, AL 35487 USA; [Riederer, Peter F.] Univ Wurzburg, Clin & Policlin Psychiat Psychosomat & Psychother, Wurzburg, Germany; [Bogdanovic, Nenad] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden; [Hakonarson, Hakon] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Pulm Med,Dept Pediat, Philadelphia, PA 19104 USA		Van Deerlin, VM (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vivianna@mail.med.upenn.edu; trojanow@mail.med.upenn.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020; Van Broeckhoven, Christine/G-8362-2017; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Lashley, Tammaryn/D-2583-2009; Sander-Effron, Samuel/AAX-2231-2020; Pickering-Brown, Stuart/D-4008-2009; Cairns, Nigel/AAB-9713-2020; Tunon, Teresa/B-2525-2017; Seilhean, Danielle D/O-6899-2018; Arnold, Steven E/J-7546-2012; Van Broeckhoven, Christine/M-7853-2019; White, Charles L/AAJ-1858-2021; DeCarli, Charles/B-5541-2009; Shaw, Pamela/E-6193-2010; Ince, Paul G/A-5064-2009; Frosch, Matthew P/ABD-7456-2021; Morris, John C/A-1686-2012; Troakes, Claire/K-4346-2015; Martinez-Lage, Maria/S-6665-2019; Shaw, Pamela J/A-7620-2010; Neumann, Manuela/F-6558-2011; Mayeux, Richard/E-9788-2013; Hardy, John/C-2451-2009; Halliday, Glenda M/E-8555-2011; Effron, Sam Sander/AAF-9758-2021; Tunon, Maria Jesus/L-2456-2017; Spina, Salvatore/M-4463-2019; Munoz, David G./AAQ-8003-2020; Kumar-Singh, Samir/G-6280-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Pickering-Brown, Stuart/0000-0003-1561-6054; Cairns, Nigel/0000-0001-9858-3344; Tunon, Teresa/0000-0001-6589-1084; Seilhean, Danielle D/0000-0003-3498-4602; Van Broeckhoven, Christine/0000-0003-0183-7665; White, Charles L/0000-0002-3870-2804; Ince, Paul G/0000-0001-6677-8753; Frosch, Matthew P/0000-0002-3940-9861; Neumann, Manuela/0000-0002-6232-4057; Mayeux, Richard/0000-0001-6519-9696; Hardy, John/0000-0002-3122-0423; Halliday, Glenda M/0000-0003-0422-8398; Munoz, David G./0000-0003-0957-6244; Kumar-Singh, Samir/0000-0001-9466-6732; /0000-0002-9509-4032; Kaye, Jeffrey/0000-0002-9971-3478; Shaw, Pamela/0000-0002-8925-2567; Lashley, Tammaryn/0000-0001-7389-0348; Carroll, Steven/0000-0001-6714-4373; Troakes, Claire/0000-0002-1790-7376; Martinez-Lage, Maria/0000-0002-5859-7562; Kril, Jillian/0000-0001-9407-8674; Kwok, John/0000-0001-9574-6195; Feldman, Howard/0000-0002-9258-4538; Heutink, Peter/0000-0001-5218-1737; Rohrer, Jonathan/0000-0002-6155-8417; Grafman, Jordan H./0000-0001-8645-4457; Dickson, Dennis W/0000-0001-7189-7917; DeKosky, Steven/0000-0003-3743-2758	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Biobank at the Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium; French clinical and genetic research network; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044266, P01NS015655, P50NS038372, P50NS053488, ZIANS003023, R01NS065782, P01NS044233, P50NS015655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010124, P30AG008017, P50AG016574, P50AG005138, R01AG015116, P50AG005136, P50AG016573, P50AG016582, R01AG018440, P30AG028377, P01AG002219, P30AG019610, P30AG010129, P30AG013846, P30AG010161, P50AG005146, P50AG005131, P01AG003949, R37AG018440, P50AG005142, P50AG005681, P30AG013854, P01AG003991, P01AG019724, K08AG033101, P50AG016570, P50AG008702, P50AG025688, P30AG010133, P50AG005134, P50AG005133, P50AG008671, P01AG017586, P30AG012300] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0301152, G0601943, G0600676, G9724461, G0701441] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9724461, G0600676, G0701441, G0601943, G0301152] Funding Source: UKRI	This project was enabled by the contributions and efforts of many individuals in several supportive capacities. Most importantly, we extend our appreciation to the study subjects and families who made this research possible. Extensive technical assistance was provided by R. Greene, T. Unger and C. Kim and study coordination was provided by E. McCarty Wood. The following individuals contributed through sample ascertainment, epidemiology, coordination, and/or clinical evaluation of cases: S. Weintraub, N. Johnson, C. Shaw, V. Haroutunian, R. C. Petersen, D. S. Knopman, K. A. Josephs, D. Neary, J. Snowden, J. Heidebrink, N. Barbas, R. Re e, J. R. Burke, K. Hayden, J. Browndyke, P. Gaskell, M. Szymanski, J. D. Glass, M. Rossor, F. Moreno, B. Indakoetxea, M. Barandiaran, S. Engelborghs, P. P. De Deyn, W. S. Brooks, T. Chow, V. Meininger, L. Lacomblez and E. Gruenblatt. The following individuals contributed through pathological characterization and evaluation of cases: D. Clark, A. King, I. Bodi, D. Purohit, L. Kwong, J. E. Parisi, W. Kamphorst, I. Ruiz, T. Revesz, J.-J. Martin, R. Highley and C. Duyckaerts. The following individuals contributed through general technical assistance and/or genetic studies: J. Kirby, E. Moore, M. Baker, R. Crook, S. Rollinson, N. Halliwell, S. Usher, R. M. Richardson, M. Mishra, C. Foong, J. Ervin, K. Price Bryan, J. Ervin, C. Kubilus, A. Gorostidi, M. Cruts, I. Gijselinck, H. McCann, P. R. Schofield, G. Forster, K. Firch, J. Pomaician, I. Leber, V. Sazdovitch and I. Volkmann. We also thank the Brain Bank of University of Barcelona, Hospital Clinic, Clinic for Alzheimer's Disease and Related Disorders University of British Columbia, Australian Brain Donor Programs supported by the National Health and Medical Research Council of Australia, Biobank at the Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium and the French clinical and genetic research network on FTD/FTD-motor neuron disease (MND). Many grant funding agencies provided financial support for this study, including the US National Institutes of Health (NIH) (grant numbers AG10124, AG17586, AG16574, AG03949, AG17586, NS44266, AG15116, NS53488, AG10124, AG010133, AG08671, NS044233, NS15655, AG008017, AG13854, AG12300, AG028377, AG 019724, AG13846, AG025688, AG05133, AG08702, AG05146, AG005136, AG005681, AG03991, AG010129, AG05134, NS038372, AG02219, AG05138, AG10161, AG19610, AG19610, AG16570, AG16570, AG05142, AG005131, AG5131, AG18440, AG16582, AG16573, AG033101 and NIH Intramural Program). Additional funds were provided by Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program, the Pacific Alzheimer's disease Research Foundation (PARF) grant #C06-01, the Alzheimer's Research Trust, Alzheimer's Society, Medical Research Council (Programme Grant and Returning Scientist Award), Stichting Dioraphte (07010500), Hersenstichting (15F07.2.34), Prinses Beatrix Fonds (0060204), Winspear Family Center for Research on the Neuropathology of Alzheimer Disease, the McCune Foundation, Instituto Carlos III, Federal Ministry of Education and Research (01GI0505), SAIOTEK Program (Basque Government), Department of Innovation, Diputacion Foral de Gipuzkoa (DFG 0876/08), ILUNDAIN Fundazioa, Centro de Investigaciones Biomedicas en Red en Enfermededades Neurodegenerativas (CIBERNED), Wellcome Trust, Canadian Institutes of Health Research (75480), Fund for Scientific Research Flanders (FWOV), Alzheimer Research (SAO/FRMA), Interuniversity Attraction Poles (IAP) P6/43 network of the Belgian Science Policy Office (BELSPO), J.v.d.; Z receves a postdoctoral fellowship from the FWOV, the Joseph Iseman Fund, the Louis and Rachel Rudin Foundation, National Health and Medical Research Council of Australia, Veteran's Affairs Research Funds, Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05901 to the Arizona Parkinson's Disease Consortium), the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research, the Daljits and Elaine Sarkara Chair in Diagnostic Medicine, BrainNet Europe II, Ministerio de Ciencia y Tecnologia, Ref Saud y Farmacia 2001-4888, Burroghs Wellcome Fund Career Award for Medical Scientists and Fundacion 'La Caxia'.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Falush D, 2003, GENETICS, V164, P1567; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Goldman JS, 2004, NEUROLOGIST, V10, P227, DOI 10.1097/01.nrl.0000138735.48533.26; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Le Ber I, 2009, NEUROLOGY, V72, P1669, DOI 10.1212/WNL.0b013e3181a55f1c; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pastor P, 2003, ANN NEUROL, V54, P163, DOI 10.1002/ana.10636; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Van Deerlin VM, 2007, ARCH NEUROL-CHICAGO, V64, P1148, DOI 10.1001/archneur.64.8.1148; Wijsman EM, 2005, AM J MED GENET B, V132B, P14, DOI 10.1002/ajmg.b.30087	29	332	333	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					234	U34		10.1038/ng.536			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	WOS:000274912400012	20154673	Green Accepted, Green Submitted			2022-01-24	
J	Wang, J; Santure, AW				Wang, J.; Santure, A. W.			Parentage and Sibship Inference From Multilocus Genotype Data Under Polygamy	GENETICS			English	Article							GENETIC-ANALYSIS; POPULATION; RECONSTRUCTION; INDIVIDUALS; DNA; HERITABILITY; RELATEDNESS; PARAMETERS; PARTITION; EVOLUTION	Likelihood methods have been developed to partition individuals in a sample into sibling Clusters using genetic marker data without parental information. Most of these methods assume either both sexes are monogamous to infer full sibships only or only one sex is polygamous to infer full sibships and paternal or maternal (but not both) half sibships. We extend Our previous method to the more general case of both sexes being polygamous to infer full sibships, paternal half sibships, and maternal half sibships and to the case of a two-generation sample of individuals to infer parentage jointly, with sibships. The extension not only expands enormously the scope of application of the method, but also increases its statistical power. The method is implemented for both diploid and haplodiploid species and for codominant and dominant markers, with mutations and genotyping errors accommodated. The performance and robustness of the method are evaluated by analyzing both simulated and empirical data sets. Our method is shown to be much more powerful than pairwise methods in both parentage and sibship assignments because of the more efficient use of marker information. It is little affected by inbreeding in parents and is moderately robust to nonrandom mating and linkage of markers. We also show that individually much less informative markers, such as SNPs or AFLPs, can reach the same power for parentage and sibship inferences as the highly informative marker simple sequence repeats (SSRs), as long as a sufficient. number of loci are employed in the analysis.	[Wang, J.; Santure, A. W.] Zool Soc London, Inst Zool, London NW1 4RY, England		Wang, J (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	jinliang.wang@ioz.ac.uk		Santure, Anna/0000-0001-8965-1042	Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D011035/1] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D011035/1] Funding Source: UKRI		Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Almudevar A, 2003, THEOR POPUL BIOL, V63, P63, DOI 10.1016/S0040-5809(02)00048-5; Almudevar A, 1999, J AGR BIOL ENVIR ST, V4, P136, DOI 10.2307/1400594; Berger-Wolf TY, 2007, BIOINFORMATICS, V23, pI49, DOI 10.1093/bioinformatics/btm219; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Danzmann RG, 1997, J HERED, V88, P333, DOI 10.1093/oxfordjournals.jhered.a023112; Dasmahapatra KK, 2008, HEREDITY, V100, P286, DOI 10.1038/sj.hdy.6801075; DEVLIN B, 1990, EVOLUTION, V44, P248, DOI 10.1111/j.1558-5646.1990.tb05195.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Frankham R., 2002, INTRO CONSERVATION G; Frentiu FD, 2008, P R SOC B, V275, P639, DOI 10.1098/rspb.2007.1032; Garant D, 2005, MOL ECOL, V14, P1843, DOI 10.1111/j.1365-294X.2005.02561.x; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Goodisman MAD, 2002, EVOLUTION, V56, P70; Gottelli D, 2007, P ROY SOC B-BIOL SCI, V274, P1993, DOI 10.1098/rspb.2007.0502; Gusfield D, 2002, INFORM PROCESS LETT, V82, P159, DOI 10.1016/S0020-0190(01)00263-0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heg D, 1998, NATURE, V391, P687, DOI 10.1038/35612; Hill WG, 2008, J ANIM SCI, V86, P2508, DOI 10.2527/jas.2007-0276; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones B, 2007, GENETICS, V176, P2427, DOI 10.1534/genetics.106.067066; Jones KL, 2002, CONSERV BIOL, V16, P789, DOI 10.1046/j.1523-1739.2002.00001.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Morgan MT, 2001, EVOLUTION, V55, P272, DOI 10.1111/j.0014-3820.2001.tb01292.x; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nielsen R, 2001, GENETICS, V157, P1673; Painter Ian, 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P212, DOI 10.2307/1400404; Pearse DE, 2001, MOL ECOL, V10, P2711, DOI 10.1046/j.0962-1083.2001.01391.x; Pemberton JM, 2008, P ROY SOC B-BIOL SCI, V275, P613, DOI 10.1098/rspb.2007.1531; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Ritland K, 2000, MOL ECOL, V9, P1195, DOI 10.1046/j.1365-294x.2000.00971.x; Sieberts SK, 2002, AM J HUM GENET, V70, P170, DOI 10.1086/338444; Smith BR, 2001, GENETICS, V158, P1329; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Thomas SC, 2000, GENETICS, V155, P1961; Thomas SC, 2005, PHILOS T R SOC B, V360, P1457, DOI 10.1098/rstb.2005.1675; Thomas SC, 2002, GENET RES, V79, P227, DOI 10.1017/S0016672302005669; Wang J, 2007, HEREDITY, V99, P205, DOI 10.1038/sj.hdy.6800984; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963	50	332	338	0	82	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	2009	181	4					1579	1594		10.1534/genetics.108.100214			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499IW	WOS:000270213700034		Green Published, Bronze			2022-01-24	
J	de Roos, APW; Hayes, BJ; Spelman, RJ; Goddard, ME				de Roos, A. P. W.; Hayes, B. J.; Spelman, R. J.; Goddard, M. E.			Linkage disequilibrium and persistence of phase in Holstein-Friesian, Jersey and Angus cattle	GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION; DIVERSITY; EXTENT; MAP	When a genetic marker and a quatitative trait locus (QTL) are in linkage disequilibrium (LD) in one population, they may not be in LD in another population or their LD phase may be received. The objectives of this study were to compare the extent of LD and the persistence of LD phase across multiple cattle populations. LD measures r and r(2) were calculated for syntenic marker pairs using genomewide single-nucleotide polymorphisms (SNP) that were genotyped in Dutch and Australian Holstein-Friesian (HF) bulls, Australian Angus cattle, and New Zealand Friesian and Jersey cows. Average r(2) was similar to 0.35, 0.25, 0.22, 0.14, and 0.06 at marker distances 10, 20, 40, 100, and 1000 kb, respectively, which indicates that genomic selection within cattle breeds with r(2) >= 0.20 between adjacent markers would require similar to 50,000 SNPs. The correlation of r values between populations for the same marker pairs was close to 1 for pairs of very close markers (<10 kb) and decreased with increasing marker distance and the extent of divergence between the populations. To find markers that are in LD with QTL across diverged breeds, such as HF, Jersey, and Angrus, would require similar to 300,000 markers.	[de Roos, A. P. W.] CRV, NL-6800 AL Arnhem, Netherlands; [Hayes, B. J.; Goddard, M. E.] Primary Ind Res Victoria, Anim Genet & Genom, Allwood 3049, Australia; [Spelman, R. J.] Livestock Improvement Corp, Hamilton, New Zealand; [Goddard, M. E.] Univ Melbourne, Fac Land & Food Resources, Parkville, Vic 3052, Australia		de Roos, APW (corresponding author), CRV, POB 454, NL-6800 AL Arnhem, Netherlands.	roos.s@hr.nl	Hayes, Ben J/L-3308-2016	Hayes, Ben J/0000-0002-5606-3970; Goddard, Michael/0000-0001-9917-7946			Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Arthur PF, 2001, J ANIM SCI, V79, P2805; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Du FX, 2007, INT J BIOL SCI, V3, P166; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Farnir F, 2002, GENETICS, V161, P275; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; GODDARD ME, 2006, P 8 WORLD C GEN APPL; Hawken RJ, 2004, MAMM GENOME, V15, P819, DOI 10.1007/s00335-004-2382-4; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JASIOROWSKI HA, 1988, INT FRIESIAN STRAIN; Khatkar MS, 2006, GENETICS, V174, P79, DOI 10.1534/genetics.106.060418; Khatkar MS, 2004, GENET SEL EVOL, V36, P163, DOI 10.1051/gse:2003057; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWONTIN RC, 1964, GENETICS, V49, P49; MACEACHERN SA, 2007, THESIS TROBE U BUNDO; MacHugh DE, 1997, GENETICS, V146, P1071; MACLEOD IM, 2006, P 8 WORLD C GEN APPL; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; McRae AF, 2002, GENETICS, V160, P1113; Meuwissen THE, 2000, GENETICS, V155, P421; Meuwissen THE, 2004, GENET SEL EVOL, V36, P261, DOI 10.1051/gse:2004001; Meuwissen THE, 2001, GENETICS, V157, P1819; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Sorensen AC, 2005, J DAIRY SCI, V88, P1865, DOI 10.3168/jds.S0022-0302(05)72861-7; SPELMAN RJ, 2006, P 8 WORLD C GEN APPL; Tenesa A, 2003, J ANIM SCI, V81, P617; Thevenon S, 2007, ANIM GENET, V38, P277, DOI 10.1111/j.1365-2052.2007.01601.x; Weigel K. A., 2001, Journal of Dairy Science, V84, pE177, DOI 10.3168/jds.S0022-0302(01)70213-5; Young CW, 1996, J DAIRY SCI, V79, P502, DOI 10.3168/jds.S0022-0302(96)76392-0; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480	42	332	343	1	36	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2008	179	3					1503	1512		10.1534/genetics.107.084301			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	335TJ	WOS:000258313400030	18622038	Green Published, Bronze			2022-01-24	
J	Hodgkinson, CA; Goldman, D; Jaeger, J; Persaud, S; Kane, JM; Lipsky, RH; Malhotra, AK				Hodgkinson, CA; Goldman, D; Jaeger, J; Persaud, S; Kane, JM; Lipsky, RH; Malhotra, AK			Disrupted in Schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SCAN METAANALYSIS; AMINO-ACID OXIDASE; SUSCEPTIBILITY LOCI; HAPLOTYPE RECONSTRUCTION; TRANSLOCATION; DISRUPTED-IN-SCHIZOPHRENIA-1; GENETICS; FAMILY; GENES; NUDEL	Schizophrenia, schizoaffective disorder, and bipolar disorder are common psychiatric disorders with high heritabilities and variable phenotypes. The Disrupted in Schizophrenia 1 (DISC1) gene, on chromosome 1q42, was originally discovered and linked to schizophrenia in a Scottish kindred carrying a balanced translocation that disrupts DISC1 and DISC2. More recently, DISC1 was linked to schizophrenia, broadly defined, in the general Finnish population, through the undertransmission to affected women of a common haplotype from the region of intron 1/exon 2. We present data from a case-control study of a North American white population, confirming the underrepresentation of a common haplotype of the intron 1/exon 2 region in individuals with schizoaffective disorder. Multiple haplotypes contained within four haplotype blocks extending between exon 1 and exon 9 are associated with schizophrenia, schizoaffective disorder, and bipolar disorder. We also find overrepresentation of the exon 9 missense allele Phe607 in schizoaffective disorder. These data support the idea that these apparently distinct disorders have at least a partially convergent etiology and that variation at the DISC1 locus predisposes individuals to a variety of psychiatric disorders.	NIAAA, Sect Human Neurogenet, Rockville, MD USA; NIAAA, Neurogenet Lab, Rockville, MD USA; Zucker Hillside Hosp, Glen Oaks, NY USA		Hodgkinson, CA (corresponding author), Pk 5 Bldg,Room 451,MSC8110,12420 Parklawn Dr, Rockville, MD 20852 USA.	chodg@mail.nih.gov	Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Lipsky, Robert/0000-0001-7753-1473; Hodgkinson, Colin/0000-0002-5365-8119	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [Z01AA000302] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH001760] Funding Source: Medline		Adler CM, 2003, PSYCHIAT CLIN N AM, V26, P1, DOI 10.1016/S0193-953X(02)00085-0; AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P178; Als TD, 2004, MOL PSYCHIATR, V9, P93, DOI 10.1038/sj.mp.4001393; ARNOLD SE, 1991, ARCH GEN PSYCHIAT, V48, P625; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bailer U, 2002, BIOL PSYCHIAT, V52, P40, DOI 10.1016/S0006-3223(02)01320-3; Baron M, 2001, AM J HUM GENET, V68, P299, DOI 10.1086/318212; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Berrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; BLACKER D, 1992, AM J PSYCHIAT, V149, P1473; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Chen YS, 2004, MOL PSYCHIATR, V9, P87, DOI 10.1038/sj.mp.4001453; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Devon RS, 2001, PSYCHIATR GENET, V11, P71, DOI 10.1097/00041444-200106000-00003; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.3.CO;2-N; Foroud T, 2000, AM J MED GENET, V96, P18, DOI 10.1002/(SICI)1096-8628(20000207)96:1<18::AID-AJMG6>3.3.CO;2-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Ophoff RA, 2002, AM J HUM GENET, V71, P565, DOI 10.1086/342291; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Schwartz DG, 2000, INTERNET RES, V10, P5; Schweiker W, 1998, ANNU SOC CHRIST ETH, V18, P63; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Sklar P, 2002, ANNU REV GENOM HUM G, V3, P371, DOI 10.1146/annurev.genom.3.022502.103141; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; Sundram S, 2003, CURR MOL MED, V3, P393, DOI 10.2174/1566524033479708; Taylor MS, 2003, GENOMICS, V81, P67, DOI 10.1016/S0888-7543(02)00026-5; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C	49	332	341	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					862	872		10.1086/425586			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	WOS:000224303500011	15386212	Bronze, Green Published			2022-01-24	
J	Jensen-Seaman, MI; Furey, TS; Payseur, BA; Lu, YT; Roskin, KM; Chen, CF; Thomas, MA; Haussler, D; Jacob, HJ				Jensen-Seaman, MI; Furey, TS; Payseur, BA; Lu, YT; Roskin, KM; Chen, CF; Thomas, MA; Haussler, D; Jacob, HJ			Comparative recombination rates in the rat, mouse, and human genomes	GENOME RESEARCH			English	Article							INTEGRATED GENETIC-LINKAGE; MEIOTIC RECOMBINATION; DROSOPHILA-MELANOGASTER; NATURAL-SELECTION; MAP; EVOLUTION; PATTERNS; MUTATION; SEX; HOT	Levels of recombination vary among species, among chromosomes within species, and among regions within chromosomes in mammals. This heterogeneity may affect levels of diversity, efficiency of selection, and genome composition, as well as have practical consequences for the genetic mapping of traits. We compared the genetic maps to the genome sequence assemblies of rat, mouse, and human to estimate local recombination rates across these genomes. Humans have greater overall levels of recombination, as well as greater variance. In rat and mouse, the size of the chromosome and proximity to telomere have less effect on local recombination rate than in human. At the chromosome level, rat and mouse X chromosomes have the lowest recombination rates, whereas human chromosome X does not show the same pattern. In all species, local recombination rate is significantly correlated with several sequence variables, including GC%, CpG density, repetitive elements, and the neutral mutation rate, with some pronounced differences between species. Recombination rate in one species is not strongly correlated with the rate in another, when comparing homologous syntenic blocks of the genome. This comparative approach provides additional insight into the causes and consequences of genomic heterogeneity in recombination.	Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Bioinformat Res Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA		Jensen-Seaman, MI (corresponding author), Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA.	mseaman@mcw.edu	Thomas, Michael A/B-7489-2008	Thomas, Michael A/0000-0003-2982-0291; Furey, Terry/0000-0001-5546-9672	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL070527] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1F32HL70527-01, F32 HL070527] Funding Source: Medline		Aquadro CF, 1997, CURR OPIN GENET DEV, V7, P835, DOI 10.1016/S0959-437X(97)80048-2; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Barton H, 2002, FOOD ADDIT CONTAM, V19, P906, DOI 10.1080/02652030210145919; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERNARDI G, 1993, MOL BIOL EVOL, V10, P186; Betancourt AJ, 2002, P NATL ACAD SCI USA, V99, P13616, DOI 10.1073/pnas.212277199; Bihoreau MT, 2001, GENOMICS, V75, P57, DOI 10.1006/geno.2001.6583; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Comeron JM, 1999, GENETICS, V151, P239; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; de la Casa-Esperon E, 2002, GENETICS, V161, P1651; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Dracheva SV, 2000, GENOMICS, V63, P202, DOI 10.1006/geno.1999.6074; Dukes-McEwan J, 2002, MAMM GENOME, V13, P667, DOI 10.1007/s00335-002-4004-3; Dumas D, 2002, GENETICS, V162, P1355; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; LEVAN G, 1974, HEREDITAS, V77, P37; Maddox JF, 2001, GENOME RES, V11, P1275, DOI 10.1101/gr.GR-1350R; Marais G, 2002, MOL BIOL EVOL, V19, P1399, DOI 10.1093/oxfordjournals.molbev.a004203; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; Nachman MW, 1996, GENETICS, V142, P537; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nilsson S, 2001, GENOMICS, V74, P287, DOI 10.1006/geno.2001.6550; Noor MAF, 2001, GENETICS, V159, P581; Pal C, 2001, MOL BIOL EVOL, V18, P2323, DOI 10.1093/oxfordjournals.molbev.a003779; Payseur BA, 2000, GENETICS, V156, P1285; Petes TD, 2002, GENETICS, V162, P2049; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; QUMSIYEH MB, 1994, J HERED, V85, P455, DOI 10.1093/oxfordjournals.jhered.a111501; REEVES RH, 1990, GENOMICS, V8, P141, DOI 10.1016/0888-7543(90)90236-N; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; *RGSPC, 2004, IN PRESS NATURE; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; SASAKI M, 1986, CYTOGENET CELL GENET, V41, P83, DOI 10.1159/000132208; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Slate J, 2002, GENETICS, V160, P1587; SOKAL RR, 1995, BIOMETRY, P228; Steen RG, 1999, GENOME RES, V9, pAP1; Swinburne J, 2000, GENOMICS, V66, P123, DOI 10.1006/geno.2000.6207; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; True JR, 1996, GENETICS, V142, P507; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yauk CL, 2003, EMBO J, V22, P1389, DOI 10.1093/emboj/cdg136; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; [No title captured]	70	332	342	0	27	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2004	14	4					528	538		10.1101/gr.1970304			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	809IH	WOS:000220629900004	15059993	Bronze, Green Published			2022-01-24	
J	Bulavin, DV; Demidov, ON; Saito, S; Kauraniemi, P; Phillips, C; Amundson, SA; Ambrosino, C; Sauter, G; Nebreda, AR; Anderson, CW; Kallioniemi, A; Fornace, AJ; Appella, E				Bulavin, DV; Demidov, ON; Saito, S; Kauraniemi, P; Phillips, C; Amundson, SA; Ambrosino, C; Sauter, G; Nebreda, AR; Anderson, CW; Kallioniemi, A; Fornace, AJ; Appella, E			Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity	NATURE GENETICS			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PREMATURE SENESCENCE; GENETIC ALTERATIONS; HUMAN FIBROBLASTS; BREAST-CANCER; UV-RADIATION; P38 KINASE; PATHWAY; PROTEIN; PHOSPHATASE	Expression of oncogenic Ras in primary human cells activates p53, thereby protecting cells from transformation. We show that in Ras-expressing IMR-90 cells, p53 is phosphorylated at Ser33 and Ser46 by the p38 mitogen-activated protein kinase (MAPK). Activity of p38 MAPK is regulated by the p53-inducible phosphatase PPM1D, creating a potential feedback loop. Expression of oncogenic Ras suppresses PPM1D mRNA induction, leaving p53 phosphorylated at Ser33 and Ser46 and in an active state. Retrovirus-mediated overexpression of PPM1D reduced p53 phosphorylation at these sites, abrogated Ras-induced apoptosis and partially rescued cells from cell-cycle arrest. Inactivation of p38 MAPK (the product of Mapk14) in vivo by gene targeting or by PPM1D overexpression expedited tumor formation after injection of mouse embryo fibroblasts (MEFs) expressing E1A+Ras into nude mice. The gene encoding PPM1D (PPM1D, at 17q22/q23) is amplified in human breast-tumor cell lines and in approximately 11% of primary breast tumors, most of which harbor wildtype p53. These findings suggest that inactivation of the p38 MAPK through PPM1D overexpression resulting from PPM1D amplification contributes to the development of human cancers by suppressing p53 activation.	NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NIH, Gene Response Sect, Bethesda, MD 20892 USA; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Tampere Univ, Inst Med Technol, Canc Genet Lab, Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; European Mol Biol Lab, Heidelberg, Germany; Univ Basel, Inst Pathol, Basel, Switzerland; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA		Appella, E (corresponding author), NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.		Demidov, Oleg/U-2050-2017; ambrosino, concetta/AAB-3452-2019; Demidov, Oleg/AAC-4462-2021; Fornace, Albert J/A-7407-2008; Nebreda, Angel Rodriguez/R-9594-2019	Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; Fornace, Albert J/0000-0001-9695-085X; Kallioniemi, Anne/0000-0003-3552-8158; Dudgeon, Crissy/0000-0001-9010-2569			Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Bulavin DV, 1999, ONCOGENE, V18, P5611, DOI 10.1038/sj.onc.1202945; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Esteller M, 2000, CANCER RES, V60, P129; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Ho GH, 2001, BREAST CANCER RES TR, V65, P225, DOI 10.1023/A:1010686518990; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LI J, 2002, NATURE GENET, V31; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; OConnor PM, 1997, CANCER RES, V57, P4285; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	31	332	354	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					210	215		10.1038/ng894			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	WOS:000175903500021	12021785				2022-01-24	
J	Laberge-le Couteulx, S; Jung, HH; Labauge, P; Houtteville, JP; Lescoat, C; Cecillon, M; Marechal, E; Joutel, A; Bach, JF; Tournier-Lasserve, E				Laberge-le Couteulx, S; Jung, HH; Labauge, P; Houtteville, JP; Lescoat, C; Cecillon, M; Marechal, E; Joutel, A; Bach, JF; Tournier-Lasserve, E			Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas	NATURE GENETICS			English	Article							CHROMOSOME 7Q; GENE; MALFORMATION; PROTEINS; RAS; LOCALIZATION; APOPTOSIS; MICE; RAP1	Cavernous angiomas are vascular malformations mostly located in the central nervous system and characterized by enlarged capillary cavities without intervening brain parenchyma(1). Clinical symptoms include seizures, haemorrhage and focal neurological deficits. Cavernous angiomas prevalence is close to 0.5% in the general population(2). They may be inherited as an autosomal dominant condition in as much as 50% of cases(3). Cerebral cavernous malformations (CCM) loci were previously identified on 7q, 7p and 3q (refs 4,5). A strong founder effect was observed in the Hispano-American population, all families being linked to CCM1 on 7q (refs 4,6,7). CCM1 locus assignment was refined to a 4-cM interval bracketed by D7S2410 and D7S689 (ref. 8). Here we report a physical and transcriptional map of this interval and that CCM1, a gene whose protein product, KRIT1, interacts with RAP1A (also known as KREV1; ref. 9), a member of the RAS family of GTPases, is mutated in CCM1 families. Our data suggest the involvement of the RAP1A signal transduction pathway in vasculogenesis or angiogenesis(10).	Fac Med Necker, INSERM, U25, F-75730 Paris 15, France; CHR Cote Nacre, Serv Neurochirurg, Caen, France; Hop Lariboisiere, Lab Cytogenet, F-75010 Paris, France		Tournier-Lasserve, E (corresponding author), Fac Med Necker, INSERM, U25, 156 Rue Vaugirard, F-75730 Paris 15, France.		Laberge, Sophie/ABD-7353-2020; Joutel, Anne/K-5601-2017; Tournier-Lasserve, Elisabeth/N-7134-2017	Laberge, Sophie/0000-0003-4722-0361; Joutel, Anne/0000-0003-3963-3860; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASHA H, EMBO J, V18, P60599; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Gunel M, 1996, NEW ENGL J MED, V334, P946, DOI 10.1056/NEJM199604113341503; Gunel M, 1996, NEUROSURGERY, V38, P1265; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; JOHNSON EW, 1995, GENOME RES, V5, P368, DOI 10.1101/gr.5.4.368; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Labauge P, 1998, LANCET, V352, P1892, DOI 10.1016/S0140-6736(98)03011-6; Laberge S, 1999, EUR J HUM GENET, V7, P499, DOI 10.1038/sj.ejhg.5200324; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; PIZON V, 1988, ONCOGENE, V3, P201; Pizon V, 1996, EUR J CELL BIOL, V69, P224; Quarck R, 1996, EUR J CELL BIOL, V70, P269; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293	22	332	336	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					189	193		10.1038/13815			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	WOS:000082827500018	10508515				2022-01-24	
J	Knudson, CM; Korsmeyer, SJ				Knudson, CM; Korsmeyer, SJ			Bcl-2 and Bax function independently to regulate cell death	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY; DEFICIENT MICE; APOPTOSIS; SURVIVAL; PROTEIN; THYMOCYTES; HAIR; SELECTION; BCL-X(L); BH1	The BCL-2 family has Various pairs of antagonist and agonist proteins that regulate apoptosis, Whether their function is interdependent is uncertain. Using a genetic approach to address this question, we utilized gain- and loss-of-function models of Bcl-2 and Bax and found that apoptosis and thymic hypoplasia characteristic of Bcl-2-deficient mice are largely absent in mice also deficient in Bax. A single copy of Bax promoted apoptosis in the absence of Bcl-2. In contrast, overexpression of Bcl-2 still repressed apoptosis in the absence of Bax. While an in vivo competition exists between Bax and Bcl-2, each is able to regulate apoptosis independently.	WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, DIV MOL ONCOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, DIV MOL ONCOL, ST LOUIS, MO 63110 USA					Knudson, Charles Michael/0000-0003-3964-5466	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA049712] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA49712] Funding Source: Medline		Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Boulakia CA, 1996, ONCOGENE, V12, P529; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Farrow SN, 1996, CURR OPIN GENET DEV, V6, P45, DOI 10.1016/S0959-437X(96)90009-X; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KAMADA S, 1995, CANCER RES, V55, P354; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shimizu S, 1996, ONCOGENE, V12, P2251; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Uhlmann EJ, 1996, CANCER RES, V56, P2506; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VEISNOVACK D, 1994, AM J PATHOL, V145, P61; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	40	332	338	4	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					358	363		10.1038/ng0897-358			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	WOS:A1997XM90900017	9241272				2022-01-24	
J	Rouault, JP; Falette, N; Guehenneux, F; Guillot, C; Rimokh, R; Wang, Q; Berthet, C; MoyretLalle, C; Savatier, P; Pain, B; Shaw, P; Berger, R; Samarut, J; Magaud, JP; Ozturk, M; Samarut, C; Puisieux, A				Rouault, JP; Falette, N; Guehenneux, F; Guillot, C; Rimokh, R; Wang, Q; Berthet, C; MoyretLalle, C; Savatier, P; Pain, B; Shaw, P; Berger, R; Samarut, J; Magaud, JP; Ozturk, M; Samarut, C; Puisieux, A			Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway	NATURE GENETICS			English	Article							WILD-TYPE P53; HUMAN-BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; GENE; EXPRESSION; PROTEIN; GROWTH; CELLS; ARREST; LINE	Cell cycle regulation is critical for maintenance of genome integrity. A prominent factor that guarantees genomic stability of cells is p53 (ref. 1). The P53 gene encodes a transcription factor that has a role as a tumour suppressor(2). identification of p53-target genes should provide greater insight into the molecular mechanisms that mediate the tumour suppressor activities of p53. The rodent Pc3/Tis21 gene was initially described as an immediate early gene induced by tumour promoters and growth factors in PC12 and Swiss 3T3 cells(3,4). It is expressed in a variety of cell and tissue types and encodes a remarkably labile protein(4,5). Pc3/Tis21 has a strong sequence similarity to the human antiproliferative BTG1 gene cloned from a chromosomal translocation of a B-cell chronic lymphocytic leukaemia(6). This similarity led us to speculate that BTG1 and the putative human homologue of Pc3/Tis21 (named BTG2) were members of a new family of genes involved in growth control and/or differentiation. This hypothesis was recently strengthened by the identification of a new antiproliferative protein, named TOE, which shares sequence similarity with BTG1 and PC3/TIS21 (ref. 7). Here, we cloned and localized the human BTG2 gene. We show that BTG2 expression is induced through a p53-dependent mechanism and that BTG2 function may be relevant to cell cycle control and cellular response to DNA damage.	CTR LEON BERARD,INSERM U453,CNRS,F-69373 LYON 08,FRANCE; HOP EDOUARD HERRIOT,LAB CYTOGENET MOL,F-69437 LYON 03,FRANCE; ECOLE NORMALE SUPER LYON,LAB BIOL MOL & CELLULAIRE,CNRS UMR49,INRA,F-69373 LYON 08,FRANCE; INST PATHOL,DIV EXPT ONCOL,CH-1011 LAUSANNE,SWITZERLAND; INST GENET MOL,INSERM,U301,F-75010 PARIS,FRANCE; BILKENT UNIV,DEPT MOL BIOL & GENET,TR-06533 BILKENT,ANKARA,TURKEY				SAVATIER, Pierre/J-4663-2014; Samarut, Jacques/AAD-2587-2019; Moyret-Lalle, Caroline/G-2742-2013; ozturk, mehmet/G-3330-2014; berthet, cyril/T-4842-2017; OZTURK, MEHMET/AAS-7241-2021; Rimokh, Ruth/G-7506-2014; Pain, Bertrand/A-7686-2015	Moyret-Lalle, Caroline/0000-0002-8359-2018; berthet, cyril/0000-0003-3166-3141; OZTURK, MEHMET/0000-0002-6092-9706; Pain, Bertrand/0000-0002-1210-8444; PUISIEUX, Alain/0000-0002-9938-3798			AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARTEK J, 1990, ONCOGENE, V5, P893; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CASEY G, 1991, ONCOGENE, V6, P1791; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; CHERIFF D, 1990, P NATL ACAD SCI USA, V87, P8639; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FREBOURG T, 1992, CANCER RES, V52, P6976; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HENSLER PJ, 1994, MOL CELL BIOL, V14, P2291, DOI 10.1128/MCB.14.4.2291; KASTAN MB, 1991, CANCER RES, V51, P6304; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; MATHEWS CG, 1987, NATURE, V325, P524; MATSUDA A, 1996, ONCOGENE, V12, P705; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MIYASHITA T, 1994, CANCER RES, V54, P3131; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PARASKEVA C, 1988, INT J CANCER, V41, P908; POWELL SN, 1995, CANCER RES, V55, P1643; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; RAO PN, 1979, EFFECTS DRUGS CELL N, P475; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; SAVATIER P, 1994, ONCOGENE, V9, P809; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; STEWART N, 1995, ONCOGENE, V10, P109; TAKAHASHI K, 1993, MOL CARCINOGEN, V8, P58, DOI 10.1002/mc.2940080112; VARNUM BC, 1994, J CELL PHYSIOL, V158, P205, DOI 10.1002/jcp.1041580125; VIKHANSKAYA F, 1994, NUCLEIC ACIDS RES, V22, P1012, DOI 10.1093/nar/22.6.1012; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WALDMAN T, 1995, CANCER RES, V55, P5187; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	44	332	341	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					482	486		10.1038/ng1296-482			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	WOS:A1996VV73000029	8944033	Green Published			2022-01-24	
J	BELLUS, GA; HEFFERON, TW; DELUNA, RIO; HECHT, JT; HORTON, WA; MACHADO, M; KAITILA, I; MCINTOSH, I; FRANCOMANO, CA				BELLUS, GA; HEFFERON, TW; DELUNA, RIO; HECHT, JT; HORTON, WA; MACHADO, M; KAITILA, I; MCINTOSH, I; FRANCOMANO, CA			ACHONDROPLASIA IS DEFINED BY RECURRENT G380R MUTATIONS OF FGFR3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE CONVERSION; GLOBIN GENE; HOMOZYGOUS ACHONDROPLASIA; POINT MUTATIONS; HEMOPHILIA-A; DISEASE; HYPOCHONDROPLASIA; TRANSITIONS; FREQUENCY; FAMILY	Genomic DNA from 154 unrelated individuals with achondroplasia was evaluated for mutations in the fibroblast growth factor receptor 3 (FGFR3) transmembrane domain. AU but one, an atypical case, were found to have a glycine-to-arginine substitution at codon 380. Of these, 150 had a G-to-A transition at nt 1138, and 3 had a G-to-C transversion at this same position. On the basis of estimates of the prevalence of achondroplasia, the mutation rate at the FGFR3 1138 guanosine nucleotide is two to three orders of magnitude higher than that previously reported for tranversions and transitions in CpG dinucleotides. To date, this represents the most mutable single nucleotide reported in the human genome. The homogeneity of mutations in achondroplasia is unprecedented for an autosomal dominant disorder and may explain the relative lack of heterogeneity in the achondroplasia phenotype.	NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892; HOSP INFANTIL MEXICO FED GOMEZ,DEPT GENET,MEXICO CITY,DF,MEXICO; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX; SHRINERS HOSP CRIPPLED CHILDRENS,DEPT RES,PORTLAND,OR 97201; HELSINKI UNIV HOSP,DEPT CLIN GENET,HELSINKI,FINLAND					Bellus, Gary/0000-0001-7492-3324	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P01HG00373] Funding Source: Medline; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR41135] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD20691] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD020691] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P01HG000373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR041135] Funding Source: NIH RePORTER		AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; ANDERSEN PE, 1989, J MED GENET, V27, P37; BRAUN L, 1990, J EXP MED, V171, P129, DOI 10.1084/jem.171.1.129; BULLOCK P, 1985, SCIENCE, V230, P954, DOI 10.1126/science.2997924; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; COLLIER S, 1993, NAT GENET, V3, P260, DOI 10.1038/ng0393-260; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COOPER DN, IN PRESS METABOLIC M; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GARDNER RJM, 1977, CLIN GENET, V11, P31; Gorlin RJ, 1990, SYNDROMES HEAD NECK; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; GRUNDY CB, 1992, HUM GENET, V88, P586, DOI 10.1007/BF00219350; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; HECHT JT, 1987, AM J HUM GENET, V41, P454; HECHT JT, 1986, EUR J PEDIATR, V145, P545, DOI 10.1007/BF02429060; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Jones, 1988, SMITHS RECOGNIZABLE; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KULOZIK AE, 1986, AM J HUM GENET, V39, P239; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LANGER LO, 1967, AMER J ROENTGENOL RA, V100, P12, DOI 10.2214/ajr.100.1.12; LEMERRER M, 1994, NAT GENET, V6, P318; LOUX N, 1991, HUM GENET, V87, P373; MATSUNO Y, 1992, HUM GENET, V88, P357, DOI 10.1007/BF00197277; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MEUNKE M, 1994, NAT GENET, V8, P269; MURDOCH JL, 1970, ANN HUM GENET, V33, P227, DOI 10.1111/j.1469-1809.1970.tb01648.x; NELSON FW, 1988, ANN NEUROL, V24, P89, DOI 10.1002/ana.410240117; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OKANO Y, 1990, AM J HUM GENET, V46, P919; PARTANEN J, 1993, PHILOS T R SOC B, V340, P297, DOI 10.1098/rstb.1993.0071; PATTINSON JK, 1990, BLOOD, V76, P2242; PAULI RM, 1983, AM J MED GENET, V16, P459, DOI 10.1002/ajmg.1320160404; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; REISS J, 1991, HUM GENET, V87, P457; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SORGE J, 1990, J CLIN INVEST, V86, P1137, DOI 10.1172/JCI114818; STEINBERG RA, 1992, MOL CELL BIOL, V12, P767, DOI 10.1128/MCB.12.2.767; STOLL C, 1989, CLIN GENET, V35, P88; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; URABE K, 1990, AM J HUM GENET, V46, P1178; URIOSTE M, 1994, NAT GENET, V6, P334, DOI 10.1038/ng0494-334; VELINOV M, 1994, NAT GENET, V6, P312; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	52	332	356	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					368	373					6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	WOS:A1995QF42300002	7847369				2022-01-24	
J	BROOKCARTER, PT; PERAL, B; WARD, CJ; THOMPSON, P; HUGHES, J; MAHESHWAR, MM; NELLIST, M; GAMBLE, V; HARRIS, PC; SAMPSON, JR				BROOKCARTER, PT; PERAL, B; WARD, CJ; THOMPSON, P; HUGHES, J; MAHESHWAR, MM; NELLIST, M; GAMBLE, V; HARRIS, PC; SAMPSON, JR			DELETION OF THE TSC2 AND PKD1 GENES ASSOCIATED WITH SEVERE INFANTILE POLYCYSTIC KIDNEY-DISEASE - A CONTIGUOUS GENE SYNDROME	NATURE GENETICS			English	Article							TUBEROUS SCLEROSIS; INSITU HYBRIDIZATION	Major genes which cause tuberous sclerosis (TSC) and autosomal dominant polycystic kidney disease (ADPKD), known as TSC2 and PKD1 respectively, lie immediately adjacent to each other on chomosome 16p. Renal cysts are often found in TSC, but a specific renal phenotype, distinguished by the severity and infantile presentation of the cystic changes, is seen in a small proportion of cases. We have identified large deletions disrupting TSC2 and PKD1 in each of six such cases studied. Analysis of the deletions indicates that they inactivate PKD1, in contrast to the mutations reported in ADPKD patients, where in each case abnormal transcripts have been detected.	UNIV WALES COLL MED, INST MED GENET, CARDIFF CF4 4XN, S GLAM, WALES; JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND				Peral, Belen/F-4562-2015	Peral, Belen/0000-0003-4984-4020	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BERNSTEIN J, 1991, ANN NY ACAD SCI, V615, P36; COLE BR, 1987, J PEDIATR-US, V111, P693, DOI 10.1016/S0022-3476(87)80244-5; CREE JE, 1969, P ROY SOC MED, V62, P327, DOI 10.1177/003591576906200410; FINK GM, 1993, J AM SOC NEPHROL, V3, P1863; FINK GM, 1994, KIDNEY INT, V40, P1153; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hermann B. G., 1987, Cell, USA, V48, P813; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; NELLIST M, 1993, J MED GENET, V30, P224, DOI 10.1136/jmg.30.3.224; NELLIST M, 1993, CELL, V75, P1305; OCALLAGHAN TJ, 1975, ARCH INTERN MED, V135, P1082, DOI 10.1001/archinte.135.8.1082; PERAL B, 1994, AM J HUM GENET, V54, P899; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; STILLWELL TJ, 1987, J UROLOGY, V138, P477, DOI 10.1016/S0022-5347(17)43234-4; VANBAAL JG, 1989, CLIN GENET, V35, P167; WARD CJ, 1994, CELL, V77, P881; WEBB DW, 1993, BMJ-BRIT MED J, V306, P1258, DOI 10.1136/bmj.306.6887.1258; WENZL JE, 1970, J PEDIATR-US, V77, P673, DOI 10.1016/S0022-3476(70)80211-6; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583; ZIMMERHACKL LB, IN PRESS PEDIAT NEPH; [No title captured]	28	332	338	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1994	8	4					328	332		10.1038/ng1294-328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	WOS:A1994PV68200011	7894481				2022-01-24	
J	Ellinghaus, D; Jostins, L; Spain, SL; Cortes, A; Bethune, J; Han, B; Park, YR; Raychaudhuri, S; Pouget, JG; Hubenthal, M; Folseraas, T; Wang, YP; Esko, T; Metspalu, A; Westra, HJ; Franke, L; Pers, TH; Weersma, RK; Collij, V; D'Amato, M; Halfvarson, J; Jensen, AB; Lieb, W; Degenhardt, F; Forstner, AJ; Hofmann, A; Schreiber, S; Mrowietz, U; Juran, BD; Lazaridis, KN; Brunak, S; Dale, AM; Trembath, RC; Weidinger, S; Weichenthal, M; Ellinghaus, E; Elder, JT; Barker, JNWN; Andreassen, OA; McGovern, DP; Karlsen, TH; Barrett, JC; Parkes, M; Brown, MA; Franke, A				Ellinghaus, David; Jostins, Luke; Spain, Sarah L.; Cortes, Adrian; Bethune, Joern; Han, Buhm; Park, Yu Rang; Raychaudhuri, Soumya; Pouget, Jennie G.; Huebenthal, Matthias; Folseraas, Trine; Wang, Yunpeng; Esko, Tonu; Metspalu, Andres; Westra, Harm-Jan; Franke, Lude; Pers, Tune H.; Weersma, Rinse K.; Collij, Valerie; D'Amato, Mauro; Halfvarson, Jonas; Jensen, Anders Boeck; Lieb, Wolfgang; Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea; Schreiber, Stefan; Mrowietz, Ulrich; Juran, Brian D.; Lazaridis, Konstantinos N.; Brunak, Soren; Dale, Anders M.; Trembath, Richard C.; Weidinger, Stephan; Weichenthal, Michael; Ellinghaus, Eva; Elder, James T.; Barker, Jonathan N. W. N.; Andreassen, Ole A.; McGovern, Dermot P.; Karlsen, Tom H.; Barrett, Jeffrey C.; Parkes, Miles; Brown, Matthew A.; Franke, Andre		IIBDGC; IGAS; IPSCSG; GAPC; PAGE	Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; KINASE C-THETA; BOWEL-DISEASE; RISK LOCI; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; METAANALYSIS; PSORIASIS; VARIANTS; COMMON	We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.	[Ellinghaus, David; Bethune, Joern; Huebenthal, Matthias; Schreiber, Stefan; Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Jostins, Luke; Spain, Sarah L.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Cortes, Adrian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Div Clin Neurol, Oxford OX3 9DU, England; [Cortes, Adrian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Han, Buhm] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Han, Buhm] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Park, Yu Rang] Univ Ulsan, Asan Inst Life Sci, Asan Med Ctr, Coll Med, Seoul, South Korea; [Raychaudhuri, Soumya; Westra, Harm-Jan; Pers, Tune H.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Harvard Sch Med, Dept Med, Boston, MA USA; [Pouget, Jennie G.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Pouget, Jennie G.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Rikshosp, N-0450 Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Univ Oslo, KG Jebsen Inflammat Res Ctr, Inst Clin Med, Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Res Inst Internal Med, Div Canc Med Surg & Transplantat, Rikshosp, Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Dept Transplantat Med, Gastroenterol Sect, N-0450 Oslo, Norway; [Wang, Yunpeng; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Ulikooli 18, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA USA; [Esko, Tonu; Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Cambridge, MA USA; [Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Weersma, Rinse K.; Collij, Valerie] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [D'Amato, Mauro] BioCruces Hlth Res Inst, Bilbao, Spain; [D'Amato, Mauro] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Halfvarson, Jonas] Univ Orebro, Dept Gastroenterol, Fac Med & Hlth, SE-70182 Orebro, Sweden; [Jensen, Anders Boeck; Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea] Univ Bonn, Inst Human Genet, Bonn, Germany; [Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea] Univ Bonn, Dept Genom Life & Brain Ctr, Bonn, Germany; [Schreiber, Stefan] Univ Klinikum Schleswig Holstein, Dept Gen Internal Med, Campus Kiel, Kiel, Germany; [Mrowietz, Ulrich; Weidinger, Stephan; Weichenthal, Michael] Univ Kiel, Dept Dermatol, Univ Hosp, Schleswig Holstein, Schittenhelmstr 7, Kiel, Germany; [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London, England; [Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Barker, Jonathan N. W. N.] Kings Coll London, St Johns Inst Dermatol, Div Genet & Mol Med, London, England; [Andreassen, Ole A.] Univ Oslo, NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [McGovern, Dermot P.] F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA USA; [McGovern, Dermot P.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Brown, Matthew A.] Queensland Univ Technol, IHBI, Translat Res Inst, Brisbane, Qld 4001, Australia; [Ellinghaus, David] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany		Ellinghaus, D (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	d.ellinghaus@ikmb.uni-kiel.de	D'Amato, Mauro/F-2450-2010; Halfvarson, Jonas/AAU-4687-2020; Ellinghaus, Eva/E-6490-2012; Ellinghaus, David/ABC-3610-2020; Brown, Matthew A/E-5749-2010; Han, Buhm/AAQ-9672-2020; Franke, Lude/P-7036-2016; Ellinghaus, David/G-4467-2012; Weersma, Rinse/ABE-3807-2021; Wang, Yunpeng/W-8871-2018; Weidinger, Stephan/C-8461-2011; D'Amato, Mauro/B-5050-2019; Hubenthal, Matthias/M-8149-2015; Degenhardt, Franziska/H-4169-2017; Franke, Andre/B-2151-2010; Andreassen, Ole A./AAY-7531-2020; Lieb, Wolfgang/C-1990-2012; Brunak, Soren/O-6621-2016; Bethune, Jorn/A-9502-2016; Spain, Sarah/G-1968-2010	D'Amato, Mauro/0000-0003-2743-5197; Ellinghaus, Eva/0000-0003-2914-3382; Ellinghaus, David/0000-0002-4332-6110; Brown, Matthew A/0000-0003-0538-8211; Franke, Lude/0000-0002-5159-8802; Wang, Yunpeng/0000-0001-9831-1090; Weidinger, Stephan/0000-0003-3944-252X; D'Amato, Mauro/0000-0003-2743-5197; Hubenthal, Matthias/0000-0002-5956-3006; Franke, Andre/0000-0003-1530-5811; Parkes, Miles/0000-0002-6467-0631; Pers, Tune/0000-0003-0207-4831; Brunak, Soren/0000-0003-0316-5866; Harrison, Pille/0000-0003-4117-6910; Li, Zhixiu/0000-0002-2924-9120; Trembath, Richard/0000-0003-0550-3400; Collij, Valerie/0000-0003-3743-1544; Raychaudhuri, Soumya/0000-0002-1901-8265; Barrett, Jeffrey/0000-0002-1152-370X; Bethune, Jorn/0000-0002-6919-2595; Spain, Sarah/0000-0002-7591-8364; Barker, Jonathan/0000-0002-9030-183X; Jensen, Anders Boeck/0000-0002-5784-308X	German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01ZX1306A]; Estonian Research CouncilEstonian Research Council [IUT20-60]; Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; University of CambridgeUniversity of Cambridge; German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research NetworkFederal Ministry of Education & Research (BMBF) [2 (NGFN-2)]; National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [016.136.308]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [521-2011-2764]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF) [2013097]; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF14CC0001]; H2020 project MedBioinformatics [634143]; Norwegian PSC Research Center; German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01ZX1306A]; Estonian Research CouncilEstonian Research Council [IUT20-60]; Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; University of CambridgeUniversity of Cambridge; German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research NetworkFederal Ministry of Education & Research (BMBF) [2 (NGFN-2)]; National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [016.136.308]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [521-2011-2764]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF) [2013097]; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF14CC0001]; H2020 project MedBioinformatics [634143]; Norwegian PSC Research Center; Lundbeck FoundationLundbeckfonden [R190-2014-3904] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800675] Funding Source: researchfish; Medical Research FoundationUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [C0482] Funding Source: researchfish; NNF Center for Basic Metabolic ResearchNovo Nordisk Foundation [Pers Group] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800675] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR050511, R01AR042742, R01AR065183, R01AR063611, UH2AR067677, R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK084960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01GM092691] Funding Source: NIH RePORTER	We thank all patients with ankylosing spondylitis, Crohn's disease, PSC, psoriasis and ulcerative colitis, their families, healthy control individuals and clinicians for their participation in this study. We thank T. Wesse, T. Henke, S. Sedghpour Sabet, R. Vogler, G. Jacobs, I. Urbach, W. Albrecht, V. Pelkonen, K. Holm, H. Dahlen Sollid, B. Woldseth, J.A. Anmarkrud and L. Wenche Torbjornsen for expert help. F. Braun, W. Kreisel, T. Berg and R. Gunther are acknowledged for contributing German patients with PSC. B. A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet, in Oslo and the Nord-Trondelag Health Study (HUNT) are acknowledged for sharing the healthy Norwegian controls. This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (SysInflame grant 01ZX1306A). This project received infrastructure support from Deutsche Forschungsgemeinschaft (DFG) Excellence Cluster 306 'Inflammation at Interfaces' and the PopGen Biobank. A. F. receives an endowment professorship by the Foundation for Experimental Medicine (Zurich, Switzerland). The Estonian Genome Center at the University of Tartu (EGCUT) received targeted financing from Estonian Research Council grant IUT20-60, the Center of Excellence in Genomics (EXCEGEN) and the University of Tartu (SP1GVARENG). We acknowledge EGCUT technical personnel, especially V. Soo and S. Smit. Data analyses were carried out in part at the High-Performance Computing Center of the University of Tartu. We acknowledge support from the UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and to Addenbrooke's Hospital in partnership with the University of Cambridge. The study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network 2 (NGFN-2), National Genome Research Network plus (NGFNplus) and the Integrated Genome Research Network (IG) MooDS (grants 01GS08144 and 01GS08147). R. K. W. is supported by a VIDI grant (016.136.308) from the Netherlands Organization for Scientific Research (NWO). J.H. was supported by the Swedish Research Council (521-2011-2764). This work is supported in part by funding from the US NIH (1R01AR063759 (S. R.), 5U01GM092691-05 (S. R.), 1UH2AR067677-01 (S. R.), U19AI111224-01 (S. R.) and 1R01DK084960-05 (K.N.L.)) and Doris Duke Charitable Foundation grant 2013097. A.B.J. and S. B. acknowledge funding from the Novo Nordisk Foundation (grant NNF14CC0001) and the H2020 project MedBioinformatics (grant 634143). The study was supported by the Norwegian PSC Research Center. We thank G. Trynka for assistance in setting up GoShifter.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; de Vries AB, 2015, WORLD J GASTROENTERO, V21, P1956, DOI 10.3748/wjg.v21.i6.1956; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Han B., 2015, BIORXIV, DOI [10.1101/030783, DOI 10.1101/030783]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Jensen AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5022; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Taylor JE, 2007, BIOMETRIKA, V94, P1, DOI 10.1093/biomet/asm004; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wachowicz K, 2014, BIOCHEM SOC T, V42, P1512, DOI 10.1042/BST20140179; Wang ZM, 2014, HUM MOL GENET, V23, P6616, DOI 10.1093/hmg/ddu363; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	55	331	336	3	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					510	+		10.1038/ng.3528			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	WOS:000374834100010	26974007	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	You, MS; Yue, Z; He, WY; Yang, XH; Yang, G; Xie, M; Zhan, DL; Baxter, SW; Vasseur, L; Gurr, GM; Douglas, CJ; Bai, JL; Wang, P; Cui, K; Huang, SG; Li, XC; Zhou, Q; Wu, ZY; Chen, QL; Liu, CH; Wang, B; Li, XJ; Xu, XF; Lu, CX; Hu, M; Davey, JW; Smith, SM; Chen, MS; Xia, XF; Tang, WQ; Ke, FS; Zheng, DD; Hu, YL; Song, FQ; You, YC; Ma, XL; Peng, L; Zheng, YK; Liang, Y; Chen, YQ; Yu, LY; Zhang, YN; Liu, YY; Li, GQ; Fang, L; Li, JX; Zhou, X; Luo, YD; Gou, CY; Wang, JY; Wang, J; Yang, HM; Wang, J				You, Minsheng; Yue, Zhen; He, Weiyi; Yang, Xinhua; Yang, Guang; Xie, Miao; Zhan, Dongliang; Baxter, Simon W.; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Wang, Ping; Cui, Kai; Huang, Shiguo; Li, Xianchun; Zhou, Qing; Wu, Zhangyan; Chen, Qilin; Liu, Chunhui; Wang, Bo; Li, Xiaojing; Xu, Xiufeng; Lu, Changxin; Hu, Min; Davey, John W.; Smith, Sandy M.; Chen, Mingshun; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan; Liu, Yuanyuan; Li, Guoqing; Fang, Lin; Li, Jingxiang; Zhou, Xin; Luo, Yadan; Gou, Caiyun; Wang, Junyi; Wang, Jian; Yang, Huanming; Wang, Jun			A heterozygous moth genome provides insights into herbivory and detoxification	NATURE GENETICS			English	Article							DIAMONDBACK MOTH; PLUTELLA-XYLOSTELLA; GENE; SEQUENCE; RESISTANCE; LEPIDOPTERA; MECHANISMS; PREDICTION; EVOLUTION; ALIGNMENT	How an insect evolves to become a successful herbivore is of profound biological and practical importance. Herbivores are often adapted to feed on a specific group of evolutionarily and biochemically related host plants(1), but the genetic and molecular bases for adaptation to plant defense compounds remain poorly understood(2). We report the first whole-genome sequence of a basal lepidopteran species, Plutella xylostella, which contains 18,071 protein-coding and 1,412 unique genes with an expansion of gene families associated with perception and the detoxification of plant defense compounds. A recent expansion of retrotransposons near detoxification-related genes and a wider system used in the metabolism of plant defense compounds are shown to also be involved in the development of insecticide resistance. This work shows the genetic and molecular bases for the evolutionary success of this worldwide herbivore and offers wider insights into insect adaptation to plant feeding, as well as opening avenues for more sustainable pest management.	[You, Minsheng; He, Weiyi; Yang, Guang; Xie, Miao; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Cui, Kai; Huang, Shiguo; Liu, Chunhui; Li, Xiaojing; Xu, Xiufeng; Smith, Sandy M.; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China; [You, Minsheng; He, Weiyi; Yang, Guang; Xie, Miao; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Cui, Kai; Huang, Shiguo; Liu, Chunhui; Li, Xiaojing; Xu, Xiufeng; Smith, Sandy M.; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Peoples R China; [Yue, Zhen; Yang, Xinhua; Zhan, Dongliang; Zhou, Qing; Wu, Zhangyan; Chen, Qilin; Wang, Bo; Lu, Changxin; Hu, Min; Li, Guoqing; Fang, Lin; Li, Jingxiang; Zhou, Xin; Luo, Yadan; Gou, Caiyun; Wang, Junyi; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Baxter, Simon W.] Univ Cambridge, Dept Zool, Cambridge, England; [Baxter, Simon W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Gurr, Geoff M.] Charles Sturt Univ, EH Graham Ctr, Orange, NSW, Australia; [Douglas, Carl J.; Liu, Yuanyuan] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Davey, John W.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Smith, Sandy M.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Chen, Mingshun] Kansas State Univ, USDA ARS, Manhattan, KS 66506 USA; [Chen, Mingshun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark		You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China.	msyou@iae.fjau.edu.cn; yxg@iae.fjau.edu.cn; wangj@genomics.cn	Davey, John/B-5075-2013; Zhou, Xin/D-4025-2009; Zhou, Xin/AAI-9326-2021; GURR, GEOFFREY M/F-3519-2011; Wang, Jun/A-7261-2013; He, Weiyi/N-6148-2017; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhou, Xin/0000-0002-1407-7952; Zhou, Xin/0000-0002-1407-7952; He, Weiyi/0000-0001-8659-3123; Baxter, Simon/0000-0001-5773-6578; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Gurr, Geoff/0000-0001-5008-7966; Davey, John/0000-0002-1017-9775	Educational Department of Fujian Province [JB09315]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31230061]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/D/20310000] Funding Source: UKRI	This work was supported through a special project of Research on Diamondback Moth Genomics (grant JB09315) to M.Y. and a Minjiang Scholar Program to L.V., G.M.G., C.J.D. and S.M.S. by the Educational Department of Fujian Province and through a key project (grant 31230061) to M.Y. from the National Natural Science Foundation of China. Insect rearing and sampling, as well as some of the DNA extractions, were conducted at the Fujian Provincial Key Laboratory of Biodiversity and Eco-safety and the Key Laboratory of Integrated Pest Management for Fujian-Taiwan Crops, the Ministry of Agriculture, China. We are grateful to AD. Briscoe (University of California Irvine) for her help in organizing and for providing ORs, OBPs and CSPs from Danaus plexippus and Heliconius melpomene and to G.L. Lovei (Aarhus University) for his comments and suggestions on the manuscript. We appreciate J. Liao and M. Zou (Fujian Agriculture and Forestry University) for providing the Bt-treated P. xylostella larvae used for quantitative gene expression analysis. We thank H. Wang, J. Luo, Y. Hong, S. Pan, L. Yang, Y. Weng, Y. Hong and Y. Liu for their technical assistance in rearing insects and preparing samples.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; ANKERSMIT GW, 1953, B ENTOMOL RES, V44, P421, DOI 10.1017/S0007485300025530; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkw1099; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Buono M, 2010, CELL MOL LIFE SCI, V67, P769, DOI 10.1007/s00018-009-0203-3; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Henniges-Janssen K, 2011, HEREDITY, V107, P421, DOI 10.1038/hdy.2011.27; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kvist J., 2012, MOL ECOL, DOI [10.1111/j.1365-294X.2012.05521.x, DOI 10.1111/1.1365-294X.2012.05521.X]; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Li AG, 2006, J ECON ENTOMOL, V99, P914, DOI 10.1603/0022-0493-99.3.914; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Pillai S, 2005, NUCLEIC ACIDS RES, V33, pW25, DOI 10.1093/nar/gki491; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whiteman NK, 2010, PLANT PHYSIOL, V154, P475, DOI 10.1104/pp.110.161117; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	85	331	385	12	250	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					220	225		10.1038/ng.2524			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	WOS:000314333000020	23313953	Green Published, hybrid			2022-01-24	
J	Bishop, DT; Demenais, F; Iles, MM; Harland, M; Taylor, JC; Corda, E; Randerson-Moor, J; Aitken, JF; Avril, MF; Azizi, E; Bakker, B; Bianchi-Scarra, G; Bressac-de Paillerets, B; Calista, D; Cannon-Albright, LA; Chin-A-Woeng, T; Debniak, T; Galore-Haskel, G; Ghiorzo, P; Gut, I; Hansson, J; Hocevar, M; Hoiom, V; Hopper, JL; Ingvar, C; Kanetsky, PA; Kefford, RF; Landi, MT; Lang, J; Lubinski, J; Mackie, R; Malvehy, J; Mann, GJ; Martin, NG; Montgomery, GW; van Nieuwpoort, FA; Novakovic, S; Olsson, H; Puig, S; Weiss, M; van Workum, W; Zelenika, D; Brown, KM; Goldstein, AM; Gillanders, EM; Boland, A; Galan, P; Elder, DE; Gruis, NA; Hayward, NK; Lathrop, GM; Barrett, JH; Bishop, JAN				Bishop, D. Timothy; Demenais, Florence; Iles, Mark M.; Harland, Mark; Taylor, John C.; Corda, Eve; Randerson-Moor, Juliette; Aitken, Joanne F.; Avril, Marie-Francoise; Azizi, Esther; Bakker, Bert; Bianchi-Scarra, Giovanna; Bressac-de Paillerets, Brigitte; Calista, Donato; Cannon-Albright, Lisa A.; Chin-A-Woeng, Thomas; Debniak, Tadeusz; Galore-Haskel, Gilli; Ghiorzo, Paola; Gut, Ivo; Hansson, Johan; Hocevar, Marko; Hoiom, Veronica; Hopper, John L.; Ingvar, Christian; Kanetsky, Peter A.; Kefford, Richard F.; Landi, Maria Teresa; Lang, Julie; Lubinski, Jan; Mackie, Rona; Malvehy, Josep; Mann, Graham J.; Martin, Nicholas G.; Montgomery, Grant W.; van Nieuwpoort, Frans A.; Novakovic, Srdjan; Olsson, Hakan; Puig, Susana; Weiss, Marjan; van Workum, Wilbert; Zelenika, Diana; Brown, Kevin M.; Goldstein, Alisa M.; Gillanders, Elizabeth M.; Boland, Anne; Galan, Pilar; Elder, David E.; Gruis, Nelleke A.; Hayward, Nicholas K.; Lathrop, G. Mark; Barrett, Jennifer H.; Bishop, Julia A. Newton			Genome-wide association study identifies three loci associated with melanoma risk	NATURE GENETICS			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SUN EXPOSURE; PHENOTYPIC CHARACTERISTICS; FAMILY-HISTORY; MC1R VARIANTS; CDKN2A; GENES; MUTATIONS; WOMEN; SUSCEPTIBILITY	We report a genome-wide association study of melanoma conducted by the GenoMEL consortium based on 317K tagging SNPs for 1,650 selected cases and 4,336 controls, with replication in an additional two cohorts (1,149 selected cases and 964 controls from GenoMEL, and a population-based case-control study in Leeds of 1,163 cases and 903 controls). The genome-wide screen identified five loci with genotyped or imputed SNPs reaching P < 5 x 10(-7). Three of these loci were replicated: 16q24 encompassing MC1R (combined P = 2.54 x 10(-27) for rs258322), 11q14-q21 encompassing TYR (P = 2.41 x 10(-14) for rs1393350) and 9p21 adjacent to MTAP and flanking CDKN2A (P = 4.03 x 10(-7) for rs7023329). MC1R and TYR are associated with pigmentation, freckling and cutaneous sun sensitivity, well-recognized melanoma risk factors. Common variants within the 9p21 locus have not previously been associated with melanoma. Despite wide variation in allele frequency, these genetic variants show notable homogeneity of effect across populations of European ancestry living at different latitudes and show independent association to disease risk.	[Bishop, D. Timothy; Iles, Mark M.; Harland, Mark; Taylor, John C.; Randerson-Moor, Juliette; Barrett, Jennifer H.; Bishop, Julia A. Newton] St James Univ Hosp, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England; [Demenais, Florence; Corda, Eve] Fdn Jean Dausset CEPH, INSERM, U946, F-75010 Paris, France; [Aitken, Joanne F.] Canc Council, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Avril, Marie-Francoise] Hop Cochin, AP HP, Fac Paris 5, Serv Dermatol, F-75674 Paris, France; [Azizi, Esther; Galore-Haskel, Gilli] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Dermatol, IL-52621 Tel Hashomer, Israel; [Bakker, Bert; Weiss, Marjan] Leiden Univ, Dept Clin Genet, Ctr Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; [Bressac-de Paillerets, Brigitte] CNRS, Inst Canc Gustave Roussy, Serv Genet, FRE 2939, Villejuif, France; [Calista, Donato] Maurizio Bufalini Hosp, Dermatol Unit, Cesena, Italy; [Cannon-Albright, Lisa A.] Univ Utah, Salt Lake City, UT USA; [Chin-A-Woeng, Thomas; van Workum, Wilbert] ServiceXS, NL-2333 BZ Leiden, Netherlands; [Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Szczecin, Poland; [Gut, Ivo; Zelenika, Diana; Boland, Anne; Lathrop, G. Mark] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atorn, Evry, France; [Hansson, Johan; Hoiom, Veronica] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hocevar, Marko; Novakovic, Srdjan] Inst Oncol Ljubljana, Ljubljana, Slovenia; [Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt MEGA Epidemiol, Melbourne, Vic 3010, Australia; [Ingvar, Christian; Olsson, Hakan] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Kanetsky, Peter A.] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Kefford, Richard F.; Mann, Graham J.] Melanoma Inst Australia, Westmead, NSW, Australia; [Landi, Maria Teresa; Goldstein, Alisa M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Lang, Julie; Mackie, Rona] Univ Glasgow, Dept Med Genet, Glasgow G12 8QQ, Lanark, Scotland; [Mackie, Rona] Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow G12 8QQ, Lanark, Scotland; [Malvehy, Josep; Puig, Susana] Hosp Clin Barcelona, Melanoma Unit, Dept Dermatol, IDIBAPS, E-08036 Barcelona, Spain; [Malvehy, Josep; Puig, Susana] CIBER Enfermedades Raras, Barcelona, Spain; [Martin, Nicholas G.; Montgomery, Grant W.; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [van Nieuwpoort, Frans A.; Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Brown, Kevin M.] Translat Genom Res Inst, Melanoma Genom Lab, Phoenix, AZ USA; [Gillanders, Elizabeth M.] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [Galan, Pilar] CRNH Idf, INSERM, INRA, CNAM,UMR U557,U1125, Bobigny, France; [Elder, David E.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA		Bishop, DT (corresponding author), St James Univ Hosp, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England.	d.t.bishop@leeds.ac.uk	Aitken, Joanne F/C-5289-2009; Scarra, Giovanna Bianchi/G-8933-2014; Montgomery, Grant W/B-7148-2008; Hoiom, Veronica/F-4153-2012; Mann, Graham J/G-4758-2014; Bakker, Egbert/D-3525-2009; Paillerets, Brigitte Bressac-de/D-8954-2018; hayward, nick/AAV-8802-2020; Ingvar, Christian/AAE-9841-2019; hayward, nicholas k/C-1367-2015; Weiss, Marjan M/AAN-4979-2020; Calista, Donato/AAM-1567-2020; Demenais, Florence/G-3298-2013; Pilar, Galan/F-2908-2017; Gut, Ivo/ABF-3188-2020; Puig, Susana/AAB-2091-2020; Ghiorzo, Paola/G-2749-2014	Scarra, Giovanna Bianchi/0000-0002-6127-1192; Montgomery, Grant W/0000-0002-4140-8139; Mann, Graham J/0000-0003-1301-405X; Bakker, Egbert/0000-0002-2843-7357; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; hayward, nicholas k/0000-0003-4760-1033; Weiss, Marjan M/0000-0002-0936-1406; Demenais, Florence/0000-0001-8361-0936; Pilar, Galan/0000-0003-1706-3107; Puig, Susana/0000-0003-1337-9745; Barrett, Jenny/0000-0002-1720-7724; Olsson, Hakan/0000-0002-8794-9635; albright, lisa/0000-0003-2602-3668; Kefford, Richard/0000-0001-9251-9229; Iles, Mark/0000-0002-2603-6509; Martin, Nicholas/0000-0003-4069-8020; Ghiorzo, Paola/0000-0002-3651-8173; malvehy, josep/0000-0002-6998-914X; Aitken, Joanne/0000-0001-6859-2186; , Srdjan/0000-0002-8888-4810; Gruis, Nelleke/0000-0002-5210-9150; Bishop, Tim/0000-0002-8752-8785; Randerson-Moor, Juliette/0000-0003-0303-0072; Newton-Bishop, Julia/0000-0001-9147-6802	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA088363, R01CA083115, R01CA102422] Funding Source: NIH RePORTER; Cancer Research UKCancer Research UK [10589, C588/A4994, A4994] Funding Source: Medline; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA5558, R01 CA083115-08, R01 CA102422, R01 ROI CA83115, R0-1 CA 83115, R01 CA083115, CA88363] Funding Source: Medline		Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Berwick M, 2006, CANCER EPIDEM BIOMAR, V15, P1520, DOI 10.1158/1055-9965.EPI-06-0270; Bishop JAN, 2000, J INVEST DERMATOL, V114, P28, DOI 10.1046/j.1523-1747.2000.00823.x; Bishop JAN, 1999, BRIT J CANCER, V80, P295, DOI 10.1038/sj.bjc.6690354; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon-Albright L A, 1991, Important Adv Oncol, P39; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Chaudru V, 2004, JNCI-J NATL CANCER I, V96, P785, DOI 10.1093/jnci/djh136; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Debniak T, 2008, EUR J CANCER, V44, P110, DOI 10.1016/j.ejca.2007.10.006; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Holland EA, 1995, ONCOGENE, V11, P2289; Holland EA, 1999, GENE CHROMOSOME CANC, V25, P339, DOI 10.1002/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H; Hollenbeak CS, 2005, CANCER, V104, P1962, DOI 10.1002/cncr.21404; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pastorino L, 2008, PIGM CELL MELANOMA R, V21, P700, DOI 10.1111/j.1755-148X.2008.00512.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peric B, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-86; Platz A, 1997, J NATL CANCER I, V89, P697, DOI 10.1093/jnci/89.10.697; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Puig S, 2005, J CLIN ONCOL, V23, P3043, DOI 10.1200/JCO.2005.08.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375	42	331	335	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					920	U85		10.1038/ng.411			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	WOS:000268432900018	19578364	Green Accepted			2022-01-24	
J	Suzuki, H; Forrest, ARR; van Nimwegen, E; Daub, CO; Balwierz, PJ; Irvine, KM; Lassmann, T; Ravasi, T; Hasegawa, Y; de Hoon, MJL; Katayama, S; Schroder, K; Carninci, P; Tomaru, Y; Kanamori-Katayama, M; Kubosaki, A; Akalin, A; Ando, Y; Arner, E; Asada, M; Asahara, H; Bailey, T; Bajic, VB; Bauer, D; Beckhouse, AG; Bertin, N; Bjorkegren, J; Brombacher, F; Bulger, E; Chalk, AM; Chiba, J; Cloonan, N; Dawe, A; Dostie, J; Engstrom, PG; Essack, M; Faulkner, GJ; Fink, JL; Fredman, D; Fujimori, K; Furuno, M; Gojobori, T; Gough, J; Grimmond, SM; Gustafsson, M; Hashimoto, M; Hashimoto, T; Hatakeyama, M; Heinzel, S; Hide, W; Hofmann, O; Hornquist, M; Huminiecki, L; Ikeo, K; Imamoto, N; Inoue, S; Inoue, Y; Ishihara, R; Iwayanagi, T; Jacobsen, A; Kaur, M; Kawaji, H; Kerr, MC; Kimura, R; Kimura, S; Kimura, Y; Kitano, H; Koga, H; Kojima, T; Kondo, S; Konno, T; Krogh, A; Kruger, A; Kumar, A; Lenhard, B; Lennartsson, A; Lindow, M; Lizio, M; MacPherson, C; Maeda, N; Maher, CA; Maqungo, M; Mar, J; Matigian, NA; Matsuda, H; Mattick, JS; Meier, S; Miyamoto, S; Miyamoto-Sato, E; Nakabayashi, K; Nakachi, Y; Nakano, M; Nygaard, S; Okayama, T; Okazaki, Y; Okuda-Yabukami, H; Orlando, V; Otomo, J; Pachkov, M; Petrovsky, N; Plessy, C; Quackenbush, J; Radovanovic, A; Rehli, M; Saito, R; Sandelin, A; Schmeier, S; Schonbach, C; Schwartz, AS; Semple, CA; Sera, M; Severin, J; Shirahige, K; Simons, C; Laurent, GS; Suzuki, M; Suzuki, T; Sweet, MJ; Taft, RJ; Takeda, S; Takenaka, Y; Tan, K; Taylor, MS; Teasdale, RD; Tegner, J; Teichmann, S; Valen, E; Wahlestedt, C; Waki, K; Waterhouse, A; AWells, C; Winther, O; Wu, L; Yamaguchi, K; Yanagawa, H; Yasuda, J; Zavolan, M; Hume, DA; Arakawa, T; Fukuda, S; Imamura, K; Kai, C; Kaiho, A; Kawashima, T; Kawazu, C; Kitazume, Y; Kojima, M; Miura, H; Murakami, K; Murata, M; Ninomiya, N; Nishiyori, H; Noma, S; Ogawa, C; Sano, T; Simon, C; Tagami, M; Takahashi, Y; Kawai, J; Hayashizaki, Y				Suzuki, Harukazu; Forrest, Alistair R. R.; van Nimwegen, Erik; Daub, Carsten O.; Balwierz, Piotr J.; Irvine, Katharine M.; Lassmann, Timo; Ravasi, Timothy; Hasegawa, Yuki; de Hoon, Michiel J. L.; Katayama, Shintaro; Schroder, Kate; Carninci, Piero; Tomaru, Yasuhiro; Kanamori-Katayama, Mutsumi; Kubosaki, Atsutaka; Akalin, Altuna; Ando, Yoshinari; Arner, Erik; Asada, Maki; Asahara, Hiroshi; Bailey, Timothy; Bajic, Vladimir B.; Bauer, Denis; Beckhouse, Anthony G.; Bertin, Nicolas; Bjorkegren, Johan; Brombacher, Frank; Bulger, Erika; Chalk, Alistair M.; Chiba, Joe; Cloonan, Nicole; Dawe, Adam; Dostie, Josee; Engstrom, Par G.; Essack, Magbubah; Faulkner, Geoffrey J.; Fink, J. Lynn; Fredman, David; Fujimori, Ko; Furuno, Masaaki; Gojobori, Takashi; Gough, Julian; Grimmond, Sean M.; Gustafsson, Mika; Hashimoto, Megumi; Hashimoto, Takehiro; Hatakeyama, Mariko; Heinzel, Susanne; Hide, Winston; Hofmann, Oliver; Hornquist, Michael; Huminiecki, Lukasz; Ikeo, Kazuho; Imamoto, Naoko; Inoue, Satoshi; Inoue, Yusuke; Ishihara, Ryoko; Iwayanagi, Takao; Jacobsen, Anders; Kaur, Mandeep; Kawaji, Hideya; Kerr, Markus C.; Kimura, Ryuichiro; Kimura, Syuhei; Kimura, Yasumasa; Kitano, Hiroaki; Koga, Hisashi; Kojima, Toshio; Kondo, Shinji; Konno, Takeshi; Krogh, Anders; Kruger, Adele; Kumar, Ajit; Lenhard, Boris; Lennartsson, Andreas; Lindow, Morten; Lizio, Marina; MacPherson, Cameron; Maeda, Norihiro; Maher, Christopher A.; Maqungo, Monique; Mar, Jessica; Matigian, Nicholas A.; Matsuda, Hideo; Mattick, John S.; Meier, Stuart; Miyamoto, Sei; Miyamoto-Sato, Etsuko; Nakabayashi, Kazuhiko; Nakachi, Yutaka; Nakano, Mika; Nygaard, Sanne; Okayama, Toshitsugu; Okazaki, Yasushi; Okuda-Yabukami, Haruka; Orlando, Valerio; Otomo, Jun; Pachkov, Mikhail; Petrovsky, Nikolai; Plessy, Charles; Quackenbush, John; Radovanovic, Aleksandar; Rehli, Michael; Saito, Rintaro; Sandelin, Albin; Schmeier, Sebastian; Schonbach, Christian; Schwartz, Ariel S.; Semple, Colin A.; Sera, Miho; Severin, Jessica; Shirahige, Katsuhiko; Simons, Cas; Laurent, George St.; Suzuki, Masanori; Suzuki, Takahiro; Sweet, Matthew J.; Taft, Ryan J.; Takeda, Shizu; Takenaka, Yoichi; Tan, Kai; Taylor, Martin S.; Teasdale, Rohan D.; Tegner, Jesper; Teichmann, Sarah; Valen, Eivind; Wahlestedt, Claes; Waki, Kazunori; Waterhouse, Andrew; AWells, Christine; Winther, Ole; Wu, Linda; Yamaguchi, Kazumi; Yanagawa, Hiroshi; Yasuda, Jun; Zavolan, Mihaela; Hume, David A.; Arakawa, Takahiro; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Kaiho, Ai; Kawashima, Tsugumi; Kawazu, Chika; Kitazume, Yayoi; Kojima, Miki; Miura, Hisashi; Murakami, Kayoko; Murata, Mitsuyoshi; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Ogawa, Chihiro; Sano, Takuma; Simon, Christophe; Tagami, Michihira; Takahashi, Yukari; Kawai, Jun; Hayashizaki, Yoshihide		FANTOM Consortium; Riken Omics Sci Ctr	The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line	NATURE GENETICS			English	Article							SERUM RESPONSE FACTOR; MONOCYTE-MACROPHAGE MATURATION; MESSENGER-RNA EXPRESSION; FACTOR-BINDING-SITES; GENE-EXPRESSION; SIGNALING PATHWAYS; STEM-CELLS; GENOME; PHOSPHORYLATION; PROLIFERATION	Using deep sequencing (deepCAGE), the FANTOM4 study measured the genome-wide dynamics of transcription-start-site usage in the human monocytic cell line THP-1 throughout a time course of growth arrest and differentiation. Modeling the expression dynamics in terms of predicted cis-regulatory sites, we identified the key transcription regulators, their time-dependent activities and target genes. Systematic siRNA knockdown of 52 transcription factors confirmed the roles of individual factors in the regulatory network. Our results indicate that cellular states are constrained by complex networks involving both positive and negative regulatory interactions among substantial numbers of transcription factors and that no single transcription factor is both necessary and sufficient to drive the differentiation process.	[Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Suzuki, Harukazu; Forrest, Alistair R. R.; Daub, Carsten O.; Lassmann, Timo; Hasegawa, Yuki; de Hoon, Michiel J. L.; Katayama, Shintaro; Carninci, Piero; Tomaru, Yasuhiro; Kanamori-Katayama, Mutsumi; Kubosaki, Atsutaka; Ando, Yoshinari; Arner, Erik; Bertin, Nicolas; Bulger, Erika; Furuno, Masaaki; Hashimoto, Takehiro; Ishihara, Ryoko; Kawaji, Hideya; Kimura, Yasumasa; Kondo, Shinji; Lennartsson, Andreas; Lizio, Marina; Maeda, Norihiro; Nakano, Mika; Okuda-Yabukami, Haruka; Plessy, Charles; Severin, Jessica; Suzuki, Masanori; Suzuki, Takahiro; Waki, Kazunori; Waterhouse, Andrew; Yamaguchi, Kazumi; Yasuda, Jun] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Forrest, Alistair R. R.; Beckhouse, Anthony G.; Chalk, Alistair M.; Matigian, Nicholas A.; AWells, Christine] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [van Nimwegen, Erik; Balwierz, Piotr J.; Pachkov, Mikhail; Zavolan, Mihaela] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [van Nimwegen, Erik; Balwierz, Piotr J.; Pachkov, Mikhail; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland; [Irvine, Katharine M.; Schroder, Kate; Bailey, Timothy; Bauer, Denis] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ravasi, Timothy; Schwartz, Ariel S.; Tan, Kai] Univ Calif San Diego, Jacobs Sch Engn, Dept Bioengn, La Jolla, CA 92093 USA; [Akalin, Altuna; Engstrom, Par G.; Fredman, David; Lenhard, Boris] Bergen Ctr Computat Sci, Bergen, Norway; [Asada, Maki; Asahara, Hiroshi; Hashimoto, Megumi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Bajic, Vladimir B.; Dawe, Adam; Essack, Magbubah; Hide, Winston; Hofmann, Oliver; Kaur, Mandeep; Kruger, Adele; MacPherson, Cameron; Maqungo, Monique; Meier, Stuart; Radovanovic, Aleksandar; Schmeier, Sebastian; AWells, Christine] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Bjorkegren, Johan; Tegner, Jesper] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Computat Med Grp,Atherosclerosis Res Unit,Ctr Mol, Stockholm, Sweden; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, IIDMM, Observatory, South Africa; [Chiba, Joe; Kimura, Ryuichiro; Nakabayashi, Kazuhiko] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 162, Japan; [Cloonan, Nicole; Faulkner, Geoffrey J.; Grimmond, Sean M.; Mattick, John S.; Simons, Cas; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, ARC, St Lucia, Qld, Australia; [Dostie, Josee] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Fink, J. Lynn; Kerr, Markus C.; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Ctr Excellence Bioinformat, ARC, St Lucia, Qld, Australia; [Fujimori, Ko] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Osaka 580, Japan; [Gojobori, Takashi; Ikeo, Kazuho; Konno, Takeshi; Miyamoto, Sei; Okayama, Toshitsugu; Sera, Miho] Natl Inst Genet, Res Org Informat & Syst, Ctr Informat Biol, Shizuoka, Japan; [Gojobori, Takashi; Ikeo, Kazuho; Konno, Takeshi; Miyamoto, Sei; Okayama, Toshitsugu; Sera, Miho] Natl Inst Genet, DDBJ, Shizuoka, Japan; [Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Gustafsson, Mika; Hornquist, Michael] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden; [Hatakeyama, Mariko; Kojima, Toshio] RIKEN, Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Kanagawa, Japan; [Heinzel, Susanne; Petrovsky, Nikolai] Flinders Univ & Med Ctr, Dept Endocrinol & Diabet, Adelaide, SA, Australia; [Hide, Winston; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huminiecki, Lukasz] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Imamoto, Naoko] RIKEN, Wako Inst, Discovery & Res Inst, Cellular Dynam Lab, Saitama, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Inoue, Satoshi] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Inoue, Yusuke] Gunma Univ, Fac Engn, Dept Biol & Chem Engn, Gunma, Japan; [Iwayanagi, Takao] Hitachi Ltd, Res & Dev Grp, R&D Solut Ctr, Tokyo, Japan; [Jacobsen, Anders; Krogh, Anders; Lindow, Morten; Nygaard, Sanne; Sandelin, Albin; Valen, Eivind; Winther, Ole] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Jacobsen, Anders; Krogh, Anders; Lindow, Morten; Nygaard, Sanne; Sandelin, Albin; Valen, Eivind; Winther, Ole] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Kimura, Syuhei] Tottori Univ, Fac Engn, Dept Informat & Knowledge Engn, Tottori 680, Japan; [Kitano, Hiroaki] Syst Biol Inst, Shibuya Ku, Tokyo, Japan; [Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Gene Res, Chiba, Japan; [Kumar, Ajit; Laurent, George St.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Mar, Jessica; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Matsuda, Hideo; Takenaka, Yoichi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan; [Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Sch, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama, Japan; [Orlando, Valerio] IRCCS Fdn Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Orlando, Valerio] IGB CNR, Naples, Italy; [Otomo, Jun; Takeda, Shizu] Hitachi Ltd, Cent Res Labs, Tokyo, Japan; [Rehli, Michael] Univ Regensburg, Dept Hematol & Oncol, Regensburg, Germany; [Saito, Rintaro] Keio Univ, Fac Environm & Informat Studies, Kanagawa, Japan; [Schonbach, Christian] Nanyang Technol Univ, Div Genom & Genet, Sch Biol Sci, Singapore, Singapore; [Semple, Colin A.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Shirahige, Katsuhiko] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Comp Sci, Tokyo 152, Japan; [Sweet, Matthew J.] Univ Queensland, CRC Chron Inflammatory Dis, Sch Mol & Microbial Sci, Inst Mol Biosci, St Lucia, Qld, Australia; [Taylor, Martin S.] EMBL European Bioinformat Inst, Cambridge, England; [Tegner, Jesper] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Teichmann, Sarah] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England; [Wahlestedt, Claes] Scripps Res Inst, Jupiter, FL USA		Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	david.hume@roslin.ed.ac.uk; yosihide@gsc.riken.jp	Taft, Ryan/B-2945-2010; Bertin, Nicolas/O-9602-2019; Rehli, Michael/E-9093-2011; tegner, jesper N/R-5095-2017; Teasdale, Rohan D/B-2538-2009; Schmeier, Sebastian/D-4731-2011; Kaur, Mandeep/N-4550-2015; Arner, Erik/A-1895-2010; Wells, Christine A/A-5071-2010; Suzuki, Harukazu/N-9553-2015; Skanderup, Anders Jacobsen/K-1081-2013; de Hoon, Michiel/A-6443-2013; Irvine, Katharine M/A-5559-2011; Petrovsky, Nikolai/P-1912-2017; Valen, Eivind/A-8617-2011; Taylor, Martin S/C-3825-2009; Beckhouse, Anthony G/A-2601-2010; Bauer, Denis/C-3903-2009; Ando, Yoshinari/AAK-5668-2020; Chalk, Alistair/O-3522-2019; Nakachi, Yutaka/M-2446-2013; Kerr, Markus C/A-9864-2014; Nygaard, Sanne/M-2569-2014; Schroder, Kate/C-6132-2008; Fujimori, Ko/AAD-5428-2021; Okada, Mariko/N-6933-2015; Essack, Magbubah/R-2773-2019; Severin, Jessica/AAQ-2723-2020; Fredman, David J/H-3566-2013; Grimmond, Sean/K-3246-2019; Sandelin, Albin/G-2881-2011; Grimmond, Sean M/J-5304-2016; Hide, Winston/R-3815-2019; Matigian, Nicholas A/A-4935-2009; Simons, Cas/A-7905-2011; Tomic, Nevena/AAA-2135-2021; Hayashizaki, Yoshihide/N-6590-2015; Radovanovic, Aleksandar/D-1313-2012; Radovanovic, Aleksandar/M-3687-2019; Suzuki, Takahiro/AAW-8509-2020; Fink, Lynn/C-2031-2008; Imamoto, Naoko/A-7458-2015; AKALIN, ALTUNA/A-4424-2012; Zavolan, Mihaela/S-3888-2016; Sweet, Matthew J/F-2229-2011; Lennartsson, Andreas/E-7823-2011; Ravasi, Timothy/B-8777-2008; Schonbach, Christian/B-1998-2009; Mattick, John/ABH-6130-2020; Daub, Carsten O/A-7436-2010; Hume, David A/C-7695-2013; Faulkner, Geoffrey J/M-3168-2014; Dawe, Adam/C-5295-2009; Inoue, Yusuke/O-6207-2018; Hofmann, Oliver M/F-1800-2013; Plessy, Charles/N-5054-2015; Kimura, Yasumasa/M-9720-2013; Mattick, John S/I-7789-2012; van Nimwegen, Erik/ABF-1085-2021; Carninci, Piero/K-1568-2014; Teasdale, Rohan/AAD-6698-2019; Forrest, Alistair/A-6597-2008; Lassmann, Timo/A-8271-2008; Cloonan, Nicole/B-5272-2008; Hide, Winston A/V-2727-2017; Katayama, Shintaro/F-2958-2010; Essack, Magbubah/G-5008-2013; Matigian, Nicholas/AAF-9390-2020; Hide, Winston Hide/C-7217-2009; Kawaji, Hideya/N-5116-2015; Kawai, Jun/A-6451-2016; Semple, Colin A M/A-5613-2009; Waki, Kazunori/T-6444-2019; Bertin, Nicolas/C-3025-2008; Krogh, Anders/M-1541-2014; Bajic, Vladimir/D-2810-2009	Rehli, Michael/0000-0003-3992-932X; tegner, jesper N/0000-0002-9568-5588; Teasdale, Rohan D/0000-0001-7455-5269; Schmeier, Sebastian/0000-0002-3947-8226; Kaur, Mandeep/0000-0002-9757-4048; Arner, Erik/0000-0003-1225-4908; Wells, Christine A/0000-0003-3133-3628; Suzuki, Harukazu/0000-0002-8087-0836; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Irvine, Katharine M/0000-0002-6716-1605; Petrovsky, Nikolai/0000-0002-1580-5245; Taylor, Martin S/0000-0001-7656-330X; Beckhouse, Anthony G/0000-0002-5141-8250; Bauer, Denis/0000-0001-8033-9810; Ando, Yoshinari/0000-0002-8128-6201; Chalk, Alistair/0000-0002-9630-6236; Nakachi, Yutaka/0000-0003-1964-2495; Nygaard, Sanne/0000-0002-3002-6047; Schroder, Kate/0000-0001-9261-3805; Fujimori, Ko/0000-0002-2506-0769; Severin, Jessica/0000-0003-1274-208X; Fredman, David J/0000-0003-3507-0554; Grimmond, Sean/0000-0002-8102-7998; Sandelin, Albin/0000-0002-7109-7378; Grimmond, Sean M/0000-0002-8102-7998; Hide, Winston/0000-0002-8621-3271; Matigian, Nicholas A/0000-0001-7735-9415; Simons, Cas/0000-0003-3147-8042; Radovanovic, Aleksandar/0000-0002-8749-7608; Radovanovic, Aleksandar/0000-0002-8749-7608; Suzuki, Takahiro/0000-0002-0972-6911; Fink, Lynn/0000-0003-2912-6048; Imamoto, Naoko/0000-0002-2886-3022; AKALIN, ALTUNA/0000-0002-0468-0117; Sweet, Matthew J/0000-0002-0406-8139; Schonbach, Christian/0000-0002-0693-7617; Mattick, John/0000-0002-7680-7527; Daub, Carsten O/0000-0002-3295-8729; Faulkner, Geoffrey J/0000-0001-5769-4494; Inoue, Yusuke/0000-0002-9710-7482; Hofmann, Oliver M/0000-0002-7738-1513; Plessy, Charles/0000-0001-7410-6295; Mattick, John S/0000-0002-7680-7527; van Nimwegen, Erik/0000-0001-6338-1312; Carninci, Piero/0000-0001-7202-7243; Teasdale, Rohan/0000-0001-7455-5269; Forrest, Alistair/0000-0003-4543-1675; Lassmann, Timo/0000-0002-0138-2691; Cloonan, Nicole/0000-0001-7802-6647; Hide, Winston A/0000-0002-8621-3271; Katayama, Shintaro/0000-0001-7581-5157; Essack, Magbubah/0000-0003-2709-5356; Matigian, Nicholas/0000-0001-7735-9415; Hide, Winston Hide/0000-0002-8621-3271; Kawaji, Hideya/0000-0002-0575-0308; Semple, Colin A M/0000-0003-1765-4118; Tan, Kai/0000-0002-9104-5567; Ando, Yukio/0000-0001-7115-9105; Waki, Kazunori/0000-0001-7311-7208; Heinzel, Susanne/0000-0001-9524-2835; Winther, Ole/0000-0002-1966-3205; Matsuda, Hideo/0000-0002-4701-3779; Lennartsson, Andreas/0000-0002-3272-2505; Bertin, Nicolas/0000-0002-9835-9606; Quackenbush, John/0000-0002-2702-5879; Huminiecki, Lukasz/0000-0003-1943-4450; Valen, Eivind/0000-0003-1840-6108; Mar, Jessica/0000-0002-5147-9299; Yasuda, Jun/0000-0002-3887-6871; Okazaki, Yasushi/0000-0003-3241-5502; Ravasi, Timothy/0000-0002-9950-465X; Engstrom, Par/0000-0001-5265-2121; Hume, David/0000-0002-2615-1478; Krogh, Anders/0000-0002-5147-6282; Teichmann, Sarah/0000-0002-6294-6366; Zavolan, Mihaela/0000-0002-8832-2041; Bajic, Vladimir/0000-0001-5435-4750; Lenhard, Boris/0000-0002-1114-1509; MacPherson, Cameron/0000-0002-8945-9736	Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); RIKEN Frontier Research System, Functional RNA research program; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [ID 428261]; SNF [SNF 3100A0-118318]; Fondazione TelethonFondazione Telethon Funding Source: Custom; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105161047] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9900991B, MC_U105161047] Funding Source: researchfish; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21570151] Funding Source: KAKEN	We thank A. Ambesi, H. Atsui, M. Bansal, V. Belcastro, H. Daub, D. di Bernardo, M. Furuya, A. Hasegawa, K. Hayashida, A. Hirakiyama, F. Hori, K. Koseki, S. Kuhara, N. Miyamoto, S. Miyano, M. Nishikawa, C. Ohinata, M. Persson, S. Saihara, C. Sakaba, H. Sano, E. Shibazaki, T. Takagi, K. Toyoda, Y. Tsujimura and M. Yamamoto for discussion, encouragement and technical assistance. We thank M. Muramatsu, T. Ogawa, Y. Sakaki and A. Wada for support and encouragement. This work was mainly supported by grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y. H.), Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (Y. H.) and the RIKEN Frontier Research System, Functional RNA research program (Y. H.). A. R. R. F. is supported by a CJ Martin Fellowship from the Australian National Health and Medical Research Council (ID 428261). E. v. N. acknowledges support from SNF grant SNF # 3100A0-118318.	ABRINK M, 1994, LEUKEMIA, V8, P1579; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Biggs JR, 1998, CELL GROWTH DIFFER, V9, P667; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Carey JO, 1996, BLOOD, V87, P4316, DOI 10.1182/blood.V87.10.4316.bloodjournal87104316; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fleige A, 2007, J BIOL CHEM, V282, P24320, DOI 10.1074/jbc.M703119200; Foster N, 2007, J LEUKOCYTE BIOL, V81, P893, DOI 10.1189/jlb.0206086; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; Kauffman SA., 1993, ORIGINS ORDER SELF O; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Krishnaraju K, 1998, BLOOD, V92, P1957, DOI 10.1182/blood.V92.6.1957.418k24_1957_1966; Martino V, 2006, ONCOL REP, V15, P207; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z; Pession A, 2003, ONCOGENE, V22, P8671, DOI 10.1038/sj.onc.1207125; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schmitz G, 2008, REV PHYSIOL BIOCH P, V160, P93, DOI 10.1007/112_2008_802; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TREJO J, 1994, J BIOL CHEM, V269, P21682; TSUCHIYA S, 1982, CANCER RES, V42, P1530; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	49	331	334	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					553	562		10.1038/ng.375			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	WOS:000265575600016	19377474	Green Accepted			2022-01-24	
J	Kerkel, K; Spadola, A; Yuan, E; Kosek, J; Jiang, L; Hod, E; Li, K; Murty, VV; Schupf, N; Vilain, E; Morris, M; Haghighi, F; Tycko, B				Kerkel, Kristi; Spadola, Alexandra; Yuan, Eric; Kosek, Jolanta; Jiang, Le; Hod, Eldad; Li, Kerry; Murty, Vundavalli V.; Schupf, Nicole; Vilain, Eric; Morris, Mitzi; Haghighi, Fatemeh; Tycko, Benjamin			Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation	NATURE GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; PRADER-WILLI-SYNDROME; MONOALLELIC EXPRESSION; PROMOTER ACTIVITY; GENE; CYP2A6; IDENTIFICATION; EPIMUTATION	Allele-specific DNA methylation (ASM) is a hallmark of imprinted genes, but ASM in the larger nonimprinted fraction of the genome is less well characterized. Using methylation-sensitive SNP analysis (MSNP), we surveyed the human genome at 50K and 250K resolution, identifying ASM as recurrent genotype call conversions from heterozygosity to homozygosity when genomic DNAs were predigested with the methylation-sensitive restriction enzyme HpaII. Using independent assays, we confirmed ASM at 16 SNP-tagged loci distributed across various chromosomes. At 12 of these loci (75%), the ASM tracked strongly with the sequence of adjacent SNPs. Further analysis showed allele-specific mRNA expression at two loci from this methylation-based screen -the vanin and CYP2A6-CYP2A7 gene clusters -both implicated in traits of medical importance. This recurrent phenomenon of sequence-dependent ASM has practical implications for mapping and interpreting associations of noncoding SNPs and haplotypes with human phenotypes.	[Kerkel, Kristi; Yuan, Eric; Kosek, Jolanta; Jiang, Le; Li, Kerry; Murty, Vundavalli V.; Tycko, Benjamin] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Spadola, Alexandra] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA; [Hod, Eldad; Murty, Vundavalli V.; Tycko, Benjamin] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Schupf, Nicole] Columbia Univ, Med Ctr, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Schupf, Nicole] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10032 USA; [Vilain, Eric] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Morris, Mitzi; Haghighi, Fatemeh] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA		Tycko, B (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	bt12@columbia.edu			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21 CA125461, R21 CA128556] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA128556, R21CA125461] Funding Source: NIH RePORTER		Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; CHANDLER LA, 1987, CELL, V50, P711, DOI 10.1016/0092-8674(87)90329-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; Pitarque M, 2004, HUM MUTAT, V23, P258, DOI 10.1002/humu.20002; Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Suter CM, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573a; SUTER CM, 2007, NAT GENET, V39, P576; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; von Richter O, 2004, PHARMACOGENETICS, V14, P369, DOI 10.1097/00008571-200406000-00006; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zogel C, 2006, EUR J HUM GENET, V14, P752, DOI 10.1038/sj.ejhg.5201602	22	331	337	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					904	908		10.1038/ng.174			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	WOS:000257166500027	18568024	Green Published			2022-01-24	
J	Delous, M; Baala, L; Salomon, R; Laclef, C; Vierkotten, J; Tory, K; Golzio, C; Lacoste, T; Besse, L; Ozilou, C; Moutkine, I; Hellman, NE; Anselme, I; Silbermann, F; Vesque, C; Gerhardt, C; Rattenberry, E; Wolf, MTF; Gubler, MC; Martinovic, J; Encha-Razavi, F; Boddaert, N; Gonzales, M; Macher, MA; Nivet, H; Champion, G; Bertheleme, JP; Niaudet, P; McDonald, F; Hildebrandt, F; Johnson, CA; Vekemans, M; Antignac, C; Ruther, U; Schneider-Maunoury, S; Attie-Bitach, T; Saunier, S				Delous, Marion; Baala, Lekbir; Salomon, Remi; Laclef, Christine; Vierkotten, Jeanette; Tory, Kalman; Golzio, Christelle; Lacoste, Tiphanie; Besse, Laurianne; Ozilou, Catherine; Moutkine, Imane; Hellman, Nathan E.; Anselme, Isabelle; Silbermann, Flora; Vesque, Christine; Gerhardt, Christoph; Rattenberry, Eleanor; Wolf, Matthias T. F.; Gubler, Marie Claire; Martinovic, Jelena; Encha-Razavi, Ferechte; Boddaert, Nathalie; Gonzales, Marie; Macher, Marie Alice; Nivet, Hubert; Champion, Gerard; Bertheleme, Jean Pierre; Niaudet, Patrick; McDonald, Fiona; Hildebrandt, Friedhelm; Johnson, Colin A.; Vekemans, Michel; Antignac, Corinne; Ruether, Ulrich; Schneider-Maunoury, Sylvie; Attie-Bitach, Tania; Saunier, Sophie			The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; MUTANT FUSED-TOES; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; MUTATIONS; MOUSE; NPHP1; NEPHROCYSTIN-4; ENCODES; CILIUM	Cerebello- oculo- renal syndrome ( CORS), also called Joubert syndrome type B, and Meckel ( MKS) syndrome belong to the group of developmental autosomal recessive disorders that are associated with primary cilium dysfunction. Using SNP mapping, we identified missense and truncating mutations in RPGRIP1L ( KIAA1005) in both CORS and MKS, and we show that inactivation of the mouse ortholog Rpgrip1l ( Ftm) recapitulates the cerebral, renal and hepatic defects of CORS and MKS. In addition, we show that RPGRIP1L colocalizes at the basal body and centrosomes with the protein products of both NPHP6 and NPHP4, known genes associated with MKS, CORS and nephronophthisis ( a related renal disorder and ciliopathy). In addition, the RPGRIP1L missense mutations found in CORS individuals diminishes the interaction between RPGRIP1L and nephrocystin- 4. Our findings show that mutations in RPGRIP1L can cause the multiorgan phenotypic abnormalities found in CORS or MKS, which therefore represent a continuum of the same underlying disorder.	INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France; Univ Paris 05, F-75006 Paris, France; Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, APHP, F-75015 Paris, France; CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Univ Dusseldorf, Inst Entwicklungs & Mol Biol Tiere, EMT, D-40225 Dusseldorf, Germany; Hop Necker Enfants Malad, APHP, Dept Genet, F-75015 Paris, France; Womens Hosp Med Ctr, W Midlands Reg Genet, Birmingham B15 2TG, W Midlands, England; Univ Michigan, Dept Pediat & Human Genet, Ann Arbor, MI 48109 USA; Hop Necker Enfants Malad, F-75015 Paris, France; Hop Trousseau, Dept Foetopathol, F-75012 Paris, France; Hop Robert Debre, APHP, Dept Pediat, F-75019 Paris, France; CHU Bretonneau, Dept Nephrol & Clin Immunol, F-37000 Tours, France; CHU Angers, Dept Pediat Nephrol, F-49100 Angers, France; Ctr Perharidy, F-29680 Roscoff, France; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England		Saunier, S (corresponding author), INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France.	saunier@necker.fr	Delous, Marion/H-3850-2017; Saunier, Sophie/G-6044-2015; Schneider-Maunoury, Sylvie/K-6795-2017; Gerhardt, Christoph/AAO-4596-2020; Vesque, Christine/Q-8461-2019; ATTIE-BITACH, Tania/K-1453-2017; Delous, Marion/Q-1835-2019; Vesque, Christine/L-9839-2017; Olcese, Chiara/L-6081-2014; ANTIGNAC, Corinne/H-8945-2017	Delous, Marion/0000-0003-2666-4457; Saunier, Sophie/0000-0002-1069-0047; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Gerhardt, Christoph/0000-0002-6340-549X; ATTIE-BITACH, Tania/0000-0002-1155-3626; Delous, Marion/0000-0003-2666-4457; Gubler, Marie-Claire/0000-0002-3526-5661; legendre, flora/0000-0002-4149-1913; Golzio, Christelle/0000-0002-4420-3921; Vesque, Christine/0000-0001-7983-4953; boddaert, nathalie/0000-0003-0991-7774; ANTIGNAC, Corinne/0000-0002-9934-4940	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK068306] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK068306] Funding Source: NIH RePORTER		Anselme I, 2007, DEV BIOL, V304, P208, DOI 10.1016/j.ydbio.2006.12.025; BAALA L, IN PRESS AM J HUM GE; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Espinosa-Parrilla Y, 2002, MECH DEVELOP, V114, P187, DOI 10.1016/S0925-4773(02)00062-X; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Saunier S, 2005, CURR OPIN GENET DEV, V15, P324, DOI 10.1016/j.gde.2005.04.012; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith A., 1996, Managing Information, V3, P38; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355	30	331	335	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					875	881		10.1038/ng2039			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	WOS:000247619800018	17558409				2022-01-24	
J	Nakamura, Y; Itoh, T; Matsuda, H; Gojobori, T				Nakamura, Y; Itoh, T; Matsuda, H; Gojobori, T			Biased biological functions of horizontally transferred genes in prokaryotic genomes	NATURE GENETICS			English	Article							PATHOGENICITY ISLANDS; EVOLUTION; BACTERIA; NEISSERIA; SEQUENCE; EXCHANGE	Horizontal gene transfer is one of the main mechanisms contributing to microbial genome diversification(1-3). To clarify the overall picture of interspecific gene flow among prokaryotes, we developed a new method for detecting horizontally transferred genes and their possible donors by Bayesian inference with training models for nucleotide composition. Our method gives the average posterior probability ( horizontal transfer index) for each gene sequence, with a low horizontal transfer index indicating recent horizontal transfer. We found that 14% of open reading frames in 116 prokaryotic complete genomes were subjected to recent horizontal transfer. Based on this data set, we quantitatively determined that the biological functions of horizontally transferred genes, except mobile element genes, are biased to three categories: cell surface, DNA binding and pathogenicity-related functions. Thus, the transferability of genes seems to depend heavily on their functions.	Res Org Informat & Syst, Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; Res Org Informat & Syst, Natl Inst Genet, DNA Data Bank Japan, Shizuoka 4118540, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; Natl Inst Agrobiol Sci, Genome Res Dept, Tsukuba, Ibaraki 3058602, Japan; Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka 5608531, Japan		Gojobori, T (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Ctr Informat Biol, 1111 Yata, Shizuoka 4118540, Japan.	tgojobor@genes.nig.ac.jp	asif, huma/C-1441-2012	Matsuda, Hideo/0000-0002-4701-3779; Itoh, Takeshi/0000-0002-6291-4233			AMABILECUEVAS CF, 1992, CELL, V70, P189, DOI 10.1016/0092-8674(92)90095-T; BORODOVSKY M, 1995, NUCLEIC ACIDS RES, V23, P3554, DOI 10.1093/nar/23.17.3554; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Charlebois RL, 2003, NATURE, V421, P217, DOI 10.1038/421217a; Davis J, 2001, J BACTERIOL, V183, P4626, DOI 10.1128/JB.183.15.000-000.2001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Genereux DP, 2003, TRENDS GENET, V19, P191, DOI 10.1016/S0168-9525(03)00055-6; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang B, 2001, J MOL EVOL, V53, P244, DOI 10.1007/s002390010214; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	27	331	350	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					760	766		10.1038/ng1381			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	WOS:000222354100029	15208628	Bronze			2022-01-24	
J	Blazquez, MA; Ahn, JH; Weigel, D				Blazquez, MA; Ahn, JH; Weigel, D			A thermosensory pathway controlling flowering time in Arabidopsis thaliana	NATURE GENETICS			English	Article							MADS DOMAIN PROTEIN; CIRCADIAN CLOCK; PHYTOCHROME-B; MUTANTS; GENE; VERNALIZATION; ENCODES; LIGHT; PHENOTYPE; REPRESSOR	Onset of flowering is controlled by environmental signals such as light and temperature. Molecular-genetic studies in Arabidopsis thaliana have focused on daily light duration, or photoperiod, and transient exposure to winter-like temperatures, or vernalizationl. Yet ambient growth temperature, which is strongly affected by current changes in global climate(2), has been largely ignored. Here, we show that genes of the autonomous pathway, previously thought only to act independently of the environment as regulators of the floral repressor FLC (ref. 1), are centrally involved in mediating the effects of ambient temperature. In contrast to wild-type plants and those mutant in other pathways, autonomous-pathway mutants flower at the same time regardless of ambient temperature. In contrast, the exaggerated temperature response of cryptochrome-2 mutants is caused by temperature-dependent redundancy with the phytochrome A photoreceptor. As with vernalization and photoperiod, ambient temperature ultimately affects expression of the floral pathway integrator FT.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Max Planck Inst Dev Biol, Dept Biol Mol, D-72076 Tubingen, Germany		Weigel, D (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	weigel@weigelworld.org	Blazquez, Miguel A/B-1495-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008	Blazquez, Miguel A/0000-0001-5743-0448; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963			AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Halevy H., 1985, CRC HDB FLOWERING; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Long S.P., 1988, PLANTS TEMPERATURE; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mockler TC, 1999, DEVELOPMENT, V126, P2073; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; [No title captured]	30	331	372	2	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					168	171		10.1038/ng1085			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	WOS:000180773700014	12548286				2022-01-24	
J	Hekmat-Scafe, DS; Scafe, CR; McKinney, AJ; Tanouye, MA				Hekmat-Scafe, DS; Scafe, CR; McKinney, AJ; Tanouye, MA			Genome-wide analysis of the odorant-binding protein gene family in Drosophila melanogaster	GENOME RESEARCH			English	Article							PHEROMONE-BINDING; SEQUENCE SIMILARITY; 7-TRANSMEMBRANE PROTEINS; OLFACTORY RECEPTORS; TENEBRIO-MOLITOR; MOTH; CLONING; SPECIFICITY; EXPRESSION; ANTHERAEA	Olfaction is of considerable importance to many insects in behaviors critical for survival and reproduction, including location of food sources, selection of mates, recognition of colony con-specifics, and determination of oviposition sites. An ubiquitous, but poorly understood, component of the insect's olfactory system is a group of odorant-binding proteins (OBPs) that are present at high concentrations in the aqueous lymph surrounding the dendrites of olfactory receptor neurons. OBPs are believed to shuttle odorants from the environment to the underlying odorant receptors, for which they could potentially serve as odorant presenters. Here we show that the Drosophila genome carries 51 potential OF genes, a number comparable to that of its odorant-receptor genes. We find that the majority (73%) of these OBP-like genes occur in clusters of as many as nine genes, in contrast to what has been observed for the Drosophila odorant-receptor genes. Two of the presumptive OBP gene clusters each carries an odorant-receptor gene. We also report an intriguing subfamily of 12 putative OBPs that share a unique C-terminal structure with three conserved cysteines and a conserved praline. Members of this subfamily have not previously been described for any insect. We have performed phylogenetic analyses of the OBP-related proteins in Drosophila as well as other insects, and we discuss the duplication and divergence of the genes for this large family.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Div Insect Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Mills Coll, Dept Biol, Oakland, CA 94613 USA		Hekmat-Scafe, DS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Div Insect Biol, Berkeley, CA 94720 USA.	darla@nature.berkeley.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS31231, R01 NS031231] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031231] Funding Source: NIH RePORTER		Ache Barry W., 1994, Seminars in Cell Biology, V5, P55, DOI 10.1006/scel.1994.1008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BREER H, 1990, INSECT BIOCHEM, V20, P735, DOI 10.1016/0020-1790(90)90088-C; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; DU GH, 1995, BIOCHEMISTRY-US, V34, P8726, DOI 10.1021/bi00027a023; Felsenstein J., 1993, PHYLIP PHYLOGENY INT; Galindo K, 2001, GENETICS, V159, P1059; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Graham LA, 2001, INSECT BIOCHEM MOLEC, V31, P691, DOI 10.1016/S0965-1748(00)00177-6; Harrison PM, 2002, NUCLEIC ACIDS RES, V30, P1083, DOI 10.1093/nar/30.5.1083; Hekmat-Scafe DS, 2000, GENETICS, V155, P117; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Karlin S, 2001, NATURE, V411, P259, DOI 10.1038/35077152; Kim MS, 1998, GENETICS, V150, P711; KODRIK D, 1995, NETH J ZOOL, V45, P68; KRIEGER J, 1991, BIOCHIM BIOPHYS ACTA, V1088, P277, DOI 10.1016/0167-4781(91)90064-S; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; Krieger Juergen, 1997, Invertebrate Neuroscience, V3, P137, DOI 10.1007/BF02480368; Lobel D, 2002, CHEM SENSES, V27, P39, DOI 10.1093/chemse/27.1.39; MaibecheCoisne M, 1997, INSECT BIOCHEM MOLEC, V27, P213, DOI 10.1016/S0965-1748(96)00088-4; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; NEI M, 1986, MOL BIOL EVOL, V3, P418; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; PAESEN GC, 1995, INSECT BIOCHEM MOLEC, V25, P401, DOI 10.1016/0965-1748(94)00085-V; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; PRESTWICH GD, 1995, CHEM SENSES, V20, P461, DOI 10.1093/chemse/20.4.461; RAMING K, 1990, J COMP PHYSIOL B, V160, P503, DOI 10.1007/BF00258977; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; STEINBRECHT RA, 1992, CELL TISSUE RES, V270, P287, DOI 10.1007/BF00328015; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Steinbrecht RA, 1996, CIBA F SYMP, V200, P158; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thymianou S, 1998, INSECT MOL BIOL, V7, P345, DOI 10.1046/j.1365-2583.1998.740345.x; Todres E, 2000, INSECT MOL BIOL, V9, P581, DOI 10.1046/j.1365-2583.2000.00222.x; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Warr CG, 2000, CELL, V102, P145; Wojtasek H, 1999, BIOCHEM BIOPH RES CO, V263, P832, DOI 10.1006/bbrc.1999.1448; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278	66	331	378	4	71	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2002	12	9					1357	1369		10.1101/gr.239402			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	592YP	WOS:000177964700007	12213773	Bronze, Green Published			2022-01-24	
J	Huynen, M; Snel, B; Lathe, W; Bork, P				Huynen, M; Snel, B; Lathe, W; Bork, P			Predicting protein function by genomic context: Quantitative evaluation and qualitative inferences	GENOME RESEARCH			English	Article							ESCHERICHIA-COLI; GENE ORDER; EVOLUTION; MUTATIONS; SEQUENCE; DATABASE; DOMAIN	Various new methods have been proposed to predict Functional interactions between proteins based on the genomic context of their genes. The types of genomic context that they use are Type I: the fusion of genes; Type II: the conservation of gene-order or co-occurrence of genes in potential operons; and Type III: the co-occurrence of genes across genomes (phylogenetic profiles). Here we compare these types For their coverage, their correlations with various types of functional interaction, and their overlap with homology-based Function assignment. We apply the methods to Mycoplasma genitalium, the standard benchmarking genome in computational and experimental genomics. Quantitatively, conservation of gene order is the technique with the highest coverage, applying to 37% of the genes. By combining gene order conservation with gene fusion (6%), the co-occurrence of genes in operons in absence of gene order conservation (8%), and the co-occurrence of genes across genomes (11%), significant context information can be obtained for 50% of the genes (the categories overlap). Qualitatively, we observe that the functional interactions between genes are stronger as the requirements For physical neighborhood on the genome are more stringent, while the Fraction of potential false positives decreases. Moreover, only in cases in which gene order is conserved in a substantial Fraction of the genomes, in this case six out of twenty-five, does a single type of functional interaction (physical interaction) clearly dominate (>80%). In other cases, complementary Function information from homology searches, which is available for most of the genes with significant genomic context, is essential to predict the type of interaction. Using a combination of genomic context and homology searches, new Functional features can be predicted for 10% of M. genitalium genes.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany		Huynen, M (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	huynen@embl-heidelberg.de	Huynen, Martijn A/A-1530-2014; Snel, Berend/B-8886-2011; Huijnen, M.A./H-8051-2014; Bork, Peer/F-1813-2013	Huynen, Martijn A/0000-0001-6189-5491; Snel, Berend/0000-0002-5804-8547; Bork, Peer/0000-0002-2627-833X			ALAM KY, 1991, J BACTERIOL, V173, P6018, DOI 10.1128/jb.173.19.6018-6024.1991; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Hamet M, 1979, Adv Exp Med Biol, V122B, P231; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.3.CO;2-T; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; HUYNEN MA, 1999, SCIENCE, V286, pA1441; Huynen Martijin A., 2000, V54, P345; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KOONIN EV, 1995, P NATL ACAD SCI USA, V92, P11921, DOI 10.1073/pnas.92.25.11921; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Krogan NJ, 1998, J BACTERIOL, V180, P5891, DOI 10.1128/JB.180.22.5891-5895.1998; KULLBACK S, 1959, INFORMATION THEORY S; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Mushegian AR, 1996, TRENDS GENET, V12, P289, DOI 10.1016/0168-9525(96)20006-X; NEALE GAM, 1983, J BACTERIOL, V156, P1001, DOI 10.1128/JB.156.3.1001-1005.1983; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Selkov E, 1998, NUCLEIC ACIDS RES, V26, P43, DOI 10.1093/nar/26.1.43; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Teichmann SA, 1999, CURR OPIN STRUC BIOL, V9, P390, DOI 10.1016/S0959-440X(99)80053-0; Wu G, 1999, P NATL ACAD SCI USA, V96, P6285, DOI 10.1073/pnas.96.11.6285	34	331	344	0	8	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2000	10	8					1204	1210		10.1101/gr.10.8.1204			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	347ZC	WOS:000088958200016	10958638	Green Published, Bronze			2022-01-24	
J	PURUGGANAN, MD; ROUNSLEY, SD; SCHMIDT, RJ; YANOFSKY, MF				PURUGGANAN, MD; ROUNSLEY, SD; SCHMIDT, RJ; YANOFSKY, MF			MOLECULAR EVOLUTION OF FLOWER DEVELOPMENT - DIVERSIFICATION OF THE PLANT MADS-BOX REGULATORY GENE FAMILY	GENETICS			English	Article							FLORAL HOMEOTIC GENE; ANTIRRHINUM-MAJUS; NUCLEOTIDE SUBSTITUTION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; DNA-BINDING; EXPRESSION; DEFICIENS; SEQUENCE; RATES	Floral homeotic genes that control the specification of meristem and organ identity in developing flowers have been isolated from both Arabidopsis thaliana and Antirrhinum majus. Most of these genes belong to a large family of regulatory genes and possess a characteristic DNA binding domain known as the MADS-box. Members of this gene family display primarily floral-specific expression and are homologous to transcription factors found in several animal and fungal species. Molecular evolutionary analyses reveal that there are appreciable differences in the substitution rates between different domains of these plant MADS-box genes. Phylogenetic analyses also demonstrate that members of the plant MADS-box gene family are organized into several distinct gene groups: the AGAMOUS, APETALA3/PISTILLATA and APETALA1/AGL9 groups. The shared evolutionary history of members of a gene group appear to reflect the distinct functional roles these MADS-box genes play in flower development. Molecular evolutionary analyses also suggest that these different gene groups were established in a relatively short span of evolutionary time and that the various floral homeotic loci originated even before the appearance of the flowering plants.			PURUGGANAN, MD (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL 0116, LA JOLLA, CA 92093 USA.						ANGENENT GC, 1992, PLANT CELL, V4, P983, DOI 10.1105/tpc.4.8.983; ANGENENT GC, 1994, PLANT J, V5, P33, DOI 10.1046/j.1365-313X.1994.5010033.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; COEN ES, 1991, ANNU REV PLANT PHYS, V42, P241, DOI 10.1146/annurev.pp.42.060191.001325; Davies B, 1994, Results Probl Cell Differ, V20, P235; DICKINSON WJ, 1991, EVOL BIOL, V25, P127; DOEBLEY J, 1993, CURR OPIN GENET DEV, V3, P865, DOI 10.1016/0959-437X(93)90006-B; DOYLE JA, 1973, Q REV BIOL, V48, P399, DOI 10.1086/407701; DOYLE JJ, 1994, SYST BIOL, V43, P307; GARCIAMAROTO F, 1993, PLANT J, V4, P771, DOI 10.1046/j.1365-313X.1993.04050771.x; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Gould S. J., 1977, ONTOGENY PHYLOGENY; HANSEN G, 1993, MOL GEN GENET, V239, P310, DOI 10.1007/BF00281633; HUANG N, 1992, P NATL ACAD SCI USA, V89, P7526, DOI 10.1073/pnas.89.16.7526; HUGHES AL, 1994, MOL BIOL EVOL, V11, P417; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; KAPPEN C, 1993, GENOMICS, V18, P54, DOI 10.1006/geno.1993.1426; KEMPIN SA, 1995, SCIENCE, V267, P522, DOI 10.1126/science.7824951; KUMAR S, 1994, MOL EVOLUTIONARY GEN; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; LI WH, 1985, MOL BIOL EVOL, V2, P150; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; LU ZX, 1993, PLANT MOL BIOL, V23, P901, DOI 10.1007/BF00021545; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MARTIN W, 1989, NATURE, V339, P46, DOI 10.1038/339046a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; PNUELI L, 1991, PLANT J, V1, P255, DOI 10.1111/j.1365-313X.1991.00255.x; PNUELI L, 1994, PLANT CELL, V6, P175, DOI 10.1105/tpc.6.2.175; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; PURUGGANAN MD, 1994, GENETICS, V138, P849; Raff R. A., 1983, EMBRYOS GENES EVOLUT; Richards A. J., 1986, PLANT BREEDING SYSTE; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHMIDT RJ, 1993, PLANT CELL, V5, P729, DOI 10.1105/tpc.5.7.729; SCHWARZSOMMER Z, 1992, EMBO J, V11, P251, DOI 10.1002/j.1460-2075.1992.tb05048.x; SIDOW A, 1992, P NATL ACAD SCI USA, V89, P5098, DOI 10.1073/pnas.89.11.5098; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Stewart WN, 1983, PALEOBOTANY EVOLUTIO; Swofford D.L., 1993, PHYLOGENETIC ANAL US; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; TUCKER PK, 1993, NATURE, V364, P715, DOI 10.1038/364715a0; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	53	331	358	1	20	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	1995	140	1					345	356					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QV521	WOS:A1995QV52100028	7635298				2022-01-24	
J	WILLIAMS, BO; REMINGTON, L; ALBERT, DM; MUKAI, S; BRONSON, RT; JACKS, T				WILLIAMS, BO; REMINGTON, L; ALBERT, DM; MUKAI, S; BRONSON, RT; JACKS, T			COOPERATIVE TUMORIGENIC EFFECTS OF GERMLINE MUTATIONS IN RB AND P53	NATURE GENETICS			English	Article							WILD-TYPE P53; CELL LUNG-CANCER; RETINOBLASTOMA SUSCEPTIBILITY GENE; TUMOR-SUPPRESSOR GENE; LARGE T-ANTIGEN; TRANSGENIC MICE; BREAST-CANCER; CYCLE CONTROL; PINEAL ORGAN; APOPTOSIS	The tumour suppressor genes Rb and p53 are mutated in several types of human cancer, and many tumour types carry mutations in both genes. To study how these genes normally function, we and others have created mouse strains with Rb and p53 mutations. Here we describe the phenotypic effects of combined germline mutations in these two tumour suppressor genes. Mice mutant for both genes have reduced viability and exhibit novel pathology including pinealoblastomas, islet cell tumours, bronchial epithelial hyperplasia and retinal dysplasia. These data indicate that mutations in Rb and p53 can cooperate in the transformation of certain cell types in the mouse.	MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV WISCONSIN,DEPT OPHTHALMOL,MADISON,WI 53792; HARVARD UNIV,SCH MED,MASSACHUSETTS EYE & EAR INFIRM,DEPT OPHTHALMOL,BOSTON,MA 02114; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,DEPT PATHOL,BOSTON,MA 02111				Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301			AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CROOK T, 1991, ONCOGENE, V6, P873; DAVIDOFF AM, 1991, P NATL ACAD SCI USA, V88, P5006, DOI 10.1073/pnas.88.11.5006; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HENSEL CH, 1991, ONCOGENE, V6, P1067; HENSEL CH, 1990, CANCER RES, V50, P3067; HOLLINGSWORTH J, 1993, CURR OPIN CELL BIOL, V5, P194; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAKOBIEC FA, 1977, CANCER-AM CANCER SOC, V39, P2048, DOI 10.1002/1097-0142(197705)39:5<2048::AID-CNCR2820390522>3.0.CO;2-9; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1993, CANCER GENET CYTOGEN, V66, P83, DOI 10.1016/0165-4608(93)90233-C; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; PESIN SR, 1989, AM J OPHTHALMOL, V107, P121, DOI 10.1016/0002-9394(89)90209-2; PROSSER J, 1990, ONCOGENE, V5, P1573; RUGGERI B, 1992, ONCOGENE, V7, P1503; RYGAARD K, 1990, CANCER RES, V50, P5312; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Shew J.-Y., 1989, ONCOGENE RES, V1, P205; STANNARD C, 1985, BRIT J OPHTHALMOL, V69, P749, DOI 10.1136/bjo.69.10.749; STRATTON MR, 1990, ONCOGENE, V5, P1297; TANG A, 1988, SCIENCE, V241, P1797; VANDYKE TA, 1994, SEMIN CANCER BIOL, V5, P47; VARLEY JM, 1989, ONCOGENE, V4, P725; VARLEY JM, 1991, ONCOGENE, V6, P413; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WEINBERG RA, 1992, CANCER SURV, V12, P43; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; WURTMAN RJ, 1977, NEW ENGL J MED, V296, P1383, DOI 10.1056/NEJM197706162962405; WURTMAN RJ, 1977, NEW ENGL J MED, V296, P1329, DOI 10.1056/NEJM197706092962307; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	58	331	335	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					480	484		10.1038/ng0894-480			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	WOS:A1994PA83200013	7951317				2022-01-24	
J	LEGIUS, E; MARCHUK, DA; COLLINS, FS; GLOVER, TW				LEGIUS, E; MARCHUK, DA; COLLINS, FS; GLOVER, TW			SOMATIC DELETION OF THE NEUROFIBROMATOSIS TYPE-1 GENE IN A NEUROFIBROSARCOMA SUPPORTS A TUMOR SUPPRESSOR GENE HYPOTHESIS	NATURE GENETICS			English	Article							VONRECKLINGHAUSEN NEUROFIBROMATOSIS; GENOMIC STRUCTURE; CDNA SEQUENCE; MUTATIONS; PRODUCT; IDENTIFICATION; CLONING; DOMAIN; LOCUS; GAP	Individuals with neurofibromatosis type 1 (NF1) have an increased risk of developing benign and malignant tumours. The NF1 gene is thought to be a tumour suppressor gene, yet no direct proof at the molecular level exists to support this hypothesis. Here we describe a neurofibrosarcoma from a patient with NF1 with loss of heterozygosity for all chromosome 17 polymorphisms tested. On the remaining chromosome 17 homologue, a 200 kilobase (kb) tumour specific deletion of NF1 was demonstrated. This is the first example of a homozygous inactivation of NF1 at the molecular level in a malignant tumour from an NF1 patient and the results strongly support the tumour suppressor gene hypothesis for this disease.	UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109				Legius, Eric/H-1735-2011	Marchuk, Douglas/0000-0002-3110-6671	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS023410] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA43222] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00018] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS23410] Funding Source: Medline		BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; LEE B, 1991, AM J HUM GENET, V48, P511; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEGIUS E, 1992, GENOMICS, V13, P1316, DOI 10.1016/0888-7543(92)90055-W; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARCHUK DA, 1992, GENOMICS, V13, P672, DOI 10.1016/0888-7543(92)90140-N; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARTINGALLARDO A, IN PRESS DNA SEQUENC; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OCONNELL P, 1990, GENOMICS, V7, P547, DOI 10.1016/0888-7543(90)90198-4; Riccardi VM, 1986, NEUROFIBROMATOSIS PH; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; STEPHENS K, 1992, HUM GENET, V88, P279; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	30	331	339	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					122	126		10.1038/ng0293-122			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	WOS:A1993KL01000008	8499945				2022-01-24	
J	BERMINGHAM, E; AVISE, JC				BERMINGHAM, E; AVISE, JC			MOLECULAR ZOOGEOGRAPHY OF FRESH-WATER FISHES IN THE SOUTHEASTERN UNITED-STATES	GENETICS			English	Article									UNIV GEORGIA,DEPT GENET,ATHENS,GA 30602								Avise J.C., 1983, P147; AVISE JC, 1974, EVOLUTION, V28, P42, DOI 10.1111/j.1558-5646.1974.tb00725.x; AVISE JC, 1979, P NATL ACAD SCI USA, V76, P6694, DOI 10.1073/pnas.76.12.6694; AVISE JC, 1984, EVOLUTION, V38, P931, DOI 10.1111/j.1558-5646.1984.tb00364.x; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1984, GENETICS, V108, P237; AVISE JC, 1979, GENETICS, V92, P279; AVISE JC, 1984, J MOL EVOL, V20, P99, DOI 10.1007/BF02257369; AVISE JC, 1986, P STOCK IDENTIFICATI; BAILEY RM, 1938, THESIS U MICHIGAN; BAILEY RM, 1949, P ACAD NAT SCI PHILA, V106, P109; BERMINGHAM E, 1986, THESIS U GEORGIA ATH; BERMINGHAM E, 1986, J HERED; BEVERLEY SM, 1985, P NATL ACAD SCI USA, V82, P4753, DOI 10.1073/pnas.82.14.4753; BROWN GG, 1981, GENETICS, V97, P125; BROWN WM, 1983, EVOLUTION GENES PROT, P60; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1976; CHERNOFF B, 1982, AM ZOOL, V22, P425; CROIZAT L, 1974, SYST ZOOL, V23, P265, DOI 10.2307/2412139; CRONIN TM, 1981, SCIENCE, V211, P233, DOI 10.1126/science.211.4479.233; DAHLBERG M D, 1971, Bulletin of the Georgia Academy of Science, V29, P1; DIXON WJ, 1981, STATISTICAL SOFTWARE; DROUIN J, 1980, J MOL BIOL, V140, P15, DOI 10.1016/0022-2836(80)90354-X; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goin C. J., 1955, GUIDE REPTILES AMPHI; HEYER WR, 1982, AM ZOOL, V22, P397; KESSLER LG, 1984, SYST ZOOL, V33, P370, DOI 10.2307/2413089; LANSMAN RA, 1983, EVOLUTION, V37, P1, DOI 10.1111/j.1558-5646.1983.tb05509.x; LANSMAN RA, 1981, J MOL EVOL, V17, P214, DOI 10.1007/BF01732759; Lee D. S., 1980, ATLAS N AM FRESHWATE; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Philipp D. P., 1982, BIOCH GENETICS LARGE; PHILIPP DP, 1981, CAN J FISH AQUAT SCI, V38, P1715, DOI 10.1139/f81-220; PLATNICK NI, 1978, SYST ZOOL, V27, P1, DOI 10.2307/2412808; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; SAUNDERS NC, 1986, GENETICS, V112, P613; Sibley C.G., 1983, Current Ornithology, V1, P245; SPOLSKY C, 1984, P NATL ACAD SCI-BIOL, V81, P5802, DOI 10.1073/pnas.81.18.5802; Swift CC, 1985, ZOOGEOGRAPHY N AM FR, P213; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VAIL PR, 1979, GEOLOGICAL GEOPHYSIC, P469; WILEY EO, 1985, ANN MO BOT GARD, V72, P596, DOI 10.2307/2399217; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Winker C. D., 1977, T GULF COAST ASS GEO, V27, P409; WINKER CD, 1977, GEOLOGY, V5, P123, DOI 10.1130/0091-7613(1977)5<123:COTDSO>2.0.CO;2; WRIGHT JW, 1983, HERPETOLOGICA, V39, P410; YONEKAWA H, 1981, GENETICS, V98, P801	49	331	349	2	19	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	AUG	1986	113	4					939	965					27	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D5389	WOS:A1986D538900008	17246340				2022-01-24	
J	BAKER, BS; RIDGE, KA				BAKER, BS; RIDGE, KA			SEX AND THE SINGLE CELL .1. ON THE ACTION OF MAJOR LOCI AFFECTING SEX DETERMINATION IN DROSOPHILA-MELANOGASTER	GENETICS			English	Article											BAKER, BS (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.						ALLISON JE, 1965, ANAT REC, V153, P85, DOI 10.1002/ar.1091530110; ASHBURNER A, 1979, DROS INFORM SERV, V54; BAKER BS, 1978, GENETICS, V90, P531; BAKER WK, 1978, ANNU REV GENET, V12, P451, DOI 10.1146/annurev.ge.12.120178.002315; BELL AE, 1954, GENETICS, V39, P958; BRACK C, 1977, P NATL ACAD SCI USA, V74, P5652, DOI 10.1073/pnas.74.12.5652; Bridges CB, 1916, GENETICS, V1, P1; Bridges CB, 1925, AM NAT, V59, P127, DOI 10.1086/280023; Bridges CB, 1922, AM NAT, V56, P51, DOI 10.1086/279847; Bridges CB, 1916, GENETICS, V1, P107; Bridges CB, 1921, SCIENCE, V54, P252, DOI 10.1126/science.54.1394.252; Bridges CB, 1939, SEX INTERNAL SECRETI, P15; BRIDGES CB, 1932, SEX INTERNAL SECRETI, P55; BROWN EH, 1961, GENETICS, V46, P143; BRYANT PJ, 1969, DEV BIOL, V20, P263, DOI 10.1016/0012-1606(69)90015-3; CAPDEVILA MP, 1978, ROUX ARCH DEV BIOL, V185, P105, DOI 10.1007/BF00848672; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; CLINE TW, 1978, GENETICS, V90, P683; CLINE TW, 1976, GENETICS, V84, P723; COLIANNE JJ, 1968, DROS INFORM SERV, V45, P155; DENELL RE, 1972, DROS INFORM SERV, V48, P44; Dobzhansky T, 1941, P NATL ACAD SCI USA, V27, P556, DOI 10.1073/pnas.27.12.556; DUNCAN IW, 1975, GENETICS, V80, P733; FERRUS A, 1975, GENETICS, V79, P589; FUJIHARA T, 1978, J HERED, V69, P229, DOI 10.1093/oxfordjournals.jhered.a108936; FUKUNAGA A, 1975, GENETICS, V81, P135; FUNG STC, 1957, J EXP ZOOL, V134, P515, DOI 10.1002/jez.1401340306; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GARCIABELLIDO A, 1974, MOL GEN GENET, V128, P117, DOI 10.1007/BF02654485; GARCIABELLIDO A, 1971, DEV BIOL, V26, P264, DOI 10.1016/0012-1606(71)90126-6; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GARCIABELLIDO A, 1971, P NATL ACAD SCI USA, V68, P2222, DOI 10.1073/pnas.68.9.2222; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; GARCIABELLIDO A, 1973, DROS INFORM SERV, V50, P99; GEHRING WJ, 1976, ANNU REV GENET, V10, P209, DOI 10.1146/annurev.ge.10.120176.001233; GEHRING WJ, 1976, J EMBRYOL EXP MORPH, V35, P607; GOLUBOVSKY MD, 1972, DROS INF SERV, V49, P117; GOWEN JOHN W., 1957, HEREDITY, V11, P397, DOI 10.1038/hdy.1957.31; HALL JC, 1978, GENETIC MOSAICS CELL, V9, P259; HAMERTON J. L., 1969, Journal of Reproduction and Fertility, P25; HICKS JB, 1976, GENETICS, V83, P245; HILDRETH PE, 1965, GENETICS, V51, P659; HODGKIN JA, 1977, GENETICS, V86, P275; HOLLINGSWORTH MJ, 1964, J MORPHOL, V115, P35, DOI 10.1002/jmor.1051150104; HOLLINGSWORTH MJ, 1960, J EXP ZOOL, V143, P123, DOI 10.1002/jez.1401430202; HUANG SL, 1976, MUTAT RES, V34, P407; KAUFFMAN SA, 1977, AM ZOOL, V17, P631; KAUFFMAN SA, 1978, SCIENCE, V199, P259, DOI 10.1126/science.413193; KAUFMAN TC, 1978, GENETICS, V90, P579; Kel'shtein L. V., 1938, Biol J Moscow, V7, P1145; KIGER JA, 1976, DEV BIOL, V50, P187, DOI 10.1016/0012-1606(76)90077-4; KLASS M, 1976, DEV BIOL, V52, P1, DOI 10.1016/0012-1606(76)90002-6; Kroeger Heinrich, 1959, Wilhelm Roux Arch Entwickl Mech Org, V151, P301, DOI 10.1007/BF00577773; Lebedeff G. A., 1934, American Naturalist, V68, P68; Lebedeff GA, 1939, GENETICS, V24, P553; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIFSCHYTZ E, 1969, GENETICS, V62, P353; LINDSLEY DL, 1972, GENETICS, V71, P157; LINDSLEY DL, 1968, 627 CARN I WASH PUBL; LUCCHESI JC, 1977, AM ZOOL, V17, P685; LYON MF, 1970, NATURE, V227, P372; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; MARSH JL, 1978, NATURE, V272, P249, DOI 10.1038/272249a0; MARSHALL T, 1978, GENET RES, V32, P103, DOI 10.1017/S0016672300018590; MEYER HU, 1951, DROS INFORM SERV, V25, P71; MEYER HU, 1958, DROS INFORM SERV, V32, P83; MISCHAIKOW E, 1959, DROS INFORM SERV, V33, P98; MIYAMOTO C, 1975, GENETICS, V79, P55; MORATA G, 1977, NATURE, V265, P211, DOI 10.1038/265211a0; MORATA G, 1975, J EMBRYOL EXP MORPH, V34, P19; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; MORGAN T, 1943, CARNEGIE I WASH YB, V42, P171; MORRIS JM, 1953, AM J OBSTET GYNECOL, V65, P1192, DOI 10.1016/0002-9378(53)90359-7; MUKHERJEE AS, 1971, GENETICA, V42, P338, DOI 10.1007/BF00123328; Muller HJ, 1950, HARVEY LECT SERIES 4, VXLIII, P165; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; NEWBY WW, 1942, 4228 U TEX PUBL, P113; NOTHIGER R, 1977, ROUX ARCH DEV BIOL, V181, P367, DOI 10.1007/BF00848062; NOVITSKI E, 1951, DROS INFORM SERV, V25, P21; Ohno S., 1979, MAJOR SEX DETERMININ; OUWENEEL WJ, 1976, ADV GENET, V18, P179, DOI 10.1016/S0065-2660(08)60439-3; POULSON DF, 1963, METHODOLOGY BASIC GE, P404; PRINGLE JR, 1978, J CELL PHYSIOL, V95, P393, DOI 10.1002/jcp.1040950318; PURO J, 1964, DROS INFORM SERV, V39, P64; RITOSSA FM, 1966, GENETICS, V54, P663; SAKAGUCHI B, 1963, GENETICS, V48, P841; SANDLER L, 1972, GENETICS, V70, P261; SEIDEL S, 1963, Z VEREBUNGSL, V94, P215, DOI 10.1007/BF00894766; SELDEN JR, 1978, SCIENCE, V201, P644, DOI 10.1126/science.675252; SMITH PD, 1969, GENETICS, V61, P607; SPURWAY H, 1954, J GENET, V52, P208, DOI 10.1007/BF02981500; STEINER E, 1976, ROUX ARCH DEV BIOL, V180, P9, DOI 10.1007/BF00848882; Sturtevant AH, 1920, SCIENCE, V51, P325, DOI 10.1126/science.51.1317.325; Sturtevant AH, 1921, GENETICS, V6, P179; STURTEVANT AH, 1945, GENETICS, V30, P297; STURTEVANT AH, 1929, 399 CARN I WASH PUBL, P25; SZABAD J, 1978, DROS INFORM SERV, V53, P1215; TANAKA A, 1976, GENETICS, V84, P257; TOKUNAGA C, 1962, DEV BIOL, V4, P489, DOI 10.1016/0012-1606(62)90054-4; TONEGAWA S, 1977, P NATL ACAD SCI USA, V74, P3518, DOI 10.1073/pnas.74.8.3518; WACHTEL SS, 1978, CELL, V15, P279, DOI 10.1016/0092-8674(78)90103-4; WATANABE TK, 1975, JPN J GENET, V50, P269, DOI 10.1266/jjg.50.269; ZIEG J, 1977, SCIENCE, V196, P170, DOI 10.1126/science.322276; Zimmering S., 1961, DROS INFORM SERV, V35, P103; [No title captured]	105	331	334	2	16	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1980	94	2					383	423					41	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX235	WOS:A1980JX23500010	6771185				2022-01-24	
J	Kelley, DR; Snoek, J; Rinn, JL				Kelley, David R.; Snoek, Jasper; Rinn, John L.			Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks	GENOME RESEARCH			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; DNA; VARIANTS; REPRESENTATION; ANNOTATION; DISSECTION; ENHANCERS; FRAMEWORK; EPIGENOME	The complex language of eukaryotic gene expression remains incompletely understood. Despite the importance suggested by many noncoding variants statistically associated with human disease, nearly all such variants have unknown mechanisms. Here, we address this challenge using an approach based on a recent machine learning advance deep convolutional neural networks (CNNs). We introduce the open source package Basset to apply CNNs to learn the functional activity of DNA sequences from genomics data. We trained Basset on a compendium of accessible genomic sites mapped in 164 cell types by DNase-seq, and demonstrate greater predictive accuracy than previous methods. Basset predictions for the change in accessibility between variant alleles were far greater for Genome-wide association study (GWAS) SNPs that are likely to be causal relative to nearby SNPs in linkage disequilibrium with them. With Basset, a researcher can perform a single sequencing assay in their cell type of interest and simultaneously learn that cell's chromatin accessibility code and annotate every mutation in the genome with its influence on present accessibility and latent potential for accessibility. Thus, Basset offers a powerful computational approach to annotate and interpret the noncoding genome.	[Kelley, David R.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Snoek, Jasper] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA		Kelley, DR (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dkelley@fas.harvard.edu			National Institute of Environmental Health Sciences (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ES022984-03]; National Institute of Mental Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH102416-03]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K25ES022984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH102416] Funding Source: NIH RePORTER	We thank Abbie Groff, David Hendrickson, Marta Mele, Stephanie Fine Sasse, Chinmay Shukla, and Michael Ziller for feedback on the manuscript. D.R.K. was supported by National Institute of Environmental Health Sciences (NIH) K25 award ES022984-03. J.L.R. was supported by National Institute of Mental Health (NIH) grant R01MH102416-03.	Adams R.P, 2012, ADV NEURAL INFORM PR, V25, DOI DOI 10.5555/2999325.2999464; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; [Anonymous], 2014, ADV NEURAL INFORM PR; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krizhevsky A., 2012, ADV NEURAL INF PROCE ADV NEURAL INFORM PR, V25, P1097, DOI [DOI 10.1145/3065386, 10.1145/3065386]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Nair V, 2010, INT C MACH LEARN; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Pinello L, 2014, P NATL ACAD SCI USA, V111, pE344, DOI 10.1073/pnas.1322570111; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ray S, 2012, P NATL ACAD SCI USA, V109, pE1334, DOI 10.1073/pnas.1118515109; Reid JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-30; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Setty M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004271; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Szegedy C, 2015, ARXIV14094842CSCV; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tieleman T., 2012, NEURAL NETWORKS MACH; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Zhang X, 2015, ADV NEUR IN, V28; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	61	330	333	5	75	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2016	26	7					990	999		10.1101/gr.200535.115			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	DQ1UN	WOS:000378986000012	27197224	hybrid, Green Submitted, Green Published	Y	N	2022-01-24	
J	Loveday, C; Turnbull, C; Ramsay, E; Hughes, D; Ruark, E; Frankum, JR; Bowden, G; Kalmyrzaev, B; Warren-Perry, M; Snape, K; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Brice, G; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Shanley, S; Walker, L; Eccles, D; Evans, DG; Renwick, A; Seal, S; Lord, CJ; Ashworth, A; Reis-Filho, JS; Antoniou, AC; Rahman, N				Loveday, Chey; Turnbull, Clare; Ramsay, Emma; Hughes, Deborah; Ruark, Elise; Frankum, Jessica R.; Bowden, Georgina; Kalmyrzaev, Bolot; Warren-Perry, Margaret; Snape, Katie; Adlard, Julian W.; Barwell, Julian; Berg, Jonathan; Brady, Angela F.; Brewer, Carole; Brice, Glen; Chapman, Cyril; Cook, Jackie; Davidson, Rosemarie; Donaldson, Alan; Douglas, Fiona; Greenhalgh, Lynn; Henderson, Alex; Izatt, Louise; Kumar, Ajith; Lalloo, Fiona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Paterson, Joan; Porteous, Mary; Rogers, Mark T.; Shanley, Susan; Walker, Lisa; Eccles, Diana; Evans, D. Gareth; Renwick, Anthony; Seal, Sheila; Lord, Christopher J.; Ashworth, Alan; Reis-Filho, Jorge S.; Antoniou, Antonis C.; Rahman, Nazneen		Breast Canc Susceptibility	Germline mutations in RAD51D confer susceptibility to ovarian cancer	NATURE GENETICS			English	Article							BREAST-CANCER; FANCONI-ANEMIA; BRCA2 MUTATIONS; HOMOLOGOUS RECOMBINATION; FAMILIAL OVARIAN; SPLICING SIGNALS; GENE; DNA; PREDICTION; SEQUENCE	Recently, RAD51C mutations were identified in families with breast and ovarian cancer(1). This observation prompted us to investigate the role of RAD51D in cancer susceptibility. We identified eight inactivating RAD51D mutations in unrelated individuals from 911 breast-ovarian cancer families compared with one inactivating mutation identified in 1,060 controls (P = 0.01). The association found here was principally with ovarian cancer, with three mutations identified in the 59 pedigrees with three or more individuals with ovarian cancer (P = 0.0005). The relative risk of ovarian cancer for RAD51D mutation carriers was estimated to be 6.30 (95% CI 2.86-13.85, P = 4.8 x 10(-6)). By contrast, we estimated the relative risk of breast cancer to be 1.32 (95% CI 0.59-2.96, P = 0.50). These data indicate that RAD51D mutation testing may have clinical utility in individuals with ovarian cancer and their families. Moreover, we show that cells deficient in RAD51D are sensitive to treatment with a PARP inhibitor, suggesting a possible therapeutic approach for cancers arising in RAD51D mutation carriers.	[Loveday, Chey; Turnbull, Clare; Ramsay, Emma; Hughes, Deborah; Ruark, Elise; Bowden, Georgina; Kalmyrzaev, Bolot; Warren-Perry, Margaret; Snape, Katie; Renwick, Anthony; Seal, Sheila; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Frankum, Jessica R.; Lord, Christopher J.; Ashworth, Alan; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Adlard, Julian W.] Cookridge Hosp, Yorkshire Reg Ctr Canc Treatment, Leeds LS16 6QB, W Yorkshire, England; [Barwell, Julian] Univ Hosp Leicester Natl Hlth Serv NHS Trust, Leicestershire Genet Ctr, Leicester, Leics, England; [Berg, Jonathan] Univ Dundee, Div Med Sci, Dundee, Scotland; [Brady, Angela F.] Kennedy Galton Ctr, NW Thames Reg Genet Serv, London, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Reg Genet Serv, Exeter EX2 5DW, Devon, England; [Brice, Glen] St George Hosp, SW Thames Reg Genet Serv, London, England; [Chapman, Cyril] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Cook, Jackie] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Genet Serv, Sheffield, S Yorkshire, England; [Davidson, Rosemarie] FergusonSmith Ctr Clin Genet, W Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, S Western Reg Genet Serv, Bristol, Avon, England; [Douglas, Fiona] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Greenhalgh, Lynn] Alder Hey Childrens NHS Fdn Trust, Cheshire & Merseyside Clin Genet Serv, Liverpool, Merseyside, England; [Henderson, Alex] Newcastle Upon Tyne Hosp NHS Trust, No Genet Serv Cumbria, Newcastle Upon Tyne, Tyne & Wear, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, SE Thames Reg Genet Serv, London, England; [Kumar, Ajith] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London, England; [Lalloo, Fiona; Evans, D. Gareth] St Marys Hosp, Univ Dept Med Genet, Manchester M13 0JH, Lancs, England; [Lalloo, Fiona; Evans, D. Gareth] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Miedzybrodzka, Zosia] Univ Aberdeen, Aberdeen, Scotland; [Miedzybrodzka, Zosia] Aberdeen Royal Infirm, N Scotland Clin Genet Serv, Aberdeen, Scotland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; [Morrison, Patrick J.] Belfast Hlth & Social Care HSC Trust, No Ireland Reg Genet Serv, Belfast, Antrim, North Ireland; [Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, E Anglian Reg Genet Serv, Cambridge, England; [Porteous, Mary] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Rogers, Mark T.] Univ Wales Hosp, All Wales Med Genet Serv, Cardiff CF4 4XW, S Glam, Wales; [Shanley, Susan] Royal Marsden NHS Fdn Trust, London, England; [Walker, Lisa] Oxford Radcliffe Hosp NHS Trust, Oxford Reg Genet Serv, Oxford, England; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp NHS Trust, Southampton SO9 5NH, Hants, England; [Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England		Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	nazneen.rahman@icr.ac.uk	Eccles, Diana/K-6327-2019; Turnbull, Clare/AAA-6596-2019; Lord, Christopher J/B-3295-2012; Snape, Katie/AAA-8101-2022; Rahman, Nazneen/B-8890-2012; Lord, Christopher/AAX-7130-2021; Lucassen, Anneke/D-7764-2017; Rahman, Nazneen/D-2802-2013	Eccles, Diana/0000-0002-9935-3169; Lord, Christopher J/0000-0002-3226-0515; Eeles, Rosalind/0000-0002-3698-6241; Turnbull, Clare/0000-0002-1734-5772; Lucassen, Anneke/0000-0003-3324-4338; Campbell, James/0000-0001-6756-8766; Rahman, Nazneen/0000-0003-4376-0440; Evans, Gareth/0000-0002-8482-5784; Jacobs, Chris/0000-0002-9557-9080; Adlard, Julian/0000-0002-1693-0435	Cancer Research UKCancer Research UK [C8620/A8372, C8620/A8857, C12292/A11174]; US Military Acquisition (ACQ) Activity; Era of Hope Award [W81XWH-05-1-0204]; Breakthrough Breast Cancer; Institute of Cancer Research (UK)Cancer Research UK; NHS; Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934]; Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700491, G0000934] Funding Source: UKRI; Cancer Research UKCancer Research UK [11174] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700491, G0000934] Funding Source: researchfish	We thank all the subjects and families that participated in the research. We thank A. Hall, D. Dudakia, J. Bull, R. Linger and A. Zachariou for their assistance in recruitment, B. Ebbs for assistance in DNA extraction and running the ABI sequencers, L. Thompson for the provision of cell lines and A. Strydom for assistance in preparing the manuscript. We are very grateful to all the clinicians and counselors in the Breast Cancer Susceptibility Collaboration UK (BCSC) that have contributed to the recruitment and collection of the Familial Breast Cancer Study (FBCS) samples. The full list of BCSC contributors is provided in the Supplementary Note. This work was funded by Cancer Research UK (C8620/A8372 and C8620/A8857), US Military Acquisition (ACQ) Activity, Era of Hope Award (W81XWH-05-1-0204), Breakthrough Breast Cancer and the Institute of Cancer Research (UK). We acknowledge NHS funding to the Royal Marsden/Institute of Cancer Research National Institute for Health Research NIHR) Specialist Cancer Biomedical Research Centre. C. T. is a Medical Research Council (MRC)-funded Clinical Research Fellow. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow (C12292/A11174). We acknowledge the use of DNA from the British 1958 Birth Cohort collection funded by the MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; EASTON DF, 1993, AM J HUM GENET, V52, P678; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; International Atomic Energy Agency, 2002, ISO 11904 1, P1; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	35	330	336	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					879	U90		10.1038/ng.893			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	WOS:000294325800015	21822267	Green Accepted			2022-01-24	
J	Crossman, LC; Gould, VC; Dow, JM; Vernikos, GS; Okazaki, A; Sebaihia, M; Saunders, D; Arrowsmith, C; Carver, T; Peters, N; Adlem, E; Kerhornou, A; Lord, A; Murphy, L; Seeger, K; Squares, R; Rutter, S; Quail, MA; Rajandream, MA; Harris, D; Churcher, C; Bentley, SD; Parkhill, J; Thomson, NR; Avison, MB				Crossman, Lisa C.; Gould, Virginia C.; Dow, J. Maxwell; Vernikos, Georgios S.; Okazaki, Aki; Sebaihia, Mohammed; Saunders, David; Arrowsmith, Claire; Carver, Tim; Peters, Nicholas; Adlem, Ellen; Kerhornou, Arnaud; Lord, Angela; Murphy, Lee; Seeger, Katharine; Squares, Robert; Rutter, Simon; Quail, Michael A.; Rajandream, Mari-Adele; Harris, David; Churcher, Carol; Bentley, Stephen D.; Parkhill, Julian; Thomson, Nicholas R.; Avison, Matthew B.			The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants	GENOME BIOLOGY			English	Article							MULTIDRUG EFFLUX PUMP; DEFINED PHYLOGENETIC-RELATIONSHIPS; GRAM-NEGATIVE BACILLI; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; XANTHOMONAS-CAMPESTRIS; NOSOCOMIAL PATHOGEN; AMINOGLYCOSIDE RESISTANCE; BURKHOLDERIA-CENOCEPACIA; ANTIMICROBIAL RESISTANCE	Background: Stenotrophomonas maltophilia is a nosocomial opportunistic pathogen of the Xanthomonadaceae. The organism has been isolated from both clinical and soil environments in addition to the sputum of cystic fibrosis patients and the immunocompromised. Whilst relatively distant phylogenetically, the closest sequenced relatives of S. maltophilia are the plant pathogenic xanthomonads. Results: The genome of the bacteremia-associated isolate S. maltophilia K279a is 4,851,126 bp and of high G+C content. The sequence reveals an organism with a remarkable capacity for drug and heavy metal resistance. In addition to a number of genes conferring resistance to antimicrobial drugs of different classes via alternative mechanisms, nine resistance-nodulation-division (RND)-type putative antimicrobial efflux systems are present. Functional genomic analysis confirms a role in drug resistance for several of the novel RND efflux pumps. S. maltophilia possesses potentially mobile regions of DNA and encodes a number of pili and fimbriae likely to be involved in adhesion and biofilm formation that may also contribute to increased antimicrobial drug resistance. Conclusion: The panoply of antimicrobial drug resistance genes and mobile genetic elements found suggests that the organism can act as a reservoir of antimicrobial drug resistance determinants in a clinical environment, which is an issue of considerable concern.	[Crossman, Lisa C.; Vernikos, Georgios S.; Sebaihia, Mohammed; Saunders, David; Arrowsmith, Claire; Carver, Tim; Peters, Nicholas; Adlem, Ellen; Kerhornou, Arnaud; Lord, Angela; Murphy, Lee; Seeger, Katharine; Squares, Robert; Rutter, Simon; Quail, Michael A.; Rajandream, Mari-Adele; Harris, David; Churcher, Carol; Bentley, Stephen D.; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Cambridge CB10 1SA, England; [Gould, Virginia C.; Okazaki, Aki; Avison, Matthew B.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Dow, J. Maxwell] Natl Univ Ireland, Biosci Inst, Dept Microbiol, Biomerit Res Ctr, Cork, Ireland		Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk; matthewb.avison@bristol.ac.uk	Parkhill, Julian/G-4703-2011; Sebaihia, Mohammed/AAF-6589-2019; Quail, michael/ABE-6131-2020; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Sebaihia, Mohammed/0000-0002-3324-3346; Kerhornou, Arnaud/0000-0002-2890-295X; Avison, Matthew/0000-0003-1454-8440; Dow, Max/0000-0001-8245-2294; Gould, Ginny/0000-0002-4107-3893; Crossman, Lisa/0000-0003-2390-4750; Murphy, Lee/0000-0001-6467-7449; Thomson, Nicholas/0000-0002-4432-8505; Schofield, Ellen/0000-0003-0648-1418	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P1778, DOI 10.1128/AAC.44.7.1778-1782.2000; Avison MB, 2000, J ANTIMICROB CHEMOTH, V46, P879, DOI 10.1093/jac/46.6.879; Avison MB, 2001, ANTIMICROB AGENTS CH, V45, P413, DOI 10.1128/AAC.45.2.413-419.2001; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Bjarnsholt T, 2007, ANAL BIOANAL CHEM, V387, P409, DOI 10.1007/s00216-006-0774-x; *BSAC, SUSC TEST; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; Colombi D, 2006, CURR MICROBIOL, V53, P462, DOI 10.1007/s00284-005-0388-0; Carvalho APD, 2007, APMIS, V115, P311, DOI 10.1111/j.1600-0463.2007.apm_603.x; da Silva FR, 2001, FEMS MICROBIOL LETT, V203, P165, DOI 10.1111/j.1574-6968.2001.tb10836.x; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; de Oliveira-Garcia D, 2002, EMERG INFECT DIS, V8, P918, DOI 10.3201/eid0809.010535; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Ferluga S, 2007, MOL PLANT PATHOL, V8, P529, DOI 10.1111/J.1364-3703.2007.00415.X; Fernandes P, 2006, NAT BIOTECHNOL, V24, P1497, DOI 10.1038/nbt1206-1497; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Goss CH, 2004, THORAX, V59, P955, DOI 10.1136/thx.2003.017707; Gould VC, 2006, J ANTIMICROB CHEMOTH, V57, P199, DOI 10.1093/jac/dki453; Gould VC, 2004, J ANTIMICROB CHEMOTH, V54, P348, DOI 10.1093/jac/dkh367; Gould VC, 2006, J ANTIMICROB CHEMOTH, V57, P1070, DOI 10.1093/jac/dkl106; Hadjiliadis D, 2007, J HEART LUNG TRANSPL, V26, P834, DOI 10.1016/j.healun.2007.05.018; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kataoka D, 2003, INT J ANTIMICROB AG, V22, P601, DOI 10.1016/S0924-8579(03)00244-9; Kholodii G, 2000, RES MICROBIOL, V151, P291, DOI 10.1016/S0923-2508(00)00149-2; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Lockhart SR, 2007, J CLIN MICROBIOL, V45, P3352, DOI 10.1128/JCM.01284-07; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Minkwitz A, 2001, J CLIN MICROBIOL, V39, P139, DOI 10.1128/JCM.39.1.139-145.2001; Nicodemo AC, 2007, EUR J CLIN MICROBIOL, V26, P229, DOI 10.1007/s10096-007-0279-3; Okazaki A, 2007, ANTIMICROB AGENTS CH, V51, P359, DOI 10.1128/AAC.00795-06; Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07; Paterson DL, 2007, CRIT CARE MED, V35, P1789, DOI 10.1097/01.CCM.0000269352.39174.A4; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Ribbeck-Busch K, 2005, ENVIRON MICROBIOL, V7, P1853, DOI 10.1111/j.1462-2920.2005.00928.x; Ronald P C, 1988, Mol Plant Microbe Interact, V1, P191, DOI 10.1094/MPMI-1-191; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P791, DOI 10.1128/AAC.49.2.791-793.2005; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sader HS, 2005, INT J ANTIMICROB AG, V25, P95, DOI 10.1016/j.ijantimicag.2004.10.002; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Sanchez P, 2004, ANTIMICROB AGENTS CH, V48, P2274, DOI 10.1128/AAC.48.6.2274-2276.2004; Scarpari LM, 2003, FEMS MICROBIOL LETT, V222, P83, DOI 10.1016/S0378-1097(03)00251-9; Senol E, 2004, J HOSP INFECT, V57, P1, DOI 10.1016/j.jhin.2004.01.033; Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Torres JA, 2007, EXPERT REV ANTI-INFE, V5, P833, DOI 10.1586/14787210.5.5.833; Travassos LH, 2004, J APPL MICROBIOL, V96, P1143, DOI 10.1111/j.1365-2672.2004.02248.x; Urban TA, 2005, INFECT IMMUN, V73, P5426, DOI 10.1128/IAI.73.9.5426-5437.2005; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Windhorst S, 2002, J BIOL CHEM, V277, P11042, DOI 10.1074/jbc.M109525200; WOODARD LM, 1990, APPL ENVIRON MICROB, V56, P3766, DOI 10.1128/AEM.56.12.3766-3771.1990; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zhang LL, 2007, MOL MICROBIOL, V65, P121, DOI 10.1111/j.1365-2958.2007.05775.x	67	330	657	1	50	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2008	9	4							R74	10.1186/gb-2008-9-4-r74			13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	311BK	WOS:000256574800018	18419807	hybrid, Green Published, Green Accepted			2022-01-24	
J	Easton, DF; Deffenbaugh, AM; Pruss, D; Frye, C; Wenstrup, RJ; Allen-Brady, K; Tavtigian, SV; Monteiro, ANA; Iversen, ES; Couch, FJ; Goldgar, DE				Easton, Douglas F.; Deffenbaugh, Amie M.; Pruss, Dmitry; Frye, Cynthia; Wenstrup, Richard J.; Allen-Brady, Kristina; Tavtigian, Sean V.; Monteiro, Alvaro N. A.; Iversen, Edwin S.; Couch, Fergus J.; Goldgar, David E.			A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE VARIANTS; TRANSCRIPTIONAL ACTIVATION; EMBRYONIC LETHALITY; FAMILIAL BREAST; RISK ASSESSMENT; MUTATIONS; CLASSIFICATION; ALLELE	Mutation screening of the breast and ovarian cancer - predisposition genes BRCA1 and BRCA2 is becoming an increasingly important part of clinical practice. Classification of rare nontruncating sequence variants in these genes is problematic, because it is not known whether these subtle changes alter function sufficiently to predispose cells to cancer development. Using data from the Myriad Genetic Laboratories database of nearly 70,000 full-sequence tests, we assessed the clinical significance of 1,433 sequence variants of unknown significance ( VUSs) in the BRCA genes. Three independent measures were employed in the assessment: co-occurrence in trans of a VUS with known deleterious mutations; detailed analysis, by logistic regression, of personal and family history of cancer in VUS-carrying probands; and, in a subset of probands, an analysis of cosegregation with disease in pedigrees. For each of these factors, a likelihood ratio was computed under the hypothesis that the VUSs were equivalent to an "average" deleterious mutation, compared with neutral, with respect to risk. The likelihood ratios derived from each component were combined to provide an overall assessment for each VUS. A total of 133 VUSs had odds of at least 100: 1 in favor of neutrality with respect to risk, whereas 43 had odds of at least 20: 1 in favor of being deleterious. VUSs with evidence in favor of causality were those that were predicted to affect splicing, fell at positions that are highly conserved among BRCA orthologs, and were more likely to be located in specific domains of the proteins. In addition to their utility for improved genetics counseling of patients and their families, the global assessment reported here will be invaluable for validation of functional assays, structural models, and in silico analyses.	Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84132 USA; Univ Cambridge, Strangeways Res Labs, Genet Epidemiol Unit, Cambridge, England; Univ Utah, Sch Med, Myriad Genet Labs, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84132 USA; Int Agcy Res Canc, Genet Canc Suscepitibil Grp, F-69372 Lyon, France; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27706 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA		Goldgar, DE (corresponding author), Univ Utah, Sch Med, Dept Dermatol, 30 N 1900 E,SOM 4B454, Salt Lake City, UT 84132 USA.	david.goldgar@hsc.utah.edu	Monteiro, Alvaro N. A./A-7566-2009	Monteiro, Alvaro N. A./0000-0002-8448-4801	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA092309, P50CA116201] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50 CA116201, CA92309, R01 CA092309] Funding Source: Medline		Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Billack B, 2004, CANCER BIOL THER, V3, P458, DOI 10.4161/cbt.3.5.831; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; COLLINS N, 1995, ONCOGENE, V10, P1673; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hohenstein P, 2001, ONCOGENE, V20, P2544, DOI 10.1038/sj.onc.1204363; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Judkins T, 2005, CANCER RES, V65, P10096, DOI 10.1158/0008-5472.CAN-05-1241; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lovelock PK, 2006, J MED GENET, V43, P74, DOI 10.1136/jmg.2005.033258; Lucci-Cordisco Emanuela, 2006, Cancer Biomarkers, V2, P11; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 2006, CANCER RES, V66, P1897, DOI 10.1158/0008-5472.CAN-05-3034; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Osorio A, 2007, HUM MUTAT, V28, P477, DOI 10.1002/humu.20470; Ostrow KL, 2004, CANCER GENET CYTOGEN, V153, P177, DOI 10.1016/j.cancergencyto.2004.01.020; Petersen GM, 1998, AM J HUM GENET, V62, P1516, DOI 10.1086/301871; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; TAVTIGIAN SV, 2004, FAM CANCER, V5, P77; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Wu KJ, 2005, CANCER RES, V65, P417; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Zhou X, 2005, J AM STAT ASSOC, V100, P51, DOI 10.1198/016214504000001817	37	330	333	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					873	883		10.1086/521032			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	WOS:000250480900001	17924331	Green Published, Bronze			2022-01-24	
J	Zhang, Y; Liu, JS				Zhang, Yu; Liu, Jun S.			Bayesian inference of epistatic interactions in case-control studies	NATURE GENETICS			English	Article							ASSOCIATION; STRATEGIES	Epistatic interactions among multiple genetic variants in the human genome may be important in determining individual susceptibility to common diseases. Although some existing computational methods for identifying genetic interactions have been effective for small- scale studies, we here propose a method, denoted ' bayesian epistasis association mapping' ( BEAM), for genome- wide case- control studies. BEAM treats the disease- associated markers and their interactions via a bayesian partitioning model and computes, via Markov chain Monte Carlo, the posterior probability that each marker set is associated with the disease. Testing this on an age- related macular degeneration genome- wide association data set, we demonstrate that the method is significantly more powerful than existing approaches and that genome- wide case- control epistasis mapping with many thousands of markers is both computationally and statistically feasible.	Harvard Univ, Dept Stat, Sci Ctr 715, Cambridge, MA 02138 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA		Liu, JS (corresponding author), Harvard Univ, Dept Stat, Sci Ctr 715, 1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002518] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002518-06] Funding Source: Medline		Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Liu, 2001, MONTE CARLO STRATEGI; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Zee R. Y. L., 2002, Pharmacogenomics Journal, V2, P197, DOI 10.1038/sj.tpj.6500101; Zheng T, 2006, HUM HERED, V62, P196, DOI 10.1159/000096995; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	19	330	346	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1167	1173		10.1038/ng2110			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	WOS:000249122400030	17721534				2022-01-24	
J	Ori, N; Cohen, AR; Etzioni, A; Brand, A; Yanai, O; Shleizer, S; Menda, N; Amsellem, Z; Efroni, I; Pekker, I; Alvarez, JP; Blum, E; Zamir, D; Eshed, Y				Ori, Naomi; Cohen, Aya Refael; Etzioni, Adi; Brand, Arnon; Yanai, Osnat; Shleizer, Sharona; Menda, Naama; Amsellem, Ziva; Efroni, Idan; Pekker, Irena; Alvarez, John Paul; Blum, Eyal; Zamir, Dani; Eshed, Yuval			Regulation of LANCEOLATE by miR319 is required for compound-leaf development in tomato	NATURE GENETICS			English	Article							MICRORNAS; GROWTH; MUTANT; LOCUS; GENE; MORPHOGENESIS; SHAPE; FORM	Plant leaves show pronounced plasticity of size and form. In the classical, partially dominant mutation Lanceolate ( La) 1, the large compound leaves of tomato (Solanum lycopersicum) are converted into small simple ones. We show that LA encodes a transcription factor from the TCP family(2,3) containing an miR319-binding site(4). Five independent La isolates are gain-offunction alleles that result from point mutations within the miR319-binding site and confer partial resistance of the La transcripts to microRNA (miRNA)-directed inhibition. The reduced sensitivity to miRNA regulation leads to elevated LA expression in very young La leaf primordia and to precocious differentiation of leaf margins. In contrast, downregulation of several LA-like genes using ectopic expression of miR319 resulted in larger leaflets and continuous growth of leaf margins. Our results imply that regulation of LA by miR319 defines a flexible window of morphogenetic competence along the developing leaf margin that is required for leaf elaboration.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Fac Agr, Otto Warburg Minerva Ctr Agr Biotechnol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel		Ori, N (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	ori@agri.huji.ac.il; yuval.eshed@weizmann.ac.il	Menda, Naama/G-2915-2012	Eshed, Yuval/0000-0001-8290-0018; Efroni, Idan/0000-0002-0219-8685			Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOYNTON JE, 1965, TOMATO GENET COOP RE, V15, P24; CARUSO JL, 1968, AM J BOT, V55, P1169, DOI 10.2307/2440737; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; DENGLER NG, 1984, BOT GAZ, V145, P66, DOI 10.1086/337428; Dengler NG, 2001, INT J PLANT SCI, V162, P459, DOI 10.1086/320145; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Holtan HEE, 2003, GENETICS, V165, P1541; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; LIFSCHYTZ E, 1969, GENETICS, V62, P353; MATHAN DS, 1960, SCIENCE, V131, P36, DOI 10.1126/science.131.3392.36; MATHAN DS, 1962, AM J BOT, V49, P504, DOI 10.2307/2439421; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Stadler LJ, 1930, J HERED, V21, P3, DOI 10.1093/oxfordjournals.jhered.a103249; STETTLER RF, 1964, AM J BOT, V51, P253, DOI 10.2307/2440294; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x	30	330	365	6	107	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					787	791		10.1038/ng2036			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	WOS:000246859100024	17486095				2022-01-24	
J	Moreira, MC; Klur, S; Watanabe, M; Nemeth, AH; Le Ber, I; Moniz, JC; Tranchant, C; Aubourg, P; Tazir, M; Schols, L; Pandolfo, M; Schulz, JB; Pouget, J; Calvas, P; Shizuka-Ikeda, M; Shoji, M; Tanaka, M; Izatt, L; Shaw, CE; M'Zahem, A; Dunne, E; Bomont, P; Benhassine, T; Bouslam, N; Stevanin, G; Brice, A; Guimaraes, J; Mendonca, P; Barbot, C; Coutinho, P; Sequeiros, J; Durr, A; Warter, JM; Koenig, M				Moreira, MC; Klur, S; Watanabe, M; Nemeth, AH; Le Ber, I; Moniz, JC; Tranchant, C; Aubourg, P; Tazir, M; Schols, L; Pandolfo, M; Schulz, JB; Pouget, J; Calvas, P; Shizuka-Ikeda, M; Shoji, M; Tanaka, M; Izatt, L; Shaw, CE; M'Zahem, A; Dunne, E; Bomont, P; Benhassine, T; Bouslam, N; Stevanin, G; Brice, A; Guimaraes, J; Mendonca, P; Barbot, C; Coutinho, P; Sequeiros, J; Durr, A; Warter, JM; Koenig, M			Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; PERIPHERAL NEUROPATHY; CEREBELLAR ATROPHY; GENE; DNA; ENCODES; SEN1	Ataxia-ocular apraxia 2 (AOA2) was recently identified as a new autosomal recessive ataxia. We have now identified causative mutations in 15 families, which allows us to clinically define this entity by onset between 10 and 22 years, cerebellar atrophy, axonal sensorimotor neuropathy, oculomotor apraxia and elevated alpha-fetoprotein (AFP). Ten of the fifteen mutations cause premature termination of a large DEAxQ-box helicase, the human ortholog of yeast Sen1p, involved in RNA maturation and termination.	ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; Gunma Univ, Sch Med, Maebashi, Gumma 3718511, Japan; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Hop La Pitie Salpetriere, APHP, INSERM, U289, F-75651 Paris, France; Hop La Pitie Salpetriere, APHP, Dept Genet Cytogenet & Embryol, F-75651 Paris, France; Hosp Sto Antonio dos Capuchos, Lisbon, Portugal; Hop Univ Strasbourg, F-67091 Strasbourg, France; Hop St Vincent de Paul, INSERM, U342, F-75675 Paris, France; Ctr Hosp Univ Algier, Algiers, Algeria; Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium; Univ Tubingen, Ctr Neurol, Dept Gen Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; Hop Timone Adults, F-13385 Marseille, France; Hop Purpan, F-31059 Toulouse, France; Guys Hosp, Dept Clin Genet, London SE1 9RT, England; Univ London Kings Coll, Inst Psychiat, London SE5 8AF, England; Guys Kings & St Thomas Sch Med, London SE5 8AF, England; Ctr Hosp Univ Ben Badis, Constantine, Algeria; Inst Pasteur Alger, Algiers, Algeria; Hosp Egas Moniz, Lisbon, Portugal; Hosp Divino Espirito Santo, Dept Hematol, Azores, Portugal; Univ Porto, UnIGENe, IBMC, ICBAS, P-4150180 Oporto, Portugal; Hosp Maria Pia, Dept Neuropediat, P-4050 Oporto, Portugal; Hosp Sao Sebastiao, Dept Neurol, P-4520 Sta Maria Da Feira, Portugal		Koenig, M (corresponding author), ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	mkoenig@igbmc.u-strasbg.fr	Coutinho, Paula/K-6053-2013; Stevanin, Giovanni/E-5038-2016; Pandolfo, Massimo/B-2853-2010; Schulz, Jorg B/D-9786-2012; Bomont, Pascale L/Y-5517-2018; Schols, Ludger/ABB-2482-2021; Barbot, Clara/K-6378-2013; Dunne, Eimear/C-6785-2012; brice, alexis/AAE-8275-2019; Lima, Marta T/C-7042-2009; Brice, Alexis/A-2170-2009	Stevanin, Giovanni/0000-0001-9368-8657; Schulz, Jorg B/0000-0002-8903-0593; Bomont, Pascale L/0000-0001-7216-3261; Schols, Ludger/0000-0001-7774-5025; Barbot, Clara/0000-0002-5597-107X; Dunne, Eimear/0000-0001-9862-1398; brice, alexis/0000-0002-0941-3990; Sequeiros, Jorge/0000-0002-9846-1037; Coutinho, Paula/0000-0002-3461-230X; Nemeth, Andrea/0000-0002-2941-7657; Shoji, Mikio/0000-0003-1027-1712			Bomont P, 2000, EUR J HUM GENET, V8, P986, DOI 10.1038/sj.ejhg.5200586; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Nemeth AH, 2000, AM J HUM GENET, V67, P1320, DOI 10.1016/S0002-9297(07)62962-0; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Watanabe M, 1998, ANN NEUROL, V44, P265, DOI 10.1002/ana.410440220	15	330	339	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					225	227		10.1038/ng1303			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	WOS:000189250400008	14770181	Green Published, Bronze			2022-01-24	
J	Segurado, R; Detera-Wadleigh, SD; Levinson, DF; Lewis, CM; Gill, M; Nurnberg, JI; Craddock, N; DePaulo, JR; Baron, M; Gershon, ES; Ekholm, J; Cichon, S; Turecki, G; Claes, S; Kelsoe, JR; Schofield, PR; Badenhop, RF; Morissette, J; Coon, H; Blackwood, D; McInnes, LA; Foroud, T; Edenberg, HJ; Reich, T; Rice, JP; Goate, A; McInnis, MG; McMahon, FJ; Badner, JA; Goldin, LR; Bennett, P; Willour, VL; Zandi, PP; Liu, JJ; Gilliam, C; Juo, SH; Berrettini, WH; Yoshikawa, T; Peltonen, L; Lonnqvist, J; Nothen, MM; Schumacher, J; Windemuth, C; Rietschel, M; Propping, P; Maier, W; Alda, M; Grof, P; Rouleau, GA; Del-Favero, J; Van Broeckhoven, C; Mendlewicz, J; Adolfsson, R; Spence, MA; Luebbert, H; Adams, LJ; Donald, JA; Mitchell, PB; Barden, N; Shink, E; Byerley, W; Muir, W; Visscher, PM; Macgregor, S; Gurling, H; Kalsi, G; McQuillin, A; Escamilla, MA; Reus, VI; Leon, P; Freimer, NB; Ewald, H; Kruse, TA; Mors, O; Radhakrishna, U; Blouin, JL; Antonarakis, SE; Akarsu, N				Segurado, R; Detera-Wadleigh, SD; Levinson, DF; Lewis, CM; Gill, M; Nurnberg, JI; Craddock, N; DePaulo, JR; Baron, M; Gershon, ES; Ekholm, J; Cichon, S; Turecki, G; Claes, S; Kelsoe, JR; Schofield, PR; Badenhop, RF; Morissette, J; Coon, H; Blackwood, D; McInnes, LA; Foroud, T; Edenberg, HJ; Reich, T; Rice, JP; Goate, A; McInnis, MG; McMahon, FJ; Badner, JA; Goldin, LR; Bennett, P; Willour, VL; Zandi, PP; Liu, JJ; Gilliam, C; Juo, SH; Berrettini, WH; Yoshikawa, T; Peltonen, L; Lonnqvist, J; Nothen, MM; Schumacher, J; Windemuth, C; Rietschel, M; Propping, P; Maier, W; Alda, M; Grof, P; Rouleau, GA; Del-Favero, J; Van Broeckhoven, C; Mendlewicz, J; Adolfsson, R; Spence, MA; Luebbert, H; Adams, LJ; Donald, JA; Mitchell, PB; Barden, N; Shink, E; Byerley, W; Muir, W; Visscher, PM; Macgregor, S; Gurling, H; Kalsi, G; McQuillin, A; Escamilla, MA; Reus, VI; Leon, P; Freimer, NB; Ewald, H; Kruse, TA; Mors, O; Radhakrishna, U; Blouin, JL; Antonarakis, SE; Akarsu, N			Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLD-ORDER AMISH; SUSCEPTIBILITY LOCUS; GENETIC-LINKAGE; WIDE SEARCH; CHROMOSOME 12Q23-Q24; CONTROLLED FAMILY; MANIC-DEPRESSION; COMPLEX TRAITS; POTENTIAL LOCI; DNA MARKERS	Genome scans of bipolar disorder (BPD) have not produced consistent evidence for linkage. The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD genome scan data sets in an effort to identify regions with significant support for linkage in the combined data. The two primary analyses considered available linkage data for "very narrow" (i.e., BP-I and schizoaffective disorder - BP) and "narrow" (i.e., adding BP-II disorder) disease models, with the ranks weighted for sample size. A "broad" model (i.e., adding recurrent major depression) and unweighted analyses were also performed. No region achieved genomewide statistical significance by several simulation-based criteria. The most significant P values (<.01) were observed on chromosomes 9p22.3-21.1 ( very narrow), 10q11.21-22.1 ( very narrow), and 14q24.1-32.12 ( narrow). Nominally significant P values were observed in adjacent bins on chromosomes 9p and 18p-q, across all three disease models on chromosomes 14q and 18p-q, and across two models on chromosome 8q. Relatively few BPD pedigrees have been studied under narrow disease models relative to the schizophrenia GSMA data set, which produced more significant results. There was no overlap of the highest-ranked regions for the two disorders. The present results for the very narrow model are promising but suggest that more and larger data sets are needed. Alternatively, linkage might be detected in certain populations or subsets of pedigrees. The narrow and broad data sets had considerable power, according to simulation studies, but did not produce more highly significant evidence for linkage. We note that meta-analysis can sometimes provide support for linkage but cannot disprove linkage in any candidate region.	Univ Dublin Trinity Coll, Dept Genet, Neuropsychiat Genet Unit, Dublin 2, Ireland; St James Hosp, Dept Psychiat, Trinity Ctr Hlth Sci, Dublin 8, Ireland; NIMH, Mood & Anxiety Disorders Program, NIH, Bethesda, MD 20892 USA; NCI, Genet Epidemiol Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; UCL, Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci,Mol Psychiat Lab, Windeyer Inst Med Sci, London WC1E 6BT, England; UCL, Guys Kings & St Thomas Sch Med, Div Genet & Dev, London WC1E 6BT, England; Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; Univ Birmingham, Queen Elizabeth Psychiat Hosp, Div Neurosci, Mol Psychait Grp, Birmingham, W Midlands, England; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Columbia Univ, New York State Psychiat Inst, Dept Med Genet, Div Psychiat Genet, New York, NY USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth, Helsinki, Finland; Flanders Interuniv Inst Biotechnol, Dept Mol Genet, Antwerp, Belgium; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Psychiat, B-2020 Antwerp, Belgium; McGill Univ, Montreal Gen Hosp, Res Inst, Dept Psychiat, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal Gen Hosp, Res Inst, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; Univ Calif San Diego, Dept Psychiat, Lab Psychiat Genom, La Jolla, CA 92093 USA; Univ New S Wales, Garvan Inst Med Res, Sydney, NSW, Australia; Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia; Prince Wales Hosp, Mood Disorders Unit, Sydney, NSW, Australia; Univ Laval, Quebec City, PQ, Canada; Ctr Hosp Univ Laval, Res Ctr, Ctr Neurosci, Quebec City, PQ, Canada; Univ Utah, Salt Lake City, UT USA; Univ Edinburgh, Edinburgh, Midlothian, Scotland; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; RIKEN, Inst Phys & Chem Res, Lab Mol Psychiat, Brain Sci Inst, Saitama, Japan; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; Univ Brussels, Erasme Hosp, Dept Psychiat, Brussels, Belgium; Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; Biofrontera Pharmaceut, Leverkusen, Germany; Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Costa Rica, Escuela Med, San Jose, Costa Rica; Univ Costa Rica, Ctr Biol Mol & Celular, San Jose, Costa Rica; Aarhus Univ Hosp, Inst Basic Psychiat Res, Risskov, Denmark; Odense Univ Hosp, Dept Clin Biochem & Genet, DK-5000 Odense, Denmark; Univ Geneva, Sch Med, Dept Med Genet, CH-1211 Geneva, Switzerland; Univ Hosp, Geneva, Switzerland; Univ Hacettepe, Dept Pediat, TR-06100 Ankara, Turkey		Segurado, R (corresponding author), Univ Dublin Trinity Coll, Dept Genet, Neuropsychiat Genet Unit, Dublin 2, Ireland.	seguradr@tcd.ie	Akarsu, Nurten/E-9758-2013; Van Broeckhoven, Christine/G-8362-2017; McInnis, Melvin G/F-6963-2012; Gurling, Hugh M/A-5029-2010; Yoshikawa, Takeo/F-9599-2019; McMahon, Francis J/A-7290-2009; Liu, Jianjun/AAK-4989-2020; reus, victor i/I-7923-2015; Nothen, Markus/B-2027-2009; Lewis, Cathryn/M-8766-2019; Schumacher, Johannes/F-4970-2015; Lewis, Cathryn M/A-5225-2010; Visscher, Peter/ABB-6151-2020; Cichon, Sven/H-8803-2013; Turecki, Gustavo/K-5100-2015; Alda, Martin/F-5812-2010; Cichon, Sven/B-9618-2014; Antonarakis, Stylianos E/N-8866-2014; McQuillin, Andrew/C-1623-2008; Macgregor, Stuart/C-6442-2009; Van Broeckhoven, Christine/M-7853-2019; Juo, Suh-Hang/C-9545-2009; Juo, Suh-Hang/A-1765-2010; Segurado, Ricardo/K-6116-2014; Schofield, Peter/C-9669-2011	Akarsu, Nurten/0000-0001-5432-0032; Van Broeckhoven, Christine/0000-0003-0183-7665; McInnis, Melvin G/0000-0002-0375-6247; McMahon, Francis J/0000-0002-9469-305X; Liu, Jianjun/0000-0002-3255-3019; reus, victor i/0000-0002-8193-5697; Nothen, Markus/0000-0002-8770-2464; Lewis, Cathryn/0000-0002-8249-8476; Schumacher, Johannes/0000-0001-9217-6457; Lewis, Cathryn M/0000-0002-8249-8476; Visscher, Peter/0000-0002-2143-8760; Cichon, Sven/0000-0002-9475-086X; Alda, Martin/0000-0001-9544-3944; Cichon, Sven/0000-0002-9475-086X; Antonarakis, Stylianos E/0000-0001-8907-5823; McQuillin, Andrew/0000-0003-1567-2240; Macgregor, Stuart/0000-0001-6731-8142; Van Broeckhoven, Christine/0000-0003-0183-7665; Goate, Alison/0000-0002-0576-2472; Luebbert, Herrmann/0000-0003-3429-5233; DePaulo, J Raymond/0000-0001-9221-9226; Adolfsson, Rolf/0000-0001-9785-8473; Mitchell, Philip/0000-0002-7954-5235; Edenberg, Howard/0000-0003-0344-9690; Turecki, Gustavo/0000-0003-4075-2736; Del Favero, jurgen/0000-0002-7427-7489; Mors, Ole/0000-0002-5660-0393; Segurado, Ricardo/0000-0002-3547-6733; Schofield, Peter/0000-0003-2967-9662; Nurnberger, John/0000-0002-7674-1767; Claes, Stephan/0000-0002-1175-492X; Donald, Jennifer/0000-0002-2732-1379; Gill, Michael/0000-0003-0206-5337; Willour, Virginia/0000-0002-6639-487X	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9309834, G9810900] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 00827, M01 RR000827] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [N01 HG 65493] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01 MH 46280, R01 MH059545, K24 MH 064197, R01 MH063876, MH 42535, MH 01099, R01 MH 042463, U01 MH 46274, R01 MH062276, U01 MH 54701, U01 MH 54794, MH 43979, MH 42243, R01 MH 59545, MH 00176, 1R01 MH 3448, R01 MH049499, MH 59553, U01 MH 46282, R01 MH 49499, R01 MH042243, R01 MH059567, R01 MH059553, MH 59567, MH 47612, K24 MH064197, R01 MH 62276, MH 63876, U01 MH 54723, K02 MH 01089, R01 MH 42643] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS037484, R01 NS 37484] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH046274, R01MH049499, R01MH059545, R01MH059567, R01MH042643, U01MH046282, Z01MH002842, R01MH062276, U01MH046280, R01MH042535, R01MH042243, R01MH059553, R29MH047612, R01MH063876, U01MH054794, Z01MH002810, K02MH001089, U01MH054701, K24MH064197, R01MH043979, U01MH054723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037484] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9810900, G9309834] Funding Source: UKRI		Adams LJ, 1998, AM J HUM GENET, V62, P1084, DOI 10.1086/301826; Badenhop R, 2002, MOL PSYCHIATR, V7, P851, DOI 10.1038/sj.mp.4001114; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; Baron M, 2002, MOL PSYCHIATR, V7, P342, DOI 10.1038/sj.mp.4000998; Bennett P, 2002, MOL PSYCHIATR, V7, P189, DOI 10.1038/sj.mp.4000957; Berrettini WH, 1997, ARCH GEN PSYCHIAT, V54, P27; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blacker D, 1996, AM J MED GENET, V67, P445, DOI 10.1002/(SICI)1096-8628(19960920)67:5<445::AID-AJMG2>3.0.CO;2-J; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; COON H, 1993, AM J HUM GENET, V52, P1234; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; DETERAWADLEIGH SD, 1994, AM J MED GENET, V54, P206, DOI 10.1002/ajmg.1320540307; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Ekholm J, 2002, MOL PSYCHIATR, V7, P453, DOI 10.1038/sj.mp.4001104; ENDICOTT J, 1985, J AFFECT DISORDERS, V8, P17, DOI 10.1016/0165-0327(85)90068-0; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; GERHARD DS, 1994, AM J MED GENET, V54, P398, DOI 10.1002/ajmg.1320540421; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; Grigoroiu-Serbanescu M, 1998, AM J MED GENET, V81, P397, DOI 10.1002/(SICI)1096-8628(19980907)81:5<397::AID-AJMG8>3.0.CO;2-Q; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HEUN R, 1993, ACTA PSYCHIAT SCAND, V87, P279, DOI 10.1111/j.1600-0447.1993.tb03372.x; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; LaBuda MC, 1996, AM J HUM GENET, V59, P1343; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEBOYER M, 1991, EUR ARCH PSY CLIN N, V241, P165, DOI 10.1007/BF02219716; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; McMahon FJ, 2001, ARCH GEN PSYCHIAT, V58, P1025, DOI 10.1001/archpsyc.58.11.1025; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Merikangas KR, 2002, BIOL PSYCHIAT, V52, P457, DOI 10.1016/S0006-3223(02)01471-3; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; Polymeropoulos MH, 1996, MOL PSYCHIATR, V1, P404; Radhakrishna U, 2001, EUR J HUM GENET, V9, P39, DOI 10.1038/sj.ejhg.5200584; RICE JP, 1986, PSYCHIAT RES, V19, P285, DOI 10.1016/0165-1781(86)90121-6; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Segurado R, 2001, AM J MED GENET, V105, P580; Simpson SG, 2002, ARCH GEN PSYCHIAT, V59, P736, DOI 10.1001/archpsyc.59.8.736; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; Taylor Levi, 2002, Curr Psychiatry Rep, V4, P130, DOI 10.1007/s11920-002-0046-1; Todd Richard D, 2002, Curr Psychiatry Rep, V4, P141, DOI 10.1007/s11920-002-0048-z; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x	55	330	335	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					49	62		10.1086/376547			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	WOS:000183904900005	12802785	Green Published, Bronze			2022-01-24	
J	Wang, N; Akey, JM; Zhang, K; Chakraborty, R; Jin, L				Wang, N; Akey, JM; Zhang, K; Chakraborty, R; Jin, L			Distribution of recombination crossovers and the origin of haplotype blocks: The interplay of population history, recombination, and mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; COMMON DISEASE GENES; LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; HUMAN GENOME; HUMAN-CHROMOSOME-21; PROSPECTS; LOCUS	Recent studies suggest that haplotypes are arranged into discrete blocklike structures throughout the human genome. Here, we present an alternative haplotype block definition that assumes no recombination within each block but allows for recombination between blocks, and we use it to study the combined effects of demographic history and various population genetic parameters on haplotype block characteristics. Through extensive coalescent simulations and analysis of published haplotype data on chromosome 21, we find that (1) the combined effects of population demographic history, recombination, and mutation dictate haplotype block characteristics and (2) haplotype blocks can arise in the absence of recombination hot spots. Finally, we provide practical guidelines for designing and interpreting studies investigating haplotype block structure.	Univ Cincinnati, Ctr Genome Informat, Dept Environm Hlth, Cincinnati, OH 45267 USA		Jin, L (corresponding author), Univ Cincinnati, Ctr Genome Informat, Dept Environm Hlth, 3223 Eden Ave, Cincinnati, OH 45267 USA.		Zhang, Kun/ABE-6349-2020; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Zhang, Kun/0000-0002-7596-5224; Jin, Li/0000-0002-4546-2415; 			Bogart K. P., 2000, INTRO COMBINATORICS; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fu YX, 1999, THEOR POPUL BIOL, V56, P1, DOI 10.1006/tpbi.1999.1421; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; SATTA Y, 1993, P NATL ACAD SCI USA, V90, P7480, DOI 10.1073/pnas.90.16.7480; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1	18	330	340	0	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1227	1234		10.1086/344398			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	WOS:000178884300023	12384857	Bronze, Green Published			2022-01-24	
J	Fallin, D; Cohen, A; Essioux, L; Chumakov, I; Blumenfeld, M; Cohen, D; Schork, NJ				Fallin, D; Cohen, A; Essioux, L; Chumakov, I; Blumenfeld, M; Cohen, D; Schork, NJ			Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease	GENOME RESEARCH			English	Article							LINKAGE DISEQUILIBRIUM; APOLIPOPROTEIN-E; SEQUENCE VARIATION; TYPE-4 ALLELE; ASSOCIATION; POPULATION; MARKERS; TESTS; POWER; RISK	There is growing debate over the utility of multiple locus association analyses in the identification of genomic regions harboring sequence variants that influence common complex traits such as hypertension and diabetes. Much of this debate concerns the manner in which one can use the genotypic information from individuals gathered in simple sampling frameworks, such as the case/control designs, to actually assess the association between alleles in a particular genomic region and a trait. in this paper we describe methods for testing associations between estimated haplotype frequencies derived from multilocus genotype data and disease endpoints assuming a simple case/control sampling design. These proposed methods overcome the lack of phase information usually associated with samples of unrelated individuals and provide a comprehensive way of assessing the relationship between sequence or multiple-site variation and traits and diseases within populations. We applied the proposed methods in a study of the relationship between polymorphisms within the APOE gene region and Alzheimer's disease. Cases and controls for this study were collected from the United States and France. Our results confirm the known association between the APOE locus and Alzheimer's disease, even when the epsilon4 polymorphism is not contained in the tested haplotypes. This suggests that, in certain situations, haplotype information and linkage disequilibrium-induced associations between polymorphic loci that neighbor loci harboring functional sequence variants can be exploited to identify disease-predisposing alleles in large, freely mixing populations via estimated haplotype frequency methods.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Genset Corp, Dept Stat Genom, La Jolla, CA 92037 USA; Genset SA, F-75008 Paris, France; Harvard Univ, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Program Populat Genet, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA		Schork, NJ (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA.			Schork, Nicholas/0000-0003-0920-5013	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50HL054998] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL94-011, P50 HL054998, HL54998-01] Funding Source: Medline		Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EDWARDS A. W. F., 1992, LIKELIHOOD; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Good P, 1994, PERMUTATION TESTS; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEWONTIN RC, 1988, GENETICS, V120, P849; LONG JC, 1995, AM J HUM GENET, V56, P799; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; Nettleton D, 2000, BIOMETRICS, V56, P52, DOI 10.1111/j.0006-341X.2000.00052.x; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Ott J, 1997, GENETICS, V147, P927; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schipper RF, 1998, HUM IMMUNOL, V59, P518, DOI 10.1016/S0198-8859(98)00054-8; Schlesselman JJ., 1982, CASE CONTROL STUDIES; Schork NJ, 2000, CLIN GENET, V58, P250, DOI 10.1034/j.1399-0004.2000.580402.x; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Weir BS, 1996, GENETIC DATA ANAL; Xiong MM, 1999, AM J HUM GENET, V64, P629, DOI 10.1086/302231; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	37	330	355	1	11	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	JAN	2001	11	1					143	151		10.1101/gr.148401			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	391NH	WOS:000166361700014	11156623	Green Published, Bronze			2022-01-24	
J	De Fusco, M; Becchetti, A; Patrignani, A; Annesi, G; Gambardella, A; Quattrone, A; Ballabio, A; Wanke, E; Casari, G				De Fusco, M; Becchetti, A; Patrignani, A; Annesi, G; Gambardella, A; Quattrone, A; Ballabio, A; Wanke, E; Casari, G			The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy	NATURE GENETICS			English	Article							ACETYLCHOLINE-RECEPTOR; CHRNA4 GENE; MUTATION; BETA-2-SUBUNIT; MOUSE		TIGEM, Telethon Inst Genet & Med, Milan, Italy; Univ Milan, Dept Biosci & Biotechnol, Milan, Italy; Natl Res Council, Inst Expt Med & Biotechnol, Cosenza, Italy; Sch Med, Inst Neurol, Catanzaro, Italy		Casari, G (corresponding author), TIGEM, Telethon Inst Genet & Med, San Raffaele Biomed Sci Pk, Milan, Italy.		Becchetti, Andrea/AAF-7821-2020; Gambardella, Antonio/F-5295-2012; Annesi, Grazia/AAX-5732-2020; De Fusco, Maurizio/AAN-7358-2020; CASARI, Giorgio/J-3070-2018; QUATTRONE, Aldo/A-6734-2016	Becchetti, Andrea/0000-0002-9297-0527; Gambardella, Antonio/0000-0001-7384-3074; Partigiani, Andrea/0000-0001-8019-3911; BALLABIO, Andrea/0000-0003-1381-4604; CASARI, Giorgio/0000-0002-0115-8980; QUATTRONE, Aldo/0000-0003-2001-957X	TelethonFondazione Telethon [1046, TGM06S01] Funding Source: Medline		Buisson B, 1996, J NEUROSCI, V16, P7880; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FLORES CM, 1992, MOL PHARMACOL, V41, P31; GAMBARDELLA A, IN PRESS NEUROLOGY; Hirose S, 1999, NEUROLOGY, V53, P1749, DOI 10.1212/WNL.53.8.1749; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; Rempel N, 1998, HUM GENET, V103, P645, DOI 10.1007/s004390050885; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Tenchini ML, 1999, SLEEP, V22, P637, DOI 10.1093/sleep/22.5.637	15	330	335	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					275	276					2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500013	11062464				2022-01-24	
J	Toomes, C; James, J; Wood, AJ; Wu, CL; McCormick, D; Lench, N; Hewitt, C; Moynihan, L; Roberts, E; Woods, CG; Markham, A; Wong, M; Widmer, R; Ghaffar, KA; Pemberton, M; Hussein, IR; Temtamy, SA; Davies, R; Read, AP; Sloan, P; Dixon, MJ; Thakker, NS				Toomes, C; James, J; Wood, AJ; Wu, CL; McCormick, D; Lench, N; Hewitt, C; Moynihan, L; Roberts, E; Woods, CG; Markham, A; Wong, M; Widmer, R; Ghaffar, KA; Pemberton, M; Hussein, IR; Temtamy, SA; Davies, R; Read, AP; Sloan, P; Dixon, MJ; Thakker, NS			Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis	NATURE GENETICS			English	Article							PAPILLON-LEFEVRE-SYNDROME; DIPEPTIDYL-PEPTIDASE-I; MOLECULAR-CLONING; LINKAGE ANALYSIS; EXPRESSION; LOCALIZATION; 11Q14-Q21	Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients(1,2). Both the deciduous and permanent dentitions are affected, resulting in premature tooth loss. Palmoplantar keratosis, varying from mild psoriasiform scaly skin to overt hyperkeratosis, typically develops within the first three years of life. Keratosis also affects other sites such as elbows and knees. Most PLS patients display both periodontitis and hyperkeratosis. some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset(3-6). The PLS locus has been mapped to chromosome 11q14-q21 (refs 7-9). Using homozygosity mapping in eight small consanguineous families, we have narrowed the candidate region to a 1.2-cM interval between D11S4082 and D11S931. The gene (CTSC) encoding the lysosomal protease cathepsin C (or dipeptidyl aminopeptidase I) lies within this interval. We defined the genomic structure of CTSC and found mutations in all eight families. In two of these families we used a functional assay to demonstrate an almost total loss of cathepsin C activity in PLS patients and reduced activity in obligate carriers.	Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; Univ Manchester, Turner Dent Sch, Dept Dent Med & Surg, Manchester, Lancs, England; Queens Univ Belfast, Dept Oncol, Belfast City Hosp Tower, Belfast, Antrim, North Ireland; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; New Childrens Hosp, Dept Immunol & Infect Dis, Westmead, NSW, Australia; Westmead Hosp, Dept Paediat Dent, Dent Clin Sch, Westmead, NSW 2145, Australia; Eins Shams Univ, Dept Oral Diagnosis & Periodontol, Cairo, Egypt; Natl Res Ctr, Dept Human Genet, Cairo, Egypt; Dent Hlth Unit, Manchester, Lancs, England		Thakker, NS (corresponding author), Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England.		hussein, ibtessam M.R/H-9489-2012; Lench, Nicholas/AAB-1791-2021; Hussein, ibtessam R/L-4020-2014; woods, christopher g/A-1361-2010	Ghaffar, khaled/0000-0001-5340-789X; temtamy, samia/0000-0002-6452-823X; Lench, Nicholas/0000-0002-6108-0759; Thakker, Nalin/0000-0002-8664-1508; Toomes, Carmel/0000-0001-8373-9545	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BROWN J, 1993, SIGHT SOUND, V3, P64; BULLON P, 1993, J CLIN PERIODONTOL, V20, P662, DOI 10.1111/j.1600-051X.1993.tb00712.x; Cigic B, 1999, BIOCHEM BIOPH RES CO, V258, P6, DOI 10.1006/bbrc.1999.0570; Fardal O, 1998, J CLIN PERIODONTOL, V25, P181, DOI 10.1111/j.1600-051X.1998.tb02425.x; FISHER J, 1997, EUR J HUM GENET, V51, P56; GORLIN RJ, 1964, J PEDIATR-US, V65, P895, DOI 10.1016/S0022-3476(64)80014-7; HAMILTON RE, 1974, ORAL SURG ORAL MED O, V37, P754, DOI 10.1016/0030-4220(74)90141-8; Hart T C, 1994, Periodontol 2000, V6, P88, DOI 10.1111/j.1600-0757.1994.tb00029.x; Hart TC, 1998, AM J MED GENET, V79, P134, DOI 10.1002/(SICI)1096-8628(19980901)79:2<134::AID-AJMG9>3.0.CO;2-Q; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; KURIBAYASHI M, 1993, J BIOCHEM-TOKYO, V113, P441, DOI 10.1093/oxfordjournals.jbchem.a124064; Laass MW, 1997, HUM GENET, V101, P376, DOI 10.1007/s004390050645; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Oguzkurt P, 1996, J PEDIATR SURG, V31, P955; PARIS A, 1995, FEBS LETT, V369, P326, DOI 10.1016/0014-5793(95)00777-7; Pham CTN, 1997, J BIOL CHEM, V272, P10695, DOI 10.1074/jbc.272.16.10695; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rao NV, 1997, J BIOL CHEM, V272, P10260; SMYTH M, 1994, J NEUROCHEM, V63, P1439; Soskolne WA, 1996, J CLIN PERIODONTOL, V23, P764, DOI 10.1111/j.1600-051X.1996.tb00607.x; TEMPEL TR, 1972, J PERIODONTAL RE S10, V7, P26; WALLACE IJC, 1990, IRISH J MED SCI, V159, P203, DOI 10.1007/BF02937266	25	330	347	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					421	424		10.1038/70525			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	WOS:000084023900016	10581027	Green Published			2022-01-24	
J	Quignon, F; De Bels, F; Koken, M; Feunteun, J; Ameisen, JC; de The, H				Quignon, F; De Bels, F; Koken, M; Feunteun, J; Ameisen, JC; de The, H			PML induces a novel caspase-independent death process	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; CELL-DEATH; GROWTH-SUPPRESSOR; RAR-ALPHA; NUCLEAR-BODIES; DNA-DAMAGE; PROTEIN; APOPTOSIS; BAX; EXPRESSION	PML nuclear bodies (NBs) are nuclear matrix-associated structures altered by viruses and oncogenes. We show here that PML overexpression induces rapid cell death, independent of de novo transcription and cell cycling. PML death involves cytoplasmic features of apoptosis in the absence of caspase-3 activation, and caspase inhibitors such as zVAD accelerate PML death, zVAD also accelerates interferon (IFN)-induced death, suggesting that PML contributes to IFN-induced apoptosis. The death effector BAX and the cdk inhibitor p27KIP1 are novel NB-associated proteins recruited by PML to these nuclear domains, whereas the acute promyelocytic leukaemia (APL) PML/RAR alpha oncoprotein delocalizes them. Arsenic enhances targeting of PML BAX and p27KIP1 to NBs and synergizes with PML and IFN to induce cell death. Thus, cell death susceptibility correlates with NE recruitment of NE proteins. These findings reveal a novel cell death pathway that neither requires nor induces caspase-3 activation, and suggest that NBs participate in the control of cell survival.	Univ Paris 07, Hop St Louis, Inst Hematol,CNRS UPR 9051, Lab Associe Comite Paris Ligue Contre Canc, F-75475 Paris 10, France; Hop Bichat, INSERM CJF 9707, F-75877 Paris, France; Inst Gustave Roussy, CNRS URA 1967, F-94805 Villejuif, France		de The, H (corresponding author), Univ Paris 07, Hop St Louis, Inst Hematol,CNRS UPR 9051, Lab Associe Comite Paris Ligue Contre Canc, 1 Av C Vellefaux, F-75475 Paris 10, France.	ameisen@caramail.com; dethe@chu-stlouis.fr	Feunteun, Jean/AAZ-1267-2020; Quignon, Frederique/P-4249-2017; koken, marcel/J-8154-2012; koken, marcel/N-1349-2019	koken, marcel/0000-0002-0839-0125; koken, marcel/0000-0002-0839-0125; Feunteun, Jean/0000-0003-1212-9189			Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; BAZARBACHI A, IN PRESS BLOOD; Borden KLB, 1997, FEBS LETT, V418, P30, DOI 10.1016/S0014-5793(97)01344-6; Borden KLB, 1998, J VIROL, V72, P3819, DOI 10.1128/JVI.72.5.3819-3826.1998; Chan JYH, 1997, BIOCHEM BIOPH RES CO, V240, P640, DOI 10.1006/bbrc.1997.7692; CHELBIALIX M, IN PRESS ONCOGENE; Chen GQ, 1997, BLOOD, V89, P3345; DANIEL MT, 1993, BLOOD, V82, P1858; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Estaquier J, 1997, BLOOD, V90, P1618, DOI 10.1182/blood.V90.4.1618.1618_1618_1625; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Gianni M, 1998, BLOOD, V91, P4300, DOI 10.1182/blood.V91.11.4300.411k41_4300_4310; Gongora C, 1997, J BIOL CHEM, V272, P19457, DOI 10.1074/jbc.272.31.19457; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; Han J., 1995, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jiang WQ, 1997, CELL GROWTH DIFFER, V8, P513; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Le XF, 1998, ONCOGENE, V16, P1839, DOI 10.1038/sj.onc.1201705; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; MADANI A, 1995, ONCOGENE, V10, P2259; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Monney L, 1998, J BIOL CHEM, V273, P6121, DOI 10.1074/jbc.273.11.6121; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Okura T, 1996, J IMMUNOL, V157, P4277; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Quignon F, 1997, BBA-REV CANCER, V1333, pM53, DOI 10.1016/S0304-419X(97)00025-5; Stadler M, 1995, ONCOGENE, V11, P2565; STUURMAN N, 1997, CELL MOL BIOL LETT, V2, P137; Testa U, 1998, J CLIN INVEST, V101, P2278, DOI 10.1172/JCI1332; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	54	330	333	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					259	265		10.1038/3068			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	WOS:000076698100019	9806544				2022-01-24	
J	Miotto, O; Amato, R; Ashley, EA; MacInnis, B; Almagro-Garcia, J; Amaratunga, C; Lim, P; Mead, D; Oyolal, SO; Dhorda, M; Imwong, M; Woodrow, C; Manske, M; Stalker, J; Drury, E; Campino, S; Amenga-Etego, L; Thanh, TNN; Tran, HT; Ringwald, P; Bethellm, D; Nosten, F; Phyo, AP; Pukrittayakamee, S; Chotivanich, K; Chuor, CM; Nguon, C; Suon, S; Sreng, S; Newton, PN; Mayxay, M; Khanthavong, M; Hongvanthong, B; Htut, Y; Han, KT; Kyaw, MP; Faiz, MA; Fanello, CI; Onyamboko, M; Mokuolu, OA; Jacob, CG; Takala-Harrison, S; Plowe, CV; Day, NP; Dondorp, AM; Spencer, CCA; McVean, G; Fairhurst, RM; White, NJ; Kwiatkowski, DP				Miotto, Olivo; Amato, Roberto; Ashley, Elizabeth A.; MacInnis, Bronwyn; Almagro-Garcia, Jacob; Amaratunga, Chanaki; Lim, Pharath; Mead, Daniel; Oyolal, Samuel O.; Dhorda, Mehul; Imwong, Mallika; Woodrow, Charles; Manske, Magnus; Stalker, Jim; Drury, Eleanor; Campino, Susana; Amenga-Etego, Lucas; Thuy-Nhien Nguyen Thanh; Hien Tinh Tran; Ringwald, Pascal; Bethellm, Delia; Nosten, Francois; Phyo, Aung Pyae; Pukrittayakamee, Sasithon; Chotivanich, Kesinee; Chuor, Char Meng; Nguon, Chea; Suon, Seila; Sreng, Sokunthea; Newton, Paul N.; Mayxay, Mayfong; Khanthavong, Maniphone; Hongvanthong, Bouasy; Htut, Ye; Han, Kay Thwe; Kyaw, Myat Phone; Faiz, Md Abul; Fanello, Caterina I.; Onyamboko, Marie; Mokuolu, Olugbenga A.; Jacob, Christopher G.; Takala-Harrison, Shannon; Plowe, Christopher V.; Day, Nicholas P.; Dondorp, Arjen M.; Spencer, Chris C. A.; McVean, Gilean; Fairhurst, Rick M.; White, Nicholas J.; Kwiatkowski, Dominic P.			Genetic architecture of artemisinin-resistant Plasmodium falciparum	NATURE GENETICS			English	Article							CHLOROQUINE RESISTANCE; PARASITE CLEARANCE; PFMDR2 GENE; MALARIA; SPREAD; EPIDEMIOLOGY; MUTATIONS; PROVINCE; WORLD	We report a large multicenter genome-wide association study of Plasmodium falciparum resistance to artemisinin, the frontline antimalarial drug. Across 15 locations in Southeast Asia, we identified at least 20 mutations in kelch13 (PF3D7_1343700) affecting the encoded propeller and BTB/POZ domains, which were associated with a slow parasite clearance rate after treatment with artemisinin derivatives. Nonsynonymous polymorphisms in fd (ferredoxin), arps10 (apicoplast ribosomal protein S10), mdr2 (multidrug resistance protein 2) and crt (chloroquine resistance transporter) also showed strong associations with artemisinin resistance. Analysis of the fine structure of the parasite population showed that the fd, arps10, mdr2 and crt polymorphisms are markers of a genetic background on which kelch13 mutations are particularly likely to arise and that they correlate with the contemporary geographical boundaries and population frequencies of artemisinin resistance. These findings indicate that the risk of new resistance-causing mutations emerging is determined by specific predisposing genetic factors in the underlying parasite population.	[Miotto, Olivo; Amato, Roberto; MacInnis, Bronwyn; Almagro-Garcia, Jacob; Mead, Daniel; Oyolal, Samuel O.; Manske, Magnus; Stalker, Jim; Drury, Eleanor; Campino, Susana; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Miotto, Olivo; Amato, Roberto; MacInnis, Bronwyn; Almagro-Garcia, Jacob; Manske, Magnus; Stalker, Jim; Campino, Susana; Amenga-Etego, Lucas; Spencer, Chris C. A.; McVean, Gilean; Kwiatkowski, Dominic P.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Miotto, Olivo; Ashley, Elizabeth A.; Woodrow, Charles; Nosten, Francois; Phyo, Aung Pyae; Fanello, Caterina I.; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Matlidol Oxtord Trop Med Res Unit, Bangkok 10700, Thailand; [Amato, Roberto; Almagro-Garcia, Jacob; Spencer, Chris C. A.; McVean, Gilean; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ashley, Elizabeth A.; Dhorda, Mehul; Woodrow, Charles; Hien Tinh Tran; Nosten, Francois; Phyo, Aung Pyae; Newton, Paul N.; Mayxay, Mayfong; Fanello, Caterina I.; Onyamboko, Marie; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Amaratunga, Chanaki; Lim, Pharath; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, US NIH, Bethesda, MD 20892 USA; [Lim, Pharath; Chuor, Char Meng; Nguon, Chea; Suon, Seila; Sreng, Sokunthea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Dhorda, Mehul; Jacob, Christopher G.; Takala-Harrison, Shannon; Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dhorda, Mehul] Mahidol Univ, Asia Reg Ctr, WWARN, Bangkok 10700, Thailand; [Imwong, Mallika; Pukrittayakamee, Sasithon; Chotivanich, Kesinee] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Amenga-Etego, Lucas] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Thuy-Nhien Nguyen Thanh; Hien Tinh Tran] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Ringwald, Pascal] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Bethellm, Delia] USAMC AFRIMS, Dept Immunol & Med, Bangkok, Thailand; [Nosten, Francois; Phyo, Aung Pyae] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Newton, Paul N.; Mayxay, Mayfong] Mahosot Hosp, Lao Oxford Mahosot Wellcome Trust Res Unit LOMWRU, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Khanthavong, Maniphone; Hongvanthong, Bouasy] Minist Hlth, Ctr Mahariol Parasitol & Entomol, Viangchan, Laos; [Htut, Ye; Han, Kay Thwe; Kyaw, Myat Phone] Dept Med Res, Yarigon, Myanmar; [Faiz, Md Abul] Malaria Res Grp & Dev Care Fdn, Dhaka, Bangladesh; [Onyamboko, Marie] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Mokuolu, Olugbenga A.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria; [Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [McVean, Gilean] Univ Oxford, Dept Stat, Oxford, England		Kwiatkowski, DP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	dominic@sanger.ac.uk	Mokuolu, Olugbenga/G-4334-2016; Nosten, Francois/AAC-5509-2019; Campino, Susana/AAM-2577-2020; Miotto, Olivo/AAE-7124-2019; White, Nick/AAC-6527-2019; , Myat-Phone-Kyaw/P-1750-2019; Phyo, Aung Pyae/K-2413-2019; Fanello, Caterina/AAT-9679-2021; Mead, Daniel/AAE-6629-2019; Imwong, Mallika/ABE-6493-2020; Lim, Pharath/AAF-6699-2020	Mokuolu, Olugbenga/0000-0001-8273-5876; Nosten, Francois/0000-0002-7951-0745; Campino, Susana/0000-0003-1403-6138; White, Nick/0000-0002-1897-1978; Phyo, Aung Pyae/0000-0002-0383-9624; Fanello, Caterina/0000-0003-1932-9562; Mead, Daniel/0000-0001-7717-4330; Miotto, Olivo/0000-0001-8060-6771; Newton, Paul/0000-0002-4608-6431; Takala-Harrison, Shannon/0000-0003-4674-8500; Kwiatkowski, Dominic/0000-0002-5023-0176; Woodrow, Charles/0000-0002-5134-7165; Spencer, Christopher/0000-0002-8508-456X; Lim, Pharath/0000-0002-1012-2461; Amato, Roberto/0000-0001-8633-9221; Manske, Magnus/0000-0001-5916-0947; Ashley, Elizabeth/0000-0002-7620-4822; Oyola, Samuel O./0000-0002-6425-7345; Thuy-Nhien, Nguyen/0000-0002-4101-5706	Wellcome TrustWellcome TrustEuropean Commission; Wellcome Trust Sanger InstituteWellcome Trust [098051]; Wellcome Trust Centre for Human GeneticsWellcome Trust [090532/Z/09/Z]; Resource Centre for Genomic Epidemiology of Malaria [090770/Z/09/Z]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research ProgrammeWellcome Trust; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600718]; Bill and Melinda Gates FoundationBill & Melinda Gates Foundation [OPP1040463]; Intramural Research Program of the National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department for International Development [PO5408]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600718, MR/M006212/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [1252410, MR/M006212/1, G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI101713, ZIAAI001066, ZIAAI001000] Funding Source: NIH RePORTER	We thank the following colleagues for their efforts in support of this work: P. Vauterin, G. Band and Q.S. Le; J. Anderson, D. Dek, S. Duong, R. Gwadz, S. Mao, V. Ou, B. Sam, C. Sopha, V. Try and T. Wellems; the personnel at Phuoc Long Hospital, Bu Gia Map Health Station, Malaria Control Center of Binh Phuoc Province, Vietnam; M. Phommasansack, B. Phimphalat and C. Vilayhong; and A.K. Tshefu. Special thanks are given to V. Cornelius and K. Johnson for their continual support of the analysis group. The sequencing for this study was funded by the Wellcome Trust through core funding of the Wellcome Trust Sanger Institute (098051). The Wellcome Trust also supports the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z), the Resource Centre for Genomic Epidemiology of Malaria (090770/Z/09/Z) and the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme. The Centre for Genomics and Global Health is supported by the UK Medical Research Council (G0600718). This work was funded in part by the Bill and Melinda Gates Foundation (OPP1040463), the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health and the Department for International Development (PO5408). P.R. is a staff member of the World Health Organization. The views expressed in this publication are those of the authors and do not necessarily reflect the positions, decisions, policies or views of their employers or of the funding organizations.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Beez D, 2011, ANTIMICROB AGENTS CH, V55, P50, DOI 10.1128/AAC.00916-10; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Briolant S, 2012, ANTIMICROB AGENTS CH, V56, P2750, DOI 10.1128/AAC.05618-11; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Kimata-Ariga Y, 2007, J BIOCHEM, V142, P715, DOI 10.1093/jb/mvm184; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Manske HM, 2009, BIOINFORMATICS, V25, P2434, DOI 10.1093/bioinformatics/btp403; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Martinelli A, 2011, INT J PARASITOL, V41, P165, DOI 10.1016/j.ijpara.2010.08.008; Millet J, 2004, ANTIMICROB AGENTS CH, V48, P4869, DOI 10.1128/AAC.48.12.4869-4872.2004; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Rosenberg E, 2006, J BIOL CHEM, V281, P27039, DOI 10.1074/jbc.M601686200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sen Saunak, 2004, Current Drug Targets - Infectious Disorders, V4, P53, DOI 10.2174/1568005043480916; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; VASQUEZVIVAR J, 1992, J BIOL CHEM, V267, P6848; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; ZALIS MG, 1993, MOL BIOCHEM PARASIT, V62, P83, DOI 10.1016/0166-6851(93)90180-6	42	329	337	6	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					226	+		10.1038/ng.3189			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	WOS:000350327900012	25599401	Green Accepted, Green Submitted, Bronze	Y	N	2022-01-24	
J	Azizan, EAB; Poulsen, H; Tuluc, P; Zhou, J; Clausen, MV; Lieb, A; Maniero, C; Garg, S; Bochukova, EG; Zhao, W; Shaikh, LH; Brighton, CA; Teo, AED; Davenport, AP; Dekkers, T; Tops, B; Kuusters, B; Ceral, J; Yeo, GSH; Neogi, SG; McFarlane, I; Rosenfeld, N; Marass, F; Hadfield, J; Margas, W; Chaggar, K; Solar, M; Deinum, J; Dolphin, AC; Farooqi, IS; Striessnig, J; Nissen, P; Brown, MJ				Azizan, Elena A. B.; Poulsen, Hanne; Tuluc, Petronel; Zhou, Junhua; Clausen, Michael V.; Lieb, Andreas; Maniero, Carmela; Garg, Sumedha; Bochukova, Elena G.; Zhao, Wanfeng; Shaikh, Lalarukh Haris; Brighton, Cheryl A.; Teo, Ada E. D.; Davenport, Anthony P.; Dekkers, Tanja; Tops, Bas; Kuesters, Benno; Ceral, Jiri; Yeo, Giles S. H.; Neogi, Sudeshna Guha; McFarlane, Ian; Rosenfeld, Nitzan; Marass, Francesco; Hadfield, James; Margas, Wojciech; Chaggar, Kanchan; Solar, Miroslav; Deinum, Jaap; Dolphin, Annette C.; Farooqi, I. Sadaf; Striessnig, Joerg; Nissen, Poul; Brown, Morris J.			Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension	NATURE GENETICS			English	Article							ALDOSTERONE-PRODUCING ADENOMAS; ZONA GLOMERULOSA; CA2+ CHANNELS; CALCIUM-PUMP; CELLS; OUABAIN; INHIBITION; PREVALENCE; SARCOLIPIN; POTASSIUM	At least 5% of individuals with hypertension have adrenal aldosterone-producing adenomas (APAs). Gain-of-function mutations in KCNJ5 and apparent loss-of-function mutations in ATP1A1 and ATP2A3 were reported to occur in APAs(1,2). We find that KCNJ5 mutations are common in APAs resembling cortisol-secreting cells of the adrenal zona fasciculata but are absent in a subset of APAs resembling the aldosterone-secreting cells of the adrenal zona glomerulosa(3). We performed exome sequencing of ten zona glomerulosa-like APAs and identified nine with somatic mutations in either ATP1A1, encoding the Na+/K+ ATPase alpha 1 subunit, or CACNA1D, encoding Ca(v)1.3. The ATP1A1 mutations all caused inward leak currents under physiological conditions, and the CACNA1D mutations induced a shift of voltage-dependent gating to more negative voltages, suppressed inactivation or increased currents. Many APAs with these mutations were <1 cm in diameter and had been overlooked on conventional adrenal imaging. Recognition of the distinct genotype and phenotype for this subset of APAs could facilitate diagnosis.	[Azizan, Elena A. B.; Zhou, Junhua; Maniero, Carmela; Garg, Sumedha; Bochukova, Elena G.; Shaikh, Lalarukh Haris; Brighton, Cheryl A.; Teo, Ada E. D.; Davenport, Anthony P.; Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Ctr Clin Invest, Clin Pharmacol Unit, Cambridge, England; [Poulsen, Hanne; Clausen, Michael V.; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Disease PUMPkin, Dept Mol Biol & Genet, Aarhus, Denmark; [Tuluc, Petronel; Lieb, Andreas; Striessnig, Joerg] Univ Innsbruck, Ctr Mol Biosci, Inst Pharm, A-6020 Innsbruck, Austria; [Garg, Sumedha; Bochukova, Elena G.; Yeo, Giles S. H.; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Zhao, Wanfeng] Univ Cambridge, Addenbrookes Hosp, Fdn Trust, Hosp Natl Hlth Serv NHS,Human Res Tissue Bank, Cambridge CB2 2QQ, England; [Dekkers, Tanja; Deinum, Jaap] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Tops, Bas; Kuesters, Benno] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Ceral, Jiri; Solar, Miroslav] Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Cardioangiol 1, Hradec Kralove, Czech Republic; [Ceral, Jiri; Solar, Miroslav] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Neogi, Sudeshna Guha; McFarlane, Ian] Addenbrookes Hosp, BRC, Cambridge Natl Inst Hlth Res NIHR, Dept Clin Biochem, Cambridge, England; [Rosenfeld, Nitzan; Marass, Francesco; Hadfield, James] Univ Cambridge, Li Ka Shing Ctr, Cancer Res UK Cambridge Inst, Cambridge, England; [Margas, Wojciech; Chaggar, Kanchan; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London, England		Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Ctr Clin Invest, Clin Pharmacol Unit, Cambridge, England.	hp@mb.au.dk; m.j.brown@cai.cam.ac.uk	Zhou, Junhua/E-3528-2016; Ceral, Jiri/P-6863-2017; Marass, Francesco/U-5220-2019; Deinum, J./L-4261-2015; Davenport, Anthony P./A-5773-2008; Dolphin, Annette C/F-7416-2010; Striessnig, Joerg/S-9334-2017; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Dekkers, Tanja/H-3335-2015; O'Rahilly, Stephen/ABF-6509-2020; Solar, Miroslav/Q-1707-2017; Tops, Bastiaan/L-4697-2015	Zhou, Junhua/0000-0002-8593-8393; Ceral, Jiri/0000-0002-2636-7551; Marass, Francesco/0000-0002-8993-7320; Deinum, J./0000-0003-2465-1986; Davenport, Anthony P./0000-0002-2096-3117; Dolphin, Annette C/0000-0003-4626-4856; Striessnig, Joerg/0000-0002-9406-7120; Dekkers, Tanja/0000-0002-5091-7779; O'Rahilly, Stephen/0000-0003-2199-4449; Solar, Miroslav/0000-0002-5542-552X; Farooqi, Sadaf/0000-0001-7609-3504; Lieb, Andreas/0000-0001-9567-649X; Nissen, Poul/0000-0003-0948-6628; Yeo, Giles See How/0000-0001-8823-3615; Bochukova, Elena/0000-0003-0275-1548; Voldsgaard Clausen, Michael/0000-0002-7176-5524; Tuluc, Petronel/0000-0003-3660-6138; Tops, Bastiaan/0000-0002-1699-8210; Teo, Ada/0000-0002-8832-0409; Brighton, Cheryl/0000-0002-4662-6274	NIHR Cambridge BRC; British Heart FoundationBritish Heart Foundation [PG/07/085/23349]; Wellcome TrustWellcome TrustEuropean Commission [085686/Z/08/A, 098360/Z/12/Z]; NIHR Cambridge Biomedical Research Centre (Cardiovascular); NIHR Senior Investigator award; Austin Doyle Award; Servier AustraliaServier; Wellcome Trust PhD program in Metabolic and Cardiovascular Disease; Cambridge Overseas Trust; Sun Hung Kai Properties-Kwoks' Foundation PhD program; European UnionEuropean Commission [FP7-HEALTH-2009-241592 EurOCHIP, FP7-FOOD-266408 Full4Health]; The Carlsberg FoundationCarlsberg Foundation; The Lundbeck FoundationLundbeckfonden; L'Oreal/UNESCO; Austrian Science FundAustrian Science Fund (FWF) [F44020]; University College London, UK; program PRVOUK [P037/03]; British Heart FoundationBritish Heart Foundation [FS/11/35/28871] Funding Source: researchfish; Cancer Research UKCancer Research UK [11906, 22310] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K501050/1, G0600717, MC_UU_12012/1, G0600717B, MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12012/1, G0600717, MC_UU_12012/5] Funding Source: UKRI	Cambridge, UK. We are grateful to M. Gurnell for discussion and care of many of the patients, to N. Jamieson for all the laparoscopic adrenalectomies and to A. Marker for pathological diagnosis. We thank Dr. Yasmin for providing peripheral DNA samples from healthy, normotensive subjects. We thank R. Kuc and the Human Research Tissue Bank of Addenbrooke's Hospital, which is supported by the NIHR Cambridge BRC, for help with storage of fresh adrenal tissue for the Cambridge cohort; we particularly acknowledge B. Haynes, D. Walters, K. Brown, M. Elazoui, C. Karpinskyj, M. Bromwich and K. Payne. The work was funded by the British Heart Foundation (PG/07/085/23349), the Wellcome Trust (085686/Z/08/A), the NIHR Cambridge Biomedical Research Centre (Cardiovascular) and an NIHR Senior Investigator award to M.J.B. The work was also supported by the Austin Doyle Award funded by Servier Australia (to E. A. B. A.). C. A. B. is supported by the Wellcome Trust PhD program in Metabolic and Cardiovascular Disease. J.Z. is supported by the Cambridge Overseas Trust and the Sun Hung Kai Properties-Kwoks' Foundation PhD program. G.S.H.Y. was supported by European Union FP7-HEALTH-2009-241592 EurOCHIP and FP7-FOOD-266408 Full4Health. Aarhus, Denmark. We thank J. Egebjerg Jensen for discussion of the electrophysiology data. H. P. was supported by grants from The Carlsberg Foundation, The Lundbeck Foundation and L'Oreal/UNESCO. University of Innsbruck, Austria. The work was supported by the Austrian Science Fund (F44020). University College London, UK. We thank W. Pratt for technical assistance. The work was supported by the Wellcome Trust (098360/Z/12/Z). Hradec Kralove, Czech Republic. We thank A. Ryska, who selected the most appropriate adrenal samples for the Czech cohort. Funding is provided by program PRVOUK P037/03. Nijmegen, The Netherlands. We thank J. W. M. Lenders for introducing the collaboration and for his leading role in the recruitment of the Dutch cohort.	Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; BRALEY LM, 1978, ENDOCRINOLOGY, V103, P1997, DOI 10.1210/endo-103-6-1997; Brown MJ, 1999, POSTGRAD MED J, V75, P235, DOI 10.1136/pgmj.75.882.235; Burton TJ, 2012, J CLIN ENDOCR METAB, V97, P100, DOI 10.1210/jc.2011-1537; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; CUSHMAN P, 1969, ENDOCRINOLOGY, V84, P808, DOI 10.1210/endo-84-4-808; EFTHYMIADIS A, 1993, CELL BIOL INT, V17, P1107, DOI 10.1006/cbir.1993.1043; Funder JW, 2012, HYPERTENSION, V59, P537, DOI 10.1161/HYPERTENSIONAHA.111.187682; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Kau MM, 2005, J CELL PHYSIOL, V205, P393, DOI 10.1002/jcp.20415; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lee G, 2005, ENDOCRINOLOGY, V146, P2650, DOI 10.1210/en.2004-1102; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Mazzocchi G, 2004, PEPTIDES, V25, P1269, DOI 10.1016/j.peptides.2004.05.011; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Shigematsu K, 2009, ENDOCR PATHOL, V20, P66, DOI 10.1007/s12022-009-9060-8; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Vasilyev A, 2004, J MEMBRANE BIOL, V198, P65, DOI 10.1007/s00232-004-0660-4; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wolkersdorfer GW, 1996, J CLIN ENDOCR METAB, V81, P4129, DOI 10.1210/jc.81.11.4129; Yingst DR, 1999, METABOLISM, V48, P1167, DOI 10.1016/S0026-0495(99)90133-6	31	329	335	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1055	+		10.1038/ng.2716			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	WOS:000323748200016	23913004				2022-01-24	
J	Liu, T; Ortiz, JA; Taing, L; Meyer, CA; Lee, B; Zhang, Y; Shin, H; Wong, SS; Ma, J; Lei, Y; Pape, UJ; Poidinger, M; Chen, YW; Yeung, K; Brown, M; Turpaz, Y; Liu, XS				Liu, Tao; Ortiz, Jorge A.; Taing, Len; Meyer, Clifford A.; Lee, Bernett; Zhang, Yong; Shin, Hyunjin; Wong, Swee S.; Ma, Jian; Lei, Ying; Pape, Utz J.; Poidinger, Michael; Chen, Yiwen; Yeung, Kevin; Brown, Myles; Turpaz, Yaron; Liu, X. Shirley			Cistrome: an integrative platform for transcriptional regulation studies	GENOME BIOLOGY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MODEL-BASED ANALYSIS; CHIP-CHIP; BINDING; BIOCONDUCTOR; ARCHIVE; ARRAYS; SITES	The increasing volume of ChIP-chip and ChIP-seq data being generated creates a challenge for standard, integrative and reproducible bioinformatics data analysis platforms. We developed a web-based application called Cistrome, based on the Galaxy open source framework. In addition to the standard Galaxy functions, Cistrome has 29 ChIP-chip- and ChIP-seq-specific tools in three major categories, from preliminary peak calling and correlation analyses to downstream genome feature association, gene expression analyses, and motif discovery. Cistrome is available at http://cistrome.org/ap/.	[Liu, Tao; Taing, Len; Shin, Hyunjin; Brown, Myles; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Liu, Tao; Taing, Len; Meyer, Clifford A.; Shin, Hyunjin; Pape, Utz J.; Chen, Yiwen; Liu, X. Shirley] Harvard Univ, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Liu, Tao; Taing, Len; Meyer, Clifford A.; Shin, Hyunjin; Pape, Utz J.; Chen, Yiwen; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Ortiz, Jorge A.; Lee, Bernett; Wong, Swee S.; Poidinger, Michael; Yeung, Kevin; Turpaz, Yaron] Lilly Singapore Ctr Drug Discovery, Singapore 138648, Singapore; [Ortiz, Jorge A.] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Lee, Bernett; Poidinger, Michael] Singapore Immunol Network, Singapore 138648, Singapore; [Zhang, Yong; Ma, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Wong, Swee S.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Lei, Ying] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Yeung, Kevin] Jardine Lloyd Thompson Asia, Singapore 048583, Singapore; [Brown, Myles] Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Turpaz, Yaron] AstraZeneca Pharmaceut LP, Waltham, MA 02451 USA		Brown, M (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.	myles_brown@dfci.harvard.edu; yaron.turpaz@astrazeneca.com; xsliu@jimmy.harvard.edu	Brown, Myles/B-6906-2008; Liu, Tao/AAO-6310-2021; Brown, Myles/AAX-5332-2021; Zhang, Yong/B-4838-2011; Liu, Tao/G-3585-2010	Liu, Tao/0000-0002-8818-8313; Brown, Myles/0000-0002-8213-1658; Zhang, Yong/0000-0001-6316-2734; Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0003-0446-9001; Poidinger, Michael/0000-0002-1047-2277; Liu, Xiaole/0000-0003-4736-7339	Dana-Farber Cancer Institute; National Basic Research Program of China grant 973 ProgramNational Basic Research Program of China [2010CB944904]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG004069-04S1, DK074967, DK062434]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK074967, U19DK062434, R56DK074967] Funding Source: NIH RePORTER	Cistrome was developed by the Cistrome team at both the Dana-Farber Cancer Institute and Eli Lilly and Company. We thank Lingling Shen, Wenbo Wang, Jacqueline Wentz, Josiah Altschuler and Kar Joon Chew for their contributions to the system implementation. We also thank the many collaborators who gave us suggestions and feedback. This work is supported by the Dana-Farber Cancer Institute High Tech and Campaign Technology Fund (XSL), the National Basic Research Program of China grant 973 Program No. 2010CB944904 (YZ), NIH grants HG004069-04S1 (LT), DK074967 (MB) and DK062434 (TL).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], CISTR PROJ BITB; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Chen YW, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r11; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Liu YY, 2004, GENOME RES, V14, P451, DOI 10.1101/gr.1327604; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meyer CA, 2011, BIOINFORMATICS, V27, P1867, DOI 10.1093/bioinformatics/btr279; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Wang T, 2005, P NATL ACAD SCI USA, V102, P17400, DOI 10.1073/pnas.0505147102; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Xie Z, 2010, BIOINFORMATICS, V26, P287, DOI 10.1093/bioinformatics/btp631; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	40	329	331	1	25	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2011	12	8							R83	10.1186/gb-2011-12-8-r83			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	843CI	WOS:000296649500013	21859476	Green Published, hybrid			2022-01-24	
J	Wan, XA; Yang, C; Yang, QA; Xue, H; Fan, XD; Tang, NLS; Yu, WC				Wan, Xiang; Yang, Can; Yang, Qiang; Xue, Hong; Fan, Xiaodan; Tang, Nelson L. S.; Yu, Weichuan			BOOST: A Fast Approach to Detecting Gene-Gene Interactions in Genome-wide Case-Control Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYPE-1 DIABETES SUSCEPTIBILITY; CLASS-II MOLECULES; EPISTASIS; ASSOCIATION; MODELS	Gene-gene interactions have long been recognized to be fundamentally important for understanding genetic causes of complex disease traits. At present, identifying gene-gene interactions from genome-wide case-control studies is computationally and methodologically challenging. In this paper, we introduce a simple but powerful method, named "BOolean Operation-based Screening and Testing" (BOOST). For the discovery of unknown gene-gene interactions that underlie complex diseases, BOOST allows examination of all pairwise interactions in genome-wide case-control studies in a remarkably fast manner. We have carried out interaction analyses on seven data sets from the Wellcome Trust Case Control Consortium (WTCCC). Each analysis took less than 60 hr to completely evaluate all pairs of roughly 360,000 SNPs on a standard 3.0 GHz desktop with 4G memory running the Windows XP system. The interaction patterns identified from the type 1 diabetes data set display significant difference from those identified from the rheumatoid arthritis data set, although both data sets share a very similar hit region in the WTCCC report. BOOST has also identified some disease-associated interactions between genes in the major histocompatibility complex region in the type 1 diabetes data set. We believe that our method can serve as a computationally and statistically useful tool in the coming era of large-scale interaction mapping in genome-wide case-control studies.	[Wan, Xiang; Yang, Can; Yu, Weichuan] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Yang, Qiang] Hong Kong Univ Sci & Technol, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Xue, Hong] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Fan, Xiaodan] Chinese Univ Hong Kong, Dept Stat, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Lab Genet Dis Susceptibil, Hong Kong, Hong Kong, Peoples R China		Yu, WC (corresponding author), Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China.	eeyu@ust.hk	Yang, Can/T-6073-2018; Fan, Xiaodan/Q-2208-2018; Tang, Nelson L/P-5018-2017; YANG, Can/J-8790-2014	Yang, Can/0000-0002-4407-3055; Fan, Xiaodan/0000-0002-2744-9030; Tang, Nelson L/0000-0002-3607-5819; YANG, Can/0000-0003-3368-3082; Yang, Qiang/0000-0001-5059-8360; Xue, Hong/0000-0002-8133-9828; Yu, Weichuan/0000-0002-5510-6916	Hong Kong Research Grant CouncilHong Kong Research Grants Council [GRF621707]; Hong Kong University of Science and Technology [RPC06/07.EG09, RPC07/08.EG25, RPC10EG04]; Sir Michael and Lady Kadoorie Funded Research Into Cancer Genetics	We thank the editor and the anonymous reviewers for their constructive suggestions and comments. This work was partially supported with grant GRF621707 from the Hong Kong Research Grant Council, grants RPC06/07.EG09, RPC07/08.EG25, and RPC10EG04 from the Hong Kong University of Science and Technology, and a grant from Sir Michael and Lady Kadoorie Funded Research Into Cancer Genetics.	AGRESTI A, 2002, WILEY SERIES PROBABI; BATESON W, 2009, MENDELS PRINCIPLES H; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Dudek Scott M, 2006, Pac Symp Biocomput, P499, DOI 10.1142/9789812701626_0046; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Herold C, 2009, BIOINFORMATICS, V25, P3275, DOI 10.1093/bioinformatics/btp596; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Husain Z, 2008, J AUTOIMMUN, V30, P266, DOI 10.1016/j.jaut.2007.10.006; Lechler R., 2000, HLA HLTH DIS, V2nd; LERNER IM, 1968, HEREDITY EVOLUTION S; LEVY J, 1972, GENETICS, V72, P117; Li J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-44; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Matsuda H, 2000, PHYS REV E, V62, P3096, DOI 10.1103/PhysRevE.62.3096; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rocha N, 2008, EMBO J, V27, P1, DOI 10.1038/sj.emboj.7601945; Schwarz DF, 2010, BIOINFORMATICS, V26, P1752, DOI 10.1093/bioinformatics/btq257; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Villadangos JA, 2001, MOL IMMUNOL, V38, P329, DOI 10.1016/S0161-5890(01)00069-4; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	39	329	342	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					325	340		10.1016/j.ajhg.2010.07.021			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	WOS:000281923500002	20817139	Green Published, Green Submitted, Bronze			2022-01-24	
J	Parchman, TL; Geist, KS; Grahnen, JA; Benkman, CW; Buerkle, CA				Parchman, Thomas L.; Geist, Katherine S.; Grahnen, Johan A.; Benkman, Craig W.; Buerkle, C. Alex			Transcriptome sequencing in an ecologically important tree species: assembly, annotation, and marker discovery	BMC GENOMICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GYPSY-LIKE RETROTRANSPOSON; MICROSATELLITE MARKERS; TRANSPOSABLE ELEMENTS; ASSOCIATION GENETICS; POPULATION GENOMICS; SNP DISCOVERY; PINE; DNA; COEVOLUTION	Background: Massively parallel sequencing of cDNA is now an efficient route for generating enormous sequence collections that represent expressed genes. This approach provides a valuable starting point for characterizing functional genetic variation in non-model organisms, especially where whole genome sequencing efforts are currently cost and time prohibitive. The large and complex genomes of pines (Pinus spp.) have hindered the development of genomic resources, despite the ecological and economical importance of the group. While most genomic studies have focused on a single species (P. taeda), genomic level resources for other pines are insufficiently developed to facilitate ecological genomic research. Lodgepole pine (P. contorta) is an ecologically important foundation species of montane forest ecosystems and exhibits substantial adaptive variation across its range in western North America. Here we describe a sequencing study of expressed genes from P. contorta, including their assembly and annotation, and their potential for molecular marker development to support population and association genetic studies. Results: We obtained 586,732 sequencing reads from a 454 GS XLR70 Titanium pyrosequencer (mean length: 306 base pairs). A combination of reference-based and de novo assemblies yielded 63,657 contigs, with 239,793 reads remaining as singletons. Based on sequence similarity with known proteins, these sequences represent approximately 17,000 unique genes, many of which are well covered by contig sequences. This sequence collection also included a surprisingly large number of retrotransposon sequences, suggesting that they are highly transcriptionally active in the tissues we sampled. We located and characterized thousands of simple sequence repeats and single nucleotide polymorphisms as potential molecular markers in our assembled and annotated sequences. High quality PCR primers were designed for a substantial number of the SSR loci, and a large number of these were amplified successfully in initial screening. Conclusions: This sequence collection represents a major genomic resource for P. contorta, and the large number of genetic markers characterized should contribute to future research in this and other pines. Our results illustrate the utility of next generation sequencing as a basis for marker development and population genomics in non-model species.	[Parchman, Thomas L.; Buerkle, C. Alex] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Geist, Katherine S.] Beloit Coll, Dept Biol, Beloit, WI 53511 USA; [Grahnen, Johan A.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Benkman, Craig W.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA		Parchman, TL (corresponding author), Univ Wyoming, Dept Bot, Laramie, WY 82071 USA.	tparchma@uwyo.edu		Geist, Katherine/0000-0002-5311-8913; Buerkle, Alex/0000-0003-4222-8858	NSF DBINational Science Foundation (NSF) [0701757]; NSF DEBNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0344503]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	We appreciate constructive comments on earlier versions of the manuscript from Zach Gompert and three anonymous reviewers. An NSF DBI award (0701757) to C. A. Buerkle and an NSF DEB award (0344503) to C. W. Benkman supported this work. K. Geist was supported by an NIH INBRE program at the University of Wyoming for training undergraduates in bioinformatics. We thank DNAstar for technical guidance and expertise and for graciously allowing use of their Seqman NGen and Lasergene software packages.	ALLEX CF, 1997, P INT C INT SYST MOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; ARNO SF, 1980, J FOREST, V78, P460; Avise JC, 2004, NATURAL HIST EVOLUTI; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Benkman CW, 2004, ECOLOGY, V85, P2082, DOI 10.1890/04-0177; Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; Benkman CW, 2001, EVOLUTION, V55, P282, DOI 10.1111/j.0014-3820.2001.tb01293.x; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Burns R.M., 1990, AGR HDB, V654, P1; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CRITCHFIELD WB, 1980, WO37 US FOR SERV RES; DeMarco R, 2004, J VIROL, V78, P2967, DOI 10.1128/JVI.78.6.2967-2978.2004; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gonzalez-Martinez SC, 2006, NEW PHYTOL, V170, P227, DOI 10.1111/j.1469-8137.2006.01686.x; Guerrero FD, 2009, J MED ENTOMOL, V46, P1109, DOI 10.1603/033.046.0518; Guevara M. A., 2005, Investigacion Agraria, Sistemas y Recursos Forestales, V14, P292; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hata K, 1998, CAN J BOT, V76, P245, DOI 10.1139/cjb-76-2-245; Hicke JA, 2008, FOREST ECOL MANAG, V255, P1536, DOI 10.1016/j.foreco.2007.11.027; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kossack DS, 1999, PLANT MOL BIOL, V39, P417, DOI 10.1023/A:1006115732620; Kristiansson E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-345; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Lomax J, 2005, BRIEF BIOINFORM, V6, P298, DOI 10.1093/bib/6.3.298; LOTAN JE, 1975, S MAN LODG PIN EC WA, P471; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2007, CURR OPIN GENET DEV, V17, P539, DOI 10.1016/j.gde.2007.10.002; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; SMITH CC, 1970, ECOL MONOGR, V40, P349, DOI 10.2307/1942287; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vicient CM, 2001, PLANT PHYSIOL, V125, P1283, DOI 10.1104/pp.125.3.1283; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WHEAT CW, 2008, GENETICA; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	71	329	352	1	91	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	MAR 16	2010	11								180	10.1186/1471-2164-11-180			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	581UH	WOS:000276549800001	20233449	Green Published, gold			2022-01-24	
J	Eeles, RA; Kote-Jarai, Z; Al Olama, AA; Giles, GG; Guy, M; Severi, G; Muir, K; Hopper, JL; Henderson, BE; Haiman, CA; Schleutker, J; Hamdy, FC; Neal, DE; Donovan, JL; Stanford, JL; Ostrander, EA; Ingles, SA; John, EM; Thibodeau, SN; Schaid, D; Park, JY; Spurdle, A; Clements, J; Dickinson, JL; Maier, C; Vogel, W; Dork, T; Rebbeck, TR; Cooney, KA; Cannon-Albright, L; Chappuis, PO; Hutter, P; Zeegers, M; Kaneva, R; Zhang, HW; Lu, YJ; Foulkes, WD; English, DR; Leongamornlert, DA; Tymrakiewicz, M; Morrison, J; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Wilkinson, RA; Saunders, EJ; Page, EC; Sawyer, EJ; Edwards, SM; Dearnaley, DP; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Van As, N; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Cooper, CS; Southey, MC; Lophatananon, A; Liu, JF; Kolonel, LN; Le Marchand, L; Wahlfors, T; Tammela, TL; Auvinen, A; Lewis, SJ; Cox, A; FitzGerald, LM; Koopmeiners, JS; Karyadi, DM; Kwon, EM; Stern, MC; Corral, R; Joshi, AD; Shahabi, A; McDonnell, SK; Sellers, TA; Pow-Sang, J; Chambers, S; Aitken, J; Gardiner, RA; Batra, J; Kedda, MA; Lose, F; Polanowski, A; Patterson, B; Serth, J; Meyer, A; Luedeke, M; Stefflova, K; Ray, AM; Lange, EM; Farnham, J; Khan, H; Slavov, C; Mitkova, A; Cao, GW; Easton, DF				Eeles, Rosalind A.; Kote-Jarai, Zsofia; Al Olama, Ali Amin; Giles, Graham G.; Guy, Michelle; Severi, Gianluca; Muir, Kenneth; Hopper, John L.; Henderson, Brian E.; Haiman, Christopher A.; Schleutker, Johanna; Hamdy, Freddie C.; Neal, David E.; Donovan, Jenny L.; Stanford, Janet L.; Ostrander, Elaine A.; Ingles, Sue A.; John, Esther M.; Thibodeau, Stephen N.; Schaid, Daniel; Park, Jong Y.; Spurdle, Amanda; Clements, Judith; Dickinson, Joanne L.; Maier, Christiane; Vogel, Walther; Doerk, Thilo; Rebbeck, Timothy R.; Cooney, Kathleen A.; Cannon-Albright, Lisa; Chappuis, Pierre O.; Hutter, Pierre; Zeegers, Maurice; Kaneva, Radka; Zhang, Hong-Wei; Lu, Yong-Jie; Foulkes, William D.; English, Dallas R.; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Morrison, Jonathan; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Saunders, Edward J.; Page, Elizabeth C.; Sawyer, Emma J.; Edwards, Stephen M.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Cooper, Colin S.; Southey, Melissa C.; Lophatananon, Artitaya; Liu, Jo-Fen; Kolonel, Laurence N.; Le Marchand, Loic; Wahlfors, Tiina; Tammela, Teuvo L.; Auvinen, Anssi; Lewis, Sarah J.; Cox, Angela; FitzGerald, Liesel M.; Koopmeiners, Joseph S.; Karyadi, Danielle M.; Kwon, Erika M.; Stern, Mariana C.; Corral, Roman; Joshi, Amit D.; Shahabi, Ahva; McDonnell, Shannon K.; Sellers, Thomas A.; Pow-Sang, Julio; Chambers, Suzanne; Aitken, Joanne; Gardiner, R. A. (Frank); Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity; Polanowski, Andrea; Patterson, Briony; Serth, Juergen; Meyer, Andreas; Luedeke, Manuel; Stefflova, Klara; Ray, Anna M.; Lange, Ethan M.; Farnham, Jim; Khan, Humera; Slavov, Chavdar; Mitkova, Atanaska; Cao, Guangwen; Easton, Douglas F.		British Assoc Urological Surg; UK ProtecT Study Collaborators; PRACTICAL Consortium	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study	NATURE GENETICS			English	Article							AUSTRALIAN CASE-CONTROL; MULTIPLE; RISK; VARIANTS; ANTIGEN	Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To identify common PrCa susceptibility alleles, we previously conducted a genome-wide association study in which 541,129 SNPs were genotyped in 1,854 PrCa cases with clinically detected disease and in 1,894 controls. We have now extended the study to evaluate promising associations in a second stage in which we genotyped 43,671 SNPs in 3,650 PrCa cases and 3,940 controls and in a third stage involving an additional 16,229 cases and 14,821 controls from 21 studies. In addition to replicating previous associations, we identified seven new prostate cancer susceptibility loci on chromosomes 2, 4, 8, 11 and 22 (with P = 1.6 x 10(-8) to P = 2.7 x 10(-33)).	[Eeles, Rosalind A.; Kote-Jarai, Zsofia; Guy, Michelle; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Saunders, Edward J.; Page, Elizabeth C.; Sawyer, Emma J.; Edwards, Stephen M.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.] Inst Canc Res, Surrey, England; [Eeles, Rosalind A.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Page, Elizabeth C.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv Fdn Trust, Surrey, England; [Eeles, Rosalind A.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Page, Elizabeth C.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv Fdn Trust, London, England; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Dept Publ Hlth & Primary Care, Strangeways Lab, Cambridge, England; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Giles, Graham G.; Severi, Gianluca; Hopper, John L.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Muir, Kenneth; Lophatananon, Artitaya; Liu, Jo-Fen] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schleutker, Johanna; Wahlfors, Tiina] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Neal, David E.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Donovan, Jenny L.; Lewis, Sarah J.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Stanford, Janet L.; FitzGerald, Liesel M.; Koopmeiners, Joseph S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; [Ostrander, Elaine A.; Karyadi, Danielle M.; Kwon, Erika M.] NHGRI, NIH, Bethesda, MD 20892 USA; [John, Esther M.] No Calif Canc Ctr, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Thibodeau, Stephen N.; Schaid, Daniel; McDonnell, Shannon K.] Mayo Clin, Rochester, MN USA; [Park, Jong Y.; Sellers, Thomas A.; Pow-Sang, Julio] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA; [Spurdle, Amanda; Lose, Felicity] Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Dickinson, Joanne L.; Polanowski, Andrea; Patterson, Briony] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Maier, Christiane; Vogel, Walther; Luedeke, Manuel] Inst Human Genet & Anthropol, Ulm, Germany; [Doerk, Thilo] Hannover Med Sch, Clin Obstet, D-3000 Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, D-3000 Hannover, Germany; [Rebbeck, Timothy R.; Stefflova, Klara] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.; Stefflova, Klara] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Cooney, Kathleen A.; Ray, Anna M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Cooney, Kathleen A.; Ray, Anna M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Cannon-Albright, Lisa; Farnham, Jim] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Med Genet, Geneva, Switzerland; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland; [Hutter, Pierre] Inst Cent Hop Valaisans, Div Med Genet, Sion, Switzerland; [Zeegers, Maurice; Khan, Humera] Univ Birmingham, Unit Genet Epidemiol, Dept Publ Hlth Epidemiol & Biostat, Sch Med, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice] Maastricht Univ, Dept Complex Genet, Cluster Genet & Cell Biol, Nutr & Toxicol Res Inst,Med Ctr, Maastricht, Netherlands; [Kaneva, Radka; Mitkova, Atanaska] Med Univ Sofia, Mol Med Ctr, Sofia, Bulgaria; [Kaneva, Radka; Mitkova, Atanaska] Med Univ Sofia, Dept Chem & Biochem, Sofia, Bulgaria; [Zhang, Hong-Wei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Lu, Yong-Jie] Univ London, Inst Canc, Barts & London Sch Med & Dent, London, England; [Foulkes, William D.] McGill Univ, Program Canc Genet, Montreal, PQ, Canada; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Lophatananon, Artitaya] Chulabhorn Canc Res Ctr, Bangkok, Thailand; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Tammela, Teuvo L.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Cox, Angela] Univ Sheffield, Inst Canc Studies, Sheffield, S Yorkshire, England; [Koopmeiners, Joseph S.] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Chambers, Suzanne; Aitken, Joanne] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Aitken, Joanne] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gardiner, R. A. (Frank)] Univ Queensland, Dept Surg, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Serth, Juergen] Hannover Med Sch, Urol Clin, D-3000 Hannover, Germany; [Serth, Juergen] Hannover Med Sch, Clin Urol Oncol, D-3000 Hannover, Germany; [Meyer, Andreas] Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany; [Lange, Ethan M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Slavov, Chavdar] Med Univ Sofia, Dept Urol, Alexandrovska Univ Hosp, Sofia, Bulgaria		Eeles, RA (corresponding author), Inst Canc Res, Surrey, England.	rosalind.eeles@icr.ac.uk	Severi, Gianluca/Q-1824-2019; Auvinen, Anssi/AAL-2111-2020; English, Dallas/AAH-5005-2019; Foulkes, William D./AAR-9586-2021; Severi, Gianluca/H-3774-2018; Batra, Jyotsna/B-4130-2011; Spurdle, Amanda B/A-4978-2011; Griffiths, TR Leyshon/K-7433-2019; Chambers, Suzanne K/C-5508-2009; Kaneva, Radka P/V-6535-2017; Dickinson, Joanne/J-7728-2014; Chambers, Suzanne K/H-5957-2012; Auvinen, Anssi/AAD-9311-2020; Thomson, Russell J/H-5653-2012; Dork, Thilo/J-8620-2012; Dearnaley, David P/J-2318-2014; Kaneva, Radka/AAT-5322-2021; O'Mara, Tracy/M-7508-2016; Aitken, Joanne F/C-5289-2009; Gardiner, Robert/G-2096-2010; Wahlfors, Tiina/U-7635-2018	Severi, Gianluca/0000-0001-7157-419X; Auvinen, Anssi/0000-0003-1125-4818; English, Dallas/0000-0001-7828-8188; Foulkes, William D./0000-0001-7427-4651; Severi, Gianluca/0000-0001-7157-419X; Spurdle, Amanda B/0000-0003-1337-7897; Griffiths, TR Leyshon/0000-0002-3879-0664; Kaneva, Radka P/0000-0002-1437-1393; Chambers, Suzanne K/0000-0003-2369-6111; Thomson, Russell J/0000-0003-4949-4120; Dork, Thilo/0000-0002-9458-0282; Dearnaley, David P/0000-0002-3954-2806; O'Mara, Tracy/0000-0002-5436-3232; Lewis, Sarah/0000-0003-4311-6890; Giles, Graham/0000-0003-4946-9099; Bancroft, Elizabeth/0000-0002-5482-5660; Neal, David/0000-0002-6033-5086; Evans, Gareth/0000-0002-8482-5784; Ostrander, Elaine/0000-0001-6075-9738; Barsi, Klara/0000-0001-9338-0468; Hamdy, Freddie/0000-0003-2627-2154; Cooney, Kathleen/0000-0003-3831-6943; Mitev, Vanyo/0000-0001-7528-590X; Lu, Yong-Jie/0000-0001-6174-6621; Adeyoju, Adebanji/0000-0003-4010-5985; Schleutker, Johanna/0000-0002-1863-0305; Aitken, Joanne/0000-0001-6859-2186; Southey, Melissa/0000-0002-6313-9005; Lose, Felicity/0000-0001-8337-3547; McDonnell, Shannon/0000-0001-6201-369X; Dickinson, Joanne/0000-0003-4621-1703; albright, lisa/0000-0003-2602-3668; Saunders, Ed/0000-0003-4343-3570; Hickish, Tamas/0000-0001-6770-7279; FitzGerald, Liesel/0000-0002-6882-2698; Eeles, Rosalind/0000-0002-3698-6241; Wahlfors, Tiina/0000-0002-3910-796X; Clarke, Noel/0000-0001-7776-8059; Clements, Judith/0000-0001-6026-1964; Graham, John/0000-0003-3381-9787; huddart, robert/0000-0003-3604-1990; Alexander, Kimberly/0000-0003-3906-2412; Polanowski, Andrea/0000-0002-9612-220X; Karyadi, Danielle/0000-0003-4164-5625; van As, Nicholas/0000-0001-6829-8788; Surowy, Harald/0000-0002-3595-9188; Cox, Angela/0000-0002-5138-1099; McLaren, Duncan/0000-0002-9862-4158; batra, Jyotsna/0000-0003-4646-6247; Leongamornlert, Daniel/0000-0002-3486-3168; Farnham, James/0000-0002-8213-949X	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0501019, G0500966] Funding Source: UKRI; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA072818, R01CA063464, R01CA092579, R01CA056678, P50CA069568, U01CA089600, R01CA128813, R37CA054281, U01CA063464, R01CA084979, P50CA105641, R01CA054281, P50CA097186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007814] Funding Source: NIH RePORTER; Cancer Research UKCancer Research UK [C1287/A10118, C5047/A7357, 10118, 10588, C16913/A6835, 11022, C16913/A6135, C5047/A3354, C5047/A10692, C522/A8649] Funding Source: Medline; Department of HealthEuropean Commission Funding Source: Medline; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500966, G0501019] Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA63464, U01 CA089600-04, U01 CA089600, CA56678, N01-PC-35141, R01 CA128813-02, R01 CA084979-05, R01 CA084979, R01 CA072818-09, CA97186, R01CA84979, R01 CA056678-05, P50 CA097186, CA54281, R37 CA054281-17, R01 CA128813, P50 CA069568-12, R01 CA072818, CA92579, R01 CA063464, R37 CA054281, P50 CA069568, R01 CA092579, P50 CA105641-05, P50 CA097186-08, R01 CA063464-10, R01CA128813, R01 CA092579-05, P50 CA105641, N01 PC035141] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00064, M01 RR000064-41] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007814] Funding Source: Medline		Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Donovan J, 2003, Health Technol Assess, V7, P1; Eeles R, 2008, NAT GENET, V40, P1035, DOI 10.1038/ng0908-1035; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Severi G, 2003, J NATL CANCER I, V95, P818, DOI 10.1093/jnci/95.11.818; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Witte JS, 2009, NAT REV GENET, V10, P77, DOI 10.1038/nrg2507; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	17	329	337	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1116	U97		10.1038/ng.450			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	WOS:000270330400016	19767753	Green Submitted, Green Accepted			2022-01-24	
J	Carter, NP				Carter, Nigel P.			Methods and strategies for analyzing copy number variation using DNA microarrays	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; CDNA MICROARRAYS; ARRAY CGH; STRUCTURAL VARIATION; BREAST-CANCER; RESOLUTION; SEQUENCE; OLIGONUCLEOTIDES; IDENTIFICATION	The association of DNA copy-number variation (CNV) with specific gene function and human disease has been long known, but the wide scope and prevalence of this form of variation has only recently been fully appreciated. The latest studies using microarray technology have demonstrated that as much as 12% of the human genome and thousands of genes are variable in copy number, and this diversity is likely to be responsible for a significant proportion of normal phenotypic variation. Current challenges involve developing methods not only for detecting and cataloging CNVs in human populations at increasingly higher resolution but also for determining the association of CNVs with biological function, recent human evolution, and common and complex human disease.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England		Carter, NP (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	npc@sanger.ac.uk			Wellcome TrustWellcome TrustEuropean Commission [077008] Funding Source: Medline		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gribble SM, 2007, J MED GENET, V44, P51, DOI 10.1136/jmg.2006.044909; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; JACOBS PA, 1959, LANCET, V1, P710; Kallioniemi Anne, 1996, Methods (Orlando), V9, P113, DOI 10.1006/meth.1996.0015; KALLIONIEMI OP, 1993, SEMIN CANCER BIOL, V4, P41; Kauraniemi P, 2001, CANCER RES, V61, P8235; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; KUNZE J, 1980, NEUROPEDIATRICS, V11, P203, DOI 10.1055/s-2008-1071392; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Lejeune J, 1965, Ann Genet, V8, P11; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Mantripragada KK, 2003, J MOL MED-JMM, V81, P443, DOI 10.1007/s00109-003-0458-3; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mir KU, 2000, ANNU REV GENOM HUM G, V1, P329, DOI 10.1146/annurev.genom.1.1.329; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; MORTON CC, 1981, ACTA GENET MED GEMEL, V30, P39, DOI 10.1017/S0001566000006607; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SEDANO H O, 1971, Birth Defects Original Article Series, V7, P89; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VERMA RS, 1977, HUM GENET, V38, P231, DOI 10.1007/BF00527408; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	52	329	352	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S16	S21		10.1038/ng2028			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	WOS:000253974400004	17597776	Green Accepted			2022-01-24	
J	Freeling, M; Thomas, BC				Freeling, Michael; Thomas, Brian C.			Gene-balanced duplications, like tetraploidy, provide predictable drive to increase morphological complexity	GENOME RESEARCH			English	Article							CONSERVED NONCODING SEQUENCES; GENOME DUPLICATION; ANCIENT DUPLICATION; EVOLUTION; EXPRESSION; DIVERGENCE; ORIGIN; PRESERVATION; SEGREGATION; POLYPLOIDY	Controversy surrounds the apparent rising maximums of morphological complexity during eukaryotic evolution, with organisms increasing the number and nestedness of developmental areas as evidenced by morphological elaborations reflecting area boundaries. No "predictable drive" to increase this sort of complexity has been reported. Recent genetic data and theory in the general area of gene dosage effects has engendered a robust "gene balance hypothesis," with a theoretical base that makes specific predictions as to gene content changes following different types of gene duplication. Genomic data from both chordate and angiosperm genomes fit these predictions: Each type of duplication provides a one-way injection of a biased set of genes into the gene pool. Tetraploidies and balanced segments inject bias for those genes whose products are the subunits of the most complex biological machines or cascades, like transcription factors (TFs) and proteasome core proteins. Most duplicate genes are removed after tetraploidy. Genic balance is maintained by not removing those genes that are dose-sensitive, which tends to leave duplicate " functional modules" as the indirect products (spandrels) of purifying selection. Functional modules are the likely precursors of coadapted gene complexes, a unit of natural selection. The result is a predictable drive mechanism where " drive" is used rigorously, as in " meiotic drive." Rising morphological gain is expected given a supply of duplicate functional modules. All flowering plants have survived at least three large-scale duplications/diploidizations over the last 300 million years (Myr). An equivalent period of tetraploidy and body plan evolution may have ended for animals 500 million years ago (Mya). We argue that " balanced gene drive" is a sufficient explanation for the trend that the maximums of morphological complexity have gone up, and not down, in both plant and animal eukaryotic lineages.	Univ Calif Berkeley, Dept Plant & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Coll Nat Resources, Berkeley, CA 94720 USA		Freeling, M (corresponding author), Univ Calif Berkeley, Dept Plant & Mol Biol, Berkeley, CA 94720 USA.	freeling@nature.berkeley.edu					Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI [10.1016/j.pbi.2005.01.001, 10.1016/j.gde.2015.11.003]; Banks JA, 1999, ANNU REV PLANT PHYS, V50, P163, DOI 10.1146/annurev.arplant.50.1.163; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buckler ES, 1999, GENETICS, V153, P415; Carles CC, 2003, TRENDS PLANT SCI, V8, P394, DOI 10.1016/S1360-1385(03)00164-X; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Chapman BA, 2004, BIOINFORMATICS, V20, P180, DOI 10.1093/bioinformatics/bth022; DARWIN C, 1859, ORIGIN SPECIES, P674; DAVIDSON EH, 1995, SCIENCE, V270, P1319, DOI 10.1126/science.270.5240.1319; Dawkins R., 1986, BLIND WATCHMAKER; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Force A, 1999, GENETICS, V151, P1531; Freeman S., 2004, EVOLUTIONARY ANAL, V4 ed; Friis EM, 2005, CURR OPIN PLANT BIOL, V8, P5, DOI 10.1016/j.pbi.2004.11.006; Furlong RF, 2004, BIOL J LINN SOC, V82, P425, DOI 10.1111/j.1095-8312.2004.00329.x; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Goldschmidt RB, 1953, AM SCI, V40, P84; GOULD S, 1995, 3 CULTURE SCI REVOLU, pCH5; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Haldane JBS, 1933, AM NAT, V67, P5, DOI 10.1086/280465; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LEWIS EB, 1951, COLD SPRING HARB SYM, V16, P159, DOI 10.1101/SQB.1951.016.01.014; Li HY, 2005, NAT BIOTECHNOL, V23, P253, DOI 10.1038/nbt1065; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2000, GENETICS, V154, P459; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; MAYNARDSMITH J, 1995, MAJOR TRANSITIONS EV; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; McShea DW, 1998, ANNU REV ECOL SYST, V29, P293, DOI 10.1146/annurev.ecolsys.29.1.293; McShea DW, 1996, EVOLUTION, V50, P477, DOI 10.1111/j.1558-5646.1996.tb03861.x; MORGAN TH, 1925, EVOLUTION GENETICS, V154, P459; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Ohno S., 1970, EVOLUTION GENE DUPLI; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Paterson AH, 2005, NEW PHYTOL, V165, P658, DOI 10.1111/j.1469-8137.2005.01347.x; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; PIERCE BA, 1979, J HERPETOL, V13, P119, DOI 10.2307/1563766; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Raes Jeroen, 2003, Appl Bioinformatics, V2, P91; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rhoades MM, 1942, GENETICS, V27, P0395; Roth G, 1997, BRAIN BEHAV EVOLUT, V50, P50, DOI 10.1159/000113321; Schilthuizen M, 2000, BIOESSAYS, V22, P1134, DOI 10.1002/1521-1878(200012)22:12<1134::AID-BIES11>3.0.CO;2-5; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Simillion C, 2004, GENOME RES, V14, P1095, DOI 10.1101/gr.2179004; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tian Chao-Guang, 2005, Acta Genetica Sinica, V32, P519; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; Wagner A, 2002, MOL BIOL EVOL, V19, P1760, DOI 10.1093/oxfordjournals.molbev.a003998; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Wilkins, 2002, EVOLUTION DEV PATHWA; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Williams EJB, 2002, J MOL EVOL, V54, P511, DOI 10.1007/s00239-001-0043-8; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yuh CH, 2001, DEVELOPMENT, V128, P617; [No title captured]	96	329	340	0	54	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2006	16	7					805	814		10.1101/gr.3681406			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	059DB	WOS:000238712400001	16818725	Bronze			2022-01-24	
J	Berezikov, E; Cuppen, E; Plasterk, RHA				Berezikov, Eugene; Cuppen, Edwin; Plasterk, Ronald H. A.			Approaches to microRNA discovery	NATURE GENETICS			English	Article							NONCODING RNAS; COMPUTATIONAL IDENTIFICATION; MAMMALIAN MICRORNAS; GENE-EXPRESSION; PREDICTION; ZEBRAFISH; SEQUENCE; CONSERVATION; PRECURSORS; MIRNAS	MicroRNAs (miRNAs) are noncoding RNAs that can regulate gene expression. Several hundred genes encoding miRNAs have been experimentally identified in animals, and many more are predicted by computational methods. How can new miRNAs be discovered and distinguished from other types of small RNA? Here we summarize current methods for identifying and validating miRNAs and discuss criteria used to define an miRNA.	[Berezikov, Eugene; Cuppen, Edwin; Plasterk, Ronald H. A.] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands		Berezikov, E (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Berezikov, Eugene/D-3363-2013; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Berezikov, Eugene/0000-0002-1145-2884; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542			Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Devor EJ, 2006, J HERED, V97, P186, DOI 10.1093/jhered/esj022; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Huttenhofer A, 2006, NUCLEIC ACIDS RES, V34, P635, DOI 10.1093/nar/gkj469; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Missal K, 2005, BIOINFORMATICS, V21, P77, DOI 10.1093/bioinformatics/bti1113; Missal K, 2006, J EXP ZOOL PART B, V306B, P379, DOI 10.1002/jez.b.21086; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474	76	329	381	2	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S2	S7		10.1038/ng1794			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	WOS:000202983200002	16736019				2022-01-24	
J	Lee, SH; Girard, S; Macina, D; Busa, M; Zafer, A; Belouchi, A; Gros, P; Vidal, SM				Lee, SH; Girard, S; Macina, D; Busa, M; Zafer, A; Belouchi, A; Gros, P; Vidal, SM			Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily	NATURE GENETICS			English	Article							RESISTANCE LOCUS CMV1; GENE-COMPLEX; LY49; MHC; FAMILY; MAP; CHROMOSOME-6; SPECIFICITY; RECOGNITION; EXPRESSION	Cytomegalovirus is the leading cause of congenital viral disease and the most important opportunistic infection in immunocompromised patients(1,2). We have used a mouse experimental infection model (MCMV) to study the genetic parameters of host/virus interaction. Susceptibility to infection with MCMV is controlled by Cmv1, a chromosome 6 locus that regulates natural killer (NK) cell activity against virally infected targets(3-5). Here, we use a positional cloning strategy to isolate the gene mutated at the Cmv1 locus. Cmv1 maps within a 0.35-cM interval defined by markers D6Ott8 and D6Ott115, which corresponds to a physical distance of 1.6 Mb (refs. 6-8). A transcript map of the region identified 19 genes(8), including members of the killer cell lectin-like receptor family a (Klra, formerly Ly49; refs. 9-12), which encode inhibitory or activating NK cell receptors that interact with MHC class I molecules(13-15). Klra genes have different copy numbers and genomic organization, and are highly polymorphic among inbred strains, making it difficult to distinguish between normal allelic variants and distinct Klra genes(15-17), or possible mutations associated with Cmv1. The recombinant inbred strain BXD-8/Ty (BXD-8; ref. 18), derived from Cmv1(r) C57BL/6 (B6, resistant) and Cmv1(s) DBA/2 (susceptible), is of particular interest because it is highly susceptible to MCMV infection despite having a B6 haplotype at Cmv1, We determined that MCMV susceptibility in BXD-8 is associated with the deletion of Klra8 (formerly Ly49h).	Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; Galileo Genom Inc, Montreal, PQ, Canada; McGill Univ, Dept Biochem, Montreal, PQ, Canada		Vidal, SM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.						BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; DELAINE M, 1995, PHYS WORLD, V8, P6; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Farrell H, 2000, MICROBES INFECT, V2, P521, DOI 10.1016/S1286-4579(00)00315-4; Gosselin P, 1999, J LEUKOCYTE BIOL, V66, P165, DOI 10.1002/jlb.66.1.165; HO M, 1994, TRANSPLANT P, V5, P7; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Hurme M, 1998, SCAND J INFECT DIS, V30, P447, DOI 10.1080/00365549850161403; Idris AH, 1998, J EXP MED, V188, P2243, DOI 10.1084/jem.188.12.2243; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kuboto A, 1999, J IMMUNOL, V163, P212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Makrigiannis AP, 2000, J LEUKOCYTE BIOL, V68, P765; Makrigiannis AP, 2000, IMMUNOL RES, V21, P39, DOI 10.1385/IR:21:1:39; McQueen KL, 1998, IMMUNOGENETICS, V48, P174, DOI 10.1007/s002510050421; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; SMITH HRC, 1994, J IMMUNOL, V153, P1068; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Threlkeld MG, 1995, MANDELL DOUGLAS BENN, P1351	30	329	335	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					42	45		10.1038/88247			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	WOS:000168413300013	11326273				2022-01-24	
J	Lash, AE; Tolstoshev, CM; Wagner, L; Schuler, GD; Strausberg, RL; Riggins, GJ; Altschul, SF				Lash, AE; Tolstoshev, CM; Wagner, L; Schuler, GD; Strausberg, RL; Riggins, GJ; Altschul, SF			SAGEmap: A public gene expression resource	GENOME RESEARCH			English	Article							SEQUENCE TAGS; PROFILES; DATABASE; GENOME; CANCER; CELLS	We have constructed a public gene expression data repository and online data access and analysis, WWW and FTP sites for serial analysis of gene expression (SAGE) data. The WWW and FTP components of this resource, SAGEmap, are located at http://www.ncbi.nlm.nih.gov/sage and ftp://ncbi.nlm.nih.gov/pub/sage, respectively. We herein describe SAGE data submission procedures, the construction and characteristics of SAGE tags to gene assignments, the derivation and use of a novel statistical test designed specifically for differential-type analyses of SAGE data, and the organization and use of this resource.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; NCI, NIH, Bethesda, MD 20894 USA		Lash, AE (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.		Altschul, Stephen/R-4000-2019	Lash, Alex/0000-0003-3787-1590			Aaronson JS, 1996, GENOME RES, V6, P829, DOI 10.1101/gr.6.9.829; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Chen HX, 1998, J EXP MED, V188, P1657, DOI 10.1084/jem.188.9.1657; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Lal A, 1999, CANCER RES, V59, P5403; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Strausberg RL, 1997, NAT GENET, V15, P415, DOI 10.1038/ng0497supp-415; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	13	329	346	0	8	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	JUL	2000	10	7					1051	1060		10.1101/gr.10.7.1051			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	335VE	WOS:000088264800018	10899154	Green Published, Bronze			2022-01-24	
J	Jorde, LB; Watkins, WS; Bamshad, MJ; Dixon, ME; Ricker, CE; Seielstad, MT; Batzer, MA				Jorde, LB; Watkins, WS; Bamshad, MJ; Dixon, ME; Ricker, CE; Seielstad, MT; Batzer, MA			The distribution of human genetic diversity: A comparison of mitochondrial, autosomal, and Y-chromosome data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMAN ORIGINS; DNA-SEQUENCE DIVERSITY; TANDEM REPEAT LOCI; HUMAN-EVOLUTION; POPULATION EXPANSION; ASIAN POPULATIONS; HIGH-RESOLUTION; X-CHROMOSOME; POLYMORPHISMS; PATTERNS	We report a comparison of worldwide genetic variation among 255 individuals by using autosomal, mitochondrial, and Y-chromosome polymorphisms. Variation is assessed by use of 30 autosomal restriction-site polymorphisms (RSPs), 60 autosomal short-tandem-repeat polymorphisms (STRPs), 13 Alu-insertion polymorphisms and one LINE-1: element, 611 bp of mitochondrial control-region sequence, and 10 Y-chromosome polymorphisms. Analysis of these data reveals substantial congruity among this diverse array of genetic systems. With the exception of the autosomal RSPs, in which an ascertainment bias exists, all systems show greater gene diversity in Africans than in either Europeans or Asians. Africans also have the largest total number of alleles, as well as the largest number of unique alleles, for most systems. G(ST) values are 11%-18% for the autosomal systems and are two to three times higher for the mtDNA sequence and Y-chromosome RSPs. This difference is expected because of the lower effective population size of mtDNA and Y chromosomes. A lower value is seen for Y-chromosome STRs, reflecting a relative lack of continental population structure, as a result of rapid mutation and genetic drift. Africa has higher G(ST) values than does either Europe or Asia for all systems except the Y-chromosome STRs and Alus. All systems except the Y-chromosome STRs show less variation between populations within continents than between continents. These results are reassuring in their consistency and offer broad support for an African origin of modern human populations.	Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT 84112 USA; Harvard Sch Publ Hlth, Program Populat Genet, Boston, MA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Pathol, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biometry & Genet, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biochem, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biol Mol, New Orleans, LA USA		Jorde, LB (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu	Seielstad, Mark/T-7841-2019	Seielstad, Mark/0000-0001-5783-1401	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-00064, M01 RR000064] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-52290] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000064] Funding Source: NIH RePORTER		Arcot SS, 1996, GENOME RES, V6, P1084, DOI 10.1101/gr.6.11.1084; Arcot SS, 1997, MUTAT RES-GENOMICS, V382, P5, DOI 10.1016/S1383-5726(97)00002-2; Arcot SS, 1998, J MOL BIOL, V281, P843, DOI 10.1006/jmbi.1998.1984; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza LL, 1998, TRENDS GENET, V14, P60, DOI 10.1016/S0168-9525(97)01327-9; CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; DEKA R, 1995, ELECTROPHORESIS, V16, P1659, DOI 10.1002/elps.11501601275; Deka R, 1999, MOL BIOL EVOL, V16, P1166, DOI 10.1093/oxfordjournals.molbev.a026207; DEKA R, 1995, AM J HUM GENET, V56, P461; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EXCOFFIER L, 1992, GENETICS, V131, P479; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hammer MF, 1997, GENETICS, V145, P787; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; JORDE LB, 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kimmel M, 1998, GENETICS, V148, P1921; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Lewontin R. C., 1972, EVOLUTIONARY BIOL, V6, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LI WH, 1991, GENETICS, V129, P513; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; Merriwether DA, 1997, AM J PHYS ANTHROPOL, V102, P153, DOI 10.1002/(SICI)1096-8644(199702)102:2<153::AID-AJPA1>3.0.CO;2-#; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Meyer S, 1999, GENETICS, V152, P1103; Milewicz DM, 1996, J MOL EVOL, V42, P117, DOI 10.1007/BF02198836; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; National Research Council, 1996, EV FOR DNA EV; NEI M, 1990, POPULATION BIOL GENE, P251; Nei Masatoshi, 1993, P239; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Quintana-Murci L, 1999, ANN HUM GENET, V63, P153, DOI 10.1046/j.1469-1809.1999.6320153.x; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Relethford John H., 1995, Evolutionary Anthropology, V4, P53, DOI 10.1002/evan.1360040207; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Rogers AR, 1996, AM J HUM GENET, V58, P1033; ROGERS AR, 1995, HUM BIOL, V67, P1; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; Seielstad M, 1999, GENOME RES, V9, P558; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Shriver MD, 1997, GENOME RES, V7, P586, DOI 10.1101/gr.7.6.586; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	75	329	338	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					979	988		10.1086/302825			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	WOS:000088373200020	10712212	Green Published, Bronze			2022-01-24	
J	Rizzu, P; Van Swieten, JC; Joosse, M; Hasegawa, M; Stevens, M; Tibben, A; Niermeijer, MF; Hillebrand, M; Ravid, R; Oostra, BA; Goedert, M; van Duijn, CM; Heutink, P				Rizzu, P; Van Swieten, JC; Joosse, M; Hasegawa, M; Stevens, M; Tibben, A; Niermeijer, MF; Hillebrand, M; Ravid, R; Oostra, BA; Goedert, M; van Duijn, CM; Heutink, P			High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTAL-LOBE DEGENERATION; MULTIPLE-SYSTEM TAUOPATHY; NON-ALZHEIMER TYPE; PRE-MESSENGER-RNA; PRESENILE-DEMENTIA; NEUROFIBRILLARY PATHOLOGY; DISEASE; CHROMOSOME-17; LOCALIZATION; PARKINSONISM	Mutations in microtubule-associated protein tau recently have been identified in familial cases of frontotemporal dementia (FTD). We report the frequency of tart mutations in a large population-based study of FTD carried out in the Netherlands from January 1994 to June 1998. Thirty-seven patients had greater than or equal to 1 first-degree relative with dementia. A mutation in the taut gene was found in 17.8% of the group of patients with FTD and in 43% of patients with FTD who also had a positive family history of FTD. Three distinct missense mutations (G272V, P301L, R406W accounted for 15.6% of the mutations. These three missense mutations, and a single amino acid deletion (Delta K280) that was detected in one patient, strongly reduce the ability of tau to promote microtubule assembly. We also found an intronic mutation at position +33 after exon 9, which is likely to affect the alternative splicing of tau. Tau mutations are responsible for a large proportion of familial FTD cases; however, there are also families with FTD in which no mutations in tau have been found, which indicates locus and/or allelic heterogeneity, The different tart mutations may result in disturbances in the interactions of the protein tau with microtubules, resulting in hyperphosphorylation of tau protein, assembly into filaments, and subsequent cell death.	Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands; Netherlands Brain Bank, Amsterdam, Netherlands; MRC, Mol Biol Lab, Cambridge CB2 2QH, England		Heutink, P (corresponding author), Erasmus Univ, Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	heutink@kgen.fgg.eur.nl	Tibben, Aad/A-9540-2008	van Swieten, John/0000-0001-6278-6844; Tibben, Aad/0000-0002-4560-1710; Heutink, Peter/0000-0001-5218-1737			ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Baker M, 1997, ANN NEUROL, V42, P794, DOI 10.1002/ana.410420516; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; BRUN A, 1987, ARCH GERONTOL GERIAT, V6, P193, DOI 10.1016/0167-4943(87)90021-5; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Froelich S, 1997, AM J MED GENET, V74, P380, DOI 10.1002/(SICI)1096-8628(19970725)74:4<380::AID-AJMG8>3.0.CO;2-T; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GUSTAFSON L, 1987, ARCH GERONTOL GERIAT, V6, P209, DOI 10.1016/0167-4943(87)90022-7; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; HASEGAWA M, 1997, J BIOL CHEM, V272, P33111; Heutink P, 1997, ANN NEUROL, V41, P150, DOI 10.1002/ana.410410205; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; KNOPMAN DS, 1990, NEUROLOGY, V40, P251, DOI 10.1212/WNL.40.2.251; Lendon CL, 1998, NEUROLOGY, V50, P1546, DOI 10.1212/WNL.50.6.1546; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murrell JR, 1997, AM J HUM GENET, V61, P1131, DOI 10.1086/301594; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; PETERSEN RB, 1995, NEUROLOGY, V45, P1062, DOI 10.1212/WNL.45.6.1062; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Spillantini MG, 1996, ACTA NEUROPATHOL, V92, P42, DOI 10.1007/s004010050487; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Wijker M, 1996, HUM MOL GENET, V5, P151, DOI 10.1093/hmg/5.1.151; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Yamaoka LH, 1996, AM J HUM GENET, V59, P1306; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	41	329	335	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					414	421		10.1086/302256			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	WOS:000078740600011	9973279	Bronze, Green Published			2022-01-24	
J	Shimogawara, K; Fujiwara, S; Grossman, A; Usuda, H				Shimogawara, K; Fujiwara, S; Grossman, A; Usuda, H			High-efficiency transformation of Chlamydomonas reinhardtii by electroporation	GENETICS			English	Article							INTACT YEAST-CELLS; NUCLEAR TRANSFORMATION; SULFUR DEPRIVATION; GENE; DNA; COMPLEMENTATION; LIBRARY; MUTAGENESIS; MUTANTS	We have established a high-efficiency method for transforming the unicellular, green alga Chlamydomonas reinhardtii by electroporation. Electroporation of strains CC3395 and CC425, cell wall-less mutants devoid of argininosuccinate lyase (encoded by ARG7), in the presence of the plasmid pJD67 (which contains ARG7) was used to optimize conditions for the introduction of exogenous DNA. The conditions that were varied included osmolarity, temperature, concentration of exogenous DNA, voltage and capacitance. Following optimization, the maximum transformation frequency obtained was 2 x 10(5) transformants per mu g of DNA; this frequency is two orders of magnitude higher than obtained with the current standard method using glass beads to introduce exogenous DNA. The electroporation procedure described in this article is of general utility, and makes it feasible to isolate genes by direct complementation of Chlamydomonas reinhardtii mutants.	Teikyo Univ, Sch Med, Chem Lab, Hachioji, Tokyo 19203, Japan; Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 19203, Japan; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA		Shimogawara, K (corresponding author), Teikyo Univ, Sch Med, Chem Lab, 359 Ohtsuka, Hachioji, Tokyo 1920395, Japan.						BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; BROWN LE, 1991, MOL CELL BIOL, V11, P2328, DOI 10.1128/MCB.11.4.2328; BUTANAEV AM, 1994, MOL BIOL+, V28, P682; COSTANZO MC, 1988, GENETICS, V120, P667; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; DAVIES JP, 1994, MOL CELL BIOL, V14, P5165, DOI 10.1128/MCB.14.8.5165; DAVIES JP, 1994, PLANT CELL, V6, P53, DOI 10.2307/3869674; Davies JP, 1996, EMBO J, V15, P2150, DOI 10.1002/j.1460-2075.1996.tb00568.x; DUNAHAY TG, 1993, BIOTECHNIQUES, V15, P452; FUNKE RP, 1997, PLANT PHYSIOL, V114, p23N; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris EH, 1989, CHLAMYDOMONAS SOURCE; INFANTE A, 1995, GENETICS, V141, P87; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; MANIVASAKAM P, 1993, NUCLEIC ACIDS RES, V21, P4414, DOI 10.1093/nar/21.18.4414; NEWMAN SM, 1991, MOL GEN GENET, V230, P65, DOI 10.1007/BF00290652; PURTON S, 1994, PLANT MOL BIOL, V24, P533, DOI 10.1007/BF00024121; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; RANDOLPHANDERSON BL, 1993, MOL GEN GENET, V236, P235, DOI 10.1007/BF00277118; Rochaix JD, 1995, ANNU REV GENET, V29, P209, DOI 10.1146/annurev.ge.29.120195.001233; SAMBROOK J, 1989, MOL CLONING; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHNELL RA, 1993, GENETICS, V134, P737; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; TAM LW, 1993, GENETICS, V135, P375; Tang DKH, 1995, BIOCHEM MOL BIOL INT, V36, P1025; Vashishtha M, 1996, GENOMICS, V36, P459, DOI 10.1006/geno.1996.0491; ZHANG HT, 1994, PLANT MOL BIOL, V24, P663, DOI 10.1007/BF00023562	30	329	348	3	81	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	APR	1998	148	4					1821	1828					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZJ175	WOS:000073187000041	9560396				2022-01-24	
J	HAMMER, MF; HORAI, S				HAMMER, MF; HORAI, S			Y-CHROMOSOMAL DNA VARIATION AND THE PEOPLING OF JAPAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; EVOLUTIONARY RELATIONSHIPS; GENETIC-DISTANCE; POLYMORPHISMS; HAPLOTYPES; SEQUENCES; HISTORY; ORIGINS; ASIA	Four loci mapping to the nonrecombining portion of the Y chromosome were genotyped in Japanese populations from Okinawa, the southernmost island of Japan; Shizuoka and Aomori on the main island of Honshu; and a small sample of Taiwanese. The Y Alu polymorphic (YAP) element is present in 42% of the Japanese and absent in the Taiwanese, confirming the irregular distribution of this polymorphism in Asia. Data from the four loci were used to determine genetic distances among populations, construct Y chromosome haplotypes, and estimate the degree of genetic diversity in each population and on different Y chromosome haplotypes. Evolutionary analysis of Y haplotypes suggests that polymorphisms at the YAP (DYS287) and DXYS5Y loci originated a single time, whereas restriction patterns at the DYS1 locus and microsatellite alleles at the DYS19 locus arose more than once. Genetic distance analysis indicated that the Okinawans are differentiated from Japanese living on Honshu. The data support the hypotheses that modern Japanese populations have resulted from distinctive genetic contributions involving the ancient Jomon people and Yayoi immigrants from Korea or mainland China, with Okinawans experiencing the least amount of admixture with the Yayoi. It is suggested that YAP(+) chromosomes migrated to Japan with the Jomon people >10,000 years ago and that a large infusion of YAP(-) chromosomes entered Japan with the Yayoi migration starting 2,300 years ago. Different degrees of genetic diversity carried by these two ancient chromosomal lineages may be explained by the different lifestyles (hunter-gatherer versus agriculturalist). of the migrant groups, the size of the founding populations, and the antiquities of the founding events.	NATL INST GENET, DEPT HUMAN GENET, MISHIMA, SHIZUOKA 411, JAPAN		HAMMER, MF (corresponding author), UNIV ARIZONA, MOLEC SYSTEMAT & EVOLUT LAB, BIOSCI W, TUCSON, AZ 85721 USA.						AKAISHI S, 1975, JIBP SYNTHESIS ANTHR, P77; BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chard C.E, 1974, NE ASIA PREHISTORY; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GOMOLKA M, 1994, HUM GENET, V93, P592; GUERIN P, 1988, NUCLEIC ACIDS RES, V16, P7759, DOI 10.1093/nar/16.15.7759; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1993, MOL BIOL EVOL, V10, P971; HANIHARA K, 1984, Acta Anthropogenetica, V8, P149; HANIHARA K, 1992, HUM EVOL, V7, P85; HANIHARA T, 1991, J ANTHROPOL SOC NIP, V99, P399; HARIHARA S, 1992, HUM BIOL, V64, P161; HORAI S, 1991, PHILOS T ROY SOC B, V333, P409, DOI 10.1098/rstb.1991.0091; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1991, NEW ASPECTS GENETICS, P135; HORAI S, 1987, HUM GENET, P177; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; KOZINTSEV AG, 1993, HOMO, V44, P105; LI WH, 1977, GENETICS, V85, P331; LIN SJ, 1994, JPN J HUM GENET, V39, P299, DOI 10.1007/BF01874048; Lucotte G, 1990, Gene Geogr, V4, P21; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MISAWA S, 1974, Journal of the Anthropological Society of Nippon, V82, P135; Mizoguchi Y, 1986, PREHISTORIC HUNTER G, P107; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; MULLER S, 1994, HUM HERED, V44, P298, DOI 10.1159/000154233; NAKAGOME Y, 1992, ANN HUM GENET, V56, P311, DOI 10.1111/j.1469-1809.1992.tb01158.x; NAKAHORI Y, 1989, NUCLEIC ACIDS RES, V17, P2152, DOI 10.1093/nar/17.5.2152; NAKANAGA M, 1991, HUM BIOL, V63, P187; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, IN PRESS ORIGINAL PA; NGO KY, 1986, AM J HUM GENET, V38, P407; OMOTO K, 1976, ORIGIN AUSTR, P365; OSSENBERGN, 1986, PREHISTORIC HUNTER G, P199; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; REYNOLDS J, 1983, GENETICS, V105, P767; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROEWER L, 1992, HUM GENET, V89, P389; ROGERS AR, 1995, HUM BIOL, V67, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTOS FR, 1993, HUM GENET, V90, P655; Sokal R.R., 1981, BIOMETRY; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE AB, 1994, ANN HUM GENET, V58, P251, DOI 10.1111/j.1469-1809.1994.tb01889.x; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Suzuki H., 1981, RASSENGESCHICHTE MEN, P7; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TORRONI A, 1990, ANN HUM GENET, V54, P287; TSUCHIDA S, 1989, HUM HERED, V39, P61, DOI 10.1159/000153836; TURNER CG, 1976, SCIENCE, V193, P911; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WILSON EO, 1977, PRIMER POPULATION BI; YAMAGUCHI B, 1982, J ANTHROPOL SOC NIP, V90, P77; [No title captured]	65	329	338	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					951	962					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	WOS:A1995QP66300017	7717406				2022-01-24	
J	ROSENFELD, PJ; COWLEY, GS; MCGEE, TL; SANDBERG, MA; BERSON, EL; DRYJA, TP				ROSENFELD, PJ; COWLEY, GS; MCGEE, TL; SANDBERG, MA; BERSON, EL; DRYJA, TP			A NULL MUTATION IN THE RHODOPSIN GENE CAUSES ROD PHOTORECEPTOR DYSFUNCTION AND AUTOSOMAL RECESSIVE RETINITIS-PIGMENTOSA	NATURE GENETICS			English	Article							RETINAL DEGENERATION; SPLICING MUTATION; TRANSDUCIN; DROSOPHILA; DEFECTS; MUTANTS; DNA; IDENTIFICATION; TRANSCRIPTION; SEQUENCE	Mutations within the rhodopsin gene are known to give rise to autosomal dominant retinitis pigmentosa (RP), a common hereditary form of retinal degeneration. We now describe a patient with autosomal recessive RP who is homozygous for a nonsense mutation at codon 249 within exon 4 of the rhodopsin gene. This null mutation, the first gene defect identified in autosomal recessive retinitis pigmentosa, should result in a functionally inactive rhodopsin protein that is missing the sixth and seventh transmembrane domains including the 11-cis-retinal attachment site. We also found a different null mutation carried heterozygously by an unrelated unaffected individual. Heterozygous carriers of either mutation had normal ophthalmologic examinations but their electroretinograms revealed an abnormality in rod photoreceptor function.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,DEPT OPHTHALMOL,HOWE LAB,243 CHARLES ST,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02114								Berson E L, 1990, Trans Am Ophthalmol Soc, V88, P355; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P58; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FARRAR GJ, 1991, GENOMICS, V11, P870, DOI 10.1016/0888-7543(91)90009-4; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FARRAR GJ, 1991, GENOMICS, V11, P1170; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; GAL A, 1991, GENOMICS, V11, P468, DOI 10.1016/0888-7543(91)90159-C; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; JUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; REES DJG, 1985, NATURE, V316, P643, DOI 10.1038/316643a0; REICHEL E, 1989, AM J OPHTHALMOL, V108, P540, DOI 10.1016/0002-9394(89)90431-5; SANDBERG MA, 1990, INVEST OPHTH VIS SCI, V31, P2283; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TAKEMOTO DJ, 1986, BIOCHEM J, V235, P309, DOI 10.1042/bj2350309; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1988, J BIOL CHEM, V263, P8561; WEISS ER, 1988, J BIOL CHEM, V263, P6150; YANDELL DW, 1989, CANCER CEL, V7, P223	50	329	332	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					209	213		10.1038/ng0692-209			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	WOS:A1992JC98200015	1303237				2022-01-24	
J	Lee, I; Ajay, SS; Yook, JI; Kim, HS; Hong, SH; Kim, NH; Dhanasekaran, SM; Chinnaiyan, AM; Athey, BD				Lee, Inhan; Ajay, Subramanian S.; Yook, Jong In; Kim, Hyun Sil; Hong, Su Hyung; Kim, Nam Hee; Dhanasekaran, Saravana M.; Chinnaiyan, Arul M.; Athey, Brian D.			New class of microRNA targets containing simultaneous 5 '-UTR and 3 '-UTR interaction sites	GENOME RESEARCH			English	Article							MESSENGER-RNA DEGRADATION; POSTTRANSCRIPTIONAL REGULATION; TRANSLATION; SPECIFICITY; MECHANISMS; REPRESSION; MAMMALS; MIRNAS; IMPACT; LET-7	MicroRNAs (miRNAs) are known to post-transcriptionally regulate target mRNAs through the 3'-UTR, which interacts mainly with the 5'-end of miRNA in animals. Here we identify many endogenous motifs within human 5'-UTRs specific to the 3'-ends of miRNAs. The 3'-end of conserved miRNAs in particular has significant interaction sites in the human-enriched, less conserved 5'-UTR miRNA motifs, while human-specific miRNAs have significant interaction sites only in the conserved 5'-UTR motifs, implying both miRNA and 5'-UTR are actively evolving in response to each other. Additionally, many miRNAs with their 3'-end interaction sites in the 5'-UTRs turn out to simultaneously contain 5'-end interaction sites in the 3'-UTRs. Based on these findings we demonstrate combinatory interactions between a single miRNA and both end regions of an mRNA using model systems. We further show that genes exhibiting large-scale protein changes due to miRNA overexpression or deletion contain both UTR interaction sites predicted. We provide the predicted targets of this new miRNA target class, miBridge, as an efficient way to screen potential targets, especially for nonconserved miRNAs, since the target search space is reduced by an order of magnitude compared with the 3'-UTR alone. Efficacy is confirmed by showing SEC24D regulation with hsa-miR-605, a miRNA identified only in primate, opening the door to the study of nonconserved miRNAs. Finally, miRNAs (and associated proteins) involved in this new targeting class may prevent 40S ribosome scanning through the 5'-UTR and keep it from reaching the start-codon, preventing 60S association.	[Lee, Inhan; Athey, Brian D.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Ajay, Subramanian S.] Univ Michigan, Bioinformat Grad Program, Ann Arbor, MI 48109 USA; [Yook, Jong In; Kim, Hyun Sil; Kim, Nam Hee] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol, Seoul 120752, South Korea; [Hong, Su Hyung] Kyungpook Natl Univ, Sch Dent, Dept Dent Microbiol, Taegu 700412, South Korea; [Dhanasekaran, Saravana M.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Athey, Brian D.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA		Lee, I (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	inhan@umich.edu; jiyook@yuhs.ac		Kim, Nam Hee/0000-0002-3087-5276; Yook, Jong In/0000-0002-7318-6112; Kim, Hyun Sil/0000-0003-3614-1764; Athey, Brian/0000-0002-9793-535X; Dhanasekaran, saravana mohan/0000-0002-0489-2224	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54-DA021519]; National Research and Development Program for Cancer Control [0720270]; Basic Research Program of Korea Science and Engineering Foundation KOSEFKorea Science and Engineering Foundation [R01-2006-10203, R15-2008-01565]; Korea Research FoundationKorea Research Foundation [KRF-2007-314-C00199]; Center for Biological Modulators of the 21st Century Frontier Research and Development ProgramMinistry of Education, Science and Technology, Republic of Korea [CBM31-B3000-0100-01]; Ministry of Science and Technology, KoreaMinistry of Science and Technology (MOST) Korea; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [U54DA021519] Funding Source: NIH RePORTER	We thank X. Xie for providing the UTR motif data set; Anders H. Lund and Ulf A. Orom for discussion and preliminary experiments; Jamal Kasham and Heekon Cha for miBridge programming assistance; Jeff de Wet, John Kim, and Matthias Kretzler for discussion; YongSun Lee, Neil Smalheiser, and Nils Walters for manuscript review; and Paul D. Trombley for artwork. B. D. A and A. M. C. are supported by the National Institutes of Health to the National Center for Integrative Biomedical Informatics NCIBI (U54-DA021519); J.I.Y. is supported by National Research and Development Program for Cancer Control (0720270), Basic Research Program of Korea Science and Engineering Foundation KOSEF (R01-2006-10203, R15-2008-01565), and Korea Research Foundation Grant (KRF-2007-314-C00199); and S.H.H. was supported by the Center for Biological Modulators of the 21st Century Frontier Research and Development Program (CBM31-B3000-0100-01), the Ministry of Science and Technology, Korea.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smalheiser NR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-139; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BB, 2008, P NATL ACAD SCI USA, V105, P5343, DOI 10.1073/pnas.0801102105; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	30	328	350	0	29	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	JUL	2009	19	7					1175	1183		10.1101/gr.089367.108			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	468AY	WOS:000267786900004	19336450	Green Published, Bronze			2022-01-24	
J	Wang, CL; Mitsuya, Y; Gharizadeh, B; Ronaghi, M; Shafer, RW				Wang, Chunlin; Mitsuya, Yumi; Gharizadeh, Baback; Ronaghi, Mostafa; Shafer, Robert W.			Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance	GENOME RESEARCH			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; OLIGONUCLEOTIDE LIGATION ASSAY; SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY; GENETIC-VARIATION; LOW-FREQUENCY; POPULATIONS; PERSISTENCE; PERFORMANCE; EMERGENCE	The detection of mutant spectra within a population of microorganisms is critical for the management of drug-resistant infections. We performed ultra-deep pyrosequencing to detect minor sequence variants in HIV-1 protease and reverse transcriptase (RT) genes from clinical plasma samples. We estimated empirical error rates from four HIV-1 plasmid clones and used them to develop a statistical approach to distinguish authentic minor variants from sequencing errors in eight clinical samples. Ultra-deep pyrosequencing detected an average of 58 variants per sample compared with an average of eight variants per sample detected by conventional direct-PCR dideoxynucleotide sequencing. In the clinical sample with the largest number of minor sequence variants, all 60 variants present in >= 3% of genomes and 20 of 35 variants present in < 3% of genomes were confirmed by limiting dilution sequencing. With appropriate analysis, ultra-deep pyrosequencing is a promising method for characterizing genetic diversity and detecting minor yet clinically relevant variants in biological samples with complex genetic populations.	Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94305 USA		Shafer, RW (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.	rshafer@stanford.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR022982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI068581, R56AI068581, R01AI046148] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 S10 RR022982, S10 RR022982, S10 RR022982-01] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI068581, R01 AI046148, AI068581, R56 AI068581, AI46148] Funding Source: Medline		Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Edelstein RE, 1998, J CLIN MICROBIOL, V36, P569, DOI 10.1128/JCM.36.2.569-572.1998; Ellis GM, 2004, J CLIN MICROBIOL, V42, P3670, DOI [10.1128/JCM.42.8.3670-3674.2004, 10.1128/jcm.42.8.3670-3674.2004]; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kapoor A, 2004, J VIROL, V78, P7112, DOI 10.1128/JVI.78.13.7112-7123.2004; Langaee T, 2005, MUTAT RES-FUND MOL M, V573, P96, DOI 10.1016/j.mrfmmm.2004.07.023; LEAMON JH, 2007, GENE THER REGUL, V3, P15; Lecoutre MP, 2003, INT J PSYCHOL, V38, P37, DOI 10.1080/00207590244000250; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Malet I, 2003, J VIROL METHODS, V109, P161, DOI 10.1016/S0166-0934(03)00067-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Moser MJ, 2005, ANTIMICROB AGENTS CH, V49, P3334, DOI 10.1128/AAC.49.8.3334-3340.2005; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Shafer RW, 1997, J CLIN MICROBIOL, V35, P520, DOI 10.1128/JCM.35.2.520-522.1997; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Simons J, 2005, 14 INT HIV DRUG RES; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; TSIBRIS A, 2006, 15 INT HIV DRUG RES; Tsongalis GJ, 2005, J CLIN VIROL, V34, P268, DOI 10.1016/j.jcv.2005.01.011; *US DEP HHS PAN CL, 2006, GUID US ANT AG HIV 1; Vahey M, 1999, J CLIN MICROBIOL, V37, P2533, DOI 10.1128/JCM.37.8.2533-2537.1999	29	328	337	0	15	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	AUG	2007	17	8					1195	1201		10.1101/gr.6468307			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	196OL	WOS:000248491800008	17600086	Green Published, Bronze			2022-01-24	
J	Li, W; Zhang, Q; Oiso, N; Novak, EK; Gautam, R; O'Brien, EP; Tinsley, CL; Blake, DJ; Spritz, RA; Copeland, NG; Jenkins, NA; Amato, D; Roe, BA; Starcevic, M; Dell'Angelica, EC; Elliott, RW; Mishra, V; Kingsmore, SF; Paylor, RE; Swank, RT				Li, W; Zhang, Q; Oiso, N; Novak, EK; Gautam, R; O'Brien, EP; Tinsley, CL; Blake, DJ; Spritz, RA; Copeland, NG; Jenkins, NA; Amato, D; Roe, BA; Starcevic, M; Dell'Angelica, EC; Elliott, RW; Mishra, V; Kingsmore, SF; Paylor, RE; Swank, RT			Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)	NATURE GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; STORAGE POOL DEFICIENCY; PLATELET-DENSE GRANULES; GENETIC-VARIATION; MOUSE MODEL; 6P22.3 GENE; MUTATION; PROTEIN; HOMOLOG; TRAFFICKING	Hermansky-Pudlak syndrome (HPS; MIM 203300) is a genetically heterogeneous disorder characterized by oculocutaneous albinism, prolonged bleeding and pulmonary fibrosis due to abnormal vesicle trafficking to lysosomes and related organelles, such as melanosomes and platelet dense granules(1-3). In mice, at least 16 loci are associated with HPS4-6, including sandy (sdy; ref. 7). Here we show that the sdy mutant mouse expresses no dysbindin protein owing to a deletion in the gene Dtnbp1 (encoding dysbindin) and that mutation of the human ortholog DTNBP1 causes a novel form of HPS called HPS-7. Dysbindin is a ubiquitously expressed protein that binds to alpha- and beta-dystrobrevins, components of the dystrophin-associated protein complex (DPC) in both muscle and nonmuscle cells(8). We also show that dysbindin is a component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1; refs. 9-11), which regulates trafficking to lysosome-related organelles and includes the proteins pallidin, muted and cappuccino, which are associated with HPS in mice. These findings show that BLOC-1 is important in producing the HPS phenotype in humans, indicate that dysbindin has a role in the biogenesis of lysosome-related organelles and identify unexpected interactions between components of DPC and BLOC-1.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Toronto, Dept Med, Div Hematol & Med Oncol, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA; Mol Staging, New Haven, CT 06511 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA		Swank, RT (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.		Oiso, Naoki/H-6540-2019	Oiso, Naoki/0000-0001-5593-6496; kingsmore, stephen/0000-0002-3758-4631; Kingsmore, Stephen/0000-0001-7180-2527	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U19HD077693] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL068117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01AI039824] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL068117] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P01 AI039824-050002, P01 AI039824] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U19 HD077693] Funding Source: Medline		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huizing M, 2001, THROMB HAEMOSTASIS, V86, P233, DOI 10.1055/s-0037-1616221; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Lee ST, 1995, MOL CELLS, V5, P668; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; REDDINGTON M, 1987, BLOOD, V69, P1300; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Spritz RA, 1999, TRENDS GENET, V15, P337, DOI 10.1016/S0168-9525(99)01785-0; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; [No title captured]	30	328	341	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					84	89		10.1038/ng1229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	WOS:000185018500015	12923531	Green Accepted			2022-01-24	
J	Matthews, LR; Vaglio, P; Reboul, J; Ge, H; Davis, BP; Garrels, J; Vincent, S; Vidal, M				Matthews, LR; Vaglio, P; Reboul, J; Ge, H; Davis, BP; Garrels, J; Vincent, S; Vidal, M			Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs"	GENOME RESEARCH			English	Article							INTERACTION MAP; LARGE NUMBERS; GENOME; YEAST; SYSTEM; GENE	Protein interaction maps have provided insight into the relationships among the predicted proteins of model organisms for which a genome sequence is available. These maps have been useful in generating potential interaction networks, which have confirmed the existence of known complexes and pathways and have suggested the existence of new complexes and or crosstalk between previously unlinked pathways. However, the generation of such maps is costly and labor intensive. Here, we investigate the extent to which a protein interaction map generated in one species can be used to predict interactions in another species.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA		Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Reboul, Jerome/P-9103-2016	Reboul, Jerome/0000-0002-5513-4546; Vaglio, Philippe/0000-0003-2900-5596; Matthews, Lisa/0000-0001-5707-3065	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA080111, R33CA081658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG001715] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [7 R33 CA81658-02, P01CA80111-02, P01 CA080111] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG001715, 5R01HG01715] Funding Source: Medline		C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Endoh H, 2000, METHOD ENZYMOL, V328, P74, DOI 10.1016/S0076-6879(00)28391-2; ENDOH H, IN PRESS METHODS ENZ; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Friedberg I, 2000, PROTEIN SCI, V9, P2278, DOI 10.1110/ps.9.11.2278; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Guthrie C, 1994, Harvey Lect, V90, P59; Hillier L, 1991, PCR Methods Appl, V1, P124; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 1999, TRENDS BIOTECHNOL, V17, P374, DOI 10.1016/S0167-7799(99)01338-4; Vidal M, 1997, ADV MOLEC BIOL, P109; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Young K, 1998, NAT BIOTECHNOL, V16, P946, DOI 10.1038/nbt1098-946	26	328	347	0	10	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2001	11	12					2120	2126		10.1101/gr.205301			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	497VF	WOS:000172475600019	11731503	Green Published, Bronze			2022-01-24	
J	Shih, DQ; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, BL; Suchy, FJ; Shefer, S; Bollileni, JS; Gonzalez, FJ; Breslow, JL; Stoffel, M				Shih, DQ; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, BL; Suchy, FJ; Shefer, S; Bollileni, JS; Gonzalez, FJ; Breslow, JL; Stoffel, M			Hepatocyte nuclear factor-1 alpha is an essential regulator of bile acid and plasma cholesterol metabolism	NATURE GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR LXR-ALPHA; TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE; EXPRESSION; ATHEROSCLEROSIS; LIVER; PROTEIN; PATHWAY	Maturity-onset diabetes of the young type 3 (MODY3) is caused by haploinsufficiency of hepatocyte nuclear factor-let (encoded by TCF1). Tcf1(-/-) mice have type 2 diabetes, dwarfism, renal Fanconi syndrome, hepatic dysfunction and hypercholestrolemia. Here we explore the molecular basis for the hypercholesterolemia using oligonucleotide microchip expression analysis. We demonstrate that Tcf1(-/-) mice have a defect in bile acid transport, increased bile acid and liver cholesterol synthesis, and impaired HDL metabolism. Tcf1(-/-) liver has decreased expression of the basolateral membrane bile acid transporters Slc10a1, Slc21a3 and Slc21a5, leading to impaired portal bile acid uptake and elevated plasma bile acid concentrations. In intestine and kidneys, Tcf1(-/-) mice lack expression of the ileal bile acid transporter (Slc10a2), resulting in increased fecal and urinary bile acid excretion. The Tcf1 protein (also known as HNF-1 alpha) also regulates transcription of the gene ((Nr1h4) encoding the farnesoid X receptor-1 (Fxr-1), thereby leading to reduced expression of small heterodimer partner-1 (Shp-1) and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway. In addition, hepatocyte bile acid storage protein is absent from Tcf1(-/-) mice. Increased plasma cholesterol of Tcf1(-/-) mice resides predominantly in large, buoyant, high-density lipoprotein (HDL) particles. This is most likely due to reduced activity of the HDL-catabolic enzyme hepatic lipase (Lipc) and increased expression of HDL-cholesterol esterifying enzyme lecithin:cholesterol acyl transferase (Lcat). Our studies demonstrate that Tcf1, in addition to being an important regulator of insulin secretion, is an essential transcriptional regulator of bile acid and HDL-cholesterol metabolism.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Biochem Genet & Metab Lab, New York, NY 10021 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Univ Med & Dent New Jersey, Dept Med, Piscataway, NJ 08854 USA; NCI, Bethesda, MD 20892 USA		Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.		Breslow, Jan L/B-7544-2008	Stoffel, Markus/0000-0003-1304-5817	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD020632, R37HD020632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK055033, K11DK002076, R37DK026756, R01DK026756] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD20632] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK02076, R01DK55033-01, DK26756] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM07739] Funding Source: Medline		AALTOSETALA K, 1994, J CLIN INVEST, V93, P1776, DOI 10.1172/JCI117163; ANANTHANARAYANAN M, 1991, AM J PHYSIOL, V261, pG810, DOI 10.1152/ajpgi.1991.261.5.G810; Austin MA, 1996, CURR OPIN LIPIDOL, V7, P167, DOI 10.1097/00041433-199606000-00010; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Christie DM, 1996, AM J PHYSIOL-GASTR L, V271, pG377, DOI 10.1152/ajpgi.1996.271.2.G377; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; FELKER TE, 1978, P NATL ACAD SCI USA, V75, P3459, DOI 10.1073/pnas.75.7.3459; Foger B, 1999, J BIOL CHEM, V274, P36912, DOI 10.1074/jbc.274.52.36912; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; LAGGNER P, 1977, EUR J BIOCHEM, V77, P165, DOI 10.1111/j.1432-1033.1977.tb11654.x; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Levine DM, 1997, CLIN CHEM, V43, P669; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; MAHLEY RW, 1975, BIOCHEMISTRY-US, V14, P2817, DOI 10.1021/bi00684a005; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANZATO E, 1976, J CLIN INVEST, V57, P1248, DOI 10.1172/JCI108393; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; NORUM KR, 1971, J CLIN INVEST, V50, P1131, DOI 10.1172/JCI106585; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; POWELL DR, 1993, DNA CELL BIOL, V12, P283, DOI 10.1089/dna.1993.12.283; Sehayek E, 1998, P NATL ACAD SCI USA, V95, P10194, DOI 10.1073/pnas.95.17.10194; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; SETCHELL KDR, 1995, BIOCHEMISTRY-US, V34, P4169, DOI 10.1021/bi00013a004; Shneider BL, 1997, J BIOL CHEM, V272, P31006, DOI 10.1074/jbc.272.49.31006; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stieger B, 1998, CURR OPIN CELL BIOL, V10, P462, DOI 10.1016/S0955-0674(98)80059-8; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; STOLZ A, 1993, J BIOL CHEM, V268, P10448; TRANCHE T, 1994, LIVER GENE EXPRESSIO, P155; vanAntwerpen R, 1997, J LIPID RES, V38, P659; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	43	328	341	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					375	382		10.1038/86871			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	WOS:000167811200011	11279518				2022-01-24	
J	Valente, EM; Bentivoglio, AR; Dixon, PH; Ferraris, A; Ialongo, T; Frontali, M; Albanese, A; Wood, NW				Valente, EM; Bentivoglio, AR; Dixon, PH; Ferraris, A; Ialongo, T; Frontali, M; Albanese, A; Wood, NW			Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE PARKINSONISM; JAPANESE FAMILIES; GENE; DISEASE; MUTATIONS; DELETIONS; HOMOZYGOSITY; PROTEIN	The cause of Parkinson disease (PD) is still unknown, but genetic factors have recently been implicated in the etiology of the disease. So far, four loci responsible for autosomal dominant PD have been identified. Autosomal recessive juvenile parkinsonism (ARJP) is a clinically and genetically distinct entity; typical PD features are associated with early onset, sustained response to levodopa, and early occurrence of levodopa-induced dyskinesias, which are often severe. To date, only one ARJP gene, Parkin, has been identified, and multiple mutations have been detected both in families with autosomal recessive parkinsonism and in sporadic cases. The Parkin-associated phenotype is broad, and some cases are indistinguishable from idiopathic PD. In greater than or equal to 50% of families with ARJP that have been analyzed, no mutations could be detected in the Parkin gene. We identified a large Sicilian family with four definitely affected members (the Marsala kindred). The phenotype was characterized by early-onset (range 32-48 years) parkinsonism, with slow progression and sustained response to levodopa. Linkage of the disease to the Parkin gene was excluded. A genomewide homozygosity screen was performed in the family. Linkage analysis and haplotype construction allowed identification of a single region of homozygosity shared by all the affected members, spanning 12.5 cM on the short arm of chromosome 1. This region contains a novel locus for autosomal recessive early-onset parkinsonism, PARK6. A maximum LOD score 4.01 at recombination fraction .00 was obtained for marker D1S199.	Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England; Catholic Univ, Dept Neurol, Rome, Italy; CNR, Inst Expt Med, Rome, Italy; Natl Neurol Inst Carlo Besta, Milan, Italy		Wood, NW (corresponding author), Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucl.ac.uk	Valente, Enza Maria/G-2942-2017; Wood, Nicholas W/C-2505-2009; Bentivoglio, Anna Rita/K-3752-2018; Albanese, Alberto/K-7396-2016; Ferraris, Alessandro/E-4392-2013	Valente, Enza Maria/0000-0002-0600-6820; Wood, Nicholas W/0000-0002-9500-3348; Albanese, Alberto/0000-0002-5864-0006; Bentivoglio, Anna Rita/0000-0002-9663-095X	TelethonFondazione Telethon [C.38, E.1165] Funding Source: Medline		Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DWARKADAS S, 1994, HUM HERED, V44, P127, DOI 10.1159/000154205; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.3.CO;2-C; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leroy E, 1998, HUM GENET, V103, P424, DOI 10.1007/s004390050845; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsumine H, 1997, AM J HUM GENET, V60, P588; Nisipeanu P, 1999, NEUROLOGY, V53, P1602, DOI 10.1212/WNL.53.7.1602; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; VALENTE EM, 1999, J NEUROL S1, V246, P166; Wang CY, 1997, AM J HUM GENET, V60, P1461, DOI 10.1086/515469; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239	26	328	343	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					895	900		10.1086/319522			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	WOS:000167666000011	11254447	Green Published, Bronze			2022-01-24	
J	Holmes, SE; O'Hearn, EE; McInnis, MG; Gorelick-Feldman, DA; Kleiderlein, JJ; Callahan, C; Kwak, NG; Ingersoll-Ashworth, RG; Sherr, M; Sumner, AJ; Sharp, AH; Ananth, U; Seltzer, WK; Boss, MA; Vieria-Saecker, AM; Epplen, JT; Riess, O; Ross, CA; Margolis, RL				Holmes, SE; O'Hearn, EE; McInnis, MG; Gorelick-Feldman, DA; Kleiderlein, JJ; Callahan, C; Kwak, NG; Ingersoll-Ashworth, RG; Sherr, M; Sumner, AJ; Sharp, AH; Ananth, U; Seltzer, WK; Boss, MA; Vieria-Saecker, AM; Epplen, JT; Riess, O; Ross, CA; Margolis, RL			Expansion of a novel CAG trinucleotide repeat in the 5 ' region of PPP2R2B is associated with SCA12	NATURE GENETICS			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT		Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Psychiat Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; Louisiana State Univ, Sch Med, Dept Neurol, New Orleans, LA 70112 USA; Athena Diagnost Inc, Worcester, MA USA; Ruhr Univ Bochum, Dept Human Mol Genet, D-4630 Bochum, Germany; Univ Rostock, Dept Med Genet, D-2500 Rostock, Germany		Margolis, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.		McInnis, Melvin G/F-6963-2012	McInnis, Melvin G/0000-0002-0375-6247; Epplen, Joerg T./0000-0002-6087-3327; , Roxann/0000-0002-4266-613X	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K21MH001275, R01MH050763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS016375, P50NS016375] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH01275, MH50763] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS16375] Funding Source: Medline		Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Deng XM, 1998, J BIOL CHEM, V273, P34157, DOI 10.1074/jbc.273.51.34157; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Margolis RL, 1999, ARCH GEN PSYCHIAT, V56, P1019, DOI 10.1001/archpsyc.56.11.1019; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Ott J, 1991, ANAL HUMAN GENETIC L; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schols L, 1997, ANN NEUROL, V42, P924, DOI 10.1002/ana.410420615; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Strack S, 1998, J COMP NEUROL, V392, P515; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0	15	328	351	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					391	392		10.1038/70493			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	WOS:000084023900011	10581021				2022-01-24	
J	Fisher, SA; Tremelling, M; Anderson, CA; Gwilliam, R; Bumpstead, S; Prescott, NJ; Nimmo, ER; Massey, D; Berzuini, C; Johnson, C; Barrett, JC; Cummings, FR; Drummond, H; Lees, CW; Onnie, CM; Hanson, CE; Blaszczyk, K; Inouye, M; Ewels, P; Ravindrarajah, R; Keniry, A; Hunt, S; Carter, M; Watkins, N; Ouwehand, W; Lewis, CM; Cardon, L; Lobo, A; Forbes, A; Sanderson, J; Jewell, DP; Mansfield, JC; Deloukas, P; Mathew, CG; Parkes, M; Satsangi, J				Fisher, Sheila A.; Tremelling, Mark; Anderson, Carl A.; Gwilliam, Rhian; Bumpstead, Suzannah; Prescott, Natalie J.; Nimmo, Elaine R.; Massey, Dunecan; Berzuini, Carlo; Johnson, Christopher; Barrett, Jeffrey C.; Cummings, Fraser R.; Drummond, Hazel; Lees, Charlie W.; Onnie, Clive M.; Hanson, Catherine E.; Blaszczyk, Katarzyna; Inouye, Mike; Ewels, Philip; Ravindrarajah, Radhi; Keniry, Andrew; Hunt, Sarah; Carter, Martyn; Watkins, Nick; Ouwehand, Willem; Lewis, Cathryn M.; Cardon, Lon; Lobo, Alan; Forbes, Alastair; Sanderson, Jeremy; Jewell, Derek P.; Mansfield, John C.; Deloukas, Panos; Mathew, Christopher G.; Parkes, Miles; Satsangi, Jack		Wellcome Trust Case Control Consor	Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; IL23R; IDENTIFICATION; PHENOTYPE; VARIANTS	We report results of a nonsynonymous SNP scan for ulcerative colitis and identify a previously unknown susceptibility locus at ECM1. We also show that several risk loci are common to ulcerative colitis and Crohn's disease (IL23R, IL12B, HLA, NKX2-3 and MST1), whereas autophagy genes ATG16L1 and IRGM, along with NOD2 (also known as CARD15), are specific for Crohn's disease. These data provide the first detailed illustration of the genetic relationship between these common inflammatory bowel diseases.	[Nimmo, Elaine R.; Lees, Charlie W.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Fisher, Sheila A.; Prescott, Natalie J.; Onnie, Clive M.; Blaszczyk, Katarzyna; Lewis, Cathryn M.; Mathew, Christopher G.] Guys Hosp, Dept Med & Mol Genet, Univ London Kings Coll, Sch Med, London SE1 9RT, England; [Tremelling, Mark; Massey, Dunecan; Berzuini, Carlo; Johnson, Christopher; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Anderson, Carl A.; Barrett, Jeffrey C.; Cardon, Lon] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Gwilliam, Rhian; Bumpstead, Suzannah; Inouye, Mike; Ewels, Philip; Ravindrarajah, Radhi; Keniry, Andrew; Hunt, Sarah; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cummings, Fraser R.; Jewell, Derek P.] Univ Oxford, Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; [Hanson, Catherine E.; Mansfield, John C.] Newcastle Univ, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Carter, Martyn] Univ Sheffield, Sch Med, Royal Hallamshire Hosp, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England; [Watkins, Nick; Ouwehand, Willem] Univ Cambridge, Dept Haematol, Natl Blood Serv Ctr, Cambridge CB2 2PT, England; [Forbes, Alastair] UCL Hosp Trust, Inst Digest Dis, London NW1 2BU, England; [Sanderson, Jeremy] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England		Satsangi, J (corresponding author), Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland.	j.satsangi@ed.ac.uk	Ewels, Philip/J-7771-2013; Deloukas, Panos/B-2922-2013; Anderson, Carl A/B-8327-2013; Lewis, Cathryn/M-8766-2019; Breen, Gerome/Y-2706-2019; eyre, stephen/K-3776-2017; Dominiczak, Anna F/P-9390-2017; Lewis, Cathryn M/A-5225-2010; Prescott, Natalie J/F-6490-2011; Mathew, Christopher G/G-3434-2015; Berzuini, Carlo/AAA-7023-2019; HILL, Adrian V>S>/C-1306-2008	Ewels, Philip/0000-0003-4101-2502; Deloukas, Panos/0000-0001-9251-070X; Anderson, Carl A/0000-0003-1719-7009; Lewis, Cathryn/0000-0002-8249-8476; Breen, Gerome/0000-0003-2053-1792; eyre, stephen/0000-0002-1251-6974; Dominiczak, Anna F/0000-0003-4913-3608; Lewis, Cathryn M/0000-0002-8249-8476; Prescott, Natalie J/0000-0002-5901-7371; Mathew, Christopher G/0000-0003-4178-1838; Berzuini, Carlo/0000-0001-6056-0489; Forbes, Alastair/0000-0001-7416-9843; Lindgren, Cecilia/0000-0002-4903-9374; Lees, Charlie/0000-0002-0732-8215; Lango Allen, Hana/0000-0002-7803-8688; Dunger, Professor David/0000-0002-2566-9304; Weedon, Michael/0000-0002-6174-6135; Cummings, Fraser/0000-0002-9659-3247; Hattersley, Andrew/0000-0001-5620-473X; Hunt, Sarah/0000-0002-8350-1235; Parkes, Miles/0000-0002-6467-0631; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Barrett, Jeffrey/0000-0002-1152-370X; Munroe, Patricia/0000-0002-4176-2947; Zeggini, Eleftheria/0000-0003-4238-659X; Inouye, Michael/0000-0001-9413-6520	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800759, MC_QA137934, G0800383, G0000934, MC_U105260799, G0802320, G0400874, G0600329] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [076113, 089120, 077011, 090532] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600329, MC_U105260799, MC_qA137934, G0000934, G0400874, G0800383] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_qA137934] Funding Source: researchfish		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan I, 2007, EXP DERMATOL, V16, P881, DOI 10.1111/j.1600-0625.2007.00608.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Silverberg MS, 2003, INFLAMM BOWEL DIS, V9, P1, DOI 10.1097/00054725-200301000-00001; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051	15	327	331	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					710	712		10.1038/ng.145			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	WOS:000256212000010	18438406	Green Accepted, Green Published			2022-01-24	
J	Dunker, AK; Oldfield, CJ; Meng, JW; Romero, P; Yang, JY; Chen, JW; Vacic, V; Obradovic, Z; Uversky, VN				Dunker, A. Keith; Oldfield, Christopher J.; Meng, Jingwei; Romero, Pedro; Yang, Jack Y.; Chen, Jessica Walton; Vacic, Vladimir; Obradovic, Zoran; Uversky, Vladimir N.			The unfoldomics decade: an update on intrinsically disordered proteins	BMC GENOMICS			English	Article								Background: Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90-95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins. Results: Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships. Conclusion: Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets.	[Dunker, A. Keith; Oldfield, Christopher J.; Romero, Pedro; Chen, Jessica Walton; Vacic, Vladimir] Indiana Univ, Sch Informat, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Dunker, A. Keith; Uversky, Vladimir N.] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Uversky, Vladimir N.] Indiana Univ, Sch Med, Inst Intrinsically Disordered Prot Res, Indianapolis, IN 46202 USA; [Obradovic, Zoran] Temple Univ, Ctr Informat Sci & Technol, Philadelphia, PA 19122 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia		Dunker, AK (corresponding author), Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	kedunker@iupui.edu; cjoldfie@iupui.edu; mengj@iupui.edu; promero@compbio.iupui.edu; jyang@bwh.Harvard.edu; jchen@jcvi.org; vladimir@vacic.org; zoran@ist.temple.edu; vuversky@iupui.edu	Meng, Jingwei/K-8880-2015; Uversky, Vladimir N./F-4515-2011; Romero, Pedro R/D-4110-2018	Uversky, Vladimir N./0000-0002-4037-5857; Romero, Pedro R/0000-0002-6995-5193; Vacic, Vladimir/0000-0001-6571-2293	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM071714-01A2, R01 GM071714] Funding Source: Medline; NLM NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01 LM007688-01A1, R01 LM007688] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM071714] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM007688] Funding Source: NIH RePORTER		Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Arkin M, 2005, CURR OPIN CHEM BIOL, V9, P317, DOI 10.1016/j.cbpa.2005.03.001; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; BAGLEY SC, 1995, PROTEIN SCI, V4, P622; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671; BORK P, 1991, FEBS LETT, V286, P47, DOI 10.1016/0014-5793(91)80937-X; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bracken C, 2004, CURR OPIN STRUC BIOL, V14, P570, DOI 10.1016/j.sbi.2004.08.003; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Bryant JE, 2005, BIOCHEMISTRY-US, V44, P9275, DOI 10.1021/bi050786j; BRYANT JE, 2007, BIOCHEMISTRY, V46, P8206; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; CAMPEN AWR, 2008, PROTEIN PEP IN PRESS; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Daughdrill GW, 2005, PROTEIN FOLDING HDB, P275, DOI [10.1002/9783527619498.ch41, DOI 10.1002/9783527619498.CH41]; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Doolittle R F, 1973, Adv Protein Chem, V27, P1, DOI 10.1016/S0065-3233(08)60446-5; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker A. K., 1998, PAC S BIOCOMP, P473; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DUNKER AK, ENCY LIFE S IN PRESS; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fetrow JS, 1998, J MOL BIOL, V281, P949, DOI 10.1006/jmbi.1998.1993; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Flaugh SL, 2001, BIOMACROMOLECULES, V2, P538, DOI 10.1021/bm015502z; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Furnham N, 2004, PROTEINS, V54, P596, DOI 10.1002/prot.10568; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Garner E., 1998, GENOME INFORM SER WO, V9, P201; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Gunasekaran K, 2004, J MOL BIOL, V341, P1327, DOI 10.1016/j.jmb.2004.07.002; HALWER M, 1954, ARCH BIOCHEM BIOPHYS, V51, P79, DOI 10.1016/0003-9861(54)90455-5; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hasty J, 2001, NATURE, V411, P30, DOI 10.1038/35075182; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; HOLT C, 1993, J CHEM SOC FARADAY T, V89, P2683, DOI 10.1039/ft9938902683; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin YM, 2005, PROTEINS, V61, P167, DOI 10.1002/prot.20734; JIRGENSONS B, 1966, MAKROMOLEKUL CHEM, V91, P74; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; KARUSH F, 1950, J AM CHEM SOC, V72, P2705, DOI 10.1021/ja01162a099; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Landsteiner K, 1936, SPECIFICITY SEROLOGI; Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325; Lee KA, 2003, J BIOL CHEM, V278, P44593, DOI 10.1074/jbc.M308312200; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MacBeath G, 1998, SCIENCE, V279, P1958, DOI 10.1126/science.279.5358.1958; McMeekin T.L., 1952, J FOOD PROTECT, V15, P57; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Melamud E, 2003, PROTEINS, V53, P561, DOI 10.1002/prot.10533; Minneman K P, 2001, Mol Interv, V1, P108; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mooney SD, 2005, PROTEINS, V61, P741, DOI 10.1002/prot.20661; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Ofran Y, 2005, DRUG DISCOV TODAY, V10, P1475, DOI 10.1016/S1359-6446(05)03621-4; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; OLDFIELD CJ, 2007, 2007 INT C BIOINF CO, P553; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; PONTIUS BW, 1993, TRENDS BIOCHEM SCI, V18, P181, DOI 10.1016/0968-0004(93)90111-Y; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Romero P, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P90, DOI 10.1109/ICNN.1997.611643; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0; Scheper W, 2004, NEUROGENETICS, V5, P223, DOI 10.1007/s10048-004-0195-y; Schulz G.E., 1979, MOL MECH BIOL RECOGN, P79; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Thai TH, 2004, J IMMUNOL, V173, P4009, DOI 10.4049/jimmunol.173.6.4009; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; UVERSKY VN, 2008, CURRENT ALZ IN PRESS; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Wang P, 2005, P NATL ACAD SCI USA, V102, P18920, DOI 10.1073/pnas.0506770102; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Williams R. M., 2001, PAC S BIOCOMPUT, P89; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907	168	327	333	1	70	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics		2008	9			2					S1	10.1186/1471-2164-9-S2-S1			25	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	V92JQ	WOS:000206244200002	18831774	Green Published, gold			2022-01-24	
J	Maller, JB; Fagerness, JA; Reynolds, RC; Neale, BM; Daly, MJ; Seddon, JM				Maller, Julian B.; Fagerness, Jesen A.; Reynolds, Robyn C.; Neale, Benjamin M.; Daly, Mark J.; Seddon, Johanna M.			Variation in complement factor 3 is associated with risk of age-related macular degeneration	NATURE GENETICS			English	Article							FACTOR-H POLYMORPHISM; VARIANT; CFH; GENES; Y402H	The association of variants in complement factors H and B with age-related macular degeneration has led to more intense genetic and functional analysis of the complement pathway. We identify a nonsynonymous coding change in complement factor 3 that is strongly associated with risk of age-related macular degeneration in a large case-control sample.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Tufts Univ New England Med Ctr, New England Eye Ctr, Ophthal Epidemiol & Genet Serv, Boston, MA 02111 USA; Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AP, England; Harvard Univ, Sch Med, Boston, MA 02115 USA		Seddon, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; jseddon@tufts-nemc.org	maller, julian B/A-9323-2009; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54 RR020278] Funding Source: Medline; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY11309, N01-EY-0-2127, R01 EY011309] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54RR020278] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01EY002127, R01EY011309] Funding Source: NIH RePORTER		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; WYATT RJ, 1987, RECENT DEV MUCOSAL I; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	14	327	333	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1200	1201		10.1038/ng2131			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	WOS:000249737400014	17767156				2022-01-24	
J	Choudhury, AR; Ju, ZY; Djojosubroto, MW; Schienke, A; Lechel, A; Schaetzlein, S; Jiang, H; Stepczynska, A; Wang, CF; Buer, J; Lee, HW; von Zglinicki, T; Ganser, A; Schirmacher, P; Nakauchi, H; Rudolph, KL				Choudhury, Aaheli Roy; Ju, Zhenyu; Djojosubroto, Meta W.; Schienke, Andrea; Lechel, Andre; Schaetzlein, Sonja; Jiang, Hong; Stepczynska, Anna; Wang, Chunfang; Buer, Jan; Lee, Han-Woong; von Zglinicki, Thomas; Ganser, Arnold; Schirmacher, Peter; Nakauchi, Hiromitsu; Rudolph, K. Lenhard			Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation	NATURE GENETICS			English	Article							HUMAN FIBROBLASTS; MOUSE TELOMERASE; DNA-DAMAGE; SENESCENCE; LENGTH; P21(CIP1/WAF1); REGENERATION; CAPACITY; AGE; P53	Telomere shortening limits the proliferative lifespan of human cells by activation of DNA damage pathways, including upregulation of the cell cycle inhibitor p21 (encoded by Cdkn1a, also known as Cip1 and Waf1)) (refs. 1-5). Telomere shortening in response to mutation of the gene encoding telomerase is associated with impaired organ maintenance and shortened lifespan in humans(6) and in mice(7-9). The in vivo function of p21 in the context of telomere dysfunction is unknown. Here we show that deletion of p21 prolongs the lifespan of telomerase-deficient mice with dysfunctional telomeres. p21 deletion improved hematolymphopoiesis and the maintenance of intestinal epithelia without rescuing telomere function. Moreover, deletion of p21 rescued proliferation of intestinal progenitor cells and improved the repopulation capacity and self-renewal of hematopoietic stem cells from mice with dysfunctional telomeres. In these mice, apoptotic responses remained intact, and p21 deletion did not accelerate chromosomal instability or cancer formation. This study provides experimental evidence that telomere dysfunction induces p21-dependent checkpoints in vivo that can limit longevity at the organismal level.	Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; Helmholtz Ctr Infect Res, Dept Mucosal Immun, D-38124 Braunschweig, Germany; Univ Newcastle Upon Tyne, Inst Hlth & Aging, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany; Yonsei Univ, Coll Sci, Seoul 120749, South Korea; Dept Hematol & Oncol, D-30625 Hannover, Germany; Univ Hosp, Inst Pathol, D-69120 Heidelberg, Germany; Univ Tokyo, Inst Med Sci, Lab Stem Cell Therapy, Tokyo 1088693, Japan		Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Rudolph.Lenhard@MH-Hannover.de	Lechel, Andre/AAQ-2041-2021	Lechel, Andre/0000-0003-0221-6959; Buer, Jan/0000-0002-7602-1698; Rudolph, Karl Lenhard/0000-0002-4839-2862; von Zglinicki, Thomas/0000-0002-5939-0248; Roy Choudhury, Aaheli/0000-0001-6907-0734			ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Carnero A, 2004, ONCOGENE, V23, P6006, DOI 10.1038/sj.onc.1207839; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIPSCHITZ DA, 1984, BLOOD, V63, P502; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Min HY, 2005, IMMUNOL REV, V205, P7, DOI 10.1111/j.0105-2896.2005.00263.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	30	327	342	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					99	105		10.1038/ng1937			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	WOS:000243136500024	17143283				2022-01-24	
J	Crawford, GE; Holt, IE; Whittle, J; Webb, BD; Tai, D; Davis, S; Margulies, EH; Chen, YD; Bernat, JA; Ginsburg, D; Zhou, DX; Luo, SJ; Vasicek, TJ; Daly, MJ; Wolfsberg, TG; Collins, FS				Crawford, GE; Holt, IE; Whittle, J; Webb, BD; Tai, D; Davis, S; Margulies, EH; Chen, YD; Bernat, JA; Ginsburg, D; Zhou, DX; Luo, SJ; Vasicek, TJ; Daly, MJ; Wolfsberg, TG; Collins, FS			Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS)	GENOME RESEARCH			English	Article							IDENTIFICATION; CHROMATIN; PROMOTERS; ELEMENTS; GENES	A major goal in genomics is to Understand how genes are regulated in different tissues, stages of development, diseases, and species. Mapping DNase I hypersensitive (HS) sites within nuclear chromatin is a powerful and well-established method of identifying many different types of regulatory elements, but ill the past it has been limited to analysis of single loci. We have recently described a protocol to generate a genome-wide library of DNase HS sites. Here, we report high-throughput analysis, Using massively parallel signature sequencing (MPSS), of 230,000 tags from a DNase library generated from quiescent human CD4(+) T cells. Of the tags that uniquely map to the genome, we identified 14,190 clusters of sequences that group Within close proximity to each other. By using a real-time PCR strategy, we determined that the majority of these clusters represent valid DNase HS sites. Approximately 80% of these DNase HS Sites uniquely map within one or more annotated regions of the genome believed to contain regulatory elements, including regions 2 kb upstream of genes, CpG islands, and highly conserved sequences. Most DNase HS sites identified in CD4(+) T cells are also HS in CD8(+) T cells, B cells, hepatocytes, human umbilical vein endothelial cells (HUVECs), and HeLa cells. However, similar to 10% of the DNase HS sites are lymphocyte specific, indicating that this procedure call identify gene regulatory elements that control cell type specificity. This strategy, which call be applied to any cell line or tissue, will enable a better Understanding of how chromatin structure dictates cell function and fate.	NHGRI, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Solexa Inc, Hayward, CA 94545 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA		Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	francisc@exchange.nih.gov	Davis, Sean/AAD-1801-2021; Pillay, Nischalan/F-9536-2012; Wolfsberg, Tyra/D-8296-2017; Daly, Mark J/B-2453-2017	Davis, Sean/0000-0002-8991-6458; Wolfsberg, Tyra/0000-0001-5646-9455; Daly, Mark J/0000-0002-0949-8752; Bernat, John/0000-0003-2033-6129	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [Z01HG200304, Z01HG000185] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL39639] Funding Source: Medline		Barnett V., 1998, OUTLIERS STAT DATA; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HEBBES TR, 1992, NUCLEIC ACIDS RES, V20, P1017, DOI 10.1093/nar/20.5.1017; HEWISH D, 1977, NUCLEIC ACIDS RES, V4, P1881, DOI 10.1093/nar/4.6.1881; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5	19	327	335	3	18	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2006	16	1					123	131		10.1101/gr.4074106			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	016CJ	WOS:000235598000014	16344561	Green Published, Bronze			2022-01-24	
J	Di Pasquale, E; Beck-Peccoz, P; Persani, L				Di Pasquale, E; Beck-Peccoz, P; Persani, L			Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; INCREASED OVULATION RATE; INFERTILITY; SECRETION; OOCYTES; REGION; WOMEN; SHEEP; CELLS	Hypergonadotropic ovarian failure is a common cause of female infertility. It is a heterogeneous disorder that, in the most severe forms, is a result of ovarian dysgenesis (OD). Most OD cases are associated with major X-chromosome abnormalities, but the pathogenesis of this disorder is still largely undefined in patients with a normal karyotype. Animal models showed the important role in female reproduction played by the product of a gene located at Xp11.2 in humans (BMP15). BMP15 is an oocyte-specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth. We report two sisters with a normal karyotype who are affected with hypergonadotropic ovarian failure due to OD. The familial presentation suggested a genetic origin, and candidate genes were screened for mutations. A heterozygous nonconservative substitution in the pro region of BMP15 (Y235C) was identified in both sisters but not in 210 control alleles. This mutation was inherited from the father. Mutant BMP15 appears to be processed abnormally, is associated with reduced GC growth, and antagonizes the stimulatory activity of wild-type protein on GC proliferation. In conclusion, the first natural mutation in human BMP15 is associated with familial OD, indicating that the action of BMP15 is required for the progression of human folliculogenesis. This condition represents an exceptional example of X-linked human disease exclusively affecting heterozygous females who inherited the genetic alteration from the unaffected father. BMP15 defects are involved in the pathogenesis of hypergonadotropic ovarian failure in humans.	Univ Milan, Inst Endocrine Sci, Ist Auxol Italiano, IRCCS, I-20095 Cusano Milanino, MI, Italy; Osped Maggiore, IRCCS, Milan, Italy		Persani, L (corresponding author), Univ Milan, Inst Endocrine Sci, Ist Auxol Italiano, IRCCS, Via Zucchi 18, I-20095 Cusano Milanino, MI, Italy.	luca.persani@unimi.it	Di Pasquale, Elisa/ABI-6252-2020; Di Pasquale, Elisa/ABI-6210-2020; Persani, Luca/B-6543-2008	Di Pasquale, Elisa/0000-0003-2373-5635; Persani, Luca/0000-0003-2068-9581			Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Layman LC, 1998, FERTIL STERIL, V69, P300, DOI 10.1016/S0015-0282(97)00480-9; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Otsuka F, 2002, ENDOCRINOLOGY, V143, P4938, DOI 10.1210/en.2002-220929; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; SCHULZ E, 1994, ACROS CHIMICA ACTA, V1, P1; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; Takebayashi K, 2000, FERTIL STERIL, V74, P976, DOI 10.1016/S0015-0282(00)01539-9; TAPANAINEN J, 1987, FERTIL STERIL, V48, P576; THOMPSON DR, 1997, CLIN EFFECTIVENESS N, V1, P64; Timmreck LS, 2003, OBSTET GYN CLIN N AM, V30, P287, DOI 10.1016/S0889-8545(03)00027-5; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152	26	327	347	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					106	111		10.1086/422103			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	WOS:000222031300013	15136966	Green Published, Bronze			2022-01-24	
J	Verhoeven, K; De Jonghe, P; Coen, K; Verpoorten, N; Auer-Grumbach, M; Kwon, JM; FitzPatrick, D; Schmedding, E; De Vriendt, E; Jacobs, A; Van Gerwen, V; Wagner, K; Hartung, HP; Timmerman, V				Verhoeven, K; De Jonghe, P; Coen, K; Verpoorten, N; Auer-Grumbach, M; Kwon, JM; FitzPatrick, D; Schmedding, E; De Vriendt, E; Jacobs, A; Van Gerwen, V; Wagner, K; Hartung, HP; Timmerman, V			Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY SENSORY NEUROPATHY; TRANSPORT; FAMILY; SPTLC1; LOCUS; RILP	Charcot-Marie-Tooth type 2B (CMT2B) is clinically characterized by marked distal muscle weakness and wasting and a high frequency of foot ulcers, infections, and amputations of the toes because of recurrent infections. CMT2B maps to chromosome 3q13-q22. We refined the CMT2B locus to a 2.5-cM region and report two missense mutations (Leu129Phe and Val162Met) in the small GTP-ase late endosomal protein RAB7 which causes the CMT2B phenotype in three extended families and in three patients with a positive family history. The alignment of RAB7 orthologs shows that both missense mutations target highly conserved amino acid residues. RAB7 is ubiquitously expressed, and we found expression in sensory and motor neurons.	Univ Antwerp VIB, Dept Mol Genet, Born Bunge Fdn, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Karl Franzens Univ Graz, Inst Med Biol & Human Genet, Graz, Austria; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Hosp Brussels, Dept Neurol, Brussels, Belgium; Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany		Timmerman, V (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Timmerman, Vincent/O-7283-2019; FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008	Timmerman, Vincent/0000-0002-2162-0933; FitzPatrick, David R./0000-0003-4861-969X			Auer-Grumbach M, 2000, NEUROLOGY, V55, P1552, DOI 10.1212/WNL.55.10.1552; Auer-Grumbach M, 2000, NEUROLOGY, V54, P45, DOI 10.1212/WNL.54.1.45; AUERGRUMBACH M, IN PRESS ARCH NEUROL; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bellone E, 2002, NEUROMUSCULAR DISORD, V12, P286, DOI 10.1016/S0960-8966(01)00282-6; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; De Jonghe P, 1997, J NEUROL NEUROSUR PS, V62, P570, DOI 10.1136/jnnp.62.6.570; DEJONGHE P, 2000, NEUROMUSCULAR DIS BA; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; KWON JM, 1995, AM J HUM GENET, V57, P853; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Vitelli R, 1996, BIOCHEM BIOPH RES CO, V229, P887, DOI 10.1006/bbrc.1996.1897	21	327	341	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					722	727		10.1086/367847			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	WOS:000181152600022	12545426	Green Published, Bronze			2022-01-24	
J	Chen, XN; Levine, L; Kwok, PY				Chen, XN; Levine, L; Kwok, PY			Fluorescence polarization in homogeneous nucleic acid analysis	GENOME RESEARCH			English	Article							STRAND DISPLACEMENT AMPLIFICATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA DIAGNOSTIC METHOD; ENERGY-TRANSFER; HUMAN GENOME; ASSAY; TOOL; IDENTIFICATION; POLYMERASE; DISEASE	A new method for DNA diagnostics based on template-directed primer extension and detection by fluorescence polarization is described. In this method, amplified genomic DNA containing a polymorphic locus is incubated with oligonucleotide primers (designed to hybridize to the DNA template adjacent to the polymorphic site) in the presence of allele-specific dye-labeled dideoxyribonucleoside triphosphates and a commercially available modified Taq DNA polymerase. The primer is extended by the dye-terminator specific for the allele present on the template, increasing similar to 10-fold the molecular weight of the fluorophore. At the end of the reaction, the fluorescence polarization of the two dye-terminators in the reaction mixture are analyzed directly without separation or purification. This homogeneous DNA diagnostic method is shown to be highly sensitive and specific and is suitable for automated genotyping of large number of samples.	Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Monsanto Life Sci Co, St Louis, MO 63198 USA		Chen, XN (corresponding author), Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA.		Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01-EY12557] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [F32-HG156, R01-HG1720, R01 HG001720] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012557] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG001720] Funding Source: NIH RePORTER		Alford R. Lynn, 1994, Current Opinion in Biotechnology, V5, P29, DOI 10.1016/S0958-1669(05)80066-7; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P347, DOI 10.1093/nar/25.2.347; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; COOPER DN, 1988, HUM GENET, V78, P299, DOI 10.1007/BF00291724; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gibson NJ, 1997, CLIN CHEM, V43, P1336; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; NIKIFOROV TT, 1994, NUCLEIC ACIDS RES, V22, P4167, DOI 10.1093/nar/22.20.4167; Parker LT, 1996, BIOTECHNIQUES, V21, P694; PARRY PJ, 1991, NUCLEIC ACIDS RES, V19, P6983, DOI 10.1093/nar/19.24.6983-a; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Perrin F, 1926, J PHYS-PARIS, V7, P390, DOI 10.1051/jphysrad:01926007012039000; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Syvanen A C, 1998, Methods Mol Biol, V98, P291; SYVANEN AC, 1994, CLIN CHIM ACTA, V226, P225, DOI 10.1016/0009-8981(94)90217-8; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; Walker GT, 1996, NUCLEIC ACIDS RES, V24, P348, DOI 10.1093/nar/24.2.348; Walker GT, 1996, CLIN CHEM, V42, P1604; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913	25	327	345	1	21	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	MAY	1999	9	5					492	498					7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	197CW	WOS:000080347900012	10330129				2022-01-24	
J	Klaver, CCW; Kliffen, M; van Duijn, CM; Hofman, A; Cruts, M; Grobbee, DE; van Broeckhoven, C; de Jong, PTVM				Klaver, CCW; Kliffen, M; van Duijn, CM; Hofman, A; Cruts, M; Grobbee, DE; van Broeckhoven, C; de Jong, PTVM			Genetic association of apolipoprotein E with age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; CREUTZFELDT-JAKOB-DISEASE; PERIPHERIN/RDS GENE; ALZHEIMERS-DISEASE; CHOLESTEROL TRANSPORT; RETINITIS-PIGMENTOSA; RETINAL DYSTROPHY; PATTERN DYSTROPHY; E POLYMORPHISM; VISUAL-ACUITY	Age-related macular degeneration (AMD) is the most common geriatric eye disorder leading to blindness and is characterized by degeneration of the neuroepithelium in the macular area of the eye. Apolipoprotein E (apoE), the major apolipoprotein of the CNS and an important regulator of cholesterol and lipid transport, appears to be associated with neurodegeneration. The apoE gene (APOE) polymorphism is a strong risk factor for various neurodegenerative diseases, and the apoE protein has been demonstrated in disease-associated lesions of these disorders. Hypothesizing that variants of APOE act as a potential risk factor for AMD, we performed a genetic-association study among 88 AMD cases and 901 controls derived from the population-based Rotterdam Study in the Netherlands. The APOE polymorphism showed a significant association with the risk for AMD; the APOE epsilon 4 allele was associated with a decreased risk (odds ratio 0.43 [95% confidence interval 0.21-0.88]), and the epsilon 2 allele was associated with a slightly increased risk of AMD (odds ratio 1.5 [95% confidence interval 0.8-2.82]). To investigate whether apoE is directly involved in the pathogenesis of AMD, we studied apoE immunoreactivity in 15 AMD and 10 control maculae and found that apoE staining was consistently present in the disease-associated deposits in AMD-maculae-that is, drusen and basal laminar deposit. Our results suggest that APOE is a susceptibility gene for AMD.	Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Sch Med, Dept Ophthalmol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Sch Med, Dept Pathol, NL-3000 DR Rotterdam, Netherlands; Univ Antwerp VIB, Born Bunge Fdn, Neurogenet Lab, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Biochem, B-2020 Antwerp, Belgium; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands		de Jong, PTVM (corresponding author), Box 12141, NL-1100 AC Amsterdam, Netherlands.	dejong@epib.fgg.eur.nl	Cruts, Marc/J-6161-2013; Grobbee, Diederick/C-7651-2014; Van Broeckhoven, Christine/M-7853-2019; Klaver, Caroline C.W./A-2013-2016; Van Broeckhoven, Christine/G-8362-2017	Cruts, Marc/0000-0002-1338-992X; Grobbee, Diederick/0000-0003-4472-4468; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Klaver, Caroline/0000-0002-2355-5258			AlChalabi A, 1996, LANCET, V347, P159, DOI 10.1016/S0140-6736(96)90343-8; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Amaratunga A, 1996, J BIOL CHEM, V271, P5628, DOI 10.1074/jbc.271.10.5628; AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Gregory CY, 1996, HUM MOL GENET, V5, P1055, DOI 10.1093/hmg/5.7.1055; GRINDLE CFJ, 1978, T OPHTHAL SOC UK, V98, P172; Guillaume D, 1996, J NEUROCHEM, V66, P2410; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hoyng CB, 1996, AM J OPHTHALMOL, V121, P623, DOI 10.1016/S0002-9394(14)70627-0; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; KEEN TJ, 1994, HUM MOL GENET, V3, P367, DOI 10.1093/hmg/3.2.367; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; KLAVER CCW, 1997, INVEST OPHTH VIS SCI, V38, pS967; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Kliffen M, 1997, MICROSC RES TECHNIQ, V36, P106, DOI 10.1002/(SICI)1097-0029(19970115)36:2<106::AID-JEMT4>3.3.CO;2-E; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Kuhrt H, 1997, J BRAIN RES, V38, P223; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; NAKAZAWA M, 1994, HUM MOL GENET, V3, P1195, DOI 10.1093/hmg/3.7.1195; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Poirier J, 1995, ANN MED, V27, P663, DOI 10.3109/07853899509019253; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SMALL KW, 1992, GENOMICS, V13, P681, DOI 10.1016/0888-7543(92)90141-E; Small KW, 1996, AM J OPHTHALMOL, V121, P13, DOI 10.1016/S0002-9394(14)70529-X; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; UTERMANN G, 1985, ADV EXP MED BIOL, V183, P173; VANDERSCHAFT TL, 1992, OPHTHALMOLOGY, V99, P278; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C	54	327	338	0	16	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					200	206		10.1086/301901			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	WOS:000074761000028	9634502	Green Published, Bronze			2022-01-24	
J	ADACHI, M; SUEMATSU, S; KONDO, T; OGASAWARA, J; TANAKA, T; YOSHIDA, N; NAGATA, S				ADACHI, M; SUEMATSU, S; KONDO, T; OGASAWARA, J; TANAKA, T; YOSHIDA, N; NAGATA, S			TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; CELL-SURFACE ANTIGEN; LPR MICE; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; APOPTOTIC BODIES; MESSENGER-RNA; STEM-CELLS; RAT-LIVER; EXPRESSION	Fas, a type I membrane protein that transduces an apoptotic signal, is expressed in lymphocytes as well as in various tissues such as the liver, lung and heart. The mouse lymphoproliferation (lpr) mutation is a leaky mutation in Fas. By means of gene targeting, we generated a mouse strain which is completely deficient in Fas. In addition to the massive production of lymphocytes, the Fas-null mice showed substantial liver hyperplasia, which was accompanied by the enlargement of nuclei in hepatocytes. The Fas system seems to play a role in the apoptotic process to maintain homeostasis of the liver as well as the peripheral lymphoid organs.	OSAKA BIOSCI INST,SUITA,OSAKA 565,JAPAN; OSAKA MED CTR MATERNAL & CHILD HLTH,IZUMI,OSAKA 59002,JAPAN				Tanaka, Takashi/O-8254-2015; Nagata, Shigekazu/AAG-3203-2019; Kondo, Toru/F-9420-2012	Nagata, Shigekazu/0000-0001-9758-8426; 			ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Andrew W, 1943, AM J ANAT, V72, P199, DOI 10.1002/aja.1000720204; ARBER N, 1988, LIVER, V8, P80; BENEDETTI A, 1988, J HEPATOL, V7, P319, DOI 10.1016/S0168-8278(88)80004-7; BENEDETTI A, 1988, LIVER, V8, P172; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; IZUI S, 1984, J IMMUNOL, V133, P227; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAGI D, 1994, SCIENCE, V265, P5287; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MACMAHON AP, 1990, CELL, V62, P1037; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARIANI SM, 1994, EUR J IMMUNOL, V24, P3119, DOI 10.1002/eji.1830241231; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NI R, 1995, EXP CELL RES, V215, P332; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; TANAKA T, 1995, CELL, P353; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; WATANABE T, 1994, J TOXICOL PATHOL, V7, P353; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WU JG, 1993, J EXP MED, V178, P461, DOI 10.1084/jem.178.2.461; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	50	327	327	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					294	300		10.1038/ng1195-294			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	WOS:A1995TC63900018	7581453				2022-01-24	
J	VALENTIJN, LJ; BOLHUIS, PA; ZORN, I; HOOGENDIJK, JE; VANDENBOSCH, N; HENSELS, GW; STANTON, VP; HOUSMAN, DE; FISCHBECK, KH; ROSS, DA; NICHOLSON, GA; MEERSHOEK, EJ; DAUWERSE, HG; VANOMMEN, GJB; BAAS, F				VALENTIJN, LJ; BOLHUIS, PA; ZORN, I; HOOGENDIJK, JE; VANDENBOSCH, N; HENSELS, GW; STANTON, VP; HOUSMAN, DE; FISCHBECK, KH; ROSS, DA; NICHOLSON, GA; MEERSHOEK, EJ; DAUWERSE, HG; VANOMMEN, GJB; BAAS, F			THE PERIPHERAL MYELIN GENE PMP-22/GAS-3 IS DUPLICATED IN CHARCOT-MARIE-TOOTH DISEASE TYPE-1A	NATURE GENETICS			English	Article							GROWTH ARREST; DNA-MOLECULES; SEPARATION; LINKAGE; LOCUS; YEAST	Charcot-Marie-Tooth disease type 1A (CMT1A) is associated with a DNA duplication at chromosome 17p11.2. In view of the point mutation in the gene for peripheral myelin protein pmp-22/gas-3 in Trembler mice, a murine model for CMT1A, we have analysed whether this gene is altered in CMT1A. Here we show that the human homologue of the murine pmp-22 gene is located within the CMT1A DNA duplication, which is a direct repeat and does not interrupt the coding region of PMP-22. Expression of PMP-22 in CMT1A fibroblasts is similar to expression in control fibroblasts. Increased gene dosage or altered PMP-22 expression in the peripheral nervous system are therefore possible mechanisms by which PMP-22 is involved in CMT1A.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV SYDNEY,CONCORD HOSP,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA; LEIDEN UNIV,SYLVIUS LABS,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS		VALENTIJN, LJ (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL K2206,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS.		Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Stanton, Vincent/0000-0002-2205-6000			ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BIRD TD, 1982, AM J HUM GENET, V34, P388; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; DAUWERSE JG, IN PRESS BLOOD, V79; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; HOOGENDIJK JE, 1991, HDB CLIN NEUROLOGY; HULSEBOS TJM, 1991, CYTOGENET CELL GENET, V56, P171, DOI 10.1159/000133080; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1992, NATURE GENET, V1; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sherman F., 1986, METHODS YEAST GENETI; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	26	327	329	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					166	170		10.1038/ng0692-166			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	WOS:A1992JC98200006	1303229				2022-01-24	
J	Ishihama, Y; Schmidt, T; Rappsilber, J; Mann, M; Hartl, FU; Kerner, MJ; Frishman, D				Ishihama, Yasushi; Schmidt, Thorsten; Rappsilber, Juri; Mann, Matthias; Hartl, F. Ulrich; Kerner, Michael J.; Frishman, Dmitrij			Protein abundance profiling of the Escherichia coli cytosol	BMC GENOMICS			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; PEPTIDE RETENTION TIMES; CODON ADAPTATION INDEX; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; MULTIDIMENSIONAL CHROMATOGRAPHY; SUBCELLULAR-LOCALIZATION; ABSOLUTE QUANTIFICATION; PROTEOMIC ANALYSIS; AGGREGATION RATES	Background: Knowledge about the abundance of molecular components is an important prerequisite for building quantitative predictive models of cellular behavior. Proteins are central components of these models, since they carry out most of the fundamental processes in the cell. Thus far, protein concentrations have been difficult to measure on a large scale, but proteomic technologies have now advanced to a stage where this information becomes readily accessible. Results: Here, we describe an experimental scheme to maximize the coverage of proteins identified by mass spectrometry of a complex biological sample. Using a combination of LC-MS/MS approaches with protein and peptide fractionation steps we identified 1103 proteins from the cytosolic fraction of the Escherichia coli strain MC4100. A measure of abundance is presented for each of the identified proteins, based on the recently developed emPAI approach which takes into account the number of sequenced peptides per protein. The values of abundance are within a broad range and accurately reflect independently measured copy numbers per cell. As expected, the most abundant proteins were those involved in protein synthesis, most notably ribosomal proteins. Proteins involved in energy metabolism as well as those with binding function were also found in high copy number while proteins annotated with the terms metabolism, transcription, transport, and cellular organization were rare. The barrel-sandwich fold was found to be the structural fold with the highest abundance. Highly abundant proteins are predicted to be less prone to aggregation based on their length, pI values, and occurrence patterns of hydrophobic stretches. We also find that abundant proteins tend to be predominantly essential. Additionally we observe a significant correlation between protein and mRNA abundance in E. coli cells. Conclusion: Abundance measurements for more than 1000 E. coli proteins presented in this work represent the most complete study of protein abundance in a bacterial cell so far. We show significant associations between the abundance of a protein and its properties and functions in the cell. In this way, we provide both data and novel insights into the role of protein concentration in this model organism.	[Schmidt, Thorsten; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephen, D-85350 Martinsried, Germany; [Ishihama, Yasushi; Rappsilber, Juri; Mann, Matthias] Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense, Denmark; [Ishihama, Yasushi] Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; [Mann, Matthias] Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82512 Martinsried, Germany; [Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Kerner, Michael J.] Tech Univ Denmark, Ctr Biol Sequence Anal, BioCentrum, DK-1726 Lyngby, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EHP 3JR, Midlothian, Scotland; [Frishman, Dmitrij] GSF, Natl Res Ctr Environm Hlth, D-85764 Neuherberg, Germany		Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephen, D-85350 Martinsried, Germany.	y-ishi@ttck.keio.ac.jp; t.schmidt@wzw.tum.de; juri.rappsilber@ed.ac.uk; mmann@biochem.mpg.de; uhartl@biochem.mpg.de; kerner@cbs.dtu.dk; d.frishman@wzw.tum.de	Rappsilber, Juri/ABF-3328-2020; Mann, Matthias/A-3454-2013; Ishihama, Yasushi/B-3101-2016; Hartl, F. Ulrich/Y-8206-2019; Frishman, Dmitrij/AAT-7815-2020; Rappsilber, Juri/B-7265-2015	Mann, Matthias/0000-0003-1292-4799; Ishihama, Yasushi/0000-0001-7714-203X; Rappsilber, Juri/0000-0001-5999-1310; Schmidt, Thorsten/0000-0002-6719-0633			Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Barr JR, 1996, CLIN CHEM, V42, P1676; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gerstein M, 1997, P NATL ACAD SCI USA, V94, P11911, DOI 10.1073/pnas.94.22.11911; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hansen KC, 2003, MOL CELL PROTEOMICS, V2, P299, DOI 10.1074/mcp.M300021-MCP200; Hartigan JA, 1975, CLUSTERING ALGORITHM; HOWE JG, 1983, J BIOL CHEM, V258, P1954; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Jansen R, 2000, NUCLEIC ACIDS RES, V28, P1481, DOI 10.1093/nar/28.6.1481; Karlin S, 2001, J BACTERIOL, V183, P5025, DOI 10.1128/JB.183.17.5025-5040.2001; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Lopez-Campistrous A, 2005, MOL CELL PROTEOMICS, V4, P1205, DOI 10.1074/mcp.D500006-MCP200; MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632; Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; RAPPSILBER J, 2003, ABSTRACTS 51 AM SOC; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; SAKAMOTO Y, 1988, J CHROMATOGR, V442, P69, DOI 10.1016/S0021-9673(00)94457-1; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schmidt T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-331; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; VanBogelen RA, 1997, ELECTROPHORESIS, V18, P1243, DOI 10.1002/elps.1150180805; VANHEESWIJK WC, 1993, MOL MICROBIOL, V9, P443; Witten I. H., 2005, DATA MINING PRACTICA; Wong P, 2005, PROTEIN ENG DES SEL, V18, P503, DOI 10.1093/protein/gzi056; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	70	326	329	1	34	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 27	2008	9								102	10.1186/1471-2164-9-102			17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	287BK	WOS:000254891100003	18304323	Green Submitted, Green Published, gold			2022-01-24	
J	Miyamoto, Y; Mabuchi, A; Shi, DQ; Kubo, T; Takatori, Y; Saito, S; Fujioka, M; Sudo, A; Uchida, A; Yamamoto, S; Ozaki, K; Takigawa, M; Tanaka, T; Nakamura, Y; Jiang, Q; Ikegawa, S				Miyamoto, Yoshinari; Mabuchi, Akihiko; Shi, Dongquan; Kubo, Toshikazu; Takatori, Yoshio; Saito, Susumu; Fujioka, Mikihiro; Sudo, Akihiro; Uchida, Atsumasa; Yamamoto, Seizo; Ozaki, Koichi; Takigawa, Masaharu; Tanaka, Toshihiro; Nakamura, Yusuke; Jiang, Qing; Ikegawa, Shiro			A functional polymorphism in the 5 ' UTR of GDF5 is associated with susceptibility to osteoarthritis	NATURE GENETICS			English	Article							CHONDROSARCOMA CELL-LINE; ACID REPEAT POLYMORPHISM; SEQUENCE POLYMORPHISMS; MORPHOGENETIC PROTEINS; KNEE-OSTEOARTHRITIS; HIP OSTEOARTHRITIS; GENE; MUTATION; CHONDRODYSPLASIA; CHONDROGENESIS	Osteoarthritis (MIM 165720), characterized by degeneration of articular cartilage, is the most common form of human arthritis and a major concern for aging societies worldwide(1-3). Epidemiological and genetic studies have shown that osteoarthritis is a polygenic disease(1,4,5). Here, we report that the gene encoding growth differentiation factor 5 (GDF5) is associated with osteoarthritis in Asian populations. A SNP in the 5' UTR of GDF5 (+104T/ C; rs143383) showed significant association (P = 1.8 x 10(-13)) with hip osteoarthritis in two independent Japanese populations. This association was replicated for knee osteoarthritis in Japanese (P = 0.0021) and Han Chinese (P = 0.00028) populations. This SNP, located in the GDF5 core promoter, exerts allelic differences on transcriptional activity in chondrogenic cells, with the susceptibility allele showing reduced activity. Our findings implicate GDF5 as a susceptibility gene for osteoarthritis and suggest that decreased GDF5 expression is involved in the pathogenesis of osteoarthritis.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo 1088639, Japan; Nanjing Univ, Sch Med, Drum Tower hosp, Ctr Diagnosis Treatment Joint Dis, Nanjing 210008, Jiangsu, Peoples R China; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan; Univ Tokyo, Dept Orthopaed Surg, Tokyo 1138655, Japan; Sumitorno Hosp, Dept Orthopaed Surg, Kita Ku, Osaka 5300005, Japan; Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Orthopaed Surg, Itabashi Ku, Tokyo 1730015, Japan; RIKEN, Lab Cardiovasc Dis, SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008525, Japan; RIKEN, Lab Genotyping, SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan		Ikegawa, S (corresponding author), Osaka Rosai Hosp, Dept Orthopaed Surg, 1179-3 Nagasone Cho, Osaka 5918025, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Shi, Dongquan/ABG-6949-2021; Tanaka, Toshihiro/J-9310-2014; shi, dongquan/AAE-9956-2020; shi, dongquan/ABH-3078-2021	Ikegawa, Shiro/0000-0003-0316-2147; Tanaka, Toshihiro/0000-0001-6201-9784; shi, dongquan/0000-0002-4769-7816; Ozaki, Kouichi/0000-0003-0028-1570			Bobacz K, 2002, OSTEOARTHR CARTILAGE, V10, P394, DOI 10.1053/joca.2002.0522; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chano T, 1998, VIRCHOWS ARCH, V432, P529, DOI 10.1007/s004280050201; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; Faiyaz-Ul-Haque M, 2002, AM J MED GENET, V111, P31, DOI 10.1002/ajmg.10501; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; KELLGREN JH, 1952, BRIT MED J, V1, P181, DOI 10.1136/bmj.1.4751.181; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb01862.x; Savarirayan R, 2003, AM J MED GENET A, V117A, P136, DOI 10.1002/ajmg.a.10924; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Sugiura T, 1999, BIOCHEM BIOPH RES CO, V263, P707, DOI 10.1006/bbrc.1999.1445; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537	30	326	351	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					529	533		10.1038/2005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	WOS:000245271200024	17384641				2022-01-24	
J	Kizawa, H; Kou, I; Iida, A; Sudo, A; Miyamoto, Y; Fukuda, A; Mabuchi, A; Kotani, A; Kawakami, A; Yamamoto, S; Uchida, A; Nakamura, K; Notoya, K; Nakamura, Y; Ikegawa, S				Kizawa, H; Kou, I; Iida, A; Sudo, A; Miyamoto, Y; Fukuda, A; Mabuchi, A; Kotani, A; Kawakami, A; Yamamoto, S; Uchida, A; Nakamura, K; Notoya, K; Nakamura, Y; Ikegawa, S			An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis	NATURE GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; TGF-BETA; SEQUENCE POLYMORPHISMS; OSTEOPHYTE FORMATION; GENE-CLUSTER; KNEE; ASSOCIATION; EXPRESSION; DECORIN; DIFFERENTIATION	Osteoarthritis is the most common form of human arthritis. We investigated the potential role of asporin, an extracellular matrix component expressed abundantly in the articular cartilage of individuals with osteoarthritis, in the pathogenesis of osteoarthritis. Here we report a significant association between a polymorphism in the aspartic acid (D) repeat of the gene encoding asporin (ASPN) and osteoarthritis. In two independent populations of individuals with knee osteoarthritis, the D14 allele of ASPN is overrepresented relative to the common D13 allele, and its frequency increases with disease severity. The D14 allele is also overrepresented in individuals with hip osteoarthritis. Asporin suppresses TGF-beta-mediated expression of the genes aggrecan (AGC1) and type II collagen (COL2A1) and reduced proteoglycan accumulation in an in vitro model of chondrogenesis. The effect on TGF-beta activity is allele-specific, with the D14 allele resulting in greater inhibition than other alleles. In vitro binding assays showed a direct interaction between asporin and TGF-beta. Taken together, these findings provide another functional link between extracellular matrix proteins, TGF-beta activity and disease, suggesting new therapeutic strategies for osteoarthritis.	RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, Tokyo 1088639, Japan; Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmaceut Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; Univ Tokyo, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan; Kyorin Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1818611, Japan; Tokyo Teishin Hosp, Dept Orthoped Surg, Chiyoda Ku, Tokyo 1028798, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Orthoped Surg, Itabashi Ku, Tokyo 1730015, Japan		Ikegawa, S (corresponding author), RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015	Ikegawa, Shiro/0000-0003-0316-2147			Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Loughlin J, 2002, ARTHRITIS RHEUM, V46, P1519, DOI 10.1002/art.10260; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SINGH K, 1993, J BIOCHEM-TOKYO, V114, P702, DOI 10.1093/oxfordjournals.jbchem.a124240; Smith AJP, 2004, GENES IMMUN, V5, P451, DOI 10.1038/sj.gene.6364107; Spector TD, 1996, BRIT MED J, V312, P940; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uitterlinden AG, 2000, ARTHRITIS RHEUM-US, V43, P1456, DOI 10.1002/1529-0131(200007)43:7<1456::AID-ANR7>3.0.CO;2-M; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	37	326	339	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					138	144		10.1038/ng1496			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	WOS:000226690100019	15640800				2022-01-24	
J	Robitaille, J; MacDonald, MLE; Kaykas, A; Sheldahl, LC; Zeisler, J; Dube, MP; Zhang, LH; Singaraja, RR; Guernsey, DL; Zheng, BY; Siebert, LF; Hoskin-Mott, A; Trese, MT; Pimstone, SN; Shastry, BS; Moon, RT; Hayden, MR; Goldberg, YP; Samuels, ME				Robitaille, J; MacDonald, MLE; Kaykas, A; Sheldahl, LC; Zeisler, J; Dube, MP; Zhang, LH; Singaraja, RR; Guernsey, DL; Zheng, BY; Siebert, LF; Hoskin-Mott, A; Trese, MT; Pimstone, SN; Shastry, BS; Moon, RT; Hayden, MR; Goldberg, YP; Samuels, ME			Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy	NATURE GENETICS			English	Article							CANDIDATE GENE ANALYSIS; TARGETED DISRUPTION; LINKAGE ANALYSIS; WNT; RECEPTOR; WINGLESS; COMPLEX; PROTEIN; MUTATIONS; CARCINOMA	Familial exudative vitreoretinopathy (FEVR) is a hereditary ocular disorder characterized by a failure of peripheral retinal vascularization. Loci associated with FEVR map to 11q13-q23 (EVR1; OMIM 133780, ref. 1), Xp11.4 (EVR2; OMIM 305390, ref. 2) and 11p13-12 (EVR3; OMIM 605750, ref. 3). Here we have confirmed linkage to the 11q13-23 locus for autosomal dominant FEVR in one large multigenerational family and refined the disease locus to a genomic region spanning 1.55 Mb. Mutations in FZD4, encoding the putative Wnt receptor frizzled-4, segregated completely with affected individuals in the family and were detected in affected individuals from an additional unrelated family, but not in normal controls. FZD genes encode Wnt receptors, which are implicated in development and carcinogenesis. Injection of wildtype and mutated FZD4 into Xenopus laevis embryos revealed that wildtype, but not mutant, frizzled-4 activated calcium/calmodulin-dependent protein kinase II (CAMKII) and protein kinase C (PKC), components of the Wnt/Ca2+ signaling pathway. In one of the mutants, altered subcellular trafficking led to defective signaling. These findings support a function for frizzled-4 in retinal angiogenesis and establish the first association between a Wnt receptor and human disease.	Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada; Dalhousie Univ, Dept Ophthalmol, Izaak Walton Killam Hlth Ctr, Halifax, NS B3H 2Y9, Canada; Dalhousie Univ, Dept Pathol, Div Mol Pathol & Mol Genet, Halifax, NS B3H 4H7, Canada; Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Western Ontario, Dept Ophthalmol, London, ON, Canada; Dalhousie Univ, QEII Sci Ctr, Dept Ophthalmol, Halifax, NS, Canada; William Beaumont Hosp, Royal Oak, MI 48072 USA; Oakland Univ, Dept Biol Sci, Rochester, MI USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada		Hayden, MR (corresponding author), Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada.		Hayden, Michael R/D-8581-2011; Moon, Randall/M-5605-2019; Dube, Marie-Pierre/B-9364-2008; Moon, Randall T/B-1743-2014	Hayden, Michael R/0000-0001-5159-1419; Moon, Randall/0000-0002-9352-1408; Dube, Marie-Pierre/0000-0001-8442-4393; Moon, Randall T/0000-0002-9352-1408; MacDonald, Marcia/0000-0001-7946-0023; Sheldahl, Laird/0000-0002-3298-5436; Singaraja, Roshni/0000-0002-3418-3867			Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; de Crecchio G, 1998, CLIN GENET, V54, P315, DOI 10.1034/j.1399-0004.1998.5440409.x; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Kondo H, 2001, HUM GENET, V108, P368, DOI 10.1007/s004390100503; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; LI Y, 1992, AM J OPHTHALMOL, V113, P712, DOI 10.1016/S0002-9394(14)74800-7; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; MULLER B, 1994, GENOMICS, V20, P317, DOI 10.1006/geno.1994.1176; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Shastry BS, 2000, CLIN GENET, V58, P329, DOI 10.1034/j.1399-0004.2000.580412.x; SHASTRY BS, 1995, GENOMICS, V27, P341, DOI 10.1006/geno.1995.1052; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	27	326	342	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					326	330		10.1038/ng957			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	WOS:000178311100026	12172548				2022-01-24	
J	Vahteristo, P; Bartkova, J; Eerola, H; Syrjakoski, K; Ojala, S; Kilpivaara, O; Tamminen, A; Kononen, J; Aittomaki, K; Heikkila, P; Holli, K; Blomqvist, C; Bartek, J; Kallioniemi, OP; Nevanlinna, H				Vahteristo, P; Bartkova, J; Eerola, H; Syrjakoski, K; Ojala, S; Kilpivaara, O; Tamminen, A; Kononen, J; Aittomaki, K; Heikkila, P; Holli, K; Blomqvist, C; Bartek, J; Kallioniemi, OP; Nevanlinna, H			A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; DNA-DAMAGE CHECKPOINT; BRCA2 MUTATIONS; SUSCEPTIBILITY GENES; IN-VIVO; CHK2; KINASE; P53; PROTEIN; FINLAND	CHEK2 (previously known as "CHK2") is a cell-cycle-checkpoint kinase that phosphorylates p53 and BRCA1 in response to DNA damage. A protein-truncating mutation, 1100delC in exon 10, which abolishes the kinase function of CHEK2, has been found in families with Li-Fraumeni syndrome (LFS) and in those with a cancer phenotype that is suggestive of LFS, including breast cancer. In the present study, we found that the frequency of 1100delC was 2.0% among an unselected population-based cohort of 1,035 patients with breast cancer. This was slightly, but not significantly (P=.182), higher than the 1.4% frequency found among 1,885 population control subjects. However, a significantly elevated frequency was found among those 358 patients with a positive family history (11/358 [3.1%]; odds ratio [OR] 2.27; 95% confidence interval [CI] 1.11-4.63;, P=.021, compared with population controls). Furthermore, patients with bilateral breast cancer were sixfold more likely to be 1100delC carriers than were patients with unilateral cancer (95% CI 1.87-20.32; P=.007). Analysis of the 1100delC variant in an independent set of 507 patients with familial breast cancer with no BRCA1 and BRCA2 mutations confirmed a significantly elevated frequency of 1100delC (28/507 [5.5%]; OR 4.2; 95% CI 2.4-7.2; P=.0001), compared with controls, with a high frequency also seen in patients with only a single affected first-degree relative (18/291 [6.2%]). Finally, tissue microarray analysis indicated that breast tumors from patients with 1100delC mutations show reduced CHEK2 immunostaining. The results suggest that CHEK2 acts as a low-penetrance tumor-suppressor gene in breast cancer and that it makes a significant contribution to familial clustering of breast cancer-including families with only two affected relatives, which are more common than families that include larger numbers of affected women.	Univ Helsinki, Cent Hosp, Biomedicum Helsinki B406B, Dept Obstet & Gynecol, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Clin Genet, FIN-00029 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Pathol, FIN-00029 Helsinki, Finland; Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; Tampere Univ, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland; Tampere Univ, Dept Oncol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA; Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden		Nevanlinna, H (corresponding author), Univ Helsinki, Cent Hosp, Biomedicum Helsinki B406B, Dept Obstet & Gynecol, Haartmaninkatu 8,POB 700, FIN-00029 Helsinki, Finland.		Kallioniemi, Olli P/H-5111-2011; Bartek, Jiri/G-5870-2014	Kallioniemi, Olli P/0000-0002-3231-0332; Nevanlinna, Heli/0000-0002-0916-2976; Blomqvist, Carl/0000-0003-3041-1938; Kononen, Juha/0000-0002-0157-2137			Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartkova J, 2001, ONCOGENE, V20, P5897, DOI 10.1038/sj.onc.1204746; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chehab NH, 2000, GENE DEV, V14, P278; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Eerola H, 2000, EUR J CANCER, V36, P1143, DOI 10.1016/S0959-8049(00)00093-9; Eerola H, 2001, CANCER CAUSE CONTROL, V12, P739, DOI 10.1023/A:1011272919982; Haruki N, 2000, CANCER RES, V60, P4689; Hofmann WK, 2001, LEUKEMIA RES, V25, P333, DOI 10.1016/S0145-2126(00)00130-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Lukas C, 2001, CANCER RES, V61, P4990; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Miller CW, 2002, GENE CHROMOSOME CANC, V33, P17, DOI 10.1002/gcc.1207; Shieh SY, 2000, GENE DEV, V14, P289; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; Tavor S, 2001, LEUKEMIA LYMPHOMA, V42, P517, DOI 10.3109/10428190109064610; Vahteristo P, 2001, CANCER RES, V61, P5718; Vahteristo P, 2001, BRIT J CANCER, V84, P704, DOI 10.1054/bjoc.2000.1626; Vehmanen P, 1997, HUM MOL GENET, V6, P2309, DOI 10.1093/hmg/6.13.2309; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	326	337	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					432	438		10.1086/341943			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	WOS:000176977700023	12094328	Green Published, Bronze			2022-01-24	
J	Trapp, SC; Croteau, RB				Trapp, SC; Croteau, RB			Genomic organization of plant terpene synthases and molecular evolutionary implications	GENETICS			English	Article							FIR ABIES-GRANDIS; ARABIDOPSIS GA1 LOCUS; FUNCTIONAL EXPRESSION; GENE FAMILY; CDNA CLONING; ISOPRENOID BIOSYNTHESIS; SECONDARY METABOLITES; SESQUITERPENE CYCLASE; BACTERIAL EXPRESSION; GIBBERELLIN BIOSYNTHESIS	Terpenoids are the largest, most diverse class of plant natural products and they play numerous functional roles in primary metabolism and in ecological interactions. The first committed step in the formation of the various terpenoid classes is the transformation of the prenyl diphosphate precursors, geranyl diphosphate, farnesyl diphosphate, and geranylgeranyl diphosphate, to the parent structures of each type catalyzed by the respective monoterpene (C-10), sesquiterpene (C-15), and diterpene synthases (C-20). Over 30 cDNAs encoding plant terpenoid synthases involved in primary and secondary metabolism have been cloned and characterized. Here we describe the isolation and analysis of six genomic clones encoding terpene synthases of conifers, [(-)-pinene (C-10), ( -)-limonene(C-10), (E)-alpha -bisaboIene (C-15), delta -selinene (C-15) and abietadiene synthase (C-20) from Abies grandis and taxadiene synthase (C-20) from Taxus brevifolia], all of which are involved in natural products biosynthesis. Genome organization (intron number, size, placement and phase, and exon size) of these gymnosperm terpene syntheses was compared to eight previously characterized angiosperm terpene synthase genes and to six putative terpene synthase genomic sequences from Arabidopsis thaliana. Three distinct classes of terpene synthase genes were discerned, from which assumed patterns of sequential intron loss and the loss of an unusual internal sequence element suggest that the ancestral terpenoid synthase gene resembled a contemporary conifer diterpene synthase gene in containing at least 12 introns and 13 exons of conserved size. A model presented for the evolutionary history of plant terpene synthases suggests that this superfamily of genes responsible for natural products biosynthesis derived from terpene synthase genes involved in primary metabolism by duplication and divergence in structural and functional specialization. This novel molecular evolutionary approach focused on genes of secondary metabolism may have broad implications for the origins of natural products and for plant phylogenetics in general.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA		Croteau, RB (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	croteau@mail.wsu.edu					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASAKAWA Y, 1995, PROGR CHEM ORGANIC N, V65; BACK K, 1995, J BIOL CHEM, V270, P7375, DOI 10.1074/jbc.270.13.7375; BALTIMORE D, 1985, CELL, V40, P481, DOI 10.1016/0092-8674(85)90190-4; Bharathan G, 1999, MOL BIOL EVOL, V16, P553, DOI 10.1093/oxfordjournals.molbev.a026136; Bohlmann J, 1997, J BIOL CHEM, V272, P21784, DOI 10.1074/jbc.272.35.21784; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P6756, DOI 10.1073/pnas.95.12.6756; Bohlmann J, 2000, ARCH BIOCHEM BIOPHYS, V375, P261, DOI 10.1006/abbi.1999.1669; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bohlmann J, 1999, ARCH BIOCHEM BIOPHYS, V368, P232, DOI 10.1006/abbi.1999.1332; Buckingham J., 1998, DICT NATURAL PRODUCT; Cane D. E, 1999, COMPREHENSIVE NATURA, V2, P97; Cane D. E., 1999, COMPREHENSIVE NATURA, V2, P1; Cane D.E., 1999, COMPREHENSIVE NATURA, V2, P69; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Cane DE, 1999, COMPREHENSIVE NATURA, V2, P155; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1104/pp.107.1.1; CHAPPELL J, 1995, ANNU REV PLANT PHYS, V46, P521, DOI 10.1146/annurev.pp.46.060195.002513; Chen XY, 1996, J NAT PROD, V59, P944, DOI 10.1021/np960344w; CHRISTOPHERSEN C, 1996, STUD NAT PROD CHEM K, V18, P677; Clegg MT, 1997, P NATL ACAD SCI USA, V94, P7791, DOI 10.1073/pnas.94.15.7791; COLBY SM, 1993, J BIOL CHEM, V268, P23016; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; CROWELL PL, 1994, CRIT REV ONCOGENESIS, V5, P1; Cseke L, 1998, MOL BIOL EVOL, V15, P1491, DOI 10.1093/oxfordjournals.molbev.a025876; DAVIS EM, 1998, PLANT PHYSIOL, V116, P1192; DAWSON FA, 1994, NAVAL STORES REV MAR, P6; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Doyle JA, 1998, ANNU REV ECOL SYST, V29, P567, DOI 10.1146/annurev.ecolsys.29.1.567; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Frugoli JA, 1998, GENETICS, V149, P355; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Hager KP, 1996, FEBS LETT, V387, P94, DOI 10.1016/0014-5793(96)00477-2; HANLEY BA, 1988, NUCLEIC ACIDS RES, V16, P7159, DOI 10.1093/nar/16.14.7159; HARBORNE JB, 1991, ECOLOGICAL CHEM BIOC, P396; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; HOHN TM, 1999, COMPREHENSIVE NATURA, P201; HOLMES FA, 1995, ACS SYM SER, V583, P31; HUANG N, 1990, PLANT MOL BIOL, V14, P655, DOI 10.1007/BF00016499; Jarvis BB, 1996, RECENT ADV PHYTOCHEM, V30, P265; Jarvis BB, 2000, RECENT ADV PHYTOCHEM, V34, P1, DOI 10.1016/S0079-9920(00)80002-7; Katoh S, 1998, PHYTOCHEMISTRY, V47, P577, DOI 10.1016/S0031-9422(97)00422-6; KOEPP AE, 1995, J BIOL CHEM, V270, P8686, DOI 10.1074/jbc.270.15.8686; KUMAR V, 1993, MOL GEN GENET, V241, P440, DOI 10.1007/BF00284698; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; LEWINSOHN E, 1993, PHYTOCHEM ANALYSIS, V4, P220, DOI 10.1002/pca.2800040506; Li W.H., 1997, MOL EVOLUTION; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; MacMillan J., 1999, COMPREHENSIVE NATURA, V2, P217; MAPLESTONE RA, 1992, GENE, V115, P151, DOI 10.1016/0378-1119(92)90553-2; MATHEWS S, 1995, ANN MO BOT GARD, V82, P296, DOI 10.2307/2399882; Matthews CM, 1998, J MOL EVOL, V47, P763, DOI 10.1007/PL00006435; MAU CJD, 1994, P NATL ACAD SCI USA, V91, P8497, DOI 10.1073/pnas.91.18.8497; Newman JD, 1999, CRIT REV BIOCHEM MOL, V34, P95, DOI 10.1080/10409239991209228; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; Patterson A. H., 1993, PLANT MOL BIOL REP, V11, P122; Porter J.W., 1981, BIOSYNTHESIS ISOPREN, V1, P47; RamosValdivia AC, 1997, NAT PROD REP, V14, P591, DOI 10.1039/np9971400591; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sankawa U., 1999, COMPREHENSIVE NATURA, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Trapp SC, 1998, MOL GEN GENET, V257, P421, DOI 10.1007/s004380050666; TURNER G, 1993, EUKARYOTIC GENOME OR, P107; VanGeldre E, 1997, PLANT MOL BIOL, V33, P199, DOI 10.1023/A:1005716600612; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Waters ER, 1999, MOL BIOL EVOL, V16, P127, DOI 10.1093/oxfordjournals.molbev.a026033; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; WEST CA, 1981, BIOSYNTHESIS ISOPREN, V1, P375; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; WILLIAMS DH, 1989, J NAT PROD, V52, P1189, DOI 10.1021/np50066a001; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yuba A, 1996, ARCH BIOCHEM BIOPHYS, V332, P280, DOI 10.1006/abbi.1996.0343; Zinkel D.F., 1989, NAVAL STORES PRODUCT	83	326	365	6	77	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	2001	158	2					811	832					22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	442FY	WOS:000169275600029	11404343				2022-01-24	
J	Di Palma, F; Holme, RH; Bryda, EC; Belyantseva, IA; Pellegrino, R; Kachar, B; Steel, KP; Noben-Trauth, K				Di Palma, F; Holme, RH; Bryda, EC; Belyantseva, IA; Pellegrino, R; Kachar, B; Steel, KP; Noben-Trauth, K			Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D	NATURE GENETICS			English	Article							MYOSIN VIIA; GENE; MICE; IDENTIFICATION; DEAFNESS; CHROMOSOME-10; LOCALIZATION; ALLELE; ROLES; CA2+	Mouse chromosome 10 harbors several loci associated with hearing loss, including waltzer (v), modifier-of deaf waddler (mdfw) and Age-related hearing loss(1) (Ahl). The human region that is orthologous to the mouse 'waltzer' region is located at 10q21-q22 and contains the human deafness loci DFNB12 and USH1D (refs. 2,3). Numerous mutations at the waltzer locus have been documented causing erratic circling and hearing loss(4-7). Here we report the identification of a new gene mutated in v. The 10.5-kb Cdh23 cDNA encodes a very large, single-pass transmembrane protein, that we have called otocadherin. It has an extracellular domain that contains 27 repeats; these show significant homology to the cadherin ectodomain. In v(6J), a GT transversion creates a premature stop codon. In v(Alb), a Cr exchange generates an ectopic donor splice site, effecting deletion of 119 nucleotides of exonic sequence. In v(2J), a GA transition abolishes the donor splice site, leading to aberrant splice forms. All three alleles are predicted to cause loss of function. We demonstrate Cdh23 expression in the neurosensory epithelium and show that during early hair-cell differentiation, stereocilia organization is disrupted in v(2J) homozygotes. Our data indicate that otocadherin is a critical component of hair bundle formation. Mutations in human CDH23 cause Usher syndrome type 1D and thus, establish waltzer as the mouse model for USH1D.	Natl Inst Deafness & Other Commun Disorders, Sect Murine Genet, Genet Mol Lab, NIH, Rockville, MD USA; Natl Inst Deafness & Other Commun Disorders, Lab Cellular Biol, NIH, Rockville, MD USA; MRC, Inst Hearing Res, Nottingham, England; Marshall Univ, Sch Med, Dept Immunol & Mol Genet, Huntington, WV USA		Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Murine Genet, Genet Mol Lab, NIH, Rockville, MD USA.	nobentk@nidcd.nih.gov		Di-Palma, Federica/0000-0002-4394-0102	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [Z01DC000036, ZIADC000002, Z01DC000002, R03DC003771] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC03771] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [DZ 00036-04] Funding Source: Medline		Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; BOLZ H, 2000, NAT GENET, V27, P105; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; DEOL MS, 1956, J EMBRYOL EXP MORPH, V4, P190; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; FLAHERTY L, 1992, P NATL ACAD SCI USA, V89, P2859, DOI 10.1073/pnas.89.7.2859; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Liu XR, 1999, J NEUROSCI, V19, P6267; *MGD, 2000, MOUS GEN INF PROJ; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Rost B, 1996, METHOD ENZYMOL, V266, P525; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Self T, 1998, DEVELOPMENT, V125, P557; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Suzuki ST, 1996, J CELL SCI, V109, P2609; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Yagi T, 2000, GENE DEV, V14, P1169; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yonezawa S, 1999, HEARING RES, V134, P116, DOI 10.1016/S0378-5955(99)00080-5	29	326	333	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					103	107		10.1038/83660			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	WOS:000166187900025	11138008				2022-01-24	
J	Woods, IG; Kelly, PD; Chu, F; Ngo-Hazelett, P; Yan, YL; Huang, H; Postlethwait, JH; Talbot, WS				Woods, IG; Kelly, PD; Chu, F; Ngo-Hazelett, P; Yan, YL; Huang, H; Postlethwait, JH; Talbot, WS			A comparative map of the zebrafish genome	GENOME RESEARCH			English	Article							PUFFERFISH FUGU-RUBRIPES; RADIATION HYBRID MAP; DETAILED LINKAGE MAP; DNA-SEQUENCE; GENES; MUTATIONS; MODEL; IDENTIFICATION; GENERATION; EVOLUTION	Zebrafish mutations define the functions of hundreds of essential genes in the vertebrate genome. To accelerate the molecular analysis of zebrafish mutations and to facilitate comparisons among the genomes of zebrafish and other vertebrates, we used a homozygous diploid meiotic mapping panel to localize polymorphisms in 691 previously unmapped genes and expressed sequence tags (ESTs). Together with earlier efforts, this work raises the total number of markers scored in the mapping panel to 2119, including 1503 genes and ESTs and 616 previously characterized simple-sequence length polymorphisms. Sequence analysis of zebrafish genes mapped in this study and in prior work identified putative human orthologs for 804 zebrafish genes and ESTs. Map comparisons revealed 139 new conserved syntenies, in which two or more genes are on the same chromosome in zebrafish and human. Although some conserved syntenies are quite large, there were changes in gene order within conserved groups, apparently reflecting the relatively frequent occurrence of inversions and other intrachromosomal rearrangements since the divergence of teleost and tetrapod ancestors. Comparative mapping also shows that there is not a one-to-one correspondence between zebrafish and human chromosomes. Mapping of duplicate gene pairs identified segments of 20 linkage groups that may have arisen during a genome duplication that occurred early in the evolution of teleosts after the divergence of teleost and mammalian ancestors. This comparative map will accelerate the molecular analysis of zebrafish mutations and enhance the understanding of the evolution of the vertebrate genome.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97405 USA		Talbot, WS (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	talbot@cmgm.stanford.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR12349, R01 RR010715, R01 RR012349] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD22486, P01 HD022486] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK55378] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR010715, R01RR012349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK055378] Funding Source: NIH RePORTER		Allendorf F.W., 1984, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Driever W, 1996, DEVELOPMENT, V123, P37; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EDWARDS JH, 1991, ANN HUM GENET, V55, P17, DOI 10.1111/j.1469-1809.1991.tb00394.x; Elgar G, 1999, GENOME RES, V9, P960, DOI 10.1101/gr.9.10.960; Force A, 1999, GENETICS, V151, P1531; Gates MA, 1999, GENOME RES, V9, P334; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Haffter P, 1996, DEVELOPMENT, V123, P1; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kelly PD, 2000, GENOME RES, V10, P558, DOI 10.1101/gr.10.4.558; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; Melby AE, 1996, DEVELOPMENT, V122, P2225; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Miller CT, 2000, DEVELOPMENT, V127, P3815; Moens CB, 1996, DEVELOPMENT, V122, P3981; Murphy WJ, 2000, GENOME RES, V10, P691, DOI 10.1101/gr.10.5.691; Naruse K, 2000, GENETICS, V154, P1773; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Smith S, 2000, GENE, V247, P119, DOI 10.1016/S0378-1119(00)00110-4; Talbot WS, 2000, GENE DEV, V14, P755; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Wittbrodt J, 1998, BIOESSAYS, V20, P511, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;511::AID-BIES10&gt;3.0.CO;2-3; Young WP, 1998, GENETICS, V148, P839	37	326	337	0	18	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2000	10	12					1903	1914		10.1101/gr.10.12.1903			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	382QN	WOS:000165833900008	11116086	Green Published, Bronze			2022-01-24	
J	Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC				Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC			Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor	NATURE GENETICS			English	Article							PANCREATIC FUNCTION; STEM-CELLS; MOUSE; CFTR; IDENTIFICATION; MUTAGENESIS; EPITHELIUM; MUTATIONS; PHENOTYPE; TRANSPORT	Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction, We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium-activated Cl- conductance, Identification of modifier genes in our Cftr(m1HSC)/Cft(rm1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV GASTROENTEROL,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV CELL BIOL,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV BIOCHEM RES,TORONTO,ON M56 1X8,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA				Tsui, Lap-chee/A-1081-2010				ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; BRILLIANT MH, 1994, MAMM GENOME, V5, pS104; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; ECKMAN E, 1994, PEDIATR PULM, V10, pA62; EVANS GS, 1992, J CELL SCI, V101, P219; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LISON L, 1954, STAIN TECHNOL, V29, P13; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; RATLIFF R, 1992, NAT GENET, V4, P35; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sly WS, 1995, METABOLIC MOL BASES, VIII, P3799; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90168-4; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	35	326	332	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					280	287		10.1038/ng0396-280			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	WOS:A1996TY18300017	8589719				2022-01-24	
J	CALONGE, MT; GASPARINI, P; CHILLARON, J; CHILLON, M; GALLUCCI, M; ROUSAUD, F; ZELANTE, L; TESTAR, X; DALLAPICCOLA, B; DISILVERIO, F; BARCELO, P; ESTIVILL, X; ZORZANO, A; NUNES, V; PALACIN, M				CALONGE, MT; GASPARINI, P; CHILLARON, J; CHILLON, M; GALLUCCI, M; ROUSAUD, F; ZELANTE, L; TESTAR, X; DALLAPICCOLA, B; DISILVERIO, F; BARCELO, P; ESTIVILL, X; ZORZANO, A; NUNES, V; PALACIN, M			CYSTINURIA CAUSED BY MUTATIONS IN RBAT, A GENE INVOLVED IN THE TRANSPORT OF CYSTINE	NATURE GENETICS			English	Article							BORDER MEMBRANE-VESICLES; AMINO-ACID-TRANSPORT; EXPRESSION CLONING; RAT-KIDNEY; SYSTEM; CHAIN; TUBULES; CDNA	Cystinuria is a classic heritable aminoaciduria that involves the defective transepithelial transport of cystine and dibasic amino acids in the kidney and intestine. Six missense mutations in the human rBAT gene, which is involved in high-affinity transport of cystine and dibasic amino acids in kidney and intestine, segregate with cystinuria. These mutations account for 30% of the cystinuria chromosomes studied. Homozygosity for the most common mutation (M467T) was detected in three cystinuric siblings. Mutation M467T nearly abolished the amino acid transport activity induced by rBAT in Xenopus oocytes. These results establish rBAT as a cystinuria gene.	HOSP DURAN I REYNALS, IRO, DEPT MOLEC GENET, E-80907 BARCELONA, SPAIN; UNIV BARCELONA, FAC BIOL, DEPT BIOQUIM & FISIOL, E-08028 BARCELONA, SPAIN; OSPED CSS, IRCCS, SERV GENET MED, FOGGIA, ITALY; UNIV ROMA LA SAPIENZA, DIPARTIMENTO UROL, ROME, ITALY; FDN PUIGVERT, SERV NEFROL IUNA, E-08025 BARCELONA, SPAIN				Zorzano, Antonio/R-5479-2018; Nunes, Virginia/AAD-1014-2019; Gasparini, Paolo/B-6173-2014; Chillaron, Josep/ABF-7663-2021; Nunes, Virginia/D-4356-2014; Estivill, Xavier/A-3125-2013; Palacin, Manuel/G-9786-2015; Wilson, Matthew H/K-3193-2013; Gallucci, Michele/K-9600-2016; Dallapiccola, Bruno/K-8692-2016; Chillon, Miguel/A-2466-2009	Nunes, Virginia/0000-0002-5747-9310; Chillaron, Josep/0000-0003-3068-7598; Nunes, Virginia/0000-0002-5747-9310; Estivill, Xavier/0000-0002-0723-2256; Gallucci, Michele/0000-0002-3637-6531; Dallapiccola, Bruno/0000-0002-5031-1013; Chillon, Miguel/0000-0003-0840-2111	TelethonFondazione Telethon [E.0083] Funding Source: Medline		BERTRAN J, 1993, J BIOL CHEM, V268, P14842; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; BIBER J, 1983, PFLUG ARCH EUR J PHY, V396, P335, DOI 10.1007/BF01063939; BROWN RR, 1967, SCIENCE, V157, P432, DOI 10.1126/science.157.3787.432; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; COLCADAN L, 1980, PEDIATR RES, V14, P109; FOREMAN JW, 1980, METABOLISM, V29, P53, DOI 10.1016/0026-0495(80)90098-0; FURLONG TJ, 1990, AM J PHYSIOL, V258, pF321, DOI 10.1152/ajprenal.1990.258.2.F321; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; Garrod AE, 1908, LANCET, V2, P214; Garrod AE, 1908, LANCET, V2, P142; Garrod AE, 1908, LANCET, V2, P1; Garrod AE, 1908, LANCET, V2, P73; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; LEVY HL, 1973, ADV HUM GENET, P1; MARKOVICH D, 1993, J BIOL CHEM, V268, P1362; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1128; MCNAMARA PD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P101, DOI 10.1016/0005-2736(92)90062-Q; MCNAMARA PD, 1981, BIOCHEM J, V194, P443, DOI 10.1042/bj1940443; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZEGOVIC B, 1982, BIOSCIENCE REP, V2, P913, DOI 10.1007/BF01114898; PICKEL VM, 1993, P NATL ACAD SCI USA, V90, P7779, DOI 10.1073/pnas.90.16.7779; ROSENBERG LE, 1965, NEW ENGL J MED, V273, P1239, DOI 10.1056/NEJM196512022732303; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; ROSENBERGLE, 1966, T ASSOC AM PHYSICIAN, V79, P284; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFER JA, 1984, PFLUG ARCH EUR J PHY, V401, P143, DOI 10.1007/BF00583874; SEGAL S, 1977, SCIENCE, V197, P169, DOI 10.1126/science.877548; SEGAL S, 1989, METABOLIC BASIS INHE, P2479; SHARLAND M, 1992, J MED GENET, V29, P507; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; SINGER A, 1989, J UROLOGY, V142, P669, DOI 10.1016/S0022-5347(17)38849-3; SMITH A, 1977, MED J AUSTRALIA, V2, P153, DOI 10.5694/j.1326-5377.1977.tb99112.x; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; THIER S, 1964, SCIENCE, V143, P482, DOI 10.1126/science.143.3605.482; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; TURNELL DC, 1982, CLIN CHEM, V28, P527; VANWINKLE LJ, 1988, J BIOL CHEM, V263, P3150; VOLKL H, 1982, PFLUG ARCH EUR J PHY, V395, P190, DOI 10.1007/BF00584808; WELLS RG, 1992, P NATL ACAD SCI USA, V89, P5596, DOI 10.1073/pnas.89.12.5596	44	326	329	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1994	6	4					420	425		10.1038/ng0494-420			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	WOS:A1994ND87000025	8054986				2022-01-24	
J	MATSUNAMI, N; SMITH, B; BALLARD, L; LENSCH, MW; ROBERTSON, M; ALBERTSEN, H; HANEMANN, CO; MULLER, HW; BIRD, TD; WHITE, R; CHANCE, PF				MATSUNAMI, N; SMITH, B; BALLARD, L; LENSCH, MW; ROBERTSON, M; ALBERTSEN, H; HANEMANN, CO; MULLER, HW; BIRD, TD; WHITE, R; CHANCE, PF			PERIPHERAL MYELIN PROTEIN-22 GENE MAPS IN THE DUPLICATION IN CHROMOSOME-17P11.2 ASSOCIATED WITH CHARCOT-MARIE-TOOTH-1A	NATURE GENETICS			English	Article							MARIE-TOOTH NEUROPATHY; HEREDITARY MOTOR; LINKAGE; DISEASE	Charcot-Marie-Tooth disease 1A (CMT1A) is a hereditary demyelinating peripheral neuropathy, associated with a DNA duplication on chromosome 17p11.2. A related disorder in the mouse, trembler (Tr), maps to mouse chromosome 11 which has syntenic homology to human chromosome 17p. Recently, the peripheral myelin protein-22 (pmp-22) gene was identified as the likely Tr locus. We have constructed a partial yeast artificial chromosome contig spanning the CMT1A gene region and mapped the PMP-22 gene to the duplicated region. These observations further implicate PMP-22 as a candidate gene for CMT1A, and suggest that over-expression of this gene may be one mechanism that produces the CMT1A phenotype.	UNIV UTAH,MED CTR,DEPT PEDIAT,DIV MED GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV DUSSELDORF,DEPT NEUROL,MOLEC NEUROBIOL LAB,W-4000 DUSSELDORF 1,GERMANY; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV WASHINGTON,SCH MED,DIV NEUROL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DIV PEDIAT,SEATTLE,WA 98195				Chance, Phillip/AAX-5826-2020; Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025			AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BIRD TD, 1982, AM J HUM GENET, V34, P388; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, IN PRESS NEUROLOGY; DAVISSON MT, 1978, CYTOGENET CELL GENET, V22, P552, DOI 10.1159/000131022; DYCK PJ, 1984, DISEASES PERIPHERAL, P1609; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; LEBO RV, 1992, AM J HUM GENET, V50, P42; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MUNKE M, 1987, J MOL EVOL, V25, P134, DOI 10.1007/BF02101755; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	23	326	327	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					176	179		10.1038/ng0692-176			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	WOS:A1992JC98200008	1303231				2022-01-24	
J	HOFFMANN, AA; TURELLI, M; HARSHMAN, LG				HOFFMANN, AA; TURELLI, M; HARSHMAN, LG			FACTORS AFFECTING THE DISTRIBUTION OF CYTOPLASMIC INCOMPATIBILITY IN DROSOPHILA-SIMULANS	GENETICS			English	Article									UNIV CALIF DAVIS,DEPT GENET,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT ENTOMOL,DAVIS,CA 95616		HOFFMANN, AA (corresponding author), LA TROBE UNIV,DEPT GENET & HUMAN VARIAT,BUNDOORA 1083,AUSTRALIA.		Hoffmann, Ary/R-2972-2019; Hoffmann, Ary/C-2961-2011	Hoffmann, Ary/0000-0001-9497-7645; 			BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; BINNINGTON KC, 1989, J INVERTEBR PATHOL, V54, P344, DOI 10.1016/0022-2011(89)90118-3; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; COYNE JA, 1987, AM NAT, V129, P847, DOI 10.1086/284679; Efron B., 1982, JACKKNIFE BOOTSTRAP; FINE PEM, 1978, J INVERTEBR PATHOL, V30, P10; GROMKO MH, 1984, EVOLUTION, V38, P1273, DOI 10.1111/j.1558-5646.1984.tb05649.x; HALE LR, 1990, EVOLUTION, V44, P1383, DOI 10.1111/j.1558-5646.1990.tb05241.x; HOFFMANN AA, 1988, GENETICS, V119, P435; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOFFMANN AA, 1985, AM NAT, V125, P421, DOI 10.1086/284351; Johnston J.S., 1982, P241; KARLIN S, 1972, THEOR POPUL BIOL, V3, P186, DOI 10.1016/0040-5809(72)90026-3; LOUIS C, 1989, J INVERTEBR PATHOL, V54, P34; NIGRO L, 1990, GENETICS, V125, P551; Partridge L., 1988, P11; PYLE DW, 1981, AM NAT, V117, P133, DOI 10.1086/283694; ROSEWELL J, 1987, BIOL J LINN SOC, V32, P373, DOI 10.1111/j.1095-8312.1987.tb00438.x; SKINNER SW, 1985, GENETICS, V109, P745; Sokal R.R., 1981, BIOMETRY; STEVENS L, 1989, J INVERTEBR PATHOL, V53, P78, DOI 10.1016/0022-2011(89)90076-1	21	326	353	2	44	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	DEC	1990	126	4					933	948					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL334	WOS:A1990EL33400014	2076821				2022-01-24	
J	HELENTJARIS, T; WEBER, D; WRIGHT, S				HELENTJARIS, T; WEBER, D; WRIGHT, S			IDENTIFICATION OF THE GENOMIC LOCATIONS OF DUPLICATE NUCLEOTIDE-SEQUENCES IN MAIZE BY ANALYSIS OF RESTRICTION FRAGMENT LENGTH POLYMORPHISMS	GENETICS			English	Article									ILLINOIS STATE UNIV,DEPT BIOL SCI,NORMAL,IL 61761		HELENTJARIS, T (corresponding author), NATIVE PLANTS INC,MOLEC BIOL GRP,SALT LAKE CITY,UT 84108, USA.						Anderson Edgar, 1945, CHRON BOT, V9, P88; BENNETT MD, 1983, KEW CHROMOSOME C, V2, P71; BERNATZKY R, 1986, GENETICS, V112, P887; BERNATZKY R, 1986, MOL GEN GENET, V203, P8, DOI 10.1007/BF00330377; Cooper DC, 1937, AM NAT, V71, P582, DOI 10.1086/280745; DENNIS ES, 1985, NUCLEIC ACIDS RES, V13, P727, DOI 10.1093/nar/13.3.727; Ford L.E., 1952, THESIS IOWA STATE CO; Goodman M. M., 1983, Isozymes in plant genetics and breeding. Part B., P1; GOODMAN MM, 1980, GENETICS, V96, P697; GOTTLIEB LD, 1982, SCIENCE, V216, P373, DOI 10.1126/science.216.4544.373; HARADA KM, 1954, FACULTY AGR SCI REP, V6, P139; Helentjaris T., 1986, Maize Genetics Cooperation News Letter, P118; HELENTJARIS T, 1986, THEOR APPL GENET, V72, P761, DOI 10.1007/BF00266542; HELENTJARIS T, 1985, PLANT MOL BIOL, V5, P109, DOI 10.1007/BF00020093; HELENTJARIS T, 1986, P NATL ACAD SCI USA, V83, P6035, DOI 10.1073/pnas.83.16.6035; LAUGHNAN JR, 1949, P NATL ACAD SCI USA, V35, P167, DOI 10.1073/pnas.35.4.167; MCCARTY DR, 1986, MAIZE GENET COOP NEW, V60, P60; MCCARTY DR, 1986, MAIZE GENET COOP NEW, V60, P58; McClintock B, 1938, GENETICS, V23, P315; McCLINTOCK BARBARA, 1933, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V19, P191, DOI 10.1007/BF02462870; MCMILLIN DE, 1980, P NATL ACAD SCI-BIOL, V77, P4866, DOI 10.1073/pnas.77.8.4866; MOLINA MC, 1986, MAIZE GENET COOP NEW, V60, P77; MOLINA MD, 1982, MAIZE GENET COOP NEW, V56, P96; NEUFFER MG, 1968, MUTANTS MAIZE, P4; NOWACKI E, 1972, B ACAD POL SCI BIOL, V20, P695; PEACOCK WJ, 1981, P NATL ACAD SCI-BIOL, V78, P4490, DOI 10.1073/pnas.78.7.4490; RHOADES MM, 1953, AM J BOT, V40, P405, DOI 10.2307/2438524; RHOADES MM, 1951, AM NAT, V85, P105, DOI 10.1086/281658; RHOADES MM, 1955, CORN CORN IMPROVEMEN; SEARS ER, 1975, HDB GENETICS, V2, P59; SNOPE AJ, 1967, CHROMOSOMA, V21, P243, DOI 10.1007/BF00329549; STADLER LJ, 1953, SCIENCE, V117, P471; STEIN JP, 1983, P NATL ACAD SCI-BIOL, V80, P6485, DOI 10.1073/pnas.80.21.6485; TING YC, 1966, CYTOLOGIA, V31, P324, DOI 10.1508/cytologia.31.324; WEBER DF, 1972, CHROMOSOMA, V39, P27, DOI 10.1007/BF00320587; WEBER DF, 1974, GENETICS, V77, pS69; WENDEL JF, 1986, THEOR APPL GENET, V72, P178, DOI 10.1007/BF00266990; WENDEL JF, 1985, MAIZE GENET COOP NEW, V59, P90; WRIGHT S, 1987, MAIZE GENET COOP NEW, V61, P89	39	326	337	0	4	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	FEB	1988	118	2					353	363					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M0849	WOS:A1988M084900018	17246413				2022-01-24	
J	MAINE, GT; SINHA, P; TYE, BK				MAINE, GT; SINHA, P; TYE, BK			MUTANTS OF S-CEREVISIAE DEFECTIVE IN THE MAINTENANCE OF MINICHROMOSOMES	GENETICS			English	Article											MAINE, GT (corresponding author), CORNELL UNIV,BIOCHEM SECT,ITHACA,NY 14853, USA.				NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM26941, GM07273] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007273] Funding Source: NIH RePORTER		BEACH D, 1980, NATURE, V284, P185, DOI 10.1038/284185a0; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Blumenthal A.B., 1974, COLD SPRING HARB SYM, V38, P205; BRAUN R, 1969, BIOCHIM BIOPHYS ACTA, V174, P246, DOI 10.1016/0005-2787(69)90248-2; BROACH JR, 1980, CELL, V21, P501, DOI 10.1016/0092-8674(80)90487-0; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; BURKE W, 1975, CELL, V5, P263, DOI 10.1016/0092-8674(75)90101-4; CELNIKER SE, 1982, CELL, V31, P201, DOI 10.1016/0092-8674(82)90420-2; CHAN CSM, 1983, J MOL BIOL, V168, P505, DOI 10.1016/S0022-2836(83)80299-X; CHAN CSM, 1980, P NATL ACAD SCI-BIOL, V77, P6329, DOI 10.1073/pnas.77.11.6329; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; CLARKWALKER GD, 1974, EUR J BIOCHEM, V41, P359, DOI 10.1111/j.1432-1033.1974.tb03278.x; DUMAS LB, 1982, MOL GEN GENET, V187, P42, DOI 10.1007/BF00384381; EDENBERG HJ, 1975, ANNU REV GENET, V9, P245, DOI 10.1146/annurev.ge.09.120175.001333; FANGMAN WL, 1983, CELL, V32, P831, DOI 10.1016/0092-8674(83)90069-7; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; HARTWELL LH, 1976, J MOL BIOL, V104, P803, DOI 10.1016/0022-2836(76)90183-2; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HSIAO CL, 1981, P NATL ACAD SCI-BIOL, V78, P3760, DOI 10.1073/pnas.78.6.3760; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; JOHNSTON LH, 1978, MOL GEN GENET, V161, P205, DOI 10.1007/BF00274189; KEE SG, 1975, P NATL ACAD SCI USA, V72, P1179, DOI 10.1073/pnas.72.3.1179; KOJO H, 1981, P NATL ACAD SCI-BIOL, V78, P7261, DOI 10.1073/pnas.78.12.7261; LIVINGSTON DM, 1979, P NATL ACAD SCI USA, V76, P3727, DOI 10.1073/pnas.76.8.3727; LIVINGSTON DM, 1977, J MOL BIOL, V116, P249, DOI 10.1016/0022-2836(77)90215-7; MAINE GT, 1984, MOL CELL BIOL; NELSON RG, 1979, P NATL ACAD SCI USA, V76, P6515, DOI 10.1073/pnas.76.12.6515; NEWLON CS, 1980, ICN UCLA S MOL CELL, V19, P399; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; SHERMAN F, 1974, METHODS YEAST GENETI, P61; STINCHCOMB DT, 1982, J MOL BIOL, V158, P157, DOI 10.1016/0022-2836(82)90427-2; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; STINCHCOMB DT, 1981, ICN UCLA S MOL CELLU, V23, P437; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; SZOSTAK JW, 1979, PLASMID, V2, P536, DOI 10.1016/0147-619X(79)90053-2; TOH EA, 1981, J BACTERIOL, V145, P1421; TSCHUMPER G, 1983, GENE, V23, P221, DOI 10.1016/0378-1119(83)90054-9; YASUDA S, 1977, P NATL ACAD SCI USA, V74, P5458, DOI 10.1073/pnas.74.12.5458; ZAKIAN VA, 1982, MOL CELL BIOL, V2, P221, DOI 10.1128/MCB.2.3.221	42	326	331	0	5	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1984	106	3					365	385					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SE188	WOS:A1984SE18800003	6323245				2022-01-24	
J	Hoischen, A; van Bon, BWM; Gilissen, C; Arts, P; van Lier, B; Steehouwer, M; de Vries, P; de Reuver, R; Wieskamp, N; Mortier, G; Devriendt, K; Amorim, MZ; Revencu, N; Kidd, A; Barbosa, M; Turner, A; Smith, J; Oley, C; Henderson, A; Hayes, IM; Thompson, EM; Brunner, HG; de Vries, BBA; Veltman, JA				Hoischen, Alexander; van Bon, Bregje W. M.; Gilissen, Christian; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; de Vries, Petra; de Reuver, Rick; Wieskamp, Nienke; Mortier, Geert; Devriendt, Koen; Amorim, Marta Z.; Revencu, Nicole; Kidd, Alexa; Barbosa, Mafalda; Turner, Anne; Smith, Janine; Oley, Christina; Henderson, Alex; Hayes, Ian M.; Thompson, Elizabeth M.; Brunner, Han G.; de Vries, Bert B. A.; Veltman, Joris A.			De novo mutations of SETBP1 cause Schinzel-Giedion syndrome	NATURE GENETICS			English	Article							PROTEIN; GENE; DELINEATION; LEUKEMIA; FUSION	Schinzel-Giedion syndrome is characterized by severe mental retardation, distinctive facial features and multiple congenital malformations; most affected individuals die before the age of ten. We sequenced the exomes of four affected individuals (cases) and found heterozygous de novo variants in SETBP1 in all four. We also identified SETBP1 mutations in eight additional cases using Sanger sequencing. All mutations clustered to a highly conserved 11-bp exonic region, suggesting a dominant-negative or gain-of-function effect.	[Hoischen, Alexander; van Bon, Bregje W. M.; Gilissen, Christian; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; de Vries, Petra; de Reuver, Rick; Wieskamp, Nienke; Brunner, Han G.; de Vries, Bert B. A.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Mortier, Geert] Univ Antwerp Hosp, Ctr Med Genet, Antwerp, Belgium; [Devriendt, Koen] Leuven Univ Hosp, Ctr Human Genet, Katholieke Univ Leuven, Louvain, Belgium; [Amorim, Marta Z.] Hosp Pediat Coimbra, Serv Genet Coimbra, Coimbra, Portugal; [Revencu, Nicole] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Kidd, Alexa] Christchurch Hosp, Canterbury Hlth Labs, Christchurch, New Zealand; [Barbosa, Mafalda] Inst Nacl Saude Doutor Ricardo, Ctr Genet Med Doutor Jacinto Magalhaes, Porto, Portugal; [Turner, Anne] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Smith, Janine] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Oley, Christina] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; [Henderson, Alex] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hayes, Ian M.] No Reg Genet Serv, Auckland, New Zealand; [Thompson, Elizabeth M.] Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia		Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	j.veltman@antrg.umcn.nl	Veltman, Joris A/F-5128-2010; van Bon, Bregje/D-3720-2013; Brunner, Han/C-9928-2013; van Bon, Bregje/Q-2445-2015; Arts, Peer/Q-4139-2019; Gilissen, Christian/E-5246-2012; Mortier, Geert/D-2542-2012; Hoischen, Alexander/D-1282-2013	Veltman, Joris A/0000-0002-3218-8250; Arts, Peer/0000-0002-6742-6239; Gilissen, Christian/0000-0003-1693-9699; Mortier, Geert/0000-0001-9871-4578; Hoischen, Alexander/0000-0002-8072-4476	Netherlands Organization for Health Research and DevelopmentNetherlands Organization for Health Research and Development [917-66-36, 911-08-025, 917-86-319]; EUEuropean Commission [Health-F5-2009-223143, LSHG-CT-2006-37627]	We thank the subjects and their parents for participation in this study. We thank S. Keijzers-Vloet, J. de Ligt, N. Leijsten and personnel from the Sequencing Facility Nijmegen for technical assistance and I. Saleem for referring patient 3 to us. This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J. A. V. and to B.B.A.d.V.), the EU-funded TECHGENE project (Health-F5-2009-223143 to P.A. and J.A.V.) and the AnEUploidy project (LSHG-CT-2006-37627 to A.Hoischen, B.W.M.v.B., H.G.B., B.B.A.d.V. and J.A.V.).	Buysse K, 2008, AM J MED GENET A, V146A, P1330, DOI 10.1002/ajmg.a.32267; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; KRUEGER RC, 1990, J BIOL CHEM, V265, P12075; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Minn D, 2002, AM J MED GENET, V109, P211, DOI 10.1002/ajmg.10348; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; NIEDUSZYNSKI IA, 1990, BIOCHEM J, V271, P243, DOI 10.1042/bj2710243; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; VAREZVENEGAS R, 2002, GENE, V285, P25; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407	15	325	336	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					483	485		10.1038/ng.581			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	WOS:000278081500009	20436468				2022-01-24	
J	Hallmayer, J; Faraco, J; Lin, L; Hesselson, S; Winkelmann, J; Kawashima, M; Mayer, G; Plazzi, G; Nevsimalova, S; Bourgin, P; Hong, SSC; Honda, Y; Honda, M; Hogl, B; Longstreth, WT; Montplaisir, J; Kemlink, D; Einen, M; Chen, J; Musone, SL; Akana, M; Miyagawa, T; Duan, J; Desautels, A; Erhardt, C; Hesla, PE; Poli, F; Frauscher, B; Jeong, JH; Lee, SP; Ton, TGN; Kvale, M; Kolesar, L; Dobrovolna, M; Nepom, GT; Salomon, D; Wichmann, HE; Rouleau, GA; Gieger, C; Levinson, DF; Gejman, PV; Meitinger, T; Young, T; Peppard, P; Tokunaga, K; Kwok, PY; Risch, N; Mignot, E				Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Hesselson, Stephanie; Winkelmann, Juliane; Kawashima, Minae; Mayer, Geert; Plazzi, Giuseppe; Nevsimalova, Sona; Bourgin, Patrice; Hong, Sheng Seung-Chul; Honda, Yutaka; Honda, Makoto; Hoegl, Birgit; Longstreth, William T., Jr.; Montplaisir, Jacques; Kemlink, David; Einen, Mali; Chen, Justin; Musone, Stacy L.; Akana, Matthew; Miyagawa, Taku; Duan, Jubao; Desautels, Alex; Erhardt, Christine; Hesla, Per Egil; Poli, Francesca; Frauscher, Birgit; Jeong, Jong-Hyun; Lee, Sung-Pil; Ton, Thanh G. N.; Kvale, Mark; Kolesar, Libor; Dobrovolna, Marie; Nepom, Gerald T.; Salomon, Dan; Wichmann, H-Erich; Rouleau, Guy A.; Gieger, Christian; Levinson, Douglas F.; Gejman, Pablo V.; Meitinger, Thomas; Young, Terry; Peppard, Paul; Tokunaga, Katsushi; Kwok, Pui-Yan; Risch, Neil; Mignot, Emmanuel			Narcolepsy is strongly associated with the T-cell receptor alpha locus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFORMATION; EVOLUTION; MUTATION; REGION; GENE	Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects 1 in 2,000 individuals(1,2). Narcolepsy was first shown to be tightly associated with HLA-DR2 (ref. 3) and later sublocalized to DQB1*0602 (ref. 4). Following studies in dogs(5) and mice(6), a 95% loss of hypocretin-producing cells in postmortem hypothalami from narcoleptic individuals was reported(7,8). Using genome-wide association (GWA) in Caucasians with replication in three ethnic groups, we found association between narcolepsy and polymorphisms in the TRA@ (T-cell receptor alpha) locus, with highest significance at rs1154155 (average allelic odds ratio 1.69, genotypic odds ratios 1.94 and 2.55, P < 10(-21), 1,830 cases, 2,164 controls). This is the first documented genetic involvement of the TRA@ locus, encoding the major receptor for HLA-peptide presentation, in any disease. It is still unclear how specific HLA alleles confer susceptibility to over 100 HLA-associated disorders(9); thus, narcolepsy will provide new insights on how HLA-TCR interactions contribute to organ-specific autoimmune targeting and may serve as a model for over 100 other HLA-associated disorders(9).	[Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Kawashima, Minae; Einen, Mali; Mignot, Emmanuel] Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Kawashima, Minae; Einen, Mali; Levinson, Douglas F.; Mignot, Emmanuel] Stanford Univ, Sch Med, Dept Psychiat, Palo Alto, CA 94304 USA; [Hesselson, Stephanie; Chen, Justin; Musone, Stacy L.; Akana, Matthew; Kvale, Mark; Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA USA; [Winkelmann, Juliane; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane; Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Kawashima, Minae; Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Tokyo, Japan; [Mayer, Geert] Hephata Klin, Schwalmstadt, Germany; [Mayer, Geert] Univ Marburg, Dept Neurol, Marburg, Germany; [Plazzi, Giuseppe; Poli, Francesca] Univ Bologna, Bologna, Italy; [Nevsimalova, Sona; Kemlink, David] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Nevsimalova, Sona; Kemlink, David] Gen Teaching Hosp, Prague, Czech Republic; [Bourgin, Patrice; Erhardt, Christine] Univ Strasbourg, Hop Civil, Sleep Clin, Strasbourg, France; [Hong, Sheng Seung-Chul; Jeong, Jong-Hyun; Lee, Sung-Pil] Catholic Univ Korea, St Vincents Hosp, Dept Neuropsychiat, Suwon, South Korea; [Honda, Yutaka; Honda, Makoto] Tokyo Inst Psychiat, Tokyo, Japan; [Hoegl, Birgit; Frauscher, Birgit] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Longstreth, William T., Jr.; Ton, Thanh G. N.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Longstreth, William T., Jr.; Ton, Thanh G. N.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Montplaisir, Jacques; Desautels, Alex] Univ Montreal, Sleep Disorders Ctr, Montreal, PQ, Canada; [Duan, Jubao; Gejman, Pablo V.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Evanston, IL USA; [Hesla, Per Egil] Coliseum Majorstua Clin, Oslo, Norway; [Kolesar, Libor] Inst Clin & Expt Med, Dept Immunogenet, Prague, Czech Republic; [Dobrovolna, Marie] Inst Hematol & Blood Transfus, Natl Reference Lab DNA Diagnost, HLA Typing Lab, CR-12820 Prague, Czech Republic; [Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Salomon, Dan] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Wichmann, H-Erich; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Montreal, PQ, Canada; [Gejman, Pablo V.] N Shore Univ HlthSyts, Evanston, IL USA; [Young, Terry; Peppard, Paul] Univ Wisconsin, Sch Med, Dept Populat Hlth Sci, Madison, WI USA; [Risch, Neil] Kaiser Permanente No Calif Div Res, Oakland, CA USA; [Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA		Mignot, E (corresponding author), Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Kemlink, David/Q-3019-2019; Meitinger, Thomas/O-1318-2015; Kemlink, David/F-9567-2017; Salomon, Daniel/E-9380-2012; Nevsimalova, Sona/H-3533-2017; Wichmann, Heinz Erich/AAA-5695-2022; Kwok, Pui-Yan/F-7725-2014; Plazzi, Giuseppe/AAB-9627-2020	Kemlink, David/0000-0003-1398-5796; Nevsimalova, Sona/0000-0003-0083-3742; Kwok, Pui-Yan/0000-0002-5087-3059; Chen, Justin/0000-0002-1661-4547; Jeong, Jong-Hyun/0000-0003-3570-7607; Nepom, Gerald/0000-0002-8063-1464; Winkelmann, Juliane/0000-0003-2667-9691; Plazzi, Giuseppe/0000-0002-1051-0472; Gieger, Christian/0000-0001-6986-9554; Hogl, Birgit/0000-0003-1894-7641; Meitinger, Thomas/0000-0002-8838-8403	US National Institutes of Neurological Disease and Stroke [P50 NS2372]; National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH080957]; Czech Ministry of EducationMinistry of Education, Youth & Sports - Czech Republic [MSM0021620849, MZO 0002373601]; National institutes of Allergic and Infectious diseases [5U19 AI063603]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38523]; MIUR PRINMinistry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN) [2005065029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080957, U01MH079469, U01MH079470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS023724, R01NS038523, R37NS033797] Funding Source: NIH RePORTER	We are most indebted to all the participants of the study, most notably the subjects with narcolepsy. This study was supported primarily by the US National Institutes of Neurological Disease and Stroke grant P50 NS2372. Additional funding included National Institutes of Mental Health R01 MH080957 to E. M., 5U01 MH079470 to D. F. L., 5U01 MH079469-02 to P. V. G., R01 HL62252 to T. Y. Czech Ministry of Education MSM0021620849 and MZO 0002373601 to S. N., National institutes of Allergic and Infectious diseases 5U19 AI063603 to D. S., National Institute of Neurological Disorders and Stroke R01 NS38523 to W. T. L., MIUR PRIN Grant 2005065029 to G. P. and a grant from Grants-in-Aid for Scientific Research on Comprehensive Genomics from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. T. G. A. R. is supported by the Canadian Institutes of Health Research. Grant MGC 77493 to J. Montplaisir. E. M. is an HHMI supported investigator. We are also grateful to GAIN (the Genetic Association Information Network, NIH) and KORA (Kooperative Gesundheitsforschung in der Region Augsburg, Germany). The KORA research platform was initiated and financed by the German Federal Ministry of Education and Research and by the State of Bavaria. The authors extend their thanks to E. Wan, C. Chu, C. Ha, J. Zhang and A. Voros for technical assistance, and C. Grumet for brainstorming and constant support.	Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuschiotti P, 2007, MOL IMMUNOL, V44, P3380, DOI 10.1016/j.molimm.2007.02.017; Garcia KC, 1998, CURR OPIN BIOTECH, V9, P338, DOI 10.1016/S0958-1669(98)80004-9; Haynes MR, 2004, IMMUNOGENETICS, V56, P470, DOI 10.1007/s00251-004-0706-x; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1	25	325	329	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					708	711		10.1038/ng.372			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	WOS:000266411700020	19412176	Green Accepted			2022-01-24	
J	Fallon, PG; Sasaki, T; Sandilands, A; Campbell, LE; Saunders, SP; Mangan, NE; Callanan, JJ; Kawasaki, H; Shiohama, A; Kubo, A; Sundberg, JP; Presland, RB; Fleckman, P; Shimizu, N; Kudoh, J; Irvine, AD; Amagai, M; McLean, WHI				Fallon, Padraic G.; Sasaki, Takashi; Sandilands, Aileen; Campbell, Linda E.; Saunders, Sean P.; Mangan, Niamh E.; Callanan, John J.; Kawasaki, Hiroshi; Shiohama, Aiko; Kubo, Akiharu; Sundberg, John P.; Presland, Richard B.; Fleckman, Philip; Shimizu, Nobuyoshi; Kudoh, Jun; Irvine, Alan D.; Amagai, Masayuki; McLean, W. H. Irwin			A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming	NATURE GENETICS			English	Article							OF-FUNCTION MUTATIONS; ATOPIC-DERMATITIS; ICHTHYOSIS VULGARIS; FILAGGRIN MUTATIONS; HUMAN PROFILAGGRIN; MICE; EXPRESSION; DISEASE; ASTHMA; ECZEMA	Loss-of-function mutations in the FLG (filaggrin) gene cause the semidominant keratinizing disorder ichthyosis vulgaris(1) and convey major genetic risk for atopic dermatitis (eczema)(2-4), eczema-associated asthma(2,3) and other allergic phenotypes(5). Several low-frequency FLG null alleles occur in Europeans and Asians, with a cumulative frequency of similar to 9% in Europe(4). Here we report a 1-bp deletion mutation, 5303delA, analogous to common human FLG mutations, within the murine Flg gene in the spontaneous mouse mutant flaky tail (ft). We demonstrate that topical application of allergen to mice homozygous for this mutation results in cutaneous inflammatory infiltrates and enhanced cutaneous allergen priming with development of allergen-specific antibody responses. These data validate flaky tail as a useful model of filaggrin deficiency and provide experimental evidence for the hypothesis that antigen transfer through a defective epidermal barrier is a key mechanism underlying elevated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related atopic disease.	[Sandilands, Aileen; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Sandilands, Aileen; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Fallon, Padraic G.; Saunders, Sean P.; Mangan, Niamh E.; Irvine, Alan D.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Sasaki, Takashi; Shiohama, Aiko; Kudoh, Jun] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Sasaki, Takashi; Shiohama, Aiko; Shimizu, Nobuyoshi; Kudoh, Jun] Keio Univ, Adv Res Ctr Genome Super Power, Ibaraki, Japan; [Callanan, John J.] Univ Coll Dublin, Coll Life Sci, Conway Inst Biomol & Biomed Res, Vet Sci Ctr, Dublin 2, Ireland; [Kawasaki, Hiroshi; Kubo, Akiharu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Presland, Richard B.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA; [Presland, Richard B.; Fleckman, Philip] Univ Washington, Dept Med, Div Dermatol, Seattle, WA USA; [Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin, Ireland		McLean, WHI (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland.	w.h.i.mclean@dundee.ac.uk	Irvine, Alan D/A-3982-2008; Amagai, Masayuki/K-5325-2013; Kubo, Akiharu/I-2711-2014; Fallon, Padraic/Y-2711-2019; Sasaki, Takashi/AAD-1461-2019; McLean, William HI/C-6352-2009	Irvine, Alan D/0000-0002-9048-2044; Amagai, Masayuki/0000-0003-3314-7052; Kubo, Akiharu/0000-0003-0902-3586; Fallon, Padraic/0000-0002-8401-7293; Callanan, John/0000-0003-4356-1783; Saunders, Sean/0000-0003-1689-3598; McLean, William Henry Irwin/0000-0001-5539-5757; Sasaki, Takashi/0000-0002-6275-046X; Mangan, Niamh/0000-0003-3844-0709; Presland, Richard/0000-0003-1440-7402	Ministry of Health, Labour, and Welfare of JapanMinistry of Health, Labour and Welfare, Japan; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 AM21557, R01 AR49183]; Odland Endowed Research Fund; Science Foundation IrelandScience Foundation IrelandEuropean Commission; Children's Medical and Research Foundation, OLCHC; British Skin Foundation; National Eczema Society; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700314]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700314] Funding Source: UKRI; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01AM021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR049183] Funding Source: NIH RePORTER	We thank B. Mistry, A. Smyth, T. Adachi and M. Furuhashi for their technical assistance and T. Yoshida for his cooperation. We are grateful for the assistance of B. Cloak with photomicrography and S. Worrell with histopathology. This work was supported by the Labour Sciences Research Grants for Research on Allergic Disease and Immunology from the Ministry of Health, Labour, and Welfare of Japan (M. A.), National Institute of Health grants P01 AM21557 (P. F.), R01 AR49183 (R. B. P.) and the Odland Endowed Research Fund (P. F.). P. G. F. was supported by Science Foundation Ireland. A. D. I. is supported by the Children's Medical and Research Foundation, OLCHC. Filaggrin research in the McLean laboratory is supported by grants from The British Skin Foundation, The National Eczema Society, The Medical Research Council (Reference number G0700314) and donations from anonymous families affected by eczema in the Tayside Region of Scotland.	Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Chen L, 2008, CLIN EXP ALLERGY, V38, P1367, DOI 10.1111/j.1365-2222.2008.02987.x; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; PRESLAND RB, 1995, J INVEST DERMATOL, V104, P218, DOI 10.1111/1523-1747.ep12612770; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; ROTHNAGEL JA, 1987, J BIOL CHEM, V262, P15643; ROTHNAGEL JA, 1990, J BIOL CHEM, V265, P1862; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sasaki T, 2008, J DERMATOL SCI, V51, P113, DOI 10.1016/j.jdermsci.2008.02.009; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Sundberg JP., 1984, HDB MOUSE MUTATIONS, V2, P269; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Zhang D, 2002, J INVEST DERMATOL, V119, P905, DOI 10.1046/j.1523-1747.2002.00133.x	30	325	329	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					602	608		10.1038/ng.358			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	WOS:000265575600023	19349982	Green Accepted			2022-01-24	
J	Klein, C; Grudzien, M; Appaswamy, G; Germeshausen, M; Sandrock, I; Schaffer, AA; Rathinam, C; Boztug, K; Schwinzer, B; Rezaei, N; Bohn, G; Melin, M; Carlsson, G; Fadeel, B; Dahl, N; Palmblad, J; Henter, JI; Zeidler, C; Grimbacher, B; Welte, K				Klein, Christoph; Grudzien, Magda; Appaswamy, Giridharan; Germeshausen, Manuela; Sandrock, Inga; Schaffer, Alejandro A.; Rathinam, Chozhavendan; Boztug, Kaan; Schwinzer, Beate; Rezaei, Nima; Bohn, Georg; Melin, Malin; Carlsson, Goran; Fadeel, Bengt; Dahl, Niklas; Palmblad, Jan; Henter, Jan-Inge; Zeidler, Cornelia; Grimbacher, Bodo; Welte, Karl			HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)	NATURE GENETICS			English	Article							COLONY-STIMULATING-FACTOR; MYELOID PROGENITOR CELLS; PROTEIN HAX-1; MITOCHONDRIA; APOPTOSIS; DEATH; NEUTROPHILS; MUTATIONS; INTERACTS; LEUKEMIA	Autosomal recessive severe congenital neutropenia (SCN)(1) constitutes a primary immunodeficiency syndrome associated with increased apoptosis in myeloid cells(2,3), yet the underlying genetic defect remains unknown. Using a positional cloning approach and candidate gene evaluation, we identified a recurrent homozygous germline mutation in HAX1 in three pedigrees. After further molecular screening of individuals with SCN, we identified 19 additional affected individuals with homozygous HAX1 mutations, including three belonging to the original pedigree described by Kostmann(1). HAX1 encodes the mitochondrial protein HAX1, which has been assigned functions in signal transduction(4) and cytoskeletal control(5,6). Here, we show that HAX1 is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells. Our findings suggest that HAX1 is a major regulator of myeloid homeostasis and underline the significance of genetic control of apoptosis in neutrophil development.	Hannover Med Sch, Dept Pediat Hematol Oncol, D-30625 Hannover, Germany; Freiburg Univ Hosp, Med Ctr, Div Rheumatol & Clin Immunol, D-79106 Freiburg, Germany; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20894 USA; Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; Univ Childrens Hosp, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Karolinska Univ Hosp, Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, S-17176 Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Div Biochem & Toxicol, S-17177 Stockholm, Sweden; Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, S-14186 Stockholm, Sweden		Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Schaffer, Alejandro/N-1222-2019; Boztug, Kaan/AAM-4161-2021; Schaffer, Alejandro A/F-2902-2012; Rezaei, Nima/B-4245-2008	Boztug, Kaan/0000-0001-8387-9185; Rezaei, Nima/0000-0002-3836-1827; Henter, Jan-Inge/0000-0002-0629-2126	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA Funding Source: Medline; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [ZIALM000097, Z01LM000097] Funding Source: NIH RePORTER		Cario G, 2005, BRIT J HAEMATOL, V129, P275, DOI 10.1111/j.1365-2141.2005.05428.x; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Dufva M, 2001, J GEN VIROL, V82, P1581, DOI 10.1099/0022-1317-82-7-1581; ELSNER J, 1993, EXP HEMATOL, V21, P38; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GILMAN PA, 1970, BLOOD-J HEMATOL, V36, P576, DOI 10.1182/blood.V36.5.576.576; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Kawaguchi Y, 2000, J VIROL, V74, P10104, DOI 10.1128/JVI.74.21.10104-10111.2000; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Maianski NA, 2002, BLOOD, V99, P672, DOI 10.1182/blood.V99.2.672; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Suzuki Y, 1997, J IMMUNOL, V158, P2736; WETTE K, 2006, SEMIN HEMATOL, V43, P189; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005	30	325	340	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					86	92		10.1038/ng1940			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	WOS:000243136500022	17187068				2022-01-24	
J	Fluck, CE; Tajima, T; Pandey, AV; Arlt, W; Okuhara, K; Verge, CF; Jabs, EW; Mendonca, BB; Fujieda, K; Miller, WL				Fluck, CE; Tajima, T; Pandey, AV; Arlt, W; Okuhara, K; Verge, CF; Jabs, EW; Mendonca, BB; Fujieda, K; Miller, WL			Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome	NATURE GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; PATIENT; 17-ALPHA-HYDROXYLASE/17,20-LYASE; DEFICIENCY; MUTATIONS; PREGNANCY; DEFECTS	Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan; Sydney Childrens Hosp, Dept Endocrinol, Randwick, NSW, Australia; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ Sao Paulo, Hosp Clin, Dept Med, Sao Paulo, Brazil; Asahikawa Med Coll, Dept Pediat, Asahikawa, Hokkaido 078, Japan		Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Pandey, Amit V/A-7223-2008; Miller, Walter L/J-3696-2012; Mendonca, Berenice B/J-6917-2015; Arlt, Wiebke/B-6310-2009; Toshihiro, Tajima/A-5720-2012; Pandey, Amit V/AAO-6442-2020; Mendonca, Berenice B/C-2827-2012; Mendonca, Berenice/AAS-3742-2021	Pandey, Amit V/0000-0001-8331-5902; Mendonca, Berenice B/0000-0003-1762-1084; Arlt, Wiebke/0000-0001-5106-9719; Pandey, Amit V/0000-0001-8331-5902; Mendonca, Berenice/0000-0003-1762-1084; Flueck, Christa/0000-0002-4568-5504; Jabs, Ethylin/0000-0001-8983-5466			Adachi M, 1999, ENDOCR J, V46, P285, DOI 10.1507/endocrj.46.285; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Chun K, 1998, AM J MED GENET, V77, P219, DOI 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Kelley RI, 2002, AM J MED GENET, V110, P95, DOI 10.1002/ajmg.10510; MILLER WL, 1986, NEW ENGL J MED, V314, P1321; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; PETERSON RE, 1985, NEW ENGL J MED, V313, P1182, DOI 10.1056/NEJM198511073131903; Reardon W, 2000, J MED GENET, V37, P26, DOI 10.1136/jmg.37.1.26; Roth C, 2000, EUR J PEDIATR, V159, P189, DOI 10.1007/s004310050048; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	15	325	343	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					228	230		10.1038/ng1300			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	WOS:000189250400009	14758361	Bronze			2022-01-24	
J	Cai, ST; Han, HJ; Kohwi-Shigematsu, T				Cai, ST; Han, HJ; Kohwi-Shigematsu, T			Tissue-specific nuclear architecture and gene expession regulated by SATB1	NATURE GENETICS			English	Article							MATRIX-ATTACHMENT REGION; BINDING PROTEIN SATB1; BETA-GLOBIN LOCUS; CELL-SPECIFIC DEMETHYLATION; HISTONE H3 METHYLATION; C-MYC; CHAIN ENHANCER; IN-VIVO; CHROMATIN; DNA	Eukaryotic chromosomes are packaged in nuclei by many orders of folding. Little is known about how higher-order chromatin packaging might affect gene expression. SATB1 is a cell-type specific nuclear protein that recruits chromatin-remodeling factors and regulates numerous genes during thymocyte differentiation. Here we show that in thymocyte nuclei, SATB1 has a cage-like 'network' distribution circumscribing heterochromatin and selectively tethers specialized DNA sequences onto its network. This was shown by fluorescence in situ hybridization on wild-type and Satb1-null thymocytes using in vivo SATB1-bound sequences as probes. Many gene loci, including that of Myc and a brain-specific gene, are anchored by the SATB1 network at specific genomic sites, and this phenomenon is precisely correlated with proper regulation of distant genes. Histone-modification analyses across a gene-enriched genomic region of 70 kb showed that acetylation of histone H3 at Lys9 and Lys14 peaks at the SATB1-binding site and extends over a region of roughly 10 kb covering genes regulated by SATB1. By contrast, in Satb1-null thymocytes, this site is marked by methylation at H3 Lys9. We propose SATB1 as a new type of gene regulator with a novel nuclear architecture, providing sites for tissue-specific organization of DNA sequences and regulating region-specific histone modification.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA		Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd 84-171, Berkeley, CA 94720 USA.						Alvarez JD, 2000, GENE DEV, V14, P521; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Chan HM, 2001, J CELL SCI, V114, P2363; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Hawkins SM, 2001, J BIOL CHEM, V276, P44472, DOI 10.1074/jbc.M104193200; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KOHWI Y, 1993, GENE DEV, V7, P1766, DOI 10.1101/gad.7.9.1766; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; KOHWISHIGEMATSU T, 1992, METHOD ENZYMOL, V212, P155; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu JQ, 1997, MOL CELL BIOL, V17, P5275, DOI 10.1128/MCB.17.9.5275; Liu WM, 1999, CANCER RES, V59, P5695; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; RIEGEL JS, 1990, J IMMUNOL, V144, P3611; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SANDERS J, 1992, NUCLEIC ACIDS RES, V20, P5907, DOI 10.1093/nar/20.22.5907; Schubeler D, 2000, GENE DEV, V14, P940; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	325	348	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					42	51		10.1038/ng1146			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	WOS:000182667900015	12692553	Green Published			2022-01-24	
J	Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T				Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T			Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome	NATURE GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; HEREDITARY ESSENTIAL MYOCLONUS; ONSET TORSION DYSTONIA; D2 DOPAMINE-RECEPTOR; ALPHA-SARCOGLYCAN; COMPLEX; FAMILY; 2D	The dystonias are a common clinically and genetically heterogeneous group of movement disorders. More than ten loci for inherited forms of dystonia have been mapped, but only three mutated genes have been identified so far. These are DYT1, encoding torsin A(1) and mutant in the early-onset generalized form, GCH1 (formerly known as DYT5), encoding GTP-cyclohydrolase I and mutant in dominant dopa-responsive dystonia(2), and TH, encoding tyrosine hydroxylase and mutant in the recessive form of the disease(3). Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles(4,5). Dystonia, usually torticollis and/or writer's cramp, occurs in most but not all affected patients and may occasionally be the only symptom of the disease(6,7). In addition, patients often show prominent psychiatric abnormalities, including panic attacks and obsessive-compulsive behavior(8-10). In most MDS families, the disease is linked to a locus on chromosome 7q21 (refs. 11-13). Using a positional cloning approach, we have identified five different heterozygous loss-of-function mutations in the gene for epsilon -sarcoglycan (SGCE), which we mapped to a refined critical region of about 3.2 Mb. SGCE is expressed in all brain regions examined. Pedigree analysis shows a marked difference in penetrance depending on the parental origin of the disease allele, This is indicative of a maternal imprinting mechanism, which has been demonstrated in the mouse epsilon -sarcoglycan gene(14).	Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; GSF Munich, Natl Res Ctr, Inst Human Genet, Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; Heidelberg Univ, Dept Neurol, D-6900 Heidelberg, Germany; Neurol Hosp, Bad Aibling, Germany; Klinikum Buch, Dept Neurol, Berlin, Germany; Inst Psychiat, Dept Neurol, Munich, Germany; Bernhard Nocht Inst Trop Med, Hamburg, Germany; LionBiosci AG, Heidelberg, Germany		Gasser, T (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany.	tgasser@brain.nefo.med.uni-muenchen.de	Berg, Daniela D/A-8728-2019; Meitinger, Thomas/O-1318-2015; Muller-Myhsok, Bertram/A-3289-2013; Zimprich, Alexander/A-5232-2017	Berg, Daniela D/0000-0001-5796-5442; Zimprich, Alexander/0000-0002-1668-5177; Bauer, Michaela/0000-0001-8717-3278; Meitinger, Thomas/0000-0002-8838-8403; Castro, Mirna/0000-0002-3452-9215			Asmus F, 2001, ANN NEUROL, V49, P121, DOI 10.1002/1531-8249(200101)49:1<121::AID-ANA20>3.0.CO;2-8; DOHENY D, 2000, MOVEMENT DISORD, V15, pS162; Durr A, 2000, ANN NEUROL, V48, P127; Ettinger AJ, 1997, J BIOL CHEM, V272, P32534, DOI 10.1074/jbc.272.51.32534; FAHN S, 1991, MOVEMENT DISORD, V6, P237, DOI 10.1002/mds.870060308; Gasser T, 1998, Adv Neurol, V78, P325; Gasser T, 1996, MOVEMENT DISORD, V11, P363, DOI 10.1002/mds.870110403; Grimes DA, 2001, MOVEMENT DISORD, V16, P106, DOI 10.1002/1531-8257(200101)16:1<106::AID-MDS1022>3.0.CO;2-7; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Imamura M, 2000, HUM MOL GENET, V9, P3091, DOI 10.1093/hmg/9.20.3091; Klein C, 2000, AM J HUM GENET, V67, P1314; Klein C, 1999, P NATL ACAD SCI USA, V96, P5173, DOI 10.1073/pnas.96.9.5173; Kurlan R, 1988, Adv Neurol, V50, P385; KURLAN R, 1987, MOVEMENT DISORD, V2, P301, DOI 10.1002/mds.870020407; KYLLERMAN M, 1990, MOVEMENT DISORD, V5, P270, DOI 10.1002/mds.870050403; Lim LE, 1998, CURR OPIN NEUROL, V11, P443, DOI 10.1097/00019052-199810000-00006; LUDECKE B, 1995, HUM GENET, V95, P123; LUNDEMO G, 1985, ACTA NEUROL SCAND, V72, P176; McNally EM, 1998, FEBS LETT, V422, P27, DOI 10.1016/S0014-5793(97)01593-7; Nygaard TG, 1999, ANN NEUROL, V46, P794, DOI 10.1002/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Quinn N P, 1988, Adv Neurol, V50, P391; Scheidtmann K, 2000, NERVENARZT, V71, P839, DOI 10.1007/s001150050673; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989	27	325	340	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					66	69		10.1038/ng709			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	WOS:000170781300019	11528394				2022-01-24	
J	Chen, C; Kolodner, RD				Chen, C; Kolodner, RD			Gross chromosomal rearrangements in Saccharomyces cerevisiae replication and recombination defective mutants	NATURE GENETICS			English	Article							NIJMEGEN BREAKAGE SYNDROME; INDUCED DNA-REPLICATION; PROTEIN-A; REPAIR; YEAST; TRANSLOCATIONS; GENE; METABOLISM; DELETIONS; LEUKEMIA	Cancer progression is often associated with the accumulation of gross chromosomal rearrangements (GCRs), such as translocations, deletion of a chromosome arm, interstitial deletions or inversions(1-3). In many instances, GCRs inactivate tumour-suppressor genes or generate novel fusion proteins that initiate carcinogenesis(3,4). The mechanism underlying GCR formation appears to involve interactions between DNA sequences of little or no homology(5-8). We previously demonstrated that mutations in the gene encoding the largest subunit of the Saccharomyces cerevisiae single-stranded DNA binding protein (RFA1) increase microhomology-medialed GCR formations. To further our understanding of GCR formation, we have developed a novel mutator assay in 5. cerevisiae that allows specific detection of such events. In this assay, the rate of GCR formation was increased 600-5,000-fold by mutations in RFA1, RAD27, MRE11, XRS2 and RAD50, but was minimally affected by mutations in RAD51, RAD54, RAD57, YKU70, YKU80, LIG4 and POL30. Genetic analysis of these mutants suggested that at least three distinct pathways can suppress GCRs: two that suppress microhomology-mediated GCRs (RFA1 and RAD27) and one that suppresses non-homology-mediated GCRs (RAD50/MRE11/XRS2).	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA		Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM26017, GM50006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM026017, R01GM026017, R01GM050006] Funding Source: NIH RePORTER		Amin NS, 1996, GENETICS, V144, P479; Barr FG, 1998, NAT GENET, V19, P121, DOI 10.1038/475; Bosco G, 1998, GENETICS, V150, P1037; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen SH, 1998, J POLYM RES-TAIWAN, V5, P9, DOI 10.1007/s10965-006-0034-y; CHRZANOWSKA KH, 1995, AM J MED GENET, V57, P462, DOI 10.1002/ajmg.1320570321; GAUWERKY CE, 1993, SEMIN CANCER BIOL, V4, P333; GILMAN JG, 1987, BRIT J HAEMATOL, V67, P369, DOI 10.1111/j.1365-2141.1987.tb02360.x; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; LUZI P, 1995, HUM MOL GENET, V4, P2335, DOI 10.1093/hmg/4.12.2335; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maniar HS, 1997, GENETICS, V145, P891; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Merrill BJ, 1998, GENETICS, V148, P611; MITELMAN F, 1991, CATALOG CHROMOSOME A; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; NINIO J, 1991, GENETICS, V129, P957; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SHIKANO T, 1993, CANCER GENET CYTOGEN, V71, P22, DOI 10.1016/0165-4608(93)90198-U; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tsukamoto Y, 1997, MOL GEN GENET, V255, P543, DOI 10.1007/s004380050527; Tsukamoto Y, 1996, GENETICS, V142, P383; Umezu K, 1998, GENETICS, V148, P989; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOODSSAMUELS P, 1991, GENOMICS, V10, P94, DOI 10.1016/0888-7543(91)90489-2	29	325	326	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					81	85		10.1038/12687			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	WOS:000082337300021	10471504				2022-01-24	
J	Wolf, YI; Aravind, L; Grishin, NV; Koonin, EV				Wolf, YI; Aravind, L; Grishin, NV; Koonin, EV			Evolution of aminoacyl-tRNA synthetases - Analysis of unique domain architectures and phylogenetic trees reveals a complex history of horizontal gene transfer events	GENOME RESEARCH			English	Article							TRANSFER-RNA-SYNTHETASE; ACTIVATING POLYPEPTIDE-II; METHIONYL-TRANSFER-RNA; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; PROTEIN SEQUENCES; CRYSTAL-STRUCTURE; BINDING-SITE; PSI-BLAST; SUPERFAMILY	Phylogenetic analysis of aminoacyl-tRNA synthetases (aaRSs) of all 20 specificities from completely sequenced bacterial, archaeal, and eukaryotic genomes reveals a complex evolutionary picture. Detailed examination of the domain architecture of aaRSs using sequence profile searches delineated a network of partially conserved domains that is even more elaborate than previously suspected. Several unexpected evolutionary connections were identified, including the apparent origin of the \beta-subunit of bacterial GlyRS from the HD superfamily of hydrolases, a domain shared by bacterial AspRS and the B subunit of archaeal glutamyl-tRNA amidotransferases, and another previously undetected domain that is conserved in a subset of ThrRS, guanosine polyphosphate hydrolases and synthetases, and a family of GTPases. Comparison of domain architectures and multiple alignments resulted in the delineation of synapomorphies-shared derived characters, such as extra domains or inserts-for most of the aaRSs specificities. These synapomorphies partition sets of aaRSs with the same specificity into two or more distinct and apparently monophyletic groups. In conjunction with cluster analysis and a modification of the midpoint-rooting procedure, this partitioning was used to infer the likely root position in phylogenetic trees. The topologies of the resulting rooted trees for most of the aaRSs specificities are compatible with the evolutionary "standard model" whereby the earliest radiation event separated bacteria from the common ancestor of archaea and eukaryotes as opposed to the two other possible evolutionary scenarios for the three major divisions of life. For almost all aaRSs specificities, however, this simple scheme is confounded by displacement of some of the bacterial aaRSs by their eukaryotic or, less frequently, archaeal counterparts. Displacement of ancestral eukaryotic aaRS genes by bacterial ones, presumably of mitochondrial origin, was observed for three aaRSs. In contrast, there was no convincing evidence of displacement of archaeal aaRSs by bacterial ones. Displacement of aaRS genes by eukaryotic counterparts is most common among parasitic and symbiotic bacteria, particularly the spirochaetes, in which 10 of the 19 aaRSs seem to have been displaced by the respective eukaryotic genes and two by the archaeal counterpart. Unlike the primary radiation events between the three main divisions of life, that were readily traceable through the phylogenetic analysis of aaRSs, no consistent large-scale bacterial phylogeny could be established. In part, this may be due to additional gene displacement events among bacterial lineages. Argument is presented that, although lineage-specific gene loss might have contributed to the evolution of some of the aaRSs, this is not a viable alternative to horizontal gene transfer as the principal evolutionary phenomenon in this gene class.	NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; Texas A&M Univ, Dept Biol, College Stn, TX USA		Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov		Aravind, L/0000-0003-0771-253X			Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; ARTYMIUK PJ, 1994, NAT STRUCT BIOL, V1, P758, DOI 10.1038/nsb1194-758; BEDOUELLE H, 1993, BIOCHIMIE, V75, P1099, DOI 10.1016/0300-9084(93)90009-H; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; Brown JR, 1997, J MOL EVOL, V45, P9, DOI 10.1007/PL00006206; Brown JR, 1998, CURR BIOL, V8, pR365, DOI 10.1016/S0960-9822(98)70238-6; BROWN JR, 1995, P NATL ACAD SCI USA, V92, P2441, DOI 10.1073/pnas.92.7.2441; BRUNIE S, 1990, J MOL BIOL, V216, P411, DOI 10.1016/S0022-2836(05)80331-6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; Curnow AW, 1996, NATURE, V382, P589, DOI 10.1038/382589b0; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; CUSACK S, 1991, NUCLEIC ACIDS RES, V19, P3489, DOI 10.1093/nar/19.13.3489; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; DELARUE M, 1994, EMBO J, V13, P3219, DOI 10.1002/j.1460-2075.1994.tb06623.x; Doolittle RF, 1998, CURR OPIN GENET DEV, V8, P630, DOI 10.1016/S0959-437X(98)80030-0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ERIANI G, 1995, J MOL EVOL, V40, P499; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Freist W, 1996, BIOL CHEM H-S, V377, P343; Freist W, 1997, BIOL CHEM, V378, P1103; Freist W, 1997, BIOL CHEM, V378, P1313; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Hashimoto T, 1998, P NATL ACAD SCI USA, V95, P6860, DOI 10.1073/pnas.95.12.6860; HODGSON JE, 1994, ANTIMICROB AGENTS CH, V38, P1205, DOI 10.1128/AAC.38.5.1205; Ibba M, 1997, P NATL ACAD SCI USA, V94, P14383, DOI 10.1073/pnas.94.26.14383; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KARLIN S, 1991, ANNU REV BIOPHYS BIO, V20, P175, DOI 10.1146/annurev.biophys.20.1.175; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Koonin EV, 1998, CURR BIOL, V8, pR266, DOI 10.1016/S0960-9822(98)70169-1; Lenhard B, 1999, NUCLEIC ACIDS RES, V27, P721, DOI 10.1093/nar/27.3.721; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Makarova KS, 1999, GENOME RES, V9, P608; Markus MA, 1998, EMBO J, V17, P4559, DOI 10.1093/emboj/17.16.4559; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; NAGEL GM, 1995, J MOL EVOL, V40, P487; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; RajBhandary UL, 1997, P NATL ACAD SCI USA, V94, P11761, DOI 10.1073/pnas.94.22.11761; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; RIPMASTER TL, 1995, P NATL ACAD SCI USA, V92, P4932, DOI 10.1073/pnas.92.11.4932; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sassanfar M, 1996, BIOCHEMISTRY-US, V35, P9995, DOI 10.1021/bi9603027; Schade M, 1999, EMBO J, V18, P470, DOI 10.1093/emboj/18.2.470; Seledtsov I A, 1995, Mol Biol (Mosk), V29, P1023; Shiba K, 1998, NUCLEIC ACIDS RES, V26, P5045, DOI 10.1093/nar/26.22.5045; Shiba K, 1997, TRENDS BIOCHEM SCI, V22, P453, DOI 10.1016/S0968-0004(97)01135-3; Shiba K, 1997, J BIOL CHEM, V272, P22809, DOI 10.1074/jbc.272.36.22809; Siatecka M, 1998, EUR J BIOCHEM, V256, P80, DOI 10.1046/j.1432-1327.1998.2560080.x; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; Soma A, 1998, NUCLEIC ACIDS RES, V26, P4374, DOI 10.1093/nar/26.19.4374; Tas MPR, 1996, INT J BIOCHEM CELL B, V28, P837, DOI 10.1016/1357-2725(96)00038-6; TOTH MJ, 1990, J BIOL CHEM, V265, P1000; ULLRICH M, 1994, J BACTERIOL, V176, P7574, DOI 10.1128/JB.176.24.7574-7586.1994; WALKER DR, 1997, INTELL SYST MOL BIOL, V5, P333; Weiner AM, 1999, SCIENCE, V284, P63, DOI 10.1126/science.284.5411.63; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	75	325	329	0	45	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	1999	9	8					689	710					22	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	227DL	WOS:000082063000004	10447505				2022-01-24	
J	Pastural, E; Barrat, FJ; DufourcqLagelouse, R; Certain, S; Sanal, O; Jabado, N; Seger, R; Griscelli, C; Fischer, A; DesaintBasile, G				Pastural, E; Barrat, FJ; DufourcqLagelouse, R; Certain, S; Sanal, O; Jabado, N; Seger, R; Griscelli, C; Fischer, A; DesaintBasile, G			Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene	NATURE GENETICS			English	Article							UNCONVENTIONAL MYOSIN; PARTIAL ALBINISM; IMMUNODEFICIENCY; INVOLVEMENT; LOCUS		HOP NECKER ENFANTS MALAD,INSERM U429,UNITE RECH DEV NORMAL & PATHOL SYST IMMUNITAIRE,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,UNITE IMMUNOL & HEMATOL PEDIAT,F-75743 PARIS 15,FRANCE; HACETTEPE CHILDRENS HOSP MED CTR,ANKARA,TURKEY; UNIV KINDERSPITAL ZURICH,ABT IMMUNOL HAMATOL,CH-8032 ZURICH,SWITZERLAND				Jabado, Nada/AAN-4026-2020; de Saint Basile, Genevieve/G-9731-2017	DOGNIAUX, Stephanie/0000-0003-3309-1204; de Saint Basile, Genevieve/0000-0002-1913-5269			Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Barrat FJ, 1996, AM J HUM GENET, V59, P625; BEJAOUI M, 1989, ARCH FR PEDIATR, V46, P733; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/S0092-8674(05)80080-7; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELEJALDE BR, 1979, AM J MED GENET, V3, P65, DOI 10.1002/ajmg.1320030112; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans L. L., 1995, Molecular Biology of the Cell, V6, p145A; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; HARALDSSON A, 1991, EUR J PEDIATR, V150, P419, DOI 10.1007/BF02093723; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; HURVITZ H, 1993, EUR J PEDIATR, V152, P402, DOI 10.1007/BF01955897; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; Maniatis T, 1982, MOLECULAR; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOORE KJ, 1995, CYTOGENET CELL GENET, V69, P53, DOI 10.1159/000133937; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; STROBEL MC, 1990, MOL CELL BIOL, V10, P501, DOI 10.1128/MCB.10.2.501; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; WINDHORST DB, 1973, J INVEST DERMATOL, V60, P529, DOI 10.1111/1523-1747.ep12703609	26	325	332	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					289	292		10.1038/ng0797-289			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	WOS:A1997XG60900026	9207796				2022-01-24	
J	STRONG, TV; TAGLE, DA; VALDES, JM; ELMER, LW; BOEHM, K; SWAROOP, M; KAATZ, KW; COLLINS, FS; ALBIN, RL				STRONG, TV; TAGLE, DA; VALDES, JM; ELMER, LW; BOEHM, K; SWAROOP, M; KAATZ, KW; COLLINS, FS; ALBIN, RL			WIDESPREAD EXPRESSION OF THE HUMAN AND RAT HUNTINGTONS-DISEASE GENE IN BRAIN AND NONNEURAL TISSUES	NATURE GENETICS			English	Article							STRIATAL PROJECTION NEURONS	We have used RNA in situ hybridization to study the regional expression of the Huntington's disease gene (HD) and its rat homologue in brain and selected nonneural tissues. The HD transcript was expressed throughout the brain in both rat and human, especially in the neurons of the dentate gyrus and pyramidal neurons of the hippocampal formation, cerebellar granule cell layer, cerebellar Purkinje cells and pontine nuclei. Other brain areas expressed lower levels of the HD transcript without pronounced regional differences. Neuronal expression predominated over glial expression in all regions. HD mRNA was also expressed in colon, liver, pancreas and testes. The regional specificity of neuropathology in HD, which is most prominent in the basal ganglia, thus cannot be accounted for by the pattern of expression of HD.	UNIV MICHIGAN, DEPT INTERNAL MED, DIV MOLEC MED & GENET, 4570 MSRB II, ANN ARBOR, MI 48109 USA; NIH, NATL CTR HUMAN GENOME RES, BETHESDA, MD 20892 USA; UNIV MICHIGAN, DEPT NEUROL, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, CELL & MOLEC BIOL PROGRAM, ANN ARBOR, MI 48109 USA					Strong, Theresa/0000-0001-6783-8703; Kaatz, Kevin/0000-0002-7890-4865	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [F32HG000067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS019613, K08NS001300] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG 00067-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 19613, NS 01300] Funding Source: Medline		ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HARRINGTON KM, 1991, J NEUROPATH EXP NEUR, V50, P309; HIRSCH EC, 1989, NEUROSCI LETT, V96, P145, DOI 10.1016/0304-3940(89)90048-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MORRIS M, 1991, HUNTINGTONS DIS, P81; MYERS RH, 1989, AM J HUM GENET, V45, P615; QUARREL O, 1991, HUNTINGTONS DISEASE, P37; QUARREL O, 1991, HUNTINGTONS DISEASE, P141; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; STRONG TV, IN PRESS J CLIN INVE; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	23	325	332	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					259	265		10.1038/ng1193-259			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	WOS:A1993MF12200016	8275091				2022-01-24	
J	Armenia, J; Wankowicz, SAM; Liu, D; Gao, JJ; Kundra, R; Reznik, E; Chatila, WK; Chakravarty, D; Han, GC; Coleman, I; Montgomery, B; Pritchard, C; Morrissey, C; Barbieri, CE; Beltran, H; Sboner, A; Zafeiriou, Z; Miranda, S; Bielski, CM; Penson, AV; Tolonen, C; Huang, FW; Robinson, D; Wu, YM; Lonigro, R; Garraway, LA; Demichelis, F; Kantoff, PW; Taplin, ME; Abida, W; Taylor, BS; Scher, HI; Nelson, PS; de Bono, JS; Rubin, MA; Sawyers, CL; Chinnaiyan, AM; Schultz, N; Van Allen, EM				Armenia, Joshua; Wankowicz, Stephanie A. M.; Liu, David; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K.; Chakravarty, Debyani; Han, G. Celine; Coleman, Ilsa; Montgomery, Bruce; Pritchard, Colin; Morrissey, Colm; Barbieri, Christopher E.; Beltran, Himisha; Sboner, Andrea; Zafeiriou, Zafeiris; Miranda, Susana; Bielski, Craig M.; Penson, Alexander V.; Tolonen, Charlotte; Huang, Franklin W.; Robinson, Dan; Wu, Yi Mi; Lonigro, Robert; Garraway, Levi A.; Demichelis, Francesca; Kantoff, Philip W.; Taplin, Mary-Ellen; Abida, Wassim; Taylor, Barry S.; Scher, Howard I.; Nelson, Peter S.; de Bono, Johann S.; Rubin, Mark A.; Sawyers, Charles L.; Chinnaiyan, Arul M.; Schultz, Nikolaus; Van Allen, Eliezer M.		PCF SU2C Int Prostate Canc Dre	The long tail of oncogenic drivers in prostate cancer	NATURE GENETICS			English	Article							MUTATIONS; GENES; SPOP; TRANSCRIPTION; EVOLUTION; COFACTOR; GENOMICS; SAMPLES; SHARP	Comprehensive genomic characterization of prostate cancer has identified recurrent alterations in genes involved in androgen signaling, DNA repair, and PI3K signaling, among others. However, larger and uniform genomic analysis may identify additional recurrently mutated genes at lower frequencies. Here we aggregate and uniformly analyze exome sequencing data from 1,013 prostate cancers. We identify and validate a new class of E26 transformation-specific (ETS)-fusion-negative tumors defined by mutations in epigenetic regulators, as well as alterations in pathways not previously implicated in prostate cancer, such as the spliceosome pathway. We find that the incidence of significantly mutated genes (SMGs) follows a long-tail distribution, with many genes mutated in less than 3% of cases. We identify a total of 97 SMGs, including 70 not previously implicated in prostate cancer, such as the ubiquitin ligase CUL3 and the transcription factor SPEN. Finally, comparing primary and metastatic prostate cancer identifies a set of genomic markers that may inform risk stratification.	[Armenia, Joshua; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K.; Chakravarty, Debyani; Bielski, Craig M.; Penson, Alexander V.; Taylor, Barry S.; Sawyers, Charles L.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Armenia, Joshua; Gao, Jianjiong; Kundra, Ritika; Reznik, Ed; Chatila, Walid K.; Chakravarty, Debyani; Bielski, Craig M.; Penson, Alexander V.; Taylor, Barry S.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Wankowicz, Stephanie A. M.; Liu, David; Han, G. Celine; Huang, Franklin W.; Garraway, Levi A.; Taplin, Mary-Ellen; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wankowicz, Stephanie A. M.; Liu, David; Han, G. Celine; Tolonen, Charlotte; Huang, Franklin W.; Garraway, Levi A.; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Coleman, Ilsa; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Coleman, Ilsa; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Montgomery, Bruce; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [Pritchard, Colin] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Morrissey, Colm] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Barbieri, Christopher E.; Sboner, Andrea] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Beltran, Himisha] Weill Cornell Med, Dept Med, Div Med Oncol, New York, NY USA; [Beltran, Himisha; Rubin, Mark A.] New York Presbyterian Hosp, Weill Cornell Med Coll, Englander Inst Precis Med, New York, NY USA; [Beltran, Himisha; Rubin, Mark A.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Zafeiriou, Zafeiris; Miranda, Susana; de Bono, Johann S.] Inst Canc Res, Div Clin Studies, Biomarkers Team, London, England; [Zafeiriou, Zafeiris; Miranda, Susana; de Bono, Johann S.] Royal Marsden Hosp, London, England; [Robinson, Dan; Wu, Yi Mi; Lonigro, Robert; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Demichelis, Francesca] Univ Trento, Ctr Integrated Biol, Trento, Italy; [Kantoff, Philip W.; Abida, Wassim; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Taylor, Barry S.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA		Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.	schultzn@mskcc.org; eliezerm_vanallen@dfci.harvard.edu	Demichelis, Francesca/J-9829-2016; Kundra, Ritika/ABC-9927-2020; Schultz, Nikolaus/ABE-6347-2020; Gao, JianJiong/B-5673-2016; Liu, David/ABF-1275-2020	Demichelis, Francesca/0000-0002-8266-8631; Gao, JianJiong/0000-0002-5739-1781; Liu, David/0000-0003-0346-5033; Han, Celine/0000-0003-2004-8186; Rubin, Mark/0000-0002-8321-9950; de Bono, Johann S/0000-0002-2034-595X; Reznik, Ed/0000-0002-6511-5947	SU2C-PCF Prostate Cancer International Dream Team; Prostate Cancer Foundation Young Investigator Awards; Prostate Cancer Foundation-V Foundation Challenge Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08CA188615]; NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50-CA097186, P50-CA92629]; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; National Cancer Institute Cancer Center Core GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30-CA008748]; Robertson Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [K08CA188615, R01CA155169, U54CA224079, P30CA008748, P50CA097186, R01CA193837, P50CA092629] Funding Source: NIH RePORTER	We thank the patients for participating in this study. We also thank the Broad Cancer Genome Analysis and Data Sciences groups for analysis methodology and computational support. This work was supported by the SU2C-PCF Prostate Cancer International Dream Team, Prostate Cancer Foundation Young Investigator Awards (B.S.T., C.P., N.S., and E.M.V.A.), Prostate Cancer Foundation-V Foundation Challenge Award (E.M.V.A., P.S.N., and J.S.d.B.), NIH K08CA188615 (E.M.V.A.), NCI P50-CA097186 and NCI P50-CA92629 SPOREs in Prostate Cancer, the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, a National Cancer Institute Cancer Center Core Grant (P30-CA008748), and the Robertson Foundation (B.S.T. and N.S.).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Abida W, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00029; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Boysen G, 2015, ELIFE, V4, DOI 10.7554/eLife.09207; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI 10.1038/leu.2014.331; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Groner AC, 2016, CANCER CELL, V29, P846, DOI 10.1016/j.ccell.2016.04.012; Hartmaier RJ, 2017, CANCER RES, V77, P2464, DOI 10.1158/0008-5472.CAN-16-2479; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legare S, 2015, CANCER RES, V75, P4351, DOI 10.1158/0008-5472.CAN-14-3475; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	41	324	326	4	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2018	50	5					645	+		10.1038/s41588-018-0078-z			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE7EA	WOS:000431394900006	29610475	Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Smith-Unna, R; Boursnell, C; Patro, R; Hibberd, JM; Kelly, S				Smith-Unna, Richard; Boursnell, Chris; Patro, Rob; Hibberd, Julian M.; Kelly, Steven			TransRate: reference-free quality assessment of de novo transcriptome assemblies	GENOME RESEARCH			English	Article							RNA-SEQ DATA; EXPRESSION LEVELS; GENOME	TransRate is a tool for reference-free quality assessment of de novo transcriptome assemblies. Using only the sequenced reads and the assembly as input, we show that multiple common artifacts of de novo transcriptome assembly can be readily detected. These include chimeras, structural errors, incomplete assembly, and base errors. TransRate evaluates these errors to produce a diagnostic quality score for each contig, and these contig scores are integrated to evaluate whole assemblies. Thus, TransRate can be used for de novo assembly filtering and optimization as well as comparison of assemblies generated using different methods from the same input reads. Applying the method to a data set of 155 published de novo transcriptome assemblies, we deconstruct the contribution that assembly method, read length, read quantity, and read quality make to the accuracy of de novo transcriptome assemblies and reveal that variance in the quality of the input data explains 43% of the variance in the quality of published de novo transcriptome assemblies. Because TransRate is reference-free, it is suitable for assessment of assemblies of all types of RNA, including assemblies of long noncoding RNA, rRNA, mRNA, and mixed RNA samples.	[Smith-Unna, Richard; Boursnell, Chris; Hibberd, Julian M.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Patro, Rob] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England		Kelly, S (corresponding author), Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England.	steven.kelly@plants.ox.ac.uk			Millennium Seed Bank (Royal Botanical Gardens, Kew); Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Department for International Development; Bill & Melinda Gates FoundationBill & Melinda Gates FoundationCGIAR; Department of Biotechnology of the Government of India's Ministry of Science and Technology; European UnionEuropean Commission [637765]; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J011754/1] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J011754/1] Funding Source: UKRI	We thank the TransRate user community for testing, bug reports, and feedback. In particular, we thank Matt MacManes for meticulous testing. R.S.U. was funded by The Millennium Seed Bank (Royal Botanical Gardens, Kew). S.K. is a Royal Society University Research Fellow. C.B. was supported by a grant to J.M.H. from the Biotechnology and Biological Sciences Research Council (BBSRC), the Department for International Development, and (through a grant to BBSRC) the Bill & Melinda Gates Foundation, under the Sustainable Crop Production Research for International Development programme, a joint initiative with the Department of Biotechnology of the Government of India's Ministry of Science and Technology. This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 637765.	Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clark SC, 2013, BIOINFORMATICS, V29, P435, DOI 10.1093/bioinformatics/bts723; Curtis K., 2011, FASTER MORE ACCURATE; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liu JS, 1999, BIOINFORMATICS, V15, P38, DOI 10.1093/bioinformatics/15.1.38; Lowe E. K., 2014, PEERJ PREPRINTS, DOI [10.7287/peerj.preprints.505v1, DOI 10.7287/PEERJ.PREPRINTS.505V1]; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Peng Y, 2013, BIOINFORMATICS, V29, P326, DOI 10.1093/bioinformatics/btt219; R Core Team, 2014, R LANGUAGE ENV STAT; Rahman A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r8; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077	22	324	328	9	42	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2016	26	8					1134	1144		10.1101/gr.196469.115			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	DT8IH	WOS:000381733000012	27252236	Green Submitted, Green Published, hybrid	Y	N	2022-01-24	
J	Ong, CK; Subimerb, C; Pairojkul, C; Wongkham, S; Cutcutache, I; Yu, W; McPherson, JR; Allen, GE; Ng, CCY; Wong, BH; Myint, SS; Rajasegaran, V; Heng, HL; Gan, A; Zang, ZJ; Wu, YT; Wu, J; Lee, MH; Huang, DC; Ong, P; Chan-on, W; Cao, Y; Qian, CN; Lim, KH; Ooi, A; Dykema, K; Furge, K; Kukongviriyapan, V; Sripa, B; Wongkham, C; Yongvanit, P; Futreal, PA; Bhudhisawasdi, V; Rozen, S; Tan, P; Teh, BT				Ong, Choon Kiat; Subimerb, Chutima; Pairojkul, Chawalit; Wongkham, Sopit; Cutcutache, Ioana; Yu, Willie; McPherson, John R.; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Zang, Zhi Jiang; Wu, Yingting; Wu, Jeanie; Lee, Ming Hui; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Cao, Yun; Qian, Chao-Nan; Lim, Kiat Hon; Ooi, Aikseng; Dykema, Karl; Furge, Kyle; Kukongviriyapan, Veerapol; Sripa, Banchob; Wongkham, Chaisiri; Yongvanit, Puangrat; Futreal, P. Andrew; Bhudhisawasdi, Vajarabhongsa; Rozen, Steve; Tan, Patrick; Teh, Bin Tean			Exome sequencing of liver fluke-associated cholangiocarcinoma	NATURE GENETICS			English	Article							BILIARY-TRACT; GENOMIC ANALYSES; COPY NUMBERS; CANCER; MUTATIONS; CARCINOMA; INSTABILITY; INDUCTION; GROWTH; CELLS	Opisthorchis viverrini-related cholangiocarcinoma (CCA), a fatal bile duct cancer, is a major public health concern in areas endemic for this parasite. We report here whole-exome sequencing of eight O. viverrini-related tumors and matched normal tissue. We identified and validated 206 somatic mutations in 187 genes using Sanger sequencing and selected 15 genes for mutation prevalence screening in an additional 46 individuals with CCA (cases). In addition to the known cancer-related genes TP53 (mutated in 44.4% of cases), KRAS (16.7%) and SMAD4 (16.7%), we identified somatic mutations in 10 newly implicated genes in 14.8-3.7% of cases. These included inactivating mutations in MLL3 (in 14.8% of cases), ROBO2 (9.3%), RNF43 (9.3%) and PEG3 (5.6%), and activating mutations in the GNAS oncogene (9.3%). These genes have functions that can be broadly grouped into three biological classes: (i) deactivation of histone modifiers, (ii) activation of G protein signaling and (iii) loss of genome stability. This study provides insight into the mutational landscape contributing to O. viverrini-related CCA.	[Subimerb, Chutima; Pairojkul, Chawalit; Wongkham, Sopit; Chan-on, Waraporn; Kukongviriyapan, Veerapol; Sripa, Banchob; Wongkham, Chaisiri; Yongvanit, Puangrat; Bhudhisawasdi, Vajarabhongsa] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Ong, Choon Kiat; Subimerb, Chutima; Yu, Willie; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Teh, Bin Tean] Natl Canc Ctr, Div Med Sci, Nat Canc Ctr Singapore Van Andel Res Inst Transla, Singapore, Singapore; [Ong, Choon Kiat; Subimerb, Chutima; Yu, Willie; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Zang, Zhi Jiang; Wu, Jeanie; Lee, Ming Hui; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore NUS Grad Med Sch, Div Canc & Stem Cell Biol, Singapore, Singapore; [Cutcutache, Ioana; McPherson, John R.; Wu, Yingting; Rozen, Steve] Duke NUS Grad Med Sch, Div Neurosci & Behav Disorders, Singapore, Singapore; [Yu, Willie] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Zang, Zhi Jiang] Natl Canc Ctr, Div Cellular & Mol Res, Singapore, Singapore; [Wu, Yingting] Singapore MIT Alliance, Singapore, Singapore; [Cao, Yun; Qian, Chao-Nan] Sun Yat Sen Univ Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Ooi, Aikseng; Dykema, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Tan, Patrick] NUS, Canc Sci Inst Singapore, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore		Bhudhisawasdi, V (corresponding author), Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand.	joevajare@gmail.com; steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Ooi, Aikseng/B-8776-2012; Xiao, Yang/B-5668-2012; Wongkham, Sopit/ABB-6966-2021; Rozen, Steven G./J-5939-2013	Ooi, Aikseng/0000-0003-3853-7156; Wong, Bernice/0000-0001-8981-1376; Ong, Choon Kiat/0000-0001-6402-4288; Sripa, Banchob/0000-0001-8899-5919; Teh, Bin Tean/0000-0003-1514-1124; Rozen, Steven G./0000-0002-4288-0056; HUANG, DACHUAN/0000-0002-7518-4081	Singapore National Medical Research CouncilNational Medical Research Council, Singapore [NMRC/STAR/0006/2009]; Singapore Millennium FoundationSingapore Millennium Foundation; Lee Foundation; Singapore National Cancer Centre; Duke-NUS Graduate Medical SchoolNational University of Singapore; Cancer Science Institute, Singapore; Research Team Strengthening Grant; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; NUS Graduate School for Integrative Sciences and Engineering, SingaporeNational University of Singapore	We thank L. Farber for editing the manuscript. This work is supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), The Singapore Millennium Foundation, The Lee Foundation, the Singapore National Cancer Centre Research Fund, the Duke-NUS Graduate Medical School, the Cancer Science Institute, Singapore, the Research Team Strengthening Grant, the National Genetic Engineering and Biotechnology Center and the National Science and Technology Development Agency, Thailand. W.Y. is the recipient of the NUS Graduate School for Integrative Sciences and Engineering Scholarship, Singapore.	Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Cardinale Vincenzo, 2010, Italian Journal of Anatomy and Embryology, V115, P85; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Gilbert SF, 2000, DEV BIOL, P494; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Homayounfar K, 2009, HUM PATHOL, V40, P834, DOI 10.1016/j.humpath.2008.11.005; Idziaszczyk S, 2010, CANCER GENET CYTOGEN, V202, P67, DOI 10.1016/j.cancergencyto.2010.04.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nakanuma Y, 2010, PATHOL INT, V60, P419, DOI 10.1111/j.1440-1827.2010.02543.x; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Rashid A, 2002, CLIN CANCER RES, V8, P3156; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; VATANASAPT V, 1995, CANCER EPIDEM BIOMAR, V4, P475; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong N, 2002, J HEPATOL, V37, P633, DOI 10.1016/S0168-8278(02)00269-6; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282	31	324	333	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					690	U113		10.1038/ng.2273			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	WOS:000304551100017	22561520				2022-01-24	
J	Tsurusaki, Y; Okamoto, N; Ohashi, H; Kosho, T; Imai, Y; Hibi-Ko, Y; Kaname, T; Naritomi, K; Kawame, H; Wakui, K; Fukushima, Y; Homma, T; Kato, M; Hiraki, Y; Yamagata, T; Yano, S; Mizuno, S; Sakazume, S; Ishii, T; Nagai, T; Shiina, M; Ogata, K; Ohta, T; Niikawa, N; Miyatake, S; Okada, I; Mizuguchi, T; Doi, H; Saitsu, H; Miyake, N; Matsumoto, N				Tsurusaki, Yoshinori; Okamoto, Nobuhiko; Ohashi, Hirofumi; Kosho, Tomoki; Imai, Yoko; Hibi-Ko, Yumiko; Kaname, Tadashi; Naritomi, Kenji; Kawame, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Homma, Tomomi; Kato, Mitsuhiro; Hiraki, Yoko; Yamagata, Takanori; Yano, Shoji; Mizuno, Seiji; Sakazume, Satoru; Ishii, Takuma; Nagai, Toshiro; Shiina, Masaaki; Ogata, Kazuhiro; Ohta, Tohru; Niikawa, Norio; Miyatake, Satoko; Okada, Ippei; Mizuguchi, Takeshi; Doi, Hiroshi; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi			Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome	NATURE GENETICS			English	Article							GENE; SCHWANNOMATOSIS; SMARCB1; CANCER	By exome sequencing, we found de novo SMARCB1 mutations in two of five individuals with typical Coffin-Siris syndrome (CSS), a rare autosomal dominant anomaly syndrome. As SMARCB1 encodes a subunit of the SWItch/Sucrose NonFermenting (SWI/SNF) complex, we screened 15 other genes encoding subunits of this complex in 23 individuals with CSS. Twenty affected individuals (87%) each had a germline mutation in one of six SWI/SNF subunit genes, including SMARCB1, SMARCA4, SMARCA2, SMARCE1, ARID1A and ARID1B.	[Tsurusaki, Yoshinori; Miyatake, Satoko; Okada, Ippei; Mizuguchi, Takeshi; Doi, Hiroshi; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Div Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Iwatsuki, Saitama, Japan; [Kosho, Tomoki; Wakui, Keiko; Fukushima, Yoshimitsu] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano, Japan; [Imai, Yoko; Hibi-Ko, Yumiko] Japanese Red Cross Med Ctr, Div Pediat, Tokyo, Japan; [Kaname, Tadashi; Naritomi, Kenji] Univ Ryukyus, Fac Med, Dept Med Genet, Okinawa, Japan; [Kawame, Hiroshi] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Genet Counseling, Tokyo 112, Japan; [Kawame, Hiroshi] Nagano Childrens Hosp, Div Med Genet, Azumino, Japan; [Homma, Tomomi] Nihonkai Gen Hosp, Yamagata Prefectural & Sakata Municipal Hosp Org, Div Pediat, Sakata, Yamagata, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Hiraki, Yoko] Hiroshima Municipal Ctr Child Hlth & Dev, Hiroshima, Japan; [Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Yano, Shoji] Univ So Calif, Dept Pediat, Div Genet, Los Angeles Cty & Univ So Calif Med Ctr,Keck Sch, Los Angeles, CA 90089 USA; [Mizuno, Seiji] Cent Hosp Kasugai, Aichi Human Serv Ctr, Dept Pediat, Kasugai, Aichi, Japan; [Sakazume, Satoru; Ishii, Takuma; Nagai, Toshiro] Dokkyo Univ, Koshigaya Hosp, Dept Pediat, Sch Med, Koshigaya, Japan; [Ishii, Takuma] Hosp Disabled, Saitama, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 232, Japan; [Ohta, Tohru; Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Ishikari, Hokkaido 06102, Japan		Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan.	nmiyake@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021; Yano, Shoji/AAG-2771-2021	Yano, Shoji/0000-0001-5565-9572; Saitsu, Hirotomo/0000-0003-0723-0960; Tsurusaki, Yoshinori/0000-0002-7240-6355; Kato, Mitsuhiro/0000-0003-1485-8553	Ministry of Health, Labour and WelfareMinistry of Health, Labour and Welfare, Japan; Japan Science and Technology AgencyJapan Science & Technology Agency (JST); Strategic Research Program for Brain SciencesMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Epilepsy Research Foundation; Takeda Science FoundationTakeda Science Foundation (TSF); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Yokohama City University; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21390104, 22790823] Funding Source: KAKEN	We thank all the family members for participating in this study. This work was supported by research grants from the Ministry of Health, Labour and Welfare (to N. Miyake, H.S. and N. Matsumoto), the Japan Science and Technology Agency (to N. Matsumoto), the Strategic Research Program for Brain Sciences (to N. Matsumoto), the Japan Epilepsy Research Foundation (to H.S.) and the Takeda Science Foundation (to N. Matsumoto and N. Miyake). This study was also funded by a Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. Matsumoto), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to N. Matsumoto), a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (to N. Miyake and H.S.) and a Grant for 2011 Strategic Research Promotion of Yokohama City University (to N. Matsumoto). This study was performed at the Advanced Medical Research Center at Yokohama City University. Informed consent was obtained from all the families of affected individuals. The Institutional Review Board of Yokohama City University approved this study.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; COFFIN GS, 1970, AM J DIS CHILD, V119, P433, DOI 10.1001/archpedi.1970.02100050435009; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	14	324	340	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					376	378		10.1038/ng.2219			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	WOS:000302130600009	22426308				2022-01-24	
J	Langmead, B; Schatz, MC; Lin, J; Pop, M; Salzberg, SL				Langmead, Ben; Schatz, Michael C.; Lin, Jimmy; Pop, Mihai; Salzberg, Steven L.			Searching for SNPs with cloud computing	GENOME BIOLOGY			English	Article							HUMAN GENOME; SHORT-READ; RNA-SEQ; SEQUENCE; ALIGNMENT	As DNA sequencing outpaces improvements in computer speed, there is a critical need to accelerate tasks like alignment and SNP calling. Crossbow is a cloud-computing software tool that combines the aligner Bowtie and the SNP caller SOAPsnp. Executing in parallel using Hadoop, Crossbow analyzes data comprising 38-fold coverage of the human genome in three hours using a 320-CPU cluster rented from a cloud computing service for about $85. Crossbow is available from http://bowtie-bio.sourceforge.net/crossbow/.	[Langmead, Ben] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Langmead, Ben; Schatz, Michael C.; Pop, Mihai; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Lin, Jimmy] Univ Maryland, Coll Informat Studies, The iSchool, College Pk, MD 20742 USA		Langmead, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	blangmea@jhsph.edu	Salzberg, Steven L/F-6162-2011; Schatz, Michael/L-2690-2019; Pop, Mihai/A-7987-2013; Langmead, Ben/F-4218-2012; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Schatz, Michael/0000-0002-4118-4446; Pop, Mihai/0000-0001-9617-5304; Langmead, Ben/0000-0003-2437-1976; Salzberg, Steven/0000-0002-8859-7432	NSFNational Science Foundation (NSF) [IIS-0844494]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-LM006845, R01-HG004885]; Amazon Web Services Hadoop Testing Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG004885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM006845] Funding Source: NIH RePORTER	This work was funded in part by NSF grant IIS-0844494 (MP) and by NIH grants R01-LM006845 (SLS) and R01-HG004885 (MP). We thank the Amazon Web Services Hadoop Testing Program for providing credits, and Deepak Singh for his assistance. We also thank Miron Livny and his team for providing access to their compute cluster.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BRAVO HC, BIOMETRICS IN PRESS; BURROWS M, 1994, 124 DIG SYST RES CTR; *CROSSB, WHOL GEN RES US CLOU; Dean J, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE SIXTH SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION (OSDE '04), P137; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; *ILL PRES DEV ROAD, INN SUBST INCR OUTP; JACKSON BG, 2009, P 1 INT C BIOINF COM, P30; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; *YANHUANG PROJ, YHI GEN DAT	26	324	336	0	187	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2009	10	11							R134	10.1186/gb-2009-10-11-r134			10	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	540OT	WOS:000273344600021	19930550	Green Accepted, Green Published, hybrid			2022-01-24	
J	Cree, LM; Samuels, DC; Lopes, SCDS; Rajasimha, HK; Wonnapinij, P; Mann, JR; Dahl, HHM; Chinnery, PF				Cree, Lynsey M.; Samuels, David C.; Lopes, Susana Chuva de Sousa; Rajasimha, Harsha Karur; Wonnapinij, Passorn; Mann, Jeffrey R.; Dahl, Hans-Henrik M.; Chinnery, Patrick F.			A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; PRIMORDIAL GERM-CELLS; RANDOM GENETIC DRIFT; MOUSE EMBRYOS; D-LOOP; MTDNA; OOCYTES; MICE; PROLIFERATION; HETEROPLASMY	Mammalian mitochondrial DNA (mtDNA) is inherited principally down the maternal line, but the mechanisms involved are not fully understood. Females harboring a mixture of mutant and wild-type mtDNA (heteroplasmy) transmit a varying proportion of mutant mtDNA to their offspring. In humans with mtDNA disorders, the proportion of mutated mtDNA inherited from the mother correlates with disease severity(1-4). Rapid changes in allele frequency can occur in a single generation(5,6). This could be due to a marked reduction in the number of mtDNA molecules being transmitted from mother to offspring (the mitochondrial genetic bottleneck), to the partitioning of mtDNA into homoplasmic segregating units, or to the selection of a group of mtDNA molecules to re-populate the next generation. Here we show that the partitioning of mtDNA molecules into different cells before and after implantation, followed by the segregation of replicating mtDNA between proliferating primordial germ cells, is responsible for the different levels of heteroplasmy seen in the offspring of heteroplasmic female mice.	[Cree, Lynsey M.; Chinnery, Patrick F.] Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Samuels, David C.; Rajasimha, Harsha Karur; Wonnapinij, Passorn] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Lopes, Susana Chuva de Sousa] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Mann, Jeffrey R.] City Hope Natl Med Ctr, Div Biol, Duarte, CA 91010 USA; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Chinnery, Patrick F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England		Chinnery, PF (corresponding author), Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008	Samuels, David C/0000-0003-3529-7791; Cree, Lynsey/0000-0003-2090-1589; Chinnery, Patrick/0000-0002-7065-6617	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bergstrom CT, 1998, GENETICS, V149, P2135; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hogan B., 1994, MANIPULATING MOUSE E; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; STREFFER C, 1980, CELL TISSUE KINET, V13, P135, DOI 10.1111/j.1365-2184.1980.tb00456.x; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VILKKI J, 1990, AM J HUM GENET, V47, P95; Wright S., 1969, EVOLUTION GENETICS P	30	324	330	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					249	254		10.1038/ng.2007.63			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	WOS:000252732900026	18223651				2022-01-24	
J	Chen, WM; Abecasis, GR				Chen, Wei-Min; Abecasis, Goncalo R.			Family-based association tests for genomewide association scans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENE-EXPRESSION; WIDE ASSOCIATION; PEDIGREE ANALYSIS; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAITS; MISSING GENOTYPES; NUCLEAR FAMILIES; MODELS; MAP; STRATIFICATION	With millions of single-nucleotide polymorphisms (SNPs) identified and characterized, genomewide association studies have begun to identify susceptibility genes for complex traits and diseases. These studies involve the characterization and analysis of very-high-resolution SNP genotype data for hundreds or thousands of individuals. We describe a computationally efficient approach to testing association between SNPs and quantitative phenotypes, which can be applied to whole-genome association scans. In addition to observed genotypes, our approach allows estimation of missing genotypes, resulting in substantial increases in power when genotyping resources are limited. We estimate missing genotypes probabilistically using the Lander-Green or Elston-Stewart algorithms and combine high-resolution SNP genotypes for a subset of individuals in each pedigree with sparser marker data for the remaining individuals. We show that power is increased whenever phenotype information for ungenotyped individuals is included in analyses and that high-density genotyping of just three carefully selected individuals in a nuclear family can recover >90% of the information available if every individual were genotyped, for a fraction of the cost and experimental effort. To aid in study design, we evaluate the power of strategies that genotype different subsets of individuals in each pedigree and make recommendations about which individuals should be genotyped at a high density. To illustrate our method, we performed genomewide association analysis for 27 gene-expression phenotypes in 3-generation families (Centre d'Etude du Polymorphisme Humain pedigrees), in which genotypes for similar to 860,000 SNPs in 90 grandparents and parents are complemented by genotypes for similar to 6,700 SNPs in a total of 168 individuals. In addition to increasing the evidence of association at 15 previously identified cis-acting associated alleles, our genotype-inference algorithm allowed us to identify associated alleles at 4 cis-acting loci that were missed when analysis was restricted to individuals with the high-density SNP data. Our genotype-inference algorithm and the proposed association tests are implemented in software that is available for free.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA		Chen, WM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Heights, Ann Arbor, MI 48109 USA.	wmchen@virginia.edu	Abecasis, Goncalo R/B-7840-2010; Chen, Wei-Min/A-8469-2009	Abecasis, Goncalo/0000-0003-1509-1825			Abecasis GR, 2005, HUM HERED, V59, P118, DOI 10.1159/000085226; Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AMOS CI, 1994, AM J HUM GENET, V54, P535; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DIXON AL, IN PRESS NAT GENET; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LANGE K, 1987, AM J HUM GENET, V40, P250; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sobel E, 1996, AM J HUM GENET, V58, P1323; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Visscher PM, 2006, GENET EPIDEMIOL, V30, P30, DOI 10.1002/gepi.20124; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	44	324	326	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					913	926		10.1086/521580			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	WOS:000250480900005	17924335	Green Published, Bronze			2022-01-24	
J	Caussinus, E; Gonzalez, C				Caussinus, E; Gonzalez, C			Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster	NATURE GENETICS			English	Article							GENETIC INSTABILITY; FATE DETERMINANTS; SELF-RENEWAL; POLARITY; PROLIFERATION; NEUROBLAST; CANCER; DLG; LGL; NEUROGENESIS	Loss of cell polarity and cancer are tightly correlated(1), but proof for a causative relationship has remained elusive. In stem cells, loss of polarity and impairment of asymmetric cell division could alter cell fates and thereby render daughter cells unable to respond to the mechanisms that control proliferation(2). To test this hypothesis, we generated Drosophila melanogaster larval neuroblasts containing mutations in various genes that control asymmetric cell division and then assayed their proliferative potential after transplantation into adult hosts. We found that larval brain tissue carrying neuroblasts with mutations in raps (also called pins), mira, numb or pros grew to more than 100 times their initial size, invading other tissues and killing the hosts in 2 weeks. These tumors became immortal and could be retransplanted into new hosts for years. Six weeks after the first implantation, genome instability and centrosome alterations, two traits of malignant carcinomas(3,4), appeared in these tumors. Increasing evidence suggests that some tumors may be of stem cell origin(5,6). Our results show that loss of function of any of several genes that control the fate of a stem cell's daughters may result in hyperproliferation, triggering a chain of events that subverts cell homeostasis in a general sense and leads to cancer.	ICREA & IRBB, Cell Div Grp, Barcelona, Spain; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany		Gonzalez, C (corresponding author), ICREA & IRBB, Cell Div Grp, Parc Cient Barcelona,C Josep Samitier 1-5, Barcelona, Spain.	cgonzalez@pcb.ub.es	Gonzalez, Cayetano/K-3055-2019; Gonzalez, Cayetano/K-3933-2019	Gonzalez, Cayetano/0000-0002-5259-3608; 	ICREAICREA Funding Source: Custom		Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gatewood WB, 1997, AFR AM REV, V31, P365, DOI 10.2307/3042495; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GEHRING W, 1966, J EMBRYOL EXP MORPH, V15, P77; HADORN E, 1966, DEV BIOL, V13, P424, DOI 10.1016/0012-1606(66)90058-3; HADORN E, 1978, GENETICS BIOL DROS C, V2, P557; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Shih IM, 2001, CANCER RES, V61, P818; SUNKEL CE, 1995, EMBO J, V14, P28, DOI 10.1002/j.1460-2075.1995.tb06972.x; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; WATSON KL, 1994, J CELL SCI, P19; Wodarz A, 2000, CURR BIOL, V10, pR624, DOI 10.1016/S0960-9822(00)00658-8	30	324	337	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1125	1129		10.1038/ng1632			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	WOS:000232185600026	16142234				2022-01-24	
J	Campbell, CD; Ogburn, EL; Lunetta, KL; Lyon, HN; Freedman, ML; Groop, LC; Altshuler, D; Ardlie, KG; Hirschhorn, JN				Campbell, CD; Ogburn, EL; Lunetta, KL; Lyon, HN; Freedman, ML; Groop, LC; Altshuler, D; Ardlie, KG; Hirschhorn, JN			Demonstrating stratification in a European American population	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; STRUCTURED POPULATIONS; QUANTITATIVE TRAITS; GENOMIC CONTROL; DISEQUILIBRIUM; INFERENCE; VARIANTS; MARKERS; DISEASE; CANCER	Population stratification occurs in case-control association studies when allele frequencies differ between cases and controls because of ancestry. Stratification may lead to false positive associations, although this issue remains controversial(1-4). Empirical studies have found little evidence of stratification in European-derived populations, but potentially significant levels of stratification could not be ruled out(5-7). We studied a European American panel discordant for height, a heritable trait that varies widely across Europe(8). Genotyping 178 SNPs and applying standard analytical methods(6,9-11) yielded no evidence of stratification. But a SNP in the gene LCT that varies widely in frequency across Europe(12) was strongly associated with height (P < 10(-6)). This apparent association was largely or completely due to stratification; rematching individuals on the basis of European ancestry greatly reduced the apparent association, and no association was observed in Polish or Scandinavian individuals. The failure of standard methods to detect this stratification indicates that new methods may be required.	Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Genom Collaborat Inc, Cambridge, MA 02139 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Lund Univ, Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden		Hirschhorn, JN (corresponding author), Childrens Hosp, Program Genom, 300 Longwood Ave, Boston, MA 02115 USA.	joelh@broad.mit.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Lunetta, Kathryn/0000-0002-9268-810X			Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Allison DB, 1997, AM J HUM GENET, V60, P676; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2002, GENET EPIDEMIOL, V22, P196, DOI 10.1002/gepi.0126; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; THOMAS DC, 2002, BIOMARKERS PREV, V11, P505; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513	29	324	331	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					868	872		10.1038/ng1607			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	WOS:000230880400017	16041375				2022-01-24	
J	Silva, JP; Kohler, M; Graff, C; Oldfors, A; Magnuson, MA; Berggren, PO; Larsson, NG				Silva, JP; Kohler, M; Graff, C; Oldfors, A; Magnuson, MA; Berggren, PO; Larsson, NG			Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes	NATURE GENETICS			English	Article							GENE MUTATION; DNA; MEDICINE; MOUSE	Mitochondrial dysfunction is an important contributor to human pathology(1-4) and it is estimated that mutations of mitochondrial DNA (mtDNA) cause approximately 0.5-1% of all types of diabetes mellitus(5,6). We have generated a mouse model for mitochondrial diabetes by tissue-specific disruption of the nuclear gene encoding mitochondrial transcription factor A (Tfam, previously mtTFA; ref, 7) in pancreatic beta -cells. This transcriptional activator is imported to mitochondria, where it is essential for mtDNA expression and maintenance(8,9). The Tfam-mutant mice developed diabetes from the age of approximately 5 weeks and displayed severe mtDNA depletion, deficient oxidative phosphorylation and abnormal appearing mitochondria in islets at the ages of 7-9 weeks, We performed physiological studies of beta -cell stimulus-secretion coupling in islets isolated from 7-9-week-old mutant mice and found reduced hyperpolarization of the mitochondrial membrane potential, impaired Ca2+-signalling and lowered insulin release in response to glucose stimulation. We observed reduced beta -cell mass in older mutants. Our findings identity two phases in the pathogenesis of mitochondrial diabetes; mutant beta -cells initially display reduced stimulus-secretion coupling, later followed by beta -cell loss, This animal model reproduces the beta -cell pathology of human mitochondrial diabetes and provides genetic evidence for a critical role of the respiratory chain in insulin secretion.	Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-10401 Stockholm, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA		Larsson, NG (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-10401 Stockholm, Sweden.			Larsson, Nils-Goran/0000-0001-5100-996X; Kohler, Martin/0000-0001-6487-4303; Graff, Caroline/0000-0002-9949-2951; Magnuson, Mark/0000-0002-8824-6499; Berggren, Per-Olof/0000-0001-8991-413X			BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Graff C, 1999, J INTERN MED, V246, P11, DOI 10.1046/j.1365-2796.1999.00514.x; GUENETTE DR, 1995, CD-ROM PROF, V8, P10; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KANATSUNA T, 1981, DIABETES, V30, P231, DOI 10.2337/diabetes.30.3.231; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Otabe S, 1999, BIOCHEM BIOPH RES CO, V259, P149, DOI 10.1006/bbrc.1999.0650; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089	21	324	329	1	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					336	340		10.1038/81649			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500024	11062475				2022-01-24	
J	Grady, WM; Willis, J; Guilford, PJ; Dunbier, AK; Toro, TT; Lynch, H; Wiesner, G; Ferguson, K; Eng, C; Park, JG; Kim, SJ; Markowitz, S				Grady, WM; Willis, J; Guilford, PJ; Dunbier, AK; Toro, TT; Lynch, H; Wiesner, G; Ferguson, K; Eng, C; Park, JG; Kim, SJ; Markowitz, S			Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer	NATURE GENETICS			English	Article							CADHERIN GERMLINE MUTATIONS; CPG ISLAND METHYLATION; DNA METHYLATION; COLORECTAL-CANCER; HYPERMETHYLATION; TUMORS; CELLS		Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand; Creighton Univ, Sch Med, Dept Prevent Med, Omaha, NE 68178 USA; Ohio State Univ, Sch Med, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Sch Med, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Sch Med, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; Howard Hughes Med Inst, Cleveland, OH USA		Markowitz, S (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.		Park, Jae-Gahb/J-5494-2012	Guilford, Parry/0000-0002-7256-9576; Dunbier, Anita/0000-0003-4621-7419; Eng, Charis/0000-0002-3693-5145	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA067409, R01CA072160, K08CA077676] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [KO8 CA77676, R01 CA67409, R01 CA72160] Funding Source: Medline		Ahuja N, 1998, CANCER RES, V58, P5489; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; GRAFF JR, 1995, CANCER RES, V55, P5195; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Guilford PJ, 1999, HUM MUTAT, V14, P249, DOI 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Myohanen SK, 1998, CANCER RES, V58, P591; Prowse AH, 1997, AM J HUM GENET, V60, P765; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Stirzaker C, 1997, CANCER RES, V57, P2229; Toyota M, 1999, CANCER RES, V59, P5438	15	324	342	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					16	17		10.1038/79120			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000009	10973239				2022-01-24	
J	Paloneva, J; Kestila, M; Wu, J; Salminen, A; Bohling, T; Ruotsalainen, V; Hakola, P; Bakker, ABH; Phillips, JH; Pekkarinen, P; Lanier, LL; Timonen, T; Peltonen, L				Paloneva, J; Kestila, M; Wu, J; Salminen, A; Bohling, T; Ruotsalainen, V; Hakola, P; Bakker, ABH; Phillips, JH; Pekkarinen, P; Lanier, LL; Timonen, T; Peltonen, L			Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts	NATURE GENETICS			English	Article							POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; NATURAL-KILLER-CELLS; SCLEROSING LEUKOENCEPHALOPATHY; MEMBRANOUS LIPODYSTROPHY; CUTTING EDGE; PLO-SL; PROTEIN; GENE; RECEPTORS; ACTIVATION	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL; MIM 221770), also known as Nasu-Hakola disease, is a recessively inherited disease characterized by a combination of psychotic symptoms rapidly progressing to presenile dementia and bone cysts restricted to wrists and ankles(1-3). PLOSL has a global distribution, although most of the patients have been diagnosed in Finland(4) and Japan. with an estimated population prevalence of 2x10(-6) (ref. 2) in the Finns. We have previously identified a shared 153-kb ancestor haplotype in all Finnish disease alleles between markers D1951175 and D195608 on chromosome 19q13.1 (refs 5,6). Here we characterize the molecular defect in PLOSL by identifying one large deletion in all Finnish PLOSL alleles and another mutation in a Japanese patient, both representing loss-of-function mutations, in the gene encoding TYRO protein tyrosine kinase binding protein(7) (TYROBP; formerly DAP12). TYROBP is a transmembrane protein that has been recognized as a key activating signal transduction element in natural killer (NK) cells(8). On the plasma membrane of NK cells, TYROBP associates with activating receptors recognizing major histocompatibility complex (MHC) class I molecules(7,9). No abnormalities in NK cell function were detected in PLOSL patients homozygous for a null allele of TYROBP.	Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, Los Angeles, CA USA; Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Ctr, San Francisco, CA 94143 USA; Dept Biochem, Oulu, Finland; Bioctr Oulu, Oulu, Finland; Univ Kuopio, Dept Forens Psychiat, FIN-70211 Kuopio, Finland; DNAX Res Inst Molec & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA USA		Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, Helsinki, Finland.	lpeltonen@mednet.ucla.edu	Lanier, Lewis L/E-2139-2014; Paloneva, Juha/K-2419-2019; Bakker, Arnold B./F-8494-2010; Ijas, Petra/F-8280-2015	Lanier, Lewis L/0000-0003-1308-3952; Bakker, Arnold B./0000-0003-1489-1847; Ijas, Petra/0000-0002-7292-1971; Paloneva, Juha/0000-0003-3340-9390			ABRAMSKY O, 1989, DISSECTION TISSUE CU, P1; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Campbell KS, 1999, INT J BIOCHEM CELL B, V31, P631, DOI 10.1016/S1357-2725(99)00022-9; Chang CW, 1999, J IMMUNOL, V163, P4651; Colonna M, 1998, NATURE, V391, P642, DOI 10.1038/35515; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; EDVARDSEN P, 1983, INT ORTHOP, V7, P99; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; HAKOLA HPA, 1990, MONOGRAPHS PSYCHIAT, V17, P1; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; Heymann D, 1998, CYTOKINE, V10, P155, DOI 10.1006/cyto.1997.0277; KALIMO H, 1994, ACTA NEUROL SCAND, V89, P353; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lenkkeri U, 1998, HUM GENET, V102, P192, DOI 10.1007/s004390050676; MAKELA P, 1982, SKELETAL RADIOL, V8, P51; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Nylander PO, 1996, CLIN GENET, V50, P353; Pekkarinen P, 1998, AM J HUM GENET, V62, P362, DOI 10.1086/301722; Pekkarinen P, 1998, GENOMICS, V54, P307, DOI 10.1006/geno.1998.5591; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Rolstad B, 1998, SCAND J IMMUNOL, V47, P412; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Smith KM, 1998, J IMMUNOL, V161, P7; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	30	324	332	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2000	25	3					357	361		10.1038/77153			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900030	10888890				2022-01-24	
J	Tavernarakis, N; Wang, SL; Dorovkov, M; Ryazanov, A; Driscoll, M				Tavernarakis, N; Wang, SL; Dorovkov, M; Ryazanov, A; Driscoll, M			Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; SEQUENCE; IDENTIFICATION; DEGRADATION; MORPHOLOGY; PLANTS	Double-stranded RNA interference (RNAi) is an effective method for disrupting expression of specific genes in Caenorhabditis elegans and other organisms(1-5). Applications of this reverse-genetics tool, however, am somewhat restricted in nematodes because introduced dsRNA is not stably inherited(5). Another difficulty is that RNAi disruption of late-acting genes has been generally less consistent than that of embryonically expressed genes, perhaps because the concentration of dsRNA becomes lower as cellular division proceeds or as developmental time advances(1). In particular, some neuronally expressed genes appear refractory to dsRNA-mediated interference. We sought to extend the applicability of RNAi by in vivo expression of heritable inverted-repeat (IR) genes. We assayed the efficacy of in vivo-driven RNAi in three situations for which heritable, inducible RNAi would be advantageous: (i) production of large numbers of animals deficient for gene activities required for viability or reproduction; (ii) generation of large populations of phenocopy mutants for biochemical analysis; and (iii) effective gene inactivation in the nervous system. We report that heritable IR genes confer potent and specific gene inactivation for each of these applications. We suggest that a similar strategy might be used to test for dsRNA interference effects in higher organisms in which it is feasible to construct transgenic animals, but impossible to directly or transiently introduce high concentrations of dsRNA.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA		Driscoll, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.		Tavernarakis, Nektarios/B-9684-2013; ryazanov, alexey/J-8081-2017	Tavernarakis, Nektarios/0000-0002-5253-1466; 	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM57300] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37955, NS344435] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM057300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037955] Funding Source: NIH RePORTER		Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BRENNER S, 1974, GENETICS, V77, P71; DIBB NJ, 1989, J MOL BIOL, V205, P603, DOI 10.1016/0022-2836(89)90229-5; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; JONES D, 1986, J BIOL CHEM, V261, P2006; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; MADURO M, 1995, GENETICS, V141, P977; MELLO CC, 1994, METHODS CELL BIOL CA, P451; MITANI S, 1993, DEVELOPMENT, V119, P773; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; PARK EC, 1986, GENETICS, V113, P821; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	25	324	377	1	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					180	183		10.1038/72850			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	WOS:000085104600021	10655066				2022-01-24	
J	McPherron, AC; Lawler, AM; Lee, SJ				McPherron, AC; Lawler, AM; Lee, SJ			Regulation of anterior posterior patterning of the axial skeleton by growth differentiation factor 11	NATURE GENETICS			English	Article							BETA SUPERFAMILY; NEURAL TISSUE; MOUSE EMBRYO; HOX GENES; CELLS; EMBRYOGENESIS; EXPRESSION; MEMBER	The bones that comprise the axial skeleton have distinct morphological features characteristic of their positions along the anterior/posterior axis. We previously described a novel TGF-beta family member, myostatin (encoded by the gene Mstn, formerly Gdf8), that has an essential role in regulating skeletal muscle mass(1). We also identified a gene related to Mstn by low-stringency screening(1). While the work described here was being completed, the cloning of this gene, designated Gdf11 (also called Bmp11), was also reported by other groups(2,3). Here we show that Gdf11, a new transforming growth factor beta (TGF beta) superfamily member, has an important role in establishing this skeletal pattern. During early mouse embryogenesis, Gdf11 is expressed in the primitive streak and tail bud regions, which are sites where new mesodermal cells are generated. Homozygous mutant mice carrying a targeted deletion of Cdf11 exhibit anteriorly directed homeotic transformations throughout the axial skeleton and posterior displacement of the hindlimbs. The effect of the mutation is dose dependent, as Cdf11(+/-) mice have a milder phenotype than Gdf11(-/-) mice. Mutant embryos show alterations in patterns of Hox gene expression, suggesting that Gdf11 acts upstream of the Hox genes. Our findings suggest that Gdf11 is a secreted signal that acts globally to specify positional identity along the anterior/posterior axis.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA		Lee, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.						Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Durston AJ, 1997, CELL MOL LIFE SCI, V53, P339, DOI 10.1007/PL00000610; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; LEE SJ, 1990, MOL ENDOCRINOL, V4, P1034, DOI 10.1210/mend-4-7-1034; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; PETERSON RL, 1992, MECH DEVELOP, V37, P151, DOI 10.1016/0925-4773(92)90077-W; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; TAM PPL, 1992, DEVELOPMENT, V115, P703; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; [No title captured]	16	324	343	1	39	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1999	22	3					260	264		10.1038/10320			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	210VT	WOS:000081125900018	10391213				2022-01-24	
J	Jones, AC; Shyamsundar, MM; Thomas, MW; Maynard, J; Idziaszczyk, S; Tomkins, S; Sampson, JR; Cheadle, JP				Jones, AC; Shyamsundar, MM; Thomas, MW; Maynard, J; Idziaszczyk, S; Tomkins, S; Sampson, JR; Cheadle, JP			Comprehensive mutation analysis of TSC1 and TSC2 - and phenotypic correlations in 150 families with tuberous sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; SPLICE-SITE MUTATION; GENE-2 PRODUCT; PROTEIN; IDENTIFICATION; DELETION; HETEROZYGOSITY; HAMARTIN; COMPLEX; DOMAIN	Tuberous sclerosis (TSC [MIM 191090 and MIM 191100]) is an autosomal dominant disorder characterized by hamartomas in many organs. Two thirds of cases are sporadic and are thought to represent new mutations. TSC is caused by mutations affecting either of the presumed tumor-suppressor genes, TSC1 and TSC2. Both appear to function as tumor suppressors, because somatic loss or intragenic mutation of the corresponding wild-type allele is seen in the associated hamartomas. Here we report the first comprehensive mutation analysis of TSC1 and TSC2 in a cohort of 150 unrelated TSC patients and their families, using heteroduplex and SSCP analysis of all coding exons and using pulsed-field gel electrophoresis and conventional Southern blot analysis and long PCR to screen for large rearrangements. Mutations were characterized in 120 (80%) of the 150 cases, affecting TSC1 in 22 cases and TSC2 in 38 cases. TSC1 mutations were significantly underrepresented in sporadic cases (P = .000185). Twenty-two patients had TSC2 missense mutations that were found predominantly in the GAP-related domain (eight cases) and in a small region encoded in exons 16 and 17, between nucleotides 1849 and 1859 (eight cases), consistent with the presence of residues performing key functions at these sites. In contrast, all TSC1 mutations were predicted to be truncating, consistent with a structural or adapter role for the encoded protein, Intellectual disability was significantly more frequent in TSC2 sporadic cases than in TSC1 sporadic cases (P = .0145). These data provide the first representative picture of the distribution and spectrum of mutations across the TSC1 and TSC2 loci in clinically ascertained TSC and support a difference in severity of TSC1- and TSC2-associated disease.	Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales		Sampson, JR (corresponding author), Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales.	wmgjrs@cardiff.ac.uk	Warfield, Simon/B-3352-2009	Warfield, Simon/0000-0002-7659-3880			Ali JBM, 1998, J MED GENET, V35, P969, DOI 10.1136/jmg.35.12.969; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Beauchamp RL, 1998, HUM MUTAT, V12, P408, DOI 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.3.CO;2-G; Beaudet AL, 1996, HUM MUTAT, V8, P197; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Cooper D. N., 1993, HUMAN GENE MUTATION; Fleury P, 1980, Brain Dev, V2, P107; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Henske EP, 1996, AM J HUM GENET, V59, P400; Jobert S, 1997, EUR J HUM GENET, V5, P280, DOI 10.1159/000484778; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P3990, DOI 10.1073/pnas.94.8.3990; KUMAR A, 1995, HUM MOL GENET, V4, P2295, DOI 10.1093/hmg/4.12.2295; Kumar A, 1997, HUM MUTAT, V9, P64; KUMAR A, 1995, HUM MOL GENET, V4, P1471, DOI 10.1093/hmg/4.8.1471; Kwiatkowska J, 1998, ANN HUM GENET, V62, P277, DOI 10.1046/j.1469-1809.1998.6240277.x; Longa L, 1997, NEPHROL DIAL TRANSPL, V12, P1900, DOI 10.1093/ndt/12.9.1900; Maheshwar MM, 1996, HUM MOL GENET, V5, P131, DOI 10.1093/hmg/5.1.131; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; NELLIST M, 1993, CELL, V75, P1305; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Plank TL, 1998, CANCER RES, V58, P4766; POVEY S, 1994, ANN HUM GENET, V58, P107, DOI 10.1111/j.1469-1809.1994.tb01881.x; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; SAMPSON JR, 1992, J MED GENET, V29, P861, DOI 10.1136/jmg.29.12.861; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Soucek T, 1998, ONCOGENE, V16, P2197, DOI 10.1038/sj.onc.1201743; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; van den Ouweland AMW, 1997, AM J HUM GENET, V61, pA349; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanBakel I, 1997, HUM MOL GENET, V6, P1409, DOI 10.1093/hmg/6.9.1409; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; VANSLEGTENHORST M, IN PRESS J MED GENET; Verhoef S, 1998, HUM MUTAT, pS85; Vrtel R, 1996, J MED GENET, V33, P47, DOI 10.1136/jmg.33.1.47; Wang Q, 1998, HUM MUTAT, V11, P331; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Wilson PJ, 1996, HUM MOL GENET, V5, P249, DOI 10.1093/hmg/5.2.249; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Young JM, 1998, ANN HUM GENET, V62, P203, DOI 10.1046/j.1469-1809.1998.6230203.x; [No title captured]	47	324	346	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1305	1315		10.1086/302381			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	WOS:000080093000008	10205261	Green Published, Bronze			2022-01-24	
J	GUILLEMOT, F; CASPARY, T; TILGHMAN, SM; COPELAND, NG; GILBERT, DJ; JENKINS, NA; ANDERSON, DJ; JOYNER, AL; ROSSANT, J; NAGY, A				GUILLEMOT, F; CASPARY, T; TILGHMAN, SM; COPELAND, NG; GILBERT, DJ; JENKINS, NA; ANDERSON, DJ; JOYNER, AL; ROSSANT, J; NAGY, A			GENOMIC IMPRINTING OF MASH2, A MOUSE GENE REQUIRED FOR TROPHOBLAST DEVELOPMENT	NATURE GENETICS			English	Article							GROWTH FACTOR-II; PATERNAL GENOMES; H19 GENE; EXPRESSION; CELLS; LINKAGE; ACHAETE; EMBRYOGENESIS; CHROMOSOME-7; DROSOPHILA	The mouse gene Mash2 encodes a transcription factor required for development of trophoblast progenitors. Mash2- homozygous mutant embryos die at 10 days post-coitum from placental failure. Here we show that Mash2 is genomically imprinted. First, Mash2+/- embryos inheriting a wild-type allele from their father die at the same stage as appears almost completely repressed by 8.5 days post-coitum. Finally, we have genetically and physically mapped Mash2 to the distal region of chromosome 7, within a The mouse gene Mash2 encodes a transcription factor required for development of cluster of imprinted genes, including insulin-2, insulin-like growth factor-2 and H19.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544; PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702; CALTECH,HOWARD HUGHES MED INST,DIV BIOL,PASADENA,CA 91106; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5S 1A8,CANADA		GUILLEMOT, F (corresponding author), UNIV LOUIS PASTEUR STRASBOURG 1,CU STRASBOURG,INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE.		Nagy, Andras/G-6465-2013; Guillemot, Francois/AAV-1482-2021; Caspary, Tamara/AAH-5625-2020	Nagy, Andras/0000-0003-4311-0413; Caspary, Tamara/0000-0002-6579-7589	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N0I-CO-46000] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM51460] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM051460] Funding Source: NIH RePORTER		AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BARTON SC, 1985, J EMBRYOL EXP MORPH, V90, P267; BEECHEY CV, 1993, MOUSE GENOME, V91, P310; BEECHEY CV, 1993, MOUSE GENOME, V92, P108; BEECHEY CV, 1993, MOUSE GENOME, V91, P857; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CATTANACH BM, 1990, DEVELOPMENT, P63; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CLARKE HJ, 1988, DEVELOPMENT, V104, P175; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Green EL, 1981, GENETICS PROBABILITY, P77; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HALL JG, 1990, AM J HUM GENET, V46, P857; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JOHNSON JE, 1990, NATURE, V346, P868; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; LEE JE, 1990, DEVELOPMENT, V110, P151; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LESCISIN KR, 1989, GENE DEV, V2, P1639; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCLAUGHLIN KJ, IN PRESS GENES DEV; MOENS CB, 1993, DEVELOPMENT, V119, P485; NAGY A, 1987, DEVELOPMENT, V101, P67; POIRIER F, 1991, DEVELOPMENT, V113, P1105; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOLTER D, 1988, ANNU REV GENET, V22, P127; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; THOMSON JA, 1988, GENE DEV, V2, P1344, DOI 10.1101/gad.2.10.1344; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	50	324	333	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					235	242		10.1038/ng0395-235			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	WOS:A1995QL23200011	7773285				2022-01-24	
J	WONG, A; BOUTIS, P; HEKIMI, S				WONG, A; BOUTIS, P; HEKIMI, S			MUTATIONS IN THE CLK-1 GENE OF CAENORHABDITIS-ELEGANS AFFECT DEVELOPMENTAL AND BEHAVIORAL TIMING	GENETICS			English	Article							EARLY XENOPUS-EMBRYOS; CELL-CYCLE; C-ELEGANS; DROSOPHILA-MELANOGASTER; POTENTIAL OSCILLATIONS; LIFE-SPAN; WILD-TYPE; NEMATODE; TRANSITION; MUTANT	We have identified three allelic, maternal-effect mutations that affect developmental and behavioral timing in Caenorhabditis elegans. They result in a mean lengthening of embryonic and postembryonic development, the cell cycle period and life span, as well as the periods of the defecation, swimming and pumping cycles. These mutants also display a number of additional phenotypes related to timing. For example, the variability in the length of embryonic development is several times larger in the mutants than in the wild type, resulting in the occasional production of mutant embryos developing more rapidly than the most rapidly developing wild-type embryos. In addition, the duration of embryonic development of the mutants, but not of the wild type, depends on the temperature at which their parents were raised. Finally, individual variations in the severity of distinct mutant phenotypes are correlated in a counterintuitive way. For example, the animals with the shortest embryonic development have the longest defecation cycle and those with the longest embryonic development have the shortest defecation cycle. Most of the features affected by these mutations are believed to be controlled by biological clocks, and we therefore call the gene defined by these mutations clk-1, for ''abnormal function of biological clocks.''	MCGILL UNIV,DEPT BIOL,MONTREAL,PQ H3A 1B1,CANADA								AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; ANDRES V, 1990, J BIOL CHEM, V265, P21441; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; AVERY L, 1993, GENETICS, V133, P897; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BRENNER S, 1974, GENETICS, V77, P71; COHEN AH, 1988, NEURAL CONTROL RHYTH; CONNOR JA, 1979, J EXP BIOL, V81, P153; CORKEY BE, 1988, J BIOL CHEM, V263, P4254; DECUYPER C, 1982, AGE, V5, P42, DOI 10.1007/BF02431722; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.ph.55.030193.003343; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; FELDMAN J F, 1973, Genetics, V75, P605; FRIEDMAN DB, 1987, GENETICS, V118, P75; FRIESEN WO, 1993, ANNU REV PHYSIOL, V55, P661, DOI 10.1146/annurev.physiol.55.1.661; Gilbert S. F., 1991, DEV BIOL; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GREENWALD IS, 1980, GENETICS, V96, P147; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hess B, 1979, Ann N Y Acad Sci, V316, P203, DOI 10.1111/j.1749-6632.1979.tb29470.x; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; JOHNSON TE, 1987, P NATL ACAD SCI USA, V84, P3777, DOI 10.1073/pnas.84.11.3777; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; LIU DWC, 1994, J NEUROSCI, V14, P1953; MEECH RW, 1979, J EXP BIOL, V81, P93; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; RALPH MR, 1988, SCIENCE, V251, P1225; RAPP PE, 1977, J THEOR BIOL, V66, P497, DOI 10.1016/0022-5193(77)90299-5; SCHIERENBERG E, 1984, DEV BIOL, V101, P240, DOI 10.1016/0012-1606(84)90136-2; SCHIERENBERG E, 1985, DEV BIOL, V107, P337, DOI 10.1016/0012-1606(85)90316-1; SCHNABEL R, 1990, DEVELOPMENT, V108, P107; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sulston J., 1988, METHODS NEMATODE CAE, P587; THOMAS JH, 1990, GENETICS, V124, P855; TORNHEIM K, 1980, J THEOR BIOL, V85, P199, DOI 10.1016/0022-5193(80)90018-1; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; ZERR DM, 1990, J NEUROSCI, V10, P2749	52	324	336	0	15	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAR	1995	139	3					1247	1259					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ968	WOS:A1995QJ96800012	7768437				2022-01-24	
J	BAKER, BS; CARPENTER, AT				BAKER, BS; CARPENTER, AT			GENETIC ANALYSIS OF SEX CHROMOSOMAL MEIOTIC MUTANTS IN DROSOPHILA-MELANOGASTER	GENETICS			English	Article																	BAKER WK, 1971, P NATL ACAD SCI USA, V68, P2472, DOI 10.1073/pnas.68.10.2472; Bridges CB, 1915, J EXP ZOOL, V19, P1, DOI 10.1002/jez.1400190102; CARPENTER ATC, IN PRESS; COOPER KW, 1964, P NATL ACAD SCI USA, V52, P1248, DOI 10.1073/pnas.52.5.1248; COOPER KW, 1950, BIOLOGY DROSOPHILA; DAVIS BK, 1971, MOL GEN GENET, V113, P251, DOI 10.1007/BF00339546; DAVIS DG, 1969, GENETICS, V61, P577; GERSHENSON S, 1940, VIDENSKAP AKAD NAUK, P3; GRELL EH, 1961, GENETICS, V46, P1177; GRELL RF, 1962, GENETICS, V42, P1737; GRELL RF, 1964, P NATL ACAD SCI USA, V52, P226, DOI 10.1073/pnas.52.2.226; GRELL RF, 1962, P NATL ACAD SCI USA, V48, P165, DOI 10.1073/pnas.48.2.165; GRELL RF, 1969, GENETIC ORGANIZATION; HALL JC, 1971, THESIS U WASHINGTON; Hinton T, 1942, GENETICS, V27, P119; JENKINS JB, 1967, GENETICS, V57, P783; KOJIMA K, 1961, AM NAT, V95, P324, DOI 10.1086/282194; Lewis E. B., 1968, DROS INFORM SERV, V43, P193; LINDSLEY DL, 1958, GENETICS, V43, P547; LINDSLEY DL, 1968, REPLICATION RECOMBIN; LINDSLEY DL, IN PRESS; LINDSLEY DL, 1968, 627 CARN INST WASH P; NOVITSKI E, 1961, NATURE, V190, P989, DOI 10.1038/190989a0; PARRY DJ, IN PRESS; PEACOCK WJ, 1965, GENETICS, V51, P573; ROBBINS LG, 1971, MOL GEN GENET, V110, P144, DOI 10.1007/BF00332645; RUDKIN GT, 1963, 11 P INT C GEN HAG, V2, P359; SANDLER L, 1968, GENETICS, V60, P525; SANDLER L, 1959, GENETICS, V44, P233; SANDLER L, 1954, GENETICS, V39, P365; SANDLER L, 1972, GENETICS SPERMATOZOO; Sandler L, 1971, DROSOPHILA INORM SER, V47, P68; SEARS ER, 1952, CHROMOSOMA, V4, P535, DOI 10.1007/BF00325789; Weinstein A, 1936, GENETICS, V21, P155; ZIMMERING S, 1970, ANNU REV GENET, V4, P409, DOI 10.1146/annurev.ge.04.120170.002205	35	324	325	0	17	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1972	71	2					255	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M9471	WOS:A1972M947100006	4625747				2022-01-24	
J	Pal, C; Bengtsson-Palme, J; Kristiansson, E; Larsson, DGJ				Pal, Chandan; Bengtsson-Palme, Johan; Kristiansson, Erik; Larsson, D. G. Joakim			Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential	BMC GENOMICS			English	Article						Antibiotic resistance; Biocide resistance; Metal resistance; Bacterial genomes; Plasmids; Co-selection; Toxin-antitoxin	SILVER RESISTANCE; CROSS-RESISTANCE; BETA-LACTAMASES; PLASMIDS; SYSTEMS; MERCURY; IDENTIFICATION; MECHANISMS; EXPOSURE; BACTERIA	Background: Antibacterial biocides and metals can co-select for antibiotic resistance when bacteria harbour resistance or tolerance genes towards both types of compounds. Despite numerous case studies, systematic and quantitative data on co-occurrence of such genes on plasmids and chromosomes is lacking, as is knowledge on environments and bacterial taxa that tend to carry resistance genes to such compounds. This effectively prevents identification of risk scenarios. Therefore, we aimed to identify general patterns for which biocide/metal resistance genes (BMRGs) and antibiotic resistance genes (ARGs) that tend to occur together. We also aimed to quantify co-occurrence of resistance genes in different environments and taxa, and investigate to what extent plasmids carrying both types of genes are conjugative and/or are carrying toxin-antitoxin systems. Results: Co-occurrence patterns of resistance genes were derived from publicly available, fully sequenced bacterial genomes (n = 2522) and plasmids (n = 4582). The only BMRGs commonly co-occurring with ARGs on plasmids were mercury resistance genes and the qacE.1 gene that provides low-level resistance to quaternary ammonium compounds. Novel connections between cadmium/zinc and macrolide/aminoglycoside resistance genes were also uncovered. Several clinically important bacterial taxa were particularly prone to carry both BMRGs and ARGs. Bacteria carrying BMRGs more often carried ARGs compared to bacteria without (p < 0.0001). BMRGs were found in 86 % of bacterial genomes, and co-occurred with ARGs in 17 % of the cases. In contrast, co-occurrences of BMRGs and ARGs were rare on plasmids from all external environments (< 0.7 %) but more common on those of human and domestic animal origin (5 % and 7 %, respectively). Finally, plasmids with both BMRGs and ARGs were more likely to be conjugative (p < 0.0001) and carry toxin-antitoxin systems (p < 0.0001) than plasmids without resistance genes. Conclusions: This is the first large-scale identification of compounds, taxa and environments of particular concern for co-selection of resistance against antibiotics, biocides and metals. Genetic co-occurrences suggest that plasmids provide limited opportunities for biocides and metals to promote horizontal transfer of antibiotic resistance through co-selection, whereas ample possibilities exist for indirect selection via chromosomal BMRGs. Taken together, the derived patterns improve our understanding of co-selection potential between biocides, metals and antibiotics, and thereby provide guidance for risk-reducing actions.	[Pal, Chandan; Bengtsson-Palme, Johan; Larsson, D. G. Joakim] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, SE-41346 Gothenburg, Sweden; [Kristiansson, Erik] Chalmers Univ Technol, Dept Math Sci, SE-41296 Gothenburg, Sweden		Larsson, DGJ (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, SE-41346 Gothenburg, Sweden.	joakim.larsson@fysiologi.gu.se	Bengtsson-Palme, Johan/K-3871-2012; Larsson, D.G. Joakim/E-5243-2011; Pal, Chandan/K-9816-2015	Bengtsson-Palme, Johan/0000-0002-6528-3158; Larsson, D.G. Joakim/0000-0002-5496-0328; Pal, Chandan/0000-0002-0503-8804	Swedish Research Council for Environment, Agriculture and Spatial Planning (FORMAS)Swedish Research Council Formas [2012-86]; Swedish Research Council (VR)Swedish Research Council; Life Science Area of Advance at Chalmers University of Technology; Wallenberg FoundationEuropean Commission; Gothenburg Centre for Marine Research at the University of Gothenburg	This work was supported by the Swedish Research Council for Environment, Agriculture and Spatial Planning (FORMAS) (2012-86 to D.G.J.L); the Swedish Research Council (VR); the Life Science Area of Advance at Chalmers University of Technology; the Wallenberg Foundation; and Gothenburg Centre for Marine Research at the University of Gothenburg. We would like to thank three anonymous reviewers for their constructive input, particularly the advice on including analyses of toxin-antitoxin systems.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Amachawadi RG, 2011, APPL ENVIRON MICROB, V77, P5597, DOI 10.1128/AEM.00364-11; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Bengtsson-Palme J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-749; BENGTSSONPALME J, 2014, FRONT MICROBIOL, V5, pNIL_0001; Berg J, 2005, LETT APPL MICROBIOL, V40, P146, DOI 10.1111/j.1472-765X.2004.01650.x; Castillo M, 2008, J ANIM SCI, V86, P94, DOI 10.2527/jas.2005-686; Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014; Chapman JS, 2003, INT BIODETER BIODEGR, V51, P271, DOI 10.1016/S0964-8305(03)00044-1; Chen YT, 2007, ANTIMICROB AGENTS CH, V51, P3004, DOI 10.1128/AAC.00167-07; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egan ES, 2005, MOL MICROBIOL, V56, P1129, DOI 10.1111/j.1365-2958.2005.04622.x; Flach CF, 2015, J ANTIMICROB CHEMOTH, V70, P2709, DOI 10.1093/jac/dkv167; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gillings MR, 2008, FEMS MICROBIOL LETT, V287, P56, DOI 10.1111/j.1574-6968.2008.01291.x; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Gillings MR, 2009, ISME J, V3, P209, DOI 10.1038/ismej.2008.98; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Guglielmini J, 2014, NUCLEIC ACIDS RES, V42, P5715, DOI 10.1093/nar/gku194; Gullberg E, 2014, MBIO, V5, DOI 10.1128/mBio.01918-14; Hobman JL, 2015, J MED MICROBIOL, V64, P471, DOI 10.1099/jmm.0.023036-0; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Hornung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055045; HUGHES VM, 1983, NATURE, V302, P725, DOI 10.1038/302725a0; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kazama H, 1999, FEMS MICROBIOL LETT, V174, P379, DOI 10.1016/S0378-1097(99)00167-6; KHOLODII GY, 1993, J MOL BIOL, V230, P1103, DOI 10.1006/jmbi.1993.1228; Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Li YX, 2010, J HAZARD MATER, V177, P475, DOI 10.1016/j.jhazmat.2009.12.057; Maillard Jean-Yves, 2005, Ther Clin Risk Manag, V1, P307; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; MCDONNELL RW, 1983, ANTIMICROB AGENTS CH, V23, P151, DOI 10.1128/AAC.23.1.151; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Nachman KE, 2013, ENVIRON HEALTH PERSP, V121, P818, DOI 10.1289/ehp.1206245; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Olson AB, 2005, ANTIMICROB AGENTS CH, V49, P2112, DOI 10.1128/AAC.49.5.2112-2115.2005; Pal C, 2014, NUCLEIC ACIDS RES, V42, pD737, DOI 10.1093/nar/gkt1252; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; PUNTA M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI DOI 10.1093/nar/gkr1065; R Development Core Team, 2013, R LANG ENV STAT COMP; Randall CP, 2015, J ANTIMICROB CHEMOTH, V70, P1037, DOI 10.1093/jac/dku523; Rosser SJ, 1999, J ANTIMICROB CHEMOTH, V44, P11, DOI 10.1093/jac/44.1.11; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0; Sandegren L, 2012, J ANTIMICROB CHEMOTH, V67, P74, DOI 10.1093/jac/dkr405; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), 2009, ASS ANT RES EFF BIOC, P1; SCHOTTEL J, 1974, NATURE, V251, P335, DOI 10.1038/251335a0; Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shintani M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00242; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Skurnik D, 2010, J MED MICROBIOL, V59, P804, DOI 10.1099/jmm.0.017665-0; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stepanauskas R, 2005, ENVIRON SCI TECHNOL, V39, P3671, DOI 10.1021/es048468f; Sutterlin S, 2014, APPL ENVIRON MICROB, V80, P6863, DOI 10.1128/AEM.01803-14; Touchon M, 2014, CURR OPIN MICROBIOL, V22, P22, DOI 10.1016/j.mib.2014.09.010; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Wright GD, 2010, EXPERT OPIN DRUG DIS, V5, P779, DOI 10.1517/17460441.2010.497535; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	67	323	335	21	150	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	NOV 17	2015	16								964	10.1186/s12864-015-2153-5			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	CW8YB	WOS:000365284300008	26576951	Green Published, gold	Y	N	2022-01-24	
J	Chen, W; Gao, YQ; Xie, WB; Gong, L; Lu, K; Wang, WS; Li, Y; Liu, XQ; Zhang, HY; Dong, HX; Zhang, W; Zhang, LJ; Yu, SB; Wang, GW; Lian, XM; Luo, J				Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Liu, Xianqing; Zhang, Hongyan; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie			Genome-wide association analyses provide genetic and biochemical insights into natural variation in rice metabolism	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; COMPLEX TRAITS; CULTIVATED RICE; EXPRESSION; IDENTIFICATION; SEQUENCE; PLANTS; HEALTH; BIOSYNTHESIS; ACCUMULATION	Plant metabolites are important to world food security in terms of maintaining sustainable yield and providing food with enriched phytonutrients. Here we report comprehensive profiling of 840 metabolites and a further metabolic genome-wide association study based on similar to 6.4 million SNPs obtained from 529 diverse accessions of Oryza sativa. We identified hundreds of common variants influencing numerous secondary metabolites with large effects at high resolution. We observed substantial heterogeneity in the natural variation of metabolites and their underlying genetic architectures among different subspecies of rice. Data mining identified 36 candidate genes modulating levels of metabolites that are of potential physiological and nutritional importance. As a proof of concept, we functionally identified or annotated five candidate genes influencing metabolic traits. Our study provides insights into the genetic and biochemical bases of rice metabolome variation and can be used as a powerful complementary tool to classical phenotypic trait mapping for rice improvement.	[Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chen, Wei; Gao, Yanqiang; Xie, Weibo; Gong, Liang; Lu, Kai; Wang, Wensheng; Li, Yang; Dong, Huaxia; Zhang, Wan; Zhang, Lejing; Yu, Sibin; Wang, Gongwei; Lian, Xingming; Luo, Jie] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China; [Liu, Xianqing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Zhang, Hongyan] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China		Luo, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	xmlian@mail.hzau.edu.cn; jie.luo@mail.hzau.edu.cn	Xie, Weibo/B-3771-2008; Xie, Weibo/AAI-2412-2021	Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; Lian, Xingming/0000-0002-5307-2839; , sibin/0000-0003-0458-7526	Major State Basic Research Development Program of China (973 Program)National Basic Research Program of China [2013CB127001]; National High Technology R&D Program of China (863 Program)National High Technology Research and Development Program of China [2012AA10A303, 2012AA10A304]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31070267, 31100962]; Program for New Century Excellent Talents in University of Ministry of Education in ChinaProgram for New Century Excellent Talents in University (NCET) [NCET-09-0401]; Ministry of Science and Technology [2010CB125901, 2011CB100304]	We appreciate the critical reading and helpful comments on the manuscript made by C. Martin from John Innes Centre, UK and Q. Zhang from Huazhong Agricultural University, China. We thank W Yan for kindly providing 148 varieties from a mini-core subset of the US Department of Agriculture rice gene bank. This work was supported by the Major State Basic Research Development Program of China (973 Program) (number 2013CB127001), the National High Technology R&D Program of China (863 Program) (numbers 2012AA10A303 and 2012AA10A304), the National Natural Science Foundation of China (numbers 31070267 and 31100962) and the Program for New Century Excellent Talents in University of Ministry of Education in China (NCET-09-0401). We are also thankful for support from the Ministry of Science and Technology (numbers 2010CB125901 and 2011CB100304).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Hellmann H, 2010, MOLECULES, V15, P442, DOI 10.3390/molecules15010442; Herrero S, 2011, PLANT MOL BIOL, V76, P157, DOI 10.1007/s11103-011-9777-x; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Joseph B, 2013, ELIFE, V2, DOI 10.7554/eLife.00776; Jung KH, 2013, RICE, V6, DOI 10.1186/1939-8433-6-19; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kawaura K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-271; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Keurentjes JJB, 2009, CURR OPIN PLANT BIOL, V12, P223, DOI 10.1016/j.pbi.2008.12.003; Kliebenstein DJ, 2001, GENETICS, V159, P359; Ko JH, 2008, J PLANT PHYSIOL, V165, P435, DOI 10.1016/j.jplph.2007.01.006; Kusano M, 2012, MOL PLANT, V5, P442, DOI 10.1093/mp/ssr101; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Minorsky PV, 2002, PLANT PHYSIOL, V128, P1167, DOI 10.1104/pp.900030; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Redestig H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-176; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Shimizu T, 2012, J BIOL CHEM, V287, P19315, DOI 10.1074/jbc.M112.351270; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Traka MH, 2011, PLANT CELL, V23, P2483, DOI 10.1105/tpc.111.087916; Weng JK, 2012, SCIENCE, V337, P960, DOI 10.1126/science.1221614; Yamamoto T, 2009, DNA RES, V16, P141, DOI 10.1093/dnares/dsp006; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	53	323	362	21	372	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2014	46	7					714	721		10.1038/ng.3007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK0HP	WOS:000338093800012	24908251				2022-01-24	
J	Chmielecki, J; Crago, AM; Rosenberg, M; O'Connor, R; Walker, SR; Ambrogio, L; Auclair, D; McKenna, A; Heinrich, MC; Frank, DA; Meyerson, M				Chmielecki, Juliann; Crago, Aimee M.; Rosenberg, Mara; O'Connor, Rachael; Walker, Sarah R.; Ambrogio, Lauren; Auclair, Daniel; McKenna, Aaron; Heinrich, Michael C.; Frank, David A.; Meyerson, Matthew			Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors	NATURE GENETICS			English	Article							EXPRESSION; NAB2; COREPRESSOR; ACTIVATION; MUTATIONS	Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs.	[Chmielecki, Juliann; Walker, Sarah R.; Frank, David A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chmielecki, Juliann; Rosenberg, Mara; Ambrogio, Lauren; Auclair, Daniel; McKenna, Aaron; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA; [Crago, Aimee M.; O'Connor, Rachael] Mem Sloan Kettering Canc Ctr, Dept Surg, Sarcoma Biol Lab, New York, NY 10021 USA; [Walker, Sarah R.; Frank, David A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Walker, Sarah R.; Frank, David A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Heinrich, Michael C.] Portland Vet Affairs VA Med Ctr, Div Hematol & Med Oncol, Portland, OR USA; [Heinrich, Michael C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA		Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Heinrich, Michael/AAC-6745-2019	Crago, Aimee/0000-0002-2965-752X; Heinrich, Michael/0000-0003-3790-0478; Rosenberg, Mara/0000-0001-6400-3161; Meyerson, Matthew/0000-0002-9133-8108; O'Connor, Rachael/0000-0002-6869-7954	Carlos Slim Health Institute in Mexico; Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma [P50 CA140146]; MSKCC [P01CA47179]; American Cancer Society AstraZeneca; Kristen Ann Carr Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA047179, P50CA140146] Funding Source: NIH RePORTER	We are grateful to the individuals with SFT who contributed material for this study. We thank members of the Genomics Platform at the Broad Institute for their technical expertise and M. Abazeed and A. Dulak for critically reviewing the manuscript. This work was conducted as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA), a project funded by the Carlos Slim Health Institute in Mexico. This work was supported by a Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma (P50 CA140146) and a P01 grant (P01CA47179) to S. Singer (MSKCC). J.C. is supported by an American Cancer Society AstraZeneca Postdoctoral Fellowship. A.M.C. is supported by a grant from the Kristen Ann Carr Foundation. M.M. is supported by generous donations from M.B. Zuckerman and Team Dragonfly of the Pan-Mass Challenge. Material was collected under institutional review board (IRB)-approved protocols at the Memorial Sloan-Kettering Cancer Center and the Oregon Health & Science University Biolibrary. All patients provided informed consent.	Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bhattacharyya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007620; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; He HJ, 2006, J BIOL CHEM, V281, P31369, DOI 10.1074/jbc.M603762200; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Merk BC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-184; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Nelson EA, 2011, ONCOTARGET, V2, P518; Pal NR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-5; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Shimoyamada H, 2010, AM J PATHOL, V177, P70, DOI 10.2353/ajpath.2010.091164; Svaren J, 1996, MOL CELL BIOL, V16, P3545	15	323	343	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					131	132		10.1038/ng.2522			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	WOS:000314333000006	23313954	Green Accepted, Green Submitted			2022-01-24	
J	Bonn, S; Zinzen, RP; Girardot, C; Gustafson, EH; Perez-Gonzalez, A; Delhomme, N; Ghavi-Helm, Y; Wilczynski, B; Riddell, A; Furlong, EEM				Bonn, Stefan; Zinzen, Robert P.; Girardot, Charles; Gustafson, E. Hilary; Perez-Gonzalez, Alexis; Delhomme, Nicolas; Ghavi-Helm, Yad; Wilczynski, Bartek; Riddell, Andrew; Furlong, Eileen E. M.			Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development	NATURE GENETICS			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; HUMAN GENOME; TRANSCRIPTIONAL NETWORK; HISTONE MODIFICATIONS; MUSCLE DEVELOPMENT; CELL-TYPES; PROMOTERS; MAP; METHYLATIONS	Chromatin modifications are associated with many aspects of gene expression, yet their role in cellular transitions during development remains elusive. Here, we use a new approach to obtain cell type specific information on chromatin state and RNA polymerase II (Pol II) occupancy within the multicellular Drosophila melanogaster embryo. We directly assessed the relationship between chromatin modifications and the spatio-temporal activity of enhancers. Rather than having a unique chromatin state, active developmental enhancers show heterogeneous histone modifications and Pol II occupancy. Despite this complexity, combined chromatin signatures and Pol II presence are sufficient to predict enhancer activity de novo. Pol II recruitment is highly predictive of the timing of enhancer activity and seems dependent on the timing and location of transcription factor binding. Chromatin modifications typically demarcate large regulatory regions encompassing multiple enhancers, whereas local changes in nucleosome positioning and Pol II occupancy delineate single active enhancers. This cell type specific view identifies dynamic enhancer usage, an essential step in deciphering developmental networks.	[Bonn, Stefan; Zinzen, Robert P.; Girardot, Charles; Gustafson, E. Hilary; Perez-Gonzalez, Alexis; Delhomme, Nicolas; Ghavi-Helm, Yad; Wilczynski, Bartek; Riddell, Andrew; Furlong, Eileen E. M.] EMBL, Genome Biol Unit, Heidelberg, Germany		Furlong, EEM (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.	eileen.furlong@embl.de	Zinzen, Robert/AAG-2784-2020; Perez Gonzalez, Alexis/O-9802-2016; Zinzen, Robert P/A-3130-2015; Wilczynski, Bartek/A-5710-2009; Girardot, Charles/AAF-2417-2020; Delhomme, Nicolas/B-9187-2015	Perez Gonzalez, Alexis/0000-0002-8674-2034; Zinzen, Robert P/0000-0002-8638-5102; Wilczynski, Bartek/0000-0002-8134-0589; Girardot, Charles/0000-0003-4301-3920; Delhomme, Nicolas/0000-0002-3053-0796; Gustafson, Eleanor Hilary/0000-0003-3978-8088; Bonn, Stefan/0000-0003-4366-5662; Furlong, Eileen/0000-0002-9544-8339; Ghavi-Helm, Yad/0000-0003-2397-9576	ERASysBio (Mod Heart); Human Frontiers Science Program OrganizationHuman Frontier Science Program; International Human Frontiers Science Program OrganizationHuman Frontier Science Program; EMBL	This work was technically supported by the EMBL Genomics Core facility for Solexa sequencing and by the IT service unit. We thank S. Muller for performing Drosophila injections and all members of the Furlong laboratory for discussions and comments on the manuscript. We thank J. Lis (Cornell University) for the Rpb3 (Pol II) antibody. This work was supported by grants to E.E.M.F. from ERASysBio (Mod Heart) and the Human Frontiers Science Program Organization and by a long-term fellowship to R.P.Z. from the International Human Frontiers Science Program Organization. S.B. was funded by the EMBL Interdisciplinary Postdoc (EIPOD) programme.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Cunha PMF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001014; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wilczynski B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.35; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	48	323	330	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					148	156		10.1038/ng.1064			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	WOS:000299664400011	22231485				2022-01-24	
J	Rademakers, R; Baker, M; Nicholson, AM; Rutherford, NJ; Finch, N; Soto-Ortolaza, A; Lash, J; Wider, C; Wojtas, A; DeJesus-Hernandez, M; Adamson, J; Kouri, N; Sundal, C; Shuster, EA; Aasly, J; MacKenzie, J; Roeber, S; Kretzschmar, HA; Boeve, BF; Knopman, DS; Petersen, RC; Cairns, NJ; Ghetti, B; Spina, S; Garbern, J; Tselis, AC; Uitti, R; Das, P; Van Gerpen, JA; Meschia, JF; Levy, S; Broderick, DF; Graff-Radford, N; Ross, OA; Miller, BB; Swerdlow, RH; Dickson, DW; Wszolek, ZK				Rademakers, Rosa; Baker, Matt; Nicholson, Alexandra M.; Rutherford, Nicola J.; Finch, NiCole; Soto-Ortolaza, Alexandra; Lash, Jennifer; Wider, Christian; Wojtas, Aleksandra; DeJesus-Hernandez, Mariely; Adamson, Jennifer; Kouri, Naomi; Sundal, Christina; Shuster, Elizabeth A.; Aasly, Jan; MacKenzie, James; Roeber, Sigrun; Kretzschmar, Hans A.; Boeve, Bradley F.; Knopman, David S.; Petersen, Ronald C.; Cairns, Nigel J.; Ghetti, Bernardino; Spina, Salvatore; Garbern, James; Tselis, Alexandros C.; Uitti, Ryan; Das, Pritam; Van Gerpen, Jay A.; Meschia, James F.; Levy, Shawn; Broderick, Daniel F.; Graff-Radford, Neill; Ross, Owen A.; Miller, Bradley B.; Swerdlow, Russell H.; Dickson, Dennis W.; Wszolek, Zbigniew K.			Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids	NATURE GENETICS			English	Article							ADULT-ONSET LEUKODYSTROPHY; NASU-HAKOLA-DISEASE; NEUROAXONAL SPHEROIDS; PIGMENTED GLIA; MACROPHAGE; DEMENTIA; DAP12; EXPRESSION; MICROGLIA; SYSTEM	Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal-dominant central nervous system white-matter disease with variable clinical presentations, including personality and behavioral changes, dementia, depression, parkinsonism, seizures and other phenotypes(1,2). We combined genome-wide linkage analysis with exome sequencing and identified 14 different mutations affecting the tyrosine kinase domain of the colony stimulating factor 1 receptor (encoded by CSF1R) in 14 families with HDLS. In one kindred, we confirmed the de novo occurrence of the mutation. Followup sequencing identified an additional CSF1R mutation in an individual diagnosed with corticobasal syndrome. In vitro, CSF-1 stimulation resulted in rapid autophosphorylation of selected tyrosine residues in the kinase domain of wild-type but not mutant CSF1R, suggesting that HDLS may result from partial loss of CSF1R function. As CSF1R is a crucial mediator of microglial proliferation and differentiation in the brain, our findings suggest an important role for microglial dysfunction in HDLS pathogenesis.	[Rademakers, Rosa; Baker, Matt; Nicholson, Alexandra M.; Rutherford, Nicola J.; Finch, NiCole; Soto-Ortolaza, Alexandra; Wider, Christian; Wojtas, Aleksandra; DeJesus-Hernandez, Mariely; Adamson, Jennifer; Kouri, Naomi; Sundal, Christina; Das, Pritam; Ross, Owen A.; Dickson, Dennis W.] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Lash, Jennifer; Shuster, Elizabeth A.; Uitti, Ryan; Van Gerpen, Jay A.; Meschia, James F.; Graff-Radford, Neill; Wszolek, Zbigniew K.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Wider, Christian] Ctr Hosp Univ Vaudois CHUV UNIL, Dept Clin Neurosci, Lausanne, Switzerland; [Sundal, Christina] Gothenburg Univ, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Sahlgrenska Acad, Gothenburg, Sweden; [Aasly, Jan] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [MacKenzie, James] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland; [Roeber, Sigrun; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Boeve, Bradley F.; Knopman, David S.; Petersen, Ronald C.] Mayo Clin Minnesota, Dept Neurol, Rochester, MN USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Dept Pathol & Lab Med, Indianapolis, IN USA; [Garbern, James] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Tselis, Alexandros C.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Broderick, Daniel F.] Mayo Clin Florida, Dept Radiol, Jacksonville, FL USA; [Miller, Bradley B.] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS USA		Rademakers, R (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA.	rademakers.rosa@mayo.edu	Cairns, Nigel/AAB-9713-2020; Kouri, Naomi/G-6695-2013; Wszolek, Zbigniew K./AAB-1431-2019; Ross, Owen/D-7573-2013; Spina, Salvatore/M-4463-2019	Cairns, Nigel/0000-0001-9858-3344; Levy, Shawn/0000-0002-1369-5740; Kouri, N/0000-0002-6841-9882; Dickson, Dennis W/0000-0001-7189-7917; Ross, Owen/0000-0003-4813-756X	Mayo Benefactor and the Mayo Foundation; US National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS072187]; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS057567, IRC2NS070276]; Mayo Clinic Florida CR [MCF 90052018, MCF 90052030]; Dystonia Medical Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS065782, R01 AG026251, P50 AGO 16574, PHS P30 AG 10133, U24 AG 21886-0151]; Peebler PSP Research Foundation; American Heart AssociationAmerican Heart Association; James & Esther King Biomedical Research Program; Florida Department of Health; Myron and Jane Hanley Award in Stroke research; Leenaards Foundation; Swiss Parkinson Foundation; Mayo Clinic Florida Cerebrovascular Diseases Registry [08-003878]; Mayo Foundation for Medical Education and Research; Sven and Dagmar Salens, Stiftelse, Sweden; Swedish and Gothenburg Societies for the Neurologically Disabled; Swedish Society of Medicine Gothenburg; Gothenburg Foundation for Neurological Research; Bjornsson Foundation, Gothenburg, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065782, RC2NS070276, P50NS072187, R01NS057567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U24AG021886, P50AG016574, R01AG026251, P30AG010133] Funding Source: NIH RePORTER	We thank all family members who participated in this study, D. Gamble for help in coordinating sample and data collection from subjects with ischemic stroke, and R. Ossi for review of brain MRI scans from subjects with ischemic stroke. This work is funded by a Mayo Benefactor and the Mayo Foundation. Mayo Clinic Jacksonville is a Morris K. Udall Parkinson's Disease Research Center of Excellence supported by the US National Institute of Neurological Disorders and Stroke (P50 NS072187). Z.K.W. is partially funded by the US National Institutes of Health (NIH; R01 NS057567 and IRC2NS070276) and by Mayo Clinic Florida CR programs (MCF 90052018 and MCF 90052030). Z.K.W. is further supported by the family of Carl Edward Botch Jr. and Susan Bass Botch, and by Dystonia Medical Research Foundation. R.R. is funded by NIH grants R01 NS065782, R01 AG026251 and P50 AGO 16574 and by the Peebler PSP Research Foundation. OAR. is supported by the American Heart Association, the James & Esther King Biomedical Research Program, the Florida Department of Health and the Myron and Jane Hanley Award in Stroke research. C.W. is supported by the Leenaards Foundation and the Swiss Parkinson Foundation. The Mayo Clinic Florida Cerebrovascular Diseases Registry (IRB no. 08-003878; J.F.M., Principal Investigator) is supported by the Mayo Foundation for Medical Education and Research. C.S. is supported by grants from Sven and Dagmar Salens, Stiftelse, Sweden; the Swedish and Gothenburg Societies for the Neurologically Disabled; The Swedish Society of Medicine Gothenburg; the Gothenburg Foundation for Neurological Research; and the Bjornsson Foundation, Gothenburg, Sweden. This work is further funded by NIH PHS P30 AG 10133 (Indiana Alzheimer Disease Center, to B.G.) and NIH U24 AG 21886-0151 (National Cell Repository for Alzheimer's disease, to B.G.).	Akiguchi I, 1997, STROKE, V28, P1423, DOI 10.1161/01.STR.28.7.1423; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; AXELSSON R, 1984, ACTA PSYCHIAT SCAND, V69, P1; Baba Y, 2006, ACTA NEUROPATHOL, V111, P300, DOI 10.1007/s00401-006-0046-z; Bianchin M.M., 2010, NAT REV NEUROL, V6, DOI [10.1038/nrneuro1.2010.17-cl, DOI 10.1038/NRNEUROL.2010.17-CL]; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Browne L, 2003, EUR NEUROL, V50, P85, DOI 10.1159/000072504; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Freeman SH, 2009, BRAIN PATHOL, V19, P39, DOI 10.1111/j.1750-3639.2008.00163.x; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hancock N, 2003, J NEUROL NEUROSUR PS, V74, P1345, DOI 10.1136/jnnp.74.9.1345; Itoh K, 2006, ACTA NEUROPATHOL, V111, P39, DOI 10.1007/s00401-005-1113-6; Keegan BM, 2008, NEUROLOGY, V70, P1128, DOI 10.1212/01.wnl.0000304045.99153.8f; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Levin N, 2008, ISR MED ASSOC J, V10, P386; Marotti JD, 2004, ACTA NEUROPATHOL, V107, P481, DOI 10.1007/s00401-004-0847-x; Mascalchi M, 2006, AM J NEURORADIOL, V27, P1037; Mateen FJ, 2010, J NEUROL NEUROSUR PS, V81, P619, DOI 10.1136/jnnp.2008.169243; Moro-de-Casillas ML, 2004, J NEUROL NEUROSUR PS, V75, P1070, DOI 10.1136/jnnp.2003.028431; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; RIDGE SA, 1990, P NATL ACAD SCI USA, V87, P1377, DOI 10.1073/pnas.87.4.1377; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SMITH TW, 1990, J NEUROPATH EXP NEUR, V49, P357, DOI 10.1097/00005072-199007000-00001; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Swerdlow RH, 2009, NEUROLOGY, V72, P260, DOI 10.1212/01.wnl.0000339484.61490.a4; Tanaka J, 2000, NEUROPATHOLOGY, V20, pS25; van der Knaap MS, 2000, NEUROLOGY, V54, P463, DOI 10.1212/WNL.54.2.463; Van Gerpen JA, 2008, NEUROLOGY, V71, P925, DOI 10.1212/01.wnl.0000325916.30701.21; Wang YQ, 1999, J NEUROSCI RES, V57, P616, DOI 10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E; Wider C, 2009, NEUROLOGY, V72, P1953, DOI 10.1212/WNL.0b013e3181a826c0; Yamashita M, 2002, EUR NEUROL, V48, P20, DOI 10.1159/000064952; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200	40	323	333	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					200	205		10.1038/ng.1027			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	WOS:000299664400020	22197934	Green Accepted			2022-01-24	
J	Turner, TL; Bourne, EC; Von Wettberg, EJ; Hu, TT; Nuzhdin, SV				Turner, Thomas L.; Bourne, Elizabeth C.; Von Wettberg, Eric J.; Hu, Tina T.; Nuzhdin, Sergey V.			Population resequencing reveals local adaptation of Arabidopsis lyrata to serpentine soils	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; MICROSATELLITE MARKERS; GENOMIC ANALYSIS; CANDIDATE GENES; DIFFERENTIATION	A powerful way to map functional genomic variation and reveal the genetic basis of local adaptation is to associate allele frequency across the genome with environmental conditions(1-5). Serpentine soils, characterized by high heavy-metal content and low calcium-to-magnesium ratios, are a classic context for studying adaptation of plants to local soil conditions(6,7). To investigate whether Arabidopsis lyrata is locally adapted to serpentine soil, and to map the polymorphisms responsible for such adaptation, we pooled DNA from individuals from serpentine and nonserpentine soils and sequenced each 'gene pool' with the Illumina Genome Analyzer. The polymorphisms that are most strongly associated with soil type are enriched at heavy-metal detoxification and calcium and magnesium transport loci, providing numerous candidate mutations for serpentine adaptation. Sequencing of three candidate loci in the European subspecies of A. lyrata indicates parallel differentiation of the same polymorphism at one locus, confirming ecological adaptation, and different polymorphisms at two other loci, which may indicate convergent evolution.	[Turner, Thomas L.] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria; [Bourne, Elizabeth C.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland; [Turner, Thomas L.; Hu, Tina T.; Nuzhdin, Sergey V.] Univ So Calif, Los Angeles, CA USA; [Von Wettberg, Eric J.] Univ Calif Davis, Davis, CA 95616 USA		Turner, TL (corresponding author), Univ Calif Santa Barbara, Evolut Ecol & Marine Biol Dept, Santa Barbara, CA 93106 USA.	tturner@lifesci.ucsb.edu	von Wettberg, Eric/C-1115-2016	von Wettberg, Eric/0000-0002-2724-0317; Bourne, Elizabeth/0000-0002-6369-9133	US National Science Foundation (NSF)National Science Foundation (NSF) [DEB-0548991, RGM-076643, DEB-0723935]; University of Southern California; Macaulay Development Fund; Gregor Mendel Institute; NIH NRSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	We are grateful to M. Nordborg, R. Pakeman and R. Brooker for their advice and support, and to M. Woodhead, J. Russell and C. Booth for assistance with microsatellite analysis. This work was supported by the US National Science Foundation (NSF) grant DEB-0548991 and US National Institutes of Health (NIH) grant RGM-076643 (S. V. N.), NSF DEB-0723935 (to M. Nordborg), the University of Southern California (S. V. N., T. L. T. and T. T. H.), an NSF predoctoral fellowship (T. L. T.), the Macaulay Development Fund (E. C. B.), the Gregor Mendel Institute (T. L. T.) and an NIH NRSA fellowship (E. J. V. W.).	Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2002, MOL ECOL, V11, P591, DOI 10.1046/j.0962-1083.2002.01465.x; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Kruckeberg A. R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Turner TL, 2008, GENETICS, V179, P455, DOI 10.1534/genetics.107.083659; Turner TL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003183; Woodhead M, 2007, MOL ECOL NOTES, V7, P631, DOI 10.1111/j.1471-8286.2006.01656.x; Wright S., 1969, EVOLUTION GENETICS P, VII; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875	18	323	332	8	257	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					260	U42		10.1038/ng.515			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	WOS:000274912400017	20101244				2022-01-24	
J	Scheper, GC; van der Klok, T; van Andel, RJ; van Berkel, CGM; Sissler, M; Smet, J; Muravina, TI; Serkov, SV; Uziel, G; Bugiani, M; Schiffmann, R; Krageloh-Mann, I; Smeitink, JAM; Florentz, C; Van Coster, R; Pronk, JC; van der Knaap, MS				Scheper, Gert C.; van der Klok, Thom; van Andel, Rob J.; van Berkel, Carola G. M.; Sissler, Marie; Smet, Joel; Muravina, Tatjana I.; Serkov, Sergey V.; Uziel, Graziella; Bugiani, Marianna; Schiffmann, Raphael; Kraegeloh-Mann, Ingeborg; Smeitink, Jan A. M.; Florentz, Catherine; Van Coster, Rudy; Pronk, Jan C.; van der Knaap, Marjo S.			Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	NATURE GENETICS			English	Article							VANISHING WHITE-MATTER; DISEASE; FIBROBLASTS; TRANSLATION; MUTATIONS; DEFECTS; GENE	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) has recently been defined based on a highly characteristic constellation of abnormalities observed by magnetic resonance imaging and spectroscopy(1). LBSL is an autosomal recessive disease, most often manifesting in early childhood. Affected individuals develop slowly progressive cerebellar ataxia, spasticity and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. We performed linkage mapping with microsatellite markers in LBSL families and found a candidate region on chromosome 1, which we narrowed by means of shared haplotypes. Sequencing of genes in this candidate region uncovered mutations in DARS2, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals from all 30 families. Enzyme activities of mutant proteins were decreased. We were surprised to find that activities of mitochondrial complexes from fibroblasts and lymphoblasts derived from affected individuals were normal, as determined by different assays.	Vrije Univ Amsterdam, Dept Pediat & Child Neurol, NL-1081 HV Amsterdam, Netherlands; Univ Strasbourg 1, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Univ Hosp, Dept Pediat, Div Neurol & Metab, B-9000 Ghent, Belgium; Ist Nazl Neurol, Child Neurol Dept, I-20133 Milan, Italy; Russian Acad Med Sci, Burdenko Neurosurg Inst, Dept Neuroimaging, Moscow, Russia; NINDS, Dev & Metab Neurol BRanch, NIH, Bethesda, MD 20892 USA; Univ Tubingen, Childrens Hosp, Dept Pediat Neurol, D-72076 Tubingen, Germany; Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Vrije Univ Amsterdam, Ctr Med, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands		Scheper, GC (corresponding author), Vrije Univ Amsterdam, Dept Pediat & Child Neurol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	gc.scheper@vumc.nl	Smeitink, Jan A.M./D-6064-2011; Smeitink, Jan/C-1351-2013; Scheper, Gert C/D-7001-2014	SISSLER, Marie/0000-0001-8594-5238; Smet, Joel/0000-0002-9551-6282	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Z01NS002984] Funding Source: NIH RePORTER		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Forshew T, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023663; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Jacobs EH, 2002, FASEB J, V16, P1961, DOI 10.1096/fj.02-0272fje; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Petzold GC, 2006, J NEUROL NEUROSUR PS, V77, P889, DOI 10.1136/jnnp.2005.078568; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P347, DOI 10.1007/BF02435973; Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854; Serkov SV, 2004, NEUROPEDIATRICS, V35, P1, DOI 10.1055/s-2003-43548; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; SMET J, 2005, CELL BIOL LAB HDB, P259; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; Valk J., 2005, MAGNETIC RESONANCE M; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50	30	323	340	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					534	539		10.1038/ng2013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	WOS:000245271200025	17384640				2022-01-24	
J	Loots, GG; Kneissel, M; Keller, H; Baptist, M; Chang, J; Collette, NM; Ovcharenko, D; Plajzer-Frick, I; Rubin, EM				Loots, GG; Kneissel, M; Keller, H; Baptist, M; Chang, J; Collette, NM; Ovcharenko, D; Plajzer-Frick, I; Rubin, EM			Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease	GENOME RESEARCH			English	Article							DELTA-BETA-THALASSEMIA; CHROMOSOME 17Q12-Q21; BMP ANTAGONIST; GLOBIN GENE; SOST GENE; REGION; DENSITY; IDENTIFICATION; MARKERS; PROTEIN	Mutations in distant regulatory elements can have a negative impact on human development and health, yet because of the difficulty of detecting these critical sequences, we predominantly focus on coding sequences for diagnostic purposes. We have undertaken a comparative sequence-based approach to characterize a large noncoding region deleted in patients affected by Van Buchem (VB) disease, a severe sclerosing bone dysplasia. Using BAC recombination and transgenesis, we characterized the expression of human sclerostin (SOST) from normal (SOSTwt or Van Buchem (SOSTvb Delta) alleles. Only the SOSTwt allele faithfully expressed high levels of human SOST in the adult bone and had an impact on bone metabolism, consistent with the model that the VB noncoding deletion removes a SOST-specific regulatory element. By exploiting cross-species sequence comparisons with in vitro and in vivo enhancer assays, we were able to identify a candidate enhancer element that drives human SOST expression in osteoblast-like cell lines in vitro and in the skeletal anlage of the embryonic day 14.S (E14.S) mouse embryo, and discovered a novel function for sclerostin during limb development. Our approach represents a framework for characterizing distant regulatory elements associated with abnormal human phenotypes.	Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Novartis Inst Biomed Res, Basel, Switzerland; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Lab, Genome Biol Div, Livermore, CA 94550 USA		Loots, GG (corresponding author), Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	loots1@llnl.gov		Ovcharenko, Dmitriy/0000-0003-1271-1099; Collette, Nicole/0000-0002-9068-8712; Loots, Gabriela/0000-0001-9546-5561	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD047853] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD047853, HD47853-01] Funding Source: Medline		Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BEIGHTON P, 1977, CLIN GENET, V11, P1; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chuzhanova N, 2003, HUM MUTAT, V22, P245, DOI 10.1002/humu.10253; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; CURTIN P, 1985, J CLIN INVEST, V76, P1554, DOI 10.1172/JCI112136; CURTIN PT, 1988, BLOOD, V71, P766; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Ionasescu VV, 1996, NEUROLOGY, V47, P541, DOI 10.1212/WNL.47.2.541; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Tsui FWL, 2003, ARTHRITIS RHEUM-US, V48, P791, DOI 10.1002/art.10844; Uitterlinden AG, 2004, AM J HUM GENET, V75, P1032, DOI 10.1086/426458; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Van Hul W, 2001, EUR J RADIOL, V40, P198, DOI 10.1016/S0720-048X(01)00400-4; Van Hul W, 1998, AM J HUM GENET, V62, P391, DOI 10.1086/301721; Wang HL, 2000, MOL BRAIN RES, V78, P146, DOI 10.1016/S0169-328X(00)00087-5; Wergedal JE, 2003, J CLIN ENDOCR METAB, V88, P5778, DOI 10.1210/jc.2003-030201; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599	35	323	339	0	10	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	WOODBURY	500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA	1088-9051			GENOME RES	Genome Res.	JUL	2005	15	7					928	935		10.1101/gr.3437105			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	944JQ	WOS:000230424000003	15965026	Green Submitted, Bronze, Green Published			2022-01-24	
J	Fry, BG				Fry, BG			From genome to "venome": Molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins	GENOME RESEARCH			English	Article							PLATYPUS ORNITHORHYNCHUS-ANATINUS; NICOTINIC ACETYLCHOLINE-RECEPTORS; NATRIURETIC-PEPTIDE; HELOTHERMINE; AFFINITIES; SERPENTES; INFERENCE; MRBAYES; CLONING; FAMILY	This study analyzed the origin and evolution of snake venom proteome by means of phylogenetic analysis of the amino acid sequences of the toxins and related nonvenom proteins. The snake toxins were shown to have arisen from recruitment events of genes from within the following protein families: acetylcholinesterase, ADAM (disintegrin/metalloproteinase), AVIT, complement C3, crotasin/beta defensin, cystatin, endothelin, factor V, factor X, kallikrein, kunitz-type proteinase inhibitor, LYNX/SLUR, L-amino oxidase, lectin, natriuretic peptide, betanerve growth factor, phospholipase A(2), SPla/Ryanodine, vascular endothelial growth factor, and whey acidic protein/secretory leukoproteinase inhibitor. Toxin recruitment events were found to have occurred at least 24 times in the evolution of snake venom. Two of these toxin derivations (CRISP and kallikrein toxins) appear to have been actually the result of modifications of existing salivary proteins rather than gene recruitment events. One snake toxin type, the waglerin peptides from Tropidolaemus wagleri (Wagler's Viper), did not have a match with known proteins and may be derived from a Uniquely reptilian peptide. All of the snake toxin types still possess the bioactivity of the ancestral proteins in at least some of the toxin isoforms. However, this study revealed that the toxin types, where the ancestral protein was extensively cysteine cross-linked, were the Dries that flourished into functionally diverse, novel toxin multigene families.	Univ Melbourne, Sch Med, Australian Venom Res Unit, Parkville, Vic 3010, Australia; Bioinformat Inst, SWISS PROT Grp, Cambridge CB10 1SD, England		Fry, BG (corresponding author), Univ Melbourne, Sch Med, Australian Venom Res Unit, Level 8, Parkville, Vic 3010, Australia.						AIKEN S P, 1992, Pharmacology and Toxicology, V70, P459; BOVY PR, 1990, MED RES REV, V10, P115, DOI 10.1002/med.2610100105; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; De Plater GM, 1998, TOXICON, V36, P847, DOI 10.1016/S0041-0101(97)00176-1; de Plater GM, 1998, COMP BIOCHEM PHYS C, V120, P99, DOI 10.1016/S0742-8413(98)00030-9; DUCANCEL F, 1993, J BIOL CHEM, V268, P3052; FELSENSTEIN J, 2001, PHYLIP VERSION 3 6; Forstner MRJ, 1995, MOL PHYLOGENET EVOL, V4, P93, DOI 10.1006/mpev.1995.1010; Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091; Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Greene HW, 1997, SNAKES EVOLUTION MYS; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Kochva E., 1978, P43; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; KOCHVA E, 1963, ACTA ANAT, V52, P49; KOCHVA E, 1965, COPEIA; KOLBE HVJ, 1993, J BIOL CHEM, V268, P16458; Lee MSY, 1997, PHILOS T R SOC B, V352, P53, DOI 10.1098/rstb.1997.0005; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; MOCHCAMORALES J, 1990, TOXICON, V28, P299, DOI 10.1016/0041-0101(90)90065-F; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; MORRISSETTE J, 1995, BIOPHYS J, V68, P2280, DOI 10.1016/S0006-3495(95)80410-8; NOBILE M, 1994, J MEMBRANE BIOL, V139, P49; Nobile M, 1996, EXP BRAIN RES, V110, P15; Radis-Baptista G, 2003, TOXICON, V42, P747, DOI 10.1016/j.toxicon.2003.10.019; Rieppel O, 2003, J PALEONTOL, V77, P536, DOI 10.1666/0022-3360(2003)077<0536:TAAROH>2.0.CO;2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; STRYDOM DJ, 1973, SYST ZOOL, V22, P596, DOI 10.2307/2412964; Swofford, 2002, PAUP PHYLOGENETIC AN; Szeto TH, 2000, TOXICON, V38, P429, DOI 10.1016/S0041-0101(99)00174-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UNDERWOOD G, 1993, ZOOL J LINN SOC-LOND, V107, P3, DOI 10.1006/zjls.1993.1002; Underwood Garth, 1996, Symposia of the Zoological Society of London, V70, P1; UTALSINCHAROEN P, 1993, J BIOL CHEM, V268, P21975; Vidal N, 2002, CR BIOL, V325, P987, DOI 10.1016/S1631-0691(02)01509-3; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; Yamazaki Y, 2002, EUR J BIOCHEM, V269, P2708, DOI 10.1046/j.1432-1033.2002.02940.x	43	323	335	3	95	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2005	15	3					403	420		10.1101/gr.3228405			18	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	902CB	WOS:000227327800008	15741511	Green Published, Bronze			2022-01-24	
J	Sweet-Cordero, A; Mukherjee, S; Subramanian, A; You, H; Roix, JJ; Ladd-Acosta, C; Mesirov, J; Golub, TR; Jacks, T				Sweet-Cordero, A; Mukherjee, S; Subramanian, A; You, H; Roix, JJ; Ladd-Acosta, C; Mesirov, J; Golub, TR; Jacks, T			An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR; LUNG ADENOCARCINOMA; BREAST-CANCER; RAS; CLASSIFICATION; MUTATIONS; PATTERNS; PROTEIN; TUMORS	Using advanced gene targeting methods, generating mouse models of cancer that accurately reproduce the genetic alterations present in human tumors is now relatively straightforward. The challenge is to determine to what extent such models faithfully mimic human disease with respect to the underlying molecular mechanisms that accompany tumor progression. Here we describe a method for comparing mouse models of cancer with human tumors using gene-expression profiling. We applied this method to the analysis of a model of Kras2-mediated lung cancer and found a good relationship to human lung adenocarcinoma, thereby validating the model. Furthermore, we found that whereas a gene-expression signature of KRAS2 activation was not identifiable when analyzing human tumors with known KRAS2 mutation status alone, integrating mouse and human data uncovered a gene-expression signature of KRAS2 mutation in human lung cancer. We confirmed the importance of this signature by gene-expression analysis of short hairpin RNA-mediated inhibition of oncogenic Kras2. These experiments identified both a pattern of gene expression indicative of KRAS2 mutation and potential effectors of oncogenic KRAS2 activity in human cancer. This approach provides a strategy for using genomic analysis of animal models to probe human disease.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; MIT, Eli & Edyth L Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Eli & Edyth L Broad Inst, Cambridge, MA 02141 USA		Jacks, T (corresponding author), MIT, Ctr Canc Res, Bldg E17-517,40 Ames St, Cambridge, MA 02139 USA.	tjacks@mit.edu		Mukherjee, Sayan/0000-0002-6715-3920			Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bonner AE, 2004, ONCOGENE, V23, P1166, DOI 10.1038/sj.onc.1207234; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; MANTEL N, 1967, CANCER RES, V27, P209; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Naoki K, 2002, CANCER RES, V62, P7001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; Vapnik Y. N., 1998, STAT LEARNING THEORY; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	36	323	332	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2005	37	1					48	55		10.1038/ng1490			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	WOS:000225997500020	15608639				2022-01-24	
J	Kraakman, ATW; Niks, RE; Van den Berg, PMMM; Stam, P; Van Eeuwijk, FA				Kraakman, ATW; Niks, RE; Van den Berg, PMMM; Stam, P; Van Eeuwijk, FA			Linkage disequilibrium mapping of yield and yield stability in modern spring barley cultivars	GENETICS			English	Article							ABIOTIC STRESS TOLERANCE; QUANTITATIVE TRAIT LOCI; ENVIRONMENT INTERACTIONS; AFLP MARKERS; RFLP MARKERS; QTL; ADAPTATION; REPEATABILITY; ASSOCIATIONS; DISSECTION	Associations between markers and complex quantitative traits were investigated in a collection of 146 modern two-row spring barley cultivars, representing the current commercial germ plasm in Europe. Using 236 AFLP markers, associations between markets were found for markers as far apart as 10 cM. Subsequently, for the 146 cultivars the complex traits mean yield, adaptability (Finlay-Wilkinson slope), and stability (deviations from regression) were estimated from the analysis of variety trial data. Regression of those traits on individual marker data disclosed marker-trait associations for mean yield and yield stability. Support for identified associations was obtained from association profiles, i.e., front plots of P-values against chromosome positions. In addition, man), of the associated markets were located in regions where earlier QTL were found for yield and yield components. To study the oligogenic genetic base of the traits in more detail, Multiple linear regression of the traits on markers was carried out, rising stepwise selection. By this procedure, 18-20 markers that accounted for 40-58% of the variation were selected. Our results indicate that association mapping approaches can be a viable alternative to classical QTL approaches based on crosses between inbred lines, especially for complex traits with costly measurements.	Univ Wageningen & Res Ctr, Lab Plant Breeding, NL-6700 AJ Wageningen, Netherlands		Van Eeuwijk, FA (corresponding author), Univ Wageningen & Res Ctr, Lab Plant Breeding, POB 386, NL-6700 AJ Wageningen, Netherlands.	fred.vaneeuwijk@wur.nl	Niks, Rients/Y-4720-2019	Niks, Rients/0000-0002-3912-3775			Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; BECKER HC, 1988, PLANT BREEDING, V101, P1, DOI 10.1111/j.1439-0523.1988.tb00261.x; BECKER J, 1995, MOL GEN GENET, V249, P65, DOI 10.1007/BF00290237; BEER SC, 1997, J AGR GENOM, V3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezant JH, 1997, PLANT BREEDING, V116, P141, DOI 10.1111/j.1439-0523.1997.tb02168.x; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CATTIVELLI L, 2002, BARLEY SCI RECENT AD, P307; CHURCHILL GA, 1994, GENETICS, V138, P963; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; FINLAY KW, 1963, AUST J AGR RES, V14, P742, DOI 10.1071/AR9630742; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Forster BP, 2000, J EXP BOT, V51, P19, DOI 10.1093/jexbot/51.342.19; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; GORDON AD, 1981, CLASSIFICATION; GREENACRE MJ, 1984, THEORY APPL CORRESPO; Hansen M, 2001, GENET RES, V77, P61, DOI 10.1017/S0016672300004857; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; HOLLAND BS, 1987, BIOMETRICS, V43, P417, DOI 10.2307/2531823; HOLM S, 1979, SCAND J STAT, V6, P65; Igartua E, 1999, HEREDITY, V83, P551, DOI 10.1038/sj.hdy.6885890; Ivandic V, 2003, PLANT BREEDING, V122, P300, DOI 10.1046/j.1439-0523.2003.00841.x; Jannink Jean-Luc, 2002, P59, DOI 10.1079/9780851996011.0059; KOOREVAAR G, 1997, THESIS WAGENINGEN U; Kraft T, 2000, THEOR APPL GENET, V101, P323, DOI 10.1007/s001220051486; LEON J, 1988, PLANT BREEDING, V100, P137, DOI 10.1111/j.1439-0523.1988.tb00228.x; LIN CS, 1986, CROP SCI, V26, P894, DOI 10.2135/cropsci1986.0011183X002600050012x; LIN CS, 1991, THEOR APPL GENET, V82, P505, DOI 10.1007/BF00588606; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Marquez-Cedillo LA, 2000, THEOR APPL GENET, V101, P173, DOI 10.1007/s001220051466; Milligan BG, 2003, GENETICS, V163, P1153; Montgomery D.C., 1982, INTRO LINEAR REGRESS; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Qi X, 1997, MOL GEN GENET, V254, P330, DOI 10.1007/s004380050423; Qi X, 1998, THEOR APPL GENET, V96, P376, DOI 10.1007/s001220050752; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Romagosa I, 1996, THEOR APPL GENET, V93, P30, DOI 10.1007/BF00225723; Russell JR, 2000, MOL BREEDING, V6, P553, DOI 10.1023/A:1011372312962; Saranga Y, 2001, GENOME RES, V11, P1988, DOI 10.1101/gr.157201; Sneller CH, 1997, CROP SCI, V37, P383, DOI 10.2135/cropsci1997.0011183X003700020013x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; THOMAS H, 1997, PUTTING PLANT PHYSL; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; TIGERSTEDT PMA, 1997, ADAPTATION PLANT BRE; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Ungerer MC, 2003, GENETICS, V165, P353; vanderVoort JNAMR, 1997, MOL GEN GENET, V255, P438, DOI 10.1007/s004380050516; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Virk PS, 1996, HEREDITY, V76, P296, DOI 10.1038/hdy.1996.43; Voltas J., 2001, 7 QUANT TRAIT LOC MA; Voorrips R.E., 2001, JOINMAP 3 0 SOFTWARE; Waugh R, 1997, MOL GEN GENET, V255, P311, DOI 10.1007/s004380050502; Weller JI, 1998, GENETICS, V150, P1699; Yin X, 1999, THEOR APPL GENET, V99, P244, DOI 10.1007/s001220051230; [No title captured]	59	323	362	0	39	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2004	168	1					435	446		10.1534/genetics.104.026831			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	861CM	WOS:000224393700034	15454555	Green Published, Bronze			2022-01-24	
J	Vulliamy, T; Marrone, A; Szydlo, R; Walne, A; Mason, PJ; Dokal, I				Vulliamy, T; Marrone, A; Szydlo, R; Walne, A; Mason, PJ; Dokal, I			Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC	NATURE GENETICS			English	Article							SMALL NUCLEOLAR RNAS; APLASTIC-ANEMIA; CELLS; COMPONENT; LENGTH	Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.	Hammersmith Hosp, Imperial Coll London, Dept Haematol, Div Invest Sci, London W12 0NN, England		Mason, PJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, Campus Box 8125,660 S Euclid Ave, St Louis, MO 63110 USA.	PMason@im.wustl.edu	Szydlo, Richard/C-6678-2012; Mason, Philip J/B-1087-2008	Szydlo, Richard/0000-0003-1102-8298; Dokal, Inderjeet/0000-0003-4462-4782			Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Lindblad K, 1999, SEMIN NEUROL, V19, P289, DOI 10.1055/s-2008-1040845; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6	15	323	335	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					447	449		10.1038/ng1346			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	WOS:000221183000014	15098033	Bronze			2022-01-24	
J	Morrish, TA; Gilbert, N; Myers, JS; Vincent, BJ; Stamato, TD; Taccioli, GE; Batzer, MA; Moran, JV				Morrish, TA; Gilbert, N; Myers, JS; Vincent, BJ; Stamato, TD; Taccioli, GE; Batzer, MA; Moran, JV			DNA repair mediated by endonuclease-independent LINE-1 retrotransposition	NATURE GENETICS			English	Article							STRAND BREAK-REPAIR; HAMSTER OVARY CELL; REVERSE-TRANSCRIPTASE; V(D)J RECOMBINATION; MUSCULAR-DYSTROPHY; GENE; INSERTION; ELEMENT; ENCODES; RNA	Long interspersed elements (LINE-1s) are abundant retrotransposons in mammalian genomes that probably retrotranspose by target site-primed reverse transcription (TPRT)(1,2). During TPRT, the LINE-1 endonuclease cleaves genomic DNA 3, freeing a 3 hydroxyl that serves as a primer for reverse transcription of LINE-1 RNA by LINE-1 reverse transcriptase. The nascent LINE-1 cDNA joins to genomic DNA, generating LINE-1 structural hallmarks such as frequent 5' truncations, a 3' poly( A)(+) tail and variable-length target site duplications (TSDs)(2). Here we describe a pathway for LINE-1 retrotransposition in Chinese hamster ovary (CHO) cells that acts independently of endonuclease but is dependent upon reverse transcriptase. We show that endonuclease-independent LINE-1 retrotransposition occurs at near-wildtype levels in two mutant cell lines that are deficient in nonhomologous end-joining (NHEJ). Analysis of the pre- and post-integration sites revealed that endonuclease-independent retrotransposition results in unusual structures because the LINE-1s integrate at atypical target sequences, are truncated predominantly at their 3 ends and lack TSDs. Moreover, two of nine endonuclease-independent retrotranspositions contained cDNA fragments at their 3 ends that are probably derived from the reverse transcription of endogenous mRNA. Thus, our results suggest that LINE-1s can integrate into DNA lesions, resulting in retrotransposon-mediated DNA repair in mammalian cells.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA USA; Lankenau Inst Med Res, Wynnewood, PA USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA USA		Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48105 USA.		Gilbert, Nicolas/M-9568-2018	Gilbert, Nicolas/0000-0003-3311-7494; Morrish, Tammy/0000-0002-6725-0253			BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; CHAMBEYRON S, 2002, J BIOL CHEM     0306; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; GIACCIA AJ, 1990, AM J HUM GENET, V47, P459; Higashiyama T, 1997, EMBO J, V16, P3715, DOI 10.1093/emboj/16.12.3715; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Levin HL, 1997, CELL, V88, P5, DOI 10.1016/S0092-8674(00)81851-6; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MAGER DL, 1985, NUCLEIC ACIDS RES, V13, P6559, DOI 10.1093/nar/13.18.6559; Moran J.V., 2002, MOBILE DNA-UK, V2, P836; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pardue ML, 1997, GENETICA, V100, P73, DOI 10.1023/A:1018352706024; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; STAMATO TD, 1983, SOMAT CELL GENET, V9, P165, DOI 10.1007/BF01543175; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; VOLIVA CF, 1984, J MOL BIOL, V178, P795, DOI 10.1016/0022-2836(84)90312-7; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	30	323	333	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					159	165		10.1038/ng898			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	WOS:000175903500011	12006980				2022-01-24	
J	Mitchell, KJ; Pinson, KI; Kelly, OG; Brennan, J; Zupicich, L; Scherz, P; Leighton, PA; Goodrich, LV; Lu, XW; Avery, BJ; Tate, P; Dill, K; Pangilinan, E; Wakenight, P; Tessier-Lavigne, M; Skarnes, WC				Mitchell, KJ; Pinson, KI; Kelly, OG; Brennan, J; Zupicich, L; Scherz, P; Leighton, PA; Goodrich, LV; Lu, XW; Avery, BJ; Tate, P; Dill, K; Pangilinan, E; Wakenight, P; Tessier-Lavigne, M; Skarnes, WC			Functional analysis of secreted and transmembrane proteins critical to mouse development	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE TRAP INTEGRATIONS; INSERTIONAL MUTATIONS; REGULATED GENES; GROWTH-FACTOR; MUTANT MICE; GENOME-WIDE; TOUT-VELU; DISRUPTION; IDENTIFICATION	We describe the successful application of a modified gene-trap approach, the secretory trap, to systematically analyze the functions in vivo of large numbers of genes encoding secreted and membrane proteins. Secretory-trap insertions in embryonic stem cells can be transmitted to the germ line of mice with high efficiency and effectively mutate the target gene. Of 60 insertions analyzed in mice, one-third cause recessive lethal phenotypes affecting various stages of embryonic and postnatal development. Thus, secretory-trap mutagenesis can be used for a genome-wide functional analysis of cell signaling pathways that are critical for normal mammalian development and physiology.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA		Skarnes, WC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	skarnes@socrates.berkeley.edu	Schick, Joel/ABA-3728-2021	Schick, Joel/0000-0002-8623-4910; Brennan, Jane/0000-0003-3222-5485; Mitchell, Kevin/0000-0002-3433-4530			AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Cal S, 2000, MOL BIOL CELL, V11, P1457, DOI 10.1091/mbc.11.4.1457; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; CHEN CC, 1993, ASIA PAC J PHARMACOL, V8, P1; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CORMICK C, 1998, NAT GENET, V19, P158; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; Sam M, 1998, DEV DYNAM, V212, P304, DOI 10.1002/(SICI)1097-0177(199806)212:2<304::AID-AJA15>3.3.CO;2-Z; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Tate P, 1998, J CELL SCI, V111, P2575; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; VONMELCHNER H, 1992, GENE DEV, V6, P919, DOI 10.1101/gad.6.6.919; Voss AK, 1998, DEV DYNAM, V212, P258; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WURST W, 1995, GENETICS, V139, P889; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	55	323	334	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					241	249		10.1038/90074			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	WOS:000169656400016	11431694				2022-01-24	
J	Zhang, K; Kniazeva, M; Han, M; Li, W; Yu, ZY; Yang, ZL; Li, Y; Metzker, ML; Allikmets, R; Zack, DJ; Kakuk, LE; Lagali, PS; Wong, PW; MacDonald, IM; Sieving, PA; Figueroa, DJ; Austin, CP; Gould, RJ; Ayyagari, R; Petrukhin, K				Zhang, K; Kniazeva, M; Han, M; Li, W; Yu, ZY; Yang, ZL; Li, Y; Metzker, ML; Allikmets, R; Zack, DJ; Kakuk, LE; Lagali, PS; Wong, PW; MacDonald, IM; Sieving, PA; Figueroa, DJ; Austin, CP; Gould, RJ; Ayyagari, R; Petrukhin, K			A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; DISEASE GENE; ABCR; IDENTIFICATION; MEMBRANE; ACID; BIOSYNTHESIS; ELONGATION; MUTATIONS	Stargardt-like macular dystrophy (STGD3, MIM 600110) and autosomal dominant macular dystrophy (adMD) are inherited forms of macular degeneration characterized by decreased visual acuity, macular atrophy and extensive fundus flecks(1-3). Genetic mapping data suggest that mutations in a single gene may be responsible for both conditions, already known to bear clinical resemblance(1-3). Here we limit the minimum genetic region for STGD3 and adMD to a 0.6-cM interval by recombination breakpoint mapping and identify a single 5-bp deletion within the protein-coding region of a new retinal photoreceptor-specific gene, ELOVL4, in all affected members of STGD3 and adMD families. Bioinformatic analysis of ELOVL4 revealed that it has homology to a group of yeast proteins that function in the biosynthesis of Very long chain fatty acids. Our results are therefore the first to implicate the biosynthesis of fatty acids in the pathogenesis of inherited macular degeneration.	Merck Res Labs, Dept Pharmacol, W Point, PA USA; Merck Res Labs, Dept Human Genet, W Point, PA USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Columbia Univ, Dept Ophthalmol, New York, NY USA; Columbia Univ, Dept Pathol, New York, NY USA; Univ Michigan, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; Univ Alberta, Dept Sci Biol, Edmonton, AB, Canada; Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada		Petrukhin, K (corresponding author), Merck Res Labs, Dept Pharmacol, W Point, PA USA.		Kniazeva, Marina/D-4085-2012; Zhang, Kang/Y-2740-2019; Allikmets, Rando/ABD-4533-2021	Zhang, Kang/0000-0002-4549-1697; Petrukhin, Konstantin/0000-0002-5545-6924; MacDonald, Ian/0000-0001-7472-8385; Zack, Don/0000-0002-7966-1973	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY00401] Funding Source: Medline		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Griesinger IB, 2000, INVEST OPHTH VIS SCI, V41, P248; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lagali PS, 2000, CAN J OPHTHALMOL, V35, P315, DOI 10.1016/S0008-4182(00)80059-9; Luthria DL, 1996, J BIOL CHEM, V271, P16020, DOI 10.1074/jbc.271.27.16020; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sprecher H, 1995, J LIPID RES, V36, P2471; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	30	323	336	1	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					89	93		10.1038/83817			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	WOS:000166187900022	11138005				2022-01-24	
J	Urness, LD; Sorensen, LK; Li, DY				Urness, LD; Sorensen, LK; Li, DY			Arteriovenous malformations in mice lacking activin receptor-like kinase-1	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; CARDIOVASCULAR DEVELOPMENT; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; VASCULOGENESIS; MORPHOGENESIS; ANGIOGENESIS; EPHRIN-B2; EMBRYO	The mature circulatory system is comprised of two parallel, yet distinct, vascular networks that carry blood to and from the heart. Studies have suggested that endothelial tubes are specified as arteries and veins at the earliest stages of angiogenesis, before the onset of circulation(1-4). To understand the molecular basis for arterial-venous identity, we have focused our studies on a human vascular dysplasia, hereditary haemorrhagic telangiectasia (HHT), wherein arterial and venous beds fail to remain distinct. Genetic studies have demonstrated that HHT can be caused by loss-of-function mutations in the gene encoding activin receptor-like kinase-1 (ACVRL1; ref. 5). ACVRL1 encodes a type I receptor for the TGF-P superfamily of growth factors(6-8). At the earliest stage of vascular development, mice lacking Acvrl1 develop large shunts between arteries and veins, downregulate arterial Efnb2 and fail to confine intravascular haematopoiesis to arteries. These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of major arteries and veins. The early loss of anatomical, molecular and functional distinctions between arteries and Veins indicates that Acvrl1 is required for developing distinct arterial and venous vascular beds.	Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA		Li, DY (corresponding author), Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA.	dean.li@hci.utah.edu					Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; FLAMME I, 1992, DEVELOPMENT, V116, P435; GADSON PF, 1993, IN VITRO CELL DEV-AN, V29A, P773; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hogan B., 1986, MANIPULATING MOUSE E; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; JOHNSON I, 1989, J SOCIAL WORK PRACTI, V1, P13; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Manaia A, 2000, DEVELOPMENT, V127, P643; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pepper MS, 1996, CURR TOP MICROBIOL, V213, P31; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 1992, IN SITU HYBRIDIZATIO	26	323	330	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					328	331		10.1038/81634			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	WOS:000165176500022	11062473				2022-01-24	
J	Lindblad-Toh, K; Winchester, E; Daly, MJ; Wang, DG; Hirschhorn, JN; Laviolette, JP; Ardlie, K; Reich, DE; Robinson, E; Sklar, P; Shah, N; Thomas, D; Fan, JB; Gingeras, T; Warrington, J; Patil, N; Hudson, TJ; Lander, ES				Lindblad-Toh, K; Winchester, E; Daly, MJ; Wang, DG; Hirschhorn, JN; Laviolette, JP; Ardlie, K; Reich, DE; Robinson, E; Sklar, P; Shah, N; Thomas, D; Fan, JB; Gingeras, T; Warrington, J; Patil, N; Hudson, TJ; Lander, ES			Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse	NATURE GENETICS			English	Article							GENOME	Single-nucleotide polymorphisms (SNPs) have been the focus of much attention in human genetics because they are extremely abundant and well-suited for automated large-scale genotyping, Human SNPs, however, are less informative than other types of genetic markers (such as simple-sequence length polymorphisms or microsatellites) and thus more loci are required for mapping traits. SNPs offer similar advantages for experimental genetic organisms such as the mouse, but they entail no loss of informativeness because bi-allelic markers are fully informative in analysing crosses between inbred strains. Here we report a large-scale analysis of SNPs in the mouse genome. We characterized the rate of nucleotide polymorphism in eight mouse strains and identified a collection of 2,848 SNPs located in 1,755 sequence-tagged sites (STSs) using high-density oligonucleotide arrays. Three-quarters of these SNPs have been mapped on the mouse genome, providing a first-generation SNP map of the mouse. We have also developed a multiplex genotyping procedure by which a genome scan can be performed with only six genotyping reactions per animal.	MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02139 USA; Bristol Myers Squibb, Princeton, NJ USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Affymetrix Inc, Santa Clara, CA USA; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ H3A 2T5, Canada; MIT, Dept Biol, Cambridge, MA 02139 USA		Lindblad-Toh, K (corresponding author), MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Gingeras, Thomas/0000-0001-9106-3573	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG001806] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG01806] Funding Source: Medline		ATCHLEY WR, 1993, MOL BIOL EVOL, V10, P1150; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; FERRIS SD, 1983, GENETICS, V105, P681; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; SAGE RD, 1981, MOUSE BIOMEDICAL RES, P40; Syvanen AC, 1999, HUM MUTAT, V13, P1; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	11	323	345	1	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					381	386		10.1038/74215			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	WOS:000086192800017	10742102				2022-01-24	
J	Braverman, N; Steel, G; Obie, C; Moser, A; Moser, H; Gould, SJ; Valle, D				Braverman, N; Steel, G; Obie, C; Moser, A; Moser, H; Gould, SJ; Valle, D			Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata	NATURE GENETICS			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; SIGNAL IMPORT RECEPTOR; TARGETING SIGNAL; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; BIOGENESIS DISORDERS; HANSENULA-POLYMORPHA; ZELLWEGER SYNDROME; GENE	Rhizomelic chondrodysplasia punctata (RCDP) is a rare autosomal recessive phenotype that comprises complementation group 11 of the peroxisome biogenesis disorders (PBD). PEX7, a candidate gene for RCDP identified in yeast, encodes the receptor for peroxisomal matrix proteins with the type-2 peroxisome targeting signal (PTS2). By homology probing we identified human and murine PEX7 genes and found that expression of either corrects the PTS2-import defect characteristic of RCDP cells. In a collection of 36 RCDP probands, we found two inactivating PEX7 mutations: one, L292ter, was present in 26 of the probands, all with a severe phenotype; the second, A218V, was present in three probands, including two with a milder phenotype. A third mutation, G217R, whose functional significance is yet to be determined, was present in five probands, all compound heterozygotes with L292ter. We conclude that PEX7 is responsible for RCDP (PBD CG11) and suggest a founder effect may explain the high frequency of L292ter.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205						NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR00722, RR00052] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000722] Funding Source: NIH RePORTER		AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barth PG, 1996, AM J MED GENET, V62, P164, DOI 10.1002/(SICI)1096-8628(19960315)62:2<164::AID-AJMG9>3.0.CO;2-W; BRODY LC, 1992, J BIOL CHEM, V267, P3302; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cooper DN, 1995, METABOLIC MOL BASES, P259; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; DODT G, IN PRESS NEW YORK AC; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; ENGELHARDT JF, 1991, J BIOL CHEM, V266, P752; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FABER KN, 1995, FEBS LETT, V357, P115, DOI 10.1016/0014-5793(94)01317-T; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fukuda S, 1996, AM J HUM GENET, V59, P1210; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY RGF, 1992, J INHERIT METAB DIS, V15, P931, DOI 10.1007/BF01800236; HEIKOOP JC, 1990, J CLIN INVEST, V86, P126, DOI 10.1172/JCI114674; HEIKOOP JC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P69; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Hieter P, 1996, NAT GENET, V13, P253, DOI 10.1038/ng0796-253; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; Innis MA, 1990, PCR PROTOCOLS GUIDE; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cellbio.8.1.197; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; Lazarow PB, 1995, METABOLIC MOL BASIS, V7th, P2287; MAQUAT LE, 1995, RNA, V1, P453; MARYNEN P, 1995, GENOMICS, V30, P366, DOI 10.1006/geno.1995.0032; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1996, BBA-MOL BASIS DIS, V1315, P153, DOI 10.1016/0925-4439(95)00114-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NUOFFER JM, 1994, J INHERIT METAB DIS, V17, P60, DOI 10.1007/BF00735395; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PIKE MG, 1990, J PEDIATR-US, V116, P88, DOI 10.1016/S0022-3476(05)81651-8; POLLTHE BT, 1991, J INHERIT METAB DIS, V14, P361, DOI 10.1007/BF01811703; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Sambrook J., 1989, MOL CLONING LAB MANU; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P11325; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SMEITINK JAM, 1992, J INHERIT METAB DIS, V15, P377, DOI 10.1007/BF02435981; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	69	323	327	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					369	376		10.1038/ng0497-369			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	WOS:A1997WQ38900014	9090381				2022-01-24	
J	GODFREY, P; RAHAL, JO; BEAMER, WG; COPELAND, NG; JENKINS, NA; MAYO, KE				GODFREY, P; RAHAL, JO; BEAMER, WG; COPELAND, NG; JENKINS, NA; MAYO, KE			GHRH RECEPTOR OF LITTLE MICE CONTAINS A MISSENSE MUTATION IN THE EXTRACELLULAR DOMAIN THAT DISRUPTS RECEPTOR FUNCTION	NATURE GENETICS			English	Article							HORMONE-RELEASING HORMONE; MESSENGER-RIBONUCLEIC-ACID; PANCREATIC-ISLET TUMOR; MOUSE GENOME; RAT PLACENTA; GROWTH; GENE; EXPRESSION; SEQUENCES; DWARF	The growth hormone-releasing hormone receptor (GHRHR) is a member of the family of G protein-coupled receptors that is expressed on pituitary somatotrope cells and mediates the actions of GHRH in stimulating growth hormone (GH) synthesis and secretion. We report that the Ghrhr gene is located in the middle of mouse chromosome 6 in the same region as the little mutation. Mice homozygous for this mutation have reduced GH secretion and a dwarf phenotype. A missense mutation was identified in the extracellular domain of the little GHRHR that disrupts receptor function, suggesting that the growth deficit in these mice results from a defect in the GHRHR. Similar alterations in GHRHR might explain some isolated GH deficiencies in humans.	NORTHWESTERN UNIV, DEPT BIOCHEM, EVANSTON, IL 60208 USA; NORTHWESTERN UNIV, DEPT MOLEC BIOL, EVANSTON, IL 60208 USA; NORTHWESTERN UNIV, DEPT CELL BIOL, EVANSTON, IL 60208 USA; NCI, FREDERICK CANC RES & DEV CTR, MAMMALIAN GENET LAB, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA						NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N01-CO-74101, CA-54889] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R03CA054889] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N01CO074101] Funding Source: NIH RePORTER		ARRUFO A, 1987, P NATL ACAD SCI USA, V84, P8573; ASA SL, 1992, ENDOCRINOLOGY, V131, P2083, DOI 10.1210/en.131.5.2083; BAGNATO A, 1992, ENDOCRINOLOGY, V130, P1097, DOI 10.1210/en.130.3.1097; BEAMER WG, 1976, J ENDOCRINOL, V71, P37, DOI 10.1677/joe.0.0710037; BERRY SA, 1990, ENDOCRINOLOGY, V127, P1404, DOI 10.1210/endo-127-3-1404; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; CAMP TA, 1991, MOL ENDOCRINOL, V5, P1405, DOI 10.1210/mend-5-10-1405; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CHIAMPANI T, 1992, ENDOCRINOLOGY, V131, P2785; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DONAHUE LR, 1993, J ENDOCRINOL, V136, P91, DOI 10.1677/joe.0.1360091; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Green EL, 1981, GENETICS PROBABILITY, P77; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; HAMMER RE, 1984, NATURE, V311, P65, DOI 10.1038/311065a0; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; HELLER DL, 1988, MOL CELL BIOL, V8, P2797, DOI 10.1128/MCB.8.7.2797; HORVATH S, 1989, BRAIN RES, V481, P8, DOI 10.1016/0006-8993(89)90479-4; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; ISHAHARA T, 1991, EMBO J, V10, P1635; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; JANSSON JO, 1986, SCIENCE, V232, P511, DOI 10.1126/science.3008329; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MACGILLIVRAY MH, 1987, ENDOCRINOL METAB, P1581; MARGIORIS AN, 1990, ENDOCRINOLOGY, V126, P151, DOI 10.1210/endo-126-1-151; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MAYO KE, 1988, MOL ENDOCRINOL, V2, P606, DOI 10.1210/mend-2-7-606; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; MEIGAN G, 1988, ENDOCRINOLOGY, V123, P1098, DOI 10.1210/endo-123-2-1098; MORETTI C, 1990, ENDOCRINOLOGY, V127, P2117, DOI 10.1210/endo-127-5-2117; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; PHELPS CJ, 1987, PEPTIDES, V8, P1127, DOI 10.1016/0196-9781(87)90146-X; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SANO T, 1988, ENDOCR REV, V9, P357, DOI 10.1210/edrv-9-3-357; Schaible R., 1961, Genetics, V46, P896; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; Sneil GD, 1929, P NATL ACAD SCI USA, V15, P733, DOI 10.1073/pnas.15.9.733; SPATOLA E, 1991, ENDOCRINOLOGY, V129, P1193, DOI 10.1210/endo-129-3-1193; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; SUHR ST, 1989, MOL ENDOCRINOL, V3, P1693, DOI 10.1210/mend-3-11-1693; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; UNDERWOOD L E, 1985, P155; WILSON DB, 1988, ACTA ANAT, V131, P150	56	323	326	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					227	232		10.1038/ng0793-227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	WOS:A1993LJ84200008	8395283				2022-01-24	
J	HUDSON, RR; KAPLAN, NL				HUDSON, RR; KAPLAN, NL			THE COALESCENT PROCESS IN MODELS WITH SELECTION AND RECOMBINATION	GENETICS			English	Article									NIEHS,RES TRIANGLE PK,NC 27709								AQUADRO CF, 1986, GENETICS, V114, P1165; CHOVNICK A, 1977, CELL, V11, P1, DOI 10.1016/0092-8674(77)90312-9; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; KAPLAN N, 1985, THEOR POPUL BIOL, V28, P382, DOI 10.1016/0040-5809(85)90036-X; KAPLAN NL, 1988, GENETICS, V120, P831; KARLIN S, 1981, 2ND COURSE STOCHASTI; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; KREITMAN ME, 1986, GENETICS, V114, P93; LANGLEY CH, 1982, P NATL ACAD SCI-BIOL, V79, P5631, DOI 10.1073/pnas.79.18.5631; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; STROBECK C, 1983, GENETICS, V103, P545	12	323	328	0	20	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	NOV	1988	120	3					831	840					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7583	WOS:A1988Q758300023	3147214				2022-01-24	
J	Si, LZ; Chen, JY; Huang, XH; Gong, H; Luo, JH; Hou, QQ; Zhou, TY; Lu, TT; Zhu, JJ; Shangguan, YY; Chen, EW; Gong, CX; Zhao, Q; Jing, YF; Zhao, Y; Li, Y; Cui, LL; Fan, DL; Lu, YQ; Weng, QJ; Wang, YC; Zhan, QL; Liu, KY; Wei, XH; An, K; An, G; Han, B				Si, Lizhen; Chen, Jiaying; Huang, Xuehui; Gong, Hao; Luo, Jianghong; Hou, Qingqing; Zhou, Taoying; Lu, Tingting; Zhu, Jingjie; Shangguan, Yingying; Chen, Erwang; Gong, Chengxiang; Zhao, Qiang; Jing, Yufeng; Zhao, Yan; Li, Yan; Cui, Lingling; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Wang, Yongchun; Zhan, Qilin; Liu, Kunyan; Wei, Xinghua; An, Kyungsook; An, Gynheung; Han, Bin			OsSPL13 controls grain size in cultivated rice	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; NATURAL VARIATION; DNA-BINDING; PLANT ARCHITECTURE; VARIATION REVEALS; CELL ELONGATION; GENETIC-CONTROL; TRANSITION; EXPRESSION	Although genetic diversity has a cardinal role in domestication, abundant natural allelic variations across the rice genome that cause agronomically important differences between diverse varieties have not been fully explored. Here we implement an approach integrating genome-wide association testing with functional analysis on grain size in a diverse rice population. We report that a major quantitative trait locus, GLW7, encoding the plant-specific transcription factor OsSPL13, positively regulates cell size in the grain hull, resulting in enhanced rice grain length and yield. We determine that a tandem-repeat sequence in the 5'UTR of OsSPL13 alters its expression by affecting transcription and translation and that high expression of OsSPL13 is associated with large grains in tropical japonica rice. Further analysis indicates that the large-grain allele of GLW7 in tropical japonica rice was introgressed from indica varieties under artificial selection. Our study demonstrates that new genes can be effectively identified on the basis of genome-wide association data.	[Si, Lizhen; Chen, Jiaying; Huang, Xuehui; Gong, Hao; Luo, Jianghong; Hou, Qingqing; Zhou, Taoying; Lu, Tingting; Zhu, Jingjie; Shangguan, Yingying; Chen, Erwang; Gong, Chengxiang; Zhao, Qiang; Jing, Yufeng; Zhao, Yan; Li, Yan; Cui, Lingling; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Wang, Yongchun; Zhan, Qilin; Liu, Kunyan; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Wei, Xinghua] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [An, Kyungsook; An, Gynheung] Kyung Hee Univ, Crop Biotech Inst, Yongin, South Korea		Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn		Han, Bin/0000-0001-8695-0274; gong, hao/0000-0002-0327-6673	Chinese Academy of SciencesChinese Academy of Sciences [XDA08020101]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91535202, 31421093]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2013CBA01404]	We thank J. Wang and W. Cai for help in the construction of the MIM156 vector, K. Chong (Institute of Botany, Chinese Academy of Sciences) for providing the pTCK303 vector, P. Hu and G. Jiao for the measurements of grain quality, and J. Li, Xiaoyan Gao and Xiaoshu Gao for microscopy experiments. This work was supported by the Chinese Academy of Sciences (XDA08020101), the National Natural Science Foundation of China (91535202 and 31421093) and the Ministry of Science and Technology of China (2013CBA01404).	Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; BENHAJSALAH H, 1995, PLANT PHYSIOL, V109, P861, DOI 10.1104/pp.109.3.861; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Catterou M, 2001, PLANTA, V212, P673, DOI 10.1007/s004250000467; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Park CH, 2010, PHYTOCHEMISTRY, V71, P380, DOI 10.1016/j.phytochem.2009.11.003; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yamasaki K, 2004, J MOL BIOL, V337, P49, DOI 10.1016/j.jmb.2004.01.015; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	49	322	370	26	282	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					447	+		10.1038/ng.3518			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	WOS:000372908800016	26950093		Y	N	2022-01-24	
J	Frattini, V; Trifonov, V; Chan, JM; Castano, A; Lia, M; Abate, F; Keir, ST; Ji, AX; Zoppoli, P; Niola, F; Danussi, C; Dolgalev, I; Porrati, P; Pellegatta, S; Heguy, A; Gupta, G; Pisapia, DJ; Canoll, P; Bruce, JN; McLendon, RE; Yan, H; Aldape, K; Finocchiaro, G; Mikkelsen, T; Prive, GG; Bigner, DD; Lasorella, A; Rabadan, R; Iavarone, A				Frattini, Veronique; Trifonov, Vladimir; Chan, Joseph Minhow; Castano, Angelica; Lia, Marie; Abate, Francesco; Keir, Stephen T.; Ji, Alan X.; Zoppoli, Pietro; Niola, Francesco; Danussi, Carla; Dolgalev, Igor; Porrati, Paola; Pellegatta, Serena; Heguy, Adriana; Gupta, Gaurav; Pisapia, David J.; Canoll, Peter; Bruce, Jeffrey N.; McLendon, Roger E.; Yan, Hai; Aldape, Ken; Finocchiaro, Gaetano; Mikkelsen, Tom; Prive, Gilbert G.; Bigner, Darell D.; Lasorella, Anna; Rabadan, Raul; Iavarone, Antonio			The integrated landscape of driver genomic alterations in glioblastoma	NATURE GENETICS			English	Article							UBIQUITIN LIGASE HUWE1; HIGH-GRADE GLIOMA; DELTA-CATENIN; SOMATIC MUTATIONS; ADAPTER PROTEIN; BRAIN-TUMORS; RECEPTOR; CANCER; BCOR; DIFFERENTIATION	Glioblastoma is one of the most challenging forms of cancer to treat. Here we describe a computational platform that integrates the analysis of copy number variations and somatic mutations and unravels the landscape of in-frame gene fusions in glioblastoma. We found mutations with loss of heterozygosity in LZTR1, encoding an adaptor of CUL3-containing E3 ligase complexes. Mutations and deletions disrupt LZTR1 function, which restrains the self renewal and growth of glioma spheres that retain stem cell features. Loss-of-function mutations in CTNND2 target a neural-specific gene and are associated with the transformation of glioma cells along the very aggressive mesenchymal phenotype. We also report recurrent translocations that fuse the coding sequence of EGFR to several partners, with EGFR-SEPT14 being the most frequent functional gene fusion in human glioblastoma. EGFR-SEPT14 fusions activate STAT3 signaling and confer mitogen independence and sensitivity to EGFR inhibition. These results provide insights into the pathogenesis of glioblastoma and highlight new targets for therapeutic intervention.	[Frattini, Veronique; Castano, Angelica; Lia, Marie; Zoppoli, Pietro; Niola, Francesco; Danussi, Carla; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA; [Trifonov, Vladimir; Chan, Joseph Minhow; Abate, Francesco; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Chan, Joseph Minhow; Abate, Francesco; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Abate, Francesco] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Keir, Stephen T.; McLendon, Roger E.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA; [Keir, Stephen T.; McLendon, Roger E.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Durham, NC USA; [Keir, Stephen T.; McLendon, Roger E.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ji, Alan X.; Prive, Gilbert G.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Dolgalev, Igor; Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Porrati, Paola; Pellegatta, Serena; Finocchiaro, Gaetano] Ist Neurol C Besta, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Gupta, Gaurav; Bruce, Jeffrey N.] Columbia Univ, Med Ctr, Dept Neurosurg, New York, NY USA; [Pisapia, David J.; Canoll, Peter; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA; [Aldape, Ken] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Prive, Gilbert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA		Lasorella, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA.	al2179@columbia.edu; rabadan@dbmi.columbia.edu; ai2102@columbia.edu	Pellegatta, Serena/AAL-3693-2021; Finocchiaro, Gaetano/AAG-6791-2020; Zoppoli, Pietro/J-9954-2018; Rabadan, Raul/AAZ-7367-2020; Bruce, Jeffrey N/AAC-5307-2022; Dolgalev, Igor/AAY-6406-2020	Pellegatta, Serena/0000-0001-7804-9486; Zoppoli, Pietro/0000-0002-7860-9655; Dolgalev, Igor/0000-0003-4451-126X; Iavarone, Antonio/0000-0002-0683-4634; Rabadan, Raul/0000-0001-7946-9255; Finocchiaro, Gaetano/0000-0003-3583-4040; Chan, Joseph/0000-0001-5249-7395; Prive, Gilbert/0000-0002-0712-4319	National Cancer Institute [R01CA101644, R01CA131126, R01CA085628, R01CA127643]; Stewart Foundation; Partnership for Cure; US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 1 P50 MH094267-01]; Lymphoma Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 U54 CA121852-05, 1R01CA164152-01]; Leukemia and Lymphoma Society; Canadian Cancer Society; Cancer Research Society; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061776]; Chemotherapy Foundation; Associazione Italiana per la Ricerca sul CancroFondazione AIRC per la ricerca sul cancro; Italian Ministry of HealthMinistry of Health, Italy; Italian Ministry of Welfare/Provincia di Benevento; Federazione Italiana Associazioni Genitori Oncoematologia Pedriatica (FIAGOP); NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA085628, U54CA121852, P30CA016672, R01CA131126, R01CA190891, R01CA101644, R01CA179044, R01CA164152, R01CA127643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH094267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061776, R01NS066955, R01NS073610] Funding Source: NIH RePORTER	This work was supported by National Cancer Institute grants R01CA101644 and R01CA131126 (A. L.) and R01CA085628 and R01CA127643 (A. I.), the Stewart Foundation (R. R.), the Partnership for Cure (R. R.), US National Institutes of Health (NIH) grant NIH 1 P50 MH094267-01 (R. R.), the Lymphoma Research Foundation (R. R.), NIH 1 U54 CA121852-05 (R. R.), NIH 1R01CA164152-01 (R. R.), the Leukemia and Lymphoma Society (R. R.), the Canadian Cancer Society (G. G. P.), the Cancer Research Society (G. G. P.), the National Institute of Neurological Disorders and Stroke R01NS061776 (A. I.) and a grant from The Chemotherapy Foundation (A. I.). G. F. was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and from the Italian Ministry of Health. V. F., P.Z., C. D. and F.N. are supported by fellowships from the Italian Ministry of Welfare/Provincia di Benevento and the Federazione Italiana Associazioni Genitori Oncoematologia Pedriatica (FIAGOP) (C. D.). We thank J. Parkinson for helpful discussions on the phylogeny of LZTR1 genes, L. Bertin for help with protein blots, J. Kroll (Tumor Biology Center, Freiburg) for the LZTR1 plasmids and M. Pagano (New York University) for CUL3 expression plasmids.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chinnaiyan AM, 2010, PROG MOL BIOL TRANSL, V95, P55, DOI 10.1016/B978-0-12-385071-3.00004-6; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; FRIEDMAN HS, 1988, CANCER RES, V48, P4189; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Liu C, 2011, CARCINOGENESIS, V32, P129, DOI 10.1093/carcin/bgq224; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Nacak TG, 2006, J BIOL CHEM, V281, P5065, DOI 10.1074/jbc.M509073200; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pierotti MA, 2006, CANCER LETT, V232, P90, DOI 10.1016/j.canlet.2005.07.043; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	65	322	330	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1141	U270		10.1038/ng.2734			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	WOS:000324989600009	23917401	Green Accepted			2022-01-24	
J	Wang, ZY; Fang, BP; Chen, JY; Zhang, XJ; Luo, ZX; Huang, LF; Chen, XL; Li, YJ				Wang, Zhangying; Fang, Boping; Chen, Jingyi; Zhang, Xiongjian; Luo, Zhongxia; Huang, Lifei; Chen, Xinliang; Li, Yujun			De novo assembly and characterization of root transcriptome using Illumina paired-end sequencing and development of cSSR markers in sweetpotato (Ipomoea batatas)	BMC GENOMICS			English	Article							EST-SSR MARKERS; MICROSATELLITE MARKERS; SNP DISCOVERY; GENOME; GENERATION; GENES; BIOSYNTHESIS; POLYMORPHISM; EXPRESSION; ALIGNMENT	Background: The tuberous root of sweetpotato is an important agricultural and biological organ. There are not sufficient transcriptomic and genomic data in public databases for understanding of the molecular mechanism underlying the tuberous root formation and development. Thus, high throughput transcriptome sequencing is needed to generate enormous transcript sequences from sweetpotato root for gene discovery and molecular marker development. Results: In this study, more than 59 million sequencing reads were generated using Illumina paired-end sequencing technology. De novo assembly yielded 56,516 unigenes with an average length of 581 bp. Based on sequence similarity search with known proteins, a total of 35,051 (62.02%) genes were identified. Out of these annotated unigenes, 5,046 and 11,983 unigenes were assigned to gene ontology and clusters of orthologous group, respectively. Searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG) indicated that 17,598 (31.14%) unigenes were mapped to 124 KEGG pathways, and 11,056 were assigned to metabolic pathways, which were well represented by carbohydrate metabolism and biosynthesis of secondary metabolite. In addition, 4,114 cDNA SSRs (cSSRs) were identified as potential molecular markers in our unigenes. One hundred pairs of PCR primers were designed and used for validation of the amplification and assessment of the polymorphism in genomic DNA pools. The result revealed that 92 primer pairs were successfully amplified in initial screening tests. Conclusion: This study generated a substantial fraction of sweetpotato transcript sequences, which can be used to discover novel genes associated with tuberous root formation and development and will also make it possible to construct high density microarrays for further characterization of gene expression profiles during these processes. Thousands of cSSR markers identified in the present study can enrich molecular markers and will facilitate marker-assisted selection in sweetpotato breeding. Overall, these sequences and markers will provide valuable resources for the sweetpotato community. Additionally, these results also suggested that transcriptome analysis based on Illumina paired-end sequencing is a powerful tool for gene discovery and molecular marker development for non-model species, especially those with large and complex genome.	[Wang, Zhangying; Fang, Boping; Chen, Jingyi; Zhang, Xiongjian; Luo, Zhongxia; Huang, Lifei; Chen, Xinliang; Li, Yujun] Guangdong Acad Agr Sci, Crops Res Inst, Guangzhou 510640, Guangdong, Peoples R China		Fang, BP (corresponding author), Guangdong Acad Agr Sci, Crops Res Inst, Guangzhou 510640, Guangdong, Peoples R China.	bpfang01@163.com			earmarked fund for the National Modern Agro-industry Technology Research System [nycytx-16-B-5]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31000737]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [10151064001000018]; President Foundation of Guangdong Academy of Agricultural Sciences, China [201009]	We appreciate great advice and assistance on data analysis and comments from Dr. Xiaoping Chen. We would also like to thank the Beijing Genomics Institute now located in Shenzhen for assistance in raw data processing and related bioinformatics analysis. This work was supported by the earmarked fund for the National Modern Agro-industry Technology Research System (nycytx-16-B-5), the National Natural Science Foundation of China (No. 31000737), the Natural Science Foundation of Guangdong Province, China (No. 10151064001000018) and the President Foundation of Guangdong Academy of Agricultural Sciences, China (No. 201009).	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Baranenko V V, 2006, Tsitologiia, V48, P465; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bennett M. D, 2005, PLANT DNA C VALUES D; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Biastoff S, 2009, PHYTOCHEMISTRY, V70, P1708, DOI 10.1016/j.phytochem.2009.06.012; Buteler MI, 1999, THEOR APPL GENET, V99, P123, DOI 10.1007/s001220051216; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; HAHN SK, 1977, CROP SCI, V17, P559, DOI 10.2135/cropsci1977.0011183X001700040020x; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hannah LC, 2008, CURR OPIN BIOTECH, V19, P160, DOI 10.1016/j.copbio.2008.02.013; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hu JJ, 2004, BREEDING SCI, V54, P177, DOI 10.1270/jsbbs.54.177; Huang YW, 2010, TECHNOL CANCER RES T, V9, P139, DOI 10.1177/153303461000900203; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Kang Guo-Zhang, 2006, Yichuan, V28, P110; Li H, 1998, PLANT PHYSIOL, V118, P407, DOI 10.1104/pp.118.2.407; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Morozova O, 2008, BIOCHEM CELL BIOL, V86, P81, DOI 10.1139/O08-003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Roosens NH, 2005, PLANTA, V222, P716, DOI 10.1007/s00425-005-0006-1; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Ruchko M V, 1998, Ukr Biokhim Zh (1978), V70, P24; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tanaka M, 2005, J PLANT PHYSIOL, V162, P91, DOI 10.1016/j.jplph.2004.06.003; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu JK, 2004, GENOME, V47, P805, DOI 10.1139/G04-057; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574	69	322	356	6	106	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	DEC 24	2010	11								726	10.1186/1471-2164-11-726			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	702TI	WOS:000285918400001	21182800	Green Published, gold			2022-01-24	
J	Broske, AM; Vockentanz, L; Kharazi, S; Huska, MR; Mancini, E; Scheller, M; Kuhl, C; Enns, A; Prinz, M; Jaenisch, R; Nerlov, C; Leutz, A; Andrade-Navarro, MA; Jacobsen, SEW; Rosenbauer, F				Broeske, Ann-Marie; Vockentanz, Lena; Kharazi, Shabnam; Huska, Matthew R.; Mancini, Elena; Scheller, Marina; Kuhl, Christiane; Enns, Andreas; Prinz, Marco; Jaenisch, Rudolf; Nerlov, Claus; Leutz, Achim; Andrade-Navarro, Miguel A.; Jacobsen, Sten Eirik W.; Rosenbauer, Frank			DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; EPIGENETIC REGULATION; TRANSCRIPTION FACTORS; B-CELLS; PROGENITOR; MICE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; CANCER	DNA methylation is a dynamic epigenetic mark that undergoes extensive changes during differentiation of self-renewing stem cells. However, whether these changes are the cause or consequence of stem cell fate remains unknown. Here, we show that alternative functional programs of hematopoietic stem cells (HSCs) are governed by gradual differences in methylation levels. Constitutive methylation is essential for HSC self-renewal but dispensable for homing, cell cycle control and suppression of apoptosis. Notably, HSCs from mice with reduced DNA methyltransferase 1 activity cannot suppress key myeloerythroid regulators and thus can differentiate into myeloerythroid, but not lymphoid, progeny. A similar methylation dosage effect controls stem cell function in leukemia. These data identify DNA methylation as an essential epigenetic mechanism to protect stem cells from premature activation of predominant differentiation programs and suggest that methylation dynamics determine stem cell functions in tissue homeostasis and cancer.	[Broeske, Ann-Marie; Vockentanz, Lena; Huska, Matthew R.; Scheller, Marina; Kuhl, Christiane; Enns, Andreas; Leutz, Achim; Andrade-Navarro, Miguel A.; Rosenbauer, Frank] Max Delbruck Ctr Mol Med, Berlin, Germany; [Kharazi, Shabnam; Jacobsen, Sten Eirik W.] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, Lund, Sweden; [Mancini, Elena; Nerlov, Claus] Mouse Biol Unit, European Mol Biol Lab, Monterotondo, Italy; [Prinz, Marco] Univ Freiburg, Dept Neuropathol, Freiburg, Germany; [Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DU, England		Rosenbauer, F (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	f.rosenbauer@mdc-berlin.de	Jacobsen, Sten Eirik W/D-3974-2018; Leutz, Achim/K-9643-2013; Andrade, Miguel A/B-6565-2008	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Leutz, Achim/0000-0001-8259-927X; Andrade, Miguel A/0000-0001-6650-1711; Rosenbauer, Frank/0000-0001-7977-9421; Huska, Matthew/0000-0002-0912-745X	German Research FoundationGerman Research Foundation (DFG); German Cancer Aid (Mildred Scheel)Deutsche Krebshilfe; Helmholtz Association of German Research CentersHelmholtz Association; UK Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0501838, G0801073, G0701761] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0801073, G0701761, G0501838] Funding Source: UKRI	We thank V. Malchin, C. Graubmann and J. F. Zinke for their excellent technical assistance; J. Schoenheit for his help with real-time PCR; H. P. Rahn and Z. Ma for assistance with high-speed cell sorting; M. L. Cleary (Stanford University School of Medicine), S. Fillatreau (Deutsches Rheuma-Forschungszentrum), A. Muller (University of Wurzburg), K. Rajewsky (Harvard Medical School), M. Rehli (University of Regensburg), M. Tomasson (Washington University School of Medicine), B. L. Kee (University of Chicago) and T. Somervaille (Stanford University School of Medicine) for reagents; members of the Rosenbauer lab for discussions; D. G. Tenen for support during the initial phase of this study; and C. Plass, C. Muller-Tidow, C. Bonifer and D. G. Tenen for advice on the manuscript. This work was supported by grants from the German Research Foundation, the German Cancer Aid (Mildred Scheel) and the Helmholtz Association of German Research Centers to F. R. S. E. W. J. is the recipient of a strategic appointment grant from the UK Medical Research Council.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bottardi S, 2007, CELL CYCLE, V6, P1035, DOI 10.4161/cc.6.9.4208; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Domen Jos, 1998, Blood, V91, P2272; Ehlers A, 2008, LEUKEMIA, V22, P835, DOI 10.1038/leu.2008.12; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FIOTHO C, 2009, LEUKEMIA, V23, P1019; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KAIHO SI, 1985, ANAL BIOCHEM, V149, P117, DOI 10.1016/0003-2697(85)90483-X; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landgrebe J, 2002, GENOME BIOL, V3; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Ushijima T, 1997, P NATL ACAD SCI USA, V94, P2284, DOI 10.1073/pnas.94.6.2284; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	49	322	328	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1207	1215		10.1038/ng.463			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	WOS:000271247600013	19801979				2022-01-24	
J	Bourque, G; Leong, B; Vega, VB; Chen, X; Lee, YL; Srinivasan, KG; Chew, JL; Ruan, Y; Wei, CL; Ng, HH; Liu, ET				Bourque, Guillaume; Leong, Bernard; Vega, Vinsensius B.; Chen, Xi; Lee, Yen Ling; Srinivasan, Kandhadayar G.; Chew, Joon-Lin; Ruan, Yijun; Wei, Chia-Lin; Ng, Huck Hui; Liu, Edison T.			Evolution of the mammalian transcription factor binding repertoire via transposable elements	GENOME RESEARCH			English	Article							ENHANCER-BLOCKING ACTIVITY; EMBRYONIC STEM-CELLS; HUMAN GENOME; RESPONSE ELEMENTS; X-INACTIVATION; SITES; NETWORK; VERTEBRATE; REPEAT; MOUSE	Identification of lineage-specific innovations in genomic control elements is critical for understanding transcriptional regulatory networks and phenotypic heterogeneity. We analyzed, from an evolutionary perspective, the binding regions of seven mammalian transcription factors (ESR1, TP53, MYC, RELA, POU5F1, SOX2, and CTCF) identified on a genome-wide scale by different chromatin immunoprecipitation approaches and found that only a minority of sites appear to be conserved at the sequence level. Instead, we uncovered a pervasive association with genomic repeats by showing that a large fraction of the bona fide binding sites for five of the seven transcription factors ( ESR1, TP53, POU5F1, SOX2, and CTCF) are embedded in distinctive families of transposable elements. Using the age of the repeats, we established that these repeat-associated binding sites (RABS) have been associated with significant regulatory expansions throughout the mammalian phylogeny. We validated the functional significance of these RABS by showing that they are over-represented in proximity of regulated genes and that the binding motifs within these repeats have undergone evolutionary selection. Our results demonstrate that transcriptional regulatory networks are highly dynamic in eukaryotic genomes and that transposable elements play an important role in expanding the repertoire of binding sites.	[Bourque, Guillaume; Leong, Bernard; Vega, Vinsensius B.; Chen, Xi; Lee, Yen Ling; Srinivasan, Kandhadayar G.; Chew, Joon-Lin; Ruan, Yijun; Wei, Chia-Lin; Ng, Huck Hui; Liu, Edison T.] Genome Inst Singapore, Singapore 138672, Singapore		Bourque, G (corresponding author), Genome Inst Singapore, Singapore 138672, Singapore.	bourque@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009; Chen, Xi/C-6889-2012; Liu, Edison/C-4141-2008	NG, HUCK HUI/0000-0001-6352-8417; Chen, Xi/0000-0002-7995-6202; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502	Agency for Science, Technology and Research (A*STAR) of SingaporeAgency for Science Technology & Research (ASTAR)	We thank C. Feschotte for help in estimating the age of repeats, and N. Clarke, L. Lipovich, S. Prabhakar, and S. Pott for comments on the manuscript. This work was supported by the Agency for Science, Technology and Research (A*STAR) of Singapore.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Brosius J, 2003, GENETICA, V118, P99, DOI 10.1023/A:1024141306559; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chabot A, 2007, GENETICS, V176, P2069, DOI 10.1534/genetics.107.073429; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Pollard DA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-376; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Theuns J, 2000, HUM MOL GENET, V9, P325, DOI 10.1093/hmg/9.3.325; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tumpel S, 2006, P NATL ACAD SCI USA, V103, P5419, DOI 10.1073/pnas.0600993103; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	58	322	330	1	20	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2008	18	11					1752	1762		10.1101/gr.080663.108			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	367EU	WOS:000260536100008	18682548	Green Published, Bronze			2022-01-24	
J	Park, TJ; Mitchell, BJ; Abitua, PB; Kintner, C; Wallingford, JB				Park, Tae Joo; Mitchell, Brian J.; Abitua, Philip B.; Kintner, Chris; Wallingford, John B.			Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; SUBCELLULAR-LOCALIZATION; INTRAFLAGELLAR TRANSPORT; CENTRIOLE FORMATION; SIGNALING PATHWAYS; QUAIL OVIDUCT; POLARITY; CILIOGENESIS; WNT; EMBRYOS	The planar cell polarity (PCP) signaling system governs many aspects of polarized cell behavior. Here, we use an in vivo model of vertebrate mucociliary epithelial development to show that Dishevelled (Dvl) is essential for the apical positioning of basal bodies. We find that Dvl and Inturned mediate the activation of the Rho GTPase specifically at basal bodies, and that these three proteins together mediate the docking of basal bodies to the apical plasma membrane. Moreover, we find that this docking involves a Dvl-dependent association of basal bodies with membrane-bound vesicles and the vesicle-trafficking protein, Sec8. Once docked, basal bodies again require Dvl and Rho for the planar polarization that underlies directional beating of cilia. These results demonstrate previously undescribed functions for PCP signaling components and suggest that a common signaling apparatus governs both apical docking and planar polarization of basal bodies.	[Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA; [Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mitchell, Brian J.; Kintner, Chris] Salk Inst Biol Studies, La Jolla, CA 92186 USA		Wallingford, JB (corresponding author), Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	Park, Tae Joo/G-1460-2011	Park, Tae Joo/0000-0003-3176-177X; Abitua, Philip/0000-0002-8264-0807; Mitchell, Brian/0000-0001-6281-1536	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM074104, R01GM076507] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM074104-04, R01 GM076507-04, R01 GM074104-04S1, R01 GM076507, R01 GM074104] Funding Source: Medline		Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nokhbatolfoghahai M, 2005, J NAT HIST, V39, P887, DOI 10.1080/00222930400002937; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Raji AR, 2007, ANAT HISTOL EMBRYOL, V36, P10, DOI 10.1111/j.1439-0264.2006.00709.x; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SIVE HL, 2000, EARLY DEV XENOPUS IA; SOROKIN SP, 1968, J CELL SCI, V3, P207; STEINMAN RM, 1968, AM J ANAT, V122, P19, DOI 10.1002/aja.1001220103; Toskala E, 2005, AM J PHYSIOL-LUNG C, V289, pL454, DOI 10.1152/ajplung.00036.2005; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	50	322	328	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					871	879		10.1038/ng.104			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	WOS:000257166500022	18552847	Green Accepted			2022-01-24	
J	Cybulski, C; Gorski, B; Huzarski, T; Masojc, B; Mierzejewski, M; Debniak, T; Teodorczyk, U; Byrski, T; Gronwald, J; Matyjasik, J; Zlowocka, E; Lenner, M; Grabowska, E; Nej, K; Castaneda, J; Medrek, K; Szymanska, A; Szymanska, J; Kurzawski, G; Suchy, J; Oszurek, O; Witek, A; Narod, SA; Lubinski, J				Cybulski, C; Gorski, B; Huzarski, T; Masojc, B; Mierzejewski, M; Debniak, T; Teodorczyk, U; Byrski, T; Gronwald, J; Matyjasik, J; Zlowocka, E; Lenner, M; Grabowska, E; Nej, K; Castaneda, J; Medrek, K; Szymanska, A; Szymanska, J; Kurzawski, G; Suchy, J; Oszurek, O; Witek, A; Narod, SA; Lubinski, J			CHEK2 is a multiorgan cancer susceptibility gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; BREAST-CANCER; PROSTATE-CANCER; HEREDITARY BREAST; COLORECTAL-CANCER; MUTATIONS; 1100DELC; CHK2; RISK; CHEK2-ASTERISK-1100DELC	A single founder allele of the CHEK2 gene has been associated with predisposition to breast and prostate cancer in North America and Europe. The CHEK2 protein participates in the DNA damage response in many cell types and is therefore a good candidate for a multisite cancer susceptibility gene. Three founder alleles are present in Poland. Two of these result in a truncated CHEK2 protein, and the other is a missense substitution of an isoleucine for a threonine. We ascertained the prevalence of each of these alleles in 4,008 cancer cases and 4,000 controls, all from Poland. The majority of the common cancer sites were represented. Positive associations with protein-truncating alleles were seen for cancers of the thyroid (odds ratio [OR] 4.9; P = .0006), breast (OR 2.2; P = .02), and prostate (OR 2.2; P = .04). The missense variant I157T was associated with an increased risk of breast cancer (OR 1.4;), colon cancer (OR 2.0; P = .001), kidney cancer (OR 2.1; P = .0006), prostate cancer (OR 1.7; P = .02), and thyroid cancer (OR 1.9; P = .04). The range of cancers associated with mutations of the CHEK2 gene may be much greater than previously thought.	Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; Univ Szczecin, Interuniv Unit Mol Biol, Szczecin, Poland; Med Univ Silesia, Katowice, Poland		Narod, SA (corresponding author), Ctr Res Womens Hlth, 790 Bay St, Toronto, ON M5G 1N8, Canada.	steven.narod@sw.ca	Trubicka, Joanna/R-1215-2018; Huzarski, Tomasz/AAQ-2161-2021; BYRSKI, Tomasz/I-2844-2014; Szymanska-Pasternak, Jolanta/N-7184-2014; Narod, Steven A/AAA-6112-2022; Gronwald, Jacek/A-4576-2017; Kurzawski, Grzegorz/T-9225-2018	Trubicka, Joanna/0000-0002-9848-3674; Huzarski, Tomasz/0000-0003-3857-4854; BYRSKI, Tomasz/0000-0001-9181-5026; Szymanska-Pasternak, Jolanta/0000-0003-1643-6872; Gronwald, Jacek/0000-0002-3643-2871; Kurzawski, Grzegorz/0000-0002-2414-9868			Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Dufault MR, 2004, INT J CANCER, V110, P320, DOI 10.1002/ijc.20073; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Kilpivaara O, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e110; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Offit Kenneth, 2003, BMC Med Genet, V4, P1, DOI 10.1186/1471-2350-4-1; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Seppala EH, 2003, BRIT J CANCER, V89, P1966, DOI 10.1038/sj.bjc.6601425; Sodha N, 2000, Science, V289, P359; Vahteristo P, 2001, CANCER RES, V61, P5718	18	322	334	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1131	1135		10.1086/426403			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	WOS:000224866400018	15492928	Green Published, Bronze			2022-01-24	
J	Shimohata, T; Nakajima, T; Yamada, M; Uchida, C; Onodera, O; Naruse, S; Kimura, T; Koide, R; Nozaki, K; Sano, Y; Ishiguro, H; Sakoe, K; Ooshima, T; Sato, A; Ikeuchi, T; Oyake, M; Sato, T; Aoyagi, Y; Hozumi, I; Nagatsu, T; Takiyama, Y; Nishizawa, M; Goto, J; Kanazawa, I; Davidson, I; Tanese, N; Takahashi, H; Tsuji, S				Shimohata, T; Nakajima, T; Yamada, M; Uchida, C; Onodera, O; Naruse, S; Kimura, T; Koide, R; Nozaki, K; Sano, Y; Ishiguro, H; Sakoe, K; Ooshima, T; Sato, A; Ikeuchi, T; Oyake, M; Sato, T; Aoyagi, Y; Hozumi, I; Nagatsu, T; Takiyama, Y; Nishizawa, M; Goto, J; Kanazawa, I; Davidson, I; Tanese, N; Takahashi, H; Tsuji, S			Expanded polyglutamine stretches interact with TAF(II)130, interfering with CREB-dependent transcription	NATURE GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; NUCLEAR-LOCALIZATION; AGGREGATE FORMATION; MAMMALIAN-CELLS; ANDROGEN RECEPTOR; TRANSGENIC MICE; BINDING PROTEIN; DRPLA PROTEIN; PC12 CELLS; HUNTINGTIN	At least eight inherited neurodegenerative diseases are caused by expanded CAG repeats encoding polyglutamine (polyQ) stretches. Although cytotoxicities of expanded polyQ stretches are implicated, the molecular mechanisms of neurodegeneration remain unclear. We found that expanded! polyQ stretches preferentially bind to TAF(II)130, a coactivator involved in cAMP-responsive element binding protein (CREB)-dependent transcriptional activation, and strongly suppress CREB-dependent transcriptional activation. The suppression of CREB-dependent transcription and the cell death induced by polyQ stretches were restored by the co-expression of TAF(II)130. Our results indicate that interference of transcription by the binding of TAF(II)130 with expanded polyQ stretches is involved in the pathogenetic mechanisms underlying neurodegeneration.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan; Univ Tsukuba, TARA Ctr, Inst Appl Biochem, Tsukuba, Ibaraki, Japan; St Marianna Univ, Inst Med Sci, PRESTO JST, Kawasaki, Kanagawa, Japan; Hamamatsu Univ Sch Med, Dept Biochem, Shizuoka, Japan; Fujita Hlth Univ, Inst Comprehens Med Sci, Aichi, Japan; Jichi Med Sch, Dept Neurol, Jichi, Tochigi, Japan; Univ Tokyo, Fac Med, Inst Brain Res, Dept Neurol, Tokyo 113, Japan; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France; NYU Med Ctr, Dept Microbiol, New York, NY 10016 USA; NYU Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA		Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan.	tsuji@cc.niigaa-u.ac.jp	Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Tanese, Naoko/0000-0002-1946-3211; Hozumi, Isao/0000-0003-0984-6291; Davidson, Irwin/0000-0001-5533-1171; OHSHIMA, Takayuki/0000-0002-1501-6430; Sato, Toshiya/0000-0001-7844-9930			Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DESOUZA EB, 1987, BRAIN RES, V437, P355, DOI 10.1016/0006-8993(87)91651-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koyano S, 1999, NEUROSCI LETT, V273, P117, DOI 10.1016/S0304-3940(99)00656-4; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li SH, 1999, J NEUROSCI, V19, P5159; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Miyashita T, 1998, BIOCHEM BIOPH RES CO, V249, P96, DOI 10.1006/bbrc.1998.9096; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moulder KL, 1999, J NEUROSCI, V19, P705; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Parker D, 1996, MOL CELL BIOL, V16, P694; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; SAPP E, 1995, NEUROSCIENCE, V64, P397, DOI 10.1016/0306-4522(94)00427-7; Sato A, 1999, HUM MOL GENET, V8, P997, DOI 10.1093/hmg/8.6.997; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Timmers HJLM, 1996, BRAIN RES, V728, P141, DOI 10.1016/0006-8993(96)00080-7; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	48	322	328	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					29	36		10.1038/79139			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000013	10973244				2022-01-24	
J	Terauchi, Y; Tsuji, Y; Satoh, S; Minoura, H; Murakami, K; Okuno, A; Inukai, K; Asano, T; Kaburagi, Y; Ueki, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Sekihara, H; Yin, YX; Barrett, JC; Oda, H; Ishikawa, T; Akanuma, Y; Komuro, I; Suzuki, M; Yamamura, K; Kodama, T; Suzuki, H; Koyasu, S; Aizawa, S; Tobe, K; Fukui, Y; Yazaki, Y; Kadowaki, T				Terauchi, Y; Tsuji, Y; Satoh, S; Minoura, H; Murakami, K; Okuno, A; Inukai, K; Asano, T; Kaburagi, Y; Ueki, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Sekihara, H; Yin, YX; Barrett, JC; Oda, H; Ishikawa, T; Akanuma, Y; Komuro, I; Suzuki, M; Yamamura, K; Kodama, T; Suzuki, H; Koyasu, S; Aizawa, S; Tobe, K; Fukui, Y; Yazaki, Y; Kadowaki, T			Increased insulin sensitivity and hypoglycaemia in mice lacking the P85 alpha subunit of phosphoinositide 3-kinase	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASES; RAT ADIPOSE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; GROWTH-FACTOR; PROTEIN; SUBSTRATE-1; TRANSLOCATION	The hallmark of type 2 diabetes, the most common metabolic disorder, is a defect in insulin-stimulated glucose transport in peripheral tissues. Although a role for phosphoinositide-3-kinase (PI3K) activity in insulin-stimulated glucose transport and glucose transporter isoform 4 (Glut4) translocation has been suggested in vitro(1,2), its role in vive and the molecular link between activation of PI3K and translocation has not yet been elucidated. To determine the role of PI3K in glucose homeostasis, we generated mice with a targeted disruption of the gene encoding the p85 alpha regulatory subunit of PI3K (Pik3r1; refs 3-5). Pik3r1(-/-) mice showed increased insulin sensitivity and hypoglycaemia due to increased glucose transport in skeletal muscle and adipocytes. Insulin-stimulated PI3K activity associated with insulin receptor substrates (IRSs) was mediated via full-length p85 alpha in wild-type mice, but via the p50 alpha alternative splicing isoform of the same gene(6,7) in Pik3r1(-/-) mice. This isoform switch was associated with an increase in insulin-induced generation of phosphatidylinositol(3, 4, 5)triphosphate (PtdIns(3, 4, 5)P-3) in Pik3r1(-/-) adipocytes and facilitation of Glut4 translocation from the law-density microsome (LDM) fraction to the plasma membrane (PM). This mechanism seems to be responsible for the phenotype of Pik3r1(-/-) mice, namely increased glucose transport and hypoglycaemia. Our work provides the first direct evidence that PI3K and its regulatory subunit have a role in glucose homeostasis in vive.	Univ Tokyo, Dept Internal Med, Tokyo 1138655, Japan; Univ Tokyo, Dept Pathol, Tokyo 1138655, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 1138655, Japan; Univ Tokyo, Dept Appl Biol Chem, Biol Chem Lab, Tokyo 1138655, Japan; Osaka Univ, Dept Internal Med 2, Suita, Osaka 565, Japan; Yokohama City Univ, Dept Internal Med, Yokohama, Kanagawa 236, Japan; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 100, Japan; Kumamoto Univ, Sch Med, Lab Transgen Technol, Kumamoto 860, Japan; Kumamoto Univ, Sch Med, Dept Dev Genet, Kumamoto 860, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Morphogenesis, Kumamoto 860, Japan; Keio Univ, Sch Med, Dept Immunol, Tokyo 160, Japan		Kadowaki, T (corresponding author), Univ Tokyo, Dept Internal Med, Tokyo 1138655, Japan.		Terauchi, Yasuo/AAO-4347-2020; Suzuki, Harumi/L-1271-2013; Fukui, Yasuhisa/E-8806-2010; Koyasu, Shigeo/J-5583-2015	Suzuki, Harumi/0000-0003-3616-9361; Koyasu, Shigeo/0000-0001-9585-3038	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES050142] Funding Source: NIH RePORTER		Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; HARANO Y, 1981, J CLIN ENDOCR METAB, V52, P982, DOI 10.1210/jcem-52-5-982; Holman GD, 1997, DIABETOLOGIA, V40, P991, DOI 10.1007/s001250050780; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; KADOWAKI T, 1996, ENDOCR J, V43, P533; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PONS S, 1995, MOL CELL BIOL, V15, P4453; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; SATOH S, 1993, J BIOL CHEM, V268, P17820; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	28	322	328	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					230	235		10.1038/6023			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	WOS:000078399500030	9988280				2022-01-24	
J	Anderson, SE; Schlegel, BP; Nakajima, T; Wolpin, ES; Parvin, JD				Anderson, SE; Schlegel, BP; Nakajima, T; Wolpin, ES; Parvin, JD			BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; OVARIAN-CANCER; BREAST; DROSOPHILA	The breast cancer specific tumour suppressor protein, BRCA1 (refs 1,2), activates transcription when linked with a DNA-binding domain(3,4) and is a component of the RNA polymerase II (Pol II) holoenzyme(5,6). We show here that RNA helicase A (RHA) protein(7,8) links BRCA1 to the holoenzyme complex. The region of BRCA1 which interacts with RHA and, thus, the holoenzyme complex, corresponds to subregions of the BRCT domain of BRCA1 (ref. 9). This interaction was shown to occur in yeast nuclei, and expression in human cells of a truncated RHA molecule which retains binding to BRCA1 inhibited transcriptional activation mediated by the BRCA1 carboxy terminus. These data are the first to identify a specific protein interaction with the BRCA1 C-terminal domain and are consistent with the model that BRCA1 functions as a transcriptional coactivator.	Brigham & Womens Hosp, Dept Pathol, Div Mol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Tsukuba, Inst Appl Biochem, Ibaraki, Osaka 3058572, Japan		Parvin, JD (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Mol Oncol, 75 Francis St, Boston, MA 02115 USA.		Parvin, Jeffrey D/C-8955-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM053504] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM18829, GM53504] Funding Source: Medline		ASPENSTROM P, 1995, METHOD ENZYMOL, V256, P228; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LEE CG, 1993, J BIOL CHEM, V268, P16822; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Zhang SS, 1997, J BIOL CHEM, V272, P11487	17	322	329	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					254	256		10.1038/930			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	WOS:000074565900020	9662397				2022-01-24	
J	Ostergaard, P; Simpson, MA; Connell, FC; Steward, CG; Brice, G; Woollard, WJ; Dafou, D; Kilo, T; Smithson, S; Lunt, P; Murday, VA; Hodgson, S; Keenan, R; Pilz, DT; Martinez-Corral, I; Makinen, T; Mortimer, PS; Jeffery, S; Trembath, RC; Mansour, S				Ostergaard, Pia; Simpson, Michael A.; Connell, Fiona C.; Steward, Colin G.; Brice, Glen; Woollard, Wesley J.; Dafou, Dimitra; Kilo, Tatjana; Smithson, Sarah; Lunt, Peter; Murday, Victoria A.; Hodgson, Shirley; Keenan, Russell; Pilz, Daniela T.; Martinez-Corral, Ines; Makinen, Taija; Mortimer, Peter S.; Jeffery, Steve; Trembath, Richard C.; Mansour, Sahar			Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)	NATURE GENETICS			English	Article							MYELODYSPLASIA; CEBPA	We report an allelic series of eight mutations in GATA2 underlying Emberger syndrome, an autosomal dominant primary lymphedema associated with a predisposition to acute myeloid leukemia. GATA2 is a transcription factor that plays an essential role in gene regulation during vascular development and hematopoietic differentiation. Our findings indicate that haploinsufficiency of GATA2 underlies primary lymphedema and predisposes to acute myeloid leukemia in this syndrome.	[Brice, Glen; Hodgson, Shirley; Mansour, Sahar] St Georges Univ London, SW Thames Reg Genet Serv, London, England; [Ostergaard, Pia; Jeffery, Steve] St Georges Univ London, Med Genet Unit, London, England; [Simpson, Michael A.; Woollard, Wesley J.; Dafou, Dimitra; Trembath, Richard C.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London WC2R 2LS, England; [Connell, Fiona C.] Guys Hosp, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, London SE1 9RT, England; [Steward, Colin G.] Royal Hosp Children, Bone Marrow Transplant Unit, Bristol, Avon, England; [Kilo, Tatjana] Childrens Hosp Westmead, Haematol Unit, Sydney, NSW, Australia; [Smithson, Sarah; Lunt, Peter] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Murday, Victoria A.] Yorkhill Hosp, Dept Clin Genet, Glasgow, Lanark, Scotland; [Keenan, Russell] Alder Hey Childrens Hosp, Dept Paediat Haematol, Liverpool L12 2AP, Merseyside, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Martinez-Corral, Ines; Makinen, Taija] Canc Res UK London Res Inst, Lymphat Dev Lab, London, England; [Mortimer, Peter S.] St Georges Univ London, Dept Cardiac & Vasc Sci, London, England		Mansour, S (corresponding author), St Georges Univ London, SW Thames Reg Genet Serv, London, England.	smansour@sgul.ac.uk	Makinen, Taija/C-5765-2014; Ostergaard, Pia/H-8522-2019; Martinez-Corral, Ines/F-1799-2016; Lunt, Peter/AAF-8265-2020; Simpson, Michael/F-4737-2011	Makinen, Taija/0000-0002-9338-1257; Ostergaard, Pia/0000-0002-2190-1356; Martinez-Corral, Ines/0000-0001-9194-2412; Simpson, Michael/0000-0002-8539-8753; Dafou, Dimitra/0000-0003-4170-0612; Trembath, Richard/0000-0003-0550-3400; Steward, Colin/0000-0001-6291-0710	British Heart Foundation (BHF)British Heart Foundation [RG/08/006/25302, PG/10/58/28477, FS/06/063/21445]; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research CentreNational Institute for Health Research (NIHR); British Heart FoundationBritish Heart Foundation [PG/10/58/28477, RG/08/006/25302] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10379] Funding Source: researchfish	This study has been made possible by the commitment and courage of the families concerned, and we are indebted to them. This work was supported by the British Heart Foundation (BHF) grants RG/08/006/25302, PG/10/58/28477 and FS/06/063/21445. The authors also acknowledge support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. This research utilized the resources of the Biomics Unit at St George's University of London. We also thank T. Enver, University College London Cancer Institute, London for kindly providing the GATA2 reporter constructs.	Callier P, 2009, AM J MED GENET A, V149A, P1323, DOI 10.1002/ajmg.a.32857; DICKINSON RE, 2011, BLOOD           0715, DOI DOI 10.1182/BLOOD-2011-06-360313; Haugas M, 2010, DEV DYNAM, V239, P2452, DOI 10.1002/dvdy.22373; HSU AP, 2011, BLOOD           0613, DOI DOI 10.1182/BLOOD-2011-05-356352; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Mansour S, 2010, AM J MED GENET A, V152A, P2287, DOI 10.1002/ajmg.a.33445; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Rodrigues NP, 2008, BLOOD, V112, P4862, DOI 10.1182/blood-2008-01-136564; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	15	321	329	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					929	931		10.1038/ng.923			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	WOS:000295316200005	21892158	Green Submitted			2022-01-24	
J	Razzaque, MA; Nishizawa, T; Komoike, Y; Yagi, H; Furutani, M; Amo, R; Kamisago, M; Momma, K; Katayama, H; Nakagawa, M; Fujiwara, Y; Matsushima, M; Mizuno, K; Tokuyama, M; Hirota, H; Muneuchi, J; Higashinakagawa, T; Matsuoka, R				Razzaque, M. Abdur; Nishizawa, Tsutomu; Komoike, Yuta; Yagi, Hisato; Furutani, Michiko; Amo, Ryunosuke; Kamisago, Mitsuhiro; Momma, Kazuo; Katayama, Hiroshi; Nakagawa, Masao; Fujiwara, Yuko; Matsushima, Masaki; Mizuno, Katsumi; Tokuyama, Mika; Hirota, Hamao; Muneuchi, Jun; Higashinakagawa, Toru; Matsuoka, Rumiko			Germline gain-of-function mutations in RAF1 cause Noonan syndrome	NATURE GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; PROTEIN-KINASE-A; CARDIAC-HYPERTROPHY; SIGNALING PATHWAY; C-RAF; B-RAF; DISORDERS; PHENOTYPE; KRAS; ACTIVATION	Noonan syndrome is characterized by short stature, facial dysmorphia and a wide spectrum of congenital heart defects1,2. Mutations of PTPN11, KRAS and SOS1 in the RAS- MAPK pathway cause similar to 60% of cases of Noonan syndrome3-9. However, the gene(s) responsible for the remainder are unknown. We have identified five different mutations in RAF1 in ten individuals with Noonan syndrome; those with any of four mutations causing changes in the CR2 domain of RAF1 had hypertrophic cardiomyopathy (HCM), whereas affected individuals with mutations leading to changes in the CR3 domain did not. Cells transfected with constructs containing Noonan syndrome - associated RAF1 mutations showed increased in vitro kinase and ERK activation, and zebrafish embryos with morpholino knockdown of raf1 demonstrated the need for raf1 for the development of normal myocardial structure and function. Thus, our findings implicate RAF1 gain-of-function mutations as a causative agent of a human developmental disorder, representing a new genetic mechanism for the activation of the MAPK pathway.	Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan; Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan; Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Div Pediat Cardiol, Tokyo 1628666, Japan; Osaka Med Coll, Dept Pediat, Osaka, Japan; Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; Jikei Univ, Dept Pediat, Tokyo, Japan; Social Insurance Chukyo Hosp, Dept Pediat Cardiol, Aichi, Japan; Chiba Childrens Hosp, Dept Neonatol, Chiba, Japan; Toho Univ, Dept Pediat, Tokyo, Japan; Kitasato Univ, Dept Pediat, Kanagawa, Japan; Kyushu Univ, Dept Pediat, Fukuoka 812, Japan		Matsuoka, R (corresponding author), Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan.	rumiko@imcir.twmu.ac.jp		Razzaque, Md Abdur/0000-0002-5932-3432; Yagi, Hisato/0000-0003-1460-4043; Amo, Ryunosuke/0000-0001-8644-2296			ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Chan EYW, 2002, MOL CARCINOGEN, V33, P189, DOI 10.1002/mc.10031; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komoike Y, 2005, BIOCHEM BIOPH RES CO, V328, P858, DOI 10.1016/j.bbrc.2005.01.031; Kratz CP, 2006, CELL CYCLE, V5, P1607, DOI 10.4161/cc.5.15.3128; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Yamazaki T, 1997, J MOL CELL CARDIOL, V29, P2491, DOI 10.1006/jmcc.1997.0488; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	28	321	336	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1013	1017		10.1038/ng2078			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	WOS:000248446900020	17603482				2022-01-24	
J	Fischer, J; Lefevre, C; Morava, E; Mussini, JM; Laforet, P; Negre-Salvayre, A; Lathrop, M; Salvayre, R				Fischer, Judith; Lefevre, Caroline; Morava, Eva; Mussini, Jean-Marie; Laforet, Pascal; Negre-Salvayre, Anne; Lathrop, Mark; Salvayre, Robert			The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy	NATURE GENETICS			English	Article							CHANARIN-DORFMAN-SYNDROME; FAMILY-MEMBERS; LIPOLYSIS; METABOLISM; EXPRESSION; PROTEIN; CGI-58	Neutral lipid storage disease comprises a heterogeneous group of autosomal recessive disorders characterized by systemic accumulation of triglycerides in cytoplasmic droplets. Here we report a neutral lipid storage disease subgroup characterized by mild myopathy, absence of ichthyosis and mutations in both alleles of adipose triglyceride lipase (PNPLA2, also known as ATGL). Three of these mutations are predicted to lead to a truncated ATGL protein with an intact patatin domain containing the active site, but with defects in the hydrophobic domain. The block in triglyceride degradation was mimicked by short interfering RNA directed against ATGL. NLSDM is distinct from Chanarin-Dorfman syndrome, which is characterized by neutral lipid storage disease with ichthyosis, mild myopathy and hepatomegaly due to mutations in ABHD5 (also known as CGI-58).	Ctr Natl Genotypage, F-91057 Evry, France; Radboud Univ Nijmegen, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nantes, Ctr Hosp, Dept Internal Med, F-44093 Nantes, France; Grp Hosp Pitie Salpetriere, AP HP, Inst Myol, Ctr Ref Pathol Neuromusc, F-75651 Paris 13, France; CHU Rangueil, IFR 31, F-31432 Toulouse 04, France; Univ Toulouse 3, INSERM, U446, F-31432 Toulouse 04, France		Fischer, J (corresponding author), Ctr Natl Genotypage, F-91057 Evry, France.	fischer@cng.fr; salvayre@toulouse.inserm.fr	Morava, E./L-4529-2015; Fischer, Judith/E-6327-2016	Fischer, Judith/0000-0002-8580-8118; Negre-Salvayre, Anne/0000-0003-2136-5706			CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JORDANS GHW, 1953, ACTA MED SCAND, V145, P419; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; RADOM J, 1987, EUR J BIOCHEM, V164, P703, DOI 10.1111/j.1432-1033.1987.tb11183.x; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	15	321	339	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					28	30		10.1038/ng1951			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	WOS:000243136500014	17187067				2022-01-24	
J	Irobi, J; Van Impe, K; Seeman, P; Jordanova, A; Dierick, I; Verpoorten, N; Michalik, A; De Vriendt, E; Jacobs, A; Van Gerwen, V; Vennekens, K; Mazanec, R; Tournev, I; Hilton-Jones, D; Talbot, K; Kremensky, N; Van Den Bosch, L; Robberecht, W; Vandekerckhove, J; Van Broeckhoven, C; Gettemans, J; De Jonghe, P; Timmerman, V				Irobi, J; Van Impe, K; Seeman, P; Jordanova, A; Dierick, I; Verpoorten, N; Michalik, A; De Vriendt, E; Jacobs, A; Van Gerwen, V; Vennekens, K; Mazanec, R; Tournev, I; Hilton-Jones, D; Talbot, K; Kremensky, N; Van Den Bosch, L; Robberecht, W; Vandekerckhove, J; Van Broeckhoven, C; Gettemans, J; De Jonghe, P; Timmerman, V			Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; ALPHA-A-CRYSTALLIN; HMN-II; MISSENSE MUTATION; CANDIDATE GENES; UP-REGULATION; PROTEIN; HSP27; MEMBER; SUPERFAMILY	Distal hereditary motor neuropathies are pure motor disorders of the peripheral nervous system resulting in severe atrophy and wasting of distal limb muscles'. In two pedigrees with distal hereditary motor neuropathy type II linked to chromosome 12q24.3, we identified the same mutation (K141N) in small heat-shock 22-kDa protein 8 (encoded by HSPB8; also called HSP22). We found a second mutation (K141E) in two smaller families. Both mutations target the same amino acid, which is essential to the structural and functional integrity of the small heat-shock protein alphaA-crystallin(2). This positively charged residue, when mutated in other small heat-shock proteins, results in various human disorders(.)(3,4) Coimmunoprecipitation experiments showed greater binding of both HSPB8 mutants to the interacting partner HSPB1. Expression of mutant HSPB8 in cultured cells promoted formation of intracellular aggregates. Our findings provide further evidence that mutations in heat-shock proteins have an important role in neurodegenerative disorders.	Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; State Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Charles Univ Prague, Sch Med 2, Dept Child Neurol, Prague, Czech Republic; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Charles Univ Prague, Sch Med 2, Dept Neurol, Prague, Czech Republic; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 2JD, England; Katholieke Univ Leuven, Dept Expt Neurol, Neurobiol Lab, Louvain, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium		Timmerman, V (corresponding author), Univ Instelling Antwerp VIB, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Jordanova, Albena/H-8323-2015; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019; Timmerman, Vincent/O-7283-2019; Talbot, Kevin/F-7361-2011; Van Den Bosch, Ludo/B-7258-2012	Jordanova, Albena/0000-0002-3833-3754; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Timmerman, Vincent/0000-0002-2162-0933; Van Den Bosch, Ludo/0000-0003-0104-4067; Talbot, Kevin/0000-0001-5490-1697			Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPER SW, 1990, NUCLEIC ACIDS RES, V18, P6457, DOI 10.1093/nar/18.21.6457; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; GETTEMANS J, 1995, J BIOL CHEM, V270, P2644, DOI 10.1074/jbc.270.6.2644; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; HARDING AE, 1980, J NEUROL SCI, V45, P337, DOI 10.1016/0022-510X(80)90177-X; Irobi J, 2000, GENOMICS, V65, P34, DOI 10.1006/geno.2000.6149; Irobi J, 2002, J PERIPHER NERV SYST, V7, P87, DOI 10.1046/j.1529-8027.2002.02014.x; Irobi J, 2001, ANN HUM GENET, V65, P517, DOI [10.1046/j.1469-1809.2001.6560517.x, 10.1017/S0003480001008910]; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; TIMMERMAN V, 1992, J NEUROL SCI, V109, P41, DOI 10.1016/0022-510X(92)90091-X; Timmerman V, 1996, HUM MOL GENET, V5, P1065, DOI 10.1093/hmg/5.7.1065; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	30	321	338	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					597	601		10.1038/ng1328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	WOS:000221763700016	15122253	Bronze			2022-01-24	
J	Hosono, S; Faruqi, AF; Dean, FB; Du, YF; Sun, ZY; Wu, XH; Du, J; Kingsmore, SF; Egholm, M; Lasken, RS				Hosono, S; Faruqi, AF; Dean, FB; Du, YF; Sun, ZY; Wu, XH; Du, J; Kingsmore, SF; Egholm, M; Lasken, RS			Unbiased whole-genome amplification directly from clinical samples	GENOME RESEARCH			English	Article							POLYMERASE CHAIN-REACTION; PHI-29 DNA-POLYMERASE; PRIMER; CANCER; DIAGNOSIS; FIDELITY; GENE; CELL; PCR; RNA	Preparation of genomic DNA from clinical samples is a bottleneck in genotyping and DNA sequencing analysis and is frequently limited by the amount of specimen available. We use Multiple Displacement Amplification (MDA) to amplify the whole genome 10,000-fold directly from small amounts of whole blood, dried blood, buccal cells, cultured cells, and buffy coats specimens, generating large amounts of DNA for genetic testing. Genomic DNA was evenly amplified with complete coverage and consistent representation of all genes. All 47 loci analyzed from 44 individuals were represented in the amplified DNA at between 0.5- and 3.0-fold of the copy number in the starting genomic DNA template. A high-fidelity DNA polymerase ensures accurate representation of the DNA sequence. The amplified DNA was indistinguishable from the original genomic DNA template in 5 SNP and 10 microsatellite DNA assays on three different clinical sample types for 20 individuals. Amplification of genomic DNA directly from cells is highly reproducible, eliminates the need for DNA template purification, and allows genetic testing from small clinical samples. The low amplification bias of MDA represents a dramatic technical improvement in the ability to amplify a whole genome compared with older, PCR-based methods.	Mol Staging Inc, New Haven, CT 06511 USA		Lasken, RS (corresponding author), Mol Staging Inc, New Haven, CT 06511 USA.	rogerl@molecularstaging.com		Dean, Frank/0000-0002-9416-4449; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631			Beaucage S. L., 2001, CURRENT PROTOCOLS NU; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Cheung VG, 1996, P NATL ACAD SCI USA, V93, P14676, DOI 10.1073/pnas.93.25.14676; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Eckert K A, 1991, PCR Methods Appl, V1, P17; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Euhus DM, 2002, J NATL CANCER I, V94, P858, DOI 10.1093/jnci/94.11.858; Harty LC, 2000, CANCER EPIDEM BIOMAR, V9, P501; HIGUCHI R, 1995, PCR TECHNOLOGY PRINC, P31; HOLDING C, 1989, LANCET, V2, P532; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; Nelson JR, 2002, BIOTECHNIQUES, P44; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Paunio T, 1996, CLIN CHEM, V42, P1382; Pollock PM, 2002, NATURE, V417, P906, DOI 10.1038/417906a; REES G., 1968, J MED LAB TECHNOL, V25, P117; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	27	321	340	1	31	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2003	13	5					954	964		10.1101/gr.816903			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	674PQ	WOS:000182645500022	12695328	Bronze, Green Published			2022-01-24	
J	Betran, E; Thornton, K; Long, M				Betran, E; Thornton, K; Long, M			Retroposed new genes out of the X in Drosophila	GENOME RESEARCH			English	Article							SEX-CHROMOSOMES; GERM-LINE; MELANOGASTER; EVOLUTION; ORIGIN; TESTIS; EXPRESSION; JINGWEI; GENOME; SPERMATOGENESIS	New genes that originated by various molecular mechanisms are an essential component in understanding the evolution of genetic systems. We investigated the pattern of origin of the genes created by retroposition in Drosophila. We surveyed the whole Drosophila melanogaster genome for such new retrogenes and experimentally analyzed their functionality and evolutionary process. These retrogenes, functional as revealed by the analysis of expression, substitution, and population genetics, show a surprisingly asymmetric pattern in their origin. There is a significant excess of retrogenes that originate from the X chromosome and retropose to autosomes; new genes retroposed from autosomes are scarce. Further, we found that most of these X-derived autosomal retrogenes had evolved a testis expression pattern. These observations may be explained by natural selection favoring those new retrogenes that moved to autosomes and avoided the spermatogenesis X inactivation, and suggest the important role of genome position for the origin of new genes.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA		Long, M (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	mlong@midway.uchicago.edu		Betran, Esther/0000-0002-4742-7963; Thornton, Kevin/0000-0003-0743-4445			Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; ASHBURNER M, 1989, DROSPHILA LAB HDB; Begun DJ, 1997, GENETICS, V145, P375; BOWNES M, 1990, MOL GEN GENET, V222, P457, DOI 10.1007/BF00633856; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; CASTRILLON DH, 1993, GENETICS, V135, P489; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Eddy EM, 1998, CURR TOP DEV BIOL, V37, P141; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; Hurst LD, 1999, TRENDS GENET, V15, P383, DOI 10.1016/S0168-9525(99)01809-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; LEMEUNIER F, 1976, P ROY SOC LOND B BIO, V193, P257; Li W.H., 1997, MOL EVOLUTION; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Long M, 1999, GENE, V238, P135, DOI 10.1016/S0378-1119(99)00229-2; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; MCCARREY JR, 1994, BIOSCIENCE, V44, P20, DOI 10.2307/1312402; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Ohno S., 1970, EVOLUTION GENE DUPLI; Pasyukova E, 1997, MOL GEN GENET, V255, P115, DOI 10.1007/s004380050479; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; POWELL JR, 1997, PROGR PROSPECTS EVOL, P355; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICE WR, 1984, EVOLUTION, V38, P735, DOI [10.2307/2408385, 10.1111/j.1558-5646.1984.tb00346.x]; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Thornton K, 2002, MOL BIOL EVOL, V19, P918, DOI 10.1093/oxfordjournals.molbev.a004149; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399; WATTERSON GA, 1983, GENETICS, V105, P745; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; [No title captured]	42	321	330	0	27	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2002	12	12					1854	1859		10.1101/gr.6049			6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	621PW	WOS:000179599400006	12466289	Green Published, Bronze			2022-01-24	
J	KEMP, CJ; WHELDON, T; BALMAIN, A				KEMP, CJ; WHELDON, T; BALMAIN, A			P53-DEFICIENT MICE ARE EXTREMELY SUSCEPTIBLE TO RADIATION-INDUCED TUMORIGENESIS	NATURE GENETICS			English	Article							WILD-TYPE P53; CHROMOSOMAL INSTABILITY; IONIZING-RADIATION; SKIN TUMORS; DNA-DAMAGE; CANCER; APOPTOSIS; GENE; TRANSMISSION; DEFICIENT	Mice constitutively lacking alleles of the p53 tumour suppressor gene spontaneously develop lymphomas and sarcomas. We report here that a single dose of 4 Gy radiation dramatically decreases the latency for tumour development in p53 heterozygous mice. The pattern of genetic alterations at the remaining wild type allele in these tumours differs substantially from spontaneous tumours from similar mice indicating that p53 itself may have been a target for radiation-induced alterations. Lower dose irradiation (1 Gy) of preweanling p53 null mice also significantly decreases tumour latency, suggesting that there are additional genetic targets involved in radiation-induced malignancy. Thus p53-deficient mice provide a sensitive model system for studies of the consequences of radiation exposure.	BEATSON INST CANC RES,CRC,BEATSON LABS,GLASGOW G61 1BD,SCOTLAND; DEPT MED ONCOL,GLASGOW G61 1BD,LANARK,SCOTLAND; DEPT RADIAT ONCOL & CLIN PHYS,GLASGOW G61 1BD,LANARK,SCOTLAND								BREIMER LH, 1988, BRIT J CANCER, V57, P6, DOI 10.1038/bjc.1988.2; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KEMP CJ, 1993, CANCER RES, V53, P6022; KENNEDY AR, 1980, P NATL ACAD SCI-BIOL, V77, P7262, DOI 10.1073/pnas.77.12.7262; KEURBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; LI FP, 1988, CANCER RES, V48, P5358; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARDER BA, 1993, MOL CELL BIOL, V13, P6667, DOI 10.1128/MCB.13.11.6667; MERRITT AJ, 1994, CANCER RES, V54, P614; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; PURDIE CA, 1994, ONCOGENE, V9, P603; SEARLE AG, 1989, LOW DOSE RAD BIOL BA, P123; SLICHENMYER WJ, 1993, CANCER RES, V53, P4164; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WISEMAN RW, 1994, P NATL ACAD SCI USA, V91, P3759, DOI 10.1073/pnas.91.9.3759; YI CH, 1992, MOL CARCINOG, V5, P270; 1988, UNSCEAR UN SCI COMMI	28	321	327	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					66	69		10.1038/ng0994-66			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	WOS:A1994PE15700017	7987394				2022-01-24	
J	SCHUPBACH, T; WIESCHAUS, E				SCHUPBACH, T; WIESCHAUS, E			FEMALE STERILE MUTATIONS ON THE 2ND CHROMOSOME OF DROSOPHILA-MELANOGASTER .1. MATERNAL EFFECT MUTATIONS	GENETICS			English	Article											SCHUPBACH, T (corresponding author), PRINCETON UNIV,DEPT BIOL,PRINCETON,NJ 08544, USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 15587] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD015587] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD015587] Funding Source: NIH RePORTER		ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; ANDERSON KV, 1984, NATURE, V311, P223, DOI 10.1038/311223a0; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; CLINE TW, 1978, GENETICS, V90, P683; COUNCE SJ, 1956, Z INDUKT ABSTAMM VER, V87, P462, DOI 10.1007/BF00737164; DEGELMANN A, 1986, DEV BIOL, V115, P479, DOI 10.1016/0012-1606(86)90268-X; FOE VE, 1983, J CELL SCI, V61, P31; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; GANS M, 1975, GENETICS, V81, P683; GARCIABELLIDO A, 1983, GENETICS, V103, P235; GARCIABELLIDO A, 1979, NATURE, V278, P346, DOI 10.1038/278346a0; GERTTULA S, 1988, GENETICS, V119, P123; HOPPE PE, 1986, CELL, V46, P773, DOI 10.1016/0092-8674(86)90353-3; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; ISNENGHI E, 1983, DEV BIOL, V98, P465, DOI 10.1016/0012-1606(83)90376-7; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KEMPHUES KJ, 1986, DEV BIOL, V113, P449, DOI 10.1016/0012-1606(86)90180-6; KLINGLER M, 1988, NATURE, V335, P275, DOI 10.1038/335275a0; KONRAD DD, 1988, DEV BIOL, V127, P133; KONRAD K, 1988, W ROUXS ARCH DEV BIO, V197, P75; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LEHMANN R, 1981, ROUX ARCH DEV BIOL, V190, P226, DOI 10.1007/BF00848307; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; Lewis E. B., 1968, DROS INFORM SERV, V43, P193; LINDALEY D, 1985, DROS INFORM SERV, V62, P1; LINDSLEY DL, 1987, DROS INFORM SERV, V65, P1; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MOHLER JD, 1977, GENETICS, V85, P259; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; PERRIMON N, 1985, DEV BIOL, V110, P480, DOI 10.1016/0012-1606(85)90105-8; PERRIMON N, 1986, GENETICS, V113, P695; PERRIMON N, 1984, DEV BIOL, V105, P404, DOI 10.1016/0012-1606(84)90297-5; Poulson DF, 1940, J EXP ZOOL, V83, P271, DOI 10.1002/jez.1400830207; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; RICE TB, 1975, DEV BIOL, V43, P277, DOI 10.1016/0012-1606(75)90027-5; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; SAWICKI JA, 1978, DEV BIOL, V63, P47, DOI 10.1016/0012-1606(78)90112-4; SCHUEPBACH T, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P302; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; STEPHENSON EC, 1987, DEV BIOL, V124, P1, DOI 10.1016/0012-1606(87)90453-2; STEWARD R, 1986, GENETICS, V113, P665; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; WAKIMOTO BT, 1984, DEV BIOL, V88, P92; WIESCHAUS E, 1986, Wilhelm Roux's Archives of Developmental Biology, V195, P63; Wieschaus E., 1986, P199; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; WRIGHT TRF, 1970, ADV GENET, V15, P262; YARGER RJ, 1971, DEV BIOL, V24, P166, DOI 10.1016/0012-1606(71)90093-5; ZUSMAN SB, 1987, GENETICS, V115, P725; ZUSMAN SB, 1985, DEV BIOL, V111, P359, DOI 10.1016/0012-1606(85)90490-7	57	321	322	0	8	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JAN	1989	121	1					101	117					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R6767	WOS:A1989R676700010	2492966				2022-01-24	
J	Fairfax, BP; Makino, S; Radhakrishnan, J; Plant, K; Leslie, S; Dilthey, A; Ellis, P; Langford, C; Vannberg, FO; Knight, JC				Fairfax, Benjamin P.; Makino, Seiko; Radhakrishnan, Jayachandran; Plant, Katharine; Leslie, Stephen; Dilthey, Alexander; Ellis, Peter; Langford, Cordelia; Vannberg, Fredrik O.; Knight, Julian C.			Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DETERMINANTS; PSORIASIS; SNP; VISUALIZATION; APOPTOSIS; COMPLEX	Trans-acting genetic variants have a substantial, albeit poorly characterized, role in the heritable determination of gene expression. Using paired purified primary monocytes and B cells, we identify new predominantly cell type-specific cis and trans expression quantitative trait loci (eQTLs), including multi-locus trans associations to LYZ and KLF4 in monocytes and B cells, respectively. Additionally, we observe a B cell-specific trans association of rs11171739 at 12q13.2, a known autoimmune disease locus, with IP6K2 (P = 5.8 x 10(-15)), PRIC285 (P = 3.0 x 10(-10)) and an upstream region of CDKN1A (P = 2 x 10(-52)), suggesting roles for cell cycle regulation and peroxisome proliferator-activated receptor gamma (PPAR gamma) signaling in autoimmune pathogenesis. We also find that specific human leukocyte antigen (HLA) alleles form trans associations with the expression of AOAH and ARHGAP24 in monocytes but not in B cells. In summary, we show that mapping gene expression in defined primary cell populations identifies new cell type-specific trans-regulated networks and provides insights into the genetic basis of disease susceptibility.	[Fairfax, Benjamin P.; Makino, Seiko; Radhakrishnan, Jayachandran; Plant, Katharine; Vannberg, Fredrik O.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Leslie, Stephen] Univ Oxford, Dept Oncol, Oxford, England; [Dilthey, Alexander] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Ellis, Peter; Langford, Cordelia] Univ Cambridge, Wellcome Trust Sanger Inst, Cambridge, England; [Vannberg, Fredrik O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA		Fairfax, BP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	bfairfax@well.ox.ac.uk; julian@well.ox.ac.uk	Knight, Julian Charles/W-2399-2019; Knight, Julian/C-7242-2009	Knight, Julian Charles/0000-0002-0377-5536; Knight, Julian/0000-0002-0377-5536; Radhakrishnan, Jayachandran/0000-0001-6009-1862; Fairfax, Benjamin/0000-0001-7413-5002	Wellcome TrustWellcome TrustEuropean Commission [074318, 088891, 075491/Z/04]; European Research Council under the European UnionEuropean Research Council (ERC) [FP7/2007-2013, 281824]; National Institute for Health Research (NIHR) Oxford Biomedical Research CentreNational Institute for Health Research (NIHR); National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2008-13-017] Funding Source: researchfish	We are very grateful to all the volunteers who participated in this study, together with members of the Knight laboratory and A. Hill for their support. We thank A. Auton for his assistance in the identification of probes containing SNPs with European MAF of >0.01% using the 1000 Genomes Project data set and to J. Broxholme for bioinformatic support and mapping of all probes to the reference sequence. We thank G. Gibson, A. Hill and colleagues for critical reading of the manuscript and helpful suggestions. This work was supported by the Wellcome Trust (074318 to J. C. K., 088891 to B. P. F. and 075491/Z/04 to the core facilities at the Wellcome Trust Centre for Human Genetics), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) (281824 to J. C. K.) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre.	Akino K, 2007, CANCER SCI, V98, P88, DOI 10.1111/j.1349-7006.2006.00351.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elstak ED, 2011, BLOOD, V118, P1570, DOI 10.1182/blood-2011-02-339523; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Kim K, 2009, GENES IMMUN, V10, P482, DOI 10.1038/gene.2009.5; KNOWLES RW, 1986, J IMMUNOL, V137, P2618; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; MUKAI R, 1984, J IMMUNOL, V133, P3211; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; TEDDER TF, 1989, J IMMUNOL, V143, P712; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomaru T, 2006, ENDOCRINOLOGY, V147, P377, DOI 10.1210/en.2005-0450; Van Laer L, 1998, NAT GENET, V20, P194; Vandiedonck C, 2011, GENOME RES, V21, P1042, DOI 10.1101/gr.116681.110; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu HP, 2008, BLOOD, V112, P1166, DOI 10.1182/blood-2007-06-098327; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	67	320	322	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					502	+		10.1038/ng.2205			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	WOS:000303416300008	22446964	Green Accepted			2022-01-24	
J	Xu, B; Roos, JL; Dexheimer, P; Boone, B; Plummer, B; Levy, S; Gogos, JA; Karayiorgou, M				Xu, Bin; Roos, J. Louw; Dexheimer, Phillip; Boone, Braden; Plummer, Brooks; Levy, Shawn; Gogos, Joseph A.; Karayiorgou, Maria			Exome sequencing supports a de novo mutational paradigm for schizophrenia	NATURE GENETICS			English	Article							PROTEIN-COUPLED RECEPTORS; POPULATION; VARIANTS; DISEASE; FAMILIES; SPECTRUM; LINKAGE	Despite its high heritability, a large fraction of individuals with schizophrenia do not have a family history of the disease (sporadic cases). Here we examined the possibility that rare de novo protein-altering mutations contribute to the genetic component of schizophrenia by sequencing the exomes of 53 sporadic cases, 22 unaffected controls and their parents. We identified 40 de novo mutations in 27 cases affecting 40 genes, including a potentially disruptive mutation in DGCR2, a gene located in the schizophrenia-predisposing 22q11.2 microdeletion region. A comparison to rare inherited variants indicated that the identified de novo mutations show a large excess of non-synonymous changes in schizophrenia cases, as well as a greater potential to affect protein structure and function. Our analyses suggest a major role for de novo mutations in schizophrenia as well as a large mutational target, which together provide a plausible explanation for the high global incidence and persistence of the disease.	[Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Xu, Bin; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Roos, J. Louw] Univ Pretoria, Weskoppies Hosp, ZA-0002 Pretoria, South Africa; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Dexheimer, Phillip; Boone, Braden; Plummer, Brooks; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA		Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	jag90@columbia.edu; mk2758@columbia.edu		Levy, Shawn/0000-0002-1369-5740; Roos, Johannes/0000-0002-0572-1072; Dexheimer, Phillip/0000-0003-3965-6894	National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research on Schizophrenia and Depression (NARSAD)French National Research Agency (ANR)NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH077235, R01MH061399] Funding Source: NIH RePORTER	We thank all the families who participated in this research. We also thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment, family history assessments and diagnostic evaluations. We thank Y. Sun for technical assistance with DNA extractions and sample preparations and J. Grun for information technology support. We also thank E. Fledderman and S. Thomas for support of the sequencing studies and M. Robinson for critical project support. This work was supported in part by National Institute of Mental Health (NIMH) grants MH061399 (to M. K.) and MH077235 (to J. A. G.) and the Lieber Center for Schizophrenia Research at Columbia University. B. X. was partially supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cruz MT, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00207; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gloriam DEI, 2005, BBA-GEN SUBJECTS, V1722, P235, DOI 10.1016/j.bbagen.2004.12.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V222, P144, DOI 10.1006/bbrc.1996.0712; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	35	320	334	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					864	U72		10.1038/ng.902			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	WOS:000294325800012	21822266	Green Accepted			2022-01-24	
J	Blow, MJ; McCulley, DJ; Li, ZR; Zhang, T; Akiyama, JA; Holt, A; Plajzer-Frick, I; Shoukry, M; Wright, C; Chen, F; Afzal, V; Bristow, J; Ren, B; Black, BL; Rubin, EM; Visel, A; Pennacchio, LA				Blow, Matthew J.; McCulley, David J.; Li, Zirong; Zhang, Tao; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Wright, Crystal; Chen, Feng; Afzal, Veena; Bristow, James; Ren, Bing; Black, Brian L.; Rubin, Edward M.; Visel, Axel; Pennacchio, Len A.			ChIP-Seq identification of weakly conserved heart enhancers	NATURE GENETICS			English	Article							REGULATORY ELEMENTS; GENOME; DATABASE; MECHANISMS; VERTEBRATE; CONSTRAINT; PROMOTERS; EVOLUTION; SEQUENCES; 1-PERCENT	Accurate control of tissue-specific gene expression plays a pivotal role in heart development, but few cardiac transcriptional enhancers have thus far been identified. Extreme noncoding-sequence conservation has successfully predicted enhancers that are active in many tissues but has failed to identify substantial numbers of heart-specific enhancers. Here, we used ChIP-Seq with the enhancer-associated protein p300 from mouse embryonic day 11.5 heart tissue to identify over 3,000 candidate heart enhancers genome wide. Compared to enhancers active in other tissues we studied at this time point, most candidate heart enhancers were less deeply conserved in vertebrate evolution. Nevertheless, transgenic mouse assays of 130 candidate regions revealed that most function reproducibly as enhancers active in the heart, irrespective of their degree of evolutionary constraint. These results provide evidence for a large population of poorly conserved heart enhancers and suggest that the evolutionary conservation of embryonic enhancers can vary depending on tissue type.	[Blow, Matthew J.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Visel, Axel; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Zhang, Tao; Wright, Crystal; Chen, Feng; Bristow, James; Rubin, Edward M.; Visel, Axel; Pennacchio, Len A.] Energy Joint Genome Inst, US Dept, Walnut Creek, CA USA; [McCulley, David J.; Black, Brian L.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; [McCulley, David J.; Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA		Visel, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA.	avisel@lbl.gov; lapennacchio@lbl.gov	Visel, Axel/A-9398-2009; Blow, Matthew/G-6369-2012; Visel, Axel/T-8573-2019	Visel, Axel/0000-0002-4130-7784; Blow, Matthew/0000-0002-8844-9149; Pennacchio, Len/0000-0002-8748-3732; Black, Brian/0000-0002-6664-8913	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL066681, HL64658, HL89707]; National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG003988]; Ludwig Institute for Cancer Research; Department of Energy, University of CaliforniaUnited States Department of Energy (DOE)University of California System [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL066681, R01HL064658, P01HL089707] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE019118] Funding Source: NIH RePORTER	The authors wish to thank R. Hosseini and S. Phouanenavong for technical support. L. A. P. and E. M. R. were supported by grant HL066681, Berkeley Program for Genomic Applications, which is funded by the National Heart, Lung, and Blood Institute. L. A. P. was also supported by grant HG003988, which is funded by the National Human Genome Research Institute. B. L. B was supported by grants HL64658 and HL89707 from the National Heart, Lung, and Blood Institute. B. R. is supported by funding from the National Human Genome Research Institute and the Ludwig Institute for Cancer Research. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and was performed under the Department of Energy Contract DE-AC02-05CH11231, University of California.	APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; SCHINKE M, 2009, GENOMICS CARDIOVASCU; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	45	320	326	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					806	U107		10.1038/ng.650			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	WOS:000281388400020	20729851	Green Submitted, Green Accepted			2022-01-24	
J	Chen, H; Patterson, N; Reich, D				Chen, Hua; Patterson, Nick; Reich, David			Population differentiation as a test for selective sweeps	GENOME RESEARCH			English	Article							RECENT POSITIVE SELECTION; HUMAN GENOME; MAP; RECOMBINATION; HITCHHIKING; NEUTRALITY; FREQUENCY; REGIONS; SAMPLE; MODEL	Selective sweeps can increase genetic differentiation among populations and cause allele frequency spectra to depart from the expectation under neutrality. We present a likelihood method for detecting selective sweeps that involves jointly modeling the multilocus allele frequency differentiation between two populations. We use Brownian motion to model genetic drift under neutrality, and a deterministic model to approximate the effect of a selective sweep on single nucleotide polymorphisms (SNPs) in the vicinity. We test the method with extensive simulated data, and demonstrate that in some scenarios the method provides higher power than previously reported approaches to detect selective sweeps, and can provide surprisingly good localization of the position of a selected allele. A strength of our technique is that it uses allele frequency differentiation between populations, which is much more robust to ascertainment bias in SNP discovery than methods based on the allele frequency spectrum. We apply this method to compare continentally diverse populations, as well as Northern and Southern Europeans. Our analysis identifies a list of loci as candidate targets of selection, including well-known selected loci and new regions that have not been highlighted by previous scans for selection.	[Chen, Hua; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chen, Hua; Patterson, Nick; Reich, David] MIT, Broad Inst, Cambridge, MA 02142 USA; [Chen, Hua; Patterson, Nick; Reich, David] Harvard Univ, Cambridge, MA 02142 USA		Chen, H (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	hchen@genetics.med.harvard.edu; reich@genetics.med.harvard.edu	chen, hua/B-4810-2012	Chen, Hua/0000-0002-9829-6561	Wellcome Career Development; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 HG004168, R21 AI064519]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21AI064519] Funding Source: NIH RePORTER	D. R. was supported by a Burroughs Wellcome Career Development Award in the Biomedical Sciences, and all authors were supported by NIH grants U01 HG004168 and R21 AI064519. We thank Alon Keinan, Alkes Price, and Pardis Sabeti for helpful discussions, and the anonymous reviewers for their valuable critiques. We thank Joseph Pickrell, Melisa Hubisz, and Steve Schaffner for assistance in running their software.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Fay JC, 2000, GENETICS, V155, P1405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1993, GENETICS, V133, P693; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; LEWONTIN RC, 1973, GENETICS, V74, P175; Lindsay, 1988, CONT MATH, V80, P221, DOI DOI 10.1090/CONM/080/999014; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Oleksyk TK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001712; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; TAJIMA F, 1989, GENETICS, V123, P585; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	36	320	328	10	70	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2010	20	3					393	402		10.1101/gr.100545.109			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	563JJ	WOS:000275124600011	20086244	Green Published, Bronze			2022-01-24	
J	Zhang, XJ; Huang, W; Yang, S; Sun, LD; Zhang, FY; Zhu, QX; Zhang, FR; Zhang, C; Du, WH; Pu, XM; Li, H; Xiao, FL; Wang, ZX; Cui, Y; Hao, F; Zheng, J; Yang, XQ; Cheng, H; He, CD; Liu, XM; Xu, LM; Zheng, HF; Zhang, SM; Zhang, JZ; Wang, HY; Cheng, YL; Ji, BH; Fang, QY; Li, YZ; Zhou, FS; Han, JW; Quan, C; Chen, B; Liu, JL; Li, D; Fan, L; Zhang, AP; Liu, SX; Yang, CJ; Wang, PG; Zhou, WM; Lin, GS; Wu, WD; Fan, X; Gao, M; Yang, BQ; Lu, WS; Zhang, Z; Zhu, KJ; Shen, SK; Li, M; Zhang, XY; Cao, TT; Ren, W; Zhang, X; He, J; Tang, XF; Lu, S; Yang, JQ; Zhang, L; Wang, DN; Yuan, F; Yin, XY; Huang, HJ; Wang, HF; Lin, XY; Liu, JJ				Zhang, Xue-Jun; Huang, Wei; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Fu-Ren; Zhang, Chi; Du, Wen-Hui; Pu, Xiong-Ming; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Hao, Fei; Zheng, Jie; Yang, Xue-Qin; Cheng, Hui; He, Chun-Di; Liu, Xiao-Ming; Xu, Li-Min; Zheng, Hou-Feng; Zhang, Shu-Mei; Zhang, Jian-Zhong; Wang, Hong-Yan; Cheng, Yi-Lin; Ji, Bi-Hua; Fang, Qiao-Yun; Li, Yu-Zhen; Zhou, Fu-Sheng; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Wu, Wei-Dong; Fan, Xing; Gao, Min; Yang, Bao-Qi; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Huang, Hong-Jie; Wang, Hai-Feng; Lin, Xin-Yi; Liu, Jian-Jun			Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21	NATURE GENETICS			English	Article							VULGARIS; IL12B; POLYMORPHISMS; POPULATION; PROTEINS; SEQUENCE; COMPLEX; IL23R; SKIN	We report the first large genome-wide association study (GWAS) in a Chinese population to identify susceptibility variants for psoriasis using a two-stage case-control design. In the first stage, we carried out a genome-wide association analysis in 1,139 cases and 1,132 controls of Chinese Han ancestry using Illumina Human 610-Quad BeadChips. In the second stage, we took top SNPs forward for replication in two independent samples of 5,182 cases and 6,516 controls of Chinese Han ancestry, and 539 cases and 824 controls of Chinese Uygur ancestry. In addition to the strong replication for two known susceptibility loci MHC (rs1265181, P 1.93 x 10(-208), OR = 22.62) and IL12B (rs3213094, P-combined = 2.58 x 10(-26), OR = 0.78), we identified a new susceptibility locus within the LCE gene cluster on 1q21 (rs4085613, P-combined = 6.69 x 10(-30), OR = 0.76).	[Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Chi; Du, Wen-Hui; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Cheng, Hui; Liu, Xiao-Ming; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Ji, Bi-Hua; Fang, Qiao-Yun; Li, Yu-Zhen; Zhou, Fu-Sheng; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Fan, Xing; Gao, Min; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Liu, Jian-Jun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Chi; Du, Wen-Hui; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Cheng, Hui; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Fan, Xing; Gao, Min; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Liu, Jian-Jun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Chi; Du, Wen-Hui; Pu, Xiong-Ming; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Cheng, Hui; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Fang, Qiao-Yun; Zhou, Fu-Sheng; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Fan, Xing; Gao, Min; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Liu, Jian-Jun] Minist Educ & Anhui Prov, Key Lab Gene Resource Utilizat Severe Dis, Hefei 230032, Anhui, Peoples R China; [Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Fu-Ren; Zhang, Chi; Du, Wen-Hui; Pu, Xiong-Ming; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Yang, Xue-Qin; Cheng, Hui; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Wu, Wei-Dong; Fan, Xing; Gao, Min; Yang, Bao-Qi; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong] Anhui Med Univ, Dept Dermatol & Venerol, Hefei 230032, Anhui, Peoples R China; [Huang, Wei; Huang, Hong-Jie; Wang, Hai-Feng] Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; [Huang, Wei; Huang, Hong-Jie; Wang, Hai-Feng] Natl Engn Ctr Biochip Design & Engineer, Shanghai 201203, Peoples R China; [Zhang, Feng-Yu; Yang, Bao-Qi] Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China; [Pu, Xiong-Ming; Wu, Wei-Dong] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Dermatol, Urumqi 830001, Xinjiang, Peoples R China; [Hao, Fei] Third Mil Med Univ, Dept Dermatol, Southwest Hosp, Chongqing 400038, Peoples R China; [Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Dept Dermatol, Ruijin Hosp, Shanghai 200025, Peoples R China; [Yang, Xue-Qin] Gen Hosp AF, Dept Dermatol, PLA, Beijing 100036, Peoples R China; [He, Chun-Di] China Med Univ, Dept Dermatol, Hosp 1, Shenyang 110001, Liaoning, Peoples R China; [Liu, Xiao-Ming] Dalian Med Univ, Dept Dermatol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China; [Xu, Li-Min] Changzheng Hosp, Dept Dermatol, Tianjin 300120, Peoples R China; [Zhang, Jian-Zhong] Peking Univ, Dept Dermatol, Peoples Hosp, Beijing 100044, Peoples R China; [Ji, Bi-Hua] Wannan Med Coll, Dept Dermatol, Yijishan Hosp, Wuhu 241000, Anhui, Peoples R China; [Li, Yu-Zhen] Harbin Med Coll, Dept Dermatol, Affiliated Hosp 2, Harbin 150086, Heilongjiang, Peoples R China; [Lin, Xin-Yi; Liu, Jian-Jun] Genome Inst Singapore, Singapore 138672, Singapore		Zhang, XJ (corresponding author), Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China.	ayzxj@vip.sina.com	Chen, Gang/G-2722-2010; Zhu, Kunju/AAN-5264-2020; Pillay, Nischalan/F-9536-2012; Zhu, Qixing/AAM-4214-2020; Zhang, Fengyu/M-1396-2019; Lin, Xinyi Cindy/D-8130-2019; Liu, Jianjun/AAK-4989-2020; Cui, Yong/AAF-9300-2020; Zheng, Houfeng/K-4424-2012	Zhu, Kunju/0000-0002-3649-209X; Zhang, Fengyu/0000-0001-8504-0770; Lin, Xinyi Cindy/0000-0002-7209-6588; Liu, Jianjun/0000-0002-3255-3019; Zheng, Houfeng/0000-0001-5681-8598	Anhui Provincial Special Scientific [2007-7]; High-Tech Research and Development Program of ChinaNational High Technology Research and Development Program of China [2007AA02Z161]; Key Project of Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30530670]; National Basic Research Program of ChinaNational Basic Research Program of China [2007B516801]; General Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30671895, 30771196, 30771942]; Agency for Science & Technology and Research of Singapore (A*STAR)Agency for Science Technology & Research (ASTAR)	We thank G. P. Zhao, G. Y. Xu, L. Jin, X. Zhang, S. J. Xu and Z. G. Lin for assistance. And we would like to thank all the volunteers who took part in this work. We also want to thank L. Yi and E. Tantoso for their assistance in data analysis. This work was funded by the Anhui Provincial Special Scientific Program (2007-7), the High-Tech Research and Development Program of China (863 Plan) (2007AA02Z161), the Key Project of Natural Science Foundation of China (30530670), National Basic Research Program of China (973 Plan) (2007B516801), General Program of National Natural Science Foundation of China (30671895, 30771196, 30771942) and Agency for Science & Technology and Research of Singapore (A*STAR) (for J. J. L. and X. Y. L.).	BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Bowcock AM, 2004, J INVEST DERMATOL, V122, pXV, DOI 10.1111/j.0022-202X.2004.22627.x; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang YT, 2007, BRIT J DERMATOL, V156, P899, DOI 10.1111/j.1365-2133.2007.07820.x; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fan X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000038; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lesueur F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000906; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; SIMONS RDGP, 1949, J INVEST DERMATOL, V12, P285, DOI 10.1038/jid.1949.42; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Wang A, 2001, GENOMICS, V73, P284, DOI 10.1006/geno.2001.6518; YIP SY, 1984, J AM ACAD DERMATOL, V10, P965, DOI 10.1016/S0190-9622(84)80314-X; Zhang XJ, 2002, INT J DERMATOL, V41, P663, DOI 10.1046/j.1365-4362.2002.01596.x; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896	27	320	355	6	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					205	210		10.1038/ng.310			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	WOS:000263091300021	19169255				2022-01-24	
J	Konrad, M; Schaller, A; Seelow, D; Pandey, AV; Waldegger, S; Lesslauer, A; Vitzthum, H; Suzuki, Y; Luk, JM; Becker, C; Schlingmann, KP; Schmid, M; Rodriguez-Soriano, J; Ariceta, G; Cano, F; Enriquez, R; Juppner, H; Bakkaloglu, SA; Hediger, MA; Gallati, S; Neuhauss, SCF; Nurnberg, P; Weber, S				Konrad, Martin; Schaller, Andre; Seelow, Dominik; Pandey, Amit V.; Waldegger, Siegfried; Lesslauer, Annegret; Vitzthum, Helga; Suzuki, Yoshiro; Luk, John M.; Becker, Christian; Schlingmann, Karl P.; Schmid, Marcel; Rodriguez-Soriano, Juan; Ariceta, Gema; Cano, Francisco; Enriquez, Ricardo; Jueppner, Harald; Bakkaloglu, Sevcan A.; Hediger, Matthias A.; Gallati, Sabina; Neuhauss, Stephan C. F.; Nuernberg, Peter; Weber, Stefanie			Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOMAGNESEMIA-HYPERCALCIURIA; FAMILIAL HYPOMAGNESEMIA; PROTEIN STRUCTURES; LINKAGE ANALYSIS; PARACELLIN-1; CELLS	Claudins are major components of tight junctions and contribute to the epithelial-barrier function by restricting free diffusion of solutes through the paracellular pathway. We have mapped a new locus for recessive renal magnesium loss on chromosome 1p34.2 and have identified mutations in CLDN19, a member of the claudin multigene family, in patients affected by hypomagnesemia, renal failure, and severe ocular abnormalities. CLDN19 encodes the tight-junction protein claudin-19, and we demonstrate high expression of CLDN19 in renal tubules and the retina. The identified mutations interfere severely with either cell-membrane trafficking or the assembly of the claudin-19 protein. The identification of CLDN19 mutations in patients with chronic renal failure and severe visual impairment supports the fundamental role of claudin-19 for normal renal tubular function and undisturbed organization and development of the retina.	Univ Bern, Childrens Hosp, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, Theodor Kocher Inst, CH-3010 Bern, Switzerland; Univ Bern, Inst Biochem & Mol Med, CH-3010 Bern, Switzerland; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; Univ Cologne, Genet Inst, Cologne, Germany; Deutsch Ressourcenzentrum Genomforsch GmbH, Berlin, Germany; Univ Marburg, Childrens Hosp, Marburg, Germany; Univ Zurich, Inst Zool, Zurich, Switzerland; Univ Hamburg, Inst Vegetat Physiol & Pathophysiol, Hamburg, Germany; Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Reg Hosp Santa Maria, Visp, Switzerland; Spain Reg Hosp, Hosp Cruces, Dept Pediat, Bilbao, Spain; Gen Hosp Elche, Nephrol Sect, Elche, Spain; Univ Chile, Dept Pediat Nephrol, Santiago, Chile; Massachusetts Gen Hosp Children, Dept Pediat Nephrol, Boston, MA USA; Gazi Univ Hosp, Dept Pediat Nephrol, Ankara, Turkey; Univ Heidelberg, Childrens Hosp, D-6900 Heidelberg, Germany		Konrad, M (corresponding author), Univ Bern, Childrens Hosp, Inselspital, Freiburgstr 10, CH-3010 Bern, Switzerland.	martin.konrad@insel.ch	Pandey, Amit V/A-7223-2008; Schaller, Andre/L-4174-2018; Ariceta, Gema/J-4100-2012; Luk, John/A-4085-2008; Neuhauss, Stephan/AAX-9915-2020; Pandey, Amit V/AAO-6442-2020; Bakkaloglu, Sevcan/AAE-9884-2021	Pandey, Amit V/0000-0001-8331-5902; Schaller, Andre/0000-0001-5174-5764; Luk, John/0000-0002-6323-7940; Neuhauss, Stephan/0000-0002-9615-480X; Pandey, Amit V/0000-0001-8331-5902; Hediger, Matthias/0000-0003-1946-027X; SUZUKI, YOSHIRO/0000-0003-0010-1867; Seelow, Dominik/0000-0002-9746-4412			Benigno V, 2000, NEPHROL DIAL TRANSPL, V15, P605, DOI 10.1093/ndt/15.5.605; Blanchard A, 2001, KIDNEY INT, V59, P2206, DOI 10.1046/j.1523-1755.2001.00736.x; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lee NPY, 2006, FEBS LETT, V580, P923, DOI 10.1016/j.febslet.2006.01.019; MEIER W, 1979, HELV PAEDIATR ACTA, V34, P257; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Rahner C, 2004, J CELL SCI, V117, P3307, DOI 10.1242/jcs.01181; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RODRIGUEZSORIANO J, 1994, PEDIATR NEPHROL, V8, P431, DOI 10.1007/BF00856522; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Weber S, 2001, J AM SOC NEPHROL, V12, P1872, DOI 10.1681/ASN.V1291872	23	320	332	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					949	957		10.1086/508617			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	WOS:000241667400016	17033971	Green Published, Bronze			2022-01-24	
J	Hu, YG; Liu, YH; Pelletier, S; Buchdunger, E; Warmuth, M; Fabbro, D; Hallek, M; Van Etten, RA; Li, SG				Hu, YG; Liu, YH; Pelletier, S; Buchdunger, E; Warmuth, M; Fabbro, D; Hallek, M; Van Etten, RA; Li, SG			Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL ONCOGENE; TYROSINE KINASE; IMATINIB MESYLATE; BLAST CRISIS; MYELOPROLIFERATIVE DISEASE; PHILADELPHIA-CHROMOSOME; SIGNAL-TRANSDUCTION; CLINICAL RESISTANCE; STI571 RESISTANCE	The Abl kinase inhibitor imatinib mesylate is the preferred treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in chronic phase but is much less effective in CML blast crisis or Ph+ B-cell acute lymphoblastic leukemia (B-ALL). Here, we show that Bcr-Abl activated the Src kinases Lyn, Hck and Fgr in B-lymphoid cells. BCR-ABL1 retrovirus-transduced marrow from mice lacking all three Src kinases efficiently induced CML but not B-ALL in recipients. The kinase inhibitor CGP76030 impaired the proliferation of B-lymphoid cells expressing Bcr-Abl in vitro and prolonged survival of mice with B-ALL but not CML. The combination of CGP76030 and imatinib was superior to imatinib alone in this regard. The biochemical target of CGP76030 in leukemia cells was Src kinases, not Bcr-Abl. These results implicate Src family kinases as therapeutic targets in Ph+ B-ALL and suggest that simultaneous inhibition of Src and Bcr-Abl kinases may benefit individuals with Ph+ acute leukemia.	Jackson Lab, Bar Harbor, ME 04609 USA; Novartis Pharma AG, CH-4002 Basel, Switzerland; Univ Munich, Med Klin 3, Munich, Germany; Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA		Li, SG (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	sli@jax.org	Hallek, Michael/Y-3191-2019	Hu, Yiguo/0000-0002-3973-2140			Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cuenco GM, 2001, ONCOGENE, V20, P8236, DOI 10.1038/sj.onc.1205095; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; FINER MH, 1994, BLOOD, V83, P43; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; La Rosee P, 2002, CANCER RES, V62, P7149; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Million RP, 2000, BLOOD, V96, P664; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Stanglmaier M, 2003, LEUKEMIA, V17, P283, DOI 10.1038/sj.leu.2402778; TAUCHI T, 1994, J BIOL CHEM, V269, P15381; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wolff NC, 2001, BLOOD, V98, P2808, DOI 10.1182/blood.V98.9.2808; Yang WT, 1998, EXP HEMATOL, V26, P1126	40	320	332	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					453	461		10.1038/ng1343			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	WOS:000221183000016	15098032	Bronze, Green Published			2022-01-24	
J	Bereshchenko, OR; Gu, W; Dalla-Favera, R				Bereshchenko, OR; Gu, W; Dalla-Favera, R			Acetylation inactivates the transcriptional repressor BCL6	NATURE GENETICS			English	Article							CENTER B-CELLS; GERMINAL-CENTER FORMATION; FINGER ENCODING GENE; SOMATIC HYPERMUTATION; HISTONE DEACETYLASES; POZ DOMAIN; P53; LYMPHOMA; PROTEIN; DIFFERENTIATION	The proto-oncogene BCL6 encodes a BTB/POZ-zinc finger transcriptional repressor that is necessary for germinal-center formation and has been implicated in the pathogenesis of B-cell lymphomas. Here we show that the coactivator p300 binds and acetylates BCL6 in vivo and inhibits its function. Acetylation disrupts the ability of BCL6 to recruit histone deacetylases (HDACs), thereby hindering its capacity to repress transcription and to induce cell transformation. BCL6 is acetylated under physiologic conditions in normal germinal-center B cells and in germinal center-derived B-cell tumors. Treatment with specific inhibitors shows that levels of acetylation of BCL6 are controlled by both HDAC-dependent and SIR2-dependent pathways. Pharmacological inhibition of these pathways leads to the accumulation of the inactive acetylated BCL6 and to cell-cycle arrest and apoptosis in B-cell lymphoma cells. These results identify a new mechanism of regulation of the proto-oncogene BCL6 with potential for therapeutic exploitation. Furthermore, these findings provide a new mechanism by which acetylation can promote transcription not only by modifying histones and activating transcriptional activators, but also by inhibiting transcriptional repressors.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA		Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.			Bereshchenko, Oxana/0000-0002-2772-6042			Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Artiga MJ, 2002, AM J PATHOL, V160, P1371, DOI 10.1016/S0002-9440(10)62564-3; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chan HM, 2001, J CELL SCI, V114, P2363; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Moller MB, 1999, CLIN CANCER RES, V5, P1085; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	50	320	334	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					606	613		10.1038/ng1018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	WOS:000179593000012	12402037				2022-01-24	
J	Le, S; Moore, JK; Haber, JE; Greider, CW				Le, S; Moore, JK; Haber, JE; Greider, CW			RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase	GENETICS			English	Article							DOUBLE-STRAND-BREAK; YEAST SACCHAROMYCES-CEREVISIAE; INDUCED DNA-REPLICATION; END-JOINING REPAIR; MITOTIC RECOMBINATION; MEIOTIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; REVERSE-TRANSCRIPTASE; GENETIC REQUIREMENTS; REPEATED SEQUENCE	Telomere length is maintained by the de nova addition of telomere repeats by telomerase, yet recombination can elongate telomeres in the absence of telomerase. When the yeast telomerase RNA component, TLC1, is deleted, telomeres shorten and most cells die. However, gene conversion mediated by the RAD52 pathway allows telomere lengthening in rare survivor cells. To further investigate the role of recombination in telomere maintenance, we assayed telomere length and the ability to generate survivors in several isogenic DNA recombination mutants, including rad50, rad51, rad55 rad54, rad57 xrs2, and mre11. The rad51, rad55 rad54, and rad57 mutations increased the rate of cell death in the absence of TLC1. In contrast, although the rad50, xrs2 and mre11 strains initially had short telomeres, double mutants with tlc1 did not affect the rate of cell death, and survivors were generated at later times than tlc1 alone. while none of the double mutants of recombination genes and tlc1 (except rad52 tlc1) blocked the ability to generate survivors, a rad50 rad51 tlc1 triple mutant did not allow the generation of survivors. Thus RAD50 and RAD51 define two separate pathways that collaborate to allow cells to survive in the absence of telomerase.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Brandeis Univ, Rosensteil Ctr MS029, Waltham, MA 02454 USA		Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 617 Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	cgreider@bs.jhmi.edu		Haber, James/0000-0002-1878-0610	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [F32CA068736, P01CA016519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM043080] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 68736, CA16519] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM43080] Funding Source: Medline		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Autexier C, 1996, TRENDS BIOCHEM SCI, V21, P387, DOI 10.1016/S0968-0004(96)90128-0; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; BERNARDS A, 1983, NATURE, V303, P592, DOI 10.1038/303592a0; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; DONOVAN JW, 1994, GENE DEV, V8, P2552, DOI 10.1101/gad.8.21.2552; DUNN B, 1984, CELL, V39, P191, DOI 10.1016/0092-8674(84)90205-8; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; HOROWITZ H, 1984, NUCLEIC ACIDS RES, V12, P7105, DOI 10.1093/nar/12.18.7105; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Ivanov EL, 1997, CURR BIOL, V7, pR492, DOI 10.1016/S0960-9822(06)00246-6; Ivanov EL, 1996, GENETICS, V142, P693; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; JOHZUKA K, 1995, GENETICS, V139, P1521; Kanaar Roland, 1997, Genes and Function, V1, P165; Kironmai KM, 1997, GENES CELLS, V2, P443; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LOUIS EJ, 1990, GENETICS, V124, P533; LOUIS EJ, 1990, GENETICS, V124, P547; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, GENETICS, V143, P741; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; MALONE RE, 1990, CURR GENET, V18, P111, DOI 10.1007/BF00312598; MCDONALD JP, 1994, GENETICS, V137, P393; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Moreau S, 1999, MOL CELL BIOL, V19, P556; Morrow DM, 1997, GENETICS, V147, P371; MORTIMER RK, 1981, P NATL ACAD SCI-BIOL, V78, P5778, DOI 10.1073/pnas.78.9.5778; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; OGAWA H, 1995, ADV BIOPHYS, V31, P67, DOI 10.1016/0065-227X(95)99383-Z; Petes TD, 1991, MOL CELLULAR BIOL YE, P407; PLUTA AF, 1989, NATURE, V337, P429, DOI 10.1038/337429a0; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; RATTRAY AJ, 1995, GENETICS, V139, P45; RATTRAY AJ, 1994, GENETICS, V138, P587; Reddel RR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1254; ROSE MD, 1988, METHODS YEAST GENETI; RUDIN N, 1989, GENETICS, V122, P519; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534; Sharpe PT, 1995, CONNECT TISSUE RES, V32, P17, DOI 10.3109/03008209509013701; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukamoto Y, 1998, GENES CELLS, V3, P135, DOI 10.1046/j.1365-2443.1998.00180.x; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Tsukamoto Y, 1996, NUCLEIC ACIDS RES, V24, P2067, DOI 10.1093/nar/24.11.2067; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	74	320	324	0	13	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAY	1999	152	1					143	152					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	194XB	WOS:000080219100012	10224249				2022-01-24	
J	Cox, NJ; Frigge, M; Nicolae, DL; Concannon, P; Hanis, CL; Bell, GI; Kong, A				Cox, NJ; Frigge, M; Nicolae, DL; Concannon, P; Hanis, CL; Bell, GI; Kong, A			Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; COMPLEX TRAITS; EARLY-ONSET; GENE; MUTATIONS; MELLITUS; GLUCOKINASE; MODELS; MICE	Complex disorders such as diabetes, cardiovascular disease, asthma, hypertension and psychiatric illnesses account for a large and disproportionate share of health care costs, but remain poorly characterized with respect to aetiology. The transmission of such disorders is complex, reflecting the actions and interactions of multiple genetic and environmental factors. Genetic analyses that allow for the simultaneous consideration of susceptibility from multiple regions may improve the ability to map genes for complex disorders(1,2), but such analyses are currently computationally intensive and narrowly focused. We describe here an approach to assessing the evidence for statistical interactions between unlinked regions that allows multipoint allele-sharing analysis to take the evidence for linkage at one region into account in assessing the evidence for linkage over the rest of the genome. Using this method, we show that the interaction of genes on chromosomes 2 (NIDDM1) and 15 (near CYP19) makes a contribution to susceptibility to type 2 diabetes in Mexican Americans from Starr County, Texas.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; DeCODE Genet, IS-110 Reykjavik, Iceland; Virginia Mason Res Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA		Cox, NJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.			Nicolae, Dan/0000-0002-0918-4630; Concannon, Patrick/0000-0002-5801-1859	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK-20595, DK-47481] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-46800] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK020595, R01DK047481, P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM046800] Funding Source: NIH RePORTER		Bell GI, 1997, DIABETES REV, V5, P277; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Buhler J, 1997, HUM HERED, V47, P211, DOI 10.1159/000154415; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Iwasaki N, 1997, DIABETES, V46, P1504, DOI 10.2337/diabetes.46.9.1504; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; RISCH N, 1990, AM J HUM GENET, V46, P229; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Suarez BK, 1994, GENETIC APPROACHES M, P23; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	21	320	329	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					213	215		10.1038/6002			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	WOS:000078399500026	9988276				2022-01-24	
J	Carella, M; DAmbrosio, L; Totaro, A; Grifa, A; Valentino, MA; Piperno, A; Girelli, D; Roetto, A; Franco, B; Gasparini, P; Camaschella, C				Carella, M; DAmbrosio, L; Totaro, A; Grifa, A; Valentino, MA; Piperno, A; Girelli, D; Roetto, A; Franco, B; Gasparini, P; Camaschella, C			Mutation analysis of the HLA-H gene in Italian hemochromatosis patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-DONORS; LINKAGE DISEQUILIBRIUM; PREVALENCE	Hemochromatosis (HH) is an inborn error of iron metabolism, frequent among Caucasians, characterized by progressive iron loading that, if untreated, causes high morbidity and death. HLA-H, a putative HH gene, has recently been isolated. The large majority of patients so far studied are homozygous for a single mutation, which results in a cysteine-to-tyrosine substitution at amino acid 282 of the protein. A second, less frequent, variant, His63Asp, has an undefined role in the pathogenesis of the disease. Here we report that the Cys282Tyr change accounts for 69% of HH chromosomes in a series of 75 unrelated Italian patients who fulfilled well-defined criteria for HH diagnosis. Sixty-four percent of patients were Cys282Tyr homozygous, 10% were heterozygous, and 21% carried the normal allele. The same mutation was rare in normal controls. The His63Asp variant was less frequent but had a similar frequency among affected and normal chromosomes. Subjects without two copies of the Cys282Tyr change were both isolated patients and individuals from families with a Gp-linked disease. Mutation analysis of the HLA-H gene, carried out by RNA-SSCP in the latter patients, did not reveal any significant nucleotide abnormality in coding sequences and intron-exon boundaries. The absence of mutations in HLA-H gene was confirmed in three cases by direct sequencing. Major deletions or rearrangements of the gene were excluded by Southern blotting. The existence of patients with clinical and histological features of HH, but without mutations in HLA-H gene, suggests that in Italy the disease is more heterogeneous than reported in northern Europe.	IRCCS,CSS SAN GIOVANNI ROTONDO,FOGGIA,ITALY; AZIENDA OSPED S GERADO,IST SCI BIOMED,DIV MED 1,MONZA,ITALY; UNIV VERONA,MED CLIN,I-37100 VERONA,ITALY; UNIV TURIN,SEZ CLIN,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,TURIN,ITALY; TELETHON INST GENET & MED,MILAN,ITALY				Camaschella, Clara/A-3289-2015; Carella, Massimo/A-2804-2014; Gasparini, Paolo/B-6173-2014; Roetto, Antonella/K-4731-2016; Girelli, Domenico/B-1183-2008; FRANCO, Brunella/S-2882-2018	Carella, Massimo/0000-0002-6830-6829; Girelli, Domenico/0000-0001-9684-1899; FRANCO, Brunella/0000-0001-5588-4569; Piperno, Alberto/0000-0002-0343-0204; ROETTO, Antonella/0000-0003-1188-7375	TelethonFondazione Telethon [E.0149, TGM06S01, E.0537] Funding Source: Medline		ADAMS PC, 1995, GASTROENTEROLOGY, V109, P177, DOI 10.1016/0016-5085(95)90283-X; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; BISCEGLIA L, 1994, HUM MUTAT, V4, P136, DOI 10.1002/humu.1380040208; BOROT N, IN PRESS IMMUNOGENET; Camaschella C, 1996, HUM GENET, V97, P476; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; DIANZANI I, 1994, AM J HUM GENET, V55, P851; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; Piperno A, 1996, HEPATOLOGY, V24, P43, DOI 10.1002/hep.510240109; POWELL LW, 1988, ANN NY ACAD SCI, V836, P24; Powell W.L., 1994, IRON METABOLISM HLTH; Rothenberg BE, 1996, P NATL ACAD SCI USA, V93, P1529, DOI 10.1073/pnas.93.4.1529; SAARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; STONE C, 1994, HUM MOL GENET, V3, P2043; VELATI C, 1990, HAEMATOLOGICA, V75, P309	21	320	327	1	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					828	832					5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	WOS:A1997WT61400011	9106528				2022-01-24	
J	Li, ZK; Pinson, SRM; Park, WD; Paterson, AH; Stansel, JW				Li, ZK; Pinson, SRM; Park, WD; Paterson, AH; Stansel, JW			Epistasis for three grain yield components in rice (Oryza sativa L)	GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; MARKER-FACILITATED INVESTIGATIONS; DROSOPHILA-SIMULANS CLADE; METABOLIC CONTROL-THEORY; HYBRID MALE-STERILITY; MENDELIAN FACTORS; ASSISTED SELECTION; MOLECULAR MARKERS; MAIZE; SPECIATION	The genetic basis for three grain yield components of rice, 1000 kernel weight (KW), grain number per panicle (GN), and grain weight. per panicle (GWP), was investigated using restriction fragment length polymorphism markers and F-4 progeny testing from a cross between lice subspecies japonica (cultivar Lemont from USA) and indica (cv. Teqing from China). Following identification of 19 QTL affecting these traits, we investigated the role of epistasis in genetic control of these phenotypes. Among 63 markers distributed throughout the genome that appeared to be involved in 79 highly significant (P < 0.001) interactions, most (46 or 73%) did not appear to have ''main'' effects on the relevant traits, but influenced the trait(s) predominantly through interactions. These results indicate that epistasis is an important genetic basis for complex traits such as yield components, especially traits of low heritability such as GN and GWP. The identification of epistatic loci is an important step toward resolution of discrepancies between quantitative trait loci mapping and classical genetic dogma, contributes to better understanding of the persistence of quantitative genetic variation in populations, and impels reconsideration of optimal mapping methodology and marker-assisted breeding strategies for improvement of complex traits.	TEXAS A&M UNIV, DEPT BIOCHEM & BIOPHYS, COLLEGE STN, TX 77843 USA; TEXAS A&M UNIV, AGR SYST RES & EXTENS CTR, BEAUMONT, TX 77713 USA; USDA ARS, BEAUMONT, TX 77713 USA		Li, ZK (corresponding author), TEXAS A&M UNIV, DEPT SOIL & CROP SCI, COLLEGE STN, TX 77843 USA.						ALLARD RW, 1988, PLANT POPULATION GEN, P1; ANTHONY DL, 1995, GENETICS, V139, P1273; CABOT EL, 1994, GENETICS, V137, P175; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Chang T. T., 1975, Crop genetic resources for today and tomorrow. Exploration., P159; CLARK AG, 1991, GENETICS, V129, P909; CLARK AG, 1987, AM NAT, V130, P283, DOI 10.1086/284709; Cockerham CC, 1996, GENETICS, V143, P1437; DAVIS AW, 1994, GENETICS, V137, P191; DEVICENTE MC, 1993, GENETICS, V134, P585; DOEBLEY J, 1995, GENETICS, V141, P333; EDWARDS MD, 1987, GENETICS, V116, P113; EDWARDS MD, 1992, THEOR APPL GENET, V83, P765, DOI 10.1007/BF00226696; Falconer DS, 1981, INTRO QUANTITATIVE G; FATOKUN CA, 1992, GENETICS, V132, P841; FREUND EJ, 1971, MATH STAT; GAVRILETS S, 1993, GENETICS, V134, P609; GEORGES M, 1995, GENETICS, V139, P907; GILLESPIE JH, 1978, THEOR POPUL BIOL, V14, P1, DOI 10.1016/0040-5809(78)90002-3; HARLAN JR, 1969, JAPAN J GENETICS  S1, V44, P337; Hedrick P., 1983, GENETICS POPULATIONS; HORVAT S, 1995, GENETICS, V139, P1737; JAIN SK, 1967, AM NAT, V101, P19, DOI 10.1086/282465; Kimura M., 1971, THEORETICAL ASPECTS; KINOSHITA T, 1982, JPN J BREED, V32, P219; KOWALSKI SP, 1994, MOL GEN GENET, V245, P548, DOI 10.1007/BF00282217; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LANDE R, 1990, GENETICS, V124, P743; LANDER ES, 1989, GENETICS, V121, P185; LARK KG, 1995, P NATL ACAD SCI USA, V92, P4656, DOI 10.1073/pnas.92.10.4656; LI ZK, 1995, THEOR APPL GENET, V91, P374, DOI 10.1007/BF00220902; LI ZK, 1995, THEOR APPL GENET, V91, P382, DOI 10.1007/BF00220903; LI ZK, 1997, IN PRESS THEOR APPL; LOREN HR, 1996, SCIENCE, V272, P741; Mather K, 1982, BIOMETRICAL GENETICS; OKA HI, 1988, EVOLUTION CULTIVATED; ORR HA, 1995, GENETICS, V139, P1805; PALOPOLI MF, 1994, GENETICS, V138, P329; PATERSON AH, 1991, GENETICS, V127, P181; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PATERSON AH, 1990, GENETICS, V124, P735; POONI HS, 1987, HEREDITY, V58, P257, DOI 10.1038/hdy.1987.40; SATO T, 1983, JPN J BREED, V33, P111; SCHON CC, 1994, CROP SCI, V34, P378, DOI 10.2135/cropsci1994.0011183X003400020014x; SPASSKY B, 1965, GENETICS, V52, P653; SPICKETT SG, 1966, GENET RES, V7, P96, DOI 10.1017/S0016672300009502; STROMBERG LD, 1994, CROP SCI, V34, P1221, DOI 10.2135/cropsci1994.0011183X003400050014x; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; STUBER CW, 1992, GENETICS, V132, P823; SZATHMARY E, 1993, GENETICS, V133, P127; TANKSLEY SD, 1988, THEOR APPL GENET, V75, P811, DOI 10.1007/BF00265610; TEMPLETON AR, 1979, GENETICS, V92, P1265; TEMPLETON AR, 1980, GENETICS, V94, P1011; VAN DER VEEN J H, 1959, Genetica, V30, P201, DOI 10.1007/BF01535675; WADE MJ, 1992, OXF SURV EVOL BIOL, V8, P33; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; [No title captured]	62	320	446	0	21	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	1997	145	2					453	465					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WM599	WOS:A1997WM59900021	9071598				2022-01-24	
J	KNUDSON, AG; STRONG, LC				KNUDSON, AG; STRONG, LC			MUTATION AND CANCER - NEUROBLASTOMA AND PHEOCHROMOCYTOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																	ARENDT VA, 1960, ZBL ALLG PATH, V101, P243; Arnould G, 1967, Presse Med, V75, P2115; Aubert L, 1967, Bull Mem Soc Med Hop Paris, V118, P1155; BARNARD RO, 1964, J NEUROSURG, V21, P506, DOI 10.3171/jns.1964.21.6.0506; BARRETT A F, 1963, Clin Radiol, V14, P33, DOI 10.1016/S0009-9260(63)80008-2; BARTLETT RC, 1971, ORAL SURG ORAL MED O, V31, P206, DOI 10.1016/0030-4220(71)90075-2; BAUM JL, 1971, NEW ENGL J MED, V284, P963, DOI 10.1056/NEJM197104292841709; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Bill A H Jr, 1968, J Pediatr Surg, V3, P103, DOI 10.1016/0022-3468(68)90988-3; BLOCK MA, 1968, ARCH SURG-CHICAGO, V96, P521; BOLANDE RP, 1970, CANCER-AM CANCER SOC, V26, P162, DOI 10.1002/1097-0142(197007)26:1<162::AID-CNCR2820260122>3.0.CO;2-Y; BRODY H, 1950, AM J HUM GENET, V2, P371; CAMPBELL CB, 1968, AUSTRALAS ANN MED, V17, P331; CHAPMAN RC, 1959, AM J MED, V26, P883, DOI 10.1016/0002-9343(59)90210-4; CHARACHE H, 1954, AM J SURG, V87, P545, DOI 10.1016/0002-9610(54)90416-X; CHATTEN J, 1967, NEW ENGL J MED, V277, P1230, DOI 10.1056/NEJM196712072772304; COCHRAN W, 1963, Ulster Med J, V32, P82; CONE TE, 1957, PEDIATRICS, V19, P44; CROWE FW, 1956, MULTIPLE NEUROFIBROM; CUSHMAN P, 1962, AM J MED, V32, P352, DOI 10.1016/0002-9343(62)90126-2; DAVISON LM, 1967, BRIT J RADIOL, V40, P549, DOI 10.1259/0007-1285-40-475-549; DEGRAFF J, 1964, ACTA MED SCAND, V176, P583; Dodge HJBM, 1945, ROCKY MT MED J, V42, P35; Edmunds L H Jr, 1966, Ann Thorac Surg, V2, P742; FERNANDO PB, 1951, AMA ARCH PATHOL, V52, P182; FLETCHER J R, 1970, Archives of Surgery, V100, P257; Franssila K, 1968, Duodecim, V84, P615; FREEMAN D, 1965, ARCH PATHOL, V80, P575; GALERA H, 1968, Revista Clinica Espanola, V111, P165; Gibbons J., 1967, BR J CLIN PRACT, V21, P360; GORLIN RJ, 1968, CANCER, V22, P293, DOI 10.1002/1097-0142(196808)22:2<293::AID-CNCR2820220206>3.0.CO;2-R; GREENFIELD LJ, 1965, JNCI-J NATL CANCER I, V35, P215, DOI 10.1093/jnci/35.1.215; GRIFFIN ME, 1969, PEDIATRICS, V43, P377; Gunby PC, 1920, AM J MED SCI, V160, P207; GUSHIEN AS, 1953, AM J MED, V14, P318; HELSON L, 1969, Clinical Research, V17, P614; HERMANN H, 1964, HUMAN TUMOURS SECRET; HOTCHKISS RS, 1967, ANN SURG, V166, P1021, DOI 10.1097/00000658-196712000-00023; HUANG SN, 1968, CANCER, V21, P302, DOI 10.1002/1097-0142(196802)21:2<302::AID-CNCR2820210220>3.0.CO;2-R; HUMBLE RM, 1967, ANAESTHESIA, V22, P296, DOI 10.1111/j.1365-2044.1967.tb02731.x; HUME DM, 1960, AM J SURG, V99, P458, DOI 10.1016/0002-9610(60)90141-0; IBANEZ MI, 1967, CANCER, V20, P706, DOI 10.1002/1097-0142(1967)20:5<706::AID-CNCR2820200523>3.0.CO;2-M; KAYE ROGER H., 1964, J MOUNT SINAI HOSP, V31, P476; KERZNER MS, 1968, ARCH INTERN MED, V121, P91, DOI 10.1001/archinte.121.1.91; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1966, CANCER, V19, P1032, DOI 10.1002/1097-0142(196607)19:7<1032::AID-CNCR2820190719>3.0.CO;2-7; LEE C M Jr, 1953, Am Surg, V19, P803; LEE HY, 1970, OHIO MED J, V99, P583; LEVY M, 1970, ARCH FR PEDIATR, V27, P561; LIMA JB, 1971, AM J SURG, V121, P732, DOI 10.1016/0002-9610(71)90058-4; LJUNGBERG O, 1967, BMJ-BRIT MED J, V1, P279, DOI 10.1136/bmj.1.5535.279; LORIMIER AA, 1969, AM J DIS CHILD, V118, P441; LULU DJ, 1969, ARCH SURG-CHICAGO, V99, P641; LYNCH HT, 1968, AM J DIS CHILD, V115, P723, DOI 10.1001/archpedi.1968.02100010725016; MASHETER HC, 1963, BRIT MED J, P1518; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; MELVIN KEW, 1968, P NATL ACAD SCI USA, V59, P1216, DOI 10.1073/pnas.59.4.1216; MILES RM, 1960, ARCH SURG-CHICAGO, V80, P283, DOI 10.1001/archsurg.1960.01290190103019; MILLER RW, 1971, J NATL CANCER I, V46, P203; MILLER RW, 1968, AM J DIS CHILD, V115, P253, DOI 10.1001/archpedi.1968.02100010255015; MINNO AM, 1954, NEW ENGL J MED, V251, P959, DOI 10.1056/NEJM195412092512401; MULHOLLAND SG, 1969, J AMER MED ASSOC, V207, P1709, DOI 10.1001/jama.207.9.1709; NANKIN H, 1970, Journal of Medical Genetics, V7, P374, DOI 10.1136/jmg.7.4.374; NIBBELIN DW, 1969, NEUROLOGY, V19, P455, DOI 10.1212/WNL.19.5.455; NICHOLLS EM, 1969, HUM HERED, V19, P473, DOI 10.1159/000152255; PALOYAN E, 1970, J AMER MED ASSOC, V214, P1443, DOI 10.1001/jama.214.8.1443; Potter FL, 1942, AM J PATHOL, V18, P141; ROBERTS AH, 1967, BRIT J SURG, V54, P78, DOI 10.1002/bjs.1800540118; RUPPERT RD, 1966, METABOLIS, V15, P537, DOI 10.1016/0026-0495(66)90114-4; SAROSI G, 1968, ANN INTERN MED, V68, P1305, DOI 10.7326/0003-4819-68-6-1305; SATO T, 1967, JPN HEART J, V8, P433; SAXENA KM, 1970, AM J DIS CHILD, V120, P265, DOI 10.1001/archpedi.1970.02100080149020; SCHIMKE RN, 1968, NEW ENGL J MED, V279, P1, DOI 10.1056/NEJM196807042790101; SCHLEGEL G C, 1960, Schweiz Med Wochenschr, V90, P31; SCHNEIDE.KM, 1965, PEDIATRICS, V36, P359; SCHWEISGUTH O, 1968, J PEDIATR SURG, V3, P135; SHANKLIN DR, 1969, BIOL NEONATORUM, V14, P286; SHARP WV, 1971, ANGIOLOGY, V22, P141, DOI 10.1177/000331977102200305; SHELL FM, 1959, AM J OBSTET GYNECOL, V78, P434, DOI 10.1016/0002-9378(59)90199-1; SIPPLE JH, 1961, NEW ENGL J MED, V31, P163; SLAVOTINEK A, 1968, AUSTRALAS ANN MED, V17, P320; SMID AC, 1955, AMA AM J DIS CHILD, V90, P81, DOI 10.1001/archpedi.1955.04030010083013; SMITS M, 1961, ACTA GENET STAT MED, V11, P137; STADLER HE, 1955, J PEDIATR-US, V47, P485, DOI 10.1016/S0022-3476(55)80061-3; STEINER AL, 1968, MEDICINE, V47, P371, DOI 10.1097/00005792-196809000-00001; TISHERMAN SE, 1962, JAMA-J AM MED ASSOC, V182, P152, DOI 10.1001/jama.1962.03050410048010; URBANSKI FX, 1967, J CHRON DIS, V20, P627, DOI 10.1016/0021-9681(67)90040-9; Vries J, 1967, Ned Tijdschr Geneeskd, V111, P1509; Wahl HR, 1914, J MED RES, V30, P205; WILLIAMS CR, 1969, BRIT J SURG, V56, P437, DOI 10.1002/bjs.1800560610; WILLIAMS ED, 1966, J PATHOL BACTERIOL, V91, P71, DOI 10.1002/path.1700910109; WILLIAMS ED, 1966, J CLIN PATHOL, V19, P103, DOI 10.1136/jcp.19.2.103; WILLIAMS ED, 1968, J CLIN PATHOL, V21, P129, DOI 10.1136/jcp.21.2.129; WISE KS, 1971, BRIT MED J, V1, P441, DOI 10.1136/bmj.1.5746.441; WONG KY, 1971, AM J DIS CHILD, V121, P415, DOI 10.1001/archpedi.1971.02100160085010; Zimmermann G, 1968, Munch Med Wochenschr, V110, P333; ZIMMERMANN NJ, 1951, BEITR PATHOL ANAT, V111, P355; 1968, BRIT MED J, V2, P690	98	320	320	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	5					514	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N4590	WOS:A1972N459000003	4340974				2022-01-24	
J	Kim, JC; Badano, JL; Sibold, S; Esmail, MA; Hill, J; Hoskins, BE; Leitch, CC; Venner, K; Ansley, SJ; Ross, AJ; Leroux, MR; Katsanis, N; Beales, PL				Kim, JC; Badano, JL; Sibold, S; Esmail, MA; Hill, J; Hoskins, BE; Leitch, CC; Venner, K; Ansley, SJ; Ross, AJ; Leroux, MR; Katsanis, N; Beales, PL			The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression	NATURE GENETICS			English	Article							GAMMA-TUBULIN; CENTROSOME; OBESITY; COMPLEX; GENE; IDENTIFICATION; MUTATIONS; DYNACTIN; BINDS	BBS4 is one of several proteins that cause Bardet-Biedl syndrome (BBS), a multisystemic disorder of genetic and clinical complexity. Here we show that BBS4 localizes to the centriolar satellites of centrosomes and basal bodies of primary cilia, where it functions as an adaptor of the p150(glued) subunit of the dynein transport machinery to recruit PCM1 (pericentriolar material 1 protein) and its associated cargo to the satellites. Silencing of BBS4 induces PCM1 mislocalization and concomitant deanchoring of centrosomal microtubules, arrest in cell division and apoptotic cell death. Expression of two truncated forms of BBS4 that are similar to those found in some individuals with BBS had a similar effect on PCM1 and microtubules. Our findings indicate that defective targeting or anchoring of pericentriolar proteins and microtubule disorganization contribute to the BBS phenotype and provide new insights into possible causes of familial obesity, diabetes and retinal degeneration.	Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Neurol, Dept Electron Microscopy, London WC1N 3BG, England; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA		Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca; katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip/C-7367-2009	Badano, Jose/0000-0002-0706-8652; Katsanis, Nicholas/0000-0002-2480-0171			Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Beales PL, 1999, J MED GENET, V36, P437; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Moudjou M, 1996, J CELL SCI, V109, P875; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Ou YY, 2003, CELL MOTIL CYTOSKEL, V55, P125, DOI 10.1002/cm.10115; Rattner J. B., 1992, P45; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	29	319	327	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					462	470		10.1038/ng1352			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	WOS:000221183000017	15107855	Bronze			2022-01-24	
J	Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB				Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB			Population genetic structure of variable drug response	NATURE GENETICS			English	Article							FUNCTIONAL-SIGNIFICANCE; CYP1A2 GENE; METABOLISM; CYP2D6; POLYMORPHISMS; DEBRISOQUINE; MEPHENYTOIN; CYP2C19; HUMANS; DEFECT	Geographic patterns of genetic variation, including variation at drug metabolizing enzyme (DME) loci and drug targets, indicate that geographic structuring of inter-individual variation in drug response may occur frequently. This raises two questions: how to represent human population genetic structure in the evaluation of drug safety and efficacy, and how to relate this structure to drug response. We address these by (i) inferring the genetic structure present in a heterogeneous sample and (ii) comparing the distribution of DME variants across the inferred genetic clusters of individuals. We find that commonly used ethnic labels are both insufficient and inaccurate representations of the inferred genetic clusters, and that drug-metabolizing profiles, defined by the distribution of DME variants, differ significantly among the clusters. We note, however, that the complexity of human demographic history means that there is no obvious natural clustering scheme, nor an obvious appropriate degree of resolution. Our comparison of drug-metabolizing profiles across the inferred clusters establishes a framework for assessing the appropriate level of resolution in relating genetic structure to drug response.	UCL, Dept Biol, Galton Lab, London, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; UCL, Dept Biol, Ctr Genet Anthropol, London, England; Genost Ltd, London WC1A 2HN, England		Wilson, JF (corresponding author), UCL, Dept Biol, Galton Lab, Mortimer St, London, England.	d.goldstein@ucl.ac.uk	Wilson, James F/A-5704-2009; Weale, Michael E/F-2587-2010; Thomas, Mark G/A-2219-2012	Wilson, James F/0000-0001-5751-9178; Weale, Michael E/0000-0003-4593-1186; Thomas, Mark G/0000-0002-2452-981X			Basile VS, 2000, MOL PSYCHIATR, V5, P410, DOI 10.1038/sj.mp.4000736; Bernal ML, 1999, PHARMACOGENETICS, V9, P657, DOI 10.1097/00008571-199910000-00013; BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; Daly, 1993, AM J SPEECH-LANG PAT, V2, P6, DOI [10.1044/1058-0360.0202.06., DOI 10.1044/1058-0360.0202.06]; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356; Gaedigk A, 1998, PHARMACOGENETICS, V8, P305, DOI 10.1097/00008571-199808000-00004; Gaedigk A, 1999, PHARMACOGENETICS, V9, P669, DOI 10.1097/01213011-199912000-00002; Goldstein JA, 1996, METHOD ENZYMOL, V272, P210, DOI 10.1016/S0076-6879(96)72025-6; GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0; KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209; KOHLMEIER L, 1997, DESIGN CONCEPTS NUTR, P312; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; WEBER WW, 1997, PHARMACOGENETICS; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; 1998, INT C HARM ETHN FACT	21	319	330	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					265	269		10.1038/ng761			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	WOS:000171911000011	11685208				2022-01-24	
J	Reddy, PH; Williams, M; Charles, V; Garrett, L; Pike-Buchanan, L; Whetsell, WO; Miller, G; Tagle, DA				Reddy, PH; Williams, M; Charles, V; Garrett, L; Pike-Buchanan, L; Whetsell, WO; Miller, G; Tagle, DA			Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA	NATURE GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; INTRANUCLEAR INCLUSIONS; CAG REPEAT; NEUROLOGICAL PHENOTYPE; WIDESPREAD EXPRESSION; TRINUCLEOTIDE REPEAT; PROTEIN; BRAIN; ONSET; AGE	Huntington disease (HD) is an adult-onset, autosomal dominant inherited human neurodegenerative disorder characterized by hyperkinetic involuntary movements, including motor restlessness and chorea, slowing of voluntary movements and cognitive impairment. Selective regional neuron loss and gliosis in striatum. cerebral cortex, thalamus, subthalamus and hippocampus(1-4) are well recognized as neuropathological correlates for the clinical manifestations of HD. The underlying genetic mutation is the expansion of CAG trinucleotide repeats (coding for polyglutamines) to 36-121 copies in exon 1 of the HD gene(5-8). The HD mRNA and protein product (huntingtin) show widespread distribution(9-11), and thus much remains to be understood about the selective and progressive neurodegeneration in HD. To create an experimental animal model for HD, transgenic mice were generated showing widespread expression of full-length human HD cDNA with either 16, 48 or 89 CAG repeats. Only mice with 48 or 89 CAG repeats manifested progressive behavioural and motor dysfunction with neuron loss and gliosis in striatum, cerebral cortex, thalamus and hippocampus. These animals represent clinically relevant models for HD pathogenesis, and may provide insights into the underlying pathophysiological mechanisms of other triplet repeat disorders.	Natl Human Genome Res Inst, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Lab Genet Dis Res, Bethesda, MD 20892 USA; NIH, Off Res Serv, Vet Resources Program, Bethesda, MD 20892 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA		Tagle, DA (corresponding author), Natl Human Genome Res Inst, Genet & Mol Biol Branch, Bldg 49,Room 3A26,49 Convent Dr MSC 4442, Bethesda, MD 20892 USA.	datagle@helix.nih.gov			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-28236] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028236] Funding Source: NIH RePORTER		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Folstein S.E., 1990, HUNTINGTONS DIS; Franklin K.B.J., 1997, MOUSE BRAIN STEREOTA; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; Kosinski CM, 1997, EXP NEUROL, V144, P239, DOI 10.1006/exnr.1997.6441; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SPARGO E, 1993, J NEUROL NEUROSUR PS, V56, P487, DOI 10.1136/jnnp.56.5.487; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wood JD, 1996, HUM MOL GENET, V5, P481, DOI 10.1093/hmg/5.4.481	30	319	322	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					198	202		10.1038/2510			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	WOS:000076231300025	9771716				2022-01-24	
J	NOAKES, PG; MINER, JH; GAUTAM, M; CUNNINGHAM, JM; SANES, JR; MERLIE, JP				NOAKES, PG; MINER, JH; GAUTAM, M; CUNNINGHAM, JM; SANES, JR; MERLIE, JP			THE RENAL GLOMERULUS OF MICE LACKING S-LAMININ LAMININ BETA-2 - NEPHROSIS DESPITE MOLECULAR COMPENSATION BY LAMININ BETA-1	NATURE GENETICS			English	Article							BASEMENT-MEMBRANE; ALPORT SYNDROME; IV COLLAGEN; NEUROMUSCULAR-JUNCTION; MONOCLONAL-ANTIBODIES; SYNAPTIC CLEFT; KIDNEY; GENE; IDENTIFICATION; PATHOGENESIS	S-laminin/laminin beta 2, a homologue of the widely distributed laminin B1/beta 1 chain, is a major component of adult renal glomerular basement membrane (GEM). Immature GEM bears beta 1, which is replaced by beta 2 as development proceeds. In mutant mice that lack beta 2, the GEM remains rich in beta 1, suggesting that a feedback mechanism normally regulates GEM maturation. The beta 2-deficient GEM is structurally intact and contains normal complements of several collagenous acid noncollagenous glycoproteins. However, mutant mice develop massive proteinuria due to failure of the glomerular filtration barrier. These results support the idea that laminin beta chains are functionally distinct although they assemble to form similar structures. Laminin beta 2-deficient mice may provide a model for human congenital or idiopathic nephrotic syndromes.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110				Noakes, Peter/X-9825-2019	Noakes, Peter/0000-0001-9821-8478; Gautam, Medha/0000-0002-5418-4322			ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ABRAHAMSON DR, 1992, J HISTOCHEM CYTOCHEM, V40, P1943, DOI 10.1177/40.12.1280666; ABRAHAMSON DR, 1989, J CELL BIOL, V109, P3477, DOI 10.1083/jcb.109.6.3477; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BENDER BL, 1981, AM J PATHOL, V103, P419; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CARLSON JA, 1993, DISEASES KIDNEY, P383; COUSER WG, 1993, KIDNEY INT, V44, pS19; DANIELS BS, 1994, J LAB CLIN MED, V124, P224; DESJARDINS M, 1991, J CELL BIOL, V113, P689, DOI 10.1083/jcb.113.3.689; EDDY A, 1992, PEDIATRIC KIDNEY DIS, P329; EKBLOM P, 1992, KIDNEY PHYSL PATHOPH, P475; FALKON JR, 1994, TRENDS NEUROSCI, V17, P469; FRENK S, 1955, P SOC EXP BIOL MED, V89, P424; GREEN TL, 1992, J BIOL CHEM, V267, P2014; HONG X, 1994, NAT GENET, V8, P297; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KASHTAN CE, 1992, KIDNEY INT, V42, P115, DOI 10.1038/ki.1992.269; Kashtan CE, 1994, RENAL PATHOLOGY, P1239; KATO M, 1988, J CELL BIOL, V106, P2203, DOI 10.1083/jcb.106.6.2203; KATZ A, 1991, KIDNEY INT, V40, P643, DOI 10.1038/ki.1991.256; KESTILA M, 1994, AM J HUM GENET, V54, P757; KLEPPEL MM, 1989, LAB INVEST, V61, P278; MARTIN PT, IN PRESS SCIENCE; MCCLUSKEY RT, 1992, PATHOLOGY KIDNEY, P169; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; NASH MA, 1992, PEDIAT KIDNEY DIS, P1247; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OGURA A, 1994, NEPHRON, V68, P239, DOI 10.1159/000188264; OLSON JL, 1992, PATHOLOGY KIDNEY, P779; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; REEVES WH, 1980, J CELL BIOL, V85, P735, DOI 10.1083/jcb.85.3.735; Rohrbach DH, 1993, MOL CELLULAR ASPECTS; SANES JR, 1982, J CELL BIOL, V93, P442, DOI 10.1083/jcb.93.2.442; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SARIOLA H, 1984, DEV BIOL, V101, P86, DOI 10.1016/0012-1606(84)90119-2; SCHARER K, 1992, PEDIATRIC KIDNEY DIS, P593; Schnaper HW, 1993, DIS KIDNEY, P1731; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; Vehaskari VM, 1992, PEDIAT KIDNEY DIS, P531; WEWER UM, 1994, GENOMICS, V24, P243, DOI 10.1006/geno.1994.1612; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	51	319	328	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					400	406		10.1038/ng0895-400			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	WOS:A1995RM37500012	7670489				2022-01-24	
J	TAKIYAMA, Y; NISHIZAWA, M; TANAKA, H; KAWASHIMA, S; SAKAMOTO, H; KARUBE, Y; SHIMAZAKI, H; SOUTOME, M; ENDO, K; OHTA, S; KAGAWA, Y; KANAZAWA, I; MIZUNO, Y; YOSHIDA, M; YUASA, T; HORIKAWA, Y; OYANAGI, K; NAGAI, H; KONDO, T; INUZUKA, T; ONODERA, O; TSUJI, S				TAKIYAMA, Y; NISHIZAWA, M; TANAKA, H; KAWASHIMA, S; SAKAMOTO, H; KARUBE, Y; SHIMAZAKI, H; SOUTOME, M; ENDO, K; OHTA, S; KAGAWA, Y; KANAZAWA, I; MIZUNO, Y; YOSHIDA, M; YUASA, T; HORIKAWA, Y; OYANAGI, K; NAGAI, H; KONDO, T; INUZUKA, T; ONODERA, O; TSUJI, S			THE GENE FOR MACHADO-JOSEPH DISEASE MAPS TO HUMAN CHROMOSOME-14Q	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; NON-PORTUGUESE FAMILY; SPINOCEREBELLAR ATAXIA; HEREDITARY ATAXIA; LINKAGE ANALYSIS; AZOREAN DISEASE; JAPANESE FAMILY; LOCUS; DEGENERATION; KINDREDS	Machado-Joseph disease (MJD) is an autosomal dominant, multisystem neurodegenerative disorder involving predominantly cerebellar, pyramidal, extrapyramidal, motor neuron and oculomotor systems. Although it was first reported in families of Portuguese-Azorean descent, MJD has also been described in non-Azorean families from various countries, being one of the most common hereditary spinocerebellar degenerations. With the use of highly polymorphic microsatellite DNA polymorphisms, we have assigned the gene for MJD to the long arm of chromosome 14 (14q24.3-q32) by genetic linkage to microsatellite loci D14S55 and D14S48 (multipoint lod score Z(max) = 9.719).	JICHI MED SCH,DEPT NEUROL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; JICHI MED SCH,DEPT BIOCHEM,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; JUNTENDO UNIV,FAC MED,DEPT NEUROL,TOKYO 113,JAPAN; NIIGATA UNIV,DEPT NEUROL,NIIGATA 951,JAPAN; NIIGATA UNIV,CTR MAT BRAIN DIS,NIIGATA 951,JAPAN; UNIV TOKYO,INST BRAIN RES,DEPT NEUROL,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,FAC MED,DEPT NEUROL,TOKYO 113,JAPAN; SHINRAKUEN HOSP,DEPT NEUROL,NIIGATA 95021,JAPAN; SUIBARAGO HOSP,DEPT NEUROL,NIIGATA 95921,JAPAN; AGANO HOSP,DEPT NEUROL,YASUDA,NIIGATA 95922,JAPAN				Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472			BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BHARUCHA NE, 1986, ARCH NEUROL-CHICAGO, V43, P142, DOI 10.1001/archneur.1986.00520020036014; BOWDEN DW, 1989, AM J HUM GENET, V44, P671; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; FORSE RA, 1989, J NEUROGENET, V5, P155, DOI 10.3109/01677068909066204; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HEALTON EB, 1980, NEUROLOGY, V30, P1084, DOI 10.1212/WNL.30.10.1084; HIRAYAM K, 1991, ANN REPORT RES COMMI, P29; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JORDAN SA, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171; KITAMURA J, 1989, ARCH NEUROL-CHICAGO, V46, P425, DOI 10.1001/archneur.1989.00520400085024; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; Maniatis T, 1989, MOL CLONING; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MYERS SM, 1986, CYTOGENET CELL GENET, V43, P226, DOI 10.1159/000132328; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; OTT J, 1991, ANAL HUMAN GENETIC L, P74; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; ROSENBERG RN, 1992, MOVEMENT DISORD, V3, P193; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STEGEORGEHYSLOP P, 1992, NAT GENET, V2, P330; SUITE NDA, 1986, J NEUROGENET, V3, P177, DOI 10.3109/01677068609106847; TAKIYAMA Y, 1989, ACTA NEUROL SCAND, V79, P214, DOI 10.1111/j.1600-0404.1989.tb03741.x; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4638, DOI 10.1093/nar/18.15.4638; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2; YAKURA H, 1974, NEW ENGL J MED, V291, P154; YUASA T, 1986, ANN NEUROL, V19, P152, DOI 10.1002/ana.410190207; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1992, SCIENC E, V258, P67	39	319	321	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					300	304		10.1038/ng0793-300			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	WOS:A1993LJ84200020	8358439				2022-01-24	
J	LOCKE, J; KOTARSKI, MA; TARTOF, KD				LOCKE, J; KOTARSKI, MA; TARTOF, KD			DOSAGE-DEPENDENT MODIFIERS OF POSITION EFFECT VARIEGATION IN DROSOPHILA AND A MASS-ACTION MODEL THAT EXPLAINS THEIR EFFECT	GENETICS			English	Article											LOCKE, J (corresponding author), FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111, USA.				NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM019194] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-06927] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-05539] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-19194] Funding Source: Medline		ASHBURNER M, 1982, GENETICS, V101, P447; BAKER BS, 1980, GENETICS, V94, P383; Caspersson T, 1938, NATURE, V142, P294, DOI 10.1038/142294a0; EISSENBERG J C, 1987, Genetics, V116, pS4; ENGELS WR, 1980, GENETICS, V95, P111; ENGELS WR, 1986, FOCUS, V8, P6; Ephrussi B, 1944, GENETICS, V29, P148; GERGEN JP, 1986, CELL, V45, P289, DOI 10.1016/0092-8674(86)90393-4; GRELL EH, 1967, SCIENCE, V158, P1319, DOI 10.1126/science.158.3806.1319; GRELL EH, 1962, Z VEREBUNGSL, V93, P371, DOI 10.1007/BF00888795; GRELL EH, 1969, GENETICS, V61, pS23; GRIFFEN AB, 1940, U TEXAS PUBL, V4032, P190; HENIKOFF S, 1979, GENETICS, V93, P105; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kaufmann BP, 1942, GENETICS, V27, P537; KENNISON JA, 1987, GENETICS, V116, P75; KIDWELL MG, 1976, GENETICS, V84, P333; KOTARSKI MA, 1983, GENETICS, V105, P371; Lefevre G., 1976, GENETICS BIOL DROS A, P31; LIFSCHYTZ E, 1974, GENETICS, V78, P323; LINDALEY D, 1985, DROS INFORM SERV, V62, P1; LINDSLEY DL, 1972, GENETICS, V71, P157; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; NASH D, 1970, GENETICS, V64, P471; OBRIEN SJ, 1973, GENETICS, V75, P155; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Panshin I. B., 1938, Biol J Moscow, V7, P837; PETERSON HM, 1963, P NATL ACAD SCI USA, V50, P126, DOI 10.1073/pnas.50.1.126; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; REUTER G, 1981, MOL GEN GENET, V182, P516, DOI 10.1007/BF00293947; REUTER G, 1985, CHROMOSOMA, V93, P132, DOI 10.1007/BF00293160; REUTER G, 1987, MOL GEN GENET, V210, P429, DOI 10.1007/BF00327193; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; REUTER G, 1986, MOL GEN GENET, V202, P481, DOI 10.1007/BF00333281; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; ROBERTS PA, 1982, GENETICS, V102, P75; Schultz J, 1939, ARCH EXP ZELLFORSCH, V22, P650; SCHULTZ J, 1950, GENETICS, V35, P134; SINCLAIR DAR, 1983, MOL GEN GENET, V191, P326, DOI 10.1007/BF00334834; SPOFFORD JB, 1967, GENETICS, V57, P751; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; STEWART BR, 1974, GENETICS, V76, P301; STRICKBERGER MW, 1959, DROSOPHILA INFORM SE, V33, P183; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; Sturtevant AH, 1925, GENETICS, V10, P117; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; VELISSARIOU V, 1980, CHROMOSOMA, V77, P13, DOI 10.1007/BF00292038	47	319	319	0	1	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	SEP	1988	120	1					181	198					18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9590	WOS:A1988P959000017	3146523				2022-01-24	
J	Pasquali, L; Gaulton, KJ; Rodriguez-Segui, SA; Mularoni, L; Miguel-Escalada, I; Akerman, I; Tena, JJ; Moran, I; Gomez-Marin, C; van de Bunt, M; Ponsa-Cobas, J; Castro, N; Nammo, T; Cebola, I; Garcia-Hurtado, J; Maestro, MA; Pattou, F; Piemonti, L; Berney, T; Gloyn, AL; Ravassard, P; Gomez-Skarmeta, JL; Muller, F; McCarthy, MI; Ferrer, J				Pasquali, Lorenzo; Gaulton, Kyle J.; Rodriguez-Segui, Santiago A.; Mularoni, Loris; Miguel-Escalada, Irene; Akerman, Ildem; Tena, Juan J.; Moran, Ignasi; Gomez-Marin, Carlos; van de Bunt, Martijn; Ponsa-Cobas, Joan; Castro, Natalia; Nammo, Takao; Cebola, Ines; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Pattou, Francois; Piemonti, Lorenzo; Berney, Thierry; Gloyn, Anna L.; Ravassard, Philippe; Luis Gomez-Skarmeta, Jose; Mueller, Ferenc; McCarthy, Mark I.; Ferrer, Jorge			Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants	NATURE GENETICS			English	Article							BETA-CELL; TRANSCRIPTION FACTORS; HISTONE MODIFICATIONS; PROVIDES INSIGHTS; GENE; CHROMATIN; GENOME; EXPRESSION; GLUCOSE; LIVER	Type 2 diabetes affects over 300 million people, causing severe complications and premature death, yet the underlying molecular mechanisms are largely unknown. Pancreatic islet dysfunction is central in type 2 diabetes pathogenesis, and understanding islet genome regulation could therefore provide valuable mechanistic insights. We have now mapped and examined the function of human islet cis-regulatory networks. We identify genomic sequences that are targeted by islet transcription factors to drive islet-specific gene activity and show that most such sequences reside in clusters of enhancers that form physical three-dimensional chromatin domains. We find that sequence variants associated with type 2 diabetes and fasting glycemia are enriched in these clustered islet enhancers and identify trait-associated variants that disrupt DNA binding and islet enhancer activity. Our studies illustrate how islet transcription factors interact functionally with the epigenome and provide systematic evidence that the dysregulation of islet enhancers is relevant to the mechanisms underlying type 2 diabetes.	[Pasquali, Lorenzo; Rodriguez-Segui, Santiago A.; Mularoni, Loris; Akerman, Ildem; Castro, Natalia; Nammo, Takao; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain; [Pasquali, Lorenzo; Mularoni, Loris; Akerman, Ildem; Castro, Natalia; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Ferrer, Jorge] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Gaulton, Kyle J.; van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford OX3 7LJ, England; [Miguel-Escalada, Irene; Mueller, Ferenc] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Tena, Juan J.; Gomez-Marin, Carlos; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide Junta Andalucia, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Moran, Ignasi; Ponsa-Cobas, Joan; Cebola, Ines; Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Pattou, Francois] Univ Lille 2, INSERM Biotherapies Diabet U859, Lille, France; [Piemonti, Lorenzo] Ist Sci San Raffaele, Diabet Res Inst, I-20132 Milan, Italy; [Berney, Thierry] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Berney, Thierry] Univ Geneva, Geneva, Switzerland; [Ravassard, Philippe] Univ Paris 06, INSERM U975, CNRS UMR 7225, Biotechnol & Biotherapy Team,Ctr Rech,Inst Cervea, Paris, France		Ferrer, J (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain.	j.ferrer@imperial.ac.uk	Mularoni, Loris/B-3777-2017; Moran, Ignasi/AAA-6417-2020; Pasquali, Lorenzo/B-6239-2008; Miguel-Escalada, Irene/J-6535-2014; Tena, Juan J./Q-5995-2019; Cebola, Ines/AAG-9652-2020; Gomez-Marin, Carlos/AAX-2173-2021; Pattou, Francois/O-6151-2017; Gomez-Skarmeta, Jose Luis/B-5268-2014; Ferrer, Jorge/A-3176-2012; Piemonti, Lorenzo/P-7605-2017; Tena, Juan J/M-2265-2014; Berney, Thierry/ABE-9450-2021; McCarthy, Mark/M-3763-2015	Mularoni, Loris/0000-0001-7053-7717; Moran, Ignasi/0000-0002-3307-7106; Pasquali, Lorenzo/0000-0003-2423-1826; Miguel-Escalada, Irene/0000-0003-3461-6404; Tena, Juan J./0000-0001-8165-7984; Cebola, Ines/0000-0003-3528-4982; Pattou, Francois/0000-0001-8388-3766; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Ferrer, Jorge/0000-0002-5959-5729; Piemonti, Lorenzo/0000-0002-2172-2198; Tena, Juan J/0000-0001-8165-7984; Berney, Thierry/0000-0002-4230-9378; ravassard, philippe/0000-0002-0393-9262; Garcia-Hurtado, Javier/0000-0001-5271-3107; mueller, ferenc/0000-0002-0996-774X; McCarthy, Mark/0000-0002-4393-0510; Gaulton, Kyle/0000-0003-1318-7161; Gloyn, Anna/0000-0003-1205-1844; Rodriguez-Segui, Santiago A./0000-0003-2952-8485; van de Bunt, Martijn/0000-0002-6744-6125; Akerman, Ildem/0000-0002-9875-1421; Gomez-Marin, Carlos/0000-0001-9724-2919	National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes; Biomedical Research Council of SingaporeAgency for Science Technology & Research (ASTAR); National Research Foundation (NRF); European Foundation for the Study of Diabetes Lilly fellowship; Ministerio de Econom a y Competitividad [SAF2011-27086, BFU2010-14839, CSD2007-00008]; Innovative Medicines Initiative; Andalusian Government [CVI-3488]; Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network; Wellcome TrustWellcome TrustEuropean Commission [090532, 098381, 090367, 095101, 101033]; Juvenile Diabetes Research FoundationJuvenile Diabetes Research Foundation [31-2012-783]; Framework Programme 7 [HEALTH-F4-2007-201413]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10099] Funding Source: researchfish	We thank J.Rios (IDIBAPS) for expert statistical advice, M. Parsons (Johns Hopkins University) for Tg(ins: mCherry)jh2 transgenics and R. Stein (Vanderbilt University), J. Habener (Harvard University) and G. Gradwohl (Institute of Genetics and Molecular and Cellular Biology) for MAFA, IDX1, and NGN3 DNA constructs.We thank the DIAGRAM and MAGIC consortia, the Singapore Prospective Study Program, the Singapore Consortium of Cohort Studies, the Singapore Indian Eye Study, the Singapore Malay Eye Study and Y.Y.Teo, E.S.Tai, T.Y. Wong, W.Y. Lim and X.Wang (National University of Singapore; funded by the National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes, the Biomedical Research Council of Singapore and the National Research Foundation (NRF) Fellowship scheme).This work was carried out in part at the Centre Esther Koplowitz. This work was funded by grants from a European Foundation for the Study of Diabetes Lilly fellowship (L.Pasquali), the Ministerio de Econom a y Competitividad (SAF2011-27086 to J.F., BFU2010-14839 and CSD2007-00008 to J.L.G.S.), the Innovative Medicines Initiative (DIRECT to M.I.M. and J.F.), the Andalusian Government (CVI-3488 to J.L.G.S.), the Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network (F.M.and J.F.), the Wellcome Trust (090532, 098381 and 090367 to M.I.M., 095101 to A.L.G., 101033 to J.F.), Juvenile Diabetes Research Foundation (31-2012-783 to T.B., F.P. and L. Piemonti) and Framework Programme 7 (HEALTH-F4-2007-201413 to M.I.M.).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hindorff LA, CATALOG PUBLISHED GE; Hu LP, 2005, AM J PHYSIOL-ENDOC M, V289, pE1085, DOI 10.1152/ajpendo.00210.2005; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rozen S, 2000, Methods Mol Biol, V132, P365; Sander M, 2000, DEVELOPMENT, V127, P5533; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Tennant BR, 2013, DIABETOLOGIA, V56, P542, DOI 10.1007/s00125-012-2797-5; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	71	318	320	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					136	+		10.1038/ng.2870			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	WOS:000331208300009	24413736	Green Published, Green Accepted, Green Submitted			2022-01-24	
J	Romay, MC; Millard, MJ; Glaubitz, JC; Peiffer, JA; Swarts, KL; Casstevens, TM; Elshire, RJ; Acharya, CB; Mitchell, SE; Flint-Garcia, SA; McMullen, MD; Holland, JB; Buckler, ES; Gardner, CA				Romay, Maria C.; Millard, Mark J.; Glaubitz, Jeffrey C.; Peiffer, Jason A.; Swarts, Kelly L.; Casstevens, Terry M.; Elshire, Robert J.; Acharya, Charlotte B.; Mitchell, Sharon E.; Flint-Garcia, Sherry A.; McMullen, Michael D.; Holland, James B.; Buckler, Edward S.; Gardner, Candice A.			Comprehensive genotyping of the USA national maize inbred seed bank	GENOME BIOLOGY			English	Article						Diversity; Genotyping by sequencing; Germplasm; Maize; Public	GENOME-WIDE ASSOCIATION; FLOWERING-TIME; LINKAGE DISEQUILIBRIUM; GENETIC ARCHITECTURE; POPULATION-STRUCTURE; MAPPING POPULATION; AMERICAN MAIZE; COMPLEX TRAITS; SNP MARKERS; DENT CORN	Background: Genotyping by sequencing, a new low-cost, high-throughput sequencing technology was used to genotype 2,815 maize inbred accessions, preserved mostly at the National Plant Germplasm System in the USA. The collection includes inbred lines from breeding programs all over the world. Results: The method produced 681,257 single-nucleotide polymorphism (SNP) markers distributed across the entire genome, with the ability to detect rare alleles at high confidence levels. More than half of the SNPs in the collection are rare. Although most rare alleles have been incorporated into public temperate breeding programs, only a modest amount of the available diversity is present in the commercial germplasm. Analysis of genetic distances shows population stratification, including a small number of large clusters centered on key lines. Nevertheless, an average fixation index of 0.06 indicates moderate differentiation between the three major maize subpopulations. Linkage disequilibrium (LD) decays very rapidly, but the extent of LD is highly dependent on the particular group of germplasm and region of the genome. The utility of these data for performing genome-wide association studies was tested with two simply inherited traits and one complex trait. We identified trait associations at SNPs very close to known candidate genes for kernel color, sweet corn, and flowering time; however, results suggest that more SNPs are needed to better explore the genetic architecture of complex traits. Conclusions: The genotypic information described here allows this publicly available panel to be exploited by researchers facing the challenges of sustainable agriculture through better knowledge of the nature of genetic diversity.	[Romay, Maria C.; Glaubitz, Jeffrey C.; Casstevens, Terry M.; Elshire, Robert J.; Acharya, Charlotte B.; Mitchell, Sharon E.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Millard, Mark J.; Gardner, Candice A.] Iowa State Univ, Dept Agron, North Cent Reg Plant Intro Stn, Ames, IA 50001 USA; [Peiffer, Jason A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27606 USA; [Swarts, Kelly L.; Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA		Buckler, ES (corresponding author), Cornell Univ, Inst Genom Divers, Biotechnol Bldg, Ithaca, NY 14853 USA.	esb33@cornell.edu; Candice.Gardner@ARS.USDA.GOV	Romay, Cinta/ABE-8340-2020; Buckler, Edward/L-7651-2019	Romay, Cinta/0000-0001-9309-1586; Buckler, Edward/0000-0002-3100-371X; Elshire, Robert/0000-0003-1753-6920; Casstevens, Terry/0000-0001-7602-0487; Flint-Garcia, Sherry/0000-0003-4156-5318; Swarts, Kelly/0000-0002-0578-7426; Holland, James/0000-0002-4341-9675	Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0820619] Funding Source: National Science Foundation; Division Of Integrative Organismal SystemsNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [1238014] Funding Source: National Science Foundation		Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bastian M., 2009, P 3 INT AAAI C WEBLO, V2, P361, DOI [10.13140/2.1.1341.1520, DOI 10.13140/2.1.1341.1520]; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; BUCKNER B, 1990, PLANT CELL, V2, P867, DOI 10.1105/tpc.2.9.867; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Durand E, 2012, GENETICS, V190, P1547, DOI 10.1534/genetics.111.136903; East EM., 1908, REPORT CONNECTICUT A, V1907, P419; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Goodman MM, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P139; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Hansey CN, 2011, CROP SCI, V51, P704, DOI 10.2135/cropsci2010.03.0178; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu KJ, 2003, GENETICS, V165, P2117; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Mikel MA, 2011, CROP SCI, V51, P592, DOI 10.2135/cropsci2010.06.0332; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reif JC, 2005, MAYDICA, V50, P215; Salhuana W, 2006, MAYDICA, V51, P339; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Shull GH., 1908, AM BREEDERSASSOC REP, Vos-4, P296, DOI 10.1093/jhered/os-4.1.296; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Thompson, 2009, ASREML USER GUIDE RE; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; van Heerwaarden J, 2012, P NATL ACAD SCI USA, V109, P12420, DOI 10.1073/pnas.1209275109; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Venables W.N., 2002, MODERN APPL STAT S; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright S., 1978, VARIABILITY NATURAL, V4; YAN J, 2009, PLOS ONE, V0004; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	65	318	333	0	84	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2013	14	6							R55	10.1186/gb-2013-14-6-r55			18	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	268TU	WOS:000328194200003	23759205	gold, Green Published			2022-01-24	
J	Guduric-Fuchs, J; O'Connor, A; Camp, B; O'Neill, CL; Medina, RJ; Simpson, DA				Guduric-Fuchs, Jasenka; O'Connor, Anna; Camp, Bailey; O'Neill, Christina L.; Medina, Reinhold J.; Simpson, David A.			Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types	BMC GENOMICS			English	Article						microRNA; Deep sequencing; Extracellular vesicles; Exosomes	CIRCULATING MICRORNAS; ENDOTHELIAL-CELLS; MEMBRANE-VESICLES; RNA; EXPRESSION; BIOMARKERS; CANCER; BIOGENESIS; MECHANISM; PROTEIN	Background: MicroRNAs (miRNAs) are a class of small RNA molecules that regulate expression of specific mRNA targets. They can be released from cells, often encapsulated within extracellular vesicles (EVs), and therefore have the potential to mediate intercellular communication. It has been suggested that certain miRNAs may be selectively exported, although the mechanism has yet to be identified. Manipulation of the miRNA content of EVs will be important for future therapeutic applications. We therefore wished to assess which endogenous miRNAs are enriched in EVs and how effectively an overexpressed miRNA would be exported. Results: Small RNA libraries from HEK293T cells and vesicles before or after transfection with a vector for miR-146a overexpression were analysed by deep sequencing. A subset of miRNAs was found to be enriched in EVs; pathway analysis of their predicted target genes suggests a potential role in regulation of endocytosis. RT-qPCR in additional cell types and analysis of publicly available data revealed that many of these miRNAs tend to be widely preferentially exported. Whilst overexpressed miR-146a was highly enriched both in transfected cells and their EVs, the cellular:EV ratios of endogenous miRNAs were not grossly altered. MiR-451 was consistently the most highly exported miRNA in many different cell types. Intriguingly, Argonaute2 (Ago2) is required for miR- 451 maturation and knock out of Ago2 has been shown to decrease expression of other preferentially exported miRNAs (eg miR-150 and miR-142-3p). Conclusion: The global expression data provided by deep sequencing confirms that specific miRNAs are enriched in EVs released by HEK293T cells. Observation of similar patterns in a range of cell types suggests that a common mechanism for selective miRNA export may exist.	[Guduric-Fuchs, Jasenka; O'Connor, Anna; Camp, Bailey; O'Neill, Christina L.; Medina, Reinhold J.; Simpson, David A.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland		Simpson, DA (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	David.Simpson@qub.ac.uk	Medina, Reinhold J/A-7949-2015	Medina, Reinhold J/0000-0003-4351-7010; Simpson, David/0000-0003-0157-1211	Biotechnology and Biological Sciences Research Council (BBSRC)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H005498/1]; Science Foundation IrelandScience Foundation IrelandEuropean Commission; Trinity Centre for High Performance Computing.; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H005498/1] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H005498/1] Funding Source: UKRI	This work was supported by grant number BB/H005498/1 from the Biotechnology and Biological Sciences Research Council (BBSRC). The authors thank Gerry Mahon and Liza Colhoun for assistance with electron microscopy and Dr. G. Du (University of Texas Health Science Center at Houston, TX, USA) for kindly providing pSM30. The Trinity Genome Sequencing Laboratory is a core facility funded by Science Foundation Ireland and supported by the Trinity Centre for High Performance Computing.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Anderson HC, 2010, LAB INVEST, V90, P1549, DOI 10.1038/labinvest.2010.152; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Camussi G, 2011, AM J CANCER RES, V1, P98; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Contu R, 2010, CIRC RES, V107, P573, DOI 10.1161/CIRCRESAHA.110.227983; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Dommelen SM, 2012, J CONTROL RELEASE, V161, P635, DOI 10.1016/j.jconrel.2011.11.021; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JS, 2010, CELL CYCLE, V9, P4455, DOI 10.4161/cc.9.22.13958; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	59	318	326	0	36	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 1	2012	13								357	10.1186/1471-2164-13-357			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	062UZ	WOS:000312949800001	22849433	Green Published, gold			2022-01-24	
J	Stroud, H; Feng, SH; Kinney, SM; Pradhan, S; Jacobsen, SE				Stroud, Hume; Feng, Suhua; Kinney, Shannon Morey; Pradhan, Sriharsa; Jacobsen, Steven E.			5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells	GENOME BIOLOGY			English	Article							DNA; REPLICATION; CONVERSION; DAMAGE	Background: 5-Hydroxymethylcytosine (5hmC) was recently found to be abundantly present in certain cell types, including embryonic stem cells. There is growing evidence that TET proteins, which convert 5-methylcytosine (5mC) to 5hmC, play important biological roles. To further understand the function of 5hmC, an analysis of the genome-wide localization of this mark is required. Results: Here, we have generated a genome-wide map of 5hmC in human embryonic stem cells by hmeDIP-seq, in which hydroxymethyl-DNA immunoprecipitation is followed by massively parallel sequencing. We found that 5hmC is enriched in enhancers as well as in gene bodies, suggesting a potential role for 5hmC in gene regulation. Consistent with localization of 5hmC at enhancers, 5hmC was significantly enriched in histone modifications associated with enhancers, such as H3K4me1 and H3K27ac. 5hmC was also enriched in other protein-DNA interaction sites, such as OCT4 and NANOG binding sites. Furthermore, we found that 5hmC regions tend to have an excess of G over C on one strand of DNA. Conclusions: Our findings suggest that 5hmC may be targeted to certain genomic regions based both on gene expression and sequence composition.	[Stroud, Hume; Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Kinney, Shannon Morey; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA		Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Kinney, Shannon/AAW-5301-2021		Fred Eiserling and Judith Lengyel Graduate Doctoral Fellowship; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM60398]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060398, R37GM060398] Funding Source: NIH RePORTER	HS was supported by a Fred Eiserling and Judith Lengyel Graduate Doctoral Fellowship. SF is a Special Fellow of the Leukemia and Lymphoma Society. Research in the laboratory of SEJ was supported by National Institutes of Health grant GM60398 and by an Innovation Award from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. SEJ is an investigator of the Howard Hughes Medical Institute.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Brodie of Brodie EB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248103; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kinney SM, 2011, J BIOL CHEM; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	21	318	329	2	38	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2011	12	6							R54	10.1186/gb-2011-12-6-r54			8	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	843BF	WOS:000296646600002	21689397	Green Published, hybrid			2022-01-24	
J	Rothman, N; Garcia-Closas, M; Chatterjee, N; Malats, N; Wu, XF; Figueroa, JD; Real, FX; Van den Berg, D; Matullo, G; Baris, D; Thun, M; Kiemeney, LA; Vineis, P; De Vivo, I; Albanes, D; Purdue, MP; Rafnar, T; Hildebrandt, MAT; Kiltie, AE; Cussenot, O; Golka, K; Kumar, R; Taylor, JA; Mayordomo, JI; Jacobs, KB; Kogevinas, M; Hutchinson, A; Wang, ZW; Fu, YP; Prokunina-Olsson, L; Burdett, L; Yeager, M; Wheeler, W; Tardon, A; Serra, C; Carrato, A; Garcia-Closas, R; Lloreta, J; Johnson, A; Schwenn, M; Karagas, MR; Schned, A; Andriole, G; Grubb, R; Black, A; Jacobs, EJ; Diver, WR; Gapstur, SM; Weinstein, SJ; Virtamo, J; Cortessis, VK; Gago-Dominguez, M; Pike, MC; Stern, MC; Yuan, JM; Hunter, DJ; McGrath, M; Dinney, CP; Czerniak, B; Chen, M; Yang, HS; Vermeulen, SH; Aben, KK; Witjes, JA; Makkinje, RR; Sulem, P; Besenbacher, S; Stefansson, K; Riboli, E; Brennan, P; Panico, S; Navarro, C; Allen, NE; Bueno-De-Mesquita, HB; Trichopoulos, D; Caporaso, N; Landi, MT; Canzian, F; Ljungberg, B; Tjonneland, A; Clavel-Chapelon, F; Bishop, DT; Teo, MTW; Knowles, MA; Guarrera, S; Polidoro, S; Ricceri, F; Sacerdote, C; Allione, A; Cancel-Tassin, G; Selinski, S; Hengstler, JG; Dietrich, H; Fletcher, T; Rudnai, P; Gurzau, E; Koppova, K; Bolick, SCE; Godfrey, A; Xu, ZL; Sanz-Velez, JI; Garcia-Prats, MD; Sanchez, M; Valdivia, G; Porru, S; Benhamou, S; Hoover, RN; Fraumeni, JF; Silverman, DT; Chanock, SJ				Rothman, Nathaniel; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Malats, Nuria; Wu, Xifeng; Figueroa, Jonine D.; Real, Francisco X.; Van den Berg, David; Matullo, Giuseppe; Baris, Dalsu; Thun, Michael; Kiemeney, Lambertus A.; Vineis, Paolo; De Vivo, Immaculata; Albanes, Demetrius; Purdue, Mark P.; Rafnar, Thorunn; Hildebrandt, Michelle A. T.; Kiltie, Anne E.; Cussenot, Olivier; Golka, Klaus; Kumar, Rajiv; Taylor, Jack A.; Mayordomo, Jose I.; Jacobs, Kevin B.; Kogevinas, Manolis; Hutchinson, Amy; Wang, Zhaoming; Fu, Yi-Ping; Prokunina-Olsson, Ludmila; Burdett, Laurie; Yeager, Meredith; Wheeler, William; Tardon, Adonina; Serra, Consol; Carrato, Alfredo; Garcia-Closas, Reina; Lloreta, Josep; Johnson, Alison; Schwenn, Molly; Karagas, Margaret R.; Schned, Alan; Andriole, Gerald, Jr.; Grubb, Robert, III; Black, Amanda; Jacobs, Eric J.; Diver, W. Ryan; Gapstur, Susan M.; Weinstein, Stephanie J.; Virtamo, Jarmo; Cortessis, Victoria K.; Gago-Dominguez, Manuela; Pike, Malcolm C.; Stern, Mariana C.; Yuan, Jian-Min; Hunter, David J.; McGrath, Monica; Dinney, Colin P.; Czerniak, Bogdan; Chen, Meng; Yang, Hushan; Vermeulen, Sita H.; Aben, Katja K.; Witjes, J. Alfred; Makkinje, Remco R.; Sulem, Patrick; Besenbacher, Soren; Stefansson, Kari; Riboli, Elio; Brennan, Paul; Panico, Salvatore; Navarro, Carmen; Allen, Naomi E.; Bueno-de-Mesquita, H. Bas; Trichopoulos, Dimitrios; Caporaso, Neil; Landi, Maria Teresa; Canzian, Federico; Ljungberg, Borje; Tjonneland, Anne; Clavel-Chapelon, Francoise; Bishop, David T.; Teo, Mark T. W.; Knowles, Margaret A.; Guarrera, Simonetta; Polidoro, Silvia; Ricceri, Fulvio; Sacerdote, Carlotta; Allione, Alessandra; Cancel-Tassin, Geraldine; Selinski, Silvia; Hengstler, Jan G.; Dietrich, Holger; Fletcher, Tony; Rudnai, Peter; Gurzau, Eugen; Koppova, Kvetoslava; Bolick, Sophia C. E.; Godfrey, Ashley; Xu, Zongli; Sanz-Velez, Jose I.; Garcia-Prats, Maria D.; Sanchez, Manuel; Valdivia, Gabriel; Porru, Stefano; Benhamou, Simone; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Silverman, Debra T.; Chanock, Stephen J.			A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci	NATURE GENETICS			English	Article							CONFERS SUSCEPTIBILITY; UDP-GLUCURONOSYLTRANSFERASES; TELOMERASE MUTATIONS; SEQUENCE VARIANT; COMMON VARIANTS; DOWN-REGULATION; RISK; GENE; STRATIFICATION; POLYMORPHISMS	We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 x 10(-12)) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 x 10(-11)) on 19q12 maps to CCNE1 and rs11892031 (P = 1 x 10(-7)) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 x 10(-11)) and a tag SNP for NAT2 acetylation status (P = 4 x 10(-11)), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis.	[Rothman, Nathaniel; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Figueroa, Jonine D.; Baris, Dalsu; Albanes, Demetrius; Purdue, Mark P.; Fu, Yi-Ping; Prokunina-Olsson, Ludmila; Black, Amanda; Weinstein, Stephanie J.; Caporaso, Neil; Landi, Maria Teresa; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Silverman, Debra T.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Malats, Nuria; Real, Francisco X.] Spanish Natl Canc Res Ctr, Madrid, Spain; [Wu, Xifeng; Hildebrandt, Michelle A. T.; Chen, Meng; Yang, Hushan] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Van den Berg, David; Cortessis, Victoria K.; Gago-Dominguez, Manuela; Pike, Malcolm C.; Stern, Mariana C.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Matullo, Giuseppe; Vineis, Paolo; Guarrera, Simonetta; Polidoro, Silvia; Ricceri, Fulvio; Sacerdote, Carlotta; Allione, Alessandra] Human Genet Fdn HuGeF, Turin, Italy; [Thun, Michael; Jacobs, Eric J.; Diver, W. Ryan; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Kiemeney, Lambertus A.; Vermeulen, Sita H.; Aben, Katja K.] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred] Radboud Univ Nijmegen Med Ctr, Dept Urol, Nijmegen, Netherlands; [Vineis, Paolo; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, London, England; [De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Rafnar, Thorunn; Sulem, Patrick; Besenbacher, Soren; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Kiltie, Anne E.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Cussenot, Olivier] Tenon Hosp, AP HP, Dept Urol, Paris, France; [Cussenot, Olivier; Cancel-Tassin, Geraldine] Ctr Rech Pathol Prostat, Paris, France; [Golka, Klaus; Selinski, Silvia; Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factor, Dortmund, Germany; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Taylor, Jack A.; Bolick, Sophia C. E.; Godfrey, Ashley; Xu, Zongli] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Mayordomo, Jose I.; Sanchez, Manuel; Valdivia, Gabriel] Univ Zaragoza, Zaragoza, Spain; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming; Burdett, Laurie; Yeager, Meredith] SAIC Frederick Inc, Natl Canc Inst Frederick, Core Genotype Facil, Frederick, MD USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] Municipal Inst Med Res, Barcelona, Spain; [Kogevinas, Manolis; Tardon, Adonina; Navarro, Carmen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Wheeler, William] Informat Management Serv Inc, Rockville, MD USA; [Tardon, Adonina] Univ Oviedo, Inst Univ Oncol, Oviedo, Spain; [Carrato, Alfredo] Ramon & Cajal Univ Hosp, Madrid, Spain; [Garcia-Closas, Reina] Hosp Univ Canarias, Unidad Invest, San Cristobal la Laguna, Spain; [Lloreta, Josep] Univ Pompeu Fabra, Hosp Mar Inst Municipal Invest Med IMIM, Barcelona, Spain; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Karagas, Margaret R.; Schned, Alan] Dartmouth Med Sch, Hanover, NH USA; [Andriole, Gerald, Jr.; Grubb, Robert, III] Washington Univ, Sch Med, Dept Urol, St Louis, MO USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Helsinki, Finland; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Yuan, Jian-Min] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Hunter, David J.; McGrath, Monica] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Vermeulen, Sita H.; Makkinje, Remco R.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Brennan, Paul] Int Agcy Res Canc, Lyon, France; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Navarro, Carmen] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Allen, Naomi E.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Clavel-Chapelon, Francoise] Paris S Univ, Inst Gustave Roussy, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Bishop, David T.; Teo, Mark T. W.; Knowles, Margaret A.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Dietrich, Holger] Paul Gerhardt Fdn, Dept Urol, Wittenberg, Germany; [Fletcher, Tony] Inst Hyg & Trop Med, London, England; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugen] Univ Babes Bolyai, Ctr Environm Hlth, R-3400 Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Sanz-Velez, Jose I.; Garcia-Prats, Maria D.] San Jorge Univ Hosp, Huesca, Spain; [Porru, Stefano] Univ Brescia, Sect Occupat Med & Ind Hyg, Dept Expt & Appl Med, Brescia, Italy; [Benhamou, Simone] CEPH, Fdn Jean Dausset, U946, INSERM, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, UMR8200, CNRS, Villejuif, France		Garcia-Closas, M (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	montse.garciaclosas@icr.ac.uk	TARDON, ADONINA/B-6563-2014; Kiemeney, Lambertus A./D-3357-2009; Panico, Salvatore/K-6506-2016; Serra, C/E-6879-2014; Makkinje, Remco/Q-2406-2015; Guarrera, Simonetta/AAB-8482-2022; Prokunina-Olsson, Ludmila/A-8240-2019; Purdue, Mark P/C-9228-2016; Van Den Berg, David J/G-8598-2017; Ricceri, Fulvio/I-9910-2018; Stefansson, Kari/AAE-7187-2019; Malats, Nuria/H-7041-2015; Lloreta, J/I-2112-2014; Diver, Ryan/AAG-3469-2019; Benhamou, Simone/ABD-2590-2020; Clavel-Chapelon, Francoise/G-6733-2014; Aben, Katja KH/G-9686-2016; Garcia-Closas, Montserrat/F-3871-2015; Gago-Dominguez, Manuela/AAP-6611-2021; Yeager, Meredith/AAA-5322-2020; Kumar, Rajiv/H-6431-2019; Hengstler, Jan G./O-1415-2013; Garcia-Closas, Montserrat/AAZ-6930-2021; taylor, jack a/C-7154-2019; Vermeulen, S.H.H.M./L-4716-2015; Albanes, Demetrius/B-9749-2015; Mayordomo, Jose/K-3453-2013; Witjes, Fred/N-9665-2013; Canzian, Federico/I-2804-2014; Prokunina-Olsson, Ludmila/V-7960-2019; Lloreta-Trull, Josep/AAZ-1229-2020; Benhamou, Simone/K-6554-2015; Matullo, Giuseppe/K-6383-2016; Arribas, Francisco X Real/H-5275-2015; Kogevinas, Manolis/C-3918-2017; Weinstein, Stephanie J/P-1627-2017; Wang, Zhaoming/R-5527-2018; Fletcher, Tony/D-2394-2011	TARDON, ADONINA/0000-0001-5150-1209; Kiemeney, Lambertus A./0000-0002-2368-1326; Panico, Salvatore/0000-0002-5498-8312; Serra, C/0000-0001-8337-8356; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Purdue, Mark P/0000-0003-1177-3108; Van Den Berg, David J/0000-0002-5404-5218; Ricceri, Fulvio/0000-0001-8749-9737; Malats, Nuria/0000-0003-2538-3784; Lloreta, J/0000-0003-1644-9470; Diver, Ryan/0000-0002-5418-9000; Aben, Katja KH/0000-0002-0214-2147; Garcia-Closas, Montserrat/0000-0003-1033-2650; Kumar, Rajiv/0000-0002-6093-0395; Garcia-Closas, Montserrat/0000-0003-1033-2650; taylor, jack a/0000-0001-5303-6398; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Matullo, Giuseppe/0000-0003-0674-7757; Arribas, Francisco X Real/0000-0001-9501-498X; Kogevinas, Manolis/0000-0002-9605-0461; Weinstein, Stephanie J/0000-0002-3834-1535; Wang, Zhaoming/0000-0001-7556-3869; Fletcher, Tony/0000-0003-3385-200X; Besenbacher, Soren/0000-0003-1455-1738; Riboli, Elio/0000-0001-6795-6080; Hengstler, Jan/0000-0002-1427-5246; cussenot, olivier/0000-0002-9912-0533; Ljungberg, Borje/0000-0002-4121-3753; Yuan, Jian-Min/0000-0002-4620-3108; Kiltie, Anne/0000-0001-7208-2912; Gurzau, Eugen/0000-0002-8688-6118; Knowles, Margaret/0000-0002-9363-8657; BENHAMOU, Simone/0000-0001-5853-8047; Dinney, Colin/0000-0002-8969-711X; Allione, Alessandra/0000-0001-9599-309X; CARRATO, ALFREDO/0000-0001-7749-8140; Sacerdote, Carlotta/0000-0002-8008-5096; Bishop, Tim/0000-0002-8752-8785; Canzian, Federico/0000-0002-4261-4583; Navarro, Carmen/0000-0001-8896-7483; Jacobs, Kevin/0000-0002-4657-6473; Cortessis, Victoria/0000-0002-2339-1089; xu, zongli/0000-0002-9034-8902; Tjonneland, Anne/0000-0003-4385-2097; Cancel-Tassin, Geraldine/0000-0002-9583-6382	National Cancer Institute, US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [HHSN261200800001E]; Cancer Research UKCancer Research UK [10589, 12933] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801056B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2006-02-005] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIACP010201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZIAES049033] Funding Source: NIH RePORTER	This project has been funded in part with federal funds from the National Cancer Institute, US National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Ando Y, 2000, CANCER RES, V60, P6921; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garcia-Closas M, 2011, PHARMACOGENET GENOM, V21, P231, DOI 10.1097/FPC.0b013e32833e1b54; Giuliani L, 2001, INT J CANCER, V91, P141, DOI 10.1002/1097-0215(20010101)91:1<141::AID-IJC1005>3.0.CO;2-H; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Iida K, 2010, J BIOCHEM, V147, P353, DOI 10.1093/jb/mvp169; KANTOR AF, 1985, INT J CANCER, V35, P703, DOI 10.1002/ijc.2910350602; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; LOWER GM, 1979, ENVIRON HEALTH PERSP, V29, P71, DOI 10.2307/3429048; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Richter J, 2000, AM J PATHOL, V157, P787, DOI 10.1016/S0002-9440(10)64592-0; Rothwell A, 2007, PERS REV, V36, P23, DOI 10.1108/00483480710716704; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Strassburg CP, 2008, ARCH TOXICOL, V82, P415, DOI 10.1007/s00204-008-0314-x; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1997, CANCER RES, V57, P2979; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; [No title captured]	52	318	326	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					978	U98		10.1038/ng.687			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	WOS:000283540500015	20972438	Green Accepted			2022-01-24	
J	Stabler, RA; He, M; Dawson, L; Martin, M; Valiente, E; Corton, C; Lawley, TD; Sebaihia, M; Quail, MA; Rose, G; Gerding, DN; Gibert, M; Popoff, MR; Parkhill, J; Dougan, G; Wren, BW				Stabler, Richard A.; He, Miao; Dawson, Lisa; Martin, Melissa; Valiente, Esmeralda; Corton, Craig; Lawley, Trevor D.; Sebaihia, Mohammed; Quail, Michael A.; Rose, Graham; Gerding, Dale N.; Gibert, Maryse; Popoff, Michel R.; Parkhill, Julian; Dougan, Gordon; Wren, Brendan W.			Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium	GENOME BIOLOGY			English	Article							BINARY-TOXIN; ADP-RIBOSYLTRANSFERASE; GLYCOSYLATION ISLAND; FLUOROQUINOLONE USE; MOLECULAR ANALYSIS; CLINICAL-FEATURES; DISEASE; EPIDEMIOLOGY; FLAGELLA; OUTBREAK	Background: The continued rise of Clostridium difficile infections worldwide has been accompanied by the rapid emergence of a highly virulent clone designated PCR-ribotype 027. To understand more about the evolution of this virulent clone, we made a three-way genomic and phenotypic comparison of an 'historic' non-epidemic 027 C. difficile (CD196), a recent epidemic and hypervirulent 027 (R20291) and a previously sequenced PCR-ribotype 012 strain (630). Results: Although the genomes are highly conserved, the 027 genomes have 234 additional genes compared to 630, which may contribute to the distinct phenotypic differences we observe between these strains relating to motility, antibiotic resistance and toxicity. The epidemic 027 strain has five unique genetic regions, absent from both the non-epidemic 027 and strain 630, which include a novel phage island, a two component regulatory system and transcriptional regulators. Conclusions: A comparison of a series of 027 isolates showed that some of these genes appeared to have been gained by 027 strains over the past two decades. This study provides genetic markers for the identification of 027 strains and offers a unique opportunity to explain the recent emergence of a hypervirulent bacterium.	[Stabler, Richard A.; Dawson, Lisa; Martin, Melissa; Valiente, Esmeralda; Wren, Brendan W.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [He, Miao; Corton, Craig; Lawley, Trevor D.; Sebaihia, Mohammed; Quail, Michael A.; Rose, Graham; Parkhill, Julian; Dougan, Gordon] Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Gibert, Maryse; Popoff, Michel R.] Inst Pasteur, F-75724 Paris, France; [Gerding, Dale N.] Hines VA Hosp, Hines, IL 60141 USA		Wren, BW (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Brendan.Wren@lshtm.ac.uk	Parkhill, Julian/G-4703-2011; Sebaihia, Mohammed/AAF-6589-2019; Quail, michael/ABE-6131-2020	Parkhill, Julian/0000-0002-7069-5958; Sebaihia, Mohammed/0000-0002-3324-3346; Stabler, Richard/0000-0002-2402-6630; Rose, Graham/0000-0002-5097-5426	Wellcome TrustWellcome TrustEuropean Commission; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/E500412/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0300020] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0300020] Funding Source: UKRI	We thank Jon Brazier for provision of strain R20291 and Frances Smith for assistance with library making. We acknowledge the Wellcome Trust for funding this research.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Allen-Vercoe E, 1999, J MED MICROBIOL, V48, P771, DOI 10.1099/00222615-48-8-771; Alonso R, 2005, J MED MICROBIOL, V54, P159, DOI 10.1099/jmm.0.45809-0; [Anonymous], CLOSTRIDIUM DIFFICIL; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Bouvet PJM, 2008, J CLIN MICROBIOL, V46, P3703, DOI 10.1128/JCM.00866-08; BRAZIER JS, 2007, EUROSURVEILL, V12; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dawson LF, 2008, J MED MICROBIOL, V57, P745, DOI 10.1099/jmm.0.47744-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DELMEE M, 1990, J CLIN MICROBIOL, V28, P2210; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Drudy D, 2007, EMERG INFECT DIS, V13, P504, DOI 10.3201/eid1303.060771; Dupuy B, 2008, J MED MICROBIOL, V57, P685, DOI 10.1099/jmm.0.47775-0; GOLLEDGE CL, 1992, J ANTIMICROB CHEMOTH, V30, P141, DOI 10.1093/jac/30.2.141; Goncalves C, 2004, J CLIN MICROBIOL, V42, P1933, DOI 10.1128/JCM.42.5.1933-1939.2004; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; HAMMOND GA, 1995, MICROB PATHOGENESIS, V19, P203, DOI 10.1016/S0882-4010(95)90263-5; Hayes F, 1998, J BACTERIOL, V180, P6415; *HEALTHC COMM, INV OUTBR CLOSTR DIF; Howard SL, 2009, INFECT IMMUN, V77, P2544, DOI 10.1128/IAI.01425-08; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuijper E J, 2007, Euro Surveill, V12, pE1; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McCusker ME, 2003, EMERG INFECT DIS, V9, P730; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; Mooney H, 2007, BRIT MED J, V335, P958, DOI 10.1136/bmj.39388.597569.DB; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Patel NS, 2007, BJU INT, V99, P1333, DOI 10.1111/j.1464-410X.2006.06741.x; Pituch H, 2005, J MED MICROBIOL, V54, P143, DOI 10.1099/jmm.0.45799-0; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Postnova T, 1996, MICROBIOL-SGM, V142, P2767, DOI 10.1099/13500872-142-10-2767; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Rupnik M, 1997, FEMS MICROBIOL LETT, V148, P197, DOI 10.1016/S0378-1097(97)00033-5; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; SYUTO B, 1977, APPL ENVIRON MICROB, V33, P400, DOI 10.1128/AEM.33.2.400-405.1977; Taguchi F, 2006, J BACTERIOL, V188, P8376, DOI 10.1128/JB.00763-06; Tasteyre A, 2000, J CLIN MICROBIOL, V38, P3179, DOI 10.1128/JCM.38.9.3179-3186.2000; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; WUST J, 1983, ANTIMICROB AGENTS CH, V23, P784, DOI 10.1128/AAC.23.5.784; Yamashita Y, 1999, INFECT IMMUN, V67, P3693, DOI 10.1128/IAI.67.7.3693-3697.1999; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	68	318	328	1	41	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2009	10	9							R102	10.1186/gb-2009-10-9-r102			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	514VX	WOS:000271425300008	19781061	Green Published, Green Accepted			2022-01-24	
J	Zhang, XY; Bernatavichute, YV; Cokus, S; Pellegrini, M; Jacobsen, SE				Zhang, Xiaoyu; Bernatavichute, Yana V.; Cokus, Shawn; Pellegrini, Matteo; Jacobsen, Steven E.			Genome-wide analysis of mono-, di- and trimethylation of histone H3 lysine 4 in Arabidopsis thaliana	GENOME BIOLOGY			English	Article							SET-DOMAIN PROTEINS; DNA METHYLATION; EPIGENETIC INHERITANCE; GENE-EXPRESSION; TRITHORAX ATX1; CG METHYLATION; ACTIVE GENES; MAINTENANCE; ACETYLATION; PATTERNS	Background: Post-translational modifications of histones play important roles in maintaining normal transcription patterns by directly or indirectly affecting the structural properties of the chromatin. In plants, methylation of histone H3 lysine 4 (H3K4me) is associated with genes and required for normal plant development. Results: We have characterized the genome-wide distribution patterns of mono-, di-and trimethylation of H3K4 (H3K4me1, H3K4me2 and H3K4me3, respectively) in Arabidopsis thaliana seedlings using chromatin immunoprecipitation and high-resolution whole-genome tiling microarrays (ChIP-chip). All three types of H3K4me are found to be almost exclusively genic, and two-thirds of Arabidopsis genes contain at least one type of H3K4me. H3K4me2 and H3K4me3 accumulate predominantly in promoters and 5' genic regions, whereas H3K4me1 is distributed within transcribed regions. In addition, H3K4me3-containing genes are highly expressed with low levels of tissue specificity, but H3K4me1 or H3K4me2 may not be directly involved in transcriptional activation. Furthermore, the preferential co-localization of H3K4me3 and H3K27me3 found in mammals does not appear to occur in plants at a genome-wide level, but H3K4me2 and H3K27me3 co-localize at a higher-than-expected frequency. Finally, we found that H3K4me2/3 and DNA methylation appear to be mutually exclusive, but surprisingly, H3K4me1 is highly correlated with CG DNA methylation in the transcribed regions of genes. Conclusions: H3K4me plays widespread roles in regulating gene expression in plants. Although many aspects of the mechanisms and functions of H3K4me appear to be conserved among all three kingdoms, we observed significant differences in the relationship between H3K4me and transcription or other epigenetic pathways in plants and mammals.	[Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Bernatavichute, Yana V.; Cokus, Shawn; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Bernatavichute, Yana V.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA		Zhang, XY (corresponding author), Univ Georgia, Dept Plant Biol, Green St, Athens, GA 30602 USA.	xiaoyu@plantbio.uga.edu; Jacobsen@ucla.edu		Pellegrini, Matteo/0000-0001-9355-9564	University of Georgia; USPHS National Research Service AwardUnited States Department of Health & Human ServicesUnited States Public Health Service [GM07104]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM60398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007104, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	XZ was supported by a Faculty Research Grant (JR-040) from the University of Georgia. YVB was supported by USPHS National Research Service Award GM07104. Jacobsen lab research was supported by NIH grant GM60398. SEJ is an investigator of the Howard Hughes Medical Institute.	Alvarez-Venegas R, 2002, GENE, V285, P25, DOI 10.1016/S0378-1119(02)00401-8; Alvarez-Venegas R, 2005, NUCLEIC ACIDS RES, V33, P5199, DOI 10.1093/nar/gki830; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dong GF, 2008, BIOCHEM BIOPH RES CO, V373, P659, DOI 10.1016/j.bbrc.2008.06.096; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kankel MW, 2003, GENETICS, V163, P1109; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Kinoshita T, 2001, P NATL ACAD SCI USA, V98, P14156, DOI 10.1073/pnas.241507798; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oh SY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000077; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pien S, 2008, PLANT CELL, V20, P580, DOI 10.1105/tpc.108.058172; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reinders J, 2008, GENOME RES, V18, P469, DOI 10.1101/gr.7073008; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Saleh A, 2008, GENE, V423, P43, DOI 10.1016/j.gene.2008.06.022; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Saleh A, 2007, NUCLEIC ACIDS RES, V35, P6290, DOI 10.1093/nar/gkm464; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schubert D, 2005, CURR OPIN PLANT BIOL, V8, P553, DOI 10.1016/j.pbi.2005.07.005; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; *UCSC, UCSC GEN BIOINF; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao Z, 2004, ANN NY ACAD SCI, V1030, P661, DOI 10.1196/annals.1329.077; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2008, CURR OPIN PLANT BIOL, V11, P554, DOI 10.1016/j.pbi.2008.07.004; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	84	318	334	2	53	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2009	10	6							R62	10.1186/gb-2009-10-6-r62			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	465RK	WOS:000267604300012	19508735	Green Published, hybrid			2022-01-24	
J	Consonni, C; Humphry, ME; Hartmann, HA; Livaja, M; Durner, J; Westphal, L; Vogel, J; Lipka, V; Kemmerling, B; Schulze-Lefert, P; Somerville, SC; Panstruga, R				Consonni, Chiara; Humphry, Matthew E.; Hartmann, H. Andreas; Livaja, Maren; Durner, Jorg; Westphal, Lore; Vogel, John; Lipka, Volker; Kemmerling, Birgit; Schulze-Lefert, Paul; Somerville, Shauna C.; Panstruga, Ralph			Conserved requirement for a plant host cell protein in powdery mildew pathogenesis	NATURE GENETICS			English	Article							NONHOST RESISTANCE; DISEASE RESISTANCE; MLO RESISTANCE; SALICYLIC-ACID; BARLEY; ARABIDOPSIS; DEFENSE; GENE; SUSCEPTIBILITY; PENETRATION	In the fungal phylum Ascomycota, the ability to cause disease in plants and animals has been gained and lost repeatedly during phylogenesis(1). In monocotyledonous barley, loss-of-function mlo alleles result in effective immunity against the Ascomycete Blumeria graminis f. sp. hordei, the causal agent of powdery mildew disease(2,3). However, mlo-based disease resistance has been considered a barley-specific phenomenon to date. Here, we demonstrate a conserved requirement for MLO proteins in powdery mildew pathogenesis in the dicotyledonous plant species Arabidopsis thaliana. Epistasis analysis showed that mlo resistance in A. thaliana does not involve the signaling molecules ethylene, jasmonic acid or salicylic acid, but requires a syntaxin, glycosyl hydrolase and ABC transporter(4-6). These findings imply that a common host cell entry mechanism of powdery mildew fungi evolved once and at least 200 million years ago, suggesting that within the Erysiphales ( powdery mildews) the ability to cause disease has been a stable trait throughout phylogenesis.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; GSF, Natl Res Ctr Environm & Hlth, Inst Biochem Plant Pathol, Dept Plant Immun, D-85754 Oberschleissheim, Germany; Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle, Germany; USDA, Genom & Gene Discovery Unit, Albany, CA 94710 USA; Univ Tubingen, Dept Plant Biochem, D-72076 Tubingen, Germany		Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de	Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008; Vogel, John P/B-3176-2009; Humphry, Matthew/A-8136-2008; Lipka, Volker/C-5874-2009; Humphry, Matt/E-8072-2010; Panstruga, Ralph/F-3340-2011; Bruening, Stefan/B-8505-2011	Panstruga, Ralph/0000-0002-3756-8957; Kemmerling, Birgit/0000-0003-1174-0189; Vogel, John/0000-0003-1786-2689	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [FG32 GN19499-01] Funding Source: Medline		Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Jarosch B, 1999, MOL PLANT MICROBE IN, V12, P508, DOI 10.1094/MPMI.1999.12.6.508; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kumar J, 2001, PHYTOPATHOLOGY, V91, P127, DOI 10.1094/PHYTO.2001.91.2.127; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mori Yasuhiro, 2000, Mycoscience, V41, P437, DOI 10.1007/BF02461662; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Panstruga R, 2005, PLANT MOL BIOL, V59, P485, DOI 10.1007/s11103-005-0353-0; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1	28	318	350	1	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					716	720		10.1038/ng1806			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	WOS:000237954800029	16732289	Green Published			2022-01-24	
J	Musio, A; Selicorni, A; Focarelli, ML; Gervasini, C; Milani, D; Russo, S; Vezzoni, P; Larizza, L				Musio, A; Selicorni, A; Focarelli, ML; Gervasini, C; Milani, D; Russo, S; Vezzoni, P; Larizza, L			X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations	NATURE GENETICS			English	Article							SISTER-CHROMATID COHESION; NIPPED-B; ROBERTS-SYNDROME; HUMAN HOMOLOG; CUT GENE; DROSOPHILA; PHENOTYPE; PROTEINS; NIPBL; EXPRESSION	Cornelia de Lange syndrome is a multisystem developmental disorder characterized by facial dysmorphisms, upper limb abnormalities, growth delay and cognitive retardation. Mutations in the NIPBL gene, a component of the cohesin complex, account for approximately half of the affected individuals. We report here that mutations in SMC1L1 (also known as SMC1), which encodes a different subunit of the cohesin complex, are responsible for CdLS in three male members of an affected family and in one sporadic case.	CNR, Inst Biomed Technol, Human Genome Dept, I-20090 Segrate, Italy; Univ Milan, Fdn Policlin, Clin Pediat 1, I-20122 Milan, Italy; Univ Milan, San Paolo Sch Med, Div Med Genet, I-20142 Milan, Italy; Ist Auxol Italiano, Mol Genet Lab, I-20095 Milan, Italy		Musio, A (corresponding author), CNR, Inst Biomed Technol, Human Genome Dept, Via Fratelli Cervi,93, I-20090 Segrate, Italy.	antonio.musio@itb.cnr.it	Vezzoni, Paolo/R-3416-2019; Vezzoni, Paolo/K-3197-2018; Milani, Donatella/AAC-8430-2019; Gervasini, Cristina/A-5728-2014	Milani, Donatella/0000-0002-3087-8514; Gervasini, Cristina/0000-0002-1165-7935; MUSIO, ANTONIO/0000-0001-7701-6543			BROWN CJ, 1995, HUM MOL GENET, V4, P251, DOI 10.1093/hmg/4.2.251; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Egemen A, 2005, GENET COUNSEL, V16, P27; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Musio A, 2005, HUM MOL GENET, V14, P525, DOI 10.1093/hmg/ddi049; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; SELICORNI A, 1993, AM J MED GENET, V47, P977, DOI 10.1002/ajmg.1320470708; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548	14	318	332	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2006	38	5					528	530		10.1038/ng1779			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	WOS:000237147500013	16604071				2022-01-24	
J	McCarroll, SA; Murphy, CT; Zou, SG; Pletcher, SD; Chin, CS; Jan, YN; Kenyon, C; Bargmann, CI; Li, H				McCarroll, SA; Murphy, CT; Zou, SG; Pletcher, SD; Chin, CS; Jan, YN; Kenyon, C; Bargmann, CI; Li, H			Comparing genomic expression patterns across species identifies shared transcriptional profile in aging	NATURE GENETICS			English	Article							MESSENGER-RNA DECAY; GENE-EXPRESSION; C-ELEGANS; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; LIFE-SPAN; CALORIC RESTRICTION; OXIDATIVE STRESS; INSULIN-RECEPTOR; WIDE ANALYSIS	We developed a method for systematically comparing gene expression patterns across organisms using genome-wide comparative analysis of DNA microarray experiments. We identified analogous gene expression programs comprising shared patterns of regulation across orthologous genes. Biological features of these patterns could be identified as highly conserved subpatterns that correspond to Gene Ontology categories. Here, we demonstrate these methods by analyzing a specific biological process, aging, and show that similar analysis can be applied to a range of biological processes. We found that two highly diverged animals, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster, implement a shared adult-onset expression program of genes involved in mitochondrial metabolism, DNA repair, catabolism, peptidolysis and cellular transport. Most of these changes were implemented early in adulthood. Using this approach to search databases of gene expression data, we found conserved transcriptional signatures in larval development, embryogenesis, gametogenesis and mRNA degradation.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; UCL, Dept Biol, London, England; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol & Med Informat, San Francisco, CA 94143 USA		Li, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	haoli@genome.ucsf.edu	McCarroll, Steven A/A-8433-2009	Bargmann, Cornelia/0000-0002-8484-0618; McCarroll, Steven/0000-0002-6954-8184; Jan, Yuh Nung/0000-0003-1367-6299; Murphy, Coleen/0000-0002-8257-984X; Kenyon, Cynthia/0000-0003-3446-2636			Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lewis JA, 1995, METHOD CELL BIOL, V48, P4; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; SOMANI SM, 1992, INT J CLIN PHARM TH, V30, P1; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teichmann SA, 2002, TRENDS BIOTECHNOL, V20, P407, DOI 10.1016/S0167-7799(02)02032-2; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	50	318	329	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					197	204		10.1038/ng1291			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	WOS:000188542700024	14730301	Bronze			2022-01-24	
J	Wang, JL; Whitlock, MC				Wang, JL; Whitlock, MC			Estimating effective population size and migration rates from genetic samples over space and time	GENETICS			English	Article							NEWTS TRITURUS-CRISTATUS; ALLELE FREQUENCY CHANGES; TEMPORAL CHANGES; HETEROZYGOTE-EXCESS; MAXIMUM-LIKELIHOOD; EFFECTIVE NUMBER; MARMORATUS; DRIFT; FLOW; SELECTION	In the past, moment and likelihood methods have been developed to estimate the effective population size (N-e) on the basis of the observed changes of marker allele frequencies over time, and these have been applied to a large variety of species and populations. Such methods invariably make the critical assumption of a single isolated population receiving no immigrants over the study interval. For most populations in the real world, however, migration is not negligible and can substantially bias estimates of Ne if it is not accounted for. Here we extend previous moment and maximum-likelihood methods to allow the joint estimation of N-e and migration rate (m) using genetic samples over space and time. It is shown that, compared to genetic drift acting alone, migration results in changes in allele frequency that are greater in the short term and smaller in the long term, leading to under- and overestimation of N-e, respectively, if it is ignored. Extensive simulations are run to evaluate the newly developed moment and likelihood methods, which yield generally satisfactory estimates of both N-e and m for populations with widely different effective sizes and migration rates and patterns, given a reasonably large sample size and number of markers.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada		Wang, JL (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.		Whitlock, Michael C/G-1900-2012	Whitlock, Michael/0000-0002-0782-1843			Anderson EC, 2000, GENETICS, V156, P2109; ARNTZEN JW, 1991, EVOLUTION, V45, P805, DOI 10.1111/j.1558-5646.1991.tb04352.x; Beaumont MA, 1999, GENETICS, V153, P2013; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Dobzhansky T, 1941, GENETICS, V26, P23; Ewens W.J., 1979, MATH POPULATION GENE; Feller W, 1950, INTRO PROBABILITY TH; Fiumera AC, 2000, CONSERV BIOL, V14, P886, DOI 10.1046/j.1523-1739.2000.97337.x; Fiumera AC, 1999, ZOO BIOL, V18, P215; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Funk WC, 1999, MOL ECOL, V8, P1633, DOI 10.1046/j.1365-294x.1999.00748.x; Hayward R, 2000, HERPETOL J, V10, P129; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Jehle R, 2000, HYDROBIOLOGIA, V437, P149, DOI 10.1023/A:1026554907400; Jehle R, 2001, MOL ECOL, V10, P839, DOI 10.1046/j.1365-294X.2001.01237.x; Kantanen J, 1999, ANIM GENET, V30, P16, DOI 10.1046/j.1365-2052.1999.00379.x; KRIMBAS CB, 1971, EVOLUTION, V25, P454, DOI 10.1111/j.1558-5646.1971.tb01904.x; Labate JA, 1999, THEOR APPL GENET, V99, P1166, DOI 10.1007/s001220051321; Luikart G, 1999, GENETICS, V151, P1211; Lynch M., 1998, GENETICS ANAL QUANTI; MILNER GB, 1985, MAR FISH REV, V47, P1; NEI M, 1981, GENETICS, V98, P625; Nielsen R, 2001, GENETICS, V158, P885; PAMILO P, 1980, GENETICS, V95, P1055; POLLAK E, 1983, GENETICS, V104, P531; Press W H, 1996, NUMERICAL RECIPES FO, V1; Pudovkin AI, 1996, GENETICS, V144, P383; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; ROUSSET F, 2001, HDB STAT GENETICS, P179; Schwartz MK, 1999, ANIM CONSERV, V2, P321, DOI 10.1111/j.1469-1795.1999.tb00079.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; TAJIMA F, 1984, GENETICS, V106, P569; Turner TF, 1999, MOL ECOL, V8, P1223, DOI 10.1046/j.1365-294x.1999.00662.x; Vitalis R, 2001, GENETICS, V157, P911; Wang JL, 1999, HEREDITY, V82, P212, DOI 10.1038/sj.hdy.6884670; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2001, GENETICS, V157, P867; WAPLES RS, 1989, GENETICS, V121, P379; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Williamson EG, 1999, GENETICS, V152, P755; Wright S, 1931, GENETICS, V16, P0097	42	318	322	0	82	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JAN	2003	163	1					429	446					18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	646MW	WOS:000181039700038	12586728				2022-01-24	
J	Lespinet, O; Wolf, YI; Koonin, EV; Aravind, L				Lespinet, O; Wolf, YI; Koonin, EV; Aravind, L			The role of lineage-specific gene family expansion in the evolution of eukaryotes	GENOME RESEARCH			English	Article							COMPARATIVE GENOMICS; PROTEIN SEQUENCES; DOMAINS; CYTOCHROME-P450; SUPERFAMILY; ARABIDOPSIS; INFORMATION; MECHANISMS; COMPLEXITY; PREDICTION	A computational procedure was developed for systematic detection of lineage-specific expansions (LSEs) of protein families in sequenced genomes and applied to obtain a census of LSEs in five eukaryotic species, the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster, and the green plant Arabidopsis thaliana. A significant fraction of the proteins encoded in each of these genomes, up to 80% in A thailana, belong to LSEs. Many paralogous gene families in each of the analyzed species are almost entirely comprised of LSEs, indicating that their diversification occurred after the divergence of the major lineages of the eukaryotic crown group. The LSEs show readily discernible patterns of protein functions. The functional categories most prone to LSE are structural proteins, enzymes involved in ail organism's response to pathogens and environmental stress, and various components of signaling pathways responsible for specificity, including ubiquitin ligase E3 subunits and transcription factors. The functions of several previously uncharacterized, vastly expanded protein families were predicted through in-depth protein sequence analysis, for example, small-molecule kinases and methylases that are expanded independently ill the fly and in the nematode. The functions of several other major LSEs remain mysterious; these protein families are attractive targets for experimental discovery of novel, lineage-specific functions in eukaryotes. LSEs seem to be one of the principal means of adaptation and one of the most important sources of organizational and regulatory diversity in crown-group eukaryotes.	NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA		Koonin, EV (corresponding author), NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bldg 10, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov	Lespinet, Olivier/C-1235-2008	Lespinet, Olivier/0000-0002-4961-7461; Aravind, L/0000-0003-0771-253X; Wolf, Yuri/0000-0002-0247-8708	NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [ZIALM000073, Z01LM000073] Funding Source: NIH RePORTER		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Aravind L, 1999, CURR OPIN GENET DEV, V9, P688, DOI 10.1016/S0959-437X(99)00028-3; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; ARAVIND L, 2001, GENOME BIOL, V2; Bouchard BA, 2001, CURR OPIN HEMATOL, V8, P263, DOI 10.1097/00062752-200109000-00001; Braun EL, 2000, GENOME RES, V10, P416, DOI 10.1101/gr.10.4.416; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Coulson RMR, 2001, BIOINFORMATICS, V17, P95, DOI 10.1093/bioinformatics/17.1.95; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Dryer L, 2000, BIOESSAYS, V22, P803, DOI 10.1002/1521-1878(200009)22:9&lt;803::AID-BIES5&gt;3.0.CO;2-K; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; HAGGBLOM M, 1990, J BASIC MICROB, V30, P115, DOI 10.1002/jobm.3620300214; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Huynen MA, 1998, MOL BIOL EVOL, V15, P583, DOI 10.1093/oxfordjournals.molbev.a025959; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seigler D. S., 1998, PLANT SECONDARY META; Shiu SH, 2001, SCI STKE, V2001, DOI [10.1126/STKE.2001.113.RE22.RE22, DOI 10.1126/STKE.2001.113.RE22.RE22, DOI 10.1126/STKE.2001.113.RE22]; Sluder AE, 1999, GENOME RES, V9, P103; Sogin Mitchell L., 1996, Microbiologia (Madrid), V12, P17; Southan C, 2001, FEBS LETT, V498, P214, DOI 10.1016/S0014-5793(01)02490-5; Swofford D.L., 2003, PHYLOGENETIC ANAL US PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2	55	318	332	0	26	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2002	12	7					1048	1059		10.1101/gr.174302			12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	569LR	WOS:000176604300006	12097341	Bronze, Green Published			2022-01-24	
J	Anderson, MG; Smith, RS; Hawes, NL; Zabaleta, A; Chang, B; Wiggs, JL; John, SWM				Anderson, MG; Smith, RS; Hawes, NL; Zabaleta, A; Chang, B; Wiggs, JL; John, SWM			Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice	NATURE GENETICS			English	Article							BROWN LOCUS PROTEIN; OCULOCUTANEOUS ALBINISM; DISPERSION SYNDROME; MOUSE MUTATION; IRIS ATROPHY; TYROSINASE; MELANOCYTES; MELANOMA; TYRP1; GP75	Pigmentary glaucoma is a significant cause of human blindness. Abnormally liberated iris pigment and cell debris enter the ocular drainage structures, leading to increased intraocular pressure (IOP) and glaucoma(1-3). DBA/2J (D2) mice develop a form of pigmentary glaucoma involving iris pigment dispersion (IPD) and iris stromal atrophy (ISA)(4,5). Using high-resolution mapping techniques, sequencing and functional genetic tests, we show that IPD and ISA result from mutations in related genes encoding melanosomal proteins. IPD is caused by a premature stop codon mutation in the Gpnmb (Gpnmb(R150X)) gene, as proved by the occurrence of IPD only in D2 mice that are homozygous with respect to Gpnmb(R150X). otherwise, similar D2 mice that are not homozygous for Gpnmb(R150X) do not develop IPD. ISA is caused by the recessive Tyrp1(b) mutant allele and rescued by the transgenic introduction of wildtype Tyrp1. We hypothesize that IPD and ISA alter melanosomes, allowing toxic intermediates of pigment production to leak from melanosomes, causing iris disease and subsequent pigmentary glaucoma. This is supported by the rescue of IPD and ISA in D2 eyes with substantially decreased pigment production. These data indicate that pigment production and mutant melanosomal protein genes may contribute to human pigmentary glaucoma. The fact that hypopigmentation profoundly alleviates the D2 disease indicates that therapeutic strategies designed to decrease pigment production may be beneficial in human pigmentary glaucoma.	Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA		John, SWM (corresponding author), Howard Hughes Med Inst, Bar Harbor, ME 04609 USA.		Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105; Chang, Bo/0000-0001-8259-7290	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [F32 EY007015] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [F32EY007015] Funding Source: NIH RePORTER		Andersen JS, 1997, ARCH OPHTHALMOL-CHIC, V115, P384, DOI 10.1001/archopht.1997.01100150386012; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Boissy RE, 1998, EXP DERMATOL, V7, P198, DOI 10.1111/j.1600-0625.1998.tb00324.x; CAMPBELL DG, 1996, GLAUCOMAS, V2, P975; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; EPSTEIN DL, 1997, CHANDLER GRANTS GLAU, P220; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; HALABAN R, 1990, P NATL ACAD SCI USA, V87, P4809, DOI 10.1073/pnas.87.12.4809; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; KOBAYASHI T, 1994, J BIOL CHEM, V269, P29198; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; MOYER FH, 1966, AM ZOOL, V6, P43; Nylander K, 2000, J PATHOL, V190, P39, DOI 10.1002/(SICI)1096-9896(200001)190:1<39::AID-PATH492>3.0.CO;2-V; RITCH R, 1993, AM J OPHTHALMOL, V115, P707, DOI 10.1016/S0002-9394(14)73635-9; Stjernschantz J, 2000, ACTA OPHTHALMOL SCAN, V78, P618, DOI 10.1034/j.1600-0420.2000.078006618.x; SUGAR HS, 1966, AM J OPHTHALMOL, V62, P499; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; TAI T, 1983, CANCER RES, V43, P2773; TAYLOR BA, 1996, GENETIC VARIANTS STR, V2, P1597; Turque N, 1996, EMBO J, V15, P3338, DOI 10.1002/j.1460-2075.1996.tb00699.x; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wistrand PJ, 1997, SURV OPHTHALMOL, V41, pS129, DOI 10.1016/S0039-6257(97)80020-3; ZDARSKY E, 1990, GENETICS, V126, P443	30	318	331	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					81	85		10.1038/ng794			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	WOS:000173105600018	11743578				2022-01-24	
J	Yang, IV; Chen, E; Hasseman, JP; Liang, W; Frank, BC; Wang, SB; Sharov, V; Saeed, AI; White, J; Li, J; Lee, NH; Yeatman, TJ; Quackenbush, J				Yang, Ivana V.; Chen, Emily; Hasseman, Jeremy P.; Liang, Wei; Frank, Bryan C.; Wang, Shuibang; Sharov, Vasily; Saeed, Alexander I.; White, Joseph; Li, Jerry; Lee, Norman H.; Yeatman, Timothy J.; Quackenbush, John			Within the fold: assessing differential expression measures and reproducibility in microarray assays	GENOME BIOLOGY			English	Article							GENE-EXPRESSION	Background: 'Fold-change' cutoffs have been widely used in microarray assays to identify genes that are differentially expressed between query and reference samples. More accurate measures of differential expression and effective data-normalization strategies are required to identify high-confidence sets of genes with biologically meaningful changes in transcription. Further, the analysis of a large number of expression profiles is facilitated by a common reference sample, the construction of which must be carefully addressed. Results: We carried out a series of 'self-self' hybridizations in which aliquots of the same RNA sample were labeled separately with Cy3 and Cy5 fluorescent dyes and co-hybridized to the same microarray. From this, we can analyze the intensity-dependent behavior of microarray data, define a statistically significant measure of differential expression that exploits the structure of the fluorescent signals, and measure the inherent reproducibility of the technique. We also devised a simple procedure for identifying and eliminating low-quality data for replicates within and between slides. We examine the properties required of a universal reference RNA sample and show how pooling a small number of samples with a diverse representation of expressed genes can outperform more complex mixtures as a reference sample. Conclusion: Analysis of cell-line samples can identify systematic structure in measured gene-expression levels. A general procedure for analyzing cDNA microarray data is proposed and validated. We show that pooled reference samples should be based not only on the expression of individual genes in each cell line but also on the expression levels of genes within cell lines.	[Yang, Ivana V.; Chen, Emily; Hasseman, Jeremy P.; Liang, Wei; Frank, Bryan C.; Wang, Shuibang; Sharov, Vasily; Saeed, Alexander I.; White, Joseph; Li, Jerry; Lee, Norman H.; Quackenbush, John] Inst Genom Res, Rockville, MD 20850 USA; [Yeatman, Timothy J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA		Quackenbush, J (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	johnq@tigr.org	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X	US National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Science FoundationNational Science Foundation (NSF)	We wish to thank Y. Wang, H. Kim, K.-Y. Kwong, M. I. Klapa, and H. Wang for helpful discussions and comments on the manuscript and J. Tsai and T. Currier for bioinformatics support for the microarray work The authors also wish to thank M. Heaney and S. Lo for database support, and V. Sapiro, B. Lee, J. Shao, C. Irwin, J. Neubrech, R. Karamchedu, M. Sengamalay and E. Arnold for computer system support. This project was supported by grants from the US National Cancer Institute, the National Heart, Lung, and Blood Institute, and the National Science Foundation.	[Anonymous], PRIMER 3; Baggerly KA, 2001, J COMPUT BIOL, V8, P639, DOI 10.1089/106652701753307539; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Dudoit S, 2002, STAT SINICA, V12, P111; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gaspard R, 2001, BIOTECHNIQUES, V31, P35, DOI 10.2144/01311bm04; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; *I GEN RES, I GEN RES CANC PAG; *I GEN RES, I GEN RES SOFTW TOOL; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; *NAT CTR BIOT INF, DIG DIFF DISPL; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; LOCFIT LOCAL REGRESS	21	318	327	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2002	3	11							0062.1				13	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	V12EJ	WOS:000207582200015					2022-01-24	
J	Mersiyanova, IV; Perepelov, AV; Polyakov, AV; Sitnikov, VF; Dadali, EL; Oparin, RB; Petrin, AN; Evgrafov, OV				Mersiyanova, IV; Perepelov, AV; Polyakov, AV; Sitnikov, VF; Dadali, EL; Oparin, RB; Petrin, AN; Evgrafov, OV			A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL MYELIN PROTEIN; TREMBLER-J MOUSE; HEREDITARY MOTOR; AXONAL-TRANSPORT; TRANSGENIC MICE; POINT MUTATION; SCHWANN-CELLS; LEWY BODIES; HEAVY GENE	Charcot-Marie-Tooth (CMT) disease is the most common inherited motor and sensory neuropathy. The axonal form of the disease is designated as "CMT type 2" (CMT2). Although four loci known to be implicated in autosomal dominant CMT2 have been mapped thus far (on 1p35-p36, 3q13.1, 3q13-q22, and 7p14), no one causative gene is yet known. A large Russian family with CMT2 was found in the Mordovian Republic (Russia). Affected members had the typical CMT2 phenotype. Additionally, several patients suffered from hyperkeratosis, although the association, if any, between the two disorders is not clear. Linkage with the CMT loci already known (CMT1A, CMT1B, CMT2A, CMT2B, CMT2D, and a number of other CMT-related loci) was excluded. Genomewide screening pinpointed the disease locus in this family to chromosome 8p21, within a 16-cM interval between markers D8S136 and D8S1769. A maximum two-point LOD score of 5.93 was yielded by a microsatellite from the 5' region of the neurofilament-light gene (NF-L). Neurofilament proteins play an important role in axonal structure and are implicated in several neuronal disorders. Screening of affected family members for mutations in the NF-L gene and in the tightly linked neurofilament-medium gene (NF-M) revealed the only DNA alteration linked with the disease: a A998C transversion in the first exon of NF-L, which converts a conserved Gln333 amino acid to proline. This alteration was not found in 180 normal chromosomes. Twenty unrelated CMT2 patients, as well as 26 others with an undetermined form of CMT, also were screened for mutations in NF-L, but no additional mutations were found. It is suggested that Gln33SPro represents a rare disease-causing mutation, which results in the CMT2 phenotype.	Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; Russian State Med Univ, Moscow 117437, Russia; Res Ctr Dermatol & Venerol, Moscow, Russia; Mordovian NP Ogarev State Univ, Saransk, Russia		Mersiyanova, IV (corresponding author), Russian Acad Med Sci, Med Genet Res Ctr, Moskvorechie 1, Moscow 115478, Russia.	imers@mail.ru					ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; BENOTHMANE K, 1993, GENOMICS, V17, P370; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Birouk N, 1998, NEUROLOGY, V50, P1074, DOI 10.1212/WNL.50.4.1074; Carpenter DA, 1996, J CELL SCI, V109, P2493; Cleveland DW, 1996, NEUROLOGY, V47, pS54, DOI 10.1212/WNL.47.4_Suppl_2.54S; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; De Jonghe P, 1997, J Peripher Nerv Syst, V2, P370; De Jonghe P, 1997, J NEUROL NEUROSUR PS, V62, P570, DOI 10.1136/jnnp.62.6.570; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dyck PJ, 1993, PERIPHERAL NEUROPATH, P1094; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; EVGRAFOV OV, 1997, J PERIPHER NERV SYST, V2, P392; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Flanigan KM, 1998, ANN NEUROL, V43, P143, DOI 10.1002/ana.410430126; GEISLER N, 1981, J MOL BIOL, V151, P565, DOI 10.1016/0022-2836(81)90011-5; GOLDMAN JE, 1983, SCIENCE, V221, P1082, DOI 10.1126/science.6308771; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HIRANO A, 1991, ADV NEUROL, V56, P91; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Julien JP, 1995, BIOCHEM CELL BIOL, V73, P593, DOI 10.1139/o95-064; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; KWON JM, 1995, AM J HUM GENET, V57, P853; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Magyar JP, 1996, J NEUROSCI, V16, P5351; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.3.CO;2-1; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; POLLANEN MS, 1994, ACTA NEUROPATHOL, V88, P1, DOI 10.1007/BF00294352; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Rooke K, 1996, NEUROLOGY, V46, P789, DOI 10.1212/WNL.46.3.789; Sahenk Z, 1999, ANN NEUROL, V45, P16, DOI 10.1002/1531-8249(199901)45:1<16::AID-ART5>3.0.CO;2-F; SCHMIDT ML, 1991, LAB INVEST, V64, P352; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; SKRE H, 1974, CLIN GENET, V6, P98; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Takashima H, 1997, ANN NEUROL, V41, P771, DOI 10.1002/ana.410410613; Takashima H, 1999, NEUROMUSCULAR DISORD, V9, P368, DOI 10.1016/S0960-8966(99)00021-8; Thomas PK, 1997, BRAIN, V120, P465, DOI 10.1093/brain/120.3.465; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; Timmerman V, 1996, NEUROLOGY, V46, P1311, DOI 10.1212/WNL.46.5.1311; Tomkins J, 1998, NEUROREPORT, V9, P3967, DOI 10.1097/00001756-199812010-00036; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; Vechio JD, 1996, ANN NEUROL, V40, P603, DOI 10.1002/ana.410400410; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; VOGEL P, 1985, ANN NEUROL, V17, P455, DOI 10.1002/ana.410170507; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Xu ZS, 1996, J CELL BIOL, V133, P1061, DOI 10.1083/jcb.133.5.1061; XU ZS, 1993, J CELL SCI, P101; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	62	318	342	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					37	46		10.1086/302962			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	WOS:000088926900007	10841809	Green Published, Bronze			2022-01-24	
J	OKKEMA, PG; HARRISON, SW; PLUNGER, V; ARYANA, A; FIRE, A				OKKEMA, PG; HARRISON, SW; PLUNGER, V; ARYANA, A; FIRE, A			SEQUENCE REQUIREMENTS FOR MYOSIN GENE-EXPRESSION AND REGULATION IN CAENORHABDITIS-ELEGANS	GENETICS			English	Article							HEAVY-CHAIN GENE; C-ELEGANS; MESSENGER-RNAS; BINDING-SITES; MUSCLE; PROTEIN; PROMOTER; FAMILY; TRANSCRIPTS; GLP-1	Four Caenorhabditis elegans genes encode muscle-type specific myosin heavy chain isoforms: myo-1 and myo-2 are expressed in the pharyngeal muscles; unc-54 and myo-3 are expressed in body wall muscles. We have used transformation-rescue and lacZ fusion assays to determine sequence requirements for regulated myosin gene expression during development. Multiple tissue-specific activation elements are present for all four genes. For each of the four genes, sequences upstream of the coding region are tissue-specific promoters, as shown by their ability to drive expression of a reporter gene (lacZ) in the appropriate muscle type. Each gene contains at least one additional tissue-specific regulatory element, as defined by the ability to enhance expression of a heterologous promoter in the appropriate muscle type. In rescue experiments with unc-54, two further requirements apparently independent of tissue specificity were found: sequences within the 3' non-coding region are essential for activity while an intron near the 5' end augments expression levels. The general intron stimulation is apparently independent of intron sequence, indicating a mechanistic effect of splicing. To further characterize the myosin gene promoters and to examine the types of enhancer sequences in the genome, we have initiated a screen of C. elegans genomic DNA for fragments capable of enhancing the myo-2 promoter. The properties of enhancers recovered from this screen suggest that the promoter is limited to muscle cells in its ability to respond to enhancers.			OKKEMA, PG (corresponding author), CARNEGIE INST WASHINGTON,DEPT EMBRYOL,BALTIMORE,MD 21210, USA.		Jantsch, Verena/A-3910-2017	Jantsch, Verena/0000-0002-1978-682X; Fire, Andrew/0000-0001-6217-8312	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07532-03] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM037706, R01-GM37706] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM037706] Funding Source: NIH RePORTER		AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; ALBERTSON DG, 1985, EMBO J, V4, P2493, DOI 10.1002/j.1460-2075.1985.tb03961.x; ANDERSON P, 1984, P NATL ACAD SCI-BIOL, V81, P4470, DOI 10.1073/pnas.81.14.4470; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BEJSOVEC A, 1990, CELL, V60, P133, DOI 10.1016/0092-8674(90)90723-R; BLUMENTHAL T, 1988, TRENDS GENET, V4, P305, DOI 10.1016/0168-9525(88)90107-2; BRENNER S, 1974, GENETICS, V77, P71; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; CUMMINS C, 1988, MOL CELL BIOL, V8, P5339, DOI 10.1128/MCB.8.12.5339; DIBB NJ, 1985, J MOL BIOL, V183, P543, DOI 10.1016/0022-2836(85)90170-6; DIBB NJ, 1989, J MOL BIOL, V205, P603, DOI 10.1016/0022-2836(89)90229-5; EIDE D, 1985, P NATL ACAD SCI USA, V82, P1756, DOI 10.1073/pnas.82.6.1756; EIDE D, 1985, GENETICS, V109, P67; EIDE DJ, 1985, MOL CELL BIOL, V5, P1; EMMONS SW, 1988, NEMATODE CAENORHABDI, P47; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; FIELDS C, 1990, NUCLEIC ACIDS RES, V18, P1509, DOI 10.1093/nar/18.6.1509; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; FIRE A, 1991, DEVELOPMENT, V113, P503; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; FIRE A, 1993, GENET ANAL TECH APPL, V9, P151; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HODGKIN J, 1989, GENETICS, V123, P301; HONDA S, 1990, P NATL ACAD SCI USA, V87, P876, DOI 10.1073/pnas.87.3.876; JEFFERSON RA, 1987, J MOL BIOL, V193, P41, DOI 10.1016/0022-2836(87)90624-3; KARN J, 1983, P NATL ACAD SCI-BIOL, V80, P4253, DOI 10.1073/pnas.80.14.4253; KAY RJ, 1986, MOL CELL BIOL, V6, P3134, DOI 10.1128/MCB.6.9.3134; KLASS M, 1988, J MOL BIOL, V199, P15, DOI 10.1016/0022-2836(88)90375-0; KLASS MR, 1984, MOL CELL BIOL, V4, P529, DOI 10.1128/MCB.4.3.529; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KRAUSE M, 1986, THESIS U COLORADO BO; LAMBIE EJ, 1991, DEVELOPMENT, V112, P231; Lawrence P. A., 1992, MAKING FLY GENETICS; MacLeod A. R., 1979, Nonsense mutations and tRNA suppressors., P301; MACLEOD AR, 1977, P NATL ACAD SCI USA, V74, P5336, DOI 10.1073/pnas.74.12.5336; MACLEOD AR, 1977, J MOL BIOL, V114, P133, DOI 10.1016/0022-2836(77)90287-X; MACLEOD AR, 1981, NATURE, V291, P386, DOI 10.1038/291386a0; MACMORRIS M, 1992, MOL CELL BIOL, V12, P1652, DOI 10.1128/MCB.12.4.1652; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; MITCHELL EJ, 1989, J MOL BIOL, V208, P199, DOI 10.1016/0022-2836(89)90096-X; NEUBERGER M, 1988, NUCLEIC ACIDS RES, V16, P3969; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Ptashne M, 1986, GENETIC SWITCH GENE; PULAK RA, 1988, MOL CELL BIOL, V8, P3748, DOI 10.1128/MCB.8.9.3748; ROSENQUIST TA, 1988, GENE DEV, V2, P606, DOI 10.1101/gad.2.5.606; SCHULTZ JR, 1991, MOL CELL BIOL, V11, P1901, DOI 10.1128/MCB.11.4.1901; SPIETH J, 1985, NUCLEIC ACIDS RES, V13, P5283, DOI 10.1093/nar/13.14.5283; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; Sulston J., 1988, NEMATODE CAENORHABDI, P587; TRENT C, 1983, GENETICS, V104, P619; Waterston R, 1988, NEMATODE CAENORHABDI, P281; WAY JC, 1991, GENE DEV, V5, P2199, DOI 10.1101/gad.5.12a.2199; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WEINTRAUB H, 1988, P NATL ACAD SCI USA, V85, P5819, DOI 10.1073/pnas.85.16.5819; White J, 1988, NEMATODE CAENORHABDI, P81; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P277, DOI 10.1016/0968-0004(90)90054-F; YAOITA Y, 1990, P NATL ACAD SCI USA, V87, P7090, DOI 10.1073/pnas.87.18.7090; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	68	318	324	0	13	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1993	135	2					385	404					20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ432	WOS:A1993LZ43200014	8244003				2022-01-24	
J	ADAMS, MD; SOARES, MB; KERLAVAGE, AR; FIELDS, C; VENTER, JC				ADAMS, MD; SOARES, MB; KERLAVAGE, AR; FIELDS, C; VENTER, JC			RAPID CDNA SEQUENCING (EXPRESSED SEQUENCE TAGS) FROM A DIRECTIONALLY CLONED HUMAN INFANT BRAIN CDNA LIBRARY	NATURE GENETICS			English	Article							PHENOL-CHLOROFORM EXTRACTION; SINGLE-STEP METHOD; RNA ISOLATION; IDENTIFICATION; PRECURSOR	A human infant brain cDNA library, made specifically for production of expressed sequence tags (ESTs) was evaluated by partial sequencing of over 1,600 clones. Advantages of this library, constructed for EST sequencing, include the use of directional cloning, size selection, very low numbers of mitochondrial and ribosomal transcripts, short polyA tails, few non-recombinants and a broad representation of transcripts. 37% of the clones were identified, based on matches to over 320 different genes in the public databases. Of these, two proteins similar to the Alzheimer's disease amyloid precursor protein were identified.	NINCDS, RECEPTOR & BIOCHEM & MOLEC BIOL SECT, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA; INST GENOM RES, GAITHERSBURG, MD 20878 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT PSYCHIAT, NEW YORK, NY 10032 USA; NEW YORK STATE PSYCHIAT INST & HOSP, NEW YORK, NY 10032 USA					Kerlavage, Anthony/0000-0002-3954-9653; Fields, Chris/0000-0002-4812-0744			ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1992, NATURE, V357, P367, DOI 10.1038/357367b0; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DALESSIO JM, 1987, FOCUS, V9, P1; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KERLAVAGE A, 1993, 26TH P HAW INT C SYS, P585; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; Maniatis T, 1982, MOLECULAR; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VIDAL F, 1992, BIOCHEM BIOPH RES CO, V189, P1336, DOI 10.1016/0006-291X(92)90220-F; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Young R. A, 1985, DNA CLONING TECHNIQU, P49	21	318	324	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					373	386		10.1038/ng0893-373			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	WOS:A1993LQ17800015	8401585				2022-01-24	
J	BADNER, JA; SIEBER, WK; GARVER, KL; CHAKRAVARTI, A				BADNER, JA; SIEBER, WK; GARVER, KL; CHAKRAVARTI, A			A GENETIC-STUDY OF HIRSCHSPRUNG DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,A310 CRABTREE HALL,130 DESOTO ST,PITTSBURGH,PA 15261; CHILDRENS HOSP PITTSBURGH,DEPT PEDIAT SURG,PITTSBURGH,PA; WESTERN PENN HOSP,DEPT MED GENET,PITTSBURGH,PA 15224						NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD00774] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM33771] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K04HD000774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM033771] Funding Source: NIH RePORTER		ALGAZALI LI, 1988, J MED GENET, V25, P758, DOI 10.1136/jmg.25.11.758; ARIAS S, 1984, CYTOGENET CELL GENET, V37, P401; BADNER JA, 1988, THESIS U PITTSBURGH; BADNER JA, IN PRESS AM J MED GE; BEEDGEN B, 1986, EUR J PEDIATR, V145, P229, DOI 10.1007/BF00446075; BESSON WT, 1986, CIRCULATION, V73, P360, DOI 10.1161/01.CIR.73.2.360; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; CARMI R, 1982, BIRTH DEFECTS-ORIG, V18, P187; CARTER CO, 1981, J MED GENET, V18, P87, DOI 10.1136/jmg.18.2.87; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; FABIA J, 1970, PEDIATRICS, V45, P60; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; FERRELL RE, 1980, P NATL ACAD SCI-BIOL, V77, P1580, DOI 10.1073/pnas.77.3.1580; GARVER KL, 1985, CLIN GENET, V28, P503; GOLDBERG EL, 1984, INT J EPIDEMIOL, V13, P479, DOI 10.1093/ije/13.4.479; HALL JG, 1988, AM J HUM GENET, V43, P355; HAMILTON J, 1989, J MED GENET, V26, P272, DOI 10.1136/jmg.26.4.272; Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123; HURST JA, 1988, J MED GENET, V25, P494, DOI 10.1136/jmg.25.7.494; JACOBSCOHEN RJ, 1987, J COMP NEUROL, V255, P425, DOI 10.1002/cne.902550309; JARMAS AL, 1983, AM J MED GENET, V16, P163, DOI 10.1002/ajmg.1320160205; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LAMONT MA, 1989, J MED GENET, V26, P100, DOI 10.1136/jmg.26.2.100; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Langman J., 1981, MED EMBRYOLOGY; LAURENCE KM, 1975, J MED GENET, V12, P334, DOI 10.1136/jmg.12.4.334; LEWANDOWSKI RC, 1977, NEW CHROMOSOMAL SYND, P369; LIPSON AH, 1987, CLIN GENET, V32, P175; MAGENIS RE, 1988, AM J MED GENET, V29, P9, DOI 10.1002/ajmg.1320290103; MAHAKRISHNAN A, 1980, ARCH DERMATOL, V116, P1102, DOI 10.1001/archderm.1980.01640340012007; MAHBOUBI S, 1984, PEDIATR RADIOL, V14, P441, DOI 10.1007/BF02343439; MCKUSICK VA, 1965, B JOHNS HOPKINS HOSP, V116, P285; MORTON NE, 1974, AM J HUM GENET, V26, P489; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; PASSARGE E, 1972, Birth Defects Original Article Series, V8, P63; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PRIER L, 1981, Z KINDERCHIR, V32, P69; PUESCHEL SM, 1983, NY STATE J MED, V66, P3067; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; REYNOLDS JF, 1983, PEDIATRICS, V71, P246; SANTOS H, 1988, J MED GENET, V25, P204, DOI 10.1136/jmg.25.3.204; SEARLE A G, 1987, Genomics, V1, P3, DOI 10.1016/0888-7543(87)90099-1; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; SPARKES RS, 1984, HUM GENET, V68, P258, DOI 10.1007/BF00418397; SPOUGE D, 1985, TERATOLOGY, V32, P171, DOI 10.1002/tera.1420320204; VERDY M, 1982, J PEDIATR GASTR NUTR, V1, P603, DOI 10.1097/00005176-198212000-00027; WEBB GC, 1988, J MED GENET, V25, P125, DOI 10.1136/jmg.25.2.125; WEBSTER W, 1973, J EMBRYOL EXP MORPH, V30, P573; WRIGHT TC, 1984, P NATL ACAD SCI-BIOL, V81, P2426, DOI 10.1073/pnas.81.8.2426; [No title captured]	54	318	323	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					568	580					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	WOS:A1990CT66800021	2309705				2022-01-24	
J	Savage, JE; Jansen, PR; Stringer, S; Watanabe, K; Bryois, J; de Leeuw, CA; Nagel, M; Awasthi, S; Barr, PB; Coleman, JRI; Grasby, KL; Hammerschlag, AR; Kaminski, JA; Karlsson, R; Krapohl, E; Lam, M; Nygaard, M; Reynolds, CA; Trampush, JW; Young, H; Zabaneh, D; Hagg, S; Hansell, NK; Karlsson, IK; Linnarsson, S; Montgomery, GW; Munoz-Manchado, AB; Quinlan, EB; Schumann, G; Skene, NG; Webb, BT; White, T; Arking, DE; Avramopoulos, D; Bilder, RM; Bitsios, P; Burdick, KE; Cannon, TD; Chiba-Falek, O; Christoforou, A; Cirulli, ET; Congdon, E; Corvin, A; Davies, G; Deary, IJ; DeRosse, P; Dickinson, D; Djurovic, S; Donohoe, G; Conley, ED; Eriksson, JG; Espeseth, T; Freimer, NA; Giakoumaki, S; Giegling, I; Gill, M; Glahn, DC; Hariri, AR; Hatzimanolis, A; Keller, MC; Knowles, E; Koltai, D; Konte, B; Lahti, J; Le Hellard, S; Lencz, T; Liewald, DC; London, E; Lundervold, AJ; Malhotra, AK; Melle, I; Morris, D; Need, AC; Ollier, W; Palotie, A; Payton, A; Pendleton, N; Poldrack, RA; Raikkonen, K; Reinvang, I; Roussos, P; Rujescu, D; Sabb, FW; Scult, MA; Smeland, OB; Smyrnis, N; Starr, JM; Steen, VM; Stefanis, NC; Straub, RE; Sundet, K; Tiemeier, H; Voineskos, AN; Weinberger, DR; Widen, E; Yu, J; Abecasis, G; Andreassen, OA; Breen, G; Christiansen, L; Debrabant, B; Dick, DM; Heinz, A; Hjerling-Leffler, J; Ikram, MA; Kendler, KS; Martin, NG; Medland, SE; Pedersen, NL; Plomin, R; Polderman, TJC; Ripke, S; van der Sluis, S; Sullivan, PF; Vrieze, SI; Wright, MJ; Posthuma, D				Savage, Jeanne E.; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; Bryois, Julien; de Leeuw, Christiaan A.; Nagel, Mats; Awasthi, Swapnil; Barr, Peter B.; Coleman, Jonathan R. I.; Grasby, Katrina L.; Hammerschlag, Anke R.; Kaminski, Jakob A.; Karlsson, Robert; Krapohl, Eva; Lam, Max; Nygaard, Marianne; Reynolds, Chandra A.; Trampush, Joey W.; Young, Hannah; Zabaneh, Delilah; Hagg, Sara; Hansell, Narelle K.; Karlsson, Ida K.; Linnarsson, Sten; Montgomery, Grant W.; Munoz-Manchado, Ana B.; Quinlan, Erin B.; Schumann, Gunter; Skene, Nathan G.; Webb, Bradley T.; White, Tonya; Arking, Dan E.; Avramopoulos, Dimitrios; Bilder, Robert M.; Bitsios, Panos; Burdick, Katherine E.; Cannon, Tyrone D.; Chiba-Falek, Ornit; Christoforou, Andrea; Cirulli, Elizabeth T.; Congdon, Eliza; Corvin, Aiden; Davies, Gail; Deary, Ian J.; DeRosse, Pamela; Dickinson, Dwight; Djurovic, Srdjan; Donohoe, Gary; Conley, Emily Drabant; Eriksson, Johan G.; Espeseth, Thomas; Freimer, Nelson A.; Giakoumaki, Stella; Giegling, Ina; Gill, Michael; Glahn, David C.; Hariri, Ahmad R.; Hatzimanolis, Alex; Keller, Matthew C.; Knowles, Emma; Koltai, Deborah; Konte, Bettina; Lahti, Jari; Le Hellard, Stephanie; Lencz, Todd; Liewald, David C.; London, Edythe; Lundervold, Astri J.; Malhotra, Anil K.; Melle, Ingrid; Morris, Derek; Need, Anna C.; Ollier, William; Palotie, Aarno; Payton, Antony; Pendleton, Neil; Poldrack, Russell A.; Raikkonen, Katri; Reinvang, Ivar; Roussos, Panos; Rujescu, Dan; Sabb, Fred W.; Scult, Matthew A.; Smeland, Olav B.; Smyrnis, Nikolaos; Starr, John M.; Steen, Vidar M.; Stefanis, Nikos C.; Straub, Richard E.; Sundet, Kjetil; Tiemeier, Henning; Voineskos, Aristotle N.; Weinberger, Daniel R.; Widen, Elisabeth; Yu, Jin; Abecasis, Goncalo; Andreassen, Ole A.; Breen, Gerome; Christiansen, Lene; Debrabant, Birgit; Dick, Danielle M.; Heinz, Andreas; Hjerling-Leffler, Jens; Ikram, M. Arfan; Kendler, Kenneth S.; Martin, Nicholas G.; Medland, Sarah E.; Pedersen, Nancy L.; Plomin, Robert; Polderman, Tinca J. C.; Ripke, Stephan; van der Sluis, Sophie; Sullivan, Patrick F.; Vrieze, Scott I.; Wright, Margaret J.; Posthuma, Danielle			Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence	NATURE GENETICS			English	Article							GENERAL COGNITIVE FUNCTION; EDUCATIONAL-ATTAINMENT; TEST BATTERIES; GWAS; TRAITS; RISK; LOCI; HERITABILITY; ANNOTATION; CONSORTIUM	Intelligence is highly heritable(1) and a major determinant of human health and well-being(2). Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3-7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer's disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.	[Savage, Jeanne E.; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; de Leeuw, Christiaan A.; Hammerschlag, Anke R.; Polderman, Tinca J. C.; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Jansen, Philip R.; White, Tonya; Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Bryois, Julien; Karlsson, Robert; Hagg, Sara; Karlsson, Ida K.; Pedersen, Nancy L.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Nagel, Mats; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Awasthi, Swapnil; Kaminski, Jakob A.; Malhotra, Anil K.; Heinz, Andreas; Ripke, Stephan] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany; [Barr, Peter B.; Dick, Danielle M.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Coleman, Jonathan R. I.; Krapohl, Eva; Zabaneh, Delilah; Breen, Gerome; Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Coleman, Jonathan R. I.; Breen, Gerome] South London & Maudsley NHS Trust, NIHR Biomed Res Ctr Mental Hlth, London, England; [Grasby, Katrina L.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Kaminski, Jakob A.] Berlin Inst Hlth, Berlin, Germany; [Lam, Max] Inst Mental Hlth, Singapore, Singapore; [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Twin Registry, Odense, Denmark; [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Aging Res Ctr, Dept Publ Hlth, Odense, Denmark; [Nygaard, Marianne; Christiansen, Lene; Debrabant, Birgit] Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark; [Reynolds, Chandra A.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Trampush, Joey W.] BrainWorkup LLC, Los Angeles, CA USA; [Trampush, Joey W.] Univ Southern Calif, Keck Sch Med, Dep Psychiat & Behav Sci, Los Angeles, CA USA; [Young, Hannah; Vrieze, Scott I.] Univ Minnesota, Dept Psychol, St Paul, MN 55108 USA; [Hansell, Narelle K.; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Linnarsson, Sten; Munoz-Manchado, Ana B.; Skene, Nathan G.; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden; [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Quinlan, Erin B.; Schumann, Gunter] Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, Ctr Populat Neurosci & Precis Med PONS, London, England; [Skene, Nathan G.] UCL, Inst Neurol, Queen Sq, London, England; [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Arking, Dan E.; Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Bilder, Robert M.; Congdon, Eliza; Freimer, Nelson A.; London, Edythe] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Bitsios, Panos] Univ Crete, Dept Psychiat & Behav Sci, Fac Med, Iraklion, Greece; [Burdick, Katherine E.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Burdick, Katherine E.; Roussos, Panos] James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN 2, Bronx, NY USA; [Burdick, Katherine E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA; [Cannon, Tyrone D.] Yale Univ, Dept Psychol, New Haven, CT USA; [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Neurol, Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC USA; [Christoforou, Andrea; Le Hellard, Stephanie; Steen, Vidar M.] Haukeland Hosp, Dr Einar Martens Res Grp Biol Psychiat, Ctr Med Genet & Mol Med, Bergen, Norway; [Cirulli, Elizabeth T.] Human Longev Inc, Durham, NC USA; [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Davies, Gail; Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.; Liewald, David C.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.; Yu, Jin] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA; [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Hofstra Northwell Sch Med, Dept Psychiat, Hempstead, NY USA; [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Dickinson, Dwight] NIMH, Clin & Translat Neurosci Branch, Intramural Res Program, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Djurovic, Srdjan] Univ Bergen, Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan; Le Hellard, Stephanie; Melle, Ingrid; Steen, Vidar M.] Univ Bergen, KG Jebsen Ctr Psychosis Res, NORMENT, Bergen, Norway; [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Neuroimaging Cognit & Genom NICOG, Sch Psychol, Galway, Ireland; [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Discipline Biochem, Galway, Ireland; [Conley, Emily Drabant] 23andMe Inc, Mountain View, CA USA; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland; [Espeseth, Thomas; Reinvang, Ivar; Sundet, Kjetil] Univ Oslo, Dept Psychol, Oslo, Norway; [Espeseth, Thomas; Melle, Ingrid; Sundet, Kjetil; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Giakoumaki, Stella] Univ Crete, Dept Psychol, Rethimnon, Greece; [Giegling, Ina; Konte, Bettina; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Germany; [Glahn, David C.; Knowles, Emma] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Hariri, Ahmad R.; Scult, Matthew A.] Duke Univ, Dept Psychol & Neurosci, Lab NeuroGenet, Durham, NC USA; [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Athens, Eginit Hosp, Dept Psychiat, Sch Med, Athens, Greece; [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Mental Hlth Res Inst, Athens, Greece; [Hatzimanolis, Alex; Stefanis, Nikos C.] Theodor Theohari Cozzika Fdn, Neurobiol Res Inst, Athens, Greece; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Koltai, Deborah] Duke Univ, Med Ctr, Div Med Psychol, Psychiat & Behav Sci, Durham, NC USA; [Koltai, Deborah] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Lahti, Jari] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [London, Edythe] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [London, Edythe] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Astri J.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Need, Anna C.] Imperial Coll London, Dept Med, Div Brain Sci, London, England; [Ollier, William] Univ Manchester, Inst Populat Hlth, Ctr Integrated Genom Med Res, Manchester, Lancs, England; [Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Palotie, Aarno] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Payton, Antony] Univ Manchester, Ctr Epidemiol, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England; [Pendleton, Neil] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci,Salford Royal NHS Fdn Trust, Div Neurosci & Expt Psychol,Manchester Acad Hlth, Manchester, Lancs, England; [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roussos, Panos] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Sabb, Fred W.] Univ Oregon, Robert & Beverly Lewis Ctr Neuroimaging, Eugene, OR 97403 USA; [Smeland, Olav B.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Smeland, Olav B.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Univ Med Campus, Baltimore, MD USA; [Tiemeier, Henning; Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Voineskos, Aristotle N.] Univ Toronto, Campbell Family Mental Hlth Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Dick, Danielle M.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Dick, Danielle M.] Virginia Commonwealth Univ, Coll Behav & Emot Hlth Inst, Richmond, VA USA; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia		Posthuma, D (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands.; Posthuma, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	d.posthuma@vu.nl	DeRosse, Pamela/H-1083-2012; Kaminski, Jakob/W-1349-2019; Morris, Derek/AAW-8343-2021; Smyrnis, Nikolaos/AAA-3783-2020; Bilder, Robert M/A-8894-2008; Deary, Ian J/C-6297-2009; Wright, Margaret Jane/A-4560-2016; Ripke, Stephan/AAK-5486-2021; Kendler, Kenneth/AAF-2876-2019; Lam, Max/AAM-4946-2021; Knowles, Emma/V-2567-2019; DeRosse, Pamela/X-1412-2019; Lencz, Todd/J-3418-2014; Giegling, Ina/ABA-3677-2021; Coleman, Jonathan/T-9412-2019; Heinz, Andreas/ABB-7736-2020; Barr, Peter/AAJ-9096-2020; Hansell, Narelle K/A-4553-2016; Karlsson, Ida K/S-6064-2019; Reynolds, Chandra/AAH-2886-2020; Smeland, Olav Bjerkehagen/AAM-5284-2020; White, Tonya/AAU-2226-2021; Medland, Sarah/AAT-7595-2020; Lahti, Jari/P-2283-2019; Konte, Bettina/AAT-1142-2021; Webb, Bradley T/B-1459-2009; Andreassen, Ole A./AAY-7531-2020; Grasby, Katrina/AAU-9349-2021; Tiemeier, Henning/H-6534-2019; Lahti, Jari/P-7987-2018; Pendleton, Neil/F-2333-2015; Grasby, Katrina/M-7536-2016; Voineskos, Aristotle/J-5014-2013; Manchado, Ana Munoz/AAB-6399-2019; Knowles, Emma/P-3821-2018; Ikram, M. Arfan/AAM-5225-2021; Breen, Gerome D/A-5540-2010; Hjerling Leffler, Jens/E-3775-2012; Yu, Jin/E-3732-2013	DeRosse, Pamela/0000-0003-0823-8163; Kaminski, Jakob/0000-0001-8155-3683; Morris, Derek/0000-0002-3413-570X; Bilder, Robert M/0000-0001-5085-7852; Deary, Ian J/0000-0002-1733-263X; Wright, Margaret Jane/0000-0001-7133-4970; Lencz, Todd/0000-0001-8586-338X; Coleman, Jonathan/0000-0002-6759-0944; Heinz, Andreas/0000-0001-5405-9065; Barr, Peter/0000-0001-9321-657X; Hansell, Narelle K/0000-0002-8229-9741; Karlsson, Ida K/0000-0003-3605-7829; Smeland, Olav Bjerkehagen/0000-0002-3761-5215; White, Tonya/0000-0003-0271-1896; Medland, Sarah/0000-0003-1382-380X; Lahti, Jari/0000-0002-4310-5297; Konte, Bettina/0000-0001-5287-308X; Webb, Bradley T/0000-0002-0576-5366; Tiemeier, Henning/0000-0002-4395-1397; Lahti, Jari/0000-0002-4310-5297; Pendleton, Neil/0000-0003-0794-2386; Grasby, Katrina/0000-0001-8539-0228; Knowles, Emma/0000-0003-0642-267X; Breen, Gerome D/0000-0003-2053-1792; de Leeuw, Christiaan/0000-0003-1076-9828; Polderman, Tinca/0000-0001-5564-301X; Young, Hannah/0000-0002-4248-9612; Koltai, Deborah/0000-0002-4254-9902; Raikkonen, Katri/0000-0003-3124-3470; Hagg, Sara/0000-0002-2452-1500; Walters, James/0000-0002-6980-4053; Savage, Jeanne/0000-0002-2034-8341; Nygaard, Marianne/0000-0003-0703-2665; Pedersen, Nancy/0000-0001-8057-3543; Debrabant, Birgit/0000-0002-1964-3204; van der Sluis, Sophie/0000-0001-9958-7216; Hjerling Leffler, Jens/0000-0002-4539-1776; Payton, Antony/0000-0003-0335-152X; Posthuma, Danielle/0000-0001-7582-2365; Munoz Manchado, Ana/0000-0002-1121-6072; Ikram, Mohammad Arfan/0000-0003-0372-8585; Voineskos, Aristotle/0000-0003-0156-0395; Plomin, Robert/0000-0002-0756-3629; Jansen, Philip/0000-0003-1550-2444; Djurovic, Srdjan/0000-0002-8140-8061; Watanabe, Kyoko/0000-0002-3303-8860; Trampush, Joey/0000-0003-0830-508X; Poldrack, Russell/0000-0001-6755-0259; Cirulli Rogers, Liz/0000-0001-7808-2809; ripke, stephan/0000-0003-3622-835X; Giakoumaki, Stella/0000-0002-4166-8125; Zabaneh, Delilah/0000-0003-4740-3862; Yu, Jin/0000-0002-2990-6602; Skene, Nathan/0000-0002-6807-3180; Awasthi, Swapnil/0000-0002-9692-8123; Palotie, Aarno/0000-0002-2527-5874	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [433-09-228, VIDI 452-12-014, VICI 453-13-005, 645-000-003]; Sophia Foundation for Scientific Research (SSWO) [S14-27]; Netherlands Scientific Organization (NWO)Netherlands Organization for Scientific Research (NWO) [480-05-003]; Vrije Universiteit, Amsterdam, The NetherlandsNetherlands Government; Dutch Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission [20143863]; Wellcome TrustWellcome TrustEuropean Commission [108726/Z/15/Z]; Swedish Brain Foundation; Dutch National Computing and Networking Services, SurfSARA; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; UK Biobank resource [16406]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG008983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085018, K01MH098126, ZIAMH002717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG049789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA023974, R37AA011408, P50AA022537, K02AA018755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA037904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD018164] Funding Source: NIH RePORTER; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1, BB/F022441/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600237, G0100594, G19/2, G0901461] Funding Source: UKRI	This work was funded by the Netherlands Organization for Scientific Research through the following grants: NWO Brain and Cognition 433-09-228 (D.P.), NWO MagW VIDI 452-12-014 (S.v.d.S.), NWO VICI 453-13-005 (D.P.), and 645-000-003 (D.P.). P.R.J. was funded by the Sophia Foundation for Scientific Research (SSWO, grant S14-27 to P.R.J.). The analyses were carried out on the Genetic Cluster Computer, which is financed by the Netherlands Scientific Organization (NWO: 480-05-003 to D.P.), Vrije Universiteit, Amsterdam, The Netherlands, and the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services, SurfSARA. J.H.-L. was funded by the Swedish Research Council (Vetenskapsradet, award 20143863), StratNeuro, the Wellcome Trust (108726/Z/15/Z), and the Swedish Brain Foundation (Hjarnfonden). N.G.S. was supported by the Wellcome Trust (108726/Z/15/Z). J.B. was funded by the Swiss National Science Foundation. This research has been conducted using the UK Biobank resource under application 16406. We thank the numerous participants, researchers, and staff from many studies who collected and contributed to the data. Additional acknowledgements can be found in the Supplementary Information.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Carroll JB., 1993, HUMAN COGNITIVE ABIL; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Coleman JRI, 2019, MOL PSYCHIATR, V24, P182, DOI 10.1038/s41380-018-0040-6; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Hill WD, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.246; Jensen A. R., 1998, G FACTOR SCI MENTAL; Johnson W, 2004, INTELLIGENCE, V32, P95, DOI 10.1016/S0160-2896(03)00062-X; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Johnson W, 2009, INTELLIGENCE, V37, P466, DOI 10.1016/j.intell.2009.05.006; Kendler KS, 2015, AM J PSYCHIAT, V172, P259, DOI 10.1176/appi.ajp.2014.14040516; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Le Hellard S, 2017, SCHIZOPHRENIA BULL, V43, P654, DOI 10.1093/schbul/sbw085; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Peloso GM, 2016, EUR J HUM GENET, V24, P924, DOI 10.1038/ejhg.2015.197; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Plomin R, 2018, NAT REV GENET, V19, P148, DOI 10.1038/nrg.2017.104; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Richards M, 2011, INT J EPIDEMIOL, V40, P516, DOI 10.1093/ije/dyq166; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Trampush JW, 2017, MOL PSYCHIATR, V22, P336, DOI 10.1038/mp.2016.244; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wraw C, 2015, INTELLIGENCE, V53, P23, DOI 10.1016/j.intell.2015.08.001; Zabaneh D, 2018, MOL PSYCHIATR, V23, P1226, DOI 10.1038/mp.2017.121; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	53	317	321	13	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					912	+		10.1038/s41588-018-0152-6			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	WOS:000437224400005	29942086	Green Accepted, Green Published, Green Submitted	Y	N	2022-01-24	
J	Endele, S; Rosenberger, G; Geider, K; Popp, B; Tamer, C; Stefanova, I; Milh, M; Kortum, F; Fritsch, A; Pientka, FK; Hellenbroich, Y; Kalscheuer, VM; Kohlhase, J; Moog, U; Rappold, G; Rauch, A; Ropers, HH; von Spiczak, S; Tonnies, H; Villeneuve, N; Villard, L; Zabel, B; Zenker, M; Laube, B; Reis, A; Wieczorek, D; Van Maldergem, L; Kutsche, K				Endele, Sabine; Rosenberger, Georg; Geider, Kirsten; Popp, Bernt; Tamer, Ceyhun; Stefanova, Irina; Milh, Mathieu; Kortuem, Fanny; Fritsch, Angela; Pientka, Friederike K.; Hellenbroich, Yorck; Kalscheuer, Vera M.; Kohlhase, Juergen; Moog, Ute; Rappold, Gudrun; Rauch, Anita; Ropers, Hans-Hilger; von Spiczak, Sarah; Toennies, Holger; Villeneuve, Nathalie; Villard, Laurent; Zabel, Bernhard; Zenker, Martin; Laube, Bodo; Reis, Andre; Wieczorek, Dagmar; Van Maldergem, Lionel; Kutsche, Kerstin			Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; MOLECULAR DETERMINANTS; GENETIC ENHANCEMENT; EPSILON-1 SUBUNIT; MICE LACKING; SITE; DISCRIMINATION; REFINEMENT; DISEASE; PATTERN	N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the mammalian brain. Two glycine-binding NR1 subunits and two glutamate-binding NR2 subunits each form highly Ca2+-permeable cation channels which are blocked by extracellular Mg2+ in a voltage-dependent manner(1). Either GRIN2B or GRIN2A, encoding the NMDA receptor subunits NR2B and NR2A, was found to be disrupted by chromosome translocation breakpoints in individuals with mental retardation and/or epilepsy. Sequencing of GRIN2B in 468 individuals with mental retardation revealed four de novo mutations: a frameshift, a missense and two splice-site mutations. In another cohort of 127 individuals with idiopathic epilepsy and/or mental retardation, we discovered a GRIN2A nonsense mutation in a three-generation family. In a girl with early-onset epileptic encephalopathy, we identified the de novo GRIN2A mutation c.1845C>A predicting the amino acid substitution p.N615K. Analysis of NR1-NR2A(N615K) (NR2A subunit with the p.N615K alteration) receptor currents revealed a loss of the Mg2+ block and a decrease in Ca2+ permeability. Our findings suggest that disturbances in the neuronal electrophysiological balance during development result in variable neurological phenotypes depending on which NR2 subunit of NMDA receptors is affected.	[Rosenberger, Georg; Kortuem, Fanny; Fritsch, Angela; Pientka, Friederike K.; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Endele, Sabine; Popp, Bernt; Rauch, Anita; Zenker, Martin; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Geider, Kirsten; Tamer, Ceyhun; Laube, Bodo] Tech Univ Darmstadt, Abt Mol & Zellulare Neurophysiol, Darmstadt, Germany; [Stefanova, Irina; Hellenbroich, Yorck] Univ Lubeck, Inst Humangenet, Lubeck, Germany; [Milh, Mathieu; Villard, Laurent] Fac Med Timone, U910, INSERM, Marseille, France; [Milh, Mathieu] Hop Enfants La Timone, Dept Paediat Neurol, Marseille, France; [Kalscheuer, Vera M.; Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Kohlhase, Juergen] Ctr Human Genet, Freiburg, Germany; [Moog, Ute] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany; [Rappold, Gudrun] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [von Spiczak, Sarah] Univ Med Ctr Schleswig Holstein, Dept Neuropaediat, Kiel, Germany; [Toennies, Holger] Univ Med Ctr Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Villeneuve, Nathalie] Hop Henri Gastaut, Ctr St Paul, Marseille, France; [Villard, Laurent] Univ Aix Marseille 2, Marseille, France; [Zabel, Bernhard] Univ Hosp Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Zabel, Bernhard] Inst Human Genet, Freiburg, Germany; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, Liege, Belgium		Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	kkutsche@uke.de	Villard, Laurent/E-3941-2016; milh, mathieu/F-9165-2013; Van Maldergem, Lionel/G-9849-2017; Wieczorek, Dagmar/AAU-6008-2021; Popp, Bernt/M-2157-2019; Rauch, Anita/C-5568-2014; Reis, Andre/D-2309-2009; Van Maldergem, Lionel/O-3242-2019	Villard, Laurent/0000-0001-6657-5008; Van Maldergem, Lionel/0000-0001-8880-5214; Wieczorek, Dagmar/0000-0003-2812-6492; Popp, Bernt/0000-0002-3679-1081; Rauch, Anita/0000-0003-2930-3163; Reis, Andre/0000-0002-6301-6363; Van Maldergem, Lionel/0000-0001-8880-5214; Kalscheuer, Vera/0000-0001-6898-3259	German Ministry of Research and EducationFederal Ministry of Education & Research (BMBF) [01GS08160, 01GS08168- 9, 01GS08161, 01GS08164]; Fondation Fran aise pour la Recherche sur l'Epilepsie; Gemeinnutzige HertieStiftung; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [FOR 885/IRP5]	We thank all subjects and healthy (control) individuals for their participation in this study; P. De Jonghe for providing DNA samples of individuals with idiopathic epilepsy; A. Gal and B. Horsthemke for continuous support; H.-H. Richardt and H. Petri for clinical evaluation of subjects 3 and 1; A. Tzschach and M. Hoeltzenbein for initial help with collecting clinical data of subject 2; S. Fuchs for chromosome analysis; B. Lubker and C. Menzel for FISH analysis; R. Ullmann and A. Ahmed for array comparative genomic hybridization (CGH) on subject 2, O. Riess and M. Bonin for copy number variation analysis on subjects 8 and 9, and I. Gohring and A. B. Ekici for microarray analysis of the Erlanger cohort; S. Berkel, J. Hoyer and K. Cremer for support with data maintenance; and A. Diem, S. Freier, I. Jantke, S. Meien and K. Ziegler for skillfull technical assistance. This work was part of the German Mental Retardation Network (MRNET) funded through a grant from the German Ministry of Research and Education to A. Rauch and A. Reis (01GS08160), G. Rappold (01GS08168- 9), H.- H. R. (01GS08161) and D. W. (01GS08164). M. M. was supported by the Fondation Fran aise pour la Recherche sur l'Epilepsie, B. L. was supported by the Gemeinnutzige HertieStiftung, and G. Rosenberger and K. K. were supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 885/IRP5).	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ding YX, 2010, DEV MED CHILD NEUROL, V52, P1028, DOI 10.1111/j.1469-8749.2010.03746.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Madry C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00006; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; REUTLINGER C, 2010, EPILEPSIA       0402, DOI DOI 10.1111/J.1528-1167.2010.02555.X; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	38	317	325	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1021	U153		10.1038/ng.677			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	WOS:000283540500023	20890276				2022-01-24	
J	Koolen, DA; Vissers, LELM; Pfundt, R; de Leeuw, N; Knight, SJL; Regan, R; Kooy, RF; Reyniers, E; Romano, C; Fichera, M; Schinzel, A; Baumer, A; Anderlid, BM; Schoumans, J; Knoers, NV; van Kessel, AG; Sistermans, EA; Veltman, JA; Brunner, HG; de Vries, BBA				Koolen, David A.; Vissers, Lisenka E. L. M.; Pfundt, Rolph; de Leeuw, Nicole; Knight, Samantha J. L.; Regan, Regina; Kooy, R. Frank; Reyniers, Edwin; Romano, Corrado; Fichera, Marco; Schinzel, Albert; Baumer, Alessandra; Anderlid, Britt-Marie; Schoumans, Jacqueline; Knoers, Nine V.; van Kessel, Ad Geurts; Sistermans, Erik A.; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. A.			A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FRONTOTEMPORAL DEMENTIA; TAU; MAPT	Submicroscopic genomic copy number changes have been identified only recently as an important cause of mental retardation. We describe the detection of three interstitial, overlapping 17q21.31 microdeletions in a cohort of 1,200 mentally retarded individuals associated with a clearly recognizable clinical phenotype of mental retardation, hypotonia and a characteristic face. The deletions encompass the MAPT and CRHR1 genes and are associated with a common inversion polymorphism.	Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Antwerp VIB, Dept Med Genet, B-2610 Antwerp, Belgium; IRCCS, Oasi Inst Res Mental Retardat & Brain Aging, I-94018 Troina, Italy; Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; Karolinska Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden		de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	b.devries@antrg.umcn.nl	Veltman, Joris A/F-5128-2010; Fichera, Marco/K-9220-2016; van Kessel, Ad Geurts/A-2810-2010; Vissers, Lisenka ELM/A-2598-2015; Pfundt, Rolph/L-4576-2015; Koolen, D.A./L-4448-2015; Brunner, Han/C-9928-2013; Sistermans, Erik/B-1109-2009; Kooy, Frank/F-5276-2014; Romano, Corrado/B-9695-2008; de Leeuw, N./L-4480-2015	Veltman, Joris A/0000-0002-3218-8250; Fichera, Marco/0000-0002-8225-6880; Vissers, Lisenka ELM/0000-0001-6470-5497; Sistermans, Erik/0000-0001-7187-4563; Kooy, Frank/0000-0003-2024-0485; Romano, Corrado/0000-0003-1049-0683; Knight, Samantha/0000-0002-6047-3462			Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Varela MC, 2006, CYTOGENET GENOME RES, V114, P89, DOI 10.1159/000091934	15	317	326	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					999	1001		10.1038/ng1853			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	WOS:000240112100015	16906164				2022-01-24	
J	Cullen, BR				Cullen, Bryan R.			Viruses and microRNAs	NATURE GENETICS			English	Article							SMALL INTERFERING RNA; HERPES-SIMPLEX-VIRUS; NUCLEAR EXPORT; GENE-EXPRESSION; MESSENGER-RNAS; IDENTIFICATION; TRANSCRIPTS; INHIBIT; REQUIREMENTS; TRANSLATION	The discovery of RNA interference and cellular microRNAs (miRNAs) has not only affected how biological research is conducted but also revealed an entirely new level of post-transcriptional gene regulation. Here, I discuss the potential functions of the virally encoded miRNAs recently identified in several pathogenic human viruses and propose that cellular miRNAs may have had a substantial effect on viral evolution and may continue to influence the in vivo tissue tropism of viruses. Our increasing knowledge of the role and importance of virally encoded miRNAs will probably offer new insights into how viruses that establish latent infections, such as herpesviruses, avoid elimination by the host innate or adaptive immune system. Research into viral miRNA function might also suggest new approaches for treating some virally induced diseases.	[Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA; [Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA		Cullen, BR (corresponding author), Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA.	culle002@mc.duke.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM071408] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM071408] Funding Source: NIH RePORTER		Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cai XZ, 2006, J VIROL, V80, P2234, DOI 10.1128/JVI.80.5.2234-2242.2006; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FRASER NW, 1992, VIROLOGY, V191, P1, DOI 10.1016/0042-6822(92)90160-Q; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Gwizdek C, 2001, J BIOL CHEM, V276, P25910, DOI 10.1074/jbc.M100493200; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Linial ML, 1999, J VIROL, V73, P1747, DOI 10.1128/JVI.73.3.1747-1755.1999; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Macrae AI, 2001, J VIROL, V75, P5315, DOI 10.1128/JVI.75.11.5315-5327.2001; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	54	317	336	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S25	S30		10.1038/ng1793			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	WOS:000202983200006	16736021				2022-01-24	
J	Gillespie, JH				Gillespie, JH			Genetic drift in an infinite population: The pseudohitchhiking model	GENETICS			English	Article							DROSOPHILA-MELANOGASTER; MOLECULAR EVOLUTION; DELETERIOUS MUTATIONS; DNA POLYMORPHISM; SELECTION; RECOMBINATION; SUBSTITUTION; FREQUENCY; REGION	Selected substitutions at one locus can induce stochastic dynamics that resemble genetic drift at a closely linked neutral locus. The pseudohitchhiking model is a one-locus model that approximates these effects and can be used to describe the major consequences of linked selection. As the changes in neutral allele frequencies when hitchhiking are rapid, diffusion theory is not appropriate for studying neutral dynamics. A stationary distribution and some results on substitution processes are presented that use the theory of continuos-time Markov processes with discontinuous sample paths. The coalescent of the pseudohitchhiking model is shown to have a random number of branches at each node, which leads to a frequency spectrum that is different from that of the equilibrium neutral model. If genetic draft, the name given to these induced stochastic effects, is a more important stochastic force than genetic drift, then a number of paradoxes that have plagued population genetics disappear.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA		Gillespie, JH (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	jhgillespie@ucdavis.edu					AGUADE M, 1989, GENETICS, V122, P607; Aguade Montserrat, 1994, P67; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERRY AJ, 1991, GENETICS, V129, P1111; BRAVERMAN JM, 1995, GENETICS, V140, P783; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cox David R., 1962, RENEWAL THEORY; GILLESPIE JH, 1993, GENETICS, V134, P971; Gillespie JH, 1999, THEOR POPUL BIOL, V55, P145, DOI 10.1006/tpbi.1998.1391; Gillespie JH, 1997, GENE, V205, P291, DOI 10.1016/S0378-1119(97)00470-8; HIRAIZUMI Y, 1960, EVOLUTION, V14, P433, DOI 10.2307/2405993; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; KAPLAN NL, 1989, GENETICS, V123, P887; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; LEWONTIN RC, 1960, GENETICS, V45, P705; LEWONTIN Richard C, 1974, GENETIC BASIS EVOLUT; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; MIYASHITA NT, 1990, GENETICS, V125, P407; OHTA T, 1990, GENETICS, V126, P219; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1975, P NATL ACAD SCI USA, V72, P4541, DOI 10.1073/pnas.72.11.4541; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WATTERSON GA, 1982, ADV APPL PROBAB, V14, P206, DOI 10.2307/1426517; WATTERSON GA, 1984, J APPLIED PROBABIL A, V19, P59; WRIGHT S, 1955, COLD SPRING HARB SYM, V20, P16, DOI 10.1101/SQB.1955.020.01.004	26	317	318	1	37	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	2000	155	2					909	919					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321VJ	WOS:000087475100036	10835409				2022-01-24	
J	Huettner, CS; Zhang, P; Van Etten, RA; Tenen, DG				Huettner, CS; Zhang, P; Van Etten, RA; Tenen, DG			Reversibility of acute B-cell leukaemia induced by BCR-ABL1	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; TRANSGENIC MICE; BCR-ABL; TYROSINE KINASE; GENE-EXPRESSION; BONE-MARROW; P210(BCR/ABL); PROMOTER; ANTIGEN	Cancer is thought to arise from multiple genetic events that establish irreversible malignancy. A different mechanism might be present in certain leukaemias initiated by a chromosomal translocation. We have taken a new approach to determine if ablation of the genetic abnormality is sufficient for reversion by generating a conditional transgenic model of BCR-ABL1 (also known as BCR-ABL)-induced leukaemia. This oncogene(1) is the of a reciprocal translocation and is associated with differ-ent forms of leukaemia(2). The most common form, p210 BCR-ABL1, is found in more than 90% of patients with chronic myelogenous leukaemia(3,4) (CML) and in up to 15% of adult patients with de novo acute lymphoblastic leukaemia(5) (ALL). Efforts to establish a useful transgenic model have been hampered by embryonic lethality when the oncogene is expressed during embryogenesis(6,7), by reduced penetrance or by extremely long latency periods(8,9). One model uses the 'knock-in' approach to induce leukaemia by p190 BCR-ABL1 (ref. 10). Given the limitations of models with p210, we used a different experimental approach(11) Lethal leukaemia developed within an acceptable time frame in all animals, and complete remission was achieved by suppression of BCR-ABL1 expression, even after multiple rounds of induction and reversion. Our results demonstrate that BCR-ABL1 is required for both induction and maintenance of leukaemia.	Harvard Univ, Inst Med, Div Hematol Oncol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA USA		Tenen, DG (corresponding author), Harvard Univ, Inst Med, Div Hematol Oncol, Cambridge, MA 02138 USA.	dtenen@caregroup.harvard.edu		Tenen, Daniel/0000-0002-6423-3888			BEDI A, 1994, BLOOD, V83, P2038; Castellanos A, 1997, BLOOD, V90, P2168, DOI 10.1182/blood.V90.6.2168.2168_2168_2174; CHEN YY, 1992, P NATL ACAD SCI USA, V89, P6683, DOI 10.1073/pnas.89.15.6683; CLARK SS, 1988, SCIENCE, V239, P775, DOI 10.1126/science.3422516; CROSS NCP, 1993, BRIT J HAEMATOL, V84, P67, DOI 10.1111/j.1365-2141.1993.tb03026.x; DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Ewald D, 1996, SCIENCE, V273, P1384, DOI 10.1126/science.273.5280.1384; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Heisterkamp Nora, 1991, Transgenic Research, V1, P45, DOI 10.1007/BF02512996; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; HONDA H, 1995, BLOOD, V85, P2853, DOI 10.1182/blood.V85.10.2853.bloodjournal85102853; Honda H, 1998, BLOOD, V91, P2067, DOI 10.1182/blood.V91.6.2067.2067_2067_2075; ILARIA RL, 1995, BLOOD, V86, P3897, DOI 10.1182/blood.V86.10.3897.bloodjournal86103897; KRAIG E, 1983, J EXP MED, V158, P192, DOI 10.1084/jem.158.1.192; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Melo JV, 1996, LEUKEMIA, V10, P751; NOWELL PC, 1960, SCIENCE, V132, P1497; Radomska HS, 1998, GENE, V222, P305, DOI 10.1016/S0378-1119(98)00491-0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VANETTEN RA, 1993, LEUKEMIA ADV TREATME, P294; VANETTEN RA, 1998, MED MANAGEMENT CHRON, P77	27	317	329	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2000	24	1					57	60		10.1038/71691			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	WOS:000084609200016	10615128				2022-01-24	
J	Allison, DB				Allison, DB			Transmission-disequilibrium tests for quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; STATISTICAL POWER; GENETIC-LINKAGE; SIB PAIRS; LOCI; ASSOCIATIONS; GUIDELINES; MARKERS; ADMIXTURE; PROGRAM	The transmission-disequilibrium test (TDT) of Spielman et al. is a family-based linkage-disequilibrium test that offers a powerful way to test for linkage between alleles and phenotypes that is either causal (i.e., the marker locus is the disease/trait allele) or due to linkage disequilibrium. The TDT is equivalent to a randomized experiment and, therefore, is resistant to confounding. When the marker is extremely close to the disease locus or is the disease locus itself, tests such as the TDT can be far more powerful than conventional linkage tests, To date, the TDT and most other family-based association tests have been applied only to dichotomous traits. This paper develops five TDT-type tests for use with quantitative traits. These tests accommodate either unselected sampling or sampling based on selection of phenotypically extreme offspring. Power calculations are provided and show that, when a candidate gene is available (1) these TDT-type tests are at least an order of magnitude more efficient than two common sib-pair tests of linkage; (2) extreme sampling results in substantial increases in power; and (3) if the most extreme 20% of the phenotypic distribution is selectively sampled, across a wide variety of plausible genetic models, quantitative-trait loci explaining as little as 5% of the phenotypic variation can be detected at the .0001 alpha level with <300 observations.			Allison, DB (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, ST LUKES ROOSEVELT HOSP, OBES RES CTR, 1111 AMSTERDAM AVE, NEW YORK, NY 10025 USA.			Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R29DK047256, P30DK026687, R01DK051716] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R29DK47256, R01DK51716, P30DK26687] Funding Source: Medline		ALF EF, 1975, PSYCHOMETRIKA, V40, P563, DOI 10.1007/BF02291557; ALLISON DB, 1995, J CONSULT CLIN PSYCH, V63, P339; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; Boomsma DI, 1996, BEHAV GENET, V26, P161, DOI 10.1007/BF02359893; Bryk A.S., 1992, HIERARCHICAL LINEAR; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; COCKETT NE, 1994, P NATL ACAD SCI USA, V91, P3019, DOI 10.1073/pnas.91.8.3019; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CURTIS D, 1995, AM J HUM GENET, V56, P811; DRAPER NR, 1966, APPLIED REGRESSION A; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; EWENS WJ, 1995, AM J HUM GENET, V57, P455; GORMAN BS, 1995, EDUC PSYCHOL MEAS, V55, P773, DOI 10.1177/0013164495055005009; Grice DE, 1996, AM J HUM GENET, V59, P644; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HAYS WL, 1988, STATISTICS; ITA GG, 1994, AM STAT, V48, P324; JIANG CJ, 1995, GENETICS, V140, P1111; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; KNAPP M, 1993, AM J HUM GENET, V52, P1085; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LONGFORD NT, 1993, RANDOM COEFFICIENT M; Marascuilo L. A., 1977, NONPARAMETRIC DISTRI; Markel P. D., 1994, Psychiatric Genetics, V4, P205, DOI 10.1097/00041444-199400440-00003; Moldin SO, 1995, GENET EPIDEMIOL, V12, P801, DOI 10.1002/gepi.1370120645; MURPHY EA, 1982, BIOSTATISTICS MED; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEALE MC, 1995, STAT MODELING MX MED; Nicholls RD, 1996, PENN CTR N, V5, P560; NICK TG, 1995, GENET EPIDEMIOL, V12, P145, DOI 10.1002/gepi.1370120204; NICKERSON DA, 1992, GENOMICS, V12, P377, DOI 10.1016/0888-7543(92)90388-9; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; Petersen R., 1985, DESIGN ANAL EXPT; RICE J, 1979, BIOMETRICS, V35, P451, DOI 10.2307/2530347; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; ROTHSTEIN HR, 1990, EDUC PSYCHOL MEAS, V50, P819, DOI 10.1177/0013164490504009; RUBIN DB, 1991, BIOMETRICS, V47, P1213, DOI 10.2307/2532381; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SPIELMAN RS, 1994, AM J HUM GENET, V54, P559; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; St Jean P., 1996, American Journal of Human Genetics, V59, pA237; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; *SUDAAN STAT SOFTW, 1995, SUDAAN; SWIFT M, 1990, AM J HUM GENET, V47, P266; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1995, AM J HUM GENET, V57, P487; [No title captured]; [No title captured]; [No title captured]	57	317	339	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					676	690					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	WOS:A1997WK40300026	9042929				2022-01-24	
J	Gusev, A; Lee, SH; Trynka, G; Finucane, H; Vilhjalmsson, BJ; Xu, H; Zang, CZ; Ripke, S; Bulik-Sullivan, B; Stahl, E; Kahler, AK; Hultman, CM; Purcell, SM; McCarroll, SA; Daly, M; Pasaniuc, B; Sullivan, PF; Neale, BM; Wray, NR; Raychaudhuri, S; Price, AL				Gusev, Alexander; Lee, S. Hong; Trynka, Gosia; Finucane, Hilary; Vilhjalmsson, Bjarni J.; Xu, Han; Zang, Chongzhi; Ripke, Stephan; Bulik-Sullivan, Brendan; Stahl, Eli; Kaehler, Anna K.; Hultman, Christina M.; Purcell, Shaun M.; McCarroll, Steven A.; Daly, Mark; Pasaniuc, Bogdan; Sullivan, Patrick F.; Neale, Benjamin M.; Wray, Naomi R.; Raychaudhuri, Soumya; Price, Alkes L.		Psychiat Genomics Consortium; SWE-SCZ Consortium	Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; PRIOR INFORMATION; GENETIC-VARIATION; DNA ELEMENTS; LARGE-SCALE; SNPS; SCHIZOPHRENIA; LOCI; EXPRESSION	Regulatory and coding variants are known to be enriched with associations identified by genome-wide association studies (GWASs) of complex disease, but their contributions to trait heritability are currently unknown. We applied variance-component methods to imputed genotype data for 11 common diseases to partition the heritability explained by genotyped SNPs (h(g)(2)) across functional categories (while accounting for shared variance due to linkage disequilibrium). Extensive simulations showed that in contrast to current estimates from GWAS summary statistics, the variance-component approach partitions heritability accurately under a wide range of complex-disease architectures. Across the 11 diseases DNaseI hypersensitivity sites (DHSs) from 217 cell types spanned 16% of imputed SNPs (and 24% of genotyped SNPs) but explained an average of 79% (SE = 8%) of h(g)(2) from imputed SNPs (5.1 x enrichment; p = 3.7 x 10(-17)) and 38% (SE = 4%) of h(g)(2) from genotyped SNPs (1.6 x enrichment, p = 1.0 x 10(-4)). Further enrichment was observed at enhancer DHSs and cell-type-specific DHSs. In contrast, coding variants, which span 1% of the genome, explained <10% of h(g)(2) despite having the highest enrichment. We replicated these findings but found no significant contribution from rare coding variants in independent schizophrenia cohorts genotyped on GWAS and exome chips. Our results highlight the value of analyzing components of heritability to unravel the functional architecture of common disease.	[Gusev, Alexander; Vilhjalmsson, Bjarni J.; Xu, Han; Zang, Chongzhi; Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lee, S. Hong; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Trynka, Gosia; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Trynka, Gosia; Ripke, Stephan; Bulik-Sullivan, Brendan; Purcell, Shaun M.; Daly, Mark; Neale, Benjamin M.; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Trynka, Gosia; Daly, Mark; Neale, Benjamin M.; Raychaudhuri, Soumya; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Finucane, Hilary] MIT, Dept Math, Cambridge, MA 02142 USA; [Xu, Han; Zang, Chongzhi] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ripke, Stephan; Bulik-Sullivan, Brendan; Purcell, Shaun M.; Daly, Mark; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Bulik-Sullivan, Brendan; Purcell, Shaun M.; McCarroll, Steven A.; Daly, Mark; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Stahl, Eli; Purcell, Shaun M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Kaehler, Anna K.; Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England		Gusev, A (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	agusev@hsph.harvard.edu; aprice@hsph.harvard.edu	Webb, Bradley T/B-1459-2009; Fanous, Ayman H/O-1263-2017; Milani, Lili/N-1097-2019; Visscher, Peter/ABB-6151-2020; Meier, Sandra/AAB-1242-2021; Pantelis, Christos/H-7722-2014; Zang, Chongzhi/D-1445-2011; Bergen, Sarah/I-8313-2012; Mattingsdal, Morten/Q-9367-2016; Lee, Sang Hong/A-2569-2011; Hansen, Thomas Folkmann/O-5965-2014; SCHALL, ULRICH ANDREAS/G-7452-2013; Melle, Ingrid S/B-4858-2011; Mortensen, Preben B/D-2358-2015; Agerbo, Esben/A-2645-2012; Mattheisen, Manuel/B-4949-2012; Konte, Bettina/AAT-1142-2021; Roffman, Joshua/G-8228-2012; Hartmann, Annette/AAS-6331-2021; Mattheisen, Manuel/S-3725-2019; Ripke, Stephan/AAK-5486-2021; Lee, Jimmy/ABB-2919-2020; Myin-Germeys, Inez/L-5106-2014; Zimprich, Fritz/O-1406-2019; O'Donovan, Michael C/P-7005-2018; Slominsky, Petr A/B-4640-2016; Liu, Jianjun/AAK-4989-2020; Hammer, Christian/C-5827-2014; Wray, Naomi/C-8639-2015; Wu, Jingqin/V-9319-2019; Andreassen, Ole A./AAY-7531-2020; van Os, Jim/C-2113-2014; Stroup, Thomas/AAB-7780-2019; Vilhjalmsson, Bjarni/ABC-1369-2020; Vilhjalmsson, Bjarni/K-3971-2014; Ruderfer, Douglas M/M-5795-2016; Zimprich, Fritz/W-1738-2017; McQuillin, Andrew/C-1623-2008; Domenici, Enrico/K-8194-2016; Collier, David A/D-1649-2011; McIntosh, Andrew M/B-9379-2008; O'Neill, Francis A/C-5582-2008; Golimbet, V/E-2328-2016; McDonald, Colm/C-1430-2009; So, Hon-Cheong/I-1100-2016; Slominsky, Petr/AAO-1852-2020; Daly, Mark J/B-2453-2017; Zai, Clement C/G-7379-2015; murray, robin/F-8658-2012; Kelly, Brian/G-7755-2013; Sigurdsson, Engilbert/D-2486-2014; Ptackova, Hana/M-9763-2017; Franke, Lude/P-7036-2016; Scott, Rodney/B-2827-2013; Grove, Jakob/K-8112-2015	Webb, Bradley T/0000-0002-0576-5366; Milani, Lili/0000-0002-5323-3102; Visscher, Peter/0000-0002-2143-8760; Pantelis, Christos/0000-0002-9565-0238; Zang, Chongzhi/0000-0003-4812-3627; Bergen, Sarah/0000-0002-5888-0034; Mattingsdal, Morten/0000-0003-4440-0324; Lee, Sang Hong/0000-0001-9701-2718; Hansen, Thomas Folkmann/0000-0001-6703-7762; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Melle, Ingrid S/0000-0002-9783-548X; Mortensen, Preben B/0000-0002-5230-9865; Agerbo, Esben/0000-0002-2849-524X; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Roffman, Joshua/0000-0003-4073-532X; Mattheisen, Manuel/0000-0002-8442-493X; Lee, Jimmy/0000-0002-7724-7445; Zimprich, Fritz/0000-0002-6998-5480; O'Donovan, Michael C/0000-0001-7073-2379; Slominsky, Petr A/0000-0003-3530-0655; Liu, Jianjun/0000-0002-3255-3019; Hammer, Christian/0000-0003-4548-7548; Wray, Naomi/0000-0001-7421-3357; Wu, Jingqin/0000-0002-2052-3875; Stroup, Thomas/0000-0002-3123-0672; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Ruderfer, Douglas M/0000-0002-2365-386X; Zimprich, Fritz/0000-0002-6998-5480; McQuillin, Andrew/0000-0003-1567-2240; Domenici, Enrico/0000-0001-7436-6919; Collier, David A/0000-0003-4087-1559; McIntosh, Andrew M/0000-0002-0198-4588; O'Neill, Francis A/0000-0002-7531-7657; Golimbet, V/0000-0002-9960-7114; McDonald, Colm/0000-0003-1661-5192; Slominsky, Petr/0000-0003-3530-0655; Daly, Mark J/0000-0002-0949-8752; Chen, Eric/0000-0002-5247-3593; murray, robin/0000-0003-0829-0519; Golimbet, Vera/0000-0002-0114-4300; Suvisaari, Jaana/0000-0001-7167-0990; Myin-Germeys, Inez/0000-0002-3731-4930; Petryshen, Tracey/0000-0002-7972-4612; Borglum, Anders/0000-0001-8627-7219; Murphy, Kieran/0000-0003-2930-4465; Perkins, Diana/0000-0001-9396-2206; Adolfsson, Rolf/0000-0001-9785-8473; Demontis, Ditte/0000-0001-9124-2766; Buxbaum, Joseph/0000-0001-8898-8313; Kelly, Brian/0000-0003-4460-1134; Pasaniuc, Bogdan/0000-0002-0227-2056; Raychaudhuri, Soumya/0000-0002-1901-8265; marsal, sara/0000-0001-5515-3854; Legge, Sophie/0000-0001-6617-0289; Toncheva, Draga/0000-0002-7451-6363; Donohoe, Gary/0000-0003-3037-7426; Moran, Jennifer/0000-0002-5664-4716; Knight, Joanne/0000-0002-7148-1660; /0000-0002-8114-7615; Tooney, Paul/0000-0003-3745-4367; Black, Donald/0000-0001-8038-1971; IWATA, Nakao/0000-0003-3189-6076; Julia Cano, Antonio/0000-0001-6064-3620; Mors, Ole/0000-0002-5660-0393; Ehrenreich, Hannelore/0000-0001-8371-5711; Stogmann, Elisabeth/0000-0003-4688-8482; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Gopal, Srihari/0000-0001-5254-2192; Sigurdsson, Engilbert/0000-0001-9404-7982; Palotie, Aarno/0000-0002-2527-5874; Corvin, Aiden/0000-0001-6717-4089; Kirov, George/0000-0002-3427-3950; Milovancevic, Milos/0000-0002-7891-1010; Ptackova, Hana/0000-0002-5694-3695; Franke, Lude/0000-0002-5159-8802; Esko, Tonu/0000-0003-1982-6569; Walters, James/0000-0002-6980-4053; Curtis, David/0000-0002-4089-9183; Bruggeman, Richard/0000-0002-3238-8471; Sim, Kang/0000-0003-3209-9626; Joa, Inge/0000-0002-5516-2336; Crowley, James/0000-0001-9051-1557; Pers, Tune/0000-0003-0207-4831; Djurovic, Srdjan/0000-0002-8140-8061; Dinan, Timothy/0000-0002-2316-7220; Escott-Price, Valentina/0000-0003-1784-5483; Papiol, Sergi/0000-0001-9366-8728; So, Hon-Cheong/0000-0002-7102-833X; Scott, Rodney/0000-0001-7724-3404; Lubinski, Jan/0000-0003-2931-3003; Grove, Jakob/0000-0003-2284-5744; Zai, Clement C/0000-0003-0496-7262; Jonsson, Erik/0000-0001-8368-6332; ripke, stephan/0000-0003-3622-835X; Quested, Digby/0000-0001-6155-3336; Pocklington, Andrew/0000-0002-2137-0452	Wellcome TrustWellcome TrustEuropean Commission [076113]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH101244, R03 HG006731, 1U01HG0070033]; Doris Duke Clinical Scientist Development AwardDoris Duke Charitable Foundation (DDCF); NIH fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32 GM106584]; Rubicon grant from the Netherlands Organization for Scientific Research; Fannie and John Hertz Foundation; Australian Research CouncilAustralian Research Council [DE130100614, FT0991360]; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [613602, 1050218]; Lundbeck FoundationLundbeckfonden [R155-2014-1724] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601635, G0800509, MR/L010305/1] Funding Source: researchfish; Chief Scientist Office [SCD/12] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601635, G0800509] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R03HG006731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM105857, F32GM106584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH020030, U01MH096296, U01MH094432, R01MH101244] Funding Source: NIH RePORTER	This study made use of data generated by the Wellcome Trust Case Control Consortium (WTCCC) and the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the WTCCC data is available at www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. We thank Manolis Kellis, Abhishek Sarkar, Joe Pickrell, X. Shirley Liu, Nick Patterson, Sara Lindstrom, Peter Kraft, and Shamil Sunyaev for helpful discussions and Amy Williams for assistance with HApI-UR. This research was funded by NIH grants R01 MH101244, R03 HG006731, and 1U01HG0070033, the Doris Duke Clinical Scientist Development Award, and NIH fellowship F32 GM106584. G.T. was supported by the Rubicon grant from the Netherlands Organization for Scientific Research. H.F. was supported by the Fannie and John Hertz Foundation. We also acknowledge grant funding from the Australian Research Council (DE130100614 and FT0991360) and the National Health and Medical Research Council (613602 and 1050218).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Eskin E, 2008, GENOME RES, V18, P653, DOI 10.1101/gr.072785.107; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fischer TM, 2004, GENET SEL EVOL, V36, P363, DOI 10.1051/gse:2004006; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gagliano SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098122; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Golan D., 2013, ARXIV13055363; Green P, 2013, SCIENCE, V340, DOI 10.1126/science.1233195; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hayeck T., 2014, MIXED MODEL CORRECTI; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Janss L, 2012, GENETICS, V192, P693, DOI 10.1534/genetics.112.141143; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee D, 2013, BIOINFORMATICS, V29, P2925, DOI 10.1093/bioinformatics/btt500; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; Lynch M., 1998, GENETICS ANAL QUANTI; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mudge JM, 2013, GENOME RES, V23, P1961, DOI 10.1101/gr.161315.113; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nakaoka H, 2009, J HUM GENET, V54, P615, DOI 10.1038/jhg.2009.95; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Patterson N., 2014, LD SCORE REGRESSION; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	80	316	319	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					535	552		10.1016/j.ajhg.2014.10.004			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	WOS:000344845000005	25439723	Green Published, Bronze			2022-01-24	
J	Gunther, T; Coop, G				Guenther, Torsten; Coop, Graham			Robust Identification of Local Adaptation from Allele Frequencies	GENETICS			English	Article							GENOME-WIDE PATTERNS; NEXT-GENERATION; DROSOPHILA-MELANOGASTER; ECOLOGICAL GENOMICS; DETECTING SELECTION; POSITIVE SELECTION; LATITUDINAL CLINE; NATURAL-SELECTION; FLOWERING-TIME; GENE-FREQUENCY	Comparing allele frequencies among populations that differ in environment has long been a tool for detecting loci involved in local adaptation. However, such analyses are complicated by an imperfect knowledge of population allele frequencies and neutral correlations of allele frequencies among populations due to shared population history and gene flow. Here we develop a set of methods to robustly test for unusual allele frequency patterns and correlations between environmental variables and allele frequencies while accounting for these complications based on a Bayesian model previously implemented in the software Bayenv. Using this model, we calculate a set of "standardized allele frequencies" that allows investigators to apply tests of their choice to multiple populations while accounting for sampling and covariance due to population history. We illustrate this first by showing that these standardized frequencies can be used to detect nonparametric correlations with environmental variables; these correlations are also less prone to spurious results due to outlier populations. We then demonstrate how these standardized allele frequencies can be used to construct a test to detect SNPs that deviate strongly from neutral population structure. This test is conceptually related to F-ST and is shown to be more powerful, as we account for population history. We also extend the model to next-generation sequencing of population pools-a cost-efficient way to estimate population allele frequencies, but one that introduces an additional level of sampling noise. The utility of these methods is demonstrated in simulations and by reanalyzing human SNP data from the Human Genome Diversity Panel populations and pooled next-generation sequencing data from Atlantic herring. An implementation of our method is available from http://gcbias.org.	[Guenther, Torsten] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-70593 Stuttgart, Germany; [Coop, Graham] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Coop, Graham] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA		Gunther, T (corresponding author), Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, D-70593 Stuttgart, Germany.	tguenther@zoho.com; gmcoop@ucdavis.edu	Gunther, Torsten/I-3355-2019	Gunther, Torsten/0000-0001-9460-390X; Coop, Graham/0000-0001-8431-0302	German Federal Ministry for Education and Research (Synbreed) [0315528D]; Volkswagen FoundationVolkswagen [I/84225]; Sloan FoundationAlfred P. Sloan Foundation	We thank Jeremy Berg, Gideon Bradburd, Yaniv Brandvain, Fabian Freund, Chuck Langley, Joe Pickrell, Jonathan Pritchard, Peter Ralph, Jeffrey Ross-Ibarra, Karl Schmid, and Alisa Sedghifar for helpful discussions and comments on earlier versions of the manuscript. We acknowledge the various comments we received from readers of the preprint of the manuscript available on the arXiv. The X<SUP>T</SUP>X estimates for the HGDP data were kindly made available through the HGDP selection browser (hgdp.uchicago.edu/) by Joe Pickrell. We also thank Alvaro Martinez Barrio and Leif Andersson for sharing the herring data. T.G. was supported by the German Federal Ministry for Education and Research (Synbreed, 0315528D) and by a Volkswagen Foundation scholarship (I/84225), affording him a visit to the University of California, Davis. G.C. was supported by a Sloan Foundation fellowship.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Banta JA, 2012, ECOL LETT, V15, P769, DOI 10.1111/j.1461-0248.2012.01796.x; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Cheng CD, 2012, GENETICS, V190, P1417, DOI 10.1534/genetics.111.137794; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fabian DK, 2012, MOL ECOL, V21, P4748, DOI 10.1111/j.1365-294X.2012.05731.x; Fang Z, 2012, GENETICS, V191, P883, DOI 10.1534/genetics.112.138578; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397; Guillot G., 2012, ARXIV12060889; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hancock AM, 2011, MOL BIOL EVOL, V28, P601, DOI 10.1093/molbev/msq228; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hinohara K, 2009, HUM GENET, V126, P539, DOI 10.1007/s00439-009-0698-6; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Huxley J. S., 1939, Bijdragen tot de Dierkunde, V27, P491; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; LEWONTIN RC, 1973, GENETICS, V74, P175; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Limborg MT, 2012, ECOL EVOL, V2, P1, DOI 10.1002/ece3.59; Long QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015292; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mayr E., 1942, SYSTEMATICS ORIGIN S; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; NEI M, 1975, GENETICS, V80, P395; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Orozco-TerWengel P, 2012, MOL ECOL, V21, P4931, DOI 10.1111/j.1365-294X.2012.05673.x; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Pyhajarvi T., 2012, ARXIV12080634; R Development Core Team, 2011, R LANG ENV STAT COMP; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; REYNOLDS J, 1983, GENETICS, V105, P767; ROBERTSON A, 1975, GENETICS, V81, P775; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rutanen J, 2007, OBESITY, V15, P2902, DOI 10.1038/oby.2007.345; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Samanta S, 2009, THEOR POPUL BIOL, V75, P312, DOI 10.1016/j.tpb.2009.03.005; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wermter AK, 2005, EUR J ENDOCRINOL, V152, P851, DOI 10.1530/eje.1.01917; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	93	316	319	3	202	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2013	195	1					205	+		10.1534/genetics.113.152462			34	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214YC	WOS:000324174200017	23821598	Bronze, Green Submitted, Green Published			2022-01-24	
J	Kelley, D; Rinn, J				Kelley, David; Rinn, John			Transposable elements reveal a stem cell-specific class of long noncoding RNAs	GENOME BIOLOGY			English	Article							GENE-EXPRESSION; HUMAN GENOME; HUMAN TRANSCRIPTOME; CHROMATIN STATE; REPETITIVE DNA; ALU ELEMENT; EVOLUTION; DIFFERENTIATION; RETROTRANSPOSON; SEQUENCES	Background: Numerous studies over the past decade have elucidated a large set of long intergenic noncoding RNAs (lincRNAs) in the human genome. Research since has shown that lincRNAs constitute an important layer of genome regulation across a wide spectrum of species. However, the factors governing their evolution and origins remain relatively unexplored. One possible factor driving lincRNA evolution and biological function is transposable element (TE) insertions. Here, we comprehensively characterize the TE content of lincRNAs relative to genomic averages and protein coding transcripts. Results: Our analysis of the TE composition of 9,241 human lincRNAs revealed that, in sharp contrast to protein coding genes, 83% of lincRNAs contain a TE, and TEs comprise 42% of lincRNA sequence. lincRNA TE composition varies significantly from genomic averages - L1 and Alu elements are depleted and broad classes of endogenous retroviruses are enriched. TEs occur in biased positions and orientations within lincRNAs, particularly at their transcription start sites, suggesting a role in lincRNA transcriptional regulation. Accordingly, we observed a dramatic example of HERVH transcriptional regulatory signals correlating strongly with stem cell-specific expression of lincRNAs. Conversely, lincRNAs devoid of TEs are expressed at greater levels than lincRNAs with TEs in all tissues and cell lines, particularly in the testis. Conclusions: TEs pervade lincRNAs, dividing them into classes, and may have shaped lincRNA evolution and function by conferring tissue-specific expression from extant transcriptional regulatory signals.	[Kelley, David; Rinn, John] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Kelley, David; Rinn, John] Broad Inst MIT& Harvard, Cambridge, MA 02142 USA; [Kelley, David; Rinn, John] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA		Rinn, J (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	john_rinn@harvard.edu		Rinn, John/0000-0002-7231-7539	NIH from the National Heart, Lung and Blood Institute.United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007893];  [NIHP01 GM099117];  [DP2OD006670];  [NIHP50 HG006193-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007893] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD006670] Funding Source: NIH RePORTER	The authors acknowledge Cole Trapnell for Cufflinks assistance; Moran Cabili, Loyal Goff, and Cole Trapnell for assistance building the lincRNA catalog; David Hendrickson for feedback on the manuscript; and Sabine Loewer for personal communication regarding HERVH elements in iPSC-upregulated lincRNAs. D. K. is supported by NIH training grant T32HL007893 from the National Heart, Lung and Blood Institute.. J.L.R. Is an Damon Runyon Innovation, Smith Family Foundation and Searle Scholar. This work was supported by NIHP01 GM099117, DP2OD006670 and NIHP50 HG006193-01.	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Barak M, 2009, NUCLEIC ACIDS RES, V37, P6905, DOI 10.1093/nar/gkp729; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Cartault F, 2012, P NATL ACAD SCI USA, V109, P4980, DOI 10.1073/pnas.1111596109; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huda A, 2011, GENE, V475, P39, DOI 10.1016/j.gene.2010.12.010; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin L, 2009, HUM MOL GENET, V18, P2204, DOI 10.1093/hmg/ddp152; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Mourier Tobias, 2009, Briefings in Functional Genomics & Proteomics, V8, P493, DOI 10.1093/bfgp/elp036; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nam JW, 2012, GENOME RES, V22, P2529, DOI 10.1101/gr.140475.112; Newkirk D, 2011, J COMPUT BIOL, V18, P1495, DOI 10.1089/cmb.2011.0185; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rudinger-Thirion J, 2011, P NATL ACAD SCI USA, V108, pE794, DOI 10.1073/pnas.1103698108; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sjottem E, 1996, J VIROL, V70, P188; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Steinbiss S, 2009, BIOINFORMATICS, V25, P533, DOI 10.1093/bioinformatics/btn657; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	92	316	330	2	45	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2012	13	11							R107	10.1186/gb-2012-13-11-r107			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	102UC	WOS:000315868700007	23181609	Green Published, hybrid			2022-01-24	
J	Wang, XW; Luan, JB; Li, JM; Bao, YY; Zhang, CX; Liu, SS				Wang, Xiao-Wei; Luan, Jun-Bo; Li, Jun-Min; Bao, Yan-Yuan; Zhang, Chuan-Xi; Liu, Shu-Sheng			De novo characterization of a whitefly transcriptome and analysis of its gene expression during development	BMC GENOMICS			English	Article							BEMISIA-TABACI HEMIPTERA; B-BIOTYPE; ALEYRODIDAE; GENERATION; RESISTANCE; BEGOMOVIRUSES; INVASION	Background: Whitefly (Bemisia tabaci) causes extensive crop damage throughout the world by feeding directly on plants and by vectoring hundreds of species of begomoviruses. Yet little is understood about its genes involved in development, insecticide resistance, host range plasticity and virus transmission. Results: To facilitate research on whitefly, we present a method for de novo assembly of whitefly transcriptome using short read sequencing technology (Illumina). In a single run, we produced more than 43 million sequencing reads. These reads were assembled into 168,900 unique sequences (mean size = 266 bp) which represent more than 10-fold of all the whitefly sequences deposited in the GenBank (as of March 2010). Based on similarity search with known proteins, these analyses identified 27,290 sequences with a cut-off E-value above 10(-5). Assembled sequences were annotated with gene descriptions, gene ontology and clusters of orthologous group terms. In addition, we investigated the transcriptome changes during whitefly development using a tag-based digital gene expression (DGE) system. We obtained a sequencing depth of over 2.5 million tags per sample and identified a large number of genes associated with specific developmental stages and insecticide resistance. Conclusion: Our data provides the most comprehensive sequence resource available for whitefly study and demonstrates that the Illumina sequencing allows de novo transcriptome assembly and gene expression analysis in a species lacking genome information. We anticipate that next generation sequencing technologies hold great potential for the study of the transcriptome in other non-model organisms.	[Wang, Xiao-Wei; Luan, Jun-Bo; Li, Jun-Min; Bao, Yan-Yuan; Zhang, Chuan-Xi; Liu, Shu-Sheng] Zhejiang Univ, Inst Insect Sci, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, Hangzhou 310029, Zhejiang, Peoples R China		Wang, XW (corresponding author), Zhejiang Univ, Inst Insect Sci, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, Hangzhou 310029, Zhejiang, Peoples R China.	xwwang@zju.edu.cn; shshliu@zju.edu.cn	Zhang, Chuan-Xi/K-7978-2019; Liu, Shu-Sheng/D-2300-2013	Zhang, Chuan-Xi/0000-0002-7784-1188; Li, Junmin/0000-0002-8385-8912	National Basic Research Programme of ChinaNational Basic Research Program of China [2009CB119203]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30730061]; China National Science-Technology [2006BAD08A18]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2009QNA6025]	We thank the technical assistance of Dan-Mei Yao and Jin-Hua Liu. We are grateful to Ding Jeak Ling for comments on the manuscript. Financial support for this study was provided by the National Basic Research Programme of China (Project 2009CB119203), the National Natural Science Foundation of China (Project 30730061), the China National Science-Technology Support Programme (Project 2006BAD08A18) and the Fundamental Research Funds for the Central Universities (2009QNA6025).	Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Ghanim M, 2007, PEST MANAG SCI, V63, P776, DOI 10.1002/ps.1410; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Jiu M, 2006, J PHYTOPATHOL, V154, P587, DOI 10.1111/j.1439-0434.2006.01151.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Leshkowitz D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-79; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Nauen R, 2002, PEST MANAG SCI, V58, P868, DOI 10.1002/ps.557; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parthasarathy R, 2007, J INSECT PHYSIOL, V53, P216, DOI 10.1016/j.jinsphys.2006.09.009; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015	32	316	344	1	126	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	JUN 24	2010	11								400	10.1186/1471-2164-11-400			11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	625CQ	WOS:000279870400001	20573269	gold, Green Published			2022-01-24	
J	Myers, S; Freeman, C; Auton, A; Donnelly, P; McVean, G				Myers, Simon; Freeman, Colin; Auton, Adam; Donnelly, Peter; McVean, Gil			A common sequence motif associated with recombination hot spots and genome instability in humans	NATURE GENETICS			English	Article							MEIOTIC RECOMBINATION; GERMLINE MUTATION; ALLELE DIVERSITY; MINISATELLITE; HOTSPOT; COMPLEX; CROSSOVERS; REARRANGEMENTS; MICRODELETION; GENERATION	In humans, most meiotic crossover events are clustered into short regions of the genome known as recombination hot spots. We have previously identified DNA motifs that are enriched in hot spots, particularly the 7-mer CCTCCCT. Here we use the increased hot-spot resolution afforded by the Phase 2 HapMap and novel search methods to identify an extended family of motifs based around the degenerate 13-mer CCNCCNTNNCCNC, which is critical in recruiting crossover events to at least 40% of all human hot spots and which operates on diverse genetic backgrounds in both sexes. Furthermore, these motifs are found in hypervariable minisatellites and are clustered in the breakpoint regions of both disease-causing nonallelic homologous recombination hot spots and common mitochondrial deletion hot spots, implicating the motif as a driver of genome instability.	[Myers, Simon] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Myers, Simon; Freeman, Colin; Auton, Adam; Donnelly, Peter; McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Auton, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England		Myers, S (corresponding author), Massachusetts Inst Technol & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	myers@stats.ox.ac.uk	Myers, Simon R/A-6792-2015; Auton, Adam J/B-1159-2009	Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408	Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Wolfson Foundation; EUEuropean Commission; Wellcome TrustWellcome TrustEuropean Commission	We thank J. Lupski for help with compiling information on NAHR hot spots and G. Coop for discussion. We thank the Engineering and Physical Sciences Research Council (EPSRC), the Wolfson Foundation, the EU and the Wellcome Trust for financial support.	Andreassen R, 1998, HUM MOL GENET, V7, P2113, DOI 10.1093/hmg/7.13.2113; Baudat F, 2007, PLOS GENET, V3, P1029, DOI 10.1371/journal.pgen.0030100; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Berg I, 2003, AM J HUM GENET, V72, P1436, DOI 10.1086/375629; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Lopes J, 2006, MOL CELL BIOL, V26, P6675, DOI 10.1128/MCB.00649-06; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; May CA, 1996, HUM MOL GENET, V5, P1823, DOI 10.1093/hmg/5.11.1823; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950	30	316	320	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1124	1129		10.1038/ng.213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	WOS:000258761200028	19165926				2022-01-24	
J	Bray, N; Dubchak, I; Pachter, L				Bray, N; Dubchak, I; Pachter, L			AVID: A global alignment program	GENOME RESEARCH			English	Article							GENE STRUCTURE; SEQUENCE; MOUSE; SIMILARITIES; SEARCH	In this paper we describe a new global alignment method called AVID. The method is designed to be fast, memory efficient, and practical for sequence alignments of large genomic regions up to megabases long. We present numerous applications of the method, ranging front the comparison of assemblies to alignment of large syntemic genomic regions and whole genome human/mouse alignments. We have also performed a quantitative comparison of AVID with other popular alignment tools. To this end, we have established a format for the representation of alignments and methods for their comparison. These formats and methods should be useful for future studies. The tools we have developed for the alignment comparisons, as well as the AVID program, are publicly available.	Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA		Pachter, L (corresponding author), Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA.	lpachter@math.berkeley.edu		Pachter, Lior/0000-0002-9164-6231	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002362] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01-HG02362-01, R01 HG002362] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Benos PV, 2001, GENOME RES, V11, P710, DOI 10.1101/gr.173801; Brudno M, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P138, DOI 10.1109/CSB.2002.1039337; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; CHAIN P, 2001, EXAMINING PROBLEMS W; COURONNE O, 2003, GENOME RES; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dubchak Inna, 2002, Brief Bioinform, V3, P18, DOI 10.1093/bib/3.1.18; Gusfield D., 1997, ACM SIGACT NEWS, V28, P41; Jareborg N, 1999, GENOME RES, V9, P815, DOI 10.1101/gr.9.9.815; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Miller W, 2001, BIOINFORMATICS, V17, P391, DOI 10.1093/bioinformatics/17.5.391; Morgenstern B, 1998, BIOINFORMATICS, V14, P290, DOI 10.1093/bioinformatics/14.3.290; Morgenstern B, 2002, BIOINFORMATICS, V18, P777, DOI 10.1093/bioinformatics/18.6.777; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PACHTER I, 1999, THESIS MIT CAMBRIDGE; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Smith SR, 2001, J POLIT PHILOS, V9, P19, DOI 10.1111/1467-9760.00116; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiehe T, 2000, Brief Bioinform, V1, P381, DOI 10.1093/bib/1.4.381	24	316	328	1	9	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2003	13	1					97	102		10.1101/gr.789803			6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	638BZ	WOS:000180550800011	12529311	Green Published, Green Accepted, Bronze			2022-01-24	
J	Santoro, R; Li, JW; Grummt, I				Santoro, R; Li, JW; Grummt, I			The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription	NATURE GENETICS			English	Article							POLYMERASE I TRANSCRIPTION; HISTONE METHYLATION; DNA METHYLATION; CHROMATIN; ISWI; TEMPLATES; SUBUNIT; HDAC1; FORM	Epigenetic control mechanisms silence about half of the ribosomal RNA (rRNA) genes in metabolically active cells. In exploring the mechanism by which the active or silent state of rRNA genes is inherited, we found that NoRC, a nucleolar remodeling complex containing Snf2h (also called Smarca5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin, subfamily a, member 5), represses rDNA transcription. NoRC mediates rDNA silencing by recruiting DNA methyltransferase and histone deacetylase activity to the rDNA promoter, thus establishing structural characteristics of heterochromatin such as DNA methylation, histone hypoacetylation and methylation of the Lys9 residue of histone H3. These results indicate that active and inactive rRNA genes can be demarcated by their associated proteins, and link chromatin remodeling to DNA methylation and specific histone modifications.	German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany		Grummt, I (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany.	I.Grummt@DKFZ-Heidelberg.de	Santoro, Raffaella/L-2637-2013				Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; GOODMARK JP, 2000, CELL, V103, P423; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	26	316	323	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					393	396		10.1038/ng1010			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	WOS:000179034800014	12368916				2022-01-24	
J	Fallin, D; Schork, NJ				Fallin, D; Schork, NJ			Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; PCR	Haplotype analyses have become increasingly common in genetic studies of human disease because of their ability to identify unique chromosomal segments likely to harbor disease-predisposing genes. The study of haplotypes is also used to investigate many population processes, such as migration and immigration rates, linkage-disequilibrium strength, and the relatedness of populations. Unfortunately, many haplotype-analysis methods require phase information that can be difficult to obtain from samples of nonhaploid species. There are, however, strategies for estimating haplotype frequencies from unphased diploid genotype data collected on a sample of individuals that make use of the expectation-maximization (EM) algorithm to overcome the missing phase information. The accuracy of such strategies, compared with other phase-determination methods, must be assessed before their use can be advocated. In this study we consider and explore sources of error between EM-derived haplotype frequency estimates and their population parameters, noting that much of this error is due to sampling error, which is inherent in all studies, even when phase can be determined. In light of this, we focus on the additional error between haplotype frequencies within a sample data set and EM-derived haplotype frequency estimates incurred by the estimation procedure. We assess the accuracy of haplotype frequency estimation as a function of a number of factors, including sample size, number of loci studied, allele frequencies, and locus-specific alellic departures from Hardy-Weinberg and linkage equilibrium. We point out the relative impacts of sampling error and estimation error, calling attention to the pronounced accuracy of EM estimates once sampling error has been accounted for. We also suggest that many factors that may influence accuracy can be assessed empirically within a data set-a fact that can be used to Create "diagnostics" that a user can turn to for assessing potential inaccuracies in estimation.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA		Fallin, D (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Campus,2500 Metrohlth Dr,Rammelkamp, Cleveland, OH 44109 USA.			Schork, Nicholas/0000-0003-0920-5013	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50 HL054998, HL54998-01, HL94011] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50HL054998] Funding Source: NIH RePORTER		CLARK AG, 1990, MOL BIOL EVOL, V7, P111; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; LEWONTIN RC, 1964, GENETICS, V49, P49; LONG JC, 1995, AM J HUM GENET, V56, P799; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; SCHORK N, 2000, UNPUB GENOME RES; WEIR BS, 1996, GENETIC DATA ANAL, pR2	10	316	325	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					947	959		10.1086/303069			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	WOS:000089651100016	10954684	Bronze, Green Published			2022-01-24	
J	HAWTHORNE, DC; MORTIMER, RK				HAWTHORNE, DC; MORTIMER, RK			CHROMOSOME MAPPING IN SACCHAROMYCES - CENTROMERE-LINKED GENES	GENETICS			English	Article																	ADAMS AM, 1949, CAN J RES C, V27, P179, DOI 10.1139/cjr49c-015; BARRATT RW, 1954, ADV GENET, V6, P1, DOI 10.1016/S0065-2660(08)60127-3; BRENESPOMALES A, 1955, NATURE, V176, P841, DOI 10.1038/176841a0; CATCHESIDE DG, 1951, GENETICS MICROORGANI; CHEN SY, 1950, HEREDITY, V4, P337, DOI 10.1038/hdy.1950.26; CHEN SY, 1950, CR HEBD ACAD SCI, V230, P1897; DOUGLAS HC, 1954, J BACTERIOL, V68, P662, DOI 10.1128/JB.68.6.662-670.1954; EPHRUSSI B, 1949, ANN I PASTEUR PARIS, V76, P419; FOWELL RR, 1952, NATURE, V170, P578, DOI 10.1038/170578a0; HAWTHORNE DC, 1955, GENETICS, V40, P511; HAWTHORNE DC, 1956, CR TRAV LAB CARLS P, V26, P149; Hawthorne DC, 1955, THESIS U WASHINGTON; HOWE HB, 1956, GENETICS, V41, P610; JOHNSTON JR, 1959, J BACTERIOLOGY, V78, P272; LINDEGREN C. C, 1951, INDIAN PHYTOPATH, V4, P11; Lindegren CC, 1944, BOT GAZ, V105, P304, DOI 10.1086/335229; LINDEGREN CC, 1959, NATURE, V183, P800, DOI 10.1038/183800a0; LINDEGREN CC, 1949, YEAST CELL ITS GENET; MAGNI GE, 1949, COMPT REND TRAV LA P, V25, P285; Mather K, 1935, J GENET, V30, P53, DOI 10.1007/BF02982205; MICHIE D, 1953, NATURE, V171, P26, DOI 10.1038/171026a0; MORTIMER RK, 1957, USAEC UCRL3746 REP; PERKINS DD, 1953, GENETICS, V38, P187; PERKINS DD, 1949, GENETICS, V34, P607; POMPER S, 1949, P NATL ACAD SCI USA, V35, P456, DOI 10.1073/pnas.35.8.456; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; ROMAN H, 1956, CR TRAV LAB CARLS P, V26, P299; ROMAN R, 1958, COLD SPRING HARBOR S, V23, P155; STANTIAL HELEN, 1935, TRANS ROY SOC CANADA SECT 3, V29, P175; Weinstein A, 1936, GENETICS, V21, P155; WHITEHOUSE HLK, 1950, NATURE, V165, P893, DOI 10.1038/165893a0; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WINGE O., 1948, COMPT REND TRAV LAB CARLSBERG [COPENHAGEN SER PHYSIOL], V24, P263	33	316	317	1	2	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1960	45	8					1085	1110					26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE115	WOS:A1960WE11500141	17247984				2022-01-24	
J	Pfeufer, A; van Noord, C; Marciante, KD; Arking, DE; Larson, MG; Smith, AV; Tarasov, KV; Muller, M; Sotoodehnia, N; Sinner, MF; Verwoert, GC; Li, M; Kao, WHL; Kottgen, A; Coresh, J; Bis, JC; Psaty, BM; Rice, K; Rotter, JI; Rivadeneira, F; Hofman, A; Kors, JA; Stricker, BHC; Uitterlinden, AG; van Duijn, CM; Beckmann, BM; Sauter, W; Gieger, C; Lubitz, SA; Newton-Cheh, C; Wang, TJ; Magnani, JW; Schnabel, RB; Chung, MK; Barnard, J; Smith, JD; Van Wagoner, DR; Vasan, RS; Aspelund, T; Eiriksdottir, G; Harris, TB; Launer, LJ; Najjar, SS; Lakatta, E; Schlessinger, D; Uda, M; Abecasis, GR; Muller-Myhsok, B; Ehret, GB; Boerwinkle, E; Chakravarti, A; Soliman, EZ; Lunetta, KL; Perz, S; Wichmann, HE; Meitinger, T; Levy, D; Gudnason, V; Ellinor, PT; Sanna, S; Kaab, S; Witteman, JCM; Alonso, A; Benjamin, EJ; Heckbert, SR				Pfeufer, Arne; van Noord, Charlotte; Marciante, Kristin D.; Arking, Dan E.; Larson, Martin G.; Smith, Albert Vernon; Tarasov, Kirill V.; Mueller, Martina; Sotoodehnia, Nona; Sinner, Moritz F.; Verwoert, Germaine C.; Li, Man; Kao, W. H. Linda; Koettgen, Anna; Coresh, Josef; Bis, Joshua C.; Psaty, Bruce M.; Rice, Kenneth; Rotter, Jerome I.; Rivadeneira, Fernando; Hofman, Albert; Kors, Jan A.; Stricker, Bruno H. C.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Beckmann, Britt M.; Sauter, Wiebke; Gieger, Christian; Lubitz, Steven A.; Newton-Cheh, Christopher; Wang, Thomas J.; Magnani, Jared W.; Schnabel, Renate B.; Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.; Vasan, Ramachandran S.; Aspelund, Thor; Eiriksdottir, Gudny; Harris, Tamara B.; Launer, Lenore J.; Najjar, Samer S.; Lakatta, Edward; Schlessinger, David; Uda, Manuela; Abecasis, Goncalo R.; Mueller-Myhsok, Bertram; Ehret, Georg B.; Boerwinkle, Eric; Chakravarti, Aravinda; Soliman, Elsayed Z.; Lunetta, Kathryn L.; Perz, Siegfried; Wichmann, H-Erich; Meitinger, Thomas; Levy, Daniel; Gudnason, Vilmundur; Ellinor, Patrick T.; Sanna, Serena; Kaeaeb, Stefan; Witteman, Jacqueline C. M.; Alonso, Alvaro; Benjamin, Emelia J.; Heckbert, Susan R.			Genome-wide association study of PR interval	NATURE GENETICS			English	Article							ATRIAL-FIBRILLATION; COMMON VARIANTS; SODIUM-CHANNEL; HEART-RATE; ATHEROSCLEROSIS RISK; NATIONAL HEART; SYSTEM; DESIGN; INDIVIDUALS; VARIABILITY	The electrocardiographic PR interval (or PQ interval) reflects atrial and atrioventricular nodal conduction, disturbances of which increase risk of atrial fibrillation. We report a meta-nalysis of genome-wide association studies for PR interval from seven population-based European studies in the CHARGE Consortium: AGES, ARIC, CHS, FHS, KORA, Rotterdam Study, and SardiNIA (N = 28,517). We identified nine loci associated with PR interval at P < 5 x 10(-8). At the 3p22.2 locus, we observed two independent associations in voltage-gated sodium channel genes, SCN10A and SCN5A. Six of the loci were near cardiac developmental genes, including CAV1-CAV2, NKX25 (CSX1), SOX5, WNT11, MEIS1, and TBX5-TBX3, providing pathophysiologically interesting candidate genes. Five of the loci, SCN5A, SCN10A, NKX2-5, CAV1-CAV2, and SOX5, were also associated with atrial fibrillation (N = 5,741 cases, P < 0.0056). This suggests a role for common variation in ion channel and developmental genes in atrial and atrioventricular conduction as well as in susceptibility to atrial fibrillation.	[Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany; [Pfeufer, Arne; Meitinger, Thomas] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [van Noord, Charlotte; Verwoert, Germaine C.; Rivadeneira, Fernando; Hofman, Albert; Stricker, Bruno H. C.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Noord, Charlotte] Dutch Med Evaluat Board, The Hague, Netherlands; [van Noord, Charlotte; Witteman, Jacqueline C. M.] Netherlands Consortium Healthy Aging Leiden, Leiden, Netherlands; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Larson, Martin G.; Wang, Thomas J.; Schnabel, Renate B.; Vasan, Ramachandran S.; Levy, Daniel; Benjamin, Emelia J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Heart Prevent Clin & Res Inst, Iceland Heart Assoc, Kopavogur, Iceland; [Tarasov, Kirill V.; Najjar, Samer S.; Lakatta, Edward] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Tarasov, Kirill V.; Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Mueller, Martina; Sauter, Wiebke; Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Mueller, Martina; Sinner, Moritz F.; Beckmann, Britt M.; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-80804 Munich, Germany; [Verwoert, Germaine C.; Rivadeneira, Fernando; Stricker, Bruno H. C.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Li, Man; Kao, W. H. Linda; Koettgen, Anna; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Res Inst, Seattle, WA USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Dept Common Dis Genet Program, Inst Med Genet, W Hollywood, CA USA; [Kors, Jan A.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Stricker, Bruno H. C.] Inspectorate Hlth Care, The Hague, Netherlands; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Lubitz, Steven A.; Newton-Cheh, Christopher; Wang, Thomas J.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Wang, Thomas J.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Med Clin Cardiol 2, Mainz, Germany; [Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Heart & Vasc Res Inst, Cleveland, OH 44106 USA; [Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Heart Prevent Clin & Res Inst, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Baltimore, MD 21224 USA; [Uda, Manuela; Sanna, Serena] CNR, Ist Neurogenet Neurofarmacol, Cagliari, Italy; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Chakravarti, Aravinda] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Univ, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE,Med Ctr, Winston Salem, NC 27109 USA; [Perz, Siegfried] Helmholtz Ctr, Inst Biol & Med Imaging, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Cardiol & Prevent Med Div,Evans Dept Med, Boston, MA 02118 USA		Pfeufer, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany.	arne.pfeufer@web.de; heckbert@u.washington.edu	Sinner, Moritz/AAW-5043-2020; Levy, Daniel/ABF-6873-2021; Rice, Kenneth M/A-4150-2013; Wichmann, Heinz Erich/AAA-5695-2022; Rivadeneira, Fernando/O-5385-2015; Smith, Albert Vernon/K-5150-2015; Pfeufer, Arne/B-6634-2013; Schnabel, Renate B/ABE-6668-2021; Kottgen, Anna/D-2920-2012; Ramachandran, Vasan/Y-2527-2019; Soliman, Elsayed/AAD-7135-2020; Gudnason, Vilmundur/AAE-7126-2019; Soliman, Elsayed/D-8124-2011; Uda, Manuela/AAC-2645-2019; EHRET, Georg B/A-9532-2009; Van Wagoner, David R/C-6783-2008; Aspelund, Thor/K-7022-2019; Alonso, Alvaro/A-4917-2010; Schnabel, Renate B/F-6527-2014; Kaab, Stefan/H-3915-2012; Aspelund, Thor/F-4826-2011; Gudnason, Vilmundur/K-6885-2015; Lakatta, Edward/AAL-1447-2020; sanna, serena/H-3009-2019; Muller-Nurasyid, Martina/I-8735-2018; Aspelund, Thor/C-5983-2008; Muller-Myhsok, Bertram/A-3289-2013; Li, Man/AAX-3400-2020; Meitinger, Thomas/O-1318-2015; Launer, Lenore J/A-8218-2010; Abecasis, Goncalo R/B-7840-2010; Levy, Daniel/ABB-2752-2021; Rotter, Jerome/AAY-6598-2021; Smith, Jonathan D./H-9723-2013; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Rice, Kenneth M/0000-0001-5779-4495; Rivadeneira, Fernando/0000-0001-9435-9441; Smith, Albert Vernon/0000-0003-1942-5845; Schnabel, Renate B/0000-0001-7170-9509; Ramachandran, Vasan/0000-0001-7357-5970; Soliman, Elsayed/0000-0001-5632-8150; Gudnason, Vilmundur/0000-0001-5696-0084; Soliman, Elsayed/0000-0001-5632-8150; Uda, Manuela/0000-0002-4890-6456; EHRET, Georg B/0000-0002-5730-0675; Van Wagoner, David R/0000-0001-8250-9828; Aspelund, Thor/0000-0002-7998-5433; Alonso, Alvaro/0000-0002-2225-8323; Gudnason, Vilmundur/0000-0001-5696-0084; sanna, serena/0000-0002-3768-1749; Muller-Nurasyid, Martina/0000-0003-3793-5910; Aspelund, Thor/0000-0002-7998-5433; Li, Man/0000-0002-3839-0281; Meitinger, Thomas/0000-0002-8838-8403; Larson, Martin/0000-0002-9631-1254; Ellinor, Patrick/0000-0002-2067-0533; Smith, Jonathan D./0000-0002-0415-386X; Gieger, Christian/0000-0001-6986-9554; Van Duijn, Cornelia/0000-0002-2374-9204; Ballantyne, Christie/0000-0002-6432-1730; Wang, Thomas/0000-0003-4063-6508; Benjamin, Emelia/0000-0003-4076-2336; Tarasov, Kirill/0000-0001-7799-4670; Abecasis, Goncalo/0000-0003-1509-1825; Lunetta, Kathryn/0000-0002-9268-810X; Lakatta, Edward/0000-0002-4772-0035	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [N01-AG-12100]; US National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Hjartavernd (Icelandic Heart Association); Althingi (Icelandic parliament); US National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); US National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); US National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD); NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694, R01-HL-054512, R01-HL090620, P50-HL077107, N01-HC85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01-HL-080295, R01-HL-087652]; US National Human Genome Research Institute (NHGRI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01-HG004402]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN268200625226C, UL1-RR025005, N01-HC-25195, HL-076784, AG-028321, N01-HC25195, HL-080025, 6R01-NS-17950]; Donald W. Reynolds Cardiovascular Clinical Research Center; Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic; US National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR-00425]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK063491]; US National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Cedars-Sinai Board of Governors; Boston University School of Medicine and Boston Medical Center (LINGA-II); Robert Dawson Evans Endowment; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHN 1149/1-1]; PfizerPfizer; Bundesministerium fur Bildung und Forschung Nationales GenomforschungsnetzFederal Ministry of Education & Research (BMBF); Leducq FoundationLeducq Foundation [07-03 Ludvig 03]; Ludwig-Maximilians University (LMU) [FuFoLe 557/569]; Helmholtz Zentrum Munchen fur Gesundheit und Umwelt; The Netherlands Organisation for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [175.010.2005.011, 911.03.012, 050-060-810]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Erasmus Medical Center, Erasmus University Rotterdam; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [NO1-AG-1-2109, 263-MA-410953];  [01-GS-0499];  [01-GR-0103];  [01-GR-0803];  [AFNET 01-GI-0204 01-GS-0838]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000675, ZIAAG006000, ZIAAG007270, ZIAAG000799] Funding Source: NIH RePORTER	We gratefully acknowledge all of the participants in the studies. AGES: US National Institutes of Health (NIH) N01-AG-12100, US National Institute on Aging (NIA) and NIH Intramural Research Programs, Hjartavernd (Icelandic Heart Association), Althingi (Icelandic parliament), US National Heart, Lung, and Blood Institute (NHLBI), US National Eye Institute and US National Institute on Deafness and Other Communication Disorders. ARIC: NHLBI N01-HC-55015, N01-HC-55016, N01-HC-55018 through N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694 and R01-HL-054512; US National Human Genome Research Institute (NHGRI) U01-HG004402; NIH HHSN268200625226C; and the Donald W. Reynolds Cardiovascular Clinical Research Center. Infrastructure was supported by NIH UL1-RR025005. CCAF: NHLBI R01-HL090620 and P50-HL077107, and intramural funding from the Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic. CHS: NHLBI N01-HC85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01-HL-080295, R01-HL-087652 and R01-HL088456; US National Center for Research Resources M01-RR-00425; National Institute of Diabetes and Digestive and Kidney Diseases DK063491; US National Institute of Neurological Disorders and Stroke; and the Cedars-Sinai Board of Governors. FHS: NIH N01-HC-25195, HL-076784, AG-028321, N01-HC25195, HL-080025 and 6R01-NS-17950; NHLBI N01-HC-25195; Boston University School of Medicine and Boston Medical Center (LINGA-II); the Robert Dawson Evans Endowment; the Doris Duke Charitable Foundation; the SHARe project; Deutsche Forschungsgemeinschaft fellowship SCHN 1149/1-1; Affymetrix contract for genotyping services (N02-HL-6-4278); and Pfizer. KORA/AFNET: We thank B. Putz, M. Putz and G. Fischer for their contributions to genotyping and imputation. Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz; 01-GS-0499, 01-GR-0103, 01-GR-0803, AFNET 01-GI-0204 01-GS-0838, the Leducq Foundation 07-03 Ludvig 03, Ludwig-Maximilians University (LMU) FuFoLe 557/569, the LMU Excellence Initiative, MC Health as part of LMUinnovativ, the Helmholtz Zentrum Munchen fur Gesundheit und Umwelt and the state of Bavaria. Rotterdam Study: We thank P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their help in creating the database, K. Estrada for his help with the analyses and M. Struchalin for contributions to genotype imputation. Nederlandse Organisatie voor Wetenschappelijk Onderzoek (The Netherlands Organisation for Scientific Research) 175.010.2005.011, 911.03.012 and 050-060-810, the Research Institute of Diseases in the Elderly, Netherlands Genome Initiative, Stichting Zorgonderzoek Nederland-Medische Wetenschappen (The Netherlands Organisation for Health Research and Development), Netherlands Hartstichting, Netherlands Ministry of Education Culture and Science, Netherlands Ministry of Health Welfare and Sports; the European Commission; Erasmus Medical Center, Erasmus University Rotterdam and the municipality of Rotterdam. SardiNIA: We thank A. Scuteri and M. Orr for longstanding, continual support of the project and for phenotype characterization. NIA NO1-AG-1-2109, 263-MA-410953, NIH and NIA Intramural Research Programs, NHGRI and NHLBI. Role of the sponsors: None of the funding organizations had any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review or approval of the manuscript. More detailed acknowledgments can be found in the Supplementary Note.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Jay PY, 2004, ANAT REC PART A, V280A, P966, DOI 10.1002/ar.a.20102; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; OLSSON SB, 1971, ACTA MED SCAND, V190, P381; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PERZ S, 2004, ANAL BIOMEDICAL SIGN, P47; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; SCHINZEL A, 1987, J MED GENET, V24, P778, DOI 10.1136/jmg.24.12.778; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sinner MF, 2008, EUR HEART J, V29, P907, DOI 10.1093/eurheartj/ehm619; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	51	315	319	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2010	42	2					153	U89		10.1038/ng.517			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	WOS:000274084400013	20062060	Green Accepted			2022-01-24	
J	Yuan, X; Waterworth, D; Perry, JRB; Lim, N; Song, K; Chambers, JC; Zhang, W; Vollenweider, P; Stirnadel, H; Johnson, T; Bergmann, S; Beckmann, ND; Li, Y; Ferrucci, L; Melzer, D; Hernandez, D; Singleton, A; Scott, J; Elliott, P; Waeber, G; Cardon, L; Frayling, TM; Kooner, JS; Mooser, V				Yuan, Xin; Waterworth, Dawn; Perry, John R. B.; Lim, Noha; Song, Kijoung; Chambers, John C.; Zhang, Weihua; Vollenweider, Peter; Stirnadel, Heide; Johnson, Toby; Bergmann, Sven; Beckmann, Noam D.; Li, Yun; Ferrucci, Luigi; Melzer, David; Hernandez, Dena; Singleton, Andrew; Scott, James; Elliott, Paul; Waeber, Gerard; Cardon, Lon; Frayling, Timothy M.; Kooner, Jaspal S.; Mooser, Vincent			Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; CARBOXYPEPTIDASE-N; ADIPONUTRIN GENE; RISK-FACTORS; PROTEINS; DISEASE; HEMOCHROMATOSIS; EXPRESSION; MUTATIONS; MEMBRANE	Plasma liver-enzyme tests are widely used in the clinic for the diagnosis of liver diseases and for monitoring the response to drug treatment. There is considerable evidence that human genetic variation influences plasma levels of liver enzymes. However, such genetic variation has not been systematically assessed. In the present Study, we performed a genome-wide association study of plasma liver-enzyme levels in three populations (total n = 7715) with replication in three additional cohorts (total n 4704). We identified two loci influencing plasma levels of alanine-aminotransferase (ALT) (CPN1-ERLIN1-CHUK on chromosome 10 and PNPLA3-SAMM50 on chromosome 22), one locus influencing gamma-glutamyl transferase (GGT) levels (HNF1A on chromosome 12), and three loci for alkaline phosphatase (ALP) levels (ALPL on chromosome 1, GPLD1 on chromosome 6, and JMJD1C-REEP3 on chromosome 10). In addition, we confirmed the associations between the GGTI locus and GGT levels and between the ABO locus and ALP levels. None of the ALP-associated SNPs were associated with other liver tests, suggesting intestine and/or bone specificity. The mechanisms underlying the associations may involve cis- or trans-transcriptional effects (some of the identified variants were associated with mRNA transcription in human liver or lymphoblastoid cells), dysfunction of the encoded proteins (caused by missense variations at the functional domains), or other unknown pathways. These findings may help in the interpretation of liver-enzyme tests and provide candidate genes for liver diseases of viral, metabolic, autoimmune, or toxic origin. The specific associations with ALP levels may point to genes for bone or intestinal diseases.	[Yuan, Xin; Waterworth, Dawn; Lim, Noha; Song, Kijoung; Cardon, Lon; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA 19406 USA; [Stirnadel, Heide; Li, Yun] GlaxoSmithKline, Worldwide Epidemiol, Harlow EX2 5DW, Essex, England; [Perry, John R. B.; Melzer, David; Frayling, Timothy M.] Univ Exeter, Penn Coll Med & Dent, Inst Biomed & Clin Sci, Exeter CM19 5AW, Devon, England; [Chambers, John C.; Zhang, Weihua; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 11G, England; [Vollenweider, Peter; Waeber, Gerard] CHUV Univ Hosp, Dept Med, CH-1011 Lausanne, Switzerland; [Johnson, Toby; Bergmann, Sven; Beckmann, Noam D.] CHUV Univ Hosp, Div Med Genet, CH-1011 Lausanne, Switzerland; [Johnson, Toby] CHUV Univ Hosp, Inst Social & Preventat Med, CH-1011 Lausanne, Switzerland; [Johnson, Toby; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Ferrucci, Luigi] NIA, Gerontol Res Ctr, Clin Res Branch, Longitudinal Studies Sect, Baltimore, MD 21224 USA; [Hernandez, Dena; Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Li, Yun] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA		Mooser, V (corresponding author), GlaxoSmithKline, Div Genet, King Of Prussia, PA 19406 USA.	vincent.2.mooser@gsk.com	Colaus, PsyColaus/K-6607-2013; Singleton, Andrew B/C-3010-2009; Lim, Noha/ABA-2509-2020	Frayling, Timothy/0000-0001-8362-2603; Elliott, Paul/0000-0002-7511-5684; Johnson, Toby/0000-0002-5998-3270; Bergmann, Sven/0000-0002-6785-9034; Waeber, Gerard/0000-0003-4193-788X; Melzer, David/0000-0002-0170-3838	GlaxoSmithKlineGlaxoSmithKline; National Institute on Aging, National Institutes of Health, and Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1 Z01 AG000965-02]; British Heart FoundationBritish Heart Foundation [SP/04/002]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700931, G0601966] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700931, G0601966] Funding Source: researchfish; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [Z01AG000965] Funding Source: NIH RePORTER	The CoLaus study was sponsored in part by GlaxoSmithKline, a pharmaceutical company. X.Y., D.W., N.L., K.S., H.S., L.C., and V.M. are full-time employees of GlaxoSmithKhne. The InCHIANTI study was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, and Department of Health and Human Services, project number 1 Z01 AG000965-02. LOLIPOP was supported by the British Heart Foundation Grant SP/04/002. We thank the individuals who volunteered to participate in the CoLaus Study, as well as the staff at Lausanne University Hospital and within GlaxoSmithKline who made this collection possible. The computations for CoLaus imputation were performed in part at the Vital-IT center for high performance computing of the Swiss Institute of Bioinformatics. We thank Jacques Beckmann for his comments.	Adams PC, 2007, LANCET, V370, P1855, DOI 10.1016/S0140-6736(07)61782-6; Bathum L, 2001, CLIN CHEM, V47, P81; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brun-Heath I, 2007, EUR J MED GENET, V50, P367, DOI 10.1016/j.ejmg.2007.06.005; CEREGHINI S, 1990, EMBO J, V9, P2257, DOI 10.1002/j.1460-2075.1990.tb07396.x; Chalasani N, 2006, J CLIN ENDOCR METAB, V91, P2279, DOI 10.1210/jc.2006-0075; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Foreman JE, 2005, PHYSIOL GENOMICS, V23, P295, DOI 10.1152/physiolgenomics.00062.2005; Forlani G, 2008, J ENDOCRINOL INVEST, V31, P146, DOI 10.1007/BF03345581; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Johansson LE, 2006, DIABETES, V55, P826, DOI 10.2337/diabetes.55.03.06.db05-1075; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moldes M, 2006, EUR J ENDOCRINOL, V155, P461, DOI 10.1530/eje.1.02229; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; SKIDGEL RA, 1988, BIOCHEM BIOPH RES CO, V154, P1323, DOI 10.1016/0006-291X(88)90284-7; Stepec S, 2008, ANN HEMATOL, V87, P667, DOI 10.1007/s00277-008-0463-2; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; WALKER BA, 1971, CLIN CHIM ACTA, V35, P433, DOI 10.1016/0009-8981(71)90218-X; Whitfield JB, 2002, CLIN CHEM, V48, P1426; WHITFIELD JB, 1983, AM J HUM GENET, V35, P978; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	44	315	324	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					520	528		10.1016/j.ajhg.2008.09.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	WOS:000260239200010	18940312	Bronze, Green Published			2022-01-24	
J	Irizarry, RA; Ladd-Acosta, C; Carvalho, B; Wu, H; Brandenburg, SA; Jeddeloh, JA; Wen, B; Feinberg, AP				Irizarry, Rafael A.; Ladd-Acosta, Christine; Carvalho, Benilton; Wu, Hao; Brandenburg, Sheri A.; Jeddeloh, Jeffrey A.; Wen, Bo; Feinberg, Andrew P.			Comprehensive high-throughput arrays for relative methylation (CHARM)	GENOME RESEARCH			English	Article							DNA METHYLATION; IMPRINTED DOMAIN; MICROARRAY DATA; CANCER-CELLS; HETEROCHROMATIN; NORMALIZATION; EPIGENOMICS; PROMOTER; GENES; ASSAY	This study was originally conceived to test in a rigorous way the specificity of three major approaches to high-throughput array-based DNA methylation analysis: (1) MeDIP, or methylated DNA immunoprecipitation, an example of antibody-mediated methyl-specific fractionation; (2) HELP, or HpaII tiny fragment enrichment by ligation-mediated PCR, an example of differential amplification of methylated DNA; and (3) fractionation by McrBC, an enzyme that cuts most methylated DNA. These results were validated using 1466 Illumina methylation probes on the GoldenGate methylation assay and further resolved discrepancies among the methods through quantitative methylation pyrosequencing analysis. While all three methods provide useful information, there were significant limitations to each, specifically bias toward CpG islands in MeDIP, relatively incomplete coverage in HELP, and location imprecision in McrBC. However, we found that with an original array design strategy using tiling arrays and statistical procedures that average information from neighboring genomic locations, much improved specificity and sensitivity could be achieved, e. g., similar to 100% sensitivity at 90% specificity with McrBC. We term this approach "comprehensive high-throughput arrays for relative methylation" (CHARM). While this approach was applied to McrBC analysis, the array design and computational algorithms are fractionation method-independent and make this a simple, general, relatively inexpensive tool suitable for genome-wide analysis, and in which individual samples can be assayed reliably at very high density, allowing locus-level genome-wide epigenetic discrimination of individuals, not just groups of samples. Furthermore, unlike the other approaches, CHARM is highly quantitative, a substantial advantage in application to the study of human disease.	[Irizarry, Rafael A.; Carvalho, Benilton; Wu, Hao] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Ladd-Acosta, Christine; Brandenburg, Sheri A.; Wen, Bo; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Ladd-Acosta, Christine; Brandenburg, Sheri A.; Wen, Bo; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Jeddeloh, Jeffrey A.] Genomics LLC, St Louis, MO 63108 USA		Irizarry, RA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	afeinberg@jhu.edu; afeinberg@jhu.edu	Wu, Hao/H-3899-2017; Wen, Bo/P-5332-2019; Wu, Hao/AAG-8660-2020; Feinberg, Andrew/AAY-7666-2020; Carvalho, Benilton/G-1868-2012; Carvalho, Benilton/L-9329-2019	Wu, Hao/0000-0003-1269-7354; Wen, Bo/0000-0003-0394-7366; Wu, Hao/0000-0003-1269-7354; Carvalho, Benilton/0000-0001-5122-5646; Carvalho, Benilton/0000-0001-5122-5646; Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37 CA054358-18, R37 CA054358] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01 RR021967, R01 RR021967-02] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG003233, P50 HG003233] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM083084, R01 GM083084-02] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA054358] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR021967] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM083084] Funding Source: NIH RePORTER		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Feinberg AP, 2001, NAT GENET, V27, P9, DOI 10.1038/83825; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; HARDLE W, 1995, APPL STAT-J ROY ST C, V44, P258, DOI 10.2307/2986349; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jiang GC, 2004, J CELL BIOCHEM, V93, P286, DOI 10.1002/jcb.20146; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Reinhold WC, 2007, MOL CANCER THER, V6, P391, DOI 10.1158/1535-7163.MCT-06-0609; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rosa AL, 2005, CHROMOSOME RES, V13, P809, DOI 10.1007/s10577-005-1015-4; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; TUKEV I, 1977, EXPLORATORY DATA ANA; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	35	315	325	1	43	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2008	18	5					780	790		10.1101/gr.7301508			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	295WK	WOS:000255504600010	18316654	Green Published, Green Accepted, Bronze			2022-01-24	
J	Murdoch, S; Djuric, U; Mazhar, B; Seoud, M; Khan, R; Kuick, R; Bagga, R; Kircheisen, R; Ao, A; Ratti, B; Hanash, S; Rouleau, GA; Slim, R				Murdoch, S; Djuric, U; Mazhar, B; Seoud, M; Khan, R; Kuick, R; Bagga, R; Kircheisen, R; Ao, A; Ratti, B; Hanash, S; Rouleau, GA; Slim, R			Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans	NATURE GENETICS			English	Article							NITRIC-OXIDE; MICE; PREGNANCY; PROTEIN; LOCUS	Hydatidiform mole (HM) is an abnormal human pregnancy with no embryo and cystic degeneration of placental villi. We report five mutations in the maternal gene NALP7 in individuals with familial and recurrent HMs. NALP7 is a member of the CATERPILLER protein family involved in inflammation and apoptosis. NALP7 is the first maternal effect gene identified in humans and is also responsible for recurrent spontaneous abortions, stillbirths and intrauterine growth retardation.	McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H3G 1A4, Canada; Pakistan Inst Med Sci, Dept Obstet & Gynecol, Maternal & Child Hlth Ctr Unit 11, Islamabad, Pakistan; Amer Univ Beirut, Dept Obstet & Gynecol, Beirut, Lebanon; Univ Michigan, Dept Pediat & Commun Dis, Ann Arbor, MI 48109 USA; Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh 160012, India; Inst Klin Genet, D-55131 Mainz, Germany; Notre Dame Hosp, Ctr Study Brain Dis, Montreal, PQ H2L 4M1, Canada		Slim, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada.	rima.slim@muhc.mcgill.ca	ao, asangla/Q-5454-2019; Slim, Rima/J-4104-2019; Bagga, Rashmi/Y-1680-2019	Slim, Rima/0000-0002-4060-2159; Bagga, Rashmi/0000-0003-2693-2343; Djuric, Ugljesa/0000-0003-0027-3079			Agarwal P, 2004, ACTA OBSTET GYN SCAN, V83, P213, DOI 10.1111/j.0001-6349.2004.077b.x; Chiu PM, 2001, HISTOPATHOLOGY, V38, P243, DOI 10.1046/j.1365-2559.2001.01065.x; Deb Kaushik, 2004, Archives of Gynecology and Obstetrics, V270, P133, DOI 10.1007/s00404-004-0623-0; Harma M, 2004, EUR J GYNAECOL ONCOL, V25, P333; Hodges MD, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e95; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mazhar S, 1995, J PAKISTAN I MED SCI, V6, P383; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Savion S, 2002, AM J REPROD IMMUNOL, V47, P118, DOI 10.1034/j.1600-0897.2002.1o027.x; Strakova Z, 2002, J REPROD IMMUNOL, V55, P35, DOI 10.1016/S0165-0378(01)00141-3; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019	15	315	338	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					300	302		10.1038/ng1740			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	WOS:000235589600010	16462743				2022-01-24	
J	Wilcox, WR; Banikazemi, M; Guffon, N; Waldek, S; Lee, P; Linthorst, GE; Desnick, RJ; Germain, DP				Wilcox, WR; Banikazemi, M; Guffon, N; Waldek, S; Lee, P; Linthorst, GE; Desnick, RJ; Germain, DP		Int Fabry Dis Study Grp	Long-term safety and efficacy of enzyme replacement therapy for Fabry disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-GALACTOSIDASE; GLOBOTRIAOSYLCERAMIDE; INFUSION	Elsewhere, we reported the safety and efficacy results of a multicenter phase 3 trial of recombinant human alpha-galactosidase A (rh-alphaGalA) replacement in patients with Fabry disease. All 58 patients who were enrolled in the 20-wk phase 3 double-blind, randomized, and placebo-controlled study received subsequently 1 mg/kg of rh-alphaGalA ( agalsidase beta, Fabrazyme, Genzyme Corporation) biweekly in an ongoing open-label extension study. Evidence of long-term efficacy, even in patients who developed IgG antibodies against rh-alphaGalA, included the continuously normal mean plasma globotriaosylceramide (GL-3) levels during 30 mo of the extension study and the sustained capillary endothelial GL-3 clearance in 98% (39/40) of patients who had a skin biopsy taken after treatment for 30 mo (original placebo group) or 36 mo (original enzyme-treated group). The mean serum creatinine level and estimated glomerular filtration rate also remained stable after 30-36 mo of treatment. Infusion-associated reactions decreased over time, as did anti-rh-alphaGalA IgG antibody titers. Among seroconverted patients, after 30-36 mo of treatment, seven patients tolerized (no detectable IgG antibody), and 59% had greater than or equal to4-fold reductions in antibody titers. As of 30 mo into the extension trial, three patients were withdrawn from the study because of positive serum IgE or skin tests; however, all have been rechallenged successfully at the time of this report. Thus, enzyme replacement therapy for 30-36 mo with agalsidase beta resulted in continuously decreased plasma GL-3 levels, sustained endothelial GL-3 clearance, stable kidney function, and a favorable safety profile.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Cedars Sinai Burns & Allen Res Inst, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Hop Edouard Herriot, Lyon, France; Hope Hosp, Manchester, Lancs, England; UCL Hosp, London, England; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Hop Europeen Georges Pompidou, Paris, France		Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, 5th Ave & 100th St, New York, NY 10029 USA.	rjdesnick@mssm.edu	GERMAIN, Dominique P./AAD-6747-2020	GERMAIN, Dominique/0000-0002-8355-007X			Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; COLOMBI A, 1967, HELV MED ACTA, V34, P67; De Schoenmakere G, 2003, NEPHROL DIAL TRANSPL, V18, P33, DOI 10.1093/ndt/18.1.33; Desnick R.J., 2001, METABOLIC MOL BASES, V8th ed., P3733, DOI [DOI 10.1036/ommbid.181, 10.1036/ommbid.181]; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; GUFFON N, IN PRESS J INHERIT M; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; RICHARDS SM, 1993, BLOOD, V82, P1402; Rosenberg M, 1999, BLOOD, V93, P2081, DOI 10.1182/blood.V93.6.2081.406k07_2081_2088; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Thadhani R, 2002, KIDNEY INT, V61, P249, DOI 10.1046/j.1523-1755.2002.00097.x; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Waldek S, 2003, NEW ENGL J MED, V348, P1186, DOI 10.1056/NEJM200303203481224; Ware JE., 1997, SF 36 HLTH SURVEY MA; Weidemann F, 2003, CIRCULATION, V108, P1299, DOI 10.1161/01.CIR.0000091253.71282.04; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	20	315	334	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					65	74		10.1086/422366			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	WOS:000222031300008	15154115	Bronze, Green Published			2022-01-24	
J	Smith, FJD; Eady, RAJ; Leigh, IM; McMillan, JR; Rugg, EL; Kelsell, DP; Bryant, SP; Spurr, NK; Geddes, JF; Kirtschig, G; Milana, G; deBono, AG; Owaribe, K; Wiche, G; Pulkkinen, L; Uitto, J; McLean, WHI; Lane, EB				Smith, FJD; Eady, RAJ; Leigh, IM; McMillan, JR; Rugg, EL; Kelsell, DP; Bryant, SP; Spurr, NK; Geddes, JF; Kirtschig, G; Milana, G; deBono, AG; Owaribe, K; Wiche, G; Pulkkinen, L; Uitto, J; McLean, WHI; Lane, EB			Plectin deficiency results in muscular dystrophy with epidermolysis bullosa	NATURE GENETICS			English	Article							MONOCLONAL-ANTIBODY; RAT PLECTIN; SIMPLEX; GENE; IDENTIFICATION; HEMIDESMOSOMES; DISEASES; LINKAGE; PANEL; IMMUNOLOCALIZATION	We report that mutation in the gene for plectin, a cytoskeleton-membrane anchorage protein, is a cause of autosomal recessive muscular dystrophy associated with skin blistering (epidermolysis bullosa simplex). The evidence comes from absence of plectin by antibody staining in affected individuals from four families, supportive genetic analysis (localization of the human plectin gene to chromosome 8q24.13-qter and evidence for disease segregation with markers in this region) and finally the identification of a homozygous frameshift mutation detected in plectin cDNA. Absence of the large multifunctional cytoskeleton protein plectin can simultaneously account for structural failure in both muscle and skin.	UNIV DUNDEE, DEPT ANAT & PHYSIOL, CANC RES CAMPAIGN, CRC CELL STRUCT RES GRP, DUNDEE DD1 4HN, SCOTLAND; UNITED MED & DENT SCH, ST THOMAS HOSP, ST JOHNS INST DERMATOL, LONDON SE1 7EH, ENGLAND; UNIV LONDON QUEEN MARY & WESTFIELD COLL, ROYAL LONDON SCH MED, ACAD DEPT DERMATOL, LONDON E1 2BL, ENGLAND; UNIV LONDON QUEEN MARY & WESTFIELD COLL, ROYAL LONDON SCH MED, DEPT MORBID ANAT, LONDON E1 2BL, ENGLAND; IMPERIAL CANC RES FUND, CLARE HALL LABS, POTTERS BAR EN6 3LD, HERTS, ENGLAND; UNIV MARBURG, DERMATOL CLIN, D-35037 MARBURG, GERMANY; CITTA UNIV CATANIA, MOL BIOL LAB, PEDIAT CLIN, I-95100 CATANIA, ITALY; ST LUKES HOSP, GUARDAMANGIA, MALTA; NAGOYA UNIV, GRAD SCH HUMAN INFORMAT, NAGOYA, AICHI 46401, JAPAN; VIENNA BIOCTR, INST BIOCHEM & MOL CELL BIOL, A-1030 VIENNA, AUSTRIA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT DERMATOL & CUTANEOUS BIOL, PHILADELPHIA, PA 19107 USA; KUOPIO UNIV HOSP, DIV MED GENET, SF-70210 KUOPIO, FINLAND				Kelsell, David P/F-8767-2011; McLean, William HI/C-6352-2009; McMillan, James R/C-6657-2009; WICHE, Gerhard/AAA-3227-2021	McLean, William Henry Irwin/0000-0001-5539-5757; Kelsell, David/0000-0002-9910-7144; Wiche, Gerhard/0000-0001-9550-5463	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01-AR38923] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Christiano A M, 1996, Exp Dermatol, V5, P1, DOI 10.1111/j.1600-0625.1996.tb00086.x; COOPER DN, 1993, ANN MED, V25, P11, DOI 10.3109/07853899309147851; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; DORIGUZZI C, 1993, EUR NEUROL, V33, P454, DOI 10.1159/000116993; Eady R. A. J., 1985, METHODS SKIN RES, P1; EADY RAJ, 1994, ARCH DERMATOL RES, V287, P2, DOI 10.1007/BF00370710; FINE JD, 1989, ARCH DERMATOL, V125, P931, DOI 10.1001/archderm.125.7.931; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1989, ARCH DERMATOL, V125, P520, DOI 10.1001/archderm.125.4.520; Foisner R, 1995, J STRUCT BIOL, V115, P304, DOI 10.1006/jsbi.1995.1055; FOISNER R, 1994, ACTA HISTOCHEM, V96, P421, DOI 10.1016/S0065-1281(11)80029-2; Gache Y, 1996, J CLIN INVEST, V97, P2289, DOI 10.1172/JCI118671; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; ISHIDAYAMAMOTO A, 1991, J INVEST DERMATOL, V97, P959, DOI 10.1111/1523-1747.ep12491885; Jones JCR, 1991, CURR OPIN CELL BIOL, V3, P127, DOI 10.1016/0955-0674(91)90175-X; JONES SAV, 1995, J CUTAN PATHOL, V22, P365, DOI 10.1111/j.1600-0560.1995.tb01421.x; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KELSELL DP, 1995, ANN HUM GENET, V59, P233, DOI 10.1111/j.1469-1809.1995.tb00743.x; KENNEDY AR, 1985, BRIT J DERMATOL, V113, P651, DOI 10.1111/j.1365-2133.1985.tb02400.x; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; KURPAKUS MA, 1991, EXP CELL RES, V194, P139, DOI 10.1016/0014-4827(91)90143-I; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LEGAN PK, 1992, BIOESSAYS, V14, P385, DOI 10.1002/bies.950140608; LEIGH IM, 1993, ARCH DERMATOL, V129, P1571, DOI 10.1001/archderm.129.12.1571; Liu CG, 1996, P NATL ACAD SCI USA, V93, P4278, DOI 10.1073/pnas.93.9.4278; MATSUI C, 1995, J INVEST DERMATOL, V105, P648, DOI 10.1111/1523-1747.ep12324108; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, IN PRESS GENES DEV; McMillan JR, 1996, ARCH DERMATOL RES, V288, P91, DOI 10.1007/s004030050029; NIEMI KM, 1988, ARCH DERMATOL, V124, P551, DOI 10.1001/archderm.124.4.551; OLAISEN B, 1973, HUM HERED, V23, P189, DOI 10.1159/000152573; PARRISH JE, 1994, SOMAT CELL MOLEC GEN, V20, P143, DOI 10.1007/BF02290684; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; SHIMIZU H, 1989, ARCH DERMATOL RES, V281, P443, DOI 10.1007/BF00510078; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; Stevens M.A, 1996, THEORY PRACTICE HIST; TANAKA T, 1990, J INVEST DERMATOL, V94, P617, DOI 10.1111/1523-1747.ep12876200; VERRANDO P, 1991, LAB INVEST, V64, P85; WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83; WICHE G, 1989, CRIT REV BIOCHEM MOL, V24, P41, DOI 10.3109/10409238909082551; WICHE G, 1983, J CELL BIOL, V97, P887, DOI 10.1083/jcb.97.3.887; WICHE G, 1984, EXP CELL RES, V155, P43, DOI 10.1016/0014-4827(84)90766-3; WICHE G, 1993, J CELL BIOL, V121, P607, DOI 10.1083/jcb.121.3.607; WICHE G, 1989, BIOCHEM J, V259, P1	50	315	317	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1996	13	4					450	457		10.1038/ng0896-450			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	WOS:A1996VB62000026	8696340				2022-01-24	
J	REENAN, RAG; KOLODNER, RD				REENAN, RAG; KOLODNER, RD			CHARACTERIZATION OF INSERTION MUTATIONS IN THE SACCHAROMYCES-CEREVISIAE MSH1 AND MSH2 GENES - EVIDENCE FOR SEPARATE MITOCHONDRIAL AND NUCLEAR FUNCTIONS	GENETICS			English	Article							DOUBLE-STRAND BREAKS; MISMATCH REPAIR GENE; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; NUCLEOTIDE-SEQUENCE; SALMONELLA-TYPHIMURIUM; INITIATION SITE; MEIOTIC RECOMBINATION; DNA HELICASE; YEAST	The MSH1 and MSH2 genes of Saccharomyces cerevisiae are predicted to encode proteins that are homologous to the Escherichia coli MutS and Streptococcus pneumoniae HexA proteins and their homologs. Disruption of the MSH1 gene caused a petite phenotype which was established rapidly. A functional MSH1 gene present on a single-copy centromere plasmid was incapable of rescuing the established msh1 petite phenotype. Analysis of msh1 strains demonstrated that mutagenesis and large-scale rearrangement of mitochondrial DNA had occurred. 4',6-Diamidino-2-phenylindole (DAPI) staining of msh1 yeast revealed an aberrant distribution of mtDNA. Haploid msh2 mutants displayed an increase of 85-fold in the rate of spontaneous mutation to canavanine resistance. Sporulation of homozygous msh2/msh2 diploids gave rise to a high level of lethality which was compounded during increased vegetative growth prior to sporulation. msh2 mutations also affected gene conversion of two HIS4 alleles. The his4x mutation, lying near the 5' end of the gene, was converted with equal frequency in both wild-type and msh2 strains. However, many of the events in the msh2 background were post-meiotic segregation (PMS) events (46.4 %) while none (<0.25 %) of the aberrant segregations in wild type were PMS events. The his4b allele, lying 1.6 kb downstream of his4x, was converted at a 10-fold higher frequency in the msh2 background than in the corresponding wild-type strain. Like the his4x allele, his4b showed a high level of PMS (30%) in the msh2 background compared to the corresponding wild-type strain where no (<0.26%) PMS events were observed. These results indicate that MSH1 plays a role in repair or stability of mtDNA and MSH2 plays a role in repair of 4-bp insertion/deletion mispairs in the nucleus.	HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA		REENAN, RAG (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV CELLULAR & MOLEC BIOL, BOSTON, MA 02115 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000305] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00305] Funding Source: Medline		ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; BISHOP DK, 1987, NATURE, V328, P362, DOI 10.1038/328362a0; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; COX EC, 1976, ANNU REV GENET, V10, P135, DOI 10.1146/annurev.ge.10.120176.001031; DETLOFF P, 1992, GENETICS, V132, P113; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; FOGEL S, 1967, GENETICS, V57, P455; FOGEL S, 1981, MOL BIOL YEAST SACCH, V1, P289; FOURY F, 1987, EMBO J, V6, P1441, DOI 10.1002/j.1460-2075.1987.tb02385.x; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; FUJII H, 1989, J BIOL CHEM, V264, P10057; GASC AM, 1989, GENETICS, V121, P29; GLICKMAN B, 1978, MOL GEN GENET, V163, P307, DOI 10.1007/BF00271960; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; HABER LT, 1988, J BACTERIOL, V170, P197, DOI 10.1128/jb.170.1.197-202.1988; HASTINGS PJ, 1984, COLD SPRING HARB SYM, V49, P49, DOI 10.1101/SQB.1984.049.01.008; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HUISMAN O, 1987, GENETICS, V112, P409; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KRAMER B, 1989, MOL CELL BIOL, V9, P4432, DOI 10.1128/MCB.9.10.4432; KRAMER W, 1989, J BACTERIOL, V171, P5339, DOI 10.1128/jb.171.10.5339-5346.1989; LACKS S, 1970, J BACTERIOL, V101, P373, DOI 10.1128/JB.101.2.373-383.1970; LACKS SA, 1982, CELL, V31, P327, DOI 10.1016/0092-8674(82)90126-X; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LICHTEN M, 1990, P NATL ACAD SCI USA, V87, P7653, DOI 10.1073/pnas.87.19.7653; LINTON JP, 1989, MOL CELL BIOL, V9, P3058, DOI 10.1128/MCB.9.7.3058; MANNARELLI BM, 1985, P NATL ACAD SCI USA, V82, P4468, DOI 10.1073/pnas.82.13.4468; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P436; PETIT MA, 1991, GENETICS, V129, P327; PRIEBE SD, 1988, J BACTERIOL, V170, P190, DOI 10.1128/jb.170.1.190-196.1988; PRUDHOMME M, 1989, J BACTERIOL, V171, P5332, DOI 10.1128/jb.171.10.5332-5338.1989; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; REENAN RAG, 1992, GENETICS, V132, pR30; SCHULTES NP, 1990, GENETICS, V126, P813; SHERMAN F, 1986, LABORATORY COURSE MA; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SYMINGTON LS, 1983, CELL, V35, P805, DOI 10.1016/0092-8674(83)90113-7; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TIRABY G, 1973, GENETICS, V75, P35; TISHKOFF DX, 1991, MOL CELL BIOL, V11, P2593, DOI 10.1128/MCB.11.5.2593; WILLIAMSON MS, 1985, GENETICS, V110, P609; [No title captured]; [No title captured]	49	315	323	0	19	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	1992	132	4					975	985					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JZ832	WOS:A1992JZ83200011	1334021				2022-01-24	
J	KLITTICH, CJR; LESLIE, JF				KLITTICH, CJR; LESLIE, JF			NITRATE REDUCTION MUTANTS OF FUSARIUM-MONILIFORME (GIBBERELLA-FUJIKUROI)	GENETICS			English	Article									KANSAS STATE UNIV AGR & APPL SCI,DEPT PLANT PATHOL,MANHATTAN,KS 66506								ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Arst HN, 1985, GENE MANIPULATIONS F, P309; Burnett J. H., 1984, The applied mycology of Fusarium., P39; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1710; CORRELL JC, 1986, PHYTOPATHOLOGY, V76, P396, DOI 10.1094/Phyto-76-396; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; COVE DJ, 1976, HEREDITY, V36, P191, DOI 10.1038/hdy.1976.24; COVE DJ, 1976, MOL GEN GENET, V146, P147, DOI 10.1007/BF00268083; CULLIS CA, 1986, TRENDS GENET, V2, P307, DOI 10.1016/0168-9525(86)90285-4; ENGELS WR, 1983, ANNU REV GENET, V17, P315; Garrett R H, 1978, Adv Microb Physiol, V18, P1; GREEN MM, 1980, ANN REV GENET, V14, P102; HAEFNER K, 1967, Z ALLG MIKROBIOL, V7, P229, DOI 10.1002/jobm.3630070308; HSIEH WH, 1977, PHYTOPATHOLOGY, V67, P1041, DOI 10.1094/Phyto-67-1041; KATHARIOU S, 1982, GENETICS, V102, P19; KUHLMAN EG, 1982, MYCOLOGIA, V74, P759, DOI 10.2307/3792862; LESLIE JF, 1987, J GEN MICROBIOL, V133, P1279; LILLIS M, 1986, TRENDS GENET, V2, P183, DOI 10.1016/0168-9525(86)90221-0; Marasas W.F.O., 1984, TOXIGENIC FUSARIUM S; MARZLUF GA, 1981, MICROBIOL REV, V45, P437, DOI 10.1128/MMBR.45.3.437-461.1981; MARZLUF GA, 1985, MOL GENETICS FILAMEN, P83; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nelson PE, 1981, FUSARIUM DISEASES BI; PAQUIN CE, 1984, SCIENCE, V226, P53, DOI 10.1126/science.226.4670.53; PERRINE KG, 1986, CURR GENET, V10, P677, DOI 10.1007/BF00410916; PUHALLA JE, 1983, EXP MYCOL, V7, P328, DOI 10.1016/0147-5975(83)90017-8; PUHALLA JE, 1985, EXP MYCOL, V9, P39, DOI 10.1016/0147-5975(85)90045-3; PUHALLA JE, 1981, FUSARIUM DIS BIOL TA, P291; ROEDER GS, 1980, SCIENCE, V209, P1375, DOI 10.1126/science.6251544; SIDHU GS, 1986, CAN J BOT, V64, P117, DOI 10.1139/b86-019; TOMSETT AB, 1980, GENETICS, V95, P649; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; YODER OC, 1986, PHYTOPATHOLOGY, V76, P383, DOI 10.1094/Phyto-76-383	33	315	333	0	9	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAR	1988	118	3					417	423					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M4404	WOS:A1988M440400005	17246415				2022-01-24	
J	Trapnell, C				Trapnell, Cole			Defining cell types and states with single-cell genomics	GENOME RESEARCH			English	Article							MESSENGER-RNA-SEQ; TRANSCRIPTIONAL LANDSCAPE; CHROMATIN ACCESSIBILITY; HIGHLY PARALLEL; IN-VIVO; EXPRESSION; STEM; LINEAGE; PLURIPOTENT; DYNAMICS	A revolution in cellular measurement technology is under way: For the first time, we have the ability to monitor global gene regulation in thousands of individual cells in a single experiment. Such experiments will allow us to discover new cell types and states and trace their developmental origins. They overcome fundamental limitations inherent in measurements of bulk cell population that have frustrated efforts to resolve cellular states. Single-cell genomics and proteomics enable not only precise characterization of cell state, but also provide a stunningly high-resolution view of transitions between states. These measurements may finally make explicit the metaphor that C.H. Waddington posed nearly 60 years ago to explain cellular plasticity: Cells are residents of a vast "landscape" of possible states, over which they travel during development and in disease. Single-cell technology helps not only locate cells on this landscape, but illuminates the molecular mechanisms that shape the landscape itself. However, single-cell genomics is a field in its infancy, with many experimental and computational advances needed to fully realize its full potential.	Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA		Trapnell, C (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA.	coletrap@uw.edu	t, lf/AAJ-4924-2020		Damon Runyon Cancer Research Foundation; Alfred P. Sloan Foundation FellowshipAlfred P. Sloan Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD088158] Funding Source: NIH RePORTER	I am grateful to Jay Shendure and Vijay Ramani for a critical reading of the manuscript. I am supported by a Dale Frey Award for Breakthrough Scientists through the Damon Runyon Cancer Research Foundation as well as an Alfred P. Sloan Foundation Fellowship.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Boareto M, 2015, P NATL ACAD SCI USA, V112, pE402, DOI 10.1073/pnas.1416287112; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fu GK, 2014, P NATL ACAD SCI USA, V111, P1891, DOI 10.1073/pnas.1323732111; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kauffman SA., 1993, ORIGINS ORDER SELF O; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/nmeth.1448, 10.1038/NMETH.1448]; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Magwene PM, 2003, BIOINFORMATICS, V19, P842, DOI 10.1093/bioinformatics/btg081; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nakamura T, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv134; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Qiu P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001123; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/nmeth.1315, 10.1038/NMETH.1315]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Waddington CH, 1957, STRATEGY GENES DISCU, V1st; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364	73	314	317	4	50	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2015	25	10					1491	1498		10.1101/gr.190595.115			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CS5ZS	WOS:000362157400012	26430159	Green Published, Green Submitted, hybrid	Y	N	2022-01-24	
J	Kakiuchi, M; Nishizawa, T; Ueda, H; Gotoh, K; Tanaka, A; Hayashi, A; Yamamoto, S; Tatsuno, K; Katoh, H; Watanabe, Y; Ichimura, T; Ushiku, T; Funahashi, S; Tateishi, K; Wada, I; Shimizu, N; Nomura, S; Koike, K; Seto, Y; Fukayama, M; Aburatani, H; Ishikawa, S				Kakiuchi, Miwako; Nishizawa, Takashi; Ueda, Hiroki; Gotoh, Kengo; Tanaka, Atsushi; Hayashi, Akimasa; Yamamoto, Shogo; Tatsuno, Kenji; Katoh, Hiroto; Watanabe, Yoshiaki; Ichimura, Takashi; Ushiku, Tetsuo; Funahashi, Shinichi; Tateishi, Keisuke; Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Koike, Kazuhiko; Seto, Yasuyuki; Fukayama, Masashi; Aburatani, Hiroyuki; Ishikawa, Shumpei			Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma	NATURE GENETICS			English	Article							TNM CLASSIFICATION; 7TH EDITION; CANCER; GTPASES; EXPRESSION; ADHESION; PATHWAY; COHORT; RAS	Diffuse-type gastric carcinoma (DGC) is characterized by a highly malignant phenotype with prominent infiltration and stromal induction. We performed whole-exome sequencing on 30 DGC cases and found recurrent RHOA nonsynonymous mutations. With validation sequencing of an additional 57 cases, RHOA mutation was observed in 25.3% (22/87) of DGCs, with mutational hotspots affecting the Tyr42, Arg5 and Gly17 residues in RHOA protein. These positions are highly conserved among RHO family members, and Tyr42 and Arg5 are located outside the guanine nucleotide binding pocket. Several lines of functional evidence indicated that mutant RHOA works in a gain-of-function manner. Comparison of mutational profiles for the major gastric cancer subtypes showed that RHOA mutations occur specifically in DGCs, the majority of which were histopathologically characterized by the presence of poorly differentiated adenocarcinomas together with more differentiated components in the gastric mucosa. Our findings identify a potential therapeutic target for this poor-prognosis subtype of gastric cancer with no available molecularly targeted drugs.	[Kakiuchi, Miwako; Ueda, Hiroki; Gotoh, Kengo; Yamamoto, Shogo; Tatsuno, Kenji; Aburatani, Hiroyuki; Ishikawa, Shumpei] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Kakiuchi, Miwako; Tateishi, Keisuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Nishizawa, Takashi; Funahashi, Shinichi] Forerunner Pharma Res Co Ltd, Tokyo, Japan; [Tanaka, Atsushi; Hayashi, Akimasa; Ichimura, Takashi; Ushiku, Tetsuo; Fukayama, Masashi; Ishikawa, Shumpei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Yamamoto, Shogo; Tatsuno, Kenji; Aburatani, Hiroyuki] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo, Japan; [Katoh, Hiroto; Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Watanabe, Yoshiaki] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kamakura, Kanagawa, Japan; [Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan		Ishikawa, S (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan.	sish.gpat@mri.tmd.ac.jp	Tatsuno, Kenji/B-1765-2008; Tanaka, Atsushi/AAY-1154-2020	Kakiuchi, Miwako/0000-0002-6300-6771; Nomura, Sachiyo/0000-0003-4293-6205; Tanaka, Atsushi/0000-0003-1229-4539	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22134003]; JSPS (Japan Society for the Promotion of Science) KAKENHI grantMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24221011]; Health Labor Sciences Research Grant; grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan	We would like to thank K. Shiina, K. Sakuma, K. Nakano, A. Nishimoto and R. Sato for technical assistance. This study was supported by Grants-in-Aid for Scientific Research in Innovative Areas to the "Systems Cancer Project" (grant 22134003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.I.), by JSPS (Japan Society for the Promotion of Science) KAKENHI grant 24221011 (HA.), by a Health Labor Sciences Research Grant (HA.) and by a grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.Y., K. Tatsuno and HA.). The supercomputing resource was provided by the Human Genome Center (University of Tokyo).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bang Y, 2009, J CLIN ONCOL, V27; Borrmann R, 1926, VERDAUUNGSSCHLAUCH R, V4, P812, DOI DOI 10.1007/978-3-7091-5436-6_7; Carothers AM, 2006, EXP CELL RES, V312, P387, DOI 10.1016/j.yexcr.2005.11.019; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chiaravalli AM, 2012, WORLD J GASTROENTERO, V18, P896, DOI 10.3748/wjg.v18.i9.896; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hayashi T, 2013, CANCER-AM CANCER SOC, V119, P1330, DOI 10.1002/cncr.27928; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Kaneko S, 2001, BRIT J CANCER, V84, P400, DOI 10.1054/bjoc.2000.1602; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Kong X, 2012, J SURG ONCOL, V106, P346, DOI 10.1002/jso.23004; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Stiekema J, 2013, EJSO-EUR J SURG ONC, V39, P686, DOI 10.1016/j.ejso.2013.02.026; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	31	314	323	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					583	587		10.1038/ng.2984			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	WOS:000336870700014	24816255				2022-01-24	
J	Tian, C; Stokowski, RP; Kershenobich, D; Ballinger, DG; Hinds, DA				Tian, Chao; Stokowski, Renee P.; Kershenobich, David; Ballinger, Dennis G.; Hinds, David A.			Variant in PNPLA3 is associated with alcoholic liver disease	NATURE GENETICS			English	Article							ADIPONUTRIN; AMERICANS; CIRRHOSIS; RISK	Two genome-wide association studies (GWAS) have described associations of variants in PNPLA3 with nonalcoholic fatty liver and plasma liver enzyme levels. We investigated the contributions of these variants to liver disease in Mestizo subjects with a history of alcohol dependence. We found that rs738409 in PNPLA3 is strongly associated with alcoholic liver disease and clinically evident alcoholic cirrhosis (unadjusted OR = 2.25, P = 1.7 x 10(-10); ancestry-adjusted OR = 1.79, P = 1.9 x 10(-5)).	[Tian, Chao; Stokowski, Renee P.; Ballinger, Dennis G.; Hinds, David A.] Perlegen Sci, Mountain View, CA USA; [Kershenobich, David] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Ballinger, Dennis G.] Complete Genom, Mountain View, CA USA		Hinds, DA (corresponding author), Perlegen Sci, Mountain View, CA USA.	david_hinds@perlegen.com					Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Flores YN, 2008, AM J GASTROENTEROL, V103, P2231, DOI 10.1111/j.1572-0241.2008.02022.x; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hoyumpa A, 2005, HEPATOLOGY, V42, p442A; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kollerits B, 2010, J MED GENET, V47, P116, DOI 10.1136/jmg.2009.066597; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Yoon Y.-H., 2008, 83 NAT I ALC AB ALC; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	15	314	318	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					21	23		10.1038/ng.488			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	WOS:000273055100010	19946271	Bronze			2022-01-24	
J	Zhu, YL; Song, QJ; Hyten, DL; Van Tassell, CP; Matukumalli, LK; Grimm, DR; Hyatt, SM; Fickus, EW; Young, ND; Cregan, PB				Zhu, YL; Song, QJ; Hyten, DL; Van Tassell, CP; Matukumalli, LK; Grimm, DR; Hyatt, SM; Fickus, EW; Young, ND; Cregan, PB			Single-nucleotide polymorphisms in soybean	GENETICS			English	Article							MOLECULAR POPULATION-GENETICS; SEQUENCE REPEAT MARKERS; LINKAGE DISEQUILIBRIUM; DNA POLYMORPHISM; GLYCINE-MAX; LOCUS; GENES; DISCOVERY; PATTERNS; ALLELE	Single-nucleotide polymorphisms (SNPs) provide an abundant source of DNA polymorphisms in a number of eukaryotic species. Information on the frequency, nature, and distribution of SNPs in plant genomes is limited. Thus, our objectives were (1) to determine SNP frequency in coding and noncoding soybean (Glycine max L. Merr.) DNA sequence amplified from genomic DNA using PCR primers designed to complete genes, cDNAs, and random genomic sequence; (2) to characterize haplotype variation in these sequences; and (3) to provide initial estimates of linkage disequilibrium (LD) in soybean. Approximately 28.7 kbp of coding sequence, 37.9 kbp of noncoding perigenic DNA, and 9.7 kbp of random noncoding genomic DNA were sequenced in each of 25 diverse soybean genotypes. Over the >76 kbp, mean nucleotide diversity expressed as Watterson's theta was 0.00097. Nucleotide diversity was 0.00053 and 0.00111 in coding and in noncoding perigenic DNA, respectively, lower than estimates in the autogamous model species Arabidopsis thaliana. Haplotype analysis of SNP-containing fragments revealed a deficiency of haplotypes vs. the number that would be anticipated at linkage equilibrium. In 49 fragments with three or more SNPs, five haplotypes were present in one fragment while four or less were present in the remaining 48, thereby supporting the suggestion of relatively limited genetic variation in cultivated soybean. Squared allele-frequency correlations (r(2)) among haplotypes at 54 loci with two or more SNPs indicated low genome-wide LD. The low level of LD and the limited haplotype diversity suggested that the genome of any given soybean accession is a mosaic of three or four haplotypes. To facilitate SNP discovery and the development of a transcript map, subsets of four to six diverse genotypes, whose sequence analysis would permit the discovery of at least 75% of all SNPs present in the 25 genotypes as well as 90% of the common (frequency >0.10) SNPs, were identified.	USDA ARS, BARC W, Soybean Genomics & Improvement Lab, Beltsville, MD 20705 USA; George Mason Univ, SCS, Fairfax, VA 22030 USA; Nanjing Agr Univ, Dept Agron, Nanjing 210095, Peoples R China; Nanchang Univ, Dept Biosci & Biotechnol, Nanchang 330047, Peoples R China; Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; USDA ARS, Anim Improvement Programs Lab, Beltsville, MD 20705 USA; USDA ARS, Gene Evaluat & Mapping Lab, Beltsville, MD 20705 USA		Cregan, PB (corresponding author), USDA ARS, BARC W, Soybean Genomics & Improvement Lab, Bldg 006,Rm 100, Beltsville, MD 20705 USA.	creganp@ba.ars.usda.gov	Van Tassell, Curtis P./A-7544-2009; Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087; Hyten, David/0000-0001-6324-9389; Young, Nevin/0000-0001-6463-4772			Aguade M, 2001, MOL BIOL EVOL, V18, P1, DOI 10.1093/oxfordjournals.molbev.a003714; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; *COMM GEN VULN MAJ, 1972, GEN VULN MAJ CROPS; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Coryell VH, 1999, THEOR APPL GENET, V98, P690, DOI 10.1007/s001220051122; Cregan PB, 1999, THEOR APPL GENET, V99, P811, DOI 10.1007/s001220051300; Cregan PB, 1999, THEOR APPL GENET, V98, P919, DOI 10.1007/s001220051151; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; DELANNAY X, 1983, CROP SCI, V23, P944, DOI 10.2135/cropsci1983.0011183X002300050031x; GIZLICE Z, 1994, CROP SCI, V34, P1143, DOI 10.2135/cropsci1994.0011183X003400050001x; GRIBBONS JD, 1976, NONPARAMETRIC METHOD, P56; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HANFSTINGL U, 1994, GENETICS, V138, P811; HYMOWITZ T, 1990, ADVANCES IN NEW CROPS, P159; Jin L., 1995, American Journal of Human Genetics, V57, pA26; Kawabe A, 1999, GENETICS, V153, P1445; Kawabe A, 2000, GENETICS, V156, P1339; Keim P., 1988, Soybean Genetics Newsletter, V15, P150; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kuittinen H, 2000, GENETICS, V155, P863; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nordborg M, 1996, P ROY SOC B-BIOL SCI, V263, P1033, DOI 10.1098/rspb.1996.0152; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Olsen KM, 2002, GENETICS, V160, P1641; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; POLLAK E, 1987, GENETICS, V117, P353; Purugganan MD, 1999, GENETICS, V151, P839; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SCALLON BJ, 1987, MOL GEN GENET, V208, P107, DOI 10.1007/BF00330430; Shoemaker RC, 1996, GENETICS, V144, P329; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stone RT, 2002, MAMM GENOME, V13, P211, DOI 10.1007/s00335-001-2124-9; Taillon-Miller P, 1999, GENOME RES, V9, P499; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir B. S, 1990, GENETIC DATA ANAL ME; Weir BS, 1996, GENETIC DATA ANAL; XUE ZT, 1992, PLANT MOL BIOL, V18, P897, DOI 10.1007/BF00019204; ZAKHAROVA ES, 1989, THEOR APPL GENET, V78, P852, DOI 10.1007/BF00266670; ZHU T, 1995, THEOR APPL GENET, V90, P991, DOI 10.1007/BF00222912	51	314	390	0	46	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAR	2003	163	3					1123	1134					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	664DR	WOS:000182046900024	12663549				2022-01-24	
J	Gebbia, M; Ferrero, GB; Pilia, G; Bassi, MT; Aylsworth, AS; PenmanSplitt, M; Bird, LM; Bamforth, JS; Burn, J; Schlessinger, D; Nelson, DL; Casey, B				Gebbia, M; Ferrero, GB; Pilia, G; Bassi, MT; Aylsworth, AS; PenmanSplitt, M; Bird, LM; Bamforth, JS; Burn, J; Schlessinger, D; Nelson, DL; Casey, B			X-linked situs abnormalities result from mutations in ZIC3	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; GENE FAMILY; LATERALITY; DEFECTS; EMBRYOS; XENOPUS; MEMBER; DNA	Vertebrates position unpaired organs of the chest and abdomen asymmetrically along the left-right (LR) body axis. Each structure comes to lie non-randomly with respect to the midline in an overall position designated sites solitus, exemplified in humans by placement of the heart, stomach and spleen consistently to the left. Aberrant LR axis development can lead to randomization of individual organ position (sites ambiguus) or to mirror-image reversal of all lateralized structures (sites inversus)(1). Previously we mapped a locus for sites abnormalities in humans, HTX1, to Xq26.2 by linkage analysis in a single family (LR1) and by detection of a deletion in an unrelated sites ambiguus male (Family LR2; refs 2,3). From this chromosomal region we have positionally cloned ZIC3, a gene encoding a putative zinc-finger transcription factor. One frameshift, two missense and two nonsense mutations have been identified in familial and sporadic sites ambiguus. The frameshift allele is also associated with sites inverses among some heterozygous females, suggesting that ZIC3 functions in the earliest stages of LR-axis formation. ZIC3, which has not been previously implicated in vertebrate LR-axis development, is the first gene unequivocally associated with human sites abnormalities.	BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; WASHINGTON UNIV, DEPT MOL MICROBIOL, ST LOUIS, MO 63130 USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CTR NEUROSCI, CHAPEL HILL, NC 27599 USA; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; CHILDRENS HOSP & HLTH CTR, SAN DIEGO, CA 92123 USA; UNIV ALBERTA HOSP, DEPT MED GENET, EDMONTON, AB T6G 2B7, CANADA				Bassi, Maria Teresa T/A-3517-2014; Ferrero, Giovanni Battista/K-5265-2018; Bird, Lynne/AAG-9533-2021	Bassi, Maria Teresa T/0000-0002-8236-1197; Ferrero, Giovanni Battista/0000-0002-3793-5788; Bird, Lynne/0000-0003-4833-3747	NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [HG00201] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K08 HD01078, P30 HD24064] Funding Source: Medline; TelethonFondazione Telethon [E.0110, TGM06S01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD001078] Funding Source: NIH RePORTER		Aruga J, 1996, GENE, V172, P291, DOI 10.1016/0378-1119(96)00111-4; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Casey B, 1996, AM J MED GENET, V61, P325, DOI 10.1002/(SICI)1096-8628(19960202)61:4<325::AID-AJMG5>3.0.CO;2-T; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; CIMBORA DM, 1995, DEV BIOL, V169, P580, DOI 10.1006/dbio.1995.1171; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Danos MC, 1996, DEV BIOL, V177, P96, DOI 10.1006/dbio.1996.0148; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gebbia M, 1996, CIRCULATION, V94, P1909, DOI 10.1161/01.CIR.94.8.1909; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; KOSAKI K, IN PRESS SEMIN CELL; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Larsen WJ, 1993, HUMAN EMBRYOLOGY; Levin M, 1997, BIOESSAYS, V19, P287, DOI 10.1002/bies.950190406; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lohr JL, 1997, DEVELOPMENT, V124, P1465; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pilia G, 1996, GENOMICS, V34, P55, DOI 10.1006/geno.1996.0240; Splitt MP, 1997, HEART, V77, P369, DOI 10.1136/hrt.77.4.369; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155	28	314	322	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1997	17	3					305	308		10.1038/ng1197-305			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	WOS:A1997YD66700024	9354794				2022-01-24	
J	Lussier, M; White, AM; Sheraton, J; diPaolo, T; Treadwell, J; Southard, SB; Horenstein, CI; ChenWeiner, J; Ram, AFJ; Kapteyn, JC; Roemer, TW; Vo, DH; Bondoc, DC; Hall, J; Zhong, WW; Sdicu, AM; Davies, J; Klis, FM; Robbins, PW; Bussey, H				Lussier, M; White, AM; Sheraton, J; diPaolo, T; Treadwell, J; Southard, SB; Horenstein, CI; ChenWeiner, J; Ram, AFJ; Kapteyn, JC; Roemer, TW; Vo, DH; Bondoc, DC; Hall, J; Zhong, WW; Sdicu, AM; Davies, J; Klis, FM; Robbins, PW; Bussey, H			Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae	GENETICS			English	Article							BUD-SITE SELECTION; PROTEIN O-GLYCOSYLATION; INTACT YEAST-CELLS; CALCOFLUOR WHITE; GLYCOPROTEIN-BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; WALL; PATHWAY; MUTANTS; EXPRESSION	The sequenced yeast genome offers a unique resource for the analysis of eukaryotic cell function and enables genome wide screens for genes involved in cellular processes. We have identified genes involved in cell surface assembly by screening transposon-mutagenized cells for altered sensitivity to calcofluor white, followed by supplementary screens to further characterize mutant phenotypes. The mutated genes were directly retrieved from genomic DNA and then matched uniquely to a gene in the yeast genome database. Eighty-two genes with apparent perturbation of the cell surface were identified, with mutations in 65 of them displaying at least one further cell surface phenotype in addition to their modified sensitivity to calcofluor. Fifty of these genes were previously known, 17 encoded proteins whose function could be anticipated through sequence homology or previously recognized phenotypes and 15 genes had no previously known phenotype.	MCGILL UNIV, DEPT BIOL, MONTREAL, PQ H3A 1B1, CANADA; MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA; BIOCTR, INST MOL CELL BIOL, NL-1098 SM AMSTERDAM, NETHERLANDS; YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06520 USA; UNIV BRITISH COLUMBIA, DEPT MICROBIOL & IMMUNOL, VANCOUVER, BC, CANADA				Klis, Frans M/B-9085-2008; Ram, Arthur FJ/S-4648-2017	Klis, Frans M/0000-0003-0079-9492; Ram, Arthur FJ/0000-0002-2487-8016; Robbins, Phillips/0000-0002-5121-1524	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [45188, 31318] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAGULEY BC, 1979, EUR J BIOCHEM, V97, P345, DOI 10.1111/j.1432-1033.1979.tb13120.x; BALLOU L, 1991, P NATL ACAD SCI USA, V88, P3209, DOI 10.1073/pnas.88.8.3209; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; BROWN JL, 1994, MOL GENETICS YEAST P, P217; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; Burda P, 1996, P NATL ACAD SCI USA, V93, P7160, DOI 10.1073/pnas.93.14.7160; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; BUSSEY H, 1991, MOL MICROBIOL, V5, P2339, DOI 10.1111/j.1365-2958.1991.tb02079.x; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Chun KT, 1996, GENETICS, V142, P39; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; CONIBEAR E, 1995, CELL, V83, P513, DOI 10.1016/0092-8674(95)90088-8; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; DANG VD, 1994, YEAST, V10, P1273, DOI 10.1002/yea.320101004; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; DEMORA JF, 1993, FEMS MICROBIOL LETT, V111, P43, DOI 10.1111/j.1574-6968.1993.tb06359.x; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; DONNINI C, 1992, YEAST, V8, P83, DOI 10.1002/yea.320080203; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; ENNIS DG, 1993, J BACTERIOL, V175, P7373, DOI 10.1128/JB.175.22.7373-7382.1993; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; ESTRUCH F, 1990, NUCLEIC ACIDS RES, V18, P6959, DOI 10.1093/nar/18.23.6959; EVANS IH, 1980, BIOCHIM BIOPHYS ACTA, V602, P201, DOI 10.1016/0005-2736(80)90302-8; Fleet GH, 1991, YEASTS, V4, P199; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; HAUSLER A, 1992, GLYCOBIOLOGY, V2, P77, DOI 10.1093/glycob/2.1.77; HAUSLER A, 1992, P NATL ACAD SCI USA, V89, P6846, DOI 10.1073/pnas.89.15.6846; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HILL K, 1992, GENETICS, V130, P273; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; JIANG B, 1995, MOL GEN GENET, V248, P260, DOI 10.1007/BF02191592; JOHZUKA K, 1995, GENETICS, V139, P1521; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; KOPECKA M, 1984, FOLIA MICROBIOL, V29, P441, DOI 10.1007/BF02873157; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; LEHLE L, 1995, GLYCOPROTEINS, P1; Lussier M, 1997, YEAST, V13, P267, DOI 10.1002/(SICI)1097-0061(19970315)13:3<267::AID-YEA72>3.3.CO;2-B; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; LUSSIER M, 1995, J BIOL CHEM, V270, P2770, DOI 10.1074/jbc.270.6.2770; LUSSIER M, 1995, J CELL BIOL, V131, P913, DOI 10.1083/jcb.131.4.913; MADDEN K, 1992, TRENDS CELL BIOL, V2, P21; MARSHALLCARLSON L, 1991, GENETICS, V128, P505; MATSUURA A, 1993, MOL GEN GENET, V238, P6, DOI 10.1007/BF00279524; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Mosch HU, 1997, GENETICS, V145, P671; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; MURGUI A, 1985, BIOCHIM BIOPHYS ACTA, V841, P215, DOI 10.1016/0304-4165(85)90024-8; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.0.CO;2-L; OLIVER S, 1994, NATURE, V368, P14, DOI 10.1038/368014a0; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896, DOI 10.1128/MCB.12.11.4896; PARSONS WJ, 1988, MOL PHARMACOL, V34, P37; POSAS F, 1993, FEBS LETT, V318, P282, DOI 10.1016/0014-5793(93)80529-4; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; RAM AFJ, 1995, FEBS LETT, V358, P165, DOI 10.1016/0014-5793(94)01418-Z; ROEMER T, 1994, J CELL BIOL, V127, P567, DOI 10.1083/jcb.127.2.567; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; RUZAL SM, 1994, MICROBIOL-SGM, V140, P2173, DOI 10.1099/13500872-140-8-2173; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SIMON JR, 1993, METHOD ENZYMOL, V217, P478; SONI R, 1993, CURR GENET, V24, P455, DOI 10.1007/BF00351857; TZAGOLOFF A, 1993, BIOCHEM MOL BIOL INT, V31, P593; VAMBUTAS A, 1991, EUR J BIOCHEM, V201, P643, DOI 10.1111/j.1432-1033.1991.tb16325.x; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VOORNBROUWER T, 1993, BIOCHIM BIOPHYS ACTA, V1216, P325, DOI 10.1016/0167-4781(93)90166-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WILKIE D, 1983, INT REV CYTOL, P157; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	81	314	345	0	7	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	1997	147	2					435	450					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY919	WOS:A1997XY91900008	9335584				2022-01-24	
J	DORMAN, JB; ALBINDER, B; SHROYER, T; KENYON, C				DORMAN, JB; ALBINDER, B; SHROYER, T; KENYON, C			THE AGE-1 AND DAF-2 GENES FUNCTION IN A COMMON PATHWAY TO CONTROL THE LIFE-SPAN OF CAENORHABDITIS-ELEGANS	GENETICS			English	Article							DAUER FORMATION; MUTANTS	Recessive mutations in two genes, daf-2 and age-1, extend the lifespan of Caenorhabditis elegans significantly. The daf-2 gene also regulates formation of an alternative developmental state called the dauer. Here we asked whether these two genes function in the same or different lifespan pathways. We found that the longevity of both age-1 and daf-2 mutants requires the activities of the same two genes, daf-16 and daf-18. In addition, the daf-2(e1370); age-1(hx546) double mutant did not live significantly longer than the daf-2 single mutant. We also found that, like daf-2 mutations, the age-1(hx546) mutation affects certain aspects of dauer formation. These findings suggest that age-1 and daf-2 mutations do act in the same lifespan pathway and extend lifespan by triggering similar if not identical processes.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143						NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG011816] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG11816-01] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM07810] Funding Source: Medline		BRENNER S, 1974, GENETICS, V77, P71; Finch C.E., 1990, LONGEVITY SENESCENCE; FRIEDMAN DB, 1988, GENETICS, V118, P75; GOTTLIEB S, 1994, GENETICS, V137, P107; HORVITZ HR, 1988, NEMATODE CAENORHABDI, P157; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; LARSEN PL, 1995, GENETICS, V139, P1567; RIDDLE D.L., 1988, NEMATODE CAENORHABDI, P393; RIDDLE DL, 1981, NATURE, V290, P268; Sulston J., 1988, NEMATODE CAENORHABDI, P587; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1992, GENETICS, V130, P105; WARD S, 1981, J CELL BIOL, V81, P26; Woolson R. F, 1987, STATISTICAL METHODS	16	314	331	2	26	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	DEC	1995	141	4					1399	1406					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH419	WOS:A1995TH41900015	8601482				2022-01-24	
J	GARDNER, EJ				GARDNER, EJ			FOLLOW-UP STUDY OF A FAMILY GROUP EXHIBITING DOMINANT INHERITANCE FOR A SYNDROME INCLUDING INTESTINAL POLYPS, OSTEOMAS, FIBROMAS AND EPIDERMAL CYSTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																	CURTH HO, 1955, ARCH DERMATOL, V71, P95, DOI 10.1001/archderm.1955.01540250097018; DEVIC, 1912, ARCH MAL APPAR DIG, V6, P278; DUKES C E, 1958, Dis Colon Rectum, V1, P413; DUKES CE, 1952, ANN EUGENIC, V17, P1; DUKES CUTHBERT, 1930, CANCER REV, V5, P241; FADER M, 1962, Oral Surg Oral Med Oral Pathol, V15, P153, DOI 10.1016/0030-4220(62)90004-X; FITZGERALD GM, 1943, J AM DENT ASSOC, V30, P1408; GARDNER EJ, 1952, CANCER, V5, P695, DOI 10.1002/1097-0142(195207)5:4<695::AID-CNCR2820050407>3.0.CO;2-5; GARDNER EJ, 1953, AM J HUM GENET, V5, P139; GARDNER EJ, 1950, AM J HUM GENET, V2, P41; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GARDNER EJ, 1952, AM J HUM GENET, V4, P31; GARDNER EJ, 1955, NOVANT ANNI LEGGI ME, P321; Gottesman J, 1930, AM J MED SCI, V179, P370; GUMPEL RC, 1956, ANN INTERN MED, V45, P1045, DOI 10.7326/0003-4819-45-6-1045; HELWIG EB, 1947, SURG GYNECOL OBSTET, V84, P36; JEGHERS H, 1949, NEW ENGL J MED, V241, P1031, DOI 10.1056/NEJM194912292412601; JEGHERS H, 1949, NEW ENGL J MED, V241, P993, DOI 10.1056/NEJM194912222412501; JOHNSON LC, 1953, B NEW YORK ACAD MED, V29, P164; LABERGE MY, 1958, P MAYO CLINIC, V32, P749; LAZAR HP, 1957, ARCH INTERN MED, V100, P290, DOI 10.1001/archinte.1957.00260080116023; LEUCHTENBERGER C, 1954, LAB INVEST, V3, P132; LOCKHARTMUMMERY JP, 1934, DISEASES RECTUM COLO; MCKITTRICK LS, 1935, NEW ENGL J MED, V212, P263; Miller RH, 1937, ANN SURG, V105, P511; O'BRIEN J P, 1955, N Y State J Med, V55, P1877; OLDFIELD MC, 1954, BRIT J SURG, V41, P534, DOI 10.1002/bjs.18004116917; PLENK HP, 1954, RADIOLOGY, V62, P830, DOI 10.1148/62.6.830; REED TE, 1955, AM J HUM GENET, V7, P236; SMITH W G, 1958, Dis Colon Rectum, V1, P323, DOI 10.1007/BF02616659; THOMA KH, 1936, INT J ORTHOD ORAL, V22, P1177; WEINER RS, 1955, NEW ENGL J MED, V253, P795, DOI 10.1056/NEJM195511102531901; WOOLF CM, 1955, CANCER, V8, P403, DOI 10.1002/1097-0142(1955)8:2<403::AID-CNCR2820080220>3.0.CO;2-E	33	314	315	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1962	14	4					376	+					1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2965A	WOS:A19622965A00001	13946545				2022-01-24	
J	TAYLOR, JH				TAYLOR, JH			SISTER CHROMATID EXCHANGES IN TRITIUM-LABELED CHROMOSOMES	GENETICS			English	Article																	Brumfield RT, 1943, P NATL ACAD SCI USA, V29, P190, DOI 10.1073/pnas.29.6.190; CROUSE HV, 1954, SCIENCE, V119, P485, DOI 10.1126/science.119.3094.485; LACOUR LF, 1954, CHROMOSOMA, V6, P696, DOI 10.1007/BF01259956; Nebel BR, 1936, GENETICS, V21, P605; OSTERGREN H, 1954, BOT NOTISER, V4, P357; SWANSON CP, 1947, P NATL ACAD SCI USA, V33, P229, DOI 10.1073/pnas.33.8.229; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TAYLOR JH, 1957, AM NAT, V91, P209, DOI 10.1086/281980; TAYLOR JH, 1956, PHYS TECH, V3, P545; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	10	314	316	0	6	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731			GENETICS	Genetics		1958	43	4					515	529					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WU180	WOS:A1958WU18000009	17247775				2022-01-24	
J	Lai, JS; Li, RQ; Xu, X; Jin, WW; Xu, ML; Zhao, HN; Xiang, ZK; Song, WB; Ying, K; Zhang, M; Jiao, YP; Ni, PX; Zhang, JG; Li, D; Guo, XS; Ye, KX; Jian, M; Wang, B; Zheng, HS; Liang, HQ; Zhang, XQ; Wang, SC; Chen, SJ; Li, JS; Fu, Y; Springer, NM; Yang, HM; Wang, JA; Dai, JR; Schnable, PS; Wang, J				Lai, Jinsheng; Li, Ruiqiang; Xu, Xun; Jin, Weiwei; Xu, Mingliang; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Ying, Kai; Zhang, Mei; Jiao, Yinping; Ni, Peixiang; Zhang, Jianguo; Li, Dong; Guo, Xiaosen; Ye, Kaixiong; Jian, Min; Wang, Bo; Zheng, Huisong; Liang, Huiqing; Zhang, Xiuqing; Wang, Shoucai; Chen, Shaojiang; Li, Jiansheng; Fu, Yan; Springer, Nathan M.; Yang, Huanming; Wang, Jian; Dai, Jingrui; Schnable, Patrick S.; Wang, Jun			Genome-wide patterns of genetic variation among elite maize inbred lines	NATURE GENETICS			English	Article							SSP MAYS L.; DIVERSITY; SEQUENCE; ARABIDOPSIS; RECOMBINATION; POLYMORPHISMS; CHROMOSOME-1; SELECTION; WHOLE	We have resequenced a group of six elite maize inbred lines, including the parents of the most productive commercial hybrid in China. This effort uncovered more than 1,000,000 SNPs, 30,000 indel polymorphisms and 101 low-sequence-diversity chromosomal intervals in the maize genome. We also identified several hundred complete genes that show presence/absence variation among these resequenced lines. We discuss the potential roles of complementation of presence/absence variations and other deleterious mutations in contributing to heterosis. High-density SNP and indel polymorphism markers reported here are expected to be a valuable resource for future genetic studies and the molecular breeding of this important crop.	[Lai, Jinsheng; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Zhang, Mei; Jiao, Yinping] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lai, Jinsheng; Jin, Weiwei; Xu, Mingliang; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Zhang, Mei; Jiao, Yinping; Wang, Shoucai; Chen, Shaojiang; Li, Jiansheng; Dai, Jingrui] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Li, Ruiqiang; Xu, Xun; Ni, Peixiang; Zhang, Jianguo; Li, Dong; Guo, Xiaosen; Ye, Kaixiong; Jian, Min; Wang, Bo; Zheng, Huisong; Liang, Huiqing; Zhang, Xiuqing; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Ying, Kai; Fu, Yan; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark		Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	jlai@cau.edu.cn; schnable@iastate.edu; wangj@genomics.cn	Springer, Nathan/F-2680-2013; Ye, Kaixiong/C-2297-2017; Xu, Xun/AAI-6763-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Springer, Nathan/0000-0002-7301-4759; Ye, Kaixiong/0000-0003-4658-7292; Xu, Xun/0000-0002-5338-5173; Wang, Jun/0000-0002-2113-5874; Schnable, Patrick/0000-0001-9169-5204; Zhang, Jianguo/0000-0003-0723-1701; Wang, Jun/0000-0002-8540-8931	973 programNational Basic Research Program of China [2009CB118400, 2007CB815703, 2007CB815705, 2007CB109000]; 863 projectNational High Technology Research and Development Program of China [2010AA10A106]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30725008]; Shenzhen Bureau of Science Technology AMP; Information, China [ZYC200903240077A, CXB200903110066A]; Chinese Academy of ScienceChinese Academy of Sciences [GJHZ0701-6]; Danish Natural Science Research CouncilDanish Natural Science Research Council; US National Science FoundationNational Science Foundation (NSF) [DBI-0527192]	Supported by the 973 program (2009CB118400; 2007CB815703; 2007CB815705; 2007CB109000), the 863 project (2010AA10A106), the National Natural Science Foundation of China (30725008), the Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A), the Chinese Academy of Science (GJHZ0701-6), the Ole Romer grant from the Danish Natural Science Research Council and the US National Science Foundation (DBI-0527192). We thank L. Goodman for editing the manuscript.	Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Everitt B S, 1996, Stat Methods Med Res, V5, P107, DOI 10.1177/096228029600500202; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; TAJIMA F, 1983, GENETICS, V105, P437; Tenaillon MI, 2002, GENETICS, V162, P1401; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620	32	313	354	1	167	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1027	+		10.1038/ng.684			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	WOS:000283540500024	20972441				2022-01-24	
J	Desai, MM; Fisher, DS				Desai, Michael M.; Fisher, Daniel S.			Beneficial mutation-selection balance and the effect of linkage on positive selection	GENETICS			English	Article							CLONAL INTERFERENCE; DIMINISHING RETURNS; EVOLUTION; ADAPTATION; RECOMBINATION; LIMITS; SPEED; PROBABILITY	When beneficial mutations are rare, they accumulate by a series of selective sweeps. But when they are common, many beneficial mutations will occur before any can fix, so there will be many different mutant lineages in the population concurrently. In an asexual population, these different mutant lineages interfere and not all can fix simultaneously. In addition, further beneficial mutations can accumulate in mutant lineages while these are still a minority of the population. In this article, we analyze the dynamics of such multiple mutations and the interplay between multiple mutations and interference between clones. These result in substantial variation in fitness accumulating within a single asexual population. The amount of variation is determined by a balance between selection,which destroys variation, and beneficial mutations, which create more. The behavior depends in a subtle way on the population parameters: the population size, the beneficial mutation rate, and the distribution of the fitness increments of the potential beneficial mutations. The mutation-selection balance leads to a continually evolving population with a steady-state fitness variation. This variation increases logarithmically with both population size and mutation rate and sets the rate at which the population accumulates beneficial mutations, which thus also grows only logarithmically with population size and mutation rate. These results imply that mutator phenotypes are less effective in larger asexual populations. They also have consequences for the advantages (or disadvantages) of sex via the Fisher-Muller effect; these are discussed briefly	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA		Desai, MM (corresponding author), Princeton Univ, Carl Icahn Lab, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	mmdesai@princeton.edu	Fisher, Daniel S/A-4134-2011	Desai, Michael/0000-0002-9581-1150	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50-GM068763-01, P50 GM068763] Funding Source: Medline		Allen LJS, 2003, INTRO STOCHASTIC PRO; Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Barton NH, 2005, GENETICS, V169, P2353, DOI 10.1534/genetics.104.032821; BARTON NH, 1995, GENETICS, V140, P821; BODMER WF, 1970, PROKARYOTIC EUKARYOT, P279; Campos PRA, 2004, EVOLUTION, V58, P932; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Comeron JM, 1999, GENETICS, V151, P239; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher, 1930, GENETICAL THEORY NAT; Gerrish P, 2001, NATURE, V413, P299, DOI 10.1038/35095046; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie JH., 1998, POPULATION GENETICS; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Johnson T, 2002, GENETICA, V115, P283, DOI 10.1023/A:1020687416478; Johnson T, 2002, GENETICS, V162, P395; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Kessler DA, 1997, J STAT PHYS, V87, P519, DOI 10.1007/BF02181235; Kim Y, 2005, GENETICS, V171, P1377, DOI 10.1534/genetics.105.045252; Kim Y, 2003, GENETICS, V164, P389; LI WH, 1987, J MOL EVOL, V24, P337, DOI 10.1007/BF02134132; McVean GAT, 2000, GENETICS, V155, P929; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Orr HA, 2000, GENETICS, V155, P961; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Przeworski M, 1999, MOL BIOL EVOL, V16, P246, DOI 10.1093/oxfordjournals.molbev.a026106; Ridgway D, 1998, J STAT PHYS, V90, P191, DOI 10.1023/A:1023203818384; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P587, DOI 10.1073/pnas.242719299; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; Wahl LM, 2001, EVOLUTION, V55, P2606; Wilke CO, 2004, GENETICS, V167, P2045, DOI 10.1534/genetics.104.027136	38	313	315	1	35	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	2007	176	3					1759	1798		10.1534/genetics.106.067678			40	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195MM	WOS:000248416300031	17483432	Green Submitted, Bronze, Green Published			2022-01-24	
J	Birney, E; Andrews, TD; Bevan, P; Caccamo, M; Chen, Y; Clarke, L; Coates, G; Cuff, J; Curwen, V; Cutts, T; Down, T; Eyras, E; Fernandez-Suarez, XM; Gane, P; Gibbins, B; Gilbert, J; Hammond, M; Hotz, HR; Iyer, V; Jekosch, K; Kahari, A; Kasprzyk, A; Keefe, D; Keenan, S; Lehvaslaiho, H; McVicker, G; Melsopp, C; Meidl, P; Mongin, E; Pettett, R; Potter, S; Proctor, G; Rae, M; Searle, S; Slater, G; Smedley, D; Smith, J; Spooner, W; Stabenau, A; Stalker, J; Storey, R; Ureta-Vidal, A; Woodwark, KC; Cameron, G; Durbin, R; Cox, A; Hubbard, T; Clamp, M				Birney, E; Andrews, TD; Bevan, P; Caccamo, M; Chen, Y; Clarke, L; Coates, G; Cuff, J; Curwen, V; Cutts, T; Down, T; Eyras, E; Fernandez-Suarez, XM; Gane, P; Gibbins, B; Gilbert, J; Hammond, M; Hotz, HR; Iyer, V; Jekosch, K; Kahari, A; Kasprzyk, A; Keefe, D; Keenan, S; Lehvaslaiho, H; McVicker, G; Melsopp, C; Meidl, P; Mongin, E; Pettett, R; Potter, S; Proctor, G; Rae, M; Searle, S; Slater, G; Smedley, D; Smith, J; Spooner, W; Stabenau, A; Stalker, J; Storey, R; Ureta-Vidal, A; Woodwark, KC; Cameron, G; Durbin, R; Cox, A; Hubbard, T; Clamp, M			An overview of ensembl	GENOME RESEARCH			English	Article							ACCESS; GENOME; DATABASE	Ensembl (http://www.ensembl.org/) is a bioinformatics project to organize biological information around the sequences of large genomes. It is a comprehensive source of stable automatic annotation of individual genomes, and of the synteny and orthology relationships between them. It is also a framework for integration of any biological data that can be mapped onto features derived from the genomic sequence. Ensembl is available as an interactive Web site, a set of flat files, and as a complete, portable open Source software system for handling genomes. All data are provided without restriction, and code is freely available. Ensembl's aims are to continue to "widen" this biological integration to include other model organisms relevant to understanding human biology as they become available; to "deepen" this integration to provide an ever more seamless linkage between equivalent components in different species; and to provide further classification of functional elements in the genome that have been previously elusive.	EMBL European Bioinformat Inst, Cambridge CB10 1SA, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England		Birney, E (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	birney@ebi.ac.uk	Andrews, Dan/ABG-4815-2020; Hubbard, Tim J.P./AAT-4571-2020; Eduardo, Eyras/L-1053-2014; Durbin, Richard/AAE-7178-2019; Eyras, Eduardo/A-1560-2010; Eyras, Eduardo/ABG-7144-2020; Hubbard, Tim J/C-2567-2008; Smedley, Damian/AAL-8172-2021; Fernandez, Xose/ABA-7117-2020	Hubbard, Tim J.P./0000-0002-1767-9318; Eduardo, Eyras/0000-0003-0793-6218; Durbin, Richard/0000-0002-9130-1006; Eyras, Eduardo/0000-0003-0793-6218; Hubbard, Tim J/0000-0002-1767-9318; Fernandez, Xose/0000-0001-7139-6215; Clarke, Laura/0000-0002-5989-6898; Birney, Ewan/0000-0001-8314-8497; Kahari, Andreas/0000-0001-9945-5694; Coates, Guy/0000-0002-8055-4796; Storey, Roy/0000-0003-1375-7136; Keenan, Stephen/0000-0002-9141-7690; Gane, Paul/0000-0002-9153-5240; McVicker, Graham/0000-0003-0991-0951; Smith, James/0000-0002-0445-8305; Gilbert, James/0000-0001-8079-3159; Bevan, Paul/0000-0002-0656-9164; Andrews, Dan/0000-0003-3922-6376; Slater, Guy/0000-0002-4202-8285; Lehvaslaiho, Heikki/0000-0002-6263-1356; Howe, Kerstin/0000-0003-2237-513X	Wellcome TrustWellcome TrustEuropean Commission [062023] Funding Source: Medline		Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Mongin E, 2004, TRENDS PARASITOL, V20, P49, DOI 10.1016/j.pt.2003.11.003; MUNGALL C, 2002, GENOME BIOL, V3; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Stein LD, 1998, GENOME RES, V8, P1308, DOI 10.1101/gr.8.12.1308; Wain HM, 2004, NUCLEIC ACIDS RES, V32, pD255, DOI 10.1093/nar/gkh072; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073	10	313	325	0	4	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2004	14	5					925	928		10.1101/gr.1860604			4	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	817IR	WOS:000221171700017	15078858	Green Published, Bronze			2022-01-24	
J	Kasprzyk, A; Keefe, D; Smedley, D; London, D; Spooner, W; Melsopp, C; Hammond, M; Rocca-Serra, P; Cox, T; Birney, E				Kasprzyk, A; Keefe, D; Smedley, D; London, D; Spooner, W; Melsopp, C; Hammond, M; Rocca-Serra, P; Cox, T; Birney, E			EnsMart: A generic system for fast and flexible access to biological data	GENOME RESEARCH			English	Article							GENOME BROWSER; RETRIEVAL; DBSNP; SRS; TOOL	The EnsMart system (www.ensembl.org/EnsMart) provides a generic data warehousing solution for fast and flexible querying of large biological data sets and integration with third-party data and tools. The system consists of a query-optimized database and interactive, user-friendly interfaces. EnsMart has been applied to Ensembl, where it extends its genomic browser capabilities, facilitating rapid retrieval of customized data sets. A wide variety of complex queries, on various types of annotations, for numerous species are supported. These can be applied to many research problems, ranging from SNP selection for candidate gene screening, through cross-species evolutionary comparisons, to microarray annotation. Users can group and refine biological data according to many criteria, including cross-species analyses, disease links, sequence variations, and expression patterns. Both tabulated list data and biological sequence output can be generated dynamically, in HTML, text, Microsoft Excel, and compressed formats. A wide range of sequence types, such as cDNA, peptides, coding regions, UTRs, and exons, with additional upstream and downstream regions, can be retrieved. The EnsMart database can be accessed via a public Web site, or through a lava application suite. Both implementations and the database are freely available for local installation, and can be extended or adapted to 'non-Ensembl' data sets.	European Bioinformat Inst, Cambridge CB10 1SH, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SH, England		Kasprzyk, A (corresponding author), European Bioinformat Inst, Cambridge CB10 1SH, England.	arek@ebi.ac.uk	Smedley, Damian/AAL-8172-2021	Birney, Ewan/0000-0001-8314-8497			Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; DEVLIN B, 1997, DATA WAREHOUSE ARCHI, pCH2; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; ETZOLD T, 1993, COMPUT APPL BIOSCI, V9, P49; Etzold T, 1996, METHOD ENZYMOL, V266, P114; Giardine B, 2003, GENOME RES, V13, P732, DOI 10.1101/gr.603103; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMBALL R, 1998, DATA WAREHOUSE LIFEC, pCH5; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sherry ST, 1999, GENOME RES, V9, P677; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Tsai J, 2001, GENOME BIOL, V2; VILO J, 2003, ANAL GENE EXPRESSION, pCH5; Zdobnov EM, 2002, BIOINFORMATICS, V18, P1149, DOI 10.1093/bioinformatics/18.8.1149	23	313	326	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2004	14	1					160	169		10.1101/gr.1645104			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	761FD	WOS:000187889600019	14707178	Bronze, Green Published			2022-01-24	
J	Wang, XJ; Reyes, JL; Chua, NH; Gaasterland, T				Wang, XJ; Reyes, JL; Chua, NH; Gaasterland, T			Prediction and identification of Arabidopsis thaliana microRNAs and their mRNA targets	GENOME BIOLOGY			English	Article							COMPUTATIONAL IDENTIFICATION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PLANT MICRORNAS; PROTEIN; STRESS; TIME; HOMOLOG; REVEALS; COMPLEX	Background: A class of eukaryotic non-coding RNAs termed microRNAs ( miRNAs) interact with target mRNAs by sequence complementarity to regulate their expression. The low abundance of some miRNAs and their time- and tissue-specific expression patterns make experimental miRNA identification difficult. We present here a computational method for genome-wide prediction of Arabidopsis thaliana microRNAs and their target mRNAs. This method uses characteristic features of known plant miRNAs as criteria to search for miRNAs conserved between Arabidopsis and Oryza sativa. Extensive sequence complementarity between miRNAs and their target mRNAs is used to predict miRNA-regulated Arabidopsis transcripts. Results: Our prediction covered 63% of known Arabidopsis miRNAs and identified 83 new miRNAs. Evidence for the expression of 25 predicted miRNAs came from northern blots, their presence in the Arabidopsis Small RNA Project database, and massively parallel signature sequencing (MPSS) data. Putative targets functionally conserved between Arabidopsis and O. sativa were identified for most newly identified miRNAs. Independent microarray data showed that the expression levels of some mRNA targets anti-correlated with the accumulation pattern of their corresponding regulatory miRNAs. The cleavage of three target mRNAs by miRNA binding was validated in 5' RACE experiments. Conclusions: We identified new plant miRNAs conserved between Arabidopsis and O. sativa and report a wide range of transcripts as potential miRNA targets. Because MPSS data are generated from polyadenylated RNA molecules, our results suggest that at least some miRNA precursors are polyadenylated at certain stages. The broad range of putative miRNA targets indicates that miRNAs participate in the regulation of a variety of biological processes.	Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA		Gaasterland, T (corresponding author), Rockefeller Univ, Lab Computat Genom, 1230 York Ave, New York, NY 10021 USA.	gaasterland@rockefeller.edu	Reyes, Jose/D-7331-2013	Reyes, Jose L./0000-0001-5129-9741	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 44640, P50 GM062529, R01 GM044640, GM 62529, R56 GM044640] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM044640, R56GM044640, P50GM062529] Funding Source: NIH RePORTER		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Brenner S, 2000, P NATL ACAD SCI USA, V97, P1665, DOI 10.1073/pnas.97.4.1665; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Enright AJ, 2004, GENOME BIOL, V5; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hoth S, 2003, FEBS LETT, V554, P373, DOI 10.1016/S0014-5793(03)01194-3; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Mette MF, 2002, PLANT PHYSIOL, V130, P6, DOI 10.1104/pp.007047; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Smalheiser NR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-403; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; SEQUENCES; ANNOTATION DBS	53	313	378	2	38	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2004	5	9							R65	10.1186/gb-2004-5-9-r65			15	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	851AM	WOS:000223656100010	15345049	hybrid, Green Published			2022-01-24	
J	Sorrells, ME; La Rota, M; Bermudez-Kandianis, CE; Greene, RA; Kantety, R; Munkvold, JD; Miftahudin; Mahmoud, A; Ma, XF; Gustafson, PJ; Qi, LLL; Echalier, B; Gill, BS; Matthews, DE; Lazo, GR; Chao, SM; Anderson, OD; Edwards, H; Linkiewicz, AM; Dubcovsky, J; Akhunov, ED; Dvorak, J; Zhang, DS; Nguyen, HT; Peng, JH; Lapitan, NLV; Gonzalez-Hernandez, JL; Anderson, JA; Hossain, K; Kalavacharla, V; Kianian, SF; Choi, DW; Close, TJ; Dilbirligi, M; Gill, KS; Steber, C; Walker-Simmons, MK; McGuire, PE; Qualset, CO				Sorrells, ME; La Rota, M; Bermudez-Kandianis, CE; Greene, RA; Kantety, R; Munkvold, JD; Miftahudin; Mahmoud, A; Ma, XF; Gustafson, PJ; Qi, LLL; Echalier, B; Gill, BS; Matthews, DE; Lazo, GR; Chao, SM; Anderson, OD; Edwards, H; Linkiewicz, AM; Dubcovsky, J; Akhunov, ED; Dvorak, J; Zhang, DS; Nguyen, HT; Peng, JH; Lapitan, NLV; Gonzalez-Hernandez, JL; Anderson, JA; Hossain, K; Kalavacharla, V; Kianian, SF; Choi, DW; Close, TJ; Dilbirligi, M; Gill, KS; Steber, C; Walker-Simmons, MK; McGuire, PE; Qualset, CO			Comparative DNA sequence analysis of wheat and rice genomes	GENOME RESEARCH			English	Article							COMPARATIVE GENETICS; DRAFT SEQUENCE; MAIZE; COLINEARITY; MAP; CHROMOSOMES; GRASSES; REGIONS; SORGHUM; RECOMBINATION	The use of DNA sequence-based comparative genomics for evolutionary studies and for transferring information from model species to crop species has revolutionized molecular genetics and crop improvement strategies. This study compared 4485 expressed sequence tags (ESTs) that were physically mapped in wheat chromosome bins, to the public rice genome sequence data from 2251 ordered BAC/PAC clones using BLAST. A rice genome view of homologous wheat genome locations based on comparative sequence analysis revealed numerous chromosomal rearrangements that will significantly complicate the use of rice as a model for cross-species transfer of information in nonconserved regions.	Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; Univ Missouri, Dept Agron, Columbia, MO 65211 USA; Univ Missouri, USDA ARS, Columbia, MO 65211 USA; Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA; Univ Calif Davis, Dept Agron & Range Sci, Davis, CA 95616 USA; Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA; Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80524 USA; Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; ARS, USDA, Natl Program Staff, Beltsville, MD 20705 USA; Univ Calif Davis, Genet Resources Conservat Program, Davis, CA 95616 USA		Sorrells, ME (corresponding author), Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA.	mes12@cornell.edu	Dubcovsky, Jorge/T-5214-2019; Ma, Xue-Feng/AAO-7225-2020; Gonzalez, Jose/ABD-4665-2020; Lazo, Gerard/A-8900-2009; Anderson, James/AAI-2477-2021; Dubcovsky, Jorge/A-4969-2008	Gonzalez, Jose/0000-0002-2119-0179; Lazo, Gerard/0000-0002-9160-2052; Anderson, James/0000-0003-4655-6517; Dubcovsky, Jorge/0000-0002-7571-4345; Ma, Xuefeng/0000-0002-0942-9116; Miftahudin, M./0000-0002-5641-1090; Linkiewicz, Anna/0000-0002-0167-3237			AHN S, 1993, MOL GEN GENET, V241, P483, DOI 10.1007/BF00279889; Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Band MR, 2000, GENOME RES, V10, P1359, DOI 10.1101/gr.145900; Bennetzen JL, 2002, PLANT MOL BIOL, V48, P821, DOI 10.1023/A:1014841515249; Chen M, 1997, P NATL ACAD SCI USA, V94, P3431, DOI 10.1073/pnas.94.7.3431; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Dickson D, 2001, NATURE, V409, P551, DOI 10.1038/35054705; Dubcovsky J, 1996, GENETICS, V143, P983; DUBCOVSKY J, 1995, GENETICS, V140, P1367; DUNFORD RP, 1995, NUCLEIC ACIDS RES, V23, P2724, DOI 10.1093/nar/23.14.2724; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Faris JD, 2000, GENETICS, V154, P823; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gill KS, 1996, GENETICS, V143, P1001; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Han F, 1999, GENOME, V42, P1071, DOI 10.1139/gen-42-6-1071; HULBERT SH, 1990, P NATL ACAD SCI USA, V87, P4251, DOI 10.1073/pnas.87.11.4251; Keller B, 2000, TRENDS PLANT SCI, V5, P246, DOI 10.1016/S1360-1385(00)01629-0; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; Lagudah ES, 2001, PLANT PHYSIOL BIOCH, V39, P335, DOI 10.1016/S0981-9428(00)01233-X; Leister D, 1998, P NATL ACAD SCI USA, V95, P370, DOI 10.1073/pnas.95.1.370; Li WL, 2002, GENETICS, V160, P1153; Moore G, 1997, PLANT MOL BIOL, V35, P17, DOI 10.1023/A:1005849912205; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Moore G, 2000, ANNU REV PLANT PHYS, V51, P195, DOI 10.1146/annurev.arplant.51.1.195; NARANJO T, 1987, GENOME, V29, P873, DOI 10.1139/g87-149; Qi LiLi, 2003, Functional & Integrative Genomics, V3, P39; Rebeiz M, 2000, ANIM BIOTECHNOL, V11, P75, DOI 10.1080/10495390009525951; SanMiguel PJ, 2002, FUNCT INTEGR GENOMIC, V2, P70, DOI 10.1007/s10142-002-0056-4; Sarma RN, 2000, GENOME, V43, P191, DOI 10.1139/gen-43-1-191; SEARS ER, 1978, P INT WHEAT GENET S, V5, P389; SEARS ER, 1954, MISSOURI AGR EXPT ST, V572; Sorrells ME, 2000, STADLER GEN, P183; TANKSLEY SD, 1995, TRENDS GENET, V11, P63, DOI 10.1016/S0168-9525(00)88999-4; Tarchini R, 2000, PLANT CELL, V12, P381, DOI 10.1105/tpc.12.3.381; Tikhonov AP, 1999, P NATL ACAD SCI USA, V96, P7409, DOI 10.1073/pnas.96.13.7409; Van Deynze AE, 1998, THEOR APPL GENET, V97, P356, DOI 10.1007/s001220050906; VANDEYNZE AE, 1995, MOL GEN GENET, V248, P744, DOI 10.1007/BF02191715; VANDEYNZE AE, 1995, GENOME, V38, P45, DOI 10.1139/g95-006; VANDEYNZE AE, 1995, MOL GEN GENET, V249, P349, DOI 10.1007/BF00290536; Wilson WA, 1999, GENETICS, V153, P453; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	50	313	330	1	41	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2003	13	8					1818	1827		10.1101/gr.1113003			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	707VQ	WOS:000184530900004	12902377	hybrid, Green Published			2022-01-24	
J	Bourque, G; Pevzner, PA				Bourque, G; Pevzner, PA			Genome-scale evolution: Reconstructing gene orders in the ancestral species	GENOME RESEARCH			English	Article							RADIATION HYBRID MAP	Recent progress in genome-scale sequencing and comparative mapping raises new challenges In studies of genome rearrangements. Although the pairwise genome rearrangement problem is well-studied, algorithms for reconstructing rearrangement scenarios for multiple species are in great need. The previous approaches to multiple genome rearrangement problem were largely based on the breakpoint distance rather than on a more biologically accurate rearrangement (reversal) distance. Another shortcoming of the existing software tools Is their inability to analyze rearrangements (inversions, translocations, fusions, and fissions) of multichromosomal genomes. This paper proposes a new multiple genome rearrangement algorithm that is based on the rearrangement (rather than breakpoint) distance and that is applicable to both unichromosomal and mutlichromosomal genomes. We further apply this algorithm for genome-scale phylogenetic tree reconstruction and deriving ancestral gene orders. In particular, our analysis Suggests a new improved rearrangement scenario for a very difficult Campanulaceae cpDNA dataset and a putative rearrangement scenario for human, mouse and cat genomes.	Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA		Bourque, G (corresponding author), Univ So Calif, Dept Math, Los Angeles, CA 90089 USA.	gbourque@usc.edu					BAFNA V, 1995, MOL BIOL EVOL, V12, P239; BERGERON A, 2001, LECT NOTES COMPUTER, V2089, P106; BERMAN P, 1996, LECT NOTES COMPUT SC, V1075, P168; Blanchette, 1997, Genome Inform Ser Workshop Genome Inform, V8, P25; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; BUNEMAN P, 1971, MATH ARCHAEOLOGICAL, P00387; Caprara A., 1999, P 3 ANN INT C COMP M, P84; Cosner, 2000, COMP GENOMICS EMPIRI, P99; Cosner M E, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P104; Dobzhansky T, 1938, GENETICS, V23, P28; Graur D., 2000, FUNDAMENTALS MOL EVO, V2; Hannenhalli S, 1999, J ACM, V46, P1, DOI 10.1145/300515.300516; Hannenhalli S, 1995, AN S FDN CO, P581, DOI 10.1109/SFCS.1995.492588; Hannenhalli S, 1996, PROCEEDINGS OF THE SEVENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P304; Hannenhalli S., 1995, Proceedings of the Twenty-Seventh Annual ACM Symposium on the Theory of Computing, P178, DOI 10.1145/225058.225112; Kaplan H, 1997, PROCEEDINGS OF THE EIGHTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P344; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIANG ZM, 1995, MECH MACH THEORY, V30, P299, DOI 10.1016/0094-114X(94)00036-K; MORET B, 2001, P 9 INT C INT SYST M, P165; Moret B M, 2001, Pac Symp Biocomput, P583; Murphy WJ, 2001, GENOME BIOL, V2; Murphy WJ, 2000, GENOME RES, V10, P691, DOI 10.1101/gr.10.5.691; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Palmer Jeffrey D., 1992, P99; PEVZNER P, 2000, COMPUTATIONAL MOL BI, pCH10; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; Sankoff D., 1996, International Journal of Foundations of Computer Science, V7, P1, DOI 10.1142/S0129054196000026; Sankoff D., 1992, P 3 ANN S COMB PATT, P121; Sankoff David, 1997, LECT NOTES COMPUTER, P251; TESLER G, 2002, IN PRESS BIOINFORMAT; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang L. S., 2001, P 33 ANN ACM S THEOR, P637; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; WATTERSON GA, 1982, J THEOR BIOL, V99, P1, DOI 10.1016/0022-5193(82)90384-8; [No title captured]	39	313	323	0	10	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2002	12	1					26	36					11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	508AN	WOS:000173064900004	11779828				2022-01-24	
J	DUPREZ, L; PARMA, J; VANSANDE, J; ALLGEIER, A; LECLERE, J; SCHVARTZ, C; DELISLE, MJ; DECOULX, M; ORGIAZZI, J; DUMONT, J; VASSART, G				DUPREZ, L; PARMA, J; VANSANDE, J; ALLGEIER, A; LECLERE, J; SCHVARTZ, C; DELISLE, MJ; DECOULX, M; ORGIAZZI, J; DUMONT, J; VASSART, G			GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM	NATURE GENETICS			English	Article							CONSTITUTIVELY ACTIVE MUTANTS; TSH RECEPTOR; CYCLIC-AMP; CELL-PROLIFERATION; THYROID ADENOMAS; POINT MUTATIONS; ACTIVATION; PHOSPHATIDYLINOSITOL; AUTOANTIBODIES; RHODOPSIN	The thyrotropin receptor (TSHR), a member of the large family of G protein-coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase. We report two different mutations in the TSHR gene of affected members of two large pedigrees with non-autoimmune autosomal dominant hyperthyroidism (toxic thyroid hyperplasia), that involve residues in the third (Val509Ala) and seventh (Cys672Tyr) transmembrane segments. When expressed by transfection in COS-7 cells, the mutated receptors display a higher constitutive activation of adenylyl cyclase than wild type. This new disease entity is the germline counterpart of hyperfunctioning thyroid adenomas, in which different somatic mutations with similar functional characteristics have been demonstrated.	FREE UNIV BRUSSELS,FAC MED,INST RECH INTERDISCIPLINAIRE,BRUSSELS,BELGIUM; CHU NANCY,SERV ENDOCRINOL,NANCY,FRANCE; INST JEAN GODINOT,UNITE MED NUCL & BIOPHYS,REIMS,FRANCE; CTR HOSP REG & UNIV LILLE,SERV CLIN MED,F-59037 LILLE,FRANCE; CTR HOSP LYON SUD,HOSPICES CIVILS LYON,SERV MED INTERNE,PIERRE BENITE,FRANCE; FREE UNIV BRUSSELS,SERV GENET MED,B-1070 BRUSSELS,BELGIUM								BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; DUMONT JE, 1989, METABOLIC BASIS INHE, P1843; FRIEDMAN JM, 1987, WERNERS THYROID, P634; GROSS B, 1991, BIOCHEM BIOPH RES CO, V177, P679, DOI 10.1016/0006-291X(91)91842-Z; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOSUGI S, 1992, J BIOL CHEM, V267, P24153; KOSUGI S, 1993, MOL ENDOCRINOL, V7, P1009, DOI 10.1210/me.7.8.1009; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LECLERE J, 1984, J CLIN ENDOCR METAB, V59, P175, DOI 10.1210/jcem-59-1-175; LECLERE J, 1982, ANN ENDOCRINOL-PARIS, V43, P553; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MCKENZIE JM, 1989, J CLIN ENDOCR METAB, V69, P1093, DOI 10.1210/jcem-69-6-1093; OSULLIVAN C, 1991, MOL CARCINOGEN, V4, P345, DOI 10.1002/mc.2940040503; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; REN Q, 1993, J BIOL CHEM, V268, P16483; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; RUF J, 1985, EUR J IMMUNOL, V15, P268, DOI 10.1002/eji.1830150311; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SUAREZ HG, 1991, ONCOGENE, V6, P677; THOMAS JL, 1982, ACTA ENDOCRINOL-COP, V100, P512, DOI 10.1530/acta.0.1000512; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596	33	313	324	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					396	401		10.1038/ng0794-396			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	WOS:A1994NU30600014	7920658				2022-01-24	
J	Weinhold, N; Jacobsen, A; Schultz, N; Sander, C; Lee, W				Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris; Lee, William			Genome-wide analysis of noncoding regulatory mutations in cancer	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; LUNG-CANCER; DNA; GENES; ADENOCARCINOMA; PARAGANGLIOMA; DISCOVERY; PROTEINS; MELANOMA; TUMORS	Cancer primarily develops because of somatic alterations in the genome. Advances in sequencing have enabled large-scale sequencing studies across many tumor types, emphasizing the discovery of alterations in protein-coding genes. However, the protein-coding exome comprises less than 2% of the human genome. Here we analyze the complete genome sequences of 863 human tumors from The Cancer Genome Atlas and other sources to systematically identify noncoding regions that are recurrently mutated in cancer. We use new frequency- and sequence-based approaches to comprehensively scan the genome for noncoding mutations with potential regulatory impact. These methods identify recurrent mutations in regulatory elements upstream of PLEKHS1, WDR74 and SDHD, as well as previously identified mutations in the TERT promoter. SDHD promoter mutations are frequent in melanoma and are associated with reduced gene expression and poor prognosis. The non-protein-coding cancer genome remains widely unexplored, and our findings represent a step toward targeting the entire genome for clinical purposes.	[Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris; Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Jacobsen, Anders] Univ Copenhagen, Dept Biol, Sect Computat & RNA Biol, Copenhagen, Denmark; [Lee, William] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA		Lee, W (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	leew1@mskcc.org	Skanderup, Anders Jacobsen/K-1081-2013; Schultz, Nikolaus/ABE-6347-2020	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Schultz, Nikolaus/0000-0002-0131-4904	TCGA GDAC grant from the US National Institutes of Health [NCI U24-CA143840]; Danish Research CouncilDet Frie Forskningsrad (DFF); Carlsberg FoundationCarlsberg Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA143840] Funding Source: NIH RePORTER	The authors thank TCGA as well as numerous other groups who have made their data available for public analysis. The authors additionally thank the CGHub team, members of the Memorial Sloan Kettering Cancer Center Bioinformatics Core, G. Ratsch and J. Chodera for the setup and administration of high-performance computing resources. This work was supported in part by a TCGA GDAC grant from the US National Institutes of Health for N.W., N.S., CS. and W.L. (NCI U24-CA143840) and grants from the Danish Research Council and the Carlsberg Foundation for A.J.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lehmann KV, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks800; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Schneider C, 2011, SEMIN DIAGN PATHOL, V28, P167, DOI 10.1053/j.semdp.2011.04.001; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670	34	312	314	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1160	1165		10.1038/ng.3101			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	WOS:000344131900005	25261935	Green Accepted			2022-01-24	
J	Ishimaru, K; Hirotsu, N; Madoka, Y; Murakami, N; Hara, N; Onodera, H; Kashiwagi, T; Ujiie, K; Shimizu, B; Onishi, A; Miyagawa, H; Katoh, E				Ishimaru, Ken; Hirotsu, Naoki; Madoka, Yuka; Murakami, Naomi; Hara, Nao; Onodera, Haruko; Kashiwagi, Takayuki; Ujiie, Kazuhiro; Shimizu, Bun-ichi; Onishi, Atsuko; Miyagawa, Hisashi; Katoh, Etsuko			Loss of function of the IAA-glucose hydrolase gene TGW6 enhances rice grain weight and increases yield	NATURE GENETICS			English	Article							STRICTOSIDINE SYNTHASE; EXPRESSION; SIZE; IDENTIFICATION; TEMPERATURE; ENDOSPERM; ENCODES; HISTORY; STARCH; ENZYME	Increases in the yield of rice, a staple crop for more than half of the global population, are imperative to support rapid population growth. Grain weight is a major determining factor of yield. Here, we report the cloning and functional analysis of THOUSAND-GRAIN WEIGHT 6 (TGW6), a gene from the Indian landrace rice Kasalath. TGW6 encodes a novel protein with indole-3-acetic acid (IAA)-glucose hydrolase activity. In sink organs, the Nipponbare tgw6 allele affects the timing of the transition from the syncytial to the cellular phase by controlling IAA supply and limiting cell number and grain length. Most notably, loss of function of the Kasalath allele enhances grain weight through pleiotropic effects on source organs and leads to significant yield increases. Our findings suggest that TGW6 may be useful for further improvements in yield characteristics in most cultivars.	[Ishimaru, Ken; Hirotsu, Naoki; Madoka, Yuka; Murakami, Naomi; Hara, Nao; Onodera, Haruko; Kashiwagi, Takayuki; Ujiie, Kazuhiro; Katoh, Etsuko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Shimizu, Bun-ichi] Toyo Univ, Grad Sch Life Sci, Itakura, Japan; [Onishi, Atsuko; Miyagawa, Hisashi] Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan		Ishimaru, K (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	kenshi@nias.affrc.go.jp	Hirotsu, Naoki/C-6128-2014	Hirotsu, Naoki/0000-0002-9893-7111; Kashiwagi, Takayuki/0000-0002-0096-8113	National Bioresource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan; Bio Cosmos Program and Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry and Fisheries of Japan [QTL-4007]	We thank T. Meshi for helpful and important suggestions, Y. Shimoda and A. Miyamoto for help with experiments, T. Yanai and S. Yoshimizu for rice growth, K. Shimamoto (Nara Institute of Science and Technology) for providing the pANDA vector, K. Toshimitsu (Japan International Cooperation Agency) for providing seeds of NERICA and T. Kobayakawa for helpful discussions. The wild rice accessions used in this study were distributed from the National Institute of Genetics supported by the National Bioresource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was supported by grants from the Bio Cosmos Program and Genomics for Agricultural Innovation (QTL-4007), Ministry of Agriculture, Forestry and Fisheries of Japan.	Brown RC, 1996, J PLANT RES, V109, P301, DOI 10.1007/BF02344477; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dingkuhn M., 1991, CONCEPTS NEW PLANT T; Dolan MA, 2008, PROTEINS, V72, P1243, DOI 10.1002/prot.22022; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Harlan J.R., 1992, CROPS MAN; Hirose T, 2006, PHYSIOL PLANTARUM, V128, P425, DOI 10.1111/j.1399-3054.2006.00758.x; Hoshikawa K., 1989, GROWING RICE PLANT A; HOSHIKAWA K, 1967, JAP J CROP SCI, V36, P151; Ishimaru K, 2005, J EXP BOT, V56, P2745, DOI 10.1093/jxb/eri267; Ishimaru K, 2004, PLANT PHYSIOL BIOCH, V42, P855, DOI 10.1016/j.plaphy.2004.10.008; Ishimaru K, 2003, PLANT PHYSIOL, V133, P1083, DOI 10.1104/pp.103.027607; Ishimaru K, 2007, PLANT PHYSIOL BIOCH, V45, P799, DOI 10.1016/j.plaphy.2007.07.004; Jakubowska A, 2005, J PLANT PHYSIOL, V162, P207, DOI 10.1016/j.jplph.2004.05.015; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kurata N, 2006, PLANT PHYSIOL, V140, P12, DOI 10.1104/pp.105.063008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsuda F, 2005, BIOSCI BIOTECH BIOCH, V69, P778, DOI 10.1271/bbb.69.778; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Mizutani M, 2010, J EXP BOT, V61, P791, DOI 10.1093/jxb/erp343; Nagata K, 2001, PLANT PROD SCI, V4, P173, DOI 10.1626/pps.4.173; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stockigt J, 2008, PLANT PHYSIOL BIOCH, V46, P340, DOI 10.1016/j.plaphy.2007.12.011; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tsunoda Y, 2005, PROTEIN EXPRES PURIF, V42, P268, DOI 10.1016/j.pep.2005.04.002; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766	45	312	383	23	233	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					707	+		10.1038/ng.2612			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	WOS:000319563900022	23583977				2022-01-24	
J	Comadran, J; Kilian, B; Russell, J; Ramsay, L; Stein, N; Ganal, M; Shaw, P; Bayer, M; Thomas, W; Marshall, D; Hedley, P; Tondelli, A; Pecchioni, N; Francia, E; Korzun, V; Walther, A; Waugh, R				Comadran, Jordi; Kilian, Benjamin; Russell, Joanne; Ramsay, Luke; Stein, Nils; Ganal, Martin; Shaw, Paul; Bayer, Micha; Thomas, William; Marshall, David; Hedley, Pete; Tondelli, Alessandro; Pecchioni, Nicola; Francia, Enrico; Korzun, Viktor; Walther, Alexander; Waugh, Robbie			Natural variation in a homolog of Antirrhinum CENTRORADIALIS contributed to spring growth habit and environmental adaptation in cultivated barley	NATURE GENETICS			English	Article							FLOWERING-LOCUS-T; GENOME-WIDE ASSOCIATION; GENE; TIME; DOMESTICATION; WHEAT; PHOTOPERIOD; ORTHOLOG; QTL; FT	As early farming spread from the Fertile Crescent in the Near East around 10,000 years before the present(1), domesticated crops encountered considerable ecological and environmental change. Spring-sown crops that flowered without the need for an extended period of cold to promote flowering and day length insensitive crops able to exploit the longer, cooler days of higher latitudes emerged and became established. To investigate the genetic consequences of adaptation to these new environments, we identified signatures of divergent selection in the highly differentiated modern-day spring and winter barleys. In one genetically divergent region, we identify a natural variant of the barley homolog of Antirrhinum CENTRORADIALIS(2) (HvCEN) as a contributor to successful environmental adaptation. The distribution of HvCEN alleles in a large collection of wild and landrace accessions indicates that this involved selection and enrichment of preexisting genetic variants rather than the acquisition of mutations after domestication.	[Comadran, Jordi; Russell, Joanne; Ramsay, Luke; Shaw, Paul; Bayer, Micha; Thomas, William; Marshall, David; Hedley, Pete; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci Grp, Dundee, Scotland; [Kilian, Benjamin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Dept Genome Divers Grp, Gatersleben, Germany; [Ganal, Martin] TraitGenetics, Gatersleben, Germany; [Tondelli, Alessandro] Genom Res Ctr, Consiglio Ric Sperimentaz Agr CRA, Fiorenzuola Darda, Italy; [Pecchioni, Nicola; Francia, Enrico] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Korzun, Viktor] KWS LOCHOW, KWS Cereals Biotechnol, Bergen, Germany; [Walther, Alexander] Univ Gothenburg, Reg Climate Grp, Dept Earth Sci, Gothenburg, Sweden		Waugh, R (corresponding author), James Hutton Inst, Cell & Mol Sci Grp, Dundee, Scotland.	robbie.waugh@hutton.ac.uk	Stein, Nils/F-7507-2017; Tondelli, Alessandro/AAJ-1720-2020; Francia, Enrico/N-7931-2019; Shaw, Paul D/E-9718-2011; Hedley, Peter/F-1149-2011; Francia, Enrico/C-8444-2015; Korzun, Viktor/U-6352-2019; Pecchioni, Nicola/E-5389-2015; Tondelli, Alessandro/I-7433-2015; Bayer, Micha/F-2255-2013	Stein, Nils/0000-0003-3011-8731; Tondelli, Alessandro/0000-0001-9299-7773; Francia, Enrico/0000-0001-8709-1002; Shaw, Paul D/0000-0002-0202-1150; Hedley, Peter/0000-0003-0866-324X; Francia, Enrico/0000-0001-8709-1002; Korzun, Viktor/0000-0003-0760-8249; Pecchioni, Nicola/0000-0003-1704-2541; Tondelli, Alessandro/0000-0001-9299-7773; Kilian, Benjamin/0000-0002-9145-6980; Bayer, Micha/0000-0003-0041-3115; Marshall, David/0000-0001-9309-2570	Scottish Government Rural and Environment Science and Analytical Services Division Research Programme [WP 5.2]; European Union International Research Cooperation with Mediterranean Partner Countries program [ICA3-CT2002-10026, FP7-212019]; German Science FoundationGerman Research Foundation (DFG) [SPP1530]; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D522003/1] Funding Source: researchfish; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D522003/1] Funding Source: UKRI	We thank A. Graner, S. Friedel, F. Blattner, R. Sharma, R.K. Pasam, R. Neef and G. Willcox for discussions, K. Mayer and M. Pfeifer for searches for conservation of synteny in sequenced model grass genomes, J. Plieske and G. Durstewitz for their assistance in mapping and development of the cluster file and C. Trautewig, M. Ziems, K. Wolf, N. Uzrek and J. Morris for excellent technical assistance. We thank H. Ozkan, E. Fridman and the IPK Genebank for providing seeds and/or DNA for barley accessions. The authors would like to acknowledge the support given by the Scottish Government Rural and Environment Science and Analytical Services Division Research Programme (WP 5.2), the European Union International Research Cooperation with Mediterranean Partner Countries program ICA3-CT2002-10026 (Mapping Adaptation of Barley to Drought Environments) and Framework Programme 7 (FP7) TriticeaeGenome grant (FP7-212019), and the German Science Foundation Priority Programme SPP1530 to B.K.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Bradley D, 1996, NATURE, V379, P791, DOI 10.1038/379791a0; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2011, THEOR APPL GENET, V122, P523, DOI 10.1007/s00122-010-1466-7; Coventry SJ, 2003, AUST J AGR RES, V54, P1103, DOI 10.1071/AR02194; Diamond J., 1997, GUNS GERMS STEEL FAT; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kilian B, 2009, PLANT GENET GENOMICS, V7, P81, DOI 10.1007/978-0-387-77489-3_3; Koti K, 2006, EUPHYTICA, V152, P17, DOI 10.1007/s10681-006-9170-z; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; Sameri M, 2011, BREEDING SCI, V61, P183, DOI 10.1270/jsbbs.61.183; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; von Bothmer R, 2003, DEV PL GEN, V7, P9; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yasuda S., 1971, P388; Zohary D., 2000, DOMESTICATION PLANTS	40	312	318	0	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1388	1392		10.1038/ng.2447			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	WOS:000311713200021	23160098				2022-01-24	
J	Henry, SA; Kohlwein, SD; Carman, GM				Henry, Susan A.; Kohlwein, Sepp D.; Carman, George M.			Metabolism and Regulation of Glycerolipids in the Yeast Saccharomyces cerevisiae	GENETICS			English	Article							UNFOLDED PROTEIN RESPONSE; DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; FATTY-ACID SYNTHESIS; ACYL-COA SYNTHETASE; MESSENGER-RNA STABILITY; PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; NUCLEUS-VACUOLE JUNCTIONS; MEMBRANE-LIPID SYNTHESIS; PHOSPHOLIPASE-D ACTIVITY; GENOME-WIDE ANALYSIS	Due to its genetic tractability and increasing wealth of accessible data, the yeast Saccharomyces cerevisiae is a model system of choice for the study of the genetics, biochemistry, and cell biology of eukaryotic lipid metabolism. Glycerolipids (e.g., phospholipids and triacylglycerol) and their precursors are synthesized and metabolized by enzymes associated with the cytosol and membranous organelles, including endoplasmic reticulum, mitochondria, and lipid droplets. Genetic and biochemical analyses have revealed that glycerolipids play important roles in cell signaling, membrane trafficking, and anchoring of membrane proteins in addition to membrane structure. The expression of glycerolipid enzymes is controlled by a variety of conditions including growth stage and nutrient availability. Much of this regulation occurs at the transcriptional level and involves the Ino2-Ino4 activation complex and the Opi1 repressor, which interacts with Ino2 to attenuate transcriptional activation of UAS(INO)-containing glycerolipid biosynthetic genes. Cellular levels of phosphatidic acid, precursor to all membrane phospholipids and the storage lipid triacylglycerol, regulates transcription of UAS(INO)-containing genes by tethering Opi1 to the nuclear/endoplasmic reticulum membrane and controlling its translocation into the nucleus, a mechanism largely controlled by inositol availability. The transcriptional activator Zap1 controls the expression of some phospholipid synthesis genes in response to zinc availability. Regulatory mechanisms also include control of catalytic activity of glycerolipid enzymes by water-soluble precursors, products and lipids, and covalent modification of phosphorylation, while in vivo function of some enzymes is governed by their subcellular location. Genome-wide genetic analysis indicates coordinate regulation between glycerolipid metabolism and a broad spectrum of metabolic pathways.	[Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA		Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14850 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014	Kohlwein, Sepp Dieter/0000-0002-1030-0598	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM-19629, GM-28140, GM-50679]; Austrian Science FundsAustrian Science Fund (FWF) [F30 LIPOTOX]; Ph.D. program Molecular Enzymology; Austrian Federal Government for Science and Research; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [F 3005] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM019629, R01GM028140, R37GM019629, R01GM050679, R01GM019629, R37GM028140] Funding Source: NIH RePORTER	We are indebted to Maria Laura Gaspar for her collaboration in preparing Figure 2 and to Yu-Fang Chang for providing fluorescence microscopy images of Opi1 localization for Figure 3. We also acknowledge our colleagues Yu-Fang Chang, Maria Laura Gaspar, Harald Hofbauer, Gil-Soo Han, Stephen Jesch, and Manuel Villa for critical reading of the manuscript and many helpful discussions. Work in the Henry laboratory is supported by National Institutes of Health (NIH) grant GM-19629. Work in the Kohlwein laboratory is supported by grants from the Austrian Science Funds (project F30 LIPOTOX), the Ph.D. program Molecular Enzymology, and the Austrian Federal Government for Science and Research (Project GOLD in the framework of the Austrian Genome Program GEN-AU). Work in the Carman laboratory is supported by NIH grants GM-28140 and GM-50679.	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ALFEEL W, 1992, P NATL ACAD SCI USA, V89, P4534, DOI 10.1073/pnas.89.10.4534; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; ASHBURNER BP, 1995, MOL CELL BIOL, V15, P1709; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Athenstaedt K, 2000, J BIOL CHEM, V275, P235, DOI 10.1074/jbc.275.1.235; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; BAELEE MS, 1984, J BIOL CHEM, V259, P857; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Block-Alper L, 2002, MOL BIOL CELL, V13, P40, DOI 10.1091/mbc.01-07-0366; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner JH, 2009, CURR OPIN CELL BIOL, V21, P127, DOI 10.1016/j.ceb.2009.01.007; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CARTER JR, 1966, J LIPID RES, V7, P678; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; CHIRALA SS, 1992, P NATL ACAD SCI USA, V89, P10232, DOI 10.1073/pnas.89.21.10232; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Choi HS, 2007, J BIOL CHEM, V282, P31217, DOI 10.1074/jbc.M705098200; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Daum G, 2007, BIOCHIMIE, V89, P243, DOI 10.1016/j.biochi.2006.06.018; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; Deng L, 2010, BBA-MOL CELL BIOL L, V1801, P635, DOI 10.1016/j.bbalip.2010.02.008; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2010, ADV EXP MED BIOL, V688, P217; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dietz M, 2003, MOL MICROBIOL, V48, P1119, DOI 10.1046/j.1365-2958.2003.03501.x; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; DURONIO RJ, 1992, J CELL BIOL, V117, P515, DOI 10.1083/jcb.117.3.515; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Elkhaimi M, 2000, NUCLEIC ACIDS RES, V28, P3160, DOI 10.1093/nar/28.16.3160; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Faergeman NJ, 2004, BIOCHEM J, V380, P907, DOI 10.1042/BJ20031949; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Fernandez-Murray JP, 2009, J BIOL CHEM, V284, P36034, DOI 10.1074/jbc.M109.063958; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fyrst H, 1999, BIOCHEMISTRY-US, V38, P5864, DOI 10.1021/bi9824590; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gardocki ME, 2005, BBA-MOL CELL BIOL L, V1735, P89, DOI 10.1016/j.bbalip.2005.05.006; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; GREENBERG ML, 1983, J BACTERIOL, V153, P791, DOI 10.1128/JB.153.2.791-799.1983; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Griac P, 2007, BBA-MOL CELL BIOL L, V1771, P737, DOI 10.1016/j.bbalip.2007.02.008; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Ham HJ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.046946; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Hancock LC, 2006, GENETICS, V173, P621, DOI 10.1534/genetics.106.057489; HANSON BA, 1980, J BACTERIOL, V142, P79, DOI 10.1128/JB.142.1.79-89.1980; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HARINGTON A, 1994, EMBO J, V13, P5531, DOI 10.1002/j.1460-2075.1994.tb06890.x; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HJELMSTAD RH, 1988, J BIOL CHEM, V263, P19748; HJELMSTAD RH, 1987, J BIOL CHEM, V262, P3909; HJELMSTAD RH, 1991, J BIOL CHEM, V266, P5094; HJELMSTAD RH, 1990, J BIOL CHEM, V265, P1755; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; HOMANN MJ, 1987, J BACTERIOL, V169, P3276, DOI 10.1128/jb.169.7.3276-3280.1987; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Hung W, 1997, EUR J BIOCHEM, V245, P241, DOI 10.1111/j.1432-1033.1997.00241.x; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; Jaschke Y, 2011, MOL GENET GENOMICS, V285, P91, DOI 10.1007/s00438-010-0589-5; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jandrositz A, 2005, BBA-MOL CELL BIOL L, V1735, P50, DOI 10.1016/j.bbalip.2005.04.005; Jani NM, 2009, FEMS YEAST RES, V9, P552, DOI 10.1111/j.1567-1364.2009.00514.x; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jesch S. A., 2005, CELL BIOL DYNAMICS Y, V36, P105; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; JOHNSON DR, 1994, J BIOL CHEM, V269, P18037; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KELLEY MJ, 1987, J BIOL CHEM, V262, P14563; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Kersting MC, 2006, J BIOL CHEM, V281, P13110, DOI 10.1074/jbc.M601612200; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KIYONO K, 1987, J BIOCHEM-TOKYO, V102, P1089, DOI 10.1093/oxfordjournals.jbchem.a122147; KLIG LS, 1984, P NATL ACAD SCI-BIOL, V81, P3816, DOI 10.1073/pnas.81.12.3816; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kohlwein SD, 2010, BBA-MOL CELL BIOL L, V1801, P222, DOI 10.1016/j.bbalip.2009.12.016; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; KUZIORA MA, 1983, J BIOL CHEM, V258, P1648; Kvam E, 2005, MOL BIOL CELL, V16, P3987, DOI 10.1091/mbc.E05-04-0290; Le Guedard M, 2009, FEBS J, V276, P6412, DOI 10.1111/j.1742-4658.2009.07355.x; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; Liu C, 2000, J BIOL CHEM, V275, P31972, DOI 10.1074/jbc.M003055200; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; LOEWY BS, 1984, MOL CELL BIOL, V4, P2479, DOI 10.1128/MCB.4.11.2479; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mattiazzi M, 2010, MOL GENET GENOMICS, V283, P519, DOI 10.1007/s00438-010-0533-8; Mayr JA, 1996, FEBS LETT, V393, P236, DOI 10.1016/0014-5793(96)00893-9; MCDONOUGH VM, 1992, J BIOL CHEM, V267, P5931; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MCGRAW P, 1989, GENETICS, V122, P317; MCMASTER CR, 1994, J BIOL CHEM, V269, P28010; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Merkel O, 2005, BIOCHEM J, V387, P489, DOI 10.1042/BJ20041272; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; MinSeok R, 1996, J BIOCHEM, V120, P1040; MORASH SC, 1994, J BIOL CHEM, V269, P28769; Muccioli GG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005942; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.E03-11-0798; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; NIKAWA J, 1987, EUR J BIOCHEM, V167, P7, DOI 10.1111/j.1432-1033.1987.tb13297.x; NIKAWA J, 1984, EUR J BIOCHEM, V143, P251, DOI 10.1111/j.1432-1033.1984.tb08366.x; NIKAWA J, 1987, J BIOL CHEM, V262, P4876; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Paltauf F., 1992, MOL CELL BIOL YEAST, P415; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Patton-Vogt JL, 1998, GENETICS, V149, P1707; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Qian OY, 1999, GENETICS, V152, P89; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Rijken PJ, 2009, J BIOL CHEM, V284, P27609, DOI 10.1074/jbc.M109.016311; Rockenfeller P, 2010, CELL CYCLE, V9, P2836, DOI 10.4161/cc.9.14.12346; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Schnabl M, 2003, EUR J BIOCHEM, V270, P3133, DOI 10.1046/j.1432-1033.2003.03688.x; Schneiter R, 1997, CELL, V88, P431, DOI 10.1016/S0092-8674(00)81882-6; Schneiter R, 2000, MOL CELL BIOL, V20, P2984, DOI 10.1128/MCB.20.9.2984-2995.2000; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; SCHULLER HJ, 1994, EUR J BIOCHEM, V225, P213, DOI 10.1111/j.1432-1033.1994.00213.x; SCHULLER HJ, 1992, EMBO J, V11, P107, DOI 10.1002/j.1460-2075.1992.tb05033.x; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; SCHWEIZER M, 1986, MOL GEN GENET, V203, P479, DOI 10.1007/BF00422073; Shelton SN, 2003, BIOCHEM J, V371, P533, DOI 10.1042/BJ20021407; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Shirra MK, 2005, GENETICS, V169, P1957, DOI 10.1534/genetics.104.038075; Shirra MK, 1999, GENETICS, V152, P73; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Simockova M, 2008, J BIOL CHEM, V283, P17107, DOI 10.1074/jbc.M800868200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stalberg K, 2008, J LIPID RES, V49, P1794, DOI 10.1194/jlr.M800129-JLR200; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; Stolz LE, 1998, GENETICS, V148, P1715; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; SUMMERS EF, 1988, GENETICS, V120, P909; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takata Y, 2002, J BIOL CHEM, V277, P22670, DOI 10.1074/jbc.M201116200; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tanaka K, 2008, BBA-MOL CELL BIOL L, V1781, P391, DOI 10.1016/j.bbalip.2008.06.001; Tatzer V, 2002, MOL BIOL CELL, V13, P4429, DOI 10.1091/mbc.E02-04-0196; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; TSUKAGOSHI Y, 1987, EUR J BIOCHEM, V169, P477, DOI 10.1111/j.1432-1033.1987.tb13635.x; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; van Gestel RA, 2010, J PROTEOMICS, V73, P806, DOI 10.1016/j.jprot.2009.11.009; Vemula M, 2003, J BIOL CHEM, V278, P45269, DOI 10.1074/jbc.M308812200; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Waksman M, 1996, J BIOL CHEM, V271, P2361, DOI 10.1074/jbc.271.5.2361; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Wenz P, 2001, NUCLEIC ACIDS RES, V29, P4625, DOI 10.1093/nar/29.22.4625; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Wiradjaja F, 2001, J BIOL CHEM, V276, P7643, DOI 10.1074/jbc.M010471200; Wolinski H, 2009, METHODS MOL BIOL, V548, P75, DOI 10.1007/978-1-59745-540-4_5; Wolinski Heimo, 2008, V457, P151, DOI 10.1007/978-1-59745-261-8_11; WOODS A, 1994, J BIOL CHEM, V269, P19509; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	372	312	316	2	74	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	FEB	2012	190	2					317	349		10.1534/genetics.111.130286			33	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	897CW	WOS:000300621200006	22345606	Green Published			2022-01-24	
J	Horton, MW; Hancock, AM; Huang, YS; Toomajian, C; Atwell, S; Auton, A; Muliyati, NW; Platt, A; Sperone, FG; Vilhjalmsson, BJ; Nordborg, M; Borevitz, JO; Bergelson, J				Horton, Matthew W.; Hancock, Angela M.; Huang, Yu S.; Toomajian, Christopher; Atwell, Susanna; Auton, Adam; Muliyati, N. Wayan; Platt, Alexander; Sperone, F. Gianluca; Vilhjalmsson, Bjarni J.; Nordborg, Magnus; Borevitz, Justin O.; Bergelson, Joy			Genome-wide patterns of genetic variation in worldwide Arabidopsis thaliana accessions from the RegMap panel	NATURE GENETICS			English	Article							RECOMBINATION; SEQUENCE; ADAPTATION; POLYMORPHISMS; ASSOCIATION; EVOLUTION; SELECTION; HELITRON; CLIMATE; SWEEPS	Arabidopsis thaliana is native to Eurasia and is naturalized across the world. Its ability to be easily propagated and its high phenotypic variability make it an ideal model system for functional, ecological and evolutionary genetics. To date, analyses of the natural genetic variation of A. thaliana have involved small numbers of individual plants or genetic markers. Here we genotype 1,307 worldwide accessions, including several regional samples, using a 250K SNP chip. This allowed us to produce a high-resolution description of the global pattern of genetic variation. We applied three complementary selection tests and identified new targets of selection. Further, we characterized the pattern of historical recombination in A. thaliana and observed an enrichment of hotspots in its intergenic regions and repetitive DNA, which is consistent with the pattern that is observed for humans but which is strikingly different from that observed in other plant species. We have made the seeds we used to produce this Regional Mapping (RegMap) panel publicly available. This panel comprises one of the largest genomic mapping resources currently available for global natural isolates of a non-human species.	[Horton, Matthew W.; Hancock, Angela M.; Muliyati, N. Wayan; Sperone, F. Gianluca; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Huang, Yu S.; Atwell, Susanna; Platt, Alexander; Vilhjalmsson, Bjarni J.; Nordborg, Magnus] Univ So Calif, Los Angeles, CA USA; [Toomajian, Christopher] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Auton, Adam] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Nordborg, Magnus] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria		Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Vilhjalmsson, Bjarni/K-3971-2014; Atwell, Susanna/H-8630-2016; Toomajian, Christopher/ABA-2615-2021; Vilhjalmsson, Bjarni/ABC-1369-2020; Borevitz, Justin/B-5423-2012	Vilhjalmsson, Bjarni/0000-0003-2277-9249; Atwell, Susanna/0000-0001-8680-9721; Toomajian, Christopher/0000-0002-6763-0678; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Borevitz, Justin/0000-0001-8408-3699; Horton, Matthew/0000-0002-7537-0730; Bergelson, Joy/0000-0001-7893-7387; Platt, Alexander/0000-0003-3783-4781; Nordborg, Magnus/0000-0001-7178-9748; Hancock, Angela/0000-0002-4768-3377	National Science FoundationNational Science Foundation (NSF); Graduate Assistance in Areas of National Need (GAANN) training grantUS Department of Education; Achievement Rewards for College Scientists (ARCS) Foundation; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM057994, GM083068]; Dropkin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM057994, R01GM083068] Funding Source: NIH RePORTER	We thank M. Hubisz for the code for the CLR statistic and for help in using the software. We also thank E. Leffler for helpful discussions regarding recombination hotspots. M.W.H. was supported by a National Science Foundation Predoctoral Fellowship, a Graduate Assistance in Areas of National Need (GAANN) training grant and an Achievement Rewards for College Scientists (ARCS) Foundation Scholarship. This research was supported by US National Institutes of Health grant GM057994 (J.B.), US National Institutes of Health grant GM083068 (J.B. and M.N.), National Science Foundation 2010 grants (M.N. and J.B.) and a Dropkin Foundation Fellowship (A.M.H.). This is contribution number 11-3634-J from the Kansas Agricultural Experiment Station (C.T.).	Alonso-Blanco C, 2003, GENETICS, V164, P711; Anastasio AE, 2011, PLANT J, V67, P554, DOI 10.1111/j.1365-313X.2011.04606.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2008, GENETICS, V178, P2031, DOI 10.1534/genetics.107.083279; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chiang GCK, 2011, MOL ECOL, V20, P3336, DOI 10.1111/j.1365-294X.2011.05181.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gill KS, 1996, GENETICS, V144, P1883; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He LM, 2009, P NATL ACAD SCI USA, V106, P8410, DOI 10.1073/pnas.0902972106; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Lewandowska-Sabat AM, 2010, MOL ECOL, V19, P4753, DOI 10.1111/j.1365-294X.2010.04840.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Yandeau-Nelson MD, 2005, GENETICS, V169, P917, DOI 10.1534/genetics.104.035089; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003	43	312	315	2	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					212	216		10.1038/ng.1042			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	WOS:000299664400022	22231484	Green Accepted			2022-01-24	
J	Rung, J; Cauchi, S; Albrechtsen, A; Shen, LS; Rocheleau, G; Cavalcanti-Proenca, C; Bacot, F; Balkau, B; Belisle, A; Borch-Johnsen, K; Charpentier, G; Dina, C; Durand, E; Elliott, P; Hadjadj, S; Jarvelin, MR; Laitinen, J; Lauritzen, T; Marre, M; Mazur, A; Meyre, D; Montpetit, A; Pisinger, C; Posner, B; Poulsen, P; Pouta, A; Prentki, M; Ribel-Madsen, R; Ruokonen, A; Sandbaek, A; Serre, D; Tichet, J; Vaxillaire, M; Wojtaszewski, JFP; Vaag, A; Hansen, T; Polychronakos, C; Pedersen, O; Froguel, P; Sladek, R				Rung, Johan; Cauchi, Stephane; Albrechtsen, Anders; Shen, Lishuang; Rocheleau, Ghislain; Cavalcanti-Proenca, Christine; Bacot, Francois; Balkau, Beverley; Belisle, Alexandre; Borch-Johnsen, Knut; Charpentier, Guillaume; Dina, Christian; Durand, Emmanuelle; Elliott, Paul; Hadjadj, Samy; Jaervelin, Marjo-Riitta; Laitinen, Jaana; Lauritzen, Torsten; Marre, Michel; Mazur, Alexander; Meyre, David; Montpetit, Alexandre; Pisinger, Charlotta; Posner, Barry; Poulsen, Pernille; Pouta, Anneli; Prentki, Marc; Ribel-Madsen, Rasmus; Ruokonen, Aimo; Sandbaek, Anelli; Serre, David; Tichet, Jean; Vaxillaire, Martine; Wojtaszewski, Jorgen F. P.; Vaag, Allan; Hansen, Torben; Polychronakos, Constantin; Pedersen, Oluf; Froguel, Philippe; Sladek, Robert			Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR SUBSTRATE-1 GENE; MUSCLE GLYCOGEN-SYNTHASE; SUSCEPTIBILITY LOCI; BETA-CELL; RISK LOCI; DISRUPTION; MICE; POLYMORPHISM; METAANALYSIS	Genome-wide association studies have identified common variants that only partially explain the genetic risk for type 2 diabetes (T2D). Using genome-wide association data from 1,376 French individuals, we identified 16,360 SNPs nominally associated with T2D and studied these SNPs in an independent sample of 4,977 French individuals. We then selected the 28 best hits for replication in 7,698 Danish subjects and identified 4 SNPs showing strong association with T2D, one of which (rs2943641, P = 9.3 x 10(-12), OR = 1.19) was located adjacent to the insulin receptor substrate 1 gene (IRS1). Unlike previously reported T2D risk loci, which predominantly associate with impaired beta cell function, the C allele of rs2943641 was associated with insulin resistance and hyperinsulinemia in 14,358 French, Danish and Finnish participants from population-based cohorts; this allele was also associated with reduced basal levels of IRS1 protein and decreased insulin induction of IRS1-associated phosphatidylinositol-3-OH kinase activity in human skeletal muscle biopsies.	[Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Borch-Johnsen, Knut; Poulsen, Pernille; Ribel-Madsen, Rasmus; Vaag, Allan; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rung, Johan; Shen, Lishuang; Rocheleau, Ghislain; Bacot, Francois; Belisle, Alexandre; Mazur, Alexander; Montpetit, Alexandre; Serre, David; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Cauchi, Stephane; Cavalcanti-Proenca, Christine; Dina, Christian; Durand, Emmanuelle; Meyre, David; Vaxillaire, Martine; Froguel, Philippe] CNRS, UMR 8090, Inst Biol, Lille, France; [Cauchi, Stephane; Cavalcanti-Proenca, Christine; Dina, Christian; Durand, Emmanuelle; Meyre, David; Vaxillaire, Martine; Froguel, Philippe] Univ Lille 2, Inst Pasteur, Lille, France; [Albrechtsen, Anders] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Rocheleau, Ghislain; Polychronakos, Constantin; Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Balkau, Beverley] INSERM, U780, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Orsay, France; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Elliott, Paul; Jaervelin, Marjo-Riitta; Pouta, Anneli] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Hadjadj, Samy] Univ Poitiers, Poitiers Hosp, Ctr Invest Clin INSERM 0801, Unite Format & Rech,INSERM U927, Poitiers, France; [Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jaervelin, Marjo-Riitta] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Helsinki, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lauritzen, Torsten; Sandbaek, Anelli] Univ Aarhus, Dept Gen Practice, Aarhus C, Denmark; [Marre, Michel] Bichat Claude Bernard Univ Hosp, Dept Endocrinol Diabetol & Nutr, AP HP, Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Marre, Michel] Diderot Univ, Paris, France; [Pisinger, Charlotta] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Posner, Barry] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Posner, Barry] McGill Univ, Polypeptide Hormone Lab, Montreal, PQ, Canada; [Posner, Barry] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Prentki, Marc] Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Tichet, Jean] Inst Interreg Sante, La Riche, France; [Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Copenhagen Muscle Res Ctr, Inst Exercise & Sport Sci, Copenhagen NV, Denmark; [Vaag, Allan] Lund Univ, Unit Diabet & Endocrinol, Dept Clin Sci, Malmo Univ Hosp, Malmo, Sweden; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense M, Denmark; [Polychronakos, Constantin] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; [Pedersen, Oluf] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus C, Denmark; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Genom Med, London, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Med, London, England		Pedersen, O (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	oluf@hagedorn.dk; phillipe.froguel@good.ibl.fr; robert.sladek@mcgill.ca	Shen, Lishuang/B-3040-2013; Sladek, Robert/R-2391-2019; Pedersen, Oluf/Z-1731-2019; Dina, Christian R/D-3535-2015; FROGUEL, Philippe/O-6799-2017; Albrechtsen, Anders/K-4281-2013; Meyre, David/D-7315-2011; Wojtaszewski, Jorgen FP/P-6583-2014; Pedersen, Oluf/AAG-8015-2020	Sladek, Robert/0000-0002-2730-1204; Pedersen, Oluf/0000-0002-3321-3972; Dina, Christian R/0000-0002-7722-7348; FROGUEL, Philippe/0000-0003-2972-0784; Albrechtsen, Anders/0000-0001-7306-031X; Meyre, David/0000-0003-4850-7444; Wojtaszewski, Jorgen FP/0000-0001-9785-6830; Marre, Michel/0000-0002-3071-1837; Shen, Lishuang/0000-0002-0436-0199; Pisinger, Charlotta/0000-0002-7970-3168; Vaag, Allan Arthur/0000-0002-3690-2191; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Elliott, Paul/0000-0002-7511-5684; Polychronakos, Constantin/0000-0002-7624-6635; wojtaszewski, jorgen/0000-0001-8185-3408	Genome CanadaGenome Canada; Genome Quebec; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; French Government (Agence Nationale de la Recherche)French National Research Agency (ANR); French Region of Nord Pas De Calais (Contrat de Projets Etat-Region)Region Hauts-de-France; Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; LillyEli Lilly; Novartis Pharma; Sanofi-AventisSanofi-Aventis; Institut National de la Sante et de la Recherche Medicale (INSERM)Institut National de la Sante et de la Recherche Medicale (Inserm); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; Fondation de FranceFondation de France; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Office National Interprofessionnel des Vins; Ardix Medical; Bayer DiagnosticsBayer AG; Becton Dickinson; Cardionics; Merck Sante; Novo NordiskNovo Nordisk; Pierre Fabre; Roche and Topcon; Oulu University Hospital, Finland; Academy of FinlandAcademy of FinlandEuropean Commission; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [QLG1-CT-2000-01643]; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction; Prevention and Care (LUCAMP); European UnionEuropean Commission [LSHM-CT-2004-512013, LSHM-CT-2004-005272, LSHM-CT-2006-518153]; Danish Diabetes Association; Danish Agency for Science, Technology and Innovation [271-06-0539]; Canadian Chair in diabetes and metabolism; Fonds de la recherche en sante du QuebecFonds de la Recherche en Sante du Quebec; Montreal General Hospital Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801056B, G0600331, G0801056] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0801056, G0600331] Funding Source: UKRI	This work was funded by Genome Canada, Genome Quebec and the Canada Foundation for Innovation. This work was also supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets Etat-Region), and the following charities: Association Francaise des Diabetiques, Programme National de Recherche sur le Diabete and Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques. The D. E. S. I. R. study has been supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salaries, Lilly, Novartis Pharma and Sanofi-Aventis, Institut National de la Sante et de la Recherche Medicale (INSERM) (Reseaux en Sante Publique, Interactions entre les determinants de la sante), Association Diabete Risque Vasculaire, Federation Francaise de Cardiologie, Fondation de France, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques, Office National Interprofessionnel des Vins, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon. The D. E. S. I. R. Study Group: INSERM U780: B. Balkau, P. Ducimetiere, E. Eschwege; INSERM U367: F. Alhenc-Gelas; Centre Hospitalier Universitaire D'Angers: Y. Gallois, A. Girault; Bichat Hospital: F. Fumeron, M. Marre; Medical Examination Services: Alencon, Angers, Caen, Chateauroux, Cholet, Le Mans and Tours; Research Institute for General Medicine: J. Cogneau; General practitioners of the region; Cross-Regional Institute for Health: C. Born, E. Caces, M. Cailleau, J. G. Moreau, F. Rakotozafy, J. Tichet, S. Vol. The NFBC 1986 study has been supported by the Oulu University Hospital, Finland, the Academy of Finland and the European Commission (Framework 5 award QLG1-CT-2000-01643). The Danish study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP), the European Union (EUGENE2) grant LSHM-CT-2004-512013, EXGENESIS grant LSHM-CT-2004-005272, the Danish Diabetes Association and the Danish Agency for Science, Technology and Innovation, grant no. 271-06-0539. This study was supported in part by a grant from the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European Community). M. P. is the recipient of a Canadian Chair in diabetes and metabolism. R. S. is a Chercheur-boursier of the Fonds de la recherche en sante du Quebec and the recipient of an MGH One Hundred and Seventy-Fifth Anniversary Award from Research Institute of the Montreal General Hospital Foundation. We thank L. Peltonen-Palotie for her contribution in DNA extraction and distribution; M. Deweider and F. Allegaert for the DNA bank management; R. Frechette, V. Catudal, D. Vincent, A. Forman, I.-L. Wantzin, T. Lorentzen, M. Stendal, M. H. Kristensen, T. Brunt and A. L. Nielsen for their technical or management assistance. Large-scale computations were performed using the Consortium Laval, Universite du Quebec, McGill and Eastern Quebec supercomputer facility. We are sincerely indebted to all subjects who participated in this study.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; CLAUSEN JO, 1995, LANCET, V346, P397, DOI 10.1016/S0140-6736(95)92779-4; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Florez JC, 2007, DIABETOLOGIA, V50, P1209, DOI 10.1007/s00125-007-0657-5; Florez JC, 2004, DIABETES, V53, P3313, DOI 10.2337/diabetes.53.12.3313; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jellema A, 2003, DIABETOLOGIA, V46, P990, DOI 10.1007/s00125-003-1126-4; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Poulsen P, 2005, DIABETES, V54, P1289, DOI 10.2337/diabetes.54.5.1289; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2004, DIABETES, V53, P3319, DOI 10.2337/diabetes.53.12.3319; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	312	318	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1110	U89		10.1038/ng.443			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	WOS:000270330400015	19734900				2022-01-24	
J	Northcott, PA; Nakahara, Y; Wu, XC; Feuk, L; Ellison, DW; Croul, S; Mack, S; Kongkham, PN; Peacock, J; Dubuc, A; Ra, YS; Zilberberg, K; Mcleod, J; Scherer, SW; Rao, JS; Eberhart, CG; Grajkowska, W; Gillespie, Y; Lach, B; Grundy, R; Pollack, IF; Hamilton, RL; Van Meter, T; Carlotti, CG; Boop, F; Bigner, D; Gilbertson, RJ; Rutka, JT; Taylor, MD				Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Feuk, Lars; Ellison, David W.; Croul, Sid; Mack, Stephen; Kongkham, Paul N.; Peacock, John; Dubuc, Adrian; Ra, Young-Shin; Zilberberg, Karen; Mcleod, Jessica; Scherer, Stephen W.; Rao, J. Sunil; Eberhart, Charles G.; Grajkowska, Wiesia; Gillespie, Yancey; Lach, Boleslaw; Grundy, Richard; Pollack, Ian F.; Hamilton, Ronald L.; Van Meter, Timothy; Carlotti, Carlos G.; Boop, Frederick; Bigner, Darrell; Gilbertson, Richard J.; Rutka, James T.; Taylor, Michael D.			Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SMALL-MOLECULE INHIBITOR; CEREBELLAR DEVELOPMENT; COMPLEX; CELLS; DIFFERENTIATION; ABNORMALITIES; TRANSCRIPTION; LEUKEMIA; PROTEIN	We used high-resolution SNP genotyping to identify regions of genomic gain and loss in the genomes of 212 medulloblastomas, malignant pediatric brain tumors. We found focal amplifications of 15 known oncogenes and focal deletions of 20 known tumor suppressor genes (TSG), most not previously implicated in medulloblastoma. Notably, we identified previously unknown amplifications and homozygous deletions, including recurrent, mutually exclusive, highly focal genetic events in genes targeting histone lysine methylation, particularly that of histone 3, lysine 9 (H3K9). Post-translational modification of histone proteins is critical for regulation of gene expression, can participate in determination of stem cell fates and has been implicated in carcinogenesis. Consistent with our genetic data, restoration of expression of genes controlling H3K9 methylation greatly diminishes proliferation of medulloblastoma in vitro. Copy number aberrations of genes with critical roles in writing, reading, removing and blocking the state of histone lysine methylation, particularly at H3K9, suggest that defective control of the histone code contributes to the pathogenesis of medulloblastoma.	[Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Mack, Stephen; Kongkham, Paul N.; Peacock, John; Dubuc, Adrian; Ra, Young-Shin; Zilberberg, Karen; Mcleod, Jessica; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Mack, Stephen; Peacock, John; Dubuc, Adrian; Zilberberg, Karen; Mcleod, Jessica; Taylor, Michael D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Northcott, Paul A.; Mack, Stephen; Kongkham, Paul N.; Dubuc, Adrian; Zilberberg, Karen; Rutka, James T.; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Feuk, Lars; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Feuk, Lars; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ellison, David W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Croul, Sid] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Rao, J. Sunil] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Grajkowska, Wiesia] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Gillespie, Yancey] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Lach, Boleslaw] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Grundy, Richard] Univ Nottingham, Nottingham NG7 2RD, England; [Pollack, Ian F.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Van Meter, Timothy] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; [Carlotti, Carlos G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg, Div Neurosurg, Sao Paulo, Brazil; [Boop, Frederick] St Jude Childrens Hosp, Div Pediat Neurosurg, Memphis, TN 38105 USA; [Bigner, Darrell] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA		Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mdtaylor@sickkids.ca	Scherer, Stephen W/B-3785-2013; Gilbertson, Richard James/ABE-1346-2021; Northcott, Paul A/N-4022-2018; Ellison, David/N-4806-2018; Carlotti, Carlos G/C-1608-2012	Scherer, Stephen W/0000-0002-8326-1999; Gilbertson, Richard James/0000-0001-7539-9472; Carlotti, Carlos G/0000-0002-7055-0564; Kongkham, Paul/0000-0002-1047-9305; Taylor, Michael/0000-0001-7009-3466; Grajkowska, Wieslawa/0000-0001-8318-5781; Croul, Sidney/0000-0002-2224-5485; Mack, Stephen C./0000-0001-9620-4742	Hospital for Sick Children Foundation; Neurosurgery Research and Education Foundation; BRAINCHILD; Laurie Berman fund in Brain Tumor Research; American Brain Tumor Association; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Hospital for Sick ChildrenUniversity of Toronto; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA129541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055089] Funding Source: NIH RePORTER	We thank the individuals and families who agreed to take part in these studies. We thank S. Egan, J. Ellis and R. Bremner for critical review of the manuscript. We thank R. Wechsler- Reya (Duke), A. M. Kenney (Memorial- Sloan Kettering) and D. Rowitch (University of California San Francisco) for reagents and helpful discussions. We are grateful to K. Helin (University of Copenhagen) for providing JMJD2C expression constructs. We thank P. Paroutis for artwork and S. Archer for editing. We are grateful to C. Marshall and J. Wei for assistance with copy number analysis. This work was supported by the Canadian Cancer Society and the Pediatric Brain Tumor Foundation. M. D. T. is supported by a Sontag Foundation Distinguished Scholar award. Additional research support was obtained from the Hospital for Sick Children Foundation, The Neurosurgery Research and Education Foundation, BRAINCHILD, the 407 Express Toll Route, and the Walker family. M. D. T. was supported by the Laurie Berman fund in Brain Tumor Research, the American Brain Tumor Association and a ClinicianScientist award from the Canadian Institutes of Health Research. P. A. N. was supported by a Restracomp salary award from the Hospital for Sick Children.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marino S, 2000, GENE DEV, V14, P994; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Olson MV, 2007, CANCER RES, V67, P4005, DOI 10.1158/0008-5472.CAN-06-2973; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Reardon DA, 1997, CANCER RES, V57, P4042; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06	30	312	318	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					465	472		10.1038/ng.336			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	WOS:000264659000022	19270706	Green Accepted			2022-01-24	
J	Weedon, MN; Lettre, G; Freathy, RM; Lindgren, CM; Voight, BF; Perry, JRB; Elliott, KS; Hackett, R; Guiducci, C; Shields, B; Zeggini, E; Lango, H; Lyssenko, V; Timpson, NJ; Burtt, NP; Rayner, NW; Saxena, R; Ardlie, K; Tobias, JH; Ness, AR; Ring, SM; Palmer, CNA; Morris, AD; Peltonen, L; Salomaa, V; Smith, GD; Groop, LC; Hattersley, AT; McCarthy, MI; Hirschhorn, JN; Frayling, TM				Weedon, Michael N.; Lettre, Guillaume; Freathy, Rachel M.; Lindgren, Cecilia M.; Voight, Benjamin F.; Perry, John R. B.; Elliott, Katherine S.; Hackett, Rachel; Guiducci, Candace; Shields, Beverley; Zeggini, Eleftheria; Lango, Hana; Lyssenko, Valeriya; Timpson, Nicholas J.; Burtt, Noel P.; Rayner, Nigel W.; Saxena, Richa; Ardlie, Kristin; Tobias, Jonathan H.; Ness, Andrew R.; Ring, Susan M.; Palmer, Colin N. A.; Morris, Andrew D.; Peltonen, Leena; Salomaa, Veikko; Smith, George Davey; Groop, Leif C.; Hattersley, Andrew T.; McCarthy, Mark I.; Hirschhorn, Joel N.; Frayling, Timothy M.		Diabet Genetics Initiative; Wellcome Trust Case Control Con	A common variant of HMGA2 is associated with adult and childhood height in the general population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY HEIGHT; C GENE; RISK; HERITABILITY; DISEASE; STRATIFICATION; SUSCEPTIBILITY; METHODOLOGY; PHENOTYPE	Human height is a classic, highly heritable quantitative trait. To begin to identify genetic variants influencing height, we examined genome-wide association data from 4,921 individuals. Common variants in the HMGA2 oncogene, exemplified by rs1042725, were associated with height (P= 4x10(-8)). HMGA2 is also a strong biological candidate for height, as rare, severe mutations in this gene alter body size in mice and humans, so we tested rs1042725 in additional samples. We confirmed the association in 19,064 adults from four further studies (P= 3x10(-11), overall P= 4x10(-16), including the genome-wide association data). We also observed the association in children (P=1x 10(-6), N= 6,827) and a tall/short case-control study (P= 4x10(-6), N=3,207). We estimate that rs1042725 explains similar to 0.3% of population variation in height (similar to 0.4 cm increased adult height per C allele). There are few examples of common genetic variants reproducibly associated with human quantitative traits; these results represent, to our knowledge, the first consistently replicated association with adult and childhood height.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Childrens Hosp, Div Genet & Endocrinol, Program Genom, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diab Endocrinol & Metab, Oxford OX3 7LJ, England; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diab & Endocrinol, S-20502 Malmo, Sweden; Univ Helsinki, Helsinki Univ Cent Hosp,Dep Med, Folkhalsan Genet Inst,Folkhalsan Res Ctr, Res Program Mol Med, Helsinki, Finland; Univ Bristol, MRC Ctr Causal Analyses Translat Epidemiol, Bristol BS8 2PR, Avon, England; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Bristol, Clin Sci S Bristol, Bristol BS2 8AE, Avon, England; Univ Bristol, Bristol Dent Sch, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Dundee, Ninewells Hosp, Sch Med,Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp, Sch Med, Div Med & Therapeut,Diab Res Grp, Dundee DD1 9SY, Scotland; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FI-00300 Helsinki, Finland; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA		Frayling, TM (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Saxena, Richa/AAG-7279-2020; Tobias, Jon/E-2832-2014; Timpson, Nicholas John/O-7548-2015; Ness, Andy R/M-7612-2013; Voight, Benjamin/F-1775-2011; Allen, Hana Lango/G-9026-2012; Berryman, Katie/J-4236-2014; Davey Smith, George/A-7407-2013; Morris, Andrew D/C-2837-2009; Attrill, Lauren/V-1688-2018; Palmer, Colin NA/C-7053-2008; Fox, Laura J/C-6249-2016; Study, GoDARTS/K-9448-2016; McCarthy, Mark/M-3763-2015	Tobias, Jon/0000-0002-7475-3932; Timpson, Nicholas John/0000-0002-7141-9189; Ness, Andy R/0000-0003-3548-9523; Allen, Hana Lango/0000-0002-7803-8688; Davey Smith, George/0000-0002-1407-8314; Palmer, Colin NA/0000-0002-6415-6560; Freathy, Rachel/0000-0003-4152-2238; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lindgren, Cecilia/0000-0002-4903-9374; McCarthy, Mark/0000-0002-4393-0510; Weedon, Michael/0000-0002-6174-6135; Hattersley, Andrew/0000-0001-5620-473X; Frayling, Timothy/0000-0001-8362-2603; s, hema/0000-0002-3440-9475; Zeggini, Eleftheria/0000-0003-4238-659X; Saxena, Richa/0000-0003-2233-1065	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0500070, G9815508(74882), G9815508, G0600705] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01 HG004171] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [076113, 090532, 079557, 072960, GR072960, 076467] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600705, G0500070] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004171] Funding Source: NIH RePORTER		Battista S, 1999, CANCER RES, V59, P4793; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Ruyter-Spira CP, 1998, J HERED, V89, P295, DOI 10.1093/jhered/89.4.295; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	30	312	328	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1245	1250		10.1038/ng2121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	WOS:000249737400020	17767157	Green Accepted, Green Published			2022-01-24	
J	Barrick, JE; Breaker, RR				Barrick, Jeffrey E.; Breaker, Ronald R.			The distributions, mechanisms, and structures of metabolite-binding riboswitches	GENOME BIOLOGY			English	Article							CONTROLS GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; COMPARATIVE GENOMICS; LIGAND-BINDING; TRANSCRIPTION TERMINATION; LYSINE BIOSYNTHESIS; TRANSPORT GENES; RIBOSOMAL-RNA; BOX REGULON; BACTERIA	Background: Riboswitches are noncoding RNA structures that appropriately regulate genes in response to changing cellular conditions. The expression of many proteins involved in fundamental metabolic processes is controlled by riboswitches that sense relevant small molecule ligands. Metabolite-binding riboswitches that recognize adenosylcobalamin (AdoCbl), thiamin pyrophosphate (TPP), lysine, glycine, flavin mononucleotide (FMN), guanine, adenine, glucosamine-6-phosphate (GlcN6P), 7-aminoethyl 7-deazaguanine (preQ(I)), and S-adenosylmethionine (SAM) have been reported. Results: We have used covariance model searches to identify examples of ten widespread riboswitch classes in the genomes of organisms from all three domains of life. This data set rigorously defines the phylogenetic distributions of these riboswitch classes and reveals how their gene control mechanisms vary across different microbial groups. By examining the expanded aptamer sequence alignments resulting from these searches, we have also re-evaluated and refined their consensus secondary structures. Updated riboswitch structure models highlight additional RNA structure motifs, including an unusual double T-loop arrangement common to AdoCbl and FMN riboswitch aptamers, and incorporate new, sometimes noncanonical, base-base interactions predicted by a mutual information analysis. Conclusion: Riboswitches are vital components of many genomes. The additional riboswitch variants and updated aptamer structure models reported here will improve future efforts to annotate these widespread regulatory RNAs in genomic sequences and inform ongoing structural biology efforts. There remain significant questions about what physiological and evolutionary forces influence the distributions and mechanisms of riboswitches and about what forms of regulation substitute for riboswitches that appear to be missing in certain lineages.	[Barrick, Jeffrey E.; Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Barrick, Jeffrey E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA		Breaker, RR (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Breaker, Ronald/0000-0002-2165-536X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R33DK070270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM068819] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R33 DK070270, DK070270] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM068819, R01 GM068819] Funding Source: Medline		Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Altman S, 2005, P NATL ACAD SCI USA, V102, P11284, DOI 10.1073/pnas.0505271102; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; BREAKER RR, 2005, RNA WORLD, P89; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gold L, 2002, CHEM BIOL, V9, P1259, DOI 10.1016/S1074-5521(02)00286-7; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; Gutell RR, 2000, J MOL BIOL, V300, P791, DOI 10.1006/jmbi.2000.3900; Hampel KJ, 2006, BIOCHEMISTRY-US, V45, P7861, DOI 10.1021/bi060337z; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; *INF, INF RNA AL; Jansen JA, 2006, NAT STRUCT MOL BIOL, V13, P517, DOI 10.1038/nsmb1094; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Lee JC, 2003, J MOL BIOL, V325, P65, DOI 10.1016/S0022-2836(02)01106-3; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Leontis NB, 2002, BIOCHIMIE, V84, P961, DOI 10.1016/S0300-9084(02)01463-3; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Lindgreen S, 2006, BIOINFORMATICS, V22, P2988, DOI 10.1093/bioinformatics/btl514; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Madigan M.T., 2003, BROCK BIOL MICROORGA, V10th; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Mira A, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-50; MirandaRios J, 1997, J BACTERIOL, V179, P6887, DOI 10.1128/jb.179.22.6887-6893.1997; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; RICHTERDAHLFORS AA, 1992, MOL MICROBIOL, V6, P743, DOI 10.1111/j.1365-2958.1992.tb01524.x; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Soukup GA, 2006, NUCLEIC ACIDS RES, V34, P968, DOI 10.1093/nar/gkj497; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Unniraman S, 2002, NUCLEIC ACIDS RES, V30, P675, DOI 10.1093/nar/30.3.675; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Wan XF, 2005, J COMPUT SCI TECH-CH, V20, P465, DOI 10.1007/s11390-005-0465-7; Weinberg Z, 2006, BIOINFORMATICS, V22, P35, DOI 10.1093/bioinformatics/bti743; WEINBERG Z, 2004, P 8 ANN INT C COMP M, P243; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Weinberg Z, 2004, BIOINFORMATICS, V20, P334, DOI 10.1093/bioinformatics/bth925; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2005, ARCH MICROBIOL, V183, P151, DOI 10.1007/s00203-005-0758-9; Winkler WC, 2001, RNA, V7, P1165, DOI 10.1017/S1355838201002370; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	97	312	324	4	71	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2007	8	11							R239	10.1186/gb-2007-8-11-r239			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	247SQ	WOS:000252101100013	17997835	Green Published, hybrid			2022-01-24	
J	Kanno, T; Huettel, B; Mette, MF; Aufsatz, W; Jaligot, E; Daxinger, L; Kreil, DP; Matzke, M; Matzke, AJM				Kanno, T; Huettel, B; Mette, MF; Aufsatz, W; Jaligot, E; Daxinger, L; Kreil, DP; Matzke, M; Matzke, AJM			Atypical RNA polymerase subunits required for RNA-directed DNA methylation	NATURE GENETICS			English	Article							SMALL INTERFERING RNA; HUMAN-CELLS; GENE; ARABIDOPSIS; TRANSCRIPTION; TRANSPOSON; THALIANA; NUCLEAR; VIRUS	RNA- directed DNA methylation, one of several RNA interference - mediated pathways in the nucleus(1), has been documented in plants(2,3) and in human cells(4,5). Despite progress in identifying the DNA methyltransferases, histone-modifying enzymes and RNA interference proteins needed for RNA- directed DNA methylation(1), the mechanism remains incompletely understood. We screened for mutants defective in RNA- directed DNA methylation and silencing of a transgene promoter in Arabidopsis thaliana and identified three drd complementation groups(6). DRD1 is a SNF2- like protein(6) required for RNA- directed de novo methylation. We report here that DRD2 and DRD3 correspond to the second- largest subunit and largest subunit, respectively, of a fourth class of DNA- dependent RNA polymerase ( polymerase IV) that is unique to plants. DRD3 is a functionally diversified homolog of NRPD1a or SDE4, identified in a separate screen for mutants defective in post- transcriptional gene silencing(7,8). The identical DNA methylation patterns observed in all three drd mutants suggest that DRD proteins cooperate to create a substrate for RNA- directed de novo methylation.	Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, A-1090 Vienna, Austria; IAM, WWTF Vienna Sci Chair Bioinformat, Dept Biotechnol, A-1190 Vienna, Austria		Matzke, M (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, UZA2,Althanstr 14-2D-541, A-1090 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Daxinger, Lucia/A-6840-2013; Matzke, Antonius/H-8698-2015; Jaligot, Estelle/A-9035-2011; Kreil, D/O-1783-2013; Matzke, Marjori/H-8689-2015	Jaligot, Estelle/0000-0002-9252-5271; Kreil, D/0000-0001-7538-2056; Daxinger, Lucia/0000-0001-6557-6201			Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bellaoui M, 2004, PLANTA, V219, P819, DOI 10.1007/s00425-004-1295-5; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; KANNO T, IN PRESS EMBO REP; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zorio DAR, 2001, CURR BIOL, V11, pR144, DOI 10.1016/S0960-9822(01)00063-X	29	312	326	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2005	37	7					761	765		10.1038/ng1580			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	WOS:000230196400025	15924141				2022-01-24	
J	Dill, A; Sun, TP				Dill, A; Sun, TP			Synergistic derepression of gibberellin signaling by removing RGA and GAI function in Arabidopsis thaliana	GENETICS			English	Article							ALEURONE PROTOPLASTS; PLASMA-MEMBRANE; ALPHA-SUBUNIT; DWARF MUTANTS; ABSCISIC-ACID; L HEYNH; GENE; TRANSDUCTION; ENCODES; PROTEIN	RGA and GAI are negative regulators of the gibberellin (CA) signal transduction pathway in Arabidopsis thaliana. These genes may have partially redundant functions because they are highly homologous, and plants containing single null mutations at these loci are phenotypically similar to wild type. Previously, rga loss-of-function Mutations were shown to partially suppress defects of the GA-deficient ga1-3 mutant. Phenotypes rescued include abaxial trichome initiation, rosette radius, flowering time, stem elongation, and apical dominance. Here we present work showing that the rga-24 and gai-t6 null mutations have a synergistic effect on plant growth. Although gai-t6 alone has little effect, when combined, with rga-24, they completely rescued the above defects of ga1-3 to wild-type or GA-overdose phenotype. However, seed germination and flower development defects were not restored. Additionally, rga-24 and rga-24/gai-t6 but not gai-t6 alone caused increased feedback inhibition of expression of a GA biosynthetic gene in both the ga1-3 and wild-type backgrounds. These results demonstrate that RGA and GAIhave partially redundant functions in maintaining the repressive state of the CA-signa-ling pathway, but RGA plays a more dominant role than GAL Removing both RGA and GAI function allows for complete derepression of many aspects of GA signaling.	Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Durham, NC 27708 USA		Sun, TP (corresponding author), Duke Univ, Dept Biol, Dev Cell & Mol Biol Grp, Box 91000, Durham, NC 27708 USA.						Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Chandler PM, 1999, PLANT PHYSIOL, V120, P623, DOI 10.1104/pp.120.2.623; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Cowling RJ, 1998, PLANT PHYSIOL, V117, P1195, DOI 10.1104/pp.117.4.1195; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; GILROY S, 1994, PLANT PHYSIOL, V104, P1185, DOI 10.1104/pp.104.4.1185; Harberd NP, 1998, BIOESSAYS, V20, P1001, DOI 10.1002/(SICI)1521-1878(199812)20:12&lt;1001::AID-BIES6&gt;3.0.CO;2-O; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; HOOLEY R, 1991, PLANTA, V183, P274, DOI 10.1007/BF00197799; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; KOORNNEEF M, 1985, PHYSIOL PLANTARUM, V65, P33, DOI 10.1111/j.1399-3054.1985.tb02355.x; LANAHAN MB, 1988, PLANTA, V175, P107, DOI 10.1007/BF00402887; Lovegrove A, 2000, TRENDS PLANT SCI, V5, P102, DOI 10.1016/S1360-1385(00)01571-5; MITSUNAGA S, 1994, THEOR APPL GENET, V87, P705, DOI 10.1007/BF00222896; Ogawa M, 2000, GENE, V245, P21, DOI 10.1016/S0378-1119(00)00018-4; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Phillips AL, 1998, PLANT PHYSIOL BIOCH, V36, P115, DOI 10.1016/S0981-9428(98)80096-X; PHINNEY BO, 1956, P NATL ACAD SCI USA, V42, P185, DOI 10.1073/pnas.42.4.185; POTTS WC, 1985, PHYSIOL PLANTARUM, V63, P357, DOI 10.1111/j.1399-3054.1985.tb02310.x; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Sanchez-Fernandez R, 1998, J EXP BOT, V49, P1609, DOI 10.1093/jexbot/49.326.1609; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Silverstone AL, 1997, GENETICS, V146, P1087; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2000, CURR OPIN PLANT BIOL, V3, P374, DOI 10.1016/S1369-5266(00)00099-6; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251	41	312	350	2	62	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	OCT	2001	159	2					777	785					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	485GJ	WOS:000171744900030	11606552				2022-01-24	
J	Smith, AN; Skaug, J; Choate, KA; Nayir, A; Bakkaloglu, A; Ozen, S; Hulton, SA; Sanjad, SA; Al-Sabban, EA; Lifton, RP; Scherer, SW; Karet, FE				Smith, AN; Skaug, J; Choate, KA; Nayir, A; Bakkaloglu, A; Ozen, S; Hulton, SA; Sanjad, SA; Al-Sabban, EA; Lifton, RP; Scherer, SW; Karet, FE			Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing	NATURE GENETICS			English	Article							H+-ATPASE; GENE; HYPERTENSION; LINKAGE; VPH1P	The multi-subunit H+-ATPase pump is present at particularly high density on the apical (luminal) surface of alpha-intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification(1). The complete subunit composition of the apical ATPase, however, has not been fully agreed upon. Functional failure of alpha-intercalated cells results in a group of disorders, the distal renal tubular acidoses (dRTA), whose features include metabolic acidosis accompanied by disturbances of potassium balance, urinary calcium solubility, bone physiology and growth(2). Mutations in the gene encoding the B-subunit of the apical pump (ATP6B1) cause dRTA accompanied by deafness(3). We previously localized a gene for dRTA with preserved hearing to 7q33-34 (ref. 4). We report here the identification of this gene, ATP6N1B, which encodes an 840 amino acid novel kidney-specific isoform of ATP6N1A, the 116-kD non-catalytic accessory subunit of the proton pump. Northern-blot analysis demonstrated ATP6N1B expression in kidney but not other main organs. Immunofluorescence studies in human kidney cortex revealed that ATP6N1B localizes almost exclusively to the apical surface of alpha-intercalated cells. We screened nine dRTA kindreds with normal audiometry that linked to the ATP6N1B locus, and identified different homozygous mutations in ATP6N1B in eight. These include nonsense, deletion and splice-site changes, all of which will truncate the protein. Our findings identify a new kidney-specific proton pump 116-kD accessory subunit that is highly expressed in proton-secreting cells in the distal nephron, and illustrate its essential role in normal vectorial acid transport into the urine by the kidney.	Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge, England; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Istanbul Univ, Dept Pediat Nephrol, Istanbul, Turkey; Univ Hacettepe, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England; Amer Univ Beirut, Dept Pediat, Med Ctr, Beirut, Lebanon; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia		Karet, FE (corresponding author), Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge, England.		NAYIR, AHMET NEVZAT/A-9276-2019; Scherer, Stephen W/B-3785-2013; OZEN, SEZA/I-9096-2013	Scherer, Stephen W/0000-0002-8326-1999; Karet, Fiona/0000-0002-2457-2869			Bastani B, 1996, MINER ELECTROL METAB, V22, P396; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRODY LC, 1995, GENOMICS, V25, P238, DOI 10.1016/0888-7543(95)80131-5; Brown D, 2000, AM J PHYSIOL-RENAL, V278, pF192, DOI 10.1152/ajprenal.2000.278.2.F192; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GILLESPIE J, 1991, FEBS LETT, V282, P69, DOI 10.1016/0014-5793(91)80446-A; GLUCK S, 1987, J BIOL CHEM, V262, P15780; Gluck SL, 1996, ANNU REV PHYSIOL, V58, P427, DOI 10.1146/annurev.physiol.58.1.427; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; Karet FE, 1999, AM J HUM GENET, V65, P1656, DOI 10.1086/302679; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; MUNROE DJ, 1994, GENOMICS, V19, P506, DOI 10.1006/geno.1994.1100; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; PENG SB, 1994, J BIOL CHEM, V269, P17262; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X	21	312	323	2	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					71	75		10.1038/79208			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000021	10973252				2022-01-24	
J	Wassif, CA; Maslen, C; Kachilele-Linjewile, S; Lin, D; Linck, LM; Connor, WE; Steiner, RD; Porter, FD				Wassif, CA; Maslen, C; Kachilele-Linjewile, S; Lin, D; Linck, LM; Connor, WE; Steiner, RD; Porter, FD			Mutations in the human sterol Delta(7)-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE CHOLESTEROL-BIOSYNTHESIS; PLASMA; YEAST	The Smith-Lemli-Opitz syndrome (SLOS; also known as "RSH syndrome" [MIM 270400]) is an autosomal recessive multiple malformation syndrome due to a defect in cholesterol biosynthesis. Children with SLOS have elevated serum 7-dehydrocholesterol (7-DHC) levels and typically have low serum cholesterol levels. On the basis of this biochemical abnormality, it has been proposed that mutations in the human sterol Delta(7)-reductase (7-DHC reductase; E.C.1.3.1.21) gene cause SLOS. However, one could also propose a defect in a gene that encodes a protein necessary for either the expression or normal function of sterol Delta(7)-reductase. We cloned cDNA encoding a human sterol Delta(7)-reductase (DHCR7) on the basis of its homology with the sterol Delta(7)-reductase from Arabidopsis thaliana, and we confirmed the enzymatic function of the human gene product by expression in SLOS fibroblasts. SLOS fibroblasts transfected with human sterol Delta(7)-reductase cDNA showed a significant reduction in 7-DHC levels, compared with those in SLOS fibroblasts transfected with the vector alone. Using radiation-hybrid mapping, we show that the DHCR7 gene is encoded at chromosome 11q12-13. To establish that defects in this gene cause SLOS, we sequenced cDNA clones from SLOS patients. In three unrelated patients we have identified four different mutant alleles. Our results demonstrate both that the cDNA that we have identified encodes the human sterol Delta(7)-reductase and that mutations in DHCR7 are responsible for at least some cases of SLOS.	NICHHD, Heritable Disorders Branch, NIH, Unit Mol Dysmorphol, Bethesda, MD 20892 USA; Oregon Hlth Sci Univ, Congenital Heart Res Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Med, Div Endocrinol Diabet Clin Nutr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Doembecher Childrens Hosp, Child Dev & Rehabil Ctr, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Doembecher Childrens Hosp, Child Dev & Rehabil Ctr, Dept Mol & Med Genet, Portland, OR 97201 USA		Porter, FD (corresponding author), NICHHD, Heritable Disorders Branch, NIH, Unit Mol Dysmorphol, Bldg 10,Room 9S241,10 Ctr Dr, Bethesda, MD 20892 USA.		Steiner, Robert D./AAJ-5756-2020	Steiner, Robert D./0000-0003-4177-4590; Wassif, Christopher/0000-0002-2524-1420	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5 M01 RR 00334] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000334] Funding Source: NIH RePORTER		ALLEY TL, 1995, AM J HUM GENET, V56, P1411; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BERRY R, 1989, AM J MED GENET, V34, P358, DOI 10.1002/ajmg.1320340312; BIALER MG, 1987, AM J MED GENET, V28, P723, DOI 10.1002/ajmg.1320280320; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.3.CO;2-5; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; Dehart DB, 1997, AM J MED GENET, V68, P328, DOI 10.1002/(SICI)1096-8628(19970131)68:3<328::AID-AJMG15>3.0.CO;2-V; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORLIN RJ, 1990, OXFORD MONOGRAMS MED, V19, P890; IRONS M, 1993, LANCET, V341, P1414, DOI 10.1016/0140-6736(93)90983-N; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; LEI KJ, 1992, MOL ENDOCRINOL, V6, P703, DOI 10.1210/me.6.5.703; LIN DS, 1993, J LIPID RES, V34, P491; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; NATOWICZ MR, 1994, AM J MED GENET, V50, P364, DOI 10.1002/ajmg.1320500413; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; ROUX C, 1980, J NUTR, V110, P2310, DOI 10.1093/jn/110.11.2310; Scherer SW, 1997, GENOMICS, V44, P232, DOI 10.1006/geno.1997.4842; SHEFER S, 1995, J CLIN INVEST, V96, P1779, DOI 10.1172/JCI118223; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; TINT GS, 1995, J PEDIATR-US, V127, P82, DOI 10.1016/S0022-3476(95)70261-X; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205	27	312	318	0	10	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					55	62		10.1086/301936			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	WOS:000074761000010	9634533	Green Published, Bronze			2022-01-24	
J	XU, H; WU, XR; WEWER, UM; ENGVALL, E				XU, H; WU, XR; WEWER, UM; ENGVALL, E			MURINE MUSCULAR-DYSTROPHY CAUSED BY A MUTATION IN THE LAMININ ALPHA-2 (LAMA2) GENE	NATURE GENETICS			English	Article							A-CHAIN; EPIDERMOLYSIS-BULLOSA; MOLECULAR-GENETICS; MEROSIN; PROTEIN; LOCALIZATION; EXPRESSION; JUNCTION; VARIANTS; CLONING	The classic murine muscular dystrophy strain, dy, was first described almost 40 years ago. We have identified the molecular basis of an allele of dy, called dy(2J), by detecting a mutation in the laminin alpha 2 chain gene - the first identified mutation in laminin-2. The G to A mutation in a splice site consensus sequence causes abnormal splicing and expression of multiple mRNAs. One mRNA is translated into an alpha 2 polypeptide with a deletion in domain VI. The truncated protein apparently lacks important qualities of the wild type protein and is unable to provide sufficient muscle stability.	LA JOLLA CANC RES FDN,LA JOLLA,CA 92037; UNIV STOCKHOLM,WENNER GREN INST,DEPT DEV BIOL,S-10691 STOCKHOLM,SWEDEN; UNIV COPENHAGEN,INST PATHOL ANAT,DK-2100 COPENHAGEN,DENMARK								ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; AMBRUSTMACHER VW, 1994, PATHOLOGY, P1349; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CHANG AC, 1993, J IMMUNOL, V151, P1789; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; ENGVALL E, 1992, EXP CELL RES, V198, P115, DOI 10.1016/0014-4827(92)90156-3; ENGVALL E, 1983, ARCH BIOCHEM BIOPHYS, V222, P649, DOI 10.1016/0003-9861(83)90562-3; ENGVALL E, 1993, KIDNEY INT, V43, P2, DOI 10.1038/ki.1993.2; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FARNOUD MR, 1994, LAB INVEST, V70, P399; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cb.07.110191.003015; HAAPARANTA T, 1991, MATRIX, V11, P151, DOI 10.1016/S0934-8832(11)80153-8; HAGG T, 1989, NEURON, V3, P721, DOI 10.1016/0896-6273(89)90241-9; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; LELVO I, 1988, P NATL ACAD SCI USA, V85, P1544; MACPIKE AD, 1976, P SOC EXP BIOL MED, V151, P670, DOI 10.3181/00379727-151-39283; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MELER H, 1970, LIFE SCI, V9, P137; MICHELSON AM, 1955, P NATL ACAD SCI USA, V41, P1079, DOI 10.1073/pnas.41.12.1079; NISSINEN M, 1991, BIOCHEM J, V276, P369, DOI 10.1042/bj2760369; PAULSSON M, 1991, J BIOL CHEM, V266, P17545; PUIKKINEN L, 1994, NAT GENET, V6, P293; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SIMONASSMANN P, 1994, DEV DYNAM, V201, P71, DOI 10.1002/aja.1002010108; STIRLING CA, 1975, J ANAT, V119, P169; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; UTANI A, 1994, J BIOL CHEM, V269, P19167; VUOLTEENAHO R, 1994, J CELL BIOL, V124, P381, DOI 10.1083/jcb.124.3.381; WEINBERG HJ, 1975, BRAIN RES, V88, P532, DOI 10.1016/0006-8993(75)90666-6; WEST WT, 1960, ANAT REC, V137, P279, DOI 10.1002/ar.1091370306; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286	40	312	316	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					297	302		10.1038/ng1194-297			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	WOS:A1994PP76500022	7874173				2022-01-24	
J	MOULTON, T; CRENSHAW, T; HAO, Y; MOOSIKASUWAN, J; LIN, N; DEMBITZER, F; HENSLE, T; WEISS, L; MCMORROW, L; LOEW, T; KRAUS, W; GERALD, W; TYCKO, B				MOULTON, T; CRENSHAW, T; HAO, Y; MOOSIKASUWAN, J; LIN, N; DEMBITZER, F; HENSLE, T; WEISS, L; MCMORROW, L; LOEW, T; KRAUS, W; GERALD, W; TYCKO, B			EPIGENETIC LESIONS AT THE H19 LOCUS IN WILMS-TUMOR PATIENTS	NATURE GENETICS			English	Article							GROWTH FACTOR-II; BECKWITH-WIEDEMANN SYNDROME; REPEAT POLYMORPHISM; HUMAN CANCERS; GENE; EXPRESSION; MOUSE; RNA; CELLS; HYPOMETHYLATION	To test the potential role of H19 as a tumour suppressor gene we have examined its expression and DNA methylation in Wilms' tumours (WTs). In most WTs (18/25), H19 RNA was reduced at least 20-fold from fetal kidney levels. Of the expression-negative tumours ten retained 11p15.5 heterozygosity: in nine of these, H19 DNA was biallelically hypermethylated and in two cases hypermethylation locally restricted to H19 sequences was also present in the non-neoplastic kidney parenchyma. IGF2 mRNA was expressed in most but not all WTs and expression patterns were consistent with IGF2/H19 enhancer competition without obligate inverse coupling. These observations implicate genetic and epigenetic inactivation of H19 in Wilms' tumorigenesis.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV ONCOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV NEUROPATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT SURG,DIV PEDIAT SURG,NEW YORK,NY 10032; CITY HOPE NATL MED CTR,DEPT PATHOL,DUARTE,CA 91010; UNIV MED & DENT NEW JERSEY,COOPER HOSP,MED CTR,DEPT PEDIAT,DIV HEMATOL ONCOL,CAMDEN,NJ 08103; SO ILLINOIS UNIV,SCH MED,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,SPRINGFIELD,IL 62702; SCOTTISH RITE CHILDRENS HOSP,DEPT PEDIAT,DIV GENET,ATLANTA,GA 30342; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021								BACCARINI P, 1993, AM J PATHOL, V143, P1535; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; COPPES MJ, 1992, GENE CHROMOSOME CANC, V5, P326, DOI 10.1002/gcc.2870050408; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FIDLER AE, 1992, LANCET, V339, P243, DOI 10.1016/0140-6736(92)90042-2; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; HAN DKM, 1992, CIRC RES, V71, P711, DOI 10.1161/01.RES.71.3.711; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; HASELBACHER GK, 1987, P NATL ACAD SCI USA, V84, P1104, DOI 10.1073/pnas.84.4.1104; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; KLINEDINST DK, 1991, MUTAT RES, V250, P365, DOI 10.1016/0027-5107(91)90193-R; LITTLE MH, 1992, EUR J CANCER, V28A, P1876, DOI 10.1016/0959-8049(92)90027-Y; LUSTIG O, IN PRESS MOL REP DEV; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; POIRIER F, 1991, DEVELOPMENT, V113, P1105; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P3753, DOI 10.1093/nar/19.13.3753-a; RACHMILEWITZ J, 1992, MOL REPROD DEV, V32, P196, DOI 10.1002/mrd.1080320303; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; Riggins Gregory J., 1992, Human Molecular Genetics, V1, P775, DOI 10.1093/hmg/1.9.775; SCOTT J, 1985, NATURE, V317, P260, DOI 10.1038/317260a0; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; TYCKO B, 1994, AM J PATHOL, V144, P431; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WILES MV, 1988, DEVELOPMENT, V104, P403; YANDELL DW, 1986, SOMAT CELL MOLEC GEN, V12, P255, DOI 10.1007/BF01570784; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	40	312	318	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					440	447		10.1038/ng0794-440			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	WOS:A1994NU30600022	7920666				2022-01-24	
J	JOUTEL, A; BOUSSER, MG; BIOUSSE, V; LABAUGE, P; CHABRIAT, H; NIBBIO, A; MACIAZEK, J; MEYER, B; BACH, MA; WEISSENBACH, J; LATHROP, GM; TOURNIERLASSERVE, E				JOUTEL, A; BOUSSER, MG; BIOUSSE, V; LABAUGE, P; CHABRIAT, H; NIBBIO, A; MACIAZEK, J; MEYER, B; BACH, MA; WEISSENBACH, J; LATHROP, GM; TOURNIERLASSERVE, E			A GENE FOR FAMILIAL HEMIPLEGIC MIGRAINE MAPS TO CHROMOSOME-19	NATURE GENETICS			English	Article							LINKAGE; COMA	Familial hemiplegic migraine is an autosomal dominant disorder of unknown pathogenesis in which the migrainous attacks are marked by the occurrence of a transient hemiplegia during the aura, While investigating CADASIL, mapped previously to chromosome 19, we observed that some patients had recurrent attacks of migraine with aura. Although the clinical and neuroimaging features of familial hemiplegic migraine differ markedly from CADASIL, we hypothesized that the same gene could be involved in the pathogenesis of both conditions. We chose two large pedigrees for linkage analysis of familial hemiplegic migraine. A maximum lod score > 8 was found with two markers that are also strongly linked to CADASIL. Multilocus linkage analysis suggested that the loci responsible for the two diseases reside within an interval of about 30 cM on chromosome 19.	UNIV PARIS 05,PATHOL IMMUNITE LAB,156 RUE VAUGIRARD,F-75730 PARIS 15,FRANCE; HOP ST ANTOINE,SERV NEUROL,F-75571 PARIS 12,FRANCE; CHU MONTPELLIER,NEUROL CLIN,F-34059 MONTPELLIER,FRANCE; INST PASTEUR,UNITE GENET MOLEC HUMAINE,CNRS,URA 1445,F-75724 PARIS 15,FRANCE; CEPH,INSERM,U358,PARIS,FRANCE; GENETHON,F-91000 EURY,FRANCE				Joutel, Anne/K-5601-2017; Chabriat, Hugues/G-5699-2010	Joutel, Anne/0000-0003-3963-3860; Chabriat, Hugues/0000-0001-8436-6074			BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; BLAU JN, 1955, LANCET, V2, P1115; Clarke J M, 1910, Br Med J, V1, P1534; CODINA A, 1971, REV NEUROL, V124, P526; FITZSIMONS RB, 1985, BRAIN, V108, P555, DOI 10.1093/brain/108.3.555-a; GLISTA GG, 1975, MAYO CLIN PROC, V50, P307; HENRY P, 1990, Circulation et Metabolisme du Cerveau, V7, P229; LANCE JW, 1982, MECHANISM MANAGEMENT; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MUNTE TF, 1990, J NEUROL, V237, P59, DOI 10.1007/BF00319672; OHTA M, 1967, NEUROLOGY, V17, P813, DOI 10.1212/WNL.17.8.813; PAGES M, 1993, SEM HOP PARIS, V12, P337; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; TOURNIERLASSERVE E, 1991, STROKE, V22, P1297, DOI 10.1161/01.STR.22.10.1297; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITTY CWM, 1953, J NEUROL NEUROSUR PS, V16, P172, DOI 10.1136/jnnp.16.3.172; YOUNG GF, 1970, ARCH NEUROL-CHICAGO, V23, P201, DOI 10.1001/archneur.1970.00480270011002; ZIFKIN B, 1980, ANN NEUROL, V8, P329, DOI 10.1002/ana.410080319; 1988, CEPHALALGIA S7, V8, P19	20	312	316	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					40	45		10.1038/ng0993-40			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	WOS:A1993LV56500013	8220421				2022-01-24	
J	Browning, BL; Zhou, Y; Browning, SR				Browning, Brian L.; Zhou, Ying; Browning, Sharon R.			A One-Penny Imputed Genome from Next-Generation Reference Panels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE IMPUTATION; WIDE ASSOCIATION; GENETIC-VARIATION; HAPLOTYPE MAP; POPULATIONS	Genotype imputation is commonly performed in genome-wide association studies because it greatly increases the number of markers that can be tested for association with a trait. In general, one should perform genotype imputation using the largest reference panel that is available because the number of accurately imputed variants increases with reference panel size. However, one impediment to using larger reference panels is the increased computational cost of imputation. We present a new genotype imputation method, Beagle 5.0, which greatly reduces the computational cost of imputation from large reference panels. We compare Beagle 5.0 with Beagle 4.1, Impute4, Minimac3, and Minimac4 using 1000 Genomes Project data, Haplotype Reference Consortium data, and simulated data for 10k, 100k, 1M, and 10M reference samples. All methods produce nearly identical accuracy, but Beagle 5.0 has the lowest computation time and the best scaling of computation time with increasing reference panel size. For 10k, 100k, 1M, and 10M reference samples and 1,000 phased target samples, Beagle 5.0' s computation time is 33 (10k), 123 (100k), 433 (1M), and 5333 (10M) faster than the fastest alternative method. Cost data from the Amazon Elastic Compute Cloud show that Beagle 5.0 can perform genome-wide imputation from 10M reference samples into 1,000 phased target samples at a cost of less than one US cent per sample.	[Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Browning, Brian L.; Zhou, Ying; Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Browning, BL (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.; Browning, BL (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	browning@uw.edu	Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010; Zhou, Ying/AAT-2949-2020; Browning, Brian/ABC-4543-2021	Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633; Zhou, Ying/0000-0002-8107-3927; 	National Human Genome Research Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG008359]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG008359] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under award number R01HG008359. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Brody JA, 2017, NAT GENET, V49, P1560, DOI 10.1038/ng.3968; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Bycroft C., 2017, GENOME WIDE GENETIC, P166298, DOI DOI 10.1101/166298; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Lappalainen I, 2015, NAT GENET, V47, P692, DOI 10.1038/ng.3312; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li N, 2003, GENETICS, V165, P2213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McClure Matthew, 2012, Frontiers in Genetics, V3, P140, DOI 10.3389/fgene.2012.00140; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	32	311	316	6	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					338	348		10.1016/j.ajhg.2018.07.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	WOS:000443819500003	30100085	Green Published, Green Submitted, Bronze	Y	N	2022-01-24	
J	Miotto, O; Almagro-Garcia, J; Manske, M; MacInnis, B; Campino, S; Rockett, KA; Amaratunga, C; Lim, P; Suon, S; Sreng, S; Anderson, JM; Duong, S; Nguon, C; Chuor, CM; Saunders, D; Se, Y; Lon, C; Fukuda, MM; Amenga-Etego, L; Hodgson, AVO; Asoala, V; Imwong, M; Takala-Harrison, S; Nosten, F; Su, XZ; Ringwald, P; Ariey, F; Dolecek, C; Hien, TT; Boni, MF; Thai, CQ; Amambua-Ngwa, A; Conway, DJ; Djimde, AA; Doumbo, OK; Zongo, I; Ouedraogo, JB; Alcock, D; Drury, E; Auburn, S; Koch, O; Sanders, M; Hubbart, C; Maslen, G; Ruano-Rubio, V; Jyothi, D; Miles, A; O'Brien, J; Gamble, C; Oyola, SO; Rayner, JC; Newbold, CI; Berriman, M; Spencer, CCA; McVean, G; Day, NP; White, NJ; Bethell, D; Dondorp, AM; Plowe, CV; Fairhurst, RM; Kwiatkowski, DP				Miotto, Olivo; Almagro-Garcia, Jacob; Manske, Magnus; MacInnis, Bronwyn; Campino, Susana; Rockett, Kirk A.; Amaratunga, Chanaki; Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Anderson, Jennifer M.; Duong, Socheat; Nguon, Chea; Chuor, Char Meng; Saunders, David; Se, Youry; Lon, Chantap; Fukuda, Mark M.; Amenga-Etego, Lucas; Hodgson, Abraham V. O.; Asoala, Victor; Imwong, Mallika; Takala-Harrison, Shannon; Nosten, Francois; Su, Xin-zhuan; Ringwald, Pascal; Ariey, Frederic; Dolecek, Christiane; Tran Tinh Hien; Boni, Maciej F.; Cao Quang Thai; Amambua-Ngwa, Alfred; Conway, David J.; Djimde, Abdoulaye A.; Doumbo, Ogobara K.; Zongo, Issaka; Ouedraogo, Jean-Bosco; Alcock, Daniel; Drury, Eleanor; Auburn, Sarah; Koch, Oliver; Sanders, Mandy; Hubbart, Christina; Maslen, Gareth; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Miles, Alistair; O'Brien, John; Gamble, Chris; Oyola, Samuel O.; Rayner, Julian C.; Newbold, Chris I.; Berriman, Matthew; Spencer, Chris C. A.; McVean, Gilean; Day, Nicholas P.; White, Nicholas J.; Bethell, Delia; Dondorp, Arjen M.; Plowe, Christopher V.; Fairhurst, Rick M.; Kwiatkowski, Dominic P.			Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia	NATURE GENETICS			English	Article							CHLOROQUINE RESISTANCE; PARASITE CLEARANCE; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; DRUG-RESISTANCE; MALARIA; SPREAD; PYRIMETHAMINE; PFCRT; GENE	We describe an analysis of genome variation in 825 P. falciparum samples from Asia and Africa that identifies an unusual pattern of parasite population structure at the epicenter of artemisinin resistance in western Cambodia. Within this relatively small geographic area, we have discovered several distinct but apparently sympatric parasite subpopulations with extremely high levels of genetic differentiation. Of particular interest are three subpopulations, all associated with clinical resistance to artemisinin, which have skewed allele frequency spectra and high levels of haplotype homozygosity, indicative of founder effects and recent population expansion. We provide a catalog of SNPs that show high levels of differentiation in the artemisinin-resistant subpopulations, including codon variants in transporter proteins and DNA mismatch repair proteins. These data provide a population-level genetic framework for investigating the biological origins of artemisinin resistance and for defining molecular markers to assist in its elimination.	[Miotto, Olivo; Almagro-Garcia, Jacob; Rockett, Kirk A.; Amenga-Etego, Lucas; Koch, Oliver; Miles, Alistair; Newbold, Chris I.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo; Imwong, Mallika; Nosten, Francois; Day, Nicholas P.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Miotto, Olivo; Almagro-Garcia, Jacob; Manske, Magnus; MacInnis, Bronwyn; Campino, Susana; Rockett, Kirk A.; Alcock, Daniel; Drury, Eleanor; Sanders, Mandy; Maslen, Gareth; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Oyola, Samuel O.; Rayner, Julian C.; Newbold, Chris I.; Berriman, Matthew; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Almagro-Garcia, Jacob; Rockett, Kirk A.; Hubbart, Christina; Ruano-Rubio, Valentin; Miles, Alistair; O'Brien, John; Spencer, Chris C. A.; McVean, Gilean; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Amaratunga, Chanaki; Lim, Pharath; Anderson, Jennifer M.; Su, Xin-zhuan; Fairhurst, Rick M.] NIAID, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Duong, Socheat; Nguon, Chea; Chuor, Char Meng] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Saunders, David; Fukuda, Mark M.; Bethell, Delia] US Army Med Component, Armed Forces Res Inst Med Sci USAMC AFRIMS, Dept Immunol & Med, Bangkok, Thailand; [Se, Youry; Lon, Chantap] USAMC AFRIMS, Phnom Penh, Cambodia; [Fukuda, Mark M.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Amenga-Etego, Lucas; Hodgson, Abraham V. O.; Asoala, Victor] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Takala-Harrison, Shannon; Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Nosten, Francois; Dolecek, Christiane; Tran Tinh Hien; Boni, Maciej F.; Day, Nicholas P.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Ctr Trop Med, Oxford, England; [Ringwald, Pascal] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Ariey, Frederic] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Dolecek, Christiane; Tran Tinh Hien; Boni, Maciej F.; Cao Quang Thai] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Amambua-Ngwa, Alfred; Conway, David J.] MRC Labs, Fajara, Gambia; [Conway, David J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Djimde, Abdoulaye A.; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Fac Pharm, Malaria Res & Training Ctr, Bamako, Mali; [Zongo, Issaka; Ouedraogo, Jean-Bosco] Direct Reg Ouest, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Gamble, Chris] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Newbold, Chris I.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England		Kwiatkowski, DP (corresponding author), Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England.	dominic@sanger.ac.uk	Miotto, Olivo/AAE-7124-2019; White, Nick/AAC-6527-2019; Berriman, Matthew/A-7618-2011; Mead, Daniel/AAE-6629-2019; Lim, Pharath/AAF-6699-2020; Nosten, Francois/AAC-5509-2019; ariey, frederic/P-1185-2017; Amambua-Ngwa, Alfred/ABA-7305-2020; Jyothi, Dushyanth/H-9517-2014; Campino, Susana/AAM-2577-2020; Koch, Oliver/A-9480-2016; Imwong, Mallika/ABE-6493-2020; Auburn, Sarah/N-2266-2013	White, Nick/0000-0002-1897-1978; Berriman, Matthew/0000-0002-9581-0377; Mead, Daniel/0000-0001-7717-4330; Nosten, Francois/0000-0002-7951-0745; ariey, frederic/0000-0002-0680-1090; Jyothi, Dushyanth/0000-0002-0448-5303; Campino, Susana/0000-0003-1403-6138; Su, Xinzhuan/0000-0003-3246-3248; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Auburn, Sarah/0000-0002-4638-536X; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Conway, David/0000-0002-8711-3037; Takala-Harrison, Shannon/0000-0003-4674-8500; Manske, Magnus/0000-0001-5916-0947; Miles, Alistair/0000-0001-9018-4680; Koch, Oliver/0000-0003-3454-2855; McVean, Gil/0000-0002-5012-4162; Maslen, Gareth/0000-0001-7318-3678; Kwiatkowski, Dominic/0000-0002-5023-0176; Lim, Pharath/0000-0002-1012-2461; Miotto, Olivo/0000-0001-8060-6771; Rayner, Julian/0000-0002-9835-1014; Oyola, Samuel O./0000-0002-6425-7345; Newbold, Chris/0000-0002-9274-3789	Wellcome Trust through core funding of the Wellcome Trust Sanger Institute [098051]; Wellcome Trust through core funding of the Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; Wellcome Trust through a Strategic AwardWellcome Trust [090770/Z/09/Z]; MRC through the MRC Centre for Genomics and Global HealthUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600718]; MRC through an MRC ProfessorshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G19/9]; Wellcome TrustWellcome TrustEuropean Commission; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute International ScholarshipHoward Hughes Medical Institute [55005502]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G19/9, MC_EX_MR/K02440X/1, MC_U190081987, G0600718] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_EX_MR/K02440X/1, G0600718, G19/9, 1252410, MC_U190081987] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [ZIAAI001000, ZIAAI001066, R01AI101713, ZIAAI000892] Funding Source: NIH RePORTER	We would like to thank V. Cornelius and R. Giacomantonio for their support in producing and reviewing this manuscript; S. Uk and E.S. Phelps for their contributions in the Cambodian studies; and T. Anderson for helpful review comments. The sequencing, genotyping and analysis components of this study were supported by the Wellcome Trust through core funding of the Wellcome Trust Sanger Institute (098051), core funding of the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and a Strategic Award (090770/Z/09/Z) and the MRC through the MRC Centre for Genomics and Global Health (G0600718) and an MRC Professorship to D.P.K. (G19/9). Other parts of this study were partly supported by the Wellcome Trust; the MRC; the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; and a Howard Hughes Medical Institute International Scholarship (55005502) to A.A.D. P.R. is a staff member of the World Health Organization; he alone is responsible for the views expressed in this publication, and they do not necessarily represent the decisions, policy or views of the World Health Organization.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Isozumi R, 2010, J CLIN MICROBIOL, V48, P70, DOI 10.1128/JCM.01449-09; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lim P, 2003, ANTIMICROB AGENTS CH, V47, P87, DOI 10.1128/AAC.47.1.87-94.2003; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plowe Christopher V, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS11, DOI 10.1016/j.trstmh.2008.11.002; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Shankar J, 2008, GENE, V410, P223, DOI 10.1016/j.gene.2007.12.015; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0; WHO, 2011, GLOB PLAN ART RES CO	45	311	316	0	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					648	+		10.1038/ng.2624			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	WOS:000319563900012	23624527	Green Accepted			2022-01-24	
J	Adler, CJ; Dobney, K; Weyrich, LS; Kaidonis, J; Walker, AW; Haak, W; Bradshaw, CJA; Townsend, G; Soltysiak, A; Alt, KW; Parkhill, J; Cooper, A				Adler, Christina J.; Dobney, Keith; Weyrich, Laura S.; Kaidonis, John; Walker, Alan W.; Haak, Wolfgang; Bradshaw, Corey J. A.; Townsend, Grant; Soltysiak, Arkadiusz; Alt, Kurt W.; Parkhill, Julian; Cooper, Alan			Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions	NATURE GENETICS			English	Article							16S RIBOSOMAL-RNA; BACTERIAL COMMUNITY COMPOSITION; PERIODONTAL-DISEASE; DIVERSITY; CALCULUS; TRANSMISSION; RESILIENCE; CARIES; DNA	The importance of commensal microbes for human health is increasingly recognized(1-5), yet the impacts of evolutionary changes in human diet and culture on commensal microbiota remain almost unknown. Two of the greatest dietary shifts in human evolution involved the adoption of carbohydrate-rich Neolithic (farming) diets(6,7) (beginning similar to 10,000 years before the present(6,8)) and the more recent advent of industrially processed flour and sugar (in similar to 1850)(9). Here, we show that calcified dental plaque (dental calculus) on ancient teeth preserves a detailed genetic record throughout this period. Data from 34 early European skeletons indicate that the transition from hunter-gatherer to farming shifted the oral microbial community to a disease-associated configuration. The composition of oral microbiota remained unexpectedly constant between Neolithic and medieval times, after which (the now ubiquitous) cariogenic bacteria became dominant, apparently during the Industrial Revolution. Modern oral microbiotic ecosystems are markedly less diverse than historic populations, which might be contributing to chronic oral (and other) disease in postindustrial lifestyles.	[Adler, Christina J.; Weyrich, Laura S.; Haak, Wolfgang; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Adler, Christina J.; Weyrich, Laura S.; Haak, Wolfgang; Bradshaw, Corey J. A.; Cooper, Alan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Adler, Christina J.] Univ Sydney, Inst Dent Res, Westmead Millennium Inst, Fac Dent, Sydney, NSW 2006, Australia; [Dobney, Keith] Univ Aberdeen, Dept Archaeol, Sch Geosci, Aberdeen, Scotland; [Kaidonis, John; Townsend, Grant] Univ Adelaide, Sch Dent, Adelaide, SA, Australia; [Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] South Australian Res & Dev Inst, Henley Beach, SA, Australia; [Soltysiak, Arkadiusz] Univ Warsaw, Dept Bioarchaeol, Inst Archaeol, Warsaw, Poland; [Alt, Kurt W.] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany		Cooper, A (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia.	alan.cooper@adelaide.edu.au	Cooper, Alan/E-8171-2012; Bradshaw, Corey J.A./A-1311-2008; Haak, Wolfgang/C-2362-2014; Parkhill, Julian/G-4703-2011; Walker, Alan W./AAE-8102-2019; Haak, Wolfgang/Z-4947-2019	Cooper, Alan/0000-0002-7738-7851; Bradshaw, Corey J.A./0000-0002-5328-7741; Haak, Wolfgang/0000-0003-2475-2007; Parkhill, Julian/0000-0002-7069-5958; Walker, Alan W./0000-0001-5099-8495; Haak, Wolfgang/0000-0003-2475-2007; Adler, Christina/0000-0002-4731-5291; Soltysiak, Arkadiusz/0000-0002-9040-5022; Weyrich, Laura/0000-0001-5243-4634; Dobney, Keith/0000-0001-9036-4681	Australian Research CouncilAustralian Research Council; Wellcome TrustWellcome TrustEuropean Commission [WT092799/Z/10/Z, WT098051]; Sir Mark Mitchell Foundation	We thank the Australian Research Council, the Wellcome Trust (WT092799/Z/10/Z and WT098051) and the Sir Mark Mitchell Foundation for funding support.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Asikainen S, 1996, ORAL MICROBIOL IMMUN, V11, P387, DOI 10.1111/j.1399-302X.1996.tb00200.x; Aufderheide A.C., 1998, CAMBRIDGE ENCY HUMAN; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Beier S, 2008, APPL ENVIRON MICROB, V74, P188, DOI 10.1128/AEM.00327-07; BRAIDWOOD R, 1961, SCIENCE, V133, P2008, DOI 10.1126/science.133.3469.2008; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Childe VG, 1925, DAWN EUROPEAN CIVILI; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dave S, 2008, ORAL DIS, V14, P95, DOI 10.1111/j.1601-0825.2007.01438.x; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; GRINE FE, 1990, ARCH ORAL BIOL, V35, P381, DOI 10.1016/0003-9969(90)90185-D; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Kerr NW, 1998, J PERIODONTAL RES, V33, P131; La Duc MT, 2004, MICROB ECOL, V47, P150, DOI 10.1007/s00248-003-1012-0; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lieverse AR, 1999, INT J OSTEOARCHAEOL, V9, P219, DOI 10.1002/(SICI)1099-1212(199907/08)9:4<219::AID-OA475>3.0.CO;2-V; Lilley J., 1994, ARCHAEOLOGY YORK, V12, P291; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MARSH P D, 1991, Proceedings of the Finnish Dental Society, V87, P515; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Marsh Philip D, 2010, Dent Clin North Am, V54, P441, DOI 10.1016/j.cden.2010.03.002; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; Oelze VM, 2011, J ARCHAEOL SCI, V38, P270, DOI 10.1016/j.jas.2010.08.027; Petchey OL, 2009, THEOR ECOL-NETH, V2, P177, DOI 10.1007/s12080-009-0041-9; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Preus HR, 2011, J ARCHAEOL SCI, V38, P1827, DOI 10.1016/j.jas.2011.03.020; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/nmeth.1361, 10.1038/NMETH.1361]; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Scott GR, 2012, J ARCHAEOL SCI, V39, P1388, DOI 10.1016/j.jas.2011.09.029; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VANDERMEERSCH B, 1994, CR ACAD SCI II, V319, P727; VANSTEENBERGEN TJM, 1993, J MED MICROBIOL, V39, P416, DOI 10.1099/00222615-39-6-416; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	50	311	321	6	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					450	455		10.1038/ng.2536			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	115VS	WOS:000316840600018	23416520	Green Accepted, Green Submitted			2022-01-24	
J	Earl, D; Bradnam, K; St John, J; Darling, A; Lin, DW; Fass, J; Hung, OKY; Buffalo, V; Zerbino, DR; Diekhans, M; Nguyen, N; Ariyaratne, PN; Sung, WK; Ning, ZM; Haimel, M; Simpson, JT; Fonseca, NA; Birol, I; Docking, TR; Ho, IY; Rokhsar, DS; Chikhi, R; Lavenier, D; Chapuis, G; Naquin, D; Maillet, N; Schatz, MC; Kelley, DR; Phillippy, AM; Koren, S; Yang, SP; Wu, W; Chou, WC; Srivastava, A; Shaw, TI; Ruby, JG; Skewes-Cox, P; Betegon, M; Dimon, MT; Solovyev, V; Seledtsov, I; Kosarev, P; Vorobyev, D; Ramirez-Gonzalez, R; Leggett, R; MacLean, D; Xia, FF; Luo, RB; Li, ZY; Xie, YL; Liu, BH; Gnerre, S; MacCallum, I; Przybylski, D; Ribeiro, FJ; Yin, SY; Sharpe, T; Hall, G; Kersey, PJ; Durbin, R; Jackman, SD; Chapman, JA; Huang, XQ; DeRisi, JL; Caccamo, M; Li, YR; Jaffe, DB; Green, RE; Haussler, D; Korf, I; Paten, B				Earl, Dent; Bradnam, Keith; St John, John; Darling, Aaron; Lin, Dawei; Fass, Joseph; Hung On Ken Yu; Buffalo, Vince; Zerbino, Daniel R.; Diekhans, Mark; Ngan Nguyen; Ariyaratne, Pramila Nuwantha; Sung, Wing-Kin; Ning, Zemin; Haimel, Matthias; Simpson, Jared T.; Fonseca, Nuno A.; Birol, Inanc; Docking, T. Roderick; Ho, Isaac Y.; Rokhsar, Daniel S.; Chikhi, Rayan; Lavenier, Dominique; Chapuis, Guillaume; Naquin, Delphine; Maillet, Nicolas; Schatz, Michael C.; Kelley, David R.; Phillippy, Adam M.; Koren, Sergey; Yang, Shiaw-Pyng; Wu, Wei; Chou, Wen-Chi; Srivastava, Anuj; Shaw, Timothy I.; Ruby, J. Graham; Skewes-Cox, Peter; Betegon, Miguel; Dimon, Michelle T.; Solovyev, Victor; Seledtsov, Igor; Kosarev, Petr; Vorobyev, Denis; Ramirez-Gonzalez, Ricardo; Leggett, Richard; MacLean, Dan; Xia, Fangfang; Luo, Ruibang; Li, Zhenyu; Xie, Yinlong; Liu, Binghang; Gnerre, Sante; MacCallum, Iain; Przybylski, Dariusz; Ribeiro, Filipe J.; Yin, Shuangye; Sharpe, Ted; Hall, Giles; Kersey, Paul J.; Durbin, Richard; Jackman, Shaun D.; Chapman, Jarrod A.; Huang, Xiaoqiu; DeRisi, Joseph L.; Caccamo, Mario; Li, Yingrui; Jaffe, David B.; Green, Richard E.; Haussler, David; Korf, Ian; Paten, Benedict			Assemblathon 1: A competitive assessment of de novo short read assembly methods	GENOME RESEARCH			English	Article							SHORT DNA-SEQUENCES; STRING GRAPH; GENOME; ALIGNMENT; ALGORITHMS; ACCURACY; MILLIONS; BASE	Low-cost short read sequencing technology has revolutionized genomics, though it is only just becoming practical for the high-quality de novo assembly of a novel large genome. We describe the Assemblathon 1 competition, which aimed to comprehensively assess the state of the art in de novo assembly methods when applied to current sequencing technologies. In a collaborative effort, teams were asked to assemble a simulated Illumina HiSeq data set of an unknown, simulated diploid genome. A total of 41 assemblies from 17 different groups were received. Novel haplotype aware assessments of coverage, contiguity, structure, base calling, and copy number were made. We establish that within this benchmark: ( 1) It is possible to assemble the genome to a high level of coverage and accuracy, and that ( 2) large differences exist between the assemblies, suggesting room for further improvements in current methods. The simulated benchmark, including the correct answer, the assemblies, and the code that was used to evaluate the assemblies is now public and freely available from http://www.assemblathon.org/.	[Earl, Dent; St John, John; Diekhans, Mark; Ngan Nguyen; Haussler, David; Paten, Benedict] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Earl, Dent; St John, John; Zerbino, Daniel R.; Diekhans, Mark; Ngan Nguyen; Green, Richard E.; Haussler, David; Paten, Benedict] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Bradnam, Keith; Darling, Aaron; Lin, Dawei; Fass, Joseph; Hung On Ken Yu; Buffalo, Vince; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Lin, Dawei; Fass, Joseph; Buffalo, Vince] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ariyaratne, Pramila Nuwantha; Sung, Wing-Kin] Genome Inst Singapore, Computat & Math Biol Grp, Singapore 119077, Singapore; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 119077, Singapore; [Ning, Zemin; Simpson, Jared T.; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Haimel, Matthias; Kersey, Paul J.] EMBL EBI, Cambridge CB10 1SA, England; [Fonseca, Nuno A.] Univ Porto, CRACS INESC Porto LA, P-4169007 Oporto, Portugal; [Birol, Inanc; Docking, T. Roderick; Jackman, Shaun D.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Ho, Isaac Y.; Rokhsar, Daniel S.; Chapman, Jarrod A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chikhi, Rayan; Lavenier, Dominique; Chapuis, Guillaume] ENS Cachan IRISA, Dept Comp Sci, F-35042 Rennes, France; [Chikhi, Rayan; Lavenier, Dominique; Chapuis, Guillaume; Naquin, Delphine; Maillet, Nicolas] IRISA, CNRS Symbiose, F-35042 Rennes, France; [Lavenier, Dominique; Naquin, Delphine; Maillet, Nicolas] INRIA, F-35042 Rennes, France; [Schatz, Michael C.] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA; [Kelley, David R.; Phillippy, Adam M.; Koren, Sergey] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Phillippy, Adam M.; Koren, Sergey] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD 20702 USA; [Yang, Shiaw-Pyng; Wu, Wei] Monsanto Co, Chesterfield, MO 63017 USA; [Chou, Wen-Chi; Srivastava, Anuj; Shaw, Timothy I.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Ruby, J. Graham; Skewes-Cox, Peter; Betegon, Miguel; Dimon, Michelle T.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Skewes-Cox, Peter] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA 94143 USA; [Ruby, J. Graham; Skewes-Cox, Peter; Betegon, Miguel; Dimon, Michelle T.; DeRisi, Joseph L.; Haussler, David] Howard Hughes Med Inst, Bethesda, MD 20814 USA; [Solovyev, Victor] Univ London, Dept Comp Sci, London WC1E 7HU, England; [Seledtsov, Igor; Kosarev, Petr; Vorobyev, Denis] Softberry Inc, Mt Kisco, NY 10549 USA; [Ramirez-Gonzalez, Ricardo; Caccamo, Mario] Norwich Res Pk, Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Leggett, Richard; MacLean, Dan] Norwich Res Pk, Sainsbury Lab, Norwich NR4 71H, Norfolk, England; [Xia, Fangfang] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Luo, Ruibang; Li, Zhenyu; Xie, Yinlong; Liu, Binghang; Li, Yingrui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Gnerre, Sante; MacCallum, Iain; Przybylski, Dariusz; Ribeiro, Filipe J.; Yin, Shuangye; Sharpe, Ted; Hall, Giles; Jaffe, David B.] Broad Inst, Cambridge, MA 02142 USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; [Korf, Ian] Univ Calif Davis, Genome Ctr, Santa Cruz, CA 95064 USA		Paten, B (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	benedict@soe.ucsc.edu	Ning, Zemin/D-2411-2013; Yin, Shuangye/C-3707-2009; Koren, Sergey/AAE-8314-2019; Ramirez, Ricardo/H-4808-2019; Darling, Aaron/G-8119-2017; Durbin, Richard/AAE-7178-2019; Birol, Inanc/G-5440-2011; INESC-TEC, CRACS/F-7527-2012; Srivastava, Anuj/L-4705-2019; Li, Yingrui/K-1064-2015; Schatz, Michael/L-2690-2019; Phillippy, Adam M/U-5731-2018; MacLean, Dan/C-7046-2013; Fonseca, Nuno A./B-7801-2009; Maillet, Nicolas/AAN-8085-2020; Solovyev, Victor/C-4614-2013; Shaw, Timothy I/AAE-8523-2019; Buffalo, Vince/J-1647-2019; Bradnam, Keith/A-5570-2009; Jackman, Shaun/G-9622-2013	Yin, Shuangye/0000-0002-2779-2584; Ramirez, Ricardo/0000-0001-5745-7085; Durbin, Richard/0000-0002-9130-1006; Birol, Inanc/0000-0003-0950-7839; Schatz, Michael/0000-0002-4118-4446; Phillippy, Adam M/0000-0003-2983-8934; MacLean, Dan/0000-0003-1032-0887; Fonseca, Nuno A./0000-0003-4832-578X; Solovyev, Victor/0000-0001-8885-493X; Shaw, Timothy I/0000-0002-9316-1924; Buffalo, Vince/0000-0003-4510-1609; Ning, Zemin/0000-0003-4359-776X; Green, Richard/0000-0003-0516-5827; Vorobyev, Denis/0000-0001-5471-3477; Leggett, Richard/0000-0003-3044-4297; Zerbino, Daniel/0000-0001-5350-3056; Luo, Ruibang/0000-0001-9711-6533; Chou, Wen-Chi/0000-0001-8408-3533; Bradnam, Keith/0000-0002-3881-294X; Haimel, Matthias/0000-0002-0320-0214; Betegon, Miguel/0000-0001-7625-6190; Darling, Aaron/0000-0003-2397-7925; Koren, Sergey/0000-0002-1472-8962; Rokhsar, Daniel/0000-0002-8704-2224; Docking, Rod/0000-0003-3248-4081; Kersey, Paul/0000-0002-7054-800X; Skewes-Cox, Peter/0000-0003-1633-5190; Sung, Wing-Kin/0000-0001-7806-7086; Naquin, Delphine/0000-0001-9174-4686; Jackman, Shaun/0000-0002-9275-5966	NHGRIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004695, U41HG004568, P41HG002371, U54HG004555]; NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1U24CA143858-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HG00064]; Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30725008, 30890032, 30811130531, 30221004]; National Basic Research Program of China (973 program)National Basic Research Program of China [2011CB809200]; Chinese 863 programNational High Technology Research and Development Program of China [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; NSFNational Science Foundation (NSF) [DBI 0821263, EF-0949453];  [PTDC/BIA-BEC/100616/2008];  [PTDC/EIA-EIA/100897/2008]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA143858] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG004555, P41HG002371, R01HG003474, U01HG004695, U41HG004568] Funding Source: NIH RePORTER	We thank Robert Edgar, Arend Sidow, and George Asimenos for their help with using Evolver. We thank three anonymous reviewers for comments and discussion on previous versions of this manuscript. We acknowledge the following grants: ENCODE DAC (data analysis center) subaward on NHGRI grant no. U01HG004695 to the European Bioinformatics Institute; ENCODE DCC (data coordination center) NHGRI grant no. U41HG004568; Browser (Center for Genomic Science) NHGRI grant no. P41HG002371; GENCODE subaward on NHGRI grant no. U54HG004555 to the Sanger Center; NCI 1U24CA143858-01; NIH HG00064; PTDC/BIA-BEC/100616/2008; PTDC/EIA-EIA/100897/2008; the Fundacao para a Ciencia e Tecnologia; National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004); a National Basic Research Program of China (973 program no. 2011CB809200); the Chinese 863 program (2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707); NSF, Major Research Instrumentation grant DBI 0821263 (University of Georgia Georgia Advanced Computing Resource Center), and NSF EF-0949453.	Alekseyev MA, 2009, GENOME RES, V19, P943, DOI 10.1101/gr.082784.108; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bergeron A, 2006, J COMPUT BIOL, V13, P567, DOI 10.1089/cmb.2006.13.567; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Du J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000432; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Holmes I, 1998, J COMPUT BIOL, V5, P493, DOI 10.1089/cmb.1998.5.493; Hubisz MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017034; Huson D., 2001, P WORKSH ALG BIOINF, P294; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; KENT W, 2000, UCSCCRL0017; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Medvedev P, 2009, J COMPUT BIOL, V16, P1101, DOI 10.1089/cmb.2009.0047; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; PANDEY V, 2008, APPL BIOSYSTEMS SOLI, P29; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Paten B, 2011, J COMPUT BIOL, V18, P469, DOI 10.1089/cmb.2010.0252; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Worley KC, 2010, NATURE, V463, P303, DOI 10.1038/463303a; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	73	311	319	1	81	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	DEC	2011	21	12					2224	2241		10.1101/gr.126599.111			18	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	860AU	WOS:000297918600021	21926179	Bronze, Green Published			2022-01-24	
J	Kiemeney, LA; Thorlacius, S; Sulem, P; Geller, F; Aben, KKH; Stacey, SN; Gudmundsson, J; Jakobsdottir, M; Bergthorsson, JT; Sigurdsson, A; Blondal, T; Witjes, JA; Vermeulen, SH; Hulsbergen-van de Kaa, CA; Swinkels, DW; Ploeg, M; Cornel, EB; Vergunst, H; Thorgeirsson, TE; Gudbjartsson, D; Gudjonsson, SA; Thorleifsson, G; Kristinsson, KT; Mouy, M; Snorradottir, S; Placidi, D; Campagna, M; Arici, C; Koppova, K; Gurzau, E; Rudnai, P; Kellen, E; Polidoro, S; Guarrera, S; Sacerdote, C; Sanchez, M; Saez, B; Valdivia, G; Ryk, C; De Verdier, P; Lindblom, A; Golka, K; Bishop, DT; Knowles, MA; Nikulasson, S; Petursdottir, V; Jonsson, E; Geirsson, G; Kristjansson, B; Mayordomo, JI; Steineck, G; Porru, S; Buntinx, F; Zeegers, MP; Fletcher, T; Kumar, R; Matullo, G; Vineis, P; Kiltie, AE; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Rafnar, T; Stefansson, K				Kiemeney, Lambertus A.; Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Aben, Katja K. H.; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Witjes, J. Alfred; Vermeulen, Sita H.; Hulsbergen-van de Kaa, Christina A.; Swinkels, Dorine W.; Ploeg, Martine; Cornel, Erik B.; Vergunst, Henk; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Koppova, Kvetoslava; Gurzau, Eugene; Rudnai, Peter; Kellen, Eliane; Polidoro, Silvia; Guarrera, Simonetta; Sacerdote, Carlotta; Sanchez, Manuel; Saez, Berta; Valdivia, Gabriel; Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika; Golka, Klaus; Bishop, D. Timothy; Knowles, Margaret A.; Nikulasson, Sigfus; Petursdottir, Vigdis; Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin; Mayordomo, Jose I.; Steineck, Gunnar; Porru, Stefano; Buntinx, Frank; Zeegers, Maurice P.; Fletcher, Tony; Kumar, Rajiv; Matullo, Giuseppe; Vineis, Paolo; Kiltie, Anne E.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari			Sequence variant on 8q24 confers susceptibility to urinary bladder cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UROTHELIAL CELL-CARCINOMA; PROSTATE-CANCER; LUNG-CANCER; NICOTINE DEPENDENCE; GENE-EXPRESSION; P63 EXPRESSION; BREAST-CANCER; RISK; DISEASE	We conducted a genome-wide SNP association study on 1,803 urinary bladder cancer (UBC) cases and 34,336 controls from Iceland and The Netherlands and follow up studies in seven additional case-control groups (2,165 cases and 3,800 controls). The strongest association was observed with allele T of rs9642880 on chromosome 8q24, 30 kb upstream of MYC (allele-specific odds ratio (OR) = 1.22; P = 9.34 x 10(-12)). Approximately 20% of individuals of European ancestry are homozygous for rs9642880[T], and their estimated risk of developing UBC is 1.49 times that of noncarriers. No association was observed between UBC and the four 8q24 variants previously associated with prostate, colorectal and breast cancers, nor did rs9642880 associate with any of these three cancers. A weaker signal, but nonetheless of genome-wide significance, was captured by rs710521[A] located near TP63 on chromosome 3q28 (allele-specific OR = 1.19; P = 1.15 x 10(-7)).	[Kiemeney, Lambertus A.; Aben, Katja K. H.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred; Ploeg, Martine] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; [Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Hulsbergen-van de Kaa, Christina A.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [Cornel, Erik B.] Streekziekenhuis Midden Twente, Dept Urol, NL-7550 AM Hengelo, Netherlands; [Vergunst, Henk] Canisius Wilhelmina Ziekenhuis, Dept Urol, NL-6500 GS Nijmegen, Netherlands; [Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Porru, Stefano] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Med & Ind Hyg, I-25125 Brescia, Italy; [Koppova, Kvetoslava] State Hlth Inst, SK-97556 Banska Bystrica, Slovakia; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca 400166, Romania; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Kellen, Eliane; Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium; [Kellen, Eliane] Catholic Univ Louvain, Ctr Canc Prevent LUCK, B-3000 Louvain, Belgium; [Polidoro, Silvia; Matullo, Giuseppe; Vineis, Paolo] ISI Fdn, Turin, Italy; [Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, I-10123 Turin, Italy; Ctr Canc Epidemiol & Prevent CPO Piemonte, I-10123 Turin, Italy; [Sanchez, Manuel] Univ Hosp, Div Urol, Zaragoza 50009, Spain; [Valdivia, Gabriel] Univ Zaragoza, Sch Med, Dept Urol, E-50009 Zaragoza, Spain; [Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Golka, Klaus] Univ Dortmund, Inst Occupat Physiol, Dortmund, Germany; [Bishop, D. Timothy] St James Univ Hosp, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Knowles, Margaret A.; Kiltie, Anne E.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Leeds LS9 7TF, W Yorkshire, England; [Nikulasson, Sigfus; Petursdottir, Vigdis] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Mayordomo, Jose I.] Hlth Sci Inst, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; [Steineck, Gunnar] Karolinska Hosp, Dept Oncol & Pathol, S-17176 Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden; [Buntinx, Frank] Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Zeegers, Maurice P.] Univ Birmingham, Dept Publ Hlth & Epidemiol, Unit Genet Epidemiol, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice P.] Nutr & Toxicol Res Inst, Dept Complex Genet, NL-6200 MD Maastricht, Netherlands; [Fletcher, Tony] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland		Stefansson, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands.	b.kiemeney@ebh.umcn.nl; kstefans@decode.is	Mayordomo, Jose/K-3453-2013; Stefansson, Kari/AAE-7187-2019; Campagna, Marcello/L-1011-2016; Swinkels, Dorine W./H-8098-2014; Kumar, Rajiv/H-6431-2019; Aben, Katja KH/G-9686-2016; Steineck, Gunnar/W-1515-2019; Matullo, Giuseppe/K-6383-2016; Witjes, Fred/N-9665-2013; Kiemeney, Lambertus A./D-3357-2009; de Kaa, Christina A Hulsbergen-van/L-4399-2015; Arici, Cecilia/AAO-7689-2020; Buntinx, Frank/E-4950-2011; Guarrera, Simonetta/AAB-8482-2022; Vermeulen, S.H.H.M./L-4716-2015; Placidi, Donatella/A-6965-2011; Fletcher, Tony/D-2394-2011	Campagna, Marcello/0000-0002-5277-8477; Swinkels, Dorine W./0000-0002-1040-9446; Kumar, Rajiv/0000-0002-6093-0395; Aben, Katja KH/0000-0002-0214-2147; Steineck, Gunnar/0000-0002-0787-3969; Matullo, Giuseppe/0000-0003-0674-7757; Kiemeney, Lambertus A./0000-0002-2368-1326; Arici, Cecilia/0000-0003-1493-590X; Placidi, Donatella/0000-0003-1606-5397; Ryk, Charlotta/0000-0002-7881-7614; Bergthorsson, Jon Thor/0000-0002-0560-2639; Knowles, Margaret/0000-0002-9363-8657; Bishop, Tim/0000-0002-8752-8785; Kiltie, Anne/0000-0001-7208-2912; Saez, Berta/0000-0003-0753-1165; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Geller, Frank/0000-0002-9238-3269; Sacerdote, Carlotta/0000-0002-8008-5096; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Fletcher, Tony/0000-0003-3385-200X; Gudbjartsson, Daniel/0000-0002-5222-9857; Gurzau, Eugen/0000-0002-8688-6118; Zeegers, Maurice/0000-0002-2387-083X	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [LSHC-CT-2005-018827, LSHM-CT-2004-005166]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-DA017932]; Radboud University Nijmegen Medical Centre; Cancer Research UKCancer Research UK; Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European UnionEuropean Commission [513943]; compagnia di San PaoloCompagnia di San Paolo; Italian Association for Cancer Research, ItalyFondazione AIRC per la ricerca sul cancro; Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA017932] Funding Source: NIH RePORTER	We thank the individuals that participated in the study and whose contribution made this work possible. We also thank the nurses at Noatun (deCODE's participant recruitment center) and the personnel at the deCODE core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic UBC cases. Collection of samples and data in Iceland and The Netherlands was funded in part by the European Commission (POLYGENE: LSHC-CT-2005-018827 and GENADDICT: LSHM-CT-2004-005166), the National Institute of Health (R01-DA017932) and a research investment grant of the Radboud University Nijmegen Medical Centre. The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety'' (Contract No 513943); by a grant of the compagnia di San Paolo, the Italian Association for Cancer Research, Italy and the Piedmont Region Progetti di Ricerca Sanitaria Finalizzata.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Koga F, 2003, CLIN CANCER RES, V9, P5501; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; *NAT CANC I DIV CA, 2007, SURV EP END RES PROG; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	30	311	319	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1307	1312		10.1038/ng.229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	WOS:000260501500022	18794855	Green Accepted			2022-01-24	
J	Merner, ND; Hodgkinson, KA; Haywood, AFM; Connors, S; French, VM; Drenckhahn, JD; Kupprion, C; Ramadanova, K; Thierfelder, L; McKenna, W; Gallagher, B; Morris-Larkin, L; Bassett, AS; Parfrey, PS; Young, TL				Merner, Nancy D.; Hodgkinson, Kathy A.; Haywood, Annika F. M.; Connors, Sean; French, Vanessa M.; Drenckhahn, Joerg-Detlef; Kupprion, Christine; Ramadanova, Kalina; Thierfelder, Ludwig; McKenna, William; Gallagher, Barry; Morris-Larkin, Lynn; Bassett, Anne S.; Parfrey, Patrick S.; Young, Terry-Lynn			Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERM FOLLOW-UP; ECHOCARDIOGRAPHIC MEASUREMENTS; DYSPLASIA; DYSPLASIA/CARDIOMYOPATHY; INVOLVEMENT; FAMILIES; IDENTIFICATION; NEWFOUNDLAND; ASSOCIATION; POPULATION	Autosomal-dominant arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) causes sudden cardiac death and is characterized by clinical and genetic heterogeneity. Fifteen unrelated ARVC families with a disease-associated haplotype on chromosome 3p (ARVD5) were ascertained from a genetically isolated population. Identification of key recombination events reduced the disease region to a 2.36 Mb interval containing 20 annotated genes. Bidirectional resequencing showed one rare variant in transmembrane protein 43 (TMEM43 1073C -> T, S358L), was carried on all recombinant ARVD5 ancestral haplotypes from affected subjects and not found in population controls. The mutation occurs in a highly conserved transmembrane domain of TMEM43 and is predicted to be deleterious. Clinical outcomes in 257 affected and 151 unaffected subjects were compared, and penetrance was determined. We concluded that ARVC at locus ARVD5 is a lethal, fully penetrant, sex-influenced morbid disorder. Median life expectancy was 41 years in affected males compared to 71 years in affected females (relative risk 6.8, 95% CI 1.3-10.9). Heart failure was a late manifestation in survivors. Although little is known about the function of the TMEM43 gene, it contains a response element for PPAR gamma (an adipogenic transcription factor), which may explain the fibrofatty replacement of the myocardium, a characteristic pathological finding in ARVC.	[Merner, Nancy D.; Hodgkinson, Kathy A.; Haywood, Annika F. M.; Connors, Sean; French, Vanessa M.; Morris-Larkin, Lynn; Parfrey, Patrick S.; Young, Terry-Lynn] Mem Univ Newfoundland, Fac Med, St John, NF A1B 3V6, Canada; [Drenckhahn, Joerg-Detlef; Kupprion, Christine; Ramadanova, Kalina; Thierfelder, Ludwig] Max Delbruck Ctr Mol Med, Max Delbruck Zentrum, D-13122 Berlin, Germany; [McKenna, William] Heart Hosp, London W1G 8PH, England; [Gallagher, Barry] James Paton Mem Reg Hlth Ctr, Dept Pathol, Gander, NF A1V 1P7, Canada; [Bassett, Anne S.] Univ Toronto, Clin Genet Res Program, Ctr Addict & Mental Hlth, Toronto, ON M6J 1H4, Canada		Young, TL (corresponding author), Mem Univ Newfoundland, Fac Med, St John, NF A1B 3V6, Canada.	tlyoung@mun.ca	McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Young, Terry-Lynn/0000-0003-4673-6470; Merner, Nancy/0000-0002-8954-0155; Drenckhahn, Jorg-Detlef/0000-0001-8347-7696			Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; BLOMSTROMLUNDQVIST C, 1987, BRIT HEART J, V58, P477; BREITHARDT G, 1991, J AM COLL CARDIOL, V17, P999, DOI 10.1016/0735-1097(91)90822-Q; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corrado D, 2000, HEART, V83, P588, DOI 10.1136/heart.83.5.588; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dokuparti MVN, 2005, J HUM GENET, V50, P375, DOI 10.1007/s10038-005-0273-5; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; GUIRAUDON GM, 1983, CIRCULATION, V67, P463, DOI 10.1161/01.CIR.67.2.463; Hamid MS, 2002, J AM COLL CARDIOL, V40, P1445, DOI 10.1016/S0735-1097(02)02307-0; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; HENRY WL, 1978, CIRCULATION, V57, P278, DOI 10.1161/01.CIR.57.2.278; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hodgkinson KA, 2005, J AM COLL CARDIOL, V45, P400, DOI 10.1016/j.jacc.2004.08.068; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lindstrom L, 2005, CLIN PHYSIOL FUNCT I, V25, P171, DOI 10.1111/j.1475-097X.2005.00607.x; Lobo FV, 1999, CAN J CARDIOL, V15, P1239; MacRae CA, 2006, J CLIN INVEST, V116, P1825, DOI 10.1172/JCI29174; Mannion John, 1977, PEOPLING NEWFOUNDLAN; MARSHALL W, 1988, NEW ENGL J MED, V319, P174; Matsuo Shinro, 2007, Int J Cardiol, V115, pe129, DOI 10.1016/j.ijcard.2006.09.012; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Nava A, 2000, J AM COLL CARDIOL, V36, P2226, DOI 10.1016/S0735-1097(00)00997-9; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; *NYHA CC, 1964, NOMENCLATURE CRITERI, P114; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pinamonti B, 1998, CIRCULATION, V98, P1943, DOI 10.1161/01.CIR.98.18.1943; Protonotarios N, 2001, J AM COLL CARDIOL, V38, P1477, DOI 10.1016/S0735-1097(01)01568-6; Rahman P, 2003, HUM MOL GENET, V12, pR167, DOI 10.1093/hmg/ddg257; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Wlodarska EK, 2005, INT J CARDIOL, V105, P126, DOI 10.1016/j.ijcard.2004.11.016; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	45	311	320	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					809	821		10.1016/j.ajhg.2008.01.010			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	WOS:000255103900001	18313022	Bronze, Green Published			2022-01-24	
J	Conneely, KN; Boehnke, M				Conneely, Karen N.; Boehnke, Michael			So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CLINICAL-TRIALS; ASSOCIATION; GENES; DISTRIBUTIONS; PROBABILITIES; COMPUTATION; SIMULATION; DISEASE	Contemporary genetic association studies may test hundreds of thousands of genetic variants for association, often with multiple binary and continuous traits or under more than one model of inheritance. Many of these association tests may be correlated with one another because of linkage disequilibrium between nearby markers and correlation between traits and models. Permutation tests and simulation-based methods are often employed to adjust groups of correlated tests for multiple testing, since conventional methods such as Bonferroni correction are overly conservative when tests are correlated. We present here a method of computing P values adjusted for correlated tests (P-ACT) that attains the accuracy of permutation or simulation-based tests in much less computation time, and we show that our method applies to many common association tests that are based on multiple traits, markers, and genetic models. Simulation demonstrates that P-ACT attains the power of permutation testing and provides a valid adjustment for hundreds of correlated association tests. In data analyzed as part of the Finland-United States Investigation of NIDDM Genetics (FUSION) study, we observe a near one-to-one relationship (r(2) > .999) between P-ACT and the corresponding permutation-based P values, achieving the same precision as permutation testing but thousands of times faster.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA		Conneely, KN (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St,Suite 301, Atlanta, GA 30322 USA.	kconneely@genetics.emory.edu			Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01 HG000040] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG000376, HG00376, T32 HG000040] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R29HG000376, R01HG000376, Z01HG000040, T32HG000040] Funding Source: NIH RePORTER		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bonnycastle LL, 2006, DIABETES, V55, P2534, DOI 10.2337/db06-0178; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cramer H., 1946, MATH METHODS STAT; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fisher R.A., 1932, STAT METHODS RES WOR; Genz A, 2002, J COMPUT GRAPH STAT, V11, P950, DOI 10.1198/106186002394; GENZ A, 2007, MVTNORM MULTIVARIATE; Genz A, 1992, J COMPUTATIONAL GRAP, V1, P141, DOI DOI 10.2307/1390838; GENZ A, 2000, MVTDST SET FORTRAN S; Genz A, 1993, COMPUTING SCI STAT, V25, P400; Hinkley DV., 1974, THEORETICAL STAT; HOLM S, 1979, SCAND J STAT, V6, P65; JAMES S, 1991, STAT MED, V10, P1123, DOI 10.1002/sim.4780100712; Kimmel G, 2006, AM J HUM GENET, V79, P481, DOI 10.1086/507317; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin DY, 2005, AM J HUM GENET, V77, P513, DOI 10.1086/432817; McCullagh P, 1989, GEN LINEAR MODELS; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; R Development Core Team, 2007, R LANG ENV STAT COMP; Salyakina D, 2005, HUM HERED, V60, P19, DOI 10.1159/000087540; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Seaman SR, 2005, AM J HUM GENET, V76, P399, DOI 10.1086/428140; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wei LJ, 1997, STAT MED, V16, P833, DOI 10.1002/(SICI)1097-0258(19970430)16:8<833::AID-SIM538>3.0.CO;2-2; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	32	311	314	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1158	1168		10.1086/522036			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	WOS:000251098800004	17966093	Bronze, Green Published			2022-01-24	
J	Thomson, W; Barton, A; Ke, X; Eyre, S; Hinks, A; Bowes, J; Donn, R; Symmons, D; Hider, S; Bruce, IN; Wilson, AG; Marinou, I; Morgan, A; Emery, P; Carter, A; Steer, S; Hocking, L; Reid, DM; Wordsworth, P; Harrison, P; Strachan, D; Worthington, J				Thomson, Wendy; Barton, Anne; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Donn, Rachelle; Symmons, Deborah; Hider, Samantha; Bruce, Ian N.; Wilson, Anthony G.; Marinou, Ioanna; Morgan, Ann; Emery, Paul; Carter, Angela; Steer, Sophia; Hocking, Lynne; Reid, David M.; Wordsworth, Paul; Harrison, Pille; Strachan, David; Worthington, Jane		Consortium, WTCC; Consortium, Y	Rheumatoid arthritis association at 6q23	NATURE GENETICS			English	Article							NF-KAPPA-B; POPULATION; RESPONSES; PTPN22; RISK; GENE; A20	The Wellcome Trust Case Control Consortium (WTCCC) identified nine single SNPs putatively associated with rheumatoid arthritis at P = 1 x 10(-5)-5 x 10(-7) in a genome-wide association screen. One, rs6920220, was unequivocally replicated ( trend P = 1.1 x 10(-8)) in a validation study, as described here. This SNP maps to 6q23, between the genes oligodendrocyte lineage transcription factor 3 (OLIG3) and tumor necrosis factor-alpha-induced protein 3 ( TNFAIP3).	Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; Univ Leeds, Inst Genet, Acad Unit Mol Vasc Med, Hlth & Therapeut Labs, Leeds LS2 9JT, W Yorkshire, England; Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London SE5 9RS, England; Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland; Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England		Worthington, J (corresponding author), Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England.	jane.worthington@manchester.ac.uk	O'Donovan, Michael C/P-7005-2018; eyre, stephen/K-3776-2017; Barton, Anne/N-2053-2014; Timpson, Nicholas John/O-7548-2015; Bowes, John/B-3472-2015; Worthington, Jane/M-9770-2014; Hinks, Anne/E-1853-2015; Brown, Matthew A/E-5749-2010; Attrill, Lauren/V-1688-2018; Dominiczak, Anna F/P-9390-2017; Ke, Xiayi/C-7674-2009; Evans, David/H-6325-2013; Prescott, Natalie/F-6490-2011; McCarthy, Mark/M-3763-2015; dobson, richard/C-9269-2011	O'Donovan, Michael C/0000-0001-7073-2379; eyre, stephen/0000-0002-1251-6974; Barton, Anne/0000-0003-3316-2527; Timpson, Nicholas John/0000-0002-7141-9189; Bowes, John/0000-0003-4659-031X; Worthington, Jane/0000-0003-0544-042X; Hinks, Anne/0000-0001-8843-3967; Brown, Matthew A/0000-0003-0538-8211; Dominiczak, Anna F/0000-0003-4913-3608; Lango Allen, Hana/0000-0002-7803-8688; Weedon, Michael/0000-0002-6174-6135; Walker, Neil/0000-0001-9796-7688; Dunger, Professor David/0000-0002-2566-9304; Lindgren, Cecilia/0000-0002-4903-9374; Evans, David/0000-0003-0663-4621; Bishop, Tim/0000-0002-8752-8785; Newport, Melanie/0000-0002-8946-7525; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Conaghan, Philip/0000-0002-3478-5665; Hattersley, Andrew/0000-0001-5620-473X; Munroe, Patricia/0000-0002-4176-2947; Symmons, Deborah/0000-0002-8625-1200; Thomson, Wendy/0000-0002-9022-5179; Lees, Charlie/0000-0002-0732-8215; Jones, Lisa/0000-0002-5122-8334; Hall, Alistair/0000-0003-0306-7887; Morgan, Ann/0000-0003-1109-624X; Donn, Rachelle/0000-0001-6976-9828; Hocking / Mennie, Lynne J/0000-0002-2414-2826; Prescott, Natalie/0000-0002-5901-7371; Zeggini, Eleftheria/0000-0003-4238-659X; Caulfield, Mark/0000-0001-9295-3594; McCarthy, Mark/0000-0002-4393-0510; Hensor, Elizabeth/0000-0002-5245-4755; Parkes, Miles/0000-0002-6467-0631; Wilson, Anthony Gerard/0000-0003-4855-3926; Tobin, Martin/0000-0002-3596-7874; dobson, richard/0000-0003-4224-9245; Bruce, Ian/0000-0003-3047-500X; Grozeva, Detelina/0000-0003-3239-8415; Harrison, Pille/0000-0003-4117-6910	Arthritis Research UKVersus Arthritis [17552] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934(68341), G0000934] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02, 076113, 068545, 090532] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934] Funding Source: UKRI		Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Filippi A, 2005, P NATL ACAD SCI USA, V102, P4377, DOI 10.1073/pnas.0407284102; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harrison P, 2006, RHEUMATOLOGY, V45, P1009, DOI 10.1093/rheumatology/kei250; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Steer S, 2005, ARTHRITIS RHEUM, V52, P358, DOI 10.1002/art.20737; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	13	311	315	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1431	1433		10.1038/ng.2007.32			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	WOS:000251267400007	17982455	Green Accepted			2022-01-24	
J	Lupski, JR				Lupski, James R.			Genomic rearrangements and sporadic disease	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; MARIE-TOOTH-DISEASE; CHROMOSOMAL REARRANGEMENTS; HOMOLOGOUS RECOMBINATION; STRUCTURAL VARIATION; CONGENITAL-MALFORMATIONS; CONSTITUTIONAL T(11/22); SEGMENTAL DUPLICATIONS; SPONTANEOUS MUTATION; DNA REARRANGEMENTS	Many clinical phenotypes occur sporadically despite genetics contributing partly or entirely to their cause. To what extent are de novo mutations the cause of sporadic traits? Locus-specific mutation rates for genomic rearrangements appear to be two to four orders of magnitude greater than nucleotide-specific rates for base substitutions. Widespread implementation of high-resolution genome analyses to detect de novo copy-number variation may identify the cause of traits previously intractable to conventional genetic analyses.	[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Univ, Texas Childrens Hosp, Houston, TX 77030 USA		Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl,604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu					BAIRD PA, 1988, AM J HUM GENET, V42, P677; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bort S, 1997, AM J HUM GENET, V60, P230; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; LUPSKI JR, 2001, METABOLIC MOL BASES, P5759; LUPSKI JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Marques W, 2005, J NEUROL, V252, P972, DOI 10.1007/s00415-005-0797-9; Nachman MW, 2000, GENETICS, V156, P297; Nelis E, 1996, EUR J HUM GENET, V4, P25; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; SHY ME, 2005, PERIPHERAL NEUROPATH, V1, P1623; SKRE H, 1974, CLIN GENET, V6, P98; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P179, DOI 10.1007/978-1-59745-039-3_12; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; WISE CA, 1993, AM J HUM GENET, V53, P853; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	69	311	324	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S43	S47		10.1038/ng2084			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	WOS:000253974400008	17597781				2022-01-24	
J	Roepman, P; Wessels, LFA; Kettelarij, N; Kemmeren, P; Miles, AJ; Lijnzaad, P; Tilanus, MGJ; Koole, R; Hordijk, GJ; van der Vliet, PC; Reinders, MJT; Slootweg, PJ; Holstege, FCP				Roepman, P; Wessels, LFA; Kettelarij, N; Kemmeren, P; Miles, AJ; Lijnzaad, P; Tilanus, MGJ; Koole, R; Hordijk, GJ; van der Vliet, PC; Reinders, MJT; Slootweg, PJ; Holstege, FCP			An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas	NATURE GENETICS			English	Article							GENE-EXPRESSION; MOLECULAR CLASSIFICATION; TUMOR PROGRESSION; SHOULDER PAIN; CANCER; DISSECTION; SITES; PRESERVATION; REVEALS	Metastasis is the process by which cancers spread to distinct sites in the body. It is the principal cause of death in individuals suffering from cancer. For some types of cancer, early detection of metastasis at lymph nodes close to the site of the primary tumor is pivotal for appropriate treatment. Because it can be difficult to detect lymph node metastases reliably, many individuals currently receive inappropriate treatment. We show here that DNA microarray gene-expression profiling can detect lymph node metastases for primary head and neck squamous cell carcinomas that arise in the oral cavity and oropharynx. The predictor, established with an 82-tumor training set, outperforms current clinical diagnosis when independently validated. The 102 predictor genes offer unique insights into the processes underlying metastasis. The results show that the metastatic state can be deciphered from the primary tumor gene-expression pattern and that treatment can be substantially improved.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Univ Med Ctr utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr utrecht, Dept Oral & Maxillofacial Surg, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr utrecht, Dept Otorhinolaryngol, NL-3584 CX Utrecht, Netherlands		Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@med.uu.nl	Lijnzaad, Philip/ABE-4205-2021; Holstege, Frank/AAM-9944-2021; Slootweg, P.J./H-8089-2014	Lijnzaad, Philip/0000-0002-7535-583X; Kemmeren, Patrick/0000-0003-2237-7354			Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Freier K, 2003, CANCER RES, V63, P1179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HAHN SS, 1987, INT J RADIAT ONCOL, V13, P1143, DOI 10.1016/0360-3016(87)90186-6; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; JONES AS, 1994, CLIN OTOLARYNGOL, V19, P63, DOI 10.1111/j.1365-2273.1994.tb01150.x; JONES AS, 1993, EUR ARCH OTO-RHINO-L, V250, P446; JONES KR, 1992, ARCH OTOLARYNGOL, V118, P483; Matsuo S, 1999, PATHOL INT, V49, P383, DOI 10.1046/j.1440-1827.1999.00887.x; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pillsbury HC, 1997, LARYNGOSCOPE, V107, P1294, DOI 10.1097/00005537-199710000-00004; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; SHORT SO, 1984, AM J SURG, V148, P478, DOI 10.1016/0002-9610(84)90373-8; Simon R, 2003, J NATL CANCER I, V95, P14, DOI 10.1093/jnci/95.1.14; Takes RP, 2001, J PATHOL, V194, P298, DOI 10.1002/1096-9896(200107)194:3<298::AID-PATH900>3.0.CO;2-Q; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wilgen CP, 2003, J CRANIO MAXILL SURG, V31, P183, DOI 10.1016/S1010-5182(03)00030-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Woolgar JA, 1999, BRIT J ORAL MAX SURG, V37, P205, DOI 10.1054/bjom.1999.0035	30	311	325	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					182	186		10.1038/ng1502			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	WOS:000226690100026	15640797				2022-01-24	
J	Seri, M; Cusano, R; Gangarossa, S; Caridi, G; Bordo, D; Lo Nigro, C; Ghiggeri, GM; Ravazzolo, R; Savino, M; Del Vecchio, M; d'Apolito, M; Iolascon, A; Zelante, LL; Savoia, A; Balduini, CL; Noris, P; Magrini, U; Belletti, S				Seri, M; Cusano, R; Gangarossa, S; Caridi, G; Bordo, D; Lo Nigro, C; Ghiggeri, GM; Ravazzolo, R; Savino, M; Del Vecchio, M; d'Apolito, M; Iolascon, A; Zelante, LL; Savoia, A; Balduini, CL; Noris, P; Magrini, U; Belletti, S		May-Hegglin Fechtner Syndrome Cors	Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes	NATURE GENETICS			English	Article							MYOSIN HEAVY-CHAINS; LEUKOCYTE INCLUSIONS; NONMUSCLE; MACROTHROMBOCYTOPENIA; VARIANT; PROTEIN; GENE	The autosomal dominant, giant-platelet disorders(1), May-Hegglin anomaly(2,3) (MHA; MIM 155100). Fechtner syndrome(4) (FTNS; MIM 153640) and Sebastian syndrome(5) (SBS), share the triad of thrombocytopenia. large platelets and characteristic leukocyte inclusions ('Dohle-like' bodies). MHA and SBS can be differentiated by subtle ultrastructural leukocyte inclusion features, whereas FTNS is distinguished by the additional Alport-like clinical features of sensorineural deafness, cataracts and nephritis(4). The similarities between these platelet disorders and our recent refinement of the MHA (ref. 6) and FTNS (ref. 7) disease loci to an overlapping region of 480 kb on chromosome 22 suggested that all three disorders are allelic. Among the identified candidate genes is the gene encoding nonmuscle myosin heavy chain 9 (MYH9; refs 8-10). which is expressed in platelets(9) and upregulated during granulocyte differentiation(10). We identified six MYH9 mutations (one nonsense and five missense) in seven unrelated probands from MHA. SBS and FTNS families. On the basis of molecular modelling, the two mutations affecting the myosin head were predicted to impose electrostatic and conformational changes, whereas the truncating mutation deleted the unique carboxyterminal tailpiece. The remaining missense mutations, all affecting highly conserved coiled-coil domain positions, imparted destabilizing electrostatic and polar changes. Thus, our results suggest that mutations in MYH9 result in three megakaryocyte/platelet/leukocyte syndromes and are important in the pathogenesis of sensorineural deafness, cataracts and nephritis.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Struct Neurobiol & Proteom Lab, New York, NY USA; Osped Civile, Clin Pathol Lab, Venice, Italy; Univ Pavia, IRCCS San Matteo, Dept Internal Med, I-27100 Pavia, Italy; Univ Pavia, IRCCS San Matteo, Dept Pathol, I-27100 Pavia, Italy; Univ Bari, Dept Biomed Evolut Age, Bari, Italy; IRCCS Hosp CSS, Med Genet Serv, Foggia, Italy; Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; IST, Adv Biotechnol Ctr, Genoa, Italy; Inst G Gaslini, Lab Nephrol, Genoa, Italy; Inst G Gaslini, Genet Mol Lab, Genoa, Italy		Seri, M (corresponding author), Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA.		Caridi, Gianluca/F-7052-2010; Balduini, Carlo L/D-9299-2015; d'Apolito, Maria/G-5793-2012; Iolascon, Achille/A-4461-2014; Heath, Karen Elise/K-7760-2014; Heath, K. E./ABG-4658-2020; Savoia, Anna/B-6463-2014; Ghiggeri, Gian Marco/N-4712-2015; d'Apolito, Maria/AAQ-9290-2021; Seri, Marco/A-4339-2014	Caridi, Gianluca/0000-0001-6700-3001; Balduini, Carlo L/0000-0001-6121-9311; Heath, Karen Elise/0000-0002-5816-7044; Heath, K. E./0000-0002-5816-7044; Savoia, Anna/0000-0002-2407-2696; Ghiggeri, Gian Marco/0000-0003-3659-9062; Noris, Patrizia/0000-0002-5035-3707; Seri, Marco/0000-0003-2425-2176	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5 M01 RR00071] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [5 R37 DK34045] Funding Source: Medline; TelethonFondazione Telethon [E.1313] Funding Source: Medline		BIZZARO N, 1997, MED LAB, V5, P165; CITI S, 1988, J MUSCLE RES CELL M, V9, P306, DOI 10.1007/BF01773874; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; CUSANO R, IN PRESS EUR J HUM G; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; GREINACHER A, 1990, BLUT, V61, P282, DOI 10.1007/BF01732878; HARRINGTON WF, 1984, ANNU REV BIOCHEM, V53, P35, DOI 10.1146/annurev.bi.53.070184.000343; HEGGLIN R, 1945, Helv Med Acta, V12, P439; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119; Lalwani AK, 1999, AM J HUM GENET, V64, P318, DOI 10.1086/302216; LUCAS RC, 1975, PROTIDES BIOL FLUIDS, P465; Martignetti JA, 2000, AM J HUM GENET, V66, P1449, DOI 10.1086/302873; May R, 1909, DTSCH ARCH KLIN MED, V96, P1; Mhawech P, 2000, AM J CLIN PATHOL, V113, P176, DOI 10.1309/FC4H-LM5V-VCW8-DNJU; Moxey-Mims MM, 1999, PEDIATR NEPHROL, V13, P782, DOI 10.1007/s004670050700; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Noris P, 1998, AM J MED, V104, P355, DOI 10.1016/S0002-9343(98)00062-X; PETERSON LC, 1985, BLOOD, V65, P397; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Urato AC, 1998, AM J OBSTET GYNECOL, V179, P260, DOI 10.1016/S0002-9378(98)70283-2; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506	30	311	321	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					103	105					3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	WOS:000089078000028	10973259				2022-01-24	
J	Zhang, QG; Siebert, R; Yan, MH; Hinzmann, B; Cui, XL; Xue, LQ; Rakestraw, KM; Naeve, CW; Beckmann, G; Weisenburger, DD; Sanger, WG; Nowotny, H; Vesely, M; Callet-Bauchu, E; Salles, G; Dixit, VM; Rosenthal, A; Schlegelberger, B; Morris, SW				Zhang, QG; Siebert, R; Yan, MH; Hinzmann, B; Cui, XL; Xue, LQ; Rakestraw, KM; Naeve, CW; Beckmann, G; Weisenburger, DD; Sanger, WG; Nowotny, H; Vesely, M; Callet-Bauchu, E; Salles, G; Dixit, VM; Rosenthal, A; Schlegelberger, B; Morris, SW			Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)	NATURE GENETICS			English	Article							NF-KAPPA-B; SOMATIC HYPERMUTATION; TRANSCRIPTION FACTORS; CELL LYMPHOMA; ACTIVATION; TRANSFORMATION; REQUIREMENT; APOPTOSIS; DISEASE; CARD	Mucosa-associated lymphoid tissue (MALT) lymphomas most frequently involve the gastrointestinal tract and are the most common subset of extranodal non-Hodgkin lymphoma(1) (NHL). Here we describe overexpression of BCL10, a novel apoptotic signalling gene that encodes an amino-terminal caspase recruitment domain (CARD; ref. 2), in MALT lymphomas due to the recurrent t(1;14)(p22;q32) (ref. 3). BCL10 cDNAs from t(1;14)-positive MALT tumours contained a variety of mutations, most resulting in truncations either in or carboxy terminal to the CARD. Wild-type BCL10 activated NF-kappa B but induced apoptosis of MCF7 and 293 cells. CARD-truncation mutants were unable to induce cell death or activate NF-kappa B, whereas mutants with C-terminal truncations retained NF-kappa B activation but did not induce apoptosis, Mutant BCL10 overexpression might have a twofold lymphomagenic effect: loss of BCL10 pro-apoptosis may confer a survival advantage to MALT B-cells, and constitutive NF-kappa B activation may provide both anti-apoptotic and proliferative signals mediated via its transcriptional targets.	St Jude Childrens Res Hosp, Dept Pathol & Lab Med, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Ctr Biotechnol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38163 USA; Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; MetaGen Gesell Genomforsch mbH, D-14195 Berlin, Germany; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Ctr Human Genet, Omaha, NE 68198 USA; Hanusch Hosp, Ludwig Boltzmann Inst Leukemia Res & Hematol, A-1140 Vienna, Austria; Lainz Hosp, Jakob Erdheim Inst Pathol, A-1130 Vienna, Austria; Univ Lyon 1, Ctr Hosp Lyon Sud, Hematol Lab, F-69495 Pierre Benite, France; Univ Lyon 1, Ctr Hosp Lyon Sud, Serv Hematol, F-69495 Pierre Benite, France; Univ Kiel, Dept Human Genet, D-24105 Kiel, Germany		Morris, SW (corresponding author), St Jude Childrens Res Hosp, Dept Pathol & Lab Med, 332 N Lauderdale St, Memphis, TN 38105 USA.		dixit, vishva m/A-4496-2012; Siebert, Reiner/A-8049-2010; Salles, Gilles/AAS-2242-2021; Salles, Gilles/Z-2336-2019	dixit, vishva m/0000-0001-6983-0326; Salles, Gilles/0000-0002-9541-8666; 	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-27165] Funding Source: Medline		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Besancon F, 1998, P NATL ACAD SCI USA, V95, P8081, DOI 10.1073/pnas.95.14.8081; Cesarman E, 1997, SEMIN DIAGN PATHOL, V14, P54; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Lee H, 1995, Curr Top Microbiol Immunol, V194, P247; Luque I, 1997, SEMIN CANCER BIOL, V8, P103, DOI 10.1006/scbi.1997.0061; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; OFFIT K, 1991, GENE CHROMOSOME CANC, V3, P189, DOI 10.1002/gcc.2870030304; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; SCHLEGELBERGER B, 1994, LEUKEMIA, V8, P72; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Siebert R, 1998, BLOOD, V91, P984, DOI 10.1182/blood.V91.3.984.984_984_990; Snow EC, 1997, CURR TOP MICROBIOL, V224, P211; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Storb U, 1998, IMMUNOL REV, V162, P5, DOI 10.1111/j.1600-065X.1998.tb01424.x; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; TILLY H, 1994, BLOOD, V84, P1043; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Willis TG, 1997, BLOOD, V90, P2456; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; WOTHERSPOON AC, 1992, CANCER GENET CYTOGEN, V58, P35, DOI 10.1016/0165-4608(92)90130-Z; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Zucca E, 1998, BRIT J HAEMATOL, V100, P3, DOI 10.1046/j.1365-2141.1998.00513.x	27	311	324	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					63	68		10.1038/8767			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	WOS:000080096300024	10319863				2022-01-24	
J	NELSON, JC; SORRELLS, ME; VANDEYNZE, AE; LU, YH; ATKINSON, M; BERNARD, M; LEROY, P; FARIS, JD; ANDERSON, JA				NELSON, JC; SORRELLS, ME; VANDEYNZE, AE; LU, YH; ATKINSON, M; BERNARD, M; LEROY, P; FARIS, JD; ANDERSON, JA			MOLECULAR MAPPING OF WHEAT - MAJOR GENES AND REARRANGEMENTS IN HOMOEOLOGOUS GROUP-4, GROUP-5, AND GROUP-7	GENETICS			English	Article							MILLING ENERGY REQUIREMENT; BARLEY HORDEUM-VULGARE; LEAF RUST RESISTANCE; TRITICUM-AESTIVUM L; LINKAGE MAP; BREAD WHEAT; CHROMOSOMAL LOCATION; HEXAPLOID WHEAT; COMMON WHEAT; GENOME	A molecular-marker linkage map of hexaploid wheat (Triticum aestivum L. em. Thell) provides a framework for integration with the classical genetic map and a record of the chromosomal rearrangements involved in the evolution of this crop species. We have constructed restriction fragment length polymorphism (RFLP) maps of the A-, B-, and D-genome chromosomes of homoeologous groups 4, 5, and 7 of wheat using 114 F-7 lines from a synthetic x cultivated wheat cross and clones from 10 DNA libraries. Chromosomal breakpoints for known ancestral reciprocal translocations involving these chromosomes and for a known pericentric inversion on chromosome 4A were localized by linkage and aneuploid analysis. Known genes mapped include the major vernalization genes Vrn1 and Vrn3 on chromosome arms 5AL and 5DL, the red-coleoptile gene Rc1 on 7AS, and presumptively the leaf-rust (Puccinia recondita f.sp. tritici) resistance gene Lr34 on 7DS and the kernel-hardness gene Ha on 5DS. RFLP markers previously obtained for powdery-mildew (Blumeria graminis f.sp. tritici) resistance genes Pm2 and Pm1 were localized on chromosome arms 5DS and 7AL.	CORNELL UNIV,DEPT PLANT BREEDING & BIOMETRY,F-63039 CLERMONT FERRAND,FRANCE; N DAKOTA STATE UNIV,DEPT CROP & WEED SCI,FARGO,ND 58105		NELSON, JC (corresponding author), CORNELL UNIV,DEPT PLANT BREEDING & BIOMETRY,252 EMERSON HALL,ITHACA,NY 14853, USA.		Anderson, James/AAI-2477-2021; Atkinson, Mark/K-1813-2013	Anderson, James/0000-0003-4655-6517; Faris, Justin/0000-0002-9653-3287; Atkinson, Mark/0000-0003-4237-3588			AHN S, 1993, MOL GEN GENET, V241, P483, DOI 10.1007/BF00279889; AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; BARUA UM, 1993, GENOME, V36, P1080, DOI 10.1139/g93-143; CAUSSE MA, 1994, GENETICS, V138, P1251; CHALMERS KJ, 1993, THEOR APPL GENET, V87, P314, DOI 10.1007/BF01184917; CHAO S, 1989, THEOR APPL GENET, V78, P495, DOI 10.1007/BF00290833; Devos KM, 1992, THEOR APPL GENET, V83, P931, DOI 10.1007/BF00232953; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; DEVOS KM, 1993, THEOR APPL GENET, V85, P784, DOI 10.1007/BF00225020; DVORAK J, 1983, CAN J GENET CYTOL, V25, P210; DYCK PL, 1994, GENOME, V37, P556, DOI 10.1139/g94-079; EASTWOOD RF, 1994, GENOME, V37, P311, DOI 10.1139/g94-043; FORSTER BP, 1990, THEOR APPL GENET, V80, P806, DOI 10.1007/BF00224196; GALE MD, 1975, HEREDITY, V35, P417, DOI 10.1038/hdy.1975.112; Gill B. S., 1987, Wheat and wheat improvement., P243; Gill B. S., 1993, Progress in genome mapping of wheat and related species: Proceedings of the 3rd Public Workshop of the International Triticeae Mapping Initiative, 22-26 September 1992, CIMMYT, Mexico., P10; GILL BS, 1974, P NATL ACAD SCI USA, V71, P4086, DOI 10.1073/pnas.71.10.4086; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; GRANER A, 1991, THEOR APPL GENET, V83, P250, DOI 10.1007/BF00226259; GRANER A, 1994, BARLEY GENET NEWSL, V23, P53; Haldane JBS, 1931, GENETICS, V16, P0357; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hart G. E., 1987, Wheat and wheat improvement., P199; HART GE, 1977, HEREDITY, V39, P263, DOI 10.1038/hdy.1977.67; HART GE, 1993, GENETIC MAPS; HEUN M, 1991, GENOME, V34, P437, DOI 10.1139/g91-066; KING IP, 1994, GENOME, V37, P882, DOI 10.1139/g94-125; KLEINHOFS A, 1993, THEOR APPL GENET, V86, P705, DOI 10.1007/BF00222660; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LAW CN, 1975, HEREDITY, V36, P49; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; LIU YG, 1991, JPN J GENET, V66, P617, DOI 10.1266/jjg.66.617; LU YH, 1994, AGRONOMIE, V14, P33, DOI 10.1051/agro:19940104; MA ZQ, 1994, GENOME, V37, P871, DOI 10.1139/g94-123; MA ZQ, 1993, THEOR APPL GENET, V85, P750, DOI 10.1007/BF00225015; MATTERN P, 1973, 4 INT WHEAT GEN S CO, P703; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; MCINTOSH RA, 1988, 7TH P INT WHEAT GEN, P1225; MILLER TE, 1988, 7TH P INT WHEAT GEN; MORRISON WR, 1989, J CEREAL SCI, V9, P41, DOI 10.1016/S0733-5210(89)80020-7; NARANJO T, 1990, THEOR APPL GENET, V79, P397, DOI 10.1007/BF01186085; NARANJO T, 1987, GENOME, V29, P873, DOI 10.1139/g87-149; NELSON JC, 1995, GENOME, V38, P525, DOI 10.1139/g95-068; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; NELSON JC, 1994, THESIS CORNELL U ITH; ODONOUGHUE LS, 1995, GENOME, V38, P368, DOI 10.1139/g95-048; ODONOUGHUE LS, 1992, GENOME, V35, P765, DOI 10.1139/g92-117; PLASCHKE J, 1993, THEOR APPL GENET, V85, P1049, DOI 10.1007/BF00215046; RAYBURN AL, 1985, CAN J GENET CYTOL, V27, P246, DOI 10.1139/g85-036; REITER RS, 1992, P NATL ACAD SCI USA, V89, P1477, DOI 10.1073/pnas.89.4.1477; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; ROELFS AP, 1992, RUST DISEASES WHEAT; ROWLAND GG, 1974, CAN J GENET CYTOL, V16, P137, DOI 10.1139/g74-013; SAITO A, 1991, JPN J BREED, V41, P665; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Sears ER, 1944, GENETICS, V29, P232; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SNAPE JW, 1985, THEOR APPL GENET, V71, P518, DOI 10.1007/BF00251199; SUTKA J, 1977, EUPHYTICA, V26, P475, DOI 10.1007/BF00027010; TAHIR CM, 1969, JPN J GENET, V44, P1, DOI 10.1266/jjg.44.1; Van Deynze AE, 1995, GENOME, V38, P47; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; WORLAND AJ, 1987, 7TH P INT WHEAT GEN, P669; XIE DX, 1993, THEOR APPL GENET, V87, P70, DOI 10.1007/BF00223747; [No title captured]	69	311	344	1	18	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1995	141	2					721	731					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX019	WOS:A1995RX01900024	8647405				2022-01-24	
J	MARQUIS, ST; RAJAN, JV; WYNSHAWBORIS, A; XU, TJ; YIN, GY; ABEL, KJ; WEBER, BL; CHODOSH, LA				MARQUIS, ST; RAJAN, JV; WYNSHAWBORIS, A; XU, TJ; YIN, GY; ABEL, KJ; WEBER, BL; CHODOSH, LA			THE DEVELOPMENTAL PATTERN OF BRCA1 EXPRESSION IMPLIES A ROLE IN DIFFERENTIATION OF THE BREAST AND OTHER TISSUES	NATURE GENETICS			English	Article							CELLULAR TUMOR-ANTIGEN; FAMILIAL BREAST; GENE-EXPRESSION; OVARIAN-CANCER; P53; LACTOFERRIN	We have examined the developmental expression of the murine breast and ovarian cancer susceptibility gene, Brca1, to investigate its role in the control of cell growth and differentiation. Specifically, we have analysed Brca1 expression during embryonic development, in adult tissues, and during postnatal mammary gland development, particularly in response to ovarian hormones. Our results suggest that Brca1 is expressed in rapidly proliferating cell types undergoing differentiation. In the mammary gland, Brca1 expression is induced during puberty, pregnancy, and following treatment of ovariectomized animals with 17 beta-estradiol and progesterone. These observations imply that Brca1 is involved in the processes of proliferation and differentiation in multiple tissues, notably in the mammary gland in response to ovarian hormones.	UNIV PENN, SCH MED, DEPT MOLEC & CELLULAR ENGN, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, INST HUMAN GENE THERAPY, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT INTERNAL MED, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DIV ENDOCRINOL DIABET & METAB, PHILADELPHIA, PA 19104 USA; NIH, NATL CTR HUMAN GENOME RES, GENET DIS RES LAB, BETHESDA, MD 20892 USA; UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA						NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA057601, P20CA066179] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA57601, 1P20CA66179] Funding Source: Medline		ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; EASTON DF, 1993, AM J HUM GENET, V52, P678; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; HOBBS AA, 1982, J BIOL CHEM, V257, P3598; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; MCGREGOR DH, 1977, J NATL CANCER I, V59, P799, DOI 10.1093/jnci/59.3.799; MCMASTER MT, 1992, MOL ENDOCRINOL, V6, P101, DOI 10.1210/me.6.1.101; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERRITT AJ, 1994, CANCER RES, V54, P614; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MORRISON BW, 1994, ONCOGENE, V9, P3417; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Russo J, 1993, Eur J Cancer Prev, V2 Suppl 3, P85; SCHMID P, 1991, DEVELOPMENT, V113, P857; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; WILKINSON DG, 1992, INSITUHYBRIDIZATION	29	311	316	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1995	11	1					17	26		10.1038/ng0995-17			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	WOS:A1995RR72800010	7550308				2022-01-24	
J	WILHELMSEN, KC; LYNCH, T; PAVLOU, E; HIGGINS, M; NYGAARD, TG				WILHELMSEN, KC; LYNCH, T; PAVLOU, E; HIGGINS, M; NYGAARD, TG			LOCALIZATION OF DISINHIBITION-DEMENTIA-PARKINSONISM-AMYATROPHY COMPLEX TO 17Q21-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ONSET ALZHEIMERS-DISEASE; MOTOR NEURON DISEASE; PRECURSOR PROTEIN GENE; X-CHROMOSOME MARKERS; NERVE GROWTH-FACTOR; LINKAGE ANALYSIS; SUPEROXIDE-DISMUTASE; RADIATION HYBRID; HUMAN GENOME	Disinhibition-dementia-parkinsonism-amyotrophy complex (DDPAC) is defined by familial adult-onset behavioral disturbance, followed by frontal lobe dementia, parkinsonism, and amyotrophy in variable proportions. A genetic etiology of DDPAC was suspected because of the familial clustering in family Mo, despite their wide geographic distribution. We have mapped the DDPAC locus to a 12-cM (sex averaged) region between D17S800 and D17S787 on chromosome 17q21-22. The basis for the variability of the clinical findings and pathology in DDPAC is unknown but suggests that the DDPAC locus should be screened as a candidate locus in family studies of conditions with behavioral abnormalities and neurological degeneration.			WILHELMSEN, KC (corresponding author), COLUMBIA PRESBYTERIAN MED CTR, INST NEUROL, DEPT NEUROL, 710 W 168TH ST, NEW YORK, NY 10032 USA.						ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; Acampora D, 1991, Oxf Surv Eukaryot Genes, V7, P1; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BENTLEY KL, 1989, CYTOGENET CELL GENET, V51, P961; BONDUELLE M, 1968, J NEUROL SCI, V6, P315, DOI 10.1016/0022-510X(68)90099-3; Bonduelle M, 1975, HDB CLIN NEUROLOGY, V22, P281; BOUDOURESQUES J, 1967, REV NEUROL-FRANCE, V116, P693; BRUN A, 1987, ARCH GERONTOL GERIAT, V6, P193, DOI 10.1016/0167-4943(87)90021-5; Bruyn G.W., 1975, HDB CLIN NEUROLOGY, VVol. 22, P353; BURNSTEIN MH, 1981, PSYCHOSOMATICS, V22, P151; CAIDAS M, 1966, ACTA NEUROL PSYCHIAT, V66, P125; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUMMINGS JL, 1981, NEUROLOGY, V31, P1415, DOI 10.1212/WNL.31.11.1415; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DEINARD AS, 1992, NUCLEIC ACIDS RES, V20, P1171, DOI 10.1093/nar/20.5.1171-a; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; GILBERT JJ, 1988, ANN NEUROL, V24, P688, DOI 10.1002/ana.410240518; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GREEN P, 1992, CYTOGENET CELL GENET, V59, P122, DOI 10.1159/000133221; Haberlandt W. F., 1964, AMYOTROPHISCHE LATER; HOROUPIAN DS, 1984, ANN NEUROL, V16, P305, DOI 10.1002/ana.410160306; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; HUDSON AJ, 1981, BRAIN, V104, P217, DOI 10.1093/brain/104.2.217; HUGHES CP, 1973, NEUROLOGY, V23, P344; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KORMANNBORTOLOTTO MH, 1992, MECH AGEING DEV, V65, P9, DOI 10.1016/0047-6374(92)90122-T; KOSIK KS, 1990, MOL NEUROBIOL, V4, P171, DOI 10.1007/BF02780339; LASSER DM, 1993, GENOMICS, V16, P785, DOI 10.1006/geno.1993.1269; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LAW A, 1992, HUM GENET, V88, P562, DOI 10.1007/BF00219345; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; MATA M, 1983, NEUROLOGY, V33, P1439, DOI 10.1212/WNL.33.11.1439; MITSUYAMA Y, 1985, EUR ARCH PSY CLIN N, V235, P1, DOI 10.1007/BF00380961; MORITA K, 1987, ARCH GERONTOL GERIAT, V6, P263, DOI 10.1016/0167-4943(87)90026-4; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RAFFIONI S, 1993, ANNU REV BIOCHEM, V62, P823; RODGERSJOHNSON P, 1986, NEUROLOGY, V36, P7, DOI 10.1212/WNL.36.1.7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROSENBERG RN, 1989, ANN NEUROL, V25, P152, DOI 10.1002/ana.410250208; SCHMITT HP, 1984, ANN NEUROL, V16, P642, DOI 10.1002/ana.410160604; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SIDDIQUE T, 1989, NEUROLOGY, V39, P919, DOI 10.1212/WNL.39.7.919; STEWART SS, 1988, ANNU REV MED, V39, P193, DOI 10.1146/annurev.me.39.020188.001205; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STOFFEL M, 1992, NUCLEIC ACIDS RES, V20, P1172, DOI 10.1093/nar/20.5.1172; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203; Yoshida M, 1992, Rinsho Shinkeigaku, V32, P1193	64	311	313	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1159	1165					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	WOS:A1994QB68400012	7977375				2022-01-24	
J	GISPERT, S; TWELLS, R; OROZCO, G; BRICE, A; WEBER, J; HEREDERO, L; SCHEUFLER, K; RILEY, B; ALLOTEY, R; NOTHERS, C; HILLERMANN, R; LUNKES, A; KHATI, C; STEVANIN, G; HERNANDEZ, A; MAGARINO, C; KLOCKGETHER, T; DURR, A; CHNEIWEISS, H; ENCZMANN, J; FARRALL, M; BECKMANN, J; MULLAN, M; WERNET, P; AGID, Y; FREUND, HJ; WILLIAMSON, R; AUBURGER, G; CHAMBERLAIN, S				GISPERT, S; TWELLS, R; OROZCO, G; BRICE, A; WEBER, J; HEREDERO, L; SCHEUFLER, K; RILEY, B; ALLOTEY, R; NOTHERS, C; HILLERMANN, R; LUNKES, A; KHATI, C; STEVANIN, G; HERNANDEZ, A; MAGARINO, C; KLOCKGETHER, T; DURR, A; CHNEIWEISS, H; ENCZMANN, J; FARRALL, M; BECKMANN, J; MULLAN, M; WERNET, P; AGID, Y; FREUND, HJ; WILLIAMSON, R; AUBURGER, G; CHAMBERLAIN, S			CHROMOSOMAL ASSIGNMENT OF THE 2ND LOCUS FOR AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA (SCA2) TO CHROMOSOME 12Q23-24.1	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; LINKAGE; SYSTEM	The autosomal dominant cerebellar ataxias (ADCA) are a group of neurodegenerative disorders characterized by onset with gait ataxia, dysarthria, dysmetria and dysdiadochokinesia. We have demonstrated previously genetic heterogeneity within these disorders by excluding the disease locus from the documented spinocerebellar ataxia locus (SCA1) on chromosome 6p in a large Cuban founder population. We now report the assignment of a second locus for ADCA (SCA2) to chromosome 12q23-24.1 following linkage analyses carried out for the Cuban pedigrees, with probable flanking markers D12S58 and phospholipase A2. Investigation of linkage to the interval containing SCA2 for seven French ADCA families, previously excluded from linkage to SCA1, provides preliminary data suggesting the existence of a third ADCA locus (SCA3).	UNIV HOSP DUESSELDORF, DEPT NEUROL, MOORENSTR 5, W-4000 DUSSELDORF, GERMANY; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, ST MARYS HOSP, SCH MED, DEPT BIOCHEM & MOLEC GENET, LONDON W2 1PG, ENGLAND; NATL CTR MED GENET, HAVANA, CUBA; LENIN HOSP, DEPT NEUROL, HOLGUIN, CUBA; MARSHFIELD MED RES FDN, MARSHFIELD, WI 54449 USA; INST HAEMATOL & IMMUNOL, HAVANA, CUBA; UNIV HOSP TUEBINGEN, DEPT NEUROL, TUBINGEN, GERMANY; UNIV HOSP DUESSELDORF, INST TRANSFUS MED, IMMUNOL LAB, DUSSELDORF, GERMANY; CTR ETUD POLYMORPHISME HUMAIN, F-75010 PARIS, FRANCE; UNIV S FLORIDA, SUNCOAST GERONTOL CTR, TAMPA, FL 33612 USA; ROYAL POSTGRAD MED SCH, DEPT MED, MRC, MOLEC MED GRP, LONDON W12 0HS, ENGLAND; COLL FRANCE, INSERM, U114, F-75231 PARIS 05, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, SERV NEUROL & NEUROPSYCHOL, F-75651 PARIS 13, FRANCE				brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Beckmann, Jacques S/A-9772-2008; Stevanin, Giovanni/E-5038-2016; herve, chneiweiss/Q-6818-2019	brice, alexis/0000-0002-0941-3990; Beckmann, Jacques S/0000-0002-9741-1900; Stevanin, Giovanni/0000-0001-9368-8657; herve, chneiweiss/0000-0001-7675-5061			AUBURGER G, 1990, AM J HUM GENET, V46, P1163; Brown S., 1892, BRAIN, V15, P250; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; GIPSERT S, 1993, HUM HERED, V43, P12; HOPPENER JWM, 1985, HUM GENET, V69, P157, DOI 10.1007/BF00293288; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KHATI C, IN PRESS NEUROLOGY; KONIGSMARK BW, 1971, BRITH DEFECTS ORIG A, V1, P178; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; OTT J, 1979, TRANSPLANT P, V11, P1689; POGACAR S, 1978, ARCH NEUROL-CHICAGO, V35, P156, DOI 10.1001/archneur.1978.00500270038008; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; WEATHERALL DJ, 1984, NEW GENETICS CLIN PR; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, CYTOGENET CELL GENET, V58, P1864; WEINER LP, 1967, ARCH NEUROL-CHICAGO, V16, P364, DOI 10.1001/archneur.1967.00470220028004; YAKURA H, 1974, NEW ENGL J MED, V291, P154	23	311	314	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					295	299		10.1038/ng0793-295			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	WOS:A1993LJ84200019	8358438				2022-01-24	
J	SCHURR, TG; BALLINGER, SW; GAN, YY; HODGE, JA; MERRIWETHER, DA; LAWRENCE, DN; KNOWLER, WC; WEISS, KM; WALLACE, DC				SCHURR, TG; BALLINGER, SW; GAN, YY; HODGE, JA; MERRIWETHER, DA; LAWRENCE, DN; KNOWLER, WC; WEISS, KM; WALLACE, DC			AMERINDIAN MITOCHONDRIAL DNAS HAVE RARE ASIAN MUTATIONS AT HIGH-FREQUENCIES, SUGGESTING THEY DERIVED FROM 4 PRIMARY MATERNAL LINEAGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									EMORY UNIV, SCH MED, DEPT BIOCHEM, 109 WOODRUFF MEM BLDG, ATLANTA, GA 30322 USA; EMORY UNIV, SCH MED, DEPT ANTHROPOL, ATLANTA, GA 30322 USA; CTR DIS CONTROL, CTR INFECT DIS, DIV HOST FACTORS, ATLANTA, GA 30333 USA; UNIV AGR MALAYSIA, DEPT BIOTECHNOL, SERDANG, MALAYSIA; PENN STATE UNIV, DEPT BIOL, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, GRAD PROGRAM GENET, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, DEPT ANTHROPOL, UNIVERSITY PK, PA 16802 USA; PENN STATE UNIV, GRAD PROGRAM GENET, UNIVERSITY PK, PA 16802 USA; NIDDKD, DIABET & ARTHRIT EPIDEMIOL SECT, PHOENIX, AZ USA				Schurr, Theodore/A-1336-2007				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BADA JL, 1984, NATURE, V312, P442, DOI 10.1038/312442a0; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; BLANC H, 1983, AM J HUM GENET, V35, P167; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, P485; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1982, THESIS U CALIFORNIA; CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DILLEHAY TD, 1982, J FIELD ARCHAEOL, V9, P547; DORAN GH, 1986, NATURE, V323, P803, DOI 10.1038/323803a0; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Greenberg J.H., 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; GUIDON N, 1986, NATURE, V321, P769, DOI 10.1038/321769a0; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; Haury E.W, 1976, HOHOKAM DESERT FARME; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Johnson W.C, 1983, EARLY MAN NEW WORLD, P163; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; LAMPL M, 1979, 1ST AM ORIGINS AFFIN, P7; LAWRENCE DN, 1980, TISSUE ANTIGENS, V16, P152, DOI 10.1111/j.1399-0039.1980.tb00596.x; MacNeish Richard S., 1983, EARLY MAN NEW WORLD, P125; MATSON GA, 1968, AM J PHYS ANTHROPOL, V29, P311, DOI 10.1002/ajpa.1330290308; Maxam A M, 1980, Methods Enzymol, V65, P499; MESTRINER MA, 1980, AM J PHYS ANTHROPOL, V52, P95, DOI 10.1002/ajpa.1330520112; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; Mourant AE, 1976, DISTRIBUTION HUMAN B, V2nd; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JV, 1986, AM J HUM GENET, V38, P649; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; NEEL JV, 1980, POPULATION STRUCTURE, P173; NELSON DE, 1986, SCIENCE, V232, P749, DOI 10.1126/science.232.4751.749; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; OWEN RC, 1984, ORIGINS MODERN HUMAN, P517; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SALZANO FM, 1980, J HUM EVOL, V9, P179, DOI 10.1016/0047-2484(80)90018-4; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214; SALZANO FM, 1978, HUM BIOL, V50, P121; Santachiara Benerecetti A S, 1988, Ann Hum Genet, V52, P39; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STONEKING M, 1986, GENETIC VARIATION IT, P87; Szathmary E., 1985, OUT ASIA PEOPLING AM, P79; TANIS RJ, 1977, AM J HUM GENET, V29, P419; TAYLOR RE, 1985, AM ANTIQUITY, V50, P136, DOI 10.2307/280638; Turner II C. G., 1983, EARLY MAN NEW WORLD, P147; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; YU MS, 1988, SCI CHINA SER B, V31, P860; [No title captured]; [No title captured]; [No title captured]	80	311	317	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					613	623					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	WOS:A1990CT66800026	1968708				2022-01-24	
J	DOBZHANSKY, T				DOBZHANSKY, T			GENETICS OF NATURAL POPULATIONS .13. RECOMBINATION AND VARIABILITY IN POPULATIONS OF DROSOPHILA-PSEUDOOBSCURA	GENETICS			English	Article																	Bridges CB, 1922, AM NAT, V56, P51, DOI 10.1086/279847; Bridges CB, 1939, SEX INTERNAL SECRETI, P15; Chetverikov S.S., 1926, ZH EKSPERIM BIOL   A, V2, p[3, 167]; Dobzhansky T, 1939, BIOL REV CAMB PHILOS, V14, P339, DOI 10.1111/j.1469-185X.1939.tb00847.x; Dobzhansky T, 1943, GENETICS, V28, P304; Dobzhansky T, 1943, GENETICS, V28, P162; Dobzhansky T, 1944, GENETICS, V29, P270; Dobzhansky T, 1942, GENETICS, V27, P463; Dobzhansky TH, 1941, GENETICS ORIGIN SPEC; DUBININ NP, 1946, GENETICS, V31, P21; Goodale HD, 1937, AM NAT, V71, P433, DOI 10.1086/280731; IVES PT, 1945, GENETICS, V30, P167; Jones, 1919, INBREEDING OUTBREEDI; Jones DF, 1917, GENETICS, V2, P466; Jones Donald F., 1925, GENETICS PLANT ANIMA; Mather K, 1944, PROC R SOC SER B-BIO, V132, P308, DOI 10.1098/rspb.1944.0020; Mather K, 1942, PROC R SOC SER B-BIO, V131, P50, DOI 10.1098/rspb.1942.0017; Mather K, 1943, BIOL REV CAMB PHILOS, V18, P32, DOI 10.1111/j.1469-185X.1943.tb00287.x; Mather K, 1942, J GENET, V43, P309, DOI 10.1007/BF02982906; Mather K, 1941, J GENET, V41, P159, DOI 10.1007/BF02983019; Muller HJ, 1918, GENETICS, V3, P422; Payne F., 1918, Indiana University Studies Bloomington, V5, P1; PAYNE F, 1921, GENETICS, V6, P501; SINGLETON W. RALPH, 1941, AMER NAT, V75, P48, DOI 10.1086/280928; Spencer WP, 1944, GENETICS, V29, P520; WIGAN L. G., 1942, Annals of Eugenics, V11, P354; WRIGHT S, 1946, GENETICS, V31, P125; Zeleny C, 1922, GENETICS, V7, P1	28	311	321	2	17	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1946	31	3					269	290					22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW828	WOS:A1946XW82800003	20985721				2022-01-24	
J	Flannick, J; Thorleifsson, G; Beer, NL; Jacobs, SBR; Grarup, N; Burtt, NP; Mahajan, A; Fuchsberger, C; Atzmon, G; Benediktsson, R; Blangero, J; Bowden, DW; Brandslund, I; Brosnan, J; Burslem, F; Chambers, J; Cho, YS; Cho, YS; Douglas, DA; Duggirala, R; Dymek, Z; Farjoun, Y; Fennell, T; Fontanillas, P; Forsen, T; Gabriel, S; Glaser, B; Gudbjartsson, DF; Hanis, C; Hansen, T; Hreidarsson, AB; Hveem, K; Ingelsson, E; Isomaa, B; Johansson, S; Jorgensen, T; Jorgensen, ME; Kathiresan, S; Kong, A; Kooner, J; Kravic, J; Laakso, M; Lee, JY; Lind, L; Lindgren, CM; Linneberg, A; Masson, G; Meitinger, T; Mohlke, KL; Molven, A; Morris, AP; Potluri, S; Rauramaa, R; Ribel-Madsen, R; Richard, AM; Rolph, T; Saloemaa, V; Segre, AV; Skarstrand, H; Steinthorsdottir, V; Stringham, HM; Sulem, P; Tai, ES; Teo, YY; Teslovich, T; Thorsteinsdottir, U; Trimmer, JK; Tuomi, T; Tuomilehto, J; Vaziri-Sani, F; Voight, BF; Voight, BF; Boehnke, M; McCarthy, MI; Njolstad, PR; Pedersen, O; Groop, L; Cox, DR; Stefansson, K; Altshuler, D				Flannick, Jason; Thorleifsson, Gudmar; Beer, Nicola L.; Jacobs, Suzanne B. R.; Grarup, Niels; Burtt, Noel P.; Mahajan, Anubha; Fuchsberger, Christian; Atzmon, Gil; Benediktsson, Rafn; Blangero, John; Bowden, Don W.; Brandslund, Ivan; Brosnan, Julia; Burslem, Frank; Chambers, John; Cho, Yoon Shin; Christensen, Cramer; Douglas, Desiree A.; Duggirala, Ravindranath; Dymek, Zachary; Farjoun, Yossi; Fennell, Timothy; Fontanillas, Pierre; Forsen, Tom; Gabriel, Stacey; Glaser, Benjamin; Gudbjartsson, Daniel F.; Hanis, Craig; Hansen, Torben; Hreidarsson, Astradur B.; Hveem, Kristian; Ingelsson, Erik; Isomaa, Bo; Johansson, Stefan; Jorgensen, Torben; Jorgensen, Marit Eika; Kathiresan, Sekar; Kong, Augustine; Kooner, Jaspal; Kravic, Jasmina; Laakso, Markku; Lee, Jong-Young; Lind, Lars; Lindgren, Cecilia M.; Linneberg, Allan; Masson, Gisli; Meitinger, Thomas; Mohlke, Karen L.; Molven, Anders; Morris, Andrew P.; Potluri, Shobha; Rauramaa, Rainer; Ribel-Madsen, Rasmus; Richard, Ann-Marie; Rolph, Tim; Salomaa, Veikko; Segre, Ayellet V.; Skaerstrand, Hanna; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Sulem, Patrick; Tai, E. Shyong; Teo, Yik Ying; Teslovich, Tanya; Thorsteinsdottir, Unnur; Trimmer, Jeff K.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Vaziri-Sani, Fariba; Voight, Benjamin F.; Wilson, James G.; Boehnke, Michael; McCarthy, Mark I.; Njolstad, Pal R.; Pedersen, Oluf; Groop, Leif; Cox, David R.; Stefansson, Kari; Altshuler, David		Go-T2D Consortium; T2D-Genes Consortium	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes	NATURE GENETICS			English	Article							ZINC TRANSPORTER ZNT8; GENOME-WIDE ASSOCIATION; GLUCOSE-HOMEOSTASIS; COMMON VARIANTS; BETA-CELL; INSULIN; RARE; PATHOPHYSIOLOGY; EXPRESSION; RESPONSES	Loss-of-function mutations protective against human disease provide in vivo validation of therapeutic targets1-3, but none have yet been described for type 2 diabetes (T2D). Through sequencing or genotyping of -150,000 individuals across 5 ancestry groups, we identified 12 rare protein-truncating variants in SLC30A8, which encodes an islet zinc transporter (ZnT8) 4 and harbors a common variant (p. Trp325Arg) associated with T2D risk and glucose and proinsulin levels5-7. Collectively, carriers of protein-truncating variants had 65% reduced T2D risk (P = 1.7 x 10(-6)), and non-diabetic Icelandic carriers of a frameshift variant (p. Lys34Serfs* 50) demonstrated reduced glucose levels (-0.17 s. d., P = 4.6 x 10(-4)). The two most common proteintruncating variants (p. Arg138* and p. Lys34Serfs* 50) individually associate with T2D protection and encode unstable ZnT8 proteins. Previous functional study of SLC30A8 suggested that reduced zinc transport increases T2D risk(8,9), and phenotypic heterogeneity was observed in mouse Slc30a8 knockouts(10-15). In contrast, loss-of-function mutations in humans provide strong evidence that SLC30A8 haploinsufficiency protects against T2D, suggesting ZnT8 inhibition as a therapeutic strategy in T2D prevention.	[Flannick, Jason; Beer, Nicola L.; Jacobs, Suzanne B. R.; Burtt, Noel P.; Dymek, Zachary; Farjoun, Yossi; Fennell, Timothy; Fontanillas, Pierre; Gabriel, Stacey; Kathiresan, Sekar; Lindgren, Cecilia M.; Segre, Ayellet V.; Voight, Benjamin F.; Njolstad, Pal R.; Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Flannick, Jason; Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Kong, Augustine; Masson, Gisli; Steinthorsdottir, Valgerdur; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Beer, Nicola L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Grarup, Niels; Hansen, Torben; Ribel-Madsen, Rasmus; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Mahajan, Anubha; Ingelsson, Erik; Lindgren, Cecilia M.; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Fuchsberger, Christian; Stringham, Heather M.; Teslovich, Tanya; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Benediktsson, Rafn; Hreidarsson, Astradur B.] Landspitali Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Blangero, John; Duggirala, Ravindranath] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC USA; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Brosnan, Julia; Richard, Ann-Marie; Rolph, Tim; Trimmer, Jeff K.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Burslem, Frank] Prescient Life Sci, Cardiovasc & Metab Dis Practice, London, England; [Chambers, John] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Chambers, John; Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Healthcare Natl Hlth Serv NHS Trust, London, England; [Chambers, John; Kooner, Jaspal] Ealing Hosp NHS Trust, Southall, Middx, England; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Christensen, Cramer] Vejle Hosp, Dept Internal Med & Endocrinol, Vejle, Denmark; [Douglas, Desiree A.; Skaerstrand, Hanna; Vaziri-Sani, Fariba] Lund Univ, Dept Clin Sci, Unit Diabet & Celiac Dis, Malmo, Sweden; [Forsen, Tom; Tuomi, Tiinamaija] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Forsen, Tom] Vaasa Hlth Care Ctr, Diabetes Care Unit, Vaasa, Finland; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel; [Glaser, Benjamin] IDRG, Holon, Israel; [Hanis, Craig] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Hveem, Kristian] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Levanger, Norway; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Johansson, Stefan; Molven, Anders; Njolstad, Pal R.] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med, Copenhagen, Denmark; [Jorgensen, Torben; Linneberg, Allan] Aalborg Univ, Fac Med, Aalborg, Denmark; [Jorgensen, Marit Eika] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, NHLI, London, England; [Kravic, Jasmina; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lee, Jong-Young] Korea Natl Inst Hlth, Osong Hlth Technol, Ctr Genome Sci, Seoul, Chungcheongbuk, South Korea; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Potluri, Shobha; Cox, David R.] Pfizer Inc, Appl Quantitat Genotherapeut, San Francisco, CA USA; [Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Tai, E. Shyong; Teo, Yik Ying] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Dept Med, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Teo, Yik Ying] Genome Inst Singapore, Agcy Sci Technol & Res, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabetes Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Phys & Biophys, Jackson, MS 39216 USA; [McCarthy, Mark I.] Churchill Hosp, Hlth Res NIHR Biomed Res Ctr, Oxford Natl Inst, Oxford, England; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Groop, Leif] Univ Helsinki, Finnish Inst Mol Med FIMM, Helsinki, Finland; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA 02139 USA		Altshuler, D (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA.	kstefans@decode.is; altshuler@molbio.mgh.harvard.edu	Jorgensen, Torben/Z-1335-2018; Meitinger, Thomas/O-1318-2015; Johansson, Stefan/C-4394-2011; Blangero, John/ABA-7175-2021; Pedersen, Oluf/Z-1731-2019; Benediktsson, Rafn/R-2457-2018; Fuchsberger, Christian/ABD-7127-2021; Vaziri-Sani, Fariba/J-6390-2014; Pedersen, Oluf/AAG-8015-2020; Chen, Peng/E-5546-2015; Altshuler, David M/A-4476-2009; Glaser, Benjamin/F-8411-2017; Stefansson, Kari/AAE-7187-2019; Lee, Jong-Young/M-6319-2013; Grarup, Niels/K-2807-2015; McCarthy, Mark/M-3763-2015	Johansson, Stefan/0000-0002-2298-7008; Pedersen, Oluf/0000-0002-3321-3972; Benediktsson, Rafn/0000-0002-2954-9801; Fuchsberger, Christian/0000-0002-5918-8947; Vaziri-Sani, Fariba/0000-0002-9953-2829; Chen, Peng/0000-0002-1422-4641; Altshuler, David M/0000-0002-7250-4107; Glaser, Benjamin/0000-0003-4711-5000; Lee, Jong-Young/0000-0002-0092-9958; Grarup, Niels/0000-0001-5526-1070; Brandslund, Ivan/0000-0002-4203-5442; Hansen, Torben/0000-0001-8748-3831; Mahajan, Anubha/0000-0001-5585-3420; Tai, E Shyong/0000-0003-2929-8966; Yoon, Joon/0000-0002-9509-119X; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Lindgren, Cecilia/0000-0002-4903-9374; Jorgensen, Torben/0000-0001-9453-2830; Meitinger, Thomas/0000-0002-8838-8403; Jorgensen, Marit Eika/0000-0001-8356-5565; Linneberg, Allan/0000-0002-0994-0184; Tuomi, Tiinamaija/0000-0002-8306-6202; McCarthy, Mark/0000-0002-4393-0510; Jacobs, Suzanne/0000-0002-8103-1700; Kong, Augustine/0000-0001-8193-5438	US National Institutes of Health (NIH) TrainingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5-T32-GM007748-33]; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF) [2006087]; Fulbright Diabetes UK FellowshipDiabetes UK [BDA 11/0004348]; Broad Institute from Pfizer, Inc.; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 DK085501, U01 DK085524, U01 DK085545, U01 DK085584]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [Dnr 521-2010-3490, Dnr 349-2006-237]; European Research Council (ERC)European Research Council (ERC)European Commission [GENETARGET T2D, GA269045]; ENGAGE [2007-201413]; CEED3 [2008-223211]; Sigrid Juselius FoundationSigrid Juselius Foundation; Folkh lsan Research Foundation; ERCEuropean Research Council (ERC)European Commission [AdG 293574]; Research Council of NorwayResearch Council of Norway [197064/V50]; KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck FoundationLundbeckfonden; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited; Wellcome TrustWellcome TrustEuropean Commission [WT098017, WT064890, WT090532, WT090367, WT098381]; Uppsala University; Swedish Research Council and the Swedish Heart- Lung Foundation; Academy of FinlandAcademy of FinlandEuropean Commission [124243, 102318, 123885, 139635]; Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes [1510/31/06]; Commission of the European CommunityEuropean Commission [HEALTH-F2-2007-201681]; Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project [LSHM-CT-2004-005272]; City of Kuopio and Social Insurance Institution of Finland; Finnish Foundation for Cardiovascular Disease; NIH/NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U01-DK085545]; National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [N01 HC-95170, N01 HC-95171, N01 HC-95172]; European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation (Barndiabetesfonden);  [5U01DK085526];  [DK088389];  [U54HG003067];  [R01DK072193];  [R01DK062370];  [Z01HG000024]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0611-10099] Funding Source: researchfish; Novo Nordisk FondenNovo Nordisk Foundation [NNF13OC0005637] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC095170, N01HC095172, N01HC095171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R13CA124293] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [Z01HG000024, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U01DK085501, U01DK085584, R01DK098032, R01DK093757, U01DK085526, U01DK085545, U01DK085524, R01DK062370, U01DK062370, RC2DK088389, R01DK072193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007748] Funding Source: NIH RePORTER	This manuscript is dedicated to the memory of David R. Cox, our dear friend and colleague, who was relentlessly supportive of this work-and more generally, of the use of human genetics to improve human health. He is missed, but his legacy goes on. We gratefully acknowledge the contribution of all similar to 150,000 participants from the various population studies that contributed to this work. J.F. was supported in part by US National Institutes of Health (NIH) Training Grant 5-T32-GM007748-33. D. A. was supported by funding from the Doris Duke Charitable Foundation (2006087). N. L. B. was supported by a Fulbright Diabetes UK Fellowship (BDA 11/0004348). This work was supported in part by funding to the Broad Institute (principal investigator D. A.) from Pfizer, Inc. Funding for the GoT2D and T2D-GENES studies was provided by grants 5U01DK085526 (NIH/NIDDK; Multiethnic Study of Type 2 Diabetes Genes), DK088389 (NIH/NIDDK; Low-Pass Sequencing and High-Density SNP Genotyping for Type 2 Diabetes) and U54HG003067 (National Human Genome Research Institute (NHGRI); Large-Scale Sequencing and Analysis of Genomes), as well as by NIH grants U01 DK085501, U01 DK085524, U01 DK085545 and U01 DK085584. The Malm Preventive Project and the Scania Diabetes Registry were supported by grants from the Swedish Research Council (Dnr 521-2010-3490 to L. G. and Dnr 349-2006-237 to the Lund University Diabetes Centre), as well as by a European Research Council (ERC) grant (GENETARGET T2D, GA269045) and two European Union grants (ENGAGE (2007-201413) and CEED3 (2008-223211)) to L. G. The Botnia study was supported by funding from the Sigrid Juselius Foundation and the Folkh lsan Research Foundation. P. R. N. was funded by the ERC (AdG 293574), the Research Council of Norway (197064/V50), the KG Jebsen Foundation, the University of Bergen, the Western Norway Health Authority, the European Association for the Study of Diabetes Sabbatical Leave Programme and Innovest. The Danish studies were supported by the Lundbeck Foundation (Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp); http://www.lucamp.org/) and the Danish Council for Independent Research. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk/). The PIVUS/ ULSAM cohort was supported by Wellcome Trust grants WT098017, WT064890 and WT090532, Uppsala University, the Uppsala University Hospital, the Swedish Research Council and the Swedish Heart- Lung Foundation. The METSIM study was supported by the Academy of Finland (contract 124243), the Finnish Heart Foundation, the Finnish Diabetes Foundation, Tekes (contract 1510/31/06), the Commission of the European Community (HEALTH-F2-2007-201681) and grants R01DK062370 and R01DK072193 (NIH/NIDDK) and grant (NHGRI). The FUSION study was supported by grants R01DK062370 and R01DK072193 (NIH/NIDDK) and grant Z01HG000024 (NHGRI). The DR's EXTRA Study was supported by the Ministry of Education and Culture of Finland (627; 2004-2011), the Academy of Finland (102318; 123885), Kuopio University Hospital, the Finnish Diabetes Association, the Finnish Heart Association and the P ivikki and Sakari Sohlberg Foundation and by grants from the European Commission Framework Programme 6 Integrated Project (EXGENESIS); LSHM-CT-2004-005272, City of Kuopio and Social Insurance Institution of Finland (4/26/2010). V.; Salomaa is funded by the Academy of Finland, grant 139635, and by the Finnish Foundation for Cardiovascular Disease. Sequencing and genotyping of British individuals was supported by Wellcome Trust grants WT090367, WT090532 and WT098381 and by NIH/NIDDK grant U01-DK085545. Funding for the Jackson Heart Study (JHS) was provided by the National Heart, Lung, and Blood Institute (NHLBI) and by the National Institute on Minority Health and Health Disparities (N01 HC-95170, N01 HC-95171 and N01 HC-95172). A. P. M. acknowledges support from Wellcome Trust grants WT098017, WT090532 and WT064890. F.V.-S. and H. S. were supported by the European Union Seventh Framework Programme, DIAPREPP (Diabetes Type 1 Prediction, Early Pathogenesis and Prevention, grant agreement 202013), and by the Swedish Child Diabetes Foundation (Barndiabetesfonden).	Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xavier GD, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/906590	28	310	315	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					357	+		10.1038/ng.2915			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	WOS:000334510100011	24584071	Green Accepted			2022-01-24	
J	Yan, JB; Kandianis, CB; Harjes, CE; Bai, L; Kim, EH; Yang, XH; Skinner, DJ; Fu, ZY; Mitchell, S; Li, Q; Fernandez, MGS; Zaharieva, M; Babu, R; Fu, Y; Palacios, N; Li, JS; DellaPenna, D; Brutnell, T; Buckler, ES; Warburton, ML; Rocheford, T				Yan, Jianbing; Kandianis, Catherine Bermudez; Harjes, Carlos E.; Bai, Ling; Kim, Eun-Ha; Yang, Xiaohong; Skinner, Debra J.; Fu, Zhiyuan; Mitchell, Sharon; Li, Qing; Fernandez, Maria G. Salas; Zaharieva, Maria; Babu, Raman; Fu, Yang; Palacios, Natalia; Li, Jiansheng; DellaPenna, Dean; Brutnell, Thomas; Buckler, Edward S.; Warburton, Marilyn L.; Rocheford, Torbert			Rare genetic variation at Zea mays crtRB1 increases beta-carotene in maize grain	NATURE GENETICS			English	Article							BIOFORTIFICATION; BIOSYNTHESIS; ARABIDOPSIS; HYDROXYLASE; PROVITAMIN; GERMPLASM; LOCUS; CROPS	Breeding to increase beta-carotene levels in cereal grains, termed provitamin A biofortification, is an economical approach to address dietary vitamin A deficiency in the developing world. Experimental evidence from association and linkage populations in maize (Zea mays L.) demonstrate that the gene encoding beta-carotene hydroxylase 1 (crtRB1) underlies a principal quantitative trait locus associated with beta-carotene concentration and conversion in maize kernels. crtRB1 alleles associated with reduced transcript expression correlate with higher beta-carotene concentrations. Genetic variation at crtRB1 also affects hydroxylation efficiency among encoded allozymes, as observed by resultant carotenoid profiles in recombinant expression assays. The most favorable crtRB1 alleles, rare in frequency and unique to temperate germplasm, are being introgressed via inexpensive PCR marker-assisted selection into tropical maize germplasm adapted to developing countries, where it is most needed for human health.	[Kandianis, Catherine Bermudez; Skinner, Debra J.; Fu, Yang; Rocheford, Torbert] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Yan, Jianbing; Zaharieva, Maria; Babu, Raman; Palacios, Natalia; Warburton, Marilyn L.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico; [Yan, Jianbing; Yang, Xiaohong; Fu, Zhiyuan; Li, Qing; Fu, Yang; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Yan, Jianbing; Harjes, Carlos E.; Mitchell, Sharon; Fernandez, Maria G. Salas; Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Kandianis, Catherine Bermudez; Skinner, Debra J.; Fu, Yang; Rocheford, Torbert] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Bai, Ling; Brutnell, Thomas] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Kim, Eun-Ha; DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Fernandez, Maria G. Salas] Iowa State Univ, Dept Agron, Ames, IA USA; [Buckler, Edward S.] USDA ARS, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA; [Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS USA; [Harjes, Carlos E.] Monsanto Co, Leesburg, GA USA		Rocheford, T (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	marilyn.warburton@ars.usda.gov; torbert@purdue.edu	Pillay, Nischalan/F-9536-2012; Brutnell, Thomas/M-2840-2013; Buckler, Edward/L-7651-2019; Warburton, Marilyn/J-2250-2017	Brutnell, Thomas/0000-0002-3581-8211; Buckler, Edward/0000-0002-3100-371X; Skinner, Debra/0000-0003-4715-670X; Warburton, Marilyn/0000-0002-9542-9912; palacios rojas, natalia/0000-0002-3072-4611	US Agency for International DevelopmentUnited States Agency for International Development (USAID); HarvestPlus; National Science Foundation (NSF)National Science Foundation (NSF) [DBI-0321467, DBI-0820619, DBI-0604923, DBI-0501713, 30821140352]; USDA-ARSUnited States Department of Agriculture (USDA)USDA Agricultural Research Service; TRIAD Foundation; China Scholarship Fund; JBT Fellowship-UIUC	We thank K. Pixley and J. Chandler for seed and field experiment coordination and W. White, P. Bermudez, S. Islam, C. Paul, W. Liu, S. Xu and Y. Zhou for carotenoid HPLC profiling. Helpful comments on the manuscript from J. Wilkinson and J. Yu are appreciated. This research was supported by the US Agency for International Development (T. R.), HarvestPlus (T. R., D. D. P., J. Y., J. L., M. L. W.), National Science Foundation (NSF) DBI-0321467, DBI-0820619 (E. S. B.), NSF DBI-0604923 (T. R.), USDA-ARS (E. S. B.), NSF DBI-0501713 (T. B.), TRIAD Foundation (T. B.), China NSF-30821140352 (J. L., J. Y.), China Scholarship Fund (Y. F.) and JBT Fellowship-UIUC (C. B. K.).	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Cunningham FX, 2007, EUKARYOT CELL, V6, P533, DOI 10.1128/EC.00265-06; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; KANDIANIS C, THESIS U ILLINOIS UR; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI [10.1104/pp.107.098996, 10.1104/PP.107.098996]; MATTHEWS PD, 2007, FOOD COLORANTS CHEM, P361; Ooijen J., 2001, JOINMAP VERSION 3 0; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Pritchard JK, 2000, GENETICS, V155, P945; SAS Institute, 2008, SAS STAT US GUID VER; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tanumihardjo SA, 2008, COMPR REV FOOD SCI F, V7, P329; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; UTZ HF, 1993, PLABQTL COMPUTER PRO; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng, 2005, WINDOWS QTL CARTOGRA	25	310	336	4	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					322	U74		10.1038/ng.551			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	WOS:000276150500011	20305664	Green Published			2022-01-24	
J	Adey, A; Morrison, HG; Asan; Xun, X; Kitzman, JO; Turner, EH; Stackhouse, B; MacKenzie, AP; Caruccio, NC; Zhang, XQ; Shendure, J				Adey, Andrew; Morrison, Hilary G.; Asan; Xun, Xu; Kitzman, Jacob O.; Turner, Emily H.; Stackhouse, Bethany; MacKenzie, Alexandra P.; Caruccio, Nicholas C.; Zhang, Xiuqing; Shendure, Jay			Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition	GENOME BIOLOGY			English	Article							AMPLIFICATION-FREE; SHORT-READ; SEQUENCE; DNA; TN5; SEQ	We characterize and extend a highly efficient method for constructing shotgun fragment libraries in which transposase catalyzes in vitro DNA fragmentation and adaptor incorporation simultaneously. We apply this method to sequencing a human genome and find that coverage biases are comparable to those of conventional protocols. We also extend its capabilities by developing protocols for sub-nanogram library construction, exome capture from 50 ng of input DNA, PCR-free and colony PCR library construction, and 96-plex sample indexing.	[Asan; Xun, Xu; Zhang, Xiuqing] BGI Shenzhen, Shenzhen 518000, Peoples R China; [Adey, Andrew; Kitzman, Jacob O.; Turner, Emily H.; Stackhouse, Bethany; MacKenzie, Alexandra P.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Morrison, Hilary G.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Caruccio, Nicholas C.] Epictr Biotechnol, Madison, WI 53713 USA		Zhang, XQ (corresponding author), BGI Shenzhen, Shenzhen 518000, Peoples R China.	zhangxq@genomics.org.cn; shendure@u.washington.edu	Shendure, Jay/AAU-3684-2021; Xu, Xun/AAI-6763-2020	Xu, Xun/0000-0002-5338-5173; Shendure, Jay/0000-0002-1516-1865; Turner, Emily/0000-0001-9040-9229; Morrison, Hilary/0000-0003-0281-326X	National Institutes of Health/National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL094976]; National Institutes of Health/National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R21 HG004749]; National Institutes of Health/National Institute of Allergy and Infectious Disease Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases at the University of WashingtonUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [3U54AI05714]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2006AA02A301]; NSFNational Science Foundation (NSF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R21HG004749] Funding Source: NIH RePORTER	We would like to acknowledge W Reznikoff for conceptual contributions; H Grunenwald and others at Epicentre for early access to materials; C Lee, J Hiatt, R Patwardhan, L Felker, R Qiu, B O'Roak, and other members of the Shendure Lab for assistance with protocol development and sequencing; the genome sequencing platform of BGI-Shenzhen, especially Wu Kui, Jiang Hui, Chen Mingfeng, Liu Lin, Yu Lili and Kaileung Yuan, for their contributions to YH1 and Drosophila genome sequencing; He Weiming, Liu Xingwang and Yang Lei for their genotyping work; and I. Meek and E. Wong-Ho (Caliper) for size selections on the LabChip XT. This work was supported in part by grants from the National Institutes of Health/National Heart Lung and Blood Institute (R01 HL094976 to JS), the National Institutes of Health/National Human Genome Research Institute (R21 HG004749 to JS), the National Institutes of Health/National Institute of Allergy and Infectious Disease Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases at the University of Washington (3U54AI05714), the Ministry of Science and Technology of China, 863 program (2006AA02A301), and an NSF Graduate Research Fellowship (to JOK).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; LENNON NJ, GENOME BIOL, V11, pR15; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Reznikoff WS, 2008, ANNU REV GENET, V42, P269, DOI 10.1146/annurev.genet.42.110807.091656; Reznikoff WS, 2003, MOL MICROBIOL, V47, P1199, DOI 10.1046/j.1365-2958.2003.03382.x; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; YI X, SCIENCE, V329, P75	23	310	313	5	52	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.		2010	11	12							R119	10.1186/gb-2010-11-12-r119			17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	721TT	WOS:000287379000001	21143862	Green Published, hybrid			2022-01-24	
J	Birnbaum, S; Ludwig, KU; Reutter, H; Herms, S; Steffens, M; Rubini, M; Baluardo, C; Ferrian, M; de Assis, NA; Alblas, MA; Barth, S; Freudenberg, J; Lauster, C; Schmidt, G; Scheer, M; Braumann, B; Berge, SJ; Reich, RH; Schiefke, F; Hemprich, A; Potzsch, S; Steegers-Theunissen, RP; Potzsch, B; Moebus, S; Horsthemke, B; Kramer, FJ; Wienker, TF; Mossey, PA; Propping, P; Cichon, S; Hoffmann, P; Knapp, M; Nothen, MM; Mangold, E				Birnbaum, Stefanie; Ludwig, Kerstin U.; Reutter, Heiko; Herms, Stefan; Steffens, Michael; Rubini, Michele; Baluardo, Carlotta; Ferrian, Melissa; de Assis, Nilma Almeida; Alblas, Margrieta A.; Barth, Sandra; Freudenberg, Jan; Lauster, Carola; Schmidt, Guel; Scheer, Martin; Braumann, Bert; Berge, Stefaan J.; Reich, Rudolf H.; Schiefke, Franziska; Hemprich, Alexander; Poetzsch, Simone; Steegers-Theunissen, Regine P.; Poetzsch, Bernd; Moebus, Susanne; Horsthemke, Bernhard; Kramer, Franz-Josef; Wienker, Thomas F.; Mossey, Peter A.; Propping, Peter; Cichon, Sven; Hoffmann, Per; Knapp, Michael; Noethen, Markus M.; Mangold, Elisabeth			Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; EXPRESSION; RISK; IRF6; METAANALYSIS; DISEASE; DESIGN; CANCER; SCAN	We conducted a genome-wide association study involving 224 cases and 383 controls of Central European origin to identify susceptibility loci for nonsyndromic cleft lip with or without cleft palate (NSCL/P). A 640-kb region at chromosome 8q24.21 was found to contain multiple markers with highly significant evidence for association with the cleft phenotype, including three markers that reached genome-wide significance. The 640-kb cleft-associated region was saturated with 146 SNP markers and then analyzed in our entire NSCL/P sample of 462 unrelated cases and 954 controls. In the entire sample, the most significant SNP (rs987525) had a P value of 3.34 x 10(-24). The odds ratio was 2.57 (95% CI = 2.02-3.26) for the heterozygous genotype and 6.05 (95% CI = 3.88-9.43) for the homozygous genotype. The calculated population attributable risk for this marker is 0.41, suggesting that this study has identified a major susceptibility locus for NSCL/P.	[Birnbaum, Stefanie; Reutter, Heiko; de Assis, Nilma Almeida; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.; Mangold, Elisabeth] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Birnbaum, Stefanie; Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Ludwig, Kerstin U.; Herms, Stefan; Alblas, Margrieta A.; Barth, Sandra; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Steffens, Michael; Wienker, Thomas F.; Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Rubini, Michele; Baluardo, Carlotta; Ferrian, Melissa] Univ Ferrara, Dept Expt & Diagnost Med, Med Genet Unit, I-44100 Ferrara, Italy; [Freudenberg, Jan] Northshore LIJ Univ Hosp, Feinstein Inst Med Res, Ctr Genom & Human Genet, New York, NY USA; [Lauster, Carola; Schmidt, Guel] Humboldt Univ, Dept Cleft Lip & Cleft Palate Surg, Berlin, Germany; [Scheer, Martin] Univ Cologne, Dept Oral & Maxillofacial Surg, Cologne, Germany; [Braumann, Bert] Univ Cologne, Dept Orthodont, Cologne, Germany; [Berge, Stefaan J.] Radboud Univ Nijmegen, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Reich, Rudolf H.] Univ Bonn, Dept Oral & Maxillofacial Plast Surg, D-5300 Bonn, Germany; [Schiefke, Franziska; Hemprich, Alexander] Univ Leipzig, Dept Oral & Maxillofacial Surg, Leipzig, Germany; [Poetzsch, Simone] Univ Magdeburg, D-39106 Magdeburg, Germany; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Rotterdam, Netherlands; [Poetzsch, Bernd] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Duisburg, Germany; [Horsthemke, Bernhard] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Duisburg, Germany; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Orthodont Unit, Dundee, Scotland		Mangold, E (corresponding author), Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany.	e.mangold@uni-bonn.de	Cichon, Sven/B-9618-2014; Cichon, Sven/H-8803-2013; Berge, Stefaan/AAP-3708-2020; Hoffmann, Per/A-5149-2010; Berge, S.J./H-8011-2014; Ludwig, Kerstin U/H-7828-2019; Herms, Stefan/J-1949-2014; Nothen, Markus/B-2027-2009	Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Hoffmann, Per/0000-0002-6573-983X; Ludwig, Kerstin U/0000-0002-8541-2519; Herms, Stefan/0000-0002-2786-8200; Nothen, Markus/0000-0002-8770-2464; Steffens, Michael/0000-0002-6445-8593; Rubini, Michele/0000-0003-1448-9516; Mossey, Peter/0000-0002-9914-6901; Ferrian, Melissa/0000-0002-3746-4576	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; Heinz Nixdorf Foundation, Germany; European Comission FP5 [QLG1-CT-2000-01019]; University of Ferrara; CNPq/BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	We thank the subjects and their families for their participation in the study as well as the German support group for people with cleft lip and/or palate (Deutsche Selbsthilfevereinigung fur Lippen-Gaumen-Fehlbildungen e. V.). We acknowledge M. Saffar, H. Koch, C. Opitz, M. Krimmel, K. Gundlach, K. Lohrer and B. Blaumeiser for their kind support in contacting subjects. The EUROCRAN project included contributions from R. Brusati, G. Garattini, E. Calzolari, M. Accordi and A. Franchella (Italy), W. C. Shaw, P. Nelson and P. Houston (UK), S. de Weerd and I. Krapels (Netherlands), V. Kozelj and B. Peterlin (Slovenia), Y. Anastassov (Bulgaria), S. Hanstein (Estonia), A. Czeizel (Hungary), I. Klimova (Slovak Republic) and J. Little (Canada). We also thank S. Raeder, S. Uhlhaas, N. Kluck, A. Flosdorff and M. Arbustini for their laboratory work; H. Henschke and A. Diaz Lacava for their database management; and S. Boehringer for discussions. The study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and individual grants MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1). The Heinz Nixdorf Recall cohort was established with the generous support of the Heinz Nixdorf Foundation, Germany (Chairman: Dr. jur. G. Schmidt). The EUROCRAN study was supported by the European Comission FP5 (contract no. QLG1-CT-2000-01019) and the ITALCLEFT study by a FAR-2008 grant from the University of Ferrara. N.A. is supported by the CNPq/Brazil.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker T, 2004, AM J HUM GENET, V75, P561, DOI 10.1086/424390; Cann HM, 2002, SCIENCE, V296, P261; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Hirano T, 2008, MUTAT RES-FUND MOL M, V640, P97, DOI 10.1016/j.mrfmmm.2007.12.008; Jackson MR, 2002, ANN HUM GENET, V66, P307, DOI 10.1017/S0003480002001203; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Mossey PA, 2002, CLEFT LIP PALATE ORI, P127; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; [No title captured]	29	310	324	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					473	477		10.1038/ng.333			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	WOS:000264659000023	19270707				2022-01-24	
J	Piepho, HP; Mohring, J				Piepho, Hans-Peter; Moehring, Jens			Computing heritability and selection response from unbalanced plant breeding trials	GENETICS			English	Article							PREDICTION	Heritability is often used by plant breeders and geneticists as a measure of precision of a trial or a series of trials. Its main use is for computing the response to selection. Most formulas proposed for calculating heritability implicitly assume balanced data and independent genotypic effects. Both of these assumptions are often violated in plant breeding trials. This article proposes a simulation-based approach to tackle the problem. The key idea is to directly simulate the quantity of interest, e.g., response to selection, rather than trying to approximate it using some ad hoc measure of heritability. The approach is illustrated by three examples.	Univ Hohenheim, Inst Pflanzen & Grunland, Fachgebiet Bioinformat, D-70599 Stuttgart, Germany		Piepho, HP (corresponding author), Univ Hohenheim, Inst Pflanzen & Grunland, Fachgebiet Bioinformat, Fruwirthstr 23, D-70599 Stuttgart, Germany.	piepho@uni-hohenheim.de		Piepho, Hans-Peter/0000-0001-7813-2992			BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Cox GM., 1957, EXPT DESIGNS; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Efron B, 1993, INTRO BOOTSTRAP; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; HANSON WD, 1963, PUB NATL ACAD SCI NA, V982; Helms TC, 2006, CROP SCI, V46, P1137, DOI 10.2135/cropsci2005.07-0212; HENDERSON CR, 1977, J DAIRY SCI, V60, P783, DOI 10.3168/jds.S0022-0302(77)83935-0; Holland JB, 2002, PL BRED RE, V22, P9; John JA, 1995, CYCLIC COMPUTER GENE; KACKAR RN, 1984, J AM STAT ASSOC, V79, P853, DOI 10.2307/2288715; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; Mrode R. A., 2000, LINEAR MODELS PREDIC; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; Oakey H, 2006, THEOR APPL GENET, V113, P809, DOI 10.1007/s00122-006-0333-z; Patterson H.D., 1997, STAT METHODS PLANT V, P139, DOI DOI 10.1007/978-94-009-1503-9_9; Piepho HP, 2006, HORTSCIENCE, V41, P446, DOI 10.21273/HORTSCI.41.2.446; Piepho HP, 2006, CROP SCI, V46, P192, DOI 10.2135/cropsci2005.04-0038; PIEPHO HP, 2000, BIOMET EPIDEMIOL MED, V31, P123; PIEPHO HP, 2007, IN PRESS EUPHYTICA; Searle S. R., 1992, VARIANCE COMPONENTS	21	310	313	0	36	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	2007	177	3					1881	1888		10.1534/genetics.107.074229			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	237JA	WOS:000251368800050	18039886	Green Published, Bronze			2022-01-24	
J	Moseley, ML; Zu, T; Ikeda, Y; Gao, WC; Mosemiller, AK; Daughters, RS; Chen, G; Weatherspoon, MR; Clark, HB; Ebner, TJ; Day, JW; Ranum, LPW				Moseley, Melinda L.; Zu, Tao; Ikeda, Yoshio; Gao, Wangcai; Mosemiller, Anne K.; Daughters, Randy S.; Chen, Gang; Weatherspoon, Marcy R.; Clark, H. Brent; Ebner, Timothy J.; Day, John W.; Ranum, Laura P. W.			Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8	NATURE GENETICS			English	Article							SCA8 REPEAT EXPANSION; CEREBELLAR CORTEX; MYOTONIC-DYSTROPHY; TRANSGENIC MICE; ANTISENSE TRANSCRIPTION; BINDING PROTEIN; PARALLEL FIBER; CTG EXPANSION; LOCUS; RNA	We previously reported that a (CTG)(n) expansion causes spinocerebellar ataxia type 8 (SCA8), a slowly progressive ataxia with reduced penetrance. We now report a transgenic mouse model in which the full-length human SCA8 mutation is transcribed using its endogenous promoter. (CTG)(116) expansion, but not (CTG)(11) control lines, develop a progressive neurological phenotype with in vivo imaging showing reduced cerebellar-cortical inhibition. 1C2-positive intranuclear inclusions in cerebellar Purkinje and brainstem neurons in SCA8 expansion mice and human SCA8 autopsy tissue result from translation of a polyglutamine protein, encoded on a previously unidentified antiparallel transcript (ataxin 8, ATXN8) spanning the repeat in the CAG direction. The neurological phenotype in SCA8 BAC expansion but not BAC control lines demonstrates the pathogenicity of the (CTG-CAG)(n) expansion. Moreover, the expression of noncoding (CUG)(n) expansion transcripts (ataxin 8 opposite strand, ATXN8OS) and the discovery of intranuclear polyglutamine inclusions suggests SCA8 pathogenesis involves toxic gain-of-function mechanisms at both the protein and RNA levels.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA		Ranum, LPW (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	ranum001@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040389] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040389, R01 NS40389] Funding Source: Medline		Benzow KA, 2002, MAMM GENOME, V13, P134, DOI 10.1007/s0033501-2105-2; Brusco A, 2002, J NEUROL, V249, P923, DOI 10.1007/s00415-002-0760-y; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649; Dorsman JC, 2002, HUM MOL GENET, V11, P1487, DOI 10.1093/hmg/11.13.1487; Dunbar RL, 2004, NEUROSCIENCE, V126, P213, DOI 10.1016/j.neuroscience.2004.02.020; Ebner TJ, 2005, PROG BRAIN RES, V148, P125, DOI 10.1016/S0079-6123(04)48011-X; Gao WC, 2003, J NEUROSCI, V23, P1859; Hanson CL, 2000, NEUROSCIENCE, V96, P317, DOI 10.1016/S0306-4522(99)00470-4; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Ikeda Y, 2000, NEUROLOGY, V54, P950, DOI 10.1212/WNL.54.4.950; Ikeda Y, 2004, AM J HUM GENET, V75, P3, DOI 10.1086/422014; Ikeda Y, 2000, J NEUROL SCI, V182, P76, DOI 10.1016/S0022-510X(00)00446-9; Izumi Y, 2003, AM J HUM GENET, V72, P704, DOI 10.1086/367775; Juvonen V, 2000, ANN NEUROL, V48, P354, DOI 10.1002/1531-8249(200009)48:3<354::AID-ANA10>3.3.CO;2-1; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Margolis RL, 2004, ANN NEUROL, V56, P670, DOI 10.1002/ana.20248; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martins S, 2005, AM J MED GENET B, V139B, P109, DOI 10.1002/ajmg.b.30235; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Orr HT, 2000, NEUROBIOL DIS, V7, P129, DOI 10.1006/nbdi.2000.0305; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Schols L, 2003, ANN NEUROL, V54, P110, DOI 10.1002/ana.10608; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Silveira I, 2000, AM J HUM GENET, V66, P830, DOI 10.1086/302827; Sobrido MJ, 2001, NEUROLOGY, V57, P1310, DOI 10.1212/WNL.57.7.1310; Stevanin G, 2000, NAT GENET, V24, P213, DOI 10.1038/73408; Sulek A, 2003, AM J HUM GENET, V73, P972, DOI 10.1086/378524; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vincent JB, 2000, AM J HUM GENET, V66, P819, DOI 10.1086/302803; Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	50	310	319	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					758	769		10.1038/ng1827			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	WOS:000238669300011	16804541				2022-01-24	
J	Wittke-Thompson, JK; Pluzhnikov, A; Cox, NJ				Wittke-Thompson, JK; Pluzhnikov, A; Cox, NJ			Rational inferences about departures from Hardy-Weinberg equilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE DISTRIBUTIONS; PROSTATE-CANCER; CROHNS-DISEASE; ASSOCIATION; SUSCEPTIBILITY; GENE; POLYMORPHISMS; POPULATION; SELECTION; MUTATION	Previous studies have explored the use of departure from Hardy-Weinberg equilibrium (DHW) for fine mapping Mendelian disorders and for general fine mapping. Other studies have used Hardy-Weinberg tests for genotyping quality control. To enable investigators to make rational decisions about whether DHW is due to genotyping error or to underlying biology, we developed an analytic framework and software to determine the parameter values for which DHW might be expected for common diseases. We show analytically that, for a general disease model, the difference between population and Hardy-Weinberg-expected genotypic frequencies (Delta) at the susceptibility locus is a function of the susceptibility-allele frequency (q), heterozygote relative risk (beta), and homozygote relative risk (gamma). For unaffected control samples, Delta is a function of risk in nonsusceptible homozygotes (alpha), the population prevalence of disease (K-p), q, beta, and gamma. We used these analytic functions to calculate D and the number of cases or controls needed to detect DHW for a range of genetic models consistent with common diseases (1.1 <= gamma <= 10 and 0.005 <= K-p <= 0.2). Results suggest that significant DHW can be expected in relatively small samples of patients over a range of genetic models. We also propose a goodness-of-fit test to aid investigators in determining whether a DHW observed in the context of a case-control study is consistent with a genetic disease model. We illustrate how the analytic framework and software can be used to help investigators interpret DHW in the context of association studies of common diseases.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA		Cox, NJ (corresponding author), Univ Chicago, Dept Human Genet, 507H CLSC,920 E 58th St, Chicago, IL 60637 USA.	ncox@genetics.bsd.uchicago.edu			NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK055889, DK-58026, U01 DK058026, DK-55889] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01 GM061393, U01-GM61393] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK055889, U01DK058026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01GM061393] Funding Source: NIH RePORTER		Castle WE, 1903, P AM ACAD ARTS SCI, V39, P223, DOI 10.2307/20021870; Cramer H., 1946, MATH METHODS STAT; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; Gyorffy B, 2004, GUT, V53, P614; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Kocsis I, 2004, KIDNEY INT, V65, P1956, DOI 10.1111/j.1523-1755.2004.00596.x; Kocsis I, 2004, NEUROLOGY, V63, P357, DOI 10.1212/01.WNL.0000130248.66159.92; Levecque C, 2003, HUM MOL GENET, V12, P79, DOI 10.1093/hmg/ddg009; LI CC, 1967, AM J HUM GENET, V19, P70; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Nejentsev S, 2003, HUM IMMUNOL, V64, P345, DOI 10.1016/S0198-8859(02)00825-X; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Osawa H, 2004, AM J HUM GENET, V75, P678, DOI 10.1086/424761; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; RISCH N, 1990, AM J HUM GENET, V46, P222; Wang LZ, 2003, CANCER LETT, V202, P53, DOI 10.1016/j.canlet.2003.08.001; WEINBERG W, 2005, PAPERS HUMAN GENETIC; Weir BS., 1996, GENETIC DATA ANAL, VII, P91; Xu JF, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y	24	310	318	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					967	986		10.1086/430507			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	WOS:000229047900005	15834813	Green Published, Bronze			2022-01-24	
J	Noben-Trauth, K; Zheng, QY; Johnson, KR				Noben-Trauth, K; Zheng, QY; Johnson, KR			Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss	NATURE GENETICS			English	Article							SYNDROME TYPE 1D; INBRED STRAINS; MICE; LOCUS; SUSCEPTIBILITY; STEREOCILIA; MUTATIONS; HARMONIN; MODEL; MOUSE	Age-related hearing loss (AHL) in common inbred mouse strains is a genetically complex quantitative trait. We found a synonymous single-nucleotide polymorphism in exon 7 of Cdh23 that shows significant association with AHL and the deafness modifier mdfw (modifer of deafwaddler). The hypomorphic Cdh23(753A) allele causes in-frame skipping of exon 7. Altered adhesion or reduced stability of CDH23 may confer susceptibility to AHL. Homozygosity at Cdh23(753A) or in combination with heterogeneous secondary factors is a primary determinant of AHL in mice.	Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, Rockville, MD 20850 USA; Jackson Lab, Bar Harbor, ME 04609 USA		Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, 5 Res Court, Rockville, MD 20850 USA.		Zheng, Qing/C-1731-2012		NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC004376-01A1, R21 DC005846-01A1, R21 DC005846, R01 DC005827, R01 DC005827-03, R01 DC009246, R01 DC004301, R01 DC004301-05] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [Z01DC000036, R01DC004301, R01DC009246, R21DC005846, R01DC005827, R03DC004376] Funding Source: NIH RePORTER		Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Davis RR, 2001, HEARING RES, V155, P82, DOI 10.1016/S0378-5955(01)00250-7; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; Johnson KR, 2002, GENOMICS, V80, P461, DOI 10.1006/geno.2002.6858; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; von Brederlow B, 2002, HUM MUTAT, V19, P268, DOI 10.1002/humu.10049; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zheng QY, 2001, HEARING RES, V154, P45, DOI 10.1016/S0378-5955(01)00215-5	15	310	326	1	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					21	23		10.1038/ng1226			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	WOS:000185018500006	12910270	Green Accepted			2022-01-24	
J	Roix, JJ; McQueen, PG; Munson, PJ; Parada, LA; Misteli, T				Roix, JJ; McQueen, PG; Munson, PJ; Parada, LA; Misteli, T			Spatial proximity of translocation-prone gene loci in human lymphomas	NATURE GENETICS			English	Article							HUMAN LEUKEMIC-CELLS; C-MYC; CHROMOSOME-ABERRATIONS; NUCLEAR TOPOGRAPHY; CANCER; INTERPHASE; LOCATION; ABL; BCR; DIFFERENTIATION	Cancer cells frequently have disease-specific chromosome rearrangements(1-4). It is poorly understood why translocations between chromosomes recur at specific breakpoints in the genome. Here we provide evidence that higher-order spatial genome organization is a contributing factor in the formation of recurrent translocations. We show that MYC, BCL and immunoglobulin loci, which are recurrently translocated in various B-cell lymphomas, are preferentially positioned in close spatial proximity relative to each other in normal B cells. Loci in spatial proximity are non-randomly positioned towards the nuclear interior in normal B cells. This locus proximity is the consequence of higher-order genome structure rather than a property of individual genes. Our results suggest that the formation of specific translocations in human lymphomas, and perhaps other tissues, is determined in part by higher-order spatial organization of the genome.	NCI, NIH, Bethesda, MD 20892 USA; NIH, Math & Stat Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA		Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			CENTER FOR INFORMATION TECHNOLOGYUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT) [ZIACT000227, Z01CT000227] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01BC010309, ZIABC010309] Funding Source: NIH RePORTER		Bartova E, 2000, LEUKEMIA RES, V24, P233, DOI 10.1016/S0145-2126(99)00174-5; Bartova E, 2000, GENE, V244, P1, DOI 10.1016/S0378-1119(99)00572-7; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Harris N L, 2001, Hematology Am Soc Hematol Educ Program, P194, DOI 10.1182/asheducation-2001.1.194; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kozubek S, 2002, CHROMOSOMA, V111, P321, DOI 10.1007/s00412-002-0210-8; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Parreira L, 1997, HUM GENET, V100, P588, DOI 10.1007/s004390050558; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sachs RK, 1997, INT J RADIAT BIOL, V71, P1; Siebert R, 2001, CURR OPIN ONCOL, V13, P316, DOI 10.1097/00001622-200109000-00002; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; STEVENS MA, 1982, ENCY STAT SCI, V4, P393; TEUOLSKKY WH, 1992, NUMERICAL RECIPES C, P609; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhou J, 2002, MOL CELL BIOL, V22, P4876, DOI 10.1128/MCB.22.13.4876-4889.2002; [No title captured]	29	310	321	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					287	291		10.1038/ng1177			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	WOS:000183815300015	12808455				2022-01-24	
J	Blott, S; Kim, JJ; Moisio, S; Schmidt-Kuntzel, A; Cornet, A; Berzi, P; Cambisano, N; Ford, C; Grisart, B; Johnson, D; Karim, L; Simon, P; Snell, R; Spelman, R; Wong, J; Vilkki, J; Georges, M; Farnir, F; Coppieters, W				Blott, S; Kim, JJ; Moisio, S; Schmidt-Kuntzel, A; Cornet, A; Berzi, P; Cambisano, N; Ford, C; Grisart, B; Johnson, D; Karim, L; Simon, P; Snell, R; Spelman, R; Wong, J; Vilkki, J; Georges, M; Farnir, F; Coppieters, W			Molecular dissection of a quantitative trait locus: A phenylalanine-to-tyrosine substitution in the transmembrane domain of the bovine growth hormone receptor is associated with a major effect on milk yield and composition	GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC DISSECTION; COMPOSITION MAPS; ANIMAL-MODELS; GENOME; CATTLE; QTL; SOMATOTROPIN; INFORMATION	We herein report on our efforts to improve the mapping resolution of a QTL with major effect on milk yield and composition that was previously mapped to bovine chromosome 20. By using a denser chromosome 20 marker map and by exploiting linkage disequilibrium using two distinct approaches, we provide strong evidence that a chromosome segment including the gene coding for the growth hormone receptor accounts for at least part of the chromosome 20 QTL effect. By sequencing individuals with known QTL genotype, we identify an F to Y substitution in the transmembrane domain of the growth hormone receptor gene that is associated with a strong effect on milk yield and composition in the general population.	Univ Liege, Fac Med Vet, Dept Genet, B-4000 Liege, Belgium; Agr Res Ctr MTT, Jokioinen 31600, Finland; Livestock Improvement Corp, Hamilton, New Zealand; Univ Auckland, Vialactia Biosci NZ Ltd, Sch Med, Auckland, New Zealand		Georges, M (corresponding author), Univ Liege, Fac Med Vet, Dept Genet, B43,20 Bd Colonster, B-4000 Liege, Belgium.		Coppieters, Wouter/AAF-5030-2021	Coppieters, Wouter/0000-0001-8109-7825; Snell, Russell/0000-0002-8166-4014; Blott, Sarah/0000-0003-0233-6846; Georges, Michel/0000-0003-4124-2375			Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Arranz JJ, 1998, ANIM GENET, V29, P107, DOI 10.1046/j.1365-2052.1998.00307.x; Bauman DE, 1999, J DAIRY SCI, V82, P2564, DOI 10.3168/jds.S0022-0302(99)75511-6; Boldman K. G., 1993, MANUAL USE MTDFREML; Charlier C, 1996, GENOME RES, V6, P580, DOI 10.1101/gr.6.7.580; CHURCHILL GA, 1994, GENETICS, V138, P963; Coppieters W, 1998, MAMM GENOME, V9, P540, DOI 10.1007/s003359900815; Coppieters W, 1998, GENETICS, V149, P1547; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Falconer D, 1996, INTRO QUANTITATIVE G INTRO QUANTITATIVE G; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Farnir F, 2002, GENETICS, V161, P275; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; GEORGES M, 1995, GENETICS, V139, P907; GODOWSKI PJ, 1989, P NATL ACAD SCI USA, V86, P8083, DOI 10.1073/pnas.86.20.8083; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; HAUSER SD, 1990, MOL CELL ENDOCRINOL, V72, P187, DOI 10.1016/0303-7207(90)90143-V; HEAP D, 1995, J ANIM SCI, V73, P1529; HUDSON RR, 1985, GENETICS, V109, P611; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; Karim L, 2000, ANIM GENET, V31, P396, DOI 10.1046/j.1365-2052.2000.00684.x; Kim JJ, 2002, ASIAN AUSTRAL J ANIM, V15, P1250, DOI 10.5713/ajas.2002.1250; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Lynch M, 1997, GENETICS ANAL QUANTI; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; Meuwissen THE, 2000, GENETICS, V155, P421; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; MOUNT DW, 2001, BIOINFORMATICS SEQUE; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Spelman RJ, 1996, GENETICS, V144, P1799; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Visscher PM, 1996, GENETICS, V143, P1013; Warren W, 2000, MAMM GENOME, V11, P662, DOI 10.1007/s003350010126	37	310	338	0	24	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	JAN	2003	163	1					253	266					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	646MW	WOS:000181039700023	12586713				2022-01-24	
J	Bufe, B; Hofmann, T; Krautwurst, D; Raguse, JD; Meyerhof, W				Bufe, B; Hofmann, T; Krautwurst, D; Raguse, JD; Meyerhof, W			The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides	NATURE GENETICS			English	Article							ADAPTATION; IDENTIFICATION; TRANSDUCTION; EXPRESSION; FAMILY; CELLS	Bitter taste generally causes aversion, which protects humans from ingesting toxic substances. But bitter flavors also contribute to the palatability of food and beverages, thereby influencing nutritional habits in humans(1). Although many studies have examined bitter taste(2-6), the underlying receptor mechanisms remain poorly understood. Anatomical, functional and genetic data from rodents suggest the existence of a family of receptors that are responsive to bitter compounds(7-9). Here we report that a human member of this family, TAS2R16, is present in taste receptor cells on the tongue and is activated by bitter beta-glucopyranosides. Responses to these phytonutrients show a similar concentration dependence and desensitization in transfected cells and in experiments assessing taste perception in humans. Bitter compounds consisting of a hydrophobic residue attached to glucose by a beta-glycosidic bond activate TAS2R16. Thus, TAS2R16 links the recognition of a specific chemical structure to the perception of bitter taste. If the ability of TAS2R16 to detect substances with common molecular properties is typical of the bitter receptor family, it may explain how a few receptors permit the perception of numerous bitter substances.	German Inst Human Nutr, Dept Mol Genet, D-14558 Potsdam, Germany; German Res Ctr Food Chem, Garching, Germany; Clin & Policlin Oral & Maxillofacial Surg & Plast, Charite, Berlin, Germany		Meyerhof, W (corresponding author), German Inst Human Nutr, Dept Mol Genet, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	meyerhof@mail.dife.de	Krautwurst, Dietmar/AAD-5579-2019; Bufe, Bernd/N-6685-2018	Krautwurst, Dietmar/0000-0002-3350-8682; Bufe, Bernd/0000-0003-1610-0658			Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ammon C, 2001, ARCH PHYSIOL BIOCHEM, V110, P137; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Drewnowski A, 2001, NUTR REV, V59, P163, DOI 10.1111/j.1753-4887.2001.tb07007.x; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dulac C, 2000, CELL, V100, P607, DOI 10.1016/S0092-8674(00)80697-2; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Frank O, 2001, J AGR FOOD CHEM, V49, P231, DOI 10.1021/jf0010073; Keast RSJ, 2002, CHEM SENSES, V27, P123, DOI 10.1093/chemse/27.2.123; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KUBO I, 1994, PHYSIOL BEHAV, V56, P1203, DOI 10.1016/0031-9384(94)90367-0; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; MAILGAARD M, 1999, SENSORY EVALUATION T, P122; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MEYERHOF W, 1992, P NATL ACAD SCI USA, V89, P10267, DOI 10.1073/pnas.89.21.10267; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Roosterman D, 1997, J NEUROENDOCRINOL, V9, P741, DOI 10.1046/j.1365-2826.1997.00632.x; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Torre V, 1995, J NEUROSCI, V15, P7757; Vane JR, 2000, J PHYSIOL PHARMACOL, V51, P573; VONLEIBIG J, 1844, CHEM BRIEFE; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	26	310	329	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					397	401		10.1038/ng1014			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	WOS:000179034800015	12379855				2022-01-24	
J	Swain, A; Zanaria, E; Hacker, A; LovellBadge, R; Camerino, G				Swain, A; Zanaria, E; Hacker, A; LovellBadge, R; Camerino, G			Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function	NATURE GENETICS			English	Article							DETERMINING REGION; DETERMINING GENE; EVOLUTION; MICE; ACID; SRY	Duplications of a chromosome Xp21 locus DSS (dosage sensitive sex reversal) are associated with male to female sex reversal. An unusual member of the nuclear hormone receptor superfamily, DAX1, maps to the DSS critical region and is responsible for X-linked adrenal hypoplasia congenita. Here we describe the isolation of the mouse Dax1 gene and its pattern of expression during development. Expression was detected in the first stages of gonadal and adrenal differentiation and in the developing hypothalamus. Moreover, Dax1 expression is down-regulated coincident with overt differentiation in the testis, but persists in the developing ovary. Comparison of the predicted protein products of the human and mouse genes show that specific domains are evolving rapidly. Our results suggest a basis for adrenal insufficiency and hypogonadotropic hypogonadism in males affected by adrenal hypoplasia congenita and are consistent with a role for DAX1 in gonadal sex determination.	UNIV PAVIA, I-27100 PAVIA, ITALY; NATL INST MED RES, MRC, LAB DEV GENET, LONDON NW7 1AA, ENGLAND; UNIV SASSARI, IST ISTOL & EMBRIOL, I-07100 SASSARI, ITALY					Lovell-Badge, Robin/0000-0001-9364-4179; Swain, Amanda/0000-0001-8666-1608	TelethonFondazione Telethon [B.05] Funding Source: Medline		BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BOUGET W, 1995, NATURE, V375, P377; BUEHR M, 1993, DEVELOPMENT, V117, P273; CAPEL B, 1993, ADV DEV BIOL, V2, P1; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DABOVIC B, IN PRESS MAMMALIAN G; DRESSER DW, 1995, HUM MOL GENET, V4, P1613, DOI 10.1093/hmg/4.9.1613; FECHNER PY, 1993, J CLIN ENDOCR METAB, V76, P1248, DOI 10.1210/jc.76.5.1248; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GERMAN J, 1978, SCIENCE, V202, P53, DOI 10.1126/science.567843; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HACKER A, 1995, DEVELOPMENT, V121, P1603; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; KLETTER GB, 1991, TRENDS ENDOCRIN MET, V2, P123, DOI 10.1016/1043-2760(91)90001-4; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LovellBadge R, 1995, PHILOS T R SOC B, V350, P205, DOI 10.1098/rstb.1995.0153; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MUELLER RF, 1994, J MED GENET, V31, P471, DOI 10.1136/jmg.31.6.471; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NORDQVIST K, 1994, NAT GENET, V7, P7, DOI 10.1038/ng0594-7; ROGLER LE, 1993, MOL ENDOCRINOL, V7, P453, DOI 10.1210/me.7.3.453; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SEIDL K, 1989, DEV BIOL, V136, P481, DOI 10.1016/0012-1606(89)90273-X; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TUCKER PK, 1993, NATURE, V364, P715, DOI 10.1038/364715a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	40	310	318	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					404	409		10.1038/ng0496-404			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	WOS:A1996UC55300019	8630494				2022-01-24	
J	HORVITZ, HR; SULSTON, JE				HORVITZ, HR; SULSTON, JE			ISOLATION AND GENETIC-CHARACTERIZATION OF CELL-LINEAGE MUTANTS OF THE NEMATODE CAENORHABDITIS-ELEGANS	GENETICS			English	Article									MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND		HORVITZ, HR (corresponding author), MIT,DEPT BIOL,CAMBRIDGE,MA 02139, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM024663, R01GM024663, R01GM024943] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 24943, GM 24663] Funding Source: Medline		ALBERTSON DG, 1978, DEV BIOL, V63, P165, DOI 10.1016/0012-1606(78)90122-7; BRENNER S, 1974, GENETICS, V77, P71; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; Davidson E. H., 1976, GENE ACTIVITY EARLY; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376; GURDON JB, 1974, CONTROL GENE EXPRESS; Herman R.K., 1980, P227; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1974, THESIS U CAMBRIDGE C; HODGKIN JA, 1977, GENETICS, V86, P275; HORVITZ HR, 1979, MOL GEN GENET, V175, P129, DOI 10.1007/BF00425528; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KIMBLE J. E., 1979, STEM CELLS CELL LINE; MORATA G, 1977, NATURE, V265, P211, DOI 10.1038/265211a0; SNUSTAD DP, 1968, VIROLOGY, V35, P550, DOI 10.1016/0042-6822(68)90285-7; STURTEVANT AH, 1945, GENETICS, V30, P297; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; SULSTON JE, DEV BIOL; WATERSTON RH, 1978, NATURE, V275, P715, DOI 10.1038/275715a0; WHITE J, 1979, ELECTRO OPTICS S AUG, P23; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0	24	310	336	1	25	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1980	96	2					435	454					20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG195	WOS:A1980LG19500009	7262539				2022-01-24	
J	Arribere, JA; Bell, RT; Fu, BXH; Artiles, KL; Hartman, PS; Fire, AZ				Arribere, Joshua A.; Bell, Ryan T.; Fu, Becky X. H.; Artiles, Karen L.; Hartman, Phil S.; Fire, Andrew Z.			Efficient Marker-Free Recovery of Custom Genetic Modifications with CRISPR/Cas9 in Caenorhabditis elegans	GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; DNA TRANSFORMATION; COLLAGEN GENES; CAS SYSTEMS; C. ELEGANS; RNA; ENDONUCLEASE; MUTAGENESIS; MORPHOLOGY; MUTATIONS	Facilitated by recent advances using CRISPR/Cas9, genome editing technologies now permit custom genetic modifications in a wide variety of organisms. Ideally, modified animals could be both efficiently made and easily identified with minimal initial screening and without introducing exogenous sequence at the locus of interest or marker mutations elsewhere. To this end, we describe a coconversion strategy, using CRISPR/Cas9 in which screening for a dominant phenotypic oligonucleotide-templated conversion event at one locus can be used to enrich for custom modifications at another unlinked locus. After the desired mutation is identified among the F-1 progeny heterozygous for the dominant marker mutation, F-2 animals that have lost the marker mutation are picked to obtain the desired mutation in an unmarked genetic background. We have developed such a coconversion strategy for Caenorhabditis elegans, using a number of dominant phenotypic markers. Examining the coconversion at a second (unselected) locus of interest in the marked F-1 animals, we observed that 14-84% of screened animals showed homologous recombination. By reconstituting the unmarked background through segregation of the dominant marker mutation at each step, we show that custom modification events can be carried out recursively, enabling multiple mutant animals to be made. While our initial choice of a coconversion marker [rol-6(su1006)] was readily applicable in a single round of coconversion, the genetic properties of this locus were not optimal in that CRISPR-mediated deletion mutations at the unselected rol-6 locus can render a fraction of coconverted strains recalcitrant to further rounds of similar mutagenesis. An optimal marker in this sense would provide phenotypic distinctions between the desired mutant/+ class and alternative +/+, mutant/null, null/null, and null/+ genotypes. Reviewing dominant alleles from classical C. elegans genetics, we identified one mutation in dpy-10 and one mutation in sqt-1 that meet these criteria and demonstrate that these too can be used as effective conversion markers. Coconversion was observed using a variety of donor molecules at the second (unselected) locus, including oligonucleotides, PCR products, and plasmids. We note that the coconversion approach described here could be applied in any of the variety of systems where suitable coconversion markers can be identified from previous intensive genetic analyses of gain-of-function alleles.	[Arribere, Joshua A.; Artiles, Karen L.; Fire, Andrew Z.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Bell, Ryan T.; Fu, Becky X. H.; Fire, Andrew Z.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Hartman, Phil S.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA		Arribere, JA (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr L235, Stanford, CA 94305 USA.	arribere@stanford.edu; afire@stanford.edu		Fire, Andrew/0000-0001-6217-8312	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM37706, T32GM007790, T32HG000044]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM037706, T32GM007790, F32GM112474] Funding Source: NIH RePORTER	We thank Alexandre Paix and Geraldine Seydoux for first drawing our attention to the oligonucleotide-templated approach. We are grateful to Craig Mello, Victor Ambros, and their colleagues at the University of Massachusetts for sharing of plasmids. We thank Michael Nonet for helpful discussions and critical reading of the manuscript; Pin An Chen and Erik Jorgensen for detailed information on the nature of unc-109(n499); and Christian Frokjaer-Jensen, Julia Pak, and Nimit Jain for discussions, help with injection, and critical reading of the manuscript. This work was supported by National Institutes of Health grants R01GM37706, T32GM007790, and T32HG000044.	BRENNER S, 1974, GENETICS, V77, P71; Chen P. A., 2013, THESIS U UTAH SALT L; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Evans PM, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-22; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; GREENWALD IS, 1980, GENETICS, V96, P147; Gunnery S, 1999, J MOL BIOL, V286, P745, DOI 10.1006/jmbi.1998.2518; Hong Y, 2000, MOL CELL BIOL, V20, P2285, DOI 10.1128/MCB.20.6.2285-2295.2000; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; KRAMER JM, 1993, GENETICS, V135, P1035; KRAMER JM, 1988, CELL, V55, P555, DOI 10.1016/0092-8674(88)90214-0; Lemmens BBLG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003276; LEVY AD, 1993, MOL BIOL CELL, V4, P803, DOI 10.1091/mbc.4.8.803; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; PARK EC, 1986, GENETICS, V113, P821; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Wang Z, 1999, J BIOL CHEM, V274, P37565, DOI 10.1074/jbc.274.53.37565; Zhao P, 2014, CELL RES, V24, P247, DOI 10.1038/cr.2014.9	32	309	314	3	53	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	NOV	2014	198	3					837	U842		10.1534/genetics.114.169730			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS6KT	WOS:000344373300003	25161212	Green Published			2022-01-24	
J	Chan-on, W; Nairismagi, ML; Ong, CK; Lim, WK; Dima, S; Pairojkul, C; Lim, KH; McPherson, JR; Cutcutache, I; Heng, HL; Ooi, L; Chung, A; Chow, P; Cheow, PC; Lee, SY; Choo, SP; Tan, IBH; Duda, D; Nastase, A; Myint, SS; Wong, BH; Gan, AN; Rajasegaran, V; Ng, CCY; Nagarajan, S; Jusakul, A; Zhang, SL; Vohra, P; Yu, W; Huang, DC; Sithithaworn, P; Yongvanit, P; Wongkham, S; Khuntikeo, N; Bhudhisawasdi, V; Popescu, I; Rozen, SG; Tan, P; Teh, B				Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Dima, Simona; Pairojkul, Chawalit; Lim, Kiat Hon; McPherson, John R.; Cutcutache, Ioana; Heng, Hong Lee; Ooi, London; Chung, Alexander; Chow, Pierce; Cheow, Peng Chung; Lee, Ser Yee; Choo, Su Pin; Tan, Iain Bee Huat; Duda, Dan; Nastase, Anca; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Zhang, Shenli; Vohra, Priya; Yu, Willie; Huang, DaChuan; Sithithaworn, Paiboon; Yongvanit, Puangrat; Wongkham, Sopit; Khuntikeo, Narong; Bhudhisawasdi, Vajaraphongsa; Popescu, Irinel; Rozen, Steven G.; Tan, Patrick; Teh, Bin Tean			Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers	NATURE GENETICS			English	Article							OPISTHORCHIS-VIVERRINI; FREQUENT MUTATION; TUMOR-SUPPRESSOR; COPY NUMBERS; CHOLANGIOCARCINOMA; PATHOGENESIS; PHENOTYPE; PATHWAYS; PATIENT; ARID1A	The impact of different carcinogenic exposures on the specific patterns of somatic mutation in human tumors remains unclear. To address this issue, we profiled 209 cholangiocarcinomas (CCAs) from Asia and Europe, including 108 cases caused by infection with the liver fluke Opisthorchis viverrini and 101 cases caused by non-O. viverrini-related etiologies. Whole-exome sequencing (n = 15) and prevalence screening (n = 194) identified recurrent somatic mutations in BAP1 and ARID1A, neither of which, to our knowledge, has previously been reported to be mutated in CCA. Comparisons between intrahepatic O. viverrini-related and non-O. viverrini-related CCAs demonstrated statistically significant differences in mutation patterns: BAP1, IDH1 and IDH2 were more frequently mutated in non-O. viverrini CCAs, whereas TP53 mutations showed the reciprocal pattern. Functional studies demonstrated tumor suppressive functions for BAP1 and ARID1A, establishing the role of chromatin modulators in CCA pathogenesis. These findings indicate that different causative etiologies may induce distinct somatic alterations, even within the same tumor type.	[Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Heng, Hong Lee; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Yu, Willie; Huang, DaChuan; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Heng, Hong Lee; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Zhang, Shenli; Vohra, Priya; Yu, Willie; Huang, DaChuan; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore, Grad Sch Med, Div Canc & Stem Cell Biol, Singapore, Singapore; [Chan-on, Waraporn; Pairojkul, Chawalit; Sithithaworn, Paiboon; Yongvanit, Puangrat; Wongkham, Sopit; Khuntikeo, Narong; Bhudhisawasdi, Vajaraphongsa] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Dima, Simona; Nastase, Anca; Popescu, Irinel] Fundeni Clin Inst, Ctr Digest Dis & Liver Transplantat, Bucharest, Romania; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [McPherson, John R.; Cutcutache, Ioana; Rozen, Steven G.] Duke Natl Univ Singapore, Grad Sch Med, Div Neurosci & Behav Disorders, Singapore, Singapore; [Ooi, London; Chung, Alexander; Chow, Pierce; Cheow, Peng Chung; Lee, Ser Yee] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Choo, Su Pin; Tan, Iain Bee Huat] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Duda, Dan] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Duda, Dan] Harvard Univ, Sch Med, Boston, MA USA; [Yu, Willie] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick; Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore		Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.	vajara_b@kku.ac.th; irinel.popescu@icfundeni.ro; steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Sithithaworn, Paiboon/E-4378-2019; POPESCU, IRINEL/B-3048-2008; Dima, Simona/P-5582-2019; Lim, Weng Khong/Q-8661-2019; Popescu, Irinel/S-9228-2019; CHOO, Su Pin/ABB-3892-2020; Wongkham, Sopit/ABB-6966-2021; Lee, Ser Yee/H-3116-2013; Duda, Dan G/H-8523-2014; Dima, Simona Olimpia/B-8822-2017; Rozen, Steven G./J-5939-2013	Sithithaworn, Paiboon/0000-0002-9480-1778; Lim, Weng Khong/0000-0003-4391-1130; Lee, Ser Yee/0000-0001-9119-7408; Duda, Dan G/0000-0001-7065-8797; Chow, Pierce/0000-0003-0584-2584; Dukes, Priya/0000-0002-8801-4671; Jusakul, Apinya/0000-0001-7652-7771; Tan, Iain/0000-0003-4951-0354; Wong, Bernice/0000-0001-8981-1376; HUANG, DACHUAN/0000-0002-7518-4081; Ong, Choon Kiat/0000-0001-6402-4288; Rozen, Steven G./0000-0002-4288-0056; Teh, Bin Tean/0000-0003-1514-1124	Singapore National Medical Research CouncilNational Medical Research Council, Singapore [NMRC/STAR/0006/2009]; Singapore Millennium FoundationSingapore Millennium Foundation; Lee Foundation; Singapore National Cancer Centre Research Fund; Duke-National University of Singapore Graduate Medical SchoolNational University of Singapore; Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong; Executive Agency for Higher Education, Research and Development, Romania; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; National University of Singapore Graduate School for Integrative Sciences and Engineering scholarshipNational University of Singapore	We thank B. Haaland for reviewing all statistical tests performed in this study and the Duke-National University of Singapore Genome Biology Facility for performing whole-exome sequencing and methylation assays. We thank D. Jefferson (New England Medical Center, Tufts University) for the H69 cell line. We thank B. Sripa (Khon Kean University) for the M139 cell line. This work was supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), the Singapore Millennium Foundation, the Lee Foundation, the Singapore National Cancer Centre Research Fund, the Duke-National University of Singapore Graduate Medical School, the Cancer Science Institute, Singapore, the Verdant Foundation, Hong Kong, Innovation Funding from the Executive Agency for Higher Education, Research and Development, Romania, a Research Team Strengthening Grant, the National Genetic Engineering and Biotechnology Center and the National Science and Technology Development Agency, Thailand. W.Y. is the recipient of a National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship.	Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; IARC, 1994, IARC MONOGR EVAL CAR, V61, P121; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Neubert G, 2013, GENE, V512, P453, DOI 10.1016/j.gene.2012.10.061; Olsson L, 2014, LEUKEMIA, V28, P302, DOI 10.1038/leu.2013.206; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Saichua P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002228; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	39	309	313	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1474	U100		10.1038/ng.2806			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	WOS:000327715800014	24185513				2022-01-24	
J	Gry, M; Rimini, R; Stromberg, S; Asplund, A; Ponten, F; Uhlen, M; Nilsson, P				Gry, Marcus; Rimini, Rebecca; Stromberg, Sara; Asplund, Anna; Ponten, Fredrik; Uhlen, Mathias; Nilsson, Peter			Correlations between RNA and protein expression profiles in 23 human cell lines	BMC GENOMICS			English	Article							GENE-EXPRESSION; PROSTATE-CANCER; IMAGE-ANALYSIS; MICROARRAYS; ABUNDANCE; NORMALIZATION; ADAPTATION; SYSTEM; CDNA; TOOL	Background: The Central Dogma of biology holds, in famously simplified terms, that DNA makes RNA makes proteins, but there is considerable uncertainty regarding the general, genome-wide correlation between levels of RNA and corresponding proteins. Therefore, to assess degrees of this correlation we compared the RNA profiles (determined using both cDNA- and oligo-based microarrays) and protein profiles ( determined immunohistochemically in tissue microarrays) of 1066 gene products in 23 human cell lines. Results: A high mean correlation coefficient (0.52) was obtained from the pairwise comparison of RNA levels determined by the two platforms. Significant correlations, with correlation coefficients exceeding 0.445, between protein and RNA levels were also obtained for a third of the specific gene products. However, the correlation coefficients between levels of RNA and protein products of specific genes varied widely, and the mean correlations between the protein and corresponding RNA levels determined using the cDNA- and oligo-based microarrays were 0.25 and 0.20, respectively. Conclusion: Significant correlations were found in one third of the examined RNA species and corresponding proteins. These results suggest that RNA profiling might provide indirect support to antibodies' specificity, since whenever a evident correlation between the RNA and protein profiles exists, this can sustain that the antibodies used in the immunoassay recognized their cognate antigens.	[Gry, Marcus; Rimini, Rebecca; Uhlen, Mathias; Nilsson, Peter] AlbaNova Univ Ctr, KTH, Sch Biotechnol, Dept Prote, S-10691 Stockholm, Sweden; [Gry, Marcus; Stromberg, Sara; Asplund, Anna; Ponten, Fredrik] Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden		Nilsson, P (corresponding author), AlbaNova Univ Ctr, KTH, Sch Biotechnol, Dept Prote, S-10691 Stockholm, Sweden.	marcus.gry@genpat.uu.se; rimini@kth.se; sara.stromberg@genpat.uu.se; anna.asplund@genpat.uu.se; fredrik.ponten@genpat.uu.se; mathias@biotech.kth.se; nipe@kth.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016; Nilsson, Peter/E-4547-2010	Uhlen, Mathias/0000-0002-4858-8056; Nilsson, Peter/0000-0002-4657-8532; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	We are grateful to Annelie Walden and Anna Westring at the KTH Microarray Center for DNA microarray production and experimental performance. This work was supported by grants from the Knut and Alice Wallenberg Foundation.	Andersson AC, 2006, J HISTOCHEM CYTOCHEM, V54, P1413, DOI 10.1369/jhc.6A7001.2006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asplund A, 2008, BRIT J DERMATOL, V158, P527, DOI 10.1111/j.1365-2133.2007.08418.x; BENGTSSON H, 2008, AROMA OBJECT ORIENTE; Carlson MW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-117; Cross SS, 2001, J CLIN PATHOL, V54, P385, DOI 10.1136/jcp.54.5.385; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; Lehr HA, 2001, AM J CLIN PATHOL, V115, P814; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lundberg E, 2008, J PROTEOMICS, V71, P448, DOI 10.1016/j.jprot.2008.06.014; Mousses S, 2002, CANCER RES, V62, P1256; R Core Team R, 2017, R LANG ENV STAT COMP; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stromberg S, 2007, PROTEOMICS, V7, P2142, DOI 10.1002/pmic.200700199; Trauger SA, 2008, J PROTEOME RES, V7, P1027, DOI 10.1021/pr700609j; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; 2008, CSH PROTOCOLS CALCUL	23	309	310	0	26	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 7	2009	10								365	10.1186/1471-2164-10-365			14	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	490OU	WOS:000269511200001	19660143	gold, Green Published			2022-01-24	
J	Arifuzzaman, M; Maeda, M; Itoh, A; Nishikata, K; Takita, C; Saito, R; Ara, T; Nakahigashi, K; Huang, HC; Hirai, A; Tsuzuki, K; Nakamura, S; Altaf-Ul-Amin, M; Oshima, T; Baba, T; Yamamoto, N; Kawamura, T; Ioka-Nakamichi, T; Kitagawa, M; Tomita, M; Kanaya, S; Wada, C; Mori, H				Arifuzzaman, M; Maeda, M; Itoh, A; Nishikata, K; Takita, C; Saito, R; Ara, T; Nakahigashi, K; Huang, HC; Hirai, A; Tsuzuki, K; Nakamura, S; Altaf-Ul-Amin, M; Oshima, T; Baba, T; Yamamoto, N; Kawamura, T; Ioka-Nakamichi, T; Kitagawa, M; Tomita, M; Kanaya, S; Wada, C; Mori, H			Large-scale identification of protein-protein interaction of Escherichia coli K-12	GENOME RESEARCH			English	Article							RNA-POLYMERASE; CHAPERONE SYSTEM; IN-VIVO; DNAK; BINDING; AGGREGATION; TERMINATION; COMPLEXES; SUBUNIT; FAMILY	Protein-protein interactions play key roles in protein function and the structural organization of a cell. A thorough description of these interactions should facilitate elucidation of cellular activities, targeted-drug design, and whole cell engineering. A large-scale comprehensive pull-down assay was performed using a His-tagged Escherichia coli ORF clone library. Of 4339 bait proteins tested, partners were found for 2667, including 779 of unknown function. Proteins copurifying with hexahistidine-tagged baits on a Ni2+-NTA column were identified by MALDI-TOF MS (matrix-assisted laser desorption ionization time of flight mass spectrometry). An extended analysis of these interacting networks by bioinformatics and experimentation should provide new insights and novel strategies for E. coli systems biology.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Japan Bioind Assoc, Tokyo Res Labs, Kyowa Hakko Branch, Machida, Tokyo 1948533, Japan; CREST, JST, Kawaguchi, Saitama 3320012, Japan; Keio Univ, Inst Adv Biosci, Yamagata 9970035, Japan; Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; Natl Yang Ming Univ, Inst Bioinformat, Taipei 112, Taiwan; Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan		Wada, C (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	cwada@lif.kyoto-u.ac.jp; hmori@gtc.naist.jp	Huang, Hsuan-Cheng/C-7266-2011; Mori, Hirotada/B-4934-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Ara, Takeshi/0000-0003-1754-2837			Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BELL PJ, 1989, J BACTERIOL, V171, P3494, DOI 10.1128/jb.171.6.3494-3503.1989; BRANDI A, 1994, BIOCHIMIE, V76, P1090, DOI 10.1016/0300-9084(94)90035-3; BUCK D, 1985, BIOCHEMISTRY-US, V24, P6245, DOI 10.1021/bi00343a031; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GUEST JR, 1992, J GEN MICROBIOL, V138, P2253, DOI 10.1099/00221287-138-11-2253; GUEST JR, 1992, CURR TOP CELL REGUL, V33, P231; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Ito T, 2002, MOL CELL PROTEOMICS, V1, P561, DOI 10.1074/mcp.R200005-MCP200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kainz M, 1998, J MOL BIOL, V284, P1379, DOI 10.1006/jmbi.1998.2272; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kimura M, 1996, GENES CELLS, V1, P517, DOI 10.1046/j.1365-2443.1996.d01-258.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; LAU LF, 1983, J BIOL CHEM, V258, P9391; Li ZW, 1998, P NATL ACAD SCI USA, V95, P12158, DOI 10.1073/pnas.95.21.12158; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Nehrke Keith W., 1993, Gene Expression, V3, P119; QUAIL MA, 1994, MOL MICROBIOL, V12, P95, DOI 10.1111/j.1365-2958.1994.tb00998.x; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; SIGMUND CD, 1988, BIOCHEMISTRY-US, V27, P5622, DOI 10.1021/bi00415a034; Silver P, 2004, SCIENTIST, V18, P30; Sommerville J, 1996, FASEB J, V10, P435, DOI 10.1096/fasebj.10.4.8647342; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	42	309	319	2	40	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2006	16	5					686	691		10.1101/gr.4527806			6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	038LF	WOS:000237220600014	16606699	Bronze, Green Published			2022-01-24	
J	Bystrykh, L; Weersing, E; Dontje, B; Sutton, S; Pletcher, MT; Wiltshire, T; Su, AI; Vellenga, E; Wang, JT; Manly, KF; Lu, L; Chesler, EJ; Alberts, R; Jansen, RC; Williams, RW; Cooke, MP; de Haan, G				Bystrykh, L; Weersing, E; Dontje, B; Sutton, S; Pletcher, MT; Wiltshire, T; Su, AI; Vellenga, E; Wang, JT; Manly, KF; Lu, L; Chesler, EJ; Alberts, R; Jansen, RC; Williams, RW; Cooke, MP; de Haan, G			Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'	NATURE GENETICS			English	Article							MICE; DISSECTION; LESSONS; MOUSE	We combined large-scale mRNA expression analysis and gene mapping to identify genes and loci that control hematopoietic stem cell (HSC) function. We measured mRNA expression levels in purified HSCs isolated from a panel of densely genotyped recombinant inbred mouse strains. We mapped quantitative trait loci (QTLs) associated with variation in expression of thousands of transcripts. By comparing the physical transcript position with the location of the controlling QTL, we identified polymorphic cis-acting stem cell genes. We also identified multiple trans-acting control loci that modify expression of large numbers of genes. These groups of coregulated transcripts identify pathways that specify variation in stem cells. We illustrate this concept with the identification of candidate genes involved with HSC turnover. We compared expression QTLs in HSCs and brain from the same mice and identified both shared and tissue- specific QTLs. Our data are accessible through WebQTL, a web-based interface that allows custom genetic linkage analysis and identification of coregulated transcripts.	Univ Groningen, Dept Stem Cell Biol, NL-9713 AV Groningen, Netherlands; Novartis Res Fdn, Gen Inst, San Diego, CA 92121 USA; Acad Hosp, Dept Haematol, Groningen, Netherlands; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands		de Haan, G (corresponding author), Univ Groningen, Dept Stem Cell Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	g.de.haan@med.rug.nl	de Haan, Gerald/AAF-8963-2019; Jansen, Ritsert C/C-1160-2013; Chesler, Elissa/K-4641-2019; de Haan, Gerald/D-2081-2015; Williams, Robert W./H-8789-2016	de Haan, Gerald/0000-0001-9706-0138; Jansen, Ritsert C/0000-0003-2977-9110; Chesler, Elissa/0000-0002-5642-5062; de Haan, Gerald/0000-0001-9706-0138; Williams, Robert W./0000-0001-8924-4447; Su, Andrew I./0000-0002-9859-4104			BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; BOULTWOOD J, 1994, BLOOD, V84, P3253; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Fortunel NO, 2003, SCIENCE, V302, P393; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kamminga LM, 2000, EXP HEMATOL, V28, P1451, DOI 10.1016/S0301-472X(00)00543-9; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Muller-Sieburg CE, 2000, BLOOD, V95, P2446, DOI 10.1182/blood.V95.7.2446.007k13_2446_2448; PEARCE SR, 1995, MAMM GENOME, V6, P537, DOI 10.1007/BF00356172; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scherer A, 2003, BIOTECHNIQUES, V34, P546, DOI 10.2144/03343rr01; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	26	309	318	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					225	232		10.1038/ng1497			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	WOS:000227297800013	15711547				2022-01-24	
J	Pharkya, P; Burgard, AP; Maranas, CD				Pharkya, P; Burgard, AP; Maranas, CD			OptStrain: A computational framework for redesign of microbial production systems	GENOME RESEARCH			English	Article							METHYLOBACTERIUM-EXTORQUENS AM1; ESCHERICHIA-COLI; METABOLIC PATHWAYS; HYDROGEN-PRODUCTION; GEOBACTER-SULFURREDUCENS; GENOME; RECONSTRUCTION; DATABASE; BACTERIA; MODEL	This paper introduces the hierarchical computational framework OptStrain aimed at guiding pathway modifications, through reaction additions and deletions, of microbial networks for the overproduction of targeted compounds. These compounds may range from electrons or hydrogen in biofuel cell and environmental applications to complex drug precursor molecules. A comprehensive database of biotransformations, referred to as the Universal database (with >5700 reactions), is compiled and regularly updated by downloading and curating reactions from multiple biopathway database sources. Combinatorial optimization is then used to elucidate the set(s) of non-native functionalitles, extracted from this Universal database, to add to the examined production host for enabling the desired product formation. Subsequently, competing functionalities that divert flux away from the targeted product are identified and removed to ensure higher product yields coupled with growth. This work represents an advancement over earlier efforts by establishing an integrated computational framework capable of constructing stoichiometrically balanced pathways, imposing maximum product yield requirements, pinpointing the optimal substrate(s), and evaluating different microbial hosts. The range and utility of OptStrain are demonstrated by addressing two very different product molecules. The hydrogen case study pinpoints reaction elimination strategies for improving hydrogen yields using two different substrates for three separate production hosts. In contrast, the vanillin study primarily showcases which non-native pathways need to be added into Escherichia coli. In summary, OptStrain provides a useful tool to aid microbial strain design and, more importantly, it establishes an integrated framework to accommodate future modeling developments.	Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA		Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398			Anthony C., 1982, BIOCH METHYLOTROPHS; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Arita M, 2000, SIMULAT PRACT THEORY, V8, P109, DOI 10.1016/S0928-4869(00)00006-9; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Brooke A., 1998, GAMS USERS GUIDE; BROWN M, 1999, PERL PROGRAMMERS REF; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2001, BIOTECHNOL BIOENG, V74, P364, DOI 10.1002/bit.1127; Castellanos M, 2004, P NATL ACAD SCI USA, V101, P6681, DOI 10.1073/pnas.0400962101; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Chin HL, 2003, BIOTECHNOL PROGR, V19, P383, DOI 10.1021/bp0200604; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6; David H, 2003, EUR J BIOCHEM, V270, P4243, DOI 10.1046/j.1432-1033.2003.03798.x; Desai RP, 1999, J BIOTECHNOL, V71, P191, DOI 10.1016/S0168-1656(99)00022-X; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Ellis LBM, 2003, NUCLEIC ACIDS RES, V31, P262, DOI 10.1093/nar/gkg048; Eppstein D., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P154, DOI 10.1109/SFCS.1994.365697; Fan LT, 2002, COMPUT CHEM, V26, P265, DOI 10.1016/S0097-8485(01)00119-X; Finneran KT, 2002, ENVIRON MICROBIOL, V4, P510, DOI 10.1046/j.1462-2920.2002.00317.x; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Kataoka N, 1997, WATER SCI TECHNOL, V36, P41, DOI 10.1016/S0273-1223(97)00505-2; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; LI C, 2004, IN PRESS CHEM ENG SC; Li K, 1998, J AM CHEM SOC, V120, P10545, DOI 10.1021/ja9817747; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; MAVROVOUNIOTIS ML, 1990, BIOTECHNOL BIOENG, V36, P1119, DOI 10.1002/bit.260361107; McShan DC, 2003, BIOINFORMATICS, V19, P1692, DOI 10.1093/bioinformatics/btg217; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; MISAWA N, 1991, APPL ENVIRON MICROB, V57, P1847, DOI 10.1128/AEM.57.6.1847-1849.1991; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Nandi R, 1998, CRIT REV MICROBIOL, V24, P61, DOI 10.1080/10408419891294181; Nandi R, 1996, ENZYME MICROB TECH, V19, P20, DOI 10.1016/0141-0229(95)00176-X; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; PAPOUTSAKIS ET, 1985, BIOTECHNOL BIOENG, V27, P50, DOI 10.1002/bit.260270108; PAPOUTSAKIS ET, 1984, BIOTECHNOL BIOENG, V26, P174, DOI 10.1002/bit.260260210; Pharkya P, 2003, BIOTECHNOL BIOENG, V84, P887, DOI 10.1002/bit.10857; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Segre Daniel, 2003, OMICS A Journal of Integrative Biology, V7, P301, DOI 10.1089/153623103322452413; Selkov E, 1998, NUCLEIC ACIDS RES, V26, P43, DOI 10.1093/nar/26.1.43; SERESSIOTIS A, 1988, BIOTECHNOL BIOENG, V31, P587, DOI 10.1002/bit.260310611; Stephanopoulos G, 2002, NAT BIOTECHNOL, V20, P666, DOI 10.1038/nbt0702-666; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Valdes J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-51; Van Dien SJ, 2003, BIOTECHNOL BIOENG, V84, P45, DOI 10.1002/bit.10745; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Varner J, 1999, CURR OPIN BIOTECH, V10, P146, DOI 10.1016/S0958-1669(99)80025-1	56	309	327	2	21	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	NOV	2004	14	11					2367	2376		10.1101/gr.2872004			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	868LC	WOS:000224914100018	15520298	Bronze, Green Published			2022-01-24	
J	Luo, GB; Santoro, IM; McDaniel, LD; Nishijima, I; Mills, M; Youssoufian, H; Vogel, H; Schultz, RA; Bradley, A				Luo, GB; Santoro, IM; McDaniel, LD; Nishijima, I; Mills, M; Youssoufian, H; Vogel, H; Schultz, RA; Bradley, A			Cancer predisposition caused by elevated mitotic recombination in Bloom mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; WERNERS-SYNDROME GENES; INTESTINAL ADENOMAS; RECQ FAMILY; HELICASE; CLONING; MOUSE; HOMOLOG; LOCALIZATION; DISRUPTION	Bloom syndrome is a disorder associated with genomic instability that causes affected people to be prone to cancer. Bloom cell lines show increased sister chromatid exchange, yet are proficient in the repair of various DNA lesions. The underlying cause of this disease are mutations in a gene encoding a RECQ DNA helicase. Using embryonic stem cell technology, we have generated viable Bloom mice that are prone to a wide variety of cancers. Cell lines from these mice show elevations in the rates of mitotic recombination. We demonstrate that the increased rate of loss of heterozygosity (LOH) resulting from mitotic recombination in vivo constitutes the underlying mechanism causing tumour susceptibility in these mice.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA		Bradley, A (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge, England.			Vogel, Otto Hannes/0000-0002-0960-3508; Bradley, Allan/0000-0002-2349-8839			Abuin A, 1996, MOL CELL BIOL, V16, P1851; Bilger A, 1996, SEMIN CANCER BIOL, V7, P249, DOI 10.1006/scbi.1996.0033; Chakraverty RK, 1999, BIOESSAYS, V21, P286; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; COLLET B, 1995, INTERNET WORLD, V6, P8; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1994, CURRENT PROTOCOLS HU; Gharibyan V, 1999, MOL CARCINOGEN, V26, P261, DOI 10.1002/(SICI)1098-2744(199912)26:4<261::AID-MC5>3.0.CO;2-A; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; Jacoby RF, 1996, CANCER RES, V56, P710; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.bi.63.070194.005015; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; LUONGO C, 1994, CANCER RES, V54, P5947; Luria SE, 1943, GENETICS, V28, P491; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Watt PM, 1996, GENETICS, V144, P935; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	34	309	315	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					424	429		10.1038/82548			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	WOS:000165671700013	11101838				2022-01-24	
J	Nielsen, DM; Ehm, MG; Weir, BS				Nielsen, DM; Ehm, MG; Weir, BS			Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; POSITIONAL CLONING; GENE; RESOLUTION; FAMILIES; REGION	We review and extend a recent suggestion that line-scale localization of a disease-susceptibility locus for a complex disease be done on the basis of deviations from Hardy-Weinberg equilibrium among affected individuals. This deviation is driven by linkage disequilibrium between disease and marker loci in the whole population and requires a heterogeneous genetic basis for the disease. A finding of marker-locus Hardy-Weinberg disequilibrium therefore implies disease heterogeneity and marker-disease linkage disequilibrium, Although a lack of departure of Hardy-Weinberg disequilibrium at marker loci implies that disease susceptibility-weighted linkage disequilibria are zero, given disease heterogeneity, it does not follow that the usual measures of linkage disequilibrium are zero. For disease-susceptibility loci with more than two alleles, therefore, care is needed in the drawing of inferences from marker Hardy-Wreinberg disequilibria.	Glaxo Wellcome Inc, Bioinformat Dept, Res Triangle Pk, NC 27709 USA; N Carolina State Univ, Dept Stat, Program Stat Genet, Raleigh, NC 27695 USA		Ehm, MG (corresponding author), Glaxo Wellcome Inc, Bioinformat Dept, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.			Nielsen, Dahlia/0000-0003-0123-6085	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM45344] Funding Source: Medline		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; GLASER B, 1995, HUM MOL GENET, V4, P879, DOI 10.1093/hmg/4.5.879; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Kaplan NL, 1997, AM J HUM GENET, V60, P691; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MENG RC, 1966, J AM STAT ASSOC, V61, P965, DOI 10.2307/2283192; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Tregouet DA, 1997, AM J HUM GENET, V61, P189, DOI 10.1086/513895; Weir BS, 1996, GENETIC DATA ANAL	16	309	321	2	11	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1531	1540		10.1086/302114			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	WOS:000076985200029	9867708	Bronze, Green Published			2022-01-24	
J	KANG, S; JAWORSKI, A; OHSHIMA, K; WELLS, RD				KANG, S; JAWORSKI, A; OHSHIMA, K; WELLS, RD			EXPANSION AND DELETION OF CTG REPEATS FROM HUMAN-DISEASE GENES ARE DETERMINED BY THE DIRECTION OF REPLICATION IN ESCHERICHIA-COLI	NATURE GENETICS			English	Article							UNUSUAL DNA STRUCTURES; MYOTONIC-DYSTROPHY; ESCHERICHIA-COLI; TYPE-1	Several human hereditary neurological and neurodegenerative disease genes are associated with the expansion of CTG repeats. Here we show that the frequency of genetic expansions or deletions in Escherichia coli depends on the direction of replication. Large expansions occur predominantly when the CTGs are in the leading strand template rather than the lagging strand. However, deletions are more prominant when the CTGs are in the opposite orientation. Most deletions generated products of defined size classes. Strand slippage coupled with non-classical DNA structures may account for these observations and relate to expansion-deletion mechanisms in eukaryotic chromosomes for disease genes.	TEXAS A&M UNIV, MED CTR, INST BIOSCI & TECHNOL, HOUSTON, TX 77030 USA						NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM030822] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM30822] Funding Source: Medline		BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.biochem.63.1.745; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; KANG S, 1992, J BIOL CHEM, V267, P19435; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PODHAJSKA AJ, 1985, GENE, V40, P163, DOI 10.1016/0378-1119(85)90038-1; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WELLS RD, 1993, GENOME ANAL, V7, P107; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; WOHLRAB F, 1987, J BIOL CHEM, V262, P6407	25	309	311	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					213	218		10.1038/ng0695-213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	WOS:A1995RA85700020	7663518				2022-01-24	
J	CASTRILLON, DH; GONCZY, P; ALEXANDER, S; RAWSON, R; EBERHART, CG; VISWANATHAN, S; DINARDO, S; WASSERMAN, SA				CASTRILLON, DH; GONCZY, P; ALEXANDER, S; RAWSON, R; EBERHART, CG; VISWANATHAN, S; DINARDO, S; WASSERMAN, SA			TOWARD A MOLECULAR-GENETIC ANALYSIS OF SPERMATOGENESIS IN DROSOPHILA-MELANOGASTER - CHARACTERIZATION OF MALE-STERILE MUTANTS GENERATED BY SINGLE P ELEMENT MUTAGENESIS	GENETICS			English	Article							EGF RECEPTOR HOMOLOG; FAINT-LITTLE-BALL; INSERTIONAL MUTAGENESIS; CDC25 HOMOLOG; BETA-TUBULIN; MUTATION; LOCUS; CHROMOSOME; OOGENESIS; MEIOSIS	We describe 83 recessive autosomal male-sterile mutations, generated by single P element mutagenesis in Drosophila melanogaster. Each mutation has been localized to a lettered subdivision of the polytene map. Reversion analyses, as well as complementation tests using available chromosomal deficiencies, indicate that the insertions are responsible for the mutant phenotypes. These mutations represent 63 complementation groups, 58 of which are required for spermatogenesis. Phenotypes of the spermatogenesis mutants were analyzed by light microscopy. Mutations in 12 loci affect germline proliferation, spermatocyte growth, or meiosis. Mutations in 46 other loci disrupt differentiation and maturation of spermatids into motile sperm. This collection of male-sterile mutants provides the basis for a molecular genetic analysis of spermatogenesis.	ROCKEFELLER UNIV,NEW YORK,NY 10021		CASTRILLON, DH (corresponding author), UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235, USA.			Gonczy, Pierre/0000-0002-6305-6883; DiNardo, Stephen/0000-0003-4131-5511	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-08014] Funding Source: Medline		ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BELOTE JM, 1983, DEV BIOL, V95, P512, DOI 10.1016/0012-1606(83)90054-4; BERG CA, 1991, GENETICS, V127, P515; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BRINK NG, 1968, MUTAT RES, V5, P192, DOI 10.1016/0027-5107(68)90093-6; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; COOLEY L, 1988, TRENDS GENET, V4, P254, DOI 10.1016/0168-9525(88)90032-7; COURTOT C, 1992, DEVELOPMENT, V116, P405; COX GN, 1976, GENETICS, V83, pS17; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; FASANO L, 1988, ROUX ARCH DEV BIOL, V197, P507, DOI 10.1007/BF00385685; FULLER MT, 1993, DEV DROSOPHILA; GAILEY DA, 1991, DEVELOPMENT, V113, P879; GAILEY DA, 1989, GENETICS, V121, P773; GATEFF E, 1982, EMBRYONIC DEV CELLUL, P621; GAUSZ J, 1991, GENETICS, V98, P775; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; GONCZY P, 1992, DEVELOPMENT, V114, P89; GONZALEZ C, 1989, GENET RES, V54, P205, DOI 10.1017/S0016672300028664; HACKSTEIN JHP, 1991, EUR J CELL BIOL, V56, P151; HACKSTEIN JHP, 1990, ROUX ARCH DEV BIOL, V199, P251, DOI 10.1007/BF01709505; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; KARPEN GH, 1992, GENETICS, V132, P737; KARSCHMIZRACHI I, 1993, IN PRESS NUCLEIC ACI; KEMPHUES KJ, 1979, P NATL ACAD SCI USA, V76, P3991, DOI 10.1073/pnas.76.8.3991; KEMPHUES KJ, 1980, CELL, V21, P445, DOI 10.1016/0092-8674(80)90481-X; KOTARSKI MA, 1983, GENETICS, V105, P371; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; LIEBRICH W, 1982, CELL TISSUE RES, V224, P161, DOI 10.1007/BF00217275; LIFSCHYTZ E, 1987, INT REV CYTOL, V109, P211, DOI 10.1016/S0074-7696(08)61723-4; LIFSCHYTZ E, 1977, DEV BIOL, V58, P276, DOI 10.1016/0012-1606(77)90092-6; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D.L., 1992, GENOME DROSOPHILA ME; LINDSLEY DL, 1972, GENETICS, V71, P157; LINDSLEY DL, 1969, GENETICS S1, V61, pS69; MALONE RE, 1990, CELL, V61, P375, DOI 10.1016/0092-8674(90)90517-I; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; MEYER GF, 1968, Z ZELLFORSCH MIK ANA, V84, P141; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; OLIVIERI G, 1965, MUTAT RES, V2, P366, DOI 10.1016/0027-5107(65)90072-2; PERRIMON N, 1989, GENETICS, V121, P333; PERRIMON N, 1986, GENETICS, V113, P695; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; REGAN CL, 1990, GENETICS, V125, P77; ROBERTSON HM, 1988, GENETICS, V118, P461; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; SCHUPBACH T, 1991, GENETICS, V129, P1119; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SHELLENBARGER DL, 1979, DEV BIOL, V71, P308, DOI 10.1016/0012-1606(79)90172-6; SHOUP JR, 1967, J CELL BIOL, V32, P663, DOI 10.1083/jcb.32.3.663; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; TOKAYASU K, 1972, Z ZELLFORSCH, V124, P479; TOKAYASU KT, 1972, Z ZELLFORSCH, V127, P492; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	60	309	313	0	12	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	OCT	1993	135	2					489	505					17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ432	WOS:A1993LZ43200021	8244010				2022-01-24	
J	HINDS, HL; ASHLEY, CT; SUTCLIFFE, JS; NELSON, DL; WARREN, ST; HOUSMAN, DE; SCHALLING, M				HINDS, HL; ASHLEY, CT; SUTCLIFFE, JS; NELSON, DL; WARREN, ST; HOUSMAN, DE; SCHALLING, M			TISSUE SPECIFIC EXPRESSION OF FMR-1 PROVIDES EVIDENCE FOR A FUNCTIONAL-ROLE IN FRAGILE-X SYNDROME	NATURE GENETICS			English	Article							LINKED MENTAL-RETARDATION; DNA; PREVALENCE	We have performed mRNA in situ hybridization studies and northern blot analysis in the mouse and human, respectively, to determine the normal gene expression patterns of FMR-1. Expression in the adult mouse was localized to several regions of the brain and the tubules of the testes, which are two of the major organs affected in fragile X syndrome. Universal and very strong expression was observed in early mouse embryos, with differentially decreasing expression during subsequent stages of embryonic development. The early embryonic onset and tissue specificity of FMR-1 gene expression is consistent with involvement in the fragile X phenotype, and also suggests additional organ systems in which clinical manifestations of reduced FMR-1 gene expression may occur.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; BAYLOR COLL MED,HOUSTON,TX 77030; HOWARD HUGHES MED INST,CTR HUMAN GENOME,INST MOLEC GENET,HOUSTON,TX; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,ATLANTA,GA 30322				Warren, Stephen T/A-2498-2012; Sutcliffe, James S/C-1348-2012	Sutcliffe, James S/0000-0001-5200-6007	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5P01-HL41484] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD20521, 1R01-HD29256] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD020521, R01HD029256, R01HD020521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL041484] Funding Source: NIH RePORTER		BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; Davies KE, 1989, FRAGILE X SYNDROME; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; KAHKONEN M, 1987, HUM GENET, V77, P85; LUBS HA, 1969, AM J HUM GENET, V21, P231; Maino D M, 1990, J Am Optom Assoc, V61, P316; MANDEL JL, AM J MED GENET, V43, P5; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEMBREY ME, 1986, TRENDS NEUROSCI, V9, P58, DOI 10.1016/0166-2236(86)90021-4; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1990, J AM ACAD CHILD PSY, V29, P885, DOI 10.1097/00004583-199011000-00007; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REISS AL, 1990, BIOL PSYCHIAT, V27, P223, DOI 10.1016/0006-3223(90)90652-I; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SCHALLING M, 1992, GENE EXPRESSION NEUR, P231; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; TURNER G, 1980, AM J MED GENET, V7, P407, DOI 10.1002/ajmg.1320070403; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WILLEMS PJ, 1993, NATURE GENET, V3, P31; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	33	309	315	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					36	43		10.1038/ng0193-36			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	WOS:A1993KF37200010	8490651				2022-01-24	
J	BOARD, PG				BOARD, PG			BIOCHEMICAL GENETICS OF GLUTATHIONE-S-TRANSFERASE IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOARD, PG (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DEPT HUMAN BIOL,CANBERRA,ACT 2601,AUSTRALIA.						BOARD PG, ANAL BIOCH; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; GUTHENBERG C, 1979, ACTA CHEM SCAND B, V33, P595, DOI 10.3891/acta.chem.scand.33b-0595; HABIG WH, 1976, GLUTATHIONE METABOLI, P225; JAKOBY WB, 1976, GLUTATHIONE METABOLI, P213; KAMISAKA K, 1975, EUR J BIOCHEM, V60, P153, DOI 10.1111/j.1432-1033.1975.tb20987.x; KETTERER B, 1976, GLUTATHIONE METABOLI, P243; KOSKELO K, 1980, SCAND J CLIN LAB INV, V40, P179, DOI 10.3109/00365518009093023; MARCUS CJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P287, DOI 10.1016/S0003-9861(78)80011-3; STENERSEN J, 1979, BIOCHEM J, V181, P47, DOI 10.1042/bj1810047; TAKAHATA N, 1979, P NATL ACAD SCI USA, V76, P4521, DOI 10.1073/pnas.76.9.4521	11	309	313	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					36	43					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	WOS:A1981LA93000004	7468592				2022-01-24	
J	Shi, CY; Yang, H; Wei, CL; Yu, O; Zhang, ZZ; Jiang, CJ; Sun, J; Li, YY; Chen, Q; Xia, T; Wan, XC				Shi, Cheng-Ying; Yang, Hua; Wei, Chao-Ling; Yu, Oliver; Zhang, Zheng-Zhu; Jiang, Chang-Jun; Sun, Jun; Li, Ye-Yun; Chen, Qi; Xia, Tao; Wan, Xiao-Chun			Deep sequencing of the Camellia sinensis transcriptome revealed candidate genes for major metabolic pathways of tea-specific compounds	BMC GENOMICS			English	Article							FUNCTIONAL GENOMICS; RNA-SEQ; SECONDARY METABOLISM; GLUTAMINE-SYNTHETASE; EST ANALYSIS; THEANINE; BIOSYNTHESIS; EXPRESSION; CATECHINS; SYNTHASE	Background: Tea is one of the most popular non-alcoholic beverages worldwide. However, the tea plant, Camellia sinensis, is difficult to culture in vitro, to transform, and has a large genome, rendering little genomic information available. Recent advances in large-scale RNA sequencing (RNA-seq) provide a fast, cost-effective, and reliable approach to generate large expression datasets for functional genomic analysis, which is especially suitable for non-model species with un-sequenced genomes. Results: Using high-throughput Illumina RNA-seq, the transcriptome from poly (A)(+) RNA of C. sinensis was analyzed at an unprecedented depth (2.59 gigabase pairs). Approximate 34.5 million reads were obtained, trimmed, and assembled into 127,094 unigenes, with an average length of 355 bp and an N50 of 506 bp, which consisted of 788 contig clusters and 126,306 singletons. This number of unigenes was 10-fold higher than existing C. sinensis sequences deposited in GenBank (as of August 2010). Sequence similarity analyses against six public databases (Uniprot, NR and COGs at NCBI, Pfam, InterPro and KEGG) found 55,088 unigenes that could be annotated with gene descriptions, conserved protein domains, or gene ontology terms. Some of the unigenes were assigned to putative metabolic pathways. Targeted searches using these annotations identified the majority of genes associated with several primary metabolic pathways and natural product pathways that are important to tea quality, such as flavonoid, theanine and caffeine biosynthesis pathways. Novel candidate genes of these secondary pathways were discovered. Comparisons with four previously prepared cDNA libraries revealed that this transcriptome dataset has both a high degree of consistency with previous EST data and an approximate 20 times increase in coverage. Thirteen unigenes related to theanine and flavonoid synthesis were validated. Their expression patterns in different organs of the tea plant were analyzed by RT-PCR and quantitative real time PCR (qRT-PCR). Conclusions: An extensive transcriptome dataset has been obtained from the deep sequencing of tea plant. The coverage of the transcriptome is comprehensive enough to discover all known genes of several major metabolic pathways. This transcriptome dataset can serve as an important public information platform for gene expression, genomics, and functional genomic studies in C. sinensis.	[Shi, Cheng-Ying; Yang, Hua; Wei, Chao-Ling; Yu, Oliver; Zhang, Zheng-Zhu; Jiang, Chang-Jun; Sun, Jun; Li, Ye-Yun; Chen, Qi; Xia, Tao; Wan, Xiao-Chun] Anhui Agr Univ, Minist Agr, Minist Educ, Key Lab Tea Biochem & Biotechnol, Hefei 230036, Peoples R China; [Yu, Oliver] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA		Wan, XC (corresponding author), Anhui Agr Univ, Minist Agr, Minist Educ, Key Lab Tea Biochem & Biotechnol, Hefei 230036, Peoples R China.	xcwan@ahau.edu.cn		Zhang, Zhengzhu/0000-0003-1564-1428	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30972400]; Special Capital for the Construction of Modern Agriculture Industry Technical System, Ministry of Agriculture & Ministry of Finance of China; US DOEUnited States Department of Energy (DOE) [DE-SC0001295]; US NSFNational Science Foundation (NSF) [MCB-0923779]; USDAUnited States Department of Agriculture (USDA) [2010-65116-20514]	We appreciate the technical support for Illumina sequencing and initial data analysis from Beijing Genome Institute at Shenzhen, China. We are grateful to Cheng-Bin Xiang from University of Science and Technology of China and Anita K. Snyder for comments on the manuscript. We thank Jia-Yue Jiang, Yun-Sheng Wang, Zhuo-Chen Wang, Yi-Lin Wu, Zhen Zhu, Lin-Li Lu and Yang Luo for material collection and RNA extraction. This work was supported in part by the National Natural Science Foundation of China ( Project 30972400), and Special Capital for the Construction of Modern Agriculture Industry Technical System, Ministry of Agriculture & Ministry of Finance of China, grants to Xiao-Chun Wan, and US DOE (DE-SC0001295), US NSF (MCB-0923779) and USDA (2010-65116-20514) grants to Oliver Yu.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Chen L, 2005, PLANT SCI, V168, P359, DOI 10.1016/j.plantsci.2004.08.009; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kato M, 2004, FRONT BIOSCI-LANDMRK, V9, P1833, DOI 10.2741/1364; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kidron H, 2007, MOL BIOL EVOL, V24, P79, DOI 10.1093/molbev/msl133; Kristiansson E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-345; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin GZ, 2007, PROTEIN EXPRES PURIF, V55, P287, DOI 10.1016/j.pep.2007.05.013; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Park JS, 2004, PLANT SCI, V166, P953, DOI 10.1016/j.plantsci.2003.12.010; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rani A, 2009, FUNCT INTEGR GENOMIC, V9, P271, DOI 10.1007/s10142-008-0098-3; Rogers PJ, 2008, PSYCHOPHARMACOLOGY, V195, P569, DOI 10.1007/s00213-007-0938-1; SASAOKA K, 1965, AGR BIOL CHEM TOKYO, V29, P984, DOI 10.1080/00021369.1965.10858501; SASAOKA K, 1963, AGR BIOL CHEM TOKYO, V27, P467, DOI 10.1080/00021369.1963.10858131; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; [史成颖 SHI Cheng-ying], 2009, [南京农业大学学报, Journal of Nanjing Agricultural University], V32, P126; Shi ChengYing, 2007, Journal of Anhui Agricultural University, V34, P360; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Singh K, 2008, TREE PHYSIOL, V28, P1349, DOI 10.1093/treephys/28.9.1349; Singh K, 2009, TREE PHYSIOL, V29, P837, DOI 10.1093/treephys/tpp022; Sompornpailin K, 2002, PLANT MOL BIOL, V50, P485, DOI 10.1023/A:1019850921627; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suzuki H, 2003, APPL ENVIRON MICROB, V69, P6399, DOI 10.1128/AEM.69.11.6399-6404.2003; TAKEO T, 1978, PHYTOCHEMISTRY, V17, P313, DOI 10.1016/S0031-9422(00)94173-6; TAKEUCHI A, 1994, PLANT CELL PHYSIOL, V35, P1011; Tanaka J., 2006, J REMOTE SENSING SOC, V101, P1, DOI DOI 10.5979/CHA.2006.1; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TSUSHIDA T, 1985, AGR BIOL CHEM TOKYO, V49, P2913, DOI 10.1080/00021369.1985.10867191; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WANG Y, 2008, TEA SCI, V28, P429; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Yamamoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P784, DOI 10.1271/bbb.69.784; Yamamoto T., 1998, CHEM APPL GREEN TEA; Yu O, 2005, ADV AGRON, V86, P147, DOI 10.1016/S0065-2113(05)86003-1	59	308	353	5	182	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 28	2011	12								131	10.1186/1471-2164-12-131			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	734FV	WOS:000288320700001	21356090	Green Published, gold			2022-01-24	
J	Thomson, NR; Clayton, DJ; Windhorst, D; Vernikos, G; Davidson, S; Churcher, C; Quail, MA; Stevens, M; Jones, MA; Watson, M; Barron, A; Layton, A; Pickard, D; Kingsley, RA; Bignell, A; Clark, L; Harris, B; Ormond, D; Abdellah, Z; Brooks, K; Cherevach, I; Chillingworth, T; Woodward, J; Norberczak, H; Lord, A; Arrowsmith, C; Jagels, K; Moule, S; Mungall, K; Sanders, M; Whitehead, S; Chabalgoity, JA; Maskell, D; Humphrey, T; Roberts, M; Barrow, PA; Dougan, G; Parkhill, J				Thomson, Nicholas R.; Clayton, Debra J.; Windhorst, Daniel; Vernikos, Georgios; Davidson, Susanne; Churcher, Carol; Quail, Michael A.; Stevens, Mark; Jones, Michael A.; Watson, Michael; Barron, Andy; Layton, Abigail; Pickard, Derek; Kingsley, Robert A.; Bignell, Alex; Clark, Louise; Harris, Barbara; Ormond, Doug; Abdellah, Zahra; Brooks, Karen; Cherevach, Inna; Chillingworth, Tracey; Woodward, John; Norberczak, Halina; Lord, Angela; Arrowsmith, Claire; Jagels, Kay; Moule, Sharon; Mungall, Karen; Sanders, Mandy; Whitehead, Sally; Chabalgoity, Jose A.; Maskell, Duncan; Humphrey, Tom; Roberts, Mark; Barrow, Paul A.; Dougan, Gordon; Parkhill, Julian			Comparative genome analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 provides insights into evolutionary and host adaptation pathways	GENOME RESEARCH			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; PATHOGENICITY ISLANDS; SEQUENCE-ANALYSIS; IDENTIFICATION; GENES; GALLINARUM; INFECTION; VIRULENCE; DNA	We have determined the complete genome sequences of a host-promiscuous Salmonella enterica serovar Enteritidis PT4 isolate P125109 and a chicken-restricted Salmonella enterica serovar Gallinarum isolate 287/91. Genome comparisons between these and other Salmonella isolates indicate that S. Gallinarum 287/ 91 is a recently evolved descendent of S. Enteritidis. Significantly, the genome of S. Gallinarum has undergone extensive degradation through deletion and pseudogene formation. Comparison of the pseudogenes in S. Gallinarum with those identified previously in other host-adapted bacteria reveals the loss of many common functional traits and provides insights into possible mechanisms of host and tissue adaptation. We propose that experimental analysis in chickens and mice of S. Enteritidis-harboring mutations in functional homologs of the pseudogenes present in S. Gallinarum could provide an experimentally tractable route toward unraveling the genetic basis of host adaptation in S. enterica.	[Thomson, Nicholas R.; Vernikos, Georgios; Churcher, Carol; Quail, Michael A.; Barron, Andy; Pickard, Derek; Kingsley, Robert A.; Bignell, Alex; Clark, Louise; Harris, Barbara; Ormond, Doug; Abdellah, Zahra; Brooks, Karen; Cherevach, Inna; Chillingworth, Tracey; Woodward, John; Norberczak, Halina; Lord, Angela; Arrowsmith, Claire; Jagels, Kay; Moule, Sharon; Mungall, Karen; Sanders, Mandy; Whitehead, Sally; Dougan, Gordon; Parkhill, Julian] Sanger Inst, Wellcome Trust, Pathogen Sequencing Unit, Cambridge CB10 1SA, England; [Clayton, Debra J.; Davidson, Susanne; Stevens, Mark; Watson, Michael; Layton, Abigail] Inst Anim Hlth, Div Microbiol, Compton RG20 7NN, Berks, England; [Windhorst, Daniel] Lohmann Anim Hlth GmbH & Co, D-27472 Cuxhaven, Germany; [Jones, Michael A.; Barrow, Paul A.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Chabalgoity, Jose A.] Univ Republica, Sch Med, Dept Biotechnol, Montevideo 11600, Uruguay; [Maskell, Duncan] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Humphrey, Tom] Univ Bristol, Sch Clin Vet Sci, Bristol BS40 5DU, Avon, England; [Roberts, Mark] Univ Glasgow, Fac Vet Med, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland		Thomson, NR (corresponding author), Sanger Inst, Wellcome Trust, Pathogen Sequencing Unit, Cambridge CB10 1SA, England.	nrt@sanger.ac.uk	Jones, Michael/AAS-3718-2021; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Jones, Michael/G-9945-2011; Thomson, Nicholas/P-5988-2014	Jones, Michael/0000-0003-3918-6773; Parkhill, Julian/0000-0002-7069-5958; Jones, Michael/0000-0003-3918-6773; Watson, Mick/0000-0003-4211-0358; Thomson, Nicholas/0000-0002-4432-8505	Wellcome Trust Beowulf Genomics InitiativeWellcome Trust	We thank the core sequencing and informatics teams at the Sanger Institute for their assistance and The Wellcome Trust for its support of the Sanger Institute Pathogen Sequencing Unit. This project was funded through The Wellcome Trust Beowulf Genomics Initiative.	BARROW PA, 1991, AVIAN PATHOL, V20, P145, DOI 10.1080/03079459108418749; Barrow PA, 2000, REV SCI TECH OIE, V19, P351, DOI 10.20506/rst.19.2.1225; BARROW PA, 1991, AVIAN PATHOL, V20, P339; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; Bishop AL, 2005, J BACTERIOL, V187, P2469, DOI 10.1128/JB.187.7.2469-2482.2005; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Collighan RJ, 2001, VET MICROBIOL, V80, P235, DOI 10.1016/S0378-1135(01)00309-1; Cooke FJ, 2007, J CLIN MICROBIOL, V45, P2590, DOI 10.1128/JCM.00729-07; CRICHTON PB, 1990, J MED MICROBIOL, V32, P145, DOI 10.1099/00222615-32-3-145; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Edwards RA, 2000, P NATL ACAD SCI USA, V97, P1258, DOI 10.1073/pnas.97.3.1258; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; KILGER G, 1993, J CLIN MICROBIOL, V31, P1108, DOI 10.1128/JCM.31.5.1108-1110.1993; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; LI J, 1993, J MED MICROBIOL, V38, P129, DOI 10.1099/00222615-38-2-129; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McMeechan A, 2005, MICROBIOL-SGM, V151, P3969, DOI 10.1099/mic.0.28292-0; Mmolawa PT, 2003, J BACTERIOL, V185, P3473, DOI 10.1128/JB.185.11.3473-3475.2003; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; RODRIGUE DC, 1990, EPIDEMIOL INFECT, V105, P21, DOI 10.1017/S0950268800047609; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Rychlik I, 1998, FEMS MICROBIOL LETT, V159, P255, DOI 10.1111/j.1574-6968.1998.tb12869.x; SCHNEIDER E, 1992, J BIOL CHEM, V267, P5148; Shah DH, 2005, MICROBIOL-SGM, V151, P3957, DOI 10.1099/mic.0.28126-0; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; SMITH H. W., 1955, JOUR COMP PATH AND THERAP, V65, P37, DOI 10.1016/S0368-1742(55)80005-7; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Sweeney NJ, 1996, INFECT IMMUN, V64, P3504, DOI 10.1128/IAI.64.9.3504-3511.1996; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Titheradge AJB, 1996, MOL MICROBIOL, V22, P437, DOI 10.1046/j.1365-2958.1996.00126.x; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x; Wong KK, 1998, INFECT IMMUN, V66, P3365, DOI 10.1128/IAI.66.7.3365-3371.1998; Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x; Woodward MJ, 1996, VET REC, V138, P411, DOI 10.1136/vr.138.17.411; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x	58	308	1725	0	52	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2008	18	10					1624	1637		10.1101/gr.077404.108			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	355HU	WOS:000259700800009	18583645	Green Published, Bronze			2022-01-24	
J	Kohlhase, J; Wischermann, A; Reichenbach, H; Froster, U; Engel, W				Kohlhase, J; Wischermann, A; Reichenbach, H; Froster, U; Engel, W			Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome	NATURE GENETICS			English	Article							HOMEOTIC GENE; DROSOPHILA EMBRYO; SPALT; REGION; HOMOLOG; SYSTEM; HEAD; DPP; EYE	Townes-Brocks syndrome (TBS, OMIM #107480) is a rare autosomal-dominant malformation syndrome with a combination of anal, renal, limb and ear anomalies(1), Cytogenetic findings(2) suggested that the gene mutated in TBS maps to chromosome 16q12.1, where SALL1 (previously known as HSAL1), a human homologue of spalt (sal), is located(3). SAL is a developmental regulator in Drosophila melanogaster(4-8) and is conserved throughout evolution(3,9-11). No phenotype has yet been attributed to mutations in vertebrate sal-like genes. The expression patterns of sal-like genes in mouse(9), Xenopus(10) and the fish Medaka(11), and the finding that Medaka sal is regulated by Sonic hedgehog (Shh; ref. 11), prompted us to examine SALL1 as a TBS candidate gene. Here we demonstrate that SALL1 mutations cause TBS in a family with vertical transmission of TBS12 and in an unrelated family with a sporadic case of TBS. Both mutations are predicted to result in a prematurely terminated SALL1 protein lacking all putative DNA binding domains. TBS therefore represents another human developmental disorder caused by mutations in a putative C2H2 zinc-finger transcription factor.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Kinderkrankenhaus, Kinderchirurg Klin, D-50735 Cologne, Germany; Univ Leipzig Klinikum, Inst Human Genet, D-04103 Leipzig, Germany		Kohlhase, J (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-37073 Gottingen, Germany.						CAMERON TH, 1991, AM J MED GENET, V41, P1, DOI 10.1002/ajmg.1320410102; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DEPINANETO JM, 1984, AM J MED GENET, V18, P147, DOI 10.1002/ajmg.1320180118; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; FERRAZ FG, 1989, ANN GENET-PARIS, V32, P120; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Ishikiriyama S, 1996, AM J MED GENET, V61, P191, DOI 10.1002/ajmg.1320610203; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koster R, 1997, DEVELOPMENT, V124, P3147; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Newman WG, 1997, CLIN DYSMORPHOL, V6, P57; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; ROSSMILLER DR, 1994, OTOLARYNG HEAD NECK, V111, P175, DOI 10.1016/S0194-5998(94)70588-7; Serville F., 1993, Genetic Counseling, V4, P109; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tickle C, 1996, DEV GENET, V19, P1, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;1::AID-DVG1&gt;3.0.CO;2-D; TOWNES PL, 1972, J PEDIATR-US, V81, P321, DOI 10.1016/S0022-3476(72)80302-0; Valentini RP, 1997, J BIOL CHEM, V272, P8466, DOI 10.1074/jbc.272.13.8466; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wischermann A, 1997, MONATSSCHR KINDERH, V145, P382, DOI 10.1007/s001120050137	28	308	322	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					81	83		10.1038/ng0198-81			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	WOS:000071259600028	9425907				2022-01-24	
J	GREEN, AJ; SMITH, M; YATES, JRW				GREEN, AJ; SMITH, M; YATES, JRW			LOSS OF HETEROZYGOSITY ON CHROMOSOME 16P13.3 IN HAMARTOMAS FROM TUBEROUS SCLEROSIS PATIENTS	NATURE GENETICS			English	Article							GENE LOCUS	Tuberous sclerosis (TSC) is an autosomal dominant condition with characteristic skin lesions, mental handicap, seizures and the development of hamartomas in the brain, heart, kidneys and other organs. Linkage studies have shown locus heterogeneity with a TSC gene mapped to chromosome 9q34 and a second, recently identified on 16p13.3. We have analysed DNA markers in eight hamartomas and one tumour from TSC patients and found allele loss on 16p13.3 in three angiomyolipomas, one cardiac rhabdomyoma, one cortical tuber and one giant cell astrocytoma. We suggest that the RSC gene on 16p13.3 functions like a tumour suppressor gene, in accordance with Knudsen's hypothesis.	ADDENBROOKES HOSP,DEPT CLIN GENET,CAMBRIDGE CB2 2QQ,CAMBS,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,CAMBS,ENGLAND; UNIV CALIF IRVINE,IRVINE,CA 92717				Green, Andrew/AAJ-7592-2020	Green, Andrew/0000-0002-1077-7417			ALPER JC, 1983, PAEDIAT DERMATOLOGY, V1, P56; BURLEY MW, 1993, IN PRESS CYTOGENET C; COMINGS DE, 1980, AM J HUM GENET, V32, P285; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FRYER AE, 1987, LANCET, V1, P659; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; HARDING CO, 1990, AM J MED GENET, V37, P443, DOI 10.1002/ajmg.1320370402; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Maniatis T, 1982, MOLECULAR; Neumann H. P. H., 1992, American Journal of Human Genetics, V51, pA104; ROCHA G, 1962, ARCH DERMATOL, V85, P722, DOI 10.1001/archderm.1962.01590060032006; SEIZINGER BR, 1993, NAT GENET, V3, P97, DOI 10.1038/ng0293-97; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; WEBB DW, 1993, ARCH DIS CHILD, V68, P367, DOI 10.1136/adc.68.3.367; 1993, CELL, V75, P1	18	308	312	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					193	196		10.1038/ng0294-193			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	WOS:A1994MU76300016	8162074	Green Published			2022-01-24	
J	NEI, M; MILLER, JC				NEI, M; MILLER, JC			A SIMPLE METHOD FOR ESTIMATING AVERAGE NUMBER OF NUCLEOTIDE SUBSTITUTIONS WITHIN AND BETWEEN POPULATIONS FROM RESTRICTION DATA	GENETICS			English	Article											NEI, M (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225, USA.						BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, V15, P485; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Efron B., 1982, JACKKNIFE BOOTSTRAP; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; JUKES T H, 1969, P21; KAPLAN N, 1979, J MOL EVOL, V13, P295, DOI 10.1007/BF01731370; MILLER JC, 1989, THESIS CORNELL U ITH; NEI M, 1981, GENETICS, V97, P145; NEI M, 1983, GENETICS, V105, P207; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1989, MOL BIOL EVOL, V6, P240; Nei M., 1987, MOL EVOLUTIONARY GEN	14	308	327	0	6	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	AUG	1990	125	4					873	879					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DQ895	WOS:A1990DQ89500022	1975792				2022-01-24	
J	Braasch, I; Gehrke, AR; Smith, JJ; Kawasaki, K; Manousaki, T; Pasquier, J; Amores, A; Desvignes, T; Batzel, P; Catchen, J; Berlin, AM; Campbell, MS; Barrell, D; Martin, KJ; Mulley, JF; Ravi, V; Lee, AP; Nakamura, T; Chalopin, D; Fan, S; Wcisel, D; Canestro, C; Sydes, J; Beaudry, FEG; Sun, Y; Hertel, J; Beam, MJ; Fasold, M; Ishiyama, M; Johnson, J; Kehr, S; Lara, M; Letaw, JH; Litman, GW; Litman, RT; Mikami, M; Ota, T; Saha, NR; Williams, L; Stadler, PF; Wang, H; Taylor, JS; Fontenot, Q; Ferrara, A; Searle, SMJ; Aken, B; Yandell, M; Schneider, I; Yoder, JA; Volff, JN; Meyer, A; Amemiya, CT; Venkatesh, B; Holland, PWH; Guiguen, Y; Bobe, J; Shubin, NH; Di Palma, F; Alfoldi, J; Lindblad-Toh, K; Postlethwait, JH				Braasch, Ingo; Gehrke, Andrew R.; Smith, Jeramiah J.; Kawasaki, Kazuhiko; Manousaki, Tereza; Pasquier, Jeremy; Amores, Angel; Desvignes, Thomas; Batzel, Peter; Catchen, Julian; Berlin, Aaron M.; Campbell, Michael S.; Barrell, Daniel; Martin, Kyle J.; Mulley, John F.; Ravi, Vydianathan; Lee, Alison P.; Nakamura, Tetsuya; Chalopin, Domitille; Fan, Shaohua; Wcisel, Dustin; Canestro, Cristian; Sydes, Jason; Beaudry, Felix E. G.; Sun, Yi; Hertel, Jana; Beam, Michael J.; Fasold, Mario; Ishiyama, Mikio; Johnson, Jeremy; Kehr, Steffi; Lara, Marcia; Letaw, John H.; Litman, Gary W.; Litman, Ronda T.; Mikami, Masato; Ota, Tatsuya; Saha, Nil Ratan; Williams, Louise; Stadler, Peter F.; Wang, Han; Taylor, John S.; Fontenot, Quenton; Ferrara, Allyse; Searle, Stephen M. J.; Aken, Bronwen; Yandell, Mark; Schneider, Igor; Yoder, Jeffrey A.; Volff, Jean-Nicolas; Meyer, Axel; Amemiya, Chris T.; Venkatesh, Byrappa; Holland, Peter W. H.; Guiguen, Yann; Bobe, Julien; Shubin, Neil H.; Di Palma, Federica; Alfoeldi, Jessica; Lindblad-Toh, Kerstin; Postlethwait, John H.			The spotted gar genome illuminates vertebrate evolution and facilitates human-teleost comparisons	NATURE GENETICS			English	Article							RAY-FINNED FISH; MHC CLASS-I; COMPLEX-CLASS-I; COMPREHENSIVE ANALYSIS; PROVIDES INSIGHTS; GENE DUPLICATION; HOX GENES; 2 ROUNDS; ZEBRAFISH; COELACANTH	To connect human biology to fish biomedical models, we sequenced the genome of spotted gar (Lepisosteus oculatus), whose lineage diverged from teleosts before teleost genome duplication (TGD). The slowly evolving gar genome has conserved in content and size many entire chromosomes from bony vertebrate ancestors. Gar bridges teleosts to tetrapods by illuminating the evolution of immunity, mineralization and development (mediated, for example, by Hox, ParaHox and microRNA genes). Numerous conserved noncoding elements (CNEs; often cis regulatory) undetectable in direct human-teleost comparisons become apparent using gar: functional studies uncovered conserved roles for such cryptic CNEs, facilitating annotation of sequences identified in human genome-wide association studies. Transcriptomic analyses showed that the sums of expression domains and expression levels for duplicated teleost genes often approximate the patterns and levels of expression for gar genes, consistent with subfunctionalization. The gar genome provides a resource for understanding evolution after genome duplication, the origin of vertebrate genomes and the function of human regulatory sequences.	[Braasch, Ingo; Amores, Angel; Desvignes, Thomas; Batzel, Peter; Sydes, Jason; Beam, Michael J.; Letaw, John H.; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Gehrke, Andrew R.; Nakamura, Tetsuya; Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Kawasaki, Kazuhiko] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Manousaki, Tereza] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Greece; [Pasquier, Jeremy; Guiguen, Yann; Bobe, Julien] INRA, LPGP, UR1037, Campus Beaulieu, F-35042 Rennes, France; [Catchen, Julian] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Berlin, Aaron M.; Johnson, Jeremy; Lara, Marcia; Williams, Louise; Di Palma, Federica; Alfoeldi, Jessica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA; [Campbell, Michael S.; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Barrell, Daniel; Searle, Stephen M. J.; Aken, Bronwen] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Barrell, Daniel; Aken, Bronwen] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England; [Martin, Kyle J.; Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford, England; [Mulley, John F.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Ravi, Vydianathan; Lee, Alison P.; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore; [Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France; [Fan, Shaohua; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Wcisel, Dustin; Yoder, Jeffrey A.] N Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Wcisel, Dustin; Yoder, Jeffrey A.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Canestro, Cristian] Univ Barcelona, Dept Genet, Barcelona, Spain; [Canestro, Cristian] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Beaudry, Felix E. G.; Taylor, John S.] Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada; [Sun, Yi; Wang, Han] Soochow Univ, Ctr Circadian Clocks, Suzhou, Peoples R China; [Sun, Yi; Wang, Han] Soochow Univ, Coll Med, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Hertel, Jana; Fasold, Mario; Kehr, Steffi; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Ishiyama, Mikio] Nippon Dent Univ Coll Niigata, Dept Dent Hyg, Niigata, Japan; [Litman, Gary W.; Litman, Ronda T.] Univ S Florida, Morsani Coll Med, Dept Pediat, St Petersburg, FL 33701 USA; [Mikami, Masato] Nippon Dent Univ, Sch Life Dent Niigata, Dept Microbiol, Niigata, Japan; [Ota, Tatsuya] SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Saha, Nil Ratan; Amemiya, Chris T.] Benaroya Res Inst, Mol Genet Program, Seattle, WA USA; [Fontenot, Quenton; Ferrara, Allyse] Nicholls State Univ, Dept Biol Sci, Thibodaux, LA 70310 USA; [Schneider, Igor] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Meyer, Axel] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Braasch, Ingo] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Campbell, Michael S.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Martin, Kyle J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Chalopin, Domitille] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Fan, Shaohua] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Hertel, Jana] UFZ Helmholtz Ctr Environm Res, Young Investigators Grp Bioinformat & Transcript, Leipzig, Germany; [Fasold, Mario] ecSeq Bioinformat, Leipzig, Germany; [Di Palma, Federica] Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England		Braasch, I; Postlethwait, JH (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	braasch@msu.edu; jpostle@uoneuro.uoregon.edu	Schor, Jana/F-8503-2017; Thomas, Desvignes/AAX-3526-2020; Braasch, Ingo/A-6948-2010; Bobe, Julien/I-6851-2017; Ravi, Vydianathan/B-2759-2009; Wang, Han/A-9774-2008; Beaudry, Felix/AAL-9802-2020; Canestro, Cristian/L-9661-2014; Yoder, Jeffrey A./I-5329-2019; Meyer, Axel/C-9826-2009; Schneider, Igor/K-6164-2012; Stadler, Peter F./L-7857-2015	Schor, Jana/0000-0003-1200-6234; Thomas, Desvignes/0000-0001-5126-8785; Braasch, Ingo/0000-0003-4766-611X; Bobe, Julien/0000-0002-9355-8227; Ravi, Vydianathan/0000-0003-0807-7697; Wang, Han/0000-0003-2420-3147; Canestro, Cristian/0000-0003-4623-8105; Yoder, Jeffrey A./0000-0002-6083-1311; Meyer, Axel/0000-0002-0888-8193; Schneider, Igor/0000-0002-9046-7338; Ota, Tatsuya/0000-0002-1115-5169; Amores, Angel/0000-0002-9307-3609; Di-Palma, Federica/0000-0002-4394-0102; Lee, Alison/0000-0002-3773-1021; Venkatesh, Byrappa/0000-0003-3620-0277; Stadler, Peter F./0000-0002-5016-5191; Martin, Kyle/0000-0002-4081-6835; Mulley, John/0000-0002-1537-7316; Guiguen, Yann/0000-0001-5464-6219; Smith, Jeramiah/0000-0001-5333-5531; Nakamura, Tetsuya/0000-0003-0183-1685; Kehr, Stephanie/0000-0001-8461-5763	US National Institutes of Health (NIH)/National Human Genome Research Institute [U54 HG03067]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 OD011116, R24 OD01119004, T32 HD055164, R01 AI057559, R24 OD010922, R01 GM079492]; Feodor Lynen Fellowship from the Alexander von Humboldt FoundationAlexander von Humboldt Foundation; Volkswagen Foundation Initiative Evolutionary Biology [I/84 815]; National Science Foundation (NSF)National Science Foundation (NSF) [1311436]; Uehara Memorial Foundation Research FellowshipUehara Memorial Foundation; Japan Society for the Promotion of Science Postdoctoral Research FellowshipMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Marine Biological Laboratory Research Award; Brazilian National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [402754/2012-3, 477658/2012-1]; Brinson Foundation; University of Chicago Biological Sciences DivisionUniversity of Chicago; NSFNational Science Foundation (NSF) [BCS0725227]; National Strategic Reference Framework [SPARCOMP, 36]; Ministry of Education and Religious Affairs of Greece; Agence Nationale de la Recherche (ANR)French National Research Agency (ANR) [ANR-10-GENM-017]; Wellcome TrustWellcome TrustEuropean Commission [WT095908, WT098051]; European Molecular Biology Laboratory; Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), SingaporeAgency for Science Technology & Research (ASTAR); European Research CouncilEuropean Research Council (ERC)European Commission [268513]; Ministerio de Ciencia e InnovacionInstituto de Salud Carlos IIISpanish GovernmentEuropean Commission [BFU2010-14875, BFU2015-71340]; Generalitat de Catalunya, AGAURAgencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya [SGR2014-290]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2012CB947600]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31030062]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD055164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR020833] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI057559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R21GM079492] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24OD011199, R24OD010922, R01OD011116] Funding Source: NIH RePORTER; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/T/000PR5885] Funding Source: UKRI	We thank the Broad Institute Genomics Platform for constructing and sequencing gar DNA and RNA libraries and J. Turner-Maier for the gar transcriptome assembly. We thank the teams of the Bayousphere Research Laboratory (Nicholls State University) and the University of Oregon Fish Facility for gar work and husbandry. We thank J. Westlund for the design of the species illustrations. The generation of gar sequences and assemblies by the Broad Institute of MIT and Harvard University was supported by US National Institutes of Health (NIH)/National Human Genome Research Institute grant U54 HG03067. This work was further supported by US NIH grants R01 OD011116 (alias R01 RR020833) and R24 OD01119004 (J.H.P.); a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation and the Volkswagen Foundation Initiative Evolutionary Biology, grant I/84 815 (I.B.); US NIH grant T32 HD055164 and National Science Foundation (NSF) Doctoral Dissertation Improvement Grant 1311436 (A.R.G.); Uehara Memorial Foundation Research Fellowship 2013, Japan Society for the Promotion of Science Postdoctoral Research Fellowship 2012-127 and Marine Biological Laboratory Research Award 2014 (T.N.); Brazilian National Council for Scientific and Technological Development (CNPq) grants 402754/2012-3 and 477658/2012-1 (I.S.); the Brinson Foundation and the University of Chicago Biological Sciences Division (N.H.S.); NSF grant BCS0725227 (K.K.); call 'ARISTEIA I' of the National Strategic Reference Framework 2007-2013 (SPARCOMP, 36), Ministry of Education and Religious Affairs of Greece (T.M.); Agence Nationale de la Recherche (ANR) grant ANR-10-GENM-017 (PhyloFish; J.B.); the Wellcome Trust (grants WT095908 and WT098051) and the European Molecular Biology Laboratory (D.B., S.M.J.S. and B.A.); the Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore (B.V.); European Research Council grant 268513 (P.W.H.H. and K.J.M.); the Ministerio de Ciencia e Innovacion (BFU2010-14875 and BFU2015-71340) and the Generalitat de Catalunya, AGAUR (SGR2014-290) (C. C.); US NIH grant R01 AI057559 (G.W.L. and J.A.Y.); US NIH grants R24 OD010922 and R01 GM079492 (C. T. A.); and the National Basic Research Program of China (973 Program) (2012CB947600) and the National Natural Science Foundation of China (NSFC) (31030062) (H.W.).	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 1999, METHOD CELL BIOL, V60, P323; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; [Anonymous], 2007, THESIS; Batzel P., 2015, ZENODO, DOI [10.5281/zenodo.35461, DOI 10.5281/ZENODO.35461]; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Braasch I, 2014, COMP BIOCHEM PHYS C, V163, P24, DOI 10.1016/j.cbpc.2014.01.005; Broughton RE, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.2ca8041495ffafd0c92756e75247483e; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cannon JP, 2008, IMMUNITY, V29, P228, DOI 10.1016/j.immuni.2008.05.018; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chalopin D, 2015, GENOME BIOL EVOL, V7, P567, DOI 10.1093/gbe/evv005; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Crow KD, 2012, GENOME BIOL EVOL, V4, P937, DOI 10.1093/gbe/evs067; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Desvignes T, 2014, GENE, V546, P386, DOI 10.1016/j.gene.2014.05.036; Dijkstra JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-260; Dirscherl H, 2014, DEV COMP IMMUNOL, V46, P11, DOI 10.1016/j.dci.2014.02.018; Dirscherl H, 2014, IMMUNOGENETICS, V66, P185, DOI 10.1007/s00251-013-0748-z; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Force A, 1999, GENETICS, V151, P1531; Frankenberg SR, 2014, DEVELOPMENT, V141, P2921, DOI 10.1242/dev.108407; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grande L, 2010, COPEIA, P1; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimholt U, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0309-1; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hagedorn EJ, 2014, EXP CELL RES, V329, P220, DOI 10.1016/j.yexcr.2014.07.030; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hertel Jana, 2015, Life-Basel, V5, P905, DOI 10.3390/life5010905; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Kawasaki K, 2009, DEV GENES EVOL, V219, P147, DOI 10.1007/s00427-009-0276-x; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurosawa G, 2006, GENE, V370, P75, DOI 10.1016/j.gene.2005.11.015; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lee O, 2015, CRIT REV TOXICOL, V45, P124, DOI 10.3109/10408444.2014.965805; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; Long W L, 2001, BMC Dev Biol, V1, P6, DOI 10.1186/1471-213X-1-6; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Mulley JF, 2010, MOL BIOL EVOL, V27, P2386, DOI 10.1093/molbev/msq121; Murray, 1859, ORIGIN SPECIES MEANS; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson J.S., 2006, FISHES WORLD, V4th Edn; Nikaido M, 2013, GENOME RES, V23, P1740, DOI 10.1101/gr.158105.113; OHNO S, 1969, CHROMOSOMA, V26, P35, DOI 10.1007/BF00319498; Ohno S., 1970, P1; Pagan AJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018499; Parra ZE, 2010, EUR J IMMUNOL, V40, P2319, DOI 10.1002/eji.201040515; Patton EE, 2011, METHOD CELL BIOL, V105, P339, DOI 10.1016/B978-0-12-381320-6.00014-X; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; R Development Core Team, 2015, R LANG ENV STAT COMP; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Reitzel AM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-6; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ryll B, 2014, EVOL DEV, V16, P123, DOI 10.1111/ede.12071; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; Sasagawa I., 2008, FRONTIERMAT SCI CH, V2, P134, DOI [10.1007/s11706-008-0023-7, DOI 10.1007/S11706-008-0023-7]; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIRE JY, 1994, ANAT REC, V240, P189, DOI 10.1002/ar.1092400206; Smith JJ, 2015, GENOME RES, V25, P1081, DOI 10.1101/gr.184135.114; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; TAJIMA F, 1993, GENETICS, V135, P599; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Toloza-Villalobos J, 2015, J MOL EVOL, V80, P57, DOI 10.1007/s00239-014-9660-x; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	132	307	321	7	115	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					427	+		10.1038/ng.3526			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	WOS:000372908800014	26950095	Green Published, hybrid, Green Accepted, Green Submitted	Y	N	2022-01-24	
J	Leidinger, P; Backes, C; Deutscher, S; Schmitt, K; Mueller, SC; Frese, K; Haas, J; Ruprecht, K; Paul, F; Stahler, C; Lang, CJG; Meder, B; Bartfai, T; Meese, E; Keller, A				Leidinger, Petra; Backes, Christina; Deutscher, Stephanie; Schmitt, Katja; Mueller, Sabine C.; Frese, Karen; Haas, Jan; Ruprecht, Klemens; Paul, Friedemann; Staehler, Cord; Lang, Christoph J. G.; Meder, Benjamin; Bartfai, Tamas; Meese, Eckart; Keller, Andreas			A blood based 12-miRNA signature of Alzheimer disease patients	GENOME BIOLOGY			English	Article						Alzheimer disease; miRNA; biomarker; next-generation sequencing; quantitative Real Time PCR	MICRORNA EXPRESSION PROFILES; FALSE DISCOVERY RATE; AMYLOID-BETA; GRID1 GENE; SCHIZOPHRENIA; ASSOCIATION; PREDICTION; TARGETS; PROTEIN; ANNOTATION	Background: Alzheimer disease (AD) is the most common form of dementia but the identification of reliable, early and non-invasive biomarkers remains a major challenge. We present a novel miRNA-based signature for detecting AD from blood samples. Results: We apply next-generation sequencing to miRNAs from blood samples of 48 AD patients and 22 unaffected controls, yielding a total of 140 unique mature miRNAs with significantly changed expression levels. Of these, 82 have higher and 58 have lower abundance in AD patient samples. We selected a panel of 12 miRNAs for an RT-qPCR analysis on a larger cohort of 202 samples, comprising not only AD patients and healthy controls but also patients with other CNS illnesses. These included mild cognitive impairment, which is assumed to represent a transitional period before the development of AD, as well as multiple sclerosis, Parkinson disease, major depression, bipolar disorder and schizophrenia. miRNA target enrichment analysis of the selected 12 miRNAs indicates an involvement of miRNAs in nervous system development, neuron projection, neuron projection development and neuron projection morphogenesis. Using this 12-miRNA signature, we differentiate between AD and controls with an accuracy of 93%, a specificity of 95% and a sensitivity of 92%. The differentiation of AD from other neurological diseases is possible with accuracies between 74% and 78%. The differentiation of the other CNS disorders from controls yields even higher accuracies. Conclusions: The data indicate that deregulated miRNAs in blood might be used as biomarkers in the diagnosis of AD or other neurological diseases.	[Leidinger, Petra; Backes, Christina; Deutscher, Stephanie; Schmitt, Katja; Mueller, Sabine C.; Meese, Eckart; Keller, Andreas] Univ Saarland, Dept Human Genet, D-66421 Homburg, Germany; [Frese, Karen; Haas, Jan; Meder, Benjamin] Heidelberg Univ, D-69120 Heidelberg, Germany; [Ruprecht, Klemens; Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-10117 Berlin, Germany; [Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany; [Staehler, Cord; Keller, Andreas] Siemens Healthcare, Strategy, D-91052 Erlangen, Germany; [Lang, Christoph J. G.] Univ Erlangen Nurnberg, Neurol Unit, D-91054 Erlangen, Germany; [Bartfai, Tamas] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA		Keller, A (corresponding author), Univ Saarland, Dept Human Genet, Kirrbergerstr,Bldg 60, D-66421 Homburg, Germany.	keller.andreas@siemens.com	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895; Mueller, Sabine/0000-0001-5184-1254; paul, friedemann/0000-0002-6378-0070	Siemens HealthcareSiemens AG; DFGGerman Research Foundation (DFG)European Commission [LE2783/1-1, ME917/20-1]	This work was supported by Siemens Healthcare, and in part by DFG grants LE2783/1-1 and ME917/20-1.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Bauer AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034151; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bocchio-Chiavetto L, 2013, EUR NEUROPSYCHOPHARM, V23, P602, DOI 10.1016/j.euroneuro.2012.06.013; Braskie MN, 2013, J ALZHEIMERS DIS, V33, pS313, DOI 10.3233/JAD-2012-129016; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Delay C, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-70; Deutsche Gesellschaft fur Psychiatrie PuND, 2009, S3 LEITHL DEM; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1, DOI DOI 10.1001/ARCHNEUR0L.2012.1282.[; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fenoglio C, 2012, INT J MOL SCI, V13, P13227, DOI 10.3390/ijms131013227; Fita IG, 2011, ROM J MORPHOL EMBRYO, V52, P975; Frankfort SV, 2008, CURR CLIN PHARMACOL, V3, P123, DOI 10.2174/157488408784293723; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gandy S, 2011, NATURE, V475, pS15, DOI 10.1038/475S15a; Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17; Geekiyanage H, 2012, EXP NEUROL, V235, P491, DOI 10.1016/j.expneurol.2011.11.026; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Gerrish A, 2012, J ALZHEIMERS DIS, V28, P377, DOI 10.3233/JAD-2011-110824; Guo SZ, 2007, SCHIZOPHR RES, V93, P385, DOI 10.1016/j.schres.2007.03.007; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Malaplate-Armand C, 2009, REV NEUROL-FRANCE, V165, P511, DOI 10.1016/j.neurol.2008.10.015; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Tan MS, 2012, NEUROSCI LETT, V516, P226, DOI 10.1016/j.neulet.2012.03.093; Team R, 2008, R LANG ENV STAT COMP; Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011; Tsunekawa Y, 2012, EMBO J, V31, P1879, DOI 10.1038/emboj.2012.43; UNDEN A, 1984, EUR J BIOCHEM, V145, P525, DOI 10.1111/j.1432-1033.1984.tb08588.x; Villa C, 2011, REJUV RES, V14, P275, DOI 10.1089/rej.2010.1123; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546	62	307	316	3	55	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2013	14	7							R78	10.1186/gb-2013-14-7-r78			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	268UA	WOS:000328194900010	23895045	Green Accepted, hybrid, Green Published			2022-01-24	
J	Sivakumaran, S; Agakov, F; Theodoratou, E; Prendergast, JG; Zgaga, L; Manolio, T; Rudan, I; McKeigue, P; Wilson, JF; Campbell, H				Sivakumaran, Shanya; Agakov, Felix; Theodoratou, Evropi; Prendergast, James G.; Zgaga, Lina; Manolio, Teri; Rudan, Igor; McKeigue, Paul; Wilson, James F.; Campbell, Harry			Abundant Pleiotropy in Human Complex Diseases and Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-ANALYSIS; ANGIOTENSIN-II; CHOLESTEROL; SCHIZOPHRENIA; ALLOPURINOL; DEFICIENCY; SELECTIN; LOCI; SCAN	We present a systematic review of pleiotropy among SNPs and genes reported to show genome-wide association with common complex diseases and traits. We find abundant evidence of pleiotropy; 233 (16.9%) genes and 77 (4.6%) SNPs show pleiotropic effects. SNP pleiotropic status was associated with gene location (p = 0.024; pleiotropic SNPs more often exonic 114.5% versus 4.9% for nonpleiotropic, trait-associated SNPs] and less often intergenic [15.8% versus 23.6%]), "predicted transcript consequence" (p = 0.001; pleiotropic SNPs more often predicted to be structurally deleterious [5% versus 0.4%] but not more often in regulatory sequences), and certain disease classes. We develop a method to calculate the likelihood that pleiotropic links between traits occurred more often than expected and demonstrate that this approach can identify etiological links that are already known (such as between fetal hemoglobin and malaria risk) and those that are not yet established (e.g., between plasma campesterol levels and gallstones risk; and between immunoglobulin A and juvenile idiopathic arthritis). Examples of pleiotropy will accumulate over time, but it is already clear that pleiotropy is a common property of genes and SNPs associated with disease traits, and this will have implications for identification of molecular targets for drug development, future genetic risk-profiling, and classification of diseases.	[Sivakumaran, Shanya; Agakov, Felix; Theodoratou, Evropi; Zgaga, Lina; Rudan, Igor; McKeigue, Paul; Wilson, James F.; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Agakov, Felix] Pharmatics Ltd, Edinburgh EH15 3LZ, Midlothian, Scotland; [Prendergast, James G.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia; [Manolio, Teri] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA		Campbell, H (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	harry.campbell@ed.ac.uk	Zgaga, Lina/Q-9415-2018; Wilson, James F/A-5704-2009; Rudan, Igor/I-1467-2012; Theodoratou, Evropi/C-3430-2014; Campbell, Harry/E-2959-2010	Zgaga, Lina/0000-0003-4089-9703; Wilson, James F/0000-0001-5751-9178; Rudan, Igor/0000-0001-6993-6884; Theodoratou, Evropi/0000-0001-5887-9132; Campbell, Harry/0000-0002-6169-6262; Prendergast, James/0000-0001-8916-018X; Agakov, Felix/0000-0003-4280-9062	Cancer Research UKCancer Research UK [C31250/A10107]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800604] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0800604] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish	E.T. is funded by Cancer Research UK Fellowship C31250/A10107.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, MED HYPOTHESES, V62, P309, DOI 10.1016/S0306-9877(03)00332-3; Bishop C.M., 2006, PATTERN RECOGN; BISHOP CM, 1994, IEE P-VIS IMAGE SIGN, V141, P217, DOI 10.1049/ip-vis:19941330; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Buie LW, 2006, ANN PHARMACOTHER, V40, P2200, DOI 10.1345/aph.1H222; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Cooper Zachary N, 2006, IRB, V28, P1; Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101; Das UN, 2005, MED SCI MONITOR, V11, pRA155; De la Herran-Arita Alberto K, 2011, Front Neurol, V2, P26, DOI 10.3389/fneur.2011.00026; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dickerson FB, 2009, SCHIZOPHR RES, V109, P66, DOI 10.1016/j.schres.2008.12.028; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilliam BE, 2008, CLIN EXP RHEUMATOL, V26, P492; Gruneberg H, 1938, PROC R SOC SER B-BIO, V125, P123, DOI 10.1098/rspb.1938.0017; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; Huang WH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S68; Hudson M, 2008, J AUTOIMMUN, V31, P156, DOI 10.1016/j.jaut.2008.05.002; HUGO Gene Nomenclature Committee, 2011, HGNC DAT; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Jakulj L, 2010, J LIPID RES, V51, P3016, DOI 10.1194/jlr.M008128; Jing Gao, 2006, Applied Computing 2006. 21st Annual ACM Symposium on Applied Computing, P635; Jones R, 2005, PAEDIATR PERINAT EP, V19, P264, DOI 10.1111/j.1365-3016.2005.00664.x; Karasik D, 2010, BONE, V46, P1226, DOI 10.1016/j.bone.2010.01.382; Koivusalo AI, 2010, DIGEST LIVER DIS, V42, P61, DOI 10.1016/j.dld.2009.06.006; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI 10.1016/j.sigpro.2003.07.018; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCELIECE RJ, 1977, THEORY INFORM CODING; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; McGrath J, 2011, SCHIZOPHRENIA BULL, V37, P272, DOI 10.1093/schbul/sbq121; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; National Human Genome Research Institute, CAT GEN WID ASS STUD; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; PASVOL G, 1976, LANCET, V1, P1269; Peirce B., 1852, ASTRON J, V2, P161, DOI [10.1086/100259, DOI 10.1086/100259]; Peirce B., 1877, P AM ACAD ARTS SCI, V13, P348, DOI DOI 10.2307/25138498; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Rousseeuw P., 1996, ROBUST REGRESSION OU; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Shear HL, 1998, BLOOD, V92, P2520, DOI 10.1182/blood.V92.7.2520.2520_2520_2526; Sorensen HJ, 2011, SCHIZOPHRENIA BULL, V37, P982, DOI 10.1093/schbul/sbp167; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Sudhop T, 2002, GUT, V51, P860, DOI 10.1136/gut.51.6.860; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tarassenko L., 1995, Fourth International Conference on `Artificial Neural Networks' (Conf. Publ. No.409), P442, DOI 10.1049/cp:19950597; Valdes AM, 2008, RHEUM DIS CLIN N AM, V34, P581, DOI 10.1016/j.rdc.2008.04.008; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wachbroit R, 1998, KENNEDY INST ETHIC J, V8, P131, DOI 10.1353/ken.1998.0013; Wade CH, 2006, AM J MED GENET C, V142C, P284, DOI 10.1002/ajmg.c.30110; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Wright S., 1968, EVOLUTION GENETICS P, V1; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yildiz B, 2007, EUR J PEDIATR, V166, P1179, DOI 10.1007/s00431-006-0360-4; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	76	307	314	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					607	618		10.1016/j.ajhg.2011.10.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	WOS:000297090100002	22077970	Green Published, Bronze			2022-01-24	
J	Reich, D; Patterson, N; Kircher, M; Delfin, F; Nandineni, MR; Pugach, I; Ko, AMS; Ko, YC; Jinam, TA; Phipps, ME; Saitou, N; Wollstein, A; Kayser, M; Paabo, S; Stoneking, M				Reich, David; Patterson, Nick; Kircher, Martin; Delfin, Frederick; Nandineni, Madhusudan R.; Pugach, Irina; Ko, Albert Min-Shan; Ko, Ying-Chin; Jinam, Timothy A.; Phipps, Maude E.; Saitou, Naruya; Wollstein, Andreas; Kayser, Manfred; Paeaebo, Svante; Stoneking, Mark			Denisova Admixture and the First Modern Human Dispersals into Southeast Asia and Oceania	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; NEW-GUINEA; GENETIC DIVERSITY; MTDNA; COLONIZATION; AUSTRALIANS; SETTLEMENT; JACKKNIFE; PACIFIC; ORIGINS	It has recently been shown that ancestors of New Guineans and Bougainville Islanders have inherited a proportion of their ancestry from Denisovans, an archaic hominin group from Siberia. However, only a sparse sampling of populations from Southeast Asia and Oceania were analyzed. Here, we quantify Denisova admixture in 33 additional populations from Asia and Oceania. Aboriginal Australians, Near Oceanians, Polynesians, Fijians, east Indonesians, and Mamanwa (a "Negrito" group from the Philippines) have all inherited genetic material from Denisovans, but mainland East Asians, western Indonesians, Jehai (a Negrito group from Malaysia), and Onge (a Negrito group from the Andaman Islands) have not. These results indicate that Denisova gene flow occurred into the common ancestors of New Guineans, Australians, and Mamanwa but not into the ancestors of the Jehai and Onge and suggest that relatives of present-day East Asians were not in Southeast Asia when the Denisova gene flow occurred. Our finding that descendants of the earliest inhabitants of Southeast Asia do not all harbor Denisova admixture is inconsistent with a history in which the Denisova interbreeding occurred in mainland Asia and then spread over Southeast Asia, leading to all its earliest modern human inhabitants. Instead, the data can be most parsimoniously explained if the Denisova gene flow occurred in Southeast Asia itself. Thus, archaic Denisovans must have lived over an extraordinarily broad geographic and ecological range, from Siberia to tropical Asia.	[Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Kircher, Martin; Delfin, Frederick; Nandineni, Madhusudan R.; Pugach, Irina; Ko, Albert Min-Shan; Paeaebo, Svante; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost, Lab DNA Fingerprinting, Hyderabad 500001, Andhra Pradesh, India; [Ko, Ying-Chin] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan; [Jinam, Timothy A.; Saitou, Naruya] Natl Inst Genet, Div Populat Genet, Mishima, Shizuoka 4118540, Japan; [Phipps, Maude E.] Monash Univ, Sch Med & Hlth Sci, Selangor 46150, Malaysia; [Wollstein, Andreas] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Wollstein, Andreas; Kayser, Manfred] Erasmus MC Univ Med Ctr Rotterdam, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands		Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; stoneking@eva.mpg.de	Phipps, Maude/F-7590-2012; Kircher, Martin/H-6909-2019	Phipps, Maude/0000-0001-8314-068X; Kircher, Martin/0000-0001-9278-5471; Ko, Albert Min-Shan/0000-0002-2096-1330; Nandineni, Madhusudan Reddy/0000-0002-8933-4503; Delfin, Frederick/0000-0002-8201-0661; Jinam, Timothy/0000-0003-4757-096X	SOKENDAI Graduate Student Overseas Travel Fund; Max Planck SocietyMax Planck SocietyFoundation CELLEX; National Science FoundationNational Science Foundation (NSF) [1032255]	We thank the volunteers who donated DNA samples. We acknowledge F.A. Almeda Jr., J.P. Erazo, D. Gil, the late J. Kuhl, E.S. Larase, I. Motinola, G. Patagan, W. Sinco, A. Sofro, U. Tadmor, and R. Trent for assistance with sample collections. We thank M. Meyer for preparing DNA libraries for high-throughput sequencing; A. Batik and P. Nurenberg for assistance with genotyping; and O. Bar-Yosef, K. Bryc, R.E. Green, J.-J. Hublin, J. Kelso, D. Lieberman, B. Pakendorf, M. Slatkin, and B. Viola for comments on the manuscript. T.A. Jinam was supported by a grant from the SOKENDAI Graduate Student Overseas Travel Fund. This work was supported by the Max Planck Society and by a National Science Foundation HOMINID grant (1032255).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cann HM, 2002, SCIENCE, V296, P261; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cordaux R, 2003, AM J HUM GENET, V72, P1586, DOI 10.1086/375407; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; KUNSCH HR, 1989, ANN STAT, V17, P1217, DOI 10.1214/aos/1176347265; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MATSUMOTO H, 1979, AM J HUM GENET, V31, P70; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mona S, 2009, MOL BIOL EVOL, V26, P1865, DOI 10.1093/molbev/msp097; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040	34	307	321	6	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					516	528		10.1016/j.ajhg.2011.09.005			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	834HV	WOS:000295951300006	21944045	Green Published, Bronze			2022-01-24	
J	Onoufriadis, A; Simpson, MA; Pink, AE; Di Meglio, P; Smith, CH; Pullabhatla, V; Knight, J; Spain, SL; Nestle, FO; Burden, AD; Capon, F; Trembath, RC; Barker, JN				Onoufriadis, Alexandros; Simpson, Michael A.; Pink, Andrew E.; Di Meglio, Paola; Smith, Catherine H.; Pullabhatla, Venu; Knight, Jo; Spain, Sarah L.; Nestle, Frank O.; Burden, A. David; Capon, Francesca; Trembath, Richard C.; Barker, Jonathan N.			Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERLEUKIN-1-RECEPTOR ANTAGONIST; AUTOINFLAMMATORY DISEASE; SUSCEPTIBILITY; ARTHRITIS; VARIANTS	Generalized pustular psoriasis (GPP) is a rare and yet potentially lethal clinical variant of psoriasis, characterized by the formation of sterile cutaneous pustules, neutrophilia, fever and features of systemic inflammation. We sequenced the exomes of five unrelated individuals diagnosed with GPP. Nonsynonymous, splice-site, insertion, and deletion variants with an estimated population frequency of <0.01 were considered as candidate pathogenic mutations. A homozygous c.338C>T (p.Ser113Leu) missense substitution of IL36RN was identified in two individuals, with a third subject found to be a compound heterozygote for c.338C>T (p.Ser113Leu) and a c.142C>T (p.Arg48Trp) missense substitution. IL36RN (previously known as IL1F5) encodes an IL-1 family receptor antagonist, which opposes the activity of the IL-36A and IL-36G innate cytokines. Homology searches revealed that GPP mutations alter evolutionarily conserved residues. Homozygosity for the c.338C>T (p.Ser113Leu) variant is associated with an elevated proinflamrnatory response following ex vivo stimulation with IL36A. These findings suggest loss of function of IL36RN as the genetic basis of GPP and implicate innate immune dysregulation in this severe episodic inflammatory disease, thereby highlighting IL-1 signaling as a potential target for therapeutic intervention.	[Onoufriadis, Alexandros; Simpson, Michael A.; Pullabhatla, Venu; Knight, Jo; Spain, Sarah L.; Capon, Francesca; Trembath, Richard C.] Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England; [Pink, Andrew E.; Di Meglio, Paola; Smith, Catherine H.; Nestle, Frank O.; Barker, Jonathan N.] Kings Coll London, Sch Med, Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England; [Burden, A. David] Univ Glasgow, Dept Dermatol, Glasgow G11 6NT, Lanark, Scotland		Trembath, RC (corresponding author), Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England.	richard.trembath@kcl.ac.uk; jonathan.barker@kcl.ac.uk	Capon, Francesca/F-4763-2011; Simpson, Michael/F-4737-2011; Knight, Jo/F-4946-2011; Smith, Catherine H./G-5268-2012; Spain, Sarah/G-1968-2010	Capon, Francesca/0000-0003-2432-5793; Simpson, Michael/0000-0002-8539-8753; Smith, Catherine H./0000-0001-9918-1144; Knight, Joanne/0000-0002-7148-1660; Barker, Jonathan/0000-0002-9030-183X; Di Meglio, Paola/0000-0002-2066-7780; Pink, Andrew/0000-0001-5151-5539; Spain, Sarah/0000-0002-7591-8364; Trembath, Richard/0000-0003-0550-3400	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601387]; Wellcome TrustWellcome TrustEuropean Commission [GR07873MA]; British Skin Foundation [1006]; The Generation Trust; MRC/BAD/BSFUK Research & Innovation (UKRI)Medical Research Council UK (MRC)US-Israel Binational Science Foundation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research CentreNational Institute for Health Research (NIHR); Guy's & St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1000342] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000342, G0600698B, G0601387] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10379, ACF-2008-17-009] Funding Source: researchfish	The authors express their gratitude to the families for participating in this study. This work was supported by an MRC Programme grant to R.C.T., F.O.N., and J.N.B. (G0601387), a Wellcome Trust Programme grant to F.O.N. (GR07873MA), and a British Skin Foundation award to F.C. (1006). A.O. is supported by a studentship funded by The Generation Trust. A.E.P. is supported by an MRC/BAD/BSF Clinical Research Training Fellowship. The authors acknowledge the use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We acknowledge technical assistance from Anna Bertoni and Christian Hundhausen.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Dunn EF, 2003, BIOCHEMISTRY-US, V42, P10938, DOI 10.1021/bi0341197; Griffiths C., 2010, ROOKS TXB DERMATOLOG, V8th ed.; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Viguier M, 2010, ANN INTERN MED, V153, P66, DOI 10.7326/0003-4819-153-1-201007060-00030; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	16	307	321	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					432	437		10.1016/j.ajhg.2011.07.022			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	WOS:000294939800008	21839423	Green Published, Bronze			2022-01-24	
J	Eminli, S; Foudi, A; Stadtfeld, M; Maherali, N; Ahfeldt, T; Mostoslavsky, G; Hock, H; Hochedlinger, K				Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Mostoslavsky, Gustavo; Hock, Hanno; Hochedlinger, Konrad			Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells	NATURE GENETICS			English	Article							HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; PROGENITOR CELLS; NUCLEAR TRANSFER; MATURE B; GENERATION; INDUCTION; SYSTEM; OCT4; EXPRESSION	The reprogramming of somatic cells into induced pluripotent stem (iPS) cells upon overexpression of the transcription factors Oct4, Sox2, Klf4 and cMyc is inefficient. It has been assumed that the somatic differentiation state provides a barrier for efficient reprogramming; however, direct evidence for this notion is lacking. Here, we tested the potential of mouse hematopoietic cells at different stages of differentiation to be reprogrammed into iPS cells. We show that hematopoietic stem and progenitor cells give rise to iPS cells up to 300 times more efficiently than terminally differentiated B and T cells do, yielding reprogramming efficiencies of up to 28%. Our data provide evidence that the differentiation stage of the starting cell has a critical influence on the efficiency of reprogramming into iPS cells. Moreover, we identify hematopoietic progenitors as an attractive cell type for applications of iPS cell technology in research and therapy.	[Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Hock, Hanno; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Hock, Hanno; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA USA; [Eminli, Sarah; Stadtfeld, Matthias; Maherali, Nimet; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Hock, Hanno; Hochedlinger, Konrad] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Eminli, Sarah] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol 2, Hamburg, Germany; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Gastroenterol Sect, Dept Med, Boston, MA 02118 USA; [Mostoslavsky, Gustavo] Boston Univ, Ctr Regenerat Med, Boston, MA 02215 USA		Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	hock.hanno@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu	Foudi, Adlen/L-7251-2018; Ahfeldt, Tim/E-2935-2017	Foudi, Adlen/0000-0001-5002-5490; Mostoslavsky, Gustavo/0000-0002-0784-2169; Stadtfeld, Matthias/0000-0002-5852-9906; Ahfeldt, Tim/0000-0001-6377-7376	Ellison Foundation to Massachusetts General Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD003266] Funding Source: NIH RePORTER	We thank H. Xie for sharing the C/ EBPa overexpression vector, R. Mostoslavsky for critical reading of the manuscript, L. Prickett and K. Folz- Donahue for help with FACS and P. Follett for help with blastocyst injections. A. F. was the recipient of the Lady Tata Memorial Trust Award. A Postdoctoral Fellowship from Schering Foundation supported M. S. This work was supported by a contribution from the Ellison Foundation to Massachusetts General Hospital start- up funds for H. H., by an American Society of Hematology ( ASH) Scholar Award to H. H. and by the Harvard Stem Cell Institute. Support to K. H. came from the US National Institutes of Health ( NIH) Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2007, NAT GENET, V39, P136, DOI 10.1038/ng0207-136; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; RAMSDELL F, 2006, CURR PROTOC IMMUNOL, V71; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	51	307	316	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					968	U29		10.1038/ng.428			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	WOS:000269382100007	19668214	Green Accepted			2022-01-24	
J	Holmans, P; Green, EK; Pahwa, JS; Ferreira, MAR; Purcell, SM; Sklar, P; Owen, MJ; O'Donovan, MC; Craddock, N				Holmans, Peter; Green, Elaine K.; Pahwa, Jaspreet Singh; Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela; Owen, Michael J.; O'Donovan, Michael C.; Craddock, Nick		Wellcome Trust Case Control Consor	Gene Ontology Analysis of GWA Study Data Sets Provides Insights into the Biology of Bipolar Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; LINKS; PRIORITIZATION; SCHIZOPHRENIA; VARIANTS; PROTEIN; RISK; LOCI; AXIS	We present a method for testing overrepresentation of biological pathways, indexed by gene-ontology terms, in lists of significant SNPs from genome-wide association studies. This method corrects for linkage disequilibrium between SNPs, variable gene size, and multiple testing of nonindependent pathways. The method was applied to the Wellcome Trust Case-Control Consortium Crohn disease (CD) data set. At a general level, the biological basis of CD is relatively well known for a complex genetic trait, and it thus acted as a test of the method. The method, known as ALIGATOR (Association LIst Go AnnoTatOR), successfully detected biological pathways implicated in CD. The method was also applied to a meta-analysis of bipolar disorder, and it implicated the modulation of transcription and cellular activity, including that which occurs via hormonal action, as an important player in pathogenesis.	[Holmans, Peter; Green, Elaine K.; Pahwa, Jaspreet Singh; Owen, Michael J.; O'Donovan, Michael C.; Craddock, Nick] Sch Med, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF23 6BQ, S Glam, Wales; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Purcell, Shaun M.; Sklar, Pamela] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Ferreira, Manuel A. R.] Genet Epidemiol Queensland Inst Med Res, Brisbane, Qld 4029, Australia		Holmans, P (corresponding author), Sch Med, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF23 6BQ, S Glam, Wales.	holmanspa@cardiff.ac.uk	Ferreira, Manuel A R/D-3609-2013; O'Donovan, Michael C/P-7005-2018; Holmans, Peter/F-4518-2015	Ferreira, Manuel A R/0000-0001-9059-1825; O'Donovan, Michael C/0000-0001-7073-2379; Holmans, Peter/0000-0003-0870-9412	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801418] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0801418] Funding Source: UKRI		Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Alterovitz G, 2007, NUCLEIC ACIDS RES, V35, pD322, DOI 10.1093/nar/gkl799; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Cariappa A, 1998, GUT, V43, P210, DOI 10.1136/gut.43.2.210; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; Craddock N, 2009, SCHIZOPHRENIA BULL, V35, P482, DOI 10.1093/schbul/sbp020; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Forcione DG, 1996, P NATL ACAD SCI USA, V93, P5094, DOI 10.1073/pnas.93.10.5094; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; GOODWIN J, 2007, MANIC DEPRESSIVE ILL; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; HAMSHERE ML, 2009, BR J PSYCHI IN PRESS; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hendrick V, 1998, PSYCHIAT CLIN N AM, V21, P277, DOI 10.1016/S0193-953X(05)70005-8; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lazarus JH, 1998, THYROID, V8, P909, DOI 10.1089/thy.1998.8.909; Lee Vivian, 2005, In Silico Biology, V5, P5; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Sakiyarna T, 2008, INFLAMM BOWEL DIS, V14, P310, DOI 10.1002/ibd.20328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Young EA, 2002, ENDOCRIN METAB CLIN, V31, P63, DOI 10.1016/S0889-8529(01)00002-0; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	307	313	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					13	24		10.1016/j.ajhg.2009.05.011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	WOS:000267997600004	19539887	Green Published, Bronze			2022-01-24	
J	Rahimov, F; Marazita, ML; Visel, A; Cooper, ME; Hitchler, MJ; Rubini, M; Domann, FE; Govil, M; Christensen, K; Bille, C; Melbye, M; Jugessur, A; Lie, RT; Wilcox, AJ; Fitzpatrick, DR; Green, ED; Mossey, PA; Little, J; Steegers-Theunissen, RP; Pennacchio, LA; Schutte, BC; Murray, JC				Rahimov, Fedik; Marazita, Mary L.; Visel, Axel; Cooper, Margaret E.; Hitchler, Michael J.; Rubini, Michele; Domann, Frederick E.; Govil, Manika; Christensen, Kaare; Bille, Camille; Melbye, Mads; Jugessur, Astanand; Lie, Rolv T.; Wilcox, Allen J.; Fitzpatrick, David R.; Green, Eric D.; Mossey, Peter A.; Little, Julian; Steegers-Theunissen, Regine P.; Pennacchio, Len A.; Schutte, Brian C.; Murray, Jeffrey C.		NISC Comparative Sequencing Pr	Disruption of an AP-2 alpha binding site in an IRF6 enhancer is associated with cleft lip	NATURE GENETICS			English	Article							OROFACIAL CLEFTS; ORAL CLEFTS; PALATE; GENE; POPULATION; SEQUENCES; POLYMORPHISMS; CONTRIBUTES; EXPRESSION; MUTATIONS	Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)(1) is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)(2). Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G>A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P = 1 x 10(-11)) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.	[Rahimov, Fedik; Schutte, Brian C.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Marazita, Mary L.; Cooper, Margaret E.; Govil, Manika] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Visel, Axel; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Div, Berkeley, CA 94720 USA; [Hitchler, Michael J.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt Diagnost Med, I-44100 Ferrara, Italy; [Christensen, Kaare; Bille, Camille] Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malinformat, DK-5000 Odense C, Denmark; [Melbye, Mads] Danish Epidemiol Sci Ctr, State Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jugessur, Astanand; Lie, Rolv T.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Fitzpatrick, David R.] Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, US Natl Inst Hlth Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Dundee DD1 4HR, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Steegers-Theunissen, Regine P.] Univ Med Ctr, NL-3015 GD Rotterdam, Netherlands		Murray, JC (corresponding author), Univ Iowa, Dept Pediat, 2182 ML,S Grand Ave, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	Christensen, Kaare/C-2360-2009; Visel, Axel/A-9398-2009; Wilcox, Allen J/C-7723-2019; FitzPatrick, David R/C-7301-2013; Visel, Axel/T-8573-2019; Rahimov, Fedik/H-2685-2013; Little, Julian/AAR-6117-2020	Christensen, Kaare/0000-0002-5429-5292; Visel, Axel/0000-0002-4130-7784; Wilcox, Allen J/0000-0002-3376-1311; Little, Julian/0000-0001-5026-5531; melbye, mads/0000-0001-8264-6785; Rubini, Michele/0000-0003-1448-9516; Mossey, Peter/0000-0002-9914-6901; Domann, Frederick/0000-0002-0489-2179; Pennacchio, Len/0000-0002-8748-3732; Rahimov, Fedik/0000-0001-6519-7404; FitzPatrick, David R./0000-0003-4861-969X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 DE16215, P30 ES05605, R37 DE08559, R01-DE13513, 1 UL1 RR024979-01, R01-CA73612, R01-HG003988]; Intramural Research Program of the National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); Intramural Research Program of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS); European Commission FP5European CommissionEuropean Commission Joint Research Centre; EUROCRAN [QLG1-CT-2000-01019]; American Heart AssociationAmerican Heart Association;  [DE-AC02-05CH11231];  [T32 CA078586]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA073612, T32CA078586] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIBHG000196, R01HG003988, ZIAHG000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE016148, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE008559, P50DE009170, R01DE013513, P50DE016215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZIAES049027, R01ES010876, P30ES005605] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_U127561093] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U127561093] Funding Source: UKRI	We would like to thank A. Kinoshita, K. Frees, A. Mansilla, J. L'Heureux, M. Johnson, H. Morrison, G. Wehby, N. Rorick, K. Bedell and L. Powers for technical assistance and S. McConnell, D. Benton and M. DeVore for their administrative assistance. We would also like to thank A. Klingelhutz (University of Iowa) for kindly providing us with HFK cell line. This work was supported by grants from the National Institutes of Health (NIH): P50 DE16215 (J.C.M., M.L.M., B.C.S.), P30 ES05605 (J.C.M.), R37 DE08559 (J.C.M., M.L.M.), R01-DE13513 (B.C.S.), 1 UL1 RR024979-01 (J.C.M., B.C.S.), R01-CA73612 (F.E.D.), R01-HG003988 administered under Department of Energy Contract DE-AC02-05CH11231 (L.A.P.) as well as by the Intramural Research Program of the National Human Genome Research Institute (E.D.G.), in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (A.J.W.), and European Commission FP5: EUROCRAN Project (contract no. QLG1-CT-2000-01019) (M.R., P.A.M., J.L., R.P.S.-T.). A.V. was supported by the American Heart Association. M.J.H. received salary support from T32 CA078586.	Bille C, 2007, EUR J EPIDEMIOL, V22, P173, DOI 10.1007/s10654-006-9099-5; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Harville EW, 2005, AM J EPIDEMIOL, V162, P448, DOI 10.1093/aje/kwi214; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Mitchell LE, 2002, CLEFT PALATE-CRAN J, V39, P93, DOI 10.1597/1545-1569(2002)039<0093:GFTDAA>2.0.CO;2; Mossey P, 2007, ORTHOD CRANIOFAC RES, V10, P114, DOI 10.1111/j.1601-6343.2007.00398.x; Nguyen RHN, 2007, ANN EPIDEMIOL, V17, P763, DOI 10.1016/j.annepidem.2007.04.008; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Provenzano MJ, 2007, EXP MOL PATHOL, V83, P277, DOI 10.1016/j.yexmp.2007.06.001; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	30	307	323	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1341	1347		10.1038/ng.242			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	WOS:000260501500028	18836445	Green Accepted, Green Submitted			2022-01-24	
J	Lowe, CE; Cooper, JD; Brusko, T; Walker, NM; Smyth, DJ; Bailey, R; Bourget, K; Plagnol, V; Field, S; Atkinson, M; Clayton, DG; Wicker, LS; Todd, JA				Lowe, Christopher E.; Cooper, Jason D.; Brusko, Todd; Walker, Neil M.; Smyth, Deborah J.; Bailey, Rebecca; Bourget, Kirsi; Plagnol, Vincent; Field, Sarah; Atkinson, Mark; Clayton, David G.; Wicker, Linda S.; Todd, John A.			Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; INSULIN GENE; T-CELLS; INTERLEUKIN-2; SEQUENCE; RECEPTOR; LOCUS; HLA; SUSCEPTIBILITY	Genome- wide association studies are now identifying disease- associated chromosome regions. However, even after convincing replication, the localization of the causal variant( s) requires comprehensive resequencing, extensive genotyping and statistical analyses in large sample sets leading to targeted functional studies. Here, we have localized the type 1 diabetes ( T1D) association in the interleukin 2 receptor alpha ( IL2RA) gene region to two independent groups of SNPs, spanning overlapping regions of 14 and 40 kb, encompassing IL2RA intron 1 and the 5' regions of IL2RA and RBM17 ( odds ratio 2.04, 95% confidence interval 1.70 - 2.45; P 1.92 x 10(-28); control frequency 0.635). Furthermore, we have associated IL2RA T1D susceptibility genotypes with lower circulating levels of the biomarker, soluble IL- 2RA ( P 6.28 x 10(-28)), suggesting that an inherited lower immune responsiveness predisposes to T1D.	Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; Univ Florida, Coll Med, Gainesville, FL 32610 USA		Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Todd, John A/A-3542-2010; Wicker, Linda S/F-7384-2010	Todd, John A/0000-0003-2740-8148; Plagnol, Vincent/0000-0002-5597-9215; smyth, deborah/0000-0002-6330-2669; Walker, Neil/0000-0001-9796-7688	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0000934] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [068545/Z/02, 061859] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0000934] Funding Source: UKRI		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Burren Oliver S., 2004, Human Genomics, V1, P98; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GIORDANO C, 1989, DIABETES, V38, P310, DOI 10.2337/diabetes.38.3.310; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Ionescu-Tirgoviste C, 2001, DIABETOLOGIA, V44, pB60, DOI 10.1007/PL00002956; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KLOSE RJ, 1993, TRENDS BIOCHEM SCI, V52, P506; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Makis AC, 2005, J INFECTION, V51, P206, DOI 10.1016/j.jinf.2004.10.013; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; ROBB RJ, 1987, J IMMUNOL, V139, P855; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; She JX, 1999, P NATL ACAD SCI USA, V96, P8116, DOI 10.1073/pnas.96.14.8116; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	49	307	314	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1074	1082		10.1038/ng2102			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	WOS:000249122400016	17676041				2022-01-24	
J	Barrett, JC; Cardon, LR				Barrett, Jeffrey C.; Cardon, Lon R.			Evaluating coverage of genome-wide association studies	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX DISEASE; POLYMORPHISM; FUTURE; POWER	Genome-wide association studies involving hundreds of thousands of SNPs in thousands of cases and controls are now underway. The first of many analytical challenges in these studies involves the choice of SNPs to genotype. It is not practical to construct a different panel of tag SNPs for each study, so the first generation of genome-wide scans will use predefined, commercially available marker panels, which will in part dictate their success or failure. We compare different approaches in use today, and show that although many of them provide substantial coverage of common variation in non-African populations, the precise extent is strongly dependent on the frequencies of alleles of interest and on specific considerations of study design. Overall, despite substantial differences in genotyping technologies, marker selection strategies and number of markers assayed, the first-generation high-throughput platforms all offer similar levels of genome coverage.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England		Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk		Barrett, Jeffrey/0000-0002-1152-370X	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; DALY M, 2006, NAT GENET       0521; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dong SL, 2001, GENOME RES, V11, P1418, DOI 10.1101/gr.171101; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jorgenson E, 2006, AM J HUM GENET, V78, P884, DOI 10.1086/503751; Ke XY, 2005, HUM MOL GENET, V14, P2757, DOI 10.1093/hmg/ddi309; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	19	307	320	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					659	662		10.1038/ng1801			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	WOS:000237954800019	16715099				2022-01-24	
J	Inoue, K; Khajavi, M; Ohyama, T; Hirabayashi, S; Wilson, J; Reggin, JD; Mancias, P; Butler, IJ; Wilkinson, MF; Wegner, M; Lupski, JR				Inoue, K; Khajavi, M; Ohyama, T; Hirabayashi, S; Wilson, J; Reggin, JD; Mancias, P; Butler, IJ; Wilkinson, MF; Wegner, M; Lupski, JR			Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR SOX10; WAARDENBURG-HIRSCHSPRUNG-DISEASE; MESSENGER-RNA DECAY; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; NONSENSE-MEDIATED DECAY; MARIE-TOOTH-DISEASE; REGULATORY MECHANISM; CLINICAL PHENOTYPES; FUNCTIONAL-ANALYSIS; P-0 MUTATIONS	The molecular mechanisms by which different mutations in the same gene can result in distinct disease phenotypes remain largely unknown. Truncating mutations of SOX10 cause either a complex neurocristopathy designated PCWH or a more restricted phenotype known as Waardenburg-Shah syndrome (WS4; OMIM 277580). Here we report that although all nonsense and frameshift mutations that cause premature termination of translation generate truncated SOX10 proteins with potent dominant-negative activity, the more severe disease phenotype, PCWH, is realized only when the mutant mRNAs escape the nonsense-mediated decay (NMD) pathway. We observe similar results for truncating mutations of MPZ that convey distinct myelinopathies. Our experiments show that triggering NMD and escaping NMD may cause distinct neurological phenotypes.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Nagano Childrens Hosp, Div Pediat Neurol, Nagano, Japan; Great Ormond St Hosp Children, Dept Neurol, London WC1N 3JH, England; Meritcare Neurosci Clin, Fargo, ND USA; Univ Texas, Sch Med, Dept Neurol, Houston, TX USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA		Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu		Wegner, Michael/0000-0002-4586-3294; Ohyama, Tomoko/0000-0003-1697-1138			BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Bondurand N, 1999, HUM MOL GENET, V8, P1785, DOI 10.1093/hmg/8.9.1785; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI200214841; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FORGET BG, 1974, NATURE, V247, P379, DOI 10.1038/247379a0; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Inoue K, 2002, ANN NEUROL, V52, P836, DOI 10.1002/ana.10404; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; JACOBS JM, 1992, ACTA NEUROPATHOL, V83, P670, DOI 10.1007/BF00299420; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Pingault V, 2000, ANN NEUROL, V48, P671, DOI 10.1002/1531-8249(200010)48:4<671::AID-ANA17>3.0.CO;2-8; Pingault V, 2002, HUM GENET, V111, P198, DOI 10.1007/s00439-002-0765-8; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Sham MH, 2001, J MED GENET, V38, DOI 10.1136/jmg.38.9.e30; Shames I, 2003, J NEUROPATH EXP NEUR, V62, P751, DOI 10.1093/jnen/62.7.751; Snead MP, 1999, J MED GENET, V36, P353; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Toki F, 2003, PEDIATR SURG INT, V19, P725, DOI 10.1007/s00383-003-1057-7; Touraine RL, 2000, AM J HUM GENET, V66, P1496, DOI 10.1086/302895; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Wong MH, 1996, J CELL BIOL, V134, P1531, DOI 10.1083/jcb.134.6.1531; Yoshida M, 2001, NEUROCHEM RES, V26, P703, DOI 10.1023/A:1010999622760	44	307	317	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					361	369		10.1038/ng1322			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	WOS:000220647200019	15004559	Bronze			2022-01-24	
J	Oshima, K; Kakizawa, S; Nishigawa, H; Jung, HY; Wei, W; Suzuki, S; Arashida, R; Nakata, D; Miyata, S; Ugaki, M; Namba, S				Oshima, K; Kakizawa, S; Nishigawa, H; Jung, HY; Wei, W; Suzuki, S; Arashida, R; Nakata, D; Miyata, S; Ugaki, M; Namba, S			Reductive evolution suggested from the complete genome sequence of a plant-pathogenic phytoplasma	NATURE GENETICS			English	Article							DIVERSITY	The minimal gene set essential for life has long been sought. We report the 860-kb genome of the obligate intracellular plant pathogen phytoplasma (Candidatus Phytoplasma asteris, OY strain). The phytoplasma genome encodes even fewer metabolic functions than do mycoplasma genomes. It lacks the pentose phosphate cycle and, more unexpectedly, ATP-synthase subunits, which are thought to be essential for life. This may be the result of reductive evolution as a consequence of life as an intracellular parasite in a nutrient-rich environment.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan		Namba, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, 202 Biosci Bldg,5-1-5 Kashiwanoha, Chiba 2778562, Japan.		Suzuki, Shiho/Z-4458-2019; kakizawa, shigeyuki/L-8901-2018	kakizawa, shigeyuki/0000-0003-3885-4434; Suzuki, Shiho/0000-0003-3168-1729; Oshima, Kenro/0000-0001-7327-4481			Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; DOI Y., 1967, Annals of the Phytopathological Society of Japan, V33, P259; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; NAMBA S, 1993, INT J SYST BACTERIOL, V43, P461, DOI 10.1099/00207713-43-3-461; Nishigawa H, 2002, MICROBIOL-SGM, V148, P1389, DOI 10.1099/00221287-148-5-1389; Oshima K, 2001, PHYTOPATHOLOGY, V91, P1024, DOI 10.1094/PHYTO.2001.91.11.1024; Oshima Kenro, 2002, Journal of General Plant Pathology, V68, P225, DOI 10.1007/PL00013081; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931	15	307	472	0	34	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					27	29		10.1038/ng1277			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	WOS:000187666800010	14661021	Bronze			2022-01-24	
J	Iyer, LM; Anantharaman, V; Aravind, L				Iyer, LM; Anantharaman, V; Aravind, L			Ancient conserved domains shared by animal soluble guanylyl cyclases and bacterial signaling proteins	BMC GENOMICS			English	Article							NITRIC-OXIDE SYNTHASE; DEINOCOCCUS-RADIODURANS; SECONDARY STRUCTURE; OXYGEN SENSOR; GGDEF DOMAIN; BOVINE LUNG; GAF DOMAIN; PSI-BLAST; BINDING; PREDICTION	Background: Soluble guanylyl cyclases (SGCs) are dimeric enzymes that transduce signals downstream of nitric oxide (NO) in animals. They sense NO by means of a heme moiety that is bound to their N-terminal extensions. Results: Using sequence profile searches we show that the N-terminal extensions of the SGCs contain two globular domains. The first of these, the HNOB (Heme NO Binding) domain, is a predominantly alpha-helical domain and binds heme via a covalent linkage to histidine. Versions lacking this conserved histidine and are likely to interact with heme non-covalently. We detected HNOB domains in several bacterial lineages, where they occur fused to methyl accepting domains of chemotaxis receptors or as standalone proteins. The standalone forms are encoded by predicted operons that also contain genes for two component signaling systems and GGDEF-type nucleotide cyclases. The second domain, the HNOB associated (HNOBA) domain occurs between the HNOB and the cyclase domains in the animal SGCs. The HNOBA domain is also detected in bacteria and is always encoded by a gene, which occurs in the neighborhood of a gene for a HNOB domain. Conclusion: The HNOB domain is predicted to function as a heme-dependent sensor for gaseous ligands, and transduce diverse downstream signals, in both bacteria and animals. The HNOBA domain functionally interacts with the HNOB domain, and possibly binds a ligand, either in cooperation, or independently of the latter domain. Phyletic profiles and phylogenetic analysis suggest that the HNOB and HNOBA domains were acquired by the animal lineage via lateral transfer from a bacterial source.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA		Iyer, LM (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	lakshmin@ncbi.nlm.nih.gov; ananthar@ncbi.nlm.nih.gov; aravind@ncbi.nlm.nih.gov	Anantharaman, Vivek/ABB-9991-2021; Iyer, Lakshminarayan M./H-2996-2019	Anantharaman, Vivek/0000-0001-8395-0009; Aravind, L/0000-0003-0771-253X			Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Anantharaman V, 2001, TRENDS BIOCHEM SCI, V26, P579, DOI 10.1016/S0968-0004(01)01968-5; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Becker E M, 2001, BMC Pharmacol, V1, P13, DOI 10.1186/1471-2210-1-13; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Darnell, 1999, MOL CELL BIOL; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Foerster J, 1996, EUR J BIOCHEM, V240, P380, DOI 10.1111/j.1432-1033.1996.0380h.x; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; LeMoual H, 1996, J MOL BIOL, V261, P568, DOI 10.1006/jmbi.1996.0483; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mougel C, 2001, TRENDS BIOCHEM SCI, V26, P582, DOI 10.1016/S0968-0004(01)01969-7; Murad F, 1994, Adv Pharmacol, V26, P19, DOI 10.1016/S1054-3589(08)60049-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8; Perutz MF, 1999, CHEM BIOL, V6, pR291, DOI 10.1016/S1074-5521(99)80121-5; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1997, J MOL BIOL, V270, P471, DOI 10.1006/jmbi.1997.1101; Schaffer AA, 1999, BIOINFORMATICS, V15, P1000; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Walter P., 2002, MOL BIOL CELL, V91, P401; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9; [No title captured]	47	307	314	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 3	2003	4								5	10.1186/1471-2164-4-5			8	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	654RK	WOS:000181509700001	12553882	Green Published, gold			2022-01-24	
J	Batzoglou, S; Jaffe, DB; Stanley, K; Butler, J; Gnerre, S; Mauceli, E; Berger, B; Mesirov, JP; Lander, ES				Batzoglou, S; Jaffe, DB; Stanley, K; Butler, J; Gnerre, S; Mauceli, E; Berger, B; Mesirov, JP; Lander, ES			ARACHNE: A whole-genome shotgun assembler	GENOME RESEARCH			English	Article							DNA-SEQUENCE; DROSOPHILA; PROGRAM	We describe a new computer system, called ARACHNE, for assembling genome sequence using paired-end whole-genome shotgun reads. ARACHNE has several key features, including an efficient and sensitive procedure for finding read overlaps, a procedure for scoring overlaps that achieves high accuracy by correcting errors before assembly, read merger based on forward-reverse links, and detection of repeat contigs by forward-reverse link inconsistency. To test ARACHNE, we created simulated reads providing similar to10-fold coverage of the genomes of H. influenzae, S. cerevisiae, and A melanogaster, as well as human chromosomes 21 and 22. The assemblies of these simulated reads yielded nearly complete coverage of the respective genomes, with a small number of contigs joined into a smaller number of supercontigs (or scaffolds). For example, analysis of the A melanogaster genome yielded similar to98% coverage with an N50 contig length of 324 kb and an N50 supercontig length of 5143 kb. The assembly accuracy was high, although not perfect: small errors occurred at a frequency of roughly 1 per 1 Mb (typically, deletion of similar to1 kb in size), with a very small number of other misassemblies. The assembly was rapid: the Drosophila assembly required only 21 hours on a single 667 MHz processor and used 8.4 Gb of memory.	MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02141 USA; MIT, Comp Sci Lab, Cambridge, MA 02139 USA; Univ Nebraska, Dept Math & Stat, Lincoln, NE 68588 USA; MIT, Dept Math, Cambridge, MA 02141 USA; MIT, Dept Biol, Cambridge, MA 02141 USA		Lander, ES (corresponding author), MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02141 USA.	lander@wi.mit.edu					Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BATZOGLOU S, 2000, THESIS MIT; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHEN T, 1997, P 8 S COMB PATT MATC, P206; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Green P, 1994, PHRAP DOCUMENTATION; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim S, 1999, J COMPUT BIOL, V6, P163, DOI 10.1089/cmb.1999.6.163; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pevzner P. a., 2001, P 5 ANN INT C COMP M, P256; PIETOLA H, 1984, NUCLEIC ACIDS RES, V12, P307; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [DOI 10.1089/GST.1995.1.9, DOI 10.1089/gst.1995.1.9]	25	307	334	0	14	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JAN	2002	12	1					177	189		10.1101/gr.208902			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	508AN	WOS:000173064900019	11779843	Green Published, Bronze			2022-01-24	
J	Brophy, VH; Jampsa, RL; Clendenning, JB; McKinstry, LA; Jarvik, GP; Furlong, CE				Brophy, VH; Jampsa, RL; Clendenning, JB; McKinstry, LA; Jarvik, GP; Furlong, CE			Effects of 5 ' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM PARAOXONASE; HIGH-DENSITY-LIPOPROTEIN; BOVINE PLASMA ARYLESTERASE; CORONARY-ARTERY DISEASE; E-DEFICIENT MICE; DIABETES-MELLITUS; ESTERASE-ACTIVITY; MOLECULAR-BASIS; STATUS REQUIRES; MOUSE MODEL	Human HDL-associated paraoxonase (PON1) hydrolyzes a number of toxic organophosphorous compounds and reduces oxidation of LDLs and HDLs. These properties of PON1 account for its ability to protect against pesticide poisonings and atherosclerosis. PON1 also hydrolyzes a number of lactone and cyclic-carbonate drugs. Among individuals in a population, PON1 levels vary widely. We previously identified three polymorphisms in the PON1 regulatory region that affect expression levels in cultured human hepatocytes. In this study, we determined the genotypes of three regulatory-region polymorphisms for 376 white individuals and examined their effect on plasma-PON1 levels, determined by rates of phenylacetate hydrolysis. The -108 polymorphism had a significant effect on PON1-activity level, whereas the -162 polymorphism had a lesser effect. The -909 polymorphism, which is in linkage disequilibrium with the other sites, appears to have little or no independent effect on PON1-activity level in vivo. Other studies have found that the L55M polymorphism in the PON1-coding region is associated with differences in both PON1-mRNA and PON1-activity levels. The results presented here indicate that the L55M effect of lowered activity is not due to the amino acid change but is, rather, largely due to linkage disequilibrium with the -108 regulatory-region polymorphism. The codon 55 polymorphism marginally appeared to account for 15.3% of the variance in PON1 activity, but this dropped to 5% after adjustments for the effects of the -108 and Q192R polymorphisms were made. The -108C/T polymorphism accounted for 22.8% of the observed variability in PON1-expression levels, which was much greater than that attributable to the other PON1 polymorphisms. We also identified four sequence differences in the 3' UTR of the PON1 mRNA.	Univ Washington, Dept Genet, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Furlong, CE (corresponding author), Univ Washington, Dept Genet, Div Med Genet, Box 357360, Seattle, WA 98195 USA.		Jarvik, Gail P/N-6476-2014; Brophy, Victoria/V-8964-2019	Jarvik, Gail P/0000-0002-6710-8708; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES009883, P30ES007033, P01ES009601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000057] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG 00057-22, T32 AG000057] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [1 PO1 ES09601, P30 ES007033, ES09883, P30 ES07033, R01 ES009883] Funding Source: Medline		ADKINS S, 1993, AM J HUM GENET, V52, P598; ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; Aviram M, 1998, ARTERIOSCL THROM VAS, V18, P1617, DOI 10.1161/01.ATV.18.10.1617; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Aviram M, 2000, AM J CLIN NUTR, V71, P1062; Biggadike K, 2000, J MED CHEM, V43, P19, DOI 10.1021/jm990436t; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Blatter Garin Marie-Claude, 1997, Journal of Clinical Investigation, V99, P62; Brophy VH, 2000, PHARMACOGENETICS, V10, P453, DOI 10.1097/00008571-200007000-00008; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Cao HB, 1999, J LIPID RES, V40, P133; Cascorbi I, 1999, PHARMACOGENETICS, V9, P755, DOI 10.1097/00008571-199912000-00010; Costa L. G., 1987, TOXICOLOGY PESTICIDE, P263; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; DON MM, 1975, BIOCHEM J, V151, P625, DOI 10.1042/bj1510625; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Furlong CE, 1998, NEUROTOXICOLOGY, V19, P645; FURLONG CE, 1989, ANAL BIOCHEM, V180, P242, DOI 10.1016/0003-2697(89)90424-7; FURLONG CE, 1993, CHEM-BIOL INTERACT, V87, P35, DOI 10.1016/0009-2797(93)90023-R; FURLONG CE, 1988, AM J HUM GENET, V43, P230; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; Hedrick CC, 2000, ARTERIOSCL THROM VAS, V20, P1946, DOI 10.1161/01.ATV.20.8.1946; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Imai Y, 2000, ATHEROSCLEROSIS, V149, P435, DOI 10.1016/S0021-9150(99)00340-8; James RW, 2000, DIABETES, V49, P1390, DOI 10.2337/diabetes.49.8.1390; James RW, 2000, CIRCULATION, V101, P2252, DOI 10.1161/01.CIR.101.19.2252; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; La Du B N, 1986, Prog Clin Biol Res, V214, P87; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Leviev I, 1997, ARTERIOSCL THROM VAS, V17, P2935, DOI 10.1161/01.ATV.17.11.2935; LI WF, 1993, J TOXICOL ENV HEALTH, V40, P337, DOI 10.1080/15287399309531798; LI WF, 1995, TOXICOL LETT, V76, P219, DOI 10.1016/0378-4274(95)80006-Y; Li WF, 2000, PHARMACOGENETICS, V10, P767, DOI 10.1097/00008571-200012000-00002; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mackness B, 1998, ATHEROSCLEROSIS, V139, P341, DOI 10.1016/S0021-9150(98)00095-1; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7; MACKNESS MI, 1985, COMP BIOCHEM PHYS B, V82, P675, DOI 10.1016/0305-0491(85)90506-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nishio E, 1997, BIOCHEM BIOPH RES CO, V236, P289, DOI 10.1006/bbrc.1997.6961; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; Ray A, 2000, J IMMUNOL, V165, P3411, DOI 10.4049/jimmunol.165.6.3411; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Sakai T, 1998, INTERNAL MED, V37, P581, DOI 10.2169/internalmedicine.37.581; Schmidt H, 1998, STROKE, V29, P2043, DOI 10.1161/01.STR.29.10.2043; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; Tomas M, 2000, ARTERIOSCL THROM VAS, V20, P2113, DOI 10.1161/01.ATV.20.9.2113; Tougou K, 1998, DRUG METAB DISPOS, V26, P355; van der Gaag MS, 1999, ATHEROSCLEROSIS, V147, P405, DOI 10.1016/S0021-9150(99)00243-9; Van Lenten BJ, 2001, J BIOL CHEM, V276, P1923, DOI 10.1074/jbc.M004074200; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359	56	307	336	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1428	1436		10.1086/320600			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	WOS:000169094600013	11335891	Bronze, Green Published			2022-01-24	
J	Eng, CM; Banikazemi, M; Gordon, RE; Goldman, M; Phelps, R; Kim, L; Gass, A; Winston, J; Dikman, S; Fallon, JT; Brodie, S; Stacy, CB; Mehta, D; Parsons, R; Norton, K; O'Callaghan, M; Desnick, RJ				Eng, CM; Banikazemi, M; Gordon, RE; Goldman, M; Phelps, R; Kim, L; Gass, A; Winston, J; Dikman, S; Fallon, JT; Brodie, S; Stacy, CB; Mehta, D; Parsons, R; Norton, K; O'Callaghan, M; Desnick, RJ			A phase 1/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-GALACTOSIDASE-A; THERAPY	Fabry disease results from deficient alpha -galactosidase A (alpha -Gal A) activity and the pathologic accumulation of the globotriaosylceramide (GL-3) and related glycosphingolipids, primarily in vascular endothelial lysosomes. Treatment is currently palliative, and affected patients generally die in their 40s or 50s. Preclinical studies of recombinant human alpha -Gal A (r-h alpha GalA) infusions in knockout mice demonstrated reduction of GL-3 in tissues and plasma, providing rationale for a phase 1/2 clinical trial. Here, we report a single-center, open-label, dose-ranging study of r-h alpha GalA treatment in 15 patients, each of whom received five infusions at one of five dose regimens. Intravenously administered r-h alpha GalA was cleared from the circulation in a dose-dependent manner, via both saturable and non-saturable pathways. Rapid and marked reductions in plasma and tissue GL-3 were observed biochemically, histologically, and/or ultrastructurally. Clearance of plasma GL-3 was dose-dependent. In patients with pre- and posttreatment biopsies, mean GL-3 content decreased 84% in liver (n = 13), was markedly reduced in kidney in four of five patients, and after five doses was modestly lowered in the endomyocardium of four of seven patients. GL-3 deposits were cleared to near normal or were markedly reduced in the vascular endothelium of liver, skin, heart, and kidney, on the basis of light- and electron-microscopic evaluation. In addition, patients reported less pain, increased ability to sweat, and improved quality-of-life measures. Infusions were well tolerated; four patients experienced mild-to-moderate reactions, suggestive of hypersensitivity, that were managed conservatively. Of 15 patients, 8 (53%) developed IgG antibodies to r-h alpha GalA; however, the antibodies were not neutralizing, as indicated by unchanged pharmacokinetic values for infusions 1 and 5. This study provides the basis for a phase 3 trial of enzyme-replacement therapy for Fabry disease.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA; Genzyme Corp, Cambridge, MA USA		Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.			Fallon, John/0000-0002-7677-4868	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR000071, 5 M01 RR00071] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [5 R37 DK34045, R37 DK034045] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37DK034045] Funding Source: NIH RePORTER		BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; COLOMBI A, 1967, HELV MED ACTA, V34, P67; Desnick R J, 1980, Birth Defects Orig Artic Ser, V16, P393; Desnick R.J., 2001, METABOLIC MOL BASES, V8th ed., P3733, DOI [DOI 10.1036/ommbid.181, 10.1036/ommbid.181]; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; DESNICK RJ, 1979, P NATL ACAD SCI USA, V76, P5326, DOI 10.1073/pnas.76.10.5326; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; ENG CM, 1993, AM J HUM GENET, V53, P1186; Grabowski GA, 1998, BLOOD REV, V12, P115, DOI 10.1016/S0268-960X(98)90023-6; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; MAPES CA, 1970, SCIENCE, V169, P987, DOI 10.1126/science.169.3949.987; Matsuura F, 1998, GLYCOBIOLOGY, V8, P329, DOI 10.1093/glycob/8.4.329; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mistry Pramod K., 1999, Journal of Hepatology, V30, P1; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Valle, 1995, METABOLIC MOL BASES, P2741; VANSCHEIDT W, 1991, NEW ENGL J MED, V324, P395; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; Ware JE., 1997, SF 36 HLTH SURVEY MA; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	22	307	318	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					711	722		10.1086/318809			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	WOS:000166994200015	11179018	Green Published, Bronze			2022-01-24	
J	Markel, P; Shu, P; Ebeling, C; Carlson, GA; Nagle, DL; Smutko, JS; Moore, KJ				Markel, P; Shu, P; Ebeling, C; Carlson, GA; Nagle, DL; Smutko, JS; Moore, KJ			Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; DEFICIENT MICE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; SUSCEPTIBILITY; INTERVALS	Congenic breeding strategies are becoming increasingly important as a greater number of complex trait linkages are identified. Traditionally, the development od a congenic strain Ras been a time-consuming endeavour, requiring ten generations of backcrosses. The recent advent of a dense molecular genetic map of the mouse permits methods that can reduce the time needed for congenic-strain production by 18-24 months. We present a theoretical evaluation of marker-assisted congenic production and provide the empirical data that support it. We present this 'speed congenic' method in a user-friendly manner to encourage other investigators to pursue this or similar methods of congenic production.	MILLENNIUM PHARMACEUT,CAMBRIDGE,MA 02139; MCLAUGHLIN RES INST,GREAT FALLS,MT 59405								GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Green, 1966, BIOL LAB MOUSE; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Markel PD, 1997, GENOME RES, V7, P92, DOI 10.1101/gr.7.2.92; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Silver L. M., 1995, MOUSE GENETICS CONCE; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Threadgill DW, 1997, MAMM GENOME, V8, P441, DOI 10.1007/s003359900464; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	15	307	313	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					280	284		10.1038/ng1197-280			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	WOS:A1997YD66700020	9354790				2022-01-24	
J	Ivanov, EL; Sugawara, N; FishmanLobell, J; Haber, JE				Ivanov, EL; Sugawara, N; FishmanLobell, J; Haber, JE			Genetic requirements for the single-strand annealing pathway of double-strand break repair in Saccharomyces cerevisiae	GENETICS			English	Article							MOUSE L-CELLS; MATING TYPE; DNA ENDS; RECOMBINATION; YEAST; PROTEIN; RAD51; MODEL	HO endonuclease-induced double-strand breaks (DSBs) within a direct duplication of Escherichia coli lacZ genes are repaired either by gene conversion or by single-strand annealing (SSA), with >80% being SSA. Preciously it was demonstrated that the RAD52 gene is required for DSB-induced SSA. In the present study, the effects of other genes belonging to the RAD52 epistasis group were analyzed. We show that RAD51, RAD54, RAD55, and RAD57 genes are not required for SSA irrespective of whether recombination occurred in plasmid or chromosomal DNA. In both plasmid and chromosomal constructs with homologous sequences in direct orientation, the proportion of SSA events over gene conversion was significantly elevated in the mutant strains. However, gene conversion was not affected when the two lacZ sequences were in inverted orientation. These results suggest that there is a competition between SSA and gene conversion processes that favors SSA in the absence of RAD51, RAD54, RAD55 and RAD57. Mutations in RAD50 and XRS2 genes do not prevent the completion, but markedly retard the kinetics, of DSB repair by both mechanisms in the lacZ direct repeat plasmid, a result resembling the effects of these genes during mating-type (MAT) switching.	BRANDEIS UNIV,ROSENSTIEL BASIC MED SCI RES CTR,WALTHAM,MA 02254; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254					Haber, James/0000-0002-1878-0610	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM120056, R37GM020056, R01GM020056] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-20056] Funding Source: Medline		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1995, CURR GENET, V27, P298, DOI 10.1007/BF00352096; ALANI E, 1989, GENETICS, V122, P47; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; FAN HY, 1994, GENETICS, V137, P945; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIRMENICH AA, 1995, MOL CELL BIOL, V15, P1620; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; HALBROOK J, 1994, MOL CELL BIOL, V14, P8037, DOI 10.1128/MCB.14.12.8037; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; KLEIN HL, 1995, BIOESSAYS, V17, P147, DOI 10.1002/bies.950170210; LIEFSHITZ B, 1995, GENETICS, V140, P1199; LIN FL, 1984, MOL CELL BIOL, V4, P1020, DOI 10.1128/MCB.4.6.1020; LIN FLM, 1990, MOL CELL BIOL, V10, P103, DOI 10.1128/MCB.10.1.103; LOVETT ST, 1987, GENETICS, V116, P547; MCDONALD JP, 1994, GENETICS, V137, P393; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; OZENBERGER BA, 1991, MOL CELL BIOL, V11, P1222, DOI 10.1128/MCB.11.3.1222; Petes TD, 1991, MOL CELLULAR BIOL YE, P407; RATTRAY AJ, 1995, GENETICS, V139, P45; RATTRAY AJ, 1994, GENETICS, V138, P587; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUBY SW, 1983, METHOD ENZYMOL, V101, P253; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; RUDIN N, 1989, GENETICS, V122, P519; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; SCHILD D, 1983, CELLULAR RESPONSES D, P417; Sherman F., 1986, METHODS YEAST GENETI; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x	43	307	310	0	10	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	MAR	1996	142	3					693	704					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TX455	WOS:A1996TX45500005	8849880				2022-01-24	
J	MHATRE, AN; TRIFIRO, MA; KAUFMAN, M; KAZEMIESFARJANI, P; FIGLEWICZ, D; ROULEAU, G; PINSKY, L				MHATRE, AN; TRIFIRO, MA; KAUFMAN, M; KAZEMIESFARJANI, P; FIGLEWICZ, D; ROULEAU, G; PINSKY, L			REDUCED TRANSCRIPTIONAL REGULATORY COMPETENCE OF THE ANDROGEN RECEPTOR IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE GENETICS			English	Article							GLUCOCORTICOID RECEPTOR; TRINUCLEOTIDE REPEAT; MOLECULAR-BASIS; GENE; ACTIVATION; EXPRESSION; BINDING; LOCALIZATION; TESTOSTERONE; PROTEIN	Expansion of the long (CAG; glutamine)n repeat in the first exon of the X-linked human androgen receptor gene (hAR) causes spinal and bulbar muscular atrophy, frequently in association with mild androgen insensitivity. The relevant normal motor neurons are preferentially stimulated by androgen, however no motor neuron disorder occurs with any other known AR mutation, including those that cause complete androgen insensitivity. We have found that a polyglutamine (Gln) expanded AR transactivates an androgen-responsive reporter gene subnormally. Other groups have reported that a poly Gln-deleted AR transactivates normally. A parsimonious interpretation of all these facts is that poly Gln expansion causes the AR to lose a function that is necessary for full androgen sensitivity and to gain a function that is selectively motor neuronotoxic.	SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST MED RES,3755 COTE ST,MONTREAL H3T 1E2,QUEBEC,CANADA; MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL H3G 1A4,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT NEUROSCI,MONTREAL H3A 1B1,QUEBEC,CANADA								ARAKI I, 1991, J NEUROSCI, V11, P3025; ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BREEDLOVE SM, 1986, J NEUROBIOL, V17, P157, DOI 10.1002/neu.480170304; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN CJ, 1989, AM J HUM GENET, V44, P264; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; FABER PW, 1991, BIOCHEM J, V278, P269, DOI 10.1042/bj2780269; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; FRANKEL AD, 1991, CELL, V65, P717, DOI 10.1016/0092-8674(91)90378-C; GOLDSTEIN LA, 1992, J COMP NEUROL, V326, P147, DOI 10.1002/cne.903260113; GOTTLIEB B, 1987, J STEROID BIOCHEM, V28, P279, DOI 10.1016/0022-4731(87)91019-3; HAUSER KF, 1987, BRAIN RES, V406, P62, DOI 10.1016/0006-8993(87)90769-4; HIGUCHI R, 1989, SIMPLE RAPID PREPARA; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; ING NH, 1992, J BIOL CHEM, V267, P17617; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KAZEMIESFARJANI P, 1993, MOL ENDOCRINOL, V7, P37, DOI 10.1210/me.7.1.37; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KUJAWA KA, 1989, EXP NEUROL, V105, P80, DOI 10.1016/0014-4886(89)90174-X; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MATSUURA T, 1992, NEUROLOGY, V42, P1724, DOI 10.1212/WNL.42.9.1724; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MHATRE A, 1992, AM J HUM GENET, V51; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; OLNEY RK, 1990, NEUROLOGY, V47, P1111; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIROTTA V, 1987, EMBO J, V6, P791; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; SAR M, 1977, SCIENCE, V197, P77, DOI 10.1126/science.867053; SHERIDAN PJ, 1982, BRAIN RES, V235, P225, DOI 10.1016/0006-8993(82)91002-2; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; STRAHLE U, 1988, COLD SPRING HARB SYM, V53, P835, DOI 10.1101/SQB.1988.053.01.095; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARNER CL, 1992, NEUROLOGY, V42, P2181, DOI 10.1212/WNL.42.11.2181; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU WHA, 1989, J NEUROSCI, V9, P3908; YU WHA, 1986, J NEUROSCI, V6, P1302; YU WHA, 1983, EXP NEUROL, V80, P349, DOI 10.1016/0014-4886(83)90288-1	53	307	311	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					184	188		10.1038/ng1093-184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	WOS:A1993MA05600018	8252045				2022-01-24	
J	Bezzina, CR; Barc, J; Mizusawa, Y; Remme, CA; Gourraud, JB; Simonet, F; Verkerk, AO; Schwartz, PJ; Crotti, L; Dagradi, F; Guicheney, P; Fressart, V; Leenhardt, A; Antzelevitch, C; Bartkowiak, S; Schulze-Bahr, E; Zumhagen, S; Behr, ER; Bastiaenen, R; Tfelt-Hansen, J; Olesen, MS; Kaab, S; Beckmann, BM; Weeke, P; Watanabe, H; Endo, N; Minamino, T; Horie, M; Ohno, S; Hasegawa, K; Makita, N; Nogami, A; Shimizu, W; Aiba, T; Froguel, P; Balkau, B; Lantieri, O; Torchio, M; Wiese, C; Weber, D; Wolswinkel, R; Coronel, R; Boukens, BJ; Bezieau, S; Charpentier, E; Chatel, S; Despres, A; Gros, F; Kyndt, F; Lecointe, S; Lindenbaum, P; Portero, V; Violleau, J; Gessler, M; Tan, HL; Roden, DM; Christoffels, VM; Le Marec, H; Wilde, AA; Probst, V; Schott, JJ; Dina, C; Redon, R				Bezzina, Connie R.; Barc, Julien; Mizusawa, Yuka; Remme, Carol Ann; Gourraud, Jean-Baptiste; Simonet, Floriane; Verkerk, Arie O.; Schwartz, Peter J.; Crotti, Lia; Dagradi, Federica; Guicheney, Pascale; Fressart, Veronique; Leenhardt, Antoine; Antzelevitch, Charles; Bartkowiak, Susan; Schulze-Bahr, Eric; Zumhagen, Sven; Behr, Elijah R.; Bastiaenen, Rachel; Tfelt-Hansen, Jacob; Olesen, Morten Salling; Kaeaeb, Stefan; Beckmann, Britt M.; Weeke, Peter; Watanabe, Hiroshi; Endo, Naoto; Minamino, Tohru; Horie, Minoru; Ohno, Seiko; Hasegawa, Kanae; Makita, Naomasa; Nogami, Akihiko; Shimizu, Wataru; Aiba, Takeshi; Froguel, Philippe; Balkau, Beverley; Lantieri, Olivier; Torchio, Margherita; Wiese, Cornelia; Weber, David; Wolswinkel, Rianne; Coronel, Ruben; Boukens, Bas J.; Bezieau, Stephane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Gessler, Manfred; Tan, Hanno L.; Roden, Dan M.; Christoffels, Vincent M.; Le Marec, Herve; Wilde, Arthur A.; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard			Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; QT INTERVAL DURATION; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; GENETIC-VARIATION; CONDUCTION SYSTEM; LOCI; EXPRESSION; HETEROGENEITY; SCN10A	Brugada syndrome is a rare cardiac arrhythmia disorder, causally related to SCN5A mutations in around 20% of cases(1-3). Through a genome-wide association study of 312 individuals with Brugada syndrome and 1,115 controls, we detected 2 significant association signals at the SCN10A locus (rs10428132) and near the HEY2 gene (rs9388451). Independent replication confirmed both signals (meta-analyses: rs10428132, P = 1.0 x 10(-68); rs9388451, P = 5.1 x 10(-17)) and identified one additional signal in SCN5A (at 3p21; rs11708996, P = 1.0 x 10(-14)). The cumulative effect of the three loci on disease susceptibility was unexpectedly large (P-trend = 6.1 x 10(-81)). The association signals at SCN5A-SCN10A demonstrate that genetic polymorphisms modulating cardiac conduction(4-7) can also influence susceptibility to cardiac arrhythmia. The implication of association with HEY2, supported by new evidence that Hey2 regulates cardiac electrical activity, shows that Brugada syndrome may originate from altered transcriptional programming during cardiac development(8). Altogether, our findings indicate that common genetic variation can have a strong impact on the predisposition to rare diseases.	[Bezzina, Connie R.; Barc, Julien; Mizusawa, Yuka; Remme, Carol Ann; Wolswinkel, Rianne; Coronel, Ruben; Boukens, Bas J.; Tan, Hanno L.; Wilde, Arthur A.] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Barc, Julien] ICIN Netherlands Heart Inst, Utrecht, Netherlands; [Gourraud, Jean-Baptiste; Simonet, Floriane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] INSERM, UMR 1087, Inst Thorax, Nantes, France; [Gourraud, Jean-Baptiste; Simonet, Floriane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] CNRS, UMR 6291, Nantes, France; [Gourraud, Jean-Baptiste; Simonet, Floriane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] Univ Nantes, Nantes, France; [Gourraud, Jean-Baptiste; Chatel, Stephanie; Despres, Aurore; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] Ctr Hosp Univ CHU Nantes, Inst Thorax, Serv Cardiol, Nantes, France; [Verkerk, Arie O.; Boukens, Bas J.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Peter J.; Crotti, Lia; Dagradi, Federica; Torchio, Margherita] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Schwartz, Peter J.; Crotti, Lia; Dagradi, Federica; Torchio, Margherita] Ist Auxol Italiano, IRCCS, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy; [Schwartz, Peter J.] Hatter Inst Cardiovasc Res Africa, Cardiovasc Genet Lab, Cape Town, South Africa; [Schwartz, Peter J.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Schwartz, Peter J.] Univ Stellenbosch, Dept Med, ZA-7600 Stellenbosch, South Africa; [Schwartz, Peter J.] King Saud Univ, Coll Med, Dept Family & Community Med, Chair Sudden Death, Riyadh 11461, Saudi Arabia; [Crotti, Lia] Helmholtz Ctr Munich, Inst Human Genet, Neuherberg, Germany; [Guicheney, Pascale; Fressart, Veronique] Fac Med Pierre & Marie Curie, INSERM, U956, Paris, France; [Guicheney, Pascale; Fressart, Veronique] Univ Paris 06, Inst Federatif Rech 14, UMRS 956, Paris, France; [Fressart, Veronique] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, Unite Fonct Cardiogenet & Myogenet Mol & Cellulai, F-75634 Paris, France; [Leenhardt, Antoine] Hop Bichat Claude Bernard, AP HP, Serv Cardiol, Ctr Reference Malad Cardiaques Hereditaires, F-75877 Paris, France; [Leenhardt, Antoine] INSERM, U698, Paris, France; [Leenhardt, Antoine] Univ Paris Diderot, Paris, France; [Antzelevitch, Charles; Bartkowiak, Susan] Masonic Med Res Lab, Dept Expt Cardiol, Utica, NY USA; [Schulze-Bahr, Eric; Zumhagen, Sven] Univ Hosp, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Behr, Elijah R.; Bastiaenen, Rachel] St Georges Univ London, Cardiovasc Sci Res Ctr, London, England; [Tfelt-Hansen, Jacob; Olesen, Morten Salling] Univ Copenhagen, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia DARC, Copenhagen, Denmark; [Tfelt-Hansen, Jacob; Olesen, Morten Salling] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, DK-2100 Copenhagen, Denmark; [Kaeaeb, Stefan; Beckmann, Britt M.] Univ Munich, Univ Hosp Munich, Dept Med 1, Munich, Germany; [Kaeaeb, Stefan] Deutsch Forschungszentrum Herz Kreislauferkrankun, Partner Site Munich Heart Alliance, Munich, Germany; [Weeke, Peter; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med & Pharmacol, Nashville, TN 37212 USA; [Watanabe, Hiroshi; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Div Orthopaed Surg, Niigata, Japan; [Horie, Minoru; Ohno, Seiko; Hasegawa, Kanae] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan; [Makita, Naomasa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Physiol, Nagasaki 852, Japan; [Nogami, Akihiko] Yokohama Rosai Hosp, Div Heart Rhythm Management, Yokohama, Kanagawa, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Shimizu, Wataru; Aiba, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, Suita, Osaka, Japan; [Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Froguel, Philippe] Lille Nord France Univ, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Balkau, Beverley] Ctr Rech Epidemiol & Sante Populat CESP, INSERM, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Lantieri, Olivier] Inst Inter Reg Sante IRSA, La Riche, France; [Wiese, Cornelia; Weber, David; Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany; [Bezieau, Stephane; Kyndt, Florence] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France		Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl; richard.redon@inserm.fr	olesen, morten/AAC-5752-2021; Charpentier, Eric/D-5277-2015; FROGUEL, Philippe/O-6799-2017; Le Marec, Herve/D-2718-2015; Redon, Richard/F-3303-2014; torchio, margherita/AAA-7061-2020; Coronel, Ruben/AAZ-8948-2020; Simonet, Floriane/D-3538-2015; CHATEL, Stephanie/D-2536-2015; Ohno, Seiko/Q-3969-2019; Schwartz, Peter J/J-4267-2016; Horie, Minoru/ABG-7128-2020; Lindenbaum, Pierre/A-7154-2008; Minamino, Tohru/P-8145-2018; Bezieau, stephane/G-5621-2015; LECOINTE, Simon/D-3565-2015; KYNDT, Florence/D-6370-2015; Guicheney, Pascale/D-1034-2017; Dina, Christian R/D-3535-2015; Crotti, Lia/AAB-3914-2019; barc, julien/K-5495-2014; probst, vincent/D-4996-2015; Roden, Dan/ABD-5412-2021; Violleau, Jade/D-4810-2015; Schott, jean-Jacques/F-8842-2013; Gourraud, Jean baptiste/D-6421-2015; Kaab, Stefan/H-3915-2012; Tfelt-Hansen, Jacob/AAU-8691-2020; dagradi, federica/J-9610-2016	FROGUEL, Philippe/0000-0003-2972-0784; Le Marec, Herve/0000-0002-8288-8693; Redon, Richard/0000-0001-7751-2280; Coronel, Ruben/0000-0001-9433-6119; CHATEL, Stephanie/0000-0003-0677-5627; Ohno, Seiko/0000-0003-1209-8896; Schwartz, Peter J/0000-0003-0367-1048; Lindenbaum, Pierre/0000-0003-0148-9787; Minamino, Tohru/0000-0003-1627-6151; Bezieau, stephane/0000-0003-0095-1319; KYNDT, Florence/0000-0001-6651-1696; Guicheney, Pascale/0000-0002-7663-2050; Dina, Christian R/0000-0002-7722-7348; barc, julien/0000-0003-4106-5946; probst, vincent/0000-0002-5492-8619; Schott, jean-Jacques/0000-0002-9578-9475; Tfelt-Hansen, Jacob/0000-0003-3895-9316; Gessler, Manfred/0000-0002-7915-6045; Bastiaenen, Rachel/0000-0002-5018-8035; Charpentier, Eric/0000-0002-8571-7603; Bezzina, Connie/0000-0002-0633-3514; Olesen, Morten Salling/0000-0001-9477-5322; Antzelevitch, Charles/0000-0001-7349-1582; Leenhardt, Antoine/0000-0001-7368-4528; Behr, Elijah/0000-0002-8731-2853; Antzelevitch, Charles/0000-0001-5215-4667; Portero, Vincent/0000-0002-7221-859X; Verkerk, Arie/0000-0003-2140-834X; Boukens, Bastiaan J/0000-0001-6449-145X; dagradi, federica/0000-0002-1090-3292; Gourraud, Jean Baptiste/0000-0002-6961-2131; Torchio, Margherita/0000-0003-3887-6772; crotti, lia/0000-0001-8739-6527	Leducq FoundationLeducq Foundation [CVD-05]; Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); French Ministry of Health [PHRC AOR04070, P040411, PHRCI DGS2001/0248]; INSERM (ATIP-Avenir program); French Regional Council of Pays-de-la-LoireRegion Pays de la Loire; Netherlands Heart Institute [061.02]; Division for Earth and Life Sciences (ALW) [836.09.003]; Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO); Netherlands Heart FoundationNetherlands Heart Foundation [NHS 2007B202, 2009B066]; European Society of Cardiology; Netherlands Heart Institute (ICIN); French-Dutch Academy through the Van Gogh program; Interdisziplin ren Zentrums fur Klinische Forschung (IZKF) of the University of Munster; Collaborative Research Center [SFB656]; German Research FoundationGerman Research Foundation (DFG) [DFG-SFB 688, TP A16]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002084] Funding Source: UKRI; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24591038, 23390209] Funding Source: KAKEN; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL049989, R01HL047678, U19HL065962] Funding Source: NIH RePORTER	We thank L. Beekman, C. de Gier-de Vries, B. de Jonge and the Genomic Platform of Nantes (Biogenouest Genomics) for technical support. We are also grateful to the French Clinical Network against Inherited Cardiac Arrhythmias, which includes the University Hospitals of Nantes, Bordeaux, Rennes, Tours, Brest, Strasbourg, La Reunion, Angers and Montpellier. This study was funded by research grants from the Leducq Foundation (CVD-05; Alliance Against Sudden Cardiac Death), the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant-in-aid for the Project in Sado for Total Health, PROST), the French Ministry of Health (PHRC AOR04070, P040411 and PHRCI DGS2001/0248), INSERM (ATIP-Avenir program to R. R.) and the French Regional Council of Pays-de-la-Loire. This research was also supported by the Netherlands Heart Institute (grant 061.02 to C. A. R. and C. R. B.) and the Division for Earth and Life Sciences (ALW; project 836.09.003 to C. A. R.) with financial aid from the Netherlands Organization for Scientific Research (NWO). C. R. B. acknowledges support from the Netherlands Heart Foundation (NHS 2007B202 and 2009B066). J.B. was supported by a research grant from the European Society of Cardiology and the Netherlands Heart Institute (ICIN) and by the French-Dutch Academy through the Van Gogh program. E.S.-B. was supported by the Interdisziplin ren Zentrums fur Klinische Forschung (IZKF) of the University of Munster and the Collaborative Research Center SFB656. M. G. acknowledges support from the German Research Foundation (DFG-SFB 688 and TP A16). This manuscript is dedicated to the memory of Denis Escande, who founded the Leducq Foundation Network Alliance Against Sudden Cardiac Death.	Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Byers S, 1998, J AM STAT ASSOC, V93, P577, DOI 10.2307/2670109; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Frayley C., 2006, MCLUST VERSION 3 R N; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Hermida JS, 2010, AM J CARDIOL, V106, P1758, DOI 10.1016/j.amjcard.2010.07.049; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kolder ICRM, 2012, J MOL CELL CARDIOL, V52, P620, DOI 10.1016/j.yjmcc.2011.12.014; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Little RJA., 1987, STAT ANAL MISSING DA; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pirinen M, 2012, NAT GENET, V44, P848, DOI 10.1038/ng.2346; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Priori SG, 2000, CIRCULATION, V102, P2509, DOI 10.1161/01.CIR.102.20.2509; Priori SG, 2002, EUROPACE, V4, P3, DOI 10.1053/eupc.2001.0214; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Rubin DB, 1987, MULTIPLE IMPUTATION, pi, DOI [DOI 10.1002/9780470316696.FMATTER, 10.1002/9780470316696.fmatter, DOI 10.1002/9780470316696]; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Sakuma M, 2008, J BONE MINER METAB, V26, P373, DOI 10.1007/s00774-007-0841-1; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stouffer S. A., 1949, STUDIES SOCIAL PSYCH, V1; Straus SMJM, 2004, J CLIN EPIDEMIOL, V57, P98, DOI 10.1016/S0895-4356(03)00210-5; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Verkerk AO, 2012, CIRC RES, V111, P333, DOI 10.1161/CIRCRESAHA.112.274035; Wilde AAM, 2010, J MOL CELL CARDIOL, V49, P543, DOI 10.1016/j.yjmcc.2010.07.012; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173	60	306	310	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1044	+		10.1038/ng.2712			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	WOS:000323748200014	23872634	Green Accepted			2022-01-24	
J	Burdon, KP; Macgregor, S; Hewitt, AW; Sharma, S; Chidlow, G; Mills, RA; Danoy, P; Casson, R; Viswanathan, AC; Liu, JZ; Landers, J; Henders, AK; Wood, J; Souzeau, E; Crawford, A; Leo, P; Wang, JJ; Rochtchina, E; Nyholt, DR; Martin, NG; Montgomery, GW; Mitchell, P; Brown, MA; Mackey, DA; Craig, JE				Burdon, Kathryn P.; Macgregor, Stuart; Hewitt, Alex W.; Sharma, Shiwani; Chidlow, Glyn; Mills, Richard A.; Danoy, Patrick; Casson, Robert; Viswanathan, Ananth C.; Liu, Jimmy Z.; Landers, John; Henders, Anjali K.; Wood, John; Souzeau, Emmanuelle; Crawford, April; Leo, Paul; Wang, Jie Jin; Rochtchina, Elena; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.; Mitchell, Paul; Brown, Matthew A.; Mackey, David A.; Craig, Jamie E.			Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1	NATURE GENETICS			English	Article							VISUALIZATION; GENOTYPE; FAMILY; ANRIL; GENE	We report a genome-wide association study for open-angle glaucoma (OAG) blindness using a discovery cohort of 590 individuals with severe visual field loss (cases) and 3,956 controls. We identified associated loci at TMCO1 (rs4656461[G] odds ratio (OR) = 1.68, P = 6.1 x 10(-10)) and CDKN2B-AS1 (rs4977756[A] OR = 1.50, P = 4.7 x 10(-9)). We replicated these associations in an independent cohort of cases with advanced OAG (rs4656461 P = 0.010; rs4977756 P = 0.042) and two additional cohorts of less severe OAG (rs4656461 combined discovery and replication P = 6.00 x 10(-14), OR = 1.51, 95% CI 1.35-1.68; rs4977756 combined P = 1.35 x 10(-14), OR = 1.39, 95% CI 1.28-1.51). We show retinal expression of genes at both loci in human ocular tissues. We also show that CDKN2A and CDKN2B are upregulated in the retina of a rat model of glaucoma.	[Burdon, Kathryn P.; Hewitt, Alex W.; Sharma, Shiwani; Mills, Richard A.; Landers, John; Souzeau, Emmanuelle; Crawford, April; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Macgregor, Stuart; Liu, Jimmy Z.; Henders, Anjali K.; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Hewitt, Alex W.; Wang, Jie Jin; Mackey, David A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Chidlow, Glyn; Casson, Robert; Wood, John] Univ Adelaide, Adelaide, SA, Australia; [Chidlow, Glyn; Casson, Robert; Wood, John] Hanson Inst, S Australian Inst Ophthalmol, Adelaide, SA, Australia; [Danoy, Patrick; Leo, Paul; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Viswanathan, Ananth C.] Moorfields Eye Hosp, London, England; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Mackey, David A.] Univ Tasmania, Discipline Med, Hobart, Tas, Australia		Craig, JE (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia.	jamie.craig@flinders.edu.au	Nyholt, Dale R/J-3174-2017; Wang, Jie Jin/P-1499-2014; Montgomery, Grant W/B-7148-2008; Mackey, David A/H-5340-2014; Brown, Matthew A/E-5749-2010; Macgregor, Stuart/C-6442-2009; Mitchell, Paul/P-1498-2014; Casson, Robert/D-1561-2013; Martin, Nicholas/R-9235-2019; Leo, Paul/R-4464-2019; Burdon, Kathryn/A-5026-2009; Leo, Paul J/B-3470-2011; Souzeau, Emmanuelle/AAB-5608-2022; Hewitt, Alex W/D-1936-2013; Henders, Anjali/E-3126-2017	Nyholt, Dale R/0000-0001-7159-3040; Wang, Jie Jin/0000-0001-9491-4898; Montgomery, Grant W/0000-0002-4140-8139; Mackey, David A/0000-0001-7914-4709; Brown, Matthew A/0000-0003-0538-8211; Macgregor, Stuart/0000-0001-6731-8142; Martin, Nicholas/0000-0003-4069-8020; Burdon, Kathryn/0000-0001-8217-1249; Leo, Paul J/0000-0001-8325-4134; Souzeau, Emmanuelle/0000-0002-2015-6577; Hewitt, Alex W/0000-0002-5123-5999; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X; Mills, Richard/0000-0002-7386-2571; Henders, Anjali/0000-0003-3672-1451	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia [535074]; Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Pfizer AustraliaPfizerPfizer Australia; Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Jack Brockhoff Foundation; National Eye Institute (NEI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); NHMRCNational Health and Medical Research Council of Australia [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485, 552498, 496674, 613705, 595944, 613674]; Cooperative Research Centre for Discovery of Genes for Common Human DiseasesAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme; Cerylid Biosciences (Melbourne); Australian Research CouncilAustralian Research Council [FT0991022]; Glaucoma Australia and Endometriosis Associations	This research was funded by the National Health and Medical Research Council (NHMRC) of Australia, project grant 535074 to J.E.C., A. W. H., S. M., D. A. M. and K. P. B. We also thank the following organizations for their financial support: Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation, Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), Pfizer Australia, Glaucoma Australia, American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Jack Brockhoff Foundation, and National Eye Institute (NEI) Project Grant (2007-2010). The Australian Twin Registry is supported by an NHMRC Enabling Grant (2004-2009). The Queensland Institute of Medical Research (QIMR) Study was also supported by grants from the NHMRC (241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485 and 552498), the Cooperative Research Centre for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne) and donations from N. and S. Hawkins.; S. M. and K. P. B. are supported by NHMRC Career Development Awards (496674, 613705 and 595944). D. R. N. was supported by the NHMRC Fellowship (339462 and 613674) and Australian Research Council Future Fellowship (FT0991022) schemes. G. W. M., M. A. B. and J.E.C. are supported by the NHMRC Fellowships Scheme. D. A. M. is a recipient of the Pfizer Australia Senior Research Fellowship.; We thank all participants of the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG), the Glaucoma Inheritance Study in Tasmania (GIST), the Blue Mountains Eye study (BMES), the Queensland Institute of Medical Research (QIMR) study, Oxford Endometriosis Gene Study (OXEGENE), the Nurses Health Study (NHS) and the Brisbane Adolescent Twin Study (BATS) and the staff who have collated clinical data and DNA samples over many years. We thank Glaucoma Australia and Endometriosis Associations for supporting study recruitment. We thank S. Nicolaides, Queensland Medical Laboratory and SA Pathology for pro bono collection and delivery of blood samples and other pathology services for assistance with blood collection.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beavis WB, 1994, P 49 ANN CORN SORGH, P250; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Green CM, 2007, CLIN EXP OPHTHALMOL, V35, P793, DOI 10.1111/j.1442-9071.2007.01612.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hewitt AW, 2009, CLIN EXP OPHTHALMOL, V37, P836, DOI 10.1111/j.1442-9071.2009.02181.x; HEWITT AW, 2009, CLIN EXPT OPHTHALMOL, V37, P903; Iwamuro S, 1999, J BIOCHEM-TOKYO, V126, P48, DOI 10.1093/oxfordjournals.jbchem.a022435; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; R Development Core Team, 2008, R LANG ENV STAT COMP; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rao KN, 2010, INVEST OPHTH VIS SCI, V51, P4937, DOI 10.1167/iovs.10-5553; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xin BZ, 2010, P NATL ACAD SCI USA, V107, P258, DOI 10.1073/pnas.0908457107; Zhang ZS, 2010, MOL BIOL REP, V37, P1611, DOI 10.1007/s11033-009-9573-8	32	306	318	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					574	U110		10.1038/ng.824			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	WOS:000291017000016	21532571	Green Accepted			2022-01-24	
J	Newton-Cheh, C; Eijgelsheim, M; Rice, KM; de Bakker, PIW; Yin, XY; Estrada, K; Bis, JC; Marciante, K; Rivadeneira, F; Noseworthy, PA; Sotoodehnia, N; Smith, NL; Rotter, JI; Kors, JA; Witteman, JCM; Hofman, A; Heckbert, SR; O'Donnell, CJ; Uitterlinden, AG; Psaty, BM; Lumley, T; Larson, MG; Stricker, BHC				Newton-Cheh, Christopher; Eijgelsheim, Mark; Rice, Kenneth M.; de Bakker, Paul I. W.; Yin, Xiaoyan; Estrada, Karol; Bis, Joshua C.; Marciante, Kristin; Rivadeneira, Fernando; Noseworthy, Peter A.; Sotoodehnia, Nona; Smith, Nicholas L.; Rotter, Jerome I.; Kors, Jan A.; Witteman, Jacqueline C. M.; Hofman, Albert; Heckbert, Susan R.; O'Donnell, Christopher J.; Uitterlinden, Andre G.; Psaty, Bruce M.; Lumley, Thomas; Larson, Martin G.; Stricker, Bruno H. Ch			Common variants at ten loci influence QT interval duration in the QTGEN Study	NATURE GENETICS			English	Article							NOS1 REGULATOR NOS1AP; SUDDEN CARDIAC DEATH; PHOSPHOLAMBAN GENE; HEART; ASSOCIATION; SCN5A; KCNH2; REPOLARIZATION; POLYMORPHISM; MUTATION	QT interval duration, reflecting myocardial repolarization on the electrocardiogram, is a heritable risk factor for sudden cardiac death and drug-induced arrhythmias. We conducted a meta-analysis of three genome-wide association studies in 13,685 individuals of European ancestry from the Framingham Heart Study, the Rotterdam Study and the Cardiovascular Health Study, as part of the QTGEN consortium. We observed associations at P < 5 x 10(-8) with variants in NOS1AP, KCNQ1, KCNE1, KCNH2 and SCN5A, known to be involved in myocardial repolarization and mendelian long-QT syndromes. Associations were found at five newly identified loci, including 16q21 near NDRG4 and GINS3, 6q22 near PLN, 1p36 near RNF207, 16p13 near LITAF and 17q12 near LIG3 and RFFL. Collectively, the 14 independent variants at these 10 loci explain 5.4-6.5% of the variation in QT interval. These results, together with an accompanying paper, offer insights into myocardial repolarization and suggest candidate genes that could predispose to sudden cardiac death and drug-induced arrhythmias.	[Newton-Cheh, Christopher; Noseworthy, Peter A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; de Bakker, Paul I. W.] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Newton-Cheh, Christopher; de Bakker, Paul I. W.] MIT, Cambridge, MA 02139 USA; [Newton-Cheh, Christopher; Yin, Xiaoyan; O'Donnell, Christopher J.; Larson, Martin G.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Eijgelsheim, Mark; Rivadeneira, Fernando; Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rice, Kenneth M.; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Yin, Xiaoyan; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bis, Joshua C.; Marciante, Kristin; Sotoodehnia, Nona; Smith, Nicholas L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Sch Med, Div Cardiol, Seattle, WA 98195 USA; [Smith, Nicholas L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Vet Adm Off Res & Dev, Seattle Epidemiol Res Ctr, Seattle, WA USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Kors, Jan A.; Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Netherlands Genom Initiat Sponsored Netherlands C, NL-3000 CA Rotterdam, Netherlands; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth, Ctr Hlth Studies, Seattle, WA USA; [O'Donnell, Christopher J.] NHLBI, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands		Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA.	b.stricker@erasmusmc.nl	Rivadeneira, Fernando/O-5385-2015; Rotter, Jerome/AAY-6598-2021; Rice, Kenneth M/A-4150-2013; de Bakker, Paul IW/B-8730-2009	Rivadeneira, Fernando/0000-0001-9435-9441; Rice, Kenneth M/0000-0001-5779-4495; de Bakker, Paul IW/0000-0001-7735-7858; Larson, Martin/0000-0002-9631-1254	Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); Boston University School of Medicine [N01-HC-25195]; Affymetrix [N02-HL-6-4278]; Doris Duke Charitable FoundationDoris Duke Charitable Foundation (DDCF); Burroughs Wellcome FundBurroughs Wellcome Fund; Department of Medicine at Boston University School of Medicine; Boston Medical Center; PfizerPfizer; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry for Health, Welfare and Sports, the European Commission (DG XII)European CommissionEuropean Commission Joint Research Centre; Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO InvestmentsNetherlands Organization for Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Research Institute for Diseases [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO)Netherlands Government [050-060-810]; CHS [N01-HC85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 HL080295, R01 HL087652]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR00069]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK063491]; CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology); US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23-HL-080025]; Doris Duke Charitable Foundation Clinical Scientist Development AwardAmerican Heart AssociationDoris Duke Charitable Foundation (DDCF); Burroughs Wellcome Fund Career AwardBurroughs Wellcome Fund; Netherlands Heart FoundationNetherlands Heart Foundation [2007B221]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC085086, N01HC045133, N01HC025195, N01HC015103, N01HC085081, N01HC035129, N01HC085080, N01HC075150, N01HC085079, N01HC085083, N01HC085085, N01HC085082, N01HC055222, N01HC085084] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL080025, R01HL087652, R01HL064278, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK063491] Funding Source: NIH RePORTER	The Framingham Heart Study work was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (contract #N01-HC-25195), its contract with Affymetrix for genotyping services (contract #N02-HL-6-4278), and the Doris Duke Charitable Foundation (C.N.-C.) and Burroughs Wellcome Fund (C.N.-C.). The Framingham analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The measurement of ECG intervals in Framingham Heart Study generation 1 and 2 samples was done by eResearch Technology and supported by an unrestricted grant from Pfizer. The measurement of ECG intervals in the Framingham Heart Study generation 3 sample was completed by A. Hirji and S. Kovvali using AMPS software provided through an unrestricted academic license by Analyzing Medical Parameters for Solutions (A.M.P.S., LLC). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (#175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project #050-060-810. The CHS research reported in this article was supported by contract numbers N01-HC85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00069 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The authors acknowledge the essential role of the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium in development and support of this manuscript. CHARGE members include the Netherland's Rotterdam Study, the NHLBI's Atherosclerosis Risk in Communities (ARIC) Study, Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS), and the NIA's Iceland Age, Gene/Environment Susceptibility (AGES) Study. C. N.-C. is supported by US National Institutes of Health grant K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. M. E.; is funded by the Netherlands Heart Foundation (#2007221). J.I.R. is supported by the Cedars-Sinai Board of Governors' Chair in Medical Genetics. The authors wish to thank the following people: G. Crawford and C. Guiducci (Broad Institute of Harvard and Massachusetts Institute of Technology) who completed the Sequenom-based technical validation genotyping of the Framingham Heart Study samples; P. Arp and M. Jhamai (Erasmus Medical Center) for Illumina array genotyping and Taqman-based technical validation genotyping of the Rotterdam Study samples; and Dr. M. Moorhouse, M. Verkerk and S. Bervoets (Erasmus Medical Center) for database management in the Rotterdam Study; and the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The QTGEN consortium would like to thank the QTSCD consortium for the opportunity to exchange top results pre-publication.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Burke A, 2005, CIRCULATION, V112, P798, DOI 10.1161/CIRCULATIONAHA.104.482760; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eijgelsheim M, 2009, HUM MOL GENET, V18, P347, DOI 10.1093/hmg/ddn341; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Li Y, 2006, AM J HUM GENET S, VS79, P2290; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Newton-Cheh C, 2007, CURR OPIN GENET DEV, V17, P213, DOI 10.1016/j.gde.2007.04.010; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pietila E, 2002, J AM COLL CARDIOL, V40, P511, DOI 10.1016/S0735-1097(02)01979-4; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; SALISBURY BA, 2006, HEART RHYTHM, V3, pS98, DOI DOI 10.1016/J.HRTHM.2006.02.297; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sotoodehnia N, 2005, CIRCULATION, V111, pE223; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wei J, 1999, CIRCULATION, V100, P495	45	306	314	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					399	406		10.1038/ng.364			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	WOS:000264659000012	19305408	Green Accepted			2022-01-24	
J	Dunoyer, P; Himber, C; Voinnet, O				Dunoyer, P; Himber, C; Voinnet, O			DICER-LIKE 4 is required for RNA interference and produces the 21-nucleotide small interfering RNA component of the plant cell-to-cell silencing signal	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; GENE; ARABIDOPSIS; VIRUS; BIOGENESIS; MICRORNAS; ELEGANS; SGS3	In RNA interference(1,2), the RNase-III enzyme Dicer(3) processes exogenous double-stranded RNA into small interfering RNAs (siRNAs). siRNAs guide RNA-induced silencing complexes to cleave homologous transcripts, enabling gene-specific knockdown(4). In plants, double-stranded RNA is processed into siRNA species of 21 nucleotides (nt) and 24 nt (ref. 5), but, unlike in nematodes(6), the Dicer enzymes involved in this processing have not been identified. Additionally, in both plants and nematodes, systemic signals(7-10) with RNA components convey the sequence-specific effects of RNA interference between cells. Here, we describe Arabidopsis thaliana mutants with altered silencing cell-to-cell movement beyond the vasculature. At least three SILENCING MOVEMENT DEFICIENT genes (SMD1, SMD2 and SMD3) are required for trafficking, the extent of which correlates with siRNA levels in the veins. Five alleles defective in synthesis of 21-nt, but not 24-nt, siRNAs carry mutations in Dicer-like 4 (DCL4) that are involved in biogenesis of trans-acting siRNAs(11,12). We show that the biogenesis and function of trans-acting siRNA can be genetically uncoupled from a bona fide DCL4-dependent pathway that accounts for RNA interference and for production of the 21-nt siRNA component of the plant cell-to-cell silencing signal.	CNRS, UPR 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France		Voinnet, O (corresponding author), CNRS, UPR 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544			Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	25	306	325	0	40	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1356	1360		10.1038/ng1675			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	WOS:000233657300016	16273107				2022-01-24	
J	Qi, LL; Echalier, B; Chao, S; Lazo, GR; Butler, GE; Anderson, OD; Akhunov, ED; Dvorak, J; Linkiewicz, AM; Ratnasiri, A; Dubcovsky, J; Bermudez-Kandianis, CE; Greene, RA; Kantety, R; La Rota, CM; Munkvold, JD; Sorrells, SF; Sorrells, ME; Dilbirligi, M; Sidhu, D; Erayman, M; Randhawa, HS; Sandhu, D; Bondareva, SN; Gill, KS; Mahmoud, AA; Ma, XF; Miftahudin; Gustafson, JP; Conley, EJ; Nduati, V; Gonzalez-Hernandez, JL; Anderson, JA; Peng, JH; Lapitan, NLV; Hossain, KG; Kalavacharla, V; Kianian, SF; Pathan, MS; Zhang, DS; Nguyen, HT; Choi, DW; Fenton, RD; Close, TJ; McGuire, PE; Qualset, CO; Gill, BS				Qi, LL; Echalier, B; Chao, S; Lazo, GR; Butler, GE; Anderson, OD; Akhunov, ED; Dvorak, J; Linkiewicz, AM; Ratnasiri, A; Dubcovsky, J; Bermudez-Kandianis, CE; Greene, RA; Kantety, R; La Rota, CM; Munkvold, JD; Sorrells, SF; Sorrells, ME; Dilbirligi, M; Sidhu, D; Erayman, M; Randhawa, HS; Sandhu, D; Bondareva, SN; Gill, KS; Mahmoud, AA; Ma, XF; Miftahudin; Gustafson, JP; Conley, EJ; Nduati, V; Gonzalez-Hernandez, JL; Anderson, JA; Peng, JH; Lapitan, NLV; Hossain, KG; Kalavacharla, V; Kianian, SF; Pathan, MS; Zhang, DS; Nguyen, HT; Choi, DW; Fenton, RD; Close, TJ; McGuire, PE; Qualset, CO; Gill, BS			A chromosome bin map of 16,000 expressed sequence tag loci and distribution of genes among the three genomes of polyploid wheat	GENETICS			English	Article							HOMOEOLOGOUS GROUP-6 CHROMOSOMES; PHYSICAL MAPS; LINKAGE MAP; HEXAPLOID WHEAT; LOW RECOMBINATION; DRAFT SEQUENCE; COMMON WHEAT; RICH REGIONS; IDENTIFICATION; CLONING	Because of the huge size of the common wheat (Triticum aestivum L., 2n = 6x = 42, AABBDD) genome of 17,300 Mb, sequencing and mapping of the expressed portion is a logical first step for gene discovery. Here we report mapping of 7104 expressed sequence tag (EST) unigenes by Southern hybridization into a chromosome bin map using a set of wheat aneuploids and deletion stocks. Each EST detected a mean of 4.8 restriction fragments and 2.8 loci. More loci were mapped in the B genome (5774) than in the A (5173) or D (5146) genomes. The EST density was significantly higher for the D genome than for the A or B. In general, EST density increased relative to the physical distance from the centromere. The majority of EST-dense regions are in the distal parts of chromosomes. Most of the agronomically important genes are located in EST-dense regions. The chromosome bin map of ESTs is a unique resource for SNP analysis, comparative mapping, structural and functional analysis, and polyploid evolution, as well as providing a framework for constructing a sequence-ready, BAC-contig map of the wheat genome.	Kansas State Univ, Dept Plant Pathol, Wheat Genet Resource Ctr, Manhattan, KS 66506 USA; Univ Calif Davis, Genet Resources Conservat Program, Davis, CA 95616 USA; USDA, ARS, Western Reg Res Ctr, Albany, CA 94710 USA; Univ Arizona, Dept Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; Univ Calif Davis, Dept Agron & Range Sci, Davis, CA 95616 USA; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; Univ Missouri, Dept Agron, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA; Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA		Gill, BS (corresponding author), Kansas State Univ, Dept Plant Pathol, Wheat Genet Resource Ctr, Throckmorton Hall, Manhattan, KS 66506 USA.	bsg@ksu.edu	Anderson, James/AAI-2477-2021; Gonzalez, Jose/ABD-4665-2020; Ma, Xue-Feng/AAO-7225-2020; Dubcovsky, Jorge/A-4969-2008; Qi, LI/AAF-3389-2019; Randhawa, Harpinder/AAQ-7207-2021; Dubcovsky, Jorge/T-5214-2019; Lazo, Gerard/A-8900-2009	Anderson, James/0000-0003-4655-6517; Gonzalez, Jose/0000-0002-2119-0179; Dubcovsky, Jorge/0000-0002-7571-4345; Lazo, Gerard/0000-0002-9160-2052; Sorrells, Shawn/0000-0002-0010-6628; Sandhu, Devinder/0000-0003-4193-3408; Ma, Xuefeng/0000-0002-0942-9116; Linkiewicz, Anna/0000-0002-0167-3237; Miftahudin, M./0000-0002-5641-1090			Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Akhunov ED, 2003, P NATL ACAD SCI USA, V100, P10836, DOI 10.1073/pnas.1934431100; Anderson OD, 2002, GENOME, V45, P367, DOI 10.1139/G01-137; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; Boyko EV, 1999, THEOR APPL GENET, V99, P16, DOI 10.1007/s001220051204; Cadalen T, 1997, THEOR APPL GENET, V94, P367, DOI 10.1007/s001220050425; CHAO S, 1989, THEOR APPL GENET, V78, P495, DOI 10.1007/BF00290833; Conley EJ, 2004, GENETICS, V168, P625, DOI 10.1534/genetics.104.034801; Covitz PA, 1998, PLANT PHYSIOL, V117, P1325, DOI 10.1104/pp.117.4.1325; Davis GL, 1999, GENETICS, V152, P1137; DELANEY DE, 1995, THEOR APPL GENET, V91, P780, DOI 10.1007/BF00220959; DELANEY DE, 1995, THEOR APPL GENET, V91, P568, DOI 10.1007/BF00223281; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DEVOS K, 1993, OUTLOOK AGR, V22, P93, DOI 10.1177/003072709302200205; DEVOS KM, 1995, THEOR APPL GENET, V91, P282, DOI 10.1007/BF00220890; Dubcovsky J, 1996, GENETICS, V143, P983; Dvorak J, 1998, GENETICS, V148, P423; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; ENDO TR, 1984, CHROMOSOMA, V89, P361, DOI 10.1007/BF00331253; Ewing RM, 1999, GENOME RES, V9, P950, DOI 10.1101/gr.9.10.950; Faris JD, 2000, GENETICS, V154, P823; Faris JD, 2003, GENETICS, V164, P311; Faris JD, 2002, GENOME, V45, P706, DOI [10.1139/g02-036, 10.1139/G02-036]; Fernandes J, 2002, PLANT PHYSIOL, V128, P896, DOI 10.1104/pp.010681; FRIEBE B, 1994, EUPHYTICA, V78, P1; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gill KS, 1996, GENETICS, V144, P1883; GILL KS, 1993, CHROMOSOMA, V102, P374, DOI 10.1007/BF00360401; Gill KS, 1996, GENETICS, V143, P1001; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HOHMANN U, 1994, MOL GEN GENET, V245, P644, DOI 10.1007/BF00282228; Hossain KG, 2004, GENETICS, V168, P687, DOI 10.1534/genetics.104.034850; Huang L, 2003, GENETICS, V164, P655; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jia J, 1996, THEOR APPL GENET, V92, P559, DOI 10.1007/BF00224558; Jiang JM, 1994, CHROMOSOME RES, V2, P59, DOI 10.1007/BF01539455; KOTA RS, 1993, GENOME, V36, P548, DOI 10.1139/g93-075; Lazo GR, 2004, GENETICS, V168, P585, DOI 10.1534/genetics.104.034777; Li WL, 2002, GENETICS, V160, P1153; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Liu SX, 2003, GENOME, V46, P817, DOI [10.1139/g03-066, 10.1139/G03-066]; Lunde China F., 2003, Functional & Integrative Genomics, V3, P25; LUO MC, 2003, P 10 INT WHEAT GEN S, V1, P294; Marino CL, 1996, GENOME, V39, P359, DOI 10.1139/g96-046; MCINTOSH RA, 2003, P 10 INT WHEAT GEN S, V4, P1; MICKELSONYOUNG L, 1995, THEOR APPL GENET, V90, P1007, DOI 10.1007/BF00222914; Miftahudin, 2004, GENETICS, V168, P651, DOI 10.1534/genetics.104.034827; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Nachit MM, 2001, THEOR APPL GENET, V102, P177, DOI 10.1007/s001220051633; NARANJO T, 1987, GENOME, V29, P873, DOI 10.1139/g87-149; NELSON JC, 1995, GENOME, V38, P525, DOI 10.1139/g95-068; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; NELSON JC, 1995, GENETICS, V141, P721; Peng JH, 2004, GENETICS, V168, P609, DOI 10.1534/genetics.104.034793; Peng JH, 2000, GENETICA, V109, P199, DOI 10.1023/A:1017573726512; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Qi LiLi, 2003, Functional & Integrative Genomics, V3, P39; Qi LL, 2001, THEOR APPL GENET, V103, P998, DOI 10.1007/s001220100699; Randhawa HS, 2004, GENETICS, V168, P677, DOI 10.1534/genetics.104.034843; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Sandhu D, 2001, GENETICS, V157, P1735; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Sears E.R., 1978, P 5 INT WHEAT GEN S, P389; Sears ER, 1954, U MISSOURI AGR EXPT, V572; Shoemaker R, 2002, GENOME, V45, P329, DOI 10.1139/g01-150; Singh RP, 2003, EUPHYTICA, V129, P371, DOI 10.1023/A:1022216327934; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; Weng Y, 2000, THEOR APPL GENET, V100, P519; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan YN, 2002, GENOME RES, V12, P1345, DOI 10.1101/gr.185902	82	306	338	1	40	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2004	168	2					701	712		10.1534/genetics.104.034868			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870MW	WOS:000225063100012	15514046	Green Published, Bronze			2022-01-24	
J	Moreira, MC; Barbot, C; Tachi, N; Kozuka, N; Uchida, E; Gibson, T; Mendonca, P; Costa, M; Barros, J; Yanagisawa, T; Watanabe, M; Ikeda, Y; Aoki, M; Nagata, T; Coutinho, P; Sequeiros, J; Koenig, M				Moreira, MC; Barbot, C; Tachi, N; Kozuka, N; Uchida, E; Gibson, T; Mendonca, P; Costa, M; Barros, J; Yanagisawa, T; Watanabe, M; Ikeda, Y; Aoki, M; Nagata, T; Coutinho, P; Sequeiros, J; Koenig, M			The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin	NATURE GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; DNA STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; HEREDITARY MOTOR; LIGASE-III; NEUROPATHY; TELANGIECTASIA; KINASE; ATM	The newly recognized ataxia-ocular apraxia 1 (AOA1; MIM 208920)(1-4) is the most frequent cause of autosomal recessive ataxia in Japan(2,4-9) and is second only to Friedreich ataxia in Portugal(10). It shares several neurological features with ataxia-telanglectasia, including early onset ataxia, oculomotor apraxia and cerebellar atrophy, but does not share its extraneurological features (immune deficiency, chromosomal instability and hypersensitivity to X-rays). AOA1 is also characterized by axonal motor neuropathy(3,5,9) and the later decrease of serum albumin levels and elevation of total cholesterol(2,4,5,9). We have identified the gene causing AOA1 and the major Portuguese and Japanese mutations. This gene encodes a new, ubiquitously expressed protein that we named aprataxin. This protein is composed of three domains that share distant homology with the amino-terminal domain of polynucleotide kinase 3'-phosphatase (PNKP), with histidine-triad (HIT) proteins and with DNA-binding C2H2 zinc-finger proteins, respectively. PNKP is involved in DNA single-strand break repair (SSBR)(11) following exposure to ionizing radiation and reactive oxygen species. Fragile-HIT proteins (FHIT) cleave diadenosine tetraphosphate, which is potentially produced during activation of the SSBR complex(12). The results suggest that aprataxin is a nuclear protein with a role in DNA repair reminiscent of the function of the protein defective in ataxia-telangiectasia, but that would cause a phenotype restricted to neurological signs when mutant.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Univ Porto, IBMC, UnIGENe, Oporto, Portugal; Univ Porto, ICBAS, Oporto, Portugal; Hosp Maria Pia, Dept Neurol, Oporto, Portugal; Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; European Mol Biol Lab, Heidelberg, Germany; Hosp Divino Espirito Santo, Dept Hematol, Azores, Portugal; Hosp Pedro Hispano, Dept Neurol, Matosinhos, Portugal; Hosp Geral Sto Antonio, Dept Neurol, Oporto, Portugal; Isesaki Fukushima Hosp, Dept Neurol, Iseaki, Japan; Gunma Univ, Sch Med, Dept Neurol, Maebashi, Gumma, Japan; Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; Hosp S Sebastiao, Div Neurol, Santa Maria da Feira, Portugal		Koenig, M (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, CU Strasbourg, Illkirch Graffenstaden, France.		Barbot, Clara/K-6378-2013; Coutinho, Paula/K-6053-2013	Barbot, Clara/0000-0002-5597-107X; Barros, Jose/0000-0001-6183-5050; Gibson, Toby James/0000-0003-0657-5166; Coutinho, Paula/0000-0002-3461-230X; Sequeiros, Jorge/0000-0002-9846-1037			AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GIBSON TJ, 1988, PROTEIN ENG, V2, P209, DOI 10.1093/protein/2.3.209; Hanihara T, 1995, Rinsho Shinkeigaku, V35, P83; Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kubota H, 1995, No To Shinkei, V47, P289; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; MOREIRA MC, 1999, ARQ MED, V13, P39; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Tachi N, 2000, EUR NEUROL, V43, P82, DOI 10.1159/000008140; UEKAWA K, 1992, CLIN NEUROL, V32, P1067; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; YOSHIHARA K, 1981, J BIOL CHEM, V256, P6756	26	306	315	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					189	193		10.1038/ng1001-189			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	WOS:000171374100026	11586300				2022-01-24	
J	Anderson, SL; Coli, R; Daly, IW; Kichula, EA; Rork, MJ; Volpi, SA; Ekstein, J; Rubin, BY				Anderson, SL; Coli, R; Daly, IW; Kichula, EA; Rork, MJ; Volpi, SA; Ekstein, J; Rubin, BY			Familial dysautonomia is caused by mutations of the IKAP gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVE GROWTH-FACTOR	The defective gene DYS, which is responsible for familial dysautonomia (FD) and has been mapped to a 0.5-cM region on chromosome 9q31, has eluded identification. We identified and characterized the RNAs encoded by this region of chromosome 9 in cell lines derived from individuals homozygous for the major FD haplotype, and we observed that the RNA encoding the I kappaB kinase complex-associated protein (IKAP) lacks exon 20 and, as a result of a frameshift, encodes a truncated protein. Sequence analysis reveals a T-->C transition in the donor splice site of intron 20. In individuals bearing a minor FD haplotype, a missense mutation in exon 19 disrupts a consensus serine/threonine kinase phosphorylation site. This mutation results in defective phosphorylation of IKAP. These mutations were observed to be present in a random sample of Ashkenazi Jewish individuals, at approximately the predicted carrier frequency of FD. These findings demonstrate that mutations in the gene encoding IKAP are responsible for FD.	Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; Comm Prevent Jewish Dis, Brooklyn, NY USA		Rubin, BY (corresponding author), Fordham Univ, Dept Biol Sci, Larkin Hall 160, Bronx, NY 10458 USA.						Axelrod F B, 1974, Adv Pediatr, V21, P75; Axelrod FB, 1996, PRIMER AUTONOMIC NER, P242; Blumenfeld A, 1999, AM J HUM GENET, V64, P1110, DOI 10.1086/302339; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; BREAKEFIELD XO, 1986, MOL BIOL MED, V3, P483; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; MAAYAN C, 1987, CLIN GENET, V32, P106; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; RILEY CM, 1949, PEDIATRICS, V3, P468; RUBIN BY, 1988, J IMMUNOL, V141, P1180; Yajima H, 1997, BIOSCI BIOTECH BIOCH, V61, P704, DOI 10.1271/bbb.61.704	13	306	309	1	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					753	758		10.1086/318808			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	WOS:000166994200018	11179021	Green Published, Bronze			2022-01-24	
J	Horwitz, M; Benson, KF; Person, RE; Aprikyan, AG; Dale, DC				Horwitz, M; Benson, KF; Person, RE; Aprikyan, AG; Dale, DC			Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis	NATURE GENETICS			English	Article							CELLS; SPECIFICITY; THROMBIN; COMPLEX; GENE	Human cyclic haematopoiesis (cyclic neutropenia, MIM 162800) is an autosomal dominant disease in which blood-cell production from the bone marrow oscillates with 21-day periodicity(1,2). Circulating neutrophils vary between almost normal numbers and zero. During intervals of neutropenia, affected individuals are at risk for opportunistic infection(3). Monocytes, platelets, lymphocytes and reticulocytes also cycle with the same frequency. Here we use a genome-wide screen and positional cloning to map the locus to chromosome 19p13.3. We identified 7 different single-base substitutions in the gene (ELA2) encoding neutrophil elastase (EC 3.4.21.37, also known as leukocyte elastase, elastase 2 and medullasin), a serine protease of neutrophil and monocyte granules, on unique haplotypes in 13 of 13 families as well as a new mutation in a sporadic case. Neutrophil elastase (a 240-aa mature protein predominantly found in neutrophil granules(4)) is the target for protease inhibition by alpha(1)-antitrypsin, and its unopposed release destroys tissue at sites of inflammation. We hypothesize that a perturbed interaction between neutrophil elastase and serpins or other substrates may regulate mechanisms governing the clock-like timing of haematopoiesis.	Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA		Horwitz, M (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA.			Horwitz, Marshall/0000-0002-1683-1680	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK18951] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK018951] Funding Source: NIH RePORTER		Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Berger SP, 1996, J AM SOC NEPHROL, V7, P694; BIETH JG, 1998, HDB PROTEOLYTIC ENZY, P54; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cregge RJ, 1998, J MED CHEM, V41, P2461, DOI 10.1021/jm970812e; DALE DC, 1988, BLOOD REV, V2, P178, DOI 10.1016/0268-960X(88)90023-9; Fasman KH, 1997, NUCLEIC ACIDS RES, V25, P72, DOI 10.1093/nar/25.1.72; Haurie C, 1998, BLOOD, V92, P2629, DOI 10.1182/blood.V92.8.2629.420a35_2629_2640; Hung SH, 1998, PROTEIN ENG, V11, P669, DOI 10.1093/protein/11.8.669; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; Palmer SE, 1996, AM J MED GENET, V66, P413, DOI 10.1002/(SICI)1096-8628(19961230)66:4<413::AID-AJMG5>3.0.CO;2-L; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; TAKAHASHI H, 1988, J BIOL CHEM, V263, P2543; TAKAHASHI H, 1988, J BIOL CHEM, V263, P14739; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Whisstock J, 1996, PROTEINS, V26, P288, DOI 10.1002/(SICI)1097-0134(199611)26:3<288::AID-PROT5>3.0.CO;2-A	23	306	316	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					433	436		10.1038/70544			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	WOS:000084023900019	10581030				2022-01-24	
J	Munroe, PB; Olgunturk, RO; Fryns, JP; Van Maldergem, L; Ziereisen, F; Yuksel, B; Gardiner, RM; Chung, E				Munroe, PB; Olgunturk, RO; Fryns, JP; Van Maldergem, L; Ziereisen, F; Yuksel, B; Gardiner, RM; Chung, E			Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome	NATURE GENETICS			English	Article							VITAMIN-K; ASSIGNMENT; MOUSE; MAP	Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and midfacial hypoplasia(1). A genome search using homozygosity mapping provided evidence of linkage to chromosome 12p12.3-13.1 (maximum multipoint lod score, 4.06). MGP was a candidate on the basis of its localization to this chromosomal region and the known function of its protein(2-4). MGP maps to chromosome 12p near D12S363 (refs 2,3). Human MCP is a 10-kD skeletal extracellular matrix (ECM) protein that consists of an 84-aa mature protein and a 19-aa transmembrane signal peptide(5). It is a member of the Gla protein family, which includes osteocalcin(6), another skeletal ECM protein, and a number of coagulation factors(7) (factors II, VII, IX, X and proteins S and C). All members of this family have glutamic acid residues modified to gamma-carboxyglutamic acids (Gla) by a specific gamma-carboxylase using Vitamin K as a cofactors(8,9). The modified glutamic acid residues of Gla proteins confer a high affinity for mineral ions such as calcium, phosphate and hydroxyapatite crystals, the mineral components of the skeletal ECM. The pattern and tissue distribution of Mgp expression in mice suggest a role for Mgp in regulating ECM calcification(10). Mglap-deficient mice (Mglap(-/-)) have been reported to have inappropriate calcification of cartilage(4). Mutational analysis of MGP in three unrelated probands identified three different mutations: c.69delG, IVS1-2A-->G and c.113T-->A. All three mutations predict a non-functional MGP. Our data indicate that mutations in MGP are responsible for KS and confirm its role in the regulation of extracellular matrix calcification.	UCL Royal Free & Univ Coll Med Sch, Dept Paediat, Rayne Inst, London, England; Gazi Univ Hosp, Dept Paediat Cardiol, Ankara, Turkey; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; Inst Pathol & Genet, Ctr Human Genet, Loverval, Belgium; Hop Univ Enfants Reine Fabiola, Dept Radiol, Brussels, Belgium; Chase Farm Hosp NHS Trust, Dept Paediat, London, England		Munroe, PB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Paediat, Rayne Inst, Univ St, London, England.	p.munroe@ucl.ac.uk	Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Munroe, Patricia/0000-0002-4176-2947			CANCELA L, 1990, J BIOL CHEM, V265, P15040; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; CORMODE EJ, 1986, AM J MED GENET, V24, P289, DOI 10.1002/ajmg.1320240209; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; FASCO MJ, 1982, J BIOL CHEM, V257, P1210; FRANKE TF, 1995, CELL, V81, P1; FRASER JD, 1988, J BIOL CHEM, V263, P11033; FRYNS JP, 1984, EUR J PEDIATR, V142, P201, DOI 10.1007/BF00442449; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GALLOP PM, 1980, NEW ENGL J MED, V302, P1460, DOI 10.1056/NEJM198006263022608; HALE JE, 1988, J BIOL CHEM, V263, P5820; HOWE AM, 1995, AM J MED GENET, V58, P238, DOI 10.1002/ajmg.1320580309; JOHNSON TL, 1991, GENOMICS, V11, P770, DOI 10.1016/0888-7543(91)90089-W; KEUTEL J, 1972, Birth Defects Original Article Series, V8, P60; KHOSROSHAHI HE, 1989, EUR J PEDIATR, V149, P188, DOI 10.1007/BF01958278; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LUO GB, 1995, J BONE MINER RES, V10, P325; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; PAULI RM, 1987, AM J HUM GENET, V41, P566; PETTIFOR JM, 1975, J PEDIATR-US, V86, P459; Say B, 1973, Pediatr Radiol, V1, P127, DOI 10.1007/BF00973228; SHEFFIELD LJ, 1976, J PEDIATR-US, V89, P916, DOI 10.1016/S0022-3476(76)80596-3; SPRANGER JW, 1970, HUM GENET, V11, P190; Watanabe I, 1998, J HUM GENET, V43, P75, DOI 10.1007/s100380050044	27	306	313	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					142	144		10.1038/5102			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	WOS:000077960700027	9916809				2022-01-24	
J	CASCORBI, I; DRAKOULIS, N; BROCKMOLLER, J; MAURER, A; SPERLING, K; ROOTS, I				CASCORBI, I; DRAKOULIS, N; BROCKMOLLER, J; MAURER, A; SPERLING, K; ROOTS, I			ARYLAMINE N-ACETYLTRANSFERASE (NAT2) MUTATIONS AND THEIR ALLELIC LINKAGE IN UNRELATED CAUCASIAN INDIVIDUALS - CORRELATION WITH PHENOTYPIC ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEBRISOQUINE HYDROXYLATION; ACETYLATION POLYMORPHISM; HUMAN LIVER; GENOTYPE; CAFFEINE; GENE; CARCINOGENS; POPULATION; EXPRESSION; CANCER	The polymorphic arylamine N-acetyltransferase (NAT2; EC 2.3.1.5) is supposed to be a susceptibility factor for several drug side effects and certain malignancies. A group of 844 unrelated German subjects was genotyped for their acetylation type, and 563 of them were also phenotyped. Seven mutations of the NAT2 gene were evaluated by allele-specific PCR (mutation 341C to T) and PCR-RFLP for mutations at nt positions 191, 282, 481, 590, 803, and 857. From the mutation pattern eight different alleles, including the wild type coding for rapid acetylation and seven alleles coding for slow phenotype, were determined. Four hundred ninety-seven subjects had a genotype of slow acetylation (58.9%; 95% confidence limits 55.5%-62.2%). Phenotypic acetylation capacity was expressed as the ratio of 5-acetylamino-6-formylamino-3-methyluracil and 1-methylxanthine in urine after caffeine intake. Some 6.7% of the cases deviated in genotype and phenotype, but sequencing DNA of these probands revealed no new mutations. Furthermore, linkage pattern of the mutations was always confirmed, as tested in 533 subjects. In vivo acetylation capacity of homozygous wild-type subjects (NAT2*4/*4) was significantly higher than in heterozygous genotypes (P = .001). All mutant alleles showed low in vivo acetylation capacities, including the previously not-yet-defined alleles *5A, *5C, and *13. Moreover, distinct slow genotypes differed significantly among each other, as reflected in lower acetylation capacity of *6A, *7B, and *13 alleles than the group of *5 alleles. The study demonstrated differential phenotypic activity of various NAT2 genes and gives a solid basis for clinical and molecular-epidemiological investigations.	HUMBOLDT UNIV BERLIN,CLIN CHARITE,INST KLIN PHARMAKOL,D-10098 BERLIN,GERMANY; HUMBOLDT UNIV BERLIN,UNIV CLIN VIRCHOW,INST HUMAN GENET,BERLIN,GERMANY				Cascorbi, Ingolf/A-4519-2009; Cascorbi, Ingolf/AAT-1927-2021	Cascorbi, Ingolf/0000-0002-2182-9534; Drakoulis, Nikolaos/0000-0002-7545-8089			AGUNDEZ JAG, 1994, CLIN PHARMACOL THER, V56, P202, DOI 10.1038/clpt.1994.124; BECHTEL YC, 1993, CLIN PHARMACOL THER, V54, P134, DOI 10.1038/clpt.1993.124; BELL DA, 1993, CARCINOGENESIS, V14, P1689, DOI 10.1093/carcin/14.8.1689; BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; CRIBB AE, 1994, PHARMACOGENETICS, V4, P166, DOI 10.1097/00008571-199406000-00009; DEGUCHI T, 1990, J BIOL CHEM, V265, P12757; DIXON WJ, 1992, BMDP STATISTICAL SOF; Evans D., 1992, Protein engineering: Proceedings of an AFRC conference on protein engineering in the agricultural and food industry, Selwyn College, Cambridge, 16-17 September 1991., P95; EVANS DAP, 1964, J LAB CLIN MED, V63, P394; FERGUSON RJ, 1994, DRUG METAB DISPOS, V22, P371; GRAF T, 1992, EUR J CLIN PHARMACOL, V43, P399, DOI 10.1007/BF02220616; GRANT DM, 1984, BRIT J CLIN PHARMACO, V17, P459, DOI 10.1111/j.1365-2125.1984.tb02372.x; GRANT DM, 1989, NUCLEIC ACIDS RES, V17, P3978, DOI 10.1093/nar/17.10.3978; HASHIGUCHI M, 1992, CLIN PHARMACOL THER, V52, P274, DOI 10.1038/clpt.1992.141; HAYES RB, 1993, CARCINOGENESIS, V14, P675, DOI 10.1093/carcin/14.4.675; HEIN DW, 1994, HUM MOL GENET, V3, P729; HEIN DW, 1993, CARCINOGENESIS, V14, P1633, DOI 10.1093/carcin/14.8.1633; HICKMAN D, 1994, BIOCHEM J, V297, P441, DOI 10.1042/bj2970441; HICKMAN D, 1991, BIOCHEM PHARMACOL, V42, P1007, DOI 10.1016/0006-2952(91)90282-A; LIN HJ, 1993, AM J HUM GENET, V52, P827; LIN HJ, 1994, PHARMACOGENETICS, V4, P125, DOI 10.1097/00008571-199406000-00003; MASHIMO M, 1992, HUM GENET, V90, P139; MROZIKIEWICZ PM, 1994, CLIN PHARMACOL THER, V56, P626, DOI 10.1038/clpt.1994.187; OHSAKO S, 1990, J BIOL CHEM, V265, P4630; RELLING MV, 1992, CLIN PHARMACOL THER, V52, P643, DOI 10.1038/clpt.1992.203; ROOTS I, 1988, KLIN WOCHENSCHR, V66, P87; Roots I, 1992, PHARMACOGENETICS DRU, P815; ROOTS I, 1989, XENOBIOTIC METABOLIS, P499; ROTHMAN N, 1993, PHARMACOGENETICS, V3, P250, DOI 10.1097/00008571-199310000-00004; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; VATSIS KP, 1991, P NATL ACAD SCI USA, V88, P6333, DOI 10.1073/pnas.88.14.6333; VATSIS KP, 1995, PHARMACOGENETICS, V5, P1, DOI 10.1097/00008571-199502000-00001; WEBER WW, 1993, PHARMACOGENETICS, V3, P209, DOI 10.1097/00008571-199308000-00006	34	306	313	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					581	592					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	WOS:A1995RR60500007	7668286				2022-01-24	
J	REED, PW; DAVIES, JL; COPEMAN, JB; BENNETT, ST; PALMER, SM; PRITCHARD, LE; GOUGH, SCL; KAWAGUCHI, Y; CORDELL, HJ; BALFOUR, KM; JENKINS, SC; POWELL, EE; VIGNAL, A; TODD, JA				REED, PW; DAVIES, JL; COPEMAN, JB; BENNETT, ST; PALMER, SM; PRITCHARD, LE; GOUGH, SCL; KAWAGUCHI, Y; CORDELL, HJ; BALFOUR, KM; JENKINS, SC; POWELL, EE; VIGNAL, A; TODD, JA			CHROMOSOME-SPECIFIC MICROSATELLITE SETS FOR FLUORESCENCE-BASED, SEMIAUTOMATED GENOME MAPPING	NATURE GENETICS			English	Article							MARKERS; LOCI	To facilitate large-scale genetic mapping of the human genome, we have developed chromosome-specific sets of microsatellite marker loci suitable for use with a fluorescence-based automated DNA fragment analyser. We present 254 dinucleotide repeat marker loci (80% from the Genethon genetic linkage map) arranged into 39 sets, covering all 22 autosomes and the X chromosome. The average distance between adjacent markers is 13 centiMorgans, and less than 4% of the genome lies more than 20 cM from the nearest marker. Each set of microsatellites consists of up to nine marker loci, with allele size ranges that do not overlap. We selected marker loci on the basis of their reliability in the polymerase chain reaction, polymorphism content, map position and the accuracy with which alleles can be scored automatically by the Genotyper(TM) program.	UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,NUFFIELD ORTHOPAED CTR,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7LD,ENGLAND; GENETHON,F-91000 EVRY,FRANCE				Todd, John A/A-3542-2010; Powell, Elizabeth/B-4455-2011; Vignal, Alain/I-6253-2017	Todd, John A/0000-0003-2740-8148; Powell, Elizabeth/0000-0001-5008-8061; Vignal, Alain/0000-0002-6797-2125; Cordell, Heather/0000-0002-1879-5572	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CALLEN DF, 1993, AM J HUM GENET, V52, P922; DIEHL SR, 1990, AM J HUM GENET, V47, pA177; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; SCHWENGEL DA, IN PRESS GENOMICS; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Weber J, 1989, AM J HUM GENET, V44, P338; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	19	306	308	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					390	395		10.1038/ng0794-390			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	WOS:A1994NU30600013	7920657				2022-01-24	
J	NURSE, P; THURIAUX, P				NURSE, P; THURIAUX, P			REGULATORY GENES-CONTROLLING MITOSIS IN THE FISSION YEAST SCHIZOSACCHAROMYCES-POMBE	GENETICS			English	Article									UNIV BERN, INST MICROBIOL, CH-3000 BERN, SWITZERLAND; UNIV EDINBURGH, DEPT ZOOL, EDINBURGH EH9 3JT, MIDLOTHIAN, SCOTLAND								Cashel M, 1974, RIBOSOMES, P733; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FANTES PA, 1975, J THEOR BIOL, V50, P213, DOI 10.1016/0022-5193(75)90034-X; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; FANTES PA, 1977, J CELL SCI, V24, P51; Gutz H., 1974, HDB GENETICS, V1, P395; HERSHKO A, 1971, NATURE-NEW BIOL, V232, P206, DOI 10.1038/newbio232206a0; HOFER F, 1979, CURR GENET, V1, P45, DOI 10.1007/BF00413306; KOHLI J, 1979, J BIOL CHEM, V254, P1546; MITCHISON JM, 1957, EXP CELL RES, V13, P244, DOI 10.1016/0014-4827(57)90005-8; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; NURSE P, 1977, EXP CELL RES, V107, P365, DOI 10.1016/0014-4827(77)90358-5; OLIVER SG, 1977, MOL GEN GENET, V154, P145, DOI 10.1007/BF00330830; SIMCHEN G, 1978, ANNU REV GENET, V12, P161, DOI 10.1146/annurev.ge.12.120178.001113; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133, DOI 10.1038/newbio241133a0; STURANI E, 1973, BIOCHIM BIOPHYS ACTA, V319, P153, DOI 10.1016/0005-2787(73)90006-3; THURIAUX P, 1978, MOL GEN GENET, V161, P215, DOI 10.1007/BF00274190; THURIAUX P, CURRENT GENET; WOLFNER M, 1975, J MOL BIOL, V96, P273, DOI 10.1016/0022-2836(75)90348-4	21	306	313	0	18	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1980	96	3					627	637					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ513	WOS:A1980LJ51300005	7262540				2022-01-24	
J	Botstein, D; Fink, GR				Botstein, David; Fink, Gerald R.			Yeast: An Experimental Organism for 21st Century Biology	GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PROTEIN-PROTEIN INTERACTIONS; GENE-EXPRESSION; BUDDING YEAST; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; ADAPTIVE EVOLUTION; DNA ASSOCIATION; GLOBAL ANALYSIS; DUPLICATION	In this essay, we revisit the status of yeast as a model system for biology. We first summarize important contributions of yeast to eukaryotic biology that we anticipated in 1988 in our first article on the subject. We then describe transformative developments that we did not anticipate, most of which followed the publication of the complete genomic sequence of Saccharomyces cerevisiae in 1996. In the intervening 23 years it appears to us that yeast has graduated from a position as the premier model for eukaryotic cell biology to become the pioneer organism that has facilitated the establishment of the entirely new fields of study called "functional genomics" and "systems biology." These new fields look beyond the functions of individual genes and proteins, focusing on how these interact and work together to determine the properties of living cells and organisms.	[Botstein, David] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Fink, Gerald R.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Fink, Gerald R.] MIT, Cambridge, MA 02139 USA		Botstein, D (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	botstein@genomics.princeton.edu			National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 046406, GM-071508, GM40266, GM035010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM040266, R37GM046406, R01GM035010, P50GM071508, R37GM035010, R01GM046406] Funding Source: NIH RePORTER	We are grateful for support from National Institute of General Medical Sciences grants GM 046406 and GM-071508 to D. B. and GM40266 and GM035010 to G.R.F.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BOTSTEIN D, 1988, SCIENCE, V240, P1439, DOI 10.1126/science.3287619; Botstein D, 2010, MOL BIOL CELL, V21, P4, DOI 10.1091/mbc.E09-07-0575; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DOBZHANSKY T, 1946, GENETICS, V31, P269; Dolinski K, 2005, GENOME RES, V15, P1611, DOI 10.1101/gr.3727505; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fields S, 2009, PROTEOMICS, V9, P5209, DOI 10.1002/pmic.200900236; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Friis E. M., 1987, ORIGINS ANGIOSPERMS; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gammie AE, 2007, GENETICS, V177, P707, DOI 10.1534/genetics.107.071084; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Heinicke S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000766; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hibbs MA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000322; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huttenhower C, 2009, BIOINFORMATICS, V25, P2404, DOI 10.1093/bioinformatics/btp397; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam FH, 2010, METHOD ENZYMOL, V470, P509, DOI 10.1016/S0076-6879(10)70020-3; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lee JH, 2011, PLANT SCI, V180, P352, DOI 10.1016/j.plantsci.2010.10.008; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; NOVICK P, 1989, GENETICS, V121, P659; Ohno S., 1970, EVOLUTION GENE DUPLI; Pop A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-180; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STURTEVANT AH, 1956, GENETICS, V41, P118; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wapinski I, 2010, P NATL ACAD SCI USA, V107, P5505, DOI 10.1073/pnas.0911905107; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wohlbach DJ, 2009, CURR OPIN GENET DEV, V19, P571, DOI 10.1016/j.gde.2009.09.007; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	75	305	311	2	64	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	NOV	2011	189	3					695	704		10.1534/genetics.111.130765			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848BD	WOS:000297020800003	22084421	Green Published, Bronze			2022-01-24	
J	Kallberg, H; Padyukov, L; Plenge, RM; Ronnelid, J; Gregersen, PK; van der Helm-van Mil, AHM; Toes, REM; Huizinga, TW; Klareskog, L; Alfredsson, L				Kallberg, Henrik; Padyukov, Leonid; Plenge, Robert M.; Ronnelid, Johan; Gregersen, Peter K.; van der Helm-van Mil, Annette H. M.; Toes, Rene E. M.; Huizinga, Tom W.; Klareskog, Lars; Alfredsson, Lars		Epidemiological Investigation	Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED EPITOPE; CITRULLINATED PROTEINS; SWEDISH EIRA; RISK; SUSCEPTIBILITY; POLYMORPHISM; REPLICATION; ASSOCIATION; ANTIBODIES; FAMILIES	Gene-gene and gene-environment interactions are key features in the development of rheumatoid arthritis ( RA) and other complex diseases. The aim of this study was to use and compare three different definitions of interaction between the two major genetic risk factors of RA - the HLA-DRB1 shared epitope ( SE) alleles and the PTPN22 R620W allele - in three large case-control studies: the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study, the North American RA Consortium (NARAC) study, and the Dutch Leiden Early Arthritis Clinic study ( in total, 1,977 cases and 2,405 controls). The EIRA study was also used to analyze interactions between smoking and the two genes. "Interaction" was defined either as a departure from additivity, as interaction in a multiplicative model, or in terms of linkage disequilibrium - for example, deviation from independence of penetrance of two unlinked loci. Consistent interaction, defined as departure from additivity, between HLA- DRB1 SE alleles and the A allele of PTPN22 R620W was seen in all three studies regarding anti-CCP-positive RA. Testing for multiplicative interactions demonstrated an interaction between the two genes only when the three studies were pooled. The linkage disequilibrium approach indicated a gene-gene interaction in EIRA and NARAC, as well as in the pooled analysis. No interaction was seen between smoking and PTPN22 R620W. A new pattern of interactions is described between the two major known genetic risk factors and the major environmental risk factor concerning the risk of developing anti-CCP - positive RA. The data extend the basis for a pathogenetic hypothesis for RA involving genetic and environmental factors. The study also raises and illustrates principal questions concerning ways to define interactions in complex diseases.	Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; Karolinska Hosp, Karolinska Inst, Rheumatol Unit, Dept Med, S-10401 Stockholm, Sweden; Stockholm Cty Council, Stockholm Ctr Publ Hlth, Stockholm, Sweden; Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; Univ Uppsala, Unit Clin Immunol, S-75105 Uppsala, Sweden; N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands		Kallberg, H (corresponding author), Karolinska Inst, Inst Environm Med, Box 210, S-17177 Stockholm, Sweden.	henrik.kallberg@ki.se	Alfredsson, Lars/AAC-9007-2019; Padyukov, Leonid/A-4890-2009; Ronnelid, Johan/O-2077-2019	Alfredsson, Lars/0000-0003-1688-6697; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186; Toes, Rene/0000-0002-9618-6414; van der Helm - van Mil, Annette/0000-0001-8572-1437	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR044422, N01AR022263] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01 AR44422, N01-AR-2-2263, R01 AR044422] Funding Source: Medline		Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bengtsson C, 2005, ANN RHEUM DIS, V64, P1588, DOI 10.1136/ard.2004.031666; Gregersen PK, 2005, ARTHRITIS RHEUM-US, V52, P1952, DOI 10.1002/art.21125; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, ARTHRITIS RHEUM, V48, pS348; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Rothman K.J., 2002, EPIDEMIOLOGY INTRO; Stolt P, 2005, ANN RHEUM DIS, V64, P582, DOI 10.1136/ard.2004.022053; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; van Aken J, 2003, CLIN EXP RHEUMATOL, V21, pS100; vanderMeer FJM, 1997, THROMB HAEMOSTASIS, V78, P631; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	27	305	314	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					867	875		10.1086/516736			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	WOS:000245973200005	17436241	Green Published, Bronze			2022-01-24	
J	Qian, W; Jia, YT; Ren, SX; He, YQ; Feng, JX; Lu, LF; Sun, QH; Ying, G; Tang, DJ; Tang, H; Wu, W; Hao, P; Wang, LF; Jiang, BL; Zeng, SY; Gu, WY; Lu, G; Rong, L; Tian, YC; Yao, ZJ; Fu, G; Chen, BS; Fang, RX; Qiang, BQ; Chen, Z; Zhao, GP; Tang, JL; He, CZ				Qian, W; Jia, YT; Ren, SX; He, YQ; Feng, JX; Lu, LF; Sun, QH; Ying, G; Tang, DJ; Tang, H; Wu, W; Hao, P; Wang, LF; Jiang, BL; Zeng, SY; Gu, WY; Lu, G; Rong, L; Tian, YC; Yao, ZJ; Fu, G; Chen, BS; Fang, RX; Qiang, BQ; Chen, Z; Zhao, GP; Tang, JL; He, CZ			Comparative and functional genomic analyses of the pathogenicity of phytopathogen Xanthomonas campestris pv. campestris	GENOME RESEARCH			English	Article							IV SECRETION; VIRULENCE; GENES; EXPRESSION; SEQUENCE; PLANT; BIOSYNTHESIS; CLUSTER; SYSTEM; REARRANGEMENT	Xanthomonas campestris pathovar campestris (Xcc) is the causative agent of crucifer black rot disease, which causes severe losses in agricultural yield world-wide. This bacterium is a model organism for studying plant-bacteria interactions. We sequenced the complete genome of Xcc 8004 (5,148,708 bp), which is highly conserved relative to that of Xcc ATCC 33913. Comparative genomics analysis indicated that, in addition to a significant genomic-scale rearrangement cross the replication axis between two IS1478 elements, loss and acquisition of blocks of genes, rather than point mutations, constitute the main genetic variation between the two Xcc strains. Screening of a high-density transposon insertional mutant library (16,512 clones) of Xcc 8004 against a host plant (Brassica oleraceae) identified 75 nonredundant, single-copy insertions in protein-coding sequences (CDSs) and intergenic regions. In addition to known virulence factors, full virulence was found to require several additional metabolic pathways and regulatory systems, such as fatty acid degradation, type IV secretion system, cell signaling, and amino acids and nucleotide metabolism. Among the identified pathogenicity-related genes, three of unknown function were found in Xcc 8004-specific chromosomal segments, revealing a direct correlation between genomic dynamics and Xcc virulence. The present combination of comparative and functional genomic analyses provides valuable information about the genetic basis of Xcc pathogenicity, which may offer novel insight toward the development of efficient methods for prevention of this important plant disease.	Chinese Natl Human Genome Ctr Shanghai, Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; Chinese Acad Sci, Inst Microbiol, Natl Key Lab Plant Genom, Beijing 100080, Peoples R China; Fudan Univ, Sch Life Sci, Dept Microbiol, Natl Key Lab Genet Engn, Shanghai 200433, Peoples R China; Guangxi Univ, Guangxi Key Lab Subtrop Bioresources Conservat &, Nanning 530004, Guangxi, Peoples R China; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Shanghai Ctr Bioinformat Technol, Shanghai 200235, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol, Bioinformat Ctr, Shanghai 200032, Peoples R China; Chinese Natl Human Genome Ctr Beijing, Beijing 100176, Peoples R China		Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China.	gpzhao@sibs.ac.cn; jitang@gxu.edu.cn; hecz@im.ac.cn	Jia, Yantao/AAF-2936-2020; Wang, Lifeng/I-4888-2012	Jia, Yantao/0000-0001-8700-4271; Wang, Lifeng/0000-0003-4752-6547; qian, wei/0000-0002-7041-5354; Hao, Pei/0000-0002-1498-7059			Alcantara RB, 2004, INFECT IMMUN, V72, P4911, DOI 10.1128/IAI.72.8.4911-4917.2004; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alvarez AM, 2000, MECH RESISTANCE PLAN, P21, DOI [10.1007/978-94-011-3937-3_2, DOI 10.1007/978-94-011-3937-3_2]; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; Burdman S, 2004, MOL PLANT MICROBE IN, V17, P602, DOI 10.1094/MPMI.2004.17.6.602; Buttner D, 2003, CURR OPIN PLANT BIOL, V6, P312, DOI 10.1016/S1369-5266(03)00064-5; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chan JWYF, 1999, BIOTECHNOL ADV, V17, P489, DOI 10.1016/S0734-9750(99)00025-7; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Civerolo, 1993, XANTHOMONAS; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DECRECYLAGARD V, 1990, J BACTERIOL, V172, P5877, DOI 10.1128/jb.172.10.5877-5883.1990; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; DOW JM, 1990, APPL ENVIRON MICROB, V56, P2994, DOI 10.1128/AEM.56.10.2994-2998.1990; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Eisen JA, 2000, GENOME BIOL, V1; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hughes D, 2000, GENOME BIOL, V1; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Lin NT, 1996, BIOCHEM BIOPH RES CO, V218, P12, DOI 10.1006/bbrc.1996.0003; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MAHAN MJ, 1995, P NATL ACAD SCI USA, V92, P669, DOI 10.1073/pnas.92.3.669; Matsunaga I, 1997, J BIOL CHEM, V272, P23592, DOI 10.1074/jbc.272.38.23592; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Newman MA, 2002, PLANT J, V29, P487, DOI 10.1046/j.0960-7412.2001.00233.x; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Smith H, 1998, TRENDS MICROBIOL, V6, P239, DOI 10.1016/S0966-842X(98)01250-5; Storch KF, 1999, EMBO J, V18, P1146, DOI 10.1093/emboj/18.5.1146; Sun QH, 2003, FEMS MICROBIOL LETT, V226, P145, DOI 10.1016/S0378-1097(03)00583-4; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Vuilleumier S, 2002, APPL MICROBIOL BIOT, V58, P138, DOI 10.1007/s00253-001-0836-0; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Whittam TS, 2002, CURR OPIN GENET DEV, V12, P719, DOI 10.1016/S0959-437X(02)00361-1; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wren BW, 2000, NAT REV GENET, V1, P30, DOI 10.1038/35049551; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101	62	305	857	2	110	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUN	2005	15	6					757	767		10.1101/gr.3378705			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	933IW	WOS:000229623100001	15899963	Green Published, Bronze			2022-01-24	
J	Swigonova, Z; Lai, JS; Ma, JX; Ramakrishna, W; Llaca, V; Bennetzen, JL; Messing, J				Swigonova, Z; Lai, JS; Ma, JX; Ramakrishna, W; Llaca, V; Bennetzen, JL; Messing, J			Close split of sorghum and maize genome progenitors	GENOME RESEARCH			English	Article							DUPLICATED SEGMENTS; GENETIC-MAP; EVOLUTION; SEQUENCE; RICE; IDENTIFICATION; MUTATIONS; GRASSES; NUMBERS; MODEL	It is generally believed that maize (Zea mays L. ssp. mays) arose as a tetraploid; however, the two progenitor genomes cannot be unequivocally traced within the genome of modern maize. We have taken a new approach to investigate the origin of the maize genome. We isolated and sequenced large genomic fragments from the regions surrounding five duplicated loci from the maize genome and their orthologous loci in sorghum, and then we compared these sequences with the orthologous regions in the rice genome. Within the studied segments, we identified 11 genes that were conserved in location, order, and orientation. We performed phylogenetic and distance analyses and examined the patterns of estimated times of divergence for sorghum and maize gene orthologs and also the time of divergence for maize orthologs. Our results support a tetraploid origin of maize. This analysis also indicates contemporaneous divergence of the ancestral sorghum genome and the two maize progenitor genomes about 11.9 million years ago (Mya). On the basis of a putative conversion event detected for one of the genes, tetraploidization must have Occurred before 4.8 Mya, and therefore, preceded the major maize genome expansion by gene amplification and retrotransposition.	Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; Dept Biol Sci, W Lafayette, IN 47907 USA; Genet Program, W Lafayette, IN 47907 USA		Messing, J (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.	messing@waksman.rutgers.edu	Ramakrishna, Wusirika/M-6646-2017; Wusirika, Ramakrishna/O-9116-2019	Ramakrishna, Wusirika/0000-0002-8571-5827; Messing, Joachim/0000-0001-8260-2643			AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; CELARIER ROBERT P., 1956, CYTOLOGIA, V21, P272, DOI 10.1508/cytologia.21.272; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; Gaut BS, 2000, P NATL ACAD SCI USA, V97, P7008, DOI 10.1073/pnas.97.13.7008; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gomez MI, 1998, J HERED, V89, P188, DOI 10.1093/jhered/89.2.188; GOODMAN MM, 1980, GENETICS, V96, P697; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Graur D., 2000, FUNDAMENTALS MOL EVO, P99; HELENTJARIS T, 1988, GENETICS, V118, P353; Hu JP, 1996, GENETICS, V142, P1021; Karper RE, 1936, AM J BOT, V23, P369, DOI 10.2307/2436099; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; KISHIMOTO N, 1994, THEOR APPL GENET, V88, P722, DOI 10.1007/BF01253976; Li W.-H., 1997, MOL EVOLUTION, P177; LIN YR, 1995, GENETICS, V141, P391; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCMILLIN DE, 1980, P NATL ACAD SCI-BIOL, V77, P4866, DOI 10.1073/pnas.77.8.4866; MEHRA PN, 1975, CYTOLOGIA, V40, P61, DOI 10.1508/cytologia.40.61; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; NAGAMURA Y, 1995, BREEDING SCI, V45, P373; NEI M, 1985, MOL BIOL EVOL, V2, P66; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; PEREIRA MG, 1994, GENOME, V37, P236, DOI 10.1139/g94-033; PESCHKE VM, 1987, SCIENCE, V238, P804, DOI 10.1126/science.238.4828.804; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PURUGGANAN MD, 1994, GENETICS, V138, P849; Ramakrishna W, 2002, GENETICS, V162, P1389; RHOADES MM, 1951, AM NAT, V85, P105, DOI 10.1086/281658; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Song R, 2002, GENOME RES, V12, P1549, DOI 10.1101/gr.268302; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; Song RT, 2001, GENOME RES, V11, P1817, DOI 10.1101/gr.197301; Swofford D.L., 2003, PHYLOGENETIC ANAL US PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WENDEL JF, 1986, THEOR APPL GENET, V72, P178, DOI 10.1007/BF00266990; WENDEL JF, 1985, MAIZE GENET COOP NEW, V59, P90; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yim YS, 2002, PLANT PHYSIOL, V130, P1686, DOI 10.1104/pp.013474; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523	52	305	329	2	24	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2004	14	10A					1916	1923		10.1101/gr.2332504			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	861HE	WOS:000224405900010	15466289	Bronze, Green Published			2022-01-24	
J	Guo, DH; Li, MY; Zhang, Y; Yang, P; Eckenrode, S; Hopkins, D; Zheng, WP; Purohit, S; Podolsky, RH; Muir, A; Wang, JZ; Dong, Z; Brusko, T; Atkinson, M; Pozzilli, P; Zeidler, A; Raffel, LJ; Jacob, CO; Park, Y; Serrano-Rios, M; Larrad, MTM; Zhang, ZX; Garchon, HJ; Bach, JF; Rotter, JI; She, JX; Wang, CY				Guo, DH; Li, MY; Zhang, Y; Yang, P; Eckenrode, S; Hopkins, D; Zheng, WP; Purohit, S; Podolsky, RH; Muir, A; Wang, JZ; Dong, Z; Brusko, T; Atkinson, M; Pozzilli, P; Zeidler, A; Raffel, LJ; Jacob, CO; Park, Y; Serrano-Rios, M; Larrad, MTM; Zhang, ZX; Garchon, HJ; Bach, JF; Rotter, JI; She, JX; Wang, CY			A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes	NATURE GENETICS			English	Article							CHROMOSOME 11Q13; LINKAGE-DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; SIGNAL-TRANSDUCTION; ACTIVATION; GENES; MELLITUS; IDDM4; TAB2; RECEPTOR	Previous studies have suggested more than 20 genetic intervals that are associated with susceptibility to type 1 diabetes (T1D)(1,2), but identification of specific genes has been challenging and largely limited to known candidate genes. Here, we report evidence for an association between T1D and multiple single-nucleotide polymorphisms in 197 kb of genomic DNA in the IDDM5 interval. We cloned a new gene (SUMO4), encoding small ubiquitin-like modifier 4 protein, in the interval. A substitution (M55V) at an evolutionarily conserved residue of the crucial CUE domain of SUMO4 was strongly associated with T1D (P = 1.9 x 10(-7)). SUMO4 conjugates to IkappaBalpha and negatively regulates NFkappaB transcriptional activity. The M55V substitution resulted in 5.5 times greater NFkappaB transcriptional activity and similar to2 times greater expression of IL12B, an NFkappaB-dependent gene. These findings suggest a new pathway that may be implicated in the pathogenesis of T1D.	Med Coll Georgia, Ctr Biotechnol & Gen Med, Augusta, GA 30912 USA; Med Coll Georgia, Off Biostat & Bioinformat, Augusta, GA 30912 USA; Med Coll Georgia, Childrens Med Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; Univ Roma La Sapienza, Ist Clin Med 2, Rome, Italy; Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA; Hanyang Univ Hosp, Seoul, South Korea; Univ Complutense, Fac Med, E-28040 Madrid, Spain; Beijing Red Cross Blood Ctr, HLA Lab, Beijing, Peoples R China; INSERM, Unite Rech, U580, Ctr Assoc Claude Bernard, Paris, France		She, JX (corresponding author), Med Coll Georgia, Ctr Biotechnol & Gen Med, 1120 15th St,CA4098, Augusta, GA 30912 USA.	jshe@mail.mcg.edu; cwang@mail.mcg.edu	Pozzilli, Paolo/A-5235-2010; Purohit, Sharad/ABA-8054-2021; zhang, yan/AAG-7349-2019	zhang, yan/0000-0003-0906-9410; Wang, Cong-Yi/0000-0001-7914-168X			Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; DENG GY, 1995, AM J HUM GENET, V56, P528; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Eckenrode S, 2000, HUM GENET, V106, P14, DOI 10.1007/s004399900186; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Onengut-Gumuscu S, 2002, IMMUNOL REV, V190, P182, DOI 10.1034/j.1600-065X.2002.19014.x; Owerbach D, 2000, DIABETES, V49, P508, DOI 10.2337/diabetes.49.3.508; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Twells RCJ, 2003, HUM GENET, V113, P99, DOI 10.1007/s00439-003-0940-6; Twells RCJ, 2001, GENOMICS, V72, P231, DOI 10.1006/geno.2000.6492; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6	30	305	338	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					837	841		10.1038/ng1391			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	WOS:000222974000015	15247916				2022-01-24	
J	Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; Flanagan, AM; Alitalo, K; Boshoff, C				Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; Flanagan, AM; Alitalo, K; Boshoff, C			Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma	NATURE GENETICS			English	Article							GROWTH-FACTOR; CELLS; HUMAN-HERPESVIRUS-8; TRANSFORMATION; INFECTION; CULTURE; LESIONS; VEGF	The biology of Kaposi sarcoma is poorly understood because the dominant cell type in Kaposi sarcoma lesions is not known(1-4). We show by gene expression microarrays that neoplastic cells of Kaposi sarcoma are closely related to lymphatic endothelial cells (LECs) and that Kaposi sarcoma herpesvirus (KSHV)(5,6) infects both LECs and blood vascular endothelial cells (BECs) in vitro. The gene expression microarray profiles of infected LECs and BECs show that KSHV induces transcriptional reprogramming of both cell types. The lymphangiogenic molecules VEGF-D and angiopoietin-2 were elevated in the plasma of individuals with acquired immune deficiency syndrome and Kaposi sarcoma. These data show that the gene expression profile of Kaposi sarcoma resembles that of LECs, that KSHV induces a transcriptional drift in both LECs and BECs and that lymphangiogenic molecules are involved in the pathogenesis of Kaposi sarcoma.	UCL, Wolfson Inst Biomed Res, Viral Oncol Grp, Canc Res UK, London WC1E 6BT, England; Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Helsinki Univ Cent Hosp, FIN-00014 Helsinki, Finland; UCL, Inst Orthopaed, London WC1E 6BT, England		Boshoff, C (corresponding author), UCL, Wolfson Inst Biomed Res, Viral Oncol Grp, Canc Res UK, Cruciform Bldg,Gower St, London WC1E 6BT, England.	c.boshoff@ucl.ac.uk	Makinen, Taija/C-5765-2014; Alitalo, Kari K/J-5013-2014	Makinen, Taija/0000-0002-9338-1257; Alitalo, Kari K/0000-0002-7331-0902; Lagos, Dimitris/0000-0003-0637-281X; Trotter, Matthew/0000-0003-3702-915X; Flanagan, Adrienne/0000-0002-2832-1303; Henderson, Stephen/0000-0002-9032-3828			Ascherl G, 1999, BLOOD, V93, P4232; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Brockmeyer N H, 1999, Eur J Med Res, V4, P95; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Ciufo DM, 2001, J VIROL, V75, P5614, DOI 10.1128/JVI.75.12.5614-5626.2001; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gallo RC, 1998, SCIENCE, V282, P1837, DOI 10.1126/science.282.5395.1837; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; HONG YK, 2004, NAT GENET       0627, DOI DOI 10.1038/NG1383; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KAAYA EE, 1995, J ACQ IMMUN DEF SYND, V10, P295; Kahn HJ, 2002, MODERN PATHOL, V15, P434, DOI 10.1038/modpathol.3880543; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lebbe C, 1997, ARCH DERMATOL RES, V289, P421, DOI 10.1007/s004030050215; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; REGEZI JA, 1993, AM J PATHOL, V143, P240; Renwick N, 2002, AIDS RES HUM RETROV, V18, P695, DOI 10.1089/088922202760072302; Samaniego F, 1997, J IMMUNOL, V158, P1887; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; [No title captured]	30	305	315	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					687	693		10.1038/ng1384			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	WOS:000222354100017	15220918	Bronze			2022-01-24	
J	Meyers, BC; Tingley, SV; Morgante, M				Meyers, BC; Tingley, SV; Morgante, M			Abundance, distribution, and transcriptional activity of repetitive elements in the maize genome	GENOME RESEARCH			English	Article							TY1-COPIA GROUP RETROTRANSPOSONS; ZEA-MAYS; SEQUENCE; GENES; ORGANIZATION; EVOLUTION; REGIONS; DNA; HETEROGENEITY; ARABIDOPSIS	Long terminal repeat (LTR) retrotransposons have been shown to make up much of the maize genome. Although these elements are known to be prevalent in plant genomes of a middle-to-large size, little information is available on the relative proportions composed by specific families of elements in a single genome. We sequenced a library of randomly sheared genomic DNA from maize to characterize this genome. BLAST analysis of these sequences demonstrated that the maize genome is composed of diverse sequences that represent numerous families of retrotransposons. The largest families contain the previously described elements Huck, Ji, and Opie. Approximately 5% of the sequences are predicted to encode proteins. The genomic abundance of 16 families of elements was estimated by hybridization to an array of 10,752 maize bacterial artificial chromosome (BAC) clones. Comparisons of the number of elements present on individual BACs indicated that retrotransposons are in general randomly distributed across the maize genome. A second library was constructed that was selected to contain sequences hypomethylated in the maize genome. Sequence analysis of this library indicated that retroelements abundant in the genome are poorly represented in hypomethylated regions. Fifty-six retroelement sequences corresponding to the integrase and reverse transcriptase domains were isolated from similar to 407,000 maize expressed sequence tags (ESTs). Phylogenetic analysis of these and the genomic retroelement sequences indicated that elements most abundant in the genome are less abundant at the transcript level than are more rare retrotransposons. Additional phylogenies also demonstrated that rice and maize retrotransposon families are frequently more closely related to each other than to families within the same species. An analysis of the GC content of the maize genomic library and that of maize ESTs did not support recently published data that the gene space in maize is found within a narrow GC range, but does indicate that genic sequences have a higher GC content than intergenic sequences (52% vs. 47% GC).	Dupont Co Inc, DuPont Crop Genet Genom, Newark, DE 19714 USA		Morgante, M (corresponding author), Dupont Co Inc, DuPont Crop Genet Genom, Newark, DE 19714 USA.	michele.morgante@usa.dupont.com	Meyers, Blake C/B-6535-2012; Martinez, Octavio/B-7375-2009	Meyers, Blake C/0000-0003-3436-6097; MORGANTE, Michele/0000-0003-2591-2156			Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ananiev EV, 1998, P NATL ACAD SCI USA, V95, P13073, DOI 10.1073/pnas.95.22.13073; Ananiev EV, 1998, GENETICS, V149, P2025; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barakat A, 1997, P NATL ACAD SCI USA, V94, P6857, DOI 10.1073/pnas.94.13.6857; Barakat A, 1998, P NATL ACAD SCI USA, V95, P10044, DOI 10.1073/pnas.95.17.10044; Barakat A, 2000, FEBS LETT, V471, P161, DOI 10.1016/S0014-5793(00)01393-4; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bradnam KR, 1999, MOL BIOL EVOL, V16, P666, DOI 10.1093/oxfordjournals.molbev.a026149; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Buckler ES, 1999, GENETICS, V153, P415; CARELS N, 1995, P NATL ACAD SCI USA, V92, P11057, DOI 10.1073/pnas.92.24.11057; Carels N, 2000, GENETICS, V154, P1819; Chen MS, 1998, GENETICS, V148, P435; CORDESSE F, 1993, J MOL EVOL, V36, P369, DOI 10.1007/BF00182184; DENNIS ES, 1984, J MOL EVOL, V20, P341, DOI 10.1007/BF02104740; DUNHAM I, 1999, GENOME ANAL LAB MANU, V3; Edwards KJ, 1996, GENOME, V39, P811, DOI 10.1139/g96-102; Elgar G, 1999, GENOME RES, V9, P960, DOI 10.1101/gr.9.10.960; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; FLAVELL AJ, 1992, MOL GEN GENET, V231, P233, DOI 10.1007/BF00279796; FLAVELL AJ, 1992, GENETICA, V86, P203, DOI 10.1007/BF00133721; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Gill KS, 1996, GENETICS, V144, P1883; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Heslop-Harrison JS, 1997, GENETICA, V100, P197, DOI 10.1023/A:1018337831039; Hilton H, 1998, GENETICS, V150, P863; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; HU WM, 1995, MOL GEN GENET, V248, P471, DOI 10.1007/BF02191647; Jordan IK, 1998, MOL BIOL EVOL, V15, P1160, DOI 10.1093/oxfordjournals.molbev.a026023; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEETON PRJ, 1993, MOL GEN GENET, V237, P97, DOI 10.1007/BF00282789; Llaca V, 1998, PLANT J, V15, P211, DOI 10.1046/j.1365-313X.1998.00200.x; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Marillonnet S, 1998, GENETICS, V150, P1245; Mascarenhas JP, 1994, CUR TOP PL, V12, P39; Panstruga R, 1998, NUCLEIC ACIDS RES, V26, P1056, DOI 10.1093/nar/26.4.1056; Pearce SR, 1996, MOL GEN GENET, V250, P305, DOI 10.1007/s004380050080; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Shirasu K, 2000, GENOME RES, V10, P908, DOI 10.1101/gr.10.7.908; Suoniemi A, 1997, GENETICA, V100, P219, DOI 10.1023/A:1018398016018; Suoniemi A, 1998, PLANT J, V13, P699, DOI 10.1046/j.1365-313X.1998.00071.x; Terzian C, 2000, MOL BIOL EVOL, V17, P908, DOI 10.1093/oxfordjournals.molbev.a026371; Tikhonov AP, 1999, P NATL ACAD SCI USA, V96, P7409, DOI 10.1073/pnas.96.13.7409; TURCICH MP, 1994, SEX PLANT REPROD, V7, P2, DOI 10.1007/BF00241882; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vicient CM, 1999, PLANT CELL, V11, P1769, DOI 10.1105/tpc.11.9.1769; VOYTAS DF, 1992, P NATL ACAD SCI USA, V89, P7124, DOI 10.1073/pnas.89.15.7124; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; WILSON RK, 1997, GENOME ANAL LAB MANU, V1; YOSHIOKA Y, 1993, P NATL ACAD SCI USA, V90, P6562, DOI 10.1073/pnas.90.14.6562	63	305	340	1	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2001	11	10					1660	1676		10.1101/gr.188201			17	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	480HM	WOS:000171456000008	11591643	Green Published, Bronze			2022-01-24	
J	Vervoort, R; Lennon, A; Bird, AC; Tulloch, B; Axton, R; Miano, MG; Meindl, A; Meitinger, T; Ciccodicola, A; Wright, AF				Vervoort, R; Lennon, A; Bird, AC; Tulloch, B; Axton, R; Miano, MG; Meindl, A; Meitinger, T; Ciccodicola, A; Wright, AF			Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; POSITIONAL CLONING; GENE; IDENTIFICATION; SEQUENCES; FAMILIES; DNA; RP3; TRANSCRIPTION; HOMOLOGY	The gene RPGR was previously identified in the RP3 region of Xp21.1 and shown to be mutated in 10-20% of patients with the progressive retinal degeneration X-linked retinitis pigmentosa(1,2) (XLRP). The mutations predominantly affected a domain homologous to RCC1, a guanine nucleotide exchange factor for the small GTPase Ran, although they were present in fewer than the 70-75% of XLRP patients predicted from linkage studies(3-6) Mutations in the RP2 locus at Xp11.3 were found in a further 10-20% of XLRP patients, as predicted from linkage studies(6-8). Because the mutations in the remainder of the XLRP patients may reside in undiscovered exons of RPGR, we sequenced a 172-kb region containing the entire gene. Analysis of the sequence disclosed a new 3' terminal exon that was mutated in 60% of XLRP patients examined. This exon encodes 567 amino acids, with a repetitive domain rich in glutamic acid residues. The sequence is conserved in the mouse, bovine and Fugu rubripes genes. it is preferentially expressed in mouse and bovine retina, further supporting its importance for retinal function. Our results suggest that mutations in RPGR are the only cause of RP3 type XLRP and account for the disease in over 70% of XLRP patients and an estimated 11% of all retinitis pigmentosa patients.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; UCL, Dept Clin Ophthalmol, London WC1E 6BT, England; Moorfields Eye Hosp, London, England; CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; Univ Munich, Dept Med Genet, Munich, Germany; GSF, Res Ctr, Clin Ophthalmol Res Cooperat, Neuherberg, Germany		Wright, AF (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	alan.wright@hgu.mrc.ac.uk	Meitinger, Thomas/O-1318-2015; Miano, Maria Giuseppina/AAX-8437-2020; Miano, Maria Giuseppina/E-9056-2011; Giuseppina, Miano Maria/B-9169-2015	Miano, Maria Giuseppina/0000-0003-1396-9673; Miano, Maria Giuseppina/0000-0003-1396-9673; Meitinger, Thomas/0000-0002-8838-8403; Ciccodicola, Alfredo/0000-0002-9924-1482	TelethonFondazione Telethon [E.1093] Funding Source: Medline		Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cooper D. N., 1993, HUMAN GENE MUTATION; Dry KL, 1999, HUM MUTAT, V13, P141, DOI 10.1002/(SICI)1098-1004(1999)13:2<141::AID-HUMU6>3.3.CO;2-H; DRY KL, 1995, HUM MOL GENET, V4, P2347, DOI 10.1093/hmg/4.12.2347; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MEINDL A, 1995, HUM MOL GENET, V4, P2339, DOI 10.1093/hmg/4.12.2339; Miano MG, 1999, EUR J HUM GENET, V7, P687, DOI 10.1038/sj.ejhg.5200352; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 1996, HUM MOL GENET, V5, P827, DOI 10.1093/hmg/5.6.827; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; WOOTTON JC, 1994, CURR OPIN STRUC BIOL, V4, P413, DOI 10.1016/S0959-440X(94)90111-2; Xu Y, 1994, Genet Eng (N Y), V16, P241; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565	23	305	313	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					462	466		10.1038/78182			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	WOS:000088615000027	10932196				2022-01-24	
J	Grachtchouk, M; Rong, M; Yu, S; Zhang, XY; Sasaki, H; Hui, CC; Dlugosz, AA				Grachtchouk, M; Rong, M; Yu, S; Zhang, XY; Sasaki, H; Hui, CC; Dlugosz, AA			Basal cell carcinomas in mice overexpressing Gli2 in skin	NATURE GENETICS			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTOR; HUMAN HOMOLOG; NEURAL-TUBE; EXPRESSION; MUTATIONS; GENE		Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Osaka Univ, Inst Mol & Cellular Biol, Dev Biol Lab, Osaka, Japan		Dlugosz, AA (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.				NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046592] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA46592] Funding Source: Medline		Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Booth DR, 1999, CANCER METAST REV, V18, P261, DOI 10.1023/A:1006377425099; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Ding Q, 1998, DEVELOPMENT, V125, P2533; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee J, 1997, DEVELOPMENT, V124, P2537; MARKEY AC, 1992, BRIT J DERMATOL, V126, P154, DOI 10.1111/j.1365-2133.1992.tb07813.x; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; SMOLLER BR, 1994, BRIT J DERMATOL, V131, P28, DOI 10.1111/j.1365-2133.1994.tb08453.x; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	16	305	313	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					216	217		10.1038/73417			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	WOS:000085590600009	10700170				2022-01-24	
J	Anderson, LK; Reeves, A; Webb, LM; Ashley, T				Anderson, LK; Reeves, A; Webb, LM; Ashley, T			Distribution of crossing over on mouse synaptonemal complexes using immunofluorescent localization of MLH1 protein	GENETICS			English	Article							DNA MISMATCH REPAIR; RECOMBINATION NODULES; MEIOTIC RECOMBINATION; CHIASMA DISTRIBUTION; ELECTRON-MICROSCOPY; DROSOPHILA-MELANOGASTER; LYCOPERSICON-ESCULENTUM; SORDARIA-MACROSPORA; HUMAN SPERMATOCYTES; SOLANACEOUS PLANTS	We have used immunofluorescent localization to examine the distribution of MLH1 (MutL homolog) foci on synaptonemal complexes (SCs) from juvenile male mice. MLH1 is a mismatch repair protein necessary for meiotic recombination in mice, and MLH1 foci have been proposed to mark crossover sites. We present evidence that the number and distribution of MLH1 foci on SCs closely correspond to the number and distribution of chiasmata on diplotene-metaphase I chromosomes. MLH1 foci were typically excluded from SC in centromeric heterochromatin. For SCs with one MLH1 focus, most foci were located near the middle of long SCs, but near the distal end of short SCs. For SCs with two MLH1 foci, the distribution of foci was bimodal regardless of SC length, with most foci located near the proximal and distal ends. The distribution of MLH1 foci indicated interference between foci. We observed a consistent relative distance (percent of SC length in euchromatin) between two foci on SCs of different lengths, suggesting that positive interference between MLH1 foci is a function of relative SC length. The extended length of pachytene SCs, as compared to more condensed diplotene-metaphase I bivalents, makes mapping crossover events and interference distances using MLH1 fuci more accurate than using chiasmata.	Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA		Anderson, LK (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	lorrie@lamar.colostate.edu		Reeves, Aaron/0000-0001-6387-7481	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-49779] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM049779] Funding Source: NIH RePORTER		ASHLEY T, 1988, GENETICS, V118, P307; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1996, CHROMOSOME RES, V4, P562, DOI 10.1007/BF02261719; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BROWN SW, 1955, GENETICS, V40, P850; CARMI P, 1978, CARLSBERG RES COMMUN, V43, P117, DOI 10.1007/BF02906508; CARPENTER ATC, 1975, P NATL ACAD SCI USA, V72, P3186, DOI 10.1073/pnas.72.8.3186; CARPENTER ATC, 1988, GENETIC RECOMBINATIO, P5209; CHANDLEY AC, 1986, HUM GENET, V72, P50, DOI 10.1007/BF00278817; Charles DR, 1938, J GENET, V36, P103, DOI 10.1007/BF02982376; De Boer P.D., 1989, CHROMOSOME PAIRING F, P37; DIETRICH AJJ, 1983, GENETICA, V61, P119, DOI 10.1007/BF00123222; EGEL R, 1995, TRENDS GENET, V11, P206, DOI 10.1016/S0168-9525(00)89046-0; EVANS EP, 1989, GENETIC VARIANTS STR, P576; FANG JS, 1981, CHROMOSOMA, V82, P437, DOI 10.1007/BF00285768; FOSS E, 1993, GENETICS, V133, P681; FOX DP, 1973, CHROMOSOMA, V43, P289, DOI 10.1007/BF00294277; GLAMANN J, 1986, CARLSBERG RES COMMUN, V51, P143, DOI 10.1007/BF02907321; GUITART M, 1985, GENETICA, V67, P21, DOI 10.1007/BF02424457; HALDANE J. B. S., 1931, CYTOLOGIA, V3, P54; HALE DW, 1994, CYTOGENET CELL GENET, V65, P278, DOI 10.1159/000133648; HENDERSON SA, 1963, HEREDITY, V18, P173, DOI 10.1038/hdy.1963.20; HENG HHQ, 1994, CHROMOSOMA, V103, P401, DOI 10.1007/BF00362284; HERICKHOFF L, 1993, HEREDITY, V71, P373, DOI 10.1038/hdy.1993.152; HOLM PB, 1980, CARLSBERG RES COMMUN, V45, P483, DOI 10.1007/BF02932921; HOLM PB, 1983, CARLSBERG RES COMMUN, V48, P385, DOI 10.1007/BF02911918; HOLMQUIST GP, 1989, J MOL EVOL, V28, P469, DOI 10.1007/BF02602928; HULTEN M, 1974, HEREDITAS, V76, P55; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; JAGIELLO G, 1979, CYTOGENET CELL GENET, V23, P53, DOI 10.1159/000131302; JONES GH, 1984, CONTROLLING EVENTS M, P293; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; LAURIE DA, 1981, HEREDITY, V47, P409, DOI 10.1038/hdy.1981.102; LAURIE DA, 1980, THESIS U BIRMINGHAM; LAWRIE NM, 1995, CHROMOSOMA, V140, P308; LINDSLEY DL, 1977, PHILOS T R SOC B, V277, P295, DOI 10.1098/rstb.1977.0019; LYON MF, 1976, GENET RES, V28, P291, DOI 10.1017/S0016672300016980; Mather K, 1936, J GENET, V33, P207, DOI 10.1007/BF02982533; Mather K, 1939, GENETICS, V24, P413; MATHER K, 1937, CYTOLOGIA FUJII JUBI, V1, P514; MOENS PB, 1987, J CELL BIOL, V105, P93, DOI 10.1083/jcb.105.1.93; MOSES MJ, 1980, ANIMAL MODELS HUMAN, P169; Nachman MW, 1996, GENETICS, V142, P537; OBRIEN SJ, 1987, GENETIC MAPS 1987; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Pigozzi MI, 1997, CHROMOSOME RES, V5, P421, DOI 10.1023/A:1018404610973; POLANI PE, 1972, CHROMOSOMA, V36, P343, DOI 10.1007/BF00336793; POORMAN PA, 1981, CHROMOSOMA, V83, P419, DOI 10.1007/BF00327363; RABBITTS P, 1995, NAT GENET, V9, P369, DOI 10.1038/ng0495-369; RAHN MI, 1986, CYTOGENET CELL GENET, V43, P187, DOI 10.1159/000132319; REID T, 1992, P NATL ACAD SCI USA, V89, P1388; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; SHAW DD, 1976, CHROMOSOMA, V59, P103, DOI 10.1007/BF00328480; SHERMAN JD, 1995, GENETICS, V141, P683; SPEED RM, 1977, CHROMOSOMA, V64, P241, DOI 10.1007/BF00328080; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; STACK SM, 1984, J CELL SCI, V71, P159; STACK SM, 1993, CHROMOSOMES TODAY, V11, P301; STEPHENS SG, 1961, AM NAT, V95, P279, DOI 10.1086/282189; Sybenga, 1975, MEIOTIC CONFIGURATIO; Sybenga J, 1996, GENOME, V39, P473, DOI 10.1139/g96-061; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; WEST SC, 1994, CELL, V76, P9, DOI 10.1016/0092-8674(94)90168-6; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; ZICKLER D, 1977, CHROMOSOMA, V61, P289, DOI 10.1007/BF00288615; ZICKLER D, 1992, GENETICS, V132, P135	70	305	322	0	9	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	APR	1999	151	4					1569	1579					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183NR	WOS:000079560100027	10101178				2022-01-24	
J	Hager, J; Dina, C; Francke, S; Dubois, S; Houari, M; Vatin, V; Vaillant, E; Lorentz, N; Basdevant, A; Clement, K; Guy-Grand, B; Froguel, P				Hager, J; Dina, C; Francke, S; Dubois, S; Houari, M; Vatin, V; Vaillant, E; Lorentz, N; Basdevant, A; Clement, K; Guy-Grand, B; Froguel, P			A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10	NATURE GENETICS			English	Article							LEPTIN RECEPTOR GENE; HUMAN OB GENE; QUANTITATIVE TRAIT; MARKERS FLANKING; EXTREME OBESITY; PIMA-INDIANS; LINKAGE; MUTATION; ABSENCE; WEIGHT	Obesity, a common multifactorial disorder, is a major risk factor for type 2 diabetes, hypertension and coronary heart disease(1) (CHD). According to the definition of the World Health Organization (WHO), approximately 6-10% of the population in Westernized countries are considered obese(2). Epidemiological studies have shown that 30-70% of the variation in body weight may be attributable to genetic factors. To date, two genome-wide scans using different obesity-related quantitative traits have provided candidate regions for obesity(3,4). We have undertaken a genome-wide scan in affected sibpairs to identify chromosomal regions linked to obesity in a collection of French families. Model-free multipoint linkage analyses revealed evidence for linkage to a region on chromosome 10p (MLS=4.85). Two further loci on chromosomes 5cen-q and 2p showed suggestive evidence for linkage of serum leptin levels in a genome-wide context. The peak on chromosome 2 coincided with the region containing the gene (POMC) encoding pro-opiome-lanocortin, a locus previously linked to leptin levels and fat mass in a Mexican-American population(3) and shown to be mutated in obese humans(5). Our results suggest that there is a major gene on chromosome 10p implicated in the development of human obesity, and the existence of two further loci influencing leptin levels.	Inst Biol, CNRS EP 10, F-59019 Lille, France; Hop Hotel Dieu, Dept Nutr, Paris, France; Univ Bonn, Inst Klin Biochem, D-5300 Bonn, Germany		Froguel, P (corresponding author), Inst Biol, CNRS EP 10, 1 Rue Prof Calmette, F-59019 Lille, France.	jorg.hager@xenope.pasteur.lille.fr; froguel@xenope.pasteur-lille.fr	Dina, Christian R/D-3535-2015; Clement, karine/R-1120-2017; FROGUEL, Philippe/O-6799-2017	Dina, Christian R/0000-0002-7722-7348; FROGUEL, Philippe/0000-0003-2972-0784			Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Francke S, 1997, HUM GENET, V100, P491, DOI 10.1007/s004390050540; FRAYN KN, 1992, CLIN SCI, V82, P1, DOI 10.1042/cs0820001; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; NAGGERT JK, 1995, NAT GENET, V10, P153; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Norman RA, 1996, DIABETES, V45, P1229, DOI 10.2337/diabetes.45.9.1229; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; TIRET L, 1992, GENET EPIDEMIOL, V9, P389, DOI 10.1002/gepi.1370090603; TRAN LD, 1994, SAGE STAT ANAL GENET; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	27	305	314	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					304	308		10.1038/3123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	WOS:000076698100029	9806554				2022-01-24	
J	Bassett, JHD; Forbes, SA; Pannett, AAJ; Lloyd, SE; Christie, PT; Wooding, C; Edwards, CR; Monson, JP; Sampson, J; Wass, JAH; Harding, B; Besser, GM; Wheeler, MH; Thakker, RV				Bassett, JHD; Forbes, SA; Pannett, AAJ; Lloyd, SE; Christie, PT; Wooding, C; Edwards, CR; Monson, JP; Sampson, J; Wass, JAH; Harding, B; Besser, GM; Wheeler, MH; Thakker, RV			Characterization of mutations in patients with multiple endocrine neoplasia type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY RETINOBLASTOMA; MOLECULAR-GENETICS; CHROMOSOME-11; SPECTRUM; MUTAGENESIS; ASSOCIATION; MECHANISMS; DISEASE; ALLELES	Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by turners of the parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene, on chromosome 11q13, has recently been cloned, and mutations have been identified. We have characterized such MEN1 mutations, assessed the reliability of SSCP analysis for the detection of these mutations, and estimated the age-related penetrance for MEN1. Sixty-three unrelated MEN1 kindreds (195 affected and 396 unaffected members) were investigated for mutations in the 2,790-bp coding region and splice sites, by SSCP and DNA sequence analysis. We identified 47 mutations (12 nonsense mutations, 21 deletions, 7 insertions, 1 donor splice-site mutation, and 6 missense mutations), that were scattered throughout the coding region, together with six polymorphisms that had heterozygosity frequencies of 2%-44%. More than 10% of the mutations arose de novo, and four mutation hot spots accounted for > 25% of the mutations. SSCP was found to be a sensitive and specific mutational screening method that detected > 85% of the mutations, Two hundred and one MEN1 mutant-gene carriers (155 affected and 46 unaffected) were identified, and these helped to define the age-related penetrance of MEN1 as 7%, 52%, 87%, 95%, 99%, and 100% at 10, 20, 30, 40, 50, and 60 years of age, respectively. These results provide the basis for a molecular-generic screening approach that will supplement the clinical evaluation and genetic counseling of members of MEN1 families.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC,Clin Sci Ctr,Mol Endocrinol Grp, London W12 0NN, England; St Bartholomews Hosp, Dept Endocrinol, London, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, London, England; Univ Wales Hosp, Inst Med Genet, Cardiff, S Glam, Wales; Cardiff Royal Infirm, Dept Surg, Cardiff, S Glam, Wales; Radcliffe Infirm, Dept Endocrinol, Oxford OX2 6HE, England		Thakker, RV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC,Clin Sci Ctr,Mol Endocrinol Grp, Du Cane Rd, London W12 0NN, England.	rthakker@rpms.ac.uk		Thakker, Rajesh/0000-0002-1438-3220			Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Bassett JHD, 1997, HUM GENET, V100, P657, DOI 10.1007/s004390050569; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; Brown MA, 1997, TRENDS GENET, V13, P202, DOI 10.1016/S0168-9525(97)01132-3; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; COOPER DN, 1991, HUM GENET, V87, P409; Courseaux A, 1996, GENOMICS, V37, P354, DOI 10.1006/geno.1996.0570; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; KRAWCZAK M, 1991, HUM GENET, V86, P425; LARSSON C, 1992, J CLIN INVEST, V89, P1344, DOI 10.1172/JCI115720; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LARSSON C, 1995, J INTERN MED, V238, P239, DOI 10.1111/j.1365-2796.1995.tb00929.x; Lemmens I, 1997, GENOMICS, V44, P94, DOI 10.1006/geno.1997.4872; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Pang JT, 1996, HUM GENET, V97, P732; PANG JT, 1994, EUR J CANCER, V30A, P1961, DOI 10.1016/0959-8049(94)00387-K; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; RIPLEY LS, 1986, J MOL BIOL, V191, P601, DOI 10.1016/0022-2836(86)90448-1; Stock JL, 1997, J CLIN ENDOCR METAB, V82, P486, DOI 10.1210/jc.82.2.486; THAKKER RV, 1993, J CLIN INVEST, V91, P2815, DOI 10.1172/JCI116524; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; THAKKER RV, 1993, CLIN ENDOCRINOL, V38, P1, DOI 10.1111/j.1365-2265.1993.tb00964.x; Thakker RV, 1995, ENDOCRINOLOGY, P2815; Trump D, 1996, QJM-INT J MED, V89, P653; VARMUS HE, 1984, ANNU REV GENET, V18, P553; WERMER P, 1954, AM J MED, V16, P363, DOI 10.1016/0002-9343(54)90353-8	29	305	310	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					232	244		10.1086/301729			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	WOS:000072416000005	9463336	Bronze, Green Published			2022-01-24	
J	THOMSON, G				THOMSON, G			MAPPING DISEASE GENES - FAMILY-BASED ASSOCIATION STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; HAPLOTYPE-RELATIVE-RISK; LINKAGE DISEQUILIBRIUM; HLA; IDDM; MARKER; INHERITANCE; STRENGTH; ANTIGENS; COMPLEX	With recent rapid advances in mapping of the human genome, including highly polymorphic and closely linked markers, studies of marker associations with disease are increasingly relevant for mapping disease genes. The use of nuclear-family data in association studies was initially developed to avoid possible ethnic mismatching between patients and randomly ascertained controls. The parental marker alleles not transmitted to an affected child or never transmitted to an affected sib pair form the so-called AFBAC (affected family-based controls) population. In this paper, the theoretical foundation of the AFBAC method is proved for any single-locus model of disease and for any nuclear family-based ascertainment scheme. In a random-mating population, when there is a marker association with disease, the AFBAC population provides an unbiased estimate of the overall population (control) marker alleles when the recombination fraction (theta) between the marker and disease genes is sufficiently small that it can be taken as zero (theta = 0). With population stratification, only marker associations present in the subpopulations will be detected with family-based analyses. Of more importance, however, is the fact that, when theta not equal 0, differences between transmitted parental (patient) marker allele frequencies and non- or never-transmitted parental marker allele frequencies (implying a marker association with disease) can only be observed for marker genes linked to a disease gene (theta < 1/2). Thus, associations of unlinked marker loci with disease at the population level, caused by population stratification, migration, or admixture, are eliminated. This validates the use of family-based association tests as an appropriate strategy for mapping disease genes.			THOMSON, G (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,3060 VALLEY LIFE SCI BLDG,BERKELEY,CA 94720, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD012731] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD12731] Funding Source: Medline		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Breslow N, 1980, STATISTICAL METHODS, V32; COX NJ, 1988, AM J HUM GENET, V42, P167; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEAN M, 1994, AM J HUM GENET, V55, P788; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FALK CT, 1989, GENET EPIDEMIOL, V6, P95, DOI 10.1002/gepi.1370060118; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; FIELD LL, 1986, GENET EPIDEMIOL S, V1, P323; HILL WG, 1994, AM J HUM GENET, V54, P705; HODGE SE, 1993, AM J HUM GENET, V53, P367; HODGE SE, 1994, AM J HUM GENET, V54, P560; JIN K, 1994, BIOMETRICS, V50, P1189, DOI 10.2307/2533457; JORDE LB, 1994, AM J HUM GENET, V54, P884; KHOURY MJ, 1994, AM J HUM GENET, V55, P414; KLITZ W, 1992, EVOL BIOL, V26, P35; KNAPP M, 1993, AM J HUM GENET, V52, P1085; LECHLER R, 1994, HLA DISEASE; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; MAXWELL AE, 1970, BRIT J PSYCHIAT, V116, P651, DOI 10.1192/bjp.116.535.651; MOTRO U, 1985, GENETICS, V110, P525; NEI M, 1973, GENETICS, V75, P213; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Risch N., 1992, American Journal of Human Genetics, V51, pA13; Rothman K., 1986, MODERN EPIDEMIOLOGY; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1994, AM J HUM GENET, V54, P559; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; SPIELMAN RS, 1993, AM J HUM GENET, V53, P863; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; SUAREZ BK, 1994, AM J HUM GENET, V54, P554; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1993, GENET EPIDEMIOL, V10, P289, DOI 10.1002/gepi.1370100503; THOMSON G, 1977, GENETICS, V85, P753; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1991, IMMUNOGENETICS AUTOI, V1, P188; THOMSON G, 1995, AM J HUM GENET, V57; THOMSON G, 1976, POPULATION GENETICS, P465; TIRET I, 1993, ANN HUM GENET, V57, P141, DOI 10.1111/j.1469-1809.1993.tb00895.x; TIWARI JL, 1985, HLA DISEASE ASS	52	305	306	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					487	498					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	WOS:A1995RL77100032	7668275				2022-01-24	
J	LASPADA, AR; ROLING, DB; HARDING, AE; WARNER, CL; SPIEGEL, R; HAUSMANOWAPETRUSEWICZ, I; YEE, WC; FISCHBECK, KH				LASPADA, AR; ROLING, DB; HARDING, AE; WARNER, CL; SPIEGEL, R; HAUSMANOWAPETRUSEWICZ, I; YEE, WC; FISCHBECK, KH			MEIOTIC STABILITY AND GENOTYPE-PHENOTYPE CORRELATION OF THE TRINUCLEOTIDE REPEAT IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE GENETICS			English	Article							FRAGILE-X; GENE; LOCALIZATION	Expansion of the trinucleotide repeat (CAG)n in the first exon of the androgen receptor gene is associated with a rare motor neuron disorder, X-linked spinal and bulbar muscular atrophy. We have found that expanded (CAG)n alleles undergo alteration in length when transmitted from parent to offspring. Of 45 meioses examined, 12 (27%) demonstrated a change in CAG repeat number. Both expansions and contractions were observed, although their magnitude was small. There was a greater rate of instability in male meiosis than in female meiosis. We also found evidence for a correlation between disease severity and CAG repeat length, but other factors seem to contribute to the phenotypic variability in this disorder.	NATL HOSP,INST NEUROL,LONDON WC1N 3BG,ENGLAND; MILLARD FILLMORE HOSP,INST DENT NEUROL,BUFFALO,NY 14209; UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; POLISH ACAD SCI,NEUROMUSCULAR UNIT,PL-02097 WARSAW,POLAND; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110		LASPADA, AR (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,CRB 250,U22 CURIE BLVD,PHILADELPHIA,PA 19104, USA.		La Spada, Albert/AAG-8809-2020				ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN CJ, 1989, AM J HUM GENET, V44, P264; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FISCHBECK KH, 1991, ADV NEUROL, V56, P209; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H	21	305	307	1	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					301	304		10.1038/ng1292-301			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	WOS:A1992KB49500014	1303283				2022-01-24	
J	WRIGHT, S; DOBZHANSKY, T				WRIGHT, S; DOBZHANSKY, T			GENETICS OF NATURAL POPULATIONS .12. EXPERIMENTAL REPRODUCTION OF SOME OF THE CHANGES CAUSED BY NATURAL SELECTION IN CERTAIN POPULATIONS OF DROSOPHILA-PSEUDOOBSCURA	GENETICS			English	Article																	Dobzhansky T, 1943, GENETICS, V28, P304; Dobzhansky T, 1943, GENETICS, V28, P162; Dobzhansky T, 1944, GENETICS, V29, P270; Dobzhansky T, 1942, GENETICS, V27, P463; DOBZHANSKY T, 1944, CARNEGIE I WASH PUBL, V554, P1; DUBININ NP, 1945, AM NAT, V79, P570, DOI 10.1086/281297; Fisher Ronald A., 1922, P R SOC EDINBURGH, V42, P321, DOI DOI 10.1007/BF02459576; GERSHENSON S, 1945, GENETICS, V30, P233; Hovanitz W, 1944, GENETICS, V29, P31; L'Heritier P., 1937, Archives de Zoologie Experimentale et Generale Paris, V78, P255; LHERITIER P, 1933, CR ACAD SCI, V198, P770; TIMOFEEFF-RESSOVSKY N. W., 1940, BIOL ZENTRALBL, V60, P130; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5	14	305	309	2	14	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1946	31	2					125	156					32	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW827	WOS:A1946XW82700002	21021044				2022-01-24	
J	Zhou, Q; Wang, HY; Schwartz, DM; Stoffels, M; Park, YH; Zhang, Y; Yang, D; Demirkaya, E; Takeuchi, M; Tsai, WXL; Lyons, JJ; Yu, XM; Ouyang, C; Chen, C; Chin, DT; Zaal, K; Chandrasekharappa, SC; Hanson, EP; Yu, Z; Mullikin, JC; Hasni, SA; Wertz, IE; Ombrello, AK; Stone, DL; Hoffmann, P; Jones, A; Barham, BK; Leavis, HL; van Royen-Kerkof, A; Sibley, C; Batu, ED; Gul, A; Siegel, RM; Boehm, M; Milner, JD; Ozen, S; Gadina, M; Chae, J; Laxer, RM; Kastner, DL; Aksentijevich, I				Zhou, Qing; Wang, Hongying; Schwartz, Daniella M.; Stoffels, Monique; Park, Yong Hwan; Zhang, Yuan; Yang, Dan; Demirkaya, Erkan; Takeuchi, Masaki; Tsai, Wanxia Li; Lyons, Jonathan J.; Yu, Xiaomin; Ouyang, Claudia; Chen, Celeste; Chin, David T.; Zaal, Kristien; Chandrasekharappa, Settara C.; Hanson, Eric P.; Yu, Zhen; Mullikin, James C.; Hasni, Sarfaraz A.; Wertz, Ingrid E.; Ombrello, Amanda K.; Stone, Deborah L.; Hoffmann, Patrycja; Jones, Anne; Barham, Beverly K.; Leavis, Helen L.; van Royen-Kerkof, Annet; Sibley, Cailin; Batu, Ezgi D.; Guel, Ahmet; Siegel, Richard M.; Boehm, Manfred; Milner, Joshua D.; Ozen, Seza; Gadina, Massimo; Chae, JaeJin; Laxer, Ronald M.; Kastner, Daniel L.; Aksentijevich, Ivona			Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease	NATURE GENETICS			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NLRP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; GERMLINE MUTATIONS; TUMOR SUPPRESSION; LUBAC DEFICIENCY; UBIQUITIN; ASSOCIATION	Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity(1). Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-kappa B regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behcet's disease, which is typically considered a polygenic disorder with onset in early adulthood(2). A20 is a potent inhibitor of the NF-kappa B signaling pathway(3). Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of I kappa B alpha and nuclear translocation of the NF-kappa B p65 subunit together with increased expression of NF-kappa B-mediated proinflammatory cytokines. A20 restricts NF-kappa B signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-kappa B-dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.	[Zhou, Qing; Wang, Hongying; Stoffels, Monique; Park, Yong Hwan; Takeuchi, Masaki; Chen, Celeste; Chin, David T.; Ombrello, Amanda K.; Stone, Deborah L.; Hoffmann, Patrycja; Jones, Anne; Barham, Beverly K.; Chae, JaeJin; Kastner, Daniel L.; Aksentijevich, Ivona] NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA; [Schwartz, Daniella M.] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Mol Immunol & Inflammat Branch, Bethesda, MD USA; [Zhang, Yuan; Lyons, Jonathan J.; Yu, Xiaomin; Milner, Joshua D.] Lab Allerg Dis, Natl Inst Allergy & Infect Dis, Genet & Pathogenesis Allergy Sect, Bethesda, MD USA; [Yang, Dan; Yu, Zhen; Boehm, Manfred] Lab Cardiovasc Regenerat Med Natl Heart Lung, Bethesda, MD USA; [Yang, Dan; Yu, Zhen; Boehm, Manfred] Blood Inst, Bethesda, MD USA; [Demirkaya, Erkan] Gulhane Mil Med Acad, FMF Arthrit Vasculitis & Orphan Dis Res Ctr FAVOR, Ankara, Turkey; [Tsai, Wanxia Li; Gadina, Massimo] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Translat Immunol Sect, Bethesda, MD USA; [Ouyang, Claudia; Hanson, Eric P.; Siegel, Richard M.] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Autoimmun Branch, Bethesda, MD USA; [Zaal, Kristien] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Light Imaging Sect, Bethesda, MD USA; [Chandrasekharappa, Settara C.] NHGRI, Canc Genet & Comparat Genom Branch, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, Natl Inst Hlth Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Hasni, Sarfaraz A.] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Syst Autoimmune Branch, Bethesda, MD USA; [Wertz, Ingrid E.] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA; [Leavis, Helen L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [van Royen-Kerkof, Annet] Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands; [Sibley, Cailin] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Batu, Ezgi D.; Ozen, Seza] Hacettepe Univ, Dept Pediat Rheumatol, Ankara, Turkey; [Guel, Ahmet] Istanbul Univ, Dept Internal Med, Istanbul, Turkey; [Laxer, Ronald M.] Univ Toronto, Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada		Aksentijevich, I (corresponding author), NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA.	aksentii@mail.nih.gov	Batu, Ezgi Deniz/F-9761-2018; OZEN, SEZA/I-9096-2013; Yu, Xiaomin/I-6407-2016; Zhang, Yuan/C-7777-2018; Gul, Ahmet/AAT-7787-2020; Gadina, Massimo/R-4195-2019; Demirkaya, Erkan/F-5082-2019; Aksentijevich, Ivona/AAF-1335-2019	Batu, Ezgi Deniz/0000-0003-1065-2363; Zhang, Yuan/0000-0001-9932-917X; Gul, Ahmet/0000-0001-8219-3720; Demirkaya, Erkan/0000-0003-4525-1789; Lyons, Jonathan/0000-0002-2346-8189; Schwartz, Daniella/0000-0002-1660-8438; Ombrello, Amanda/0000-0001-5563-9416; Hanson, Eric/0000-0002-0318-4779	Intramural Research Programs of the National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI); National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); US National Institutes of Health Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Research Fellowship Program for International Researchers - Scientific and Technological Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [B.14.2.TBT.0.06.01-219-84]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [ZIAHL006077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZICHG200346, ZIAHG200373, ZIBHG000196, ZIAHG000029, ZIAHG200374, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [ZIAAI001183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [ZICAR041186, ZICAR041181, ZIEAR041176, K23AR068440, ZIDAR041180, ZIAAR041187, ZIAAR041133, ZIAAR041175] Funding Source: NIH RePORTER	We thank V. Dixit for helpful discussions. We also thank all the patients and their families, and the healthy children and adult controls, for their enthusiastic support during this research study. This research was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, and the US National Institutes of Health Clinical Center. S.O. received royalties for consulting and speaking from Novartis and SOBI. H.L.L. received royalties for consulting from Baxter. E.D. was recipient of the Research Fellowship Program for International Researchers, which is supported by the Scientific and Technological Research Council of Turkey (TUBITAK; B.14.2.TBT.0.06.01-219-84).	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jesus AA, 2014, ANNU REV MED, V65, P223, DOI 10.1146/annurev-med-061512-150641; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Ma CA, 2011, HUM MUTAT, V32, P318, DOI 10.1002/humu.21439; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Moghaddas F, 2015, CYTOKINE, V74, P237, DOI 10.1016/j.cyto.2015.02.012; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nititham J, 2015, GENES IMMUN, V16, P120, DOI 10.1038/gene.2014.75; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Russo RAG, 2014, RHEUMATOLOGY, V53, P1927, DOI 10.1093/rheumatology/keu170; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang HY, 2013, P NATL ACAD SCI USA, V110, P5127, DOI 10.1073/pnas.1221211110; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	48	304	315	4	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					67	+		10.1038/ng.3459			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	WOS:000367255300015	26642243	Green Accepted, Green Published	Y	N	2022-01-24	
J	Guo, GW; Sun, XJ; Chen, C; Wu, S; Huang, PD; Li, ZS; Dean, M; Huang, Y; Jia, WL; Zhou, Q; Tang, AF; Yang, ZQ; Li, XX; Song, PF; Zhao, XK; Ye, R; Zhang, SQ; Lin, Z; Qi, MF; Wan, SQ; Xie, LF; Fan, F; Nickerson, ML; Zou, XJ; Hu, XD; Xing, L; Lv, ZJ; Mei, HB; Gao, SJ; Liang, CZ; Gao, ZB; Lu, JX; Yu, Y; Liu, CX; Li, L; Fang, XD; Jiang, ZM; Yang, J; Li, CL; Zhao, X; Chen, J; Zhang, F; Lai, YQ; Lin, ZG; Zhou, FJ; Chen, H; Chan, HC; Tsang, S; Theodorescu, D; Li, YR; Zhang, XQ; Wang, J; Yang, HM; Gui, YT; Wang, J; Cai, ZM				Guo, Guangwu; Sun, Xiaojuan; Chen, Chao; Wu, Song; Huang, Peide; Li, Zesong; Dean, Michael; Huang, Yi; Jia, Wenlong; Zhou, Quan; Tang, Aifa; Yang, Zuoquan; Li, Xianxin; Song, Pengfei; Zhao, Xiaokun; Ye, Rui; Zhang, Shiqiang; Lin, Zhao; Qi, Mingfu; Wan, Shengqing; Xie, Liangfu; Fan, Fan; Nickerson, Michael L.; Zou, Xiangjun; Hu, Xueda; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Gao, Shengjie; Liang, Chaozhao; Gao, Zhibo; Lu, Jingxiao; Yu, Yuan; Liu, Chunxiao; Li, Lin; Fang, Xiaodong; Jiang, Zhimao; Yang, Jie; Li, Cailing; Zhao, Xin; Chen, Jing; Zhang, Fang; Lai, Yongqi; Lin, Zheguang; Zhou, Fangjian; Chen, Hao; Chan, Hsiao Chang; Tsang, Shirley; Theodorescu, Dan; Li, Yingrui; Zhang, Xiuqing; Wang, Jian; Yang, Huanming; Gui, Yaoting; Wang, Jun; Cai, Zhiming			Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation	NATURE GENETICS			English	Article							MUTATIONS; FGFR3; ANEUPLOIDY; CARCINOMA; FUSIONS; VARIANT	Bladder cancer is one of the most common cancers worldwide, with transitional cell carcinoma (TCC) being the predominant form. Here we report a genomic analysis of TCC by both whole-genome and whole-exome sequencing of 99 individuals with TCC. Beyond confirming recurrent mutations in genes previously identified as being mutated in TCC, we identified additional altered genes and pathways that were implicated in TCC. Notably, we discovered frequent alterations in STAG2 and ESPL1, two genes involved in the sister chromatid cohesion and segregation (SCCS) process. Furthermore, we also detected a recurrent fusion involving FGFR3 and TACC3, another component of SCCS, by transcriptome sequencing of 42 DNA-sequenced tumors. Overall, 32 of the 99 tumors (32%) harbored genetic alterations in the SCCS process. Our analysis provides evidence that genetic alterations affecting the SCCS process may be involved in bladder tumorigenesis and identifies a new therapeutic possibility for bladder cancer.	[Guo, Guangwu; Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol Surg, Shenzhen, Peoples R China; [Guo, Guangwu; Chen, Chao; Huang, Peide; Jia, Wenlong; Zhou, Quan; Yang, Zuoquan; Song, Pengfei; Ye, Rui; Lin, Zhao; Wan, Shengqing; Fan, Fan; Hu, Xueda; Gao, Shengjie; Gao, Zhibo; Yu, Yuan; Li, Lin; Fang, Xiaodong; Yang, Jie; Zhao, Xin; Zhang, Fang; Li, Yingrui; Zhang, Xiuqing; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Natl Reg Key Technol Engn Lab Clin Applicat Canc, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Engn Lab Tumor Clin Immune Gene Therapy, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor, Shenzhen, Peoples R China; [Wu, Song] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Song; Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Dean, Michael; Nickerson, Michael L.] NCI, Canc & Inflammat Program, US Natl Inst Hlth NIH, Frederick, MD 21701 USA; [Li, Xianxin; Lu, Jingxiao; Jiang, Zhimao; Li, Cailing; Chen, Jing; Lai, Yongqi; Lin, Zheguang; Gui, Yaoting] Peking Univ Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Zhao, Xiaokun] Cent Southern Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Liu, Chunxiao] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Tsang, Shirley] BioMatrix, Rockville, MD USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Dept Surg, Aurora, CO USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark		Cai, ZM (corresponding author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol Surg, Shenzhen, Peoples R China.	guiyaoting@hotmail.com; wangj@genomics.org.cn; caizhiming2000@163.com	Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Chan, Hsiao Chang/E-1507-2016; Li, Yingrui/K-1064-2015; Fang, Xiaodong/K-6743-2018; zou, xiangjun/ABG-6926-2021; Chen, Hao/D-3425-2012; Chen, Hao/AAH-4124-2020; Jia, Justin/AAV-4349-2021; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Gao, Shengjie/S-4016-2017	Dean, Michael C/0000-0003-2234-0631; Fang, Xiaodong/0000-0001-7061-3337; zou, xiangjun/0000-0001-5146-599X; Chen, Hao/0000-0001-8319-8101; Chen, Hao/0000-0001-8319-8101; Jia, Justin/0000-0002-7136-9919; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Peide, Huang/0000-0001-6108-5069; Ye, Rui/0000-0002-4866-088X; Gao, Shengjie/0000-0002-5221-8381	Chinese High-Tech (863) ProgramNational High Technology Research and Development Program of China [2012AA02A201, 2012AA02A208]; Guangdong Innovative Research Team Program [2009010016]; State Key Development Program for Basic Research of China-973 ProgramNational Basic Research Program of ChinaState Key Development Program for Basic Research of China [2011CB809203, 2014CB745200]; Shenzhen Municipal Government of China [JC201005260191A, CXB201108250096A, ZDSY20120615154448514, BGI20100001]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIABC011301, ZIABC011300] Funding Source: NIH RePORTER	This work was supported by grants from the Chinese High-Tech (863) Program (2012AA02A201 and 2012AA02A208), the Guangdong Innovative Research Team Program (2009010016), the State Key Development Program for Basic Research of China-973 Program (2011CB809203 and 2014CB745200) and the Shenzhen Municipal Government of China (JC201005260191A, CXB201108250096A, ZDSY20120615154448514 and BGI20100001).	Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bertino JR, 1996, ONCOLOGIST, V1, P223, DOI DOI 10.1634/THEONCOLOGIST.1-4-223; CAIRNS P, 1991, ONCOGENE, V6, P2305; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; CORDONCARDO C, 1994, INT J CANCER, V56, P347, DOI 10.1002/ijc.2910560309; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hornigold N, 1999, ONCOGENE, V18, P2657, DOI 10.1038/sj.onc.1202854; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamada NA, 2011, CYTOGENET GENOME RES, V132, P248, DOI 10.1159/000322717; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	39	304	315	3	123	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1459	U213		10.1038/ng.2798			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	WOS:000327715800011	24121792	Green Accepted			2022-01-24	
J	Hon, GC; Rajagopal, N; Shen, Y; McCleary, DF; Yue, F; Dang, MD; Ren, B				Hon, Gary C.; Rajagopal, Nisha; Shen, Yin; McCleary, David F.; Yue, Feng; Dang, My D.; Ren, Bing			Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; CPG ISLAND SHORES; HUMAN GENOME; REGULATORY SEQUENCES; GENE-EXPRESSION; HUMAN PLACENTA; CHROMATIN; CANCER; HYPOMETHYLATION; METHYLOME	Mammalian development requires cytosine methylation, a heritable epigenetic mark of cellular memory believed to maintain a cell's unique gene expression pattern. However, it remains unclear how dynamic DNA methylation relates to cell type-specific gene expression and animal development. Here, by mapping base-resolution methylomes in 17 adult mouse tissues at shallow coverage, we identify 302,864 tissue-specific differentially methylated regions (tsDMRs) and estimate that >6.7% of the mouse genome is variably methylated. Supporting a prominent role for DNA methylation in gene regulation, most tsDMRs occur at distal cis-regulatory elements. Unexpectedly, some tsDMRs mark enhancers that are dormant in adult tissues but active in embryonic development. These 'vestigial' enhancers are hypomethylated and lack active histone modifications in adult tissues but nevertheless exhibit activity during embryonic development. Our results provide new insights into the role of DNA methylation at tissue-specific enhancers and suggest that epigenetic memory of embryonic development may be retained in adult tissues.	[Hon, Gary C.; Shen, Yin; McCleary, David F.; Yue, Feng; Dang, My D.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA USA; [Rajagopal, Nisha; Ren, Bing] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Gen Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, San Diego Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA		Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA USA.	biren@ucsd.edu			Ludwig Institute for Cancer Research; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HG003991, ES017166]; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG006997, R01HG003991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [U01ES017166] Funding Source: NIH RePORTER	We thank S. Kuan, Z. Ye and L. Edsall for their assistance in sequencing and the initial processing of sequencing reads. This work is funded by the Ludwig Institute for Cancer Research and the US National Institutes of Health (R01 HG003991 and ES017166).	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GILBERT SF, 2000, DEV BIOL; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; MONK M, 1987, DEVELOPMENT, V99, P371; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 2002, J NUTR, V132, p2462S, DOI 10.1093/jn/132.8.2462S; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Reichert H, 2009, BIOL LETTERS, V5, P112, DOI 10.1098/rsbl.2008.0337; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035	59	304	307	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1198	U340		10.1038/ng.2746			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	WOS:000324989600016	23995138	Green Accepted, Green Submitted			2022-01-24	
J	Saitsu, H; Nishimura, T; Muramatsu, K; Kodera, H; Kumada, S; Sugai, K; Kasai-Yoshida, E; Sawaura, N; Nishida, H; Hoshino, A; Ryujin, F; Yoshioka, S; Nishiyama, K; Kondo, Y; Tsurusaki, Y; Nakashima, M; Miyake, N; Arakawa, H; Kato, M; Mizushima, N; Matsumoto, N				Saitsu, Hirotomo; Nishimura, Taki; Muramatsu, Kazuhiro; Kodera, Hirofumi; Kumada, Satoko; Sugai, Kenji; Kasai-Yoshida, Emi; Sawaura, Noriko; Nishida, Hiroya; Hoshino, Ai; Ryujin, Fukiko; Yoshioka, Seiichiro; Nishiyama, Kiyomi; Kondo, Yukiko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Arakawa, Hirokazu; Kato, Mitsuhiro; Mizushima, Noboru; Matsumoto, Naomichi			De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood	NATURE GENETICS			English	Article							BRAIN IRON ACCUMULATION; PROTEIN FAMILY; BINDING-SITES; ATG PROTEINS; MICE; MECHANISMS; MITOPHAGY; PROPPINS; DISTINCT; DISEASE	Static encephalopathy of childhood with neurodegeneration in adulthood (SENDA) is a recently established subtype of neurodegeneration with brain iron accumulation (NBIA)(1-3). By exome sequencing, we found de novo heterozygous mutations in WDR45 at Xp11.23 in two individuals with SENDA, and three additional WDR45 mutations were identified in three other subjects by Sanger sequencing. Using lymphoblastoid cell lines (LCLs) derived from the subjects, aberrant splicing was confirmed in two, and protein expression was observed to be severely impaired in all five. WDR45 encodes WD-repeat domain 45 (WDR45). WDR45 (also known as WIP14) is one of the four mammalian homologs of yeast Atgl 8, which has an important role in autophagy(4,5). Lower autophagic activity and accumulation of aberrant early autophagic structures were demonstrated in the LCLs of the affected subjects. These findings provide direct evidence that an autophagy defect is indeed associated with a neurodegenerative disorder in humans.	[Saitsu, Hirotomo; Kodera, Hirofumi; Nishiyama, Kiyomi; Kondo, Yukiko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Nishimura, Taki; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Grad Sch, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Muramatsu, Kazuhiro; Sawaura, Noriko; Arakawa, Hirokazu] Gunma Univ, Dept Pediat, Grad Sch Med, Gunma, Japan; [Kumada, Satoko; Kasai-Yoshida, Emi] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Tokyo, Japan; [Sugai, Kenji] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Nishida, Hiroya; Hoshino, Ai] Natl Rehabil Ctr Children Disabil, Dept Pediat, Tokyo, Japan; [Ryujin, Fukiko; Yoshioka, Seiichiro] Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; [Kato, Mitsuhiro] Yamagata Univ, Dept Pediat, Fac Med, Yamagata 990, Japan		Saitsu, H (corresponding author), Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	hsaitsu@yokohama-cu.ac.jp; nmizu@m.u-tokyo.ac.jp; naomat@yokohama-cu.ac.jp	NISHIMURA, TAKI/I-6616-2018; Mizushima, Noboru/C-3635-2009; Muramatsu, Kazuhiro/AAA-6350-2021; Saitsu, Hirotomo/AAM-7131-2021	NISHIMURA, TAKI/0000-0003-4019-5984; Mizushima, Noboru/0000-0002-6258-6444; Muramatsu, Kazuhiro/0000-0001-9256-5591; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553; Tsurusaki, Yoshinori/0000-0002-7240-6355			Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Kasai-Yoshida E, 2013, MOVEMENT DISORD, V28, P397, DOI 10.1002/mds.25158; Kimura Y, 2013, BRAIN DEV-JPN, V35, P458, DOI 10.1016/j.braindev.2012.07.008; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lu Q, 2011, DEV CELL, V21, P343, DOI 10.1016/j.devcel.2011.06.024; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	34	304	310	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2013	45	4					445	449		10.1038/ng.2562			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	WOS:000316840600017	23435086				2022-01-24	
J	Zhang, DD; Cheng, LJ; Badner, JA; Chen, C; Chen, Q; Luo, W; Craig, DW; Redman, M; Gershon, ES; Liu, CY				Zhang, Dandan; Cheng, Lijun; Badner, Judith A.; Chen, Chao; Chen, Qi; Luo, Wei; Craig, David W.; Redman, Margot; Gershon, Elliot S.; Liu, Chunyu			Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; NEUROPATHOLOGY CONSORTIUM; LINKAGE DISEQUILIBRIUM; GENOME; METHYLTRANSFERASE; EXPRESSION; ASSOCIATION; POPULATION; SIGNATURES; METHYLOME	We have observed extensive interindividual differences in DNA methylation of 8590 CpG sites of 6229 genes in 153 human adult cerebellum samples, enriched in CpG island "shores" and at further distances from CpG islands. To search for genetic factors that regulate this variation, we performed a genome-wide association study (GWAS) mapping of methylation quantitative trait loci (mQTLs) for the 8590 testable CpG sites. cis association refers to correlation of methylation with SNPs within 1 Mb of a CpG site. 736 CpG sites showed phenotype-wide significant cis association with 2878 SNPs (after permutation correction for all tested markers and methylation phenotypes). In trans analysis of methylation, which tests for distant regulation effects, associations of 12 CpG sites and 38 SNPs remained significant after phenotype-wide correction. To examine the functional effects of mQTLs, we analyzed 85 genes that were with genetically regulated methylation we observed and for which we had quality gene expression data. Ten genes showed SNP-methylation-expression three-way associations-the same SNP simultaneously showed significant association with both DNA methylation and gene expression, while DNA methylation was significantly correlated with gene expression. Thus, we demonstrated that DNA methylation is frequently a heritable continuous quantitatively variable trait in human brain. Unlike allele-specific methylation, genetic polymorphisms mark both cis- and trans-regulatory genetic sites at measurable distances from their CpG sites. Some of the genetically regulated DNA methylation is directly connected with genetically regulated gene expression variation.	[Zhang, Dandan; Cheng, Lijun; Badner, Judith A.; Chen, Chao; Chen, Qi; Luo, Wei; Gershon, Elliot S.; Liu, Chunyu] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Gershon, Elliot S.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Craig, David W.; Redman, Margot] Translat Genom Res Inst, Phoenix, AZ 85004 USA		Liu, CY (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	cliu@yoda.bsd.uchicago.edu	Liu, chunyu/Q-3901-2017; Liu, Chunyu/G-7561-2012; Craig, David Wesley/K-6961-2019	Liu, Chunyu/0000-0002-5986-4415; Craig, David Wesley/0000-0003-2040-1955; zhang, dandan/0000-0001-5305-9856	NARSAD Distinguished Investigator Awards; Brain Research Foundation at the University of ChicagoUniversity of Chicago; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MHO80425, 51101 MH61613]; Geraldi Norton Foundation; Eklund Family; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH061613, R01MH080425] Funding Source: NIH RePORTER	The authors thank the families of the individuals involved in this study. The Stanley Medical Research Institute and its Collaborators, Drs. Elashoff, Torrey, and Webster, generously gave us access to their sample collections. This work was Supported by NARSAD Distinguished Investigator Awards (to E.S.G.), the Brain Research Foundation at the University of Chicago (to C.L.), NIH MHO80425 (to C.L.), and NIH 51101 MH61613 (to E.S.G.). Support from the Geraldi Norton Foundation and the Eklund Family is also gratefully acknowledged. We declare no conflict of interest.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, DOI 10.1176; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Oates NA, 2006, AM J HUM GENET, V79, P155, DOI 10.1086/505031; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Storey John D, 2003, Methods Mol Biol, V224, P149; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019	36	304	305	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					411	419		10.1016/j.ajhg.2010.02.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	WOS:000275678800012	20215007	Bronze, Green Published			2022-01-24	
J	Greenway, SC; Pereira, AC; Lin, JC; DePalma, SR; Israel, SJ; Mesquita, SM; Ergul, E; Conta, JH; Korn, JM; McCarroll, SA; Gorham, JM; Gabriel, S; Altshuler, DM; Quintanilla-Dieck, MD; Artunduaga, MA; Eavey, RD; Plenge, RM; Shadick, NA; Weinblatt, ME; De Jager, PL; Hafler, DA; Breitbart, RE; Seidman, JG; Seidman, CE				Greenway, Steven C.; Pereira, Alexandre C.; Lin, Jennifer C.; DePalma, Steven R.; Israel, Samuel J.; Mesquita, Sonia M.; Ergul, Emel; Conta, Jessie H.; Korn, Joshua M.; McCarroll, Steven A.; Gorham, Joshua M.; Gabriel, Stacey; Altshuler, David M.; Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Eavey, Roland D.; Plenge, Robert M.; Shadick, Nancy A.; Weinblatt, Michael E.; De Jager, Philip L.; Hafler, David A.; Breitbart, Roger E.; Seidman, Jonathan G.; Seidman, Christine E.			De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; DEPENDENT PROBE AMPLIFICATION; MUTATIONS CAUSE NOONAN; HYPERTROPHIC CARDIOMYOPATHY; CHROMOSOME 1Q21.1; ALAGILLE-SYNDROME; HUMAN GENOME; SCHIZOPHRENIA; DELETIONS; DUPLICATIONS	Tetralogy of Fallot (TOF), the most common severe congenital heart malformation, occurs sporadically, without other anomaly, and from unknown cause in 70% of cases. Through a genome-wide survey of 114 subjects with TOF and their unaffected parents, we identified 11 de novo copy number variants (CNVs) that were absent or extremely rare (<0.1%) in 2,265 controls. We then examined a second, independent TOF cohort (n = 398) for additional CNVs at these loci. We identified CNVs at chromosome 1q21.1 in 1% (5/512, P = 0.0002, OR = 22.3) of nonsyndromic sporadic TOF cases. We also identified recurrent CNVs at 3p25.1, 7p21.3 and 22q11.2. CNVs in a single subject with TOF occurred at six loci, two that encode known (NOTCH1, JAG1) disease-associated genes. Our findings predict that at least 10% (4.5-15.5%, 95% confidence interval) of sporadic nonsyndromic TOF cases result from de novo CNVs and suggest that mutations within these loci might be etiologic in other cases of TOF.	[Greenway, Steven C.; Lin, Jennifer C.; DePalma, Steven R.; Israel, Samuel J.; Korn, Joshua M.; McCarroll, Steven A.; Gorham, Joshua M.; Altshuler, David M.; Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Pereira, Alexandre C.; Mesquita, Sonia M.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Ergul, Emel; Conta, Jessie H.; Breitbart, Roger E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Korn, Joshua M.; McCarroll, Steven A.; Gabriel, Stacey; Altshuler, David M.; Plenge, Robert M.; De Jager, Philip L.; Hafler, David A.] Broad Inst Harvard, Cambridge, MA USA; [Korn, Joshua M.; McCarroll, Steven A.; Gabriel, Stacey; Altshuler, David M.; Plenge, Robert M.; De Jager, Philip L.; Hafler, David A.] MIT, Cambridge, MA 02139 USA; [Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Eavey, Roland D.] Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA; [Plenge, Robert M.; Shadick, Nancy A.; Weinblatt, Michael E.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA		Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Greenway, Steven C/S-7777-2019; Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107	Howard Hughes Medical InstituteHoward Hughes Medical Institute; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Broad Institute; Pediatric Scientist Development ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P50HL074734] Funding Source: NIH RePORTER	We gratefully acknowledge the participation of families. We also thank C. Sougnez and M. Parkin for technical assistance and R. Geggel for supplying TOF images. This work was supported by grants from the Howard Hughes Medical Institute (C. E. S.), US National Institutes of Health (to C. E. S., J. G. S. and R. E. B. and to the Broad Institute (National Center for Research Resources)), Pediatric Scientist Development Program (S. C. G.) and Sarnoff Cardiovascular Research Foundation (J. C. L.). Multiple sclerosis controls were genotyped in collaboration with Affymetrix, Inc.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richards AA, 2008, PEDIATR RES, V64, P358, DOI 10.1203/PDR.0b013e31818095d0; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stern RF, 2004, BIOTECHNIQUES, V37, P399, DOI 10.2144/04373ST04; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550	38	304	317	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					931	U98		10.1038/ng.415			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	WOS:000268432900020	19597493	Green Accepted			2022-01-24	
J	Kim, HJ; Lee, HJ; Kim, H; Cho, SW; Kim, JS				Kim, Hye Joo; Lee, Hyung Joo; Kim, Hyojin; Cho, Seung Woo; Kim, Jin-Soo			Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly	GENOME RESEARCH			English	Article							ARTIFICIAL TRANSCRIPTION FACTORS; DOUBLE-STRAND BREAKS; DNA-SEQUENCES; HOMOLOGOUS RECOMBINATION; PHENOTYPIC ALTERATION; INCREASE PRODUCTION; MAMMALIAN-CELLS; BUILDING-BLOCKS; PROTEINS; SELECTION	Broad applications of zinc finger nuclease (ZFN) technology-which allows targeted genome editing-in research, medicine, and biotechnology are hampered by the lack of a convenient, rapid, and publicly available method for the synthesis of functional ZFNs. Here we describe an efficient and easy-to-practice modular-assembly method using publicly available zinc fingers to make ZFNs that can modify the DNA sequences of predetermined genomic sites in human cells. We synthesized and tested hundreds of ZFNs to target dozens of different sites in the human CCR5 gene-a co-receptor required for HIV infection-and found that many of these nucleases induced site-specific mutations in the CCR5 sequence. Because human cells that harbor CCR5 null mutations are functional and normal, these ZFNs might be used for (1) knocking out CCR5 to produce T-cells that are resistant to HIV infection in AIDS patients or (2) inserting therapeutic genes at "safe sites'' in gene therapy applications.	[Kim, Hye Joo; Lee, Hyung Joo; Kim, Hyojin; Cho, Seung Woo; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Kim, Hye Joo; Kim, Jin-Soo] Seoul Natl Univ, Biotechnol Incubating Ctr, ToolGen Inc, Seoul 151724, South Korea		Kim, JS (corresponding author), Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea.	jskim01@snu.ac.kr	Wilson, Matthew H/K-3193-2013; Kim, Hyongbum Henry/D-5804-2019; Cho, Seung Woo/B-2441-2019; Lee, Hyung Joo/D-1398-2009; KIM, Jin-Soo/M-6918-2013	Kim, Hyongbum Henry/0000-0002-4693-738X; Cho, Seung Woo/0000-0001-9091-0937; Lee, Hyung Joo/0000-0002-7030-5390; KIM, Jin-Soo/0000-0003-4847-1306			Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Bae KH, 2006, MOL CELLS, V21, P376; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Camenisch TD, 2008, MINI-REV MED CHEM, V8, P669, DOI 10.2174/138955708784567458; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chames P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni175; Chelli M, 2001, J BIOL CHEM, V276, P46975, DOI 10.1074/jbc.M106432200; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dreier B, 2000, J MOL BIOL, V303, P489, DOI 10.1006/jmbi.2000.4133; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kwon HS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni068; Kwon RJ, 2006, BIOTECHNOL LETT, V28, P9, DOI 10.1007/s10529-005-4680-7; Lee DK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh114; Lee DK, 2003, GENOME RES, V13, P2708, DOI 10.1101/gr.1397903; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Park KS, 2005, BIOTECHNOL PROGR, V21, P664, DOI 10.1021/bp049658x; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Scott CT, 2005, NAT BIOTECHNOL, V23, P915, DOI 10.1038/nbt0805-915; Shioda T, 2001, J VIROL, V75, P3462, DOI 10.1128/JVI.75.7.3462-3468.2001; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wilson JH, 2008, P NATL ACAD SCI USA, V105, P5653, DOI 10.1073/pnas.0802298105; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Yun CO, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn398	50	304	312	0	37	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2009	19	7					1279	1288		10.1101/gr.089417.108			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	468AY	WOS:000267786900015	19470664	Green Published, Bronze			2022-01-24	
J	Gerdes, JM; Liu, Y; Zaghloul, NA; Leitch, CC; Lawson, SS; Kato, M; Beachy, PA; Beales, PL; Demartino, GN; Fisher, S; Badano, JL; Katsanis, N				Gerdes, Jantje M.; Liu, Yangfan; Zaghloul, Norann A.; Leitch, Carmen C.; Lawson, Shaneka S.; Kato, Masaki; Beachy, Philip A.; Beales, Philip L.; Demartino, George N.; Fisher, Shannon; Badano, Jose L.; Katsanis, Nicholas			Disruption of the basal body comprises proteasomal function and perturbs intracellular Wnt response	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; PLANAR CELL POLARITY; INTRAFLAGELLAR TRANSPORT PROTEINS; NEURAL-TUBE DEFECTS; BETA-CATENIN; LOOP-TAIL; TRANSCRIPTION FACTORS; CONVERGENT EXTENSION; SIGNALING PATHWAYS; MOUSE	Primary cilia and basal bodies are evolutionarily conserved organelles that mediate communication between the intracellular and extracellular environments. Here we show that bbs1, bbs4 and mkks ( also known as bbs6), which encode basal body proteins, are required for convergence and extension in zebrafish and interact with wnt11 and wnt5b. Suppression of bbs1, bbs4 and mkks transcripts results in stabilization of beta-catenin with concomitant upregulation of T-cell factor ( TCF)-dependent transcription in both zebrafish embryos and mammalian ciliated cells, a defect phenocopied by the silencing of the axonemal kinesin subunit KIF3A but not by chemical disruption of the cytoplasmic microtubule network. These observations are attributable partly to defective degradation by the proteasome; suppression of BBS4 leads to perturbed proteasomal targeting and concomitant accumulation of cytoplasmic beta-catenin. Cumulatively, our data indicate that the basal body is an important regulator of Wnt signal interpretation through selective proteolysis and suggest that defects in this system may contribute to phenotypes pathognomonic of human ciliopathies.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Texas, Southwestern Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Inst Pasteur, Montevideo, Uruguay; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA		Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Fisher, Shannon/K-7351-2012; Beales, Philip/C-7367-2009; Gerdes, Jantje Mareike/M-9868-2014; Masaki, Kato/AAW-2603-2020; lawson, shaneka/AAV-1569-2021; Katsanis, Nicholas/E-1837-2012	Gerdes, Jantje Mareike/0000-0001-6885-5441; Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801843] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; ITOH K, 2005, J BIOL, V4, P1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marlow F, 2004, DEVELOPMENT, V131, P203, DOI 10.1242/dev.00915; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; ROSENBAUM JL, 1967, J CELL BIOL, V34, P345, DOI 10.1083/jcb.34.1.345; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wigley WC, 1999, J CELL BIOL, V145, P481; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	50	304	311	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1350	1360		10.1038/ng.2007.12			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	WOS:000250575900019	17906624				2022-01-24	
J	Zhivotovsky, LA; Underhill, PA; Cinnioglu, C; Kayser, M; Morar, B; Kivisild, T; Scozzari, R; Cruciani, F; Destro-Bisol, G; Spedini, G; Chambers, GK; Herrera, RJ; Yong, KK; Gresham, D; Tournev, I; Feldman, MW; Kalaydjieva, L				Zhivotovsky, LA; Underhill, PA; Cinnioglu, C; Kayser, M; Morar, B; Kivisild, T; Scozzari, R; Cruciani, F; Destro-Bisol, G; Spedini, G; Chambers, GK; Herrera, RJ; Yong, KK; Gresham, D; Tournev, I; Feldman, MW; Kalaydjieva, L			The effective mutation rate at Y chromosome short tandem repeats, with application to human population-divergence time	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-ROOTING PEDIGREES; MICROSATELLITE LOCI; GENETIC DISTANCES; HAPLOTYPES; HISTORY; ORIGINS; DIVERSITY; RESOLUTION; MARKERS; FREQUENCIES	We estimate an effective mutation rate at an average Y chromosome short-tandem repeat locus as 6.9 x 10(-4) per 25 years, with a standard deviation across loci of 5.7 x 10(-4), using data on microsatellite variation within chromosome haplogroups defined by unique-event polymorphisms in populations with documented short-term histories, as well as comparative data on worldwide populations at both the Y chromosome and various autosomal loci. This value is used to estimate the times of the African Bantu expansion, the divergence of Polynesian populations (the Maoris, Cook Islanders, and Samoans), and the origin of Gypsy populations from Bulgaria.	Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; Univ Western Australia, Western Australian Inst Med Res, Perth, WA, Australia; Estonian Bioctr, Tartu, Estonia; Univ Roma La Sapienza, Dept Genet & Mol Biol, Rome, Italy; Univ Roma La Sapienza, Dept Human & Anim Biol, Sect Anthropol, Rome, Italy; Victoria Univ Wellington, Sch Biol Sci, Inst Mol Systemat, Wellington, New Zealand; Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Fdn Hlth Problems Ethn Minorities, Sofia, Bulgaria		Zhivotovsky, LA (corresponding author), Inst Gen Genet, 3 Gubkin St, Moscow 119991, Russia.		Zhivotovsky, Lev A/A-1351-2012; Cruciani, Fulvio/G-6105-2012; Kivisild, Toomas/P-5889-2017; Morar, Bharti/O-8697-2014	Kivisild, Toomas/0000-0002-6297-7808; Morar, Bharti/0000-0003-3897-1403; Cruciani, Fulvio/0000-0002-6900-024X; Chambers, Geoffrey/0000-0003-1019-6855; Destro Bisol, Giovanni/0000-0002-4232-9715	FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R03TW005540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM028428, R01GM028016] Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R03 TW005540] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM107466, P01 GM028428, GM28428, GM28016, R01 GM028016] Funding Source: Medline		Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bosch E, 2002, FORENSIC SCI INT, V125, P42, DOI 10.1016/S0379-0738(01)00627-2; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Di Rienzo A, 1998, GENETICS, V148, P1269; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Fraser A., 1992, GYPSIES; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hancock I, 2000, SCHOLARSHIP GYPSY ST; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Holtkemper U, 2001, HUM MOL GENET, V10, P629, DOI 10.1093/hmg/10.6.629; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Irwin G., 1992, PREHISTORIC EXPLORAT; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; MARUSHIAKOVA E, 1997, STUDIUM TSIGANOLOGIE, V18; MCFADGEN BG, 1994, RADIOCARBON, V36, P221, DOI 10.1017/S0033822200040510; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; Nebel A, 2001, EUR J HUM GENET, V9, P22, DOI 10.1038/sj.ejhg.5200577; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SLATKIN M, 1995, GENETICS, V139, P457; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Sutton D. G., 1994, ORIGINS 1 NEW ZEALAN, P243; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; VANSINA J, 1984, J AFR HIST, V25, P129, DOI 10.1017/S0021853700022829; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; White PS, 1999, GENOMICS, V57, P433, DOI 10.1006/geno.1999.5782; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZHIVOTOVSKY LA, 1995, P NATL ACAD SCI USA, V92, P11549, DOI 10.1073/pnas.92.25.11549; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P2141, DOI 10.1093/oxfordjournals.molbev.a003759; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	59	304	319	0	22	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					50	61		10.1086/380911			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	WOS:000187723500005	14691732	Green Published, Bronze			2022-01-24	
J	Zhang, ZL; Harrison, PM; Liu, Y; Gerstein, M				Zhang, ZL; Harrison, PM; Liu, Y; Gerstein, M			Millions of years of evolution preserved: A comprehensive catalog of the processed pseudogenes in the human genome	GENOME RESEARCH			English	Article							POLYMERASE-CHAIN-REACTION; RIBOSOMAL-PROTEIN PSEUDOGENES; NUCLEOTIDE SUBSTITUTION; EXPRESSED PSEUDOGENE; MOLECULAR FOSSILS; MITOCHONDRIAL-DNA; NATURAL-SELECTION; GENE; SEQUENCE; IDENTIFICATION	Processed pseudogenes were created by reverse-transcription of mRNAs; they provide snapshots of ancient genes existing millions of years ago in the genome. To find them in the present-day human, we developed a pipeline using features such as intron-absence, frame-disruption, polyadenylation, and truncation. This has enabled us to identify in recent genome drafts similar to8000 processed pseudogenes (distributed from http://pseudogene.org). Overall, processed pseudogenes are very similar to their closest corresponding human gene, being 94% complete in coding regions, with sequence similarity of 75% for amino acids and 86% for nucleotides. Their chromosomal distribution appears random and dispersed, with the numbers on chromosomes proportional to length, suggesting sustained "bombardment" over evolution. However, it does vary with GC-content: Processed pseudogenes occur mostly in intermediate GC-content regions. This is similar to Alus but contrasts with functional genes and LI-repeats. Pseudogenes, moreover, have age profiles similar to Alus. The number of pseudogenes associated with a given gene follows a power-law relationship, with a few genes giving rise to many pseudogenes and most giving rise to few. The prevalence of processed pseudogenes agrees well with germ-line gene expression. Highly expressed ribosomal proteins account for similar to20% of the total. Other notables include cyclophilin-A, keratin, GAPDH, and cytochrome c.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA		Gerstein, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	Mark.Gerstein@yale.edu	Wilson, Matthew H/K-3193-2013; Zhang, Zhaolei/G-2369-2017		NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50HG002357] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P50 HG002357, NP50 HG02357-01] Funding Source: Medline		Alberts B., 1994, MOL BIOL CELL, V3rd; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; BENHAM FJ, 1989, GENOMICS, V5, P209, DOI 10.1016/0888-7543(89)90048-7; Bensasson D, 2000, MOL BIOL EVOL, V17, P406, DOI 10.1093/oxfordjournals.molbev.a026320; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Bernardi G, 2001, GENE, V276, P3, DOI 10.1016/S0378-1119(01)00644-8; Birney E, 2001, NATURE, V409, P827, DOI 10.1038/35057004; Boger ET, 2001, J MUSCLE RES CELL M, V22, P477, DOI 10.1023/A:1014507705858; Bramlage B, 1997, DIFFERENTIATION, V62, P13, DOI 10.1046/j.1432-0436.1997.6210013.x; BRISTOW J, 1993, J BIOL CHEM, V268, P12919; CHOONGKITTAWORN NM, 1993, BIOL REPROD, V49, P300, DOI 10.1095/biolreprod49.2.300; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Edgar AJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-18; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; EVANS MJ, 1988, P NATL ACAD SCI USA, V85, P9625, DOI 10.1073/pnas.85.24.9625; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fujii GH, 1999, ONCOGENE, V18, P1765, DOI 10.1038/sj.onc.1202492; GARCIAMEUNIER P, 1993, MAMM GENOME, V4, P695, DOI 10.1007/BF00357792; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GRAUR D, 1989, J MOL EVOL, V28, P279, DOI 10.1007/BF02103423; Guo N, 1998, MAMM GENOME, V9, P246, DOI 10.1007/s003359900735; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Harrison PM, 2002, NUCLEIC ACIDS RES, V30, P1083, DOI 10.1093/nar/30.5.1083; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Harrison PM, 2001, NUCLEIC ACIDS RES, V29, P818, DOI 10.1093/nar/29.3.818; Homma K, 2002, GENE, V294, P25, DOI 10.1016/S0378-1119(02)00794-1; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Hurteau GJ, 2002, ANAL BIOCHEM, V307, P304, DOI 10.1016/S0003-2697(02)00058-1; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KAMMA H, 1995, EXP CELL RES, V221, P187, DOI 10.1006/excr.1995.1366; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KRISMANN M, 1995, J CLIN ONCOL, V13, P2769, DOI 10.1200/JCO.1995.13.11.2769; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Luscombe NM, 2002, GENOME BIOL, V3; MACAYA G, 1976, J MOL BIOL, V108, P237, DOI 10.1016/S0022-2836(76)80105-2; Maestre J, 1995, EMBO J, V14, P6333, DOI 10.1002/j.1460-2075.1995.tb00324.x; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; Mounsey A, 2002, GENOME RES, V12, P770, DOI [10.1101/gr208802. Article published online before print in April , 10.1101/gr.208802]; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pavlicek A, 2001, GENE, V276, P39, DOI 10.1016/S0378-1119(01)00645-X; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Perna NT, 1996, CURR BIOL, V6, P128, DOI 10.1016/S0960-9822(02)00441-4; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Ruud P, 1999, INT J CANCER, V80, P119, DOI 10.1002/(SICI)1097-0215(19990105)80:1<119::AID-IJC22>3.0.CO;2-X; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shackleford G M, 2001, BMC Genomics, V2, P8, DOI 10.1186/1471-2164-2-8; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tourmen Y, 2002, GENOMICS, V80, P71, DOI 10.1006/geno.2002.6798; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weil D, 1997, GENE, V187, P115, DOI 10.1016/S0378-1119(96)00733-0; Weiner AM, 1999, CURR BIOL, V9, pR842, DOI 10.1016/S0960-9822(00)80041-X; Welch JE, 2000, J ANDROL, V21, P328; WILDE CD, 1986, CRIT REV BIOCHEM MOL, V19, P323; WILLENBRINK W, 1995, GENOMICS, V28, P101, DOI 10.1006/geno.1995.1112; Wine RN, 1997, BIOL REPROD, V56, P439, DOI 10.1095/biolreprod56.2.439; Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202; WOOD DP, 1994, J HISTOCHEM CYTOCHEM, V42, P505, DOI 10.1177/42.4.7510319; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Zhang Z, 2003, GAME-ON 2003: 4TH INTERNATIONAL CONFERENCE ON INTELLIGENT GAMES AND SIMULATION, P61; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zhang ZL, 2003, GENOMICS, V81, P468, DOI 10.1016/S0888-7543(03)00004-1; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902; ZHOU BS, 1992, CANCER RES, V52, P4280	96	304	322	0	20	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	DEC	2003	13	12					2541	2558		10.1101/gr.1429003			18	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	749KZ	WOS:000186920200004	14656962	Green Published, Bronze			2022-01-24	
J	Litt, A; Irish, VF				Litt, A; Irish, VF			Duplication and diversification in the APETALA1/FRUITFULL floral homeotic gene lineage: Implications for the evolution of floral development	GENETICS			English	Article							MADS-BOX GENES; CONTROLLING FLOWER DEVELOPMENT; MOLECULAR EVOLUTION; ANTIRRHINUM-MAJUS; MERISTEM IDENTITY; FRUIT-DEVELOPMENT; SEED PLANTS; TRANSCRIPTION FACTOR; REPRODUCTIVE-ORGANS; CONTROLLING PETAL	Phylogenetic analyses of angiosperm MADS-box genes suggest that this gene family has undergone multiple duplication events followed by sequence divergence. To determine when such events have taken place and to understand the relationships of particular MADS-box gene lineages, we have identified APETALA1/FRUITFULL-like MADS-box genes from a variety of angiosperm species. Our phylogenetic analyses show two gene clades within the core eudicots, euAP1 (including Arabidopsis APETALA1 and Antirrhinum SQUAMOSA) and euFUL (including Arabidopsis FRUITFULL). Non-core eudicot species have only sequences similar to euFUL genes (FUL-like). The predicted protein products of euFUL and FUL-like genes share a conserved C-terminal motif. In contrast, predicted products of members of the euAP1 gene clade contain a different C terminus that includes an acidic transcription activation domain and a farnesylation signal. Sequence analyses indicate that the euAP1 amino acid motifs may have arisen via a translational frameshift from the euFUL/FUL-like motif. The euAP1 gene clade includes key regulators of floral development that have been implicated in the specification of perianth identity. However, the presence of euAP1 genes only in core eudicots suggests that there may have been changes in mechanisms of floral development. that are correlated with the fixation of floral structure seen in this clade.	Yale Univ, New Haven, CT 06520 USA		Litt, A (corresponding author), Yale Univ, 266 Whitney Ave, New Haven, CT 06520 USA.	amy.litt@yale.edu					Albert VA, 1998, MOL SYSTEMATICS PLAN, P349; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; ANGENENT GC, 1995, PLANT CELL, V7, P1569, DOI 10.1105/tpc.7.10.1569; Becker A, 2000, MOL BIOL EVOL, V17, P1425, DOI 10.1093/oxfordjournals.molbev.a026243; Berbel A, 2001, PLANT J, V25, P441, DOI 10.1046/j.1365-313x.2001.00974.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Buchner P, 1998, PLANT MOL BIOL, V38, P1253, DOI 10.1023/A:1006008212200; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Doyle Jeff J., 1994, Systematic Biology, V43, P307, DOI 10.2307/2413671; DRINNAN AN, 1994, PL SYST EVOL S, V8, P93; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; EGEACORTINES M, 2000, TRENDS PLANT SCI, V5, P471; Elo A, 2001, PHYSIOL PLANTARUM, V112, P95, DOI 10.1034/j.1399-3054.2001.1120113.x; ENDRESS PK, 1992, INT J PLANT SCI, V153, pS106, DOI 10.1086/297069; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; ENDRESS PK, 1994, PLANT SYST EVOL, V192, P79, DOI 10.1007/BF00985910; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Gocal GFW, 2001, PLANT PHYSIOL, V125, P1788, DOI 10.1104/pp.125.4.1788; Gu Q, 1998, DEVELOPMENT, V125, P1509; Hasebe M, 1999, J PLANT RES, V112, P463, DOI 10.1007/PL00013878; HASEBE M, 1997, EVOLUTION DIVERSIFIC, P179; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; Immink RGH, 1999, DEVELOPMENT, V126, P5117; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Jang SH, 2002, PLANT CELL PHYSIOL, V43, P230, DOI 10.1093/pcp/pcf015; Jia HW, 2000, PLANT SCI, V155, P115, DOI 10.1016/S0168-9452(00)00191-6; KEMPIN SA, 1995, SCIENCE, V267, P522, DOI 10.1126/science.7824951; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 1999, NATURE, V399, P144, DOI 10.1038/20172; Krizek BA, 1996, P NATL ACAD SCI USA, V93, P4063, DOI 10.1073/pnas.93.9.4063; Krogan NT, 2000, NEW PHYTOL, V147, P505, DOI 10.1046/j.1469-8137.2000.00728.x; Kyozuka J, 1997, PLANT MOL BIOL, V35, P573, DOI 10.1023/A:1005885808652; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Lawton-Rauh AL, 2000, TRENDS ECOL EVOL, V15, P144, DOI 10.1016/S0169-5347(99)01816-9; Lowman AC, 1999, J HERED, V90, P514, DOI 10.1093/jhered/90.5.514; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Mellerowicz EJ, 1998, PLANTA, V206, P619, DOI 10.1007/s004250050440; Moon YH, 1999, PLANT PHYSIOL, V120, P1193, DOI 10.1104/pp.120.4.1193; Mouradov A, 1998, P NATL ACAD SCI USA, V95, P6537, DOI 10.1073/pnas.95.11.6537; Muller BM, 2001, PLANT J, V28, P169, DOI 10.1046/j.1365-313X.2001.01139.x; Pelucchi N, 2002, SEX PLANT REPROD, V15, P113, DOI 10.1007/s00497-002-0151-7; Pouteau S, 1997, DEVELOPMENT, V124, P3343; Purugganan MD, 1997, J MOL EVOL, V45, P392, DOI 10.1007/PL00006244; Purugganan MD, 1998, P NATL ACAD SCI USA, V95, P8130, DOI 10.1073/pnas.95.14.8130; PURUGGANAN MD, 1995, GENETICS, V140, P345; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; Shindo S, 1999, EVOL DEV, V1, P180, DOI 10.1046/j.1525-142x.1999.99024.x; Soltis DE, 2003, AM J BOT, V90, P461, DOI 10.3732/ajb.90.3.461; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Southerton SG, 1998, PLANT PHYSIOL, V118, P365, DOI 10.1104/pp.118.2.365; Sundstrom J, 1999, DEV GENET, V25, P253, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;253::AID-DVG8&gt;3.0.CO;2-P; Swofford D.L., 2000, PAUP PHYLOGENETIC AN; TANDRE K, 1995, PLANT MOL BIOL, V27, P69, DOI 10.1007/BF00019179; Taylor DM, 2001, RADIOACTIV ENVIRONM, V1, P1; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; [No title captured]	71	304	349	0	33	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	OCT	2003	165	2					821	833					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737HT	WOS:000186224900032	14573491				2022-01-24	
J	Deng, MH; Mehta, S; Sun, FZ; Chen, T				Deng, MH; Mehta, S; Sun, FZ; Chen, T			Inferring domain-domain interactions from protein-protein interactions	GENOME RESEARCH			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION MAPS; GENE-EXPRESSION; YEAST; PREDICTION; ALGORITHM	The interaction between proteins is one of the most important features of protein functions. Behind protein-protein interactions there are protein domains interacting physically with one another to perform the necessary functions. Therefore, understanding protein interactions at the domain level gives a global view of the protein interaction network, and possibly of protein functions. Two research groups used yeast two-hybrid assays to generate 5719 interactions between proteins of the yeast Saccharomyces cerevisiae. This allows us to study the large-scale conserved patterns of interactions between protein domains. Using evolutionarily conserved domains defined in a protein-domain database called PFAM (http://PFAM.wustl.edu), we apply a Maximum Likelihood Estimation method to infer interacting domains that are consistent with the observed protein-protein interactions. We estimate the probabilities of interactions between every pair of domains and measure the accuracies of our predictions at the protein level. Using the inferred domain-domain interactions, we predict interactions between proteins. Our predicted protein-protein interactions have a significant overlap with the protein-protein interactions (MIPS: http://mips.gfs.de) obtained by methods other than the two-hybrid assays. The mean correlation coefficient of the gene expression profiles for our predicted interaction pairs is significantly higher than that for random pairs. Our method has shown robustness in analyzing incomplete data sets and dealing with various experimental errors. We found several novel protein-protein interactions such as RPSOA interacting with APG17 and TAF40 interacting with SPT3, which are consistent with the functions of the proteins.	Univ So Calif, Dept Biol Sci, Program Mol & Computat Biol, Los Angeles, CA 90089 USA		Sun, FZ (corresponding author), Univ So Calif, Dept Biol Sci, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.		Sun, Fengzhu/G-4373-2010; Deng, Minghua/B-1316-2012; Deng, Minghua/B-5430-2012	Sun, Fengzhu/0000-0002-8552-043X; Deng, Minghua/0000-0002-9143-1898	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R29DK053392] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK53392] Funding Source: Medline		Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gomez SM, 2001, GENETICS, V159, P1291; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Hazbun TR, 2001, P NATL ACAD SCI USA, V98, P4277, DOI 10.1073/pnas.091096398; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Ito T, 2001, TRENDS BIOTECHNOL, V19, pS23, DOI 10.1016/S0167-7799(01)01790-5; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wojcik J, 2001, Bioinformatics, V17 Suppl 1, pS296	26	304	322	1	29	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724 USA	1088-9051			GENOME RES	Genome Res.	OCT	2002	12	10					1540	1548		10.1101/gr.153002			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	600ND	WOS:000178396400009	12368246	Bronze, Green Published			2022-01-24	
J	Su, B; Xiao, JH; Underhill, P; Deka, R; Zhang, WL; Akey, J; Huang, W; Shen, D; Lu, D; Luo, JC; Chu, JY; Tan, JZ; Shen, PD; Davis, R; Cavalli-Sforza, L; Chakraborty, R; Xiong, MM; Du, RF; Oefner, P; Chen, Z; Jin, L				Su, B; Xiao, JH; Underhill, P; Deka, R; Zhang, WL; Akey, J; Huang, W; Shen, D; Lu, D; Luo, JC; Chu, JY; Tan, JZ; Shen, PD; Davis, R; Cavalli-Sforza, L; Chakraborty, R; Xiong, MM; Du, RF; Oefner, P; Chen, Z; Jin, L			Y-chromosome evidence for a northward migration of modern humans into eastern Asia during the last Ice Age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-EVOLUTION; MITOCHONDRIAL-DNA; FOSSIL EVIDENCE; POPULATIONS; CHINA	The timing and nature of the arrival and the subsequent expansion of modern humans into eastern Asia remains controversial. Using Y-chromosome biallelic markers, we investigated the ancient human-migration patterns in eastern Asia. Our data indicate that southern populations in eastern Asia are much more polymorphic than northern populations, which have only a subset of the southern haplotypes. This pattern indicates that the first settlement of modern humans in eastern Asia occurred in mainland Southeast Asia during the last Ice Age, coinciding with the absence of human fossils in eastern Asia, 50,000-100,000 years ago. After the initial peopling, a great northward migration extended into northern China and Siberia.	Univ Texas, Ctr Human Genet, Houston, TX 77030 USA; Fudan Univ, Morgan Tan Int Ctr Life Sci, Shanghai 200433, Peoples R China; Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China; Natl Human Genome Ctr, Shanghai, Peoples R China; Shanghai Second Med Univ, Rui Jin Hosp, Shanghai, Peoples R China; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; Chinese Acad Sci, Inst Genet, Beijing, Peoples R China		Jin, L (corresponding author), Univ Texas, Ctr Human Genet, 6901 Bertner, Houston, TX 77030 USA.		Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; 			BALLINGER SW, 1992, GENETICS, V130, P139; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; BROOKS AS, 1990, NATURE, V344, P288, DOI 10.1038/344288a0; BROWN P, 1992, PHILOS T ROY SOC B, V337, P235, DOI 10.1098/rstb.1992.0101; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Dawson A.G., 1992, ICE AGE EARTH LATE Q; Etler DA, 1996, ANNU REV ANTHROPOL, V25, P275, DOI 10.1146/annurev.anthro.25.1.275; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; LI TY, 1992, NATURE, V357, P404; Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; Poirier F.E, 1995, HUMAN EVOLUTION CHIN; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Turner CG, 1993, ORIGIN PAST MODERN H, P216; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 1997, AM J HUM GENET, V61, pA18; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; Weng Z, 1989, ACTA ANTHR SIN, V8, P261; WILSON AC, 1992, SCI AM, V266, P68; Wolpoff MH, 1996, SCIENCE, V274, P704; ZHAO T, 1986, ACTA ANTHR SIN, V6, P1	30	304	370	1	33	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1718	1724		10.1086/302680			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	WOS:000084282500027	10577926	Bronze, Green Published			2022-01-24	
J	Bradshaw, HD; Otto, KG; Frewen, BE; McKay, JK; Schemske, DW				Bradshaw, HD; Otto, KG; Frewen, BE; McKay, JK; Schemske, DW			Quantitative trait loci affecting differences in floral morphology between two species of monkeyflower (Mimulus)	GENETICS			English	Article							MENDELIAN FACTORS; LINKAGE MAP; GENETICS; MARKERS; EVOLUTION; PLANTS; POLYMORPHISMS; SPECIATION; MUTATIONS; GROWTH	Conspicuous differences in floral morphology are partly responsible for reproductive isolation between two sympatric species of monkeyflower because of their effect on visitation of the flowers by different pollinators. Mimulus lewisii flowers are visited primarily by bumblebees, whereas M. cardinalis flowers are visited mostly by hummingbirds. The genetic control of 12 morphological differences between the flowers of M. lewisii and M. cardinalis was explored in a large linkage mapping population of F-2 plants (n = 465) to provide an accurate estimate of the number and magnitude of effect of quantitative trait loci (QTLs) governing each character. Between one and six QTLs were identified for each trait. Most (9/12) traits appear to be controlled in part by at least one major QTL explaining greater than or equal to 25% of the total phenotypic variance. This implies that either single genes of individually large effect or linked clusters of genes with a large cumulative effect can play a role in the evolution of reproductive isolation and speciation.	Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; Univ Washington, Dept Bot, Seattle, WA 98195 USA		Bradshaw, HD (corresponding author), Univ Washington, Coll Forest Resources, Box 354115, Seattle, WA 98195 USA.		McKay, John/K-3875-2012	McKay, John/0000-0003-4311-5513			ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Beavis WB, 1994, P 49 ANN CORN SORGH, P250; Beavis William D., 1998, P145; BRADSHAW HD, 1995, NATURE, V376, P762, DOI 10.1038/376762a0; Camargo LEA, 1996, THEOR APPL GENET, V92, P610, DOI 10.1007/BF00224565; CHARLESWORTH B, 1992, AM NAT, V140, P126, DOI 10.1086/285406; CHURCHILL GA, 1994, GENETICS, V138, P963; COYNE JA, 1985, AM NAT, V126, P141, DOI 10.1086/284404; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; DOEBLEY J, 1993, GENETICS, V134, P559; Fisher R A, 1930, GENETICAL THEORY NAT, P1; GEORGES M, 1995, GENETICS, V139, P907; GOTTLIEB LD, 1984, AM NAT, V123, P681, DOI 10.1086/284231; Grandillo S, 1996, THEOR APPL GENET, V92, P935, DOI 10.1007/BF00224033; GRANT V, 1994, P NATL ACAD SCI USA, V91, P10407, DOI 10.1073/pnas.91.22.10407; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HIESEY WM, 1971, EXPT STUDIES NATURE, V5, P1; HILU KW, 1983, EVOL BIOL, V16, P97; KNAPP SJ, 1995, THEOR APPL GENET, V91, P74, DOI 10.1007/BF00220861; LANDE R, 1990, GENETICS, V124, P743; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Lin JZ, 1996, GENOME, V39, P63, DOI 10.1139/g96-009; Lin JZ, 1997, GENETICS, V146, P1115; LINOLN SE, 1992, MAPPING GENES CONTRO, P1; Liu J, 1996, GENETICS, V142, P1129; Lynch M., 1998, GENETICS ANAL QUANTI, P1; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.1111/j.1558-5646.1996.tb04480.x, 10.2307/2410788]; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; OTT J, 1985, ANAL HUMAN GENETIC L, P1; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson Andrew H., 1998, P163; SMITH JM, 1983, ANNU REV GENET, V17, P11, DOI 10.1146/annurev.ge.17.120183.000303; STEBBINS GL, 1950, VARIATION EVOLUTION, P1; STUBER CW, 1992, GENETICS, V132, P823; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Visscher PM, 1996, THEOR APPL GENET, V93, P691, DOI 10.1007/BF00224064; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; ZENG ZB, 1994, GENETICS, V136, P1457	43	304	317	1	81	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	MAY	1998	149	1					367	382					16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZN696	WOS:000073672500030	9584110				2022-01-24	
J	Paetkau, D; Waits, LP; Clarkson, PL; Craighead, L; Strobeck, C				Paetkau, D; Waits, LP; Clarkson, PL; Craighead, L; Strobeck, C			An empirical evaluation of genetic distance statistics using microsatellite data from bear (Ursidae) populations	GENETICS			English	Article							ALLELE FREQUENCIES; PHYLOGENETIC TREES; EVOLUTION; LOCI; INSTABILITY; REPEATS; DIRECTIONALITY; PHYLOGEOGRAPHY; CONSTRAINTS; SEQUENCES	A large microsatellite data set from three species of bear (Ursidae) was used to empirically test the performance of six genetic distance measures in resolving relationships at a Variety of scales ranging from adjacent areas in a continuous distribution to species that diverged several million years ago. At the finest scale, while some distance measures performed extremely well, statistics developed specifically to accommodate the mutational processes of microsatellites performed relatively poorly, presumably because of the relatively higher Variance of these statistics. At the other extreme, no statistic was able to resolve the close sister relationship of polar bears and brown bears from more distantly related pairs of species. This failure is most likely due to constraints on allele distributions at microsatellite loci. At intermediate scales, both within continuous distributions and in comparisons to insular populations of late Pleistocene origin, it was not possible to define the point where linearity was lost for each of the statistics, except that it is clearly lost after relatively short periods of independent evolution. All of the statistics were affected by the amount of genetic diversity within the populations being compared, significantly complicating the interpretation of genetic distance data.	UNIV ALBERTA,DEPT BIOL SCI,EDMONTON,AB T6G 2E9,CANADA; UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84102; GOVT NW TERR,DEPT RENEWABLE RESOURCES,INUVIK,NT X0E 0T0,CANADA; MONTANA STATE UNIV,DEPT BIOL,BOZEMAN,MT 59717				Jansen, Heiko T./A-5770-2008; Strobeck, Curtis/A-3762-2014; Strobeck, Curtis/E-9998-2011	Jansen, Heiko T./0000-0003-0178-396X; Strobeck, Curtis/0000-0002-6171-3130; Waits, Lisette/0000-0002-1323-0812			Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Amos W, 1996, NAT GENET, V12, P13, DOI 10.1038/ng0196-13; BANFIELD AWF, 1987, MAMMALS CANADA; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; CALLEN DF, 1993, AM J HUM GENET, V52, P922; CANFIELD J, 1987, GRIZZLY BEAR COMPEND, P27; CHAKRABORTY R, 1977, EVOLUTION, V31, P347, DOI [10.2307/2407757, 10.1111/j.1558-5646.1977.tb01017.x]; CRAIGHEAD L, 1995, J HERED, V86, P255, DOI 10.1093/oxfordjournals.jhered.a111578; Dyke A.S., 1987, GEROGR PHYS QUATERN, V41, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Feldman MW, 1997, GENETICS, V145, P207; FITZSIMMONS NN, 1995, MOL BIOL EVOL, V12, P432; Flint R.F., 1971, GLACIAL QUATERNARY G; FORBES SH, 1995, MOL BIOL EVOL, V12, P1106; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; KIMURA M, 1964, GENETICS, V49, P725; McLachlan G, 1992, DISCRIMINANT ANAL ST; MCLELLAN B, 1994, INT C BEAR RES MAN, V9, P85; Nauta MJ, 1996, GENETICS, V143, P1021; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; PAETKAU D, 1995, MOL ECOL, V4, P519, DOI 10.1111/j.1365-294X.1995.tb00248.x; Paetkau D, 1996, CAN J ZOOL, V74, P192, DOI 10.1139/z96-023; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; PAETKAU D, 1997, IN PRESS CONSERV BIO; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; RUBINSZTEIN DC, 1995, NAT GENET, V10, P337, DOI 10.1038/ng0795-337; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; SLATKIN M, 1995, GENETICS, V139, P457; Sokal RR, 1995, BIOMETRY; Stirling I., 1993, BEARS MAJESTIC CREAT; Takezaki N, 1996, GENETICS, V144, P389; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P567, DOI 10.1006/mpev.1996.0051; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAYLOR M, 1995, ARCTIC, V48, P147; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WAITS LP, 1996, THESIS U UTAH SALT L; WAITS LP, 1997, IN PRESS CONSERV BIO; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	52	304	311	2	40	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	DEC	1997	147	4					1943	1957					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YK654	WOS:A1997YK65400035	9409849				2022-01-24	
J	Marra, MA; Kucaba, TA; Dietrich, NL; Green, ED; Brownstein, B; Wilson, RK; McDonald, KM; Hillier, LW; McPherson, JD; Waterston, RH				Marra, MA; Kucaba, TA; Dietrich, NL; Green, ED; Brownstein, B; Wilson, RK; McDonald, KM; Hillier, LW; McPherson, JD; Waterston, RH			High throughput fingerprint analysis of large-insert clones	GENOME RESEARCH			English	Article							COSMID CLONES; PHYSICAL MAP; C-ELEGANS; GENOME; SEQUENCE; CHROMOSOMES	As part of the Human Genome Project, the Washington University Genome Sequencing Center has commenced systematic sequencing of human chromsome 7. To organize and supply the effort, we have undertaken the construction of sequence-ready physical maps for defined chromosomal intervals. Map construction is a serial process composed of three main activities. First, candidate STS-positive large-insert PAC and BAC clones are identified. Next, these candidate clones are subjected to fingerprint analysis. Finally, the fingerprint data are used to assemble sequence-ready maps. The fingerprinting method we have devised is key to the success of the overall approach. We present here the details of the method and show that the fingerprints are of sufficient quality to permit the construction of megabase-size contigs in defined regions of the human genome. We anticipate that the high throughput and precision characteristic of our fingerprinting method will make it of general utility.	NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892; WASHINGTON UNIV,SCH MED,CTR GENET MED,ST LOUIS,MO 63108		Marra, MA (corresponding author), WASHINGTON UNIV,SCH MED,GENOME SEQUENCING CTR,ST LOUIS,MO 63108, USA.		McPherson, John D/D-2633-2017; Wilson, Richard K./AAF-4139-2019; Marra, Marco A/B-5987-2008	McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Marra, Marco A/0000-0001-7146-7175	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [P01HG000956, P50HG001458] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [1P50HG01458, 5P01HG00956] Funding Source: Medline		COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Marra M, 1996, GENOME RES, V6, P1118, DOI 10.1101/gr.6.11.1118; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; RILES L, 1993, GENETICS, V134, P81; Sambrook J., 1989, MOL CLONING LAB MANU; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; SODERLUND C, 1997, IN PRESS CABIOS, V13; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Taylor K, 1996, GENOME RES, V6, P235, DOI 10.1101/gr.6.4.235; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WILSON RK, 1997, IN PRESS GENOME ANAL; Wong GKS, 1997, P NATL ACAD SCI USA, V94, P5225, DOI 10.1073/pnas.94.10.5225	16	304	311	0	4	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724	1054-9803			GENOME RES	Genome Res.	NOV	1997	7	11					1072	1084		10.1101/gr.7.11.1072			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	YH823	WOS:A1997YH82300007	9371743	Bronze, Green Published			2022-01-24	
J	Kalchman, MA; Koide, HB; McCutcheon, K; Graham, RK; Nichol, K; Nishiyama, K; KazemiEsfarjani, P; Lynn, FC; Wellington, C; Metzler, M; Goldberg, YP; Kanazawa, I; Gietz, RD; Hayden, MR				Kalchman, MA; Koide, HB; McCutcheon, K; Graham, RK; Nichol, K; Nishiyama, K; KazemiEsfarjani, P; Lynn, FC; Wellington, C; Metzler, M; Goldberg, YP; Kanazawa, I; Gietz, RD; Hayden, MR			HIP1, a human homologue of S-cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; REPEAT LENGTH; LEUCINE-ZIPPER; DISEASE; PROTEIN; GENE; EXPRESSION; CYTOSKELETON; EXPANSION; IDENTIFY	Huntington disease (HD) is associated with the expansion of a polyglutamine tract, greater than 35 repeats, in the HD gene product, huntingtin. Here we describe a novel huntingtin interacting protein, HIP1, which co-localizes with huntingtin and shares sequence homology and biochemical characteristics with Sla2p, a protein essential for function of the cytoskeleton in Saccharomyces cerevisiae. The huntingtin-HIP1 interaction is restricted to the brain and is inversely correlated to the polyglutamine length in huntingtin. This provides the first molecular link between huntingtin and the neuronal cytoskeleton and suggests that, in HD, loss of normal huntingtin-HIP1 interaction may contribute to a defect in membrane-cytoskeletal integrity in the brain.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V6T 1Z4,CANADA; UNIV TOKYO,FAC MED,DEPT CLIN NEUROL & NEUROSCI,TOKYO 113,JAPAN; UNIV MANITOBA,FAC MED,DEPT HUMAN GENET,WINNIPEG,MB R3E 0W3,CANADA				Hayden, Michael R/D-8581-2011; Metzler, Markus/AAS-2066-2021; Graham, Rona K/R-7358-2018	Hayden, Michael R/0000-0001-5159-1419; Metzler, Markus/0000-0002-4523-1676; Graham, Rona K/0000-0003-3722-6241; Lynn, Francis/0000-0001-9318-1063			ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ARAI M, 1994, J NEUROSCI RES, V38, P348, DOI 10.1002/jnr.490380313; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Bhide PG, 1996, J NEUROSCI, V16, P5523; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GIETZ RD, 1996, IN PRESS CELL BIOL L; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; HARPER PS, 1991, HUNTINGTONS DIS, P31; Hayden MR, 1981, HUNTINGTONS CHOREA, P59, DOI [10.1007/978-1-4471-1308-9_5, DOI 10.1007/978-1-4471-1308-9_5]; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; *HUNT DIS COLL RES, 1993, CELL, V72, P971; JOHN M, 1994, J BIOL CHEM, V269, P16247; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Koshy B, 1996, HUM MOL GENET, V5, P1311, DOI 10.1093/hmg/5.9.1311; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; MacLennan D H, 1987, Soc Gen Physiol Ser, V41, P287; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; NA S, 1995, J BIOL CHEM, V270, P375; Nasir J, 1996, HUM MOL GENET, V5, P1431, DOI 10.1093/hmg/5.Supplement_1.1431; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PEARLMAN JA, 1994, FEBS LETT, V354, P183, DOI 10.1016/0014-5793(94)01119-2; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; REES DJ, 1990, NATURE, V347, P18; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SHULL GE, 1985, NATURE, V316, P33; Sirover MA, 1996, LIFE SCI, V58, P2271, DOI 10.1016/0024-3205(96)00123-3; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Suzuki T, 1996, BIOCHEM BIOPH RES CO, V219, P708, DOI 10.1006/bbrc.1996.0299; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P100; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Wood J. D., 1996, American Journal of Human Genetics, V59, pA295; WOOD JD, 1996, HUM MOL GENET, V5, P418; Zoghbi HY, 1996, NAT GENET, V14, P237, DOI 10.1038/ng1196-237	49	304	308	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					44	53		10.1038/ng0597-44			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	WOS:A1997WX02400021	9140394				2022-01-24	
J	Matsumine, H; Saito, M; ShimodaMatsubayashi, S; Tanaka, H; Ishikawa, A; NakagawaHattori, Y; Yokochi, M; Kobayashi, T; Igarashi, S; Takano, H; Sanpei, K; Koike, R; Mori, H; Kondo, T; Mizutani, Y; Schaffer, AA; Yamamura, Y; Nakamura, S; Kuzuhara, S; Tsuji, S; Mizuno, Y				Matsumine, H; Saito, M; ShimodaMatsubayashi, S; Tanaka, H; Ishikawa, A; NakagawaHattori, Y; Yokochi, M; Kobayashi, T; Igarashi, S; Takano, H; Sanpei, K; Koike, R; Mori, H; Kondo, T; Mizutani, Y; Schaffer, AA; Yamamura, Y; Nakamura, S; Kuzuhara, S; Tsuji, S; Mizuno, Y			Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANGANESE-SUPEROXIDE-DISMUTASE; LINKAGE ANALYSIS; COMPLEX-I; DISEASE; TRAITS; DNA; MAP	An autosomal recessive form of juvenile Parkinsonism (AR-JP) (MIM 600116) is a levodopa-responsive Parkinsonism whose pathological finding is a highly selective degeneration of dopaminergic neurons in the zona compacta of the substantia nigra. By linkage analysis of diallelic polymorphism of the Mn-superoxide dismutase gene (SOD2), we found a family with AR-JP showing perfect segregation of the disease with the SOD2 locus. By extending the linkage analysis to 13 families with AR-JP, we discovered strong evidence for the localization of the AR-JP gene at chromosome 6q25.2-27, including the SOD2 locus, with the maximal cumulative pairwise LOD scores of 7.26 and 7.71 at DGS305 (theta=.03) and D6S253 (theta=.02), respectively. Observation of obligate recombination events, as well as multipoint linkage analysis, placed the AR-JP gene in a 17-cM interval between D6S437 and D6S264. Delineation of the AR-JP gene will be an important step toward our understanding of the molecular mechanism underlying selective degeneration of the nigral neurons.	JUNTENDO UNIV,SCH MED,DEPT NEUROL,TOKYO 113,JAPAN; TOKYO METROPOLITAN EBARA HOSP,DEPT NEUROL,TOKYO,JAPAN; TOKYO METROPOLITAN MATSUZAWA HOSP,DEPT CLIN PATHOL,TOKYO,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; NISHI OJIYA NATL HOSP,DEPT NEUROL,NIIGATA,JAPAN; RICE UNIV,DEPT COMP SCI,HOUSTON,TX 77251; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; HIROSHIMA UNIV,SCH MED,DEPT HLTH SCI,HIROSHIMA,JAPAN; HIROSHIMA UNIV,SCH MED,DEPT INTERNAL MED 3,HIROSHIMA,JAPAN; MIE UNIV,SCH MED,DEPT NEUROL,TSU,MIE,JAPAN				Mizutani, Yasuhisa/B-3809-2009; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012				BECK Y, 1987, NUCLEIC ACIDS RES, V15, P9076, DOI 10.1093/nar/15.21.9076; BOVERIS A, 1977, ADV EXP BIOL MED, V10, P161; BUTLER RM, 1994, PARALLEL COMPUT, V20, P547, DOI 10.1016/0167-8191(94)90028-0; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHURCH SL, 1992, GENOMICS, V14, P823, DOI 10.1016/S0888-7543(05)80202-2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; GIBB WRG, 1993, PARKINSONS DIS MOVEM, P253; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARTMAN JR, 1988, Patent No. 284105; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; HASSAN HM, 1988, FREE RADICAL BIO MED, V5, P377, DOI 10.1016/0891-5849(88)90111-6; HATTORI N, 1991, ANN NEUROL, V30, P563, DOI 10.1002/ana.410300409; HECKL K, 1988, NUCLEIC ACIDS RES, V16, P6224, DOI 10.1093/nar/16.13.6224; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; KONDO T, 1990, MOV DISORD S, V5, P29; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; MIZUNO Y, 1987, BIOCHEM BIOPH RES CO, V143, P294, DOI 10.1016/0006-291X(87)90664-4; MIZUTANI Y, 1988, CLIN NEUROL, V28, P1542; Mizutani Y, 1993, GENDAIIRYOU TOKYO, V25, P11; Ott J, 1991, ANAL HUMAN GENETIC L; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Sambrook J., 1989, MOL CLONING LAB MANU; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Takubo Hideki, 1996, Brain and Nerve (Tokyo), V48, P587; TANAKA H, 1991, NEUROLOGY, V41, P719, DOI 10.1212/WNL.41.5.719; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239; YAMAMURA Y, 1993, CLIN NEUROL, V33, P491; ZIEGLER A, 1993, GENOME PRIORITY REPO, V1, P269	39	304	321	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					588	596					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	WOS:A1997WK40300015	9042918				2022-01-24	
J	Hoglund, P; Haila, S; Socha, J; Tomaszewski, L; SaarialhoKere, U; KarjalainenLindsberg, ML; Airola, K; Holmberg, C; delaChapelle, A; Kere, J				Hoglund, P; Haila, S; Socha, J; Tomaszewski, L; SaarialhoKere, U; KarjalainenLindsberg, ML; Airola, K; Holmberg, C; delaChapelle, A; Kere, J			Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; EXPRESSION; HYBRIDIZATION; LOCALIZATION; POPULATIONS; TRANSPORT; ENCODES; FINLAND		CHILD HLTH CTR,DEPT GASTROENTEROL & NUTR,WARSAW,POLAND; UNIV HELSINKI,DEPT DERMATOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,HAARTMAN INST,DEPT PATHOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,FIN-00014 HELSINKI,FINLAND		Hoglund, P (corresponding author), UNIV HELSINKI,HAARTMAN INST,DEPT MED GENET,HAARTMANINKATU 3,FIN-00014 HELSINKI,FINLAND.		Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271			BIEBERDO.FA, 1972, J CLIN INVEST, V51, P1958, DOI 10.1172/JCI107002; BUCHAN AMJ, 1989, TXB PHYSL, P1438; Byeon MK, 1996, ONCOGENE, V12, P387; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Hoglund P, 1996, GENOME RES, V6, P202, DOI 10.1101/gr.6.3.202; HOLMBERG C, 1975, J CLIN INVEST, V56, P302, DOI 10.1172/JCI108094; KERE J, 1993, P NATL ACAD SCI USA, V90, P10686, DOI 10.1073/pnas.90.22.10686; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; NORIO R, 1971, Clinical Genetics, V2, P182; PEARSON AJG, 1973, Q J MED, V167, P453; PROSSER IW, 1989, AM J PATHOL, V135, P1073; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; TOMASZEWSKI L, 1987, MAT MED POL, V4, P271; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; TURNBERG LA, 1971, GUT, V12, P544, DOI 10.1136/gut.12.7.544	22	304	309	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					316	319		10.1038/ng1196-316			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	WOS:A1996VQ14600027	8896562				2022-01-24	
J	VIDAL, F; ABERDAM, D; MIQUEL, C; CHRISTIANO, AM; PULKKINEN, L; UITTO, J; ORTONNE, JP; MENEGUZZI, G				VIDAL, F; ABERDAM, D; MIQUEL, C; CHRISTIANO, AM; PULKKINEN, L; UITTO, J; ORTONNE, JP; MENEGUZZI, G			INTEGRIN BETA-4 MUTATIONS ASSOCIATED WITH JUNCTIONAL EPIDERMOLYSIS-BULLOSA WITH PYLORIC ATRESIA	NATURE GENETICS			English	Article							MESSENGER-RNA; ALPHA-6-BETA-4 INTEGRIN; PEMPHIGOID ANTIGEN; CYTOPLASMIC DOMAIN; NONSENSE MUTATIONS; EPITHELIAL-CELLS; HEMIDESMOSOMES; EXPRESSION; ADHESION; SUBUNIT	Pyloric atresia associated with junctional epidermolysis bullosa (PA-JEB), is a rare inherited disorder characterized by pyloric stenosis and blistering of the skin as primary manifestations. We demonstrate that in one PA-JEB patient the disease resulted from two distinct mutations in the beta 4 integrin gene alleles. The paternal mutation consists of a one base pair deletion causing a shift in the open reading frame, and a downstream premature termination codon. The maternal mutation occurs in a donor splice site, and results in in-frame exon skipping involving the cytoplasmic domain of the polypeptide. Our results implicate mutations in the beta 4 integrin gene in some forms of PA-JEB.	FAC MED NICE,INSERM,U385,F-06107 NICE 2,FRANCE; HOP LOUIS PASTEUR,SERV DERMATOL,F-06002 NICE 1,FRANCE; THOMAS JEFFERSON UNIV,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107				Aberdam, Daniel/G-3299-2013	Meneguzzi, Guerrino/0000-0002-1609-6540; Aberdam, Daniel/0000-0002-4019-5418	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01-AR-38923] Funding Source: Medline		ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.me.38.020187.001135; BAUDOIN C, 1994, J CLIN INVEST, V93, P862, DOI 10.1172/JCI117041; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Chang C H, 1983, Pediatr Pathol, V1, P449; DELUCA M, 1990, P NATL ACAD SCI USA, V87, P6888, DOI 10.1073/pnas.87.17.6888; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FRIEDEN IJ, 1986, J AM ACAD DERMATOL, V14, P646, DOI 10.1016/S0190-9622(86)70082-0; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; GEORGE JN, 1990, BLOOD, V75, P1383; GIANCOTTI FG, 1992, J CELL BIOL, V118, P951, DOI 10.1083/jcb.118.4.951; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cb.07.110191.003015; HERTLE MD, 1992, J CLIN INVEST, V89, P1892, DOI 10.1172/JCI115794; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; HOGERVORST F, 1991, EUR J BIOCHEM, V199, P425, DOI 10.1111/j.1432-1033.1991.tb16140.x; HOGERVORST F, 1990, EMBO J, V9, P765, DOI 10.1002/j.1460-2075.1990.tb08171.x; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; JONKMAN MF, 1992, J INVEST DERMATOL, V99, P489, DOI 10.1111/1523-1747.ep12616168; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; KURPAKUS MA, 1991, J CELL BIOL, V115, P1737, DOI 10.1083/jcb.115.6.1737; LACOUR JP, 1992, EUR J PEDIATR, V151, P252, DOI 10.1007/BF02072223; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; LESTRINGANT GG, 1992, ARCH DERMATOL, V128, P1083, DOI 10.1001/archderm.128.8.1083; MARCHISIO PC, 1991, J CELL BIOL, V112, P761, DOI 10.1083/jcb.112.4.761; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; McKusick V.A., 1992, MENDELIAN INHERITANC; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MUELLER S, 1989, J INVEST DERMATOL, V92, P33, DOI 10.1111/1523-1747.ep13070476; NIESSEN CM, 1994, J CELL SCI, V107, P543; ORTONNE JP, 1990, J INVEST DERMATOL, V94, P400; OWARIBE K, 1991, EXP CELL RES, V192, P622, DOI 10.1016/0014-4827(91)90084-8; PHILLIPS RJ, 1994, HISTOPATHOLOGY, V24, P571; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SOLOWSKA J, 1991, J CELL BIOL, V114, P1079, DOI 10.1083/jcb.114.5.1079; SONNENBERG A, 1988, NATURE, V336, P487, DOI 10.1038/336487a0; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SPINARDI L, 1993, MOL BIOL CELL, V4, P871, DOI 10.1091/mbc.4.9.871; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; SUZUKI S, 1990, EMBO J, V9, P757, DOI 10.1002/j.1460-2075.1990.tb08170.x; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; TANAKA T, 1989, J INVEST DERMATOL, V94, P617	50	304	306	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					229	234		10.1038/ng0695-229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	WOS:A1995RA85700023	7545057				2022-01-24	
J	Saito, H; Posas, F				Saito, Haruo; Posas, Francesc			Response to Hyperosmotic Stress	GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; HOG MAPK PATHWAY; CELL-CYCLE PROGRESSION; SIGNAL-TRANSDUCTION PATHWAY; 2C SER/THR PHOSPHATASE; CDK-DEPENDENT PHOSPHORYLATION; MESSENGER-RNA STABILITY; OSMOTIC-STRESS; HIGH-OSMOLARITY	An appropriate response and adaptation to hyperosmolarity, i.e., an external osmolarity that is higher than the physiological range, can be a matter of life or death for all cells. It is especially important for free-living organisms such as the yeast Saccharomyces cerevisiae. When exposed to hyperosmotic stress, the yeast initiates a complex adaptive program that includes temporary arrest of cell-cycle progression, adjustment of transcription and translation patterns, and the synthesis and retention of the compatible osmolyte glycerol. These adaptive responses are mostly governed by the high osmolarity glycerol ( HOG) pathway, which is composed of membrane-associated osmosensors, an intracellular signaling pathway whose core is the Hog1 MAP kinase ( MAPK) cascade, and cytoplasmic and nuclear effector functions. The entire pathway is conserved in diverse fungal species, while the Hog1 MAPK cascade is conserved even in higher eukaryotes including humans. This conservation is illustrated by the fact that the mammalian stress-responsive p38 MAPK can rescue the osmosensitivity of hog1 Delta mutations in response to hyperosmotic challenge. As the HOG pathway is one of the best-understood eukaryotic signal transduction pathways, it is useful not only as a model for analysis of osmostress responses, but also as a model for mathematical analysis of signal transduction pathways. In this review, we have summarized the current understanding of both the upstream signaling mechanism and the downstream adaptive responses to hyperosmotic stress in yeast.	[Saito, Haruo] Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, Tokyo 1088638, Japan; [Posas, Francesc] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain		Saito, H (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, Tokyo 1088638, Japan.	h-saito@ims.u-tokyo.ac.jp; francesc.posas@upf.edu	Posas, Francesc/K-1364-2013; Saito, Haruo/AAF-6113-2019	Posas, Francesc/0000-0002-4164-7076; Saito, Haruo/0000-0001-7891-1689	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministerio de Economia y Competitividad (Spanish Government)Spanish Government; Consolider Ingenio ProgrammeSpanish Government; FP7 UNICELLSYS grant; Fundacion Marcelino Botin; Academia program from Institucio Catalana de Recerca i Estudis Avancats (Generalitat de Catalunya)ICREA	We thank Pauline O'Grady and Kazuo Tatebayashi for critical reading of the manuscript. The laboratory of H.S. is supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The laboratory of F.P. is supported by grants from the Ministerio de Economia y Competitividad (Spanish Government), the Consolider Ingenio 2010 Programme, and a FP7 UNICELLSYS grant. F.P. is also supported by the Fundacion Marcelino Botin and by the Academia program from Institucio Catalana de Recerca i Estudis Avancats (Generalitat de Catalunya).	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; Aguilera A, 2005, NAT STRUCT MOL BIOL, V12, P737, DOI 10.1038/nsmb0905-737; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Ash J, 2003, GENETICS, V163, P9; Ault AD, 2002, EUKARYOT CELL, V1, P174, DOI 10.1128/EC.1.2.174-180.2002; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Beese SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000738; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; Belli G, 2001, MOL MICROBIOL, V39, P1022, DOI 10.1046/j.1365-2958.2001.02297.x; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; Bhattacharjya S, 2004, J MOL BIOL, V344, P1071, DOI 10.1016/j.jmb.2004.09.018; Bicknell AA, 2010, J BIOL CHEM, V285, P17545, DOI 10.1074/jbc.M109.084681; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; BLOMBERG A, 1989, J BACTERIOL, V171, P1087, DOI 10.1128/jb.171.2.1087-1092.1989; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BOGUSLAWSKI G, 1992, J GEN MICROBIOL, V138, P2425, DOI 10.1099/00221287-138-11-2425; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bouwman J, 2011, YEAST, V28, P43, DOI 10.1002/yea.1819; BREWSTER JL, 1994, YEAST, V10, P425, DOI 10.1002/yea.320100402; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chellappan S. P., 2001, SCI STKE, V93, ppe1; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Cullen PJ, 2000, GENETICS, V155, P1005; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; de Nadal Eulalia, 2008, V20, P81, DOI 10.1007/4735_2007_0244; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dmitrieva NI, 2002, P NATL ACAD SCI USA, V99, P184, DOI 10.1073/pnas.231623498; Edmunds JW, 2006, SCIENCE, V313, P449, DOI 10.1126/science.1131158; Edwards MC, 1997, GENETICS, V147, P1063; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Ekiel I, 2009, MOL BIOL CELL, V20, P5117, DOI 10.1091/mbc.E09-07-0645; Elion EA, 2001, J CELL SCI, V114, P3967; Eraso P, 2011, MOL MICROBIOL, V79, P1339, DOI 10.1111/j.1365-2958.2010.07528.x; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Fassler JS, 2011, EUKARYOT CELL, V10, P156, DOI 10.1128/EC.00245-10; Fassler JS, 2010, METHOD ENZYMOL, V471, P291, DOI 10.1016/S0076-6879(10)71016-8; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.e04-10-0884; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Garcia-Gimeno MA, 2000, MOL CELL BIOL, V20, P4340, DOI 10.1128/MCB.20.12.4340-4349.2000; Gari E, 2001, GENE DEV, V15, P2803; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Gat-Viks I, 2007, GENOME RES, V17, P358, DOI 10.1101/gr.5750507; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Grimshaw SJ, 2004, J BIOL CHEM, V279, P2192, DOI 10.1074/jbc.M305605200; Guha N, 2007, MOL BIOL CELL, V18, P2419, DOI 10.1091/mbc.e06-10-0946; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hayashi M, 2006, J BIOCHEM, V139, P797, DOI 10.1093/jb/mvj089; He XJ, 2009, EUKARYOT CELL, V8, P768, DOI 10.1128/EC.00021-09; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Horie T, 2008, MOL CELL BIOL, V28, P5172, DOI 10.1128/MCB.00589-08; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Janiak-Spens F, 1999, J BACTERIOL, V181, P411, DOI 10.1128/JB.181.2.411-417.1999; Janiak-Spens F, 2000, MOL MICROBIOL, V37, P136, DOI 10.1046/j.1365-2958.2000.01973.x; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Janiak-Spens F, 2000, J BACTERIOL, V182, P6673, DOI 10.1128/JB.182.23.6673-6678.2000; Jansen G, 2001, MOL GENET GENOMICS, V265, P102, DOI 10.1007/s004380000394; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Joaquin M, 2012, EMBO J, V31, P2952, DOI 10.1038/emboj.2012.122; Jorgensen P., 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-3-REVIEWS1022; Kapteyn JC, 2001, MOL MICROBIOL, V39, P469, DOI 10.1046/j.1365-2958.2001.02242.x; Kaserer AO, 2010, METHOD ENZYMOL, V471, P59, DOI 10.1016/S0076-6879(10)71004-1; Kaserer AO, 2009, BIOCHEMISTRY-US, V48, P8044, DOI 10.1021/bi900886g; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Ketela T, 1998, MOL GEN GENET, V259, P372, DOI 10.1007/s004380050824; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Kobayashi Y, 2008, BIOCHEM BIOPH RES CO, V368, P50, DOI 10.1016/j.bbrc.2008.01.033; Krantz M, 2006, CURR GENET, V49, P137, DOI 10.1007/s00294-005-0038-x; Krantz M, 2006, CURR GENET, V49, P152, DOI 10.1007/s00294-005-0039-9; Krantz M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.36; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Kwan JJ, 2006, J MOL BIOL, V356, P142, DOI 10.1016/j.jmb.2005.11.012; Kwan JJ, 2004, J MOL BIOL, V342, P681, DOI 10.1016/j.jmb.2004.06.064; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Li XR, 1999, J BIOL CHEM, V274, P24220, DOI 10.1074/jbc.274.34.24220; Lo WS, 2005, EMBO J, V24, P997, DOI 10.1038/sj.emboj.7600577; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MacNeill S. A., 1997, MOL CELLULAR BIOL YE, VIII, P697; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MAGER WH, 1993, MOL MICROBIOL, V10, P253, DOI 10.1111/j.1365-2958.1993.tb01951.x; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Marles JA, 2004, MOL CELL, V14, P813, DOI 10.1016/j.molcel.2004.05.024; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martinez-Montanes F, 2010, OMICS, V14, P619, DOI 10.1089/omi.2010.0046; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Mattison CP, 2000, GENE DEV, V14, P1229; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Mody A, 2009, NAT CELL BIOL, V11, P484, DOI 10.1038/ncb1856; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Mollapour M, 2006, FEMS YEAST RES, V6, P1274, DOI 10.1111/j.1567-1364.2006.00118.x; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; NEHLIN JO, 1992, NUCLEIC ACIDS RES, V20, P5271, DOI 10.1093/nar/20.20.5271; Nelson B, 2004, GENETICS, V166, P67, DOI 10.1534/genetics.166.1.67; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Norbeck J, 1998, FEMS MICROBIOL LETT, V158, P121, DOI 10.1016/S0378-1097(97)00511-9; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Ostrander DB, 1999, J BACTERIOL, V181, P2527, DOI 10.1128/JB.181.8.2527-2534.1999; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Parmar JH, 2011, MOL BIOSYST, V7, P1138, DOI 10.1039/c0mb00224k; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Pascual-Ahuir A, 2006, METHODS, V40, P272, DOI 10.1016/j.ymeth.2006.06.007; Patterson JC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001275; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(00)00002-2; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Pitoniak A, 2009, MOL BIOL CELL, V20, P3101, DOI 10.1091/mbc.E08-07-0760; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Porter SW, 2005, BBA-PROTEINS PROTEOM, V1748, P138, DOI 10.1016/j.bbapap.2004.12.009; Porter SW, 2003, EUKARYOT CELL, V2, P27, DOI 10.1128/EC.2.1.27-33.2003; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; RAD MR, 1992, MOL GEN GENET, V236, P145; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Reiser V, 2006, MOL BIOL CELL, V17, P3136, DOI 10.1091/mbc.E05-12-1102; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Rensing L, 2009, J THEOR BIOL, V257, P578, DOI 10.1016/j.jtbi.2009.01.015; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MICROBIOL-UK, V145, P715, DOI 10.1099/13500872-145-3-715; Rep M, 1999, MOL CELL BIOL, V19, P5474; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Saito H, 2001, CHEM REV, V101, P2497, DOI 10.1021/cr000243+; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schaber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014791; Schaber J, 2010, EUR BIOPHYS J BIOPHY, V39, P1547, DOI 10.1007/s00249-010-0612-0; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shankarnarayan S, 2008, J BIOL CHEM, V283, P23496; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Siderius M, 2000, MOL MICROBIOL, V36, P1381, DOI 10.1046/j.1365-2958.2000.01955.x; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Song HK, 1999, J MOL BIOL, V293, P753, DOI 10.1006/jmbi.1999.3215; Sotelo J, 2006, EUKARYOT CELL, V5, P1826, DOI 10.1128/EC.00225-06; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Sprague GF, 1998, GENE DEV, V12, P2817, DOI 10.1101/gad.12.18.2817; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tamas MJ, 2000, FEBS LETT, V472, P159, DOI 10.1016/S0014-5793(00)01445-9; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanigawa M, 2012, MOL CELL BIOL, V32, P2861, DOI 10.1128/MCB.06111-11; Tao W, 1999, J BIOL CHEM, V274, P360, DOI 10.1074/jbc.274.1.360; Tatebayashi K, 2003, EMBO J, V22, P3624, DOI 10.1093/emboj/cdg353; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; Toh-e A, 2001, GENES GENET SYST, V76, P393, DOI 10.1266/ggs.76.393; TOKISHITA S, 1994, MOL MICROBIOL, V13, P435, DOI 10.1111/j.1365-2958.1994.tb00438.x; Tomas-Cobos L, 2004, J BIOL CHEM, V279, P22010, DOI 10.1074/jbc.M400609200; Torres-Quiroz F, 2010, J BIOL CHEM, V285, P20088, DOI 10.1074/jbc.M109.063578; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Vadaie N, 2008, J CELL BIOL, V181, P1073, DOI 10.1083/jcb.200704079; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Vendrell A, 2011, EMBO REP, V12, P1062, DOI 10.1038/embor.2011.154; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; VINCENT AC, 1992, MOL CELL BIOL, V12, P5394, DOI 10.1128/MCB.12.12.5394; Wang LC, 2012, EMBO J, V31, P2648, DOI 10.1038/emboj.2012.99; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Watanabe T, 2010, BIORESOURCE TECHNOL, V101, P9710, DOI 10.1016/j.biortech.2010.07.079; WERTMAN KF, 1992, GENETICS, V132, P337; Westfall P, 2006, AM STAT, V60, P1, DOI 10.1198/000313006X93258; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xu G, 1996, MOL MICROBIOL, V20, P773, DOI 10.1111/j.1365-2958.1996.tb02516.x; Xu OP, 2003, STRUCTURE, V11, P1569, DOI 10.1016/j.str.2003.10.016; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; Yaakov G, 2003, MOL CELL BIOL, V23, P4826, DOI 10.1128/MCB.23.14.4826-4840.2003; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yang HY, 2009, EMBO J, V28, P1380, DOI 10.1038/emboj.2009.104; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshida T, 2007, METHOD ENZYMOL, V423, P184, DOI 10.1016/S0076-6879(07)23008-3; Young C, 2002, EUKARYOT CELL, V1, P1032, DOI 10.1128/EC.1.6.1032-1040.2002; Yuzyuk T, 2003, MOL BIOL CELL, V14, P3013, DOI 10.1091/mbc.E02-11-0747; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zapater M, 2005, CELL CYCLE, V4, P6, DOI 10.4161/cc.4.1.1344; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zarrinpar A, 2004, MOL CELL, V14, P825, DOI 10.1016/j.molcel.2004.06.011; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhan XL, 1999, GENE DEV, V13, P2811, DOI 10.1101/gad.13.21.2811; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x; Zou XF, 2008, J THEOR BIOL, V250, P139, DOI 10.1016/j.jtbi.2007.09.024	311	303	312	3	77	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	OCT	2012	192	2					289	318		10.1534/genetics.112.140863			30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016VI	WOS:000309547400001	23028184	Bronze, Green Published			2022-01-24	
J	Freedman, ML; Monteiro, ANA; Gayther, SA; Coetzee, GA; Risch, A; Plass, C; Casey, G; De Biasi, M; Carlson, C; Duggan, D; James, M; Liu, PY; Tichelaar, JW; Vikis, HG; You, M; Mills, IG				Freedman, Matthew L.; Monteiro, Alvaro N. A.; Gayther, Simon A.; Coetzee, Gerhard A.; Risch, Angela; Plass, Christoph; Casey, Graham; De Biasi, Mariella; Carlson, Chris; Duggan, David; James, Michael; Liu, Pengyuan; Tichelaar, Jay W.; Vikis, Haris G.; You, Ming; Mills, Ian G.			Principles for the post-GWAS functional characterization of cancer risk loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; HUMAN GENE-EXPRESSION; GERMLINE EPIMUTATION; VARIANTS; BREAST; IDENTIFICATION; EPIGENOMICS; ELEMENTS; UNDERLIE		[Mills, Ian G.] Univ Oslo, Nord European Mol Biol Lab EMBL Partnership, Norwegian Ctr Mol Med, Oslo, Norway; [Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Freedman, Matthew L.] Eli & Edythe L Broad Inst MIT & Harvard, Cambridge, MA USA; [Monteiro, Alvaro N. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Gayther, Simon A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gayther, Simon A.] UCL, Elizabeth Garrett Anderson Inst Womens Hlth EGA, Translat Res Lab, London, England; [Coetzee, Gerhard A.] Univ So Calif, Dept Urol, Norris Canc Ctr, Los Angeles, CA USA; [Risch, Angela; Plass, Christoph] German Canc Res Ctr, Div Epigenom & Canc Risk Factors, D-6900 Heidelberg, Germany; [Casey, Graham] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Carlson, Chris] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Duggan, David] Translat Genom Res Inst TGen, Phoenix, AZ USA; [James, Michael; Liu, Pengyuan; Tichelaar, Jay W.; Vikis, Haris G.; You, Ming] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Mills, Ian G.] Canc Res UK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England		Mills, IG (corresponding author), Univ Oslo, Nord European Mol Biol Lab EMBL Partnership, Norwegian Ctr Mol Med, Oslo, Norway.	ian.mills@ncmm.uio.no	Mills, Ian/AAK-9292-2020; James, Michael/L-7772-2019; Pillay, Nischalan/F-9536-2012; Plass, Christoph/H-7192-2014; Monteiro, Alvaro N. A./A-7566-2009; coetzee, Gerhard/AAT-6203-2020; Risch, Angela/H-2669-2013; Coetzee, Gerhard/AAG-8439-2019; De Biasi, Mariella/M-7646-2017	Mills, Ian/0000-0001-5347-5083; Monteiro, Alvaro N. A./0000-0002-8448-4801; Risch, Angela/0000-0002-8026-5505; De Biasi, Mariella/0000-0002-0687-8872; Coetzee, Gerhard/0000-0001-8820-8364; James, Michael/0000-0002-8112-1108	NIH Post-Genome Wide Association InitiativeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U19CA148537-01, 1U19CA148065-01, 1U19CA148112-01, 1U19CA148107-01, 1U19CA148127-01]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0801875] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801875] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U19CA148127, U19CA148107, U19CA148112, U19CA148065, U19CA148537] Funding Source: NIH RePORTER	We would like to thank F. Bunz and all the members of the NIH Post-Genome Wide Association Initiative for helpful discussions and, in particular, I. Tomlinson (Wellcome Trust Centre for Human Genetics, Oxford). The contributing groups are supported by funding made available through the NIH Post-Genome Wide Association Initiative in response to Call (http://grants.nih.gov./grants/oer.htm). This Call sustains research across five cancer organ sites (prostate: 1U19CA148537-01; breast: 1U19CA148065-01; ovarian: 1U19CA148112-01; colorectal: 1U19CA148107-01; and lung: 1U19CA148127-01). For further information on this Initiative, please refer to the website: (http://epi.grants.cancer.gov/). In addition, this article is the product of the first attempt to engage the entire scientific community in the drafting of a scientific paper through open-access websites. We would like to thank R. Hoffmann at WikiGenes for hosting the pre-submission version of this submission (http://www.wikigenes.org/e/pub/e/84.html) and his unstinting energy and enthusiasm for this project and also Nature Precedings for hosting the same version (http://precedings.nature.com/documents/5162/version/1).	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; [Anonymous], 2010, NAT GENET, V42, P551, DOI 10.1038/ng0710-551; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bumgarner Roger E., 2009, V541, P225, DOI 10.1007/978-1-59745-243-4_11; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; COETZEE GA, 2010, CELL CYCLE, V9, P47; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saccone NL, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-58; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	57	303	316	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					513	518		10.1038/ng.840			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	WOS:000291017000006	21614091	Green Accepted			2022-01-24	
J	Leveillard, T; Mohand-Said, S; Lorentz, O; Hicks, D; Fintz, AC; Clerin, E; Simonutti, M; Forster, V; Cavusoglu, N; Chalmel, F; Dolle, P; Poch, O; Lambrou, G; Sahel, JA				Leveillard, T; Mohand-Said, S; Lorentz, O; Hicks, D; Fintz, AC; Clerin, E; Simonutti, M; Forster, V; Cavusoglu, N; Chalmel, F; Dolle, P; Poch, O; Lambrou, G; Sahel, JA			Identification and characterization of rod-derived cone viability factor	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; SURVIVAL; DEGENERATION; THIOREDOXIN; MOUSE; CELLS; PHOTORECEPTORS; MUTATIONS; PROTEINS	Retinitis pigmentosa is an untreatable, inherited retinal disease that leads to blindness. The disease initiates with the loss of night vision due to rod photoreceptor degeneration, followed by irreversible, progressive loss of cone photoreceptor(1-3). Cone loss is responsible for the main visual handicap, as cones are essential for day and high-acuity vision(4). Their loss is indirect, as most genes associated with retinitis pigmentosa are not expressed by these cells. We previously showed that factors secreted from rods are essential for cone viability(5-8). Here we identified one such trophic factor by expression cloning and named it rod-derived cone viability factor (RdCVF). RdCVF is a truncated thioredoxin-like protein specifically expressed by photoreceptors. The identification of this protein offers new treatment possibilities for retinitis pigmentosa.	Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol & Retine, F-75571 Paris 12, France; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Novartis Pharma AG Ophthalmol Res WKL127 1 04, CH-4002 Basel, Switzerland; UCL, Inst Ophthalmol, London WC1E 6BT, England		Leveillard, T (corresponding author), Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol & Retine, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	leveilla@st-antoine.inserm.fr	Sahel, Jose-Alain/F-3172-2017; Chalmel, Frederic/L-5360-2018; Leveillard, Thierry/AAR-1804-2020; Chalmel, Frederic/AAM-1079-2021; Chalmel, Frederic/M-1297-2016; Dolle, Pascal/A-8037-2010	Sahel, Jose-Alain/0000-0002-4831-1153; Chalmel, Frederic/0000-0002-0535-3628; Leveillard, Thierry/0000-0001-5692-8770; Chalmel, Frederic/0000-0002-0535-3628; Dolle, Pascal/0000-0002-9294-9090; Cavusoglu, Nukhet/0000-0001-9350-5312; Clerin, Emmanuelle/0000-0003-1451-6051			ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Cau E, 1997, DEVELOPMENT, V124, P1611; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DOWLING JE, 1987, RETINAL CELLS PROCES; Fintz AC, 2003, INVEST OPHTH VIS SCI, V44, P818, DOI 10.1167/iovs.01-1144; Fontaine V, 1998, J NEUROSCI, V18, P9662; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Massey FJ., 1969, INTRO STAT ANAL; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	21	303	306	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					755	759		10.1038/ng1386			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	WOS:000222354100028	15220920	Bronze, Green Submitted			2022-01-24	
J	Krylov, DM; Wolf, YI; Rogozin, IB; Koonin, EV				Krylov, DM; Wolf, YI; Rogozin, IB; Koonin, EV			Gene loss, protein sequence divergence, gene dispensability, expression level, and interactivity are correlated in eukaryotic evolution	GENOME RESEARCH			English	Article							GENOME EVOLUTION; ORIGIN; GENERATION; DATABASE	Lineage-specific gene loss, to a large extent, accounts for the differences in gene repertoires between genomes, particularly among eukaryotes. We derived a parsimonious scenario of gene losses for eukaryotic orthologous groups (KOGs) from seven complete eukaryotic genomes. The scenario involves substantial gene loss in fungi, nematodes, and insects. Based on this evolutionary scenario and estimates of the divergence times between major eukaryotic phyla, we introduce a numerical measure, the propensity for gene loss (PGL). We explore the connection among the propensity of a gene to be lost in evolution (PGL value), protein sequence divergence, the effect of gene knockout on fitness, the number of protein-protein interactions, and expression level for the genes in KOGs. Significant correlations between PGL and each of these variables were detected. Genes that have a lower propensity to be lost in eukaryotic evolution accumulate fewer substitutions in their protein sequences and tend to be essential for the organism viability, tend to be highly expressed, and have many interaction partners. The dependence between PGL and gene dispensability and interactivity is much stronger than that for sequence evolution rate. Thus, propensity of a gene to be lost during evolution seems to be a direct reflection of its biological importance.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA		Koonin, EV (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	koonin@ncbi.nim.nih.gov	Puigbo, Pere/A-2214-2008	Rogozin, Igor/0000-0003-0802-4851; Wolf, Yuri/0000-0002-0247-8708			Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Baraba si A.-L., 2002, LINKED NEW SCI NETWO; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; FARRIS JS, 1977, SYST ZOOL, V26, P77, DOI 10.2307/2412867; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grishin NV, 2000, GENOME RES, V10, P991, DOI 10.1101/gr.10.7.991; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kimura M., 1983, NEUTRAL THEORY MOL E; Koonin EV, 1996, CURR OPIN GENET DEV, V6, P757, DOI 10.1016/S0959-437X(96)80032-3; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Pal C, 2001, GENETICS, V158, P927; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TATUSOV RL, 2003, IN PRESS BMC BIOINFO; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Wolfe KH, 2003, NAT GENET, V33, P255, DOI 10.1038/ng1088; [No title captured]	43	303	308	0	18	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2003	13	10					2229	2235		10.1101/gr.1589103			7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	731GR	WOS:000185876400003	14525925	Green Published, Bronze			2022-01-24	
J	Lam, LT; Pickeral, OK; Peng, AC; Rosenwald, A; Hurt, EM; Giltnane, JM; Averett, LM; Zhao, H; Davis, RE; Sathyamoorthy, M; Wahl, LM; Harris, ED; Mikovits, JA; Monks, AP; Hollingshead, MG; Sausville, EA; Staudt, LM				Lam, Lloyd T.; Pickeral, Oxana K.; Peng, Amy C.; Rosenwald, Andreas; Hurt, Elaine M.; Giltnane, Jena M.; Averett, Lauren M.; Zhao, Hong; Davis, R. Eric; Sathyamoorthy, Mohan; Wahl, Larry M.; Harris, Eric D.; Mikovits, Judy A.; Monks, Anne P.; Hollingshead, Melinda G.; Sausville, Edward A.; Staudt, Louis M.			Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol	GENOME BIOLOGY			English	Article								Background: Flavopiridol, a flavonoid currently in cancer clinical trials, inhibits cyclin-dependent kinases (CDKs) by competitively blocking their ATP-binding pocket. However, the mechanism of action of flavopiridol as an anti-cancer agent has not been fully elucidated. Results: Using DNA microarrays, we found that flavopiridol inhibited gene expression broadly, in contrast to two other CDK inhibitors, roscovitine and 9-nitropaullone. The gene expression profile of flavopiridol closely resembled the profiles of two transcription inhibitors, actinomycin D and 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole (DRB), suggesting that flavopiridol inhibits transcription globally. We were therefore able to use flavopiridol to measure mRNA turnover rates comprehensively and we found that different functional classes of genes had distinct distributions of mRNA turnover rates. In particular, genes encoding apoptosis regulators frequently had very short half-lives, as did several genes encoding key cell-cycle regulators. Strikingly, genes that were transcriptionally inducible were disproportionately represented in the class of genes with rapid mRNA turnover. Conclusions: The present genomic-scale measurement of mRNA turnover uncovered a regulatory logic that links gene function with mRNA half-life. The observation that transcriptionally inducible genes often have short mRNA half-lives demonstrates that cells have a coordinated strategy to rapidly modulate the mRNA levels of these genes. In addition, the present results suggest that flavopiridol may be more effective against types of cancer that are highly dependent on genes with unstable mRNAs.	[Lam, Lloyd T.; Pickeral, Oxana K.; Rosenwald, Andreas; Hurt, Elaine M.; Giltnane, Jena M.; Averett, Lauren M.; Zhao, Hong; Davis, R. Eric; Sathyamoorthy, Mohan; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Peng, Amy C.] EMMES Corp, Rockville, MD 20850 USA; [Wahl, Larry M.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Harris, Eric D.; Mikovits, Judy A.; Monks, Anne P.; Hollingshead, Melinda G.; Sausville, Edward A.] NCI, Dev Therapeut Program, DTP Clin Trials Unit, Div Canc Treatment & Diag, Bethesda, MD 20892 USA		Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@box-l.nih.gov	Staudt, Louis/AAC-5324-2019; Giltnane, Jennifer/D-2584-2013				Alessi F, 1998, EXP CELL RES, V245, P8, DOI 10.1006/excr.1998.4216; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; BALKWILL F, 2000, CYTOKINE NETWORK; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown CY, 1996, P NATL ACAD SCI USA, V93, P13721, DOI 10.1073/pnas.93.24.13721; Carlson B. A., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P424; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Dang CV, 1999, MOL CELL BIOL, V19, P1; DAVIS LS, 1994, CURRENT PROTOCOLS IM; deAzevedo WF, 1996, P NATL ACAD SCI USA, V93, P2735, DOI 10.1073/pnas.93.7.2735; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fleiss JLLB., 1981, STAT METHODS RATES P, V3rd ed; Gray N, 1999, CURR MED CHEM, V6, P859; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Gussio R, 2000, ANTI-CANCER DRUG DES, V15, P53; Kitada S, 2000, BLOOD, V96, P393; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Parker BW, 1998, BLOOD, V91, P458, DOI 10.1182/blood.V91.2.458.458_458_465; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Planchais S, 1997, PLANT J, V12, P191, DOI 10.1046/j.1365-313X.1997.12010191.x; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schultz C, 1999, J MED CHEM, V42, P2909, DOI 10.1021/jm9900570; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; Senderowicz AM, 1998, J CLIN ONCOL, V16, P2986, DOI 10.1200/JCO.1998.16.9.2986; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; *STAUDT LAB, STAUDT LAB MRNA TURN; WORLAND PJ, 1993, BIOCHEM PHARMACOL, V46, P1831, DOI 10.1016/0006-2952(93)90590-S; Zaharevitz DW, 1999, CANCER RES, V59, P2566; ARE MRNA DATABASE AR	42	303	303	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2001	2	10							0041.1				11	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	V12FG	WOS:000207584500006					2022-01-24	
J	Kobayashi, K; Sinasac, DS; Iijima, M; Boright, AP; Begum, L; Lee, JR; Yasuda, T; Ikeda, S; Hirano, R; Terazono, H; Crackower, MA; Kondo, I; Tsui, LC; Scherer, SW; Saheki, T				Kobayashi, K; Sinasac, DS; Iijima, M; Boright, AP; Begum, L; Lee, JR; Yasuda, T; Ikeda, S; Hirano, R; Terazono, H; Crackower, MA; Kondo, I; Tsui, LC; Scherer, SW; Saheki, T			The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein	NATURE GENETICS			English	Article							ORTHOTOPIC LIVER-TRANSPLANTATION; SECRETORY TRYPSIN-INHIBITOR; ARGININOSUCCINATE SYNTHETASE; CLASSICAL CITRULLINEMIA; MESSENGER-RNA; UREA CYCLE; MUTATIONS; CLONING; CALCIUM; DNA	Citrullinaemia (CTLN) is an autosomal recessive disease caused by deficiency of argininosuccinate synthetase (ASS). Adultonset type II citrullinaemia (CTLN2) is characterized by a liverspecific ASS deficiency with no abnormalities in hepatic ASS mRNA or the gene ASS (refs 1-17). CTLN2 patients (1/100.000 in Japan(13)) suffer from a disturbance of consciousness and coma, and most die with cerebral edema within a few years of onset. CTLN2 differs from classical citrullinaemia (CTLN1, OMIM 215700) in that CTLN1 is neonatal or infantile in onset, with ASS enzyme defects (in all tissues) arising due to mutations in ASS on chromosome 9q34 (refs 18-21). We collected 118 CTLN2 families, and localized the CTLN2 locus to chromosome 7q21.3 by homozygosity mapping analysis of individuals from 18 consanguineous unions. Using positional cloning we identified a novel gene, SLC5A13, and found five different DNA sequence alterations that account for mutations in all consanguineous patients examined. SLC25A13 encodes a 3.4-kb transcript expressed most abundantly in liver. The protein encoded by SLC25A13, named citrin, is bipartite in structure, containing a mitochondrial carrier motif and four EF-hand domains, suggesting it is a calcium-dependent mitochondrial solute transporter with a role in urea cycle function.	Kagoshima Univ, Fac Med, Dept Biochem, Kagoshima 890820, Japan; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Yagi Clin, Aira 8995400, Japan; Ehime Univ, Sch Med, Dept Hyg, Shigenobu, Ehime 7910295, Japan		Kobayashi, K (corresponding author), Kagoshima Univ, Fac Med, Dept Biochem, 8-35-1 Sakuragaoka, Kagoshima 890820, Japan.		Tsui, Lap-chee/A-1081-2010; Scherer, Stephen W/B-3785-2013	Scherer, Stephen W/0000-0002-8326-1999; Sinasac, David/0000-0002-3749-5989			Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Hegele RA, 1997, J CLIN ENDOCR METAB, V82, P3373, DOI 10.1210/jc.82.10.3373; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; IMAMURA Y, 1987, CLIN CHIM ACTA, V164, P201, DOI 10.1016/0009-8981(87)90071-4; Kakinoki H, 1997, HUM MUTAT, V9, P250, DOI 10.1002/(SICI)1098-1004(1997)9:3<250::AID-HUMU6>3.3.CO;2-K; Kawamoto S, 1997, CLIN TRANSPLANT, V11, P453; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; KOBAYASHI K, 1986, AM J HUM GENET, V38, P667; KOBAYASHI K, 1995, FEBS LETT, V372, P69, DOI 10.1016/0014-5793(95)00948-9; KOBAYASHI K, 1994, AM J HUM GENET, V55, P1103; KOBAYASHI K, 1995, HUM GENET, V96, P454; Kobayashi K, 1997, HEPATOLOGY, V25, P1160, DOI 10.1002/hep.510250519; KOBAYASHI K, 1993, AM J HUM GENET, V53, P1024; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SAHEKI T, 1982, CLIN CHIM ACTA, V118, P93; SAHEKI T, 1987, CLIN CHIM ACTA, V170, P297, DOI 10.1016/0009-8981(87)90140-9; SAHEKI T, 1987, REV PHYSIOL BIOCH P, V108, P21, DOI 10.1007/BFb0034071; SAHEKI T, 1981, CLIN CHIM ACTA, V109, P325, DOI 10.1016/0009-8981(81)90318-1; Saheki T, 1983, ADV EXP MED BIOL, V153, P63; SAHEKI T, 1985, GUANIDINES, P149; SAHEKI T, 1986, J CLIN BIOCHEM NUTR, V1, P129; SASE M, 1985, HUM GENET, V69, P130, DOI 10.1007/BF00293282; TODO S, 1992, HEPATOLOGY, V15, P419, DOI 10.1002/hep.1840150311; YAGI Y, 1988, AM J CLIN PATHOL, V89, P735, DOI 10.1093/ajcp/89.6.735; Yazaki M, 1996, TRANSPLANTATION, V62, P1679, DOI 10.1097/00007890-199612150-00027	30	303	346	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					159	163		10.1038/9667			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	WOS:000080680900020	10369257				2022-01-24	
J	Igarashi, S; Koide, R; Shimohata, T; Yamada, M; Hayashi, Y; Takano, H; Date, H; Oyake, M; Sato, T; Sato, A; Egawa, S; Ikeuchi, T; Tanaka, H; Nakano, R; Tanaka, K; Hozumi, I; Inuzuka, T; Takahashi, H; Tsuji, S				Igarashi, S; Koide, R; Shimohata, T; Yamada, M; Hayashi, Y; Takano, H; Date, H; Oyake, M; Sato, T; Sato, A; Egawa, S; Ikeuchi, T; Tanaka, H; Nakano, R; Tanaka, K; Hozumi, I; Inuzuka, T; Takahashi, H; Tsuji, S			Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch	NATURE GENETICS			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; SPINOCEREBELLAR ATAXIA TYPE-1; TRINUCLEOTIDE CAG REPEAT; CATALYZED CROSS-LINKING; MACHADO-JOSEPH DISEASE; GLUTAMINE REPEATS; NEURODEGENERATIVE DISEASES; HUNTINGTONS-DISEASE; COMPLEMENTARY-DNA; TRANSGENIC MICE	To elucidate the molecular mechanisms whereby expanded polyglutamine stretches elicit a gain of toxic function, we expressed full-length and truncated DRPLA (dentatorubral-pallidoluysian atrophy) cDNAs with or without expanded CAG repeats in COS-7 cells. We found that truncated DRPLA proteins containing an expanded polyglutamine stretch form filamentous peri-and intranuclear aggregates and undergo apoptosis. The apoptotic cell death was partially suppressed by the transglutaminase inhibitors cystamine and monodansyl cadaverine (but not putrescine), suggesting involvement of a transglutaminase reaction and providing a potential basis for the development of therapeutic measures for GAG-repeat expansion diseases.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan		Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1-757 Asahimachi, Niigata 951, Japan.	tsuji@cc.niigata-u.ac.jp		Sato, Toshiya/0000-0001-7844-9930; Hozumi, Isao/0000-0003-0984-6291			BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DICKSON RB, 1981, J BIOL CHEM, V256, P3454; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; JACKSON M, 1995, NEUROPATH APPL NEURO, V21, P18, DOI 10.1111/j.1365-2990.1995.tb01024.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KLEMAN JP, 1995, BIOCHEMISTRY-US, V34, P13768, DOI 10.1021/bi00042a007; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LORAND L, 1979, BIOCHEMISTRY-US, V18, P1756, DOI 10.1021/bi00576a019; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; ONODERA O, 1995, AM J HUM GENET, V57, P1050; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	38	303	309	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					111	117		10.1038/ng0298-111			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	WOS:000071779500017	9462738				2022-01-24	
J	Wierdl, M; Dominska, M; Petes, TD				Wierdl, M; Dominska, M; Petes, TD			Microsatellite instability in yeast: Dependence on the length of the microsatellite	GENETICS			English	Article							SIMPLE REPETITIVE DNA; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; FRAMESHIFT MUTATION; REPEATS; RECOMBINATION; REPLICATION; DELETION; GENES; SPECIFICITY	One of the most common microsatellites in eukaryotes consists of tandem arrays [usually 15-50 base pairs (bp) in length] of the dinucleotide GT. We examined the rates of instability for poly GT tracts of 15, 33, 51, 99 and 105 bp in wild-type and mismatch repair-deficient strains of Saccharomyces cerevisiae Rates of instability increased more than two orders of magnitude as tracts increased in size from 15 to 99 bp in both wild-type and msh2 strains. The types of alterations observed in long and short tracts in wild-type strains were different in two ways. First, tracts greater than or equal to 51 bp had significantly more large deletions than tracts less than or equal to 33 bp. Second, for the 99- and 105-bp tracts, almost all events involving single repeats were additions; for the smaller tracts, both additions and deletions of single repeats were common.	UNIV N CAROLINA, DEPT BIOL, CURRICULUM GENET & MOL BIOL, CHAPEL HILL, NC 27599 USA						NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-52319] Funding Source: Medline		AHN BY, 1988, MOL CELL BIOL, V8, P2442, DOI 10.1128/MCB.8.6.2442; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; BICHARA M, 1995, GENETICS, V140, P897; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; delaChapelle A, 1995, ANNU REV GENET, V29, P329, DOI 10.1146/annurev.ge.29.120195.001553; FARBER RA, 1994, HUM MOL GENET, V3, P253, DOI 10.1093/hmg/3.2.253; FREUND AM, 1989, P NATL ACAD SCI USA, V86, P7465, DOI 10.1073/pnas.86.19.7465; HABER J E, 1992, Current Opinion in Cell Biology, V4, P401, DOI 10.1016/0955-0674(92)90005-W; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KLEIN HL, 1995, BIOESSAYS, V17, P147, DOI 10.1002/bies.950170210; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kroutil LC, 1996, BIOCHEMISTRY-US, V35, P1046, DOI 10.1021/bi952178h; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Maurer DJ, 1996, MOL CELL BIOL, V16, P6617; NAG DK, 1990, GENETICS, V125, P753; REENAN RAG, 1992, GENETICS, V132, P975; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; SMITH GP, 1973, COLD SPRING HARB SYM, V38, P507, DOI 10.1101/SQB.1974.038.01.055; STRAND M, 1995, P NATL ACAD SCI USA, V92, P10418, DOI 10.1073/pnas.92.22.10418; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STREISINGER G, 1985, GENETICS, V109, P633; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TRAN HT, 1995, MOL CELL BIOL, V15, P5607; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wierdl M, 1996, GENETICS, V143, P713; [No title captured]	37	303	329	0	4	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	JUL	1997	146	3					769	779					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XJ908	WOS:A1997XJ90800003	9215886				2022-01-24	
J	CANN, RL; BROWN, WM; WILSON, AC				CANN, RL; BROWN, WM; WILSON, AC			POLYMORPHIC SITES AND THE MECHANISM OF EVOLUTION IN HUMAN MITOCHONDRIAL-DNA	GENETICS			English	Article									UNIV MICHIGAN,DIV BIOL SCI,ANN ARBOR,MI 48109		CANN, RL (corresponding author), UNIV CALIF BERKELEY,DEPT BIOCHEM,BERKELEY,CA 94720, USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R03DE012412] Funding Source: NIH RePORTER; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [DEB81-12412] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM30144] Funding Source: Medline		ADAMS J, 1982, P NATL ACAD SCI-BIOL, V79, P3560, DOI 10.1073/pnas.79.11.3560; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BORST P, 1981, NATURE, V290, P443, DOI 10.1038/290443a0; BRIMACOMBE R, 1983, PROG NUCLEIC ACID RE, V28, P1, DOI 10.1016/S0079-6603(08)60081-1; BROWN GG, 1982, P NATL ACAD SCI-BIOL, V79, P3246, DOI 10.1073/pnas.79.10.3246; BROWN GG, 1981, GENETICS, V97, P125; BROWN GG, 1984, ENDOCYTOBIOLOGY, V2; Brown W.M., 1983, P62; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1981, ANN NY ACAD SCI, V361, P119, DOI 10.1111/j.1749-6632.1981.tb54361.x; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1982, HUMAN GENETICS A, P157; CANN RL, 1982, THESIS U CALIFORNIA; CARLSON SS, 1977, BIOCHEMISTRY-US, V16, P1437, DOI 10.1021/bi00626a031; CHING E, 1982, BIOCHEMISTRY-US, V21, P3188, DOI 10.1021/bi00256a024; CHRISTIANSEN G, 1983, NUCLEIC ACIDS RES, V11, P37, DOI 10.1093/nar/11.1.37; Dayhoff MO, 1972, ATLAS PROTEIN SEQUEN; DROUIN J, 1979, ICN UCLA S P EXTRACH, V15, P471; FERRIS SD, 1983, NUCLEIC ACIDS RES, V11, P2917; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432; FERRIS SD, 1983, GENETICS, V105, P681; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; GAVRILOVA LP, 1981, J MOL BIOL, V149, P69, DOI 10.1016/0022-2836(81)90260-6; GORINI L, 1974, RIBOSOMES, P791; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; JUKES TH, 1981, J MOL EVOL, V18, P15, DOI 10.1007/BF01733206; KURLAND CG, 1979, NONSENSE MUTATIONS T, P97; LABUDA D, 1983, J MOL BIOL, V167, P205, DOI 10.1016/S0022-2836(83)80042-4; LIPMAN DJ, 1983, J MOL BIOL, V163, P363, DOI 10.1016/0022-2836(83)90063-3; Maniatis T, 1982, MOLECULAR; MARIOTTINI P, 1983, CELL, V32, P1269, DOI 10.1016/0092-8674(83)90308-2; MATTHEWS DE, 1978, FEBS LETT, V86, P76, DOI 10.1016/0014-5793(78)80102-1; MCILWAIN H, 1946, NATURE, V158, P898, DOI 10.1038/158898a0; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; OLIVER NA, 1983, J BIOL CHEM, V258, P5834; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; OSHEROFF N, 1983, J BIOL CHEM, V258, P5731; PALLERONI NJ, 1973, INT J SYST BACTERIOL, V23, P333, DOI 10.1099/00207713-23-4-333; SINCLAIR JH, 1971, BIOCHEMISTRY-US, V10, P2761, DOI 10.1021/bi00790a017; TAKAHATA N, 1983, GENET RES; THOMPSON JF, 1983, CELL, V33, P19, DOI 10.1016/0092-8674(83)90330-6; TOIVONEN LA, 1983, BIOCHEM GENET, V21, P299, DOI 10.1007/BF00499140; TORCZYNSKI R, 1983, NUCLEIC ACIDS RES, V11, P4879, DOI 10.1093/nar/11.14.4879; WALLACE DG, 1971, P NATL ACAD SCI USA, V68, P3127, DOI 10.1073/pnas.68.12.3127; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Yarus M, 1979, Prog Nucleic Acid Res Mol Biol, V23, P195; YARUS M, 1982, CELL, V32, P1269; [No title captured]	55	303	328	0	12	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1984	106	3					479	499					21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SE188	WOS:A1984SE18800010	6323246				2022-01-24	
J	FERRIS, SD; SAGE, RD; PRAGER, EM; RITTE, U; WILSON, AC				FERRIS, SD; SAGE, RD; PRAGER, EM; RITTE, U; WILSON, AC			MITOCHONDRIAL-DNA EVOLUTION IN MICE	GENETICS			English	Article									UNIV CALIF BERKELEY, MUSEUM VERTEBRATE ZOOL, BERKELEY, CA 94720 USA		FERRIS, SD (corresponding author), UNIV CALIF BERKELEY, DEPT BIOCHEM, BERKELEY, CA 94720 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM021509, R01GM021509] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-21509] Funding Source: Medline		ADOLPH S, 1981, J HERED, V72, P219, DOI 10.1093/oxfordjournals.jhered.a109478; AVISE JC, 1979, P NATL ACAD SCI USA, V76, P6694, DOI 10.1073/pnas.76.12.6694; AVISE JC, 1979, GENETICS, V92, P279; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BIELSCHOWSKY M, 1970, CANCER RES, V30, P834; BONHOMME F, 1983, Z SAUGETIERKD, V48, P78; BRITTON J, 1978, BIOCHEM GENET, V16, P213, DOI 10.1007/BF00484079; BROTHWELL D, 1981, S ZOOLOGICAL SOC LON, V47, P1; BROWN GG, 1982, P NATL ACAD SCI-BIOL, V79, P3246, DOI 10.1073/pnas.79.10.3246; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1982, HUMAN GENETICS A, P157; CANN RL, 1982, THESIS U CALIFORNIA; CONNOR JL, 1978, MOUSE NEWS LETT, V58, P61; FERRIS SD, 1983, NUCLEIC ACIDS RES, V11, P2917; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; GEORGE M, 1982, THESIS U CALIFORNIA; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; GROPP A, 1982, CYTOGENET CELL GENET, V34, P67, DOI 10.1159/000131794; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HILKENS J, 1981, MAMMARY TUMORS MOUSE, P11; HUSTON MM, 1983, J EXP MED, V157, P2154, DOI 10.1084/jem.157.6.2154; KERR RA, 1983, SCIENCE, V221, P143, DOI 10.1126/science.221.4606.143; KING BO, 1981, PLASMID, V5, P313, DOI 10.1016/0147-619X(81)90008-1; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; LANSMAN RA, 1983, EVOLUTION, V37, P1, DOI 10.1111/j.1558-5646.1983.tb05509.x; LINDAHL KF, 1983, GENETICS, V103, P483; LYNCH CJ, 1969, LAB ANIM CARE, V19, P214; Marshall J.T., 1981, MOUSE BIOMEDICAL RES, P17; MARSHALL JT, 1981, S ZOOL SOC LOND, V47, P15; Morse H., 1978, ORIGINS INBRED MICE; Morse H. C., 1978, ORIGINS INBRED MICE, P3; NASH HR, 1983, HEREDITY, V50, P303, DOI 10.1038/hdy.1983.32; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; POTTER M, 1979, INBRED GENETICALLY 1, P16; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; SAGE RD, 1981, MOUSE BIOMEDICAL RES, V0001, P00039; SAGE RD, 1981, MOUSE NEWS LETT, V64, P73; SAGE RD, 1978, ORIGINS INBRED MICE, P519; Sarich V.M., 1980, P399; Sarich VM, 1972, BIOCHEM GENET, V7, P205, DOI 10.1007/BF00484818; Schwarz Ernst, 1943, JOUR MAMMAL, V24, P59, DOI 10.2307/1374781; STAATS J, 1980, CANCER RES, V40, P2083; STAATS J, 1964, CANCER RES, V24, P147; TCHERNOV E, 1983, 4TH INT C ARCH; THALER L, 1981, S ZOOL SOC LOND, V47, P27; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WILSON AC, 1977, MOL HUMAN CYTOGENETI, V7, P375; YONEKAWA H, 1981, GENETICS, V98, P801; YONEKAWA H, 1982, DIFFERENTIATION, V22, P222, DOI 10.1111/j.1432-0436.1982.tb01255.x; YONEKAWA H, 1980, JPN J GENET, V55, P289, DOI 10.1266/jjg.55.289	58	303	309	0	15	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics		1983	105	3					681	721					41	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RN089	WOS:A1983RN08900014	6315529				2022-01-24	
J	GANS, M; AUDIT, C; MASSON, M				GANS, M; AUDIT, C; MASSON, M			ISOLATION AND CHARACTERIZATION OF SEX-LINKED FEMALE-STERILE MUTANTS IN DROSOPHILA-MELANOGASTER	GENETICS			English	Article									CTR GENET MOLEC,CNRS,91190 GIF SUR YVETTE,FRANCE								BAKKEN AH, 1973, DEV BIOL, V33, P100, DOI 10.1016/0012-1606(73)90167-X; BISCHOFF WL, 1971, GENETICS, V69, P453; BULL AL, 1966, J EXP ZOOL, V161, P221, DOI 10.1002/jez.1401610207; CHAN LN, 1971, P NATL ACAD SCI USA, V68, P2217, DOI 10.1073/pnas.68.9.2217; CHANDLEY AC, 1962, NATURE, V193, P299, DOI 10.1038/193299b0; Davidson E. H., 1968, GENE ACTIVITY EARLY; FIELDING CJ, 1967, J EMBRYOL EXP MORPH, V17, P375; FULLILOVE SL, 1974, DEV BIOL, V38, P291, DOI 10.1016/0012-1606(74)90008-6; GEHRING WJ, 1973, GENETIC MECHANISMS D, P103; Geigy R., 1931, Revue Suisse de Zoologie, V38, P187; GILL KS, 1963, J EXP ZOOL, V152, P251, DOI 10.1002/jez.1401520304; HATHAWAY DS, 1961, J EMBRYOL EXP MORPH, V9, P310; ILLMENSEE K, 1974, P NATL ACAD SCI USA, V71, P1016, DOI 10.1073/pnas.71.4.1016; KALTHOFF K, 1971, DEV BIOL, V25, P119, DOI 10.1016/0012-1606(71)90022-4; KAPLAN WD, 1970, AM NAT, V104, P261, DOI 10.1086/282660; KING RC, 1961, EXP CELL RES, V23, P108, DOI 10.1016/0014-4827(61)90067-2; KING RC, 1975, HDB GENETICS, V3, P757; KING RC, 1970, OVARIAN DEVELOPMENT; Lewis E. B., 1968, DROS INFORM SERV, V43, P193; LINDSLEY DL, 1968, 627 CARN I WASH PUBL; LOCKSHIN RA, 1966, SCIENCE, V154, P775, DOI 10.1126/science.154.3750.775; MITCHELL HK, 1966, J INSECT PHYSIOL, V12, P755, DOI 10.1016/0022-1910(66)90028-X; OKADA M, 1974, DEV BIOL, V37, P43, DOI 10.1016/0012-1606(74)90168-7; PICARD G, 1971, CR ACAD SCI D NAT, V272, P2484; RICE TB, 1975, DEV BIOL, V43, P277, DOI 10.1016/0012-1606(75)90027-5; RICE TB, 1973, THESIS YALE U; SCHNEIDERMAN HA, 1971, NATURE, V234, P187, DOI 10.1038/234187a0; SHANNON MP, 1972, GENETICA, V43, P244, DOI 10.1007/BF00123632; SPURWAY H, 1948, J GENET, V49, P126, DOI 10.1007/BF02986830; YAJIMA H, 1960, J EMBRYOL EXP MORPH, V8, P198; ZALOKAR M, IN PRESS	31	303	303	0	4	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1975	81	4					683	704					22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC393	WOS:A1975BC39300006	814037				2022-01-24	
J	Kondo, S; Ueda, R				Kondo, Shu; Ueda, Ryu			Highly Improved Gene Targeting by Germline-Specific Cas9 Expression in Drosophila	GENETICS			English	Article						CRISPR; Cas9; Drosophila	ZINC-FINGER NUCLEASES; TRANSGENIC RNAI; GENOME; EFFICIENT; MELANOGASTER; MUTAGENESIS; CLEAVAGE; SYSTEM; CRISPR/CAS9; REVEALS	We report a simple yet extremely efficient platform for systematic gene targeting by the RNA-guided endonuclease Cas9 in Drosophila. The system comprises two transgenic strains: one expressing Cas9 protein from the germline-specific nanos promoter and the other ubiquitously expressing a custom guide RNA (gRNA) that targets a unique site in the genome. The two strains are crossed to form an active Cas9-gRNA complex specifically in germ cells, which cleaves and mutates the target site. We demonstrate rapid generation of mutants in seven neuropeptide and two microRNA genes in which no mutants have been described. Founder animals stably expressing Cas9-gRNA transmitted germline mutations to an average of 60% of their progeny, a dramatic improvement in efficiency over the previous methods based on transient Cas9 expression. Simultaneous cleavage of two sites by co-expression of two gRNAs efficiently induced internal deletion with frequencies of 4.3-23%. Our method is readily scalable to high-throughput gene targeting, thereby accelerating comprehensive functional annotation of the Drosophila genome.	Grad Univ Adv Studies, Natl Inst Genet, Invertebrate Genet Lab, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan		Kondo, S (corresponding author), Natl Inst Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	skondo@nig.ac.jp		Kondo, Shu/0000-0002-4625-8379			Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bateman JR, 2008, GENETICS, V180, P1763, DOI 10.1534/genetics.108.094508; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2002, GENETICS, V161, P1169; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Holtzman S, 2010, FLY, V4, P349, DOI 10.4161/fly.4.4.13304; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keeler KJ, 1996, MOL CELL BIOL, V16, P522; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Lee AM, 2006, GENETICS, V174, P1867, DOI 10.1534/genetics.106.064121; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Ryder Edward, 2003, Briefings in Functional Genomics & Proteomics, V2, P57, DOI 10.1093/bfgp/2.1.57; Van Doren M, 1998, CURR BIOL, V8, P243; Wakiyama M, 2005, BIOCHEM BIOPH RES CO, V331, P1163, DOI 10.1016/j.bbrc.2005.03.240; WALLACE B, 1970, GENETICS, V64, P553; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825	34	302	314	6	56	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	NOV	2013	195	3					715	+		10.1534/genetics.113.156737			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292AN	WOS:000329874100007	24002648	Bronze, Green Published			2022-01-24	
J	Chen, WJ; Lin, Y; Xiong, ZQ; Wei, W; Ni, W; Tan, GH; Guo, SL; He, J; Chen, YF; Zhang, QJ; Li, HF; Lin, Y; Murong, SX; Xu, JF; Wang, N; Wu, ZY				Chen, Wan-Jin; Lin, Yu; Xiong, Zhi-Qi; Wei, Wei; Ni, Wang; Tan, Guo-He; Guo, Shun-Ling; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Li, Hong-Fu; Lin, Yi; Murong, Shen-Xing; Xu, Jianfeng; Wang, Ning; Wu, Zhi-Ying			Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia	NATURE GENETICS			English	Article							HUMAN-CHROMOSOME 16; CHOREOATHETOSIS; DISORDERS; LINKAGE; LOCUS; CHANNELOPATHIES; GENES; MAPS	Paroxysmal kinesigenic dyskinesia is the most common type of paroxysmal movement disorder and is often misdiagnosed clinically as epilepsy. Using whole-exome sequencing followed by Sanger sequencing, we identified three truncating mutations within PRRT2 (NM_145239.2) in eight Han Chinese families with histories of paroxysmal kinesigenic dyskinesia: c.514_517delTCTG (p.Ser172Argfs*3) in one family, c.649dupC (p.Arg217Profs*8) in six families and c.972delA (p.Val325Serfs*12) in one family. These truncating mutations co-segregated exactly with the disease in these families and were not observed in 1,000 control subjects of matched ancestry. PRRT2 is a newly discovered gene consisting of four exons encoding the proline-rich transmembrane protein 2, which encompasses 340 amino acids and contains two predicted transmembrane domains. PRRT2 is highly expressed in the developing nervous system, and a truncating mutation alters the subcellular localization of the PRRT2 protein. The function of PRRT2 and its role in paroxysmal kinesigenic dyskinesia should be further investigated.	[Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, Inst Brain Sci, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, Inst Brain Sci, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Lin, Yu; Wei, Wei; Ni, Wang; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Lin, Yi; Murong, Shen-Xing; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China; [Chen, Wan-Jin; Lin, Yu; Wei, Wei; Ni, Wang; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Lin, Yi; Murong, Shen-Xing; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Peoples R China; [Xiong, Zhi-Qi; Tan, Guo-He; Guo, Shun-Ling] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xu, Jianfeng] Fudan Univ, Fudan Inst Urol, Shanghai Med Coll, Huashan Hosp, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Fudan Van Andel Res Inst VARI, Ctr Genet Epidemiol, Sch Life Sci, Shanghai 200433, Peoples R China		Wu, ZY (corresponding author), Fudan Univ, Inst Brain Sci, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	ningwang63@yahoo.com; zhiyingwu@fudan.edu.cn			National Natural Science Foundation (China)National Natural Science Foundation of China (NSFC) [81125009]; Huashan Hospital; Fudan University; Fujian Medical University [2009D064]	The authors sincerely thank the participants for their help and willingness to take part in this study. The authors also thank the Beijing Genomics Institute (BGI)-Shenzhen for assistance in the analysis of exome sequence data. This work was supported by a grant from the National Natural Science Foundation (China; 81125009 to Z.-Y.W.) and a grant from Huashan Hospital for the special professorship of Fudan University (to Z.-Y.W.) and by a key program of scientific research of Fujian Medical University (2009D064 to N.W.).	Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bhatia KP, 2000, MOVEMENT DISORD, V15, P429, DOI 10.1002/1531-8257(200005)15:3<429::AID-MDS1001>3.0.CO;2-R; Bruno MK, 2004, NEUROLOGY, V63, P2280, DOI 10.1212/01.WNL.0000147298.05983.50; Celesia GG, 2001, CLIN NEUROPHYSIOL, V112, P2, DOI 10.1016/S1388-2457(00)00496-X; GOODENOUGH DJ, 1978, ARCH NEUROL-CHICAGO, V35, P827, DOI 10.1001/archneur.1978.00500360051010; Hu XL, 2011, CEREB CORTEX, V21, P2158, DOI 10.1093/cercor/bhq284; KERTESZ AZ, 1967, NEUROLOGY, V17, P680, DOI 10.1212/WNL.17.7.680; Kikuchi T, 2007, J HUM GENET, V52, P334, DOI 10.1007/s10038-007-0116-7; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ono S, 2011, MOVEMENT DISORD, V26, P761, DOI 10.1002/mds.23475; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682; Valente EM, 2000, BRAIN, V123, P2040, DOI 10.1093/brain/123.10.2040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	20	302	348	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1252	U116		10.1038/ng.1008			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	WOS:000297931400022	22101681				2022-01-24	
J	Wain, LV; Verwoert, GC; O'Reilly, PF; Shi, G; Johnson, T; Johnson, AD; Bochud, M; Rice, KM; Henneman, P; Smith, AV; Ehret, GB; Amin, N; Larson, MG; Mooser, V; Hadley, D; Dorr, M; Bis, JC; Aspelund, T; Esko, T; Janssens, ACJW; Zhao, JH; Heath, S; Laan, M; Fu, JY; Pistis, G; Luan, JA; Arora, P; Lucas, G; Pirastu, N; Pichler, I; Jackson, AU; Webster, RJ; Zhang, F; Peden, JF; Schmidt, H; Tanaka, T; Campbell, H; Igl, W; Milaneschi, Y; Hottenga, JJ; Vitart, V; Chasman, DI; Trompet, S; Bragg-Gresham, JL; Alizadeh, BZ; Chambers, JC; Guo, XQ; Lehtimaki, T; Kuhnel, B; Lopez, LM; Polasek, O; Boban, M; Nelson, CP; Morrison, AC; Pihur, V; Ganesh, SK; Hofman, A; Kundu, S; Mattace-Raso, FUS; Rivadeneira, F; Sijbrands, EJG; Uitterlinden, AG; Hwang, SJ; Vasan, RS; Wang, TJ; Bergmann, S; Vollenweider, P; Waeber, G; Laitinen, J; Pouta, A; Zitting, P; McArdle, WL; Kroemer, HK; Volker, U; Volzke, H; Glazer, NL; Taylor, KD; Harris, TB; Alavere, H; Haller, T; Keis, A; Tammesoo, ML; Aulchenko, Y; Barroso, I; Khaw, KT; Galan, P; Hercberg, S; Lathrop, M; Eyheramendy, S; Org, E; Sober, S; Lu, XW; Nolte, IM; Penninx, BW; Corre, T; Masciullo, C; Sala, C; Groop, L; Voight, BF; Melander, O; O'Donnell, CJ; Salomaa, V; d'Adamo, AP; Fabretto, A; Faletra, F; Ulivi, S; Del Greco, MF; Facheris, M; Collins, FS; Bergman, RN; Beilby, JP; Hung, J; Musk, AW; Mangino, M; Shin, SY; Soranzo, N; Watkins, H; Goel, A; Hamsten, A; Gider, P; Loitfelder, M; Zeginigg, M; Hernandez, D; Najjar, SS; Navarro, P; Wild, SH; Corsi, AM; Singleton, A; de Geus, EJC; Willemsen, G; Parker, AN; Rose, LM; Buckley, B; Stott, D; Orru, M; Uda, M; van der Klauw, MM; Zhang, WH; Li, XZ; Scott, J; Chen, YDI; Burke, GL; Kahonen, M; Viikari, J; Doring, A; Meitinger, T; Davies, G; Starr, JM; Emilsson, V; Plump, A; Lindeman, JH; 't Hoen, PAC; Konig, IR; Felix, JF; Clarke, R; Hopewell, JC; Ongen, H; Breteler, M; Debette, S; DeStefano, AL; Fornage, M; Mitchell, GF; Smith, NL; Holm, H; Stefansson, K; Thorleifsson, G; Thorsteinsdottir, U; Samani, NJ; Preuss, M; Rudan, I; Hayward, C; Deary, IJ; Wichmann, HE; Raitakari, OT; Palmas, W; Kooner, JS; Stolk, RP; Jukema, JW; Wright, AF; Boomsma, DI; Bandinelli, S; Gyllensten, UB; Wilson, JF; Ferrucci, L; Schmidt, R; Farrall, M; Spector, TD; Palmer, LJ; Tuomilehto, J; Pfeufer, A; Gasparini, P; Siscovick, D; Altshuler, D; Loos, RJF; Toniolo, D; Snieder, H; Gieger, C; Meneton, P; Wareham, NJ; Oostra, BA; Metspalu, A; Launer, L; Rettig, R; Strachan, DP; Beckmann, JS; Witteman, JCM; Erdmann, J; van Dijk, KW; Boerwinkle, E; Boehnke, M; Ridker, PM; Jarvelin, MR; Chakravarti, A; Abecasis, GR; Gudnason, V; Newton-Cheh, C; Levy, D; Munroe, PB; Psaty, BM; Caulfield, MJ; Rao, DC; Tobin, MD; Elliott, P; van Duijn, CM				Wain, Louise V.; Verwoert, Germaine C.; O'Reilly, Paul F.; Shi, Gang; Johnson, Toby; Johnson, Andrew D.; Bochud, Murielle; Rice, Kenneth M.; Henneman, Peter; Smith, Albert V.; Ehret, Georg B.; Amin, Najaf; Larson, Martin G.; Mooser, Vincent; Hadley, David; Doerr, Marcus; Bis, Joshua C.; Aspelund, Thor; Esko, Tonu; Janssens, A. Cecile J. W.; Zhao, Jing Hua; Heath, Simon; Laan, Maris; Fu, Jingyuan; Pistis, Giorgio; Luan, Jian'an; Arora, Pankaj; Lucas, Gavin; Pirastu, Nicola; Pichler, Irene; Jackson, Anne U.; Webster, Rebecca J.; Zhang, Feng; Peden, John F.; Schmidt, Helena; Tanaka, Toshiko; Campbell, Harry; Igl, Wilmar; Milaneschi, Yuri; Hottenga, Jouke-Jan; Vitart, Veronique; Chasman, Daniel I.; Trompet, Stella; Bragg-Gresham, Jennifer L.; Alizadeh, Behrooz Z.; Chambers, John C.; Guo, Xiuqing; Lehtimaki, Terho; Kuehnel, Brigitte; Lopez, Lorna M.; Polasek, Ozren; Boban, Mladen; Nelson, Christopher P.; Morrison, Alanna C.; Pihur, Vasyl; Ganesh, Santhi K.; Hofman, Albert; Kundu, Suman; Mattace-Raso, Francesco U. S.; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Hwang, Shih-Jen; Vasan, Ramachandran S.; Wang, Thomas J.; Bergmann, Sven; Vollenweider, Peter; Waeber, Gerard; Laitinen, Jaana; Pouta, Anneli; Zitting, Paavo; McArdle, Wendy L.; Kroemer, Heyo K.; Voelker, Uwe; Voelzke, Henry; Glazer, Nicole L.; Taylor, Kent D.; Harris, Tamara B.; Alavere, Helene; Haller, Toomas; Keis, Aime; Tammesoo, Mari-Liis; Aulchenko, Yurii; Barroso, Ines; Khaw, Kay-Tee; Galan, Pilar; Hercberg, Serge; Lathrop, Mark; Eyheramendy, Susana; Org, Elin; Sober, Siim; Lu, Xiaowen; Nolte, Ilja M.; Penninx, Brenda W.; Corre, Tanguy; Masciullo, Corrado; Sala, Cinzia; Groop, Leif; Voight, Benjamin F.; Melander, Olle; O'Donnell, Christopher J.; Salomaa, Veikko; d'Adamo, Adamo Pio; Fabretto, Antonella; Faletra, Flavio; Ulivi, Sheila; Del Greco, Fabiola M.; Facheris, Maurizio; Collins, Francis S.; Bergman, Richard N.; Beilby, John P.; Hung, Joseph; Musk, A. William; Mangino, Massimo; Shin, So-Youn; Soranzo, Nicole; Watkins, Hugh; Goel, Anuj; Hamsten, Anders; Gider, Pierre; Loitfelder, Marisa; Zeginigg, Marion; Hernandez, Dena; Najjar, Samer S.; Navarro, Pau; Wild, Sarah H.; Corsi, Anna Maria; Singleton, Andrew; de Geus, Eco J. C.; Willemsen, Gonneke; Parker, Alex N.; Rose, Lynda M.; Buckley, Brendan; Stott, David; Orru, Marco; Uda, Manuela; van der Klauw, Melanie M.; Zhang, Weihua; Li, Xinzhong; Scott, James; Chen, Yii-Der Ida; Burke, Gregory L.; Kahonen, Mika; Viikari, Jorma; Doering, Angela; Meitinger, Thomas; Davies, Gail; Starr, John M.; Emilsson, Valur; Plump, Andrew; Lindeman, Jan H.; 't Hoen, Peter A. C.; Koenig, Inke R.; Felix, Janine F.; Clarke, Robert; Hopewell, Jemma C.; Ongen, Halit; Breteler, Monique; Debette, Stephanie; DeStefano, Anita L.; Fornage, Myriam; Mitchell, Gary F.; Smith, Nicholas L.; Holm, Hilma; Stefansson, Kari; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Samani, Nilesh J.; Preuss, Michael; Rudan, Igor; Hayward, Caroline; Deary, Ian J.; Wichmann, H-Erich; Raitakari, Olli T.; Palmas, Walter; Kooner, Jaspal S.; Stolk, Ronald P.; Jukema, J. Wouter; Wright, Alan F.; Boomsma, Dorret I.; Bandinelli, Stefania; Gyllensten, Ulf B.; Wilson, James F.; Ferrucci, Luigi; Schmidt, Reinhold; Farrall, Martin; Spector, Tim D.; Palmer, Lyle J.; Tuomilehto, Jaakko; Pfeufer, Arne; Gasparini, Paolo; Siscovick, David; Altshuler, David; Loos, Ruth J. F.; Toniolo, Daniela; Snieder, Harold; Gieger, Christian; Meneton, Pierre; Wareham, Nicholas J.; Oostra, Ben A.; Metspalu, Andres; Launer, Lenore; Rettig, Rainer; Strachan, David P.; Beckmann, Jacques S.; Witteman, Jacqueline C. M.; Erdmann, Jeanette; van Dijk, Ko Willems; Boerwinkle, Eric; Boehnke, Michael; Ridker, Paul M.; Jarvelin, Marjo-Riitta; Chakravarti, Aravinda; Abecasis, Goncalo R.; Gudnason, Vilmundur; Newton-Cheh, Christopher; Levy, Daniel; Munroe, Patricia B.; Psaty, Bruce M.; Caulfield, Mark J.; Rao, Dabeeru C.; Tobin, Martin D.; Elliott, Paul; van Duijn, Cornelia M.		LifeLines Cohort Study; EchoGen Consortium; AortaGen Consortium; CHARGE Consortium Heart Failure; KidneyGen Consortium; CKDGen Consortium; Cardiogenics Consortium; CardioGram	Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure	NATURE GENETICS			English	Article							ADRENERGIC-RECEPTOR TRAFFICKING; CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; HEART-FAILURE; HYPERTENSION; METAANALYSIS; MORTALITY; GENE; MICE; RELEVANCE	Numerous genetic loci have been associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans(1-3). We now report genome-wide association studies of pulse pressure (PP) and mean arterial pressure (MAP). In discovery (N = 74,064) and follow-up studies (N = 48,607), we identified at genome-wide significance (P = 2.7 x 10(-8) to P = 2.3 x 10(-13)) four new PP loci (at 4q12 near CHIC2, 7q22.3 near PIK3CG, 8q24.12 in NOV and 11q24.3 near ADAMTS8), two new MAP loci (3p21.31 in MAP4 and 10q25.3 near ADRB1) and one locus associated with both of these traits (2q24.3 near FIGN) that has also recently been associated with SBP in east Asians. For three of the new PP loci, the estimated effect for SBP was opposite of that for DBP, in contrast to the majority of common SBP- and DBP-associated variants, which show concordant effects on both traits. These findings suggest new genetic pathways underlying blood pressure variation, some of which may differentially influence SBP and DBP.	[O'Reilly, Paul F.; Chambers, John C.; Zhang, Weihua; Li, Xinzhong; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Verwoert, Germaine C.; Mattace-Raso, Francesco U. S.; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Shi, Gang; Rao, Dabeeru C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Shi, Gang; Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Johnson, Toby; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Johnson, Andrew D.; Larson, Martin G.; Hwang, Shih-Jen; Vasan, Ramachandran S.; Wang, Thomas J.; O'Donnell, Christopher J.; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA USA; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Henneman, Peter; 't Hoen, Peter A. C.; van Dijk, Ko Willems] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands; [Smith, Albert V.; Aspelund, Thor; Emilsson, Valur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykajvik, Iceland; [Ehret, Georg B.; Pihur, Vasyl; Chakravarti, Aravinda] Johns Hopkins Univ Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Ehret, Georg B.] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Ehret, Georg B.] Univ Hosp Geneva, Dept Specialties Internal Med, Geneva, Switzerland; [Amin, Najaf; Janssens, A. Cecile J. W.; Hofman, Albert; Kundu, Suman; Mattace-Raso, Francesco U. S.; Sijbrands, Eric J. G.; Aulchenko, Yurii; Felix, Janine F.; Breteler, Monique; Witteman, Jacqueline C. M.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Larson, Martin G.] Boston Univ, Dept Math, Boston, MA 02215 USA; [Mooser, Vincent] GlaxoSmithKline, Genet Div R&D, King Of Prussia, PA USA; [Hadley, David; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London, England; [Hadley, David] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [Doerr, Marcus] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Bis, Joshua C.; Siscovick, David; Psaty, Bruce M.] Univ Washington, Dept Med, Div Internal Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Esko, Tonu; Alavere, Helene; Haller, Toomas; Keis, Aime; Tammesoo, Mari-Liis; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Esko, Tonu; Laan, Maris; Org, Elin; Sober, Siim; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Zhao, Jing Hua; Luan, Jian'an; Loos, Ruth J. F.; Wareham, Nicholas J.] Inst Metab Sci, Med Res Council MRC Epidemiol Unit, Cambridge, England; [Heath, Simon; Lathrop, Mark] Inst Genom, Commissariat Energie Atom, Ctr Natl Genotypage, Evry, France; [Fu, Jingyuan; Alizadeh, Behrooz Z.; Lu, Xiaowen; Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pistis, Giorgio; Corre, Tanguy; Masciullo, Corrado; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Arora, Pankaj; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Lucas, Gavin] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Pirastu, Nicola; d'Adamo, Adamo Pio; Gasparini, Paolo] Univ Trieste, Ist Ricovero & Cura Carattere Sci IRCCS Burlo Gar, Inst Maternal & Child Hlth, Trieste, Italy; [Pichler, Irene; Del Greco, Fabiola M.; Facheris, Maurizio; Pfeufer, Arne] European Acad Bozen Bolzano EURAC, Inst Genet Med, Bolzano, Italy; [Pichler, Irene; Del Greco, Fabiola M.; Facheris, Maurizio; Pfeufer, Arne] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Jackson, Anne U.; Bragg-Gresham, Jennifer L.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Webster, Rebecca J.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [Zhang, Feng; Mangino, Massimo; Shin, So-Youn; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Peden, John F.; Watkins, Hugh; Goel, Anuj; Ongen, Halit; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Peden, John F.; Watkins, Hugh; Goel, Anuj; Farrall, Martin] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Schmidt, Helena; Gider, Pierre; Zeginigg, Marion] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Tanaka, Toshiko; Milaneschi, Yuri; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Campbell, Harry; Wild, Sarah H.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Igl, Wilmar; Gyllensten, Ulf B.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Hottenga, Jouke-Jan] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Vitart, Veronique; Navarro, Pau; Hayward, Caroline; Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Chambers, John C.; Zhang, Weihua; Kooner, Jaspal S.] Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England; [Guo, Xiuqing; Taylor, Kent D.; Chen, Yii-Der Ida] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho; Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Kuehnel, Brigitte; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Lopez, Lorna M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Polasek, Ozren] Univ Split, Sch Med, Dept Publ Hlth, Split, Croatia; [Boban, Mladen] Univ Split, Sch Med, Dept Pharmacol, Split, Croatia; [Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Morrison, Alanna C.] Univ Texas Houston Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Ganesh, Santhi K.] Univ Michigan Med Ctr, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI USA; [Vasan, Ramachandran S.] Boston Univ Sch Med, Div Epidemiol & Prevent, Boston, MA USA; [Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Internal Med, Lausanne, Switzerland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynaecol, Oulu, Finland; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi, Finland; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children ALSPAC, Bristol, Avon, England; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, Greifswald, Germany; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Glazer, Nicole L.] Boston Univ Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA USA; [Harris, Tamara B.; Launer, Lenore] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Barroso, Ines; Shin, So-Youn; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Barroso, Ines] Univ Cambridge Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Galan, Pilar; Hercberg, Serge] INSERM, U557, Paris, France; [Galan, Pilar; Hercberg, Serge] INRA, U1125, Paris, France; [Galan, Pilar; Hercberg, Serge] Univ Paris 13, Bobigny, France; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Penninx, Brenda W.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Groop, Leif] Lund Univ, Malmo Univ Hosp, Diabet & Endocrinol Res Unit, Dept Clin Sci, Malmo, Sweden; [Voight, Benjamin F.; Altshuler, David; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [Salomaa, Veikko] THL Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Beilby, John P.] PathW Lab Med, Nedlands, WA, Australia; [Beilby, John P.; Hung, Joseph; Musk, A. William; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [Hung, Joseph; Musk, A. William] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Musk, A. William] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Hamsten, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Loitfelder, Marisa; Schmidt, Reinhold] Med Univ Graz, Sect Special Neurol, Dept Neurol, Graz, Austria; [Hernandez, Dena; Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Najjar, Samer S.] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Najjar, Samer S.] Washington Hosp Ctr, MedStar Hlth Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; [Corsi, Anna Maria] Tuscany Reg Hlth Agcy, Florence, Italy; [de Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, EMGO Inst, Amsterdam, Netherlands; [Parker, Alex N.] Amgen Inc, Cambridge, MA USA; [Buckley, Brendan] Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Stott, David] Univ Glasgow, Sch Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Orru, Marco; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, Monserrato, Italy; [van der Klauw, Melanie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Burke, Gregory L.] Wake Forest Univ Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Doering, Angela; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Meitinger, Thomas; Pfeufer, Arne] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Plump, Andrew] Merck Res Lab, Rahway, NJ USA; [Lindeman, Jan H.] Leiden Univ Med Ctr, Dept Vasc Surg, Leiden, Netherlands; ['t Hoen, Peter A. C.] Leiden Univ Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; [Koenig, Inke R.; Preuss, Michael] Univ Lubeck, Inst Med Biometrie & Stat, Lubeck, Germany; [Felix, Janine F.] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Debette, Stephanie] Boston Univ Sch Med, Dept Neurol, Boston, MA USA; [DeStefano, Anita L.] Boston Univ Sch Publ Hlth, Boston, MA USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [Smith, Nicholas L.; Siscovick, David; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Ctr Dept Vet Affairs Off Res & Dev, Seattle, WA USA; [Smith, Nicholas L.; Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA; [Holm, Hilma; Stefansson, Kari; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur] deCODE Genet Inc, Reykjavik, Iceland; [Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Samani, Nilesh J.] Glenfield Hosp, Leicester Natl Inst Hlth Res NIHR Biomed Res Unit, Leicester, Leics, England; [Preuss, Michael; Erdmann, Jeanette] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Rudan, Igor] Univ Split Med Sch, Croatian Ctr Global Hlth, Split, Croatia; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Palmas, Walter] Columbia Univ, New York, NY USA; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Bandinelli, Stefania] ASF, Geriatr Unit, Florence, Italy; [Palmer, Lyle J.] Ontario Canc Inst Res, Toronto, ON, Canada; [Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Pfeufer, Arne] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Meneton, Pierre] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; [van Dijk, Ko Willems] Leiden Univ Med Ctr, Dept Internal Med, Leiden, Netherlands; [Boerwinkle, Eric] Ctr Human Genet, Houston, TX USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr, Oulu, Finland; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Rao, Dabeeru C.] Washington Univ, Dept Math, Sch Med, St Louis, MO 63130 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA Ctr Environm & Hlth, London, England; [van Duijn, Cornelia M.] Erasmus MC, Ctr Med Syst Biol, Rotterdam, Netherlands		Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	mt47@leicester.ac.uk; p.elliott@imperial.ac.uk; c.vanduijn@erasmusmc.nl	Boban, Mladen/E-2777-2017; Rice, Kenneth M/A-4150-2013; Stolk, Ronald P/B-2341-2013; Aspelund, Thor/C-5983-2008; Levy, Daniel/ABB-2752-2021; Wichmann, Heinz Erich/AAA-5695-2022; Erdmann, Jeanette/P-7513-2014; Toniolo, Daniela/AAE-2969-2019; Rudan, Igor/I-1467-2012; Meneton, Pierre/T-1216-2019; HERCBERG, Serge/B-4429-2008; Aulchenko, Yurii/M-8270-2013; mangino, massimo/F-5134-2011; Hayward, Caroline/M-8818-2016; Arora, Pankaj/F-3437-2011; Rivadeneira, Fernando/O-5385-2015; Aspelund, Thor/K-7022-2019; Lopez, Lorna/AAR-4912-2020; Colaus, PsyColaus/K-6607-2013; Gale, Daniel/D-5594-2013; Abecasis, Goncalo R/B-7840-2010; Haller, Toomas/N-3797-2019; Peters, Annette/A-6117-2011; Kronenberg, Florian/B-1736-2008; Zgaga, Lina/Q-9415-2018; Amin, Najaf N/D-1859-2012; Gudnason, Vilmundur/K-6885-2015; Bakker, Stephan J. L./J-4023-2015; Pilar, Galan/F-2908-2017; Palmer, Lyle John/N-1948-2019; Navarro, Pau/AAJ-8091-2021; de Geus, Eco J.C./M-9318-2015; Raitakari, Olli/AAQ-7389-2021; Altshuler, David M/A-4476-2009; Polasek, Ozren/B-6002-2011; Uda, Manuela/AAC-2645-2019; Alizadeh, Behrooz Z Ziad/J-2921-2017; Penninx, Brenda WJH/S-7627-2017; van Dijk, Ko Willems/AAT-4681-2021; Bochud, Murielle/A-3981-2010; Lucas, Gavin/D-4346-2012; Konig, Inke R/A-4544-2009; Gudnason, Vilmundur/AAE-7126-2019; Li, Man/AAX-3400-2020; Schmidt, Reinhold/E-1137-2014; Raso, Francesco Mattace-/L-2541-2015; Singleton, Andrew B/C-3010-2009; d'Adamo, Adamo Pio/G-4064-2011; Munzel, Thomas/A-2912-2014; Stefansson, Kari/AAE-7187-2019; 't Hoen, Peter/A-4857-2012; Newman, Anne B./C-6408-2013; Eggermann, Thomas/F-3807-2014; Hadley, David/I-6902-2012; EHRET, Georg B/A-9532-2009; Dorr, Marcus/F-1919-2010; Feitosa, Mary F/K-8044-2012; Gasparini, Paolo/B-6173-2014; Jukema, J. Wouter/ABD-6503-2021; van der Klauw, M. M./A-2138-2014; Khaw, Kay-Tee/AAZ-3209-2021; Levy, Daniel/ABF-6873-2021; Kundu, Suman/I-2603-2019; Fu, Jingyuan/ABE-6868-2020; Hoen, Peter A 't/D-3950-2018; Loos, Ruth J F/Q-2862-2016; Heath, Simon C/J-4138-2012; Breteler, Monique M.B./J-5058-2014; Deary, Ian J/C-6297-2009; Laan, Maris/A-4100-2011; Maria, Hernandez-Fuentes/B-5011-2010; Boomsma, Dorret I/AAX-4470-2020; Giallauria, Francesco/B-5681-2013; Debette, Stephanie/T-4946-2019; Ulivi, Sheila/H-3700-2013; Erdmann, Jeanette/A-4417-2009; Lopez, Lorna M/F-7265-2010; Campbell, Harry/E-2959-2010; Maxwell, Patrick H/C-5557-2008; Sijbrands, Eric/A-1065-2009; Meitinger, Thomas/O-1318-2015; Org, Elin/AAJ-9631-2021; Serge, Hercberg/F-3038-2017; Hypponen, Elina/B-2596-2014; Johnson, Andrew D/G-6520-2013; Wilson, James F/A-5704-2009; Schalling, Martin/F-1518-2015; Beckmann, Jacques S/A-9772-2008; Gillebert, Thierry C/F-5551-2014; Sala, Cinzia Felicita/AAN-1900-2020; Ramachandran, Vasan/Y-2527-2019; Smith, Albert Vernon/K-5150-2015; Dominiczak, Anna F/P-9390-2017; Shi, Gang/D-3301-2016; Pirastu, Nicola/G-4358-2011; van Dijk, Ko Willems/A-1798-2008; Palmer, Lyle John/K-3196-2014; Pfeufer, Arne/B-6634-2013; Fu, Jingyuan/E-8980-2012; Lightstone, Liz/M-4331-2014; Ziegler, Andreas/G-4246-2012	Boban, Mladen/0000-0003-1570-9621; Rice, Kenneth M/0000-0001-5779-4495; Stolk, Ronald P/0000-0002-0518-1205; Aspelund, Thor/0000-0002-7998-5433; Erdmann, Jeanette/0000-0002-4486-6231; Toniolo, Daniela/0000-0001-9545-6032; Rudan, Igor/0000-0001-6993-6884; HERCBERG, Serge/0000-0002-3168-1350; Aulchenko, Yurii/0000-0002-7899-1575; mangino, massimo/0000-0002-2167-7470; Hayward, Caroline/0000-0002-9405-9550; Arora, Pankaj/0000-0003-2420-3550; Rivadeneira, Fernando/0000-0001-9435-9441; Aspelund, Thor/0000-0002-7998-5433; Lopez, Lorna/0000-0002-0241-9783; Gale, Daniel/0000-0002-9170-1579; Haller, Toomas/0000-0002-5069-6523; Peters, Annette/0000-0001-6645-0985; Kronenberg, Florian/0000-0003-2229-1120; Zgaga, Lina/0000-0003-4089-9703; Gudnason, Vilmundur/0000-0001-5696-0084; Bakker, Stephan J. L./0000-0003-3356-6791; Pilar, Galan/0000-0003-1706-3107; Palmer, Lyle John/0000-0002-1628-3055; Navarro, Pau/0000-0001-5576-8584; de Geus, Eco J.C./0000-0001-6022-2666; Altshuler, David M/0000-0002-7250-4107; Polasek, Ozren/0000-0002-5765-1862; Uda, Manuela/0000-0002-4890-6456; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Penninx, Brenda WJH/0000-0001-7779-9672; van Dijk, Ko Willems/0000-0002-2172-7394; Bochud, Murielle/0000-0002-5727-0218; Konig, Inke R/0000-0003-0504-6465; Gudnason, Vilmundur/0000-0001-5696-0084; Li, Man/0000-0002-3839-0281; d'Adamo, Adamo Pio/0000-0001-9367-4909; Munzel, Thomas/0000-0001-5503-4150; Newman, Anne B./0000-0002-0106-1150; EHRET, Georg B/0000-0002-5730-0675; Dorr, Marcus/0000-0001-7471-475X; Feitosa, Mary F/0000-0002-0933-2410; Jukema, J. Wouter/0000-0002-3246-8359; van der Klauw, M. M./0000-0001-7178-009X; Levy, Daniel/0000-0003-1843-8724; Kundu, Suman/0000-0002-6305-2559; Fu, Jingyuan/0000-0001-5578-1236; Hoen, Peter A 't/0000-0003-4450-3112; Loos, Ruth J F/0000-0002-8532-5087; Heath, Simon C/0000-0002-9550-0897; Breteler, Monique M.B./0000-0002-0626-9305; Deary, Ian J/0000-0002-1733-263X; Laan, Maris/0000-0002-8519-243X; Maria, Hernandez-Fuentes/0000-0002-7558-9441; Giallauria, Francesco/0000-0003-4119-9397; Debette, Stephanie/0000-0001-8675-7968; Ulivi, Sheila/0000-0003-3606-835X; Campbell, Harry/0000-0002-6169-6262; Maxwell, Patrick H/0000-0002-0338-2679; Sijbrands, Eric/0000-0001-8857-7389; Serge, Hercberg/0000-0002-3168-1350; Hypponen, Elina/0000-0003-3670-9399; Johnson, Andrew D/0000-0001-6369-5178; Wilson, James F/0000-0001-5751-9178; Schalling, Martin/0000-0001-5011-2922; Beckmann, Jacques S/0000-0002-9741-1900; Gillebert, Thierry C/0000-0002-3832-919X; Ramachandran, Vasan/0000-0001-7357-5970; Smith, Albert Vernon/0000-0003-1942-5845; Dominiczak, Anna F/0000-0003-4913-3608; van Dijk, Ko Willems/0000-0002-2172-7394; Palmer, Lyle John/0000-0002-1628-3055; Eyheramendy, Susana/0000-0003-4723-9660; Pirastu, Nicola/0000-0002-5363-3886; ELOSUA, ROBERTO/0000-0001-8235-0095; Hamburg, Naomi/0000-0001-5504-5589; Stumvoll, Michael/0000-0001-6225-8240; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Larson, Martin/0000-0002-9631-1254; Kleber, Marcus/0000-0003-0663-7275; Waeber, Gerard/0000-0003-4193-788X; Gasparini, Paolo/0000-0002-0859-0856; Van Duijn, Cornelia/0000-0002-2374-9204; Wallace, Chris/0000-0001-9755-1703; O'Reilly, Paul/0000-0001-7515-0845; Gieger, Christian/0000-0001-6986-9554; Lawlor, Debbie A/0000-0002-6793-2262; Barroso, Ines/0000-0001-5800-4520; Wang, Thomas/0000-0003-4063-6508; Amin, Najaf/0000-0002-8944-1771; Koenig, Wolfgang/0000-0002-2064-9603; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hopewell, Jemma/0000-0002-3870-8018; Fuchsberger, Christian/0000-0002-5918-8947; Stritzke, Jan/0000-0003-3143-7005; Couper, David/0000-0002-4313-9235; Volker, Uwe/0000-0002-5689-3448; Esko, Tonu/0000-0003-1982-6569; Wild, Philipp/0000-0003-4413-9752; Zeller, Tanja/0000-0003-3379-2641; Pichler, Irene/0000-0001-8251-0757; Goel, Anuj/0000-0003-2307-4021; Brown, Morris/0000-0001-8409-1082; Caulfield, Mark/0000-0001-9295-3594; Nitsch, Dorothea/0000-0001-5767-248X; Tobin, Martin/0000-0002-3596-7874; Abecasis, Goncalo/0000-0003-1509-1825; Faletra, Flavio/0000-0003-1483-3612; Org, Elin/0000-0001-8688-9717; DeStefano, Anita/0000-0002-9335-2819; Beilby, John/0000-0002-4915-2254; Johnson, Toby/0000-0002-5998-3270; SCUTERI, ANGELO/0000-0003-4784-5441; Magi, Reedik/0000-0002-2964-6011; Soranzo, Nicole/0000-0003-1095-3852; Kahonen, Mika/0000-0002-4510-7341; Glazer, Nicole/0000-0002-6397-609X; Willemsen, Gonneke/0000-0003-3755-0236; Mattace-Raso, Francesco/0000-0002-1688-6497; Janssens, A Cecile/0000-0002-6153-4976; Wain, Louise/0000-0003-4951-1867; Nelson, Christopher/0000-0001-8025-2897; Lakatta, Edward/0000-0002-4772-0035; Kovacs, Peter/0000-0002-0290-5423; Emilsson, Valur/0000-0001-9982-0524; Lightstone, Liz/0000-0002-4603-4076; s, hema/0000-0002-3440-9475; Elliott, Paul/0000-0002-7511-5684; Melander, Olle/0000-0002-2581-484X; Felix, Janine/0000-0002-9801-5774; Kleefstra, Nanne/0000-0003-1473-8519; Pilz, Stefan/0000-0002-7959-1311; Forouhi, Nita/0000-0002-5041-248X; Aherrahrou, Zouhair/0000-0002-1241-8733; wilkinson, ian/0000-0001-6598-9399; Ziegler, Andreas/0000-0002-8386-5397; Lord, Graham/0000-0003-2069-4743; Loehr, Laura/0000-0002-9054-1825; Munroe, Patricia/0000-0002-4176-2947; De Bacquer, Dirk/0000-0002-3202-7238; Meitinger, Thomas/0000-0002-8838-8403; Org, Elin/0000-0003-1451-9375; Zemunik, Tatijana/0000-0001-8120-2891; Ouwehand, Willem/0000-0002-7744-1790; Bergmann, Sven/0000-0002-6785-9034; De Meyer, Tim/0000-0003-2994-9693; Preuss, Michael/0000-0001-5266-8465; Pramstaller, Peter P/0000-0002-9831-8302; Lucas, Gavin/0000-0003-4166-9416; Morrison, Alanna/0000-0001-6381-4296; Ongen, Halit/0000-0002-4197-5790	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Heart, Lung, and Blood Institute, European; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9521010, G0701863, MC_U137686857, G0700704, G0601966, G0902313, MC_U127561128, MC_U127592696, G0700931, G0801056, MC_U106188470, MC_PC_U127592696, MC_PC_U127561128] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [N01HC025195, N01HC095159, N01HC055015, N01HC085079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL043851, K23HL080025, R01HL086694, R01HL087647, R01HL105756, ZIAHL006002, U10HL054512] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG007480, ZIAAG001050] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [R01MD009164] Funding Source: NIH RePORTER; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1] Funding Source: researchfish; Kidney Research UKKidney Research UK (KRUK) [RP24/2/2006] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0401527, G0701863, G0902313, MC_U127592696, MC_U127561128, MC_PC_U127592696, G9521010, G0801056, G0601966, G0700931, MC_U106188470, G0700704B, G1000143, G0700704, MC_U106179471, MC_PC_U127561128, G0801056B, MC_U137686857] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10315] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505, CZB/4/710] Funding Source: researchfish	A number of the participating studies and authors are members of the CHARGE and Global BPgen consortia. Many funding mechanisms by the US National Institutes of Health and National Heart, Lung, and Blood Institute, European and private funding agencies contributed to this work, and a full list of acknowledgements is provided in the Supplementary Note.	Blacher J, 2005, NAT CLIN PRACT CARD, V2, P450, DOI 10.1038/ncpcardio0307; Cheng GM, 2005, AM J PHYSIOL-HEART C, V288, pH1193, DOI 10.1152/ajpheart.00109.2004; Cools J, 1999, BLOOD, V94, P1820, DOI 10.1182/blood.V94.5.1820.417k09_1820_1824; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Domanski M, 2002, JAMA-J AM MED ASSOC, V287, P2677, DOI 10.1001/jama.287.20.2677; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Dorn GW, 2010, PHYSIOL REV, V90, P1013, DOI 10.1152/physrev.00001.2010; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ellis PD, 2000, ARTERIOSCL THROM VAS, V20, P1912, DOI 10.1161/01.ATV.20.8.1912; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kitsios GD, 2010, AM J HYPERTENS, V23, P305, DOI 10.1038/ajh.2009.251; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Perrino C, 2007, CIRCULATION, V116, P2571, DOI 10.1161/CIRCULATIONAHA.107.706515; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; ROSE G, 2005, CORONARY HEART DIS E, P631; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018	33	302	307	1	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					1005	U122		10.1038/ng.922			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	WOS:000295316200017	21909110	Green Submitted, Green Accepted, Green Published			2022-01-24	
J	Wang, GP; Ciuffi, A; Leipzig, J; Berry, CC; Bushman, FD				Wang, Gary P.; Ciuffi, Angela; Leipzig, Jeremy; Berry, Charles C.; Bushman, Frederic D.			HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications	GENOME RESEARCH			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENOME-WIDE ANALYSIS; DNA INTEGRATION; HUMAN HOMOLOG; GENE-THERAPY; LEDGF/P75; PROTEINS; VECTORS; NUCLEAR; TARGETS	Integration of retroviral DNA into host cell DNA is a defining feature of retroviral replication. HIV integration is known to be favored in active transcription units, which promotes efficient transcription of the viral genes, but the molecular mechanisms responsible for targeting are not fully clarified. Here we used pyrosequencing to map 40,569 unique sites of HIV integration. Computational prediction of nucleosome positions in target DNA indicated that integration sites are periodically distributed on the nucleosome surface, consistent with favored integration into outward-facing DNA major grooves in chromatin. Analysis of integration site positions in the densely annotated ENCODE regions revealed a wealth of new associations between integration frequency and genomic features. Integration was particularly favored near transcription-associated histone modifications, including H3 acetylation, H4 acetylation, and H3 K4 methylation, but was disfavored in regions rich in transcription-inhibiting modifications, which include H3 K27 trimethylation and DNA CpG methylation. Statistical modeling indicated that effects of histone modification on HIV integration were partially independent of other genomic features influencing integration. The pyrosequencing and bioinformatic methods described here should be useful for investigating many aspects of retroviral DNA integration.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Calif San Diego, Sch Med, Dept Family Prevent Med, La Jolla, CA 92093 USA		Bushman, FD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu	Ciuffi, Angela/K-5798-2017	Ciuffi, Angela/0000-0003-2333-513X; Bushman, Frederic/0000-0003-4740-4056; Leipzig, Jeremy/0000-0001-7224-9620	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI007634, R01AI052845] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32 AI007634, T32 AI07634, R01 AI052845, AI52845, U19 AI066290, AI66290] Funding Source: Medline		Barr SD, 2005, J VIROL, V79, P12035, DOI 10.1128/JVI.79.18.12035-12044.2005; Barr SD, 2006, MOL THER, V14, P218, DOI 10.1016/j.ymthe.2006.03.012; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2001, LATERAL DNA TRANSFER; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2006, MOL THER, V13, P366, DOI 10.1016/j.ymthe.2005.10.009; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Coffin JM, 1997, RETROVIRUSES; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hizi A, 2005, J BIOL CHEM, V280, P39086, DOI 10.1074/jbc.M506363200; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, P NATL ACAD SCI USA, V89, P9237, DOI 10.1073/pnas.89.19.9237; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	48	302	310	0	19	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2007	17	8					1186	1194		10.1101/gr.6286907			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	196OL	WOS:000248491800007	17545577	Green Published, Bronze			2022-01-24	
J	Simone, C; Forcales, SV; Hill, DA; Imbalzano, AN; Latella, L; Puri, PL				Simone, C; Forcales, SV; Hill, DA; Imbalzano, AN; Latella, L; Puri, PL			p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; MAP KINASE; MYOD; DIFFERENTIATION; BINDING; FAMILY; ACETYLATION; ROLES; MEF2C; PCAF	During skeletal myogenesis, genomic reprogramming toward terminal differentiation is achieved by recruiting chromatin-modifying enzymes to muscle-specific loci(1,2). The relative contribution of extracellular signaling cascades in targeting these enzymes to individual genes is unknown. Here we show that the differentiation-activated p38 pathway(3-5) targets the SWI-SNF chromatin-remodeling complex to myogenic loci. Upon differentiation, p38 kinases were recruited to the chromatin of muscle-regulatory elements. Blockade of p38alpha/beta repressed the transcription of muscle genes by preventing recruitment of the SWI-SNF complex at these elements without affecting chromatin binding of muscle-regulatory factors and acetyltransferases. The SWI-SNF subunit BAF60 could be phosphorylated by p38alpha-beta in vitro, and forced activation of p38alpha/beta in myoblasts by expression of a constitutively active MKK6 (refs. 5-7) promoted unscheduled SWI-SNF recruitment to the myogenin promoter. Conversely, inactivation of SWI-SNF enzymatic subunits abrogated MKK6-dependent induction of muscle gene expression. These results identify an unexpected function of differentiation-activated p38 in converting external cues into chromatin modifications at discrete loci, by selectively targeting SWI-SNF to muscle-regulatory elements.	Fdn A Cesalpino, Inst Cell Biol & Tissue Engn, Dulbecco Telethon Inst, Gene Express Lab, I-00128 Rome, Italy; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92093 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA		Puri, PL (corresponding author), Fdn A Cesalpino, Inst Cell Biol & Tissue Engn, Dulbecco Telethon Inst, Gene Express Lab, San Raffaele Biomed Sci Pk Rome, I-00128 Rome, Italy.	plpuri@dti.telethon.it	Forcales, Sonia-V./B-2157-2013; Simone, Cristiano/K-3452-2018; Forcales, Sonia/AAU-8996-2020; Latella, Lucia/K-7834-2016	Forcales, Sonia-V./0000-0002-7111-4959; Simone, Cristiano/0000-0002-2628-7658; Forcales, Sonia/0000-0002-7111-4959; LATELLA, LUCIA/0000-0003-1317-9233; Puri, Pier Lorenzo/0000-0003-4964-0095	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM056244] Funding Source: NIH RePORTER; TelethonFondazione Telethon [GFP01009, TCP00081] Funding Source: Medline		Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DEBRIL MB, 2003, J BIOL CHEM, V16, P16677; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 2000, GENE DEV, V14, P574; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 1999, MOL CELL BIOL, V19, P21	29	302	312	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					738	743		10.1038/ng1378			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	WOS:000222354100025	15208625	Bronze			2022-01-24	
J	Repping, S; Skaletsky, H; Brown, L; van Daalen, SKM; Korver, CM; Pyntikova, T; Kuroda-Kawaguchi, T; de Vries, JWA; Oates, RD; Silber, S; van der Veen, F; Page, DC; Rozen, S				Repping, S; Skaletsky, H; Brown, L; van Daalen, SKM; Korver, CM; Pyntikova, T; Kuroda-Kawaguchi, T; de Vries, JWA; Oates, RD; Silber, S; van der Veen, F; Page, DC; Rozen, S			Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection	NATURE GENETICS			English	Article							INTRACHROMOSOMAL RECOMBINATION; HUMAN-POPULATIONS; INFERTILE MEN; COPY NUMBER; AZFC REGION; DAZ GENES; MICRODELETIONS; MARKER; MALES; YQ11	Many human Y-chromosomal deletions are thought to severely impair reproductive fitness, which precludes their transmission to the next generation and thus ensures their rarity in the population. Here we report a 1.6-Mb deletion that persists over generations and is sufficiently common to be considered a polymorphism. We hypothesized that this deletion might affect spermatogenesis because it removes almost half of the Y chromosome's AZFc region, a gene-rich segment that is critical for sperm production(1,2). An association study established that this deletion, called gr/gr, is a significant risk factor for spermatogenic failure. The gr/gr deletion has far lower penetrance with respect to spermatogenic failure than previously characterized Y-chromosomal deletions; it is often transmitted from father to son. By studying the distribution of gr/gr-deleted chromosomes across the branches of the Y chromosome's genealogical tree, we determined that this deletion arose independently at least 14 times in human history. We suggest that the existence of this deletion as a polymorphism reflects a balance between haploid selection, which culls gr/gr-deleted Y chromosomes from the population, and homologous recombination, which continues to generate new gr/gr deletions.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; Ichikawa Gen Hosp, Tokyo Dent Coll, Reprod Ctr, Chiba, Japan; Boston Univ, Med Ctr, Dept Urol, Boston, MA 02118 USA; St Lukes Hosp, Infertil Ctr, St Louis, MO 63017 USA		Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Rozen, Steven G./J-5939-2013	Rozen, Steven G./0000-0002-4288-0056; Oates, Robert/0000-0003-2330-6697; Repping, Sjoerd/0000-0002-6959-149X			Bienvenu T, 2001, ANN GENET-PARIS, V44, P125, DOI 10.1016/S0003-3995(01)01078-4; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Vries JWA, 2002, FERTIL STERIL, V77, P68, DOI 10.1016/S0015-0282(01)02935-1; Ellis N, 2002, GENOME RES, V12, P339; Ewis AA, 2002, J HUM GENET, V47, P257, DOI 10.1007/s100380200035; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kuroki Y, 1999, J HUM GENET, V44, P289, DOI 10.1007/s100380050162; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soucie JM, 1998, AM J HEMATOL, V59, P288, DOI 10.1002/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; WHO, 1992, WHO LAB MAN EX HUM S; Yen P, 2001, NAT GENET, V29, P243, DOI 10.1038/ng1101-243	28	302	327	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					247	251		10.1038/ng1250			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	WOS:000186273300020	14528305				2022-01-24	
J	Toyo-oka, K; Shionoya, A; Gambello, MJ; Cardoso, C; Leventer, R; Ward, HL; Ayala, R; Tsai, LH; Dobyns, W; Ledbetter, D; Hirotsune, S; Wynshaw-Boris, A				Toyo-oka, K; Shionoya, A; Gambello, MJ; Cardoso, C; Leventer, R; Ward, HL; Ayala, R; Tsai, LH; Dobyns, W; Ledbetter, D; Hirotsune, S; Wynshaw-Boris, A			14-3-3 epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome	NATURE GENETICS			English	Article							PROTEIN PHOSPHATASE 2A; CYTOPLASMIC DYNEIN; CORTICAL DEVELOPMENT; EMBRYONIC LETHALITY; LISSENCEPHALY GENE; LIS1 GENE; PHOSPHORYLATION; DROSOPHILA; CDK5; MALFORMATION	Heterozygous deletions of 17p13.3 result in the human neuronal migration disorders isolated lissencephaly sequence (ILS) and the more severe Miller Dieker syndrome (MDS). Mutations in PAFAH1B1 (the gene encoding LIS1) are responsible for ILS and contribute to MDS, but the genetic causes of the greater severity of MDS are unknown. Here, we show that the gene encoding 14-3-3epsilon (YWHAE), one of a family of ubiquitous phosphoserine/threonine binding proteins, is always deleted in individuals with MDS. Mice deficient in Ywhae have defects in brain development and neuronal migration, similar to defects observed in mice heterozygous with respect to Pafah1b1. Mice heterozygous with respect to both genes have more severe migration defects than single heterozygotes. 14-3-3epsilon binds to CDK5/p35-phosphorylated NUDEL and this binding maintains NUDEL phosphorylation. Similar to LIS1, deficiency of 14-3-3epsilon results in mislocalization of NUDEL and LIS1, consistent with reduction of cytoplasmic dynein function. These results establish a crucial role for 14-3-3epsilon in neuronal development by sustaining the effects of CDK5 phosphorylation and provide a molecular explanation for the differences in severity of human neuronal migration defects with 17p13.3 deletions.	Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Ctr Canc, La Jolla, CA 92093 USA; Japan Sci & Technol Corp, Ctr Genome Med Sci, Saitama Med Sch, PRESTO, Hidaka, Saitama 3501241, Japan; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02115 USA; Fac Med Timone, INSERM, U491, F-13385 Marseille 05, France; Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia		Wynshaw-Boris, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Canc, 9500 Gilman Dr,Mailstop 0627, La Jolla, CA 92093 USA.		Cardoso, Carlos/H-4520-2016; Dobyns, William/AAI-2768-2020; Cardoso, Carlos/M-2767-2019; Dobyns, William/ABC-6525-2021; Toyooka, Kazuhito/AAQ-6928-2020; Toyooka, Kazuhito/AAH-7175-2019	Cardoso, Carlos/0000-0003-1914-9553; Dobyns, William/0000-0002-7681-2844; Cardoso, Carlos/0000-0003-1914-9553; Toyooka, Kazuhito/0000-0002-0173-0430; Toyooka, Kazuhito/0000-0002-0173-0430			Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fleck MW, 2000, J NEUROSCI, V20, P2439; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Huang DQ, 1999, P NATL ACAD SCI USA, V96, P14445, DOI 10.1073/pnas.96.25.14445; LEDBETTER SA, 1992, AM J HUM GENET, V50, P182; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Price NE, 1999, MOL BRAIN RES, V73, P68, DOI 10.1016/S0169-328X(99)00237-5; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tsuda M, 2002, CELL GROWTH DIFFER, V13, P131; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; VEERANNA, 1995, J NEUROCHEM, V64, P2681; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Weinstein DE, 1999, DEV BRAIN RES, V116, P29, DOI 10.1016/S0165-3806(99)00072-3; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003	50	302	318	0	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					274	285		10.1038/ng1169			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	WOS:000183815300014	12796778				2022-01-24	
J	Huang, L; Brooks, SA; Li, WL; Fellers, JP; Trick, HN; Gill, BS				Huang, L; Brooks, SA; Li, WL; Fellers, JP; Trick, HN; Gill, BS			Map-based cloning of leaf rust resistance gene Lr21 from the large and polyploid genome of bread wheat	GENETICS			English	Article							MEIOTIC RECOMBINATION; MOLECULAR CHARACTERIZATION; PLANT TRANSFORMATION; ARABIDOPSIS-THALIANA; AEGILOPS-TAUSCHII; HEXAPLOID WHEAT; DENSITY; BARLEY; CONVERSION; EXPRESSION	We report the map-based cloning of the leaf rust resistance gene Lr21, previously mapped to a gene-rich region at the distal end of chromosome arm 1DS of bread wheat (Triticum aestivum L.). Molecular cloning of Lr21 was facilitated by diploid/polyploid shuttle mapping strategy. Cloning of Lr21 was confirmed by genetic transformation and by a stably inherited resistance phenotype in transgenic plants. Lr21 spans 4318 bp and encodes a 1080-amino-acid protein containing a conserved nucleotide-binding site (NBS) domain, 13 imperfect leucine-rich repeats (LRRs), and a unique 151-amino-acid sequence missing from known NBS-LRR proteins at the N terminus. Fine-structure genetic analysis at the Lr21 locus detected a noncrossover (recombination without exchange of flanking markers) within a 1415-bp region resulting from either a gene conversion tract of at least 191 bp or a double crossover. The successful map-based cloning approach as demonstrated here now opens the door for cloning of many crop-specific agronomic traits located in the gene-rich regions of bread wheat.	Kansas State Univ, Dept Plant Pathol, Wheat Genet Resource Ctr, Manhattan, KS 66506 USA; Kansas State Univ, USDA ARS, Plant Sci & Entomol Unit, Manhattan, KS 66506 USA		Gill, BS (corresponding author), Kansas State Univ, Dept Plant Pathol, Wheat Genet Resource Ctr, 4024 Throckmorton, Manhattan, KS 66506 USA.	bsg@ksu.edu		Trick, Harold/0000-0001-5255-5575			Altpeter F, 1996, PLANT CELL REP, V16, P12, DOI 10.1007/BF01275440; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P229, DOI DOI 10.1007/BF02672073; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BORTS RH, 1987, SCIENCE, V237, P1459, DOI 10.1126/science.2820060; Boyko E, 2002, PLANT MOL BIOL, V48, P767, DOI 10.1023/A:1014831511810; Brooks SA, 2002, GENOME, V45, P963, DOI [10.1139/g02-049, 10.1139/G02-049]; Browder LE, 1971, TECH B, V1432, P45; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; COLAU D, 1987, MOL CELL BIOL, V7, P2552, DOI 10.1128/MCB.7.7.2552; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; CURTIS D, 1989, GENETICS, V122, P653; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Faris JD, 2003, GENETICS, V164, P311; Faris JD, 2002, GENOME, V45, P706, DOI [10.1139/g02-036, 10.1139/G02-036]; Feldman M., 1995, EVOLUTION CROP PLANT, P184; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; FOGEL S, 1981, MOL BIOL YEAST SACCH, P289; Gill KS, 1996, GENETICS, V144, P1883; GILL KS, 1991, GENOME, V34, P362, DOI 10.1139/g91-058; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; GRAVES ACF, 1987, J BACTERIOL, V169, P1745, DOI 10.1128/jb.169.4.1745-1746.1987; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Hamilton CM, 1997, GENE, V200, P107, DOI 10.1016/S0378-1119(97)00388-0; Haubold B, 2002, GENETICS, V161, P1269; HILLIKER AJ, 1994, GENETICS, V137, P1019; Huang L, 2001, THEOR APPL GENET, V103, P1007, DOI 10.1007/s001220100701; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; KAMMORGAN LNW, 1989, GENOME, V32, P724, DOI 10.1139/g89-503; Kihara H., 1944, AGR HORTIC, V19, P13; Kilian A, 1997, PLANT MOL BIOL, V35, P187, DOI 10.1023/A:1005768222615; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Leister D, 1998, P NATL ACAD SCI USA, V95, P370, DOI 10.1073/pnas.95.1.370; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; OLSZEWSKI NE, 1988, NUCLEIC ACIDS RES, V16, P10765, DOI 10.1093/nar/16.22.10765; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; PATTERSON GI, 1995, GENETICS, V140, P1389; Qi LL, 2001, THEOR APPL GENET, V103, P998, DOI 10.1007/s001220100699; RAUPP WJ, 1983, PHYTOPATHOLOGY, V73, P818; Roelfs AP, 1985, CEREAL RUSTS, P3, DOI DOI 10.1016/B978-0-12-148402-6.50009-2; ROWLAND GG, 1974, CAN J GENET CYTOL, V16, P137, DOI 10.1139/g74-013; Seah S, 2000, MOL PLANT MICROBE IN, V13, P334, DOI 10.1094/MPMI.2000.13.3.334; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Stein N, 2000, P NATL ACAD SCI USA, V97, P13436, DOI 10.1073/pnas.230361597; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; WHITE MA, 1991, P NATL ACAD SCI USA, V88, P9755, DOI 10.1073/pnas.88.21.9755; Wiehe T, 2000, GENET RES, V75, P61, DOI 10.1017/S0016672399004036; Xu XJ, 1995, PLANT CELL, V7, P2151, DOI 10.1105/tpc.7.12.2151; Yao H, 2002, P NATL ACAD SCI USA, V99, P6157, DOI 10.1073/pnas.082562199; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337; [No title captured]	59	302	351	1	53	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-6731	1943-2631		GENETICS	Genetics	JUN	2003	164	2					655	664					10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696GV	WOS:000183880000027	12807786				2022-01-24	
J	Gurling, HMD; Kalsi, G; Brynjolfson, J; Sigmundsson, T; Sherrington, R; Mankoo, BS; Read, T; Murphy, P; Blaveri, E; McQuillin, A; Petursson, H; Curtis, D				Gurling, HMD; Kalsi, G; Brynjolfson, J; Sigmundsson, T; Sherrington, R; Mankoo, BS; Read, T; Murphy, P; Blaveri, E; McQuillin, A; Petursson, H; Curtis, D			Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VULNERABILITY LOCUS; WIDE SCAN; FAMILIAL SCHIZOPHRENIA; SUGGESTIVE EVIDENCE; COMPLEX TRAITS; RECEPTOR GENE; DNA MARKERS; SHORT ARM; TRANSLOCATION; REGION	We have performed genetic linkage analysis in 13 large multiply affected families, to test the hypothesis that there is extensive heterogeneity of linkage for genetic subtypes of schizophrenia. Our strategy consisted of selecting 13 kindreds containing multiple affected cases in three or more generations, an absence of bipolar affective disorder, and a single progenitor source of schizophrenia with unilineal transmission into the branch of the kindred sampled. DNA samples from these families were genotyped with 365 microsatellite markers spaced at similar to 10-cM intervals across the whole genome. We observed LOD scores >3.0 at five distinct loci, either in the sample as a whole or within single families, strongly suggesting etiological heterogeneity. Heterogeneity LOD scores >3.0 in the sample as a whole were found at 1q33.2 (LOD score 3.2; P = .0003), 5q33.2 (LOD score 3.6; P = .0001), 8p22.1-22 (LOD score 3.6; P = .0001), and 11q21 (LOD score 3.1; P = .0004). LOD scores >3.0 within single pedigrees were found at 4q13-31 (LOD score 3.2; P = .0003) and at 11q23.3-24 (LOD score 3.2; P = .0003). A LOD score of 2.9 was also found at 20q12.1-11.23 within in a single family. The fact that other studies have also detected LOD scores >3.0 at 1q33.2, 5q33.2, 8p21-22 and 11q21 suggests that these regions do indeed harbor schizophrenia-susceptibility loci. We believe that the weight of evidence for linkage to the chromosome 1q22, 5q33.2, and 8p21-22 loci is now sufficient to justify intensive investigation of these regions by methods based on linkage disequilibrium. Such studies will soon allow the identification of mutations having a direct effect on susceptibility to schizophrenia.	UCL, Royal Free & Univ Coll London Med Sch, Windeyer Inst Med Sci,Dept Psychiat & Behav Sci, Mol Psychiat Lab, London W1T 4JF, England; St Bartholomews & Royal London Sch Med & Dent, Dept Psychol Med, London, England; Univ Hosp, Landspitali, Dept Psychiat, Reykjavik, Iceland		Gurling, HMD (corresponding author), UCL, Royal Free & Univ Coll London Med Sch, Windeyer Inst Med Sci,Dept Psychiat & Behav Sci, Mol Psychiat Lab, 46 Cleveland St, London W1T 4JF, England.	h.gurling@ucl.ac.uk	McQuillin, Andrew/C-1623-2008; Gurling, Hugh M/A-5029-2010	McQuillin, Andrew/0000-0003-1567-2240; Curtis, David/0000-0002-4089-9183			ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; BARON M, 1986, BIOL PSYCHIAT, V21, P1051, DOI 10.1016/0006-3223(86)90286-6; Blackwood D, 1998, AM J MED GENET, V81, P532; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; Byerley W, 1999, MOL PSYCHIATR, V4, pS4; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Cheng HF, 1997, J FOOD DRUG ANAL, V5, P41; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Curtis D, 1999, GENET EPIDEMIOL, V17, pS115; CURTIS D, 1995, AM J HUM GENET, V57, P703; CURTIS D, 1995, NAT GENET, V9, P13, DOI 10.1038/ng0195-13; Devon RS, 1997, AM J MED GENET, V74, P82, DOI 10.1002/(SICI)1096-8628(19970221)74:1<82::AID-AJMG17>3.0.CO;2-N; Devon RS, 1997, PSYCHIATR GENET, V7, P165; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Ekelund J, 1997, AM J MED GENET, V74, P559; Ekelund J, 1999, MOL PSYCHIATR, V4, pS3; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.3.CO;2-N; Garver DL, 1998, AM J MED GENET, V81, P454; GILL M, 1993, PSYCHOL MED, V23, P27, DOI 10.1017/S0033291700038824; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GURLING H, 1995, NAT GENET, V11, P234, DOI 10.1038/ng1195-234; GURLING H, 1996, BAILLIERES CLIN PSYC, V2, P15; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kalsi G, 1996, AM J PSYCHIAT, V153, P107; Kalsi G., 1996, American Journal of Human Genetics, V59, pA384; KALSI G, 1995, AM J MED GENET, V60, P298, DOI 10.1002/ajmg.1320600407; KALSI G, 1995, BRIT J PSYCHIAT, V167, P390, DOI 10.1192/bjp.167.3.390; Kalsi G, 1999, ANN HUM GENET, V63, P235, DOI 10.1046/j.1469-1809.1999.6330235.x; KALSI G, 1995, PSYCHOL MED, V25, P531, DOI 10.1017/S0033291700033456; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; King N, 1997, AM J MED GENET, V74, P472, DOI 10.1002/(SICI)1096-8628(19970919)74:5<472::AID-AJMG2>3.3.CO;2-Y; KOSOWER NS, 1995, AM J MED GENET, V60, P133, DOI 10.1002/ajmg.1320600209; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Levinson DF, 1999, AM J HUM GENET, V65, pA259; Lin HK, 1997, ACTA PHYS-CHIM SIN, V13, P417, DOI 10.3866/PKU.WHXB19970507; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.0.CO;2-R; Maziade M, 1995, AM J MED GENET, V60, P522, DOI 10.1002/ajmg.1320600607; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MORTON NE, 1988, ANN HUM GENET, V52, P309, DOI 10.1111/j.1469-1809.1988.tb01110.x; MULCRONE J, 1995, AM J MED GENET, V60, P103, DOI 10.1002/ajmg.1320600204; NANKO S, 1992, JPN J PSYCHIAT NEUR, V46, P155; Nurnberger J, 1998, PSYCHIATR GENET, V8, P128; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Paunio T, 2000, AM J MED GENET, V96, P460; Pritchard DJ, 1996, ANN HUM GENET, V60, P105, DOI 10.1111/j.1469-1809.1996.tb01182.x; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1990, AM J HUM GENET, V46, P222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SHERRINGTON R, 1993, HUM HERED, V43, P197, DOI 10.1159/000154177; Silverman JM, 1996, AM J MED GENET, V67, P162, DOI 10.1002/(SICI)1096-8628(19960409)67:2<162::AID-AJMG6>3.0.CO;2-U; Spitzer R.L., 1977, SCHEDULE AFFECTIVE D, V3; Spitzer R.L., 1978, RES DIAGNOSTIC CRITE; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Straub RE, 1997, AM J MED GENET, V74, P558; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; TSUANG M, 1999, AM J MED GENET, V88, P215; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Wang SB, 1996, AM J HUM GENET, V59, P731; WANG ZW, 1993, ARCH GEN PSYCHIAT, V50, P212; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	81	302	314	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					661	673		10.1086/318788			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	WOS:000166994200011	11179014	Green Published, Bronze			2022-01-24	
J	Gripp, KW; Wotton, D; Edwards, MC; Roessler, E; Ades, L; Meinecke, P; Richieri-Costa, A; Zackai, EH; Massague, J; Muenke, M; Elledge, SJ				Gripp, KW; Wotton, D; Edwards, MC; Roessler, E; Ades, L; Meinecke, P; Richieri-Costa, A; Zackai, EH; Massague, J; Muenke, M; Elledge, SJ			Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination	NATURE GENETICS			English	Article							BRAIN; GENE; PROTEINS; HEDGEHOG; LAYER	Holoprosencephaly (HPE) is the most common structural defect of the developing forebrain in humans (1 in 250 conceptuses, 1 in 16,000 live-born infants(1-3)). HPE is aetiologically heterogeneous, with both environmental and genetic causes(4,5). So far, three human HPE genes are known: SHH at chromosome region 7q36 (ref. 6); ZIC2 at 13q32 (ref. 7); and SIX3 at 2p21 (ref. 8). In animal models, genes in the Nodal signalling pathway, such as those mutated in the zebrafish mutants cyclops (refs 9,10), squint (ref. Il)and one-eyed pinhead (oep: ref. 12), cause HPE. Mice heterozygous for null alleles of both Nodal and Smad2 have cyclopia(13) Here we describe the involvement of the TO-interacting factor (TGIF), a homeodomain protein, in human HPE. We mapped TGIF to the HPE minimal critical region in 18p11.3. Heterozygous mutations in individuals with HPE affect the transcriptional repression domain of TGIF, the DNA-binding domain or the domain that interacts with SMAD2. (The latter is an effector in the signalling path-way of the neural axis developmental factor NODAL, a member of the transforming growth factor-beta (TGF-beta) family.) Several of these mutations cause a loss of TGIF function. Thus, TGIF links the NODAL signalling pathway to the bifurcation of the human forebrain and the establishment of ventral midline structures.	Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Genet & Neurol, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Natl Human Genome Res Inst, Dept Mol & Human Genet, NIH, Bethesda, MD USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA; Royal Alexandra Hosp Children, Parramatta, Australia; Altonauer Kinderkrankenhaus, Hamburg, Germany; Univ Sao Paulo, Sao Paulo, Brazil		Muenke, M (corresponding author), Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.		Ades, lionel/T-6882-2019; Richieri-Costa, Antonio/B-2514-2013	Muenke, Maximilian/0000-0002-7719-6545; Massague, Joan/0000-0001-9324-8408; Wotton, David/0000-0002-4652-5350			BARR M, 1983, J PEDIATR-US, V102, P565, DOI 10.1016/S0022-3476(83)80185-1; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bertolino E, 1996, DEV DYNAM, V205, P410, DOI 10.1002/(SICI)1097-0177(199604)205:4<410::AID-AJA5>3.0.CO;2-L; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Edwards MC, 1997, GENETICS, V147, P1063; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Golden JA, 1998, J NEUROPATH EXP NEUR, V57, P991, DOI 10.1097/00005072-199811000-00001; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Liu F, 1998, NAT GENET, V20, P325, DOI 10.1038/3793; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Ming JE, 1998, CLIN GENET, V53, P155; MUENKE M, IN PRESS METABOLIC M; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Roessler E, 1998, J INHERIT METAB DIS, V21, P481, DOI 10.1023/A:1005406719292; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; VARLET I, 1997, CURR OPIN GENE DEV, V7, P518; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6	24	302	315	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					205	208		10.1038/76074			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200022	10835638				2022-01-24	
J	Wakeley, J; Hey, J				Wakeley, J; Hey, J			Estimating ancestral population parameters	GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; SIZE; RECOMBINATION; POLYMORPHISM; SEQUENCES; NUMBER; SITES	The expected numbers of different categories of polymorphic sites are derived for two related models of population history: the isolation model, in which an ancestral population splits into two descendents, and the size-change model, in which a single population undergoes an instantaneous change in size. For the isolation model, the observed numbers of shared, fixed, and exclusive polymorphic sites are used to estimate the relative sizes of the three populations, ancestral plus two descendent, as well as the time of the split. For the size-change model, the numbers of sites segregating at particular frequencies in the sample are used to estimate the relative sizes of the ancestral and descendent populations plus the time the change took place. Parameters are estimated by choosing values that most closely equate expectations with observations. Computer simulations show that current and historical population parameters can be estimated accurately. The methods are applied to DNA data from two species of Drosophila and to some human mitochondrial DNA sequences.			Wakeley, J (corresponding author), RUTGERS STATE UNIV, DEPT BIOL SCI, NELSON BIOL LABS, POB 1059, BUSCH CAMPUS, PISCATAWAY, NJ 08855 USA.		Hey, Jody/D-1257-2009	Hey, Jody/0000-0001-5358-6488	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM-17745-01] Funding Source: Medline		DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Fisher, 1930, GENETICAL THEORY NAT; Flannery, 1992, NUMERICAL RECIPES C; FU XY, 1995, THEOR POPUL BIOL, V48, P172; FU XY, 1993, GENETICS, V133, P693; HEY J, 1991, GENETICS, V128, P831; Hey J., 1994, Experientia Supplementum (Basel), V69, P435; HEY J, 1993, MOL BIOL EVOL, V10, P804; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; JOHNSON NL, 1977, URN MODELS THEIR APP; KLIMAN RM, 1993, GENETICS, V133, P375; Pluzhnikov A, 1996, GENETICS, V144, P1247; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SATTA Y, 1991, MOL EVOLUTION MAJOR, P51; SLATKIN M, 1991, GENETICS, V129, P555; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1986, GENET RES, V48, P187, DOI 10.1017/S001667230002499X; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; TAKAHATA N, 1985, GENETICS, V110, P325; WAKELEY J, 1993, J MOL EVOL, V37, P613; WAKELEY J, 1997, IN PRESS GENET RES C; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright S, 1931, GENETICS, V16, P0097	27	302	305	0	15	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	MAR	1997	145	3					847	855					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK689	WOS:A1997WK68900029	9055093				2022-01-24	
J	Whittemore, AS; Gong, G; Itnyre, J				Whittemore, AS; Gong, G; Itnyre, J			Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three US population-based case-control studies of ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK	We investigate the familial risks of cancers of the breast and ovary, using data pooled from three populationbased case-control studies of ovarian cancer that were conducted in the United States. We base estimates of the frequency of mutations of BRCA1 (and possibly other genes) on the reported occurrence of breast cancer and ovarian cancer in the mothers and sisters of 922 women with incident ovarian cancer (cases) and in 922 women with no history of ovarian cancer (controls). Segregation analysis and goodness-of-fit testing of genetic models suggest that rare mutations (frequency .0014; 95% confidence interval .0002-.011) account for all the observed aggregation of breast cancer and ovarian cancer in these families. The estimated risk of breast cancer by age 80 years is 73.5% in mutation carriers and 6.8% in noncarriers. The corresponding estimates for ovarian cancer are 27.8% in carriers and 1.8% in noncarriers. For cancer risk in carriers, these estimates are lower than those obtained from families selected for high cancer prevalence. The estimated proportion of all U.S. cancer diagnoses, by age 80 years, that are due to germ-line BRCA1 mutations is 3.0% for breast cancer and 4.4% for ovarian cancer. Aggregation of breast cancer and ovarian cancer was less evident in the families of 163 cases with borderline ovarian cancers than in the families of cases with invasive cancers, Familial aggregation did not differ by the ethnicity of the probands, although the number of non-White and Hispanic cases (N=99) was sparse.			Whittemore, AS (corresponding author), STANFORD UNIV,SCH MED,DEPT HLTH RES & POLICY,REDWOOD BLDG,ROOM T204,STANFORD,CA 94305, USA.				NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R35CA047448] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-R29-47448] Funding Source: Medline		Auranen A, 1996, AM J EPIDEMIOL, V144, P548, DOI 10.1093/oxfordjournals.aje.a008964; CASAGRANDE JT, 1979, LANCET, V2, P170; *CASH, 1987, NEW ENGL J MED, V316, P650; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1995, AM J HUM GENET, V56, P265; FORD D, 1995, AM J HUM GENET, V57, P1457; KELSEY J, 1996, OBSERVATIONAL EPIDEM; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; NAROD SA, 1995, AM J HUM GENET, V56, P254; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; SCHILDKRAUT JM, 1988, AM J EPIDEMIOL, V128, P456, DOI 10.1093/oxfordjournals.aje.a114994; WHITTEMORE AS, 1988, AM J EPIDEMIOL, V128, P1228, DOI 10.1093/oxfordjournals.aje.a115077; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1175, DOI 10.1093/oxfordjournals.aje.a116426	14	302	304	1	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					496	504					9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	WOS:A1997WK40300005	9042908				2022-01-24	
J	Smith, RF; Wiese, BA; Wojzynski, MK; Davidson, DB; Worley, KC				Smith, RF; Wiese, BA; Wojzynski, MK; Davidson, DB; Worley, KC			BCM Search Launcher - An integrated interface to molecular biology data base search and analysis services available on the World Wide Web	GENOME RESEARCH			English	Article							SEQUENCE-ANALYSIS; DATABASES; TOOL	The BCM Search Launcher is an integrated set of World Wide Web (WWW) pages that organize molecular biology-related search and analysis services available on the WWW by function, and provide a single point of entry for related searches. The Protein Sequence Search Page, for example, provides a single sequence entry form for submitting sequences to WWW servers that offer remote access to a variety of different protein sequence search toot, including BLAST, FASTA, Smith-Waterman, BEAUTY, PROSITE, and BLOCKS searches. Other Launch pages provide access to (1) nucleic acid sequence searches, (2) multiple and pair-wise sequence alignments, (3) gene feature searches, (4) protein secondary structure prediction, and (5) miscellaneous sequence utilities (e.g., six-frame translation). The BCM Search Launcher also provides a mechanism to extend the utility of other WWW services by adding supplementary hypertext links to results returned by remote servers. For example, links to the NCBl's Entrez data base and to the Sequence Retrieval System (SRS) are added to search results returned by the NCBl's WWW BLAST server. These links provide easy access to auxiliary information, such as Medline abstracts, that can be extremely helpful when analyzing BLAST data base hits. For new or infrequent users of sequence data base search tools, we have preset the default search parameters to provide the most informative first-pass sequence analysis possible. We have also developed a batch client interface for Unix and Macintosh computers that allows multiple input sequences to be searched automatically as a background task, with the results returned as individual HTML documents directly to the user's system. The BCM Search Launcher and batch client are available on the WWW at URL http://gc.bcm.tmc.edu:8088/search-launcher.html.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; UNIV HOUSTON,DEPT BIOCHEM & BIOPHYS SCI,HOUSTON,TX 77004		Smith, RF (corresponding author), BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,CTR HUMAN GENOME,HOUSTON,TX 77030, USA.			Worley, Kim/0000-0002-0282-1000	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG000973, P30HG000210, F32HG000133] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [1R01-HG00973-01, 1F32-HG00133-01, P30-HG00210] Funding Source: Medline		ALSCHUL SF, 1994, NAT GENET, V6, P119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOGUSKI MS, 1992, J LIPID RES, V33, P957; BOGUSKI MS, 1994, CURR OPIN GENET DEV, V4, P383, DOI 10.1016/0959-437X(94)90025-6; BRENNER SE, 1995, TRENDS GENET, V11, P330, DOI 10.1016/S0168-9525(00)89094-0; BRENNER SE, 1995, SCIENCE, V268, P622, DOI 10.1126/science.7732361; CLAVERIE JM, 1993, COMPUT CHEM, V17, P191, DOI 10.1016/0097-8485(93)85010-A; COUTINHO PM, 1995, E COMMUNICATION; DEBOER T, 1993, E COMMUNICATION; EPSTEIN JA, 1994, E COMMUNICATION; ETZOLD T, 1993, COMPUT APPL BIOSCI, V9, P49; FUCHS R, 1994, COMPUT APPL BIOSCI, V10, P413; GILBERT DG, 1990, E COMMUNICATION; HARPER R, 1995, TRENDS GENET, V11, P223, DOI 10.1016/S0168-9525(00)89055-1; Harper Robert, 1994, Current Opinion in Biotechnology, V5, P4, DOI 10.1016/S0958-1669(05)80063-1; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; JACOBSON D, 1994, PROTEIN SCI, V3, P2159, DOI 10.1002/pro.5560031130; LADUNGA I, 1996, IN PRESS J MOL BIOL; MCKINNEY WP, 1995, M D COMPUT, V12, P109; MCKINNEY WP, 1995, MD COMPUT, V12, P141; RECIPON H, 1995, E COMMUNICATION; ROBISON K, 1995, E COMMUNICATION; SCHATZ BR, 1994, SCIENCE, V265, P895, DOI 10.1126/science.265.5174.895; SCHERER S, 1995, E COMMUNICATION; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; SMITH RF, 1995, IEEE ENG MED BIOL, V14, P760, DOI 10.1109/51.473270; TISDALL J, 1995, E COMMUNICATION; WALL L, 1990, PROGRAMMING PERL; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173	30	302	305	1	2	COLD SPRING HARBOR LAB PRESS	PLAINVIEW	1 BUNGTOWN RD, PLAINVIEW, NY 11724	1054-9803			GENOME RES	Genome Res.	MAY	1996	6	5					454	462		10.1101/gr.6.5.454			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	UM831	WOS:A1996UM83100010	8743995	Bronze			2022-01-24	
J	SIMARD, J; TONIN, P; DUROCHER, F; MORGAN, K; ROMMENS, J; GINGRAS, S; SAMSON, C; LEBLANC, JF; BELANGER, C; DION, F; LIU, Q; SKOLNICK, M; GOLDGAR, D; SHATTUCKEIDENS, D; LABRIE, F; NAROD, SA				SIMARD, J; TONIN, P; DUROCHER, F; MORGAN, K; ROMMENS, J; GINGRAS, S; SAMSON, C; LEBLANC, JF; BELANGER, C; DION, F; LIU, Q; SKOLNICK, M; GOLDGAR, D; SHATTUCKEIDENS, D; LABRIE, F; NAROD, SA			COMMON ORIGINS OF BRCA1 MUTATIONS IN CANADIAN BREAST AND OVARIAN-CANCER FAMILIES	NATURE GENETICS			English	Article							CHROMOSOME-17Q21; LINKAGE	Women who carry mutations in the BRCA1 gene on chromosome 17q have an 85% lifetime risk of breast cancer, and a 60% risk of ovarian cancer, We have identified BRCA1 mutations in 12 of 30 (40%) Canadian families with breast and/or ovarian cancer, including six of the eight families (75%) that contained two cases of early-onset breast cancer and two cases of ovarian cancer, Six frameshift mutations account for all 12 mutant alleles, including nucleotide insertions (two mutations) and deletions (four mutations), Four independent families carried the same 1 basepair (bp) insertion mutation in codon 1755 and four other families shared a 2 bp deletion mutation in codons 22-23. These families were not known to be related, but haplotype analysis suggests that the carriers of each of these mutations have common ancestors.	MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,DEPT BIOSTAT & EPIDEMIOL,MONTREAL H3G 1A4,PQ,CANADA; CHU LAVAL,RES CTR,MOLEC ENDOCRINOL LAB,QUEBEC CITY G1V 4G2,PQ,CANADA; UNIV LAVAL,QUEBEC CITY G1V 4G2,PQ,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; MYRIAD GENET INC,SALT LAKE CITY,UT; UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112				Narod, Steven A/AAA-6112-2022	Simard, Jacques/0000-0001-6906-3390; Leblanc, Jean-Francois/0000-0003-4568-2335; Durocher, Francine/0000-0001-8012-4641			ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NAROD SA, IN PRESS AM J HUM GE; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; TONIN P, IN PRESS HUM GENET; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	14	302	307	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					392	398		10.1038/ng1294-392			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	WOS:A1994PV68200022	7894492				2022-01-24	
J	VALENT, B; FARRALL, L; CHUMLEY, FG				VALENT, B; FARRALL, L; CHUMLEY, FG			MAGNAPORTHE-GRISEA GENES FOR PATHOGENICITY AND VIRULENCE IDENTIFIED THROUGH A SERIES OF BACKCROSSES	GENETICS			English	Article							PYRICULARIA-ORYZAE; AVIRULENCE GENES; RESISTANCE	We have identified genes for pathogenicity toward rice (Oryza sativa) and genes for virulence toward specific rice cultivars in the plant pathogenic fungus Magnaporthe grisea. A genetic cross was conducted between the weeping lovegrass (Eragrostis curvula) pathogen 4091-5-8, a highly fertile, hermaphroditic laboratory strain, and the rice pathogen O-135, a poorly fertile, female-sterile field isolate that infects weeping lovegrass as well as rice. A six-generation backcrossing scheme was then undertaken with the rice pathogen as the recurrent parent. One goal of these crosses was to generate rice pathogenic progeny with the high fertility characteristic of strain 4091-5-8, which would permit rigorous genetic analysis of rice pathogens. Therefore, progeny strains to be used as parents for backcross generations were chosen only on the basis of fertility. The ratios of pathogenic to nonpathogenic (and virulent to avirulent) progeny through the backcross generations suggested that the starting parent strains differ in two types of genes that control the ability to infect rice. First, they differ by polygenic factors that determine the extent of lesion development achieved by those progeny that infect rice. These genes do not appear to play a role in infection of weeping lovegrass because both parents and all progeny infect weeping lovegrass. Second, the parents differ by simple Mendelian determinants, "avirulence genes," that govern virulence toward specific rice cultivars in all-or-none fashion. Several crosses confirm the segregation of three unlinked avirulence genes, Avr1-CO39, Avr1-M201 and Avr1-YAMO, alleles of which determine avirulence on rice cultivars CO39, M201, and Yashiro-mochi, respectively. Interestingly, avirulence alleles of Avr1-CO39, Avr1-M201 and Avr1-YAMO were inherited from the parent strain 4091-5-8, which is a nonpathogen of rice. Middle repetitive DNA sequences ("MGR sequences"), present in approximately 40-50 copies in the genome of the rice pathogen parent, and in very low copy number in the genome of the nonpathogen of rice, were used as physical markers to monitor restoration of the rice pathogen genetic background during introgression of fertility. The introgression of highest levels of fertility into the most successful rice pathogen progeny was incomplete by the sixth generation, perhaps a consequence of genetic linkage between genes for fertility and genes for rice pathogenicity. One chromosomal DNA segment with MGR sequence homology appeared to be linked to the gene Avr1-CO39. Finally, many of the crosses described in this paper exhibited a characteristic common to many crosses involving M. grisea rice pathogen field isolates. That is, pigment-defective mutants frequently appeared among the progeny.			VALENT, B (corresponding author), DUPONT CO,DEPT CENT RES & DEV,WILMINGTON,DE 19880, USA.			Valent, Barbara/0000-0002-5088-3345			CATEN CE, 1984, CAN J BOT, V62, P1209, DOI 10.1139/b84-163; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; CRAWFORD MS, 1986, GENETICS, V114, P1111; CRUTE IR, 1986, MECH RESISTANCE PLAN, P80; Day P.R., 1974, GENETICS HOST PARASI; ELLINGBOE AH, 1990, PHYTOPATHOLOGY, V80, P108, DOI 10.1094/Phyto-80-108; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; HAMER JE, 1989, P NATL ACAD SCI USA, V86, P9981, DOI 10.1073/pnas.86.24.9981; HEATH MC, 1990, CAN J BOT, V68, P1627, DOI 10.1139/b90-209; HOWARD RJ, 1989, EXP MYCOL, V13, P403, DOI 10.1016/0147-5975(89)90036-4; KATO H, 1982, Annals of the Phytopathological Society of Japan, V48, P607, DOI 10.3186/jjphytopath.48.607; KATO H, 1978, GAMMA FIELD S, V17, P1; KIYOSAWA S, 1980, Annals of the Phytopathological Society of Japan, V46, P582, DOI 10.3186/jjphytopath.46.582; KIYOSAWA S, 1976, SABRAO J, V8, P53; KOBAYASHI DY, 1989, P NATL ACAD SCI USA, V86, P157, DOI 10.1073/pnas.86.1.157; LATTERELL FM, 1986, PHYTOPATHOLOGY, V76, P231, DOI 10.1094/Phyto-76-231; LATTERELL FM, 1975, CE9 CTR INT AGR TROP, P199; LEUNG H, 1988, PHYTOPATHOLOGY, V78, P1227, DOI 10.1094/Phyto-78-1227; MACKILL AO, 1986, PLANT DIS, V70, P125, DOI 10.1094/PD-70-125; ORBACH MJ, 1988, MOL CELL BIOL, V8, P1469, DOI 10.1128/MCB.8.4.1469; Ou SH, 1985, RICE DIS, P109; Parlevliet J. E., 1985, DIS DISTRIBUTION EPI, V2, P501, DOI DOI 10.1016/B978-0-12-148402-6.50024-9; PARLEVLIET JE, 1977, EUPHYTICA, V26, P5, DOI 10.1007/BF00032062; ROSSMAN AY, 1990, MYCOLOGIA, V82, P509, DOI 10.2307/3760024; TAMAKI S, 1988, J BACTERIOL, V170, P4846, DOI 10.1128/jb.170.10.4846-4854.1988; VALENT B, 1986, IOWA STATE J RES, V60, P569; VALENT B, 1987, UCLA S MOL CELL BIOL, V48, P83; WHALEN MC, 1988, P NATL ACAD SCI USA, V85, P6743, DOI 10.1073/pnas.85.18.6743; YAEGASHI H, 1986, Annals of the Phytopathological Society of Japan, V52, P225, DOI 10.3186/jjphytopath.52.225; YAEGASHI H, 1978, CAN J BOT, V56, P180, DOI 10.1139/b78-023; YAEGASHI H, 1981, Annals of the Phytopathological Society of Japan, V47, P677, DOI 10.3186/jjphytopath.47.677; YAMADA M, 1976, Annals of the Phytopathological Society of Japan, V42, P216, DOI 10.3186/jjphytopath.42.216; YODER OC, 1986, PHYTOPATHOLOGY, V76, P383, DOI 10.1094/Phyto-76-383; [No title captured]	36	302	338	2	19	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JAN	1991	127	1					87	101					15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EP811	WOS:A1991EP81100009	2016048				2022-01-24	
J	Xu, B; Ionita-Laza, J; Roos, JL; Boone, B; Woodrick, S; Sun, Y; Levy, S; Gogos, JA; Karayiorgou, M				Xu, Bin; Ionita-Laza, Juliana; Roos, J. Louw; Boone, Braden; Woodrick, Scarlet; Sun, Yan; Levy, Shawn; Gogos, Joseph A.; Karayiorgou, Maria			De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia	NATURE GENETICS			English	Article							ARCHITECTURE; PHENOTYPE; VARIANT	To evaluate evidence for de novo etiologies in schizophrenia, we sequenced at high coverage the exomes of families recruited from two populations with distinct demographic structures and history. We sequenced a total of 795 exomes from 231 parent-proband trios enriched for sporadic schizophrenia cases, as well as 34 unaffected trios. We observed in cases an excess of de novo nonsynonymous single-nucleotide variants as well as a higher prevalence of gene-disruptive de novo mutations relative to controls. We found four genes (LAMA2, DPYD, TRRAP and VPS39) affected by recurrent de novo events within or across the two populations, which is unlikely to have occurred by chance. We show that de novo mutations affect genes with diverse functions and developmental profiles, but we also find a substantial contribution of mutations in genes with higher expression in early fetal life. Our results help define the genomic and neural architecture of schizophrenia.	[Xu, Bin; Woodrick, Scarlet; Sun, Yan; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Ionita-Laza, Juliana] Columbia Univ, Dept Biostat, New York, NY USA; [Roos, J. Louw] Weskoppies Hosp, Pretoria, South Africa; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Boone, Braden; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Woodrick, Scarlet; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA		Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	jag90@columbia.edu; mk2758@columbia.edu		Levy, Shawn/0000-0002-1369-5740; Roos, Johannes/0000-0002-0572-1072	National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH077235, R01MH095797, R01MH061399] Funding Source: NIH RePORTER	We are enormously grateful to all the families who participated in this research. We thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment, family history assessments and diagnostic evaluations. We thank S.L. Lundy for valuable assistance with clinical database maintenance and L. Rodriguez-Murillo for help with Supplementary Figure 9. We also thank B. Plummer and NI. Robinson and the HudsonAlpha Genomics Services Laboratory for experimental support. Finally, we thank L.J. Mienie for the thymine loading test. This work was partially supported by National Institute of Mental Health (NIMH) grants MH061399 (to MAC) and MH077235 (to J.A.G.) and the Lieber Center for Schizophrenia Research at Columbia University. B.X. was partially supported by a National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award.	Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Carter MT, 2011, CLIN GENET, V80, P435, DOI 10.1111/j.1399-0004.2010.01578.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gilman S.R., NAT NEUROSC IN PRESS; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2012, NAT NEUROSCI, V15, P811, DOI 10.1038/nn.3115; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; McGrath JJ, 2009, MED J AUSTRALIA, V190, pS7, DOI 10.5694/j.1326-5377.2009.tb02366.x; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sobin C, 2003, PSYCHIAT RES, V117, P113, DOI 10.1016/S0165-1781(02)00321-9; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	31	301	306	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1365	1369		10.1038/ng.2446			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	WOS:000311713200017	23042115	Green Accepted			2022-01-24	
J	Weiss, LA; Pan, L; Abney, M; Ober, C				Weiss, LA; Pan, L; Abney, M; Ober, C			The sex-specific genetic architecture of quantitative traits in humans	NATURE GENETICS			English	Article							WHOLE-BLOOD SEROTONIN; FOUNDER POPULATION; LINKAGE ANALYSIS; SUSCEPTIBILITY ALLELES; GENDER-DIFFERENCES; LOCI; HOMOZYGOSITY; ASSOCIATION; EXPRESSION; DEPRESSION	Mapping genetically complex traits remains one of the greatest challenges in human genetics today. In particular, gene-environment and gene-gene interactions, genetic heterogeneity and incomplete penetrance make thorough genetic dissection of complex traits difficult, if not impossible. Sex could be considered an environmental factor that can modify both penetrance and expressivity of a wide variety of traits. Sex is easily determined and has measurable effects on recognizable morphology; neurobiological circuits; susceptibility to autoimmune disease, diabetes, asthma, cardiovascular and psychiatric disease; and quantitative traits like blood pressure, obesity and lipid levels, among others. In this study, we evaluated sex-specific heritability and genome-wide linkages for 17 quantitative traits in the Hutterites. The results of this study could have important implications for mapping complex trait genes.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA		Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu		Ober, Carole/0000-0003-4626-9809			Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Abney MA, 2000, AM J HUM GENET, V67, P327; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Cairney J, 2002, SOC PSYCH PSYCH EPID, V37, P401, DOI 10.1007/s00127-002-0569-0; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chen Y, 2003, J CLIN EPIDEMIOL, V56, P180, DOI 10.1016/S0895-4356(02)00593-0; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Kurina LM, 2005, J CLIN ENDOCR METAB, V90, P4747, DOI 10.1210/jc.2005-0384; Loughlin J, 2000, RHEUMATOLOGY, V39, P377, DOI 10.1093/rheumatology/39.4.377; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Newman DL, 2004, EUR J HUM GENET, V12, P584, DOI 10.1038/sj.ejhg.5201191; Newman DL, 2003, HUM MOL GENET, V12, P137, DOI 10.1093/hmg/ddg012; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Towne B, 1997, GENET EPIDEMIOL, V14, P1053, DOI 10.1002/(SICI)1098-2272(1997)14:6<1053::AID-GEPI82>3.0.CO;2-G; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003; Weiss LA, 2005, HUM GENET, V117, P81, DOI 10.1007/s00439-004-1250-3; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Weiss LA, 2004, EUR J HUM GENET, V12, P949, DOI 10.1038/sj.ejhg.5201239; Williams AJK, 2003, DIABETOLOGIA, V46, P1354, DOI 10.1007/s00125-003-1197-2; Woods SC, 2003, EXP BIOL MED, V228, P1175; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	30	301	308	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					218	222		10.1038/ng1726			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	WOS:000234953200018	16429159				2022-01-24	
J	Wu, XM; Viveiros, MM; Eppig, JJ; Bai, YC; Fitzpatrick, SL; Matzuk, MM				Wu, XM; Viveiros, MM; Eppig, JJ; Bai, YC; Fitzpatrick, SL; Matzuk, MM			Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition	NATURE GENETICS			English	Article							MOUSE; ACTIVATION; PHD; DEFICIENT; MUTATION; DEFECTS; MOTIF	The female gamete (the oocyte) serves the distinct purpose of transmitting the maternal genome and other maternal factors that are critical for post-ovulation events(1-4). Through the identification and characterization of oocyte-specific factors, we are beginning to appreciate the diverse functions of oocytes in ovarian folliculogenesis, fertilization and embryogenesis(5),(6). To understand these processes further, we identified genes called zygote arrest 1 (Zar1 and ZAR1 in mouse and human, respectively) as novel oocyte-specific genes. These encode proteins of 361 amino acids and 424 amino acids, respectively, which share 59% amino-acid identity and an atypical plant homeo-domain (PHD) motif(7). Although Zar1-null (Zar1(-/-)) mice are viable and grossly normal, Zar1(-/-) females are infertile. Ovarian development and oogenesis through the early stages of fertilization are evidently unimpaired, but most embryos from Zar1(-/-) females arrest at the one-cell stage. Distinct pronuclei form and DNA replication initiates, but the maternal and paternal genomes remain separate in arrested zygotes. Fewer than 20% of the embryos derived from Zar1(-/-) females progress to the two-cell stage and show marked reduction in the synthesis of the transcription-requiring complex(8), and no embryos develop to the four-cell stage. Thus, Zar1 is the first identified oocyte-specific maternal-effect gene that functions at the oocyte-to-embryo transition and, as such, offers new insights into the initiation of embryonic development and fertility control in mammals.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wyeth Ayerst Res, Collegeville, PA USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA		Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nnnatzuk@bcm.tmc.edu	Viveiros, Maria/P-4120-2015				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; BRADLEY A, 1987, PRODUCTION ANAL CHIM, P113; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Eppig JJ, 1999, ADV MOLEC BIOL, P3; Ferreira J, 1997, J CELL SCI, V110, P889; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kumar TR, 2000, ENDOCRINOLOGY, V141, P4270, DOI 10.1210/en.141.11.4270; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Matzuk MM, 2002, NAT MED, V8, P41, DOI 10.1038/nm-fertilityS41; MATZUK MM, 1992, BIOCHEM BIOPH RES CO, V185, P404, DOI 10.1016/S0006-291X(05)81000-9; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yan W, 2002, MOL ENDOCRINOL, V16, P1168, DOI 10.1210/me.16.6.1168	29	301	320	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					187	191		10.1038/ng1079			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	WOS:000180773700018	12539046				2022-01-24	
J	Rasmussen, SA; Yang, QH; Friedman, JM				Rasmussen, SA; Yang, QH; Friedman, JM			Mortality in neurofibromatosis 1: An analysis using US death certificates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIPHERAL-NERVE SHEATH; TYPE-1 NEUROFIBROMATOSIS; MOYAMOYA-DISEASE; FOLLOW-UP; NF1; TUMORS; RATIO	Although neurofibromatosis 1 (NF1) is a relatively common autosomal dominant condition, information about its effect on mortality is limited. We used Multiple-Cause Mortality Files, compiled from U.S. death certificates by the National Center for Health Statistics, for 1983 through 1997. We identified 3,770 cases of presumed NF1 among 32,722,122 deaths in the United States, a frequency of 1/8,700, which is one-third to one-half the estimated prevalence. Mean and median ages at death for persons with NF1 were 54.4 and 59 years, respectively, compared with 70.1 and 74 years in the general population. Results of proportionate mortality ratio (PMR) analyses showed that persons with NF1 were 34 times more likely (PMR = 34.3, 95% confidence interval [CI] 30.8-38.0) to have a malignant connective or other soft-tissue neoplasm listed on their death certificates than were persons without NF1. Overall, persons with NF1 were 1.2 times more likely than expected (PMR = 1.21, 95% CI 1.14-1.28) to have a malignant neoplasm listed on their death certificates, but the PMR was 6.07 (95% CI 4.88-7.45) for persons who died at 10-19 years of age and was 4.93 (95% CI 4.14-5.82) for those who died at 20-29 years of age. Similarly, vascular disease was recorded more often than expected on death certificates of persons with NF1 who died at <30 years of age (PMR = 3.26, 95% CI 1.31-6.71 at age <10 years; PMR = 2.68, 95% CI 1.38-4.68 at age 10-19 years; and PMR = 2.25, 95% CI 1.46-3.32 at 20-29 years) but not in older persons. This study PMR supports previous findings of decreased life expectancy for persons with NF1 and, within the limitations of death certificates, provides population-based data about NF1 morbidity and mortality that are useful to clinicians caring for patients with NF1.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada		Rasmussen, SA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway NE,MS F-45, Atlanta, GA 30341 USA.			Rasmussen, Sonja/0000-0002-0574-4928; Friedman, Jan/0000-0002-7482-9570			Ahlbom A, 1993, BIOSTATISTICS EPIDEM; Airewele GE, 2001, GENET EPIDEMIOL, V20, P75, DOI 10.1002/1098-2272(200101)20:1<75::AID-GEPI7>3.0.CO;2-Z; DECOUFLE P, 1980, AM J EPIDEMIOL, V111, P263, DOI 10.1093/oxfordjournals.aje.a112895; Fossali E, 2000, PEDIATR NEPHROL, V14, P806, DOI 10.1007/s004679900260; Hattori S, 1998, PATHOL RES PRACT, V194, P363, DOI 10.1016/S0344-0338(98)80061-7; Hennekens CR, 1987, EPIDEMIOLOGY MED, P85; Hess JL, 1996, AM J CLIN PATHOL, V105, P238; Imaizumi Yoko, 1995, Journal of Dermatology (Tokyo), V22, P191; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; JENSEN LN, 1998, AM J HUM GENET, V63, pA114; King AA, 2000, AM J MED GENET, V93, P388, DOI 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.3.CO;2-R; KUPPER LL, 1978, J CHRON DIS, V31, P15, DOI 10.1016/0021-9681(78)90077-2; Kwong KL, 1999, J PAEDIATR CHILD H, V35, P108; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; McGaughran JM, 1999, J MED GENET, V36, P197; MIETTINEN OS, 1981, AM J EPIDEMIOL, V114, P144, DOI 10.1093/oxfordjournals.aje.a113161; MUHONEN MG, 1991, SURG NEUROL, V36, P470, DOI 10.1016/0090-3019(91)90163-4; Poyhonen M, 2000, J MED GENET, V37, P632, DOI 10.1136/jmg.37.8.632; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; ROMAN E, 1984, STAT MED, V3, P7, DOI 10.1002/sim.4780030103; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P225; Shen MH, 1996, J MED GENET, V33, P2, DOI 10.1136/jmg.33.1.2; SIRKEN MG, 1987, AM J PUBLIC HEALTH, V77, P137, DOI 10.2105/AJPH.77.2.137; SOBATA E, 1988, NEUROSURGERY, V22, P544, DOI 10.1227/00006123-198803000-00016; SORENSEN SA, 1986, NEW ENGL J MED, V314, P1010, DOI 10.1056/NEJM198604173141603; Woodruff JM, 1999, AM J MED GENET, V89, P23, DOI 10.1002/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#; ZOLLER M, 1995, ACTA DERM-VENEREOL, V75, P136	27	301	312	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1110	1118		10.1086/320121			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	WOS:000168171200005	11283797	Green Published, Bronze			2022-01-24	
J	Anson-Cartwright, L; Dawson, K; Holmyard, D; Fisher, SJ; Lazzarini, RA; Cross, JC				Anson-Cartwright, L; Dawson, K; Holmyard, D; Fisher, SJ; Lazzarini, RA; Cross, JC			The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; MOUSE; DROSOPHILA; DIFFERENTIATION; EXPRESSION; GENE; IMPLANTATION; SWITCH; GCM1	Trophoblast cells of the placenta are established at the blastocyst stage and differentiate into specialized subtypes after implantation(1,2). In mice, the outer layer of the placenta consists of trophoblast giant cells that invade the uterus and promote maternal blood flow to the implantation site by producing cytokines with angiogenic(3) and vasodilatory(4) actions. The innermost layer, called the labyrinth, consists of branched villi that provide a large surface area for nutrient transport and are composed of trophoblast cells and underlying mesodermal cells derived from the allantois. The chorioallantoic villi develop after embryonic day (E) 8.5 through extensive folding and branching of an initially flat sheet of trophoblast cells, the chorionic plate, in response to contact with the allantois. We show here that Gcm1. encoding the transcription factor glial cells missing-1 (Gcm1). is expressed in small clusters of chorionic trophoblast cells at the flat chorionic plate stage and at sites of chorioallantoic folding and extension when morphogenesis begins. Mutation of Gcm1 in mice causes a complete block to branching of the chorioallantoic interface, resulting in embryonic mortality by E10 due to the absence of the placental labyrinth. In addition, chorionic trophoblast cells in Gcm1-deficient placentas do not fuse to form syncytiotrophoblast. Abnormal development of placental villi is frequently associated with fetal death and intrauterine growth restriction in humans, and our studies provide the earliest molecular insight into this aspect of placental development.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, Toronto, ON M5G 1X5, Canada; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; Mt Sinai Sch Med, Brookdale Ctr Dev & Mol Biol, New York, NY USA; Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada		Cross, JC (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Genes & Dev Res Grp, Calgary, AB, Canada.		Cross, James/F-4814-2011; Cross, James/AAU-2973-2020	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378			Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Altshuller Y, 1996, FEBS LETT, V393, P201, DOI 10.1016/0014-5793(96)00890-3; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; BECKER M, 1995, CREATIVITY RES J, V8, P219, DOI 10.1207/s15326934crj0803_2; Bernardoni R, 1998, DEVELOPMENT, V125, P3189; Bernardoni R, 1997, DEV BIOL, V191, P118; COLOSI P, 1987, MOL ENDOCRINOL, V1, P767, DOI 10.1210/mend-1-11-767; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; CROSS JC, IN PRESS SEMIN CELL; Cross JC, 1996, FETAL MATERNAL MED R, V8, P57, DOI DOI 10.1017/S0965539500001492; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HERNANDE.D, 1974, CELL TISSUE RES, V148, P381; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Hunter PJ, 1999, DEVELOPMENT, V126, P1247; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; Jacquemin P, 1998, DEV DYNAM, V212, P423, DOI 10.1002/(SICI)1097-0177(199807)212:3<423::AID-AJA10>3.0.CO;2-1; Janatpour MJ, 1999, DEV GENET, V25, P146, DOI 10.1002/(SICI)1520-6408(1999)25:2<146::AID-DVG9>3.0.CO;2-K; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; ROSSANT J, 1977, J EMBRYOL EXP MORPH, V39, P183; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wurst W., 1993, Gene targeting: a practical approach., P33; Yotsumoto S, 1998, DEV BIOL, V203, P264, DOI 10.1006/dbio.1998.9073	30	301	309	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					311	314		10.1038/77076			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	WOS:000087920900020	10888880				2022-01-24	
J	Okawa, A; Nakamura, I; Goto, S; Moriya, H; Nakamura, Y; Ikegawa, S				Okawa, A; Nakamura, I; Goto, S; Moriya, H; Nakamura, Y; Ikegawa, S			Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine	NATURE GENETICS			English	Article							NUCLEOSIDE-TRIPHOSPHATE PYROPHOSPHATASE; MEMBRANE GLYCOPROTEIN PC-1; INORGANIC PYROPHOSPHATE; EPIPHYSEAL CARTILAGE; PARATHYROID-HORMONE; ANTIGEN PC-1; PYROPHOSPHOHYDROLASE; GENERATION; CELLS; BONE	Ossification of the posterior longitudinal ligament of the spine (OPLL) is a common form of human myelopathy caused by a compression of the spinal cord by ectopic ossification of spinal ligaments(1,2). To elucidate the genetic basis for OPLL, we have been studying the ttw (tiptoe walking; previously designated twy) mouse, a naturally occurring mutant which exhibits ossification of the spinal ligaments very similar to human OPLL (refs 3,4). Using a positional candidate-gene approach, we determined the ttw phenotype is caused by a nonsense mutation (glycine 568 to stop) in the Npps gene which encodes nucleotide pyrophosphatase. This enzyme regulates soft-tissue calcification and bone mineralization by producing inorganic pyrophosphate, a major inhibitor of calcification(5-8). The accelerated bone formation characteristic of ttw mice is likely to result from dysfunction of NPPS caused by predicted truncation of the gene product, resulting in the loss of more than one-third of the native protein. Our results may lead to novel insights into the mechanism of ectopic ossification and the aetiology of human OPLL.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 108, Japan; Chiba Univ, Sch Med, Dept Orthopaed Surg, Chyuo Ku, Chiba 260, Japan; Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 390, Japan		Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.	yusuke@ims.u-tokyo.ac.jp					ALBINNI U, 1982, CHIR ORG MOVIMENTO, V70, P15; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; CASWELL AM, 1987, BIOCHIM BIOPHYS ACTA, V924, P276, DOI 10.1016/0304-4165(87)90023-7; CASWELL AM, 1988, BIOCHIM BIOPHYS ACTA, V966, P310, DOI 10.1016/0304-4165(88)90080-3; DIETRICH W, 1992, GENETICS, V131, P423; FIROOZNIA H, 1982, NEW YORK STATE J MED, V82, P1193; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; GOTO S, 1997, OSSIFICATION POSTERI, P29; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; HSU HHT, 1983, J BIOL CHEM, V258, P3463; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; OHTSUKA K, 1987, ARCH ORTHOP TRAUM SU, V106, P89, DOI 10.1007/BF00435420; Okawa A, 1998, MAMM GENOME, V9, P155, DOI 10.1007/s003359900707; ONO K, 1977, Spine, V2, P126, DOI 10.1097/00007632-197706000-00005; OYAJOBI BO, 1994, J BONE MINER RES, V9, P1259; REBBE NF, 1991, P NATL ACAD SCI USA, V88, P5192, DOI 10.1073/pnas.88.12.5192; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; SIEGEL SA, 1983, J BIOL CHEM, V258, P8601; TERAKADO A, 1995, CALCIFIED TISSUE INT, V56, P135, DOI 10.1007/BF00296345; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; VANDRIEL IR, 1987, J BIOL CHEM, V262, P4882; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; YAMAZAKI M, 1991, CALCIFIED TISSUE INT, V48, P182, DOI 10.1007/BF02570553	26	301	312	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					271	273		10.1038/956			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	WOS:000074565900025	9662402				2022-01-24	
J	Liu, HP; Styles, CA; Fink, GR				Liu, HP; Styles, CA; Fink, GR			Saccharomyces cerevisiae S288C has a mutation in FL08 a gene required for filamentous growth	GENETICS			English	Article							PSEUDOHYPHAL GROWTH; FLOCCULATION GENES; SECRETORY PATHWAY; SHUTTLE VECTORS; POLYMERASE-II; YEAST; PROTEIN; HOMOLOG; STRAINS; DNA	Diploid strains of baker's yeast Saccharomyces cerevisiae can grow in a cellular yeast form or in filaments called pseudohyphae. This dimorphic transition from yeast to pseudohyphae is induced by starvation for nitrogen. Not all laboratory strains are capable of this dimorphic switch; many grow only in the yeast form and fail to form pseudohyphae when starved for nitrogen. Analysis of the standard laboratory strain S288C shows that this defect in dimorphism results from a nonsense mutation in the FLO8 gene. This defect in FLO8 blocks pseudohyphal growth in diploids: haploid invasive growth, and flocculation. Since feral strains of S. cerevisiae are dimorphic and have a functional FLO8 gene, we suggest that the flo8 mutation was selected during laboratory cultivation.	MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; UNIV CALIF IRVINE, DEPT BIOL CHEM, IRVINE, CA 92717 USA						NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM402661] Funding Source: Medline		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BANUETT F, 1994, GENE DEV, V8, P1367, DOI 10.1101/gad.8.12.1367; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; BARRAL Y, 1995, CR ACAD SCI III-VIE, V318, P43; BIDARD F, 1995, YEAST, V11, P809, DOI 10.1002/yea.320110903; BLACKETER MJ, 1994, MOL CELL BIOL, V14, P4671, DOI 10.1128/MCB.14.7.4671; BLACKETER MJ, 1993, MOL CELL BIOL, V13, P5567, DOI 10.1128/MCB.13.9.5567; BRANDRISS MC, 1979, J BACTERIOL, V143, P1403; CARLSON M, 1981, GENETICS, V98, P41; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CORUZZI G, 1978, EUR J BIOCHEM, V92, P279, DOI 10.1111/j.1432-1033.1978.tb12746.x; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; ELION EA, 1991, COLD SPRING HARB SYM, V56, P41; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GOZALBO D, 1989, MOL GEN GENET, V216, P511, DOI 10.1007/BF00334398; HANSEN EC, 1886, RECHERCHES PHYSL MOR; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KALLAL LA, 1990, CURR GENET, V18, P293, DOI 10.1007/BF00318210; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; KIKUCHI Y, 1994, MOL GEN GENET, V245, P107, DOI 10.1007/BF00279756; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; MORTIMER RK, 1986, GENETICS, V113, P35; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; MULERO JJ, 1994, MOL GEN GENET, V242, P383, DOI 10.1007/BF00281787; MULLER PP, 1984, J MOL BIOL, V175, P431, DOI 10.1016/0022-2836(84)90178-5; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; NESS F, 1995, GENETICS, V140, P945; PRINGLE JR, 1991, IMMUNOFLUORESCENCE M; RILES L, 1993, GENETICS, V134, P81; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sherman F., 1986, METHODS YEAST GENETI; SIDDIQUI AH, 1988, MOL CELL BIOL, V8, P4634, DOI 10.1128/MCB.8.11.4634; SIKORSKI RS, 1989, GENETICS, V122, P19; STETTLER S, 1993, MOL GEN GENET, V239, P169, DOI 10.1007/BF00281615; STRATFORD M, 1989, YEAST, V5, P487, DOI 10.1002/yea.320050608; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; TAYLOR NW, 1975, J I BREWING, V81, P53, DOI 10.1002/j.2050-0416.1975.tb03661.x; TEUNISSEN AWRH, 1995, YEAST, V11, P735, DOI 10.1002/yea.320110805; TEUNISSEN AWRH, 1995, YEAST, V11, P435, DOI 10.1002/yea.320110506; TEUNISSEN AWRH, 1993, YEAST, V9, P423, DOI 10.1002/yea.320090413; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; WRIGHT RM, 1993, CURR GENET, V23, P388, DOI 10.1007/BF00312623	53	301	310	0	12	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	NOV	1996	144	3					967	978					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VP826	WOS:A1996VP82600011	8913742				2022-01-24	
J	TELENIUS, H; KREMER, B; GOLDBERG, YP; THEILMANN, J; ANDREW, SE; ZEISLER, T; ADAM, S; GREENBERG, C; IVES, EJ; CLARKE, LA; HAYDEN, MR				TELENIUS, H; KREMER, B; GOLDBERG, YP; THEILMANN, J; ANDREW, SE; ZEISLER, T; ADAM, S; GREENBERG, C; IVES, EJ; CLARKE, LA; HAYDEN, MR			SOMATIC AND GONADAL MOSAICISM OF THE HUNTINGTON DISEASE GENE CAG REPEAT IN BRAIN AND SPERM	NATURE GENETICS			English	Article							FRAGILE-X; MYOTONIC-DYSTROPHY; CTG REPEAT; INSTABILITY	Huntington disease is associated with an unstable and expanded (CAG) trinucleotide repeat. We have analysed the CAG expansion in different tissues from 12 affected individuals. All tissues examined were found to display some repeat mosaicism, with the greatest levers detected in brain and sperm. Regions within the brain showing most obvious neuropathology, such as the basal ganglia and the cerebral cortex, displayed the greatest mosaicism, whereas the cerebellar cortex, which is seldom involved, displayed the lowest degree of CAG instability. In two cases of childhood onset disease we detected differences of 8 and 13 trinucleotides between the cerebellum and other regions of the brain. Our results provide evidence for tissue specific instability of the CAG repeat, with the largest CAG repeat lengths in affected regions of the brain.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1Z4,BC,CANADA; CHILDRENS HOSP,HLTH SCI CTR,GENET & METAB SECT,WINNIPEG R3A 1S1,MB,CANADA; MEM UNIV NEWFOUNDLAND,FAC MED,HLTH SCI CTR,DIV COMMUNITY MED,ST JOHNS A1B 3V6,NF,CANADA				Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Adam, Shelin/0000-0002-4401-6157; Clarke, Lorne/0000-0003-0512-7281			ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; BLINKOV SM, 1968, HUMAN BRAIN FIGURES, P416; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Harper PS, 1991, HUNTINGTONS DISEASE; Hayden MR, 1981, HUNTINGTONS CHOREA; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER, IN PRESS NEW ENGL J; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MCDONALD ME, 1993, J MED GENET, V30, P982; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; ZHULKE C, 1993, HUM MOL GENET, V2, P2063; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467; 1983, CELL, V72, P971	33	301	303	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					409	414		10.1038/ng0494-409			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	WOS:A1994ND87000023	8054984				2022-01-24	
J	ADAMS, MD; KERLAVAGE, AR; FIELDS, C; VENTER, JC				ADAMS, MD; KERLAVAGE, AR; FIELDS, C; VENTER, JC			3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN	NATURE GENETICS			English	Article							LIPOPROTEIN RECEPTOR; LDL-RECEPTOR; ZINC FINGERS; PROTEIN; ENCODES; GENE; FAMILY; VIRUS; TOOL	We present the results of the partial sequencing of over 3,400 expressed sequence tags (ESTs) from human brain cDNA clones, which increases the number of distinct genes expressed in the brain, that are represented by ESTs, to about 6,000. By choosing clones in an unbiased manner, it is possible to construct a profile of the transcriptional activity of the brain at different stages. Proteins that comprise the cytoskeleton are the most abundant; however, a large variety of regulatory proteins are also seen. About half of the ESTs predicted to contain a protein-coding region have no matches in the public peptide databases and may represent new gene families.	NINCDS,RECEPTOR BIOCHEM & MOLECU BIOL SECT,BETHESDA,MD 20892		ADAMS, MD (corresponding author), INST GENOM RES,932 CLOPPER RD,GAITHERSBURG,MD 20878, USA.			Kerlavage, Anthony/0000-0002-3954-9653; Fields, Chris/0000-0002-4812-0744			ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADAMS MD, IN PRESS NATURE GENE; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BORK P, 1992, NATURE, V358, P287, DOI 10.1038/358287a0; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; DIBELLO PR, 1991, GENETICS, V129, P385; FIELDS CA, 1990, COMPUT APPL BIOSCI, V6, P263; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOOG C, 1991, NUCLEIC ACIDS RES, V19, P6123, DOI 10.1093/nar/19.22.6123; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; KERLAVAGE A, 1993, 26TH P HAW INT C SYS, P585; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; MARTINGALLARDO A, 1992, NAT GENET, V1, P348; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SODERLUND C, 1992, P HAWAII INT C SYSTE, P653; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; UPTON C, 1990, VIROLOGY, V179, P618, DOI 10.1016/0042-6822(90)90129-F; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	30	301	307	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					256	267		10.1038/ng0793-256			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	WOS:A1993LJ84200013	8358434				2022-01-24	
J	Weisenfeld, NI; Kumar, V; Shah, P; Church, DM; Jaffe, DB				Weisenfeld, Neil I.; Kumar, Vijay; Shah, Preyas; Church, Deanna M.; Jaffe, David B.			Direct determination of diploid genome sequences	GENOME RESEARCH			English	Article							GENETIC-VARIATION; IN-VITRO; DNA; INFORMATION; DISCOVERY	Determining the genome sequence of an organism is challenging, yet fundamental to understanding its biology. Over the past decade, thousands of human genomes have been sequenced, contributing deeply to biomedical research. In the vast majority of cases, these have been analyzed by aligning sequence reads to a single reference genome, biasing the resulting analyses, and in general, failing to capture sequences novel to a given genome. Some de novo assemblies have been constructed free of reference bias, but nearly all were constructed by merging homologous loci into single "consensus" sequences, generally absent from nature. These assemblies do not correctly represent the diploid biology of an individual. In exactly two cases, true diploid de novo assemblies have been made, at great expense. One was generated using Sanger sequencing, and one using thousands of clone pools. Here, we demonstrate a straightforward and low-cost method for creating true diploid de novo assemblies. We make a single library from similar to 1 ng of high molecular weight DNA, using the 10x Genomics microfluidic platform to partition the genome. We applied this technique to seven human samples, generating low-cost HiSeq X data, then assembled these using a new "pushbutton" algorithm, Supernova. Each computation took 2 d on a single server. Each yielded contigs longer than 100 kb, phase blocks longer than 2.5 Mb, and scaffolds longer than 15 Mb. Our method provides a scalable capability for determining the actual diploid genome sequence in a sample, opening the door to new approaches in genomic biology and medicine.	[Weisenfeld, Neil I.; Kumar, Vijay; Shah, Preyas; Church, Deanna M.; Jaffe, David B.] 10x Genomics, Pleasanton, CA 94566 USA		Jaffe, DB (corresponding author), 10x Genomics, Pleasanton, CA 94566 USA.	david.jaffe@10xgenomics.com		Shah, Preyas/0000-0002-1816-4623	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	We thank the entire team at 10x Genomics for developing the technology that enabled this project. We thank Rabbea Abbas, Brendan Galvin, Cassandra Jabara, and Susanna Jett for preparing DNA and libraries. We thank Sofia Kyriazopoulou-Panagiotopoulou, Mike Schnall-Levin, and Grace Zheng for comments on the manuscript. We thank Katie Kong for assistance in preparing the manuscript. The development of Supernova was greatly accelerated by access to genome assembly code developed at the Whitehead Institute Center for Genome Research and thence the Broad Institute during the period of 2000-2015, and open sourced through GitHub. This code was used to develop ARACHNE, ALLPATHS, ALLPATHS-LG, DISCOVAR, and DISCOVAR de novo. As the manuscript for the latter was unpublished, we note here our gratitude to NIH, Iain MacCallum, Ted Sharpe, and Eric Lander for their contributions to and support for that work.	Adey A, 2014, GENOME RES, V24, P2041, DOI 10.1101/gr.178319.114; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anantharaman T., 2001, Algorithms in Bioinformatics. First International Workshop, WABI 2001. Proceedings (Lecture Notes in Computer Science Vol.2149), P27; [Anonymous], 2007, THESIS; [Anonymous], 2013, 13033997 ARXIV; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Cao HZ, 2015, NAT BIOTECHNOL, V33, P617, DOI 10.1038/nbt.3200; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Glusman G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0073-7; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mak ACY, 2016, GENETICS, V202, P351, DOI 10.1534/genetics.115.183483; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg2939; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nguyen JV, 2010, THESIS; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903; Steinberg K.M., 2016, HIGH QUALITY ASSEMBL, DOI [10.1101/067447, DOI 10.1101/067447]; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Weisenfeld NI, 2014, NAT GENET, V46, P1350, DOI 10.1038/ng.3121; Zhang MP, 2012, NAT PROTOC, V7, P467, DOI 10.1038/nprot.2011.455; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432	47	300	304	4	51	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAY	2017	27	5					757	767		10.1101/gr.214874.116			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	ET6HP	WOS:000400392400010	28381613	Green Published, Green Submitted, hybrid	Y	N	2022-01-24	
J	Williams, MJ; Werner, B; Barnes, CP; Graham, TA; Sottoriva, A				Williams, Marc J.; Werner, Benjamin; Barnes, Chris P.; Graham, Trevor A.; Sottoriva, Andrea			Identification of neutral tumor evolution across cancer types	NATURE GENETICS			English	Article							INTRATUMOR HETEROGENEITY; COLORECTAL-CANCER; CLONAL EVOLUTION; MUTATIONS; PROGRESSION; GROWTH; MODEL; DIVERSITY; DYNAMICS; DRIVER	Despite extraordinary efforts to profile cancer genomes, interpreting the vast amount of genomic data in the light of cancer evolution remains challenging. Here we demonstrate that neutral tumor evolution results in a power-law distribution of the mutant allele frequencies reported by next-generation sequencing of tumor bulk samples. We find that the neutral power law fits with high precision 323 of 904 cancers from 14 types and from different cohorts. In malignancies identified as evolving neutrally, all clonal selection seemingly occurred before the onset of cancer growth and not in later-arising subclones, resulting in numerous passenger mutations that are responsible for intratumoral heterogeneity. Reanalyzing cancer sequencing data within the neutral framework allowed the measurement, in each patient, of both the in vivo mutation rate and the order and timing of mutations. This result provides a new way to interpret existing cancer genomic data and to discriminate between functional and non-functional intratumoral heterogeneity.	[Williams, Marc J.; Graham, Trevor A.] Queen Mary Univ London, Evolut & Canc Lab, Barts Canc Inst, London, England; [Williams, Marc J.; Barnes, Chris P.] UCL, Dept Cell & Dev Biol, London, England; [Williams, Marc J.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Werner, Benjamin; Sottoriva, Andrea] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England; [Barnes, Chris P.] UCL, Dept Genet Evolut & Environm, London, England		Graham, TA (corresponding author), Queen Mary Univ London, Evolut & Canc Lab, Barts Canc Inst, London, England.; Sottoriva, A (corresponding author), Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England.	t.graham@qmul.ac.uk; andrea.sottoriva@icr.ac.uk		Williams, Marc/0000-0001-5524-4174; Sottoriva, Andrea/0000-0001-6709-9533; Graham, Trevor/0000-0001-9582-1597; Barnes, Chris/0000-0002-9459-1395; Werner, Benjamin/0000-0002-6857-8699	Chris Rokos Fellowship in Evolution and Cancer; Geoffrey W Lewis Post-Doctoral Training fellowship; Wellcome TrustWellcome TrustEuropean Commission [105104/Z/14/Z]; Wellcome Trust through a Research Career Development FellowshipWellcome Trust [097319/Z/11/Z]; Cancer Research UK Career Development AwardCancer Research UK; UK Medical Research Council student fellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Cancer Research UKCancer Research UK [19771] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [1503539] Funding Source: researchfish	A.S. is supported by The Chris Rokos Fellowship in Evolution and Cancer. B.W. is supported by the Geoffrey W Lewis Post-Doctoral Training fellowship. This work was supported by the Wellcome Trust (105104/Z/14/Z). C.P.B. acknowledges funding from the Wellcome Trust through a Research Career Development Fellowship (097319/Z/11/Z). This work was supported by a Cancer Research UK Career Development Award to T.A.G. M.J.W. is supported by a UK Medical Research Council student fellowship.	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Basanta D, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0020; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Durrett R, 2013, ANN APPL PROBAB, V23, P230, DOI 10.1214/11-AAP824; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089244; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Jesinghaus M, 2015, AM J SURG PATHOL, V39, P1140, DOI 10.1097/PAS.0000000000000423; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kessler DA, 2013, P NATL ACAD SCI USA, V110, P11682, DOI 10.1073/pnas.1309667110; Luria SE, 1943, GENETICS, V28, P491; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Maruvka YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026480; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Polyak K, 2014, NAT MED, V20, P344, DOI 10.1038/nm.3518; Shou WY, 2015, ELIFE, V4, DOI 10.7554/eLife.07158; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Sun SH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S3-S2; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Tavar?, 1998, COMMUN STAT STOCH MO, V14, P273, DOI [DOI 10.1080/15326349808807471, 10.1080/15326349808807471]; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	42	300	304	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					238	244		10.1038/ng.3489			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	WOS:000370902600007	26780609	Green Submitted, Green Accepted	Y	N	2022-01-24	
J	Hah, N; Murakami, S; Nagari, A; Danko, CG; Kraus, WL				Hah, Nasun; Murakami, Shino; Nagari, Anusha; Danko, Charles G.; Kraus, W. Lee			Enhancer transcripts mark active estrogen receptor binding sites	GENOME RESEARCH			English	Article							GENE-EXPRESSION; CHROMATIN ACCESSIBILITY; DISTINCT CLASSES; NONCODING RNAS; BREAST-CANCER; HUMAN-CELLS; WIDESPREAD; GENOME; DIFFERENTIATION; ARCHITECTURE	We have integrated and analyzed a large number of data sets from a variety of genomic assays using a novel computational pipeline to provide a global view of estrogen receptor 1 (ESR1; a.k.a. ER alpha) enhancers in MCF-7 human breast cancer cells. Using this approach, we have defined a class of primary transcripts (eRNAs) that are transcribed uni- or bidirectionally from estrogen receptor binding sites (ERBSs) with an average transcription unit length of similar to 3-5 kb. The majority are up-regulated by short treatments with estradiol (i.e., 10, 25, or 40 min) with kinetics that precede or match the induction of the target genes. The production of eRNAs at ERBSs is strongly correlated with the enrichment of a number of genomic features that are associated with enhancers (e.g., H3K4me1, H3K27ac, EP300/CREBBP, RNA polymerase II, open chromatin architecture), as well as enhancer looping to target gene promoters. In the absence of eRNA production, strong enrichment of these features is not observed, even though ESR1 binding is evident. We find that flavopiridol, a CDK9 inhibitor that blocks transcription elongation, inhibits eRNA production but does not affect other molecular indicators of enhancer activity, suggesting that eRNA production occurs after the assembly of active enhancers. Finally, we show that an enhancer transcription "signature'' based on GRO-seq data can be used for de novo enhancer prediction across cell types. Together, our studies shed new light on the activity of ESR1 at its enhancer sites and provide new insights about enhancer function.	[Hah, Nasun; Danko, Charles G.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hah, Nasun; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Murakami, Shino; Nagari, Anusha; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Murakami, Shino; Nagari, Anusha; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Div Basic Reprod Biol Res, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Murakami, Shino; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Grad Sch Biomed Sci, Program Genet & Dev, Dallas, TX 75390 USA; [Danko, Charles G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA		Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	lee.kraus@utsouthwestern.edu		Danko, Charles/0000-0002-1999-7125; Hah, Nasun/0000-0003-1509-2799	NIH training award [T32HD052471]; PhRMA Foundation; NIH/NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK058110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD052471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK058110] Funding Source: NIH RePORTER	We thank John Lis, Leighton Core, T.K. Kim, Xin Luo, Miao Sun, and Hector Franco for helpful discussions and critical comments on this manuscript. This work was supported by an NIH training award (T32HD052471) and a postdoctoral fellowship from the PhRMA Foundation to C.D., and a grant from the NIH/NIDDK (DK058110) to W.L.K.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kolovos P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-1; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	48	300	302	0	27	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2013	23	8					1210	1223		10.1101/gr.152306.112			14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	193RS	WOS:000322579800002	23636943	hybrid, Green Submitted, Green Published			2022-01-24	
J	Mungall, CJ; Torniai, C; Gkoutos, GV; Lewis, SE; Haendel, MA				Mungall, Christopher J.; Torniai, Carlo; Gkoutos, Georgios V.; Lewis, Suzanna E.; Haendel, Melissa A.			Uberon, an integrative multi-species anatomy ontology	GENOME BIOLOGY			English	Article							PHENOTYPE ONTOLOGY; INFORMATION; TOOL; INTEROPERABILITY; EVOLUTION; FRAMEWORK; HOMOLOGY; DATABASE; SUPPORT; SYSTEM	We present Uberon, an integrated cross-species ontology consisting of over 6,500 classes representing a variety of anatomical entities, organized according to traditional anatomical classification criteria. The ontology represents structures in a species-neutral way and includes extensive associations to existing species-centric anatomical ontologies, allowing integration of model organism and human data. Uberon provides a necessary bridge between anatomical structures in different taxa for cross-species inference. It uses novel methods for representing taxonomic variation, and has proved to be essential for translational phenotype analyses. Uberon is available at http://uberon.org	[Mungall, Christopher J.; Lewis, Suzanna E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Torniai, Carlo; Haendel, Melissa A.] Oregon Hlth & Sci Univ, Lib & Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Gkoutos, Georgios V.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England		Mungall, CJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, 1 Cycltotron Rd,MS 64-121, Berkeley, CA 94720 USA.	CJMungall@lbl.gov	Gkoutos, Georgios/AAS-9936-2020; Mungall, Chris/I-6006-2019	Gkoutos, Georgios/0000-0002-2061-091X; Mungall, Chris/0000-0002-6601-2165; Haendel, Melissa/0000-0001-9114-8737; Lewis, Suzanna/0000-0002-8343-612X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HG004838, P41HG002273]; Office of Science, Office of Basic Energy Sciences, of the US Department of EnergyUnited States Department of Energy (DOE) [DE-AC02-05CH11231]; American Recovery and Reinvestment Act [1U24RR029825-01, P41HG002273-09S1]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U24RR029825] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U41HG002273, R01HG004838, P41HG002273] Funding Source: NIH RePORTER	We wish to thank the developers of other anatomical ontologies, including Onard Mejino, Jonathan Bard, Duncan Davidson, Peter Robinson, Terry Hayamizu, Terry Meehan, David Hill, Paula Mabee, Wasila Dahdul, Erik Segerdell, Cynthia Smith, Paul Schofield, David Osumi Sutherland, and Maryann Martone. In addition, we also thank Harry Hochheiser and Wacek Kusnierczyk for comments on this manuscript, and Grace Panganiban for allowing us to use her beautiful distal-less example and images. This work was supported by the National Institutes of Health grant numbers 5R01HG004838 and P41HG002273, by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract number DE-AC02-05CH11231 and by the National Institutes of Health and the American Recovery and Reinvestment Act grant numbers 1U24RR029825-01 and P41HG002273-09S1.	Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Bard JBL, 2005, J ANAT, V206, P1, DOI 10.1111/j.0021-8782.2005.00376.x; Bizer C, 2009, J WEB SEMANT, V7, P154, DOI 10.1016/j.websem.2009.07.002; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Bug WJ, 2008, NEUROINFORMATICS, V6, P175, DOI 10.1007/s12021-008-9032-z; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Courtot M, 2009, P 1 INT C BIOM ONT J; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; de Coronado S, 2009, J BIOMED INFORM, V42, P530, DOI 10.1016/j.jbi.2009.01.003; Deegan JI, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-530; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Favor J, 2008, GENETICS, V179, P1345, DOI 10.1534/genetics.108.088591; Gkoutos G V, 2004, Pac Symp Biocomput, P178; Gross A, 2011, P 2 INT C BIOM ONT J; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hawrylycz M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001065; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Hochheiser H, 2011, DEV BIOL, V355, P175, DOI 10.1016/j.ydbio.2011.02.033; Hoehndorf R, 2011, BIOINFORMATICS, V27, P1001, DOI 10.1093/bioinformatics/btr058; Hoehndorf R, 2010, BIOINFORMATICS, V26, P3112, DOI 10.1093/bioinformatics/btq578; Horridge M., 2006, OWLED; Ilic K, 2007, PLANT PHYSIOL, V143, P587, DOI 10.1104/pp.106.092825; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kruger A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r229; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Maglia AM, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P367; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; Maynard SM, 2012, BMC BIOINFORMATICS; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall C, 2009, LECT NOTES COMPUT SC, V5649, P1, DOI 10.1007/978-3-642-02846-5_1; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Mungall CJ, 2004, COMP FUNCT GENOM, V5, P509, DOI 10.1002/cfg.435; Natale DA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S9-S1; Nelms B. L., 2010, TRANSCRIPTIONAL CONT; Niknejad A, 2012, BIOINFORMATICS; Osumi-Sutherland D, 2011, P 2 INT C BIOM ONT J; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Parmentier G, 2010, BIOINFORMATICS, V26, P1766, DOI 10.1093/bioinformatics/btq283; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Rector A L, 1993, Proc Annu Symp Comput Appl Med Care, P414; Rector AL, 2003, P 2 INT C KNOWL CAPT, P121; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Schindelman G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-32; Scotland RW, 2010, BIOESSAYS, V32, P438, DOI 10.1002/bies.200900175; Segerdell E, 2010, NAT PRECEDINGS; Segerdell E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-92; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Swart EC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-8; Torniai C, 2011, P 2 INT C BIOM ONT J; Travillian R, 2011, P 2 INT C BIOM ONT J; Travillian RS, 2011, ARTIF INTELL MED, V51, P1, DOI 10.1016/j.artmed.2010.10.001; Tsarkov D, 2006, LECT NOTES ARTIF INT, V4130, P292; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Zhang SM, 2007, INT J SEMANT WEB INF, V3, P1, DOI 10.4018/jswis.2007040101; Zhang SM, 2007, STUD HEALTH TECHNOL, V129, P822	64	300	300	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2012	13	1							R5	10.1186/gb-2012-13-1-r5			20	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	960LS	WOS:000305390300005	22293552	Green Published, hybrid, Green Submitted			2022-01-24	
J	Zhu, C; Byers, KJRP; McCord, RP; Shi, ZW; Berger, MF; Newburger, DE; Saulrieta, K; Smith, Z; Shah, MV; Radhakrishnan, M; Philippakis, AA; Hu, YH; De Masi, F; Pacek, M; Rolfs, A; Murthy, T; LaBaer, J; Bulyk, ML				Zhu, Cong; Byers, Kelsey J. R. P.; McCord, Rachel Patton; Shi, Zhenwei; Berger, Michael F.; Newburger, Daniel E.; Saulrieta, Katrina; Smith, Zachary; Shah, Mita V.; Radhakrishnan, Mathangi; Philippakis, Anthony A.; Hu, Yanhui; De Masi, Federico; Pacek, Marcin; Rolfs, Andreas; Murthy, Tal; LaBaer, Joshua; Bulyk, Martha L.			High-resolution DNA-binding specificity analysis of yeast transcription factors	GENOME RESEARCH			English	Article							CHROMATIN-REMODELING COMPLEX; GENOME-WIDE LOCATION; GENE-EXPRESSION; REGULATORY NETWORKS; RSC; PROTEINS; SITES; MAP; IDENTIFICATION; MICROARRAYS	Transcription factors (TFs) regulate the expression of genes through sequence-specific interactions with DNA-binding sites. However, despite recent progress in identifying in vivo TF binding sites by microarray readout of chromatin immunoprecipitation (ChIP-chip), nearly half of all known yeast TFs are of unknown DNA-binding specificities, and many additional predicted TFs remain uncharacterized. To address these gaps in our knowledge of yeast TFs and their cis regulatory sequences, we have determined high-resolution binding profiles for 89 known and predicted yeast TFs, over more than 2.3 million gapped and ungapped 8-bp sequences ("k-mers''). We report 50 new or significantly different direct DNA-binding site motifs for yeast DNA-binding proteins and motifs for eight proteins for which only a consensus sequence was previously known; in total, this corresponds to over a 50% increase in the number of yeast DNA-binding proteins with experimentally determined DNA-binding specificities. Among other novel regulators, we discovered proteins that bind the PAC (Polymerase A and C) motif (GATGAG) and regulate ribosomal RNA (rRNA) transcription and processing, core cellular processes that are constituent to ribosome biogenesis. In contrast to earlier data types, these comprehensive k-mer binding data permit us to consider the regulatory potential of genomic sequence at the individual word level. These k-mer data allowed us to reannotate in vivo TF binding targets as direct or indirect and to examine TFs' potential effects on gene expression in similar to 1700 environmental and cellular conditions. These approaches could be adapted to identify TFs and cis regulatory elements in higher eukaryotes.	[Zhu, Cong; Byers, Kelsey J. R. P.; McCord, Rachel Patton; Berger, Michael F.; Newburger, Daniel E.; Saulrieta, Katrina; Smith, Zachary; Shah, Mita V.; Radhakrishnan, Mathangi; Philippakis, Anthony A.; De Masi, Federico; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Zhu, Cong; Byers, Kelsey J. R. P.; McCord, Rachel Patton; Berger, Michael F.; Newburger, Daniel E.; Saulrieta, Katrina; Smith, Zachary; Shah, Mita V.; Radhakrishnan, Mathangi; Philippakis, Anthony A.; De Masi, Federico; Bulyk, Martha L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [McCord, Rachel Patton; Berger, Michael F.; Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; [Shi, Zhenwei; Hu, Yanhui; Pacek, Marcin; Rolfs, Andreas; Murthy, Tal; LaBaer, Joshua] Harvard Univ, Sch Med, Harvard Inst Prote, Cambridge, MA 02141 USA; [Saulrieta, Katrina; Smith, Zachary] MIT, Dept Biol, Cambridge, MA 02139 USA; [Shah, Mita V.] Wellesley Coll, Dept Biol, Wellesley, MA 02481 USA; [Radhakrishnan, Mathangi] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Philippakis, Anthony A.] Harvard Univ, HST, Harvard MIT Div Hlth Sci & Technol, Sch Med, Boston, MA 02115 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA		Bulyk, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu	De Masi, Federico/A-4499-2010; Byers, Kelsey/M-3987-2014	De Masi, Federico/0000-0003-4859-4170; Byers, Kelsey/0000-0002-0923-8264; McCord, Rachel/0000-0003-0010-5323; Hu, Yanhui/0000-0003-1494-1402	NIH/NHGRIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG003985, R01 HG003420]; National Science Foundation Graduate Research FellowshipsNational Science Foundation (NSF); NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG003420, R01HG003985] Funding Source: NIH RePORTER	We thank G. Badis, T. R. Hughes, and J. D. Lieb for sharing 118 N-term GST fusion DNA-binding domain expression clones; G. Berriz for assistance with FuncAssociate; F. Winston, I. Laprade, and X. Li for technical assistance with yeast experiments; J.-A. Kwon and J. Love for technical assistance with Affymetrix gene expression profiling experiments; T. Gurbich for technical assistance with PBMs; and K. Struhl for helpful discussion. Plasmid pMPY-3xHA was a generous gift from K. Struhl. We thank S. Gisselbrecht, T. Siggers, and A. Dudley for critical reading of the manuscript. We also thank anonymous reviewers for helpful comments. This work was funded by grants R01 HG003985 and R01 HG003420 from NIH/NHGRI to M. L. B. M. F. B. and R. P. M. were supported in part by National Science Foundation Graduate Research Fellowships.	Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BERGER M, 2009, NAT PROTOCO IN PRESS; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Borneman AR, 2007, FUNCT INTEGR GENOMIC, V7, P335, DOI 10.1007/s10142-007-0054-7; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liko D, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704762200; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mamane Y, 1998, J BIOL CHEM, V273, P18556, DOI 10.1074/jbc.273.29.18556; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Philippakis AA, 2008, J COMPUT BIOL, V15, P655, DOI 10.1089/cmb.2007.0114; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wilson B, 2006, GENETICS, V172, P795, DOI 10.1534/genetics.105.047589; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088	57	300	309	2	20	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2009	19	4					556	566		10.1101/gr.090233.108			11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	427LX	WOS:000264781900004	19158363	Green Published, Bronze			2022-01-24	
J	Kapsimali, M; Kloosterman, WP; de Bruijn, E; Rosa, F; Plasterk, RHA; Wilson, SW				Kapsimali, Marika; Kloosterman, Wigard P.; de Bruijn, Ewart; Rosa, Frederic; Plasterk, Ronald H. A.; Wilson, Stephen W.			MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system	GENOME BIOLOGY			English	Article							MESSENGER-RNA TRANSLATION; POSTTRANSCRIPTIONAL REGULATION; TRANSGENIC ZEBRAFISH; MAMMALIAN MICRORNAS; GENE-EXPRESSION; BINDING-SITES; CELLS; BRAIN; IDENTIFICATION; INITIATION	Background: MicroRNA (miRNA) encoding genes are abundant in vertebrate genomes but very few have been studied in any detail. Bioinformatic tools allow prediction of miRNA targets and this information coupled with knowledge of miRNA expression profiles facilitates formulation of hypotheses of miRNA function. Although the central nervous system (CNS) is a prominent site of miRNA expression, virtually nothing is known about the spatial and temporal expression profiles of miRNAs in the brain. To provide an overview of the breadth of miRNA expression in the CNS, we performed a comprehensive analysis of the neuroanatomical expression profiles of 38 abundant conserved miRNAs in developing and adult zebrafish brain. Results: Our results show miRNAs have a wide variety of different expression profiles in neural cells, including: expression in neuronal precursors and stem cells (for example, miR-92b); expression associated with transition from proliferation to differentiation (for example, miR-124); constitutive expression in mature neurons (miR-124 again); expression in both proliferative cells and their differentiated progeny (for example, miR-9); regionally restricted expression (for example, miR-222 in telencephalon); and cell-type specific expression (for example, miR-218a in motor neurons). Conclusion: The data we present facilitate prediction of likely modes of miRNA function in the CNS and many miRNA expression profiles are consistent with the mutual exclusion mode of function in which there is spatial or temporal exclusion of miRNAs and their targets. However, some miRNAs, such as those with cell- type specific expression, are more likely to be co-expressed with their targets. Our data provide an important resource for future functional studies of miRNAs in the CNS.	[de Bruijn, Ewart; Plasterk, Ronald H. A.] Ctr Biomed Genet, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; [Kapsimali, Marika; Wilson, Stephen W.] UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; [Kapsimali, Marika] CNRS, DEPSN, UPR2197, F-91198 Gif Sur Yvette, France; [Kapsimali, Marika; Rosa, Frederic] Ecole Normale Super, INSERM, U784, F-75230 Paris, France		Plasterk, RHA (corresponding author), Ctr Biomed Genet, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl; s.wilson@ucl.ac.uk	Wilson, Stephen W/B-9404-2008; Zebrafish, UCL/A-3125-2009; Rosa, Frederic/L-5990-2017; Kapsimali, Marika/D-4354-2011	Wilson, Stephen W/0000-0002-8557-5940; Kapsimali, Marika/0000-0001-9327-5166	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Butler A.B., 2005, COMP VERTEBRATE NEUR; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; MEEK J, 1998, CENTRAL NERVOUS SYST, P49; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; MUELLER T, 2005, TOOL MOL NEUROGENETI; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wullimann M. F., 1996, NEUROANATOMY ZEBRAFI; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115	64	300	328	3	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2007	8	8							R173	10.1186/gb-2007-8-8-r173			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	273NT	WOS:000253938500025	17711588	Green Published, hybrid			2022-01-24	
J	Thomas, BC; Pedersen, B; Freeling, M				Thomas, Brian C.; Pedersen, Brent; Freeling, Michael			Following tetraploidy in an Arabidopsis ancestor, genes were removed preferentially from one homeolog leaving clusters enriched in dose-sensitive genes	GENOME RESEARCH			English	Article							CONSERVED NONCODING SEQUENCES; MATRIX ATTACHMENT REGIONS; DUPLICATE GENES; GENOME DUPLICATION; ANCIENT DUPLICATION; YEAST GENOME; EVOLUTION; EXPRESSION; DIVERGENCE; POLYPLOIDS	Approximately 90% of Arabidopsis' unique gene content is found in syntenic blocks that were formed during the most recent whole-genome duplication. Within these blocks, 28.6% of the genes have a retained pair; the remaining genes have been lost from one of the homeologs. We create a minimized genome by condensing local duplications to one gene, removing transposons, and including only genes within blocks defined by retained pairs. We use a moving average of retained and non-retained genes to find clusters of retention and then identify the types of genes that appear in clusters at frequencies above expectations. Significant clusters of retention exist for almost all chromosomal segments. Detailed alignments show that, for 85% of the genome, one homeolog was preferentially (1.6 x) targeted for fractionation. This homeolog fractionation bias suggests an epigenetic mechanism. We find that islands of retention contain "connected genes," those genes predicted-by the gene balance hypothesis-to be resistant to removal because the products they encode interact with other products in a dose-sensitive manner, creating a web of dependency. Gene families that are overrepresented in clusters include those encoding components of the proteasome/protein modification complexes, signal transduction machinery, ribosomes, and transcription factor complexes. Gene pair fractionation following polyploidy or segmental duplication leaves a genome enriched for "connected" genes. These clusters of duplicate genes may help explain the evolutionary origin of coregulated chromosomal regions and new functional modules.	Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Coll Nat Resources, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA		Freeling, M (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA.	freeling@nature.berkeley.edu					Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Avramova Z, 1998, NUCLEIC ACIDS RES, V26, P761, DOI 10.1093/nar/26.3.761; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Chapman BA, 2004, BIOINFORMATICS, V20, P180, DOI 10.1093/bioinformatics/bth022; Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109; Force A, 1999, GENETICS, V151, P1531; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Glazko GV, 2003, TRENDS GENET, V19, P119, DOI 10.1016/S0168-9525(03)00016-7; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Haldane JBS, 1933, AM NAT, V67, P5, DOI 10.1086/280465; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; HESLOPHARRISON JS, 1990, DEVELOPMENT, P21; Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703; Kashkush K, 2002, GENETICS, V160, P1651; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; LEWIS EB, 1951, COLD SPRING HARB SYM, V16, P159, DOI 10.1101/SQB.1951.016.01.014; Li W.H., 1997, MOL EVOLUTION; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Lynch M, 2000, GENETICS, V154, P459; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; Ohno S., 1970, EVOLUTION GENE DUPLI; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Paterson AH, 2005, NEW PHYTOL, V165, P658, DOI 10.1111/j.1469-8137.2005.01347.x; Raes Jeroen, 2003, Appl Bioinformatics, V2, P91; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Sokal RR, 1995, BIOMETRY; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stansfield W. D., 1977, SCI EVOLUTION; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tian Chao-Guang, 2005, Acta Genetica Sinica, V32, P519; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wagner A, 2002, MOL BIOL EVOL, V19, P1760, DOI 10.1093/oxfordjournals.molbev.a003998; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	56	300	305	0	32	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	JUL	2006	16	7					934	946		10.1101/gr.4708406			13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	059DB	WOS:000238712400013	16760422	Green Published, Bronze			2022-01-24	
J	Romero, P; Wagg, J; Green, ML; Kaiser, D; Krummenacker, M; Karp, PD				Romero, P; Wagg, J; Green, ML; Kaiser, D; Krummenacker, M; Karp, PD			Computational prediction of human metabolic pathways from the complete human genome	GENOME BIOLOGY			English	Article							DATABASES; ENZYMES	Background: We present a computational pathway analysis of the human genome that assigns enzymes encoded therein to predicted metabolic pathways. Pathway assignments place genes in their larger biological context, and are a necessary first step toward quantitative modeling of metabolism. Results: Our analysis assigns 2,709 human enzymes to 896 bioreactions; 622 of the enzymes are assigned roles in 135 predicted metabolic pathways. The predicted pathways closely match the known nutritional requirements of humans. This analysis identifies probable omissions in the human genome annotation in the form of 203 pathway holes ( missing enzymes within the predicted pathways). We have identified putative genes to fill 25 of these holes. The predicted human metabolic map is described by a Pathway/Genome Database called HumanCyc, which is available at http://HumanCyc.org/. We describe the generation of HumanCyc, and present an analysis of the human metabolic map. For example, we compare the predicted human metabolic pathway complement to the pathways of Escherichia coli and Arabidopsis thaliana and identify 35 pathways that are shared among all three organisms. Conclusions: Our analysis elucidates a significant portion of the human metabolic map, and also indicates probable unidentified genes in the genome. HumanCyc provides a genome-based view of human nutrition that associates the essential dietary requirements of humans with a set of metabolic pathways whose existence is supported by the human genome. The database places many human genes in a pathway context, thereby facilitating analysis of gene expression, proteomics, and metabolomics datasets through a publicly available online tool called the Omics Viewer.	SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA		Karp, PD (corresponding author), SRI Int, Bioinformat Res Grp, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pkarp@ai.sri.com	Romero, Pedro R/D-4110-2018; Karp, Peter/C-3514-2012	Romero, Pedro R/0000-0002-6995-5193; Karp, Peter/0000-0002-5876-6418	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01HG002729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM065466] Funding Source: NIH RePORTER; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R01 HG002729, R01-HG02729-01] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM65466-01] Funding Source: Medline		Benson DA, 2003, NUCLEIC ACIDS RES, V31, P23, DOI 10.1093/nar/gkg057; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; KARP PD, 1996, ISMB, V4, P116; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Mcshan DC, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P545; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010; PARKER SP, 1997, MCGRAWHILL DICT BIOS; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Romero P, 2003, J MOL MICROB BIOTECH, V5, P230, DOI 10.1159/000071075; van Helden J, 2002, E SCHERING RES FDN W, V38, P245; Vo TD, 2004, J BIOL CHEM, V279, P39532, DOI 10.1074/jbc.M403782200; Zien A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P407; METACYC GLYCOLYSIS; H SAPIENS PATHWAY OX; H SAPIENS METABOLIC; PATHWAY TOOLS OMICS; METACYC NAD; BIOCYC INTRO DOWNLOA; ECOCYC ENCY ESCHERIC; HUMANCYC ENCY HOMO S; METACYC LEUCINE; HUMANCYC RELEASE NOT; HUMANCYC PATHWAYS	35	300	311	0	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2005	6	1							R2				17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	887WW	WOS:000226337200008	15642094				2022-01-24	
J	Noma, K; Sugiyama, T; Cam, H; Verdel, A; Zofall, M; Jia, ST; Moazed, D; Grewal, SIS				Noma, K; Sugiyama, T; Cam, H; Verdel, A; Zofall, M; Jia, ST; Moazed, D; Grewal, SIS			RITS acts in cis to promote RNA interference-mediated transcriptional and post-transcriptional silencing	NATURE GENETICS			English	Article							FISSION YEAST CENTROMERES; HISTONE H3 METHYLATION; EPIGENETIC CONTROL; HETEROCHROMATIN DOMAIN; LYSINE-9 METHYLATION; DROSOPHILA; DNA; PLANTS; RECOGNITION; PATHWAYS	RNA interference is a conserved mechanism by which double-stranded RNA is processed into short interfering RNAs (siRNAs) that can trigger both post-transcriptional and transcriptional gene silencing. In fission yeast, the RNA-induced initiation of transcriptional gene silencing (RITS) complex contains Dicer-generated siRNAs and is required for heterochromatic silencing. Here we show that BITS components, including Argonaute protein, bind to all known heterochromatic loci. At the mating-type region, BITS is recruited to the centromere-homologous repeat cenH in a Dicer-dependent manner, whereas the spreading of BITS across the entire 20-kb silenced domain, as well as its subsequent maintenance, requires heterochromatin machinery including Swi6 and occurs even in the absence of Dicer. Furthermore, our analyses suggest that RNA interference machinery operates in cis as a stable component of heterochromatic domains with BITS tethered to silenced loci by methylation of histone H3 at Lys9. This tethering promotes the processing of transcripts and generation of additional siRNAs for heterochromatin maintenance.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA		Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Verdel, Andre/M-5201-2013	VERDEL, Andre/0000-0001-6048-3794; Sugiyama, Tomoyasu/0000-0001-5704-6606	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIABC010523, Z01BC010523] Funding Source: NIH RePORTER		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 1997, GENETICS, V146, P1221; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall Ira M., 2003, P205; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	35	300	313	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2004	36	11					1174	1180		10.1038/ng1452			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	WOS:000224832800020	15475954	Bronze			2022-01-24	
J	Yang, YQ; Xia, M; Jin, QF; Bendahhou, S; Shi, JY; Chen, YP; Liang, B; Lin, J; Liu, Y; Liu, B; Zhou, QS; Zhang, DW; Wang, R; Ma, N; Su, XY; Niu, KY; Pei, Y; Xu, WY; Chen, ZP; Wan, HY; Cui, JM; Barhanin, J; Chen, YH				Yang, YQ; Xia, M; Jin, QF; Bendahhou, S; Shi, JY; Chen, YP; Liang, B; Lin, J; Liu, Y; Liu, B; Zhou, QS; Zhang, DW; Wang, R; Ma, N; Su, XY; Niu, KY; Pei, Y; Xu, WY; Chen, ZP; Wan, HY; Cui, JM; Barhanin, J; Chen, YH			Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-QT SYNDROME; SUDDEN CARDIAC DEATH; RADIOFREQUENCY ABLATION; CLINICAL-IMPLICATIONS; POTASSIUM CHANNEL; PULMONARY VEINS; HERG; ARRHYTHMIA; EPIDEMIOLOGY; INITIATION	Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. We first reported an S140G mutation of KCNQ1, an alpha subunit of potassium channels, in one Chinese kindred with AF. However, the molecular defects and cellular mechanisms in most patients with AF remain to be identified. We evaluated 28 unrelated Chinese kindreds with AF and sequenced eight genes of potassium channels (KCNQ1, HERG, KCNE1, KCNE2, KCNE3, KCNE4, KCNE5, and KCNJ2). An arginine-to-cysteine mutation at position 27 (R27C) of KCNE2, the beta subunit of the KCNQ1-KCNE2 channel responsible for a background potassium current, was found in 2 of the 28 probands. The mutation was present in all affected members in the two kindreds and was absent in 462 healthy unrelated Chinese subjects. Similar to KCNQ1 S140G, the mutation had a gain-of-function effect on the KCNQ1-KCNE2 channel; unlike long QT syndrome-associated KCNE2 mutations, it did not alter HERG-KCNE2 current. The mutation did not alter the functions of the HCN channel family either. Thus, KCNE2 R27C is a gain-of-function mutation associated with the initiation and/or maintenance of AF.	Tongji Univ, Inst Med Genet, Shanghai 200065, Peoples R China; Tongji Univ, Dept Cardiol, Shanghai 200065, Peoples R China; Inst Pharmacol Mol & Cellulaire, CNRS, Valbonne, France; Case Western Reserve Univ, Cardiac Bioelect Res & Training Ctr, Cleveland, OH USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA; Case Western Reserve Univ, Univ Hosp Cleveland, Dept Cardiol, Cleveland, OH 44106 USA		Chen, YH (corresponding author), Tongji Univ, Inst Med Genet, 389 Xin Cun Rd, Shanghai 200065, Peoples R China.	yihanchen@mail.tongji.edu.cn	Liang, Bo/C-7210-2012; Zhou, Qin-shu/D-4606-2009				Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Itoh T, 1998, HUM GENET, V102, P435, DOI 10.1007/s004390050717; Jais P, 1997, CIRCULATION, V95, P572, DOI 10.1161/01.CIR.95.3.572; Liu LL, 1997, AM J PHYSIOL-HEART C, V273, pH805, DOI 10.1152/ajpheart.1997.273.2.H805; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; MACKENZIE J, 2004, BRIT MED J, V5, P529; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nattel S, 1999, CARDIOVASC RES, V42, P298, DOI 10.1016/S0008-6363(99)00022-X; Nattel S, 2000, ANNU REV PHYSIOL, V62, P51, DOI 10.1146/annurev.physiol.62.1.51; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Ryder KM, 1999, AM J CARDIOL, V84, p131R; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Van Wagoner DR, 2000, J MOL CELL CARDIOL, V32, P1101, DOI 10.1006/jmcc.2000.1147; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; ZIPES DP, 1974, CARDIOVASC RES, V8, P647, DOI 10.1093/cvr/8.5.647	27	300	314	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					899	905		10.1086/425342			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	WOS:000224303500016	15368194	Green Published, Bronze			2022-01-24	
J	Hayes, BJ; Visscher, PM; McPartlan, HC; Goddard, ME				Hayes, BJ; Visscher, PM; McPartlan, HC; Goddard, ME			Novel multilocus measure of linkage disequilibrium to estimate past effective population size	GENOME RESEARCH			English	Article							MODEL	Linkage disequilibrium (LD) between densely spaced, polymorphic genetic markers in humans and other species contains information about historical population size. Inferring past population size is of interest both from an evolutionary perspective (e.g., testing the "out of Africa" hypothesis of human evolution) and to improve models for mapping of disease and quantitative trait genes. We propose a novel multilocus measure of LD, the chromosome segment homozygosity (CSH). CSH is defined for a specific chromosome segment, up to the full length of the chromosome. In computer simulations CSH was generally less variable than the r(2) measure of LD, and variability of CSH decreased as the number of markers in the chromosome segment was increased. The essence and utility of our novel measure is that CSH over long distances reflects recent effective population size (N), whereas CSH over small distances reflects the effective size in the more distant past. We illustrate the utility of CSH by calculating CSH from human and dairy cattle SNP and microsatellite marker data, and predicting N at various times in the past for each species. Results indicated an exponentially increasing N in humans and a declining N in dairy cattle. CSH is a valuable statistic for inferring population histories from haplotype data, and has implications for mapping of disease loci.	Victorian Inst Anim Sci, Attwood, Vic 3049, Australia; Univ Edinburgh, Edinburgh EH9 3JG, Midlothian, Scotland; Univ Melbourne, Inst Land & Food Resources, Parkville, Vic 3052, Australia		Hayes, BJ (corresponding author), Victorian Inst Anim Sci, Attwood, Vic 3049, Australia.	Ben.Hayes@nre.vic.gov.au	Hayes, Ben J/L-3308-2016; Visscher, Peter/ABB-6151-2020	Hayes, Ben J/0000-0002-5606-3970; Visscher, Peter/0000-0002-2143-8760; Goddard, Michael/0000-0001-9917-7946			Bradley DG, 1999, GENETICS OF CATTLE, P15; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HUDSON RR, 1985, GENETICS, V109, P611; KIMURA M, 1964, GENETICS, V49, P725; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kuhner MK, 1998, GENETICS, V149, P429; Meuwissen THE, 2001, GENET SEL EVOL, V33, P605, DOI 10.1051/gse:2001134; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sabatti C, 2002, GENETICS, V160, P1707; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; SHRIVER MD, 1993, GENETICS, V134, P983; Slatkin M, 2001, GENETICS, V158, P865; SVED J A, 1971, Theoretical Population Biology, V2, P125; WEIR BS, 1980, GENETICS, V95, P477; Weir BS, 1996, GENETIC DATA ANAL; Young CW, 1996, J DAIRY SCI, V79, P502, DOI 10.3168/jds.S0022-0302(96)76392-0	19	300	310	0	43	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	APR	2003	13	4					635	643		10.1101/gr.387103			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	664DK	WOS:000182046300010	12654718	Green Published, Bronze			2022-01-24	
J	Sollars, V; Lu, XY; Xiao, L; Wang, XY; Garfinkel, MD; Ruden, DM				Sollars, V; Lu, XY; Xiao, L; Wang, XY; Garfinkel, MD; Ruden, DM			Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; KRUPPEL ACTIVITY; MODIFIER SCREEN; EYE DEVELOPMENT; MUTATIONS; POLYCOMB; GENES	Morphological alterations have been shown to occur in Drosophila melanogaster when function of Hsp90 (heat shock 90-kDa protein 1alpha, encoded by Hsp83) is compromised during development(1). Genetic selection maintains the altered phenotypes in subsequent generations(1). Recent experiments have shown, however, that phenotypic variation still occurs in nearly isogenic recombinant inbred strains of Arabidopsis thaliana(2). Using a sensitized isogenic D. melanogaster strain, iso-Krlf-1, we confirm this finding and present evidence supporting an epigenetic mechanism for Hsp90's capacitor function, whereby reduced activity of Hsp90 induces a heritably altered chromatin state. The altered chromatin state is evidenced by ectopic expression of the morphogen wingless in eye imaginal discs and a corresponding abnormal eye phenotype, both of which are epigenetically heritable in subsequent generations, even when function of Hsp90 is restored. Mutations in nine different genes of the trithorax group that encode chromatin-remodeling proteins also induce the abnormal phenotype. These findings suggest that Hsp90 acts as a capacitor for morphological evolution through epigenetic and genetic mechanisms.	Univ Alabama, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA		Ruden, DM (corresponding author), Univ Alabama, Dept Environm Hlth Sci, RPHB 530, Birmingham, AL 35294 USA.		Sollars, Vincent/R-3769-2019; Ruden, Douglas/ABE-1418-2021; Ruden, Douglas/A-5008-2016	Ruden, Douglas/0000-0002-0070-437X; Sollars, Vincent/0000-0002-5602-3610			Abrell S, 2000, CHROMOSOMA, V109, P334, DOI 10.1007/s004120000092; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M., 1989, DROSOPHILA LAB HDB; Bender J, 2002, CURR BIOL, V12, pR412, DOI 10.1016/S0960-9822(02)00910-7; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Dickson BJ, 1996, GENETICS, V142, P163; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Goldstein L.S.B., 1994, DROSOPHILA MELANOGAS; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; JACKLE H, 1985, COLD SPRING HARB SYM, V50, P465, DOI 10.1101/SQB.1985.050.01.058; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kohler C, 2002, CURR BIOL, V12, pR129, DOI 10.1016/S0960-9822(02)00705-4; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Mollaaghababa R, 2001, P NATL ACAD SCI USA, V98, P3958, DOI 10.1073/pnas.061497798; Paro R, 1998, CIBA F SYMP, V214, P51; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747	22	300	315	0	56	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					70	74		10.1038/ng1067			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	WOS:000180136100020	12483213				2022-01-24	
J	Lyons, LA; Laughlin, TF; Copeland, NG; Jenkins, NA; Womack, JE; OBrien, SJ				Lyons, LA; Laughlin, TF; Copeland, NG; Jenkins, NA; Womack, JE; OBrien, SJ			Comparative anchor tagged sequences (CATS) for integrative mapping of mammalian genomes	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; BOVINE GENOME; POLYMORPHISMS; MOUSE; LOCI	Precise comparisons of mammalian gene maps require common anchor loci as landmarks for conserved chromosomal segments. Using a computer script that automates DNA sequence database alignments. we designed 410 evolutionarily conserved primer pair sequences which are specific for anchor locus gene amplification from any mammalian species' DNA. Primer pairs were designed to span introns for polymorphism ascertainment. and to include sufficient exonic sequence (25-400 bp) to allow for gene identification. A total of 318 primer pairs were optimized for domestic cats, and 86% of the sequenced feline PCR products showed homology to the gene of primer origin. A screen of 20 mammals from 11 orders revealed that 35-52% of the 318 primers yielded a single PCR product without further optimization suggesting that nearly 75% can be optimized for any eutherian mammal.	NCI,FREDERICK CANC RES & DEV CTR,LAB GENOM DIVERS,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,BIOL CARCINOGENESIS & DEV PROGRAM,SAIC FREDERICK,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK,MD 21702; TEXAS A&M UNIV,DEPT VET PATHOBIOL,COLLEGE STN,TX 77843					OBRIEN, STEPHEN/0000-0001-7857-0757; Lyons, Leslie/0000-0002-1628-7726			ADAMS MD, 1995, ANTURE, V377, pS654; BARENDSE W, 1994, NAT GENET, V6, P227, DOI 10.1038/ng0394-227; BENSON DA, 1994, NUCLEIC ACIDS RES, V22, P3441, DOI 10.1093/nar/22.17.3441; BISHOP MD, 1994, GENETICS, V136, P619; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURT DW, 1995, TRENDS GENET, V11, P190, DOI 10.1016/S0168-9525(00)89042-3; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CRAWFORD AM, 1995, GENETICS, V140, P703; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; JOHANSSON M, 1995, GENOMICS, V25, P682, DOI 10.1016/0888-7543(95)80011-A; Lincoln S.E., 1991, PRIMER COMPUTER PROG; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lyons L. A., 1994, Animal Biotechnology, V5, P103, DOI 10.1080/10495399409525811; MAZZARELLA R, 1992, P NATL ACAD SCI USA, V89, P3681, DOI 10.1073/pnas.89.9.3681; NADEAU JH, 1995, NATURE, V373, P363, DOI 10.1038/373363a0; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OBRIEN SJ, 1993, GENETIC MAPS; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; WOMACK JE, 1995, CURR OPIN GENET DEV, V5, P725, DOI 10.1016/0959-437X(95)80004-O; 1996, MAMM GENOME, V7, P717	29	300	307	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					47	56		10.1038/ng0197-47			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	WOS:A1997WA37300020	8988168				2022-01-24	
J	Murakami, S; Johnson, TE				Murakami, S; Johnson, TE			A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans	GENETICS			English	Article							DNA DAMAGE; CELL-CYCLE; WILD-TYPE; MUTANTS; DROSOPHILA; LONGEVITY; LARVAE; REPAIR; LONG; SPAN	A variety of mechanisms have been proposed to explain the extension of adult life span (Age) seen in several mutants in Caenorhabditis elegans (age-1: an altered aging rate; daf-2 and daf-23: activation of a dauer-specific longevity program; spe-26: reduced fertility; clk-1: an altered biological clock). Using an assay for ultraviolet (UV) resistance in young adult hermaphrodites (survival after UV irradiation), we observed that all these Age mutants show increased resistance to UV. Moreover, mutations in daf-16 suppressed the UV resistance as well as the increased longevity of all the Age mutants. In contrast to the multiple mechanisms initially proposed, these results suggest that a single, daf-16-dependent pathway, specifies both extended life span and increased UV resistance. The mutations in daf-16 did not alter the reduced fertility of spe-26 and interestingly a daf-16 mutant is more fertile than wild type. We propose that life span and some aspects of stress resistance are jointly negatively regulated by a set of gerontogenes (genes whose alteration causes life extension) in C. elegans.			Murakami, S (corresponding author), UNIV COLORADO,INST BEHAV GENET,BOX 447,BOULDER,CO 80309, USA.		Murakami, Shin/AAQ-3454-2021	Murakami, Shin/0000-0001-8806-0611; /0000-0001-7147-8237	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R55AG008322, P01AG008761, R01AG008322] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA-00195] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-08761, AG-08322] Funding Source: Medline		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505; BAKER DG, 1985, NUCLEIC ACIDS RES, V13, P8323; BLACK HS, 1987, PHOTOCHEM PHOTOBIOL, V46, P213, DOI 10.1111/j.1751-1097.1987.tb04759.x; BRENNER S, 1974, GENETICS, V77, P71; DORMAN JB, 1995, GENETICS, V141, P1399; DUHON SA, 1996, IN PRESS DEV GENET; ELLEDGE SJ, 1989, MOL CELL BIOL, V9, P4932, DOI 10.1128/MCB.9.11.4932; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Finch C.E., 1990, LONGEVITY SENESCENCE; Friedberg, 1985, DNA REPAIR; FRIEDMAN DB, 1988, GENETICS, V118, P75; GOTTLIEB S, 1994, GENETICS, V137, P107; HARTMAN P, 1995, J GERONTOL BIOL SCI, V6, pB322; HARTMAN PS, 1989, GENETICS, V122, P379; HARTMAN PS, 1988, MUTAT RES, V208, P77, DOI 10.1016/S0165-7992(98)90003-3; HARTMAN PS, 1984, MUTAT RES, V132, P95, DOI 10.1016/0167-8817(84)90003-8; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Johnson T.E., 1984, P59; JOHNSON TE, 1988, J GERONTOL, V43, pB137, DOI 10.1093/geronj/43.5.B137; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; JOHNSTON LH, 1987, NUCLEIC ACIDS RES, V15, P5017, DOI 10.1093/nar/15.13.5017; JUNG M, 1995, SCIENCE, V268, P1619, DOI 10.1126/science.7777860; KAPELLER E, 1994, BIOESSAYS, V80, P565; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee E.T., 1992, STATISTICAL METHODS; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; MALONE EA, 1994, GENETICS, V136, P879; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MULLAART E, 1990, MUTAT RES, V237, P189, DOI 10.1016/0921-8734(90)90001-8; NORUSIS MJ, 1992, SPSS WINDOWS ADV STA; Parsell D. A, 1994, BIOL HEAT SHOCK PROT, P457; RIDDLE DL, 1981, NATURE, V290, P268; RUBY SW, 1985, MOL CELL BIOL, V5, P75, DOI 10.1128/MCB.5.1.75; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SERVICE PM, 1985, PHYSIOL ZOOL, V58, P380, DOI 10.1086/physzool.58.4.30156013; SPSS I, 1990, SPSS REF GUID; *SPSS INC, 1990, SPSS ADV STAT US GUI; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tice RR, 1985, HDB BIOL AGING, P173; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; VARKEY JP, 1995, GENE DEV, V9, P1074, DOI 10.1101/gad.9.9.1074; WEINDRUCH R, 1988, RETARDATION AGING DI; WONG A, 1995, GENETICS, V139, P1247; WOODGETT JR, 1995, CLIN EXP PHARMACOL P, V22, P281, DOI 10.1111/j.1440-1681.1995.tb01995.x	55	300	318	0	22	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	JUL	1996	143	3					1207	1218					12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU742	WOS:A1996UU74200015	8807294				2022-01-24	
J	VAN MEIR, EG; POLVERINI, PJ; CHAZIN, VR; HUANG, HJS; DETRIBOLET, N; CAVENEE, WK				VAN MEIR, EG; POLVERINI, PJ; CHAZIN, VR; HUANG, HJS; DETRIBOLET, N; CAVENEE, WK			RELEASE OF AN INHIBITOR OF ANGIOGENESIS UPON INDUCTION OF WILD-TYPE P53 EXPRESSION IN GLIOBLASTOMA CELLS	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; GENE AMPLIFICATION; SUPPRESSOR GENE; CYCLE CONTROL; CANCER; PROGRESSION; MUTATIONS; PROTEIN; PROMOTERS	The earliest genetic alteration in human astrocytoma progression is mutation of the p53 tumour suppressor gene, while one of the earliest phenotypic changes is the stimulation of neovascularization. Here, we tested the role of p53 in the angiogenic process by introducing a tetracycline-regulated wild type p53 gene into null glioblastoma cells. The parental cells expressed strong angiogenic activity while upon induction of wild type, but not mutant, p53 expression, the cells secreted a factor able to neutralize the angiogenicity of the factors produced by the parental cells as well as of basic fibroblast growth factor.	UNIV CALIF SAN DIEGO, LUDWIG INST CANC RES, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA; UNIV LAUSANNE HOSP, TUMOUR BIOL & GENET LAB, NEUROSURG SERV, CH-1011 LAUSANNE, SWITZERLAND; UNIV MICHIGAN, SCH DENT, ANN ARBOR, MI 48109 USA				Polverini, Peter/AAJ-8392-2020	Van Meir, Erwin G./0000-0003-2444-7707	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL039926] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL39926] Funding Source: Medline		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BREM S, 1972, J NATL CANCER I, V48, P347; CAVENEE WK, 1991, MUTAT RES, V247, P199, DOI 10.1016/0027-5107(91)90015-G; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOLKMAN J, 1963, CANCER, V16, P453, DOI 10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO;2-Y; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; GALL CM, 1991, ASTROCYTOMAS DIAGNOS, P241; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; GLASER BM, 1980, NATURE, V288, P483, DOI 10.1038/288483a0; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KASTAN MB, 1991, CANCER RES, V51, P6304; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Russell D., 1989, PATHOLOGY TUMORS NER; SCHWEIKI D, 1992, NATURE, V359, P843; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; VAN MEIR EG, 1994, CANCER RES, V54, P649; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	36	300	303	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					171	176		10.1038/ng1094-171			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	WOS:A1994PL12300019	7531056				2022-01-24	
J	HARLEY, HG; RUNDLE, SA; MACMILLAN, JC; MYRING, J; BROOK, JD; CROW, S; REARDON, W; FENTON, I; SHAW, DJ; HARPER, PS				HARLEY, HG; RUNDLE, SA; MACMILLAN, JC; MYRING, J; BROOK, JD; CROW, S; REARDON, W; FENTON, I; SHAW, DJ; HARPER, PS			SIZE OF THE UNSTABLE CTG REPEAT SEQUENCE IN RELATION TO PHENOTYPE AND PARENTAL TRANSMISSION IN MYOTONIC-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA	A clinical and molecular analysis of 439 individuals affected with myotonic dystrophy, from 101 kindreds, has shown that the size of the unstable CTG repeat detected in nearly all cases of myotonic dystrophy is related both to age at onset of the disorder and to the severity of the phenotype. The largest repeat sizes (1.5-6.0 kb) are seen in patients with congenital myotonic dystrophy, while the minimally affected patients have repeat sizes of <0.5 kb. Comparison of parent-child pairs has shown that most offspring have an earlier age at onset and a larger repeat size than their parents, with only 4 of 182 showing a definite decrease in repeat size, accompanied by a later age at onset or less severe phenotype. Increase in repeat size from parent to child is similar for both paternal and maternal transmissions when the increase is expressed as a proportion of the parental repeat size. Analysis of congenitally affected cases shows not only that they have, on average, the largest repeat sizes but also that their mothers have larger mean repeat sizes, supporting previous suggestions that a maternal effect is involved in the pathogenesis of this form of the disorder.			HARLEY, HG (corresponding author), UNIV WALES COLL MED,INST MED GENET,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.		MacMillan, John C/C-9591-2011	Brook, John David/0000-0002-5946-6740	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BELL J, 1947, TREASURY HUMAN INHER, V4, P343; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1991, BRAIN, V114, P2303, DOI 10.1093/brain/114.5.2303; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; HARPER PS, 1992, AM J HUM GENET, V51, P10; Harper PS, 1989, MYOTONIC DYSTROPHY, V2nd; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KOCH MC, 1991, AM J HUM GENET, V48, P1084; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PENROSE LS, 1948, ANN EUGENIC, V14, P125; REARDON W, 1992, J MED GENET, V29, P770, DOI 10.1136/jmg.29.11.770; REARDON W, 1992, AM J MED GENET, V43, P1006, DOI 10.1002/ajmg.1320430618; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	23	300	303	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1164	1174					11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	WOS:A1993LG13300018	8503448				2022-01-24	
J	TSILFIDIS, C; MACKENZIE, AE; METTLER, G; BARCELO, J; KORNELUK, RG				TSILFIDIS, C; MACKENZIE, AE; METTLER, G; BARCELO, J; KORNELUK, RG			CORRELATION BETWEEN CTG TRINUCLEOTIDE REPEAT LENGTH AND FREQUENCY OF SEVERE CONGENITAL MYOTONIC-DYSTROPHY	NATURE GENETICS			English	Article							BRITAIN	The myotonic dystrophy (DM) mutation has recently been identified as an unstable trinucleotide CTG repeat which is present 5-30 times in the normal population but which is amplified up to 2,000 times in DM. We have determined the status of the CTG repeat in 272 DM individuals. Infants with severe congenital DM, as well as their mothers, are shown to have on average a greater amplification of the CTG repeat than is seen in the noncongenital DM population. This fact, when viewed in conjunction with the tendency to increased CTG repeat length in our DM kindreds, provides evidence for the existence of genetic anticipation in the transmission of DM.	UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA K1H 8M5,ONTARIO,CANADA; UNIV OTTAWA,DEPT BIOCHEM,OTTAWA K1H 8M5,ONTARIO,CANADA; CHILDRENS HOSP EASTERN ONTARIO,OTTAWA K1H 8L1,ONTARIO,CANADA								ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DODGE PR, 1965, PEDIATRICS, V365, P3; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GLANZ A, 1984, J MED GENET, V21, P186, DOI 10.1136/jmg.21.3.186; GRIGGS RC, 1989, NEUROLOGY, V39, P420, DOI 10.1212/WNL.39.3.420; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HARPER PS, 1975, ARCH DIS CHILD, V50, P505, DOI 10.1136/adc.50.7.505; Harper PS, 1989, MYOTONIC DYSTROPHY, V2nd; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KOCH MC, 1991, AM J HUM GENET, V48, P1084; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACKENZIE AE, 1989, AM J HUM GENET, V44, P140; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; MCCOMAS AJ, 1978, J NEUROL NEUROSUR PS, V41, P882, DOI 10.1136/jnnp.41.10.882; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; TSILFIDIS C, 1991, AM J HUM GENET, V49, P961; VANIER TM, 1960, BRIT MED J, V2, P1284, DOI 10.1136/bmj.2.5208.1284; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	24	300	303	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					192	195		10.1038/ng0692-192			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	WOS:A1992JC98200011	1303233				2022-01-24	
J	SLATKIN, M				SLATKIN, M			ESTIMATING LEVELS OF GENE FLOW IN NATURAL-POPULATIONS	GENETICS			English	Article											SLATKIN, M (corresponding author), UNIV WASHINGTON,DEPT ZOOL,SEATTLE,WA 98195, USA.						AYALA FJ, 1974, GENETICS, V77, P343; BATEMAN AJ, 1947, HEREDITY, V1, P235, DOI 10.1038/hdy.1947.15; BATEMAN AJ, 1947, J GENET, V48, P257, DOI 10.1007/BF02989385; CASE SM, 1975, SYST ZOOL, V24, P281, DOI 10.2307/2412716; DUNCAN R, 1979, COPEIA, P95, DOI 10.2307/1443734; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; GILL DE, 1979, ECOLOGY, V60, P800, DOI 10.2307/1936616; GORMAN GC, 1975, EVOLUTION, V29, P52, DOI 10.1111/j.1558-5646.1975.tb00813.x; GOTTLIEB LD, 1975, EVOLUTION, V29, P213, DOI 10.1111/j.1558-5646.1975.tb00202.x; HIGHTON R, 1976, EVOLUTION, V30, P33, DOI 10.1111/j.1558-5646.1976.tb00879.x; KIMURA M, 1964, GENETICS, V49, P725; LARSON A, 1978, SYST ZOOL, V27, P431, DOI 10.2307/2412926; LEWONTIN Richard C, 1974, GENETIC BASIS EVOLUT; MAYR E., 1963, ANIMAL SPECIES EVOLU; NEI M, 1975, GENET RES, V26, P31, DOI 10.1017/S0016672300015822; PATTON JL, 1977, EVOLUTION, V31, P697, DOI 10.1111/j.1558-5646.1977.tb01064.x; SELANDER RK, 1971, U TEXAS PUBL, V7103; SINGH RS, 1979, GENETICS, V93, P997; SLATKIN M, 1980, GENETICS, V95, P503; SLATKIN M, 1978, GENETICS, V89, P793; SMITH MF, 1979, J MAMMAL, V60, P705, DOI 10.2307/1380187; Stanley S. M., 1979, MACROEVOLUTION PATTE; WINANS GA, 1980, EVOLUTION, V34, P558, DOI 10.1111/j.1558-5646.1980.tb04844.x; Wright S, 1942, GENETICS, V27, P0363; YANEV K P, 1981, Herpetologica, V37, P16; YANEV KP, 1978, THESIS U CALIFORNIA; YOKOYAMA S, 1979, GENETICS, V93, P245	27	300	324	1	27	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics		1981	99	2					323	335					13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NE833	WOS:A1981NE83300010	17249120				2022-01-24	
J	ZANNIS, VI; JUST, PW; BRESLOW, JL				ZANNIS, VI; JUST, PW; BRESLOW, JL			HUMAN APOLIPOPROTEIN-E ISOPROTEIN SUBCLASSES ARE GENETICALLY-DETERMINED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,BOSTON,MA 02115		ZANNIS, VI (corresponding author), CHILDRENS HOSP,MED CTR,BOSTON,MA 02115, USA.		Breslow, Jan L/B-7544-2008		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-15895] Funding Source: Medline		ALBERS JJ, 1978, METABOLISM, V27, P479, DOI 10.1016/0026-0495(78)90102-6; BRESLOW JL, 1977, J BIOL CHEM, V252, P2726; CAREW TE, 1976, LANCET, V1, P1315; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CURRY MD, 1976, BIOCHIM BIOPHYS ACTA, V439, P413, DOI 10.1016/0005-2795(76)90078-7; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Fredrickson D. S., 1978, METABOLIC BASIS INHE, P604; FREDRICKSON DS, 1975, ANN INTERN MED, V82, P150, DOI 10.7326/0003-4819-82-2-150; GOLDBOURT U, 1979, AM J EPIDEMIOL, V109, P296, DOI 10.1093/oxfordjournals.aje.a112683; GORDON T, 1977, ANN INTERN MED, V87, P393, DOI 10.7326/0003-4819-87-4-393; GORDON T, 1977, JAMA-J AM MED ASSOC, V238, P497, DOI 10.1001/jama.238.6.497; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HAVEL RJ, 1973, P NATL ACAD SCI USA, V70, P2015, DOI 10.1073/pnas.70.7.2015; HAZZARD WR, 1972, METABOLISM, V21, P1009, DOI 10.1016/0026-0495(72)90031-5; JAIN RS, 1979, LIFE SCI, V25, P1315, DOI 10.1016/0024-3205(79)90397-7; KUSHWAHA RS, 1978, BIOCHIM BIOPHYS ACTA, V528, P176, DOI 10.1016/0005-2760(78)90192-3; KUSHWAHA RS, 1977, ANN INTERN MED, V86, P509; MAHLEY R W, 1978, P181; MAHLEY RW, 1976, BIOCHEMISTRY-US, V15, P2979, DOI 10.1021/bi00659a007; MAHLEY RW, 1977, J LIPID RES, V18, P314; MAHLEY RW, 1975, BIOCHEMISTRY-US, V14, P2817, DOI 10.1021/bi00684a005; MARCEL YL, 1979, BIOCHIM BIOPHYS ACTA, V573, P175, DOI 10.1016/0005-2760(79)90184-X; MILLER GJ, 1975, LANCET, V1, P16; MISHKEL MA, 1975, CLIN CHIM ACTA, V58, P121, DOI 10.1016/S0009-8981(75)80004-0; NOEL SP, 1979, J CLIN INVEST, V64, P674, DOI 10.1172/JCI109508; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PAGNAN A, 1977, J LIPID RES, V18, P613; PEARSON TA, 1979, AM J EPIDEMIOL, V109, P285, DOI 10.1093/oxfordjournals.aje.a112682; RODRIGUEZ JL, 1976, ATHEROSCLEROSIS, V23, P73, DOI 10.1016/0021-9150(76)90119-2; RUDEL LL, 1979, J LIPID RES, V20, P55; SHELBURNE FA, 1974, J BIOL CHEM, V249, P1428; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; STUDIER FW, 1973, J MOL BIOL, V79, P237, DOI 10.1016/0022-2836(73)90003-X; UTERMANN G, 1979, CLIN GENET, V15, P37; UTERMANN G, 1977, CLIN GENET, V12, P139, DOI 10.1111/j.1399-0004.1977.tb00917.x; UTERMANN G, 1975, FEBS LETT, V56, P352, DOI 10.1016/0014-5793(75)81125-2; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, FEBS LETT, V101, P21, DOI 10.1016/0014-5793(79)81286-7; UTERMANN G, 1978, PROTIDES BIOL FLUIDS, P285; WARNICK GR, 1979, CLIN CHEM, V25, P279; WEIDMAN SW, 1979, J LAB CLIN MED, V93, P549; WEISGRABER KH, 1978, J BIOL CHEM, V253, P6281; ZANNIS V, 1978, J BIOL CHEM, V253, P504; ZANNIS VI, 1980, J BIOL CHEM, V255, P1759; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473; 1974, DHEW75 PUBL; 1972, TECHNICON AUTO ANAL	47	300	308	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					11	24					14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	WOS:A1981LA93000002	7468588				2022-01-24	
J	Casali, N; Nikolayevskyy, V; Balabanova, Y; Harris, SR; Ignatyeva, O; Kontsevaya, I; Corander, J; Bryant, J; Parkhill, J; Nejentsev, S; Horstmann, RD; Brown, T; Drobniewski, F				Casali, Nicola; Nikolayevskyy, Vladyslav; Balabanova, Yanina; Harris, Simon R.; Ignatyeva, Olga; Kontsevaya, Irina; Corander, Jukka; Bryant, Josephine; Parkhill, Julian; Nejentsev, Sergey; Horstmann, Rolf D.; Brown, Timothy; Drobniewski, Francis			Evolution and transmission of drug-resistant tuberculosis in a Russian population	NATURE GENETICS			English	Article							MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; NUCLEOTIDE POLYMORPHISMS; COMPENSATORY MUTATIONS; BEIJING STRAIN; GENE; ETHIONAMIDE; FITNESS; STRATEGIES; KANAMYCIN	The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.	[Casali, Nicola; Nikolayevskyy, Vladyslav; Balabanova, Yanina; Brown, Timothy; Drobniewski, Francis] Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England; [Harris, Simon R.; Bryant, Josephine; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Ignatyeva, Olga; Kontsevaya, Irina] Samara Oblast TB Dispensary, Samara, Russia; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Drobniewski, Francis] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England		Drobniewski, F (corresponding author), Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England.	f.drobniewski@qmul.ac.uk	Kontsevaya, Irina/AAJ-8173-2020; Bryant, Josephine/ABC-8288-2021; Parkhill, Julian/G-4703-2011; Harris, Simon R/K-1318-2013	Parkhill, Julian/0000-0002-7069-5958; Harris, Simon R/0000-0003-1512-6194; Kontsevaya, Irina/0000-0003-3421-7550; Drobniewski, Francis/0000-0002-5661-2490; Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Ignatyeva, Olga/0000-0003-2020-4206	European Union Framework Programme 7 (TB-EUROGEN) [201483]; Wellcome TrustWellcome TrustEuropean Commission [098051]; EUROGEN; Wellcome Trust Senior Research Fellow in Basic Biomedical ScienceWellcome Trust [095198/Z/10/Z]; European Research Council Starting GrantEuropean Research Council (ERC) [260477]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [974668] Funding Source: researchfish	We are grateful to members of the Public Health England National Mycobacterium Reference Laboratory and the Samara Regional Tuberculosis Laboratory for bacteriological work, particularly M. Stone, X. Gonzalo and A. Broda. We would also like to thank the Samara Tuberculosis Service, particularly I. Fedorin, as well as V. Kulichenko. We thank R. Hooper for expert statistical advice, S. Hoffner for bacteriological advice and S. Bentley for sequencing advice. This study was supported by European Union Framework Programme 7 (grant 201483; TB-EUROGEN), with sequencing funded by the Wellcome Trust (grant 098051) and EUROGEN. S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science (095198/Z/10/Z) and is also supported by European Research Council Starting Grant 260477.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Balabanova Y, 2005, EUR J CLIN MICROBIOL, V24, P136, DOI 10.1007/s10096-004-1268-4; Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-0003511, 10.1136/bmjopen-2011-000351]; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020531; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Cai JJ, 2008, J HERED, V99, P438, DOI 10.1093/jhered/esm127; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Hall AR, 2010, P ROY SOC B-BIOL SCI, V277, P643, DOI 10.1098/rspb.2009.1630; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Health Protection Agency, 2012, TUB UK 2012 REP; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nei M., 1987, MOL EVOLUTIONARY GEN; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reynolds MG, 2000, GENETICS, V156, P1471; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shen X, 2007, ANTIMICROB AGENTS CH, V51, P2618, DOI 10.1128/AAC.01516-06; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000455; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; Wu SP, 2009, MICROBIOL-SGM, V155, P1272, DOI 10.1099/mic.0.024638-0; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	64	299	311	1	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					279	+		10.1038/ng.2878			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	WOS:000332036700012	24464101	Green Accepted, Green Submitted			2022-01-24	
J	Wagner, JR; Busche, S; Ge, B; Kwan, T; Pastinen, T; Blanchette, M				Wagner, James R.; Busche, Stephan; Ge, Bing; Kwan, Tony; Pastinen, Tomi; Blanchette, Mathieu			The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts	GENOME BIOLOGY			English	Article							HUMAN GENOME; PATTERNS; SITES	Background: DNA methylation plays an essential role in the regulation of gene expression. While its presence near the transcription start site of a gene has been associated with reduced expression, the variation in methylation levels across individuals, its environmental or genetic causes, and its association with gene expression remain poorly understood. Results: We report the joint analysis of sequence variants, gene expression and DNA methylation in primary fibroblast samples derived from a set of 62 unrelated individuals. Approximately 2% of the most variable CpG sites are mappable in cis to sequence variation, usually within 5 kb. Via eQTL analysis with microarray data combined with mapping of allelic expression regions, we obtained a set of 2,770 regions mappable in cis to sequence variation. In 9.5% of these expressed regions, an associated SNP was also a methylation QTL. Methylation and gene expression are often correlated without direct discernible involvement of sequence variation, but not always in the expected direction of negative for promoter CpGs and positive for gene-body CpGs. Population-level correlation between methylation and expression is strongest in a subset of developmentally significant genes, including all four HOX clusters. The presence and sign of this correlation are best predicted using specific chromatin marks rather than position of the CpG site with respect to the gene. Conclusions: Our results indicate a wide variety of relationships between gene expression, DNA methylation and sequence variation in untransformed adult human fibroblasts, with considerable involvement of chromatin features and some discernible involvement of sequence variation.	[Busche, Stephan; Kwan, Tony; Pastinen, Tomi] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G1, Canada; [Busche, Stephan; Ge, Bing; Kwan, Tony; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Wagner, James R.; Blanchette, Mathieu] McGill Univ, Sch Comp Sci, Montreal, PQ H3A 0E9, Canada		Pastinen, T (corresponding author), McGill Univ, Dept Human Genet, 740 Dr Penfield Ave,Room 6202, Montreal, PQ H3A 0G1, Canada.	tomi.pastinen@mcgill.ca; blanchem@cs.mcgill.ca			Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-111246]; Natural Science and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [EP1-120608]; Canada Research Chair Tier 2 award; Reseau de Medecine Genetique Appliquee (RMGA)	We thank Mathieu Lavallee-Adam for useful discussions. This work was supported by Canadian Institute of Health Research grants MOP-111246 awarded to TP and EP1-120608 awarded to TP and MB, and by a Natural Science and Engineering Research Council of Canada (NSERC) Discovery grant to MB. TP is a recipient of a Canada Research Chair Tier 2 award. SB is a recipient of a postdoctoral fellowship from the Reseau de Medecine Genetique Appliquee (RMGA). JRW is an NSERC Postgraduate Doctoral Scholar and a Walter C Sumner Memorial Fellow.	Almlof JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052260; Baylin SB, 1998, ADV CANCER RES, V72, P141; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Johnson Michelle D, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2123s99; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wagner JR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000849; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Xiang L, 2013, ONCOL LETT, V5, P735, DOI 10.3892/ol.2013.1121; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	39	299	299	0	25	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-6906	1474-760X		GENOME BIOL	Genome Biol.		2014	15	2							R37	10.1186/gb-2014-15-2-r37			17	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	AH6QU	WOS:000336256600020	24555846	Green Published, hybrid			2022-01-24	
J	Jiang, YH; Yuen, RKC; Wang, MB; Jin, X; Chen, N; Wu, XL; Ju, J; Mei, JP; Shi, YJ; He, MZ; Wang, GB; Liang, JQ; Wang, Z; Cao, DD; Carter, MT; Chrysler, C; Drmic, IE; Howe, JL; Lau, L; Marshall, CR; Merico, D; Nalpathamkalam, T; Thiruvahindrapuram, B; Thompson, A; Uddin, M; Walker, S; Luo, J; Anagnostou, E; Zwaigenbaum, L; Ring, RH; Wang, J; Lajonchere, C; Wang, J; Shih, A; Szatmari, P; Yang, HM; Dawson, G; Li, YR; Scherer, SW				Jiang, Yong-hui; Yuen, Ryan K. C.; Wang, Mingbang; Jin, Xin; Chen, Nong; Wu, Xueli; Ju, Jia; Mei, Junpu; Shi, Yujian; He, Mingze; Wang, Guangbiao; Liang, Jieqin; Wang, Zhe; Cao, Dandan; Carter, Melissa T.; Chrysler, Christina; Drmic, Irene E.; Howe, Jennifer L.; Lau, Lynette; Marshall, Christian R.; Merico, Daniele; Nalpathamkalam, Thomas; Thiruvahindrapuram, Bhooma; Thompson, Ann; Uddin, Mohammed; Walker, Susan; Luo, Jun; Anagnostou, Evdokia; Zwaigenbaum, Lonnie; Ring, Robert H.; Wang, Jian; Lajonchere, Clara; Wang, Jun; Shih, Andy; Szatmari, Peter; Yang, Huanming; Dawson, Geraldine; Li, Yingrui; Scherer, Stephen W.			Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; COPY NUMBER VARIATIONS; INTELLECTUAL DISABILITY; STRUCTURAL VARIATION; FUNCTIONAL IMPACT; KALLMANN-SYNDROME; CHARGE SYNDROME; LARGE-SCALE; EXOME; RISK	Autism Spectrum Disorder (ASD) demonstrates high heritability and familial clustering, yet the genetic causes remain only partially understood as a result of extensive clinical and genomic heterogeneity. Whole-genome sequencing (WGS) shows promise as a tool for identifying ASD risk genes as well as unreported mutations in known loci, but an assessment of its full utility in an ASD group has not been performed. We used WGS to examine 32 families with ASD to detect de novo or rare inherited genetic variants predicted to be deleterious (loss-of-function and damaging missense mutations). Among ASD probands, we identified deleterious de novo mutations in six of 32 (19%) families and X-linked or autosomal inherited alterations in ten of 32 (31%) families (some had combinations of mutations). The proportion of families identified with such putative mutations was larger than has been previously reported; this yield was in part due to the comprehensive and uniform coverage afforded by WGS. Deleterious variants were found in four unrecognized, nine known, and eight candidate ASD risk genes. Examples include CAPRIN1 and AFF2 (both linked to FMR1, which is involved in fragile X syndrome), VIP (involved in social-cognitive deficits), and other genes such as SCN2A and KCNQ2 (linked to epilepsy), NRXN1, and CHD7, which causes ASD-associated CHARGE syndrome. Taken together, these results suggest that WGS and thorough bioinformatic analyses for de novo and rare inherited mutations will improve the detection of genetic variants likely to be associated with ASD or its accompanying clinical symptoms.	[Jiang, Yong-hui] Duke Univ, Sch Med, Dept Paediat & Neurobiol, Durham, NC 27710 USA; [Yuen, Ryan K. C.; Howe, Jennifer L.; Lau, Lynette; Marshall, Christian R.; Merico, Daniele; Nalpathamkalam, Thomas; Thiruvahindrapuram, Bhooma; Uddin, Mohammed; Walker, Susan; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G IL7, Canada; [Jin, Xin; Chen, Nong; Wu, Xueli; Ju, Jia; Mei, Junpu; Shi, Yujian; He, Mingze; Wang, Guangbiao; Liang, Jieqin; Wang, Zhe; Cao, Dandan; Wang, Jian; Wang, Jun; Yang, Huanming; Li, Yingrui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Jin, Xin] Childrens Hosp Philadelphia, BGI CHOP, Philadelphia, PA 19104 USA; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Carter, Melissa T.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON MSG 2L3, Canada; [Chrysler, Christina; Drmic, Irene E.; Thompson, Ann; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4K1, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S IA1, Canada; [Luo, Jun] Natl Supercomp Ctr Tianjin, Tianjin 300457, Peoples R China; [Anagnostou, Evdokia] Univ Toronto, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T5G 0B7, Canada; [Ring, Robert H.; Lajonchere, Clara; Shih, Andy; Dawson, Geraldine] Autism Speaks, New York, NY 10016 USA; [Wang, Jun] Univ Copenhagen, Fac Hlth Sci, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia; [Wang, Jun] Aarhus Univ, Ctr iSequencing, DK-8000 Aarhus C, Denmark; [Dawson, Geraldine] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27510 USA		Li, YR (corresponding author), BGI Shenzhen, Bei Shan Rd, Shenzhen 518083, Peoples R China.	liyr@genomics.cn; stephen.scherer@sickkids.ca	Wang, Jun/A-7261-2013; Yuen, Ryan/J-4876-2012; Ring, Robert/M-1238-2016; Jin, Xin/ABF-1329-2020; Scherer, Stephen W/B-3785-2013; Li, Yingrui/K-1064-2015; Wang, Mingbang/F-4457-2018; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Yuen, Ryan/0000-0001-7273-4968; Ring, Robert/0000-0002-7037-4409; Scherer, Stephen W/0000-0002-8326-1999; Wang, Mingbang/0000-0002-5989-5377; Merico, Daniele/0000-0002-3728-4401; CAO, Dandan/0000-0003-2899-8813; He, Mingze/0000-0002-8164-2480; Dawson, Geraldine/0000-0003-1410-2764; Uddin, Mohammed/0000-0001-6867-5803; Jin, Xin/0000-0001-7554-4975; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	Autism Speaks; Autism Speaks Canada; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIMH R01MH098114-01]; National Science and Technology Ministry Project 973 program [2011CB809200]; National Science and Technology Ministry Project 863 program [2012AA02A201]; National Natural Science Foundation of China Major Program [30890032]; Shenzhen Municipal Government of China [CXB201108250094A, CXB201108250096A, ZYC200903240080A, ZYC201105170397A, ZYC201105170394A]; Enterprise Key Laboratory; Guangdong Province (the Guangdong Enterprise Key Laboratory of Human Disease Genomics); Shenzhen Key Laboratory of Gene Bank for National Life Science (National Gene Bank Project of China); NeuroDevNet; Canadian Institutes for Advanced Research; University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics InstituteGenome Canada; government of Ontario; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Hospital for Sick Children Foundation; Autism Speaks Postdoctoral Fellowship in Translational Research; NovartisNovartis; Seaside Therapeutics; Sanofi CanadaSanofi-Aventis; SynaptDx; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH098114] Funding Source: NIH RePORTER	We thank Dr. Bernie Devlin for guidance in study design, the families for their participation, The Centre for Applied Genomics, and BGI-Shenzhen This work was supported by Autism Speaks, Autism Speaks Canada, the National Institutes of Health (NIMH R01MH098114-01), the National Science and Technology Ministry Project 973 program (2011CB809200), the National Science and Technology Ministry Project 863 program (2012AA02A201), the National Natural Science Foundation of China Major Program (30890032), the Shenzhen Municipal Government of China (CXB201108250094A, CXB201108250096A, ZYC200903240080A, ZYC201105170397A, and ZYC201105170394A), the Enterprise Key Laboratory supported by Guangdong Province (the Guangdong Enterprise Key Laboratory of Human Disease Genomics), Shenzhen Key Laboratory of Gene Bank for National Life Science (National Gene Bank Project of China), NeuroDevNet, the Canadian Institutes for Advanced Research, the University of Toronto McLaughlin Centre, Genome Canada/Ontario Genomics Institute, the government of Ontario, the Canadian Institutes of Health Research, and The Hospital for Sick Children Foundation. R.K.C.Y. holds an Autism Speaks Postdoctoral Fellowship in Translational Research. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children. S.W.S. is on the Scientific Advisory Board of Population Diagnositics (a US Company) and is a founding scientist of YouNique Genomics, both of which could use data from this study. E.A. has received consultation fees from Novartis and Seaside Therapeutics. She has also received an unrestricted grant from Sanofi Canada and has received research funding from SynaptDx. G.D. is on the Professional Advisory Board for Integragen Inc.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chaudhury D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-63; Chu A, 2010, MOL PHARMACOL, V77, P95, DOI 10.1124/mol.109.060137; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; EDWARDS BM, 1995, INT J PEDIATR OTORHI, V33, P23, DOI 10.1016/0165-5876(95)01188-H; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; GeneReviews Pallais J.C., 2011, KALLMANN SYNDROME; Gillberg C, 2006, J AUTISM DEV DISORD, V36, P429, DOI 10.1007/s10803-006-0081-6; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; HARDELIN JP, 1993, HUM MOL GENET, V2, P373, DOI 10.1093/hmg/2.4.373; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johansson M, 2010, RES DEV DISABIL, V31, P9, DOI 10.1016/j.ridd.2009.07.011; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Kirkness EF, 2013, GENOME RES, V23, P826, DOI 10.1101/gr.144600.112; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mosca-Boidron AL, 2013, AM J MED GENET A, V161A, P1505, DOI 10.1002/ajmg.a.35878; Nava C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.102; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rogers SJ, 2012, J AM ACAD CHILD PSY, V51, P1052, DOI 10.1016/j.jaac.2012.08.003; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Trider CL, 2012, INT J PEDIATR OTORHI, V76, P947, DOI 10.1016/j.ijporl.2012.02.061; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Vervloed MPJ, 2006, AM J MED GENET A, V140A, P851, DOI 10.1002/ajmg.a.31193; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wisniowiecka-Kowalnik B, 2010, AM J MED GENET B, V153B, P983, DOI 10.1002/ajmg.b.31064; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	90	299	308	4	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					249	263		10.1016/j.ajhg.2013.06.012			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	WOS:000323186200005	23849776	Green Published, hybrid			2022-01-24	
J	Lopez-Herrera, G; Tampella, G; Pan-Hammarstrom, Q; Herholz, P; Trujillo-Vargas, CM; Phadwal, K; Simon, AK; Moutschen, M; Etzioni, A; Mory, A; Srugo, I; Melamed, D; Hultenby, K; Liu, CH; Baronio, M; Vitali, M; Philippet, P; Dideberg, V; Aghamohammadi, A; Rezaei, N; Enright, V; Du, LK; Salzer, U; Eibel, H; Pfeifer, D; Veelken, H; Stauss, H; Lougaris, V; Plebani, A; Gertz, EM; Schaffer, AA; Hammarstrom, L; Grimbacher, B				Lopez-Herrera, Gabriela; Tampella, Giacomo; Pan-Hammarstrom, Qiang; Herholz, Peer; Trujillo-Vargas, Claudia M.; Phadwal, Kanchan; Simon, Anna Katharina; Moutschen, Michel; Etzioni, Amos; Mory, Adi; Srugo, Izhak; Melamed, Doron; Hultenby, Kjell; Liu, Chonghai; Baronio, Manuela; Vitali, Massimiliano; Philippet, Pierre; Dideberg, Vinciane; Aghamohammadi, Asghar; Rezaei, Nima; Enright, Victoria; Du, Likun; Salzer, Ulrich; Eibel, Hermann; Pfeifer, Dietmar; Veelken, Hendrik; Stauss, Hans; Lougaris, Vassilios; Plebani, Alessandro; Gertz, E. Michael; Schaeffer, Alejandro A.; Hammarstrom, Lennart; Grimbacher, Bodo			Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and Autoimmunity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; X-LINKED AGAMMAGLOBULINEMIA; SELECTIVE IGA DEFICIENCY; LARGE COHORT; AUTOPHAGY; PROTEIN; GENE; FAMILY; PATHOGENESIS; LINKAGE	Most autosomal genetic causes of childhood-onset hypogammaglobulinemia are currently not well understood. Most affected individuals are simplex cases, but both autosomal-dominant and autosomal-recessive inheritance have been described. We performed genetic linkage analysis in consanguineous families affected by hypogammaglobulinemia. Four consanguineous families with childhood-onset humoral immune deficiency and features of autoimmunity shared genotype evidence for a linkage interval on chromosome 4q. Sequencing of positional candidate genes revealed that in each family, affected individuals had a distinct homozygous mutation in LRBA (lipopolysaccharide responsive beige-like anchor protein). All LRBA mutations segregated with the disease because homozygous individuals showed hypogammaglobulinemia and autoimmunity, whereas heterozygous individuals were healthy. These mutations were absent in healthy controls. Individuals with homozygous LRBA mutations had no LRBA, had disturbed B cell development, defective in vitro B cell activation, plasmablast formation, and immunoglobulin secretion, and had low proliferative responses. We conclude that mutations in LRBA cause an immune deficiency characterized by defects in B cell activation and autophagy and by susceptibility to apoptosis, all of which are associated with a clinical phenotype of hypogammaglobulinemia and autoimmunity.	[Lopez-Herrera, Gabriela; Trujillo-Vargas, Claudia M.; Enright, Victoria; Stauss, Hans; Grimbacher, Bodo] UCL, Royal Free Hosp, Div Infect & Immun, Dept Immunol, London NW3 2QG, England; [Lopez-Herrera, Gabriela] Natl Inst Pediat, Immunodeficiency Res Unit, Mexico City 04530, DF, Mexico; [Tampella, Giacomo; Baronio, Manuela; Vitali, Massimiliano; Lougaris, Vassilios; Plebani, Alessandro] Univ Brescia, Pediat Clin, Spedali Civili Brescia, I-25123 Brescia, Italy; [Tampella, Giacomo; Baronio, Manuela; Vitali, Massimiliano; Lougaris, Vassilios; Plebani, Alessandro] Univ Brescia, Inst Mol Med A Novicelli, Spedali Civili Brescia, I-25123 Brescia, Italy; [Pan-Hammarstrom, Qiang; Hultenby, Kjell; Liu, Chonghai; Du, Likun; Hammarstrom, Lennart] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, SE-14186 Stockholm, Sweden; [Herholz, Peer; Salzer, Ulrich; Eibel, Hermann; Grimbacher, Bodo] Univ Med Ctr, Ctr Chron Immunodeficiency, D-79108 Freiburg, Germany; [Trujillo-Vargas, Claudia M.] Univ Antioquia, Grp Primary Immunodeficiencies, Medellin 1226, Colombia; [Phadwal, Kanchan; Simon, Anna Katharina] Univ Oxford, Biomed Res Ctr Translat Immunol Lab, Natl Inst Hlth Res, Nuffield Dept Med,John Radcliffe Hosp, Oxford OX3 9DS, England; [Simon, Anna Katharina] Univ Oxford, Medcial Res Council Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Moutschen, Michel] Univ Liege, Ctr Immunol, Lab Immunoendocrinol, Inst Pathol, B-4000 Liege, Belgium; [Etzioni, Amos; Mory, Adi; Srugo, Izhak; Melamed, Doron] Technion Israel Inst Technol, Rappaport Sch Med, Div Pediat & Immunol, IL-31096 Haifa, Israel; [Liu, Chonghai] N Sichuan Med Coll, Affiliated Hosp, Dept Pediat, Nanchong 637000, Sichuan, Peoples R China; [Philippet, Pierre] Ctr Hosp Chretien Esperance, Dept Pediat, B-4420 Montegnee, Belgium; [Dideberg, Vinciane] Univ Liege, Ctr Human Genet, B-4000 Liege, Belgium; [Aghamohammadi, Asghar] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Res Ctr Immunodeficiencies, Tehran 14194, Iran; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Mol Immunol Res Ctr, Tehran 14194, Iran; [Rezaei, Nima] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran 14194, Iran; [Pfeifer, Dietmar] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Hematol, NL-2300 RC Leiden, Netherlands; [Gertz, E. Michael; Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20894 USA		Grimbacher, B (corresponding author), UCL, Royal Free Hosp, Div Infect & Immun, Dept Immunol, London NW3 2QG, England.	bodo.grimbacher@uniklinik-freiburg.de	HERRERA, GABRIELA/AAL-1781-2021; Schaffer, Alejandro A/F-2902-2012; Rezaei, Nima/B-4245-2008; hammarstrom, qiang pan/ABA-4589-2021; Schaffer, Alejandro/N-1222-2019	Rezaei, Nima/0000-0002-3836-1827; Phadwal, Kanchan/0000-0001-6745-9818; Moutschen, Michel/0000-0002-6405-1785; Du, Likun/0000-0002-8448-2187; Simon, Anna Katharina/0000-0002-4077-7995; Veelken, Hendrik/0000-0002-9108-3125; pan-hammarstrom, qiang/0000-0003-1990-8804; Salzer, Ulrich/0000-0002-1769-1157; Gertz, E. Michael/0000-0001-8390-4387; Aghamohammadi, Asghar/0000-0002-9454-1603	German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01 EO 0803]; European CommunityEuropean Commission [HEALTH-F2-2008-201549, Health-F5-2008-223292]; Marie Curie Excellence GrantEuropean Commission [MEXT-CT-2006-042316]; European Research CouncilEuropean Research Council (ERC)European Commission [24511-ImmunoSwitch]; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Cancer SocietySwedish Cancer Society; Glaxo-Smith-KlineGlaxoSmithKline; Fondazione C. Golgi, Brescia; Associazione Italiana Immunodeficienze Primitive; National Institutes of Health, National Library of Medicine, USA; CONACyT, MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [93910]; Leukaemia and Lymphoma Research UK; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; National Institute for Health Research Biomedical Research Centre, Oxford, UKNational Institute for Health Research (NIHR); BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G021422/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0900950] Funding Source: UKRI; Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G021422/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0900950B, G0900950] Funding Source: researchfish; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [ZIALM000097] Funding Source: NIH RePORTER	The authors wish to thank Sary Workman, Astrid Petersen, Fariba Tahami, Eira Rawlings, Judy Levin, Charlotte Holden, and Francisco Espinosa Rosales for their assistance. This study was supported by the German Federal Ministry of Education and Research (BMBF 01 EO 0803). The research was funded in part by the European Community's 6th and 7th Framework Programmes FP7/2007-2013 under grant agreements HEALTH-F2-2008-201549 (EURO-PADnet) and Health-F5-2008-223292 (Euro Gene Scan) and by a Marie Curie Excellence Grant to B.G. (MEXT-CT-2006-042316, MC-PIAID); European Research Council starting grant (24511-ImmunoSwitch); grants from the Swedish Research Council and Swedish Cancer Society; a Glaxo-Smith-Kline grant managed by the Primary Immunodeficiency Association UK; and a grant from the Fondazione C. Golgi, Brescia, and Associazione Italiana Immunodeficienze Primitive. This research is also supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, USA. Gabriela Lopez-Herrera received partial scholarship 93910 from CONACyT, Mexico. Giacomo Tampella is a PhD student of a joint PhD program of the Universities of Brescia and Trieste, Italy. Hans Stauss was supported by grants from Leukaemia and Lymphoma Research UK and from the Medical Research Council. Kanchan Phadwal and Anna Katharina Simon were supported by the National Institute for Health Research Biomedical Research Centre, Oxford, UK.	AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Aghamohammadi A, 2008, INT ARCH ALLERGY IMM, V147, P87, DOI 10.1159/000135694; Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Ballabio A, 2009, INT J CLIN PHARM TH, V47, pS34; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Conley ME, 2005, IMMUNOL REV, V203, P216, DOI 10.1111/j.0105-2896.2005.00233.x; Cuervo AM, 2010, NAT CELL BIOL, V12, P735, DOI 10.1038/ncb0810-735; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; De Lozanne A, 2003, TRAFFIC, V4, P6, DOI 10.1034/j.1600-0854.2003.40102.x; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Dyomin VG, 2002, GENOMICS, V80, P158, DOI 10.1006/geno.2002.6822; Ehrlich M, 2008, AUTOIMMUNITY, V41, P253, DOI 10.1080/08916930802024202; ELIN RJ, 1974, INFECT IMMUN, V10, P88, DOI 10.1128/IAI.10.1.88-91.1974; Farhoudi Abolhasan, 2003, Iran J Allergy Asthma Immunol, V2, P189; FEUCHTER AE, 1992, GENOMICS, V13, P1237, DOI 10.1016/0888-7543(92)90041-P; Finck A, 2006, EUR J HUM GENET, V14, P867, DOI 10.1038/sj.ejhg.5201634; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim A, 2009, J NEUROSCI, V29, P951, DOI 10.1523/JNEUROSCI.2582-08.2009; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Phadwal K, 2012, AUTOPHAGY, V8, P677, DOI 10.4161/auto.18935; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Plebani A, 2002, CLIN IMMUNOL, V104, P221, DOI 10.1006/clim.2002.5241; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Quinti I, 2007, J CLIN IMMUNOL, V27, P308, DOI 10.1007/s10875-007-9075-1; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2009, BLOOD, V113, P1967, DOI 10.1182/blood-2008-02-141937; Schaffer AA, 2006, HUM GENET, V118, P725, DOI 10.1007/s00439-005-0101-1; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Segui B, 1999, J BIOL CHEM, V274, P37251, DOI 10.1074/jbc.274.52.37251; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tsang WH, 2009, GENOMICS, V94, P177, DOI 10.1016/j.ygeno.2009.05.009; van der Burg M, 2011, EUR J PEDIATR, V170, P561, DOI 10.1007/s00431-011-1452-3; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; Wang JW, 2004, ONCOGENE, V23, P4089, DOI 10.1038/sj.onc.1207567; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586; Wang XL, 2000, J NEUROSCI, V20, P8551; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Warren HS, 2011, J IMMUNOL METHODS, V370, P86, DOI 10.1016/j.jim.2011.06.002; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7	75	299	315	3	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					986	1001		10.1016/j.ajhg.2012.04.015			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	WOS:000305262600005	22608502	Green Published, hybrid			2022-01-24	
J	Pansuriya, TC; van Eijk, R; d'Adamo, P; van Ruler, MAJH; Kuijjer, ML; Oosting, J; Cleton-Jansen, AM; van Oosterwijk, JG; Verbeke, SLJ; Meijer, D; van Wezel, T; Nord, KH; Sangiorgi, L; Toker, B; Liegl-Atzwanger, B; San-Julian, M; Sciot, R; Limaye, N; Kindblom, LG; Daugaard, S; Godfraind, C; Boon, LM; Vikkula, M; Kurek, KC; Szuhai, K; French, PJ; Bovee, JVMG				Pansuriya, Twinkal C.; van Eijk, Ronald; d'Adamo, Pio; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Nord, Karolin H.; Sangiorgi, Luca; Toker, Berkin; Liegl-Atzwanger, Bernadette; San-Julian, Mikel; Sciot, Raf; Limaye, Nisha; Kindblom, Lars-Gunnar; Daugaard, Soeren; Godfraind, Catherine; Boon, Laurence M.; Vikkula, Miikka; Kurek, Kyle C.; Szuhai, Karoly; French, Pim J.; Bovee, Judith V. M. G.			Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome	NATURE GENETICS			English	Article							GENOME-WIDE ANALYSIS; ACTIVATING MUTATIONS; OSTERIX EXPRESSION; FIBROUS DYSPLASIA; IN-VITRO; CHONDROSARCOMA; LINE; DLX5; DIFFERENTIATION; ESTABLISHMENT	Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions). In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors. Fourteen of 16 subjects had identical mutations in separate lesions. Immunohistochemistry to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes. Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.	[Pansuriya, Twinkal C.; van Eijk, Ronald; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Bovee, Judith V. M. G.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [d'Adamo, Pio] Univ Trieste, Inst Maternal & Child Hlth, Inst Ricovero & Cura Carattere Sci, Trieste, Italy; [Verbeke, Sofie L. J.] Univ Antwerp Hosp, Dept Pathol, Antwerp, Belgium; [Nord, Karolin H.] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Sangiorgi, Luca] Rizzoli Orthoped Inst, Dept Med Genet, Bologna, Italy; [Toker, Berkin] Istanbul Univ, Sch Med, Istanbul, Turkey; [Liegl-Atzwanger, Bernadette] Med Univ, Inst Pathol, Graz, Austria; [San-Julian, Mikel] Univ Navarra Clin, Dept Orthopaed Surg & Traumatol, Pamplona, Spain; [Sciot, Raf; Boon, Laurence M.; Vikkula, Miikka] Katholieke Univ Leuven, Dept Pathol, Louvain, Belgium; [Limaye, Nisha] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Kindblom, Lars-Gunnar] Royal Orthopaed Hosp, Dept Musculoskeletal Pathol, Birmingham B31 2AP, W Midlands, England; [Daugaard, Soeren] Univ Copenhagen, Dept Pathol, Copenhagen, Denmark; [Godfraind, Catherine] Catholic Univ Louvain, Pathol Lab, Clin Univ St Luc, B-1200 Brussels, Belgium; [Boon, Laurence M.] Catholic Univ Louvain, Div Plast Surg, Clin Univ St Luc, Ctr Vasc Anomalies, B-1200 Brussels, Belgium; [Kurek, Kyle C.] Harvard Univ, Sch Med, Dept Pathol, Childrens Hosp Boston, Boston, MA 02115 USA; [Szuhai, Karoly] Leiden Univ, Dept Mol & Cell Biol, Med Ctr, Leiden, Netherlands; [French, Pim J.] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Vikkula, Miikka] Catholic Univ Louvain, Walloon Excellence Lifesci & Biotechnol WELBIO, B-1200 Brussels, Belgium		Bovee, JVMG (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	J.V.M.G.Bovee@lumc.nl	van Wezel, Tom/AAL-5626-2021; Szuhai, Karoly/A-1100-2008; van Wezel, Tom/Z-3092-2019; kuijjer, marieke/AAG-5844-2019; d'Adamo, Adamo Pio/G-4064-2011; Vikkula, Miikka/Q-1038-2018; van Wezel, Tom/A-9599-2008	Szuhai, Karoly/0000-0002-1228-4245; van Wezel, Tom/0000-0001-5773-7730; kuijjer, marieke/0000-0001-6280-3130; d'Adamo, Adamo Pio/0000-0001-9367-4909; Vikkula, Miikka/0000-0002-6236-338X; van Wezel, Tom/0000-0001-5773-7730; sciot, raf/0000-0003-2244-5839; Hansen Nord, Karolin/0000-0002-2397-2254; Bovee, Judith/0000-0003-1155-0481; van Eijk, Ronald/0000-0001-7955-6295; van Oosterwijk, Jolieke/0000-0003-2282-6121; French, Pim/0000-0002-0668-9529	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [917-76-315]; Liddy Shriver Sarcoma Initiative; Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, networkBelgian Federal Science Policy Office [6/05]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AR048564]; FNRS-Fonds de la Recherche ScientifiqueFonds de la Recherche Scientifique - FNRS; Manton Center for Orphan Disease Research at Children's Hospital Boston [94824-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01AR048564] Funding Source: NIH RePORTER	We are grateful to all of the participants and their families for taking part in this study. We would like to thank S. Romeo and C.M.A. Reijnders for providing DNA from cartilage tumors. We are grateful to A.B. Mohseny for help with statistics, to D. van der Geest and T. Krenacs for constructing TMAs and to P. Wijers-Koster, D. de Jong, B. van den Akker, R. Duim, M. Winter, I.H. Briaire-de Bruijn and M.E. Bowen for expert technical assistance. C.J.F. Waaijer, P.C.W. Hogendoorn and C.E. de Andrea are acknowledged for fruitful discussion. We would like to acknowledge F. Bertoni, E.L. Staals and P. Bacchini for kindly providing peripheral dedifferentiated chondrosarcomas and vascular tumors, T. Kalinski for the C3842 cell line, M. Namba for the OUMS27 cell line, T. Ariizumi for the NDCS1 cell line and A. Llombart Bosch for the CH2879 cell line. J. Mulliken, J. Upton and S. Fishman kindly provided spindle cell hemangiomas. S.H.M. Verdegaal, A.H.M. Taminiau and M.A.J. van de Sande are acknowledged for contributing patient data. We are thankful to S. Boeuf, R. Forsyth and P.P. Mainil-Varlet for providing single Ollier disease cases and to W. Wutys for providing a single metachondromatosis case. The continuous support of the Netherlands Committee on Bone Tumors is highly acknowledged. The study was funded by The Netherlands Organization for Scientific Research (917-76-315 to J.V.M.G.B. and T.C.P.), the Liddy Shriver Sarcoma Initiative (to J.V.M.G.B. and J.O.), the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05, the US National Institutes of Health (AR048564) and the FNRS-Fonds de la Recherche Scientifique (all to M.V.) and the Manton Center for Orphan Disease Research at Children's Hospital Boston (94824-01 to K.K.). The study was performed within the EuroBoNeT, a European Commission-granted Network of Excellence for studying the pathology and genetics of bone tumors (018814).	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Bovee JVMG, 2010, P NATL ACAD SCI USA, V107, P1813, DOI 10.1073/pnas.0914431107; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Chin HJ, 2007, DEV GROWTH DIFFER, V49, P515, DOI 10.1111/j.1440-169x.2007.00940.x; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Cohen MM, 2001, AM J MED GENET, V98, P290, DOI 10.1002/1096-8628(20010201)98:4<290::AID-AJMG1112>3.0.CO;2-F; Collinson M, 2010, AM J MED GENET A, V152A, P3124, DOI 10.1002/ajmg.a.33567; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Andrea C.E., 2011, ONCOGENE        0801, DOI [10.1038/onc.2011.311, DOI 10.1038/ONC.2011.311]; de Andrea CE, 2011, J PATHOL, V224, P160, DOI 10.1002/path.2886; EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gaal J, 2010, J CLIN ENDOCR METAB, V95, P1274, DOI 10.1210/jc.2009-2170; Gil-Benso R, 2003, LAB INVEST, V83, P877, DOI 10.1097/01.LAB.0000073131.34648.EA; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Ikota H, 2011, BRAIN TUMOR PATHOL, V28, P107, DOI 10.1007/s10014-010-0016-y; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; Kalfa N, 2006, J CLIN ENDOCR METAB, V91, P1842, DOI 10.1210/jc.2005-2710; Kalinski T, 2005, VIRCHOWS ARCH, V446, P287, DOI 10.1007/s00428-004-1194-y; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kudo N, 2007, VIRCHOWS ARCH, V451, P691, DOI 10.1007/s00428-007-0426-3; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Leyva-Carmona M, 2009, J PEDIAT HEMATOL ONC, V31, P304, DOI 10.1097/MPH.0b013e318196a70e; Lietman SA, 2005, J BONE JOINT SURG AM, V87A, P2489, DOI 10.2106/JBJS.E.00160; LUCAS DR, 2002, WHO CLASSIFICATION T, P237; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meijer D, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-5; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, GENE CHROMOSOME CANC, V50, P673, DOI 10.1002/gcc.20889; Pansuriya TC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-2; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ranger A, 2009, NEUROSURGERY, V65, P1106, DOI 10.1227/01.NEU.0000356984.92242.D5; Reijnders CMA, 2010, AM J PATHOL, V177, P1946, DOI 10.2353/ajpath.2010.100296; Rietveld L, 2009, INT J GYNECOL PATHOL, V28, P464, DOI 10.1097/PGP.0b013e3181a05af4; Rozeman LB, 2004, HUM MUTAT, V24, P466, DOI 10.1002/humu.20095; Rozeman LB, 2009, MODERN PATHOL, V22, P1489, DOI 10.1038/modpathol.2009.120; SCHWARTZ HS, 1987, J BONE JOINT SURG AM, V69A, P269, DOI 10.2106/00004623-198769020-00016; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; SPRANGER J, 1978, PEDIATR RADIOL, V7, P215, DOI 10.1007/BF02386711; Szuhai K, 2011, HUM MUTAT, V32, pE2036, DOI 10.1002/humu.21423; Thomas DM, 2011, J PATHOL, V224, P306, DOI 10.1002/path.2928; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Verbeke SLJ, 2011, HISTOPATHOLOGY, V58, P254, DOI 10.1111/j.1365-2559.2011.03750.x; Verdegaal S.H.M., 1961, ONCOLOGIST IN PRESS; Wolff JN, 2008, BIOTECHNIQUES, V44, P193, DOI 10.2144/000112719; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008097	64	299	307	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1256	U124		10.1038/ng.1004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	WOS:000297931400023	22057234	Green Submitted, Green Accepted			2022-01-24	
J	Fritsche, LG; Loenhardt, T; Janssen, A; Fisher, SA; Rivera, A; Keilhauer, CN; Weber, BHF				Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Fisher, Sheila A.; Rivera, Andrea; Keilhauer, Claudia N.; Weber, Bernhard H. F.			Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; X-LINKED RETINOSCHISIS; MACULOPATHY; HTRA1; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; DISEASE; VARIANT; GENE	Age-related macular degeneration (AMD) is a prevalent multifactorial disorder of the central retina(1-3). Genetic variants at two chromosomal loci, 1q31 and 10q26, confer major disease risks, together accounting for more than 50% of AMD pathology(4-9). Signals at 10q26 center over two nearby genes, ARMS2 (age-related maculopathy susceptibility 2, also known as LOC387715)(8,9) and HTRA1 (high-temperature requirement factor A1)(10,11), suggesting two equally probable candidates. Here we show that a deletion-insertion polymorphism in ARMS2 (NM_001099667.1: c.*372_815del443ins54) is strongly associated with AMD, directly affecting the transcript by removing the polyadenylation signal and inserting a 54-bp element known to mediate rapid mRNA turnover. As a consequence, expression of ARMS2 in homozygous carriers of the indel variant is not detectable. Confirming previous findings(12), we demonstrate a mitochondrial association of the normal protein and further define its retinal localization to the ellipsoid region of the photoreceptors. Our data suggest that ARMS2 has a key role in AMD, possibly through mitochondria-related pathways.	[Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Rivera, Andrea; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Fisher, Sheila A.] St Thomas Hosp, London WC2R 2LS, England; [Fisher, Sheila A.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Keilhauer, Claudia N.] Univ Wurzburg, Dept Ophthalmol, D-97080 Wurzburg, Germany		Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Weber, Bernhard H.F./0000-0002-8808-7723			Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; DUDBRIDGE F, 2006, 5 MRC BIOST UN; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	28	299	309	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					892	896		10.1038/ng.170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	WOS:000257166500025	18511946				2022-01-24	
J	Sakamoto, H; Yoshimura, K; Saeki, N; Katai, H; Shimoda, T; Matsuno, Y; Saito, D; Sugimura, H; Tanioka, F; Kato, S; Matsukura, N; Matsuda, N; Nakamura, T; Hyodo, I; Nishina, T; Yasui, W; Hirose, H; Hayashi, M; Toshiro, E; Ohnami, S; Sekine, A; Sato, Y; Totsuka, H; Ando, M; Takemura, R; Takahashi, Y; Ohdaira, M; Aoki, K; Honmyo, I; Chiku, S; Aoyagi, K; Sasaki, H; Ohnami, S; Yanagihara, K; Yoon, KA; Kook, MC; Lee, YS; Park, SR; Kim, CG; Choi, IJ; Yoshida, T; Nakamura, Y; Hirohashi, S				Sakamoto, Hiromi; Yoshimura, Kimio; Saeki, Norihisa; Katai, Hitoshi; Shimoda, Tadakazu; Matsuno, Yoshihiro; Saito, Daizo; Sugimura, Haruhiko; Tanioka, Fumihiko; Kato, Shunji; Matsukura, Norio; Matsuda, Noriko; Nakamura, Tsuneya; Hyodo, Ichinosuke; Nishina, Tomohiro; Yasui, Wataru; Hirose, Hiroshi; Hayashi, Matsuhiko; Toshiro, Emi; Ohnami, Sumiko; Sekine, Akihiro; Sato, Yasunori; Totsuka, Hirohiko; Ando, Masataka; Takemura, Ryo; Takahashi, Yoriko; Ohdaira, Minoru; Aoki, Kenichi; Honmyo, Izumi; Chiku, Suenori; Aoyagi, Kazuhiko; Sasaki, Hiroki; Ohnami, Shumpei; Yanagihara, Kazuyoshi; Yoon, Kyong-Ah; Kook, Myeong-Cherl; Lee, Yeon-Su; Park, Sook Ryun; Kim, Chan Gyoo; Choi, Il Ju; Yoshida, Teruhiko; Nakamura, Yusuke; Hirohashi, Setsuo		Study Grp Millennium Genome Projec	Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer	NATURE GENETICS			English	Article							STEM-CELL ANTIGEN; MILLENNIUM GENOME; TUMOR-GROWTH; EXPRESSION; RISK; POLYMORPHISM; METASTASIS; CARCINOMA; INFERENCE; PROJECT	Gastric cancer is classified into intestinal and diffuse types, the latter including a highly malignant form, linitis plastica. A two-stage genome-wide association study (stage 1: 85,576 SNPs on 188 cases and 752 references; stage 2: 2,753 SNPs on 749 cases and 750 controls) in Japan identified a significant association between an intronic SNP (rs2976392) in PSCA (prostate stem cell antigen) and diffuse-type gastric cancer (allele-specific odds ratio (OR) 1.62, 95% CI = 1.38-1.89, P = 1.11 x 10(-9)). The association was far less significant in intestinal-type gastric cancer. We found that PSCA is expressed in differentiating gastric epithelial cells, has a cell-proliferation inhibition activity in vitro and is frequently silenced in gastric cancer. Substitution of the C allele with the risk allele T at a SNP in the first exon (rs2294008, which has r(2) = 0.995, D' = 0.999 with rs2976392) reduces transcriptional activity of an upstream fragment of the gene. The same risk allele was also significantly associated with diffuse-type gastric cancer in 457 cases and 390 controls in Korea (allele-specific OR 1.90, 95% CI = 1.56-2.33, P = 8.01 x 10(-11)). The polymorphism of the PSCA gene, which is possibly involved in regulating gastric epithelial-cell proliferation, influences susceptibility to diffuse-type gastric cancer.	[Sakamoto, Hiromi; Yoshimura, Kimio; Saeki, Norihisa; Ohnami, Sumiko; Sato, Yasunori; Aoyagi, Kazuhiko; Sasaki, Hiroki; Yoshida, Teruhiko] Natl Canc Ctr, Inst Res, Div Genet, Chuo Ku, Tokyo 1040045, Japan; [Yoshimura, Kimio] Keio Univ, Sch Med, Dept Hlth Policy & Management, Shinjuku Ku, Tokyo 1608582, Japan; [Katai, Hitoshi; Saito, Daizo; Toshiro, Emi] Natl Canc Ctr, Dept Surg Oncol, Chuo Ku, Tokyo 1040045, Japan; [Shimoda, Tadakazu; Matsuno, Yoshihiro] Natl Canc Ctr, Pathol Clin Lab Div, Chuo Ku, Tokyo 1040045, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan; [Tanioka, Fumihiko] Iwata City Hosp, Iwata, Shizuoka 4388550, Japan; [Kato, Shunji; Matsukura, Norio; Matsuda, Noriko] Nippon Med Coll Hosp, Dept Surg, Bunkyo Ku, Tokyo 1138602, Japan; [Nakamura, Tsuneya] Aichi Canc Ctr Hosp, Dept Endoscopy, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hyodo, Ichinosuke; Nishina, Tomohiro] Shikoku Canc Ctr, Dept Internal Med, Matsuyama, Ehime 7910280, Japan; [Yasui, Wataru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Pathol, Minami Ku, Hiroshima 7348551, Japan; [Hirose, Hiroshi; Hayashi, Matsuhiko] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Sekine, Akihiro; Nakamura, Yusuke] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Totsuka, Hirohiko] Hitachi Govt & Publ Corp Syst Engn Ltd, Bioinformat Grp, Ctr Res & Dev, Solut Div 4,Koto Ku, Tokyo 1358633, Japan; [Ando, Masataka] NEC Corp Ltd, BioIT Business Promot Ctr, Solut Dev Labs, Minato Ku, Tokyo 1088001, Japan; [Takemura, Ryo] StaGen Co Ltd, Stat Genet Anal Div, Taito Ku, Tokyo 1110051, Japan; [Takahashi, Yoriko; Ohdaira, Minoru; Aoki, Kenichi; Honmyo, Izumi] Mitsui Knowledge Ind Co Ltd, Chiyoda Ku, Tokyo 1010054, Japan; [Chiku, Suenori] Mizuho Informat & Res Inst Inc, Sci Solut Div, Chiyoda Ku, Tokyo 1018443, Japan; [Ohnami, Shumpei] Natl Canc Ctr, Res Inst, Cent RI Lab, Chuo Ku, Tokyo 1040045, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Res Inst, Cent Anim Lab, Chuo Ku, Tokyo 1040045, Japan; [Yoon, Kyong-Ah; Kook, Myeong-Cherl; Lee, Yeon-Su; Park, Sook Ryun; Kim, Chan Gyoo; Choi, Il Ju] Natl Canc Ctr, Res Inst & Hosp, Goyang Si 411764, Gyeonggi Do, South Korea; [Nakamura, Yusuke] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan		Yoshida, T (corresponding author), Natl Canc Ctr, Inst Res, Div Genet, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tyoshida@ncc.go.jp	Hirose, Hiroshi/F-8556-2014; Hayashi, Matsuhiko/J-4748-2013	Kim, Chan Gyoo/0000-0002-1651-2559			Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; CORREA P, 1994, CANCER RES, V54, pS1941; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Falush D, 2003, GENETICS, V164, P1567; FENOGLIOPREISER C, 2000, WHO CLASSIFICATION T, P39; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CANCER RES, V65, P9495, DOI 10.1158/0008-5472.CAN-05-2086; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Humar B, 2002, ONCOGENE, V21, P8192, DOI 10.1038/sj.onc.1205921; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Japanese Gastric Cancer Association Registration Committee, 2006, Gastric Cancer, V9, P51; Kamangar F, 2006, CANCER EPIDEM BIOMAR, V15, P1920, DOI 10.1158/1055-9965.EPI-06-0267; KARAM S, 1995, MICROSC RES TECHNIQ, V31, P193, DOI 10.1002/jemt.1070310304; Karam SM, 2003, STEM CELLS, V21, P322, DOI 10.1634/stemcells.21-3-322; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Machado JC, 1999, LAB INVEST, V79, P459; Nei M., 1987, MOL EVOLUTIONARY GEN; Noguchi M, 1997, PATHOL INT, V47, P685, DOI 10.1111/j.1440-1827.1997.tb04442.x; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Pharoah PDP, 2002, INT J CANCER, V101, P196, DOI 10.1002/ijc.10590; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; ROSAI J, 2004, ROSAI ACKERMANS SURG, P648; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Sasazuki S, 2006, CANCER EPIDEM BIOMAR, V15, P1341, DOI 10.1158/1055-9965.EPI-05-0901; Sato Y, 2004, J HUM GENET, V49, P669, DOI 10.1007/s10038-004-0205-9; Schier S, 2005, ONCOLOGY-BASEL, V69, P9, DOI 10.1159/000086625; Sharom FJ, 2004, SUB CELL BIOCHEM, V37, P285; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Tran CP, 2002, MOL CANCER RES, V1, P113; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wang GY, 2008, AM J EPIDEMIOL, V167, P7, DOI 10.1093/aje/kwm264; Yokota T, 1999, CAN J SURG, V42, P371; Yoshida T, 2003, P JPN ACAD B-PHYS, V79, P34, DOI 10.2183/pjab.79B.34; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; [No title captured]	49	299	314	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					730	740		10.1038/ng.152			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	WOS:000256212000015	18488030				2022-01-24	
J	Pasternack, SM; von Kugelgen, I; Al Aboud, K; Lee, YA; Ruschendorf, F; Voss, K; Hillmer, AM; Molderings, GJ; Franz, T; Ramirez, A; Nuernberg, P; Nothen, MM; Betz, RC				Pasternack, Sandra M.; von Kuegelgen, Ivar; Al Aboud, Khalid; Lee, Young-Ae; Rueschendorf, Franz; Voss, Katrin; Hillmer, Axel M.; Molderings, Gerhard J.; Franz, Thomas; Ramirez, Alfredo; Nuernberg, Peter; Noethen, Markus M.; Betz, Regina C.			G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth	NATURE GENETICS			English	Article							LYSOPHOSPHATIDIC ACID; INTERNATIONAL UNION; GENE; IDENTIFICATION; HYPOTRICHOSIS; PHARMACOLOGY; MUTATIONS; GPR92; 6H1	Hypotrichosis simplex is a group of nonsyndromic human alopecias. We mapped an autosomal recessive form of this disorder to chromosome 13q14.11-13q21.33, and identified homozygous truncating mutations in P2RY5, which encodes an orphan G protein-coupled receptor. Furthermore, we identified oleoyl-L-alpha-lysophosphatidic acid (LPA), a bioactive lipid, as a ligand for P2Y5 in reporter gene and radioligand binding experiments. Homology and studies of signaling transduction pathways suggest that P2Y5 is a member of a subgroup of LPA receptors, which also includes LPA4 and LPA5. Our study is the first to implicate a G protein-coupled receptor as essential for and specific to the maintenance of human hair growth. This finding may provide opportunities for new therapeutic approaches to the treatment of hair loss in humans.	[Pasternack, Sandra M.; Noethen, Markus M.; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Pasternack, Sandra M.; Molderings, Gerhard J.] Univ Bonn, Dept Pharmacol, D-53113 Bonn, Germany; [Al Aboud, Khalid] King Faisal Hosp, Dept Dermatol, Mecca 5592, Saudi Arabia; [Lee, Young-Ae] Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Lee, Young-Ae; Rueschendorf, Franz] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Voss, Katrin] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Hillmer, Axel M.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Franz, Thomas] Univ Bonn, Dept Anat, D-53115 Bonn, Germany; [Ramirez, Alfredo] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Ramirez, Alfredo] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Ramirez, Alfredo; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany		Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany.	regina.betz@uni-bonn.de	Hillmer, Axel M/N-2927-2014; von Kugelgen, Ivar/D-2989-2019; Betz, Regina C/E-8591-2011; Hillmer, Axel M/B-7485-2015; Nothen, Markus/B-2027-2009; Ramirez, Alfredo/S-5126-2019	Hillmer, Axel M/0000-0002-3381-7266; von Kugelgen, Ivar/0000-0002-2021-4028; Betz, Regina C/0000-0001-5024-3623; Hillmer, Axel M/0000-0002-3381-7266; Nothen, Markus/0000-0002-8770-2464; Ramirez, Alfredo/0000-0003-4991-763X	Direct For Biological SciencesNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0749004] Funding Source: National Science Foundation; Division Of Environmental BiologyNational Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO) [0746560] Funding Source: National Science Foundation		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Al Aboud D, 2005, SUDAN J DERMATOL, V3, P128; Al Aboud K, 2002, CLIN EXP DERMATOL, V27, P654, DOI 10.1046/j.1365-2230.2002.01088.x; BETZ RC, 2006, PROGR MONOGENIC HAIR, P43; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Li Q, 1997, BIOCHEM BIOPH RES CO, V236, P455, DOI 10.1006/bbrc.1997.6984; Miller J, 2001, J INVEST DERMATOL, V117, P612, DOI 10.1046/j.0022-202x.2001.01438.x; Molderings GJ, 2007, NEUROCHEM INT, V51, P476, DOI 10.1016/j.neuint.2007.04.022; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Takahashi T, 2003, J INVEST DERMATOL, V121, P448, DOI 10.1046/j.1523-1747.2003.12426.x; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wali A, 2007, CLIN GENET, V72, P23, DOI 10.1111/j.1399-0004.2007.00818.x; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Webb TE, 1996, BIOCHEM BIOPH RES CO, V219, P105, DOI 10.1006/bbrc.1996.0189; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	30	299	312	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					329	334		10.1038/ng.84			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	WOS:000253548400024	18297070				2022-01-24	
J	Krallinger, M; Leitner, F; Rodriguez-Penagos, C; Valencia, A				Krallinger, Martin; Leitner, Florian; Rodriguez-Penagos, Carlos; Valencia, Alfonso			Overview of the protein-protein interaction annotation extraction task of BioCreative II	GENOME BIOLOGY			English	Article							INFORMATION; DATABASE; NETWORK; GENES; MODEL	Background: The biomedical literature is the primary information source for manual protein-protein interaction annotations. Text-mining systems have been implemented to extract binary protein interactions from articles, but a comprehensive comparison between the different techniques as well as with manual curation was missing. Results: We designed a community challenge, the BioCreative II protein-protein interaction (PPI) task, based on the main steps of a manual protein interaction annotation workflow. It was structured into four distinct subtasks related to: (a) detection of protein interaction-relevant articles; (b) extraction and normalization of protein interaction pairs; (c) retrieval of the interaction detection methods used; and (d) retrieval of actual text passages that provide evidence for protein interactions. A total of 26 teams submitted runs for at least one of the proposed subtasks. In the interaction article detection subtask, the top scoring team reached an F-score of 0.78. In the interaction pair extraction and mapping to SwissProt, a precision of 0.37 (with recall of 0.33) was obtained. For associating articles with an experimental interaction detection method, an F-score of 0.65 was achieved. As for the retrieval of the PPI passages best summarizing a given protein interaction in full-text articles, 19% of the submissions returned by one of the runs corresponded to curator-selected sentences. Curators extracted only the passages that best summarized a given interaction, implying that many of the automatically extracted ones could contain interaction information but did not correspond to the most informative sentences. Conclusion: The BioCreative II PPI task is the first attempt to compare the performance of text-mining tools specific for each of the basic steps of the PPI extraction pipeline. The challenges identified range from problems in full-text format conversion of articles to difficulties in detecting interactor protein pairs and then linking them to their database records. Some limitations were also encountered when using a single (and possibly incomplete) reference database for protein normalization or when limiting search for interactor proteins to co-occurrence within a single sentence, when a mention might span neighboring sentences. Finally, distinguishing between novel, experimentally verified interactions (annotation relevant) and previously known interactions adds additional complexity to these tasks.	[Krallinger, Martin; Leitner, Florian; Rodriguez-Penagos, Carlos; Valencia, Alfonso] Spanish Nacl Canc Res Ctr CNIO, Struct Biol & BioComp Programme, E-28029 Madrid, Spain		Valencia, A (corresponding author), Spanish Nacl Canc Res Ctr CNIO, Struct Biol & BioComp Programme, C Melchor F Almagro 3, E-28029 Madrid, Spain.	valencia@cnio.es	Valencia, Alfonso/I-3127-2015; Krallinger, Martin/I-2599-2015	Valencia, Alfonso/0000-0002-8937-6789; Krallinger, Martin/0000-0002-2646-8782; Rodriguez-Penagos, Carlos/0000-0001-8744-0380; Leitner, Florian/0000-0003-4458-504X	ENFIN NoE [LSHG-CT-2005-518254]; DIAMONDS project [LSHG-CT-2004-512143]; Spanish National Bioinformatics Institute; European Science Foundation (ESF)European Science Foundation (ESF)Estonian Research Council; Genoma Espana	The PPI task and the second BioCreative assessment workshop was sponsored by grant ENFIN NoE (LSHG-CT-2005-518254), the DIAMONDS project (LSHG-CT-2004-512143) and by the Spanish National Bioinformatics Institute http://www.inab.org a platform of Genoma Espana. The BioCreative II workshop was sponsored by the Frontiers of Functional Genomics Programme of the European Science Foundation (ESF) and by Genoma Espana a http://www.gen-es.org. We also acknowledge all the publishers for allowing the use of full-text articles for the purpose of the BioCreative PPI task, especially Nature Publishing Group (NPG), Elsevier, Cell Press. We also would like to thank Lynette Hirschman and Antonio Rausell for useful feedback and discussions.	Abi-Haidar A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S11; Alex B, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s10, 10.1186/gb-2008-9-S2-S10]; Baumgartner WA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S9; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Blaschke C, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S16; CARPENTER B, P BIOCR WORKSH 22 25; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; CURRAN J, 2003, P CONLL; Donaldson I, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-11; EHRLER F, P BIOCR WORKSH 22 25; Hakenberg J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s14, 10.1186/gb-2008-9-S2-S14]; Hersh W.R., 2006, TREC 2006 GENOMICS T; Huang ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S12; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/ng0501-21; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Krallinger Martin, 2006, Genome Inform, V17, P121; LAN M, P BIOCR WORKSH 22 25; Leitner F, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s6, 10.1186/gb-2008-9-S2-S6]; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; NAKOV P, P BIOCR WORKSH 22 25; Orchard S, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P186; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Rinaldi F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S13; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SUGIYAMA K, 2003, GENOME INFORMATICS, V14, P699; BIOCREATIVE PROTEIN	31	299	309	0	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2008	9			2					S4	10.1186/gb-2008-9-S2-S4			19	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	602YB	WOS:000278173900004	18834487	Green Published, hybrid			2022-01-24	
J	Krallinger, M; Morgan, A; Smith, L; Leitner, F; Tanabe, L; Wilbur, J; Hirschman, L; Valencia, A				Krallinger, Martin; Morgan, Alexander; Smith, Larry; Leitner, Florian; Tanabe, Lorraine; Wilbur, John; Hirschman, Lynette; Valencia, Alfonso			Evaluation of text-mining systems for biology: overview of the Second BioCreative community challenge	GENOME BIOLOGY			English	Article							INFORMATION EXTRACTION; GENE	Background: Genome sciences have experienced an increasing demand for efficient text-processing tools that can extract biologically relevant information from the growing amount of published literature. In response, a range of text-mining and information-extraction tools have recently been developed specifically for the biological domain. Such tools are only useful if they are designed to meet real-life tasks and if their performance can be estimated and compared. The BioCreative challenge (Critical Assessment of Information Extraction in Biology) consists of a collaborative initiative to provide a common evaluation framework for monitoring and assessing the state-of-the-art of text-mining systems applied to biologically relevant problems. Results: The Second BioCreative assessment (2006 to 2007) attracted 44 teams from 13 countries worldwide, with the aim of evaluating current information-extraction/text-mining technologies developed for one or more of the three tasks defined for this challenge evaluation. These tasks included the recognition of gene mentions in abstracts (gene mention task); the extraction of a list of unique identifiers for human genes mentioned in abstracts (gene normalization task); and finally the extraction of physical protein-protein interaction annotation-relevant information (protein-protein interaction task). The 'gold standard' data used for evaluating submissions for the third task was provided by the interaction databases MINT (Molecular Interaction Database) and IntAct. Conclusion: The Second BioCreative assessment almost doubled the number of participants for each individual task when compared with the first BioCreative assessment. An overall improvement in terms of balanced precision and recall was observed for the best submissions for the gene mention (F score 0.87); for the gene normalization task, the best results were comparable (F score 0.81) compared with results obtained for similar tasks posed at the first BioCreative challenge. In case of the protein-protein interaction task, the importance and difficulties of experimentally confirmed annotation extraction from full-text articles were explored, yielding different results depending on the step of the annotation extraction workflow. A common characteristic observed in all three tasks was that the combination of system outputs could yield better results than any single system. Finally, the development of the first text-mining meta-server was promoted within the context of this community challenge.	[Smith, Larry; Tanabe, Lorraine; Wilbur, John] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Krallinger, Martin; Leitner, Florian; Valencia, Alfonso] Spanish Nacl Canc Res Ctr CNIO, Struct Biol & BioComp Programme, E-28029 Madrid, Spain; [Morgan, Alexander] Stanford Univ, Stanford, CA 94306 USA; [Hirschman, Lynette] Mitre Corp, Ctr Informat Technol, Bedford, MA 01730 USA		Wilbur, J (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, 8600 Rockville Pike, Bethesda, MD 20894 USA.	wilbur@ncbi.nlm.nih.gov; lynette@mitre.org; valencia@cnio.es	Valencia, Alfonso/I-3127-2015; Krallinger, Martin/I-2599-2015	Valencia, Alfonso/0000-0002-8937-6789; Krallinger, Martin/0000-0002-2646-8782; Rodriguez-Penagos, Carlos/0000-0001-8744-0380; Leitner, Florian/0000-0003-4458-504X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NLMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM); NCBI; National Science FoundationNational Science Foundation (NSF) [II-0640153]; ENFIN NoE [LSHG-CT-2005-518254]; Spanish National Bioinformatics Institute; European Science Foundation (ESF)European Science Foundation (ESF); Genoma Espana	The GM task organization was supported by the Intramural Research Program of the NIH, NLM, and NCBI. The work of the GN task organizers was supported under National Science Foundation Grant II-0640153. The PPI task and the second BioCreative assessment workshop was sponsored by grant ENFIN NoE (LSHG-CT-2005-518254) and by the Spanish National Bioinformatics Institute http://www.inab.org a platform of Genoma Espana. The BioCreative II workshop was sponsored by the Frontiers of Functional Genomics Programme of the European Science Foundation (ESF) and by Genoma Espana http://www.gen-es.org. We also acknowledge all the publishers for allowing the use of full-text articles for the purpose of the BioCreative PPI task, especially Nature Publishing Group (NPG), Elsevier, and Cell Press.	Bar-Haim R., 2006, P 2 PASCAL CHALL WOR; Blaschke C, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S16; Chatr-aryamontri A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S5; Dalal S, 1997, NAT STRUCT BIOL, V4, P548, DOI 10.1038/nsb0797-548; Guigo R, 2006, GENOME BIOL S1, V7, P1; Hersh W.R., 2006, TREC 2006 GENOMICS T; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hirschman L, 1998, COMPUT SPEECH LANG, V12, P281, DOI 10.1006/csla.1998.0102; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; KIM J, 2004, P BIOCR CHALL EV WOR; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s8, 10.1186/gb-2008-9-S2-S8]; LAFFERTY J, 2001, P ICML 01; Lopez G, 2007, PROTEINS, V69, P165, DOI 10.1002/prot.21651; McCallum A. K., MALLET MACHINE LEARN; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; NEDELLEC C, 2005, P LLL05 WORKSH; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Smith L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S2; Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3; TSURUOKA Y, 2005, P HLT EMNLP; Yeh A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S2; Yeh AS, 2003, BIOINFORMATICS, V19, pi331, DOI 10.1093/bioinformatics/btg1046	23	299	309	0	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.		2008	9			2					S1	10.1186/gb-2008-9-S2-S1			9	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	602YB	WOS:000278173900001	18834487	Green Published, hybrid			2022-01-24	
J	Cabral, WA; Chang, W; Barnes, AM; Weis, M; Scott, MA; Leikin, S; Makareeva, E; Kuznetsova, NV; Rosenbaum, KN; Tifft, CJ; Bulas, DI; Kozma, C; Smith, PA; Eyre, DR; Marini, JC				Cabral, Wayne A.; Chang, Weizhong; Barnes, Aileen M.; Weis, MaryAnn; Scott, Melissa A.; Leikin, Sergey; Makareeva, Elena; Kuznetsova, Natalia V.; Rosenbaum, Kenneth N.; Tifft, Cynthia J.; Bulas, Dorothy I.; Kozma, Chahira; Smith, Peter A.; Eyre, David R.; Marini, Joan C.			Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta	NATURE GENETICS			English	Article							MEMBRANE-ASSOCIATED PROTEOGLYCAN; CARTILAGE-ASSOCIATED PROTEIN; COLLAGEN TRIPLE-HELIX; I COLLAGEN; RESIDUES; MUTATIONS; LEPRECAN; IDENTIFICATION; FIBRILS; DISEASE	A recessive form of severe osteogenesis imperfecta that is not caused by mutations in type I collagen has long been suspected. Mutations in human CRTAP (cartilage-associated protein) causing recessive bone disease have been reported. CRTAP forms a complex with cyclophilin B and prolyl 3-hydroxylase 1, which is encoded by LEPRE1 and hydroxylates one residue in type I collagen, alpha 1(I) Pro986. We present the first five cases of a new recessive bone disorder resulting from null LEPRE1 alleles; its phenotype overlaps with lethal/severe osteogenesis imperfecta but has distinctive features. Furthermore, a mutant allele from West Africa, also found in African Americans, occurs in four of five cases. All proband LEPRE1 mutations led to premature termination codons and minimal mRNA and protein. Proband collagen had minimal 3-hydroxylation of alpha 1(I) Pro986 but excess lysyl hydroxylation and glycosylation along the collagen helix. Proband collagen secretion was moderately delayed, but total collagen secretion was increased. Prolyl 3-hydroxylase 1 is therefore crucial for bone development and collagen helix formation.	NICHHD, Bione & Extracellular Matrix Branach, NIH, Bethesda, MD 20892 USA; Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA; NICHHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Diagnost Imaging & Radiol, Washington, DC 20010 USA; Georgetown Univ Hosp, Dept Pediat, Washington, DC 20007 USA; Shriners Hosp Children, Chicago, IL 60707 USA		Marini, JC (corresponding author), NICHHD, Bione & Extracellular Matrix Branach, NIH, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov	Leikin, Sergey/A-5518-2008; Makareeva, Elena/F-5183-2011	Leikin, Sergey/0000-0001-7095-0739; Makareeva, Elena/0000-0002-5815-0760; Barnes, Aileen/0000-0001-8021-4997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD008830] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD022657, Z01HD008830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR036794, R37AR037318, R01AR037318] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01 HD008830] Funding Source: Medline; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R37 AR037318, R01 AR037318, R01 AR036794, AR37318] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD22657, P01 HD022657] Funding Source: Medline		AITCHISON K, 1988, HUM GENET, V78, P233, DOI 10.1007/BF00291667; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Byers P. H., 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2003, J BIOL CHEM, V278, P10006, DOI 10.1074/jbc.M212523200; DAW S, 1988, J MED GENET, V25, P275; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Forlino A, 1997, BIOCHEM MOL MED, V62, P26, DOI 10.1006/bmme.1997.2620; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Labuda M, 2002, BONE, V31, P19, DOI 10.1016/S8756-3282(02)00808-6; Marini JC, 2004, NELSON TXB PEDIAT, P2336; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; ROYCE PM, 1985, BIOCHEM J, V230, P475, DOI 10.1042/bj2300475; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Tonachini L, 1999, CYTOGENET CELL GENET, V87, P191, DOI 10.1159/000015463; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; WALLIS GA, 1993, J MED GENET, V30, P492, DOI 10.1136/jmg.30.6.492; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; Wu J, 2006, EXP CELL RES, V312, P3485, DOI 10.1016/j.yexcr.2006.07.013	30	299	319	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					359	365		10.1038/ng1968			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	WOS:000244480000018	17277775	Green Accepted			2022-01-24	
J	Zerjal, T; Xue, YL; Bertorelle, G; Wells, RS; Bao, WD; Zhu, SL; Qamar, R; Ayub, Q; Mohyuddin, A; Fu, SB; Li, P; Yuldasheva, N; Ruzibakiev, R; Xu, JJ; Shu, QF; Du, RF; Yang, HM; Hurles, ME; Robinson, E; Gerelsaikhan, T; Dashnyam, B; Mehdi, SQ; Tyler-Smith, C				Zerjal, T; Xue, YL; Bertorelle, G; Wells, RS; Bao, WD; Zhu, SL; Qamar, R; Ayub, Q; Mohyuddin, A; Fu, SB; Li, P; Yuldasheva, N; Ruzibakiev, R; Xu, JJ; Shu, QF; Du, RF; Yang, HM; Hurles, ME; Robinson, E; Gerelsaikhan, T; Dashnyam, B; Mehdi, SQ; Tyler-Smith, C			The genetic legacy of the mongols	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPES; SELECTION; ORIGIN	We have identified a Y-chromosomal lineage with several unusual features. It was found in 16 populations throughout a large region of Asia, stretching from the Pacific to the Caspian Sea, and was present at high frequency: similar to8% of the men in this region carry it, and it thus makes up similar to0.5% of the world total. The pattern of variation within the lineage suggested that it originated in Mongolia similar to1,000 years ago. Such a rapid spread cannot have occurred by chance; it must have been a result of selection. The lineage is carried by likely male-line descendants of Genghis Khan, and we therefore propose that it has spread by a novel form of social selection resulting from their behavior.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Harbin Med Univ, Dept Med Biol, Harbin, Peoples R China; Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy; Univ Oxford, Wellcome Trust Ctr Human Genet, Headington, England; Chinese Acad Sci, Inst Genet, Beijing, Peoples R China; Biomed & Genet Engn Labs, Islamabad, Pakistan; Uzbek Acad Sci, Inst Immunol, Tashkent 700135, Uzbekistan; Univ Cambridge, McDonald Inst, Cambridge, England; Mongolian Acad Sci, Inst Biotechnol, Ulaanbaatar, Mongolia		Tyler-Smith, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	chris@bioch.ox.ac.uk	Mehdi, Syed Qasim/L-2385-2015; qamar, raheel/D-4543-2012; Qamar, Raheel/G-3355-2015; zerjal, tatiana/AAO-9473-2020	Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Ayub, Qasim/0000-0003-3291-0917			Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; EDLESTON RS, 1865, ENTOMOLOGIST, V2, P150; Ellis N, 2002, GENOME RES, V12, P339; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Mohyuddin A, 2001, FORENSIC SCI INT, V118, P141, DOI 10.1016/S0379-0738(01)00382-6; Morgan D., 1986, MONGOLS; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Mousavi S. A., 1998, HAZARAS AFGHANISTAN; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Slatkin M, 2001, GENETICS, V158, P865; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; WILSON DS, 1994, BEHAV BRAIN SCI, V17, P585, DOI 10.1017/S0140525X00036104; Wilson IJ, 1998, GENETICS, V150, P499; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096	15	299	311	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					717	721		10.1086/367774			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	WOS:000181152600021	12592608	Green Published, Bronze			2022-01-24	
J	Daluiski, A; Engstrand, T; Bahamonde, ME; Gamer, LW; Agius, E; Stevenson, SL; Cox, K; Rosen, V; Lyons, KM				Daluiski, A; Engstrand, T; Bahamonde, ME; Gamer, LW; Agius, E; Stevenson, SL; Cox, K; Rosen, V; Lyons, KM			Bone morphogenetic protein-3 is a negative regulator of bone density	NATURE GENETICS			English	Article							SIGNALING PATHWAYS; II RECEPTORS; ACTIVIN-A; DIFFERENTIATION; EXPRESSION; CELLS; IDENTIFICATION; CULTURES; OSTEOPOROSIS; DROSOPHILA	Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta (TGF-beta) superfamily. Many BMPs are produced in bone and show osteogenic activity, suggesting that they may be determinants of bone mass. BMP3 was originally purified from bone as osteogenin, which induces osteogenic differentiation(1). Recombinant BMP3 (rhBMP3) has no biological activity, however, leaving its role in skeletal growth unclear. Here we show that BMP3 is an antagonist of osteogenic BMPs: BMP3 dorsalizes Xenopus laevis embryos, inhibits BMP2-mediated induction of Msx2 and blocks BMP2-mediated differentiation of osteoprogenitor cells into osteoblasts. These effects appear to be mediated through activin receptors. Finally, Smp3(-/-) mice have twice as much trabecular bone as wild-type littermates, indicating that BMP3, the most abundant BMP in adult bone, is a negative determinant of bone density.	Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; Inst Genet, Cambridge, MA USA; Case Western Reserve Univ, Cleveland, OH 44106 USA		Lyons, KM (corresponding author), Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA.			Agius, Eric/0000-0003-2123-9283	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [AR44528] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR044528] Funding Source: NIH RePORTER		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Candia AF, 1997, DEVELOPMENT, V124, P4467; CENTRELLA M, 1991, MOL CELL BIOL, V11, P250, DOI 10.1128/MCB.11.1.250; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Engstrand T, 2000, HUM GENE THER, V11, P205, DOI 10.1089/10430340050016274; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; HAZAMA M, 1995, BIOCHEM BIOPH RES CO, V209, P859, DOI 10.1006/bbrc.1995.1578; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; LUYTEN FP, 1992, J BIOL CHEM, V267, P3691; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Piek E, 1999, J CELL PHYSIOL, V180, P141, DOI 10.1002/(SICI)1097-4652(199908)180:2<141::AID-JCP1>3.0.CO;2-I; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; Takao M, 1996, BIOCHEM BIOPH RES CO, V219, P656, DOI 10.1006/bbrc.1996.0289; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Wozney J. M., 1993, PHYSL PHARM BONE, P725; Yi SE, 2000, DEVELOPMENT, V127, P621; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	30	299	317	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					84	88		10.1038/83810			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	WOS:000166187900021	11138004				2022-01-24	
J	Kliman, RM; Andolfatto, P; Coyne, JA; Depaulis, F; Kreitman, M; Berry, AJ; McCarter, J; Wakeley, J; Hey, J				Kliman, RM; Andolfatto, P; Coyne, JA; Depaulis, F; Kreitman, M; Berry, AJ; McCarter, J; Wakeley, J; Hey, J			The population genetics of the origin and divergence of the Drosophila simulans complex species	GENETICS			English	Article							DNA-SEQUENCE VARIATION; MOLECULAR EVOLUTION; NATURAL-SELECTION; NUCLEOTIDE POLYMORPHISM; REPRODUCTIVE ISOLATION; MELANOGASTER SUBGROUP; SEXUAL ISOLATION; PERIOD LOCUS; CODON USAGE; SPECIATION	The origins and divergence of Drosophila simulans and close relatives D. mauritiana and D. sechellia were examined using the patterns of DNA sequence variation found within and between species at 14 different genes. D. sechellia consistently revealed low levels of polymorphism, and genes from D. sechellia have accumulated mutations at a rate that is similar to 50% higher than the same genes from D. simulans. At synonymous sites, D. sechellia has experienced a significant excess of unpreferred codon substitutions. Together these observations suggest that D. sechellia has had a reduced effective population size for some time, and that it is accumulating slightly deleterious mutations as a result. D. simulans and D. mauritiana are both highly polymorphic and the two species share many polymorphisms, probably since the time of common ancestry. A simple isolation speciation model, with zero gene flow following incipient species separation, was fitted to both the simulans/mauritiana divergence and the simulans/sechellia divergence. In both cases the model fit the data quite well, and the analyses revealed little evidence of gene flow between the species. The exception is one gene copy at one locus in D. sechellia, which closely resembled other D. simulans sequences. The overall picture is of two allopatric speciation events that occurred quite near one another in time.	Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Princeton Univ, Dept Ecol Evolut & Behav, Princeton, NJ 08544 USA; Univ Paris 06, CNRS UMR 7625, F-75252 Paris 05, France; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA		Hey, J (corresponding author), Rutgers State Univ, Dept Genet, 604 Allison Rd, Piscataway, NJ 08854 USA.	jhey@mbcl.rutgers.edu	Hey, Jody/D-1257-2009	Hey, Jody/0000-0001-5358-6488; Andolfatto, Peter/0000-0003-3393-4574; Depaulis, Frantz/0000-0001-5761-2751	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM058260, R01GM058060] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 58260, R01GM58060] Funding Source: Medline		AGUADE M, 1992, GENETICS, V132, P755; AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Andolfatto P, 1999, GENETICS, V153, P1297; AVISE JC, 1989, EVOLUTION, V43, P1192, DOI [10.2307/2409356, 10.1111/j.1558-5646.1989.tb02568.x]; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERRY AJ, 1991, GENETICS, V129, P1111; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; CACCONE A, 1988, GENETICS, V118, P671; Caccone A, 1996, MOL BIOL EVOL, V13, P1224, DOI 10.1093/oxfordjournals.molbev.a025688; CARIOU ML, 1990, EXPERIENTIA, V46, P101, DOI 10.1007/BF01955430; CARIOU ML, 1987, GENET RES, V50, P181, DOI 10.1017/S0016672300023673; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Clark AG, 1997, P NATL ACAD SCI USA, V94, P7730, DOI 10.1073/pnas.94.15.7730; COHN VH, 1984, J MOL EVOL, V20, P31, DOI 10.1007/BF02101983; COOKE PH, 1989, P NATL ACAD SCI USA, V86, P1426, DOI 10.1073/pnas.86.4.1426; COYNE JA, 1992, GENET RES, V60, P25, DOI 10.1017/S0016672300030639; Coyne JA, 1997, GENETICS, V145, P1015; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; COYNE JA, 1986, EVOLUTION, V40, P673, DOI 10.1111/j.1558-5646.1986.tb00530.x; COYNE JA, 2000, IN PRESS EVOLUTION; Da Lage JL, 1998, P NATL ACAD SCI USA, V95, P6848, DOI 10.1073/pnas.95.12.6848; Dobzhansky T, 1936, GENETICS, V21, P113; Dobzhansky T., 1937, GENETICS ORIGIN SPEC; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Eanes WF, 1996, GENETICS, V144, P1027; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; Hamblin MT, 1999, GENETICS, V153, P305; Harr B, 1998, CURR BIOL, V8, P1183, DOI 10.1016/S0960-9822(07)00490-3; Hey J, 1999, TRENDS ECOL EVOL, V14, P35, DOI 10.1016/S0169-5347(98)01497-9; Hey J., 1994, Experientia Supplementum (Basel), V69, P435; Hey J, 1997, GENETICS, V145, P833; HEY J, 1993, MOL BIOL EVOL, V10, P804; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; Hilton H, 1997, GENET RES, V70, P185, DOI 10.1017/S0016672397003042; Hilton H, 1996, GENETICS, V144, P1015; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Huxley J, 1940, NEW SYSTEMATICS, P185; JOLY D, 1987, JPN J GENET, V62, P257, DOI 10.1266/jjg.62.257; Jones CD, 1998, GENETICS, V149, P1899; KAROTAM J, 1993, GENETICA, V88, P11, DOI 10.1007/BF02424448; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; KLIMAN RM, 1993, GENETICS, V133, P375; Kreitman M, 1996, BIOESSAYS, V18, P678, DOI 10.1002/bies.950180812; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; LEICHT BG, 1995, GENETICS, V139, P299; LEMEUNIER F, 1976, PROC R SOC SER B-BIO, V193, P275, DOI 10.1098/rspb.1976.0046; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McAllister BF, 1999, GENETICS, V153, P221; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Ohta T, 1996, BIOESSAYS, V18, P673, DOI 10.1002/bies.950180811; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OHTA T, 1972, J MOL EVOL, V1, P305, DOI 10.1007/BF01659161; Palopoli MF, 1996, GENETICS, V144, P1321; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price CSC, 1999, NATURE, V400, P449, DOI 10.1038/22755; Ramos-Onsins S, 1998, GENETICS, V150, P157; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.1111/j.1558-5646.1993.tb01257.x, 10.2307/2410209]; RKHA S, 1991, P NATL ACAD SCI USA, V88, P1835, DOI 10.1073/pnas.88.5.1835; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATTA Y, 1990, P NATL ACAD SCI USA, V87, P9558, DOI 10.1073/pnas.87.24.9558; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; SHIBATA H, 1995, GENETICS, V141, P223; SNOOK RR, 1994, P NATL ACAD SCI USA, V91, P11222, DOI 10.1073/pnas.91.23.11222; Sokal R.R., 1981, BIOMETRY; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1986, GENET RES, V48, P187, DOI 10.1017/S001667230002499X; Throckmorton L.H., 1975, P421; Ting CT, 2000, P NATL ACAD SCI USA, V97, P5313, DOI 10.1073/pnas.090541597; TSACAS L, 1981, Revue Francaise d'Entomologie (Nouvelle Serie), V3, P146; Wakeley J, 1996, THEOR POPUL BIOL, V49, P39, DOI 10.1006/tpbi.1996.0002; Wakeley J, 1997, GENETICS, V145, P847; Wang RL, 1996, GENETICS, V144, P1113; Wang RL, 1997, GENETICS, V147, P1091; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; YANICOSTAS C, 1989, MOL CELL BIOL, V9, P2526, DOI 10.1128/MCB.9.6.2526; Zurovcova M, 1999, GENETICS, V153, P1709	89	299	308	1	20	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	DEC	2000	156	4					1913	1931					19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	381AL	WOS:000165740100037	11102384				2022-01-24	
J	Stiewe, T; Putzer, BM				Stiewe, T; Putzer, BM			Role of the p53-homologue p73 in EZF1-induced apoptosis	NATURE GENETICS			English	Article							P53; BINDING; PROTEIN; NEUROBLASTOMA; ACTIVATION; EXPRESSION; TARGET; GROWTH; E2F; RB	Most human cancers harbour aberrations of cell-cycle control(1), which result in deregulated activity of the E2F transcription factors with concomitant enhanced cell-cycle progression(2). Oncogenic signalling by E2F1 has recently been linked to stabilization and activation of the tumour suppressor p53 (refs 1,3,4). The p73 protein shares substantial sequence homology and functional similarity with p53 (refs 5-7). Hence, several previously considered p53-independent cellular activities may be attributable to p73. Here we provide evidence that E2F1 directly activates transcription of TP73, leading to activation of p53-responsive target genes and apoptosis. Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis. Thus, p73 activation by deregulated E2F1 activity might constitute a p53-independent, anti-tumorigenic safeguard mechanism.	Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, Essen, Germany		Putzer, BM (corresponding author), Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, Essen, Germany.	brigitte.puetzer@uni-essen.de		Stiewe, Thorsten/0000-0003-0134-7826			BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Chiang SY, 1998, BIOCHEMISTRY-US, V37, P3109, DOI 10.1021/bi9721142; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lee TA, 2000, ONCOGENE, V19, P2257, DOI 10.1038/sj.onc.1203556; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Ng SW, 2000, ONCOGENE, V19, P1885, DOI 10.1038/sj.onc.1203512; ORMEROD MG, 1993, ACTA ONCOL, V32, P417, DOI 10.3109/02841869309093620; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Putzer BM, 2000, GENE THER, V7, P1317, DOI 10.1038/sj.gt.3301235; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zhu JH, 1998, CANCER RES, V58, P5061; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	28	299	303	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2000	26	4					464	469		10.1038/82617			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	WOS:000165671700022	11101847				2022-01-24	
J	Gangloff, S; Soustelle, C; Fabre, F				Gangloff, S; Soustelle, C; Fabre, F			Homologous recombination is responsible for cell death in the absence of the Sgs1 and Srs2 helicases	NATURE GENETICS			English	Article							WERNERS-SYNDROME GENES; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; BLOOMS-SYNDROME; DNA HELICASE; YEAST SGS1; MUTATIONS; RAD51; ALLELE; SEQUENCE	DNA helicases are involved in many aspects of DNA metabolism, including transcription, replication, recombination and repair. In the yeast Saccharomyces cerevisiae, the absence of the Sgs1 helicase results in genomic instability and accelerated ageing(1-4). In human cells, mutations in orthologues of SGS1 lead to Bloom (BS). Werner (WS) or Rothmund-Thomson (RTS) syndromes, which are rare, autosomal recessive diseases characterized by genetic instability associated with cancer predisposition(5-7). Although data concerning these human diseases are accumulating, there is still no clear idea of the function of the proteins involved. Here we show that sgs1 Delta mutants are deficient in DNA repair and are defective for induced recombination events that involve homologous chromosomes. The role of homologous recombination is further evidenced in haploid cells in which both Sgs1p and Srs2p are absent. Yeast SRS2 encodes another DNA helicase involved in the maintenance of genome integrity(8-10). Our data suggest that some defects observed in BS. WS or RTS are the consequence of unrestrained recombination.	CEA, UMR 217 CNRS, DSV, DRR,LERA, F-92265 Fontenay Aux Roses, France		Gangloff, S (corresponding author), CEA, UMR 217 CNRS, DSV, DRR,LERA, F-92265 Fontenay Aux Roses, France.	Serge.Gangloff@cea.fr; Francis.Fabre@cea.fr	Gangloff, Serge/B-2758-2008	Gangloff, Serge/0000-0003-1333-6091			ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Chanet R, 1996, MOL CELL BIOL, V16, P4782; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Frei C, 2000, GENE DEV, V14, P81; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; KAYTOR MD, 1995, GENETICS, V140, P1441; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; MILNE GT, 1995, GENETICS, V139, P1189; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; RONG L, 1991, GENETICS, V127, P75; RONG L, 1993, J BIOL CHEM, V268, P1252; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; Rothstein R, 2000, GENE DEV, V14, P1; SCHILD D, 1995, GENETICS, V140, P115; SHERMAN F, 1991, P21; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smith J, 1999, GENETICS, V151, P447; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Watt PM, 1996, GENETICS, V144, P935; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	26	299	302	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2000	25	2					192	194		10.1038/76055			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	WOS:000087459200019	10835635				2022-01-24	
J	Delpire, E; Lu, JM; England, R; Dull, C; Thorne, T				Delpire, E; Lu, JM; England, R; Dull, C; Thorne, T			Deafness and imbalance associated with inactivation of the secretory Ma-K-2Cl co-transporter	NATURE GENETICS			English	Article							K-CL COTRANSPORTER; INNER-EAR; NA-K-2CL COTRANSPORTER; MOLECULAR-CLONING; LOOP DIURETICS; LOCALIZATION; CELLS; GENE; EXPRESSION; MUTATION	Deaf ness can result from a variety of gene defects'. Some genes involved in the physiology of hearing encode membrane transporters that regulate the ionic composition of the fluid bathing the inner ear. The endolymph is an extracellular fluid with an atypical composition that resembles the intracellular milieu, high in K+ and low in Na+. Recent studies have emphasized the prominent role of K+ channels in endolymph secretion(2-4) and mechanical transduction(5). Coupled electroneutral transport of Na+, K+ and Cl- is: mediated by two isoforms of the. Na-K-2Cl cotransporter:the absorptive isoform BSC1 (also called NKCC2, encoded by SIc12a1 in mouse) that is exclusively expressed in kidney;- and BSC2/NKCC1 (encoded by SIc12a2 in mouse).: the secretory isoform which has a wider pattern of expression including epithelia, muscle cells; neurons, and red blood cells(6,7). These Eo-transporters: share 57% homology at the amino acid level(8-11) and are pharmacologically inhibited by loop diuretics. There is functional(12-14) and histochemical(15-17) evidence for the presence of the secretory isoform of the Na-K-2Cl co-transporter in gerbil. rat and rabbit inner ear. We disrupted mouse SIc12a2 and report here that SIc12a2(-/-) mice are deaf and exhibit classic shaker/waltzer behaviour, indicative of inner-ear defects. We localized the co-transporter to key secreting epithelia of the mouse inner ear and-show that absence of functional co-transporter leads to structural damages in the inner ear consistent with a decrease in endolymph secretion.	Vanderbilt Univ, Med Ctr, Anesthesiol Res Div, Labs Cellular & Mol Physiol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA		Delpire, E (corresponding author), Vanderbilt Univ, Med Ctr, Anesthesiol Res Div, Labs Cellular & Mol Physiol, Nashville, TN 37232 USA.						ALVAREZLEEFMANS FJ, 1998, PRESYNAPTIC INHIBITI, P50; Belal A Jr, 1980, Am J Otolaryngol, V1, P275, DOI 10.1016/S0196-0709(80)80030-5; COOPERMAN LB, 1973, AM HEART J, V85, P831, DOI 10.1016/0002-8703(73)90434-1; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Goto S, 1997, BRAIN RES, V765, P324, DOI 10.1016/S0006-8993(97)00679-3; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Ikeda K, 1997, HEARING RES, V107, P1, DOI 10.1016/S0378-5955(97)00009-9; Kalatzis V, 1998, HUM MOL GENET, V7, P1589, DOI 10.1093/hmg/7.10.1589; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; MARCUS DC, 1987, HEARING RES, V30, P55, DOI 10.1016/0378-5955(87)90183-3; MARCUS NY, 1987, AM J PHYSIOL, V253, pF613, DOI 10.1152/ajprenal.1987.253.4.F613; Mizuta K, 1997, HEARING RES, V106, P154, DOI 10.1016/S0378-5955(97)00010-5; Mount DB, 1998, J EXP BIOL, V201, P2091; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; ROSE BD, 1991, KIDNEY INT, V39, P336, DOI 10.1038/ki.1991.43; RYBAK LP, 1993, OTOLARYNG CLIN N AM, V26, P829; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; SHIGA N, 1995, BBA-BIOMEMBRANES, V1240, P48, DOI 10.1016/0005-2736(95)00175-1; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S	30	299	317	1	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					192	195		10.1038/9713			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	WOS:000080680900028	10369265				2022-01-24	
J	Shiels, A; Mackay, D; Ionides, A; Berry, V; Moore, A; Bhattacharya, S				Shiels, A; Mackay, D; Ionides, A; Berry, V; Moore, A; Bhattacharya, S			A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	47th Annual Meeting of the American-Society-of-Human-Genetics	OCT 28-NOV 01, 1997	BALTIMORE, MARYLAND	Amer Soc Human Genet			CONGENITAL CATARACT; CRYSTALLIN GENE; GAP-JUNCTION; HEREDITARY CATARACT; MOLECULAR-CLONING; LINKAGE ANALYSIS; BETA-CRYSTALLIN; PROTEIN MP70; LOCUS; MOUSE	CZP1, a locus for autosomal dominant "zonular pulveruleut" cataract, previously had been linked with the Duffy blood-group-antigen locus on chromosome Iq, Here we report genetic refinement of the CZP1 locus and show that the underlying mutation is present in GJA8, the gene for connexin50. To mag the CZP1: focus we performed linkage analysis using microsatellite markers on two distantly related branches of the original Ev, pedigree, which now spans eight generations. Significantly positive two-point LOD score (Z) values were obtained for markers D1S2669 (maximum Z [Z(max)] = 4.52; maximum recombination frequency [theta(max)] = 0) and D1S514 (Z(max) = 4.48; theta(max) = 0), Multipoint analysis gave Z(max) = 5.22 (theta(max) = 0) at marker D1S2669. Haplotyping indicated that CZP1 probably lies in the genetic interval D1S2746-(20.6 cM)-D1S2771. Sequence analysis of the entire protein-coding region of the GJA8 gene from the pedigree detected a C-->T transition in codon 88, which introduced a novel MnlI restriction-enzyme site that also cosegregated with the cataract, This missense mutation is predicted so result in the nonconservative substitution of serine for a phylogenetically conserved proline (P88S). These studies provide the first direct evidence that GJA8 plays a vital role in the maintenance of human lens transparency and identify the genetic defect believed to underlie the first inherited disease to be linked to a human autosome.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cataract Res Ctr, St Louis, MO 63110 USA; Inst Ophthalmol, Dept Mol Genet, London, England; Moorfields Eye Hosp, London, England		Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cataract Res Ctr, Box 8096, St Louis, MO 63110 USA.	shielsa@am.seer.wustl.edu	Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Mackay, Donna/0000-0002-2499-1203	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY011411, P30EY002687] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY02687, EY11411] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Adams P H, 1942, Br J Ophthalmol, V26, P152, DOI 10.1136/bjo.26.4.152; ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; Bort S, 1997, HUM GENET, V99, P746, DOI 10.1007/s004390050442; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; CHURCH RL, 1995, CURR EYE RES, V14, P215, DOI 10.3109/02713689509033517; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; FRANCOIS J, 1982, OPHTHALMOLOGICA, V184, P61, DOI 10.1159/000309186; Geyer D D, 1997, Mol Vis, V3, P13; Ionides ACW, 1997, HUM MOL GENET, V6, P47, DOI 10.1093/hmg/6.1.47; *J HOPK U, 1997, ONL MEND INH MAN OMI; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KERSCHER S, 1995, GENOMICS, V29, P445, DOI 10.1006/geno.1995.9983; Kramer P, 1996, GENOMICS, V35, P539, DOI 10.1006/geno.1996.0395; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; LUND AM, 1992, CLIN GENET, V41, P65; Mackay D, 1997, AM J HUM GENET, V60, P1474, DOI 10.1086/515468; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; Merin S., 1991, INHERITED EYE DIS, P86; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.0.CO;2-M; Nettleship E., 1909, T OPHTHAL SOC UK, V29, P188; NETTLESHIP E, 1906, T OPHTHAL SOC UK, V26, P191; PADMA T, 1995, AM J HUM GENET, V57, P840; RENWICK J H, 1970, Journal of Medical Genetics, V7, P239, DOI 10.1136/jmg.7.3.239; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; RODRIGUEZ IR, 1992, BIOCHIM BIOPHYS ACTA, V1180, P44, DOI 10.1016/0925-4439(92)90025-I; Rogaev EI, 1996, HUM MOL GENET, V5, P699, DOI 10.1093/hmg/5.5.699; SCOTT MH, 1994, OPHTHALMOLOGY, V101, P866; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Steele E C Jr, 1997, Mol Vis, V3, P5; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; WAARDENBURG PJ, 1961, GENET OPHTHALMOL, V1, P863; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; WHITE TW, 1997, MOL BIOL CELL, V8, P93; Yang DI, 1996, CURR EYE RES, V15, P307, DOI 10.3109/02713689609007625; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	49	299	315	1	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					526	532		10.1086/301762			7	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	WOS:000072894400005	9497259	Green Published, Bronze			2022-01-24	
J	Bianchi, DW; Williams, JM; Sullivan, LM; Hanson, FW; Klinger, KW; Shuber, AP				Bianchi, DW; Williams, JM; Sullivan, LM; Hanson, FW; Klinger, KW; Shuber, AP			PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	46th Annual Meeting of the American-Society-of-Human-Genetics	OCT 29-NOV 02, 1996	SAN FRANCISCO, CA	Amer Soc Human Genet			PRENATAL-DIAGNOSIS; PERIPHERAL-BLOOD; TRISOMY-21; KARYOTYPE	Fetal cells in maternal blood are a noninvasive source of fetal genetic material for prenatal diagnosis. We determined the number of fetal-cell DNA equivalents present in maternal whole-blood samples to deduce whether this number is affected by fetal karyotype. Peripheral blood samples were obtained from 199 women carrying chromosomally normal fetuses and from 31 women with male aneuploid fetuses. Male fetal-cell DNA-equivalent quantitation was determined by PCR amplification of a Y chromosome-specific sequence and was compared with PCR product amplified from known concentrations of male DNA run simultaneously. The mean number of male fetal-cell DNA equivalents detected in 16-ml blood samples from 30 women bearing a 46,XY fetus was 19 (range 0-31). The mean number of male fetal-cell DNA equivalents detected in 109 women bearing a 46,XX fetus was 2 (range 0-24). The mean number of male fetal-cell DNA equivalents detected when the fetus was male compared with when the fetus was female was highly significant (P = .0001). More fetal cells were detected in maternal blood when the fetus was aneuploid. The mean number of male fetal-cell DNA equivalents detected when the fetal karyotype was 47,XY,+21 was 110 (range 0.1-650), which was significantly higher than the number of male fetal-cell DNA equivalents detected in 46,XY fetuses (P = .0001). Fete-maternal transfusion of nucleated cells appears to be influenced by fetal karyotype. The sixfold elevation of fetal cells observed in maternal blood when the fetus had trisomy 21 indicates that noninvasive cytogenetic diagnosis of trisomy 21 should be feasible.	TUFTS UNIV NEW ENGLAND MED CTR,DEPT OBSTET & GYNECOL,BOSTON,MA 02111; TUFTS UNIV,SCH MED,BOSTON,MA 02111; BOSTON MED CTR,GEN INTERNAL MED SECT,RES UNIT,BOSTON,MA; GENZYME CORP,CAMBRIDGE,MA; PRENATAL DIAGNOST & IMAGING CTR,SACRAMENTO,CA; GENZYME GENET,FRAMINGHAM,MA		Bianchi, DW (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR,DEPT PEDIAT,750 WASHINGTON ST,BOX 394,BOSTON,MA 02111, USA.			Sullivan, Lisa/0000-0003-0726-7149			ALLEN FH, 1982, RH HEMOLYTIC DIS NEW, P1; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1994, AM J OBSTET GYNECOL, V171, P922, DOI 10.1016/S0002-9378(94)70059-1; BIANCHI DW, 1992, HUM GENET, V90, P368; BIANCHI DW, 1995, J PEDIATR-US, V127, P847, DOI 10.1016/S0022-3476(95)70018-8; DELACRUZ F, 1995, AM J OBSTET GYNECOL, V173, P1354, DOI 10.1016/0002-9378(95)91393-9; ELIAS S, 1992, LANCET, V340, P1033, DOI 10.1016/0140-6736(92)93041-K; GANSHIRTAHLERT D, 1993, AM J REPROD IMMUNOL, V30, P194; HAWES CS, 1994, AM J OBSTET GYNECOL, V170, P1297; KUHLMANN RS, 1990, AM J OBSTET GYNECOL, V163, P1264, DOI 10.1016/0002-9378(90)90704-B; LABBE S, 1989, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V18, P989; LUCOTTE G, 1991, MOL CELL PROBE, V5, P359, DOI 10.1016/S0890-8508(06)80007-1; PRICE JO, 1991, AM J OBSTET GYNECOL, V165, P1731, DOI 10.1016/0002-9378(91)90024-L; READING JP, 1995, HUM REPROD, V10, P2510; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; STROBEL SL, 1989, ARCH PATHOL LAB MED, V109, P775; SULLIVAN LM, 1992, J DENT RES, V71, P1938, DOI 10.1177/00220345920710121601; TAKABAYASHI H, 1995, PRENATAL DIAG, V15, P74, DOI 10.1002/pd.1970150116; VERLOES A, 1995, AM J OBSTET GYNECOL, V172, P167, DOI 10.1016/0002-9378(95)90108-6; Wald NJ, 1995, PRENATAL DIAG, V15, P1227, DOI 10.1002/pd.1970151305; WESSMAN M, 1992, PRENATAL DIAG, V12, P993, DOI 10.1002/pd.1970121204; ZHENG YL, 1995, PRENATAL DIAG, V15, P897, DOI 10.1002/pd.1970151004	22	299	316	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					822	829		10.1086/514885			8	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	WOS:A1997YA59100008	9382092	Bronze, Green Published			2022-01-24	
J	Wilson, RB; Roof, DM				Wilson, RB; Roof, DM			Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; FRIEDREICHS ATAXIA; CRITICAL REGION; PET MUTANTS; VITAMIN-E; PROTEIN; RNA; MUTATIONS; MENADIONE; MEDICINE	Friedreich's ataxia (FRDA) is an autosomal recessive degenerative disorder that primarily affects the nervous system and heart. Patients with FRDA have point mutations or trinucleotide repeat expansions in both alleles of FRDA, which encodes a protein termed frataxin. We show that the yeast frataxin homologue, which we have named YFH1, localizes to mitochondria and is required to maintain mitochondrial DNA, The YFH1-homologous domain of frataxin functions in yeast and a disease-associated missense mutation of this domain, or the corresponding domain in YFH1, reduces function. Our data suggest that mitochondrial dysfunction contributes to FRDA pathophysiology.	UNIV PENN,DEPT PHYSIOL,PHILADELPHIA,PA 19104		Wilson, RB (corresponding author), UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104, USA.						Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P646, DOI 10.1017/S0317167100035228; BARBEAU A, 1980, CAN J NEUROL SCI, V7, P455, DOI 10.1017/S0317167100023064; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; CARVAJAL JJ, 1995, HUM MOL GENET, V4, P1411, DOI 10.1093/hmg/4.8.1411; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; GARN H, 1994, J IMMUNOL METHODS, V168, P253, DOI 10.1016/0022-1759(94)90062-0; GENGA A, 1986, J BIOL CHEM, V261, P9328; JAHN B, 1995, J CLIN MICROBIOL, V33, P661, DOI 10.1128/JCM.33.3.661-667.1995; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KOOBS DH, 1978, ARCH PATHOL LAB MED, V102, P66; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L; Mastrogiacomo F, 1996, NEURODEGENERATION, V5, P27, DOI 10.1006/neur.1996.0004; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MONTERMINI L, 1995, AM J HUM GENET, V57, P1061; MUELLER DM, 1987, CURR GENET, V11, P359, DOI 10.1007/BF00378178; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Rose MD, 1990, METHODS YEAST GENETI; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; SANYAL A, 1995, MOL GEN GENET, V246, P56, DOI 10.1007/BF00290133; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1984, P NATL ACAD SCI-BIOL, V81, P8, DOI 10.1073/pnas.81.1.8; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; TAPPEL AL, 1972, ANN NY ACAD SCI, V203, P12, DOI 10.1111/j.1749-6632.1972.tb27851.x; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604; [No title captured]	33	299	305	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					352	357		10.1038/ng0897-352			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	WOS:A1997XM90900016	9241271				2022-01-24	
J	BLOUIN, MS; YOWELL, CA; COURTNEY, CH; DAME, JB				BLOUIN, MS; YOWELL, CA; COURTNEY, CH; DAME, JB			HOST MOVEMENT AND THE GENETIC-STRUCTURE OF POPULATIONS OF PARASITIC NEMATODES	GENETICS			English	Article							MITOCHONDRIAL-DNA; ANTHELMINTIC RESISTANCE; INSECTICIDE RESISTANCE; NATURAL-POPULATIONS; UNITED-STATES; VARIABILITY; PHYLOGENY	Mitochondrial DNA (mtDNA) sequence data were used to compare the population genetic structures of five species of parasitic nematodes from three different hosts: Ostertagia ostertagi and Haemonchus placei from cattle, H. contortus and Teladorsagia circumcincta from sheep, and Mazamastrongylus odocoilei from white-tailed deer. The parasites of sheep and cattle showed a pattern consistent with high gene flow among populations. The parasite of deer showed a pattern of substantial population subdivision and isolation by distance. It appears that host movement is an important determinant of population genetic structure in these nematodes. High gene flow in the parasites of livestock also indicates great opportunity for the spread of rare alleles that confer resistance to anthelmintic drugs. All species, including the parasite of deer, had unusually high within-population diversities (averages of 0.019-0.027 substitutions per site between pairs of individuals from the same population). Large effective population sizes (Ne), perhaps in combination with rapid mtDNA evolution, appear to be the most likely explanation for these high within-population diversities.	UNIV FLORIDA, COLL VET MED, DEPT INFECT DIS, GAINESVILLE, FL 32611 USA					Dame, John B./0000-0002-5772-5454			ANDERSON TJC, 1995, PARASITOLOGY, V110, P221, DOI 10.1017/S003118200006399X; ANDERSON TJC, 1993, PARASITOLOGY, V107, P319, DOI 10.1017/S0031182000079294; AVISE JC, 1979, P NATL ACAD SCI USA, V76, P6694, DOI 10.1073/pnas.76.12.6694; AVISE JC, 1984, EVOLUTION, V38, P931, DOI 10.1111/j.1558-5646.1984.tb00364.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BEECH RN, 1994, GENETICS, V138, P103; BERMINGHAM E, 1986, GENETICS, V113, P939; BJORN H, 1994, VET PARASITOL, V54, P321, DOI 10.1016/0304-4017(94)90106-6; BLOUIN MS, 1992, EVOLUTION, V46, P470, DOI 10.2307/2409865; CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611; CRAIG TM, 1993, VET PARASITOL, V46, P121, DOI 10.1016/0304-4017(93)90053-P; ELLSWORTH DL, 1994, EVOLUTION, V48, P122, DOI 10.1111/j.1558-5646.1994.tb01299.x; Felsenstein J, 1991, PHYLIP PHYLOGENY INF; Hayes John P., 1992, Systematic Biology, V41, P331, DOI 10.2307/2992570; HUGALL A, 1994, GENETICS, V136, P903; LYDEARD C, 1989, CAN J ZOOL, V67, P2021, DOI 10.1139/z89-287; LYMBERY AJ, 1990, PARASITOLOGY, V101, P283, DOI 10.1017/S0031182000063344; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; MULVEY M, 1991, EVOLUTION, V44, P942; NADLER SA, 1995, J PARASITOL, V81, P385, DOI 10.2307/3283820; NADLER SA, 1995, J PARASITOL, V81, P395, DOI 10.2307/3283821; NADLER SA, 1990, INT J PARASITOL, V20, P11, DOI 10.1016/0020-7519(90)90168-M; NASCETTI G, 1993, INT J PARASITOL, V23, P105, DOI 10.1016/0020-7519(93)90103-6; OKIMOTO R, 1994, J MOL EVOL, V39, P598, DOI 10.1007/BF00160405; OKIMOTO R, 1992, GENETICS, V130, P471; PHILIPPE H, 1994, DEVELOPMENT, P15; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Roush R. T., 1990, PESTICIDE RESISTANCE, DOI DOI 10.1007/978-1-4684-6429-0; SHOOP WL, 1993, PARASITOL TODAY, V9, P154, DOI 10.1016/0169-4758(93)90136-4; TABASHNIK BE, 1990, PESTICIDE RESISTANCE, P154; THOMPSON RCA, 1990, PARASITOL TODAY, V6, P345, DOI 10.1016/0169-4758(90)90410-6; UYENOYAMA MK, 1986, PESTICIDE RESISTANCE, P207; VARADY M, 1993, VET REC, V132, P387, DOI 10.1136/vr.132.15.387; WALLER PJ, 1993, VET PARASITOL, V46, P133, DOI 10.1016/0304-4017(93)90054-Q; Wyk J. A. van, 1990, Resistance of parasites to antiparasitic drugs: Round Table Conference, ICOPA VII Paris 1990., P103	35	299	307	0	35	GENETICS SOC AM	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	1943-2631			GENETICS	Genetics	NOV	1995	141	3					1007	1014					8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TB629	WOS:A1995TB62900018	8582607				2022-01-24	
J	ABERDAM, D; GALLIANO, MF; VAILLY, J; PULKKINEN, L; BONIFAS, J; CHRISTIANO, AM; TRYGGVASON, K; UITTO, J; EPSTEIN, EH; ORTONNE, JP; MENEGUZZI, G				ABERDAM, D; GALLIANO, MF; VAILLY, J; PULKKINEN, L; BONIFAS, J; CHRISTIANO, AM; TRYGGVASON, K; UITTO, J; EPSTEIN, EH; ORTONNE, JP; MENEGUZZI, G			HERLITZS JUNCTIONAL EPIDERMOLYSIS-BULLOSA IS LINKED TO MUTATIONS IN THE GENE (LAMC2) FOR THE GAMMA-2 SUBUNIT OF NICEIN/KALININ (LAMININ-5)	NATURE GENETICS			English	Article							MONOCLONAL-ANTIBODY; BASEMENT-MEMBRANES; PROTEINS; PROBE	We have linked Herlitz's junctional epidermolysis bullosa (H-JEB) to the gene (LAMC2) encoding the gamma 2 subunit of nicein/kalinin, an isolaminin (laminin-5) expressed by basal keratinocytes. In four H-JEB kindreds, a maximum two-point lod score of 5.33 at theta=0 was observed between a microsatellite near LAMC2 at 1q25-31 and the disease. In one family, a homozygous point mutation leading to a premature stop codon (CGA to TGA) was identified in exon 3 of the gene. The segregation of the mutated allele implicates the mutation in the pathology of the disorder and corroborates the linkage results.	FAC MED NICE,INSERM,U385,F-06107 NICE 2,FRANCE; THOMAS JEFFERSON UNIV,DEPT DERMATOL,PHILADELPHIA,PA 19107; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT DERMATOL,SAN FRANCISCO,CA 94110; UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND				Aberdam, Daniel/G-3299-2013	Aberdam, Daniel/0000-0002-4019-5418	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01-AR 41120, P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P01AR038923, R01AR041120] Funding Source: NIH RePORTER		ABERDAM D, IN PRESS MAMM GENOME; BARE JW, 1992, CANCER RES, V52, P1494; BAUDOIN C, IN PRESS J INVEST DE; BROWN DL, 1992, NUCLEIC ACIDS RES, V200, P141; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; BURGESON RE, IN PRESS J CLIN INVE; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1986, INT J DERMATOL, V25, P143, DOI 10.1111/j.1365-4362.1986.tb02206.x; FINE JD, 1990, ARCH DERMATOL, V126, P1187, DOI 10.1001/archderm.126.9.1187; GERECKE D, IN PRESS J BIOL CHEM; GROUP NCC, 1992, SCIENCE, V258, P148; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; ORTONNE JP, 1990, J INVEST DERMATOL, V94, P400; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SAKAI LI, 1986, J CELL BIOL, V114, P1567; Sambrook J.F., 1989, MOL CLONING LAB MANU, V2nd ed.; SIMON M, 1985, CELL, V40, P677, DOI 10.1016/0092-8674(85)90216-8; UITTO J, 1993, SEMIN DERMATOL, V12, P191; VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x; VAILLY J, IN PRESS GENOMICS; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; VERRANDO P, 1993, J INVEST DERMATOL, V101, P738, DOI 10.1111/1523-1747.ep12371685; VERRANDO P, 1991, LAB INVEST, V64, P85; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOODLEY DT, 1992, EPIDERMOLYSIS BULLOS, P19	35	299	300	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					299	304		10.1038/ng0394-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	WOS:A1994MZ56200019	8012394				2022-01-24	
J	KNOWLER, WC; WILLIAMS, RC; PETTITT, DJ; STEINBERG, AG				KNOWLER, WC; WILLIAMS, RC; PETTITT, DJ; STEINBERG, AG			GM3-5,13,14 AND TYPE-2 DIABETES-MELLITUS - AN ASSOCIATION IN AMERICAN-INDIANS WITH GENETIC ADMIXTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BLOOD SYST INC,HISTOCOMPATIBIL LAB,SCOTTSDALE,AZ; ARIZONA STATE UNIV,DEPT ANTHROPOL,TEMPE,AZ 85287; CASE WESTERN RESERVE UNIV,DEPT BIOL,CLEVELAND,OH 44106		KNOWLER, WC (corresponding author), NIDDKD,DIABET & ARTHRITIS EPIDEMIOL SECT,1550 E INDIAN SCH RD,PHOENIX,AZ 85014, USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284			ADAMS DD, 1984, LANCET, V1, P420; BENNETT PH, 1971, LANCET, V2, P125; Berg K, 1967, Diabetologia, V3, P30, DOI 10.1007/BF01269908; Breslow N, 1980, STATISTICAL METHODS, V32; BRIGGS BR, 1980, DIABETES, V29, P68, DOI 10.2337/diabetes.29.1.68; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CHAKRABORTY R, 1986, AM J PHYS ANTHROPOL, V70, P489, DOI 10.1002/ajpa.1330700408; DAUSSET J, 1977, HLA DISEASE; DREVETS C C, 1965, J Okla State Med Assoc, V58, P322; FIELD LL, 1984, LANCET, V1, P1132; GARDNER LI, 1984, DIABETES, V33, P86, DOI 10.2337/diabetes.33.1.86; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KNOWLER WC, 1983, AM J PHYS ANTHROPOL, V62, P107, DOI 10.1002/ajpa.1330620114; MANTEL N, 1959, J NATL CANCER I, V22, P719; NAKAO Y, 1981, NEW ENGL J MED, V304, P407, DOI 10.1056/NEJM198102123040706; REED TE, 1969, AM J HUM GENET, V21, P71; SCHANFIELD MS, 1981, AM J HUM GENET, V33, pA133; SERJEANTSON SW, 1983, DIABETOLOGIA, V25, P13; SERJEANTSON SW, 1981, MED J AUSTRALIA, V1, P462, DOI 10.5694/j.1326-5377.1981.tb135735.x; SMOUSE PE, 1982, BIOMETRICS, V38, P757, DOI 10.2307/2530055; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; STERN MP, 1986, DIABETES, V35, P387, DOI 10.2337/diabetes.35.4.387; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; SVEJGAARD A, 1977, HLA DISEASE, P46; TIWARI JL, 1985, HLA DISEASE ASS; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WILLIAMS RC, 1981, DIABETOLOGIA, V21, P460; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; [No title captured]; 1985, WHO TECH REP SER, V727	32	299	311	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					520	526					7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	WOS:A1988Q473600020	3177389				2022-01-24	
J	Jin, JJ; Yu, WB; Yang, JB; Song, Y; dePamphilis, CW; Yi, TS; Li, DZ				Jin, Jian-Jun; Yu, Wen-Bin; Yang, Jun-Bo; Song, Yu; dePamphilis, Claude W.; Yi, Ting-Shuang; Li, De-Zhu			GetOrganelle: a fast and versatile toolkit for accurate de novo assembly of organelle genomes	GENOME BIOLOGY			English	Article						Assembler; Assembly graph; Plastome; Mitogenome; Organelle genome	PLASTID GENOME; PLANT MITOCHONDRIAL; HORIZONTAL TRANSFER; CHLOROPLAST GENOME; DNA; EVOLUTION; GENE; DIVERSIFICATION; DYNAMICS; REVEAL	GetOrganelle is a state-of-the-art toolkit to accurately assemble organelle genomes from whole genome sequencing data. It recruits organelle-associated reads using a modified "baiting and iterative mapping" approach, conducts de novo assembly, filters and disentangles the assembly graph, and produces all possible configurations of circular organelle genomes. For 50 published plant datasets, we are able to reassemble the circular plastomes from 47 datasets using GetOrganelle. GetOrganelle assemblies are more accurate than published and/or NOVOPlasty-reassembled plastomes as assessed by mapping. We also assemble complete mitochondrial genomes using GetOrganelle. GetOrganelle is freely released under a GPL-3 license (https://github.com/Kinggerm/GetOrganelle).	[Jin, Jian-Jun; Yang, Jun-Bo; Yi, Ting-Shuang; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Yunnan, Peoples R China; [Yu, Wen-Bin; Song, Yu] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China; [Yu, Wen-Bin; Song, Yu] Chinese Acad Sci, Core Bot Gardens, Ctr Conservat Biol, Mengla 666303, Yunnan, Peoples R China; [Yu, Wen-Bin; Song, Yu] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Yezin 05282, Nay Pyi Taw, Myanmar; [dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16801 USA		Yi, TS; Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming 650201, Yunnan, Peoples R China.	tingshuangyi@mail.kib.ac.cn; dzl@mail.kib.ac.cn	Jin, JianJun/ABG-2920-2021; Li, De-Zhu/G-8203-2011	Jin, JianJun/0000-0002-7557-9198; Li, De-Zhu/0000-0002-4990-724X	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB31000000]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31720103903, 31870196]; CAS Large-scale Scientific Facilities [2017-LSFGBOWS-02]; CAS 135 Program [2017XTBG-T03]; open research project of "CrossCooperative Team" of the Germplasm Bank of Wild Species, Kunming Institute of Botany, Chinese Academy of Sciences	This study was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) (XDB31000000), the National Natural Science Foundation of China [key international (regional) cooperative research project No.31720103903], the CAS Large-scale Scientific Facilities (2017-LSFGBOWS-02), the open research project of "CrossCooperative Team" of the Germplasm Bank of Wild Species, Kunming Institute of Botany, Chinese Academy of Sciences, the National Natural Science Foundation of China (31870196), and the CAS 135 Program (2017XTBG-T03).	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bakker FT, 2016, BIOL J LINN SOC, V117, P33, DOI 10.1111/bij.12642; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bock R, 2012, GENOMICS CHLOROPLAST; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Fajardo D, 2013, TREE GENET GENOMES, V9, P489, DOI 10.1007/s11295-012-0573-9; Fu┬rster, 2020, LANDSCAPE CHLOROPLAS, DOI DOI 10.1101/665869; Gitzendanner MA, 2018, ADV BOT RES, V85, P293, DOI 10.1016/bs.abr.2017.11.016; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Graham SW, 2017, NEW PHYTOL, V214, P48, DOI 10.1111/nph.14398; Gualberto JM, 2017, ANNU REV PLANT BIOL, V68, P225, DOI 10.1146/annurev-arplant-043015-112232; Gualberto JM, 2014, BIOCHIMIE, V100, P107, DOI 10.1016/j.biochi.2013.09.016; Guo QQ, 2016, MITOCHONDRIAL DNA A, V27, P4355, DOI 10.3109/19401736.2015.1089498; Guo WH, 2016, MOL BIOL EVOL, V33, P1448, DOI 10.1093/molbev/msw024; Guo WH, 2014, GENOME BIOL EVOL, V6, P580, DOI 10.1093/gbe/evu046; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI [10.1098/rspb.2002.2218, 10.1098/rsbl.2003.0025]; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ivanova Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00204; Jackman SD, 2019, BIORXIV, DOI [10.1101/601104, DOI 10.1101/601104]; James JE, 2016, MOL ECOL, V25, P67, DOI 10.1111/mec.13475; Kolesnikov AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1424, DOI 10.1134/S0006297912130020; Kusmirek W, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2281-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HT, 2019, NAT PLANTS, V5, P461, DOI 10.1038/s41477-019-0421-0; Lilly JW, 2001, PLANT CELL, V13, P245, DOI 10.1105/tpc.13.2.245; Lima MS, 2016, MOL ECOL RESOUR, V16, P1279, DOI 10.1111/1755-0998.12585; Logacheva MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30042; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11608; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Meng GL, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz173; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mower JP, 2019, NEW PHYTOL, V222, P1061, DOI 10.1111/nph.15650; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Qu XJ, 2017, GENOME BIOL EVOL, V9, P1110, DOI 10.1093/gbe/evx071; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Roquet C, 2016, ANN BOT-LONDON, V118, P885, DOI 10.1093/aob/mcw135; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Straub SCK, 2013, GENOME BIOL EVOL, V5, P1872, DOI 10.1093/gbe/evt140; Su HJ, 2019, P NATL ACAD SCI USA, V116, P934, DOI 10.1073/pnas.1816822116; Sullivan AR, 2017, MOL BIOL EVOL, V34, P1689, DOI 10.1093/molbev/msx111; Tonti-Filippini J, 2017, PLANT J, V90, P808, DOI 10.1111/tpj.13491; Tsumura Y, 2000, MOL BIOL EVOL, V17, P1302, DOI 10.1093/oxfordjournals.molbev.a026414; Twyford AD, 2017, MOL ECOL RESOUR, V17, P858, DOI 10.1111/1755-0998.12626; Walker JF, 2015, AM J BOT, V102, P1751, DOI 10.3732/ajb.1500299; Wang YH, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00138; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Wicke S, 2018, ADV BOT RES, V85, P315, DOI 10.1016/bs.abr.2017.11.014; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31; Zhang N, 2017, PLANTA MED, V83, P1420, DOI 10.1055/s-0043-113449; Zhang SD, 2017, NEW PHYTOL, V214, P1355, DOI 10.1111/nph.14461	63	298	302	41	90	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	SEP 10	2020	21	1							241	10.1186/s13059-020-02154-5			31	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	NS5HV	WOS:000572293100001	32912315	gold, Green Submitted, Green Published	Y	Y	2022-01-24	
J	Putnam, NH; O'Connell, BL; Stites, JC; Rice, BJ; Blanchette, M; Calef, R; Troll, CJ; Fields, A; Hartley, PD; Sugnet, CW; Haussler, D; Rokhsar, DS; Green, RE				Putnam, Nicholas H.; O'Connell, Brendan L.; Stites, Jonathan C.; Rice, Brandon J.; Blanchette, Marco; Calef, Robert; Troll, Christopher J.; Fields, Andrew; Hartley, Paul D.; Sugnet, Charles W.; Haussler, David; Rokhsar, Daniel S.; Green, Richard E.			Chromosome-scale shotgun assembly using an in vitro method for long-range linkage	GENOME RESEARCH			English	Article							HYBRID ERROR-CORRECTION; STRUCTURAL VARIATION; GENOME ASSEMBLIES; MAMMALIAN GENOMES	Long-range and highly accurate de novo assembly from short-read data is one of the most pressing challenges in genomics. Recently, it has been shown that read pairs generated by proximity ligation of DNA in chromatin of living tissue can address this problem, dramatically increasing the scaffold contiguity of assemblies. Here, we describe a simpler approach ("Chicago") based on in vitro reconstituted chromatin. We generated two Chicago data sets with human DNA and developed a statistical model and a new software pipeline ("HiRise") that can identify poor quality joins and produce accurate, long-range sequence scaffolds. We used these to construct a highly accurate de novo assembly and scaffolding of a human genome with scaffold N50 of 20 Mbp. We also demonstrated the utility of Chicago for improving existing assemblies by reassembling and scaffolding the genome of the American alligator. With a single library and one lane of Illumina HiSeq sequencing, we increased the scaffold N50 of the American alligator from 508 kbp to 10 Mbp.	[Putnam, Nicholas H.; O'Connell, Brendan L.; Stites, Jonathan C.; Rice, Brandon J.; Blanchette, Marco; Calef, Robert; Troll, Christopher J.; Fields, Andrew; Hartley, Paul D.; Sugnet, Charles W.; Green, Richard E.] Dovetail Genom LLC, Santa Cruz, CA 95060 USA; [O'Connell, Brendan L.; Haussler, David; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95066 USA; [Haussler, David] Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95066 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95066 USA; [Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA		Green, RE (corresponding author), Dovetail Genom LLC, Santa Cruz, CA 95060 USA.; Green, RE (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95066 USA.	ed@soe.ucsc.edu	; Putnam, Nicholas/B-9968-2008	Green, Richard/0000-0003-0516-5827; Rokhsar, Daniel/0000-0002-8704-2224; Putnam, Nicholas/0000-0002-1315-782X	NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54HG007990] Funding Source: NIH RePORTER; Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U54 HG007990] Funding Source: Medline		Adey A, 2014, GENOME RES, V24, P2041, DOI 10.1101/gr.178319.114; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Chapman JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023501; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marie-Nelly H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6695; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Sheridan C, 2014, NAT BIOTECHNOL, V32, P111, DOI [10.1038/nbt0214-111, 10.1038/nbt0214-115a]; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Torjesen I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6690; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Weisenfeld NI, 2014, NAT GENET, V46, P1350, DOI 10.1038/ng.3121; Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112; WU CC, 2012, NAT METHODS, V9, pR1, DOI DOI 10.1038/nmeth.f.358; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	37	298	299	0	40	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	MAR	2016	26	3					342	350		10.1101/gr.193474.115			9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	DF5EF	WOS:000371373900006	26848124	hybrid, Green Submitted, Green Published	Y	N	2022-01-24	
J	Krumm, N; Turner, TN; Baker, C; Vives, L; Mohajeri, K; Witherspoon, K; Raja, A; Coe, BP; Stessman, HA; He, ZX; Leal, SM; Bernier, R; Eichler, EE				Krumm, Niklas; Turner, Tychele N.; Baker, Carl; Vives, Laura; Mohajeri, Kiana; Witherspoon, Kali; Raja, Archana; Coe, Bradley P.; Stessman, Holly A.; He, Zong-Xiao; Leal, Suzanne M.; Bernier, Raphael; Eichler, Evan E.			Excess of rare, inherited truncating mutations in autism	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; TRANSMISSION DISEQUILIBRIUM; GROWTH-FACTOR; GENES; MODEL; DELETIONS; SUPPORTS; CHD8; RISK; CNVS	To assess the relative impact of inherited and de novo variants on autism risk, we generated a comprehensive set of exonic single-nucleotide variants (SNVs) and copy number variants (CNVs) from 2,377 families with autism. We find that private, inherited truncating SNVs in conserved genes are enriched in probands (odds ratio = 1.14, P = 0.0002) in comparison to unaffected siblings, an effect involving significant maternal transmission bias to sons. We also observe a bias for inherited CNVs, specifically for small (<100 kb), maternally inherited events (P = 0.01) that are enriched in CHD8 target genes (P = 7.4 x 10(-3)). Using a logistic regression model, we show that private truncating SNVs and rare, inherited CNVs are statistically independent risk factors for autism, with odds ratios of 1.11 (P = 0.0002) and 1.23 (P = 0.01), respectively. This analysis identifies a second class of candidate genes (for example, RIMS 1, CUL7 and LZTR1) where transmitted mutations may create a sensitized background but are unlikely to be completely penetrant.	[Krumm, Niklas; Turner, Tychele N.; Baker, Carl; Vives, Laura; Mohajeri, Kiana; Witherspoon, Kali; Raja, Archana; Coe, Bradley P.; Stessman, Holly A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98104 USA; [Raja, Archana; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [He, Zong-Xiao; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98104 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009	Stessman, Holly/0000-0002-0764-3493; Turner, Tychele/0000-0001-8246-6477; Coe, Bradley/0000-0001-8471-4016	US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01MH100233]; National Institute for Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101221, R01MH100047]; Simons Foundation [SFARI 89368, SFARI 137578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101221, R01MH100047, U01MH100233] Funding Source: NIH RePORTER	We thank D. Obenshain, D. Hall, B. Koser and S. Novikova for providing support for usage of the Amazon Cloud and for assistance in the deposition of SNV and CNV call sets into the National Database for Autism Research (NDAR). We are grateful to the laboratories of M. Wigler and M. State for providing early access to exome sequencing data as well as access to SNP microarray data. We also thank T. Brown for assistance in editing this manuscript. Funding for this study was provided, in part, by the US National Institutes of Health (1U01MH100233 to E.E.E.), by the National Institute for Mental Health (R01MH101221 to E.E.E. and R01MH100047 to R.B.) and by the Simons Foundation (SFARI 89368 to R.B. and SFARI 137578 to E.E.E.). E.E.E. is an investigator of the Howard Hughes Medical Institute. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). We appreciate obtaining access to phenotypic data on Simons Foundation Autism Research Initiative (SFARI) Base. Approved researchers can obtain the SSC population data set described in this study by applying at https://base.sfari.org/.	Autism, 2012, MMWR-MORBID MORTAL W, V61, P1; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Cukier HN, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-1; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; He ZX, 2014, AM J HUM GENET, V94, P33, DOI 10.1016/j.ajhg.2013.11.021; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; KURAHASHI H, 1995, HUM MOL GENET, V4, P541, DOI 10.1093/hmg/4.4.541; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Lupski JR, 2012, NAT GENET, V44, P1291, DOI 10.1038/ng.2479; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Petrovski S., 2013, PLOS GENET, V9; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Steinman G, 2013, MED HYPOTHESES, V80, P475, DOI 10.1016/j.mehy.2013.01.010; Subtil-Rodriguez A, 2014, NUCLEIC ACIDS RES, V42, P2185, DOI 10.1093/nar/gkt1161; TAYLOR JW, 1977, AM J EPIDEMIOL, V106, P260, DOI 10.1093/oxfordjournals.aje.a112461; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	38	298	300	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					582	588		10.1038/ng.3303			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	WOS:000355386500008	25961944	Green Accepted	Y	N	2022-01-24	
J	Al Olama, AA; Kote-Jarai, Z; Berndt, SI; Conti, DV; Schumacher, F; Han, Y; Benlloch, S; Hazelett, DJ; Wang, ZM; Saunders, E; Leongamornlert, D; Lindstrom, S; Jugurnauth-Little, S; Dadaev, T; Tymrakiewicz, M; Stram, DO; Rand, K; Wan, P; Stram, A; Sheng, X; Pooler, LC; Park, K; Xia, L; Tyrer, J; Kolonel, LN; Le Marchand, L; Hoover, RN; Machiela, MJ; Yeager, M; Burdette, L; Chung, CC; Hutchinson, A; Yu, K; Goh, C; Ahmed, M; Govindasami, K; Guy, M; Tammela, TLJ; Auvinen, A; Wahlfors, T; Schleutker, J; Visakorpi, T; Leinonen, KA; Xu, JF; Aly, M; Donovan, J; Travis, RC; Key, TJ; Siddiq, A; Canzian, F; Khaw, KT; Takahashi, A; Kubo, M; Pharoah, P; Pashayan, N; Weischer, M; Nordestgaard, BG; Nielsen, SF; Klarskov, P; Roder, MA; Iversen, P; Thibodeau, SN; McDonnell, SK; Schaid, DJ; Stanford, JL; Kolb, S; Holt, S; Knudsen, B; Coll, AH; Gapstur, SM; Diver, WR; Stevens, VL; Maier, C; Luedeke, M; Herkommer, K; Rinckleb, AE; Strom, SS; Pettaway, C; Yeboah, ED; Tettey, Y; Biritwum, RB; Adjei, AA; Tay, E; Truelove, A; Niwa, S; Choklcalingam, AP; Cannon-Albright, L; Cybulski, C; Wokolorczyk, D; Kluzniak, W; Park, J; Sellers, T; Lin, HY; Isaacs, WB; Partin, AW; Brenner, H; Dieffenbach, AK; Stegmaier, C; Chen, C; Giovannucci, EL; Ma, J; Stampfer, M; Penney, KL; Mucci, L; John, EM; Ingles, SA; Kittles, RA; Murphy, AB; Pandha, H; Michael, A; Kierzek, AM; Blot, W; Signorello, LB; Zheng, W; Albanes, D; Virtamo, J; Weinstein, S; Nemesure, B; Carpten, J; Leske, C; Wu, SY; Hennis, A; Kibel, AS; Rybicki, BA; Neslund-Dudas, C; Hsing, AW; Chu, L; Goodman, PJ; Klein, EA; Zheng, SL; Batra, J; Clements, J; Spurdle, A; Teixeira, MR; Paulo, P; Maia, S; Slavov, C; Kaneva, R; Mitev, V; Witte, JS; Casey, G; Gillanders, EM; Seminara, D; Riboli, E; Hamdy, FC; Coetzee, GA; Li, QY; Freedman, ML; Hunter, DJ; Muir, K; Gronberg, H; Nea, DE; Southey, M; Giles, GG; Severi, G; Cook, MB; Nakagawa, H; Wiklund, F; Kraft, P; Chanock, SJ; Henderson, BE; Easton, DF; Eeles, RA; Haiman, CA				Al Olama, Ali Amin; Kote-Jarai, Zsofia; Berndt, Sonja I.; Conti, David V.; Schumacher, Fredrick; Han, Ying; Benlloch, Sara; Hazelett, Dennis J.; Wang, Zhaoming; Saunders, Ed; Leongamornlert, Daniel; Lindstrom, Sara; Jugurnauth-Little, Sara; Dadaev, Tokhir; Tymrakiewicz, Malgorzata; Stram, Daniel O.; Rand, Kristin; Wan, Peggy; Stram, Alex; Sheng, Xin; Pooler, Loreall C.; Park, Karen; Xia, Lucy; Tyrer, Jonathan; Kolonel, Laurence N.; Le Marchand, Loic; Hoover, Robert N.; Machiela, Mitchell J.; Yeager, Merideth; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Goh, Chee; Ahmed, Mahbubl; Govindasami, Koveela; Guy, Michelle; Tammela, Teuvo L. J.; Auvinen, Anssi; Wahlfors, Tlina; Schleutker, Johanna; Visakorpi, Tapio; Leinonen, Katri A.; Xu, Jianfeng; Aly, Markus; Donovan, Jenny; Travis, Ruth C.; Key, Tim J.; Siddiq, Afshan; Canzian, Federico; Khaw, Kay-Tee; Takahashi, Atsushi; Kubo, Michiaki; Pharoah, Paul; Pashayan, Nora; Weischer, Maren; Nordestgaard, Borge G.; Nielsen, Sune F.; Klarskov, Peter; Roder, Martin Andreas; Iversen, Peter; Thibodeau, Stephen N.; McDonnell, Shannon K.; Schaid, Daniel J.; Stanford, Janet L.; Kolb, Suzanne; Holt, Sarah; Knudsen, Beatrice; Coll, Antonio Hurtado; Gapstur, Susan M.; Diver, W. Ryan; Stevens, Victoria L.; Maier, Christiane; Luedeke, Manuel; Herkommer, Kathleen; Rinckleb, Antje E.; Strom, Sara S.; Pettaway, Curtis; Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn; Truelove, Ann; Niwa, Shelley; Choklcalingam, Anand P.; Cannon-Albright, Lisa; Cybulski, Cezary; Wokolorczyk, Dominika; Kluzniak, Wojciech; Park, Jong; Sellers, Thomas; Lin, Hui-Yi; Isaacs, William B.; Partin, Alan W.; Brenner, Hermann; Dieffenbach, Aida Karina; Stegmaier, Christa; Chen, Constance; Giovannucci, Edward L.; Ma, Jing; Stampfer, Meir; Penney, Kathryn L.; Mucci, Lorelei; John, Esther M.; Ingles, Sue A.; Kittles, Rick A.; Murphy, Adam B.; Pandha, Hardev; Michael, Agnieszka; Kierzek, Andrzej M.; Blot, William; Signorello, Lisa B.; Zheng, Wei; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Nemesure, Barbara; Carpten, John; Leske, Cristina; Wu, Suh-Yuh; Hennis, Anselm; Kibel, Adam S.; Rybicki, Benjamin A.; Neslund-Dudas, Christine; Hsing, Ann W.; Chu, Lisa; Goodman, Phyllis J.; Klein, Eric A.; Zheng, S. Lilly; Batra, Jyotsna; Clements, Judith; Spurdle, Amanda; Teixeira, Manuel R.; Paulo, Paula; Maia, Sofia; Slavov, Chavdar; Kaneva, Radka; Mitev, Vanio; Witte, John S.; Casey, Graham; Gillanders, Elizabeth M.; Seminara, Daniella; Riboli, Elio; Hamdy, Freddie C.; Coetzee, Gerhard A.; Li, Qiyuan; Freedman, Matthew L.; Hunter, David J.; Muir, Kenneth; Gronberg, Henrik; Nea, David E.; Southey, Melissa; Giles, Graham G.; Severi, Gianluca; Cook, Michael B.; Nakagawa, Hidewaki; Wiklund, Fredrik; Kraft, Peter; Chanock, Stephen J.; Henderson, Brian E.; Easton, Douglas F.; Eeles, Rosalind A.; Haiman, Christopher A.		Breast Prostate Canc Cohort Consor; Practical Prostate Canc Associatio; COGS Consortium; GAME-ON ELLIPSE Consortium	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; MYOSIN VI; RISK; JAPANESE; GLIOMA; 22Q13; MEN	Genome-wide association studies (GWAS) have identified 76 variants associated with prostate cancer risk predominantly in populations of European ancestry. To identify additional susceptibility loci for this common cancer, we conducted a meta-analysis of >10 million SNPs in 43,303 prostate cancer cases and 43,737 controls from studies in populations of European, African, Japanese and Latino ancestry. Twenty-three new susceptibility loci were identified at association P < 5 x 10(-8); 15 variants were identified among men of European ancestry, 7 were identified in multi-ancestry analyses and 1 was associated with early-onset prostate cancer. These 23 variants, in combination with known prostate cancer risk variants, explain 33% of the familial risk for this disease in European-ancestry populations. These findings provide new regions for investigation into the pathogenesis of prostate cancer and demonstrate the usefulness of combining ancestrally diverse populations to discover risk loci for disease.	[Al Olama, Ali Amin; Benlloch, Sara; Tyrer, Jonathan; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Kote-Jarai, Zsofia; Saunders, Ed; Leongamornlert, Daniel; Jugurnauth-Little, Sara; Dadaev, Tokhir; Tymrakiewicz, Malgorzata; Goh, Chee; Ahmed, Mahbubl; Govindasami, Koveela; Guy, Michelle; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Berndt, Sonja I.; Wang, Zhaoming; Hoover, Robert N.; Machiela, Mitchell J.; Yeager, Merideth; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Cook, Michael B.; Chanock, Stephen J.] Natl Canc Inst, US NIH, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Conti, David V.; Schumacher, Fredrick; Han, Ying; Hazelett, Dennis J.; Stram, Daniel O.; Rand, Kristin; Wan, Peggy; Stram, Alex; Sheng, Xin; Pooler, Loreall C.; Park, Karen; Xia, Lucy; Ingles, Sue A.; Casey, Graham; Coetzee, Gerhard A.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Conti, David V.; Schumacher, Fredrick; Hazelett, Dennis J.; Stram, Daniel O.; Ingles, Sue A.; Casey, Graham; Coetzee, Gerhard A.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Wang, Zhaoming] SAIC Frederick Inc, Natl Canc Inst, Div Canc Epidemiol & Genet, Canc Genom Res Lab, Frederick, MD USA; [Lindstrom, Sara; Chen, Constance; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Tammela, Teuvo L. J.] Univ Tampere, Tampere Univ Hosp, Dept Urol, FIN-33101 Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, Dept Epidemiol, FIN-33101 Tampere, Finland; [Wahlfors, Tlina; Schleutker, Johanna] Univ Tampere, BioMediTech, Tampere, Finland; [Wahlfors, Tlina; Schleutker, Johanna] Univ Tampere, FimLab Labs, Tampere, Finland; [Schleutker, Johanna] Univ Turku, Inst Biomed, Dept Biochem Med, Turku, Finland; [Visakorpi, Tapio; Leinonen, Katri A.] Univ Tampere, BioMediTech, Inst Biomed Technol, Tampere, Finland; [Visakorpi, Tapio; Leinonen, Katri A.] Tampere Univ Hosp, Tampere, Finland; [Xu, Jianfeng; Zheng, S. Lilly] Wake Forest Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Aly, Markus; Gronberg, Henrik; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aly, Markus] Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Donovan, Jenny] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Travis, Ruth C.; Key, Tim J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Takahashi, Atsushi] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Pharoah, Paul; Pashayan, Nora] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Weischer, Maren; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Fac Hlth & Med Sci, Herlev, Denmark; [Klarskov, Peter] Copenhagen Univ Hosp, Herlev Hosp, Dept Urol, Herlev, Denmark; [Roder, Martin Andreas; Iversen, Peter] Copenhagen Univ Hosp, Rigshosp, Copenhagen Prostate Canc Ctr, Dept Urol, Copenhagen, Denmark; [Thibodeau, Stephen N.; McDonnell, Shannon K.; Schaid, Daniel J.] Mayo Clin, Rochester, MN USA; [Stanford, Janet L.; Kolb, Suzanne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Holt, Sarah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Knudsen, Beatrice] Cedars Sinai, Translat Pathol, Los Angeles, CA USA; [Coll, Antonio Hurtado] Prostate Ctr, Vancouver, BC, Canada; [Gapstur, Susan M.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Maier, Christiane; Luedeke, Manuel] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Herkommer, Kathleen] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-80290 Munich, Germany; [Rinckleb, Antje E.; Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Pettaway, Curtis] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Univ Ghana, Sch Med, Accra, Ghana; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Korle Bu Teaching Hosp, Accra, Ghana; [Truelove, Ann; Niwa, Shelley] Westat Corp, Rockville, MD USA; [Choklcalingam, Anand P.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Cannon-Albright, Lisa] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa] Vet Affairs Med Ctr, George E Wahlen Dept, Salt Lake City, UT 84148 USA; [Cybulski, Cezary; Wokolorczyk, Dominika; Kluzniak, Wojciech] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Park, Jong; Sellers, Thomas] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Lin, Hui-Yi] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Isaacs, William B.; Partin, Alan W.] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Consortium, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Giovannucci, Edward L.; Stampfer, Meir; Penney, Kathryn L.; Mucci, Lorelei; Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ma, Jing; Stampfer, Meir; Penney, Kathryn L.; Mucci, Lorelei; Signorello, Lisa B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Cancer Prevent Inst Calif, Fremont, CA USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Murphy, Adam B.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Pandha, Hardev; Michael, Agnieszka; Kierzek, Andrzej M.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Blot, William; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37235 USA; [Albanes, Demetrius; Weinstein, Stephanie] US Natl Inst Hlth, Natl Canc Inst, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, Bethesda, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Nemesure, Barbara; Leske, Cristina; Wu, Suh-Yuh; Hennis, Anselm] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Hennis, Anselm] Translat Genom Res Inst, Phoenix, AZ USA; [Kibel, Adam S.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Rybicki, Benjamin A.; Neslund-Dudas, Christine] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Urol Surg, Boston, MA 02115 USA; [Goodman, Phyllis J.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Klein, Eric A.] Fred Hutchinson Canc Res Ctr, Ctr Stat, Southwest Oncol Grp, Seattle, WA 98104 USA; [Batra, Jyotsna; Clements, Judith] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44106 USA; [Spurdle, Amanda] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia; [Teixeira, Manuel R.; Paulo, Paula; Maia, Sofia] Queensland Univ Technol, Sch Biomed Sci, Translat Res Inst, Brisbane, Qld 4001, Australia; [Teixeira, Manuel R.] QIMR Berghofer Med Res Inst, Mol Canc Epidemiol Lab, Brisbane, Qld, Australia; [Slavov, Chavdar] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Kaneva, Radka; Mitev, Vanio] Univ Porto, Biomed Sci Inst, Oporto, Portugal; [Witte, John S.] Med Univ Sofia, Dept Urol, Sofia, Bulgaria; [Witte, John S.] Med Univ Sofia, Mol Med Ctr, Dept Med Chem & Biochem, Sofia, Bulgaria; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gillanders, Elizabeth M.; Seminara, Daniella] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Li, Qiyuan; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Muir, Kenneth] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Nea, David E.] Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge, England; [Nea, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Southey, Melissa] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Severi, Gianluca] Human Genet Fdn, Turin, Italy; [Nakagawa, Hidewaki] RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England		Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	rosalind.eeles@icr.ac.uk; haiman@usc.edu	Auvinen, Anssi/AAL-2111-2020; Kaneva, Radka/AAT-5322-2021; Weinstein, Stephanie J/P-1627-2017; Machiela, Mitchell J/H-7335-2019; Brenner, Hermann/B-4627-2017; Paulo, Paula/F-1441-2016; Albanes, Demetrius/B-9749-2015; Teixeira, Manuel/E-4885-2011; Auvinen, Anssi/AAD-9311-2020; Roder, M. Andreas/H-7701-2019; Cook, Michael B/A-5641-2009; Diver, Ryan/AAG-3469-2019; Schumacher, Fredrick/R-6043-2019; Kaneva, Radka P/V-6535-2017; Khaw, Kay-Tee/AAZ-3209-2021; Pharoah, Paul/V-6658-2019; Batra, Jyotsna/B-4130-2011; Severi, Gianluca/H-3774-2018; Spurdle, Amanda B/A-4978-2011; Zheng, Wei/O-3351-2013; Yeager, Meredith/AAA-5322-2020; Coetzee, Gerhard/AAG-8439-2019; Berndt, Sonja I/J-8423-2016; Wang, Zhaoming/R-5527-2018; Kubo, Michiaki/N-7947-2015; coetzee, Gerhard/AAT-6203-2020; Rybicki, Benjamin/L-4614-2019; Brenner, Hermann/ABE-6383-2020; Severi, Gianluca/Q-1824-2019; Wahlfors, Tiina/U-7635-2018	Auvinen, Anssi/0000-0003-1125-4818; Weinstein, Stephanie J/0000-0002-3834-1535; Machiela, Mitchell J/0000-0001-6538-9705; Brenner, Hermann/0000-0002-6129-1572; Paulo, Paula/0000-0001-8387-2127; Teixeira, Manuel/0000-0002-4896-5982; Roder, M. Andreas/0000-0002-0019-5333; Cook, Michael B/0000-0002-0533-7302; Diver, Ryan/0000-0002-5418-9000; Schumacher, Fredrick/0000-0002-3073-7463; Kaneva, Radka P/0000-0002-1437-1393; Pharoah, Paul/0000-0001-8494-732X; Severi, Gianluca/0000-0001-7157-419X; Spurdle, Amanda B/0000-0003-1337-7897; Zheng, Wei/0000-0003-1226-070X; Wang, Zhaoming/0000-0001-7556-3869; Rybicki, Benjamin/0000-0003-3190-3467; Brenner, Hermann/0000-0002-6129-1572; Severi, Gianluca/0000-0001-7157-419X; Aly, Markus/0000-0002-7602-9198; Hazelett, Dennis/0000-0003-0749-9935; Coetzee, Gerhard/0000-0001-8820-8364; Leongamornlert, Daniel/0000-0002-3486-3168; Michael, Agnieszka/0000-0002-7262-6227; Siddiq, Afshan/0000-0002-9110-1434; Saunders, Ed/0000-0003-4343-3570; albright, lisa/0000-0003-2602-3668; Pashayan, Nora/0000-0003-0843-2468; McDonnell, Shannon/0000-0001-6201-369X; Clements, Judith/0000-0001-6026-1964; Wahlfors, Tiina/0000-0002-3910-796X; Hamdy, Freddie/0000-0003-2627-2154; batra, Jyotsna/0000-0003-4646-6247; Southey, Melissa/0000-0002-6313-9005; Eeles, Rosalind/0000-0002-3698-6241; Mitev, Vanyo/0000-0001-7528-590X; Lin, Hui-Yi/0000-0002-3307-5549; Adjei, Andrew Anthony/0000-0001-5109-2919; Schleutker, Johanna/0000-0002-1863-0305; Kierzek, Andrzej/0000-0002-2605-9057; Riboli, Elio/0000-0001-6795-6080; Visakorpi, Tapio/0000-0002-5004-0364; Giles, Graham/0000-0003-4946-9099; Canzian, Federico/0000-0002-4261-4583	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U19CA148065, R01CA092447, R01CA056678, U01CA089600, UG1CA189974, R37CA054281, U01CA098233, P30CA068485, RC2CA148085, R01CA136924, UM1CA182883, ZIACP010180, R01CA084979, U01CA063464, R01CA128813, R01CA128978, R01CA068578, U19CA148112, U01CA098710, U01CA136792, R01CA088164, R01CA092579, U01CA098758, P50CA140388, P30CA042014, U19CA148537, R01CA082664, P30CA076292, U01CA127298, U01CA098216, U10CA037429, R01CA072818] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01HG004446, U01HG004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES011126, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM099568, S06GM008016] Funding Source: NIH RePORTER; Cancer Research UKCancer Research UK [17528, 16563, 15007, 16491, 16561] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10114, NF-SI-0509-10242] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; Cancer Research UKCancer Research UK [14136, 11022, 10124, 10118, 13065] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0401527, G1000143, G0900871] Funding Source: Medline; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01 CA098233, U19 CA148537, R01 CA072818, R01 CA056678, U01 CA098216, U01 CA089600, R01 CA092447, UG1 CA189974, U01 CA127298, U01 CA063464, P30 CA068485, R01 CA128813, R01 CA088164, U19 CA148065, R01 CA092579, U01 CA136792, UM1 CA182883, R37 CA054281, U01 CA098710, P30 CA042014, U10 CA037429, R01 CA068578, R01 CA128978, P30 CA076292, R01 CA082664, P50 CA140388, R01 CA136924, R01 CA084979, RC2 CA148085, U01 CA098758, U19 CA148112] Funding Source: Medline; NHGRI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [U01 HG004446, U01 HG004726] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01 ES011126, P30 ES007784] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01 GM099568, S06 GM008016] Funding Source: Medline; Prostate Cancer UK [G2011/36, G2012/48] Funding Source: Medline; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [221S0001] Funding Source: KAKEN; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0900871] Funding Source: UKRI		Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Cook MB, 2014, HUM GENET, V133, P509, DOI 10.1007/s00439-013-1387-z; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Loikkanen I, 2009, ONCOL REP, V22, P991, DOI 10.3892/or_00000526; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morris DS, 2008, BJU INT, V102, P276, DOI 10.1111/j.1464-410X.2008.07665.x; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408	29	298	301	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1103	1109		10.1038/ng.3094			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	WOS:000342554100013	25217961	Green Submitted, Green Accepted, Green Published			2022-01-24	
J	Harbour, JW; Roberson, EDO; Anbunathan, H; Onken, MD; Worley, LA; Bowcock, AM				Harbour, J. William; Roberson, Elisha D. O.; Anbunathan, Hima; Onken, Michael D.; Worley, Lori A.; Bowcock, Anne M.			Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma	NATURE GENETICS			English	Article							GENES; GNAQ	Uveal melanoma is the most common primary cancer of the eye and often results in fatal metastasis. Here, we describe mutations occurring exclusively at codon 625 of the SF3B1 gene, encoding splicing factor 3B subunit 1, in low-grade uveal melanomas with good prognosis. Thus, uveal melanoma is among a small group of cancers associated with SF3B1 mutations, and these mutations denote a distinct molecular subset of uveal melanomas.	[Harbour, J. William; Onken, Michael D.; Worley, Lori A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Roberson, Elisha D. O.; Anbunathan, Hima; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA		Harbour, JW (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jwharbour@med.miami.edu; bowcock@genetics.wustl.edu	Harbour, J. William/B-1448-2015; Onken, Michael D/H-5620-2013; Anbunathan, Hima/AAU-9360-2021; Roberson, Elisha D.O./J-1747-2012; Roberson, Elisha/ABC-1810-2020	Harbour, J. William/0000-0002-1104-9809; Onken, Michael D/0000-0003-4082-1105; Anbunathan, Hima/0000-0002-8458-4845; Roberson, Elisha D.O./0000-0001-5921-2399; Roberson, Elisha/0000-0001-5921-2399; Bowcock, Anne/0000-0001-8691-9090	US National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 CA16187001, CA12597007]; Melanoma Research Alliance; Melanoma Research Foundation; Tumori Foundation; Research to Prevent Blindness, Inc.Research to Prevent Blindness (RPB); US NIH Vision Core grant [P30 EY02687c]; US NIH training grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 T32 AR007279-32]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA161870, R01CA125970] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32AR007279] Funding Source: NIH RePORTER	This work was supported by US National Institutes of Health (NIH) grants R01 CA16187001 (A.M.B. and J.W.H.) and CA12597007 (J.W.H.), the Melanoma Research Alliance (J.W.H.), the Melanoma Research Foundation (J.W.H.), the Tumori Foundation (J.W.H.), Research to Prevent Blindness, Inc. (J.W.H.) and awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc., Unrestricted grant and the US NIH Vision Core grant P30 EY02687c. E.D.O.R. was supported under US NIH training grant 5 T32 AR007279-32. We thank L. Cao for technical assistance and C. Jordan for exome capture. We thank the patients who volunteered to participate in the study in order to make this work possible. This study was approved by the Human Studies Committee at Washington University in St. Louis, and informed consent was obtained from all subjects.	An M, 2012, INT J DEV BIOL, V56, P223, DOI 10.1387/ijdb.113383ma; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Harbour JW, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00979.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Visconte V, 2012, LEUKEMIA, V26, P2447, DOI 10.1038/leu.2012.130; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	13	298	303	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					133	135		10.1038/ng.2523			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	WOS:000314333000007	23313955	Green Accepted			2022-01-24	
